source_code,source_concept_id,source_vocabulary_id,source_domain_id,source_concept_class_id,source_description,source_description_synonym,valid_start_date,decision,review_date,reviewer_name,reviewer_specialty,reviewer_comment,orcid_id,reviewer_affiliation_name,status,author_comment,change_required
GIS1000523,0,OMOP SDOH,Observation,ADI Item,% Civilian Labor Force Population Aged 16 Years And Older Who Are Unemployed,,2018-01-01,1,,,,,,,,,
GIS1001243,0,OMOP SDOH,Observation,ADI Item,% Employed Population Aged 16 Years Or Older In White-Collar Occupations,,2018-01-01,1,,,,,,,,,
GIS1001264,0,OMOP SDOH,Observation,ADI Item,% Families Below Federal Poverty Level,,2018-01-01,1,,,,,,,,,
GIS1001742,0,OMOP SDOH,Observation,ADI Item,% Households With More Than 1 Person Per Room,,2018-01-01,1,,,,,,,,,
GIS1001744,0,OMOP SDOH,Observation,ADI Item,% Households Without A Motor Vehicle,,2018-01-01,1,,,,,,,,,
GIS1001746,0,OMOP SDOH,Observation,ADI Item,% Households Without A Telephone,,2018-01-01,1,,,,,,,,,
GIS1002331,0,OMOP SDOH,Observation,ADI Item,% Occupied Housing Units Without Complete Plumbing,,2018-01-01,1,,,,,,,,,
GIS1002336,0,OMOP SDOH,Observation,ADI Item,% Owner-Occupied Housing Units,,2018-01-01,1,,,,,,,,,
GIS1002363,0,OMOP SDOH,Observation,ADI Item,% Population Aged 25 Years Or Older With At Least A High School Diploma,,2018-01-01,1,,,,,,,,,
GIS1002365,0,OMOP SDOH,Observation,ADI Item,% Population Aged 25 Years Or Older With Less Than 9 Years Of Education,,2018-01-01,1,,,,,,,,,
GIS1002367,0,OMOP SDOH,Observation,ADI Item,% Population Below 150% Of Federal Poverty Level,,2018-01-01,1,,,,,,,,,
GIS1002569,0,OMOP SDOH,Observation,ADI Item,% Single-Parent Households With Children Younger Than 18,,2018-01-01,1,,,,,,,,,
11.5.3,0,OMOP SDOH,Observation,SDG Indicator,"(a) Damage to critical infrastructure and (b) number of disruptions to basic services, attributed to disasters",,2017-03-01,1,,,,,,,,,
12.3.1,0,OMOP SDOH,Observation,SDG Indicator,(a) Food loss index and (b) food waste index,,2017-03-01,1,,,,,,,,,
12.4.2,0,OMOP SDOH,Observation,SDG Indicator,"(a) Hazardous waste generated per capita; and (b) proportion of hazardous waste treated, by type of treatment",,2017-03-01,1,,,,,,,,,
14.1.1,0,OMOP SDOH,Observation,SDG Indicator,(a) Index of coastal eutrophication; and (b) plastic debris density,,2017-03-01,1,,,,,,,,,
15.4.2,0,OMOP SDOH,Observation,SDG Indicator,(a) Mountain Green Cover Index and (b) proportion of degraded mountain land,,2017-03-01,1,,,,,,,,,
8.10.1,0,OMOP SDOH,Observation,SDG Indicator,"(a) Number of commercial bank branches per 100,000 adults and (b) number of automated teller machines (ATMs) per 100,000 adults",,2017-03-01,1,,,,,,,,,
15.9.1,0,OMOP SDOH,Observation,SDG Indicator,(a) Number of countries that have established national targets in accordance with or similar to Aichi Biodiversity Target 2 of the Strategic Plan for Biodiversity 2011?2020 in their national biodiversity strategy and action plans and the progress repor...,"(a) Number of countries that have established national targets in accordance with or similar to Aichi Biodiversity Target 2 of the Strategic Plan for Biodiversity 2011?2020 in their national biodiversity strategy and action plans and the progress reported towards these targets; and (b) integration of biodiversity into national accounting and reporting systems, defined as implementation of the System of Environmental-Economic Accounting",2017-03-01,1,,,,,,,,,
15.a.1,0,OMOP SDOH,Observation,SDG Indicator,(a) Official development assistance on conservation and sustainable use of biodiversity; and (b) revenue generated and finance mobilized from biodiversity-relevant economic instruments,,2017-03-01,1,,,,,,,,,
15.b.1,0,OMOP SDOH,Observation,SDG Indicator,(a) Official development assistance on conservation and sustainable use of biodiversity; and (b) revenue generated and finance mobilized from biodiversity-relevant economic instruments,,2017-03-01,1,,,,,,,,,
5.a.1,0,OMOP SDOH,Observation,SDG Indicator,"(a) Proportion of total agricultural population with ownership or secure rights over agricultural land, by sex; and (b) share of women among owners or rights-bearers of agricultural land, by type of tenure",,2017-03-01,1,,,,,,,,,
geoid_coi,0,OMOP SDOH,Observation,COI Item,2010 Census Tract FIPS Codes,COI:geoid_coi,2020-01-01,1,,,,,,,,,
EPAA_2NDMAX_CO_1HR,0,OMOP SDOH,Observation,AHRQ Item,2nd Highest 1-Hour Measurement Of Carbon Monoxide (CO) In The Year (PPM),AHRQ:EPAA_2NDMAX_CO_1HR,2022-01-01,1,,,,,,,,,
EPAA_2NDMAX_PM10_24HR,0,OMOP SDOH,Observation,AHRQ Item,2nd Highest 24-Hour Average Of PM10 In The Year,AHRQ:EPAA_2NDMAX_PM10_24HR,2022-01-01,1,,,,,,,,,
EPAA_2NDMAX_SO2_24HR,0,OMOP SDOH,Observation,AHRQ Item,2nd Highest 24-Hour Average Of Sulfur Dioxide (So2) In The Year,AHRQ:EPAA_2NDMAX_SO2_24HR,2022-01-01,1,,,,,,,,,
EPAA_2NDMAX_O3_1HR,0,OMOP SDOH,Observation,AHRQ Item,2nd Highest Daily Max 1-Hour Measurement Of Ozone (O3) In The Year (PPM),AHRQ:EPAA_2NDMAX_O3_1HR,2022-01-01,1,,,,,,,,,
EPAA_2NDMAX_CO_8HR,0,OMOP SDOH,Observation,AHRQ Item,2nd Highest Non-Overlapping 8-Hour Average Of Carbon Monoxide (CO) In The Year (PPM),AHRQ:EPAA_2NDMAX_CO_8HR,2022-01-01,1,,,,,,,,,
EPAA_4THMAX_O3_8HR,0,OMOP SDOH,Observation,AHRQ Item,4th Highest Daily Max 8-Hour Average Of Ozone (O3) In The Year (PPM),AHRQ:EPAA_4THMAX_O3_8HR,2022-01-01,1,,,,,,,,,
EPAA_98PR_PM25_DAILY,0,OMOP SDOH,Observation,AHRQ Item,98th Percentile Of The Daily Average Measurements In The Year Of PM2.5 (Ug/M3),AHRQ:EPAA_98PR_PM25_DAILY,2022-01-01,1,,,,,,,,,
EPAA_98PR_NO2_1HR,0,OMOP SDOH,Observation,AHRQ Item,98th Percentile Of The Daily Max 1-Hour Measurements Of Nitrogen Dioxide (No2) In The Year (Ppb),AHRQ:EPAA_98PR_NO2_1HR,2022-01-01,1,,,,,,,,,
EPAA_99PR_SO2_1HR,0,OMOP SDOH,Observation,AHRQ Item,99th Percentile Of The Daily Max 1-Hour Measurements Of Sulfur Dioxide (So2) In The Year,AHRQ:EPAA_99PR_SO2_1HR,2022-01-01,1,,,,,,,,,
E_WLKIND,0,OMOP SDOH,Observation,EJI EBM Item,A Nationwide Geographic Data Resource That Ranks Block Groups According To Their Relative Walkability,EJI:E_WLKIND,2022-01-01,1,,,,,,,,,
GIS1000000,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Access To Clean Water,,2024-09-15,1,,,,,,,,,
574,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Access To Education,SDOHO:574; Access_to_Education,2022-01-01,1,,,,,,,,,
GIS1000012,0,OMOP SDOH,Geographic Feature,SDOH Determinant,Access To Electricity,,2024-09-15,1,,,,,,,,,
GIS1000013,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Access To Exercise,,2022-01-01,1,,,,,,,,,
GIS1000016,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Access To Exercise In Population,,2024-09-15,1,,,,,,,,,
GIS1000019,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Access To Financial Services,,2024-09-15,1,,,,,,,,,
GIS1000020,0,OMOP SDOH,Geographic Feature,COI Determinant,Access To Green Spaces,,2020-01-01,1,,,,,,,,,
220,0,OMOP SDOH,Healthcare Feature,SDOHO Construct,Access To Health Service,SDOHO:220; Access_to_Health_Service,2022-01-01,1,,,,,,,,,
744,0,OMOP SDOH,Healthcare Feature,SDOHO Construct,Access To Health Technology,SDOHO:744; Access_to_Health_Technology,2022-01-01,1,,,,,,,,,
47,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Access To Healthy And Nutritious Option,SDOHO:47; Access_to_Healthy_and_Nutritious_Option,2022-01-01,1,,,,,,,,,
GIS1000036,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Access To Healthy Food,,2020-01-01,1,,,,,,,,,
GIS1000039,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Access To Information,,2024-09-15,1,,,,,,,,,
GIS1000040,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Access To Public Transport,,2024-09-15,1,,,,,,,,,
Goal 5,0,OMOP SDOH,Observation,SDG Goal,Achieve gender equality and empower all women and girls,,2017-03-01,1,,,,,,,,,
8.2,0,OMOP SDOH,Observation,SDG Goal,"Achieve higher levels of economic productivity through diversification, technological upgrading and innovation, including through a focus on high-value added and labour-intensive sectors",,2017-03-01,1,,,,,,,,,
3.8,0,OMOP SDOH,Observation,SDG Goal,"Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all",,2017-03-01,1,,,,,,,,,
17.3.1,0,OMOP SDOH,Observation,SDG Indicator,Additional financial resources mobilized for developing countries from multiple sources,,2017-03-01,1,,,,,,,,,
175,0,OMOP SDOH,Geographic Feature,SDOHO Item,Address,SDOHO:175; Address,2022-01-01,1,,,,,,,,,
106,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Adherence,SDOHO:106; Adherence,2022-01-01,1,,,,,,,,,
GIS1000041,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County,,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_1,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 1 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_1,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_10,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 10 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_10,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_11,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 11 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_11,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_12,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 12 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_12,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_13,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 13 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_13,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_14,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 14 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_14,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_2,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 2 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_2,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_3,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 3 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_3,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_4,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 4 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_4,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_5,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 5 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_5,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_6,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 6 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_6,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_7,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 7 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_7,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_8,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 8 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_8,2022-01-01,1,,,,,,,,,
CAF_ADJ_COUNTY_9,0,OMOP SDOH,Geographic Feature,AHRQ Item,Adjacent County 9 FIPS Code (State And County),AHRQ:CAF_ADJ_COUNTY_9,2022-01-01,1,,,,,,,,,
3.7.2,0,OMOP SDOH,Observation,SDG Indicator,"Adolescent birth rate (aged 10?14 years; aged 15?19 years) per 1,000 women in that age group",,2017-03-01,1,,,,,,,,,
17.5,0,OMOP SDOH,Observation,SDG Goal,Adopt and implement investment promotion regimes for least developed countries,,2017-03-01,1,,,,,,,,,
5.c,0,OMOP SDOH,Observation,SDG Goal,Adopt and strengthen sound policies and enforceable legislation for the promotion of gender equality and the empowerment of all women and girls at all levels,,2017-03-01,1,,,,,,,,,
2.c,0,OMOP SDOH,Observation,SDG Goal,"Adopt measures to ensure the proper functioning of food commodity markets and their derivatives and facilitate timely access to market information, including on food reserves, in order to help limit extreme food price volatility",,2017-03-01,1,,,,,,,,,
10.4,0,OMOP SDOH,Observation,SDG Goal,"Adopt policies, especially fiscal, wage and social protection policies, and progressively achieve greater equality",,2017-03-01,1,,,,,,,,,
GIS1000056,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Adult Educational Attainment,,2020-01-01,1,,,,,,,,,
GIS1000059,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Advanced Placement Course Enrollment,,2020-01-01,1,,,,,,,,,
81,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Adverse Childhood Experience,SDOHO:81; Adverse_Childhood_Experience,2022-01-01,1,,,,,,,,,
82,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Adverse Life Experience,SDOHO:82; Adverse_Life_Experience,2022-01-01,1,,,,,,,,,
358,0,OMOP SDOH,Demographic Feature,SDOHO Value,African American,SDOHO:358,2022-01-01,1,,,,,,,,,
522,0,OMOP SDOH,Phenotypic Feature,SDOHO Determinant,Age,SDOHO:522; Age,2022-01-01,1,,,,,,,,,
522_POP,0,OMOP SDOH,Demographic Feature,SDOH Construct,Age In Population,,2024-09-15,1,,,,,,,,,
CDCP_PULMONARY_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,"Age-Adjusted Prevalence Of Adults Aged 18 Years And Older Who Report Ever Having Been Told By A Doctor, Nurse, Or Other Health Professional That They Had Chronic Obstructive Pulmonary Disease (Copd), Emphysema, Or Chronic Bronchitis (%)",AHRQ:CDCP_PULMONARY_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_KIDNEY_DISEASE_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,"Age-Adjusted Prevalence Of Adults Aged 18 Years And Older Who Report Ever Having Been Told By A Doctor, Nurse, Or Other Health Professional That They Have Kidney Disease (%)",AHRQ:CDCP_KIDNEY_DISEASE_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_DOCTOR_VISIT_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,"Age-Adjusted Prevalence Of Adults Aged 18 Years And Older Who Report Having Been To A Doctor For A Routine Checkup (E.G., A General Physical Exam, Not An Exam For A Specific Injury, Illness, Condition) In The Previous Year (%)",AHRQ:CDCP_DOCTOR_VISIT_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_DENTIST_VISIT_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Adults Aged 18 Years And Older Who Report Having Been To The Dentist Or Dental Clinic In The Previous Year (%),AHRQ:CDCP_DENTIST_VISIT_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_CHOLES_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,"Age-Adjusted Prevalence Of Adults Aged 18 Years And Older Who Report Having Been Told By A Doctor, Nurse, Or Other Health Professional That They Had High Cholesterol (%)",AHRQ:CDCP_CHOLES_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_CHOLES_SCR_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Adults Aged 18 Years And Older Who Report Having Their Cholesterol Checked Within The Previous 5 Years (%),AHRQ:CDCP_CHOLES_SCR_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_NO_PHY_ACTV_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,"Age-Adjusted Prevalence Of Adults Aged 18 Years And Older Who Report Not Having Participated In Any Physical Activities Or Exercises Such As Running, Calisthenics, Golf, Gardening, Or Walking For Exercise Other Than Regular Job (%)",AHRQ:CDCP_NO_PHY_ACTV_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_SLEEP_LESS7HR_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Adults Aged 18 Years And Older Who Report Usually Getting Less Than 7 Hours Of Sleep (%),AHRQ:CDCP_SLEEP_LESS7HR_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_BLOOD_MED_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Adults Aged 18 Years And Older With High Blood Pressure Taking Medicine For High Blood Pressure Control (%),AHRQ:CDCP_BLOOD_MED_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_FOBT_SIG_COL_50_75_A,0,OMOP SDOH,Observation,AHRQ Item,"Age-Adjusted Prevalence Of Adults Aged 50-75 Years Who Had 1) A Fecal Occult Blood Test (Fobt) Within The Past Year, 2) A Sigmoidoscopy Within The Past 5 Years And A Fobt Within The Past Year, Or 3) A Colonoscopy Within The Past 10 Years (%)",AHRQ:CDCP_FOBT_SIG_COL_50_75_A,2022-01-01,1,,,,,,,,,
CDCP_NO_TEETH_65_ABOVE_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Adults Aged 65 Years And Older Who Report Having Lost All Of Their Natural Teeth Because Of Tooth Decay Or Gum Disease (%),AHRQ:CDCP_NO_TEETH_65_ABOVE_A,2022-01-01,1,,,,,,,,,
CDCP_ARTHRITIS_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Arthritis Among Adults Aged 18 Years And Older (%),AHRQ:CDCP_ARTHRITIS_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_ASTHMA_ADULT_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Current Asthma Among Adults Aged 18 Years And Older (%),AHRQ:CDCP_ASTHMA_ADULT_A,2022-01-01,1,,,,,,,,,
CDCP_CERVCAN_SCR_F21_65_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Females Aged 21-65 Years Without A Hysterectomy Who Report Having Had A Recommended Cervical Cancer Screening Test (%),AHRQ:CDCP_CERVCAN_SCR_F21_65_A,2022-01-01,1,,,,,,,,,
CDCP_MAMMO_SCR_F50_74_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Females Aged 50-74 Years Who Reporting Having Had A Mammogram Within The Previous 2 Years (%),AHRQ:CDCP_MAMMO_SCR_F50_74_A,2022-01-01,1,,,,,,,,,
CDCP_PREV_SERV_F65_ABOVE_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Females Aged 65 Years And Older Who Are Up To Date On A Core Set Of Clinical Preventive Services (%),AHRQ:CDCP_PREV_SERV_F65_ABOVE_A,2022-01-01,1,,,,,,,,,
CDCP_PREV_SERV_M65_ABOVE_A,0,OMOP SDOH,Observation,AHRQ Item,Age-Adjusted Prevalence Of Males Aged 65 Years And Older Who Are Up To Date On A Core Set Of Clinical Preventive Services (%),AHRQ:CDCP_PREV_SERV_M65_ABOVE_A,2022-01-01,1,,,,,,,,,
GIS1000061,0,OMOP SDOH,Demographic Feature,SDOH Determinant,Age-Related Metrics,,2024-09-15,1,,,,,,,,,
3.a.1,0,OMOP SDOH,Observation,SDG Indicator,Age-standardized prevalence of current tobacco use among persons aged 15 years and older,,2017-03-01,1,,,,,,,,,
116,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Agender,SDOHO:116; Agender,2022-01-01,1,,,,,,,,,
2.b.1,0,OMOP SDOH,Observation,SDG Indicator,Agricultural export subsidies,,2017-03-01,1,,,,,,,,,
8.a.1,0,OMOP SDOH,Observation,SDG Indicator,Aid for Trade commitments and disbursements,,2017-03-01,1,,,,,,,,,
GIS1000105,0,OMOP SDOH,Environmental Feature,SDOH Construct,Air Pollution,,2024-09-15,1,,,,,,,,,
876,0,OMOP SDOH,Environmental Feature,SDOHO Construct,Air Quality,SDOHO:876; Air_Quality,2022-01-01,1,,,,,,,,,
GIS1000107,0,OMOP SDOH,Type Concept,Exposure Type Concept,Air Quality Database,,2024-09-15,1,,,,,,,,,
GIS1000108,0,OMOP SDOH,Environmental Feature,SDOH Determinant,Air Quality Index (AQI),,2024-09-15,1,,,,,,,,,
GIS1000103,0,OMOP SDOH,Environmental Feature,COI Determinant,Airborne Microparticles,,2020-01-01,1,,,,,,,,,
3.5.2,0,OMOP SDOH,Observation,SDG Indicator,Alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol,,2017-03-01,1,,,,,,,,,
659,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Alcohol Use,SDOHO:659; Alcohol_Use,2022-01-01,1,,,,,,,,,
MMD_READM_AIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,All Cause Readmissions Per 100 American Indian Or Alaska Native Admissions,AHRQ:MMD_READM_AIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_READM_ASIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,All Cause Readmissions Per 100 Asian Or Pacific Islander Admissions,AHRQ:MMD_READM_ASIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_READM_BLACK_RATE,0,OMOP SDOH,Observation,AHRQ Item,All Cause Readmissions Per 100 Black Admissions,AHRQ:MMD_READM_BLACK_RATE,2022-01-01,1,,,,,,,,,
MMD_READM_F_RATE,0,OMOP SDOH,Observation,AHRQ Item,All Cause Readmissions Per 100 Female Admissions,AHRQ:MMD_READM_F_RATE,2022-01-01,1,,,,,,,,,
MMD_READM_HISP_RATE,0,OMOP SDOH,Observation,AHRQ Item,All Cause Readmissions Per 100 Hispanic Admissions,AHRQ:MMD_READM_HISP_RATE,2022-01-01,1,,,,,,,,,
MMD_READM_M_RATE,0,OMOP SDOH,Observation,AHRQ Item,All Cause Readmissions Per 100 Male Admissions,AHRQ:MMD_READM_M_RATE,2022-01-01,1,,,,,,,,,
MMD_READM_OTHER_RATE,0,OMOP SDOH,Observation,AHRQ Item,All Cause Readmissions Per 100 Other Race Admissions,AHRQ:MMD_READM_OTHER_RATE,2022-01-01,1,,,,,,,,,
MMD_READM_WHITE_RATE,0,OMOP SDOH,Observation,AHRQ Item,All Cause Readmissions Per 100 White Admissions,AHRQ:MMD_READM_WHITE_RATE,2022-01-01,1,,,,,,,,,
E_DSLPM,0,OMOP SDOH,Observation,EJI EBM Item,Ambient Concentrations Of Diesel PM/M3,EJI:E_DSLPM,2022-01-01,1,,,,,,,,,
SEDH:1.3,0,OMOP SDOH,Observation,SEDH Item,American Community Survey Income Inequality Measures Based On Household Income Quintiles,SEDH:1.3,2021-01-01,1,,,,,,,,,
SEDH:1.1,0,OMOP SDOH,Observation,SEDH Item,American Community Survey Income Inequality Measures Based On Income To Poverty Ratio By Census Block Group,SEDH:1.1,2021-01-01,1,,,,,,,,,
SEDH:1.2,0,OMOP SDOH,Observation,SEDH Item,"American Community Survey Income Inequality Measures Based On Income To Poverty Ratio, Census Tracts",SEDH:1.2,2021-01-01,1,,,,,,,,,
E_AIAN,0,OMOP SDOH,Observation,SVI Item,"American Indian Or Alaska Native, Not Hispanic Or Latino Persons Estimate",SVI:E_AIAN,2018-01-01,1,,,,,,,,,
M_AIAN,0,OMOP SDOH,Observation,SVI Item,"American Indian Or Alaska Native, Not Hispanic Or Latino Persons Estimate MOE",SVI:M_AIAN,2018-01-01,1,,,,,,,,,
CEN_AIAN_NH_IND,0,OMOP SDOH,Observation,AHRQ Item,American Indian/Alaska Native Areas/Hawaiian Home Land Indicator,AHRQ:CEN_AIAN_NH_IND,2022-01-01,1,,,,,,,,,
874,0,OMOP SDOH,Observation,SDOHO Item,Americans With Disabilities Act (Ada) Compliance Construction,SDOHO:874; Americans_with_Disabilities_Act_(ADA)_Compliance_Construction,2022-01-01,1,,,,,,,,,
GIS1010310,0,OMOP SDOH,Observation,GIS Measure,Amount,,2024-09-15,1,,,,,,,,,
17.17.1,0,OMOP SDOH,Observation,SDG Indicator,Amount in United States dollars committed to public-private partnerships for infrastructure,,2017-03-01,1,,,,,,,,,
12.c.1,0,OMOP SDOH,Observation,SDG Indicator,Amount of fossil-fuel subsidies (production and consumption) per unit of GDP,,2017-03-01,1,,,,,,,,,
6.a.1,0,OMOP SDOH,Observation,SDG Indicator,Amount of water- and sanitation-related official development assistance that is part of a government- coordinated spending plan,,2017-03-01,1,,,,,,,,,
13.a.1,0,OMOP SDOH,Observation,SDG Indicator,Amounts provided and mobilized in United States dollars per year in relation to the continued existing collective mobilization goal of the $100 billion commitment through to 2025,,2017-03-01,1,,,,,,,,,
GIS1000109,0,OMOP SDOH,Observation,GIS Measure,Annual Average,,2024-09-15,1,,,,,,,,,
NEPHTN_AVG_MODAAAC_PM25,0,OMOP SDOH,Observation,AHRQ Item,Annual Average Ambient Concentrations Of PM2.5 In Micrograms Per Cubic Meter (Modeled Estimates Only),AHRQ:NEPHTN_AVG_MODAAAC_PM25,2022-01-01,1,,,,,,,,,
NEPHTN_AVG_MONAAAC_PM25,0,OMOP SDOH,Observation,AHRQ Item,Annual Average Ambient Concentrations Of PM2.5 In Micrograms Per Cubic Meter (Monitored Values Only),AHRQ:NEPHTN_AVG_MONAAAC_PM25,2022-01-01,1,,,,,,,,,
LTC_AVG_DAILY_CENSUS,0,OMOP SDOH,Observation,AHRQ Item,Annual Average Daily Census Per Reporting Facility In The County,AHRQ:LTC_AVG_DAILY_CENSUS,2022-01-01,1,,,,,,,,,
717,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Annual Family Income,SDOHO:717; Annual_Family_Income,2022-01-01,1,,,,,,,,,
8.1.1,0,OMOP SDOH,Observation,SDG Indicator,Annual growth rate of real GDP per capita,,2017-03-01,1,,,,,,,,,
8.2.1,0,OMOP SDOH,Observation,SDG Indicator,Annual growth rate of real GDP per employed person,,2017-03-01,1,,,,,,,,,
E_OZONE,0,OMOP SDOH,Observation,EJI EBM Item,Annual Mean Days Above O3 Regulatory Standard - 3-Year Average,EJI:E_OZONE,2022-01-01,1,,,,,,,,,
E_PM,0,OMOP SDOH,Observation,EJI EBM Item,Annual Mean Days Above PM2.5 Regulatory Standard - 3-Year Average,EJI:E_PM,2022-01-01,1,,,,,,,,,
11.6.2,0,OMOP SDOH,Observation,SDG Indicator,Annual mean levels of fine particulate matter (e.g. PM2.5 and PM10) in cities (population weighted),,2017-03-01,1,,,,,,,,,
EPAA_MEAN_NO2_1HR,0,OMOP SDOH,Observation,AHRQ Item,Annual Mean Of All The 1-Hour Measurements Of Nitrogen Dioxide (No2) In The Year (Ppb),AHRQ:EPAA_MEAN_NO2_1HR,2022-01-01,1,,,,,,,,,
EPAA_MEAN_SO2_1HR,0,OMOP SDOH,Observation,AHRQ Item,Annual Mean Of All The 1-Hour Measurements Of Sulfur Dioxide (So2) In The Year (Ppb),AHRQ:EPAA_MEAN_SO2_1HR,2022-01-01,1,,,,,,,,,
WUSTL_AVG_PM25,0,OMOP SDOH,Observation,AHRQ Item,Annual Mean Of Particulate Matter (PM2.5) Concentration (?g/M3),AHRQ:WUSTL_AVG_PM25,2022-01-01,1,,,,,,,,,
720,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Architecture And Engineering Occupation,SDOHO:720; Architecture_and_Engineering_Occupation,2022-01-01,1,,,,,,,,,
GIS1000110,0,OMOP SDOH,Socioeconomic Feature,ADI Construct,Area Deprivation Index (ADI),,2018-01-01,1,,,,,,,,,
GIS1000111,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Arms Control,,2024-09-15,1,,,,,,,,,
727,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Arts And Design And Entertainment And Sports And Media Occupation,SDOHO:727; Arts_and_Design_and_Entertainment_and_Sports_and_Media_Occupation,2022-01-01,1,,,,,,,,,
130,0,OMOP SDOH,Demographic Feature,SDOHO Value,Asian,SDOHO:130; Asian,2022-01-01,1,,,,,,,,,
E_ASIAN,0,OMOP SDOH,Observation,SVI Item,"Asian, Not Hispanic Or Latino Persons Estimate",SVI:E_ASIAN,2018-01-01,1,,,,,,,,,
M_ASIAN,0,OMOP SDOH,Observation,SVI Item,"Asian, Not Hispanic Or Latino Persons Estimate MOE",SVI:M_ASIAN,2018-01-01,1,,,,,,,,,
17.4,0,OMOP SDOH,Observation,SDG Goal,"Assist developing countries in attaining long-term debt sustainability through coordinated policies aimed at fostering debt financing, debt relief and debt restructuring, as appropriate, and address the external debt of highly indebted poor countries t...","Assist developing countries in attaining long-term debt sustainability through coordinated policies aimed at fostering debt financing, debt relief and debt restructuring, as appropriate, and address the external debt of highly indebted poor countries to reduce debt distress",2017-03-01,1,,,,,,,,,
551,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Associate Degree,SDOHO:551; Associate_Degree,2022-01-01,1,,,,,,,,,
GIS1010315,0,OMOP SDOH,Observation,GIS Measure,Association Measures,,2024-09-15,1,,,,,,,,,
E_CROWD,0,OMOP SDOH,Observation,SVI Item,"At Household Level (Occupied Housing Units), More People Than Rooms Estimate",SVI:E_CROWD,2018-01-01,1,,,,,,,,,
M_CROWD,0,OMOP SDOH,Observation,SVI Item,"At Household Level (Occupied Housing Units), More People Than Rooms Estimate MOE",SVI:M_CROWD,2018-01-01,1,,,,,,,,,
GIS1000112,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Attainment,,2022-01-01,1,,,,,,,,,
GIS1000114,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Attainment In Population,,2024-09-15,1,,,,,,,,,
GIS1000126,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Attention-Deficit/Hyperactivity Disorder (Adhd),,2024-09-15,1,,,,,,,,,
GIS1000136,0,OMOP SDOH,Geographic Feature,SDOH Construct,Availability Of Spaces For Physical Activity,,2024-09-15,1,,,,,,,,,
LTC_AVG_ACUITY_INDEX,0,OMOP SDOH,Observation,AHRQ Item,Average Acuity Index Of The Nursing Home Residents In The County,AHRQ:LTC_AVG_ACUITY_INDEX,2022-01-01,1,,,,,,,,,
NHC_AVG_ADJ_NURSE_STAFF,0,OMOP SDOH,Observation,AHRQ Item,Average Adjusted Hours Per Day Of Total Nurse Staff (Rn+Lpn+Aide) Per Reporting Facility,AHRQ:NHC_AVG_ADJ_NURSE_STAFF,2022-01-01,1,,,,,,,,,
LTC_AVG_AGE,0,OMOP SDOH,Observation,AHRQ Item,Average Age Of Residents Present In A Nursing Home On The 1st Thursday Of April Within A County,AHRQ:LTC_AVG_AGE,2022-01-01,1,,,,,,,,,
AMFAR_AVG_DISTSSP,0,OMOP SDOH,Observation,AHRQ Item,Average Distance In Miles To A Syringe Services Program,AHRQ:AMFAR_AVG_DISTSSP,2022-01-01,1,,,,,,,,,
AMFAR_AVG_DISTMAT,0,OMOP SDOH,Observation,AHRQ Item,Average Distance In Miles To Treatment Facilities With At Least One Form Of Medication Assisted Treatment,AHRQ:AMFAR_AVG_DISTMAT,2022-01-01,1,,,,,,,,,
8.5.1,0,OMOP SDOH,Observation,SDG Indicator,"Average hourly earnings of employees, by sex, age, occupation and persons with disabilities",,2017-03-01,1,,,,,,,,,
NHC_AVG_LIC_STAFF,0,OMOP SDOH,Observation,AHRQ Item,Average Hours Per Day Of Licensed Staff (Rn+Lpn) Per Reporting Facility,AHRQ:NHC_AVG_LIC_STAFF,2022-01-01,1,,,,,,,,,
ACS_AVG_HH_SIZE,0,OMOP SDOH,Observation,AHRQ Item,Average Household Size,AHRQ:ACS_AVG_HH_SIZE,2022-01-01,1,,,,,,,,,
2.3.2,0,OMOP SDOH,Observation,SDG Indicator,"Average income of small-scale food producers, by sex and indigenous status",,2017-03-01,1,,,,,,,,,
CHR_AVG_LIFE_EXPEC,0,OMOP SDOH,Observation,AHRQ Item,Average Life Expectancy In Years,AHRQ:CHR_AVG_LIFE_EXPEC,2022-01-01,1,,,,,,,,,
14.3.1,0,OMOP SDOH,Observation,SDG Indicator,Average marine acidity (pH) measured at agreed suite of representative sampling stations,,2017-03-01,1,,,,,,,,,
FEA_SNAP_BENEFITS_PER_CAPITA,0,OMOP SDOH,Observation,AHRQ Item,Average Monthly Snap Benefits Redeemed Per Capita (Dollar),AHRQ:FEA_SNAP_BENEFITS_PER_CAPITA,2022-01-01,1,,,,,,,,,
HE_SUPRFND,0,OMOP SDOH,Observation,COI Item,"Average Number Of Superfund Sites Within A 2-Mile Radius, Converted To Natural Log Units",COI:HE_SUPRFND,2020-01-01,1,,,,,,,,,
zHE_SUPRFND,0,OMOP SDOH,Observation,COI Item,"Average Number Of Superfund Sites Within A 2-Mile Radius, Converted To Natural Log Units, Transformed To Z-Scores And Multiplied By -1",COI:zHE_SUPRFND,2020-01-01,1,,,,,,,,,
LTC_AVG_OBS_MEDIAN_LOS,0,OMOP SDOH,Observation,AHRQ Item,Average Observed Median Length Of Stay In The County,AHRQ:LTC_AVG_OBS_MEDIAN_LOS,2022-01-01,1,,,,,,,,,
LTC_AVG_PCT_PRESSURE_ULCER,0,OMOP SDOH,Observation,AHRQ Item,Average Percentage Of High-Risk Long-Stay Nursing Home Residents With Pressure Ulcers In The County,AHRQ:LTC_AVG_PCT_PRESSURE_ULCER,2022-01-01,1,,,,,,,,,
LTC_AVG_PCT_MEDICAID,0,OMOP SDOH,Observation,AHRQ Item,Average Percentage Of Nursing Home Residents In The County Whose Primary Support Is Medicaid,AHRQ:LTC_AVG_PCT_MEDICAID,2022-01-01,1,,,,,,,,,
LTC_AVG_PCT_MEDICARE,0,OMOP SDOH,Observation,AHRQ Item,Average Percentage Of Nursing Home Residents In The County Whose Primary Support Is Medicare,AHRQ:LTC_AVG_PCT_MEDICARE,2022-01-01,1,,,,,,,,,
LTC_AVG_PCT_PVT_PATIENT_DAYS,0,OMOP SDOH,Observation,AHRQ Item,Average Percentage Of Patient Days In A Calendar Year That Were Private Pay In The County,AHRQ:LTC_AVG_PCT_PVT_PATIENT_DAYS,2022-01-01,1,,,,,,,,,
LTC_PCT_RESD_BLACK,0,OMOP SDOH,Observation,AHRQ Item,Average Percentage Of Residents Present In A Nursing Home On The 1st Thursday Of April Within The County Who Are Black,AHRQ:LTC_PCT_RESD_BLACK,2022-01-01,1,,,,,,,,,
LTC_PCT_RESD_HISPANIC,0,OMOP SDOH,Observation,AHRQ Item,Average Percentage Of Residents Present In A Nursing Home On The 1st Thursday Of April Within The County Who Are Hispanic,AHRQ:LTC_PCT_RESD_HISPANIC,2022-01-01,1,,,,,,,,,
LTC_PCT_RESD_WHITE,0,OMOP SDOH,Observation,AHRQ Item,Average Percentage Of Residents Present In A Nursing Home On The 1st Thursday Of April Within The County Who Are White,AHRQ:LTC_PCT_RESD_WHITE,2022-01-01,1,,,,,,,,,
LTC_AVG_OBS_REHOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,Average Rehospitalization Rate In The County,AHRQ:LTC_AVG_OBS_REHOSP_RATE,2022-01-01,1,,,,,,,,,
NHC_AVG_REP_NURSE_STAFF,0,OMOP SDOH,Observation,AHRQ Item,Average Reported Hours Per Day Of Total Nurse Staff (Rn+Lpn+Aide) Per Reporting Facility,AHRQ:NHC_AVG_REP_NURSE_STAFF,2022-01-01,1,,,,,,,,,
GIS1000138,0,OMOP SDOH,Observation,GIS Measure,Average Score,,2024-09-15,1,,,,,,,,,
11.7.1,0,OMOP SDOH,Observation,SDG Indicator,"Average share of the built-up area of cities that is open space for public use for all, by sex, age and persons with disabilities",,2017-03-01,1,,,,,,,,,
LTC_AVG_OBS_SUCCESSFUL_DISC_RATE,0,OMOP SDOH,Observation,AHRQ Item,Average Successful Discharge Rate In The County,AHRQ:LTC_AVG_OBS_SUCCESSFUL_DISC_RATE,2022-01-01,1,,,,,,,,,
548,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Bachelor'S Degree,SDOHO:548; Bachelor's_Degree,2022-01-01,1,,,,,,,,,
650,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Behavior Cessation,SDOHO:650; Behavior_Cessation,2022-01-01,1,,,,,,,,,
63,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Behavior Change,SDOHO:63; Behavior_Change,2022-01-01,1,,,,,,,,,
652,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Behavior Growth,SDOHO:652; Behavior_Growth,2022-01-01,1,,,,,,,,,
651,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Behavior Reduction,SDOHO:651; Behavior_Reduction,2022-01-01,1,,,,,,,,,
GIS1000139,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Behavioral And Emotional Disorders In Childhood,,2024-09-15,1,,,,,,,,,
70,0,OMOP SDOH,Phenotypic Feature,SDOHO Determinant,Biological Sex,SDOHO:70; Biological_Sex,2022-01-01,1,,,,,,,,,
GIS1000205,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Bipolar Disorder,,2024-09-15,1,,,,,,,,,
GIS1000211,0,OMOP SDOH,Demographic Feature,SDOH Construct,Birth Registration,,2024-09-15,1,,,,,,,,,
857,0,OMOP SDOH,Phenotypic Feature,SDOHO Value,Bisexuality,SDOHO:857; Bisexuality,2022-01-01,1,,,,,,,,,
356,0,OMOP SDOH,Demographic Feature,SDOHO Value,Black,SDOHO:356,2022-01-01,1,,,,,,,,,
125,0,OMOP SDOH,Demographic Feature,SDOHO Value,Black Or African American,SDOHO:125; Black_or_African_American,2022-01-01,1,,,,,,,,,
E_AFAM,0,OMOP SDOH,Observation,SVI Item,"Black/African American, Not Hispanic Or Latino Persons Estimate",SVI:E_AFAM,2018-01-01,1,,,,,,,,,
M_AFAM,0,OMOP SDOH,Observation,SVI Item,"Black/African American, Not Hispanic Or Latino Persons Estimate MOE",SVI:M_AFAM,2018-01-01,1,,,,,,,,,
SEDH:1.18,0,OMOP SDOH,Observation,SEDH Item,"Block Group Area Deprivation Index Dataset For Washington, DC",SEDH:1.18,2021-01-01,1,,,,,,,,,
16.8,0,OMOP SDOH,Observation,SDG Goal,Broaden and strengthen the participation of developing countries in the institutions of global governance,,2017-03-01,1,,,,,,,,,
4.a,0,OMOP SDOH,Observation,SDG Goal,"Build and upgrade education facilities that are child, disability and gender sensitive and provide safe, non-violent, inclusive and effective learning environments for all",,2017-03-01,1,,,,,,,,,
Goal 9,0,OMOP SDOH,Observation,SDG Goal,"Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation",,2017-03-01,1,,,,,,,,,
687,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Building And Ground Cleaning And Maintenance Occupation,SDOHO:687; Building_and_Ground_Cleaning_and_Maintenance_Occupation,2022-01-01,1,,,,,,,,,
455,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Business And Financial Operation Occupation,SDOHO:455; Business_and_Financial_Operation_Occupation,2022-01-01,1,,,,,,,,,
12.4,0,OMOP SDOH,Observation,SDG Goal,"By 2020, achieve the environmentally sound management of chemicals and all wastes throughout their life cycle, in accordance with agreed international frameworks, and significantly reduce their release to air, water and soil in order to minimize their...","By 2020, achieve the environmentally sound management of chemicals and all wastes throughout their life cycle, in accordance with agreed international frameworks, and significantly reduce their release to air, water and soil in order to minimize their adverse impacts on human health and the environment",2017-03-01,1,,,,,,,,,
14.5,0,OMOP SDOH,Observation,SDG Goal,"By 2020, conserve at least 10 per cent of coastal and marine areas, consistent with national and international law and based on the best available scientific information",,2017-03-01,1,,,,,,,,,
8.b,0,OMOP SDOH,Observation,SDG Goal,"By 2020, develop and operationalize a global strategy for youth employment and implement the Global Jobs Pact of the International Labour Organization",,2017-03-01,1,,,,,,,,,
14.4,0,OMOP SDOH,Observation,SDG Goal,"By 2020, effectively regulate harvesting and end overfishing, illegal, unreported and unregulated fishing and destructive fishing practices and implement science-based management plans, in order to restore fish stocks in the shortest time feasible, at...","By 2020, effectively regulate harvesting and end overfishing, illegal, unreported and unregulated fishing and destructive fishing practices and implement science-based management plans, in order to restore fish stocks in the shortest time feasible, at least to levels that can produce maximum sustainable yield as determined by their biological characteristics",2017-03-01,1,,,,,,,,,
17.18,0,OMOP SDOH,Observation,SDG Goal,"By 2020, enhance capacity-building support to developing countries, including for least developed countries and small island developing States, to increase significantly the availability of high-quality, timely and reliable data disaggregated by income...","By 2020, enhance capacity-building support to developing countries, including for least developed countries and small island developing States, to increase significantly the availability of high-quality, timely and reliable data disaggregated by income, gender, age, race, ethnicity, migratory status, disability, geographic location and other characteristics relevant in national contexts",2017-03-01,1,,,,,,,,,
15.1,0,OMOP SDOH,Observation,SDG Goal,"By 2020, ensure the conservation, restoration and sustainable use of terrestrial and inland freshwater ecosystems and their services, in particular forests, wetlands, mountains and drylands, in line with obligations under international agreements",,2017-03-01,1,,,,,,,,,
3.6,0,OMOP SDOH,Observation,SDG Goal,"By 2020, halve the number of global deaths and injuries from road traffic accidents",,2017-03-01,1,,,,,,,,,
15.9,0,OMOP SDOH,Observation,SDG Goal,"By 2020, integrate ecosystem and biodiversity values into national and local planning, development processes, poverty reduction strategies and accounts",,2017-03-01,1,,,,,,,,,
15.8,0,OMOP SDOH,Observation,SDG Goal,"By 2020, introduce measures to prevent the introduction and significantly reduce the impact of invasive alien species on land and water ecosystems and control or eradicate the priority species",,2017-03-01,1,,,,,,,,,
2.5,0,OMOP SDOH,Observation,SDG Goal,"By 2020, maintain the genetic diversity of seeds, cultivated plants and farmed and domesticated animals and their related wild species, including through soundly managed and diversified seed and plant banks at the national, regional and international l...","By 2020, maintain the genetic diversity of seeds, cultivated plants and farmed and domesticated animals and their related wild species, including through soundly managed and diversified seed and plant banks at the national, regional and international levels, and promote access to and fair and equitable sharing of benefits arising from the utilization of genetic resources and associated traditional knowledge, as internationally agreed",2017-03-01,1,,,,,,,,,
14.6,0,OMOP SDOH,Observation,SDG Goal,"By 2020, prohibit certain forms of fisheries subsidies which contribute to overcapacity and overfishing, eliminate subsidies that contribute to illegal, unreported and unregulated fishing and refrain from introducing new such subsidies, recognizing tha...","By 2020, prohibit certain forms of fisheries subsidies which contribute to overcapacity and overfishing, eliminate subsidies that contribute to illegal, unreported and unregulated fishing and refrain from introducing new such subsidies, recognizing that appropriate and effective special and differential treatment for developing and least developed countries should be an integral part of the World Trade Organization fisheries subsidies negotiation4",2017-03-01,1,,,,,,,,,
15.2,0,OMOP SDOH,Observation,SDG Goal,"By 2020, promote the implementation of sustainable management of all types of forests, halt deforestation, restore degraded forests and substantially increase afforestation and reforestation globally",,2017-03-01,1,,,,,,,,,
6.6,0,OMOP SDOH,Observation,SDG Goal,"By 2020, protect and restore water-related ecosystems, including mountains, forests, wetlands, rivers, aquifers and lakes",,2017-03-01,1,,,,,,,,,
4.b,0,OMOP SDOH,Observation,SDG Goal,"By 2020, substantially expand globally the number of scholarships available to developing countries, in particular least developed countries, small island developing States and African countries, for enrolment in higher education, including vocational...","By 2020, substantially expand globally the number of scholarships available to developing countries, in particular least developed countries, small island developing States and African countries, for enrolment in higher education, including vocational training and information and communications technology, technical, engineering and scientific programmes, in developed countries and other developing countries",2017-03-01,1,,,,,,,,,
11.b,0,OMOP SDOH,Observation,SDG Goal,"By 2020, substantially increase the number of cities and human settlements adopting and implementing integrated policies and plans towards inclusion, resource efficiency, mitigation and adaptation to climate change, resilience to disasters, and develop...","By 2020, substantially increase the number of cities and human settlements adopting and implementing integrated policies and plans towards inclusion, resource efficiency, mitigation and adaptation to climate change, resilience to disasters, and develop and implement, in line with the Sendai Framework for Disaster Risk Reduction 2015?2030, holistic disaster risk management at all levels",2017-03-01,1,,,,,,,,,
8.6,0,OMOP SDOH,Observation,SDG Goal,"By 2020, substantially reduce the proportion of youth not in employment, education or training",,2017-03-01,1,,,,,,,,,
14.2,0,OMOP SDOH,Observation,SDG Goal,"By 2020, sustainably manage and protect marine and coastal ecosystems to avoid significant adverse impacts, including by strengthening their resilience, and take action for their restoration in order to achieve healthy and productive oceans",,2017-03-01,1,,,,,,,,,
14.1,0,OMOP SDOH,Observation,SDG Goal,"By 2025, prevent and significantly reduce marine pollution of all kinds, in particular from land-based activities, including marine debris and nutrient pollution",,2017-03-01,1,,,,,,,,,
6.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, achieve access to adequate and equitable sanitation and hygiene for all and end open defecation, paying special attention to the needs of women and girls and those in vulnerable situations",,2017-03-01,1,,,,,,,,,
8.5,0,OMOP SDOH,Observation,SDG Goal,"By 2030, achieve full and productive employment and decent work for all women and men, including for young people and persons with disabilities, and equal pay for work of equal value",,2017-03-01,1,,,,,,,,,
12.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, achieve the sustainable management and efficient use of natural resources",,2017-03-01,1,,,,,,,,,
6.1,0,OMOP SDOH,Observation,SDG Goal,"By 2030, achieve universal and equitable access to safe and affordable drinking water for all",,2017-03-01,1,,,,,,,,,
17.19,0,OMOP SDOH,Observation,SDG Goal,"By 2030, build on existing initiatives to develop measurements of progress on sustainable development that complement gross domestic product, and support statistical capacity-building in developing countries",,2017-03-01,1,,,,,,,,,
1.5,0,OMOP SDOH,Observation,SDG Goal,"By 2030, build the resilience of the poor and those in vulnerable situations and reduce their exposure and vulnerability to climate-related extreme events and other economic, social and environmental shocks and disasters",,2017-03-01,1,,,,,,,,,
15.3,0,OMOP SDOH,Observation,SDG Goal,"By 2030, combat desertification, restore degraded land and soil, including land affected by desertification, drought and floods, and strive to achieve a land degradation- neutral world",,2017-03-01,1,,,,,,,,,
8.9,0,OMOP SDOH,Observation,SDG Goal,"By 2030, devise and implement policies to promote sustainable tourism that creates jobs and promotes local culture and products",,2017-03-01,1,,,,,,,,,
2.3,0,OMOP SDOH,Observation,SDG Goal,"By 2030, double the agricultural productivity and incomes of small-scale food producers, in particular women, indigenous peoples, family farmers, pastoralists and fishers, including through secure and equal access to land, other productive resources an...","By 2030, double the agricultural productivity and incomes of small-scale food producers, in particular women, indigenous peoples, family farmers, pastoralists and fishers, including through secure and equal access to land, other productive resources and inputs, knowledge, financial services, markets and opportunities for value addition and non-farm employment",2017-03-01,1,,,,,,,,,
7.3,0,OMOP SDOH,Observation,SDG Goal,"By 2030, double the global rate of improvement in energy efficiency",,2017-03-01,1,,,,,,,,,
4.5,0,OMOP SDOH,Observation,SDG Goal,"By 2030, eliminate gender disparities in education and ensure equal access to all levels of education and vocational training for the vulnerable, including persons with disabilities, indigenous peoples and children in vulnerable situations",,2017-03-01,1,,,,,,,,,
10.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, empower and promote the social, economic and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion or economic or other status",,2017-03-01,1,,,,,,,,,
2.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, end all forms of malnutrition, including achieving, by 2025, the internationally agreed targets on stunting and wasting in children under 5 years of age, and address the nutritional needs of adolescent girls, pregnant and lactating women and o...","By 2030, end all forms of malnutrition, including achieving, by 2025, the internationally agreed targets on stunting and wasting in children under 5 years of age, and address the nutritional needs of adolescent girls, pregnant and lactating women and older persons",2017-03-01,1,,,,,,,,,
2.1,0,OMOP SDOH,Observation,SDG Goal,"By 2030, end hunger and ensure access by all people, in particular the poor and people in vulnerable situations, including infants, to safe, nutritious and sufficient food all year round",,2017-03-01,1,,,,,,,,,
3.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births",,2017-03-01,1,,,,,,,,,
3.3,0,OMOP SDOH,Observation,SDG Goal,"By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases",,2017-03-01,1,,,,,,,,,
11.3,0,OMOP SDOH,Observation,SDG Goal,"By 2030, enhance inclusive and sustainable urbanization and capacity for participatory, integrated and sustainable human settlement planning and management in all countries",,2017-03-01,1,,,,,,,,,
7.a,0,OMOP SDOH,Observation,SDG Goal,"By 2030, enhance international cooperation to facilitate access to clean energy research and technology, including renewable energy, energy efficiency and advanced and cleaner fossil-fuel technology, and promote investment in energy infrastructure and...","By 2030, enhance international cooperation to facilitate access to clean energy research and technology, including renewable energy, energy efficiency and advanced and cleaner fossil-fuel technology, and promote investment in energy infrastructure and clean energy technology",2017-03-01,1,,,,,,,,,
11.1,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure access for all to adequate, safe and affordable housing and basic services and upgrade slums",,2017-03-01,1,,,,,,,,,
4.3,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure equal access for all women and men to affordable and quality technical, vocational and tertiary education, including university",,2017-03-01,1,,,,,,,,,
2.4,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure sustainable food production systems and implement resilient agricultural practices that increase productivity and production, that help maintain ecosystems, that strengthen capacity for adaptation to climate change, extreme weather, dro...","By 2030, ensure sustainable food production systems and implement resilient agricultural practices that increase productivity and production, that help maintain ecosystems, that strengthen capacity for adaptation to climate change, extreme weather, drought, flooding and other disasters and that progressively improve land and soil quality",2017-03-01,1,,,,,,,,,
4.1,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure that all girls and boys complete free, equitable and quality primary and secondary education leading to relevant and effective learning outcomes",,2017-03-01,1,,,,,,,,,
4.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure that all girls and boys have access to quality early childhood development, care and pre-primary education so that they are ready for primary education",,2017-03-01,1,,,,,,,,,
4.7,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure that all learners acquire the knowledge and skills needed to promote sustainable development, including, among others, through education for sustainable development and sustainable lifestyles, human rights, gender equality, promotion of...","By 2030, ensure that all learners acquire the knowledge and skills needed to promote sustainable development, including, among others, through education for sustainable development and sustainable lifestyles, human rights, gender equality, promotion of a culture of peace and non-violence, global citizenship and appreciation of cultural diversity and of culture?s contribution to sustainable development",2017-03-01,1,,,,,,,,,
1.4,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure that all men and women, in particular the poor and the vulnerable, have equal rights to economic resources, as well as access to basic services, ownership and control over land and other forms of property, inheritance, natural resources...","By 2030, ensure that all men and women, in particular the poor and the vulnerable, have equal rights to economic resources, as well as access to basic services, ownership and control over land and other forms of property, inheritance, natural resources, appropriate new technology and financial services, including microfinance",2017-03-01,1,,,,,,,,,
4.6,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure that all youth and a substantial proportion of adults, both men and women, achieve literacy and numeracy",,2017-03-01,1,,,,,,,,,
12.8,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure that people everywhere have the relevant information and awareness for sustainable development and lifestyles in harmony with nature",,2017-03-01,1,,,,,,,,,
15.4,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure the conservation of mountain ecosystems, including their biodiversity, in order to enhance their capacity to provide benefits that are essential for sustainable development",,2017-03-01,1,,,,,,,,,
7.1,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure universal access to affordable, reliable and modern energy services",,2017-03-01,1,,,,,,,,,
3.7,0,OMOP SDOH,Observation,SDG Goal,"By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes",,2017-03-01,1,,,,,,,,,
1.1,0,OMOP SDOH,Observation,SDG Goal,"By 2030, eradicate extreme poverty for all people everywhere, currently measured as people living on less than $1.25 a day",,2017-03-01,1,,,,,,,,,
7.b,0,OMOP SDOH,Observation,SDG Goal,"By 2030, expand infrastructure and upgrade technology for supplying modern and sustainable energy services for all in developing countries, in particular least developed countries, small island developing States and landlocked developing countries, in...","By 2030, expand infrastructure and upgrade technology for supplying modern and sustainable energy services for all in developing countries, in particular least developed countries, small island developing States and landlocked developing countries, in accordance with their respective programmes of support",2017-03-01,1,,,,,,,,,
6.a,0,OMOP SDOH,Observation,SDG Goal,"By 2030, expand international cooperation and capacity-building support to developing countries in water- and sanitation-related activities and programmes, including water harvesting, desalination, water efficiency, wastewater treatment, recycling and...","By 2030, expand international cooperation and capacity-building support to developing countries in water- and sanitation-related activities and programmes, including water harvesting, desalination, water efficiency, wastewater treatment, recycling and reuse technologies",2017-03-01,1,,,,,,,,,
12.3,0,OMOP SDOH,Observation,SDG Goal,"By 2030, halve per capita global food waste at the retail and consumer levels and reduce food losses along production and supply chains, including post-harvest losses",,2017-03-01,1,,,,,,,,,
6.5,0,OMOP SDOH,Observation,SDG Goal,"By 2030, implement integrated water resources management at all levels, including through transboundary cooperation as appropriate",,2017-03-01,1,,,,,,,,,
6.3,0,OMOP SDOH,Observation,SDG Goal,"By 2030, improve water quality by reducing pollution, eliminating dumping and minimizing release of hazardous chemicals and materials, halving the proportion of untreated wastewater and substantially increasing recycling and safe reuse globally",,2017-03-01,1,,,,,,,,,
7.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, increase substantially the share of renewable energy in the global energy mix",,2017-03-01,1,,,,,,,,,
14.7,0,OMOP SDOH,Observation,SDG Goal,"By 2030, increase the economic benefits to small island developing States and least developed countries from the sustainable use of marine resources, including through sustainable management of fisheries, aquaculture and tourism",,2017-03-01,1,,,,,,,,,
10.1,0,OMOP SDOH,Observation,SDG Goal,"By 2030, progressively achieve and sustain income growth of the bottom 40 per cent of the population at a rate higher than the national average",,2017-03-01,1,,,,,,,,,
11.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, provide access to safe, affordable, accessible and sustainable transport systems for all, improving road safety, notably by expanding public transport, with special attention to the needs of those in vulnerable situations, women, children, per...","By 2030, provide access to safe, affordable, accessible and sustainable transport systems for all, improving road safety, notably by expanding public transport, with special attention to the needs of those in vulnerable situations, women, children, persons with disabilities and older persons",2017-03-01,1,,,,,,,,,
16.9,0,OMOP SDOH,Observation,SDG Goal,"By 2030, provide legal identity for all, including birth registration",,2017-03-01,1,,,,,,,,,
11.7,0,OMOP SDOH,Observation,SDG Goal,"By 2030, provide universal access to safe, inclusive and accessible, green and public spaces, in particular for women and children, older persons and persons with disabilities",,2017-03-01,1,,,,,,,,,
1.2,0,OMOP SDOH,Observation,SDG Goal,"By 2030, reduce at least by half the proportion of men, women and children of all ages living in poverty in all its dimensions according to national definitions",,2017-03-01,1,,,,,,,,,
3.4,0,OMOP SDOH,Observation,SDG Goal,"By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being",,2017-03-01,1,,,,,,,,,
11.6,0,OMOP SDOH,Observation,SDG Goal,"By 2030, reduce the adverse per capita environmental impact of cities, including by paying special attention to air quality and municipal and other waste management",,2017-03-01,1,,,,,,,,,
3.1,0,OMOP SDOH,Observation,SDG Goal,"By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births",,2017-03-01,1,,,,,,,,,
10.c,0,OMOP SDOH,Observation,SDG Goal,"By 2030, reduce to less than 3 per cent the transaction costs of migrant remittances and eliminate remittance corridors with costs higher than 5 per cent",,2017-03-01,1,,,,,,,,,
16.4,0,OMOP SDOH,Observation,SDG Goal,"By 2030, significantly reduce illicit financial and arms flows, strengthen the recovery and return of stolen assets and combat all forms of organized crime",,2017-03-01,1,,,,,,,,,
11.5,0,OMOP SDOH,Observation,SDG Goal,"By 2030, significantly reduce the number of deaths and the number of people affected and substantially decrease the direct economic losses relative to global gross domestic product caused by disasters, including water-related disasters, with a focus on...","By 2030, significantly reduce the number of deaths and the number of people affected and substantially decrease the direct economic losses relative to global gross domestic product caused by disasters, including water-related disasters, with a focus on protecting the poor and people in vulnerable situations",2017-03-01,1,,,,,,,,,
4.4,0,OMOP SDOH,Observation,SDG Goal,"By 2030, substantially increase the number of youth and adults who have relevant skills, including technical and vocational skills, for employment, decent jobs and entrepreneurship",,2017-03-01,1,,,,,,,,,
4.c,0,OMOP SDOH,Observation,SDG Goal,"By 2030, substantially increase the supply of qualified teachers, including through international cooperation for teacher training in developing countries, especially least developed countries and small island developing States",,2017-03-01,1,,,,,,,,,
6.4,0,OMOP SDOH,Observation,SDG Goal,"By 2030, substantially increase water-use efficiency across all sectors and ensure sustainable withdrawals and supply of freshwater to address water scarcity and substantially reduce the number of people suffering from water scarcity",,2017-03-01,1,,,,,,,,,
3.9,0,OMOP SDOH,Observation,SDG Goal,"By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination",,2017-03-01,1,,,,,,,,,
12.5,0,OMOP SDOH,Observation,SDG Goal,"By 2030, substantially reduce waste generation through prevention, reduction, recycling and reuse",,2017-03-01,1,,,,,,,,,
9.4,0,OMOP SDOH,Observation,SDG Goal,"By 2030, upgrade infrastructure and retrofit industries to make them sustainable, with increased resource-use efficiency and greater adoption of clean and environmentally sound technologies and industrial processes, with all countries taking action in...","By 2030, upgrade infrastructure and retrofit industries to make them sustainable, with increased resource-use efficiency and greater adoption of clean and environmentally sound technologies and industrial processes, with all countries taking action in accordance with their respective capabilities",2017-03-01,1,,,,,,,,,
GIS1000212,0,OMOP SDOH,Behavioral Feature,SDOH Determinant,Caffeine Use,,2024-09-15,1,,,,,,,,,
GIS1000223,0,OMOP SDOH,Observation,SDG Goal,Capacity-building,,2017-03-01,1,,,,,,,,,
GIS1000225,0,OMOP SDOH,Type Concept,Exposure Type Concept,Case Report,,2024-09-15,1,,,,,,,,,
GIS1000224,0,OMOP SDOH,Type Concept,Exposure Type Concept,Case-Control Study,,2024-09-15,1,,,,,,,,,
SEDH:1.17,0,OMOP SDOH,Observation,SEDH Item,CDC/ATSDR Social Vulnerability Index Dataset,SEDH:1.17,2021-01-01,1,,,,,,,,,
GIS1000227,0,OMOP SDOH,Geographic Feature,SDOH Item,Census,,2024-09-15,1,,,,,,,,,
GIS1000229,0,OMOP SDOH,Type Concept,Exposure Type Concept,Census Data,,2024-09-15,1,,,,,,,,,
REGION,0,OMOP SDOH,Geographic Feature,SVI Item,Census Region Name,SVI:REGION,2018-01-01,1,,,,,,,,,
TRACTCE,0,OMOP SDOH,Observation,EJI Item,Census Tract Code,EJI:TRACTCE,2022-01-01,1,,,,,,,,,
AFFGEOID,0,OMOP SDOH,Observation,EJI Item,"Census Tract Identifier; A Concatenation Of Current State Federal Information Processing Series (FIPS) Code, County FIPS Code, And Census Tract Code",EJI:AFFGEOID,2022-01-01,1,,,,,,,,,
GIS1000230,0,OMOP SDOH,Observation,GIS Measure,Central Tendency,,2024-09-15,1,,,,,,,,,
6.6.1,0,OMOP SDOH,Observation,SDG Indicator,Change in the extent of water-related ecosystems over time,,2017-03-01,1,,,,,,,,,
6.4.1,0,OMOP SDOH,Observation,SDG Indicator,Change in water-use efficiency over time,,2017-03-01,1,,,,,,,,,
GIS1000234,0,OMOP SDOH,Healthcare Feature,AHRQ Construct,Characteristics Of Health Care Facilities,,2022-01-01,1,,,,,,,,,
GIS1000425,0,OMOP SDOH,Healthcare Feature,AHRQ Construct,Characteristics Of Health Care Providers,,2022-01-01,1,,,,,,,,,
GIS1000427,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Characteristics Of Health Care Providers In Population,,2024-09-15,1,,,,,,,,,
612,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Charity,SDOHO:612; Charity,2022-01-01,1,,,,,,,,,
700,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Child Care Cost,SDOHO:700; Child_Care_Cost,2022-01-01,1,,,,,,,,,
GIS1000513,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Child Labor,,2024-09-15,1,,,,,,,,,
GIS1000514,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Child Opportunity Index (COI),,2024-09-15,1,,,,,,,,,
GIS1000515,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,"Child Opportunity Scores, Overall COI, Metro-Normed",,2020-01-01,1,,,,,,,,,
841,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Child Parent Relationship,SDOHO:841; Child_Parent_Relationship,2022-01-01,1,,,,,,,,,
pop,0,OMOP SDOH,Observation,COI Item,"Child Population Data; Number Of Children Aged 0-17, ACS (2008-12 For 2010, 2013-17 For 2015)",COI:pop,2020-01-01,1,,,,,,,,,
GIS1000516,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Child Protection,,2024-09-15,1,,,,,,,,,
321,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Childcare Worker,SDOHO:321,2022-01-01,1,,,,,,,,,
593,0,OMOP SDOH,Observation,SDOHO Item,Children'S Health Insurance Program,SDOHO:593; Children's_Health_Insurance_Program,2022-01-01,1,,,,,,,,,
111,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Cisgender,SDOHO:111; Cisgender,2022-01-01,1,,,,,,,,,
GIS1000517,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Citizenship,,2024-09-15,1,,,,,,,,,
703,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Civic Participation,SDOHO:703; Civic_Participation,2022-01-01,1,,,,,,,,,
E_UNEMP,0,OMOP SDOH,Observation,SVI Item,Civilian (Age 16+) Unemployed Estimate,SVI:E_UNEMP,2018-01-01,1,,,,,,,,,
M_UNEMP,0,OMOP SDOH,Observation,SVI Item,Civilian (Age 16+) Unemployed Estimate MOE,SVI:M_UNEMP,2018-01-01,1,,,,,,,,,
E_DISABL,0,OMOP SDOH,Observation,SVI Item,Civilian Noninstitutionalized Population With A Disability Estimate,SVI:E_DISABL,2018-01-01,1,,,,,,,,,
M_DISABL,0,OMOP SDOH,Observation,SVI Item,Civilian Noninstitutionalized Population With A Disability Estimate MOE,SVI:M_DISABL,2018-01-01,1,,,,,,,,,
GIS1000525,0,OMOP SDOH,Type Concept,Exposure Type Concept,Claim,,2024-09-15,1,,,,,,,,,
GIS1000526,0,OMOP SDOH,Environmental Feature,SDOH Construct,Climate,,2024-09-15,1,,,,,,,,,
GIS1000529,0,OMOP SDOH,Type Concept,Exposure Type Concept,Clinical Trial,,2024-09-15,1,,,,,,,,,
701,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Clothing Cost,SDOHO:701; Clothing_Cost,2022-01-01,1,,,,,,,,,
9.4.1,0,OMOP SDOH,Observation,SDG Indicator,CO2 emission per unit of value added,,2017-03-01,1,,,,,,,,,
663,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Cocaine Smoking,SDOHO:663; Cocaine_Smoking,2022-01-01,1,,,,,,,,,
GIS1000530,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Cognitive Impairment,,2024-09-15,1,,,,,,,,,
GIS1000546,0,OMOP SDOH,Type Concept,Exposure Type Concept,Cohort Study,,2024-09-15,1,,,,,,,,,
554,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,College Completed,SDOHO:554; College_Completed,2022-01-01,1,,,,,,,,,
GIS1000547,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,College Enrollment In Nearby Institutions,,2020-01-01,1,,,,,,,,,
714,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Community And Social Service Occupation,SDOHO:714; Community_and_Social_Service_Occupation,2022-01-01,1,,,,,,,,,
704,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Community Engagement,SDOHO:704; Community_Engagement,2022-01-01,1,,,,,,,,,
GIS1000549,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Commute Duration,,2020-01-01,1,,,,,,,,,
4.1.2,0,OMOP SDOH,Observation,SDG Indicator,"Completion rate (primary education, lower secondary education, upper secondary education)",,2017-03-01,1,,,,,,,,,
722,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Computer And Mathematical Occupation,SDOHO:722; Computer_and_Mathematical_Occupation,2022-01-01,1,,,,,,,,,
179,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Concentrated Poverty,SDOHO:179; Concentrated_Poverty,2022-01-01,1,,,,,,,,,
562,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Condomless Sex,SDOHO:562; Condomless_Sex,2022-01-01,1,,,,,,,,,
16.1.2,0,OMOP SDOH,Observation,SDG Indicator,"Conflict-related deaths per 100,000 population, by sex, age and cause",,2017-03-01,1,,,,,,,,,
Goal 14,0,OMOP SDOH,Observation,SDG Goal,"Conserve and sustainably use the oceans, seas and marine resources for sustainable development",,2017-03-01,1,,,,,,,,,
670,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Construction And Extraction Occupation,SDOHO:670; Construction_and_Extraction_Occupation,2022-01-01,1,,,,,,,,,
2.b,0,OMOP SDOH,Observation,SDG Goal,"Correct and prevent trade restrictions and distortions in world agricultural markets, including through the parallel elimination of all forms of agricultural export subsidies and all export measures with equivalent effect, in accordance with the mandat...","Correct and prevent trade restrictions and distortions in world agricultural markets, including through the parallel elimination of all forms of agricultural export subsidies and all export measures with equivalent effect, in accordance with the mandate of the Doha Development Round",2017-03-01,1,,,,,,,,,
GIS1000551,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Corruption,,2024-09-15,1,,,,,,,,,
477,0,OMOP SDOH,Demographic Feature,SDOHO Determinant,Country Of Origin,SDOHO:477; Country_of_Origin,2022-01-01,1,,,,,,,,,
countyfips_coi,0,OMOP SDOH,Observation,COI Item,County FIPS Code,COI:countyfips_coi,2020-01-01,1,,,,,,,,,
COUNTYFP,0,OMOP SDOH,Observation,EJI Item,County FIPS Number,EJI:COUNTYFP,2022-01-01,1,,,,,,,,,
GEOID,0,OMOP SDOH,Observation,EJI Item,County Identifier; A Concatenation Of Current State Federal Information Processing Series (FIPS) Code And County FIPS Code,EJI:GEOID,2022-01-01,1,,,,,,,,,
SEDH:5.2,0,OMOP SDOH,Observation,SEDH Item,County Level UV Exposure Data For The Continental US,SEDH:5.2,2021-01-01,1,,,,,,,,,
COUNTY,0,OMOP SDOH,Geographic Feature,SVI Item,County Name,SVI:COUNTY,2018-01-01,1,,,,,,,,,
STCNTY,0,OMOP SDOH,Geographic Feature,SVI Item,County-Level FIPS Code,SVI:STCNTY,2018-01-01,1,,,,,,,,,
15.4.1,0,OMOP SDOH,Observation,SDG Indicator,Coverage by protected areas of important sites for mountain biodiversity,,2017-03-01,1,,,,,,,,,
3.8.1,0,OMOP SDOH,Observation,SDG Indicator,Coverage of essential health services,,2017-03-01,1,,,,,,,,,
14.5.1,0,OMOP SDOH,Observation,SDG Indicator,Coverage of protected areas in relation to marine areas,,2017-03-01,1,,,,,,,,,
3.5.1,0,OMOP SDOH,Observation,SDG Indicator,"Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders",,2017-03-01,1,,,,,,,,,
845,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Coworker And Classmate And Roommate Relationship,SDOHO:845; Coworker_and_Classmate_and_Roommate_Relationship,2022-01-01,1,,,,,,,,,
1.b,0,OMOP SDOH,Observation,SDG Goal,"Create sound policy frameworks at the national, regional and international levels, based on pro-poor and gender-sensitive development strategies, to support accelerated investment in poverty eradication actions",,2017-03-01,1,,,,,,,,,
GIS1000552,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Crime And Violence,,2022-01-01,1,,,,,,,,,
GIS1000578,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Crime And Violence In Population,,2024-09-15,1,,,,,,,,,
182,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Criminality,SDOHO:182; Criminality,2022-01-01,1,,,,,,,,,
CDCP_PULMONARY_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,"Crude Prevalence Of Adults Aged 18 Years And Older Who Report Ever Having Been Told By A Doctor, Nurse, Or Other Health Professional That They Had Chronic Obstructive Pulmonary Disease (Copd), Emphysema, Or Chronic Bronchitis (%)",AHRQ:CDCP_PULMONARY_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_KIDNEY_DISEASE_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,"Crude Prevalence Of Adults Aged 18 Years And Older Who Report Ever Having Been Told By A Doctor, Nurse, Or Other Health Professional That They Have Kidney Disease (%)",AHRQ:CDCP_KIDNEY_DISEASE_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_DOCTOR_VISIT_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,"Crude Prevalence Of Adults Aged 18 Years And Older Who Report Having Been To A Doctor For A Routine Checkup (E.G., A General Physical Exam, Not An Exam For A Specific Injury, Illness, Condition) In The Previous Year (%)",AHRQ:CDCP_DOCTOR_VISIT_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_DENTIST_VISIT_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Adults Aged 18 Years And Older Who Report Having Been To The Dentist Or Dental Clinic In The Previous Year (%),AHRQ:CDCP_DENTIST_VISIT_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_CHOLES_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,"Crude Prevalence Of Adults Aged 18 Years And Older Who Report Having Been Told By A Doctor, Nurse, Or Other Health Professional That They Had High Cholesterol (%)",AHRQ:CDCP_CHOLES_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_CHOLES_SCR_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Adults Aged 18 Years And Older Who Report Having Their Cholesterol Checked Within The Previous 5 Years (%),AHRQ:CDCP_CHOLES_SCR_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_NO_PHY_ACTV_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,"Crude Prevalence Of Adults Aged 18 Years And Older Who Report Not Having Participated In Any Physical Activities Or Exercises Such As Running, Calisthenics, Golf, Gardening, Or Walking For Exercise Other Than Regular Job (%)",AHRQ:CDCP_NO_PHY_ACTV_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_SLEEP_LESS7HR_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Adults Aged 18 Years And Older Who Report Usually Getting Less Than 7 Hours Of Sleep (%),AHRQ:CDCP_SLEEP_LESS7HR_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_BLOOD_MED_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Adults Aged 18 Years And Older With High Blood Pressure Taking Medicine For High Blood Pressure Control (%),AHRQ:CDCP_BLOOD_MED_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_FOBT_SIG_COL_50_75_C,0,OMOP SDOH,Observation,AHRQ Item,"Crude Prevalence Of Adults Aged 50-75 Years Who Had 1) A Fecal Occult Blood Test (Fobt) Within The Past Year, 2) A Sigmoidoscopy Within The Past 5 Years And A Fobt Within The Past Year, Or 3) A Colonoscopy Within The Past 10 Years (%)",AHRQ:CDCP_FOBT_SIG_COL_50_75_C,2022-01-01,1,,,,,,,,,
CDCP_NO_TEETH_65_ABOVE_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Adults Aged 65 Years And Older Who Report Having Lost All Of Their Natural Teeth Because Of Tooth Decay Or Gum Disease (%),AHRQ:CDCP_NO_TEETH_65_ABOVE_C,2022-01-01,1,,,,,,,,,
CDCP_ARTHRITIS_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Arthritis Among Adults Aged 18 Years And Older (%),AHRQ:CDCP_ARTHRITIS_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_ASTHMA_ADULT_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Current Asthma Among Adults Aged 18 Years And Older (%),AHRQ:CDCP_ASTHMA_ADULT_C,2022-01-01,1,,,,,,,,,
CDCP_CERVCAN_SCR_F21_65_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Females Aged 21-65 Years Without A Hysterectomy Who Report Having Had A Recommended Cervical Cancer Screening Test (%),AHRQ:CDCP_CERVCAN_SCR_F21_65_C,2022-01-01,1,,,,,,,,,
CDCP_MAMMO_SCR_F50_74_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Females Aged 50-74 Years Who Reporting Having Had A Mammogram Within The Previous 2 Years (%),AHRQ:CDCP_MAMMO_SCR_F50_74_C,2022-01-01,1,,,,,,,,,
CDCP_PREV_SERV_F65_ABOVE_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Females Aged 65 Years And Older Who Are Up To Date On A Core Set Of Clinical Preventive Services (%),AHRQ:CDCP_PREV_SERV_F65_ABOVE_C,2022-01-01,1,,,,,,,,,
CDCP_PREV_SERV_M65_ABOVE_C,0,OMOP SDOH,Observation,AHRQ Item,Crude Prevalence Of Males Aged 65 Years And Older Who Are Up To Date On A Core Set Of Clinical Preventive Services (%),AHRQ:CDCP_PREV_SERV_M65_ABOVE_C,2022-01-01,1,,,,,,,,,
GIS1000580,0,OMOP SDOH,Geographic Feature,SDOH Construct,Cultural And Natural Heritage,,2024-09-15,1,,,,,,,,,
979,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Culture,SDOHO:979; Culture,2022-01-01,1,,,,,,,,,
GIS1000581,0,OMOP SDOH,Observation,SDG Goal,"Data, monitoring and accountability",,2017-03-01,1,,,,,,,,,
3.6.1,0,OMOP SDOH,Observation,SDG Indicator,Death rate due to road traffic injuries,,2017-03-01,1,,,,,,,,,
392,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Debt,SDOHO:392; Debt,2022-01-01,1,,,,,,,,,
17.4.1,0,OMOP SDOH,Observation,SDG Indicator,Debt service as a proportion of exports of goods and services,,2017-03-01,1,,,,,,,,,
14.b.1,0,OMOP SDOH,Observation,SDG Indicator,Degree of application of a legal/regulatory/ policy/institutional framework which recognizes and protects access rights for small-scale fisheries,,2017-03-01,1,,,,,,,,,
14.6.1,0,OMOP SDOH,Observation,SDG Indicator,"Degree of implementation of international instruments aiming to combat illegal, unreported and unregulated fishing",,2017-03-01,1,,,,,,,,,
6.5.1,0,OMOP SDOH,Observation,SDG Indicator,Degree of integrated water resources management,,2017-03-01,1,,,,,,,,,
449_POP,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Demographics In Population,,2024-09-15,1,,,,,,,,,
GIS1000583,0,OMOP SDOH,Observation,GIS Measure,Density,,2024-09-15,1,,,,,,,,,
GIS1000584,0,OMOP SDOH,Type Concept,Exposure Type Concept,Dental Claim,,2024-09-15,1,,,,,,,,,
12.b,0,OMOP SDOH,Observation,SDG Goal,Develop and implement tools to monitor sustainable development impacts for sustainable tourism that creates jobs and promotes local culture and products,,2017-03-01,1,,,,,,,,,
16.6,0,OMOP SDOH,Observation,SDG Goal,"Develop effective, accountable and transparent institutions at all levels",,2017-03-01,1,,,,,,,,,
9.1,0,OMOP SDOH,Observation,SDG Goal,"Develop quality, reliable, sustainable and resilient infrastructure, including regional and transborder infrastructure, to support economic development and human well-being, with a focus on affordable and equitable access for all",,2017-03-01,1,,,,,,,,,
17.2,0,OMOP SDOH,Observation,SDG Goal,"Developed countries to implement fully their official development assistance commitments, including the commitment by many developed countries to achieve the target of  per cent of gross national income for official development assistance (ODA/GNI) to...","Developed countries to implement fully their official development assistance commitments, including the commitment by many developed countries to achieve the target of 0.7 per cent of gross national income for official development assistance (ODA/GNI) to developing countries and 0.15 to 0.20 per cent of ODA/GNI to least developed countries; ODA providers are encouraged to consider setting a target to provide at least 0.20 per cent of ODA/GNI to least developed countries",2017-03-01,1,,,,,,,,,
17.11.1,0,OMOP SDOH,Observation,SDG Indicator,Developing countries? and least developed countries? share of global exports,,2017-03-01,1,,,,,,,,,
8,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Diet,SDOHO:8; Diet,2022-01-01,1,,,,,,,,,
GIS1000585,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Digital Social Connectivity,,2021-01-01,1,,,,,,,,,
11.5.2,0,OMOP SDOH,Observation,SDG Indicator,Direct economic loss attributed to disasters in relation to global gross domestic product (GDP),,2017-03-01,1,,,,,,,,,
1.5.2,0,OMOP SDOH,Observation,SDG Indicator,Direct economic loss attributed to disasters in relation to global gross domestic product (GDP),,2017-03-01,1,,,,,,,,,
GIS1000587,0,OMOP SDOH,Phenotypic Feature,AHRQ Determinant,Disability,,2022-01-01,1,,,,,,,,,
GIS1000715,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Disability In Population,,2024-09-15,1,,,,,,,,,
GIS1000721,0,OMOP SDOH,Environmental Feature,SDOH Construct,Disaster Risk Reduction,,2024-09-15,1,,,,,,,,,
GIS1000722,0,OMOP SDOH,Environmental Feature,SDOH Construct,Disasters,,2024-09-15,1,,,,,,,,,
354,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Discrimination,SDOHO:354; Discrimination,2022-01-01,1,,,,,,,,,
GIS1000735,0,OMOP SDOH,Type Concept,Exposure Type Concept,Disease Registry,,2024-09-15,1,,,,,,,,,
603,0,OMOP SDOH,Healthcare Feature,SDOHO Construct,Disparate Health Care Quality,SDOHO:603; Disparate_Health_Care_Quality,2022-01-01,1,,,,,,,,,
GIS1000736,0,OMOP SDOH,Observation,GIS Measure,Dispersion Measure,,2024-09-15,1,,,,,,,,,
POS_DIST_TRAUMA_TRACT,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Designated Trauma Center, Calculated Using Population Weighted Tract Centroids",AHRQ:POS_DIST_TRAUMA_TRACT,2022-01-01,1,,,,,,,,,
POS_DIST_TRAUMA,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Designated Trauma Center, Calculated Using Population Weighted ZIP Centroids",AHRQ:POS_DIST_TRAUMA,2022-01-01,1,,,,,,,,,
POS_DIST_ED_TRACT,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Emergency Department, Calculated Using Population Weighted Tract Centroids",AHRQ:POS_DIST_ED_TRACT,2022-01-01,1,,,,,,,,,
POS_DIST_ED,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Emergency Department, Calculated Using Population Weighted ZIP Centroids",AHRQ:POS_DIST_ED,2022-01-01,1,,,,,,,,,
POS_DIST_CLINIC_TRACT,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Health Clinic (FQHC, RHC), Calculated Using Population Weighted Tract Centroids",AHRQ:POS_DIST_CLINIC_TRACT,2022-01-01,1,,,,,,,,,
POS_DIST_CLINIC,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Health Clinic (FQHC, RHC), Calculated Using Population Weighted ZIP Centroids",AHRQ:POS_DIST_CLINIC,2022-01-01,1,,,,,,,,,
POS_DIST_ALC_TRACT,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Hospital With Alcohol And Drug Abuse Inpatient Care, Calculated Using Population Weighted Tract Centroids",AHRQ:POS_DIST_ALC_TRACT,2022-01-01,1,,,,,,,,,
POS_DIST_ALC,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Hospital With Alcohol And Drug Abuse Inpatient Care, Calculated Using Population Weighted ZIP Centroids",AHRQ:POS_DIST_ALC,2022-01-01,1,,,,,,,,,
POS_DIST_MEDSURG_ICU_TRACT,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Medical-Surgical ICU, Calculated Using Population Weighted Tract Centroids",AHRQ:POS_DIST_MEDSURG_ICU_TRACT,2022-01-01,1,,,,,,,,,
POS_DIST_MEDSURG_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Medical-Surgical ICU, Calculated Using Population Weighted ZIP Centroids",AHRQ:POS_DIST_MEDSURG_ICU,2022-01-01,1,,,,,,,,,
POS_DIST_OBSTETRICS_TRACT,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Obstetrics Department, Calculated Using Population Weighted Tract Centroids",AHRQ:POS_DIST_OBSTETRICS_TRACT,2022-01-01,1,,,,,,,,,
POS_DIST_OBSTETRICS,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Obstetrics Department, Calculated Using Population Weighted ZIP Centroids",AHRQ:POS_DIST_OBSTETRICS,2022-01-01,1,,,,,,,,,
POS_DIST_PED_ICU_TRACT,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Pediatric ICU, Calculated Using Population Weighted Tract Centroids",AHRQ:POS_DIST_PED_ICU_TRACT,2022-01-01,1,,,,,,,,,
POS_DIST_PED_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Pediatric ICU, Calculated Using Population Weighted ZIP Centroids",AHRQ:POS_DIST_PED_ICU,2022-01-01,1,,,,,,,,,
HIFLD_DIST_UC_TRACT,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Urgent Care, Calculated Using Population Weighted Tract Centroids",AHRQ:HIFLD_DIST_UC_TRACT,2022-01-01,1,,,,,,,,,
HIFLD_DIST_UC,0,OMOP SDOH,Observation,AHRQ Item,"Distance In Miles To The Nearest Urgent Care, Calculated Using Population Weighted ZIP Centroids",AHRQ:HIFLD_DIST_UC,2022-01-01,1,,,,,,,,,
GIS1000740,0,OMOP SDOH,Healthcare Feature,AHRQ Construct,Distance To Provider,,2022-01-01,1,,,,,,,,,
GIS1000742,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Distance To Provider In Population,,2024-09-15,1,,,,,,,,,
796,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Divorced,SDOHO:796; Divorced,2022-01-01,1,,,,,,,,,
17.19.1,0,OMOP SDOH,Observation,SDG Indicator,Dollar value of all resources made available to strengthen statistical capacity in developing countries,,2017-03-01,1,,,,,,,,,
17.9.1,0,OMOP SDOH,Observation,SDG Indicator,"Dollar value of financial and technical assistance (including through North-South, South-South and triangular cooperation) committed to developing countries",,2017-03-01,1,,,,,,,,,
SPL_SVM_DOM2,0,OMOP SDOH,Observation,SVI Item,"Domain Consisting Of Below 200% Poverty, No High School Diploma, Unemployed, Housing Tenure, Housing Cost, No Health Insurance, And Not Internet",SVI:SPL_SVM_DOM2,2018-01-01,1,,,,,,,,,
SPL_SVM_DOM3,0,OMOP SDOH,Observation,SVI Item,"Domain Consisting Of English Language Proficiency, Aged 65 Or Older, Aged 17 Or Younger, And Civilian With A Disability",SVI:SPL_SVM_DOM3,2018-01-01,1,,,,,,,,,
SPL_EBM_THEME5,0,OMOP SDOH,Observation,EJI EBM Item,Domain Consisting Of Impaired Water Bodies,EJI:SPL_EBM_THEME5,2022-01-01,1,,,,,,,,,
SPL_SVM_DOM4,0,OMOP SDOH,Observation,SVI Item,Domain Consisting Of Number Of Mobile Homes And Housing With Group Quarters,SVI:SPL_SVM_DOM4,2018-01-01,1,,,,,,,,,
SPL_EBM_THEME1,0,OMOP SDOH,Observation,EJI EBM Item,"Domain Consisting Of Ozone, PM2.5, Air Toxics Cancer Risk, And Diesel Particulate Matter",EJI:SPL_EBM_THEME1,2022-01-01,1,,,,,,,,,
SPL_SVM_DOM1,0,OMOP SDOH,Observation,SVI Item,Domain Consisting Of Percentage Of Individuals Who Are A Racial/Ethnic Minority,SVI:SPL_SVM_DOM1,2018-01-01,1,,,,,,,,,
SPL_EBM_THEME4,0,OMOP SDOH,Observation,EJI EBM Item,"Domain Consisting Of Proximity To High Volume Roads, Proximity To Railways, And Proximity To Airports",EJI:SPL_EBM_THEME4,2022-01-01,1,,,,,,,,,
SPL_EBM_THEME2,0,OMOP SDOH,Observation,EJI EBM Item,"Domain Consisting Of Proximity To National Priority List Sites, Proximity To Release Inventory Sites, Proximity To Treatment, Storage, And Disposal Sites, Proximity To Risk Management Plan Sites, Proximity To Coal Mines, And Proximity To Lead Mines",EJI:SPL_EBM_THEME2,2022-01-01,1,,,,,,,,,
SPL_EBM_THEME3,0,OMOP SDOH,Observation,EJI EBM Item,"Domain Consisting Of Proximity To Recreational Parks, Houses Built Pre- 1980 (Lead Exposure), And Walkability Index",EJI:SPL_EBM_THEME3,2022-01-01,1,,,,,,,,,
12.2.2,0,OMOP SDOH,Observation,SDG Indicator,"Domestic material consumption, domestic material consumption per capita, and domestic material consumption per GDP",,2017-03-01,1,,,,,,,,,
800,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Domestic Partnership,SDOHO:800; Domestic_Partnership,2022-01-01,1,,,,,,,,,
660,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Drug Use,SDOHO:660; Drug_Use,2022-01-01,1,,,,,,,,,
GIS1000749,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Drugs,,2024-09-15,1,,,,,,,,,
577,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Early Childhood Education,SDOHO:577; Early_Childhood_Education,2022-01-01,1,,,,,,,,,
GIS1000750,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Early Childhood Education Centers,,2020-01-01,1,,,,,,,,,
GIS1000753,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Early Childhood Education Enrollment,,2020-01-01,1,,,,,,,,,
GIS1000756,0,OMOP SDOH,Phenotypic Feature,AHRQ Determinant,Eating Disorders,,2022-01-01,1,,,,,,,,,
GIS1000772,0,OMOP SDOH,Socioeconomic Feature,COI Construct,Economic Resource Index,,2020-01-01,1,,,,,,,,,
zSE_ECRES,0,OMOP SDOH,Observation,COI Item,"Economic Resource Index, Combines Poverty Rate, Public Assistance Rate, Homeownership Rate, High Skill Employment, And Median Household Income, Transformed To Z-Scores",COI:zSE_ECRES,2020-01-01,1,,,,,,,,,
AHRF_ECO_DEP_USDA,0,OMOP SDOH,Observation,AHRQ Item,Economic-Dependent Typology Code,AHRQ:AHRF_ECO_DEP_USDA,2022-01-01,1,,,,,,,,,
708,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Education And Training And Library Occupation,SDOHO:708; Education_and_Training_and_Library_Occupation,2022-01-01,1,,,,,,,,,
350,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Education Level,SDOHO:350; Education_Level,2022-01-01,1,,,,,,,,,
370,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Education Quality,SDOHO:370; Education_Quality,2022-01-01,1,,,,,,,,,
GIS1000774,0,OMOP SDOH,Socioeconomic Feature,AHRQ Construct,Educational Funding,,2022-01-01,1,,,,,,,,,
GIS1000776,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Educational Funding In Population,,2024-09-15,1,,,,,,,,,
GIS1000785,0,OMOP SDOH,Type Concept,Exposure Type Concept,EHR Flowsheet,,2024-09-15,1,,,,,,,,,
GIS1000786,0,OMOP SDOH,Type Concept,Exposure Type Concept,EHR Lab Result,,2024-09-15,1,,,,,,,,,
GIS1000788,0,OMOP SDOH,Type Concept,Exposure Type Concept,EHR Note,,2024-09-15,1,,,,,,,,,
GIS1000789,0,OMOP SDOH,Type Concept,Exposure Type Concept,EHR Order,,2024-09-15,1,,,,,,,,,
GIS1000790,0,OMOP SDOH,Type Concept,Exposure Type Concept,EHR Prescription,,2024-09-15,1,,,,,,,,,
GIS1000791,0,OMOP SDOH,Type Concept,Exposure Type Concept,Electronic Health Record (EHR),,2024-09-15,1,,,,,,,,,
GIS1000792,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Element Related to Family Circumstances,,2022-01-01,1,,,,,,,,,
GIS1000812,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Element Related to Psychosocial Circumstances,,2022-01-01,1,,,,,,,,,
GIS1000820,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Element Related to Upbringing,,2022-01-01,1,,,,,,,,,
GIS1000839,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Element Relevant To Anxiety,,2024-09-15,1,,,,,,,,,
GIS1000886,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Element Relevant To Autism Spectrum Disorder,,2024-09-15,1,,,,,,,,,
49,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Element Relevant To Behavior And Lifestyle,SDOHO:49; Element_Relevant_to_Behavior_and_Lifestyle,2022-01-01,1,,,,,,,,,
GIS1000918,0,OMOP SDOH,Geographic Feature,SDOH Construct,Element Relevant To Built Environment,,2024-09-15,1,,,,,,,,,
479,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Child,SDOHO:479,2022-01-01,1,,,,,,,,,
449,0,OMOP SDOH,Demographic Feature,SDOHO Construct,Element Relevant To Demographics,SDOHO:449; Demographic,2022-01-01,1,,,,,,,,,
GIS1000932,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Element Relevant To Depression,,2024-09-15,1,,,,,,,,,
218,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Economic Stability,SDOHO:218; Element_Relevant_to_Economic_Stability,2022-01-01,1,,,,,,,,,
365,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Education,SDOHO:365; Element_Relevant_to_Education,2022-01-01,1,,,,,,,,,
236,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Employment,SDOHO:236; Element_Relevant_to_Employment,2022-01-01,1,,,,,,,,,
278,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Expense,SDOHO:278; Element_Relevant_to_Expense,2022-01-01,1,,,,,,,,,
121,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Element Relevant To Female,SDOHO:121; Female,2022-01-01,1,,,,,,,,,
45,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Food,SDOHO:45; Element_Relevant_to_Food,2022-01-01,1,,,,,,,,,
171,0,OMOP SDOH,Geographic Feature,SDOHO Construct,Element Relevant To Geographic Location,SDOHO:171; Element_Relevant_to_Geographic_Location,2022-01-01,1,,,,,,,,,
GIS1001136,0,OMOP SDOH,Healthcare Feature,SDOH Construct,Element Relevant To Health,,2024-09-15,1,,,,,,,,,
741,0,OMOP SDOH,Healthcare Feature,SDOHO Construct,Element Relevant To Health Access,SDOHO:741; Element_Relevant_to_Health_Access,2022-01-01,1,,,,,,,,,
610,0,OMOP SDOH,Healthcare Feature,SDOHO Construct,Element Relevant To Health Care,SDOHO:610; Element_Relevant_to_Health_Care,2022-01-01,1,,,,,,,,,
205,0,OMOP SDOH,Healthcare Feature,SDOHO Construct,Element Relevant To Health Literacy,SDOHO:205; Element_Relevant_to_Health_Literacy,2022-01-01,1,,,,,,,,,
GIS1001140,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Element Relevant To Health-Related Behavior,,2024-09-15,1,,,,,,,,,
275,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Income,SDOHO:275; Element_Relevant_to_Income,2022-01-01,1,,,,,,,,,
613,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Insurance,SDOHO:613; Element_Relevant_to_Insurance,2022-01-01,1,,,,,,,,,
76,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Element Relevant To Male,SDOHO:76; Male,2022-01-01,1,,,,,,,,,
GIS1001161,0,OMOP SDOH,Healthcare Feature,SDOH Construct,Element Relevant To Mental Health,,2024-09-15,1,,,,,,,,,
464,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Neighborhood,SDOHO:464; Element_Relevant_to_Neighborhood,2022-01-01,1,,,,,,,,,
478,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Parent,SDOHO:478,2022-01-01,1,,,,,,,,,
299,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Person,SDOHO:299; Person,2022-01-01,1,,,,,,,,,
GIS1001182,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Element Relevant To Personality,,2024-09-15,1,,,,,,,,,
13,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Element Relevant To Physical Activity,SDOHO:13; Element_Relevant_to_Physical_Activity,2022-01-01,1,,,,,,,,,
472,0,OMOP SDOH,Geographic Feature,SDOHO Construct,Element Relevant To Physical Environment,SDOHO:472; Element_Relevant_to_Physical_Environment,2022-01-01,1,,,,,,,,,
GIS1001207,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Element Relevant To Population,,2024-09-15,1,,,,,,,,,
604,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Quality Of Care,SDOHO:604; Element_Relevant_to_Quality_of_Care,2022-01-01,1,,,,,,,,,
GIS1001240,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Element Relevant To Religion,,2024-09-15,1,,,,,,,,,
97,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Element Relevant To Sexual Behavior,SDOHO:97; Element_Relevant_to_Sexual_Behavior,2022-01-01,1,,,,,,,,,
100,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Element Relevant To Sleep,SDOHO:100; Sleep,2022-01-01,1,,,,,,,,,
798,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Social And Community Context,SDOHO:798; Element_Relevant_to_Social_and_Community_Context,2022-01-01,1,,,,,,,,,
227,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Socio-Environmental Neighborhood,SDOHO:227; Element_Relevant_to_Socio-Environmental_Neighborhood,2022-01-01,1,,,,,,,,,
740,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Element Relevant To Treatment And Medication,SDOHO:740; Element_Relevant_to_Treatment_and_Medication,2022-01-01,1,,,,,,,,,
402,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Elementary School Completed,SDOHO:402; Elementary_School_Completed,2022-01-01,1,,,,,,,,,
5.2,0,OMOP SDOH,Observation,SDG Goal,"Eliminate all forms of violence against all women and girls in the public and private spheres, including trafficking and sexual and other types of exploitation",,2017-03-01,1,,,,,,,,,
5.3,0,OMOP SDOH,Observation,SDG Goal,"Eliminate all harmful practices, such as child, early and forced marriage and female genital mutilation",,2017-03-01,1,,,,,,,,,
622,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Emergency Department Visit,SDOHO:622; Emergency_Department_Visit,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_AIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 American Indian Or Alaska Native Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ED_VISITS_AIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_ASIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 Asian Or Pacific Islander Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ED_VISITS_ASIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_BLACK_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 Black Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ED_VISITS_BLACK_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_DUAL_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 Dual Beneficiaries",AHRQ:MMD_ED_VISITS_DUAL_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_F_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 Female Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ED_VISITS_F_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_HISP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 Hispanic Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ED_VISITS_HISP_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_M_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 Male Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ED_VISITS_M_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_MED_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 Medicare Only Beneficiaries",AHRQ:MMD_ED_VISITS_MED_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_OTHER_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 Other Race Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ED_VISITS_OTHER_RATE,2022-01-01,1,,,,,,,,,
MMD_ED_VISITS_WHITE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Emergency Department Visits Per 1,000 White Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ED_VISITS_WHITE_RATE,2022-01-01,1,,,,,,,,,
GIS1001242,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Emigration,,2024-09-15,1,,,,,,,,,
236_POP,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Employment In Population,,2024-09-15,1,,,,,,,,,
GIS1001245,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Employment Rate,,2020-01-01,1,,,,,,,,,
213,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Employment Status,SDOHO:213; Employment_Status,2022-01-01,1,,,,,,,,,
17.17,0,OMOP SDOH,Observation,SDG Goal,"Encourage and promote effective public, public- private and civil society partnerships, building on the experience and resourcing strategies of partnerships",,2017-03-01,1,,,,,,,,,
12.6,0,OMOP SDOH,Observation,SDG Goal,"Encourage companies, especially large and transnational companies, to adopt sustainable practices and to integrate sustainability information into their reporting cycle",,2017-03-01,1,,,,,,,,,
10.b,0,OMOP SDOH,Observation,SDG Goal,"Encourage official development assistance and financial flows, including foreign direct investment, to States where the need is greatest, in particular least developed countries, African countries, small island developing States and landlocked developi...","Encourage official development assistance and financial flows, including foreign direct investment, to States where the need is greatest, in particular least developed countries, African countries, small island developing States and landlocked developing countries, in accordance with their national plans and programmes",2017-03-01,1,,,,,,,,,
16.2,0,OMOP SDOH,Observation,SDG Goal,"End abuse, exploitation, trafficking and all forms of violence against and torture of children",,2017-03-01,1,,,,,,,,,
5.1,0,OMOP SDOH,Observation,SDG Goal,End all forms of discrimination against all women and girls everywhere,,2017-03-01,1,,,,,,,,,
Goal 2,0,OMOP SDOH,Observation,SDG Goal,"End hunger, achieve food security and improved nutrition and promote sustainable agriculture",,2017-03-01,1,,,,,,,,,
Goal 1,0,OMOP SDOH,Observation,SDG Goal,End poverty in all its forms everywhere,,2017-03-01,1,,,,,,,,,
7.3.1,0,OMOP SDOH,Observation,SDG Indicator,Energy intensity measured in terms of primary energy and GDP,,2017-03-01,1,,,,,,,,,
93,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,English Proficiency,SDOHO:93; English_Proficiency,2022-01-01,1,,,,,,,,,
17.13,0,OMOP SDOH,Observation,SDG Goal,"Enhance global macroeconomic stability, including through policy coordination and policy coherence",,2017-03-01,1,,,,,,,,,
15.c,0,OMOP SDOH,Observation,SDG Goal,"Enhance global support for efforts to combat poaching and trafficking of protected species, including by increasing the capacity of local communities to pursue sustainable livelihood opportunities",,2017-03-01,1,,,,,,,,,
17.9,0,OMOP SDOH,Observation,SDG Goal,"Enhance international support for implementing effective and targeted capacity-building in developing countries to support national plans to implement all the Sustainable Development Goals, including through North- South, South-South and triangular coo...","Enhance international support for implementing effective and targeted capacity-building in developing countries to support national plans to implement all the Sustainable Development Goals, including through North- South, South-South and triangular cooperation",2017-03-01,1,,,,,,,,,
17.6,0,OMOP SDOH,Observation,SDG Goal,"Enhance North-South, South-South and triangular regional and international cooperation on and access to science, technology and innovation and enhance knowledge- sharing on mutually agreed terms, including through improved coordination among existing m...","Enhance North-South, South-South and triangular regional and international cooperation on and access to science, technology and innovation and enhance knowledge- sharing on mutually agreed terms, including through improved coordination among existing mechanisms, in particular at the United Nations level, and through a global technology facilitation mechanism",2017-03-01,1,,,,,,,,,
17.14,0,OMOP SDOH,Observation,SDG Goal,Enhance policy coherence for sustainable development,,2017-03-01,1,,,,,,,,,
9.5,0,OMOP SDOH,Observation,SDG Goal,"Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, in particular developing countries, including, by 2030, encouraging innovation and substantially increasing the number of research and developme...","Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, in particular developing countries, including, by 2030, encouraging innovation and substantially increasing the number of research and development workers per 1 million people and public and private research and development spending",2017-03-01,1,,,,,,,,,
14.c,0,OMOP SDOH,Observation,SDG Goal,"Enhance the conservation and sustainable use of oceans and their resources by implementing international law as reflected in the United Nations Convention on the Law of the Sea, which provides the legal framework for the conservation and sustainable us...","Enhance the conservation and sustainable use of oceans and their resources by implementing international law as reflected in the United Nations Convention on the Law of the Sea, which provides the legal framework for the conservation and sustainable use of oceans and their resources, as recalled in paragraph 158 of  The future we want?",2017-03-01,1,,,,,,,,,
17.16,0,OMOP SDOH,Observation,SDG Goal,"Enhance the Global Partnership for Sustainable Development, complemented by multi-stakeholder partnerships that mobilize and share knowledge, expertise, technology and financial resources, to support the achievement of the Sustainable Development Goals...","Enhance the Global Partnership for Sustainable Development, complemented by multi-stakeholder partnerships that mobilize and share knowledge, expertise, technology and financial resources, to support the achievement of the Sustainable Development Goals in all countries, in particular developing countries",2017-03-01,1,,,,,,,,,
5.b,0,OMOP SDOH,Observation,SDG Goal,"Enhance the use of enabling technology, in particular information and communications technology, to promote the empowerment of women",,2017-03-01,1,,,,,,,,,
Goal 7,0,OMOP SDOH,Observation,SDG Goal,"Ensure access to affordable, reliable, sustainable and modern energy for all",,2017-03-01,1,,,,,,,,,
Goal 6,0,OMOP SDOH,Observation,SDG Goal,Ensure availability and sustainable management of water and sanitation for all,,2017-03-01,1,,,,,,,,,
10.6,0,OMOP SDOH,Observation,SDG Goal,"Ensure enhanced representation and voice for developing countries in decision-making in global international economic and financial institutions in order to deliver more effective, credible, accountable and legitimate institutions",,2017-03-01,1,,,,,,,,,
10.3,0,OMOP SDOH,Observation,SDG Goal,"Ensure equal opportunity and reduce inequalities of outcome, including by eliminating discriminatory laws, policies and practices and promoting appropriate legislation, policies and action in this regard",,2017-03-01,1,,,,,,,,,
Goal 3,0,OMOP SDOH,Observation,SDG Goal,Ensure healthy lives and promote well-being for all at all ages,,2017-03-01,1,,,,,,,,,
Goal 4,0,OMOP SDOH,Observation,SDG Goal,Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all,,2017-03-01,1,,,,,,,,,
16.10,0,OMOP SDOH,Observation,SDG Goal,"Ensure public access to information and protect fundamental freedoms, in accordance with national legislation and international agreements",,2017-03-01,1,,,,,,,,,
16.7,0,OMOP SDOH,Observation,SDG Goal,"Ensure responsive, inclusive, participatory and representative decision-making at all levels",,2017-03-01,1,,,,,,,,,
1.a,0,OMOP SDOH,Observation,SDG Goal,"Ensure significant mobilization of resources from a variety of sources, including through enhanced development cooperation, in order to provide adequate and predictable means for developing countries, in particular least developed countries, to impleme...","Ensure significant mobilization of resources from a variety of sources, including through enhanced development cooperation, in order to provide adequate and predictable means for developing countries, in particular least developed countries, to implement programmes and policies to end poverty in all its dimensions",2017-03-01,1,,,,,,,,,
Goal 12,0,OMOP SDOH,Observation,SDG Goal,Ensure sustainable consumption and production patterns,,2017-03-01,1,,,,,,,,,
5.6,0,OMOP SDOH,Observation,SDG Goal,Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Programme of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome doc...,Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Programme of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome documents of their review conferences,2017-03-01,1,,,,,,,,,
5.5,0,OMOP SDOH,Observation,SDG Goal,"Ensure women?s full and effective participation and equal opportunities for leadership at all levels of decision- making in political, economic and public life",,2017-03-01,1,,,,,,,,,
882,0,OMOP SDOH,Environmental Feature,SDOHO Construct,Environment Aesthetic,SDOHO:882; Environment_Aesthetic,2022-01-01,1,,,,,,,,,
GIS1001247,0,OMOP SDOH,Type Concept,Exposure Type Concept,Environmental Health Database,,2024-09-15,1,,,,,,,,,
GIS1001248,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Environmental Impact,,2024-09-15,1,,,,,,,,,
226,0,OMOP SDOH,Environmental Feature,SDOHO Construct,Environmental Justice,SDOHO:226; Environmental_Justice,2022-01-01,1,,,,,,,,,
GIS1001249,0,OMOP SDOH,Environmental Feature,SDOH Construct,Environmental Justice Index (EJI),,2024-09-15,1,,,,,,,,,
177,0,OMOP SDOH,Observation,SDOHO Item,Environmental Justice Screening And Mapping Tool,SDOHO:177; Environmental_Justice_Screening_and_Mapping_Tool,2022-01-01,1,,,,,,,,,
GIS1001251,0,OMOP SDOH,Environmental Feature,SDOH Construct,Environmental Pollution,,2024-09-15,1,,,,,,,,,
184,0,OMOP SDOH,Observation,SDOHO Item,EPA Air Quality Index,SDOHO:184; EPA_Air_Quality_Index,2022-01-01,1,,,,,,,,,
HE_WALK,0,OMOP SDOH,Observation,COI Item,EPA Walkability Index,COI:HE_WALK,2020-01-01,1,,,,,,,,,
zHE_WALK,0,OMOP SDOH,Observation,COI Item,"EPA Walkability Index, Transformed To Z-Scores",COI:zHE_WALK,2020-01-01,1,,,,,,,,,
GIS1001254,0,OMOP SDOH,Type Concept,Exposure Type Concept,Epidemiological Study,,2024-09-15,1,,,,,,,,,
745,0,OMOP SDOH,Healthcare Feature,SDOHO Construct,Erratic Healthcare,SDOHO:745; Erratic_Healthcare,2022-01-01,1,,,,,,,,,
GIS1001255,0,OMOP SDOH,Observation,GIS Measure,Estimate,,2024-09-15,1,,,,,,,,,
AHRF_VET_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Estimate Of Female Veteran Population,AHRQ:AHRF_VET_FEMALE,2022-01-01,1,,,,,,,,,
AHRF_VET_MALE,0,OMOP SDOH,Observation,AHRQ Item,Estimate Of Male Veteran Population,AHRQ:AHRF_VET_MALE,2022-01-01,1,,,,,,,,,
AHRF_VET,0,OMOP SDOH,Observation,AHRQ Item,Estimate Of Veteran Population,AHRQ:AHRF_VET,2022-01-01,1,,,,,,,,,
NOAAS_PROPERTY_DAMAGE,0,OMOP SDOH,Observation,AHRQ Item,Estimated Amount Of Damage To Property Incurred By The Storm Events During The Year (Dollar),AHRQ:NOAAS_PROPERTY_DAMAGE,2022-01-01,1,,,,,,,,,
E_DAYPOP,0,OMOP SDOH,Observation,SVI Item,Estimated Daytime Population,"Adjunct Variable - Estimated Daytime Population, Landscan 2018; Estimated Daytime Population, Landscan 2020",2018-01-01,1,,,,,,,,,
SAIPE_MEDIAN_HH_INCOME,0,OMOP SDOH,Observation,AHRQ Item,Estimated Median Household Income,AHRQ:SAIPE_MEDIAN_HH_INCOME,2022-01-01,1,,,,,,,,,
CRE_TOT_RISK12,0,OMOP SDOH,Observation,AHRQ Item,Estimated Number Of Individuals With One Or Two Risk Factors,AHRQ:CRE_TOT_RISK12,2022-01-01,1,,,,,,,,,
CRE_TOT_RISK3,0,OMOP SDOH,Observation,AHRQ Item,Estimated Number Of Individuals With Three Or More Risk Factors,AHRQ:CRE_TOT_RISK3,2022-01-01,1,,,,,,,,,
CRE_TOT_RISK0,0,OMOP SDOH,Observation,AHRQ Item,Estimated Number Of Individuals With Zero Risk Factors,AHRQ:CRE_TOT_RISK0,2022-01-01,1,,,,,,,,,
SAIPE_TOT_POV_0_17,0,OMOP SDOH,Observation,AHRQ Item,Estimated Number Of People Aged 0-17 In Poverty,AHRQ:SAIPE_TOT_POV_0_17,2022-01-01,1,,,,,,,,,
SAIPE_TOT_POV,0,OMOP SDOH,Observation,AHRQ Item,Estimated Number Of People Of All Ages In Poverty,AHRQ:SAIPE_TOT_POV,2022-01-01,1,,,,,,,,,
SAIPE_TOT_POV_5_17,0,OMOP SDOH,Observation,AHRQ Item,Estimated Number Of Related Children Aged 5-17 In Families In Poverty,AHRQ:SAIPE_TOT_POV_5_17,2022-01-01,1,,,,,,,,,
SAIPE_PCT_POV_0_17,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of People Aged 0-17 In Poverty,AHRQ:SAIPE_PCT_POV_0_17,2022-01-01,1,,,,,,,,,
SAIPE_PCT_POV,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of People Of All Ages In Poverty,AHRQ:SAIPE_PCT_POV,2022-01-01,1,,,,,,,,,
SAIPE_PCT_POV_5_17,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of Related Children Aged 5-17 In Families In Poverty,AHRQ:SAIPE_PCT_POV_5_17,2022-01-01,1,,,,,,,,,
SAHIE_PCT_UNINSURED64_138FPL,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of Uninsured Population At Or Below 138% Of Poverty (Under 65 Years),AHRQ:SAHIE_PCT_UNINSURED64_138FPL,2022-01-01,1,,,,,,,,,
SAHIE_PCT_UNINSURED64_200FPL,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of Uninsured Population At Or Below 200% Of Poverty (Under 65 Years),AHRQ:SAHIE_PCT_UNINSURED64_200FPL,2022-01-01,1,,,,,,,,,
SAHIE_PCT_UNINSURED64_250FPL,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of Uninsured Population At Or Below 250% Of Poverty (Under 65 Years),AHRQ:SAHIE_PCT_UNINSURED64_250FPL,2022-01-01,1,,,,,,,,,
SAHIE_PCT_UNINSURED64_400FPL,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of Uninsured Population At Or Below 400% Of Poverty (Under 65 Years),AHRQ:SAHIE_PCT_UNINSURED64_400FPL,2022-01-01,1,,,,,,,,,
SAHIE_PCT_UNINSURED64_138_400FPL,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of Uninsured Population Between 138%-400% Of Poverty (Under 65 Years),AHRQ:SAHIE_PCT_UNINSURED64_138_400FPL,2022-01-01,1,,,,,,,,,
SAHIE_PCT_UNINSURED64,0,OMOP SDOH,Observation,AHRQ Item,Estimated Percentage Of Uninsured Population For All Income Levels (Under 65 Years),AHRQ:SAHIE_PCT_UNINSURED64,2022-01-01,1,,,,,,,,,
SAHIE_TOT_POP64,0,OMOP SDOH,Observation,AHRQ Item,Estimated Population Under 65 Years,AHRQ:SAHIE_TOT_POP64,2022-01-01,1,,,,,,,,,
448,0,OMOP SDOH,Demographic Feature,SDOHO Construct,Ethnicity,SDOHO:448; Ethnicity,2022-01-01,1,,,,,,,,,
448_POP,0,OMOP SDOH,Demographic Feature,SDOH Determinant,Ethnicity In Population,,2024-09-15,1,,,,,,,,,
SEDH:1.20,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Eviction Rates (By County),SEDH:1.20,2021-01-01,1,,,,,,,,,
192,0,OMOP SDOH,Observation,SDOHO Item,Excercise Vital Sign,SDOHO:192; Excercise_Vital_Sign,2022-01-01,1,,,,,,,,,
164,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Exercise Effect,SDOHO:164; Exercise_Effect,2022-01-01,1,,,,,,,,,
19,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Exercise Equipment,SDOHO:19; Exercise_Equipment,2022-01-01,1,,,,,,,,,
12,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Exercise Program,SDOHO:12; Exercise_Program,2022-01-01,1,,,,,,,,,
8.b.1,0,OMOP SDOH,Observation,SDG Indicator,"Existence of a developed and operationalized national strategy for youth employment, as a distinct strategy or as part of a national employment strategy",,2017-03-01,1,,,,,,,,,
16.a.1,0,OMOP SDOH,Observation,SDG Indicator,Existence of independent national human rights institutions in compliance with the Paris Principles,,2017-03-01,1,,,,,,,,,
GIS1001256,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Expenses,,2024-09-15,1,,,,,,,,,
363,0,OMOP SDOH,Environmental Feature,SDOHO Determinant,Exposure To Carcinogen And Pathogen,SDOHO:363; Exposure_to_Carcinogen_and_Pathogen,2022-01-01,1,,,,,,,,,
832,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Extended Family Relationship,SDOHO:832; Extended_Family_Relationship,2022-01-01,1,,,,,,,,,
17.15.1,0,OMOP SDOH,Observation,SDG Indicator,Extent of use of country-owned results frameworks and planning tools by providers of development cooperation,,2017-03-01,1,,,,,,,,,
12.8.1,0,OMOP SDOH,Observation,SDG Indicator,Extent to which (i) global citizenship education and (ii) education for sustainable development are mainstreamed in (a) national education policies; (b) curricula; (c) teacher education; and (d) student assessment,,2017-03-01,1,,,,,,,,,
13.3.1,0,OMOP SDOH,Observation,SDG Indicator,Extent to which (i) global citizenship education and (ii) education for sustainable development are mainstreamed in (a) national education policies; (b) curricula; (c) teacher education; and (d) student assessment,,2017-03-01,1,,,,,,,,,
4.7.1,0,OMOP SDOH,Observation,SDG Indicator,Extent to which (i) global citizenship education and (ii) education for sustainable development are mainstreamed in (a) national education policies; (b) curricula; (c) teacher education; and (d) student assessment,,2017-03-01,1,,,,,,,,,
GIS1001260,0,OMOP SDOH,Environmental Feature,COI Determinant,Extreme Heat Exposure,,2020-01-01,1,,,,,,,,,
SEDH:2.3,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Facebook Social Connectedness Index,SEDH:2.3,2021-01-01,1,,,,,,,,,
10.7,0,OMOP SDOH,Observation,SDG Goal,"Facilitate orderly, safe, regular and responsible migration and mobility of people, including through the implementation of planned and well-managed migration policies",,2017-03-01,1,,,,,,,,,
9.a,0,OMOP SDOH,Observation,SDG Goal,"Facilitate sustainable and resilient infrastructure development in developing countries through enhanced financial, technological and technical support to African countries, least developed countries, landlocked developing countries and small island de...","Facilitate sustainable and resilient infrastructure development in developing countries through enhanced financial, technological and technical support to African countries, least developed countries, landlocked developing countries and small island developing States",2017-03-01,1,,,,,,,,,
GIS1001263,0,OMOP SDOH,Type Concept,Exposure Type Concept,Facility Claim,,2024-09-15,1,,,,,,,,,
GIS1001266,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Family Composition,,2024-09-15,1,,,,,,,,,
804,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Family Conflict,SDOHO:804; Family_Conflict,2022-01-01,1,,,,,,,,,
GIS1001269,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Family Income,,2022-01-01,1,,,,,,,,,
564,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Family Support,SDOHO:564; Family_Support,2022-01-01,1,,,,,,,,,
671,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Farming And Fishing And Forestry Occupation,SDOHO:671; Farming_and_Fishing_and_Forestry_Occupation,2022-01-01,1,,,,,,,,,
AHRF_FARM_DEP_USDA,0,OMOP SDOH,Observation,AHRQ Item,Farming-Dependent Typology Code,AHRQ:AHRF_FARM_DEP_USDA,2022-01-01,1,,,,,,,,,
8.8.1,0,OMOP SDOH,Observation,SDG Indicator,"Fatal and non-fatal occupational injuries per 100,000 workers, by sex and migrant status",,2017-03-01,1,,,,,,,,,
580,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Federal Assistance,SDOHO:580; Federal_Assistance,2022-01-01,1,,,,,,,,,
CCD_FED_REVENUE_CNA,0,OMOP SDOH,Observation,AHRQ Item,Federal Revenue Distributed By State Through Child Nutrition Act (Dollars) Per Student,AHRQ:CCD_FED_REVENUE_CNA,2022-01-01,1,,,,,,,,,
AHRF_GOV_DEP_USDA,0,OMOP SDOH,Observation,AHRQ Item,Federal/State Government-Dependent Typology Code,AHRQ:AHRF_GOV_DEP_USDA,2022-01-01,1,,,,,,,,,
470,0,OMOP SDOH,Phenotypic Feature,SDOHO Determinant,Female Homosexuality,SDOHO:470; Female_Homosexuality,2022-01-01,1,,,,,,,,,
121_POP,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Female In Population,,2024-09-15,1,,,,,,,,,
GIS1001281,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Female Population,,2024-09-15,1,,,,,,,,,
GIS1001284,0,OMOP SDOH,Observation,SDG Goal,Finance,,2017-03-01,1,,,,,,,,,
GIS1001289,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Financial Burden,,2024-09-15,1,,,,,,,,,
281,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Financial Distressing,SDOHO:281; Financial_Distressing,2022-01-01,1,,,,,,,,,
394,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Financial Insecurity,SDOHO:394; Financial_Insecurity,2022-01-01,1,,,,,,,,,
10.5.1,0,OMOP SDOH,Observation,SDG Indicator,Financial Soundness Indicators,,2017-03-01,1,,,,,,,,,
725,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Financial Stress,SDOHO:725; Financial_Stress,2022-01-01,1,,,,,,,,,
585,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Financial Support,SDOHO:585; Financial_Support,2022-01-01,1,,,,,,,,,
17.6.1,0,OMOP SDOH,Observation,SDG Indicator,"Fixed Internet broadband subscriptions per 100 inhabitants, by speed5",,2017-03-01,1,,,,,,,,,
F_UNEMP,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Civilian Unemployed Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_UNEMP,2018-01-01,1,,,,,,,,,
F_CROWD,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Crowded Households Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_CROWD,2018-01-01,1,,,,,,,,,
F_MUNIT,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Households In Multi-Unit Housing Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_MUNIT,2018-01-01,1,,,,,,,,,
F_NOVEH,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Households With No Vehicles Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_NOVEH,2018-01-01,1,,,,,,,,,
F_HBURD,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Housing Cost- Burdened Occupied Housing Units Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_HBURD,2018-01-01,1,,,,,,,,,
F_MINRTY,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Minority Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_MINRTY,2018-01-01,1,,,,,,,,,
F_MOBILE,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Mobile Homes Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_MOBILE,2018-01-01,1,,,,,,,,,
F_AGE17,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Persons Aged 17 And Younger Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_AGE17,2018-01-01,1,,,,,,,,,
F_AGE65,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Persons Aged 65 And Older Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_AGE65,2018-01-01,1,,,,,,,,,
F_POV150,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Persons Below 150% Poverty Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_POV150,2018-01-01,1,,,,,,,,,
F_GROUPQ,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Persons In Group Quarters Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_GROUPQ,2018-01-01,1,,,,,,,,,
F_DISABL,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Persons With A Disability Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_DISABL,2018-01-01,1,,,,,,,,,
F_NOHSDP,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Persons With No High School Diploma Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_NOHSDP,2018-01-01,1,,,,,,,,,
F_SNGPNT,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Single-Parent Households Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_SNGPNT,2018-01-01,1,,,,,,,,,
F_UNINSUR,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Of Uninsured Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_UNINSUR,2018-01-01,1,,,,,,,,,
F_LIMENG,0,OMOP SDOH,Observation,SVI Item,"Flag - The Percentage Those With Limited English Is In The 90th Percentile (1 = Yes, 0 = No)",SVI:F_LIMENG,2018-01-01,1,,,,,,,,,
POINT_ZIP,0,OMOP SDOH,Geographic Feature,SVI Item,Flag For Zips Associated Bulk Mail Delivery Points For Large Facilities (ZIP Level),SVI:POINT_ZIP,2018-01-01,1,,,,,,,,,
F_ASTHMA,0,OMOP SDOH,Observation,EJI HVM Item,Flag Indicating Tracts Greater Than 0.6666 Percentile Rank With Asthma,EJI:F_ASTHMA,2022-01-01,1,,,,,,,,,
F_CANCER,0,OMOP SDOH,Observation,EJI HVM Item,Flag Indicating Tracts Greater Than 0.6666 Percentile Rank With Cancer,EJI:F_CANCER,2022-01-01,1,,,,,,,,,
F_DIABETES,0,OMOP SDOH,Observation,EJI HVM Item,Flag Indicating Tracts Greater Than 0.6666 Percentile Rank With Diabetes,EJI:F_DIABETES,2022-01-01,1,,,,,,,,,
F_BPHIGH,0,OMOP SDOH,Observation,EJI HVM Item,Flag Indicating Tracts Greater Than 0.6666 Percentile Rank With High Blood Pressure,EJI:F_BPHIGH,2022-01-01,1,,,,,,,,,
F_MHLTH,0,OMOP SDOH,Observation,EJI HVM Item,Flag Indicating Tracts Greater Than 0.6666 Percentile Rank With Not Good Mental Health,EJI:F_MHLTH,2022-01-01,1,,,,,,,,,
GIS1001293,0,OMOP SDOH,Socioeconomic Feature,AHRQ Construct,Food Access,,2022-01-01,1,,,,,,,,,
GIS1001297,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Food Access In Population,,2024-09-15,1,,,,,,,,,
GIS1001347,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Food Addiction,,2024-09-15,1,,,,,,,,,
542,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Food Assistance,SDOHO:542; Food_Assistance,2022-01-01,1,,,,,,,,,
GIS1001349,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Food Availability,,2024-09-15,1,,,,,,,,,
541,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Food Bank,SDOHO:541; Food_Bank,2022-01-01,1,,,,,,,,,
681,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Food Cost,SDOHO:681; Food_Cost,2022-01-01,1,,,,,,,,,
GIS1001351,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Food Environment,,2024-09-15,1,,,,,,,,,
44,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Food Insecurity,SDOHO:44; Food_Insecurity,2022-01-01,1,,,,,,,,,
GIS1001353,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Food Intake,,2024-09-15,1,,,,,,,,,
688,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Food Preparation And Serving Related Occupation,SDOHO:688; Food_Preparation_and_Serving_Related_Occupation,2022-01-01,1,,,,,,,,,
GIS1001430,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Food Quality,,2024-09-15,1,,,,,,,,,
GIS1001432,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Food Security,,2024-09-15,1,,,,,,,,,
186,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Food Swamp,SDOHO:186; Food_Swamp,2022-01-01,1,,,,,,,,,
GIS1001458,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Food Utilization,,2024-09-15,1,,,,,,,,,
15.1.1,0,OMOP SDOH,Observation,SDG Indicator,Forest area as a proportion of total land area,,2017-03-01,1,,,,,,,,,
GIS1001460,0,OMOP SDOH,Observation,GIS Measure,Fraction,,2024-09-15,1,,,,,,,,,
OPP_INCAR_ASN_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_ASN_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_ASN_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_ASN_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_ASN_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_ASN_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_ASN_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_ASN_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_ASN_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_ASN_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Asian Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_ASN_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_BLK_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_BLK_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_BLK_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_BLK_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_BLK_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_BLK_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_BLK_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_BLK_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_BLK_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Black Or African American Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_BLK_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_HSP_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_HSP_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_HSP_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_HSP_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_HSP_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_HSP_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_HSP_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_HSP_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_HSP_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Hispanic Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_HSP_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_NAM_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_NAM_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_NAM_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_NAM_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_NAM_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_NAM_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_NAM_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_NAM_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_NAM_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Native American Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_NAM_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_OTHER_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_OTHER_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_OTHER_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_OTHER_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_OTHER_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_OTHER_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_OTHER_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_OTHER_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_OTHER_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: Other Race Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_OTHER_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_WHT_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_WHT_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_WHT_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_WHT_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_WHT_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_INCAR_WHT_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_INCAR_WHT_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_INCAR_WHT_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_INCAR_WHT_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Fraction Incarcerated On April 1st 2010: White Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_INCAR_WHT_M_HH_75PT,2022-01-01,1,,,,,,,,,
GIS1001461,0,OMOP SDOH,Observation,GIS Measure,Frequency,,2024-09-15,1,,,,,,,,,
830,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Friend Relationship,SDOHO:830; Friend_Relationship,2022-01-01,1,,,,,,,,,
566,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Friend Support,SDOHO:566; Friend_Support,2022-01-01,1,,,,,,,,,
StateDesc,0,OMOP SDOH,Observation,EJI Item,Full State Name,EJI:StateDesc,2022-01-01,1,,,,,,,,,
233,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Full-Time Employment,SDOHO:233; Full-time_Employment,2022-01-01,1,,,,,,,,,
17.8,0,OMOP SDOH,Observation,SDG Goal,"Fully operationalize the technology bank and science, technology and innovation capacity-building mechanism for least developed countries by 2017 and enhance the use of enabling technology, in particular information and communications technology",,2017-03-01,1,,,,,,,,,
134,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Gender,SDOHO:134; Gender,2022-01-01,1,,,,,,,,,
GIS1001462,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Gender At Birth,,2024-09-15,1,,,,,,,,,
112,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Gender Identity,SDOHO:112; Gender_Identity,2022-01-01,1,,,,,,,,,
357,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Gender Inequity,SDOHO:357; Gender_Inequity,2022-01-01,1,,,,,,,,,
328,0,OMOP SDOH,Observation,SDOHO Item,General Educational Development (GED),SDOHO:328; Patient,2022-01-01,1,,,,,,,,,
GIS1001464,0,OMOP SDOH,Geographic Feature,SDOH Construct,Geography In Population,,2024-09-15,1,,,,,,,,,
ACS_GINI_INDEX,0,OMOP SDOH,Observation,AHRQ Item,Gini Index Of Income Inequality,AHRQ:ACS_GINI_INDEX,2022-01-01,1,,,,,,,,,
276,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Good Adherence,SDOHO:276,2022-01-01,1,,,,,,,,,
GIS1001472,0,OMOP SDOH,Type Concept,Exposure Type Concept,Government Data,,2024-09-15,1,,,,,,,,,
SEDA_ELA_GR3_NEG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Cohort Scale (Cs) Gap, Non-Economically Disadvantaged (Non-Ecd)-Economically Disadvantaged (Ecd)",AHRQ:SEDA_ELA_GR3_NEG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR3_WAG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Cohort Scale (Cs) Gap, White-Asian",AHRQ:SEDA_ELA_GR3_WAG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR3_WBG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Cohort Scale (Cs) Gap, White-Black Or African American",AHRQ:SEDA_ELA_GR3_WBG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR3_WHG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Cohort Scale (Cs) Gap, White-Hispanic",AHRQ:SEDA_ELA_GR3_WHG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR3_WMG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Cohort Scale (Cs) Gap, White-Multiracial",AHRQ:SEDA_ELA_GR3_WMG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR3_WNG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Cohort Scale (Cs) Gap, White-Native American",AHRQ:SEDA_ELA_GR3_WNG,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_ALL,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), All Students",AHRQ:SEDA_CS_MN_ELA_GR3_ALL,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_ASN,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), Asian Students",AHRQ:SEDA_CS_MN_ELA_GR3_ASN,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_BLK,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), Black Or African American Students",AHRQ:SEDA_CS_MN_ELA_GR3_BLK,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_ECD,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), Economically Disadvantaged (Ecd) Students",AHRQ:SEDA_CS_MN_ELA_GR3_ECD,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_HSP,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), Hispanic Students",AHRQ:SEDA_CS_MN_ELA_GR3_HSP,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_MTR,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), Multiracial Students",AHRQ:SEDA_CS_MN_ELA_GR3_MTR,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_NAM,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), Native American Students",AHRQ:SEDA_CS_MN_ELA_GR3_NAM,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_NEC,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), Non-Economically Disadvantaged (Non-Ecd) Students",AHRQ:SEDA_CS_MN_ELA_GR3_NEC,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR3_WHT,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Mean Cohort Scale (Cs), White Students",AHRQ:SEDA_CS_MN_ELA_GR3_WHT,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_ALL,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, All Students",AHRQ:SEDA_CS_TOT_ELA_GR3_ALL,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_ASN,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, Asian Students",AHRQ:SEDA_CS_TOT_ELA_GR3_ASN,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_BLK,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, Black Or African American Students",AHRQ:SEDA_CS_TOT_ELA_GR3_BLK,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_ECD,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, Economically Disadvantaged (Ecd) Students",AHRQ:SEDA_CS_TOT_ELA_GR3_ECD,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_HSP,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, Hispanic Students",AHRQ:SEDA_CS_TOT_ELA_GR3_HSP,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_MTR,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, Multiracial Students",AHRQ:SEDA_CS_TOT_ELA_GR3_MTR,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_NAM,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, Native American Students",AHRQ:SEDA_CS_TOT_ELA_GR3_NAM,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_NEC,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, Non-Economically Disadvantaged (Non-Ecd) Students",AHRQ:SEDA_CS_TOT_ELA_GR3_NEC,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR3_WHT,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Ela Sample Size, White Students",AHRQ:SEDA_CS_TOT_ELA_GR3_WHT,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR3_NEG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Cohort Scale (Cs) Gap, Non-Economically Disadvantaged (Non-Ecd)-Economically Disadvantaged (Ecd)",AHRQ:SEDA_MATH_GR3_NEG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR3_WAG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Cohort Scale (Cs) Gap, White-Asian",AHRQ:SEDA_MATH_GR3_WAG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR3_WBG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Cohort Scale (Cs) Gap, White-Black Or African American",AHRQ:SEDA_MATH_GR3_WBG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR3_WHG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Cohort Scale (Cs) Gap, White-Hispanic",AHRQ:SEDA_MATH_GR3_WHG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR3_WMG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Cohort Scale (Cs) Gap, White-Multiracial",AHRQ:SEDA_MATH_GR3_WMG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR3_WNG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Cohort Scale (Cs) Gap, White-Native American",AHRQ:SEDA_MATH_GR3_WNG,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_ALL,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), All Students",AHRQ:SEDA_CS_MN_MATH_GR3_ALL,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_ASN,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), Asian Students",AHRQ:SEDA_CS_MN_MATH_GR3_ASN,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_BLK,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), Black Or African American Students",AHRQ:SEDA_CS_MN_MATH_GR3_BLK,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_ECD,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), Economically Disadvantaged (Ecd) Students",AHRQ:SEDA_CS_MN_MATH_GR3_ECD,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_HSP,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), Hispanic Students",AHRQ:SEDA_CS_MN_MATH_GR3_HSP,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_MTR,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), Multiracial Students",AHRQ:SEDA_CS_MN_MATH_GR3_MTR,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_NAM,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), Native American Students",AHRQ:SEDA_CS_MN_MATH_GR3_NAM,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_NEC,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), Non-Economically Disadvantaged (Non-Ecd) Students",AHRQ:SEDA_CS_MN_MATH_GR3_NEC,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR3_WHT,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Mean Cohort Scale (Cs), White Students",AHRQ:SEDA_CS_MN_MATH_GR3_WHT,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_ALL,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, All Students",AHRQ:SEDA_CS_TOT_MATH_GR3_ALL,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_ASN,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, Asian Students",AHRQ:SEDA_CS_TOT_MATH_GR3_ASN,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_BLK,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, Black Or African American Students",AHRQ:SEDA_CS_TOT_MATH_GR3_BLK,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_ECD,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, Economically Disadvantaged (Ecd) Students",AHRQ:SEDA_CS_TOT_MATH_GR3_ECD,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_HSP,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, Hispanic Students",AHRQ:SEDA_CS_TOT_MATH_GR3_HSP,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_MTR,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, Multiracial Students",AHRQ:SEDA_CS_TOT_MATH_GR3_MTR,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_NAM,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, Native American Students",AHRQ:SEDA_CS_TOT_MATH_GR3_NAM,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_NEC,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, Non-Economically Disadvantaged (Non-Ecd) Students",AHRQ:SEDA_CS_TOT_MATH_GR3_NEC,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR3_WHT,0,OMOP SDOH,Observation,AHRQ Item,"Grade 3 Math Sample Size, White Students",AHRQ:SEDA_CS_TOT_MATH_GR3_WHT,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR8_NEG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Cohort Scale (Cs) Gap, Non-Economically Disadvantaged (Non-Ecd)-Economically Disadvantaged (Ecd)",AHRQ:SEDA_ELA_GR8_NEG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR8_WAG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Cohort Scale (Cs) Gap, White Asian",AHRQ:SEDA_ELA_GR8_WAG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR8_WBG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Cohort Scale (Cs) Gap, White-Black Or African American",AHRQ:SEDA_ELA_GR8_WBG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR8_WHG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Cohort Scale (Cs) Gap, White-Hispanic",AHRQ:SEDA_ELA_GR8_WHG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR8_WMG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Cohort Scale (Cs) Gap, White-Multiracial",AHRQ:SEDA_ELA_GR8_WMG,2022-01-01,1,,,,,,,,,
SEDA_ELA_GR8_WNG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Cohort Scale (Cs) Gap, White-Native American",AHRQ:SEDA_ELA_GR8_WNG,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_ALL,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), All Students",AHRQ:SEDA_CS_MN_ELA_GR8_ALL,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_ASN,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), Asian Students",AHRQ:SEDA_CS_MN_ELA_GR8_ASN,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_BLK,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), Black Or African American Students",AHRQ:SEDA_CS_MN_ELA_GR8_BLK,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_ECD,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), Economically Disadvantaged (Ecd) Students",AHRQ:SEDA_CS_MN_ELA_GR8_ECD,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_HSP,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), Hispanic Students",AHRQ:SEDA_CS_MN_ELA_GR8_HSP,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_MTR,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), Multiracial Students",AHRQ:SEDA_CS_MN_ELA_GR8_MTR,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_NAM,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), Native American Students",AHRQ:SEDA_CS_MN_ELA_GR8_NAM,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_NEC,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), Non-Economically Disadvantaged (Non-Ecd) Students",AHRQ:SEDA_CS_MN_ELA_GR8_NEC,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_ELA_GR8_WHT,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Mean Cohort Scale (Cs), White Students",AHRQ:SEDA_CS_MN_ELA_GR8_WHT,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_ALL,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, All Students",AHRQ:SEDA_CS_TOT_ELA_GR8_ALL,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_ASN,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, Asian Students",AHRQ:SEDA_CS_TOT_ELA_GR8_ASN,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_BLK,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, Black Or African American Students",AHRQ:SEDA_CS_TOT_ELA_GR8_BLK,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_ECD,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, Economically Disadvantaged (Ecd) Students",AHRQ:SEDA_CS_TOT_ELA_GR8_ECD,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_HSP,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, Hispanic Students",AHRQ:SEDA_CS_TOT_ELA_GR8_HSP,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_MTR,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, Multiracial Students",AHRQ:SEDA_CS_TOT_ELA_GR8_MTR,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_NAM,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, Native American Students",AHRQ:SEDA_CS_TOT_ELA_GR8_NAM,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_NEC,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, Non-Economically Disadvantaged (Non-Ecd) Students",AHRQ:SEDA_CS_TOT_ELA_GR8_NEC,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_ELA_GR8_WHT,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Ela Sample Size, White Students",AHRQ:SEDA_CS_TOT_ELA_GR8_WHT,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR8_NEG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Cohort Scale (Cs) Gap, Non-Economically Disadvantaged (Non-Ecd)-Economically Disadvantaged (Ecd)",AHRQ:SEDA_MATH_GR8_NEG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR8_WAG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Cohort Scale (Cs) Gap, White-Asian",AHRQ:SEDA_MATH_GR8_WAG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR8_WBG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Cohort Scale (Cs) Gap, White-Black Or African American",AHRQ:SEDA_MATH_GR8_WBG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR8_WHG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Cohort Scale (Cs) Gap, White-Hispanic",AHRQ:SEDA_MATH_GR8_WHG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR8_WMG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Cohort Scale (Cs) Gap, White-Multiracial",AHRQ:SEDA_MATH_GR8_WMG,2022-01-01,1,,,,,,,,,
SEDA_MATH_GR8_WNG,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Cohort Scale (Cs) Gap, White-Native American",AHRQ:SEDA_MATH_GR8_WNG,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_ALL,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), All Students",AHRQ:SEDA_CS_MN_MATH_GR8_ALL,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_ASN,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), Asian Students",AHRQ:SEDA_CS_MN_MATH_GR8_ASN,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_BLK,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), Black Or African American Students",AHRQ:SEDA_CS_MN_MATH_GR8_BLK,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_ECD,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), Economically Disadvantaged (Ecd) Students",AHRQ:SEDA_CS_MN_MATH_GR8_ECD,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_HSP,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), Hispanic Students",AHRQ:SEDA_CS_MN_MATH_GR8_HSP,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_MTR,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), Multiracial Students",AHRQ:SEDA_CS_MN_MATH_GR8_MTR,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_NAM,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), Native American Students",AHRQ:SEDA_CS_MN_MATH_GR8_NAM,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_NEC,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), Non-Economically Disadvantaged (Non-Ecd) Students",AHRQ:SEDA_CS_MN_MATH_GR8_NEC,2022-01-01,1,,,,,,,,,
SEDA_CS_MN_MATH_GR8_WHT,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Mean Cohort Scale (Cs), White Students",AHRQ:SEDA_CS_MN_MATH_GR8_WHT,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_ALL,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, All Students",AHRQ:SEDA_CS_TOT_MATH_GR8_ALL,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_ASN,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, Asian Students",AHRQ:SEDA_CS_TOT_MATH_GR8_ASN,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_BLK,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, Black Or African American Students",AHRQ:SEDA_CS_TOT_MATH_GR8_BLK,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_ECD,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, Economically Disadvantaged (Ecd) Students",AHRQ:SEDA_CS_TOT_MATH_GR8_ECD,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_HSP,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, Hispanic Students",AHRQ:SEDA_CS_TOT_MATH_GR8_HSP,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_MTR,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, Multiracial Students",AHRQ:SEDA_CS_TOT_MATH_GR8_MTR,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_NAM,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, Native American Students",AHRQ:SEDA_CS_TOT_MATH_GR8_NAM,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_NEC,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, Non-Economically Disadvantaged (Non-Ecd) Students",AHRQ:SEDA_CS_TOT_MATH_GR8_NEC,2022-01-01,1,,,,,,,,,
SEDA_CS_TOT_MATH_GR8_WHT,0,OMOP SDOH,Observation,AHRQ Item,"Grade 8 Math Sample Size, White Students",AHRQ:SEDA_CS_TOT_MATH_GR8_WHT,2022-01-01,1,,,,,,,,,
872,0,OMOP SDOH,Environmental Feature,SDOHO Construct,Green Space,SDOHO:872; Green_Space,2022-01-01,1,,,,,,,,,
10.1.1,0,OMOP SDOH,Observation,SDG Indicator,Growth rates of household expenditure or income per capita among the bottom 40 per cent of the population and the total population,,2017-03-01,1,,,,,,,,,
GIS1001473,0,OMOP SDOH,Behavioral Feature,SDOH Determinant,Hand Hygiene Practices,,2024-09-15,1,,,,,,,,,
GIS1001475,0,OMOP SDOH,Environmental Feature,COI Determinant,Hazardous Waste Dump Sites,,2020-01-01,1,,,,,,,,,
GIS1001477,0,OMOP SDOH,Behavioral Feature,AHRQ Construct,Health Behaviors,,2022-01-01,1,,,,,,,,,
GIS1001480,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Health Behaviors In Population,,2024-09-15,1,,,,,,,,,
196,0,OMOP SDOH,Observation,SDOHO Item,Health Care Access Score,SDOHO:196; Health_Care_Access_Score,2022-01-01,1,,,,,,,,,
267,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Health Care Payment Source,SDOHO:267; Health_Care_Payment_Source,2022-01-01,1,,,,,,,,,
GIS1001528,0,OMOP SDOH,Healthcare Feature,AHRQ Construct,Health Care Quality,,2022-01-01,1,,,,,,,,,
GIS1001530,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Health Care Quality In Population,,2024-09-15,1,,,,,,,,,
204,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Health Care Translator Service,SDOHO:204; Health_Care_Translator_Service,2022-01-01,1,,,,,,,,,
209,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Health Discussion Engagement,SDOHO:209; Health_Discussion_Engagement,2022-01-01,1,,,,,,,,,
GIS1001559,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Health Information Seeking Behaviors,,2024-09-15,1,,,,,,,,,
471,0,OMOP SDOH,Healthcare Feature,SDOHO Value,Health Insurance,SDOHO:471,2022-01-01,1,,,,,,,,,
614,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Health Insurance Coverage,SDOHO:614; Health_Insurance_Coverage,2022-01-01,1,,,,,,,,,
614_POP,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Health Insurance Coverage In Population,,2024-09-15,1,,,,,,,,,
GIS1001562,0,OMOP SDOH,Healthcare Feature,AHRQ Determinant,Health Insurance Status,,2022-01-01,1,,,,,,,,,
GIS1001564,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Health Insurance Status In Population,,2024-09-15,1,,,,,,,,,
GIS1001597,0,OMOP SDOH,Healthcare Feature,SDOH Construct,Health Literacy,,2024-09-15,1,,,,,,,,,
451,0,OMOP SDOH,Healthcare Feature,SDOHO Construct,Health Numeracy,SDOHO:451; Health_Numeracy,2022-01-01,1,,,,,,,,,
GIS1001605,0,OMOP SDOH,Healthcare Feature,AHRQ Construct,Health Outcomes,,2022-01-01,1,,,,,,,,,
GIS1001608,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Health Outcomes In Population,,2024-09-15,1,,,,,,,,,
AHRF_HPSA_DENTIST,0,OMOP SDOH,Observation,AHRQ Item,Health Professional Shortage Area (Hpsa) Code-Shortage Of Dentists,AHRQ:AHRF_HPSA_DENTIST,2022-01-01,1,,,,,,,,,
AHRF_HPSA_MENTAL,0,OMOP SDOH,Observation,AHRQ Item,Health Professional Shortage Area (Hpsa) Code-Shortage Of Mental Healthcare Providers,AHRQ:AHRF_HPSA_MENTAL,2022-01-01,1,,,,,,,,,
AHRF_HPSA_PRIM,0,OMOP SDOH,Observation,AHRQ Item,Health Professional Shortage Area (Hpsa) Code-Shortage Of Primary Care Physicians,AHRQ:AHRF_HPSA_PRIM,2022-01-01,1,,,,,,,,,
GIS1001680,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Health Screening Behaviors,,2024-09-15,1,,,,,,,,,
806,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Health Stress,SDOHO:806; Health_Stress,2022-01-01,1,,,,,,,,,
3.c.1,0,OMOP SDOH,Observation,SDG Indicator,Health worker density and distribution,,2017-03-01,1,,,,,,,,,
GIS1001510,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Healthcare Coverage,,2024-09-15,1,,,,,,,,,
724,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Healthcare Practitioner And Technical Occupation,SDOHO:724; Healthcare_Practitioner_and_Technical_Occupation,2022-01-01,1,,,,,,,,,
GIS1001520,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Healthcare Provider,,2024-09-15,1,,,,,,,,,
GIS1001526,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Healthcare Provider Availability,,2024-09-15,1,,,,,,,,,
SEDH:4.1,0,OMOP SDOH,Healthcare Feature,SEDH Construct,Healthcare Quality And Access,SEDH:4.1,2021-01-01,1,,,,,,,,,
589,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Healthcare Support,SDOHO:589; Healthcare_Support,2022-01-01,1,,,,,,,,,
690,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Healthcare Support Occupation,SDOHO:690; Healthcare_Support_Occupation,2022-01-01,1,,,,,,,,,
621,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Healthcare Visit,SDOHO:621; Healthcare_Visit,2022-01-01,1,,,,,,,,,
158,0,OMOP SDOH,Observation,SDOHO Item,Healthy Eating Index,SDOHO:158; Healthy_Eating_Index,2022-01-01,1,,,,,,,,,
3.3.4,0,OMOP SDOH,Observation,SDG Indicator,"Hepatitis B incidence per 100,000 population",,2017-03-01,1,,,,,,,,,
GIS1001683,0,OMOP SDOH,Behavioral Feature,SDOH Determinant,Herbal Supplement Use,,2024-09-15,1,,,,,,,,,
AHA_HHI_SHRTTRM_ACUTE_ADMSN_CBSA,0,OMOP SDOH,Observation,AHRQ Item,"Herfindahl-Hirschman Index For Short-Term Acute Care Hospitals (Admission, Cbsa Level)",AHRQ:AHA_HHI_SHRTTRM_ACUTE_ADMSN_CBSA,2022-01-01,1,,,,,,,,,
AHA_HHI_SHRTTRM_ACUTE_ADMSN_CTY,0,OMOP SDOH,Observation,AHRQ Item,"Herfindahl-Hirschman Index For Short-Term Acute Care Hospitals (Admission, County Level)",AHRQ:AHA_HHI_SHRTTRM_ACUTE_ADMSN_CTY,2022-01-01,1,,,,,,,,,
AHA_HHI_SHRTTRM_ACUTE_DSCHR_CBSA,0,OMOP SDOH,Observation,AHRQ Item,"Herfindahl-Hirschman Index For Short-Term Acute Care Hospitals (Discharge, Cbsa Level)",AHRQ:AHA_HHI_SHRTTRM_ACUTE_DSCHR_CBSA,2022-01-01,1,,,,,,,,,
AHA_HHI_SHRTTRM_ACUTE_DSCHR_CTY,0,OMOP SDOH,Observation,AHRQ Item,"Herfindahl-Hirschman Index For Short-Term Acute Care Hospitals (Discharge, County Level)",AHRQ:AHA_HHI_SHRTTRM_ACUTE_DSCHR_CTY,2022-01-01,1,,,,,,,,,
AHA_HHI_SHRTTRM_ACUTE_LOS_CBSA,0,OMOP SDOH,Observation,AHRQ Item,"Herfindahl-Hirschman Index For Short-Term Acute Care Hospitals (Length Of Stay, Cbsa Level)",AHRQ:AHA_HHI_SHRTTRM_ACUTE_LOS_CBSA,2022-01-01,1,,,,,,,,,
AHA_HHI_SHRTTRM_ACUTE_LOS_CTY,0,OMOP SDOH,Observation,AHRQ Item,"Herfindahl-Hirschman Index For Short-Term Acute Care Hospitals (Length Of Stay, County Level)",AHRQ:AHA_HHI_SHRTTRM_ACUTE_LOS_CTY,2022-01-01,1,,,,,,,,,
970,0,OMOP SDOH,Phenotypic Feature,SDOHO Determinant,Heterosexuality,SDOHO:970; Heterosexuality,2022-01-01,1,,,,,,,,,
65,0,OMOP SDOH,Behavioral Feature,SDOHO Value,High Added Sugar Intake,SDOHO:65; High_Added_Sugar_Intake,2022-01-01,1,,,,,,,,,
7,0,OMOP SDOH,Behavioral Feature,SDOHO Value,High Fat Intake,SDOHO:7; High_Fat_Intake,2022-01-01,1,,,,,,,,,
SEDH:1.23,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,High Intensity Drug Trafficking Areas (HIDTA),SEDH:1.23,2021-01-01,1,,,,,,,,,
AHRF_HIGH_POV_USDA,0,OMOP SDOH,Observation,AHRQ Item,High Poverty Typology Code,AHRQ:AHRF_HIGH_POV_USDA,2022-01-01,1,,,,,,,,,
404,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,High School Graduation,SDOHO:404; High_School_Graduation,2022-01-01,1,,,,,,,,,
GIS1001687,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,High School Graduation Rate,,2020-01-01,1,,,,,,,,,
15,0,OMOP SDOH,Behavioral Feature,SDOHO Value,High Sodium Intake,SDOHO:15; High_Sodium_Intake,2022-01-01,1,,,,,,,,,
GIS1001684,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,High-Quality Early Childhood Education Centers,,2020-01-01,1,,,,,,,,,
GIS1001689,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,High-Skill Employment,,2020-01-01,1,,,,,,,,,
406,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Higher Education,SDOHO:406; Higher_Education,2022-01-01,1,,,,,,,,,
617,0,OMOP SDOH,Demographic Feature,SDOHO Value,Hispanic,SDOHO:617; Hispanic,2022-01-01,1,,,,,,,,,
E_HISP,0,OMOP SDOH,Observation,SVI Item,Hispanic Or Latino Persons Estimate,SVI:E_HISP,2018-01-01,1,,,,,,,,,
M_HISP,0,OMOP SDOH,Observation,SVI Item,Hispanic Or Latino Persons Estimate MOE,SVI:M_HISP,2018-01-01,1,,,,,,,,,
885,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Homeless,SDOHO:885; Homeless,2022-01-01,1,,,,,,,,,
238,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Homemaker,SDOHO:238; Homemaker,2022-01-01,1,,,,,,,,,
GIS1001691,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Homeownership Rate,,2020-01-01,1,,,,,,,,,
467,0,OMOP SDOH,Phenotypic Feature,SDOHO Determinant,Homosexuality,SDOHO:467; Homosexuality,2022-01-01,1,,,,,,,,,
467_POP,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Homosexuality In Population,,2024-09-15,1,,,,,,,,,
623,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Hospitalization,SDOHO:623; Hospitalization,2022-01-01,1,,,,,,,,,
THEME2,0,OMOP SDOH,Socioeconomic Feature,SVI Construct,Household Characteristics,SVI:THEME2,2018-01-01,1,,,,,,,,,
GIS1001693,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Household Characteristics In Population,,2024-09-15,1,,,,,,,,,
GIS1001741,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Household Income Growth,,2024-09-15,1,,,,,,,,,
E_HH,0,OMOP SDOH,Observation,SVI Item,Households Estimate,SVI:E_HH,2018-01-01,1,,,,,,,,,
M_HH,0,OMOP SDOH,Observation,SVI Item,Households Estimate MOE,SVI:M_HH,2018-01-01,1,,,,,,,,,
E_NOVEH,0,OMOP SDOH,Observation,SVI Item,Households With No Vehicle Available Estimate,SVI:E_NOVEH,2018-01-01,1,,,,,,,,,
M_NOVEH,0,OMOP SDOH,Observation,SVI Item,Households With No Vehicle Available Estimate MOE,SVI:M_NOVEH,2018-01-01,1,,,,,,,,,
E_NOINT,0,OMOP SDOH,Observation,SVI Item,Households Without A Computer With A Broadband Internet Subscription Estimate,SVI:E_NOINT,2018-01-01,1,,,,,,,,,
M_NOINT,0,OMOP SDOH,Observation,SVI Item,Households Without A Computer With A Broadband Internet Subscription Estimate MOE,SVI:M_NOINT,2018-01-01,1,,,,,,,,,
GIS1001748,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Housing,,2022-01-01,1,,,,,,,,,
682,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Housing Cost,SDOHO:682; Housing_Cost,2022-01-01,1,,,,,,,,,
E_HBURD,0,OMOP SDOH,Observation,SVI Item,"Housing Cost- Burdened Occupied Housing Units With Annual Income Less Than $75,000 (30%+ Of Income Spent On Housing Costs) Estimate",SVI:E_HBURD,2018-01-01,1,,,,,,,,,
M_HBURD,0,OMOP SDOH,Observation,SVI Item,"Housing Cost- Burdened Occupied Housing Units With Annual Income Less Than $75,000 (30%+ Of Income Spent On Housing Costs) Estimate MOE",SVI:M_HBURD,2018-01-01,1,,,,,,,,,
GIS1001758,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Housing In Population,,2024-09-15,1,,,,,,,,,
E_MUNIT,0,OMOP SDOH,Observation,SVI Item,Housing In Structures With 10 Or More Units Estimate,SVI:E_MUNIT,2018-01-01,1,,,,,,,,,
M_MUNIT,0,OMOP SDOH,Observation,SVI Item,Housing In Structures With 10 Or More Units Estimate MOE,SVI:M_MUNIT,2018-01-01,1,,,,,,,,,
396,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Housing Instability,SDOHO:396; Housing_Instability,2022-01-01,1,,,,,,,,,
GIS1001795,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Housing Quality,,2024-09-15,1,,,,,,,,,
GIS1001797,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Housing Status,,2024-09-15,1,,,,,,,,,
THEME4,0,OMOP SDOH,Socioeconomic Feature,SVI Determinant,Housing Type & Transportation,SVI:THEME4,2018-01-01,1,,,,,,,,,
GIS1001799,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Housing Type & Transportation In Population,,2024-09-15,1,,,,,,,,,
E_HU,0,OMOP SDOH,Observation,SVI Item,Housing Units Estimate,SVI:E_HU,2018-01-01,1,,,,,,,,,
M_HU,0,OMOP SDOH,Observation,SVI Item,Housing Units Estimate MOE,SVI:M_HU,2018-01-01,1,,,,,,,,,
GIS1001835,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Housing Vacancy Rate,,2020-01-01,1,,,,,,,,,
GIS1001837,0,OMOP SDOH,Observation,EJI Item,Housing With Group Quarters,,2022-01-01,1,,,,,,,,,
GIS1001838,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Human Rights Institutions,,2024-09-15,1,,,,,,,,,
GIS1001839,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Human Rights Violations,,2024-09-15,1,,,,,,,,,
GIS1001840,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Human Trafficking,,2024-09-15,1,,,,,,,,,
168,0,OMOP SDOH,Observation,SDOHO Item,"Humiliation, Afraid, Rape, Kick Questions","SDOHO:168; Humiliation, Afraid, Rape, Kick Questions",2022-01-01,1,,,,,,,,,
GIS1001841,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Illegal Drug Trade,,2021-01-01,1,,,,,,,,,
GIS1001843,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Immigration,,2022-01-01,1,,,,,,,,,
GIS1001847,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Immigration In Population,,2024-09-15,1,,,,,,,,,
GIS1001859,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Immigration Status,,2024-09-15,1,,,,,,,,,
GIS1001862,0,OMOP SDOH,Type Concept,Exposure Type Concept,Immunization Registry,,2024-09-15,1,,,,,,,,,
GIS1001863,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Immunization Status,,2024-09-15,1,,,,,,,,,
1.3,0,OMOP SDOH,Observation,SDG Goal,"Implement nationally appropriate social protection systems and measures for all, including floors, and by 2030 achieve substantial coverage of the poor and the vulnerable",,2017-03-01,1,,,,,,,,,
12.1,0,OMOP SDOH,Observation,SDG Goal,"Implement the 10-Year Framework of Programmes on Sustainable Consumption and Production Patterns, all countries taking action, with developed countries taking the lead, taking into account the development and capabilities of developing countries",,2017-03-01,1,,,,,,,,,
13.a,0,OMOP SDOH,Observation,SDG Goal,Implement the commitment undertaken by developed- country parties to the United Nations Framework Convention on Climate Change to a goal of mobilizing jointly $100 billion annually by 2020 from all sources to address the needs of developing countries i...,Implement the commitment undertaken by developed- country parties to the United Nations Framework Convention on Climate Change to a goal of mobilizing jointly $100 billion annually by 2020 from all sources to address the needs of developing countries in the context of meaningful mitigation actions and transparency on implementation and fully operationalize the Green Climate Fund through its capitalization as soon as possible,2017-03-01,1,,,,,,,,,
10.a,0,OMOP SDOH,Observation,SDG Goal,"Implement the principle of special and differential treatment for developing countries, in particular least developed countries, in accordance with World Trade Organization agreements",,2017-03-01,1,,,,,,,,,
12.b.1,0,OMOP SDOH,Observation,SDG Indicator,Implementation of standard accounting tools to monitor the economic and environmental aspects of tourism sustainability,,2017-03-01,1,,,,,,,,,
13.3,0,OMOP SDOH,Observation,SDG Goal,"Improve education, awareness-raising and human and institutional capacity on climate change mitigation, adaptation, impact reduction and early warning",,2017-03-01,1,,,,,,,,,
8.4,0,OMOP SDOH,Observation,SDG Goal,"Improve progressively, through 2030, global resource efficiency in consumption and production and endeavour to decouple economic growth from environmental degradation, in accordance with the 10-Year Framework of Programmes on Sustainable Consumption an...","Improve progressively, through 2030, global resource efficiency in consumption and production and endeavour to decouple economic growth from environmental degradation, in accordance with the 10-Year Framework of Programmes on Sustainable Consumption and Production, with developed countries taking the lead",2017-03-01,1,,,,,,,,,
10.5,0,OMOP SDOH,Observation,SDG Goal,Improve the regulation and monitoring of global financial markets and institutions and strengthen the implementation of such regulations,,2017-03-01,1,,,,,,,,,
GIS1002065,0,OMOP SDOH,Observation,COI Item,In One Of The 100 Largest Metro Areas,,2020-01-01,1,,,,,,,,,
60,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Inadequate Calcium Intake,SDOHO:60; Inadequate_Calcium_Intake,2022-01-01,1,,,,,,,,,
609,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Incarceration,SDOHO:609; Incarceration,2022-01-01,1,,,,,,,,,
GIS1010326,0,OMOP SDOH,Observation,GIS Measure,Incidence Measure,,2024-09-15,1,,,,,,,,,
GIS1001875,0,OMOP SDOH,Observation,ADI Item,Income Disparity,,2018-01-01,1,,,,,,,,,
GIS1001882,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Income In Population,,2024-09-15,1,,,,,,,,,
GIS1001880,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Income Inequality,,2021-01-01,1,,,,,,,,,
SEDH:1.21,0,OMOP SDOH,Observation,SEDH Item,Income Inequality (American Community Survey Income Inequality Measures Based On Income To Poverty Ratio By Census Block Group),SEDH:1.21,2021-01-01,1,,,,,,,,,
GIS1001877,0,OMOP SDOH,Observation,ADI Item,Income/Employment,,2018-01-01,1,,,,,,,,,
8.a,0,OMOP SDOH,Observation,SDG Goal,"Increase Aid for Trade support for developing countries, in particular least developed countries, including through the Enhanced Integrated Framework for Trade- related Technical Assistance to Least Developed Countries",,2017-03-01,1,,,,,,,,,
2.a,0,OMOP SDOH,Observation,SDG Goal,"Increase investment, including through enhanced international cooperation, in rural infrastructure, agricultural research and extension services, technology development and plant and livestock gene banks in order to enhance agricultural productive capa...","Increase investment, including through enhanced international cooperation, in rural infrastructure, agricultural research and extension services, technology development and plant and livestock gene banks in order to enhance agricultural productive capacity in developing countries, in particular least developed countries",2017-03-01,1,,,,,,,,,
14.a,0,OMOP SDOH,Observation,SDG Goal,"Increase scientific knowledge, develop research capacity and transfer marine technology, taking into account the Intergovernmental Oceanographic Commission Criteria and Guidelines on the Transfer of Marine Technology, in order to improve ocean health a...","Increase scientific knowledge, develop research capacity and transfer marine technology, taking into account the Intergovernmental Oceanographic Commission Criteria and Guidelines on the Transfer of Marine Technology, in order to improve ocean health and to enhance the contribution of marine biodiversity to the development of developing countries, in particular small island developing States and least developed countries",2017-03-01,1,,,,,,,,,
9.3,0,OMOP SDOH,Observation,SDG Goal,"Increase the access of small-scale industrial and other enterprises, in particular in developing countries, to financial services, including affordable credit, and their integration into value chains and markets",,2017-03-01,1,,,,,,,,,
HE_RSEI,0,OMOP SDOH,Observation,COI Item,"Index Of Toxic Chemicals Released By Industrial Facilities, Converted To Natural Log Units",COI:HE_RSEI,2020-01-01,1,,,,,,,,,
zHE_RSEI,0,OMOP SDOH,Observation,COI Item,"Index Of Toxic Chemicals Released By Industrial Facilities, Converted To Natural Log Units, Transformed To Z-Scores And Multiplied By -1",COI:zHE_RSEI,2020-01-01,1,,,,,,,,,
FARA_TRACT_LILA_1_10,0,OMOP SDOH,Observation,AHRQ Item,Indicator For Low Income And Low Access Tract Measured At 1 Mile For Urban Areas And 10 Miles For Rural Areas,AHRQ:FARA_TRACT_LILA_1_10,2022-01-01,1,,,,,,,,,
FARA_TRACT_LILA_1_20,0,OMOP SDOH,Observation,AHRQ Item,Indicator For Low Income And Low Access Tract Measured At 1 Mile For Urban Areas And 20 Miles For Rural Areas,AHRQ:FARA_TRACT_LILA_1_20,2022-01-01,1,,,,,,,,,
FARA_TRACT_LILA_HALF_10,0,OMOP SDOH,Observation,AHRQ Item,Indicator For Low Income And Low Access Tract Measured At 1/2 Mile For Urban Areas And 10 Miles For Rural Areas,AHRQ:FARA_TRACT_LILA_HALF_10,2022-01-01,1,,,,,,,,,
FARA_TRACT_LILA_VEHICLE_20,0,OMOP SDOH,Observation,AHRQ Item,Indicator For Low Income And Low Access Tract Using Vehicle Access Or Low Income And Low Access Tract Measured At 20 Miles,AHRQ:FARA_TRACT_LILA_VEHICLE_20,2022-01-01,1,,,,,,,,,
FARA_TRACT_URBANICITY,0,OMOP SDOH,Observation,AHRQ Item,Indicator For Urban Tract,AHRQ:FARA_TRACT_URBANICITY,2022-01-01,1,,,,,,,,,
2.c.1,0,OMOP SDOH,Observation,SDG Indicator,Indicator of food price anomalies,,2017-03-01,1,,,,,,,,,
SEDH:1.22,0,OMOP SDOH,Observation,SEDH Item,"Individual-Oriented Social Vulnerability Index (IOSVI), Census Block Groups",SEDH:1.22,2021-01-01,1,,,,,,,,,
SEDH:1.6,0,OMOP SDOH,Observation,SEDH Item,"Individual-Oriented Social Vulnerability Index, Census Block Groups",SEDH:1.6,2021-01-01,1,,,,,,,,,
SEDH:1.7,0,OMOP SDOH,Observation,SEDH Item,"Individual-Oriented Social Vulnerability Index, Census Tracts",SEDH:1.7,2021-01-01,1,,,,,,,,,
GIS1002053,0,OMOP SDOH,Environmental Feature,COI Determinant,"Industrial Pollutants In Air, Water Or Soil",,2020-01-01,1,,,,,,,,,
GIS1002055,0,OMOP SDOH,Socioeconomic Feature,AHRQ Construct,Industry Composition,,2022-01-01,1,,,,,,,,,
GIS1002057,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Industry Composition In Population,,2024-09-15,1,,,,,,,,,
GIS1002064,0,OMOP SDOH,Geographic Feature,SDOH Construct,Infrastructure Accessibility,,2024-09-15,1,,,,,,,,,
GIS1002067,0,OMOP SDOH,Type Concept,Exposure Type Concept,Inpatient Claim,,2024-09-15,1,,,,,,,,,
669,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Installation Maintenance And Repair Occupation,SDOHO:669; Installation_Maintenance_and_Repair_Occupation,2022-01-01,1,,,,,,,,,
12.a.1,0,OMOP SDOH,Observation,SDG Indicator,Installed renewable energy-generating capacity in developing countries (in watts per capita),,2017-03-01,1,,,,,,,,,
7.b.1,0,OMOP SDOH,Observation,SDG Indicator,Installed renewable energy-generating capacity in developing countries (in watts per capita),,2017-03-01,1,,,,,,,,,
36,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Insufficient Activity,SDOHO:36; Insufficient_Activity,2022-01-01,1,,,,,,,,,
696,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Insurance Cost,SDOHO:696; Insurance_Cost,2022-01-01,1,,,,,,,,,
GIS1002068,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Insurance Coverage In Population,,2024-09-15,1,,,,,,,,,
13.2,0,OMOP SDOH,Observation,SDG Goal,"Integrate climate change measures into national policies, strategies and planning",,2017-03-01,1,,,,,,,,,
7.a.1,0,OMOP SDOH,Observation,SDG Indicator,"International financial flows to developing countries in support of clean energy research and development and renewable energy production, including in hybrid systems",,2017-03-01,1,,,,,,,,,
GIS1002093,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,International Financial Support,,2024-09-15,1,,,,,,,,,
3.d.1,0,OMOP SDOH,Observation,SDG Indicator,International Health Regulations (IHR) capacity and health emergency preparedness,,2017-03-01,1,,,,,,,,,
SEDH:1.25,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Internet Access Services,SEDH:1.25,2021-01-01,1,,,,,,,,,
GIS1002094,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Internet Connectivity,,2022-01-01,1,,,,,,,,,
GIS1002100,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Internet Connectivity In Population,,2024-09-15,1,,,,,,,,,
517,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Interpersonal Relation,SDOHO:517; Interpersonal_Relation,2022-01-01,1,,,,,,,,,
231,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Interpersonal Support,SDOHO:231; Interpersonal_Support,2022-01-01,1,,,,,,,,,
GIS1010328,0,OMOP SDOH,Observation,GIS Measure,Interquartile Range,,2024-09-15,1,,,,,,,,,
69,0,OMOP SDOH,Phenotypic Feature,SDOHO Value,Intersex,SDOHO:69; Intersex,2022-01-01,1,,,,,,,,,
398,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Job Insecurity,SDOHO:398; Job_Insecurity,2022-01-01,1,,,,,,,,,
GIS1010329,0,OMOP SDOH,Observation,GIS Measure,Kurtosis,,2024-09-15,1,,,,,,,,,
GIS1002124,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Labor Rights,,2024-09-15,1,,,,,,,,,
10.4.1,0,OMOP SDOH,Observation,SDG Indicator,Labour share of GDP,,2017-03-01,1,,,,,,,,,
400,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Lack Of Transportation For Daily Living,SDOHO:400; Lack_of_Transportation_for_Daily_Living,2022-01-01,1,,,,,,,,,
CEN_AREALAND_SQM,0,OMOP SDOH,Observation,AHRQ Item,Land Area In Square Miles,AHRQ:CEN_AREALAND_SQM,2022-01-01,1,,,,,,,,,
CEN_AREALAND_SQM_COUNTY,0,OMOP SDOH,Observation,AHRQ Item,Land Area In Square Miles (County),AHRQ:CEN_AREALAND_SQM_COUNTY,2022-01-01,1,,,,,,,,,
CEN_AREALAND_SQM_TRACT,0,OMOP SDOH,Observation,AHRQ Item,Land Area In Square Miles (Tract),AHRQ:CEN_AREALAND_SQM_TRACT,2022-01-01,1,,,,,,,,,
GIS1002125,0,OMOP SDOH,Environmental Feature,SDOH Construct,Land Quality And Land Characteristics,,2024-09-15,1,,,,,,,,,
190,0,OMOP SDOH,Environmental Feature,SDOHO Construct,Land Use Pattern,SDOHO:190; Land_Use_Pattern,2022-01-01,1,,,,,,,,,
94,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Language Proficiency,SDOHO:94; Language_Proficiency,2022-01-01,1,,,,,,,,,
GIS1002126,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Language Understanding,,2024-09-15,1,,,,,,,,,
710,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Legal Occupation,SDOHO:710; Legal_Occupation,2022-01-01,1,,,,,,,,,
8.8.2,0,OMOP SDOH,Observation,SDG Indicator,"Level of national compliance with labour rights (freedom of association and collective bargaining) based on International Labour Organization (ILO) textual sources and national legislation, by sex and migrant status",,2017-03-01,1,,,,,,,,,
6.4.2,0,OMOP SDOH,Observation,SDG Indicator,Level of water stress: freshwater withdrawal as a proportion of available freshwater resources,,2017-03-01,1,,,,,,,,,
716,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Life And Physical And Social Science Occupation,SDOHO:716; Life_and_Physical_and_Social_Science_Occupation,2022-01-01,1,,,,,,,,,
372,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Literacy,SDOHO:372; Literacy,2022-01-01,1,,,,,,,,,
PIAAC_LIT_AVG_SCORE,0,OMOP SDOH,Observation,AHRQ Item,Literacy Average Score Indirect Estimates,AHRQ:PIAAC_LIT_AVG_SCORE,2022-01-01,1,,,,,,,,,
372_POP,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Literacy In Population,,2024-09-15,1,,,,,,,,,
PIAAC_LIT_PCT_LEVEL2,0,OMOP SDOH,Observation,AHRQ Item,Literacy Percentage At Level 2 Indirect Estimates,AHRQ:PIAAC_LIT_PCT_LEVEL2,2022-01-01,1,,,,,,,,,
PIAAC_LIT_PCT_LEVEL3_OR_ABOVE,0,OMOP SDOH,Observation,AHRQ Item,Literacy Percentage At Or Above Level 3 Indirect Estimates,AHRQ:PIAAC_LIT_PCT_LEVEL3_OR_ABOVE,2022-01-01,1,,,,,,,,,
PIAAC_LIT_PCT_LEVEL1_OR_BELOW,0,OMOP SDOH,Observation,AHRQ Item,Literacy Percentage At Or Below Level 1 Indirect Estimates,AHRQ:PIAAC_LIT_PCT_LEVEL1_OR_BELOW,2022-01-01,1,,,,,,,,,
GIS1002129,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Literacy Rate,,2024-09-15,1,,,,,,,,,
887,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives Alone,SDOHO:887; Lives_Alone,2022-01-01,1,,,,,,,,,
739,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives In Apartment/Dormitory,SDOHO:739; Lives_in_Apartment/Dormitory,2022-01-01,1,,,,,,,,,
889,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives In Hospital,SDOHO:889; Lives_in_Hospital,2022-01-01,1,,,,,,,,,
891,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives In Hotel,SDOHO:891; Lives_in_Hotel,2022-01-01,1,,,,,,,,,
893,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives In Nursing Home,SDOHO:893; Lives_in_Nursing_Home,2022-01-01,1,,,,,,,,,
878,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives In Own Home,SDOHO:878; Lives_in_Own_Home,2022-01-01,1,,,,,,,,,
766,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Brother,SDOHO:766; Lives_with_Brother,2022-01-01,1,,,,,,,,,
762,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Child,SDOHO:762; Lives_with_Child,2022-01-01,1,,,,,,,,,
761,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Daughter,SDOHO:761; Lives_with_Daughter,2022-01-01,1,,,,,,,,,
986,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Family,SDOHO:986; Lives_with_Family,2022-01-01,1,,,,,,,,,
332,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Lives With Father,SDOHO:332; Lives_with_Father,2022-01-01,1,,,,,,,,,
1003,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Lives With Friend,SDOHO:1003; Lives_with_Friend,2022-01-01,1,,,,,,,,,
335,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Lives With Mother,SDOHO:335; Lives_with_Mother,2022-01-01,1,,,,,,,,,
333,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Lives With Parent,SDOHO:333; Lives_with_Parent,2022-01-01,1,,,,,,,,,
648,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Person,SDOHO:648; Lives_with_Person,2022-01-01,1,,,,,,,,,
655,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Sibling,SDOHO:655; Lives_with_Sibling,2022-01-01,1,,,,,,,,,
654,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Sister,SDOHO:654; Lives_with_Sister,2022-01-01,1,,,,,,,,,
934,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Son,SDOHO:934; Lives_with_Son,2022-01-01,1,,,,,,,,,
653,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Lives With Spouse,SDOHO:653; Lives_with_Spouse,2022-01-01,1,,,,,,,,,
GIS1002131,0,OMOP SDOH,Socioeconomic Feature,AHRQ Construct,Living Conditions,,2022-01-01,1,,,,,,,,,
GIS1002135,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Living Conditions In Population,,2024-09-15,1,,,,,,,,,
641,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Living Status,SDOHO:641; Living_Status,2022-01-01,1,,,,,,,,,
SEDH:1.4,0,OMOP SDOH,Observation,SEDH Item,Local Area Unemployment Statistics,SEDH:1.4,2021-01-01,1,,,,,,,,,
CCD_LOCAL_REVENUE_LUNCH,0,OMOP SDOH,Observation,AHRQ Item,Local Revenue From School Lunch Programs (Dollars) Per Student,AHRQ:CCD_LOCAL_REVENUE_LUNCH,2022-01-01,1,,,,,,,,,
481,0,OMOP SDOH,Demographic Feature,SDOHO Construct,Location Born,SDOHO:481; Location_Born,2022-01-01,1,,,,,,,,,
476,0,OMOP SDOH,Demographic Feature,SDOHO Construct,Location Raised,SDOHO:476; Location_Raised,2022-01-01,1,,,,,,,,,
AHRF_LOW_EDUC_USDA,0,OMOP SDOH,Observation,AHRQ Item,Low Education Typology Code,AHRQ:AHRF_LOW_EDUC_USDA,2022-01-01,1,,,,,,,,,
AHRF_LOW_EMP_USDA,0,OMOP SDOH,Observation,AHRQ Item,Low Employment Typology Code,AHRQ:AHRF_LOW_EMP_USDA,2022-01-01,1,,,,,,,,,
SEDH:1.19,0,OMOP SDOH,Observation,SEDH Item,"Low Food Access Area Dataset For Washington, DC",SEDH:1.19,2021-01-01,1,,,,,,,,,
17.13.1,0,OMOP SDOH,Observation,SDG Indicator,Macroeconomic Dashboard,,2017-03-01,1,,,,,,,,,
746,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Maintaining Care,SDOHO:746; Maintaining_Care,2022-01-01,1,,,,,,,,,
Goal 11,0,OMOP SDOH,Observation,SDG Goal,"Make cities and human settlements inclusive, safe, resilient and sustainable",,2017-03-01,1,,,,,,,,,
3.3.3,0,OMOP SDOH,Observation,SDG Indicator,"Malaria incidence per 1,000 population",,2017-03-01,1,,,,,,,,,
366,0,OMOP SDOH,Phenotypic Feature,SDOHO Value,Male Homosexual,SDOHO:366,2022-01-01,1,,,,,,,,,
466,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Male Homosexuality,SDOHO:466; Male_Homosexuality,2022-01-01,1,,,,,,,,,
76_POP,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Male In Population,,2024-09-15,1,,,,,,,,,
GIS1002146,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Male Population,,2024-09-15,1,,,,,,,,,
NEPHTN_SEX_RATIO_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Male To Female Sex Ratio At Birth Multiplied By 1,000",AHRQ:NEPHTN_SEX_RATIO_RATE,2022-01-01,1,,,,,,,,,
456,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Management And Business And Financial Operation Occupation,SDOHO:456; Management_and_Business_and_Financial_Operation_Occupation,2022-01-01,1,,,,,,,,,
629,0,OMOP SDOH,Phenotypic Feature,SDOHO Determinant,Management And Professoinal And Related Occupation,SDOHO:629; Management_and_Professoinal_and_Related_Occupation,2022-01-01,1,,,,,,,,,
460,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Management Occupation,SDOHO:460; Management_Occupation,2022-01-01,1,,,,,,,,,
9.2.2,0,OMOP SDOH,Observation,SDG Indicator,Manufacturing employment as a proportion of total employment,,2017-03-01,1,,,,,,,,,
9.2.1,0,OMOP SDOH,Observation,SDG Indicator,Manufacturing value added as a proportion of GDP and per capita,,2017-03-01,1,,,,,,,,,
AHRF_MANF_DEP_USDA,0,OMOP SDOH,Observation,AHRQ Item,Manufacturing-Dependent Typology Code,AHRQ:AHRF_MANF_DEP_USDA,2022-01-01,1,,,,,,,,,
662,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Marijuana Smoking,SDOHO:662; Marijuana_Smoking,2022-01-01,1,,,,,,,,,
511,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Marital Status,SDOHO:511; Marital_Status,2022-01-01,1,,,,,,,,,
775,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Married,SDOHO:775; Married,2022-01-01,1,,,,,,,,,
545,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Master'S Degree,SDOHO:545; Master's_Degree,2022-01-01,1,,,,,,,,,
982,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Material Deprivation,SDOHO:982; Material_Deprivation,2022-01-01,1,,,,,,,,,
12.2.1,0,OMOP SDOH,Observation,SDG Indicator,"Material footprint, material footprint per capita, and material footprint per GDP",,2017-03-01,1,,,,,,,,,
8.4.1,0,OMOP SDOH,Observation,SDG Indicator,"Material footprint, material footprint per capita, and material footprint per GDP",,2017-03-01,1,,,,,,,,,
3.1.1,0,OMOP SDOH,Observation,SDG Indicator,Maternal mortality ratio,,2017-03-01,1,,,,,,,,,
POS_MAX_DIST_TRAUMA,0,OMOP SDOH,Observation,AHRQ Item,"Maximum Distance In Miles To The Nearest Designated Trauma Center, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MAX_DIST_TRAUMA,2022-01-01,1,,,,,,,,,
POS_MAX_DIST_ED,0,OMOP SDOH,Observation,AHRQ Item,"Maximum Distance In Miles To The Nearest Emergency Department, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MAX_DIST_ED,2022-01-01,1,,,,,,,,,
POS_MAX_DIST_CLINIC,0,OMOP SDOH,Observation,AHRQ Item,"Maximum Distance In Miles To The Nearest Health Clinic (FQHC, RHC), Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MAX_DIST_CLINIC,2022-01-01,1,,,,,,,,,
POS_MAX_DIST_ALC,0,OMOP SDOH,Observation,AHRQ Item,"Maximum Distance In Miles To The Nearest Hospital With Alcohol And Drug Abuse Inpatient Care, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MAX_DIST_ALC,2022-01-01,1,,,,,,,,,
POS_MAX_DIST_MEDSURG_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Maximum Distance In Miles To The Nearest Medical-Surgical ICU, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MAX_DIST_MEDSURG_ICU,2022-01-01,1,,,,,,,,,
POS_MAX_DIST_OBSTETRICS,0,OMOP SDOH,Observation,AHRQ Item,"Maximum Distance In Miles To The Nearest Obstetrics Department, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MAX_DIST_OBSTETRICS,2022-01-01,1,,,,,,,,,
POS_MAX_DIST_PED_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Maximum Distance In Miles To The Nearest Pediatric ICU, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MAX_DIST_PED_ICU,2022-01-01,1,,,,,,,,,
HIFLD_MAX_DIST_UC,0,OMOP SDOH,Observation,AHRQ Item,"Maximum Distance In Miles To The Nearest Urgent Care, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:HIFLD_MAX_DIST_UC,2022-01-01,1,,,,,,,,,
NEPHTN_MAXDROUGHT,0,OMOP SDOH,Observation,AHRQ Item,Maximum Number Of Consecutive Weeks Of Cumulative Moderate Drought Or Worse Per Year,AHRQ:NEPHTN_MAXDROUGHT,2022-01-01,1,,,,,,,,,
EPAA_MAX_PB_3MON,0,OMOP SDOH,Observation,AHRQ Item,Maximum Of All Rolling 3-Month Averages Of Lead (Pb) In The Year (Ug/M3),AHRQ:EPAA_MAX_PB_3MON,2022-01-01,1,,,,,,,,,
GIS1010330,0,OMOP SDOH,Observation,GIS Measure,Mean,,2024-09-15,1,,,,,,,,,
NEPHTN_ARSENIC_MEAN_POP,0,OMOP SDOH,Observation,AHRQ Item,"Mean Concentration Of Arsenic At The Population Level (Micrograms Per Liter), By Year",AHRQ:NEPHTN_ARSENIC_MEAN_POP,2022-01-01,1,,,,,,,,,
NEPHTN_ARSENIC_MEAN_CSW,0,OMOP SDOH,Observation,AHRQ Item,"Mean Concentration Of Arsenic In Community Water Systems (Micrograms Per Liter), By Year",AHRQ:NEPHTN_ARSENIC_MEAN_CSW,2022-01-01,1,,,,,,,,,
POS_MEAN_DIST_TRAUMA,0,OMOP SDOH,Observation,AHRQ Item,"Mean Distance In Miles To The Nearest Designated Trauma Center, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEAN_DIST_TRAUMA,2022-01-01,1,,,,,,,,,
POS_MEAN_DIST_ED,0,OMOP SDOH,Observation,AHRQ Item,"Mean Distance In Miles To The Nearest Emergency Department, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEAN_DIST_ED,2022-01-01,1,,,,,,,,,
POS_MEAN_DIST_CLINIC,0,OMOP SDOH,Observation,AHRQ Item,"Mean Distance In Miles To The Nearest Health Clinic (FQHC, RHC), Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEAN_DIST_CLINIC,2022-01-01,1,,,,,,,,,
POS_MEAN_DIST_ALC,0,OMOP SDOH,Observation,AHRQ Item,"Mean Distance In Miles To The Nearest Hospital With Alcohol And Drug Abuse Inpatient Care, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEAN_DIST_ALC,2022-01-01,1,,,,,,,,,
POS_MEAN_DIST_MEDSURG_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Mean Distance In Miles To The Nearest Medical-Surgical ICU, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEAN_DIST_MEDSURG_ICU,2022-01-01,1,,,,,,,,,
POS_MEAN_DIST_OBSTETRICS,0,OMOP SDOH,Observation,AHRQ Item,"Mean Distance In Miles To The Nearest Obstetrics Department, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEAN_DIST_OBSTETRICS,2022-01-01,1,,,,,,,,,
POS_MEAN_DIST_PED_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Mean Distance In Miles To The Nearest Pediatric ICU, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEAN_DIST_PED_ICU,2022-01-01,1,,,,,,,,,
HIFLD_MEAN_DIST_UC,0,OMOP SDOH,Observation,AHRQ Item,"Mean Distance In Miles To The Nearest Urgent Care, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:HIFLD_MEAN_DIST_UC,2022-01-01,1,,,,,,,,,
HE_OZONE,0,OMOP SDOH,Observation,COI Item,Mean Estimated 8-Hour Average Ozone Concentration,COI:HE_OZONE,2020-01-01,1,,,,,,,,,
zHE_OZONE,0,OMOP SDOH,Observation,COI Item,"Mean Estimated 8-Hour Average Ozone Concentration, Transformed To Z-Scores And Multiplied By -1",COI:zHE_OZONE,2020-01-01,1,,,,,,,,,
HE_PM25,0,OMOP SDOH,Observation,COI Item,Mean Estimated Microparticle (PM2.5) Concentration,COI:HE_PM25,2020-01-01,1,,,,,,,,,
zHE_PM25,0,OMOP SDOH,Observation,COI Item,"Mean Estimated Microparticle (PM2.5) Concentration, Transformed To Z-Scores And Multiplied By -1",COI:zHE_PM25,2020-01-01,1,,,,,,,,,
GIS1002149,0,OMOP SDOH,Observation,GIS Measure,Measures,,2024-09-15,1,,,,,,,,,
GIS1002159,0,OMOP SDOH,Observation,GIS Measure,Median,,2024-09-15,1,,,,,,,,,
ACS_MEDIAN_AGE_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Median Age Of Female Population,AHRQ:ACS_MEDIAN_AGE_FEMALE,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_AGE_MALE,0,OMOP SDOH,Observation,AHRQ Item,Median Age Of Male Population,AHRQ:ACS_MEDIAN_AGE_MALE,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_AGE,0,OMOP SDOH,Observation,AHRQ Item,Median Age Of Total Population,AHRQ:ACS_MEDIAN_AGE,2022-01-01,1,,,,,,,,,
POS_MEDIAN_DIST_TRAUMA,0,OMOP SDOH,Observation,AHRQ Item,"Median Distance In Miles To The Nearest Designated Trauma Center, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEDIAN_DIST_TRAUMA,2022-01-01,1,,,,,,,,,
POS_MEDIAN_DIST_ED,0,OMOP SDOH,Observation,AHRQ Item,"Median Distance In Miles To The Nearest Emergency Department, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEDIAN_DIST_ED,2022-01-01,1,,,,,,,,,
POS_MEDIAN_DIST_CLINIC,0,OMOP SDOH,Observation,AHRQ Item,"Median Distance In Miles To The Nearest Health Clinic (FQHC, RHC), Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEDIAN_DIST_CLINIC,2022-01-01,1,,,,,,,,,
POS_MEDIAN_DIST_ALC,0,OMOP SDOH,Observation,AHRQ Item,"Median Distance In Miles To The Nearest Hospital With Alcohol And Drug Abuse Inpatient Care, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEDIAN_DIST_ALC,2022-01-01,1,,,,,,,,,
POS_MEDIAN_DIST_MEDSURG_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Median Distance In Miles To The Nearest Medical-Surgical ICU, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEDIAN_DIST_MEDSURG_ICU,2022-01-01,1,,,,,,,,,
POS_MEDIAN_DIST_OBSTETRICS,0,OMOP SDOH,Observation,AHRQ Item,"Median Distance In Miles To The Nearest Obstetrics Department, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEDIAN_DIST_OBSTETRICS,2022-01-01,1,,,,,,,,,
POS_MEDIAN_DIST_PED_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Median Distance In Miles To The Nearest Pediatric ICU, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MEDIAN_DIST_PED_ICU,2022-01-01,1,,,,,,,,,
HIFLD_MEDIAN_DIST_UC,0,OMOP SDOH,Observation,AHRQ Item,"Median Distance In Miles To The Nearest Urgent Care, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:HIFLD_MEDIAN_DIST_UC,2022-01-01,1,,,,,,,,,
GIS1002160,0,OMOP SDOH,Observation,ADI Item,Median Family Income In US Dollars,,2018-01-01,1,,,,,,,,,
ACS_MEDIAN_RENT,0,OMOP SDOH,Observation,AHRQ Item,Median Gross Rent (Dollars),AHRQ:ACS_MEDIAN_RENT,2022-01-01,1,,,,,,,,,
GIS1002162,0,OMOP SDOH,Observation,ADI Item,Median Gross Rent In US Dollars,,2018-01-01,1,,,,,,,,,
GIS1002164,0,OMOP SDOH,Observation,ADI Item,Median Home Value In US Dollars,,2018-01-01,1,,,,,,,,,
ACS_MEDIAN_HOME_VALUE,0,OMOP SDOH,Observation,AHRQ Item,Median Home Value Of Owner-Occupied Housing Units (Dollars),AHRQ:ACS_MEDIAN_HOME_VALUE,2022-01-01,1,,,,,,,,,
GIS1002166,0,OMOP SDOH,Observation,COI Item,Median Household Income,,2020-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC_BLACK,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income For Households With A Black Or African American Alone Householder (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC_BLACK,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC_HISP,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income For Households With A Hispanic Or Latino Householder (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC_HISP,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC_NHPI,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income For Households With A Native Hawaiian And Other Pacific Islander Alone Householder (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC_NHPI,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC_OTHER,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income For Households With A Some Other Race Alone Householder (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC_OTHER,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC_MULTI,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income For Households With A Two Or More Races Householder (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC_MULTI,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC_WHITE,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income For Households With A White Alone, Not Hispanic Or Latino Householder (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC_WHITE,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC_AIAN,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income For Households With An American Indian And Alaska Native Alone Householder (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC_AIAN,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_HH_INC_ASIAN,0,OMOP SDOH,Observation,AHRQ Item,"Median Household Income For Households With An Asian Alone Householder (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_HH_INC_ASIAN,2022-01-01,1,,,,,,,,,
SE_MHE,0,OMOP SDOH,Observation,COI Item,Median Income Of All Households,COI:SE_MHE,2020-01-01,1,,,,,,,,,
ACS_MEDIAN_NONVET_INC,0,OMOP SDOH,Observation,AHRQ Item,"Median Income Of Civilian Nonveteran Population (Dollars, Ages 18 And Over, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_NONVET_INC,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_VET_INC,0,OMOP SDOH,Observation,AHRQ Item,"Median Income Of Civilian Veterans (Dollars, Ages 18 And Over, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_VET_INC,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_INC_F,0,OMOP SDOH,Observation,AHRQ Item,"Median Income Of Female Population (Dollars, Ages 15 And Over With Income In The Past 12 Months, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_INC_F,2022-01-01,1,,,,,,,,,
ACS_MDN_GRNDPRNT_INC,0,OMOP SDOH,Observation,AHRQ Item,"Median Income Of Grandparent Householder And/Or Spouse Responsible For Grandchildren Under 18 (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MDN_GRNDPRNT_INC,2022-01-01,1,,,,,,,,,
ACS_MDN_GRNDPRNT_NO_PRNT_INC,0,OMOP SDOH,Observation,AHRQ Item,"Median Income Of Grandparent Householder And/Or Spouse Responsible For Grandchildren Under 18 And No Parent Present (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MDN_GRNDPRNT_NO_PRNT_INC,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_INC_M,0,OMOP SDOH,Observation,AHRQ Item,"Median Income Of Male Population (Dollars, Ages 15 And Over With Income In The Past 12 Months, Inflation-Adjusted To Data File Year)",AHRQ:ACS_MEDIAN_INC_M,2022-01-01,1,,,,,,,,,
GIS1002168,0,OMOP SDOH,Observation,ADI Item,Median Monthly Mortgage In US Dollars,,2018-01-01,1,,,,,,,,,
ACS_MDN_OWNER_COST_MORTGAGE,0,OMOP SDOH,Observation,AHRQ Item,Median Selected Monthly Owner Costs For Houses With A Mortgage (Dollars),AHRQ:ACS_MDN_OWNER_COST_MORTGAGE,2022-01-01,1,,,,,,,,,
ACS_MDN_OWNER_COST_NO_MORTG,0,OMOP SDOH,Observation,AHRQ Item,Median Selected Monthly Owner Costs For Houses Without A Mortgage (Dollars),AHRQ:ACS_MDN_OWNER_COST_NO_MORTG,2022-01-01,1,,,,,,,,,
ACS_MEDIAN_YEAR_BUILT,0,OMOP SDOH,Observation,AHRQ Item,Median Year Structure Built Of Housing Units,AHRQ:ACS_MEDIAN_YEAR_BUILT,2022-01-01,1,,,,,,,,,
595,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Medicaid,SDOHO:595; Medicaid,2022-01-01,1,,,,,,,,,
GIS1002170,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Medical Bills,,2024-09-15,1,,,,,,,,,
697,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Medical Expense,SDOHO:697; Medical_Expense,2022-01-01,1,,,,,,,,,
HRSA_MUA_CENSUS_TRACT,0,OMOP SDOH,Observation,AHRQ Item,Medically Underserved Areas (Muas) - Census Tract,AHRQ:HRSA_MUA_CENSUS_TRACT,2022-01-01,1,,,,,,,,,
HRSA_MUA_COUNTY,0,OMOP SDOH,Observation,AHRQ Item,Medically Underserved Areas (Muas) - County,AHRQ:HRSA_MUA_COUNTY,2022-01-01,1,,,,,,,,,
597,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Medicare,SDOHO:597; Medicare,2022-01-01,1,,,,,,,,,
SEDH:4.2,0,OMOP SDOH,Observation,SEDH Item,Medicare Part D Opioid Prescribing Rates,SEDH:4.2,2021-01-01,1,,,,,,,,,
GIS1002172,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Medication Use,,2024-09-15,1,,,,,,,,,
r_COI_met,0,OMOP SDOH,Observation,COI Item,Metro-Normed Child Opportunity Scores (From 1 To 100) For The Overall COI,COI:r_COI_met,2020-01-01,1,,,,,,,,,
GIS1002193,0,OMOP SDOH,Observation,COI Item,Metro-Normed Child Opportunity Scores (From 1 To 100) For The Social And Economic Domain,,2020-01-01,1,,,,,,,,,
msaid15,0,OMOP SDOH,Observation,COI Item,Metro/Micro Area (2015) FIPS Code,COI:msaid15,2020-01-01,1,,,,,,,,,
msaname15,0,OMOP SDOH,Observation,COI Item,Metro/Micro Area (2015) Name,COI:msaname15,2020-01-01,1,,,,,,,,,
349,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Middle School Completed,SDOHO:349; Middle_School_Completed,2022-01-01,1,,,,,,,,,
GIS1002195,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Migration,,2022-01-01,1,,,,,,,,,
GIS1002202,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Migration In Population,,2024-09-15,1,,,,,,,,,
GIS1002207,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Military Service,,2024-09-15,1,,,,,,,,,
673,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Military Specific Occupation,SDOHO:673; Military_Specific_Occupation,2022-01-01,1,,,,,,,,,
14.3,0,OMOP SDOH,Observation,SDG Goal,"Minimize and address the impacts of ocean acidification, including through enhanced scientific cooperation at all levels",,2017-03-01,1,,,,,,,,,
POS_MIN_DIST_TRAUMA,0,OMOP SDOH,Observation,AHRQ Item,"Minimum Distance In Miles To The Nearest Designated Trauma Center, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MIN_DIST_TRAUMA,2022-01-01,1,,,,,,,,,
POS_MIN_DIST_ED,0,OMOP SDOH,Observation,AHRQ Item,"Minimum Distance In Miles To The Nearest Emergency Department, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MIN_DIST_ED,2022-01-01,1,,,,,,,,,
POS_MIN_DIST_CLINIC,0,OMOP SDOH,Observation,AHRQ Item,"Minimum Distance In Miles To The Nearest Health Clinic (FQHC, RHC), Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MIN_DIST_CLINIC,2022-01-01,1,,,,,,,,,
POS_MIN_DIST_ALC,0,OMOP SDOH,Observation,AHRQ Item,"Minimum Distance In Miles To The Nearest Hospital With Alcohol And Drug Abuse Inpatient Care, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MIN_DIST_ALC,2022-01-01,1,,,,,,,,,
POS_MIN_DIST_MEDSURG_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Minimum Distance In Miles To The Nearest Medical-Surgical ICU, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MIN_DIST_MEDSURG_ICU,2022-01-01,1,,,,,,,,,
POS_MIN_DIST_OBSTETRICS,0,OMOP SDOH,Observation,AHRQ Item,"Minimum Distance In Miles To The Nearest Obstetrics Department, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MIN_DIST_OBSTETRICS,2022-01-01,1,,,,,,,,,
POS_MIN_DIST_PED_ICU,0,OMOP SDOH,Observation,AHRQ Item,"Minimum Distance In Miles To The Nearest Pediatric ICU, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:POS_MIN_DIST_PED_ICU,2022-01-01,1,,,,,,,,,
HIFLD_MIN_DIST_UC,0,OMOP SDOH,Observation,AHRQ Item,"Minimum Distance In Miles To The Nearest Urgent Care, Calculated Using Population Weighted Tract Centroids In The County",AHRQ:HIFLD_MIN_DIST_UC,2022-01-01,1,,,,,,,,,
AHRF_MINE_DEP_USDA,0,OMOP SDOH,Observation,AHRQ Item,Mining-Dependent Typology Code,AHRQ:AHRF_MINE_DEP_USDA,2022-01-01,1,,,,,,,,,
E_MINRTY,0,OMOP SDOH,Observation,SVI Item,"Minority (Hispanic Or Latino (Of Any Race); Black And African American, Not Hispanic Or Latino; American Indian And Alaska Native, Not Hispanic Or Latino; Asian, Not Hispanic Or Latino; Native Hawaiian And Other Pacific Islander, Not Hispanic Or Latino...","Minority (Hispanic Or Latino (Of Any Race); Black And African American, Not Hispanic Or Latino; American Indian And Alaska Native, Not Hispanic Or Latino; Asian, Not Hispanic Or Latino; Native Hawaiian And Other Pacific Islander, Not Hispanic Or Latino; Two Or More Races, Not Hispanic Or Latino; Other Races, Not Hispanic Or Latino) Estimate",2018-01-01,1,,,,,,,,,
M_MINRTY,0,OMOP SDOH,Observation,SVI Item,"Minority (Hispanic Or Latino (Of Any Race); Black And African American, Not Hispanic Or Latino; American Indian And Alaska Native, Not Hispanic Or Latino; Asian, Not Hispanic Or Latino; Native Hawaiian And Other Pacific Islander, Not Hispanic Or Latino...","Minority (Hispanic Or Latino (Of Any Race); Black And African American, Not Hispanic Or Latino; American Indian And Alaska Native, Not Hispanic Or Latino; Asian, Not Hispanic Or Latino; Native Hawaiian And Other Pacific Islander, Not Hispanic Or Latino; Two Or More Races, Not Hispanic Or Latino; Other Races, Not Hispanic Or Latino) Estimate MOE",2018-01-01,1,,,,,,,,,
MHSVI_RPL_THEME5_HCI_ACCESS,0,OMOP SDOH,Observation,AHRQ Item,Minority Health Social Vulnerability Index: Percentile Ranking For Health Care Infrastructure/Access Theme,AHRQ:MHSVI_RPL_THEME5_HCI_ACCESS,2022-01-01,1,,,,,,,,,
MHSVI_RPL_THEME2_HH_COMP,0,OMOP SDOH,Observation,AHRQ Item,Minority Health Social Vulnerability Index: Percentile Ranking For Household Composition Theme,AHRQ:MHSVI_RPL_THEME2_HH_COMP,2022-01-01,1,,,,,,,,,
MHSVI_RPL_THEME4_HH_TRANS,0,OMOP SDOH,Observation,AHRQ Item,Minority Health Social Vulnerability Index: Percentile Ranking For Housing/Transportation Theme,AHRQ:MHSVI_RPL_THEME4_HH_TRANS,2022-01-01,1,,,,,,,,,
MHSVI_RPL_THEME6_MV,0,OMOP SDOH,Observation,AHRQ Item,Minority Health Social Vulnerability Index: Percentile Ranking For Medical Vulnerability Theme,AHRQ:MHSVI_RPL_THEME6_MV,2022-01-01,1,,,,,,,,,
MHSVI_RPL_THEME3_MINO,0,OMOP SDOH,Observation,AHRQ Item,Minority Health Social Vulnerability Index: Percentile Ranking For Minority Status/Language Theme,AHRQ:MHSVI_RPL_THEME3_MINO,2022-01-01,1,,,,,,,,,
MHSVI_RPL_THEME1_SOCIECO,0,OMOP SDOH,Observation,AHRQ Item,Minority Health Social Vulnerability Index: Percentile Ranking For Socioeconomic Theme,AHRQ:MHSVI_RPL_THEME1_SOCIECO,2022-01-01,1,,,,,,,,,
E_MOBILE,0,OMOP SDOH,Observation,SVI Item,Mobile Homes Estimate,SVI:E_MOBILE,2018-01-01,1,,,,,,,,,
M_MOBILE,0,OMOP SDOH,Observation,SVI Item,Mobile Homes Estimate MOE,SVI:M_MOBILE,2018-01-01,1,,,,,,,,,
17.3,0,OMOP SDOH,Observation,SDG Goal,Mobilize additional financial resources for developing countries from multiple sources,,2017-03-01,1,,,,,,,,,
15.a,0,OMOP SDOH,Observation,SDG Goal,Mobilize and significantly increase financial resources from all sources to conserve and sustainably use biodiversity and ecosystems,,2017-03-01,1,,,,,,,,,
15.b,0,OMOP SDOH,Observation,SDG Goal,"Mobilize significant resources from all sources and at all levels to finance sustainable forest management and provide adequate incentives to developing countries to advance such management, including for conservation and reforestation",,2017-03-01,1,,,,,,,,,
GIS1002209,0,OMOP SDOH,Observation,GIS Measure,Mode,,2024-09-15,1,,,,,,,,,
352,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Money And Resource,SDOHO:352; Money_and_Resource,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_APR,0,OMOP SDOH,Observation,AHRQ Item,Monthly (April) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_APR,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_APR,0,OMOP SDOH,Observation,AHRQ Item,Monthly (April) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_APR,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_APR,0,OMOP SDOH,Observation,AHRQ Item,Monthly (April) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_APR,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_APR,0,OMOP SDOH,Observation,AHRQ Item,Monthly (April) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_APR,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_AUG,0,OMOP SDOH,Observation,AHRQ Item,Monthly (August) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_AUG,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_AUG,0,OMOP SDOH,Observation,AHRQ Item,Monthly (August) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_AUG,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_AUG,0,OMOP SDOH,Observation,AHRQ Item,Monthly (August) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_AUG,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_AUG,0,OMOP SDOH,Observation,AHRQ Item,Monthly (August) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_AUG,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_DEC,0,OMOP SDOH,Observation,AHRQ Item,Monthly (December) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_DEC,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_DEC,0,OMOP SDOH,Observation,AHRQ Item,Monthly (December) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_DEC,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_DEC,0,OMOP SDOH,Observation,AHRQ Item,Monthly (December) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_DEC,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_DEC,0,OMOP SDOH,Observation,AHRQ Item,Monthly (December) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_DEC,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_FEB,0,OMOP SDOH,Observation,AHRQ Item,Monthly (February) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_FEB,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_FEB,0,OMOP SDOH,Observation,AHRQ Item,Monthly (February) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_FEB,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_FEB,0,OMOP SDOH,Observation,AHRQ Item,Monthly (February) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_FEB,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_FEB,0,OMOP SDOH,Observation,AHRQ Item,Monthly (February) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_FEB,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_JAN,0,OMOP SDOH,Observation,AHRQ Item,Monthly (January) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_JAN,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_JAN,0,OMOP SDOH,Observation,AHRQ Item,Monthly (January) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_JAN,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_JAN,0,OMOP SDOH,Observation,AHRQ Item,Monthly (January) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_JAN,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_JAN,0,OMOP SDOH,Observation,AHRQ Item,Monthly (January) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_JAN,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_JUL,0,OMOP SDOH,Observation,AHRQ Item,Monthly (July) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_JUL,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_JUL,0,OMOP SDOH,Observation,AHRQ Item,Monthly (July) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_JUL,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_JUL,0,OMOP SDOH,Observation,AHRQ Item,Monthly (July) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_JUL,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_JUL,0,OMOP SDOH,Observation,AHRQ Item,Monthly (July) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_JUL,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_JUN,0,OMOP SDOH,Observation,AHRQ Item,Monthly (June) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_JUN,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_JUN,0,OMOP SDOH,Observation,AHRQ Item,Monthly (June) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_JUN,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_JUN,0,OMOP SDOH,Observation,AHRQ Item,Monthly (June) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_JUN,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_JUN,0,OMOP SDOH,Observation,AHRQ Item,Monthly (June) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_JUN,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_MAR,0,OMOP SDOH,Observation,AHRQ Item,Monthly (March) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_MAR,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_MAR,0,OMOP SDOH,Observation,AHRQ Item,Monthly (March) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_MAR,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_MAR,0,OMOP SDOH,Observation,AHRQ Item,Monthly (March) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_MAR,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_MAR,0,OMOP SDOH,Observation,AHRQ Item,Monthly (March) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_MAR,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_MAY,0,OMOP SDOH,Observation,AHRQ Item,Monthly (May) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_MAY,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_MAY,0,OMOP SDOH,Observation,AHRQ Item,Monthly (May) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_MAY,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_MAY,0,OMOP SDOH,Observation,AHRQ Item,Monthly (May) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_MAY,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_MAY,0,OMOP SDOH,Observation,AHRQ Item,Monthly (May) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_MAY,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_NOV,0,OMOP SDOH,Observation,AHRQ Item,Monthly (November) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_NOV,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_NOV,0,OMOP SDOH,Observation,AHRQ Item,Monthly (November) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_NOV,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_NOV,0,OMOP SDOH,Observation,AHRQ Item,Monthly (November) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_NOV,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_NOV,0,OMOP SDOH,Observation,AHRQ Item,Monthly (November) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_NOV,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_OCT,0,OMOP SDOH,Observation,AHRQ Item,Monthly (October) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_OCT,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_OCT,0,OMOP SDOH,Observation,AHRQ Item,Monthly (October) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_OCT,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_OCT,0,OMOP SDOH,Observation,AHRQ Item,Monthly (October) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_OCT,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_OCT,0,OMOP SDOH,Observation,AHRQ Item,Monthly (October) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_OCT,2022-01-01,1,,,,,,,,,
NOAAC_AVG_TEMP_SEP,0,OMOP SDOH,Observation,AHRQ Item,Monthly (September) Average Temperature (Fahrenheit),AHRQ:NOAAC_AVG_TEMP_SEP,2022-01-01,1,,,,,,,,,
NOAAC_MAX_TEMP_SEP,0,OMOP SDOH,Observation,AHRQ Item,Monthly (September) Maximum Temperature (Fahrenheit),AHRQ:NOAAC_MAX_TEMP_SEP,2022-01-01,1,,,,,,,,,
NOAAC_MIN_TEMP_SEP,0,OMOP SDOH,Observation,AHRQ Item,Monthly (September) Minimum Temperature (Fahrenheit),AHRQ:NOAAC_MIN_TEMP_SEP,2022-01-01,1,,,,,,,,,
NOAAC_PRECIPITATION_SEP,0,OMOP SDOH,Observation,AHRQ Item,Monthly (September) Precipitation (Inches),AHRQ:NOAAC_PRECIPITATION_SEP,2022-01-01,1,,,,,,,,,
3.4.1,0,OMOP SDOH,Observation,SDG Indicator,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease",,2017-03-01,1,,,,,,,,,
3.9.1,0,OMOP SDOH,Observation,SDG Indicator,Mortality rate attributed to household and ambient air pollution,,2017-03-01,1,,,,,,,,,
3.9.3,0,OMOP SDOH,Observation,SDG Indicator,Mortality rate attributed to unintentional poisoning,,2017-03-01,1,,,,,,,,,
3.9.2,0,OMOP SDOH,Observation,SDG Indicator,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services)",,2017-03-01,1,,,,,,,,,
200,0,OMOP SDOH,Demographic Feature,SDOHO Value,Multi-Racial,SDOHO:200; Multi-racial,2022-01-01,1,,,,,,,,,
GIS1002210,0,OMOP SDOH,Observation,SDG Goal,Multi-stakeholder partnerships,,2017-03-01,1,,,,,,,,,
CCBP_LARGE_INDUSTRY,0,OMOP SDOH,Observation,AHRQ Item,Naics Code Of Largest Industry In Region By Number Of Employees,AHRQ:CCBP_LARGE_INDUSTRY,2022-01-01,1,,,,,,,,,
SEDH:3.1,0,OMOP SDOH,Observation,SEDH Item,National Instant Criminal Background Check System (NICS),SEDH:3.1,2021-01-01,1,,,,,,,,,
SEDH:3.2,0,OMOP SDOH,Observation,SEDH Item,"National Instant Criminal Background Check System (NICS), Lethal Means Access",SEDH:3.2,2021-01-01,1,,,,,,,,,
SEDH:4.3,0,OMOP SDOH,Observation,SEDH Item,National Mental Health Services Survey,SEDH:4.3,2021-01-01,1,,,,,,,,,
12.5.1,0,OMOP SDOH,Observation,SDG Indicator,"National recycling rate, tons of material recycled",,2017-03-01,1,,,,,,,,,
SEDH:4.4,0,OMOP SDOH,Observation,SEDH Item,National Survey On Drug Use And Health,SEDH:4.4,2021-01-01,1,,,,,,,,,
194,0,OMOP SDOH,Demographic Feature,SDOHO Value,Native American,SDOHO:194; Native_American,2022-01-01,1,,,,,,,,,
E_NHPI,0,OMOP SDOH,Observation,SVI Item,"Native Hawaiian Or Other Pacific Islander, Not Hispanic Or Latino Persons Estimate",SVI:E_NHPI,2018-01-01,1,,,,,,,,,
M_NHPI,0,OMOP SDOH,Observation,SVI Item,"Native Hawaiian Or Other Pacific Islander, Not Hispanic Or Latino Persons Estimate MOE",SVI:M_NHPI,2018-01-01,1,,,,,,,,,
GIS1002212,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Native Language,,2024-09-15,1,,,,,,,,,
668,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Natural Resource And Construction And Maintenance Occupation,SDOHO:668; Natural_Resource_and_Construction_and_Maintenance_Occupation,2022-01-01,1,,,,,,,,,
NCHS_URCS_2006,0,OMOP SDOH,Geographic Feature,AHRQ Item,Nchs 2006 Rural-Urban Classification Scheme,AHRQ:NCHS_URCS_2006,2022-01-01,1,,,,,,,,,
NCHS_URCS_2013,0,OMOP SDOH,Geographic Feature,AHRQ Item,Nchs 2013 Rural-Urban Classification Scheme,AHRQ:NCHS_URCS_2013,2022-01-01,1,,,,,,,,,
485,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Neighborhood Concentrated Disadvantage,SDOHO:485; Neighborhood_Concentrated_Disadvantage,2022-01-01,1,,,,,,,,,
132,0,OMOP SDOH,Observation,SDOHO Item,Neighborhood Concentrated Disadvantage Protocol,SDOHO:132; Neighborhood_Concentrated_Disadvantage_Protocol,2022-01-01,1,,,,,,,,,
GIS1002215,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Neighborhood Quality,,2024-09-15,1,,,,,,,,,
GIS1002217,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Neighborhood Safety,,2024-09-15,1,,,,,,,,,
3.2.2,0,OMOP SDOH,Observation,SDG Indicator,Neonatal mortality rate,,2017-03-01,1,,,,,,,,,
17.2.1,0,OMOP SDOH,Observation,SDG Indicator,"Net official development assistance, total and to least developed countries, as a proportion of the Organization for Economic Cooperation and Development (OECD) Development Assistance Committee donors? gross national income (GNI)",,2017-03-01,1,,,,,,,,,
778,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Never Married,SDOHO:778; Never_Married,2022-01-01,1,,,,,,,,,
408,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,No Formal Education,SDOHO:408; No_Formal_Education,2022-01-01,1,,,,,,,,,
361,0,OMOP SDOH,Behavioral Feature,SDOHO Value,No Physical Activity,SDOHO:361; No_Physical_Activity,2022-01-01,1,,,,,,,,,
21,0,OMOP SDOH,Behavioral Feature,SDOHO Value,No Support,SDOHO:21; No_Support,2022-01-01,1,,,,,,,,,
GIS1002219,0,OMOP SDOH,Environmental Feature,SDOH Construct,Noise Pollution,,2024-09-15,1,,,,,,,,,
155,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Non-Binary Gender,SDOHO:155; Non-binary_Gender,2022-01-01,1,,,,,,,,,
620,0,OMOP SDOH,Demographic Feature,SDOHO Value,Non-Hispanic,SDOHO:620; Non-hispanic,2022-01-01,1,,,,,,,,,
937,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Non-Tobacco Products Smoking,SDOHO:937; Non-Tobacco_Products_Smoking,2022-01-01,1,,,,,,,,,
AHRF_NONSP_DEP_USDA,0,OMOP SDOH,Observation,AHRQ Item,Nonspecialized-Dependent Typology Code,AHRQ:AHRF_NONSP_DEP_USDA,2022-01-01,1,,,,,,,,,
2.5.1,0,OMOP SDOH,Observation,SDG Indicator,Number of (a) plant and (b) animal genetic resources for food and agriculture secured in either medium- or long-term conservation facilities,,2017-03-01,1,,,,,,,,,
GIS1002221,0,OMOP SDOH,Observation,COI Item,Number Of Children,,2020-01-01,1,,,,,,,,,
GIS1002223,0,OMOP SDOH,Observation,COI Item,Number Of Children Who Are American Indian And Alaska Native,,2020-01-01,1,,,,,,,,,
GIS1002226,0,OMOP SDOH,Observation,COI Item,Number Of Children Who Are Asian Or Pacific Islander,,2020-01-01,1,,,,,,,,,
GIS1002229,0,OMOP SDOH,Observation,COI Item,Number Of Children Who Are Black Or African American,,2020-01-01,1,,,,,,,,,
GIS1002232,0,OMOP SDOH,Observation,COI Item,Number Of Children Who Are Hispanic Or Latino,,2020-01-01,1,,,,,,,,,
GIS1002235,0,OMOP SDOH,Observation,COI Item,Number Of Children Who Are Non-Hispanic White,,2020-01-01,1,,,,,,,,,
GIS1002238,0,OMOP SDOH,Observation,COI Item,Number Of Children Who Are Not Non-Hispanic White,,2020-01-01,1,,,,,,,,,
GIS1002241,0,OMOP SDOH,Observation,COI Item,Number Of Children Who Are Some Other Race Or Two Or More Races,,2020-01-01,1,,,,,,,,,
OPP_INCAR_ASN_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Asian Female,AHRQ:OPP_INCAR_ASN_F_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_ASN_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Asian Male,AHRQ:OPP_INCAR_ASN_M_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Black Or African American Female,AHRQ:OPP_INCAR_BLK_F_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_BLK_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Black Or African American Male,AHRQ:OPP_INCAR_BLK_M_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Hispanic Female,AHRQ:OPP_INCAR_HSP_F_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_HSP_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Hispanic Male,AHRQ:OPP_INCAR_HSP_M_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Native American Female,AHRQ:OPP_INCAR_NAM_F_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_NAM_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Native American Male,AHRQ:OPP_INCAR_NAM_M_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Other Race Female,AHRQ:OPP_INCAR_OTHER_F_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_OTHER_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For Other Race Male,AHRQ:OPP_INCAR_OTHER_M_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For White Female,AHRQ:OPP_INCAR_WHT_F_N,2022-01-01,1,,,,,,,,,
OPP_INCAR_WHT_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Incarceration Outcome For White Male,AHRQ:OPP_INCAR_WHT_M_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Asian Female,AHRQ:OPP_TOP20_ASN_F_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Asian Male,AHRQ:OPP_TOP20_ASN_M_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Black Or African American Female,AHRQ:OPP_TOP20_BLK_F_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Black Or African American Male,AHRQ:OPP_TOP20_BLK_M_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Hispanic Female,AHRQ:OPP_TOP20_HSP_F_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Hispanic Male,AHRQ:OPP_TOP20_HSP_M_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Native American Female,AHRQ:OPP_TOP20_NAM_F_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Native American Male,AHRQ:OPP_TOP20_NAM_M_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Other Race Female,AHRQ:OPP_TOP20_OTHER_F_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For Other Race Male,AHRQ:OPP_TOP20_OTHER_M_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_F_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For White Female,AHRQ:OPP_TOP20_WHT_F_N,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_M_N,0,OMOP SDOH,Observation,AHRQ Item,Number Of Children With No Missing Data Used To Construct The Mean Predicted Probability Of Reaching The Top Quintile Of The National Household Income Distribution For White Male,AHRQ:OPP_TOP20_WHT_M_N,2022-01-01,1,,,,,,,,,
12.6.1,0,OMOP SDOH,Observation,SDG Indicator,Number of companies publishing sustainability reports,,2017-03-01,1,,,,,,,,,
12.1.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of countries developing, adopting or implementing policy instruments aimed at supporting the shift to sustainable consumption and production",,2017-03-01,1,,,,,,,,,
12.7.1,0,OMOP SDOH,Observation,SDG Indicator,Number of countries implementing sustainable public procurement policies and action plans,,2017-03-01,1,,,,,,,,,
14.c.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of countries making progress in ratifying, accepting and implementing through legal, policy and institutional frameworks, ocean-related instruments that implement international law, as reflected in the United Nations Convention on the Law of the...","Number of countries making progress in ratifying, accepting and implementing through legal, policy and institutional frameworks, ocean-related instruments that implement international law, as reflected in the United Nations Convention on the Law of the Sea, for the conservation and sustainable use of the oceans and their resources",2017-03-01,1,,,,,,,,,
17.16.1,0,OMOP SDOH,Observation,SDG Indicator,Number of countries reporting progress in multi- stakeholder development effectiveness monitoring frameworks that support the achievement of the Sustainable Development Goals,,2017-03-01,1,,,,,,,,,
16.10.2,0,OMOP SDOH,Observation,SDG Indicator,"Number of countries that adopt and implement constitutional, statutory and/or policy guarantees for public access to information",,2017-03-01,1,,,,,,,,,
17.5.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of countries that adopt and implement investment promotion regimes for developing countries, including the least developed countries",,2017-03-01,1,,,,,,,,,
1.5.3,0,OMOP SDOH,Observation,SDG Indicator,Number of countries that adopt and implement national disaster risk reduction strategies in line with the Sendai Framework for Disaster Risk Reduction 2015?2030,,2017-03-01,1,,,,,,,,,
15.6.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of countries that have adopted legislative, administrative and policy frameworks to ensure fair and equitable sharing of benefits",,2017-03-01,1,,,,,,,,,
17.18.2,0,OMOP SDOH,Observation,SDG Indicator,Number of countries that have national statistical legislation that complies with the Fundamental Principles of Official Statistics,,2017-03-01,1,,,,,,,,,
11.a.1,0,OMOP SDOH,Observation,SDG Indicator,Number of countries that have national urban policies or regional development plans that (a) respond to population dynamics; (b) ensure balanced territorial development; and (c) increase local fiscal space,,2017-03-01,1,,,,,,,,,
14.2.1,0,OMOP SDOH,Observation,SDG Indicator,Number of countries using ecosystem-based approaches to managing marine areas,,2017-03-01,1,,,,,,,,,
17.18.3,0,OMOP SDOH,Observation,SDG Indicator,"Number of countries with a national statistical plan that is fully funded and under implementation, by source of funding",,2017-03-01,1,,,,,,,,,
5.6.2,0,OMOP SDOH,Observation,SDG Indicator,"Number of countries with laws and regulations that guarantee full and equal access to women and men aged 15 years and older to sexual and reproductive health care, information and education",,2017-03-01,1,,,,,,,,,
17.14.1,0,OMOP SDOH,Observation,SDG Indicator,Number of countries with mechanisms in place to enhance policy coherence of sustainable development,,2017-03-01,1,,,,,,,,,
13.2.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of countries with nationally determined contributions, long-term strategies, national adaptation plans and adaptation communications, as reported to the secretariat of the United Nations Framework Convention on Climate Change",,2017-03-01,1,,,,,,,,,
11.5.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of deaths, missing persons and directly affected persons attributed to disasters per 100,000 population",,2017-03-01,1,,,,,,,,,
13.1.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of deaths, missing persons and directly affected persons attributed to disasters per 100,000 population",,2017-03-01,1,,,,,,,,,
1.5.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of deaths, missing persons and directly affected persons attributed to disasters per 100,000 population",,2017-03-01,1,,,,,,,,,
ED_PRXECE,0,OMOP SDOH,Observation,COI Item,"Number Of ECE Centers Within A 5-Mile Radius, Converted To Natural Log Units",COI:ED_PRXECE,2020-01-01,1,,,,,,,,,
zED_PRXECE,0,OMOP SDOH,Observation,COI Item,"Number Of ECE Centers Within A 5-Mile Radius, Converted To Natural Log Units, Transformed To Z-Scores",COI:zED_PRXECE,2020-01-01,1,,,,,,,,,
13.b.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of least developed countries and small island developing States with nationally determined contributions, long-term strategies, national adaptation plans and adaptation communications, as reported to the secretariat of the United Nations Framewo...","Number of least developed countries and small island developing States with nationally determined contributions, long-term strategies, national adaptation plans and adaptation communications, as reported to the secretariat of the United Nations Framework Convention on Climate Change",2017-03-01,1,,,,,,,,,
ED_PRXHQECE,0,OMOP SDOH,Observation,COI Item,"Number Of NAEYC Accredited Centers Within A 5-Mile Radius, Converted To Natural Log Units",COI:ED_PRXHQECE,2020-01-01,1,,,,,,,,,
zED_PRXHQECE,0,OMOP SDOH,Observation,COI Item,"Number Of NAEYC Accredited Centers Within A 5-Mile Radius, Converted To Natural Log Units, Transformed To Z-Scores",COI:zED_PRXHQECE,2020-01-01,1,,,,,,,,,
3.3.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations",,2017-03-01,1,,,,,,,,,
12.4.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of parties to international multilateral environmental agreements on hazardous waste, and other chemicals that meet their commitments and obligations in transmitting information as required by each relevant agreement",,2017-03-01,1,,,,,,,,,
3.3.5,0,OMOP SDOH,Observation,SDG Indicator,Number of people requiring interventions against neglected tropical diseases,,2017-03-01,1,,,,,,,,,
10.7.3,0,OMOP SDOH,Observation,SDG Indicator,Number of people who died or disappeared in the process of migration towards an international destination,,2017-03-01,1,,,,,,,,,
316,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Number Of Sexual Partner,SDOHO:316; Number_of_Sexual_Partner,2022-01-01,1,,,,,,,,,
487,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Number Of Shops In Walking Distance,SDOHO:487; Number_of_Shops_in_Walking_Distance,2022-01-01,1,,,,,,,,,
16.10.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of verified cases of killing, kidnapping, enforced disappearance, arbitrary detention and torture of journalists, associated media personnel, trade unionists and human rights advocates in the previous 12 months",,2017-03-01,1,,,,,,,,,
16.2.2,0,OMOP SDOH,Observation,SDG Indicator,"Number of victims of human trafficking per 100,000 population, by sex, age and form of exploitation",,2017-03-01,1,,,,,,,,,
16.1.1,0,OMOP SDOH,Observation,SDG Indicator,"Number of victims of intentional homicide per 100,000 population, by sex and age",,2017-03-01,1,,,,,,,,,
GIS1002244,0,OMOP SDOH,Socioeconomic Feature,AHRQ Construct,Numeracy,,2022-01-01,1,,,,,,,,,
PIAAC_NUM_AVG_SCORE,0,OMOP SDOH,Observation,AHRQ Item,Numeracy Average Score Indirect Estimates,AHRQ:PIAAC_NUM_AVG_SCORE,2022-01-01,1,,,,,,,,,
GIS1002246,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Numeracy In Population,,2024-09-15,1,,,,,,,,,
PIAAC_NUM_PCT_LEVEL2,0,OMOP SDOH,Observation,AHRQ Item,Numeracy Percentage At Level 2 Indirect Estimates,AHRQ:PIAAC_NUM_PCT_LEVEL2,2022-01-01,1,,,,,,,,,
PIAAC_NUM_PCT_LEVEL3_OR_ABOVE,0,OMOP SDOH,Observation,AHRQ Item,Numeracy Percentage At Or Above Level 3 Indirect Estimates,AHRQ:PIAAC_NUM_PCT_LEVEL3_OR_ABOVE,2022-01-01,1,,,,,,,,,
PIAAC_NUM_PCT_LEVEL1_OR_BELOW,0,OMOP SDOH,Observation,AHRQ Item,Numeracy Percentage At Or Below Level 1 Indirect Estimates,AHRQ:PIAAC_NUM_PCT_LEVEL1_OR_BELOW,2022-01-01,1,,,,,,,,,
320,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Nurse,SDOHO:320,2022-01-01,1,,,,,,,,,
GIS1002301,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Obsessive-Compulsive Disorder (Ocd),,2024-09-15,1,,,,,,,,,
246,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Occupation,SDOHO:246; Occupation,2022-01-01,1,,,,,,,,,
SEDH:1.27,0,OMOP SDOH,Observation,SEDH Item,Occupational Employment And Wage Statistics,SEDH:1.27,2021-01-01,1,,,,,,,,,
GIS1002310,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Occupational Hazards,,2024-09-15,1,,,,,,,,,
GIS1002326,0,OMOP SDOH,Type Concept,Exposure Type Concept,Occupational Health Database,,2024-09-15,1,,,,,,,,,
GIS1002327,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Occupational Performance,,2024-09-15,1,,,,,,,,,
142,0,OMOP SDOH,Observation,SDOHO Item,Occupational Prestige Score,SDOHO:142; Occupational_Prestige_Score,2022-01-01,1,,,,,,,,,
GIS1002330,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Occupational Safety,,2024-09-15,1,,,,,,,,,
GIS1010331,0,OMOP SDOH,Observation,GIS Measure,Occurrence Measure,,2024-09-15,1,,,,,,,,,
678,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Office And Administrative Support Occupation,SDOHO:678; Office_and_Administrative_Support_Occupation,2022-01-01,1,,,,,,,,,
229,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,On Disability,SDOHO:229; On_Disability,2022-01-01,1,,,,,,,,,
611,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Out Of Pocket,SDOHO:611; Out_of_Pocket,2022-01-01,1,,,,,,,,,
GIS1002333,0,OMOP SDOH,Type Concept,Exposure Type Concept,Outpatient Claim,,2024-09-15,1,,,,,,,,,
GIS1002334,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Over-The-Counter Medication Abuse,,2024-09-15,1,,,,,,,,,
GIS1002338,0,OMOP SDOH,Environmental Feature,COI Determinant,Ozone Concentration,,2020-01-01,1,,,,,,,,,
198,0,OMOP SDOH,Demographic Feature,SDOHO Value,Pacific Islander,SDOHO:198; Pacific_Islander,2022-01-01,1,,,,,,,,,
843,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Parent Child Relationship,SDOHO:843; Parent_Child_Relationship,2022-01-01,1,,,,,,,,,
330,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Parental Neglect,SDOHO:330,2022-01-01,1,,,,,,,,,
4.5.1,0,OMOP SDOH,Observation,SDG Indicator,"Parity indices (female/male, rural/urban, bottom/top wealth quintile and others such as disability status, indigenous peoples and conflict-affected, as data become available) for all education indicators on this list that can be disaggregated",,2017-03-01,1,,,,,,,,,
907,0,OMOP SDOH,Geographic Feature,SDOHO Value,Park,SDOHO:907; Park,2022-01-01,1,,,,,,,,,
241,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Part-Time Employment,SDOHO:241; Part-time_Employment,2022-01-01,1,,,,,,,,,
4.2.2,0,OMOP SDOH,Observation,SDG Indicator,"Participation rate in organized learning (one year before the official primary entry age), by sex",,2017-03-01,1,,,,,,,,,
4.3.1,0,OMOP SDOH,Observation,SDG Indicator,"Participation rate of youth and adults in formal and non-formal education and training in the previous 12 months, by sex",,2017-03-01,1,,,,,,,,,
9.1.2,0,OMOP SDOH,Observation,SDG Indicator,"Passenger and freight volumes, by mode of transport",,2017-03-01,1,,,,,,,,,
624,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Past Year Number Of Visit,SDOHO:624; Past_Year_Number_of_Visit,2022-01-01,1,,,,,,,,,
GIS1002340,0,OMOP SDOH,Type Concept,Exposure Type Concept,Patient Survey,,2024-09-15,1,,,,,,,,,
ACS_PER_CAPITA_INC,0,OMOP SDOH,Observation,AHRQ Item,"Per Capita Income (Dollars, Inflation-Adjusted To Data File Year)",AHRQ:ACS_PER_CAPITA_INC,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_ACTUAL_EM,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare E&M Actual Payment,AHRQ:MGV_PER_CAPITA_ACTUAL_EM,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_STD_EM,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare E&M Standardized Payment,AHRQ:MGV_PER_CAPITA_STD_EM,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_ACTUAL_HC,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare FQHC/RHC Actual Payment,AHRQ:MGV_PER_CAPITA_ACTUAL_HC,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_STD_HC,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare FQHC/RHC Standardized Payment,AHRQ:MGV_PER_CAPITA_STD_HC,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_ACTUAL_IP,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare Inpatient Actual Payment,AHRQ:MGV_PER_CAPITA_ACTUAL_IP,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_STD_IP,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare Inpatient Standardized Payment,AHRQ:MGV_PER_CAPITA_STD_IP,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_ACTUAL_OP,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare Outpatient Actual Payment,AHRQ:MGV_PER_CAPITA_ACTUAL_OP,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_STD_OP,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare Outpatient Standardized Payment,AHRQ:MGV_PER_CAPITA_STD_OP,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_ACTUAL_PA,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare Post Acute Care Actual Payment,AHRQ:MGV_PER_CAPITA_ACTUAL_PA,2022-01-01,1,,,,,,,,,
MGV_PER_CAPITA_STD_PA,0,OMOP SDOH,Observation,AHRQ Item,Per Capita Medicare Post Acute Care Standardized Payment,AHRQ:MGV_PER_CAPITA_STD_PA,2022-01-01,1,,,,,,,,,
AMFAR_MME_PER_CAPITA,0,OMOP SDOH,Observation,AHRQ Item,"Per Capita Opioids Prescribed, In Morphine Milligram Equivalents (Mme)",AHRQ:AMFAR_MME_PER_CAPITA,2022-01-01,1,,,,,,,,,
E_IMPWTR,0,OMOP SDOH,Observation,EJI EBM Item,Percent Of Tract That Intersects An Impaired/Impacted Watershed At The Huc12 Level,EJI:E_IMPWTR,2022-01-01,1,,,,,,,,,
GIS1002341,0,OMOP SDOH,Observation,GIS Measure,Percentage,,2024-09-15,1,,,,,,,,,
ED_COLLEGE,0,OMOP SDOH,Observation,COI Item,Percentage 18-24 Year-Olds Enrolled In College Within 25-Mile Radius,COI:ED_COLLEGE,2020-01-01,1,,,,,,,,,
zED_COLLEGE,0,OMOP SDOH,Observation,COI Item,"Percentage 18-24 Year-Olds Enrolled In College Within 25-Mile Radius, Transformed To Z-Scores",COI:zED_COLLEGE,2020-01-01,1,,,,,,,,,
ED_ECENROL,0,OMOP SDOH,Observation,COI Item,"Percentage 3- And 4-Year-Olds Enrolled In Nursery School, Preschool Or Kindergarten",COI:ED_ECENROL,2020-01-01,1,,,,,,,,,
zED_ECENROL,0,OMOP SDOH,Observation,COI Item,"Percentage 3- And 4-Year-Olds Enrolled In Nursery School, Preschool Or Kindergarten, Transformed To Z-Scores",COI:zED_ECENROL,2020-01-01,1,,,,,,,,,
ED_ATTAIN,0,OMOP SDOH,Observation,COI Item,Percentage Adults Ages 25 And Over With A College Degree Or Higher,COI:ED_ATTAIN,2020-01-01,1,,,,,,,,,
zED_ATTAIN,0,OMOP SDOH,Observation,COI Item,"Percentage Adults Ages 25 And Over With A College Degree Or Higher, Transformed To Z-Scores",COI:zED_ATTAIN,2020-01-01,1,,,,,,,,,
SE_EMPRAT,0,OMOP SDOH,Observation,COI Item,Percentage Adults Ages 25-54 Who Are Employed,COI:SE_EMPRAT,2020-01-01,1,,,,,,,,,
zSE_EMPRAT,0,OMOP SDOH,Observation,COI Item,"Percentage Adults Ages 25-54 Who Are Employed, Transformed To Z-Scores",COI:zSE_EMPRAT,2020-01-01,1,,,,,,,,,
EP_POV200,0,OMOP SDOH,Observation,SVI Item,Percentage Below 200% Poverty,SVI:EP_POV200,2018-01-01,1,,,,,,,,,
SE_SINGLE,0,OMOP SDOH,Observation,COI Item,Percentage Family Households That Are Single-Parent Headed,COI:SE_SINGLE,2020-01-01,1,,,,,,,,,
zSE_SINGLE,0,OMOP SDOH,Observation,COI Item,"Percentage Family Households That Are Single-Parent Headed, Transformed To Z-Scores And Multiplied By -1",COI:zSE_SINGLE,2020-01-01,1,,,,,,,,,
SE_PUBLIC,0,OMOP SDOH,Observation,COI Item,Percentage Households Receiving Cash Public Assistance Or Food Stamps/Supplemental Nutrition Assistance Program,COI:SE_PUBLIC,2020-01-01,1,,,,,,,,,
HE_FOOD,0,OMOP SDOH,Observation,COI Item,Percentage Households Without A Car Located Further Than A Half-Mile From The Nearest Supermarket,COI:HE_FOOD,2020-01-01,1,,,,,,,,,
zHE_FOOD,0,OMOP SDOH,Observation,COI Item,"Percentage Households Without A Car Located Further Than A Half-Mile From The Nearest Supermarket, Transformed To Z-Scores And Multiplied By -1",COI:zHE_FOOD,2020-01-01,1,,,,,,,,,
HE_VACANCY,0,OMOP SDOH,Observation,COI Item,Percentage Housing Units That Are Vacant,COI:HE_VACANCY,2020-01-01,1,,,,,,,,,
zHE_VACANCY,0,OMOP SDOH,Observation,COI Item,"Percentage Housing Units That Are Vacant, Transformed To Z-Scores And Multiplied By -1",COI:zHE_VACANCY,2020-01-01,1,,,,,,,,,
HE_GREEN,0,OMOP SDOH,Observation,COI Item,"Percentage Impenetrable Surface Areas Such As Rooftops, Roads Or Parking Lots",COI:HE_GREEN,2020-01-01,1,,,,,,,,,
zHE_GREEN,0,OMOP SDOH,Observation,COI Item,"Percentage Impenetrable Surface Areas Such As Rooftops, Roads Or Parking Lots, Transformed To Z-Scores And Multiplied By -1",COI:zHE_GREEN,2020-01-01,1,,,,,,,,,
HE_HLTHINS,0,OMOP SDOH,Observation,COI Item,Percentage Individuals Ages 0-64 With Health Insurance Coverage,COI:HE_HLTHINS,2020-01-01,1,,,,,,,,,
zHE_HLTHINS,0,OMOP SDOH,Observation,COI Item,"Percentage Individuals Ages 0-64 With Health Insurance Coverage, Transformed To Z-Scores",COI:zHE_HLTHINS,2020-01-01,1,,,,,,,,,
SE_OCC,0,OMOP SDOH,Observation,COI Item,"Percentage Individuals Ages 16 And Over Employed In Management, Business, Financial, Computer, Engineering, Science, Education, Legal, Community Service, Health Care Practitioner, Health Technology, Arts And Media Occupations",COI:SE_OCC,2020-01-01,1,,,,,,,,,
SE_POVRATE,0,OMOP SDOH,Observation,COI Item,Percentage Individuals Living In Households With Incomes Below 100% Of The Federal Poverty Threshold,COI:SE_POVRATE,2020-01-01,1,,,,,,,,,
MP_MINRTY,0,OMOP SDOH,Observation,SVI Item,"Percentage Minority (Hispanic Or Latino (Of Any Race); Black And African American, Not Hispanic Or Latino; American Indian And Alaska Native, Not Hispanic Or Latino; Asian, Not Hispanic Or Latino; Native Hawaiian And Other Pacific Islander, Not Hispani...","Percentage Minority (Hispanic Or Latino (Of Any Race); Black And African American, Not Hispanic Or Latino; American Indian And Alaska Native, Not Hispanic Or Latino; Asian, Not Hispanic Or Latino; Native Hawaiian And Other Pacific Islander, Not Hispanic Or Latino; Two Or More Races, Not Hispanic Or Latino; Other Races, Not Hispanic Or Latino) Estimate MOE",2018-01-01,1,,,,,,,,,
ED_HSGRAD,0,OMOP SDOH,Observation,COI Item,Percentage Ninth Graders Graduating From High School On Time,COI:ED_HSGRAD,2020-01-01,1,,,,,,,,,
zED_HSGRAD,0,OMOP SDOH,Observation,COI Item,"Percentage Ninth Graders Graduating From High School On Time, Transformed To Z-Scores",COI:zED_HSGRAD,2020-01-01,1,,,,,,,,,
CHR_PCT_MENTAL_DISTRESS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Adults Reporting 14 Or More Days Of Poor Mental Health Per Month,AHRQ:CHR_PCT_MENTAL_DISTRESS,2022-01-01,1,,,,,,,,,
CHR_PCT_PHYSICAL_DISTRESS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Adults Reporting 14 Or More Days Of Poor Physical Health Per Month,AHRQ:CHR_PCT_PHYSICAL_DISTRESS,2022-01-01,1,,,,,,,,,
CHR_PCT_EXCESS_DRINK,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Adults Reporting Binge Or Heavy Drinking,AHRQ:CHR_PCT_EXCESS_DRINK,2022-01-01,1,,,,,,,,,
CHR_PCT_POOR_HEALTH,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Adults Reporting Fair Or Poor Health (Age-Adjusted),AHRQ:CHR_PCT_POOR_HEALTH,2022-01-01,1,,,,,,,,,
CHR_PCT_PHYS_INACTIVITY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Adults Reporting No Leisure-Time Physical Activity (Ages 20 And Over),AHRQ:CHR_PCT_PHYS_INACTIVITY,2022-01-01,1,,,,,,,,,
CHR_PCT_SMOKING,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Adults Who Are Current Smokers,AHRQ:CHR_PCT_SMOKING,2022-01-01,1,,,,,,,,,
CHR_PCT_DIABETES,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Adults With Diagnosed Diabetes (Ages 20 And Over),AHRQ:CHR_PCT_DIABETES,2022-01-01,1,,,,,,,,,
FEA_PCT_FARMERS_MARKET_SFMNP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Farmers' Markets That Accept Sfmnp Benefits,AHRQ:FEA_PCT_FARMERS_MARKET_SFMNP,2022-01-01,1,,,,,,,,,
FEA_PCT_FARMERS_MARKET_SNAP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Farmers' Markets That Accept Snap Benefits,AHRQ:FEA_PCT_FARMERS_MARKET_SNAP,2022-01-01,1,,,,,,,,,
FEA_PCT_FARMERS_MARKET_WIC_CASH,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Farmers' Markets That Accept Wic Cash Value Vouchers,AHRQ:FEA_PCT_FARMERS_MARKET_WIC_CASH,2022-01-01,1,,,,,,,,,
FEA_PCT_FARMERS_MARKET_WIC,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Farmers? Markets That Accept Wic Vouchers,AHRQ:FEA_PCT_FARMERS_MARKET_WIC,2022-01-01,1,,,,,,,,,
CRDC_PCT_SATACT_IDEA,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Individuals With Disabilities Education Act (Idea) Students Who Participated In A Sat Or Act Test,AHRQ:CRDC_PCT_SATACT_IDEA,2022-01-01,1,,,,,,,,,
CRDC_PCT_GTENR_STUDENTS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students Who Are Enrolled In A Gifted And Talented Education Program,AHRQ:CRDC_PCT_GTENR_STUDENTS,2022-01-01,1,,,,,,,,,
CRDC_PCT_SATACT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students Who Participated In A Sat Or Act Test,AHRQ:CRDC_PCT_SATACT,2022-01-01,1,,,,,,,,,
CRDC_PCT_HBA_DISABLE_STUDENTS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students Who Reported As Harassed Or Bullied On The Basis Of Disability,AHRQ:CRDC_PCT_HBA_DISABLE_STUDENTS,2022-01-01,1,,,,,,,,,
CRDC_PCT_HBA_RACE_STUDENTS,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of All Students Who Reported As Harassed Or Bullied On The Basis Of Race, Color, Or National Origin",AHRQ:CRDC_PCT_HBA_RACE_STUDENTS,2022-01-01,1,,,,,,,,,
CRDC_PCT_HBA_SEX_STUDENTS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students Who Reported As Harassed Or Bullied On The Basis Of Sex,AHRQ:CRDC_PCT_HBA_SEX_STUDENTS,2022-01-01,1,,,,,,,,,
CRDC_PCT_APEXAM_ONEORMORE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students Who Took One Or More Advanced Placement Exams,AHRQ:CRDC_PCT_APEXAM_ONEORMORE,2022-01-01,1,,,,,,,,,
CRDC_PCT_LAW_REFERRAL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students Who Were Referred To A Law Enforcement Agency,AHRQ:CRDC_PCT_LAW_REFERRAL,2022-01-01,1,,,,,,,,,
CRDC_PCT_RETAIN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students Who Were Retained,AHRQ:CRDC_PCT_RETAIN,2022-01-01,1,,,,,,,,,
CRDC_PCT_LEP_STUDENTS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students With Limited English Proficiency,AHRQ:CRDC_PCT_LEP_STUDENTS,2022-01-01,1,,,,,,,,,
CRDC_PCT_SATACT_LEP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of All Students With Limited English Proficiency Who Participated In A Sat Or Act Test,AHRQ:CRDC_PCT_SATACT_LEP,2022-01-01,1,,,,,,,,,
ACS_PCT_AIAN_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of American Indian And Alaska Native Alone Population Reporting Female,AHRQ:ACS_PCT_AIAN_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_AIAN_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of American Indian And Alaska Native Alone Population Reporting Male,AHRQ:ACS_PCT_AIAN_MALE,2022-01-01,1,,,,,,,,,
ACS_PCT_POV_AIAN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of American Indian Or Alaska Native Population Below Poverty Level,AHRQ:ACS_PCT_POV_AIAN,2022-01-01,1,,,,,,,,,
EP_AIAN,0,OMOP SDOH,Observation,SVI Item,"Percentage Of American Indian Or Alaska Native, Not Hispanic Or Latino Persons Estimate",SVI:EP_AIAN,2018-01-01,1,,,,,,,,,
MP_AIAN,0,OMOP SDOH,Observation,SVI Item,"Percentage Of American Indian Or Alaska Native, Not Hispanic Or Latino Persons Estimate MOE",SVI:MP_AIAN,2018-01-01,1,,,,,,,,,
ACS_PCT_ASIAN_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Asian Alone Population Reporting Female,AHRQ:ACS_PCT_ASIAN_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_ASIAN_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Asian Alone Population Reporting Male,AHRQ:ACS_PCT_ASIAN_MALE,2022-01-01,1,,,,,,,,,
ACS_PCT_POV_ASIAN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Asian Population Below Poverty Level,AHRQ:ACS_PCT_POV_ASIAN,2022-01-01,1,,,,,,,,,
EP_ASIAN,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Asian, Not Hispanic Or Latino Persons Estimate",SVI:EP_ASIAN,2018-01-01,1,,,,,,,,,
MP_ASIAN,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Asian, Not Hispanic Or Latino Persons Estimate MOE",SVI:MP_ASIAN,2018-01-01,1,,,,,,,,,
ACS_PCT_BLACK_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Black Or African American Alone Population Reporting Female,AHRQ:ACS_PCT_BLACK_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_BLACK_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Black Or African American Alone Population Reporting Male,AHRQ:ACS_PCT_BLACK_MALE,2022-01-01,1,,,,,,,,,
ACS_PCT_POV_BLACK,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Black Or African American Population Below Poverty Level,AHRQ:ACS_PCT_POV_BLACK,2022-01-01,1,,,,,,,,,
EP_AFAM,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Black/African American, Not Hispanic Or Latino Persons Estimate",SVI:EP_AFAM,2018-01-01,1,,,,,,,,,
MP_AFAM,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Black/African American, Not Hispanic Or Latino Persons Estimate MOE",SVI:MP_AFAM,2018-01-01,1,,,,,,,,,
3.d.2,0,OMOP SDOH,Observation,SDG Indicator,Percentage of bloodstream infections due to selected antimicrobial-resistant organisms,,2017-03-01,1,,,,,,,,,
ACS_PCT_CHILDREN_GRANDPARENT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Children Living With A Grandparent Householder (Ages 17 And Below),AHRQ:ACS_PCT_CHILDREN_GRANDPARENT,2022-01-01,1,,,,,,,,,
ACS_PCT_GRANDP_NO_RESPS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Children Living With Grandparent Householder Whose Grandparent Is Not Responsible For Them,AHRQ:ACS_PCT_GRANDP_NO_RESPS,2022-01-01,1,,,,,,,,,
ACS_PCT_GRANDP_RESPS_NO_P,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Children Living With Grandparent Householder Whose Grandparent Is Responsible For Them: Parent Not Present,AHRQ:ACS_PCT_GRANDP_RESPS_NO_P,2022-01-01,1,,,,,,,,,
ACS_PCT_GRANDP_RESPS_P,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Children Living With Grandparent Householder Whose Grandparent Is Responsible For Them: Parent Present,AHRQ:ACS_PCT_GRANDP_RESPS_P,2022-01-01,1,,,,,,,,,
ACS_PCT_CHILD_DISAB,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Children With A Disability (Ages 17 And Below),AHRQ:ACS_PCT_CHILD_DISAB,2022-01-01,1,,,,,,,,,
ACS_PCT_INC50_BELOW17,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Children With Income To Poverty Ratio Under 0.50 (Ages 17 And Below),AHRQ:ACS_PCT_INC50_BELOW17,2022-01-01,1,,,,,,,,,
ACS_PCT_GOVT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Employed Population Who Are Government Workers (Ages 16 And Over),AHRQ:ACS_PCT_GOVT,2022-01-01,1,,,,,,,,,
ACS_PCT_ADMIN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Employed Population Working In Public Administration (Ages 16 And Over),AHRQ:ACS_PCT_ADMIN,2022-01-01,1,,,,,,,,,
ACS_PCT_EMPLOYED,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Labor Force That Is Employed (Ages 16 And Over),AHRQ:ACS_PCT_EMPLOYED,2022-01-01,1,,,,,,,,,
ACS_PCT_UNEMPLOY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Labor Force That Is Unemployed (Ages 16 And Over),AHRQ:ACS_PCT_UNEMPLOY,2022-01-01,1,,,,,,,,,
EP_DISABL,0,OMOP SDOH,Observation,SVI Item,Percentage Of Civilian Noninstitutionalized Population With A Disability Estimate,"Percentage Of Civilian Noninstitutionalized Population With A Disability Estimate, 2014-2018 ACS",2018-01-01,1,,,,,,,,,
MP_DISABL,0,OMOP SDOH,Observation,SVI Item,Percentage Of Civilian Noninstitutionalized Population With A Disability Estimate MOE,SVI:MP_DISABL,2018-01-01,1,,,,,,,,,
ACS_PCT_NONVET_POV_18_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Nonveterans With Income Below The Poverty Level In The Past 12 Months (Between Ages 18 And 64),AHRQ:ACS_PCT_NONVET_POV_18_64,2022-01-01,1,,,,,,,,,
ACS_PCT_VET_LABOR_FORCE_18_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Veterans In Labor Force (Between Ages 18 And 64),AHRQ:ACS_PCT_VET_LABOR_FORCE_18_64,2022-01-01,1,,,,,,,,,
ACS_PCT_VET_UNEMPL_18_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Veterans That Are Unemployed (Between Ages 18 And 64),AHRQ:ACS_PCT_VET_UNEMPL_18_64,2022-01-01,1,,,,,,,,,
ACS_PCT_VET_BACHELOR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Veterans That Have A Bachelor'S Degree Or Higher (Ages 25 And Over),AHRQ:ACS_PCT_VET_BACHELOR,2022-01-01,1,,,,,,,,,
ACS_PCT_VET_COLLEGE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Veterans That Have Some College Education Or An Associate'S Degree (Ages 25 And Over),AHRQ:ACS_PCT_VET_COLLEGE,2022-01-01,1,,,,,,,,,
ACS_PCT_VET_HS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Veterans Who Are High School Graduates Or Less Than High School Graduates (Age 25 Years And Over),AHRQ:ACS_PCT_VET_HS,2022-01-01,1,,,,,,,,,
ACS_PCT_VET_DISABLE_18_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Veterans With A Disability (Between Ages 18 And 64),AHRQ:ACS_PCT_VET_DISABLE_18_64,2022-01-01,1,,,,,,,,,
ACS_PCT_VET_POV_18_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Civilian Veterans With Income Below The Poverty Level In Past 12 Months (Between Ages 18 And 64),AHRQ:ACS_PCT_VET_POV_18_64,2022-01-01,1,,,,,,,,,
PC_PCT_MEDICARE_APPRVD_FULL_AMT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Clinicians Who Accept Medicare Approved Amounts In Full,AHRQ:PC_PCT_MEDICARE_APPRVD_FULL_AMT,2022-01-01,1,,,,,,,,,
PC_PCT_MCARE_MAY_ACPT_APPRVD_AMT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Clinicians Who May Accept The Medicare Approved Amounts,AHRQ:PC_PCT_MCARE_MAY_ACPT_APPRVD_AMT,2022-01-01,1,,,,,,,,,
AHRF_PCT_GOOD_AQ,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Days With Good Air Quality,AHRQ:AHRF_PCT_GOOD_AQ,2022-01-01,1,,,,,,,,,
NEPHTN_PCT_MODPD_PM25,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Days With PM2.5 Levels Over The National Ambient Air Quality Standard (Modeled Estimates Only),AHRQ:NEPHTN_PCT_MODPD_PM25,2022-01-01,1,,,,,,,,,
NEPHTN_PCT_MONPD_PM25,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Days With PM2.5 Levels Over The National Ambient Air Quality Standard (Monitored Values Only),AHRQ:NEPHTN_PCT_MONPD_PM25,2022-01-01,1,,,,,,,,,
ACS_PCT_NATURE,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Employed Working In Agriculture, Forestry, Fishing And Hunting, And Mining (Ages 16 And Over)",AHRQ:ACS_PCT_NATURE,2022-01-01,1,,,,,,,,,
ACS_PCT_ART,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Employed Working In Arts, Entertainment, Recreation, And Accommodation And Food Services (Ages 16 And Over)",AHRQ:ACS_PCT_ART,2022-01-01,1,,,,,,,,,
ACS_PCT_CONSTRUCT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Employed Working In Construction (Ages 16 And Over),AHRQ:ACS_PCT_CONSTRUCT,2022-01-01,1,,,,,,,,,
ACS_PCT_EDUC,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Employed Working In Educational Services, And Healthcare And Social Assistance (Ages 16 And Over)",AHRQ:ACS_PCT_EDUC,2022-01-01,1,,,,,,,,,
ACS_PCT_FINANCE,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Employed Working In Finance And Insurance, Real Estate, And Rental And Leasing (Ages 16 And Over)",AHRQ:ACS_PCT_FINANCE,2022-01-01,1,,,,,,,,,
ACS_PCT_INFORM,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Employed Working In Information Services (Ages 16 And Over),AHRQ:ACS_PCT_INFORM,2022-01-01,1,,,,,,,,,
ACS_PCT_MANUFACT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Employed Working In Manufacturing (Ages 16 And Over),AHRQ:ACS_PCT_MANUFACT,2022-01-01,1,,,,,,,,,
ACS_PCT_OTHER,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Employed Working In Other Services, Except Public Administration (Ages 16 And Over)",AHRQ:ACS_PCT_OTHER,2022-01-01,1,,,,,,,,,
ACS_PCT_PROFESS,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Employed Working In Professional, Scientific, Management, Administrative, And Waste Management Services (Ages 16 And Over)",AHRQ:ACS_PCT_PROFESS,2022-01-01,1,,,,,,,,,
ACS_PCT_RETAIL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Employed Working In Retail Trade (Ages 16 And Over),AHRQ:ACS_PCT_RETAIL,2022-01-01,1,,,,,,,,,
ACS_PCT_TRANSPORT,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Employed Working In Transportation And Warehousing, And In Utilities (Ages 16 And Over)",AHRQ:ACS_PCT_TRANSPORT,2022-01-01,1,,,,,,,,,
ACS_PCT_WHOLESALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Employed Working In Wholesale Trade (Ages 16 And Over),AHRQ:ACS_PCT_WHOLESALE,2022-01-01,1,,,,,,,,,
CCBP_PCT_HEALTH_EMPLOYMENT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Employment Attributed To Health Care,AHRQ:CCBP_PCT_HEALTH_EMPLOYMENT,2022-01-01,1,,,,,,,,,
ACS_PCT_CHILD_1FAM,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Families With Children That Are Single-Parent Families,AHRQ:ACS_PCT_CHILD_1FAM,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_KID_1PRNT,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Family Households With Female Or Male Householder, No Spouse Present",AHRQ:ACS_PCT_HH_KID_1PRNT,2022-01-01,1,,,,,,,,,
ACS_PCT_DIVORCED_F,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Female Population Divorced Or Separated (Ages 15 And Over),AHRQ:ACS_PCT_DIVORCED_F,2022-01-01,1,,,,,,,,,
ACS_PCT_NVR_MARRIED_F,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Female Population Never Married (Ages 15 And Over),AHRQ:ACS_PCT_NVR_MARRIED_F,2022-01-01,1,,,,,,,,,
ACS_PCT_MARRIED_SP_AB_F,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Female Population Now Married And Spouse Absent (Ages 15 And Over),AHRQ:ACS_PCT_MARRIED_SP_AB_F,2022-01-01,1,,,,,,,,,
ACS_PCT_MARRIED_SP_PR_F,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Female Population Now Married And Spouse Present (Ages 15 And Over),AHRQ:ACS_PCT_MARRIED_SP_PR_F,2022-01-01,1,,,,,,,,,
ACS_PCT_WIDOWED_F,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Female Population Now Widowed (Ages 15 And Over),AHRQ:ACS_PCT_WIDOWED_F,2022-01-01,1,,,,,,,,,
ACS_PCT_WORK_RES_F,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Female Population Who Worked In Place Of Residence (Ages 16 And Over),AHRQ:ACS_PCT_WORK_RES_F,2022-01-01,1,,,,,,,,,
EP_HISP,0,OMOP SDOH,Observation,SVI Item,Percentage Of Hispanic Or Latino Persons Estimate,SVI:EP_HISP,2018-01-01,1,,,,,,,,,
MP_HISP,0,OMOP SDOH,Observation,SVI Item,Percentage Of Hispanic Or Latino Persons Estimate MOE,SVI:MP_HISP,2018-01-01,1,,,,,,,,,
ACS_PCT_POV_HISPANIC,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Hispanic Or Latino Population Below Poverty Level,AHRQ:ACS_PCT_POV_HISPANIC,2022-01-01,1,,,,,,,,,
ACS_PCT_HISP_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Hispanic Or Latino Population Reporting Female,AHRQ:ACS_PCT_HISP_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_HISP_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Hispanic Or Latino Population Reporting Male,AHRQ:ACS_PCT_HISP_MALE,2022-01-01,1,,,,,,,,,
HHC_PCT_HHA_AIDE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Home Health Agencies Offering Home Health Aide Services,AHRQ:HHC_PCT_HHA_AIDE,2022-01-01,1,,,,,,,,,
HHC_PCT_HHA_MEDICAL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Home Health Agencies Offering Medical Social Services,AHRQ:HHC_PCT_HHA_MEDICAL,2022-01-01,1,,,,,,,,,
HHC_PCT_HHA_NURSING,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Home Health Agencies Offering Nursing Care Services,AHRQ:HHC_PCT_HHA_NURSING,2022-01-01,1,,,,,,,,,
HHC_PCT_HHA_OCC_THERAPY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Home Health Agencies Offering Occupational Therapy Services,AHRQ:HHC_PCT_HHA_OCC_THERAPY,2022-01-01,1,,,,,,,,,
HHC_PCT_HHA_PHYS_THERAPY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Home Health Agencies Offering Physical Therapy Services,AHRQ:HHC_PCT_HHA_PHYS_THERAPY,2022-01-01,1,,,,,,,,,
HHC_PCT_HHA_SPEECH,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Home Health Agencies Offering Speech Pathology Services,AHRQ:HHC_PCT_HHA_SPEECH,2022-01-01,1,,,,,,,,,
POS_PCT_HOSP_GOV,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Hospitals That Are Government (Federal, State, Local, District) Hospitals",AHRQ:POS_PCT_HOSP_GOV,2022-01-01,1,,,,,,,,,
POS_PCT_HOSP_FOR_PROFIT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Hospitals That Are Private For-Profit Hospitals,AHRQ:POS_PCT_HOSP_FOR_PROFIT,2022-01-01,1,,,,,,,,,
POS_PCT_HOSP_NON_PROFIT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Hospitals That Are Private Not-For-Profit Hospitals,AHRQ:POS_PCT_HOSP_NON_PROFIT,2022-01-01,1,,,,,,,,,
ACS_PCT_HOUSEHOLDER_AIAN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Householders Who Are American Indian And Alaska Native Alone,AHRQ:ACS_PCT_HOUSEHOLDER_AIAN,2022-01-01,1,,,,,,,,,
ACS_PCT_HOUSEHOLDER_ASIAN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Householders Who Are Asian Alone,AHRQ:ACS_PCT_HOUSEHOLDER_ASIAN,2022-01-01,1,,,,,,,,,
ACS_PCT_HOUSEHOLDER_BLACK,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Householders Who Are Black Or African American Alone,AHRQ:ACS_PCT_HOUSEHOLDER_BLACK,2022-01-01,1,,,,,,,,,
ACS_PCT_HOUSEHOLDER_NHPI,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Householders Who Are Native Hawaiian And Other Pacific Islander Alone,AHRQ:ACS_PCT_HOUSEHOLDER_NHPI,2022-01-01,1,,,,,,,,,
ACS_PCT_HOUSEHOLDER_OTHER,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Householders Who Are Some Other Race Alone,AHRQ:ACS_PCT_HOUSEHOLDER_OTHER,2022-01-01,1,,,,,,,,,
ACS_PCT_HOUSEHOLDER_MULT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Householders Who Are Two Or More Races,AHRQ:ACS_PCT_HOUSEHOLDER_MULT,2022-01-01,1,,,,,,,,,
ACS_PCT_HOUSEHOLDER_WHITE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Householders Who Are White Alone,AHRQ:ACS_PCT_HOUSEHOLDER_WHITE,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_NO_FD_STMP_BLW_POV,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households Not Receiving Food Stamps/Snap With Income Below The Poverty Level,AHRQ:ACS_PCT_HH_NO_FD_STMP_BLW_POV,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_FOOD_STMP_BLW_POV,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households Receiving Food Stamps/Snap With Income Below The Poverty Level,AHRQ:ACS_PCT_HH_FOOD_STMP_BLW_POV,2022-01-01,1,,,,,,,,,
EP_HOUBDN,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Households That Make Less Than 75,000",SVI:EP_HOUBDN,2018-01-01,1,,,,,,,,,
ACS_PCT_HH_FOOD_STMP,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Households That Received Food Stamps/Snap, Past 12 Months",AHRQ:ACS_PCT_HH_FOOD_STMP,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_CELLULAR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Cellular Data Plan,AHRQ:ACS_PCT_HH_CELLULAR,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_CELLULAR_ONLY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Cellular Data Plan With No Other Type Of Internet Subscription,AHRQ:ACS_PCT_HH_CELLULAR_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_PC,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Desktop Or Laptop,AHRQ:ACS_PCT_HH_PC,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_PC_ONLY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Desktop Or Laptop With No Other Type Of Computing Device,AHRQ:ACS_PCT_HH_PC_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_ALONE_ABOVE65,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Person 65 Years And Over Living Alone,AHRQ:ACS_PCT_HH_ALONE_ABOVE65,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_SMARTPHONE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Smartphone,AHRQ:ACS_PCT_HH_SMARTPHONE,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_SMARTPHONE_ONLY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Smartphone With No Other Type Of Computing Device,AHRQ:ACS_PCT_HH_SMARTPHONE_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_TABLET,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Tablet Or Other Portable Wireless Computer,AHRQ:ACS_PCT_HH_TABLET,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_TABLET_ONLY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With A Tablet Or Other Portable Wireless Computer With No Other Type Of Computing Device,AHRQ:ACS_PCT_HH_TABLET_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_INTERNET,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Any Internet Subscription,AHRQ:ACS_PCT_HH_INTERNET,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_BROADBAND_ANY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Broadband Of Any Type,AHRQ:ACS_PCT_HH_BROADBAND_ANY,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_BROADBAND,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Households With Broadband Such As Cable, Fiber Optic Or Dsl",AHRQ:ACS_PCT_HH_BROADBAND,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_BROADBAND_ONLY,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Households With Broadband Such As Cable, Fiber Optic Or Dsl With No Other Type Of Internet Subscription",AHRQ:ACS_PCT_HH_BROADBAND_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_DIAL_INTERNET_ONLY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Dial Up And No Other Type Of Internet Subscription,AHRQ:ACS_PCT_HH_DIAL_INTERNET_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_INTERNET_NO_SUBS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Internet Access Without A Subscription,AHRQ:ACS_PCT_HH_INTERNET_NO_SUBS,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_NO_INTERNET,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With No Internet Access,AHRQ:ACS_PCT_HH_NO_INTERNET,2022-01-01,1,,,,,,,,,
EP_NOVEH,0,OMOP SDOH,Observation,SVI Item,Percentage Of Households With No Vehicle Available Estimate,SVI:EP_NOVEH,2018-01-01,1,,,,,,,,,
MP_NOVEH,0,OMOP SDOH,Observation,SVI Item,Percentage Of Households With No Vehicle Available Estimate MOE,SVI:MP_NOVEH,2018-01-01,1,,,,,,,,,
ACS_PCT_HH_ABOVE65,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With One Or More People 65 Years And Over,AHRQ:ACS_PCT_HH_ABOVE65,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_1PERS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Only One Occupant,AHRQ:ACS_PCT_HH_1PERS,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_OTHER_COMP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Other Type Of Computer,AHRQ:ACS_PCT_HH_OTHER_COMP,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_OTHER_COMP_ONLY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Other Type Of Computer Only,AHRQ:ACS_PCT_HH_OTHER_COMP_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_PUB_ASSIST,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Public Assistance Income Or Food Stamps/Snap,AHRQ:ACS_PCT_HH_PUB_ASSIST,2022-01-01,1,,,,,,,,,
ACS_PCT_SAME_SEX_UNMRD_PRTNR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Same-Sex Unmarried Partner,AHRQ:ACS_PCT_SAME_SEX_UNMRD_PRTNR,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_SAT_INTERNET,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households With Satellite Internet Service,AHRQ:ACS_PCT_HH_SAT_INTERNET,2022-01-01,1,,,,,,,,,
EP_NOINT,0,OMOP SDOH,Observation,SVI Item,Percentage Of Households Without A Computer With A Broadband Internet Subscription Estimate,Percentage Of Persons Without Internet,2018-01-01,1,,,,,,,,,
MP_NOINT,0,OMOP SDOH,Observation,SVI Item,Percentage Of Households Without A Computer With A Broadband Internet Subscription Estimate MOE,SVI:MP_NOINT,2018-01-01,1,,,,,,,,,
ACS_PCT_HH_NO_COMP_DEV,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Households Without A Computing Device,AHRQ:ACS_PCT_HH_NO_COMP_DEV,2022-01-01,1,,,,,,,,,
E_HOUAGE,0,OMOP SDOH,Observation,EJI EBM Item,Percentage Of Houses Built Pre- 1980 (Lead Exposure),EJI:E_HOUAGE,2022-01-01,1,,,,,,,,,
EP_HBURD,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Housing Cost- Burdened Occupied Housing Units With Annual Income Less Than $75,000 (30%+ Of Income Spent On Housing Costs) Estimate",SVI:EP_HBURD,2018-01-01,1,,,,,,,,,
MP_HBURD,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Housing Cost- Burdened Occupied Housing Units With Annual Income Less Than $75,000 (30%+ Of Income Spent On Housing Costs) Estimate MOE",SVI:MP_HBURD,2018-01-01,1,,,,,,,,,
ACS_PCT_10UNITS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Housing In Structures With 10 Or More Units,AHRQ:ACS_PCT_10UNITS,2022-01-01,1,,,,,,,,,
EP_MUNIT,0,OMOP SDOH,Observation,SVI Item,Percentage Of Housing In Structures With 10 Or More Units Estimate,SVI:EP_MUNIT,2018-01-01,1,,,,,,,,,
MP_MUNIT,0,OMOP SDOH,Observation,SVI Item,Percentage Of Housing In Structures With 10 Or More Units Estimate MOE,SVI:MP_MUNIT,2018-01-01,1,,,,,,,,,
ACS_PCT_HU_BUILT_1979,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Housing Units Built Before 1979,AHRQ:ACS_PCT_HU_BUILT_1979,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_KITCHEN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Housing Units Lacking Complete Kitchen Facilities,AHRQ:ACS_PCT_HU_KITCHEN,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_PLUMBING,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Housing Units Lacking Complete Plumbing Facilities,AHRQ:ACS_PCT_HU_PLUMBING,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_MOBILE_HOME,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Housing Units That Are Mobile Homes,AHRQ:ACS_PCT_HU_MOBILE_HOME,2022-01-01,1,,,,,,,,,
ACS_PCT_VACANT_HU,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Housing Units Vacant,AHRQ:ACS_PCT_VACANT_HU,2022-01-01,1,,,,,,,,,
ACS_PCT_1UP_PERS_1ROOM,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Housing Units With More Than One Occupant Per Room,AHRQ:ACS_PCT_1UP_PERS_1ROOM,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_NO_VEH,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Housing Units With No Vehicle Available,AHRQ:ACS_PCT_HU_NO_VEH,2022-01-01,1,,,,,,,,,
EP_MHLTH,0,OMOP SDOH,Observation,EJI HVM Item,Percentage Of Individual Reporting Not Good Mental Health,EJI:EP_MHLTH,2022-01-01,1,,,,,,,,,
EPL_MHLTH,0,OMOP SDOH,Observation,EJI HVM Item,Percentage Of Individual Reporting Not Good Mental Health Percentile Rank,EJI:EPL_MHLTH,2022-01-01,1,,,,,,,,,
EP_ASTHMA,0,OMOP SDOH,Observation,EJI HVM Item,Percentage Of Individuals With Asthma,EJI:EP_ASTHMA,2022-01-01,1,,,,,,,,,
EP_CANCER,0,OMOP SDOH,Observation,EJI HVM Item,Percentage Of Individuals With Cancer,EJI:EP_CANCER,2022-01-01,1,,,,,,,,,
EP_DIABETES,0,OMOP SDOH,Observation,EJI HVM Item,Percentage Of Individuals With Diabetes,EJI:EP_DIABETES,2022-01-01,1,,,,,,,,,
EP_BPHIGH,0,OMOP SDOH,Observation,EJI HVM Item,Percentage Of Individuals With Raw High Blood Pressures Values,EJI:EP_BPHIGH,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_LIMIT_ENGLISH,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Limited English Speaking Households,AHRQ:ACS_PCT_HH_LIMIT_ENGLISH,2022-01-01,1,,,,,,,,,
CHR_PCT_LOW_BIRTH_WT,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Live Births With Low Birthweight (<2,500 Grams)",AHRQ:CHR_PCT_LOW_BIRTH_WT,2022-01-01,1,,,,,,,,,
CRDC_PCT_LEA_DESEGPLAN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Local Education Authorities Covered By A Desegregation Order Or Plan,AHRQ:CRDC_PCT_LEA_DESEGPLAN,2022-01-01,1,,,,,,,,,
CRDC_PCT_COUNTY_ECE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Local Education Authorities In A County That Offer Early Childhood Services To Children (Ages 0-2),AHRQ:CRDC_PCT_COUNTY_ECE,2022-01-01,1,,,,,,,,,
CRDC_PCT_CTY_KGTN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Local Education Authorities In A County That Offer One Or More Kindergarten Programs,AHRQ:CRDC_PCT_CTY_KGTN,2022-01-01,1,,,,,,,,,
CRDC_PCT_COUNTY_PREK,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Local Education Authorities In A County That Offer Pre-School Services Or Programs To Children (Ages 3?5),AHRQ:CRDC_PCT_COUNTY_PREK,2022-01-01,1,,,,,,,,,
CRDC_PCT_CTY_PSTITLEI,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Local Education Authorities In A County That Offer Preschool To Children In Title I Schools,AHRQ:CRDC_PCT_CTY_PSTITLEI,2022-01-01,1,,,,,,,,,
CRDC_PCT_CTY_PSLOWINC,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Local Education Authorities In A County That Offer Preschool To Low-Income Families,AHRQ:CRDC_PCT_CTY_PSLOWINC,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_10_POP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Low Access Population Measured At 1 Mile For Urban Areas And 10 Miles For Rural Areas,AHRQ:FARA_PCT_LA_1_10_POP,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_20_POP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Low Access Population Measured At 1 Mile For Urban Areas And 20 Miles For Rural Areas,AHRQ:FARA_PCT_LA_1_20_POP,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_HALF_10_POP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Low Access Population Measured At 1/2 Mile For Urban Areas And 10 Miles For Rural Areas,AHRQ:FARA_PCT_LA_HALF_10_POP,2022-01-01,1,,,,,,,,,
ACS_PCT_DIVORCED_M,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Male Population Divorced Or Separated (Ages 15 And Over),AHRQ:ACS_PCT_DIVORCED_M,2022-01-01,1,,,,,,,,,
ACS_PCT_NVR_MARRIED_M,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Male Population Never Married (Ages 15 And Over),AHRQ:ACS_PCT_NVR_MARRIED_M,2022-01-01,1,,,,,,,,,
ACS_PCT_MARRIED_SP_AB_M,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Male Population Now Married And Spouse Absent (Ages 15 And Over),AHRQ:ACS_PCT_MARRIED_SP_AB_M,2022-01-01,1,,,,,,,,,
ACS_PCT_MARRIED_SP_PR_M,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Male Population Now Married And Spouse Present (Ages 15 And Over),AHRQ:ACS_PCT_MARRIED_SP_PR_M,2022-01-01,1,,,,,,,,,
ACS_PCT_WIDOWED_M,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Male Population Now Widowed (Ages 15 And Over),AHRQ:ACS_PCT_WIDOWED_M,2022-01-01,1,,,,,,,,,
ACS_PCT_WORK_RES_M,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Male Population Who Worked In Place Of Residence (Ages 16 And Over),AHRQ:ACS_PCT_WORK_RES_M,2022-01-01,1,,,,,,,,,
MP_PCT_ADVTG_PEN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Medicare Eligible Beneficiaries Enrolled In A Medicare Advantage Plan Per 100 Population,AHRQ:MP_PCT_ADVTG_PEN,2022-01-01,1,,,,,,,,,
AHRF_PCT_PRESC_PEN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Medicare Eligible Beneficiaries Enrolled In A Prescription Drug Plan Per 100 Population,AHRQ:AHRF_PCT_PRESC_PEN,2022-01-01,1,,,,,,,,,
MGV_PCT_BEN_FFS_BLACK,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Medicare Ffs Beneficiaries Who Are Black Or African American,AHRQ:MGV_PCT_BEN_FFS_BLACK,2022-01-01,1,,,,,,,,,
MGV_PCT_MEDICAID,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Medicare Ffs Beneficiaries Who Are Eligible For Medicaid For At Least One Month,AHRQ:MGV_PCT_MEDICAID,2022-01-01,1,,,,,,,,,
MGV_PCT_BEN_FFS_HISPANIC,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Medicare Ffs Beneficiaries Who Are Hispanic,AHRQ:MGV_PCT_BEN_FFS_HISPANIC,2022-01-01,1,,,,,,,,,
MGV_PCT_BEN_FFS_WHITE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Medicare Ffs Beneficiaries Who Are Non-Hispanic White,AHRQ:MGV_PCT_BEN_FFS_WHITE,2022-01-01,1,,,,,,,,,
EP_MINRTY,0,OMOP SDOH,Observation,SVI Item,Percentage Of Minority Persons,SVI:EP_MINRTY,2018-01-01,1,,,,,,,,,
EP_MOBILE,0,OMOP SDOH,Observation,SVI Item,Percentage Of Mobile Homes Estimate,SVI:EP_MOBILE,2018-01-01,1,,,,,,,,,
MP_MOBILE,0,OMOP SDOH,Observation,SVI Item,Percentage Of Mobile Homes Estimate MOE,SVI:MP_MOBILE,2018-01-01,1,,,,,,,,,
ACS_PCT_NHPI_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Native Hawaiian And Other Pacific Islander Alone Population Reporting Female,AHRQ:ACS_PCT_NHPI_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_NHPI_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Native Hawaiian And Other Pacific Islander Alone Population Reporting Male,AHRQ:ACS_PCT_NHPI_MALE,2022-01-01,1,,,,,,,,,
EP_NHPI,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Native Hawaiian Or Other Pacific Islander, Not Hispanic Or Latino Persons Estimate",SVI:EP_NHPI,2018-01-01,1,,,,,,,,,
MP_NHPI,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Native Hawaiian Or Other Pacific Islander, Not Hispanic Or Latino Persons Estimate MOE",SVI:MP_NHPI,2018-01-01,1,,,,,,,,,
ACS_PCT_POV_NHPI,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Native Hawaiian Or Pacific Islander Population Below Poverty Level,AHRQ:ACS_PCT_POV_NHPI,2022-01-01,1,,,,,,,,,
ACS_PCT_AIAN_NONHISP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Non-Hispanic Population Reporting American Indian And Alaska Native Race Alone,AHRQ:ACS_PCT_AIAN_NONHISP,2022-01-01,1,,,,,,,,,
ACS_PCT_ASIAN_NONHISP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Non-Hispanic Population Reporting Asian Race Alone,AHRQ:ACS_PCT_ASIAN_NONHISP,2022-01-01,1,,,,,,,,,
ACS_PCT_BLACK_NONHISP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Non-Hispanic Population Reporting Black Or African American Race Alone,AHRQ:ACS_PCT_BLACK_NONHISP,2022-01-01,1,,,,,,,,,
ACS_PCT_MULT_RACE_NONHISP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Non-Hispanic Population Reporting Multiple Races,AHRQ:ACS_PCT_MULT_RACE_NONHISP,2022-01-01,1,,,,,,,,,
ACS_PCT_NHPI_NONHISP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Non-Hispanic Population Reporting Native Hawaiian And Pacific Islander Race Alone,AHRQ:ACS_PCT_NHPI_NONHISP,2022-01-01,1,,,,,,,,,
ACS_PCT_OTHER_NONHISP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Non-Hispanic Population Reporting Some Other Race Alone,AHRQ:ACS_PCT_OTHER_NONHISP,2022-01-01,1,,,,,,,,,
ACS_PCT_WHITE_NONHISP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Non-Hispanic Population Reporting White Race Alone,AHRQ:ACS_PCT_WHITE_NONHISP,2022-01-01,1,,,,,,,,,
ACS_PCT_NONVET_DISABLE_18_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Nonveterans With A Disability (Between Ages 18 And 64),AHRQ:ACS_PCT_NONVET_DISABLE_18_64,2022-01-01,1,,,,,,,,,
LTC_PCT_FOR_PROFIT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Nursing Homes That Are For-Profit,AHRQ:LTC_PCT_FOR_PROFIT,2022-01-01,1,,,,,,,,,
LTC_PCT_MULTI_FAC,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Nursing Homes That Are Owned Or Leased By A Multi-Facility (Chain) Organization,AHRQ:LTC_PCT_MULTI_FAC,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_BOT_TANK_LP_GAS,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Occupied Housing Units With Bottled, Tank, Or Lp Gas",AHRQ:ACS_PCT_HU_BOT_TANK_LP_GAS,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_COAL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units With Coal Or Coke Heating,AHRQ:ACS_PCT_HU_COAL,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_ELEC,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units With Electricity Heating,AHRQ:ACS_PCT_HU_ELEC,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_OIL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units With Fuel Oil Heating,AHRQ:ACS_PCT_HU_OIL,2022-01-01,1,,,,,,,,,
EP_CROWD,0,OMOP SDOH,Observation,SVI Item,Percentage Of Occupied Housing Units With More People Than Rooms Estimate,SVI:EP_CROWD,2018-01-01,1,,,,,,,,,
MP_CROWD,0,OMOP SDOH,Observation,SVI Item,Percentage Of Occupied Housing Units With More People Than Rooms Estimate MOE,SVI:MP_CROWD,2018-01-01,1,,,,,,,,,
ACS_PCT_HU_OTHER,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units With Other Heating Fuel,AHRQ:ACS_PCT_HU_OTHER,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_SOLAR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units With Solar Energy,AHRQ:ACS_PCT_HU_SOLAR,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_UTILITY_GAS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units With Utility Gas Heating,AHRQ:ACS_PCT_HU_UTILITY_GAS,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_WOOD,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units With Wood Heating,AHRQ:ACS_PCT_HU_WOOD,2022-01-01,1,,,,,,,,,
ACS_PCT_HU_NO_FUEL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units Without Fuel,AHRQ:ACS_PCT_HU_NO_FUEL,2022-01-01,1,,,,,,,,,
ACS_PCT_OWNER_HU,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units: Owner-Occupied,AHRQ:ACS_PCT_OWNER_HU,2022-01-01,1,,,,,,,,,
ACS_PCT_RENTER_HU,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Occupied Housing Units: Rented,AHRQ:ACS_PCT_RENTER_HU,2022-01-01,1,,,,,,,,,
ACS_PCT_OWNER_HU_CHILD,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Owner-Occupied Housing Units With Children,AHRQ:ACS_PCT_OWNER_HU_CHILD,2022-01-01,1,,,,,,,,,
ACS_PCT_1UP_OWNER_1ROOM,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Owner-Occupied Housing Units With More Than One Occupant Per Room,AHRQ:ACS_PCT_1UP_OWNER_1ROOM,2022-01-01,1,,,,,,,,,
ACS_PCT_OWNER_HU_COST_30PCT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Owner-Occupied Housing Units With Selected Monthly Owner Costs Equal To 30 Percent Or More Of Household Income,AHRQ:ACS_PCT_OWNER_HU_COST_30PCT,2022-01-01,1,,,,,,,,,
ACS_PCT_OWNER_HU_COST_50PCT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Owner-Occupied Housing Units With Selected Monthly Owner Costs Equal To 50 Percent Or More Of Household Income,AHRQ:ACS_PCT_OWNER_HU_COST_50PCT,2022-01-01,1,,,,,,,,,
AMFAR_PCT_DRUGDEP_ABOVE12,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of People Reporting Drug Dependence (Ages 12 And Over),AHRQ:AMFAR_PCT_DRUGDEP_ABOVE12,2022-01-01,1,,,,,,,,,
AMFAR_PCT_NONMEDPAIN_ABOVE12,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of People Reporting Nonmedical Use Of Pain Relievers (Ages 12 And Over),AHRQ:AMFAR_PCT_NONMEDPAIN_ABOVE12,2022-01-01,1,,,,,,,,,
EP_LIMENG,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Persons (Age 5+) Who Speak English ""Less Than Well"" Estimate","Percentage Of Persons (Age 5+) Who Speak English ""Less Than Well"" Estimate, 2014-2018 ACS",2018-01-01,1,,,,,,,,,
MP_LIMENG,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Persons (Age 5+) Who Speak English ""Less Than Well"" Estimate MOE",SVI:MP_LIMENG,2018-01-01,1,,,,,,,,,
EP_AGE17,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Aged 17 And Younger Estimate,"Persons Aged 17 And Younger Estimate, 2014-2018 ACS",2018-01-01,1,,,,,,,,,
MP_AGE17,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Aged 17 And Younger Estimate MOE,SVI:MP_AGE17,2018-01-01,1,,,,,,,,,
EP_AGE65,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Aged 65 And Older Estimate,"Persons Aged 65 And Older Estimate MOE, 2014-2018 ACS",2018-01-01,1,,,,,,,,,
MP_AGE65,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Aged 65 And Older Estimate MOE,SVI:MP_AGE65,2018-01-01,1,,,,,,,,,
EP_POV150,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Below 150% Poverty Estimate,SVI:EP_POV150,2018-01-01,1,,,,,,,,,
MP_POV150,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Below 150% Poverty Estimate MOE,SVI:MP_POV150,2018-01-01,1,,,,,,,,,
EP_GROUPQ,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons In Group Quarters Estimate,"Percentage Of Persons In Group Quarters Estimate, 2014-2018 ACS",2018-01-01,1,,,,,,,,,
MP_GROUPQ,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons In Group Quarters Estimate MOE,SVI:MP_GROUPQ,2018-01-01,1,,,,,,,,,
ACS_PCT_GRP_QRT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Persons In Institutionalized Group Quarters,AHRQ:ACS_PCT_GRP_QRT,2022-01-01,1,,,,,,,,,
EP_UNEMP_P,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Who Are Unemployed,SVI:EP_UNEMP_P,2018-01-01,1,,,,,,,,,
EP_UNINSUR_P,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Who Are Uninsured,SVI:EP_UNINSUR_P,2018-01-01,1,,,,,,,,,
EP_RENTER,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Who Rent,SVI:EP_RENTER,2018-01-01,1,,,,,,,,,
MP_NOHSDP,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons With No High School Diploma (25+) Estimate MOE,SVI:MP_NOHSDP,2018-01-01,1,,,,,,,,,
EP_NOHSDP,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons With No High School Diploma (Age 25+) Estimate,SVI:EP_NOHSDP,2018-01-01,1,,,,,,,,,
EP_NOINT_P,0,OMOP SDOH,Observation,SVI Item,Percentage Of Persons Without Internet,SVI:EP_NOINT_P,2018-01-01,1,,,,,,,,,
ACS_PCT_AGE_ABOVE65,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Ages 65 And Over,AHRQ:ACS_PCT_AGE_ABOVE65,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_ABOVE80,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Ages 80 And Over,AHRQ:ACS_PCT_AGE_ABOVE80,2022-01-01,1,,,,,,,,,
ACS_PCT_HEALTH_INC_138_199,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between 1.38 And 1.99 Of The Poverty Threshold (Relevant For Health Insurance Coverage),AHRQ:ACS_PCT_HEALTH_INC_138_199,2022-01-01,1,,,,,,,,,
ACS_PCT_HEALTH_INC_200_399,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between 2.00 And 3.99 Of The Poverty Threshold (Relevant For Health Insurance Coverage),AHRQ:ACS_PCT_HEALTH_INC_200_399,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_0_17,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 0-17,AHRQ:ACS_PCT_AGE_0_17,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_0_4,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 0-4,AHRQ:ACS_PCT_AGE_0_4,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_10_14,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 10-14,AHRQ:ACS_PCT_AGE_10_14,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_15_17,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 15-17,AHRQ:ACS_PCT_AGE_15_17,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_18_29,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 18-29,AHRQ:ACS_PCT_AGE_18_29,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_18_44,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 18-44,AHRQ:ACS_PCT_AGE_18_44,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_30_44,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 30-44,AHRQ:ACS_PCT_AGE_30_44,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_45_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 45-64,AHRQ:ACS_PCT_AGE_45_64,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_5_9,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 5-9,AHRQ:ACS_PCT_AGE_5_9,2022-01-01,1,,,,,,,,,
ACS_PCT_AGE_50_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Between Ages 50-64,AHRQ:ACS_PCT_AGE_50_64,2022-01-01,1,,,,,,,,,
ACS_PCT_CTZ_NONUS_BORN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Consisting Of U.S. Citizens Born Abroad Of American Parents Or Naturalized,AHRQ:ACS_PCT_CTZ_NONUS_BORN,2022-01-01,1,,,,,,,,,
ACS_PCT_CTZ_US_BORN,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Population Consisting Of U.S. Citizens Born In United States, Puerto Rico, Or U.S. Islands",AHRQ:ACS_PCT_CTZ_US_BORN,2022-01-01,1,,,,,,,,,
ACS_PCT_CTZ_NATURALIZED,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Consisting Of U.S. Citizens By Naturalization,AHRQ:ACS_PCT_CTZ_NATURALIZED,2022-01-01,1,,,,,,,,,
ACS_PCT_ARMED_FORCES,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population In Armed Forces (Ages 16 And Over),AHRQ:ACS_PCT_ARMED_FORCES,2022-01-01,1,,,,,,,,,
NEPHTN_PCT_ARSENIC_MCL_LESS10,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population In The County Served By Community Water Systems With Yearly Distribution Of Mean Arsenic Concentration <10,AHRQ:NEPHTN_PCT_ARSENIC_MCL_LESS10,2022-01-01,1,,,,,,,,,
NEPHTN_PCT_ARSENIC_MCL_GREATER10,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population In The County Served By Community Water Systems With Yearly Distribution Of Mean Arsenic Concentration >10,AHRQ:NEPHTN_PCT_ARSENIC_MCL_GREATER10,2022-01-01,1,,,,,,,,,
NEPHTN_PCT_ARSENIC_MCL_NOTDETECT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population In The County Served By Community Water Systems With Yearly Distribution Of Mean Arsenic Concentration Not Detected,AHRQ:NEPHTN_PCT_ARSENIC_MCL_NOTDETECT,2022-01-01,1,,,,,,,,,
NEPHTN_PCT_PARK,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Living Within Half A Mile Of A Park,AHRQ:NEPHTN_PCT_PARK,2022-01-01,1,,,,,,,,,
ACS_PCT_NOT_LABOR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Not In Labor Force (Ages 16 And Over),AHRQ:ACS_PCT_NOT_LABOR,2022-01-01,1,,,,,,,,,
ACS_PCT_HEALTH_INC_ABOVE400,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Over 4.00 Of The Poverty Threshold (Relevant For Health Insurance Coverage),AHRQ:ACS_PCT_HEALTH_INC_ABOVE400,2022-01-01,1,,,,,,,,,
ACS_PCT_AIAN_COMB,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting American Indian And Alaska Native Alone Or In Combination With One Or More Races,AHRQ:ACS_PCT_AIAN_COMB,2022-01-01,1,,,,,,,,,
ACS_PCT_AIAN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting American Indian And Alaska Native Race Alone,AHRQ:ACS_PCT_AIAN,2022-01-01,1,,,,,,,,,
ACS_PCT_ASIAN_COMB,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Asian Alone Or In Combination With One Or More Races,AHRQ:ACS_PCT_ASIAN_COMB,2022-01-01,1,,,,,,,,,
ACS_PCT_ASIAN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Asian Race Alone,AHRQ:ACS_PCT_ASIAN,2022-01-01,1,,,,,,,,,
ACS_PCT_BLACK_COMB,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Black Or African American Alone Or In Combination With One Or More Races,AHRQ:ACS_PCT_BLACK_COMB,2022-01-01,1,,,,,,,,,
ACS_PCT_BLACK,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Black Or African American Race Alone,AHRQ:ACS_PCT_BLACK,2022-01-01,1,,,,,,,,,
ACS_PCT_HISPANIC,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Hispanic Ethnicity,AHRQ:ACS_PCT_HISPANIC,2022-01-01,1,,,,,,,,,
ACS_PCT_MULT_RACE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Multiple Races,AHRQ:ACS_PCT_MULT_RACE,2022-01-01,1,,,,,,,,,
ACS_PCT_NHPI_COMB,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Native Hawaiian And Other Pacific Islander Alone Or In Combination With One Or More Races,AHRQ:ACS_PCT_NHPI_COMB,2022-01-01,1,,,,,,,,,
ACS_PCT_NHPI,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Native Hawaiian And Pacific Islander Race Alone,AHRQ:ACS_PCT_NHPI,2022-01-01,1,,,,,,,,,
ACS_PCT_OTHER_RACE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Some Other Race Alone,AHRQ:ACS_PCT_OTHER_RACE,2022-01-01,1,,,,,,,,,
ACS_PCT_OTHER_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Some Other Race Alone And Female,AHRQ:ACS_PCT_OTHER_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_OTHER_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Some Other Race Alone And Male,AHRQ:ACS_PCT_OTHER_MALE,2022-01-01,1,,,,,,,,,
ACS_PCT_MULT_RACE_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Two Or More Races And Female,AHRQ:ACS_PCT_MULT_RACE_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_MULT_RACE_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting Two Or More Races And Male,AHRQ:ACS_PCT_MULT_RACE_MALE,2022-01-01,1,,,,,,,,,
ACS_PCT_WHITE_COMB,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting White Alone Or In Combination With One Or More Races,AHRQ:ACS_PCT_WHITE_COMB,2022-01-01,1,,,,,,,,,
ACS_PCT_WHITE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Reporting White Race Alone,AHRQ:ACS_PCT_WHITE,2022-01-01,1,,,,,,,,,
ACS_PCT_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Is Female,AHRQ:ACS_PCT_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_FOREIGN_BORN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Is Foreign-Born,AHRQ:ACS_PCT_FOREIGN_BORN,2022-01-01,1,,,,,,,,,
ACS_PCT_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Is Male,AHRQ:ACS_PCT_MALE,2022-01-01,1,,,,,,,,,
ACS_PCT_IN_STATE_MOVE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Moved From Different County Within Same State In The Past Year (Age 1 And Over),AHRQ:ACS_PCT_IN_STATE_MOVE,2022-01-01,1,,,,,,,,,
ACS_PCT_DIF_STATE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Moved From Different State In The Past Year (Age 1 And Over),AHRQ:ACS_PCT_DIF_STATE,2022-01-01,1,,,,,,,,,
ACS_PCT_IN_COUNTY_MOVE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Moved Within The Same County In The Past Year (Age 1 And Over),AHRQ:ACS_PCT_IN_COUNTY_MOVE,2022-01-01,1,,,,,,,,,
ACS_PCT_ENGLISH,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Only Speaks English (Ages 5 And Over),AHRQ:ACS_PCT_ENGLISH,2022-01-01,1,,,,,,,,,
ACS_PCT_ENGL_NOT_ALL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Speaks A Language Other Than English That Does Not Speak English At All (Ages 5 And Over),AHRQ:ACS_PCT_ENGL_NOT_ALL,2022-01-01,1,,,,,,,,,
ACS_PCT_ENGL_NOT_WELL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Speaks A Language Other Than English That Does Not Speak English Well (Ages 5 And Over),AHRQ:ACS_PCT_ENGL_NOT_WELL,2022-01-01,1,,,,,,,,,
ACS_PCT_ENGL_VERY_WELL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Speaks A Language Other Than English That Speaks English Very Well (Ages 5 And Over),AHRQ:ACS_PCT_ENGL_VERY_WELL,2022-01-01,1,,,,,,,,,
ACS_PCT_ENGL_WELL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Speaks A Language Other Than English That Speaks English Well (Ages 5 And Over),AHRQ:ACS_PCT_ENGL_WELL,2022-01-01,1,,,,,,,,,
ACS_PCT_API_LANG,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Speaks Asian And Pacific Island Languages (Ages 5 And Over),AHRQ:ACS_PCT_API_LANG,2022-01-01,1,,,,,,,,,
ACS_PCT_SPANISH,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population That Speaks Spanish (Ages 5 And Over),AHRQ:ACS_PCT_SPANISH,2022-01-01,1,,,,,,,,,
ACS_PCT_HEALTH_INC_BELOW137,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Under 1.37 Of The Poverty Threshold (Relevant For Health Insurance Coverage),AHRQ:ACS_PCT_HEALTH_INC_BELOW137,2022-01-01,1,,,,,,,,,
ACS_PCT_CTZ_ABOVE18,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Are Citizens (Ages 18 And Over),AHRQ:ACS_PCT_CTZ_ABOVE18,2022-01-01,1,,,,,,,,,
ACS_PCT_NON_CITIZEN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Are Not U.S. Citizens,AHRQ:ACS_PCT_NON_CITIZEN,2022-01-01,1,,,,,,,,,
ACS_PCT_NONCTN_1990,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Are Not U.S. Citizens And Entered U.S. Before 1990,AHRQ:ACS_PCT_NONCTN_1990,2022-01-01,1,,,,,,,,,
ACS_PCT_NONCTN_1999,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Are Not U.S. Citizens And Entered U.S. Between 1990 And 1999,AHRQ:ACS_PCT_NONCTN_1999,2022-01-01,1,,,,,,,,,
ACS_PCT_NONCTN_2000,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Are Not U.S. Citizens And Entered U.S. Between 2000 And 2009,AHRQ:ACS_PCT_NONCTN_2000,2022-01-01,1,,,,,,,,,
ACS_PCT_NONCTN_2010,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Are Not U.S. Citizens And Entered U.S. Since 2010,AHRQ:ACS_PCT_NONCTN_2010,2022-01-01,1,,,,,,,,,
ACS_PCT_PVT_PROFIT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Are Private For-Profit Wage And Salary Workers (Ages 16 And Over),AHRQ:ACS_PCT_PVT_PROFIT,2022-01-01,1,,,,,,,,,
ACS_PCT_PVT_NONPROFIT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Are Private Not-For-Profit Wage And Salary Workers (Ages 16 And Over),AHRQ:ACS_PCT_PVT_NONPROFIT,2022-01-01,1,,,,,,,,,
CHR_PCT_FOOD,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Lack Adequate Access To Food,AHRQ:CHR_PCT_FOOD,2022-01-01,1,,,,,,,,,
ACS_PCT_OTH_EURP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Speak Other Indo-European Languages (Ages 5 And Over),AHRQ:ACS_PCT_OTH_EURP,2022-01-01,1,,,,,,,,,
ACS_PCT_OTH_LANG,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population Who Speak Other Languages (Ages 5 And Over),AHRQ:ACS_PCT_OTH_LANG,2022-01-01,1,,,,,,,,,
ACS_PCT_BACHELOR_DGR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With A Bachelor'S Degree (Ages 25 And Over),AHRQ:ACS_PCT_BACHELOR_DGR,2022-01-01,1,,,,,,,,,
ACS_PCT_DISABLE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With A Disability,AHRQ:ACS_PCT_DISABLE,2022-01-01,1,,,,,,,,,
ACS_PCT_GRADUATE_DGR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With A Master'S Or Professional School Degree Or Doctorate (Ages 25 And Over),AHRQ:ACS_PCT_GRADUATE_DGR,2022-01-01,1,,,,,,,,,
ACS_PCT_PERSON_INC_100_124,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With An Income To Poverty Ratio Between 1.00 And 1.24,AHRQ:ACS_PCT_PERSON_INC_100_124,2022-01-01,1,,,,,,,,,
ACS_PCT_PERSON_INC_125_199,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With An Income To Poverty Ratio Between 1.25 And 1.99,AHRQ:ACS_PCT_PERSON_INC_125_199,2022-01-01,1,,,,,,,,,
ACS_PCT_PERSON_INC_ABOVE200,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With An Income To Poverty Ratio Of 2.00 Or Higher,AHRQ:ACS_PCT_PERSON_INC_ABOVE200,2022-01-01,1,,,,,,,,,
ACS_PCT_PERSON_INC_BELOW99,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With An Income To Poverty Ratio Under 1.00,AHRQ:ACS_PCT_PERSON_INC_BELOW99,2022-01-01,1,,,,,,,,,
ACS_PCT_MEDICAID_ANY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Any Medicaid/Means-Tested Public Health Insurance Coverage,AHRQ:ACS_PCT_MEDICAID_ANY,2022-01-01,1,,,,,,,,,
ACS_PCT_MEDICAID_ANY_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Any Medicaid/Means-Tested Public Health Insurance Coverage (Ages 64 And Below),AHRQ:ACS_PCT_MEDICAID_ANY_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_POSTHS_ED,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Any Postsecondary Education (Ages 25 And Over),AHRQ:ACS_PCT_POSTHS_ED,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_ANY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Any Private Health Insurance Coverage,AHRQ:ACS_PCT_PRIVATE_ANY,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_ANY_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Any Private Health Insurance Coverage (Ages 64 And Below),AHRQ:ACS_PCT_PRIVATE_ANY_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_SELF_MDCR_ABOVE35,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Direct-Purchase And Medicare Health Insurance (Ages 35 And Over),AHRQ:ACS_PCT_SELF_MDCR_ABOVE35,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_MDCR_35_64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Direct-Purchase And Medicare Health Insurance (Between Ages 35 And 64),AHRQ:ACS_PCT_PRIVATE_MDCR_35_64,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_SELF,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Direct-Purchase Health Insurance Only,AHRQ:ACS_PCT_PRIVATE_SELF,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_SELF_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Direct-Purchase Health Insurance Only (Ages 64 And Below),AHRQ:ACS_PCT_PRIVATE_SELF_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_PVT_EMPL_DRCT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Employer-Based And Direct-Purchase Coverage,AHRQ:ACS_PCT_PVT_EMPL_DRCT,2022-01-01,1,,,,,,,,,
ACS_PCT_PVT_EMPL_DRCT_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Employer-Based And Direct-Purchase Coverage (Ages 64 And Below),AHRQ:ACS_PCT_PVT_EMPL_DRCT_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_MDCR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Employer-Based And Medicare Insurance Coverage,AHRQ:ACS_PCT_PRIVATE_MDCR,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_EMPL,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Employer-Based Health Insurance,AHRQ:ACS_PCT_PRIVATE_EMPL,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_EMPL_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Employer-Based Health Insurance Only (Ages 64 And Below),AHRQ:ACS_PCT_PRIVATE_EMPL_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_INC_14999,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Population With Household Income Between $10,000 And $14,999",AHRQ:ACS_PCT_HH_INC_14999,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_INC_24999,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Population With Household Income Between $15,000 And $24,999",AHRQ:ACS_PCT_HH_INC_24999,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_INC_49999,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Population With Household Income Between $25,000 And $49,999",AHRQ:ACS_PCT_HH_INC_49999,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_INC_99999,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Population With Household Income Between $50,000 And $99,999",AHRQ:ACS_PCT_HH_INC_99999,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_INC_100000,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Population With Household Income Greater Than $100,000",AHRQ:ACS_PCT_HH_INC_100000,2022-01-01,1,,,,,,,,,
ACS_PCT_HH_INC_10000,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Population With Household Income Less Than $10,000",AHRQ:ACS_PCT_HH_INC_10000,2022-01-01,1,,,,,,,,,
ACS_PCT_INC50,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Income To Poverty Ratio Under 0.50,AHRQ:ACS_PCT_INC50,2022-01-01,1,,,,,,,,,
ACS_PCT_INC50_ABOVE65,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Income To Poverty Ratio Under 0.50 (Ages 65 And Over),AHRQ:ACS_PCT_INC50_ABOVE65,2022-01-01,1,,,,,,,,,
ACS_PCT_LT_HS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Less Than High School Education (Ages 25 And Over),AHRQ:ACS_PCT_LT_HS,2022-01-01,1,,,,,,,,,
ACS_PCT_MEDICARE_ONLY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Medicare Only,AHRQ:ACS_PCT_MEDICARE_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_PUBLIC_ONLY,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Population With Medicare, Medicaid, Tricare/Military, U.S. Department Of Veterans Affairs (Va) Coverage And Other Public-Only Health Insurance Combinations",AHRQ:ACS_PCT_PUBLIC_ONLY,2022-01-01,1,,,,,,,,,
ACS_PCT_UNINSURED_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With No Health Insurance (Ages 64 And Below),AHRQ:ACS_PCT_UNINSURED_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_UNINSURED,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With No Health Insurance Coverage,AHRQ:ACS_PCT_UNINSURED,2022-01-01,1,,,,,,,,,
ACS_PCT_HS_GRADUATE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Only High School Diploma (Ages 25 And Over),AHRQ:ACS_PCT_HS_GRADUATE,2022-01-01,1,,,,,,,,,
ACS_PCT_OTHER_INS,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Other Health Insurance Coverage Combinations,AHRQ:ACS_PCT_OTHER_INS,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_OTHER,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Other Private-Only Health Insurance Combinations,AHRQ:ACS_PCT_PRIVATE_OTHER,2022-01-01,1,,,,,,,,,
ACS_PCT_PRIVATE_OTHER_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Other Private-Only Health Insurance Combinations (Ages 64 And Below),AHRQ:ACS_PCT_PRIVATE_OTHER_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_PUBLIC_OTHER,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Other Public-Only Health Insurance Combinations,AHRQ:ACS_PCT_PUBLIC_OTHER,2022-01-01,1,,,,,,,,,
ACS_PCT_PUBLIC_OTHER_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Other Public-Only Health Insurance Combinations (Ages 64 And Below),AHRQ:ACS_PCT_PUBLIC_OTHER_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_POP_SAME_SEX_SPOUSE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Same-Sex Spouse,AHRQ:ACS_PCT_POP_SAME_SEX_SPOUSE,2022-01-01,1,,,,,,,,,
ACS_PCT_POP_SAME_SEX_UNMRD_P,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Same-Sex Unmarried Partner,AHRQ:ACS_PCT_POP_SAME_SEX_UNMRD_P,2022-01-01,1,,,,,,,,,
ACS_PCT_COLLEGE_ASSOCIATE_DGR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Some College Or Associate'S Degree (Ages 25 And Over),AHRQ:ACS_PCT_COLLEGE_ASSOCIATE_DGR,2022-01-01,1,,,,,,,,,
ACS_PCT_TRICARE_VA_BELOW64,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Tricare/Military Or Va Coverage Only (Ages 64 And Below),AHRQ:ACS_PCT_TRICARE_VA_BELOW64,2022-01-01,1,,,,,,,,,
ACS_PCT_TRICARE_VA,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Population With Tricare/Military Or Va Health Insurance Coverage Only,AHRQ:ACS_PCT_TRICARE_VA,2022-01-01,1,,,,,,,,,
ACS_PCT_RENTER_HU_ABOVE65,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Renter-Occupied Housing Units Occupied By Householders Aged 65 And Above,AHRQ:ACS_PCT_RENTER_HU_ABOVE65,2022-01-01,1,,,,,,,,,
ACS_PCT_RENTER_HU_CHILD,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Renter-Occupied Housing Units With Children,AHRQ:ACS_PCT_RENTER_HU_CHILD,2022-01-01,1,,,,,,,,,
ACS_PCT_1UP_RENT_1ROOM,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Renter-Occupied Housing Units With More Than One Occupant Per Room,AHRQ:ACS_PCT_1UP_RENT_1ROOM,2022-01-01,1,,,,,,,,,
ACS_PCT_RENTER_HU_COST_30PCT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Renter-Occupied Housing Units With Rent Equal To 30 Percent Or More Of Household Income,AHRQ:ACS_PCT_RENTER_HU_COST_30PCT,2022-01-01,1,,,,,,,,,
ACS_PCT_RENTER_HU_COST_50PCT,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Renter-Occupied Housing Units With Rent Equal To 50 Percent Or More Of Household Income,AHRQ:ACS_PCT_RENTER_HU_COST_50PCT,2022-01-01,1,,,,,,,,,
EP_SNGPNT,0,OMOP SDOH,Observation,SVI Item,Percentage Of Single-Parent Households With Children Under 18 Estimate,SVI:EP_SNGPNT,2018-01-01,1,,,,,,,,,
MP_SNGPNT,0,OMOP SDOH,Observation,SVI Item,Percentage Of Single-Parent Households With Children Under 18 Estimate MOE,SVI:MP_SNGPNT,2018-01-01,1,,,,,,,,,
ACS_PCT_POV_OTHER,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Some Other Race Population Below Poverty Level,AHRQ:ACS_PCT_POV_OTHER,2022-01-01,1,,,,,,,,,
EP_OTHERRACE,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Some Other Race, Not Hispanic Or Latino Persons Estimate",SVI:EP_OTHERRACE,2018-01-01,1,,,,,,,,,
MP_OTHERRACE,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Some Other Race, Not Hispanic Or Latino Persons Estimate MOE",SVI:MP_OTHERRACE,2018-01-01,1,,,,,,,,,
CRDC_PCT_STUD_DESEGPLAN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Students Covered By A Desegregation Order Or Plan,AHRQ:CRDC_PCT_STUD_DESEGPLAN,2022-01-01,1,,,,,,,,,
ACS_PCT_NO_WORK_NO_SCHL_16_19,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Teens And Adults Who Are Unemployed And Not In School (Between Ages 16 And 19),AHRQ:ACS_PCT_NO_WORK_NO_SCHL_16_19,2022-01-01,1,,,,,,,,,
CHR_PCT_ADULT_OBESITY,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of The Adult Population That Reports A Body Mass Index (Bmi) Greater Than Or Equal To 30 Kg/M2 (Ages 20 And Over),AHRQ:CHR_PCT_ADULT_OBESITY,2022-01-01,1,,,,,,,,,
ACS_PCT_VET,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of The Civilian Population Consisting Of Veterans (Ages 18 And Over),AHRQ:ACS_PCT_VET,2022-01-01,1,,,,,,,,,
ACS_PCT_GULFWAR_VIETNAM,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of The Civilian Veteran Population That Served Between Gulf War And Vietnam Era (Ages 18 And Over),AHRQ:ACS_PCT_GULFWAR_VIETNAM,2022-01-01,1,,,,,,,,,
ACS_PCT_GULFWAR_1990_2001,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of The Civilian Veteran Population That Served During The Gulf War Period From August 1990 To August 2001 (Ages 18 And Over),AHRQ:ACS_PCT_GULFWAR_1990_2001,2022-01-01,1,,,,,,,,,
ACS_PCT_GULFWAR_2001,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of The Civilian Veteran Population That Served During The Gulf War Period From September 2001 Or Later (Ages 18 And Over),AHRQ:ACS_PCT_GULFWAR_2001,2022-01-01,1,,,,,,,,,
ACS_PCT_VIETNAM,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of The Civilian Veteran Population That Served In The Vietnam Era (Ages 18 And Over),AHRQ:ACS_PCT_VIETNAM,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_AIAN,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Tract Population Who Are American Indian Or Alaska Native Living More Than 1 Mile From The Nearest Supermarket, Supercenter, Or Large Grocery Store",AHRQ:FARA_PCT_LA_1_AIAN,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_ASIAN,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Tract Population Who Are Asian Living More Than 1 Mile From The Nearest Supermarket, Supercenter, Or Large Grocery Store",AHRQ:FARA_PCT_LA_1_ASIAN,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_BLACK,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Tract Population Who Are Black Or African American Living More Than 1 Mile From The Nearest Supermarket, Supercenter, Or Large Grocery Store",AHRQ:FARA_PCT_LA_1_BLACK,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_HISP,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Tract Population Who Are Hispanic Or Latino Living More Than 1 Mile From The Nearest Supermarket, Supercenter, Or Large Grocery Store",AHRQ:FARA_PCT_LA_1_HISP,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_NHPI,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Tract Population Who Are Native Hawaiian Or Other Pacific Islander Living More Than 1 Mile From The Nearest Supermarket, Supercenter, Or Large Grocery Store",AHRQ:FARA_PCT_LA_1_NHPI,2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_MR,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Tract Population Who Are Not Included In The White, Black Or African American, American Indian Or Alaska Native, Asian, And Native Hawaiian Or Other Pacific Islander Race Categories Or Who Identify As More Than One Race Living More Than 1...","Percentage Of Tract Population Who Are Not Included In The White, Black Or African American, American Indian Or Alaska Native, Asian, And Native Hawaiian Or Other Pacific Islander Race Categories Or Who Identify As More Than One Race Living More Than 1 Mile From The Nearest Supermarket, Supercenter, Or Large Grocery Store",2022-01-01,1,,,,,,,,,
FARA_PCT_LA_1_WHITE,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Tract Population Who Are White Living More Than 1 Mile From The Nearest Supermarket, Supercenter, Or Large Grocery Store",AHRQ:FARA_PCT_LA_1_WHITE,2022-01-01,1,,,,,,,,,
ACS_PCT_POV_MULTI,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Two Or More Races Population Below Poverty Level,AHRQ:ACS_PCT_POV_MULTI,2022-01-01,1,,,,,,,,,
EP_TWOMORE,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Two Or More Races, Not Hispanic Or Latino Persons Estimate",SVI:EP_TWOMORE,2018-01-01,1,,,,,,,,,
MP_TWOMORE,0,OMOP SDOH,Observation,SVI Item,"Percentage Of Two Or More Races, Not Hispanic Or Latino Persons Estimate MOE",SVI:MP_TWOMORE,2018-01-01,1,,,,,,,,,
ACS_PCT_HH_1FAM_FOOD_STMP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Unmarried Partner Households That Received Food Stamps/Snap Benefits,AHRQ:ACS_PCT_HH_1FAM_FOOD_STMP,2022-01-01,1,,,,,,,,,
ACS_PCT_WHITE_FEMALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of White Non-Hispanic Alone Population Reporting Female,AHRQ:ACS_PCT_WHITE_FEMALE,2022-01-01,1,,,,,,,,,
ACS_PCT_WHITE_MALE,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of White Non-Hispanic Alone Population Reporting Male,AHRQ:ACS_PCT_WHITE_MALE,2022-01-01,1,,,,,,,,,
ACS_PCT_POV_WHITE,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of White, Not Hispanic Population Below Poverty Level",AHRQ:ACS_PCT_POV_WHITE,2022-01-01,1,,,,,,,,,
ACS_PCT_WORK_NO_CAR,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers In Households With No Vehicle Available (Ages 16 And Over),AHRQ:ACS_PCT_WORK_NO_CAR,2022-01-01,1,,,,,,,,,
ACS_PCT_DRIVE_2WORK,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Workers Taking A Car, Truck, Or Van To Work (Ages 16 And Over)",AHRQ:ACS_PCT_DRIVE_2WORK,2022-01-01,1,,,,,,,,,
ACS_PCT_PUBL_TRANSIT,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Workers Taking Public Transportation, Excluding Taxicab (Ages 16 And Over)",AHRQ:ACS_PCT_PUBL_TRANSIT,2022-01-01,1,,,,,,,,,
ACS_PCT_TAXICAB_2WORK,0,OMOP SDOH,Observation,AHRQ Item,"Percentage Of Workers Taking Taxicab, Motorcycle, Bicycle, Or Other Means To Work (Ages 16 And Over)",AHRQ:ACS_PCT_TAXICAB_2WORK,2022-01-01,1,,,,,,,,,
ACS_PCT_WALK_2WORK,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers Walking To Work (Ages 16 And Over),AHRQ:ACS_PCT_WALK_2WORK,2022-01-01,1,,,,,,,,,
ACS_PCT_PUB_COMMT_29MIN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers Who Use Public Transportation With 15- To 29-Minute Commute Time (Ages 16 And Over),AHRQ:ACS_PCT_PUB_COMMT_29MIN,2022-01-01,1,,,,,,,,,
ACS_PCT_PUB_COMMT_59MIN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers Who Use Public Transportation With 30- To 59-Minute Commute Time (Ages 16 And Over),AHRQ:ACS_PCT_PUB_COMMT_59MIN,2022-01-01,1,,,,,,,,,
ACS_PCT_PUB_COMMT_15MIN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers Who Use Public Transportation With < 15-Minute Commute Time (Ages 16 And Over),AHRQ:ACS_PCT_PUB_COMMT_15MIN,2022-01-01,1,,,,,,,,,
ACS_PCT_PUB_COMMT_60MINUP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers Who Use Public Transportation With At Least 60-Minute Commute Time (Ages 16 And Over),AHRQ:ACS_PCT_PUB_COMMT_60MINUP,2022-01-01,1,,,,,,,,,
ACS_PCT_COMMT_29MIN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers With 15- To 29-Minute Commute Time (Ages 16 And Over),AHRQ:ACS_PCT_COMMT_29MIN,2022-01-01,1,,,,,,,,,
ACS_PCT_COMMT_59MIN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers With 30- To 59-Minute Commute Time (Ages 16 And Over),AHRQ:ACS_PCT_COMMT_59MIN,2022-01-01,1,,,,,,,,,
ACS_PCT_COMMT_15MIN,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers With < 15-Minute Commute Time (Ages 16 And Over),AHRQ:ACS_PCT_COMMT_15MIN,2022-01-01,1,,,,,,,,,
ACS_PCT_COMMT_60MINUP,0,OMOP SDOH,Observation,AHRQ Item,Percentage Of Workers With At Least 60-Minute Commute Time (Ages 16 And Over),AHRQ:ACS_PCT_COMMT_60MINUP,2022-01-01,1,,,,,,,,,
SE_HOME,0,OMOP SDOH,Observation,COI Item,Percentage Owner-Occupied Housing Units,COI:SE_HOME,2020-01-01,1,,,,,,,,,
ED_SCHPOV,0,OMOP SDOH,Observation,COI Item,Percentage Students In Elementary Schools Eligible For Free Or Reduced-Price Lunches,COI:ED_SCHPOV,2020-01-01,1,,,,,,,,,
zED_SCHPOV,0,OMOP SDOH,Observation,COI Item,"Percentage Students In Elementary Schools Eligible For Free Or Reduced-Price Lunches, Transformed To Z-Scores And Multiplied By -1",COI:zED_SCHPOV,2020-01-01,1,,,,,,,,,
ED_TEACHXP,0,OMOP SDOH,Observation,COI Item,Percentage Teachers In Their First And Second Year,COI:ED_TEACHXP,2020-01-01,1,,,,,,,,,
zED_TEACHXP,0,OMOP SDOH,Observation,COI Item,"Percentage Teachers In Their First And Second Year, Transformed To Z-Scores And Multiplied By -1",COI:zED_TEACHXP,2020-01-01,1,,,,,,,,,
ED_MATH,0,OMOP SDOH,Observation,COI Item,"Percentage Third Graders Scoring Proficient On Standardized Math Tests, Converted To NAEP Scale Score Points",COI:ED_MATH,2020-01-01,1,,,,,,,,,
zED_MATH,0,OMOP SDOH,Observation,COI Item,"Percentage Third Graders Scoring Proficient On Standardized Math Tests, Converted To NAEP Scale Score Points, Transformed To Z-Scores",COI:zED_MATH,2020-01-01,1,,,,,,,,,
ED_READING,0,OMOP SDOH,Observation,COI Item,"Percentage Third Graders Scoring Proficient On Standardized Reading Tests, Converted To NAEP Scale Score Points",COI:ED_READING,2020-01-01,1,,,,,,,,,
zED_READING,0,OMOP SDOH,Observation,COI Item,"Percentage Third Graders Scoring Proficient On Standardized Reading Tests, Converted To NAEP Scale Score Points, Transformed To Z-Scores",COI:zED_READING,2020-01-01,1,,,,,,,,,
EP_UNINSUR,0,OMOP SDOH,Observation,SVI Item,Percentage Uninsured In The Total Civilian Noninstitutionalized Population Estimate,Percentage Of Persons Who Are Uninsured,2018-01-01,1,,,,,,,,,
MP_UNINSUR,0,OMOP SDOH,Observation,SVI Item,Percentage Uninsured In The Total Civilian Noninstitutionalized Population Estimate MOE,SVI:MP_UNINSUR,2018-01-01,1,,,,,,,,,
SE_JOBPROX,0,OMOP SDOH,Observation,COI Item,Percentage Workers Commuting More Than One Hour One Way,COI:SE_JOBPROX,2020-01-01,1,,,,,,,,,
zSE_JOBPROX,0,OMOP SDOH,Observation,COI Item,"Percentage Workers Commuting More Than One Hour One Way, Transformed To Z-Scores And Multiplied By -1",COI:zSE_JOBPROX,2020-01-01,1,,,,,,,,,
GIS1002342,0,OMOP SDOH,Observation,GIS Measure,Percentile,,2024-09-15,1,,,,,,,,,
EPL_CROWD,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Households With More People Than Rooms Estimate,SVI:EPL_CROWD,2018-01-01,1,,,,,,,,,
EPL_NOVEH,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Households With No Vehicle Available Estimate,SVI:EPL_NOVEH,2018-01-01,1,,,,,,,,,
EPL_MUNIT,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Housing In Structures With 10 Or More Units Estimate,SVI:EPL_MUNIT,2018-01-01,1,,,,,,,,,
EPL_MINRTY_P,0,OMOP SDOH,Observation,SVI Item,"Percentile Percentage Minority (Hispanic Or Latino (Of Any Race); Black And African American, Not Hispanic Or Latino; American Indian And Alaska Native, Not Hispanic Or Latino; Asian, Not Hispanic Or Latino; Native Hawaiian And Other Pacific Islander,...","Percentile Percentage Minority (Hispanic Or Latino (Of Any Race); Black And African American, Not Hispanic Or Latino; American Indian And Alaska Native, Not Hispanic Or Latino; Asian, Not Hispanic Or Latino; Native Hawaiian And Other Pacific Islander, Not Hispanic Or Latino; Two Or More Races, Not Hispanic Or Latino; Other Races, Not Hispanic Or Latino) Estimate",2018-01-01,1,,,,,,,,,
EPL_MOBILE_P,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Mobile Homes Estimate,SVI:EPL_MOBILE_P,2018-01-01,1,,,,,,,,,
EPL_UNEMP_P,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Civilian (Age 16+) Unemployed Estimate,SVI:EPL_UNEMP_P,2018-01-01,1,,,,,,,,,
EPL_DISABL_P,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Civilian Noninstitutionalized Population With A Disability Estimate,SVI:EPL_DISABL_P,2018-01-01,1,,,,,,,,,
EPL_HBURD,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Housing Cost- Burdened Occupied Housing Units Estimate,SVI:EPL_HBURD,2018-01-01,1,,,,,,,,,
EPL_LIMENG_%,0,OMOP SDOH,Observation,SVI Item,"Percentile Percentage Of Persons (Age 5+) Who Speak English ""Less Than Well"" Estimate",SVI:EPL_LIMENG_%,2018-01-01,1,,,,,,,,,
EPL_AGE17_%,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Persons Aged 17 And Younger Estimate,SVI:EPL_AGE17_%,2018-01-01,1,,,,,,,,,
EPL_AGE65_%,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Persons Aged 65 And Older Estimate,SVI:EPL_AGE65_%,2018-01-01,1,,,,,,,,,
EPL_POV150,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Persons Below 150% Poverty Estimate,SVI:EPL_POV150,2018-01-01,1,,,,,,,,,
EPL_GROUPQ_%,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Persons In Group Quarters Estimate,SVI:EPL_GROUPQ_%,2018-01-01,1,,,,,,,,,
EPL_NOHSDP_%,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Persons With No High School Diploma (Age 25+) Estimate,SVI:EPL_NOHSDP_%,2018-01-01,1,,,,,,,,,
EPL_SNGPNT,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Single-Parent Households With Children Under 18 Estimate,SVI:EPL_SNGPNT,2018-01-01,1,,,,,,,,,
EPL_UNINSUR_P,0,OMOP SDOH,Observation,SVI Item,Percentile Percentage Of Uninsured Estimate,SVI:EPL_UNINSUR_P,2018-01-01,1,,,,,,,,,
EPL_WLKIND,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of A Nationwide Geographic Data Resource That Ranks Block Groups According To Their Relative Walkability,EJI:EPL_WLKIND,2022-01-01,1,,,,,,,,,
EPL_DSLPM,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Ambient Concentrations Of Diesel PM/M3,EJI:EPL_DSLPM,2022-01-01,1,,,,,,,,,
EPL_OZONE,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Annual Mean Days Above O3 Regulatory Standard - 3-Year Average,EJI:EPL_OZONE,2022-01-01,1,,,,,,,,,
EPL_PM,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Annual Mean Days Above PM2.5 Regulatory Standard - 3-Year Average,EJI:EPL_PM,2022-01-01,1,,,,,,,,,
RPL_HVM,0,OMOP SDOH,Observation,EJI HVM Item,Percentile Rank Of Combined Tertile Flags,EJI:RPL_HVM,2022-01-01,1,,,,,,,,,
RPL_SVM_DOM2,0,OMOP SDOH,Observation,SVI Item,"Percentile Rank Of Domain Consisting Of Below 200% Poverty, No High School Diploma, Unemployed, Housing Tenure, Housing Cost, No Health Insurance, And Not Internet",SVI:RPL_SVM_DOM2,2018-01-01,1,,,,,,,,,
RPL_SVM_DOM3,0,OMOP SDOH,Observation,SVI Item,"Percentile Rank Of Domain Consisting Of English Language Proficiency, Aged 65 Or Older, Aged 17 Or Younger, And Civilian With A Disability",SVI:RPL_SVM_DOM3,2018-01-01,1,,,,,,,,,
RPL_EBM_DOM5,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Domain Consisting Of Impaired Water Bodies,EJI:RPL_EBM_DOM5,2022-01-01,1,,,,,,,,,
RPL_SVM_DOM4,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Domain Consisting Of Number Of Mobile Homes And Housing With Group Quarters,SVI:RPL_SVM_DOM4,2018-01-01,1,,,,,,,,,
RPL_EBM_DOM1,0,OMOP SDOH,Observation,EJI EBM Item,"Percentile Rank Of Domain Consisting Of Ozone, PM2.5, Air Toxics Cancer Risk, And Diesel Particulate Matter",EJI:RPL_EBM_DOM1,2022-01-01,1,,,,,,,,,
RPL_SVM_DOM1,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Domain Consisting Of Percentage Of Individuals Who Are A Racial/Ethnic Minority,SVI:RPL_SVM_DOM1,2018-01-01,1,,,,,,,,,
RPL_EBM_DOM4,0,OMOP SDOH,Observation,EJI EBM Item,"Percentile Rank Of Domain Consisting Of Proximity To High Volume Roads, Proximity To Railways, And Proximity To Airports",EJI:RPL_EBM_DOM4,2022-01-01,1,,,,,,,,,
RPL_EBM_DOM2,0,OMOP SDOH,Observation,EJI EBM Item,"Percentile Rank Of Domain Consisting Of Proximity To National Priority List Sites, Proximity To Release Inventory Sites, Proximity To Treatment, Storage, And Disposal Sites, Proximity To Risk Management Plan Sites, Proximity To Coal Mines, And Proximit...","Percentile Rank Of Domain Consisting Of Proximity To National Priority List Sites, Proximity To Release Inventory Sites, Proximity To Treatment, Storage, And Disposal Sites, Proximity To Risk Management Plan Sites, Proximity To Coal Mines, And Proximity To Lead Mines",2022-01-01,1,,,,,,,,,
RPL_EBM_DOM3,0,OMOP SDOH,Observation,EJI EBM Item,"Percentile Rank Of Domain Consisting Of Proximity To Recreational Parks, Houses Built Pre- 1980 (Lead Exposure), And Walkability Index",EJI:RPL_EBM_DOM3,2022-01-01,1,,,,,,,,,
EPL_IMPWTR,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Percent Of Tract That Intersects An Impaired/Impacted Watershed At The Huc12 Level,EJI:EPL_IMPWTR,2022-01-01,1,,,,,,,,,
EPL_POV200,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Below 200% Poverty,SVI:EPL_POV200,2018-01-01,1,,,,,,,,,
EPL_DISABL,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Civilian Noninstitutionalized Population With A Disability Estimate,SVI:EPL_DISABL,2018-01-01,1,,,,,,,,,
EPL_HOUBDN,0,OMOP SDOH,Observation,SVI Item,"Percentile Rank Of Percentage Of Households That Make Less Than 75,000",SVI:EPL_HOUBDN,2018-01-01,1,,,,,,,,,
EPL_HOUAGE,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Percentage Of Houses Built Pre- 1980 (Lead Exposure),EJI:EPL_HOUAGE,2022-01-01,1,,,,,,,,,
EPL_ASTHMA,0,OMOP SDOH,Observation,EJI HVM Item,Percentile Rank Of Percentage Of Individuals With Asthma,EJI:EPL_ASTHMA,2022-01-01,1,,,,,,,,,
EPL_DIABETES,0,OMOP SDOH,Observation,EJI HVM Item,Percentile Rank Of Percentage Of Individuals With Diabetes,EJI:EPL_DIABETES,2022-01-01,1,,,,,,,,,
EPL_BPHIGH,0,OMOP SDOH,Observation,EJI HVM Item,Percentile Rank Of Percentage Of Individuals With Raw High Blood Pressures Values,EJI:EPL_BPHIGH,2022-01-01,1,,,,,,,,,
EPL_MINRTY,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Minority Persons,SVI:EPL_MINRTY,2018-01-01,1,,,,,,,,,
EPL_MOBILE,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Mobile Homes Estimate,SVI:EPL_MOBILE,2018-01-01,1,,,,,,,,,
EPL_LIMENG,0,OMOP SDOH,Observation,SVI Item,"Percentile Rank Of Percentage Of Persons (Age 5+) Who Speak English ""Less Than Well"" Estimate, 2014- 2018 ACS",SVI:EPL_LIMENG,2018-01-01,1,,,,,,,,,
EPL_AGE17,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Persons Aged 17 And Younger Estimate,SVI:EPL_AGE17,2018-01-01,1,,,,,,,,,
EPL_AGE65,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Persons Aged 65 And Older Estimate,SVI:EPL_AGE65,2018-01-01,1,,,,,,,,,
EPL_GROUPQ,0,OMOP SDOH,Observation,SVI Item,"Percentile Rank Of Percentage Of Persons In Group Quarters Estimate, 2014-2018 ACS",SVI:EPL_GROUPQ,2018-01-01,1,,,,,,,,,
EPL_UNEMP,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Persons Who Are Unemployed,SVI:EPL_UNEMP,2018-01-01,1,,,,,,,,,
EPL_UNINSUR,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Persons Who Are Uninsured,SVI:EPL_UNINSUR,2018-01-01,1,,,,,,,,,
EPL_RENTER,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Persons Who Rent,SVI:EPL_RENTER,2018-01-01,1,,,,,,,,,
EPL_CANCER,0,OMOP SDOH,Observation,EJI HVM Item,Percentile Rank Of Percentage Of Persons With Cancer,EJI:EPL_CANCER,2022-01-01,1,,,,,,,,,
EPL_NOINT,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentage Of Persons Without Internet,SVI:EPL_NOINT,2018-01-01,1,,,,,,,,,
EPL_NOHSDP,0,OMOP SDOH,Observation,SVI Item,Percentile Rank Of Percentile Percentage Of Persons With No High School Diploma (Age 25+) Estimate,SVI:EPL_NOHSDP,2018-01-01,1,,,,,,,,,
EPL_AIRPRT,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of Airport,EJI:EPL_AIRPRT,2022-01-01,1,,,,,,,,,
EPL_COAL,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of Coal Mines,EJI:EPL_COAL,2022-01-01,1,,,,,,,,,
EPL_NPL,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of EPA National Priority List Site,EJI:EPL_NPL,2022-01-01,1,,,,,,,,,
EPL_RMP,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of EPA Risk Management Plan Site,EJI:EPL_RMP,2022-01-01,1,,,,,,,,,
EPL_TRI,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of EPA Toxic Release Inventory Site,EJI:EPL_TRI,2022-01-01,1,,,,,,,,,
EPL_TSD,0,OMOP SDOH,Observation,EJI EBM Item,"Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of EPA Treatment, Storage, And Disposal Site",EJI:EPL_TSD,2022-01-01,1,,,,,,,,,
EPL_PARK,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of Green Space,EJI:EPL_PARK,2022-01-01,1,,,,,,,,,
EPL_ROAD,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of High-Volume Road Or Highway,EJI:EPL_ROAD,2022-01-01,1,,,,,,,,,
EPL_LEAD,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of Lead Mines,EJI:EPL_LEAD,2022-01-01,1,,,,,,,,,
EPL_RAIL,0,OMOP SDOH,Observation,EJI EBM Item,Percentile Rank Of Proportion Of Tract'S Area Within 1-Mi Buffer Of Railroad,EJI:EPL_RAIL,2022-01-01,1,,,,,,,,,
EPL_TOTCR,0,OMOP SDOH,Observation,EJI EBM Item,"Percentile Rank Of The Probability Of Contracting Cancer Over The Course Of A Lifetime, Assuming Continuous Exposure",EJI:EPL_TOTCR,2022-01-01,1,,,,,,,,,
RPL_THEME2,0,OMOP SDOH,Observation,SVI Item,Percentile Ranking For Household Characteristics Theme Summary,SVI:RPL_THEME2,2018-01-01,1,,,,,,,,,
RPL_THEME4_1,0,OMOP SDOH,Observation,SVI Item,Percentile Ranking For Housing Type/ Transportation Theme,SVI:RPL_THEME4_1,2018-01-01,1,,,,,,,,,
MHSVI_RPL_THEMES_ALL,0,OMOP SDOH,Observation,AHRQ Item,Percentile Ranking For Overall Minority Health Social Vulnerability Index,AHRQ:MHSVI_RPL_THEMES_ALL,2022-01-01,1,,,,,,,,,
CDCSVI_RPL_THEMES_ALL,0,OMOP SDOH,Observation,AHRQ Item,Percentile Ranking For Overall Social Vulnerability Index,AHRQ:CDCSVI_RPL_THEMES_ALL,2022-01-01,1,,,,,,,,,
RPL_THEME3,0,OMOP SDOH,Observation,SVI Item,Percentile Ranking For Racial And Ethnic Minority Status Theme,SVI:RPL_THEME3,2018-01-01,1,,,,,,,,,
RPL_THEME1,0,OMOP SDOH,Observation,SVI Item,Percentile Ranking For Socioeconomic Status Theme Summary,SVI:RPL_THEME1,2018-01-01,1,,,,,,,,,
RPL_EJI,0,OMOP SDOH,Observation,EJI Item,Percentile Ranks Of Spl_Eji,EJI:RPL_EJI,2022-01-01,1,,,,,,,,,
RPL_SER,0,OMOP SDOH,Observation,EJI Item,Percentile Ranks Of Spl_Ser,EJI:RPL_SER,2022-01-01,1,,,,,,,,,
GIS1002343,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Performance-Enhancing Drug Use,,2024-09-15,1,,,,,,,,,
AHRF_PER_CHLD_POV_USDA,0,OMOP SDOH,Observation,AHRQ Item,Persistent Child Poverty Typology Code,AHRQ:AHRF_PER_CHLD_POV_USDA,2022-01-01,1,,,,,,,,,
AHRF_PER_POV_USDA,0,OMOP SDOH,Observation,AHRQ Item,Persistent Poverty Typology Code,AHRQ:AHRF_PER_POV_USDA,2022-01-01,1,,,,,,,,,
605,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Person-Centered Primary Care Measure,SDOHO:605; Person-Centered_Primary_Care_Measure,2022-01-01,1,,,,,,,,,
686,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Personal Care And Service Occupation,SDOHO:686; Personal_Care_and_Service_Occupation,2022-01-01,1,,,,,,,,,
425,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Personal Loan,SDOHO:425,2022-01-01,1,,,,,,,,,
GIS1002347,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Personality Disorders,,2024-09-15,1,,,,,,,,,
E_NOHSDP,0,OMOP SDOH,Observation,SVI Item,Persons (Age 25+) With No High School Diploma Estimate,SVI:E_NOHSDP,2018-01-01,1,,,,,,,,,
M_NOHSDP,0,OMOP SDOH,Observation,SVI Item,Persons (Age 25+) With No High School Diploma Estimate MOE,SVI:M_NOHSDP,2018-01-01,1,,,,,,,,,
E_LIMENG,0,OMOP SDOH,Observation,SVI Item,"Persons (Age 5+) Who Speak English ""Less Than Well"" Estimate",SVI:E_LIMENG,2018-01-01,1,,,,,,,,,
M_LIMENG,0,OMOP SDOH,Observation,SVI Item,"Persons (Age 5+) Who Speak English ""Less Than Well"" Estimate MOE",SVI:M_LIMENG,2018-01-01,1,,,,,,,,,
E_AGE17,0,OMOP SDOH,Observation,SVI Item,Persons Aged 17 And Younger Estimate,SVI:E_AGE17,2018-01-01,1,,,,,,,,,
M_AGE17,0,OMOP SDOH,Observation,SVI Item,Persons Aged 17 And Younger Estimate MOE,SVI:M_AGE17,2018-01-01,1,,,,,,,,,
E_AGE65,0,OMOP SDOH,Observation,SVI Item,Persons Aged 65 And Older Estimate,SVI:E_AGE65,2018-01-01,1,,,,,,,,,
M_AGE65,0,OMOP SDOH,Observation,SVI Item,Persons Aged 65 And Older Estimate MOE,SVI:M_AGE65,2018-01-01,1,,,,,,,,,
E_POV150,0,OMOP SDOH,Observation,SVI Item,Persons Below 150% Poverty Estimate,SVI:E_POV150,2018-01-01,1,,,,,,,,,
M_POV150,0,OMOP SDOH,Observation,SVI Item,Persons Below 150% Poverty Estimate MOE,SVI:M_POV150,2018-01-01,1,,,,,,,,,
E_GROUPQ,0,OMOP SDOH,Observation,SVI Item,Persons In Group Quarters Estimate,SVI:E_GROUPQ,2018-01-01,1,,,,,,,,,
M_GROUPQ,0,OMOP SDOH,Observation,SVI Item,Persons In Group Quarters Estimate MOE,SVI:M_GROUPQ,2018-01-01,1,,,,,,,,,
GIS1002350,0,OMOP SDOH,Type Concept,Exposure Type Concept,Pharmacy Claim,,2024-09-15,1,,,,,,,,,
556,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Phd Degree,SDOHO:556; PhD_Degree,2022-01-01,1,,,,,,,,,
151,0,OMOP SDOH,Observation,SDOHO Item,Phenx Measure-Family Conflict,SDOHO:151; PhenX_Measure-Family_Conflict,2022-01-01,1,,,,,,,,,
698,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Phone Cost,SDOHO:698; Phone_Cost,2022-01-01,1,,,,,,,,,
472_POP,0,OMOP SDOH,Geographic Feature,SDOH Construct,Physical Environment In Population,,2024-09-15,1,,,,,,,,,
GIS1002351,0,OMOP SDOH,Geographic Feature,AHRQ Determinant,Physical Infrastructure,,2022-01-01,1,,,,,,,,,
PIAAC_POP_TARGET,0,OMOP SDOH,Observation,AHRQ Item,Piaac Target Population: Population Between Age 16-74,AHRQ:PIAAC_POP_TARGET,2022-01-01,1,,,,,,,,,
941,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Pipe Smoking,SDOHO:941; Pipe_Smoking,2022-01-01,1,,,,,,,,,
GIS1002356,0,OMOP SDOH,Demographic Feature,SDOH Determinant,Place Of Birth,,2024-09-15,1,,,,,,,,,
908,0,OMOP SDOH,Geographic Feature,SDOHO Construct,Playground,SDOHO:908; Playground,2022-01-01,1,,,,,,,,,
GIS1002360,0,OMOP SDOH,Observation,SDG Goal,Policy and institutional coherence,,2017-03-01,1,,,,,,,,,
GIS1010333,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Pollution,,2024-09-15,1,,,,,,,,,
277,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Poor Adherence,SDOHO:277,2022-01-01,1,,,,,,,,,
CEN_POPDENSITY_TRACT,0,OMOP SDOH,Observation,AHRQ Item,Population Density (Census Tract),AHRQ:CEN_POPDENSITY_TRACT,2022-01-01,1,,,,,,,,,
CEN_POPDENSITY_COUNTY,0,OMOP SDOH,Observation,AHRQ Item,Population Density (County),AHRQ:CEN_POPDENSITY_COUNTY,2022-01-01,1,,,,,,,,,
CEN_POPDENSITY,0,OMOP SDOH,Observation,AHRQ Item,Population Density (Zcta),AHRQ:CEN_POPDENSITY,2022-01-01,1,,,,,,,,,
E_TOTPOP,0,OMOP SDOH,Observation,SVI Item,Population Estimate,"Population Estimate, 2014-2018 ACS",2018-01-01,1,,,,,,,,,
M_TOTPOP,0,OMOP SDOH,Observation,SVI Item,Population Estimate MOE,"Population Estimate MOE, 2014-2018 ACS",2018-01-01,1,,,,,,,,,
AHRF_POP_LOSS_USDA,0,OMOP SDOH,Observation,AHRQ Item,Population Loss Typology Code,AHRQ:AHRF_POP_LOSS_USDA,2022-01-01,1,,,,,,,,,
EPAN_AVG_NATL_WALK_INDEX,0,OMOP SDOH,Observation,AHRQ Item,Population Weighted Average Of National Walkability Index,AHRQ:EPAN_AVG_NATL_WALK_INDEX,2022-01-01,1,,,,,,,,,
GIS1010334,0,OMOP SDOH,Observation,GIS Measure,Positional Measures,,2024-09-15,1,,,,,,,,,
GIS1002369,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Post-Traumatic Stress Disorder (Ptsd),,2024-09-15,1,,,,,,,,,
718,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Poverty,SDOHO:718; Poverty,2022-01-01,1,,,,,,,,,
718_POP,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Poverty In Population,,2024-09-15,1,,,,,,,,,
GIS1002389,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Poverty Rate,,2020-01-01,1,,,,,,,,,
GIS1002391,0,OMOP SDOH,Healthcare Feature,SEDH Construct,Prescription Drug Regulation,,2021-01-01,1,,,,,,,,,
GIS1002393,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Prescription Medication Abuse,,2024-09-15,1,,,,,,,,,
2.2.3,0,OMOP SDOH,Observation,SDG Indicator,"Prevalence of anaemia in women aged 15 to 49 years, by pregnancy status (percentage)",,2017-03-01,1,,,,,,,,,
MMD_ANXIETY_DISD,0,OMOP SDOH,Observation,AHRQ Item,Prevalence Of Anxiety Disorders Among Medicare (Dual And Non-Dual) Beneficiaries,AHRQ:MMD_ANXIETY_DISD,2022-01-01,1,,,,,,,,,
MMD_BIPOLAR_DISD,0,OMOP SDOH,Observation,AHRQ Item,Prevalence Of Bipolar Disorder Among Medicare (Dual And Non-Dual) Beneficiaries,AHRQ:MMD_BIPOLAR_DISD,2022-01-01,1,,,,,,,,,
MMD_DEPR_DISD,0,OMOP SDOH,Observation,AHRQ Item,Prevalence Of Depressive Disorders Among Medicare (Dual And Non-Dual) Beneficiaries,AHRQ:MMD_DEPR_DISD,2022-01-01,1,,,,,,,,,
2.2.2,0,OMOP SDOH,Observation,SDG Indicator,"Prevalence of malnutrition (weight for height >+2 or <-2 standard deviation from the median of the WHO Child Growth Standards) among children under 5 years of age, by type (wasting and overweight)",,2017-03-01,1,,,,,,,,,
MMD_THREE_OR_MORE_COND,0,OMOP SDOH,Observation,AHRQ Item,Prevalence Of Medicare (Dual And Non-Dual) Beneficiaries With Three Or More Claims-Based Conditions,AHRQ:MMD_THREE_OR_MORE_COND,2022-01-01,1,,,,,,,,,
2.1.2,0,OMOP SDOH,Observation,SDG Indicator,"Prevalence of moderate or severe food insecurity in the population, based on the Food Insecurity Experience Scale (FIES)",,2017-03-01,1,,,,,,,,,
MMD_PERSONALITY_DISD,0,OMOP SDOH,Observation,AHRQ Item,Prevalence Of Personality Disorders Among Medicare (Dual And Non-Dual) Beneficiaries,AHRQ:MMD_PERSONALITY_DISD,2022-01-01,1,,,,,,,,,
2.2.1,0,OMOP SDOH,Observation,SDG Indicator,Prevalence of stunting (height for age <-2 standard deviation from the median of the World Health Organization (WHO) Child Growth Standards) among children under 5 years of age,,2017-03-01,1,,,,,,,,,
MMD_OUD_IND,0,OMOP SDOH,Observation,AHRQ Item,Prevalence Of The Overarching Opioid Use Disorder (Oud) Indicator Among Medicare (Dual And Non-Dual) Beneficiaries,AHRQ:MMD_OUD_IND,2022-01-01,1,,,,,,,,,
2.1.1,0,OMOP SDOH,Observation,SDG Indicator,Prevalence of undernourishment,,2017-03-01,1,,,,,,,,,
AHRF_PREV_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,Preventable Hospital Stays Rate,AHRQ:AHRF_PREV_HOSP_RATE,2022-01-01,1,,,,,,,,,
MMD_ACUTE_PQI_AIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Acute Composite Per 100,000 American Indian Or Alaska Native Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ACUTE_PQI_AIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_ACUTE_PQI_ASIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Acute Composite Per 100,000 Asian Or Pacific Islander Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ACUTE_PQI_ASIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_ACUTE_PQI_BLACK_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Acute Composite Per 100,000 Black Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ACUTE_PQI_BLACK_RATE,2022-01-01,1,,,,,,,,,
MMD_ACUTE_PQI_F_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Acute Composite Per 100,000 Female Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ACUTE_PQI_F_RATE,2022-01-01,1,,,,,,,,,
MMD_ACUTE_PQI_HISP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Acute Composite Per 100,000 Hispanic Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ACUTE_PQI_HISP_RATE,2022-01-01,1,,,,,,,,,
MMD_ACUTE_PQI_M_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Acute Composite Per 100,000 Male Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ACUTE_PQI_M_RATE,2022-01-01,1,,,,,,,,,
MMD_ACUTE_PQI_OTHER_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Acute Composite Per 100,000 Other Race Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ACUTE_PQI_OTHER_RATE,2022-01-01,1,,,,,,,,,
MMD_ACUTE_PQI_WHITE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Acute Composite Per 100,000 White Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_ACUTE_PQI_WHITE_RATE,2022-01-01,1,,,,,,,,,
MMD_CHRONIC_PQI_AIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Chronic Composite Per 100,000 American Indian Or Alaska Native Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_CHRONIC_PQI_AIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_CHRONIC_PQI_ASIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Chronic Composite Per 100,000 Asian Or Pacific Islander Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_CHRONIC_PQI_ASIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_CHRONIC_PQI_BLACK_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Chronic Composite Per 100,000 Black Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_CHRONIC_PQI_BLACK_RATE,2022-01-01,1,,,,,,,,,
MMD_CHRONIC_PQI_F_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Chronic Composite Per 100,000 Female Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_CHRONIC_PQI_F_RATE,2022-01-01,1,,,,,,,,,
MMD_CHRONIC_PQI_HISP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Chronic Composite Per 100,000 Hispanic Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_CHRONIC_PQI_HISP_RATE,2022-01-01,1,,,,,,,,,
MMD_CHRONIC_PQI_M_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Chronic Composite Per 100,000 Male Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_CHRONIC_PQI_M_RATE,2022-01-01,1,,,,,,,,,
MMD_CHRONIC_PQI_OTHER_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Chronic Composite Per 100,000 Other Race Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_CHRONIC_PQI_OTHER_RATE,2022-01-01,1,,,,,,,,,
MMD_CHRONIC_PQI_WHITE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Chronic Composite Per 100,000 White Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_CHRONIC_PQI_WHITE_RATE,2022-01-01,1,,,,,,,,,
MMD_OVERALL_PQI_AIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Overall Composite Per 100,000 American Indian Or Alaska Native Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_OVERALL_PQI_AIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_OVERALL_PQI_ASIAN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Overall Composite Per 100,000 Asian Or Pacific Islander Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_OVERALL_PQI_ASIAN_RATE,2022-01-01,1,,,,,,,,,
MMD_OVERALL_PQI_BLACK_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Overall Composite Per 100,000 Black Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_OVERALL_PQI_BLACK_RATE,2022-01-01,1,,,,,,,,,
MMD_OVERALL_PQI_F_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Overall Composite Per 100,000 Female Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_OVERALL_PQI_F_RATE,2022-01-01,1,,,,,,,,,
MMD_OVERALL_PQI_HISP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Overall Composite Per 100,000 Hispanic Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_OVERALL_PQI_HISP_RATE,2022-01-01,1,,,,,,,,,
MMD_OVERALL_PQI_M_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Overall Composite Per 100,000 Male Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_OVERALL_PQI_M_RATE,2022-01-01,1,,,,,,,,,
MMD_OVERALL_PQI_OTHER_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Overall Composite Per 100,000 Other Race Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_OVERALL_PQI_OTHER_RATE,2022-01-01,1,,,,,,,,,
MMD_OVERALL_PQI_WHITE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Prevention Quality Overall Composite Per 100,000 White Medicare (Dual And Non-Dual) Beneficiaries",AHRQ:MMD_OVERALL_PQI_WHITE_RATE,2022-01-01,1,,,,,,,,,
16.6.1,0,OMOP SDOH,Observation,SDG Indicator,"Primary government expenditures as a proportion of original approved budget, by sector (or by budget codes or similar)",,2017-03-01,1,,,,,,,,,
ERS_RUCA1_2000,0,OMOP SDOH,Geographic Feature,AHRQ Item,Primary Rural-Urban Commuting Area Code 2000,AHRQ:ERS_RUCA1_2000,2022-01-01,1,,,,,,,,,
ERS_RUCA1_2010,0,OMOP SDOH,Geographic Feature,AHRQ Item,Primary Rural-Urban Commuting Area Code 2010 (ZIP Level),AHRQ:ERS_RUCA1_2010,2022-01-01,1,,,,,,,,,
619,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Private Insurance,SDOHO:619; Private_Insurance,2022-01-01,1,,,,,,,,,
1.b.1,0,OMOP SDOH,Observation,SDG Indicator,Pro-poor public social spending,,2017-03-01,1,,,,,,,,,
GIS1010335,0,OMOP SDOH,Observation,GIS Measure,Probabilistic Measure,,2024-09-15,1,,,,,,,,,
GIS1002395,0,OMOP SDOH,Observation,GIS Measure,Probability,,2024-09-15,1,,,,,,,,,
GIS1002396,0,OMOP SDOH,Observation,GIS Measure,Probability Of Reaching The Top Quintile,,2024-09-15,1,,,,,,,,,
OPP_TOP20_ASN_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_ASN_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_ASN_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_ASN_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_ASN_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_ASN_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_ASN_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_ASN_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_ASN_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_ASN_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_ASN_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Asian Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_ASN_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_BLK_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_BLK_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_BLK_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_BLK_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_BLK_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_BLK_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_BLK_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_BLK_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_BLK_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_BLK_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Black Or African American Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_BLK_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_HSP_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_HSP_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_HSP_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_HSP_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_HSP_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_HSP_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_HSP_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_HSP_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_HSP_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_HSP_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Hispanic Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_HSP_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_NAM_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_NAM_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_NAM_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_NAM_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_NAM_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_NAM_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_NAM_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_NAM_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_NAM_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_NAM_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Native American Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_NAM_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_OTHER_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_OTHER_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_OTHER_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_OTHER_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_OTHER_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_OTHER_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_OTHER_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_OTHER_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_OTHER_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_OTHER_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: Other Race Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_OTHER_M_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_F_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Female Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_WHT_F_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_F_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Female Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_WHT_F_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_F_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Female Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_WHT_F_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_F_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Female Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_WHT_F_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_F_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Female Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_WHT_F_HH_75PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_M_HH_100PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Male Child With Parents From 100th Household Income Percentile,AHRQ:OPP_TOP20_WHT_M_HH_100PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_M_HH_1PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Male Child With Parents From 1st Household Income Percentile,AHRQ:OPP_TOP20_WHT_M_HH_1PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_M_HH_25PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Male Child With Parents From 25th Household Income Percentile,AHRQ:OPP_TOP20_WHT_M_HH_25PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_M_HH_50PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Male Child With Parents From 50th Household Income Percentile,AHRQ:OPP_TOP20_WHT_M_HH_50PT,2022-01-01,1,,,,,,,,,
OPP_TOP20_WHT_M_HH_75PT,0,OMOP SDOH,Observation,AHRQ Item,Probability Of Reaching The Top Quintile Of The National Household Income Distribution: White Male Child With Parents From 75th Household Income Percentile,AHRQ:OPP_TOP20_WHT_M_HH_75PT,2022-01-01,1,,,,,,,,,
GIS1002397,0,OMOP SDOH,Type Concept,Exposure Type Concept,Procedure Registry,,2024-09-15,1,,,,,,,,,
672,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Production And Transportation And Material Moving Occupation,SDOHO:672; Production_and_Transportation_and_Material_Moving_Occupation,2022-01-01,1,,,,,,,,,
675,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Production Occupation,SDOHO:675; Production_Occupation,2022-01-01,1,,,,,,,,,
667,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Professional And Related Occupation,SDOHO:667; Professional_and_Related_Occupation,2022-01-01,1,,,,,,,,,
GIS1002398,0,OMOP SDOH,Type Concept,Exposure Type Concept,Professional Claim,,2024-09-15,1,,,,,,,,,
SEDH:1.10,0,OMOP SDOH,Observation,SEDH Item,Profiles Of Veteran Segments By Vulnerability Level,SEDH:1.10,2021-01-01,1,,,,,,,,,
15.2.1,0,OMOP SDOH,Observation,SDG Indicator,Progress towards sustainable forest management,,2017-03-01,1,,,,,,,,,
17.10,0,OMOP SDOH,Observation,SDG Goal,"Promote a universal, rules-based, open, non-discriminatory and equitable multilateral trading system under the World Trade Organization, including through the conclusion of negotiations under its Doha Development Agenda",,2017-03-01,1,,,,,,,,,
16.b,0,OMOP SDOH,Observation,SDG Goal,Promote and enforce non-discriminatory laws and policies for sustainable development,,2017-03-01,1,,,,,,,,,
8.3,0,OMOP SDOH,Observation,SDG Goal,"Promote development-oriented policies that support productive activities, decent job creation, entrepreneurship, creativity and innovation, and encourage the formalization and growth of micro-, small- and medium-sized enterprises, including through acc...","Promote development-oriented policies that support productive activities, decent job creation, entrepreneurship, creativity and innovation, and encourage the formalization and growth of micro-, small- and medium-sized enterprises, including through access to financial services",2017-03-01,1,,,,,,,,,
15.6,0,OMOP SDOH,Observation,SDG Goal,"Promote fair and equitable sharing of the benefits arising from the utilization of genetic resources and promote appropriate access to such resources, as internationally agreed",,2017-03-01,1,,,,,,,,,
9.2,0,OMOP SDOH,Observation,SDG Goal,"Promote inclusive and sustainable industrialization and, by 2030, significantly raise industry?s share of employment and gross domestic product, in line with national circumstances, and double its share in least developed countries",,2017-03-01,1,,,,,,,,,
13.b,0,OMOP SDOH,Observation,SDG Goal,"Promote mechanisms for raising capacity for effective climate change-related planning and management in least developed countries and small island developing States, including focusing on women, youth and local and marginalized communities",,2017-03-01,1,,,,,,,,,
Goal 16,0,OMOP SDOH,Observation,SDG Goal,"Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels",,2017-03-01,1,,,,,,,,,
12.7,0,OMOP SDOH,Observation,SDG Goal,"Promote public procurement practices that are sustainable, in accordance with national policies and priorities",,2017-03-01,1,,,,,,,,,
Goal 8,0,OMOP SDOH,Observation,SDG Goal,"Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all",,2017-03-01,1,,,,,,,,,
17.7,0,OMOP SDOH,Observation,SDG Goal,"Promote the development, transfer, dissemination and diffusion of environmentally sound technologies to developing countries on favourable terms, including on concessional and preferential terms, as mutually agreed",,2017-03-01,1,,,,,,,,,
16.3,0,OMOP SDOH,Observation,SDG Goal,Promote the rule of law at the national and international levels and ensure equal access to justice for all,,2017-03-01,1,,,,,,,,,
8.7.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion and number of children aged 5?17 years engaged in child labour, by sex and age",,2017-03-01,1,,,,,,,,,
8.10.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of adults (15 years and older) with an account at a bank or other financial institution or with a mobile-money-service provider,,2017-03-01,1,,,,,,,,,
2.4.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of agricultural area under productive and sustainable agriculture,,2017-03-01,1,,,,,,,,,
3.1.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of births attended by skilled health personnel,,2017-03-01,1,,,,,,,,,
6.3.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of bodies of water with good ambient water quality,,2017-03-01,1,,,,,,,,,
16.5.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of businesses that had at least one contact with a public official and that paid a bribe to a public official, or were asked for a bribe by those public officials during the previous 12 months",,2017-03-01,1,,,,,,,,,
16.2.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of children aged 1?17 years who experienced any physical punishment and/or psychological aggression by caregivers in the past month,,2017-03-01,1,,,,,,,,,
4.2.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of children aged 24?59 months who are developmentally on track in health, learning and psychosocial well-being, by sex",,2017-03-01,1,,,,,,,,,
4.1.1,0,OMOP SDOH,Observation,SDG Goal,"Proportion of children and young people (a) in grades 2/3; (b) at the end of primary; and (c) at the end of lower secondary achieving at least a minimum proficiency level in (i) reading and (ii) mathematics, by sex",,2017-03-01,1,,,,,,,,,
16.9.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of children under 5 years of age whose births have been registered with a civil authority, by age",,2017-03-01,1,,,,,,,,,
11.3.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of cities with a direct participation structure of civil society in urban planning and management that operate regularly and democratically,,2017-03-01,1,,,,,,,,,
15.8.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of countries adopting relevant national legislation and adequately resourcing the prevention or control of invasive alien species,,2017-03-01,1,,,,,,,,,
17.19.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of countries that (a) have conducted at least one population and housing census in the last 10 years; and (b) have achieved 100 per cent birth registration and 80 per cent death registration,,2017-03-01,1,,,,,,,,,
5.a.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of countries where the legal framework (including customary law) guarantees women?s equal rights to land ownership and/or control,,2017-03-01,1,,,,,,,,,
10.7.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of countries with migration policies that facilitate orderly, safe, regular and responsible migration and mobility of people",,2017-03-01,1,,,,,,,,,
5.c.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of countries with systems to track and make public allocations for gender equality and women?s empowerment,,2017-03-01,1,,,,,,,,,
6.3.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of domestic and industrial wastewater flows safely treated,,2017-03-01,1,,,,,,,,,
17.1.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of domestic budget funded by domestic taxes,,2017-03-01,1,,,,,,,,,
5.2.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of ever-partnered women and girls aged 15 years and older subjected to physical, sexual or psychological violence by a current or former intimate partner in the previous 12 months, by form of violence and by age",,2017-03-01,1,,,,,,,,,
14.4.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of fish stocks within biologically sustainable levels,,2017-03-01,1,,,,,,,,,
5.3.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of girls and women aged 15?49 years who have undergone female genital mutilation, by age",,2017-03-01,1,,,,,,,,,
3.b.3,0,OMOP SDOH,Observation,SDG Indicator,Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis,,2017-03-01,1,,,,,,,,,
15.1.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of important sites for terrestrial and freshwater biodiversity that are covered by protected areas, by ecosystem type",,2017-03-01,1,,,,,,,,,
17.8.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of individuals using the Internet,,2017-03-01,1,,,,,,,,,
5.b.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of individuals who own a mobile telephone, by sex",,2017-03-01,1,,,,,,,,,
8.3.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of informal employment in total employment, by sector and sex",,2017-03-01,1,,,,,,,,,
15.3.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of land that is degraded over total land area,,2017-03-01,1,,,,,,,,,
6.b.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of local administrative units with established and operational policies and procedures for participation of local communities in water and sanitation management,,2017-03-01,1,,,,,,,,,
2.5.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of local breeds classified as being at risk of extinction,,2017-03-01,1,,,,,,,,,
1.5.4,0,OMOP SDOH,Observation,SDG Indicator,Proportion of local governments that adopt and implement local disaster risk reduction strategies in line with national disaster risk reduction strategies,,2017-03-01,1,,,,,,,,,
9.b.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of medium and high-tech industry value added in total value added,,2017-03-01,1,,,,,,,,,
10.6.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of members and voting rights of developing countries in international organizations,,2017-03-01,1,,,,,,,,,
16.8.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of members and voting rights of developing countries in international organizations,,2017-03-01,1,,,,,,,,,
1.2.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of men, women and children of all ages living in poverty in all its dimensions according to national definitions",,2017-03-01,1,,,,,,,,,
11.6.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of municipal solid waste collected and managed in controlled facilities out of total municipal waste generated, by cities",,2017-03-01,1,,,,,,,,,
10.2.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of people living below 50 per cent of median income, by sex, age and persons with disabilities",,2017-03-01,1,,,,,,,,,
11.7.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of persons victim of physical or sexual harassment, by sex, age, disability status and place of occurrence, in the previous 12 months",,2017-03-01,1,,,,,,,,,
16.5.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of persons who had at least one contact with a public official and who paid a bribe to a public official, or were asked for a bribe by those public officials, during the previous 12 months",,2017-03-01,1,,,,,,,,,
9.c.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of population covered by a mobile network, by technology",,2017-03-01,1,,,,,,,,,
1.3.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of population covered by social protection floors/systems, by sex, distinguishing children, unemployed persons, older persons, persons with disabilities, pregnant women, newborns, work-injury victims and the poor and the vulnerable",,2017-03-01,1,,,,,,,,,
4.6.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of population in a given age group achieving at least a fixed level of proficiency in functional (a) literacy and (b) numeracy skills, by sex",,2017-03-01,1,,,,,,,,,
1.2.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of population living below the national poverty line, by sex and age",,2017-03-01,1,,,,,,,,,
1.4.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population living in households with access to basic services,,2017-03-01,1,,,,,,,,,
10.3.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population reporting having personally felt discriminated against or harassed in the previous 12 months on the basis of a ground of discrimination prohibited under international human rights law,,2017-03-01,1,,,,,,,,,
16.b.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population reporting having personally felt discriminated against or harassed in the previous 12 months on the basis of a ground of discrimination prohibited under international human rights law,,2017-03-01,1,,,,,,,,,
16.6.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population satisfied with their last experience of public services,,2017-03-01,1,,,,,,,,,
16.1.3,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of population subjected to (a) physical violence, (b) psychological violence and (c) sexual violence in the previous 12 months",,2017-03-01,1,,,,,,,,,
16.1.4,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population that feel safe walking alone around the area they live after dark,,2017-03-01,1,,,,,,,,,
11.2.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of population that has convenient access to public transport, by sex, age and persons with disabilities",,2017-03-01,1,,,,,,,,,
6.2.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population using (a) safely managed sanitation services and (b) a hand-washing facility with soap and water,,2017-03-01,1,,,,,,,,,
6.1.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population using safely managed drinking water services,,2017-03-01,1,,,,,,,,,
16.7.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of population who believe decision- making is inclusive and responsive, by sex, age, disability and population group",,2017-03-01,1,,,,,,,,,
7.1.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population with access to electricity,,2017-03-01,1,,,,,,,,,
3.8.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population with large household expenditures on health as a share of total household expenditure or income,,2017-03-01,1,,,,,,,,,
7.1.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of population with primary reliance on clean fuels and technology,,2017-03-01,1,,,,,,,,,
4.a.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of schools offering basic services, by type of service",,2017-03-01,1,,,,,,,,,
5.5.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of seats held by women in (a) national parliaments and (b) local governments,,2017-03-01,1,,,,,,,,,
16.4.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of seized, found or surrendered arms whose illicit origin or context has been traced or established by a competent authority in line with international instruments",,2017-03-01,1,,,,,,,,,
9.3.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of small-scale industries in total industry value added,,2017-03-01,1,,,,,,,,,
9.3.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of small-scale industries with a loan or line of credit,,2017-03-01,1,,,,,,,,,
10.a.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of tariff lines applied to imports from least developed countries and developing countries with zero-tariff,,2017-03-01,1,,,,,,,,,
4.c.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of teachers with the minimum required qualifications, by education level",,2017-03-01,1,,,,,,,,,
1.1.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of the population living below the international poverty line by sex, age, employment status and geographic location (urban/rural)",,2017-03-01,1,,,,,,,,,
10.7.4,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of the population who are refugees, by country of origin",,2017-03-01,1,,,,,,,,,
16.3.3,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of the population who have experienced a dispute in the past two years and who accessed a formal or informal dispute resolution mechanism, by type of mechanism",,2017-03-01,1,,,,,,,,,
9.1.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of the rural population who live within 2 km of an all-season road,,2017-03-01,1,,,,,,,,,
3.b.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of the target population covered by all vaccines included in their national programme,,2017-03-01,1,,,,,,,,,
5.4.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of time spent on unpaid domestic and care work, by sex, age and location",,2017-03-01,1,,,,,,,,,
1.4.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of total adult population with secure tenure rights to land, (a) with legally recognized documentation, and (b) who perceive their rights to land as secure, by sex and type of tenure",,2017-03-01,1,,,,,,,,,
1.a.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of total government spending on essential services (education, health and social protection)",,2017-03-01,1,,,,,,,,,
14.a.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of total research budget allocated to research in the field of marine technology,,2017-03-01,1,,,,,,,,,
E_AIRPRT,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of Airport,EJI:E_AIRPRT,2022-01-01,1,,,,,,,,,
E_COAL,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of Coal Mines,EJI:E_COAL,2022-01-01,1,,,,,,,,,
E_NPL,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of EPA National Priority List Site,EJI:E_NPL,2022-01-01,1,,,,,,,,,
E_RMP,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of EPA Risk Management Plan Site,EJI:E_RMP,2022-01-01,1,,,,,,,,,
E_TRI,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of EPA Toxic Release Inventory Site,EJI:E_TRI,2022-01-01,1,,,,,,,,,
E_TSD,0,OMOP SDOH,Observation,EJI EBM Item,"Proportion Of Tract'S Area Within 1-Mi Buffer Of EPA Treatment, Storage, And Disposal Site",EJI:E_TSD,2022-01-01,1,,,,,,,,,
E_PARK,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of Green Space,EJI:E_PARK,2022-01-01,1,,,,,,,,,
E_ROAD,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of High-Volume Road Or Highway,EJI:E_ROAD,2022-01-01,1,,,,,,,,,
E_LEAD,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of Lead Mines,EJI:E_LEAD,2022-01-01,1,,,,,,,,,
E_RAIL,0,OMOP SDOH,Observation,EJI EBM Item,Proportion Of Tract'S Area Within 1-Mi Buffer Of Railroad,EJI:E_RAIL,2022-01-01,1,,,,,,,,,
15.7.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of traded wildlife that was poached or illicitly trafficked,,2017-03-01,1,,,,,,,,,
15.c.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of traded wildlife that was poached or illicitly trafficked,,2017-03-01,1,,,,,,,,,
6.5.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of transboundary basin area with an operational arrangement for water cooperation,,2017-03-01,1,,,,,,,,,
11.1.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of urban population living in slums, informal settlements or inadequate housing",,2017-03-01,1,,,,,,,,,
16.3.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of victims of violence in the previous 12 months who reported their victimization to competent authorities or other officially recognized conflict resolution mechanisms,,2017-03-01,1,,,,,,,,,
5.6.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of women aged 15?49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care",,2017-03-01,1,,,,,,,,,
5.3.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of women aged 20?24 years who were married or in a union before age 15 and before age 18,,2017-03-01,1,,,,,,,,,
5.2.2,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of women and girls aged 15 years and older subjected to sexual violence by persons other than an intimate partner in the previous 12 months, by age and place of occurrence",,2017-03-01,1,,,,,,,,,
5.5.2,0,OMOP SDOH,Observation,SDG Indicator,Proportion of women in managerial positions,,2017-03-01,1,,,,,,,,,
3.7.1,0,OMOP SDOH,Observation,SDG Indicator,Proportion of women of reproductive age (aged 15?49 years) who have their need for family planning satisfied with modern methods,,2017-03-01,1,,,,,,,,,
16.2.3,0,OMOP SDOH,Observation,SDG Indicator,Proportion of young women and men aged 18?29 years who experienced sexual violence by age 18,,2017-03-01,1,,,,,,,,,
8.6.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of youth (aged 15?24 years) not in education, employment or training",,2017-03-01,1,,,,,,,,,
4.4.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportion of youth and adults with information and communications technology (ICT) skills, by type of skill",,2017-03-01,1,,,,,,,,,
16.7.1,0,OMOP SDOH,Observation,SDG Indicator,"Proportions of positions in national and local institutions, including (a) the legislatures; (b) the public service; and (c) the judiciary, compared to national distributions, by sex, age, persons with disabilities and population groups",,2017-03-01,1,,,,,,,,,
8.8,0,OMOP SDOH,Observation,SDG Goal,"Protect labour rights and promote safe and secure working environments for all workers, including migrant workers, in particular women migrants, and those in precarious employment",,2017-03-01,1,,,,,,,,,
Goal 15,0,OMOP SDOH,Observation,SDG Goal,"Protect, restore and promote sustainable use of terrestrial ecosystems, sustainably manage forests, combat desertification, and halt and reverse land degradation and halt biodiversity loss",,2017-03-01,1,,,,,,,,,
689,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Protective Service Occupation,SDOHO:689; Protective_Service_Occupation,2022-01-01,1,,,,,,,,,
14.b,0,OMOP SDOH,Observation,SDG Goal,Provide access for small-scale artisanal fishers to marine resources and markets,,2017-03-01,1,,,,,,,,,
GIS1002399,0,OMOP SDOH,Type Concept,Exposure Type Concept,Provider Survey,,2024-09-15,1,,,,,,,,,
GIS1002400,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Psychoactive Inhalant Use,,2024-09-15,1,,,,,,,,,
504,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Psychosocial Factor,SDOHO:504; Psychosocial_Factor,2022-01-01,1,,,,,,,,,
GIS1002402,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Psychotic Disorders,,2024-09-15,1,,,,,,,,,
GIS1002404,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Public Assistance Rate,,2020-01-01,1,,,,,,,,,
GIS1002406,0,OMOP SDOH,Type Concept,Exposure Type Concept,Public Environmental Data,,2024-09-15,1,,,,,,,,,
618,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Public Insurance,SDOHO:618; Public_Insurance,2022-01-01,1,,,,,,,,,
GIS1002407,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Public Safety,,2021-01-01,1,,,,,,,,,
GIS1002409,0,OMOP SDOH,Healthcare Feature,SDOH Construct,Quality Of Healthcare Services,,2024-09-15,1,,,,,,,,,
GIS1002411,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Quality Of Housing,,2024-09-15,1,,,,,,,,,
SEDH:1.5,0,OMOP SDOH,Observation,SEDH Item,Quarterly Census Of Employment And Wages,SEDH:1.5,2021-01-01,1,,,,,,,,,
126,0,OMOP SDOH,Demographic Feature,SDOHO Construct,Race,SDOHO:126; Race,2022-01-01,1,,,,,,,,,
126_POP,0,OMOP SDOH,Demographic Feature,SDOH Determinant,Race In Population,,2024-09-15,1,,,,,,,,,
Race/Ethnicity,0,OMOP SDOH,Demographic Feature,SVI Construct,Race/Ethnicity,SVI:Race/Ethnicity,2018-01-01,1,,,,,,,,,
THEME3,0,OMOP SDOH,Demographic Feature,SVI Construct,Racial & Ethnic Minority Status,SVI:THEME3,2018-01-01,1,,,,,,,,,
GIS1002420,0,OMOP SDOH,Demographic Feature,SDOH Determinant,Racial & Ethnic Minority Status In Population,,2024-09-15,1,,,,,,,,,
359,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Racial Disparity,SDOHO:359; Racial_Disparity,2022-01-01,1,,,,,,,,,
GIS1002432,0,OMOP SDOH,Environmental Feature,SDOH Construct,Radiation,,2024-09-15,1,,,,,,,,,
GIS1002441,0,OMOP SDOH,Healthcare Feature,SDOH Determinant,Radiation Therapy Metrics,,2024-09-15,1,,,,,,,,,
GIS1010338,0,OMOP SDOH,Observation,GIS Measure,Range,,2024-09-15,1,,,,,,,,,
GIS1002455,0,OMOP SDOH,Observation,GIS Measure,Rate,,2024-09-15,1,,,,,,,,,
CRE_RATE_RISK12,0,OMOP SDOH,Observation,AHRQ Item,Rate Of Individuals With One Or Two Risk Factors (%),AHRQ:CRE_RATE_RISK12,2022-01-01,1,,,,,,,,,
CRE_RATE_RISK3,0,OMOP SDOH,Observation,AHRQ Item,Rate Of Individuals With Three Or More Risk Factors (%),AHRQ:CRE_RATE_RISK3,2022-01-01,1,,,,,,,,,
CRE_RATE_RISK0,0,OMOP SDOH,Observation,AHRQ Item,Rate Of Individuals With Zero Risk Factors (%),AHRQ:CRE_RATE_RISK0,2022-01-01,1,,,,,,,,,
11.3.1,0,OMOP SDOH,Observation,SDG Indicator,Ratio of land consumption rate to population growth rate,,2017-03-01,1,,,,,,,,,
ED_APENR,0,OMOP SDOH,Observation,COI Item,Ratio Of Students Enrolled In At Least One AP Course To The Number Of 11th And 12th Graders,COI:ED_APENR,2020-01-01,1,,,,,,,,,
zED_APENR,0,OMOP SDOH,Observation,COI Item,"Ratio Of Students Enrolled In At Least One AP Course To The Number Of 11th And 12th Graders, Transformed To Z-Scores",COI:zED_APENR,2020-01-01,1,,,,,,,,,
12.c,0,OMOP SDOH,Observation,SDG Goal,"Rationalize inefficient fossil-fuel subsidies that encourage wasteful consumption by removing market distortions, in accordance with national circumstances, including by restructuring taxation and phasing out those harmful subsidies, where they exist,...","Rationalize inefficient fossil-fuel subsidies that encourage wasteful consumption by removing market distortions, in accordance with national circumstances, including by restructuring taxation and phasing out those harmful subsidies, where they exist, to reflect their environmental impacts, taking fully into account the specific needs and conditions of developing countries and minimizing the possible adverse impacts on their development in a manner that protects the poor and the affected communities",2017-03-01,1,,,,,,,,,
17.12,0,OMOP SDOH,Observation,SDG Goal,"Realize timely implementation of duty-free and quota-free market access on a lasting basis for all least developed countries, consistent with World Trade Organization decisions, including by ensuring that preferential rules of origin applicable to impo...","Realize timely implementation of duty-free and quota-free market access on a lasting basis for all least developed countries, consistent with World Trade Organization decisions, including by ensuring that preferential rules of origin applicable to imports from least developed countries are transparent and simple, and contribute to facilitating market access",2017-03-01,1,,,,,,,,,
5.4,0,OMOP SDOH,Observation,SDG Goal,"Recognize and value unpaid care and domestic work through the provision of public services, infrastructure and social protection policies and the promotion of shared responsibility within the household and the family as nationally appropriate",,2017-03-01,1,,,,,,,,,
AHRF_REC_USDA,0,OMOP SDOH,Observation,AHRQ Item,Recreation Typology Code,AHRQ:AHRF_REC_USDA,2022-01-01,1,,,,,,,,,
860,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Recreational And Leisure Opportunity,SDOHO:860; Recreational_and_Leisure_Opportunity,2022-01-01,1,,,,,,,,,
10.7.1,0,OMOP SDOH,Observation,SDG Indicator,Recruitment cost borne by employee as a proportion of monthly income earned in country of destination,,2017-03-01,1,,,,,,,,,
15.5.1,0,OMOP SDOH,Observation,SDG Indicator,Red List Index,,2017-03-01,1,,,,,,,,,
10.4.2,0,OMOP SDOH,Observation,SDG Indicator,Redistributive impact of fiscal policy2,,2017-03-01,1,,,,,,,,,
Goal 10,0,OMOP SDOH,Observation,SDG Goal,Reduce inequality within and among countries,,2017-03-01,1,,,,,,,,,
GIS1002456,0,OMOP SDOH,Demographic Feature,SDOH Construct,Refugee Population,,2024-09-15,1,,,,,,,,,
GIS1002457,0,OMOP SDOH,Type Concept,Exposure Type Concept,Registry Data,,2024-09-15,1,,,,,,,,,
GIS1010339,0,OMOP SDOH,Observation,GIS Measure,Relative Measure,,2024-09-15,1,,,,,,,,,
10.c.1,0,OMOP SDOH,Observation,SDG Indicator,Remittance costs as a proportion of the amount remitted,,2017-03-01,1,,,,,,,,,
GIS1002458,0,OMOP SDOH,Geographic Feature,SDOH Determinant,Renewable Energy,,2024-09-15,1,,,,,,,,,
7.2.1,0,OMOP SDOH,Observation,SDG Indicator,Renewable energy share in the total final energy consumption,,2017-03-01,1,,,,,,,,,
9.5.1,0,OMOP SDOH,Observation,SDG Indicator,Research and development expenditure as a proportion of GDP,,2017-03-01,1,,,,,,,,,
GIS1002459,0,OMOP SDOH,Type Concept,Exposure Type Concept,Research Data,,2024-09-15,1,,,,,,,,,
GIS1010342,0,OMOP SDOH,Type Concept,Exposure Type Concept,Research Data Exposure,,2024-09-15,1,,,,,,,,,
9.5.2,0,OMOP SDOH,Observation,SDG Indicator,Researchers (in full-time equivalent) per million inhabitants,,2017-03-01,1,,,,,,,,,
17.15,0,OMOP SDOH,Observation,SDG Goal,Respect each country?s policy space and leadership to establish and implement policies for poverty eradication and sustainable development,,2017-03-01,1,,,,,,,,,
606,0,OMOP SDOH,Healthcare Feature,SDOHO Determinant,Result Of Healthcare,SDOHO:606; Result_of_Healthcare,2022-01-01,1,,,,,,,,,
244,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Retired,SDOHO:244; Retired,2022-01-01,1,,,,,,,,,
AHRF_RET_DEST_USDA,0,OMOP SDOH,Observation,AHRQ Item,Retirement Destination Typology Code,AHRQ:AHRF_RET_DEST_USDA,2022-01-01,1,,,,,,,,,
559,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Safe Sex,SDOHO:559; Safe_Sex,2022-01-01,1,,,,,,,,,
926,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Safety Concern,SDOHO:926; Safety_Concern,2022-01-01,1,,,,,,,,,
676,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Sales And Office Occupation,SDOHO:676; Sales_and_Office_Occupation,2022-01-01,1,,,,,,,,,
677,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Sales And Related Occupation,SDOHO:677; Sales_and_Related_Occupation,2022-01-01,1,,,,,,,,,
607,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Satisfaction Of Treatment,SDOHO:607; Satisfaction_of_Treatment,2022-01-01,1,,,,,,,,,
GIS1002460,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Schizophrenia,,2024-09-15,1,,,,,,,,,
GIS1002478,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,School Poverty,,2020-01-01,1,,,,,,,,,
GIS1002481,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,School System,,2022-01-01,1,,,,,,,,,
GIS1002483,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,School System In Population,,2024-09-15,1,,,,,,,,,
GIS1002558,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Seatbelt And Helmet Use,,2024-09-15,1,,,,,,,,,
ERS_RUCA2_2000,0,OMOP SDOH,Geographic Feature,AHRQ Item,Secondary Rural-Urban Commuting Area Code 2000,AHRQ:ERS_RUCA2_2000,2022-01-01,1,,,,,,,,,
ERS_RUCA2_2010,0,OMOP SDOH,Geographic Feature,AHRQ Item,Secondary Rural-Urban Commuting Area Code 2010 (ZIP Level),AHRQ:ERS_RUCA2_2010,2022-01-01,1,,,,,,,,,
GIS1002560,0,OMOP SDOH,Socioeconomic Feature,AHRQ Construct,Segregation,,2022-01-01,1,,,,,,,,,
GIS1002562,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Segregation In Population,,2024-09-15,1,,,,,,,,,
CHR_SEGREG_BLACK,0,OMOP SDOH,Observation,AHRQ Item,Segregation Index (Higher Values Indicate Greater Residential Segregation Between Black And White Residents),AHRQ:CHR_SEGREG_BLACK,2022-01-01,1,,,,,,,,,
CHR_SEGREG_NON_WHITE,0,OMOP SDOH,Observation,AHRQ Item,Segregation Index (Higher Values Indicate Greater Residential Segregation Between Non-White And White Residents),AHRQ:CHR_SEGREG_NON_WHITE,2022-01-01,1,,,,,,,,,
248,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Self-Employed,SDOHO:248; Self-employed,2022-01-01,1,,,,,,,,,
781,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Separated,SDOHO:781; Separated,2022-01-01,1,,,,,,,,,
679,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Service Occupation,SDOHO:679; Service_Occupation,2022-01-01,1,,,,,,,,,
319,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Sex Frequency,SDOHO:319; Sex_Frequency,2022-01-01,1,,,,,,,,,
338,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Sex Partner,SDOHO:338; Sex_Partner,2022-01-01,1,,,,,,,,,
341,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Sex Safety Practice,SDOHO:341; Sex_Safety_Practice,2022-01-01,1,,,,,,,,,
344,0,OMOP SDOH,Phenotypic Feature,SDOHO Construct,Sexual Orientation,SDOHO:344; Sexual_Orientation,2022-01-01,1,,,,,,,,,
GIS1002565,0,OMOP SDOH,Observation,GIS Measure,Shape Measures,,2024-09-15,1,,,,,,,,,
835,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Sibling Relationship,SDOHO:835; Sibling_Relationship,2022-01-01,1,,,,,,,,,
9.c,0,OMOP SDOH,Observation,SDG Goal,Significantly increase access to information and communications technology and strive to provide universal and affordable access to the Internet in least developed countries by 2020,,2017-03-01,1,,,,,,,,,
17.11,0,OMOP SDOH,Observation,SDG Goal,"Significantly increase the exports of developing countries, in particular with a view to doubling the least developed countries? share of global exports by 2020",,2017-03-01,1,,,,,,,,,
16.1,0,OMOP SDOH,Observation,SDG Goal,Significantly reduce all forms of violence and related death rates everywhere,,2017-03-01,1,,,,,,,,,
GIS1002567,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Single-Headed Households,,2020-01-01,1,,,,,,,,,
E_SNGPNT,0,OMOP SDOH,Observation,SVI Item,Single-Parent Household With Children Under 18 Estimate,SVI:E_SNGPNT,2018-01-01,1,,,,,,,,,
M_SNGPNT,0,OMOP SDOH,Observation,SVI Item,Single-Parent Household With Children Under 18 Estimate MOE,SVI:M_SNGPNT,2018-01-01,1,,,,,,,,,
GIS1010345,0,OMOP SDOH,Observation,GIS Measure,Skewness,,2024-09-15,1,,,,,,,,,
GIS1002571,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Sleep Disorders,,2024-09-15,1,,,,,,,,,
GIS1002573,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Sleep Habits,,2024-09-15,1,,,,,,,,,
SEDH:1.24,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Small-Area Estimates Of Housing Characteristics,SEDH:1.24,2021-01-01,1,,,,,,,,,
216,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Smoking,SDOHO:216; Smoking,2022-01-01,1,,,,,,,,,
814,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Social Activity,SDOHO:814; Social_Activity,2022-01-01,1,,,,,,,,,
GIS1002576,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Social And Environmental Determinants Of Health (SEDH),,2024-09-15,1,,,,,,,,,
514,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Social Behaviour,SDOHO:514; Social_Behaviour,2022-01-01,1,,,,,,,,,
SEDH:2.1,0,OMOP SDOH,Socioeconomic Feature,SEDH Construct,Social Capital Index,SEDH:2.1,2021-01-01,1,,,,,,,,,
SEDH:2.2,0,OMOP SDOH,Observation,SEDH Item,Social Capital Index Dataset,SEDH:2.2,2021-01-01,1,,,,,,,,,
903,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Social Characteristic,SDOHO:903; Social_Characteristic,2022-01-01,1,,,,,,,,,
917,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Social Conflict,SDOHO:917; Social_Conflict,2022-01-01,1,,,,,,,,,
GIS1002577,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Social Context,,2022-01-01,1,,,,,,,,,
818,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Social Deprivation,SDOHO:818; Social_Deprivation,2022-01-01,1,,,,,,,,,
109,0,OMOP SDOH,Observation,SDOHO Item,Social Deprivation Index,SDOHO:109; Social_Deprivation_Index,2022-01-01,1,,,,,,,,,
GIS1002585,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Social Determinants Of Health (SDOH),,2024-09-15,1,,,,,,,,,
GIS1002598,0,OMOP SDOH,Type Concept,Exposure Type Concept,Social Determinants Of Health (SDOH) Database,,2024-09-15,1,,,,,,,,,
920,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Social Disorder,SDOHO:920; Social_Disorder,2022-01-01,1,,,,,,,,,
897,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Social Environment,SDOHO:897; Social_Environment,2022-01-01,1,,,,,,,,,
923,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Social Integration,SDOHO:923; Social_Integration,2022-01-01,1,,,,,,,,,
794,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Social Isolation,SDOHO:794; Social_Isolation,2022-01-01,1,,,,,,,,,
896,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Social Justice,SDOHO:896; Social_Justice,2022-01-01,1,,,,,,,,,
355,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Social Norms And Attitude,SDOHO:355; Social_Norms_and_Attitude,2022-01-01,1,,,,,,,,,
GIS1002599,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Social Security,,2024-09-15,1,,,,,,,,,
GIS1002601,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Social Services,,2022-01-01,1,,,,,,,,,
GIS1002603,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Social Services In Population,,2024-09-15,1,,,,,,,,,
581,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Social Support,SDOHO:581; Social_Support,2022-01-01,1,,,,,,,,,
824,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Social Vulnerability,SDOHO:824; Social_Vulnerability,2022-01-01,1,,,,,,,,,
173,0,OMOP SDOH,Observation,SDOHO Item,Social Vulnerability Index,SDOHO:173; Social_Vulnerability_Index,2022-01-01,1,,,,,,,,,
CDCSVI_RPL_THEME2_HH_COMP,0,OMOP SDOH,Observation,AHRQ Item,Social Vulnerability Index: Percentile Ranking For Household Composition Theme,AHRQ:CDCSVI_RPL_THEME2_HH_COMP,2022-01-01,1,,,,,,,,,
CDCSVI_RPL_THEME4_HH_TRANS,0,OMOP SDOH,Observation,AHRQ Item,Social Vulnerability Index: Percentile Ranking For Housing/Transportation Theme,AHRQ:CDCSVI_RPL_THEME4_HH_TRANS,2022-01-01,1,,,,,,,,,
CDCSVI_RPL_THEME3_MINO,0,OMOP SDOH,Observation,AHRQ Item,Social Vulnerability Index: Percentile Ranking For Minority Status/Language Theme,AHRQ:CDCSVI_RPL_THEME3_MINO,2022-01-01,1,,,,,,,,,
CDCSVI_RPL_THEME1_SOCIECO,0,OMOP SDOH,Observation,AHRQ Item,Social Vulnerability Index: Percentile Ranking For Socioeconomic Theme,AHRQ:CDCSVI_RPL_THEME1_SOCIECO,2022-01-01,1,,,,,,,,,
RPL_SVM,0,OMOP SDOH,Observation,SVI Item,Social Vulnerability Module Percentile Rank,SVI:RPL_SVM,2018-01-01,1,,,,,,,,,
538,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Social Worker Support,SDOHO:538; Social_Worker_Support,2022-01-01,1,,,,,,,,,
GIS1002620,0,OMOP SDOH,Socioeconomic Feature,AHRQ Construct,Socioeconomic Disadvantage Indices,,2022-01-01,1,,,,,,,,,
GIS1002622,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Socioeconomic Disadvantage Indices In Population,,2024-09-15,1,,,,,,,,,
269,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Socioeconomic Status,SDOHO:269; Socioeconomic_Status,2022-01-01,1,,,,,,,,,
269_POP,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Socioeconomic Status In Population,,2024-09-15,1,,,,,,,,,
GIS1002643,0,OMOP SDOH,Environmental Feature,SDOH Construct,Soil Contamination,,2024-09-15,1,,,,,,,,,
E_OTHERRACE,0,OMOP SDOH,Observation,SVI Item,"Some Other Race, Not Hispanic Or Latino Persons Estimate",SVI:E_OTHERRACE,2018-01-01,1,,,,,,,,,
M_OTHERRACE,0,OMOP SDOH,Observation,SVI Item,"Some Other Race, Not Hispanic Or Latino Persons Estimate MOE",SVI:M_OTHERRACE,2018-01-01,1,,,,,,,,,
162,0,OMOP SDOH,Demographic Feature,SDOHO Value,Spanish Or Latino Origin,SDOHO:162; Spanish_or_Latino_Origin,2022-01-01,1,,,,,,,,,
52,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Spirituality And Religion Practice,SDOHO:52; Spirituality_and_Religion_Practice,2022-01-01,1,,,,,,,,,
SPL_EBM,0,OMOP SDOH,Observation,EJI Item,SPL Environmental Burden Module,EJI:SPL_EBM,2022-01-01,1,,,,,,,,,
SPL_SVM,0,OMOP SDOH,Observation,EJI Item,SPL Social Vulnerability Module,EJI:SPL_SVM,2022-01-01,1,,,,,,,,,
838,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Spouse Relationship,SDOHO:838; Spouse_Relationship,2022-01-01,1,,,,,,,,,
GIS1010346,0,OMOP SDOH,Observation,GIS Measure,Standard Deviation,,2024-09-15,1,,,,,,,,,
ST_ABBR,0,OMOP SDOH,Geographic Feature,SVI Item,State Abbreviation,SVI:ST_ABBR,2018-01-01,1,,,,,,,,,
StateAbbr,0,OMOP SDOH,Observation,EJI Item,State Abbreviations,EJI:StateAbbr,2022-01-01,1,,,,,,,,,
STATEFIPS,0,OMOP SDOH,Geographic Feature,SVI Item,State FIPS Code (2-Digit),SVI:STATEFIPS,2018-01-01,1,,,,,,,,,
STATE,0,OMOP SDOH,Geographic Feature,SVI Item,State Name,SVI:STATE,2018-01-01,1,,,,,,,,,
CCD_STATE_REVENUE_LUNCH,0,OMOP SDOH,Observation,AHRQ Item,State Revenue From School Lunch Programs (Dollars) Per Student,AHRQ:CCD_STATE_REVENUE_LUNCH,2022-01-01,1,,,,,,,,,
stateusps,0,OMOP SDOH,Observation,COI Item,State USPS Code,COI:stateusps,2020-01-01,1,,,,,,,,,
COUNTYFIPS,0,OMOP SDOH,Geographic Feature,SVI Item,State-County FIPS Code (5-Digit),SVI:COUNTYFIPS,2018-01-01,1,,,,,,,,,
TRACTFIPS,0,OMOP SDOH,Geographic Feature,SVI Item,State-County-Census Tract FIPS Code (11-Digit),SVI:TRACTFIPS,2018-01-01,1,,,,,,,,,
ST,0,OMOP SDOH,Geographic Feature,SVI Item,State-Level FIPS Code,SVI:ST,2018-01-01,1,,,,,,,,,
17.18.1,0,OMOP SDOH,Observation,SDG Indicator,Statistical capacity indicator for Sustainable Development Goal monitoring,,2017-03-01,1,,,,,,,,,
17.1,0,OMOP SDOH,Observation,SDG Goal,"Strengthen domestic resource mobilization, including through international support to developing countries, to improve domestic capacity for tax and other revenue collection",,2017-03-01,1,,,,,,,,,
11.4,0,OMOP SDOH,Observation,SDG Goal,Strengthen efforts to protect and safeguard the world?s cultural and natural heritage,,2017-03-01,1,,,,,,,,,
16.a,0,OMOP SDOH,Observation,SDG Goal,"Strengthen relevant national institutions, including through international cooperation, for building capacity at all levels, in particular in developing countries, to prevent violence and combat terrorism and crime",,2017-03-01,1,,,,,,,,,
13.1,0,OMOP SDOH,Observation,SDG Goal,Strengthen resilience and adaptive capacity to climate- related hazards and natural disasters in all countries,,2017-03-01,1,,,,,,,,,
3.d,0,OMOP SDOH,Observation,SDG Goal,"Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks",,2017-03-01,1,,,,,,,,,
8.10,0,OMOP SDOH,Observation,SDG Goal,"Strengthen the capacity of domestic financial institutions to encourage and expand access to banking, insurance and financial services for all",,2017-03-01,1,,,,,,,,,
3.a,0,OMOP SDOH,Observation,SDG Goal,"Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate",,2017-03-01,1,,,,,,,,,
Goal 17,0,OMOP SDOH,Observation,SDG Goal,Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development,,2017-03-01,1,,,,,,,,,
3.5,0,OMOP SDOH,Observation,SDG Goal,"Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol",,2017-03-01,1,,,,,,,,,
503,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Stress,SDOHO:503; Stress,2022-01-01,1,,,,,,,,,
GIS1002645,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Stress Management Techniques,,2024-09-15,1,,,,,,,,,
28,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Strong Support,SDOHO:28; Strong_Support,2022-01-01,1,,,,,,,,,
252,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Student,SDOHO:252; Student,2022-01-01,1,,,,,,,,,
58,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Substance Use,SDOHO:58; Substance_Use,2022-01-01,1,,,,,,,,,
3.c,0,OMOP SDOH,Observation,SDG Goal,"Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States",,2017-03-01,1,,,,,,,,,
16.5,0,OMOP SDOH,Observation,SDG Goal,Substantially reduce corruption and bribery in all their forms,,2017-03-01,1,,,,,,,,,
26,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Sufficient Activity,SDOHO:26; Sufficient_Activity,2022-01-01,1,,,,,,,,,
GIS1002648,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Suicidal Ideation And Behaviors,,2024-09-15,1,,,,,,,,,
3.4.2,0,OMOP SDOH,Observation,SDG Indicator,Suicide mortality rate,,2017-03-01,1,,,,,,,,,
F_THEME2,0,OMOP SDOH,Observation,SVI Item,Sum Of Flags For Household Characteristics Theme,SVI:F_THEME2,2018-01-01,1,,,,,,,,,
F_THEME4,0,OMOP SDOH,Observation,SVI Item,Sum Of Flags For Housing Type/ Transportation Theme,SVI:F_THEME4,2018-01-01,1,,,,,,,,,
F_THEME3,0,OMOP SDOH,Observation,SVI Item,Sum Of Flags For Racial And Ethnic Minority Status Theme,SVI:F_THEME3,2018-01-01,1,,,,,,,,,
F_THEME1,0,OMOP SDOH,Observation,SVI Item,Sum Of Flags For Socioeconomic Status Theme,SVI:F_THEME1,2018-01-01,1,,,,,,,,,
F_TOTAL,0,OMOP SDOH,Observation,SVI Item,Sum Of Flags For The Four Themes,SVI:F_TOTAL,2018-01-01,1,,,,,,,,,
SPL_THEME2,0,OMOP SDOH,Observation,SVI Item,Sum Of Series For Household Characteristics Theme,SVI:SPL_THEME2,2018-01-01,1,,,,,,,,,
SPL_THEME4,0,OMOP SDOH,Observation,SVI Item,Sum Of Series For Housing Type/ Transportation Theme,SVI:SPL_THEME4,2018-01-01,1,,,,,,,,,
SPL_THEME3,0,OMOP SDOH,Observation,SVI Item,Sum Of Series For Racial And Ethnic Minority Status Theme,SVI:SPL_THEME3,2018-01-01,1,,,,,,,,,
SPL_THEME1,0,OMOP SDOH,Observation,SVI Item,Sum Of Series For Socioeconomic Status Theme,SVI:SPL_THEME1,2018-01-01,1,,,,,,,,,
SPL_SER,0,OMOP SDOH,Observation,EJI Item,"Summation Of The EB, And SV Module Percentile Ranks",EJI:SPL_SER,2022-01-01,1,,,,,,,,,
SPL_EJI,0,OMOP SDOH,Observation,EJI Item,"Summation Of The HVM, EBI, And SVI Module Percentile Ranks",EJI:SPL_EJI,2022-01-01,1,,,,,,,,,
HE_HEAT,0,OMOP SDOH,Observation,COI Item,Summer Days With Maximum Temperature Above 90f,COI:HE_HEAT,2020-01-01,1,,,,,,,,,
zHE_HEAT,0,OMOP SDOH,Observation,COI Item,"Summer Days With Maximum Temperature Above 90f, Transformed To Z-Scores And Multiplied By -1",COI:zHE_HEAT,2020-01-01,1,,,,,,,,,
GIS1002665,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Sun Protection Behaviors,,2024-09-15,1,,,,,,,,,
6.b,0,OMOP SDOH,Observation,SDG Goal,Support and strengthen the participation of local communities in improving water and sanitation management,,2017-03-01,1,,,,,,,,,
12.a,0,OMOP SDOH,Observation,SDG Goal,Support developing countries to strengthen their scientific and technological capacity to move towards more sustainable patterns of consumption and production,,2017-03-01,1,,,,,,,,,
9.b,0,OMOP SDOH,Observation,SDG Goal,"Support domestic technology development, research and innovation in developing countries, including by ensuring a conducive policy environment for, inter alia, industrial diversification and value addition to commodities",,2017-03-01,1,,,,,,,,,
207,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Support Healthy Eating Pattern Access,SDOHO:207; Support_Healthy_Eating_Pattern_Access,2022-01-01,1,,,,,,,,,
11.c,0,OMOP SDOH,Observation,SDG Goal,"Support least developed countries, including through financial and technical assistance, in building sustainable and resilient buildings utilizing local materials",,2017-03-01,1,,,,,,,,,
22,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Support Level,SDOHO:22; Support_Level,2022-01-01,1,,,,,,,,,
11.a,0,OMOP SDOH,Observation,SDG Goal,"Support positive economic, social and environmental links between urban, peri-urban and rural areas by strengthening national and regional development planning",,2017-03-01,1,,,,,,,,,
3.b,0,OMOP SDOH,Observation,SDG Goal,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Dec...","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",2017-03-01,1,,,,,,,,,
GIS1002667,0,OMOP SDOH,Type Concept,Exposure Type Concept,Survey Data,,2024-09-15,1,,,,,,,,,
8.1,0,OMOP SDOH,Observation,SDG Goal,"Sustain per capita economic growth in accordance with national circumstances and, in particular, at least 7 per cent gross domestic product growth per annum in the least developed countries",,2017-03-01,1,,,,,,,,,
GIS1002668,0,OMOP SDOH,Observation,SDG Goal,Sustainable Development Goals,,2017-03-01,1,,,,,,,,,
14.7.1,0,OMOP SDOH,Observation,SDG Indicator,"Sustainable fisheries as a proportion of GDP in small island developing States, least developed countries and all countries",,2017-03-01,1,,,,,,,,,
GIS1002676,0,OMOP SDOH,Observation,SDG Goal,Systemic issues,,2017-03-01,1,,,,,,,,,
8.7,0,OMOP SDOH,Observation,SDG Goal,"Take immediate and effective measures to eradicate forced labour, end modern slavery and human trafficking and secure the prohibition and elimination of the worst forms of child labour, including recruitment and use of child soldiers, and by 2025 end c...","Take immediate and effective measures to eradicate forced labour, end modern slavery and human trafficking and secure the prohibition and elimination of the worst forms of child labour, including recruitment and use of child soldiers, and by 2025 end child labour in all its forms",2017-03-01,1,,,,,,,,,
Goal 13,0,OMOP SDOH,Observation,SDG Goal,Take urgent action to combat climate change and its impacts3,,2017-03-01,1,,,,,,,,,
15.7,0,OMOP SDOH,Observation,SDG Goal,Take urgent action to end poaching and trafficking of protected species of flora and fauna and address both demand and supply of illegal wildlife products,,2017-03-01,1,,,,,,,,,
15.5,0,OMOP SDOH,Observation,SDG Goal,"Take urgent and significant action to reduce the degradation of natural habitats, halt the loss of biodiversity and, by 2020, protect and prevent the extinction of threatened species",,2017-03-01,1,,,,,,,,,
GIS1002679,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Teacher Experience,,2020-01-01,1,,,,,,,,,
GIS1002681,0,OMOP SDOH,Observation,SDG Goal,Technology,,2017-03-01,1,,,,,,,,,
GIS1010347,0,OMOP SDOH,Phenotypic Feature,SDOH Construct,Temperate environment,,2024-09-15,1,,,,,,,,,
TERRITORY,0,OMOP SDOH,Geographic Feature,SVI Item,"Territory Indicator (1= U.S. Territory, 0= U.S. State Or DC)",SVI:TERRITORY,2018-01-01,1,,,,,,,,,
LOCATION,0,OMOP SDOH,Geographic Feature,EJI Item,"Text Description Of Tract, County, State",EJI:LOCATION,2022-01-01,1,,,,,,,,,
2.a.1,0,OMOP SDOH,Observation,SDG Indicator,The agriculture orientation index for government expenditures,,2017-03-01,1,,,,,,,,,
CO,0,OMOP SDOH,Observation,SDOH Item,The Air Quality Index For The Day For CO,,2024-09-15,1,,,,,,,,,
NO2,0,OMOP SDOH,Observation,SDOH Item,The Air Quality Index For The Day For No2,,2024-09-15,1,,,,,,,,,
GIS1002684,0,OMOP SDOH,Observation,SDOH Item,The Air Quality Index For The Day For Ozone,,2024-09-15,1,,,,,,,,,
PM10,0,OMOP SDOH,Observation,SDOH Item,The Air Quality Index For The Day For PM10,,2024-09-15,1,,,,,,,,,
PM2.5,0,OMOP SDOH,Observation,SDOH Item,The Air Quality Index For The Day For PM2.5,,2024-09-15,1,,,,,,,,,
160,0,OMOP SDOH,Observation,SDOHO Item,The Alcohol Use Disorders Identification Test-Concise,SDOHO:160; The Alcohol Use Disorders Identification Test-Concise,2022-01-01,1,,,,,,,,,
RPL_EBM,0,OMOP SDOH,Observation,EJI EBM Item,The Environmental Burden Module Percentile Ranks,EJI:RPL_EBM,2022-01-01,1,,,,,,,,,
128,0,OMOP SDOH,Observation,SDOHO Item,The National Health Interview Survey,SDOHO:128; The National Health Interview Survey,2022-01-01,1,,,,,,,,,
aian,0,OMOP SDOH,Observation,COI Item,The Number Of Children Aged 0-17 Who Are American Indian And Alaska Native Alone. Source: 5-Year American Community Survey Summary Files,COI:aian,2020-01-01,1,,,,,,,,,
api,0,OMOP SDOH,Observation,COI Item,The Number Of Children Aged 0-17 Who Are Asian Or Pacific Islander Alone. Source: 5-Year American Community Survey Summary Files,COI:api,2020-01-01,1,,,,,,,,,
black,0,OMOP SDOH,Observation,COI Item,The Number Of Children Aged 0-17 Who Are Black Or African American Alone. Source: 5-Year American Community Survey Summary Files,COI:black,2020-01-01,1,,,,,,,,,
hisp,0,OMOP SDOH,Observation,COI Item,The Number Of Children Aged 0-17 Who Are Hispanic Or Latino. Source: 5-Year American Community Survey Summary Files,COI:hisp,2020-01-01,1,,,,,,,,,
nonwhite,0,OMOP SDOH,Observation,COI Item,The Number Of Children Aged 0-17 Who Are Not Non-Hispanic White Alone. Source: 5-Year American Community Survey Summary Files,COI:nonwhite,2020-01-01,1,,,,,,,,,
other2,0,OMOP SDOH,Observation,COI Item,The Number Of Children Aged 0-17 Who Are Some Other Race Alone Or Two Or More Races. Source: 5-Year American Community Survey Summary Files,COI:other2,2020-01-01,1,,,,,,,,,
white,0,OMOP SDOH,Observation,COI Item,"The Number Of Children Aged 0-17 Who Are White Alone, Not Hispanic Or Latino. Source: 5-Year American Community Survey Summary Files",COI:white,2020-01-01,1,,,,,,,,,
total,0,OMOP SDOH,Observation,COI Item,The Number Of Children Aged 0-17. Source: 5-Year American Community Survey Summary Files,COI:total,2020-01-01,1,,,,,,,,,
E_TOTCR,0,OMOP SDOH,Observation,EJI EBM Item,"The Probability Of Contracting Cancer Over The Course Of A Lifetime, Assuming Continuous Exposure",EJI:E_TOTCR,2022-01-01,1,,,,,,,,,
136,0,OMOP SDOH,Observation,SDOHO Item,The Third National Health And Nutrition Examination Survey,SDOHO:136; The Third National Health and Nutrition Examination Survey,2022-01-01,1,,,,,,,,,
GIS1002687,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Third Grade Math Proficiency,,2020-01-01,1,,,,,,,,,
GIS1002690,0,OMOP SDOH,Socioeconomic Feature,COI Determinant,Third Grade Reading Proficiency,,2020-01-01,1,,,,,,,,,
in100,0,OMOP SDOH,Observation,COI Item,"This Variable Is Equal To 1 If The Census Tract Is Located In One Of The 100 Largest Metro Areas (As Of 2015), Zero If Located In A Metro- Or Micropolitan Area That Does Not Belong To The 100 Largest Metro Areas, And Blank If It Is Located Outside A Me...","This Variable Is Equal To 1 If The Census Tract Is Located In One Of The 100 Largest Metro Areas (As Of 2015), Zero If Located In A Metro- Or Micropolitan Area That Does Not Belong To The 100 Largest Metro Areas, And Blank If It Is Located Outside A Metro- Or Micropolitan Area",2020-01-01,1,,,,,,,,,
664,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Tobacco Smoking,SDOHO:664; Tobacco_Smoking,2022-01-01,1,,,,,,,,,
661,0,OMOP SDOH,Behavioral Feature,SDOHO Determinant,Tobacco Use,SDOHO:661; Tobacco_Use,2022-01-01,1,,,,,,,,,
AHRF_TOT_MDCR_FFS_ACT_COST,0,OMOP SDOH,Observation,AHRQ Item,"Total Actual Medicare Costs, Fee For Service (Dollars)",AHRQ:AHRF_TOT_MDCR_FFS_ACT_COST,2022-01-01,1,,,,,,,,,
CDC_USCS_AGE_ADJ_INC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Age-Adjusted Cancer Incidence Per 100,000 People In The County",AHRQ:CDC_USCS_AGE_ADJ_INC_RATE,2022-01-01,1,,,,,,,,,
CDC_USCS_AGE_ADJ_MORT_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Age-Adjusted Cancer Mortality Per 100,000 People In The County",AHRQ:CDC_USCS_AGE_ADJ_MORT_RATE,2022-01-01,1,,,,,,,,,
17.7.1,0,OMOP SDOH,Observation,SDG Indicator,"Total amount of funding for developing countries to promote the development, transfer, dissemination and diffusion of environmentally sound technologies",,2017-03-01,1,,,,,,,,,
CDCA_PREV_DTH_BLACK_RATE_BELOW74,0,OMOP SDOH,Observation,AHRQ Item,"Total Avoidable Heart Disease And Stroke Deaths Per 100,000 Black Non-Hispanic Population (Ages 74 And Below)",AHRQ:CDCA_PREV_DTH_BLACK_RATE_BELOW74,2022-01-01,1,,,,,,,,,
CDCA_PREV_DTH_HISP_RATE_BELOW74,0,OMOP SDOH,Observation,AHRQ Item,"Total Avoidable Heart Disease And Stroke Deaths Per 100,000 Hispanic Population (Ages 74 And Below)",AHRQ:CDCA_PREV_DTH_HISP_RATE_BELOW74,2022-01-01,1,,,,,,,,,
CDCA_PREV_DTH_RATE_BELOW74,0,OMOP SDOH,Observation,AHRQ Item,"Total Avoidable Heart Disease And Stroke Deaths Per 100,000 Population (Ages 74 And Below)",AHRQ:CDCA_PREV_DTH_RATE_BELOW74,2022-01-01,1,,,,,,,,,
CDCA_PREV_DTH_WHITE_RATE_BELOW74,0,OMOP SDOH,Observation,AHRQ Item,"Total Avoidable Heart Disease And Stroke Deaths Per 100,000 White Non-Hispanic Population (Ages 74 And Below)",AHRQ:CDCA_PREV_DTH_WHITE_RATE_BELOW74,2022-01-01,1,,,,,,,,,
CDC_USCS_TOT_INC_COUNT,0,OMOP SDOH,Observation,AHRQ Item,Total Cancer Incidence In The County,AHRQ:CDC_USCS_TOT_INC_COUNT,2022-01-01,1,,,,,,,,,
CDC_USCS_TOT_MORT_COUNT,0,OMOP SDOH,Observation,AHRQ Item,Total Cancer Mortality In The County,AHRQ:CDC_USCS_TOT_MORT_COUNT,2022-01-01,1,,,,,,,,,
CDCA_HEART_DTH_RATE_ABOVE35,0,OMOP SDOH,Observation,AHRQ Item,"Total Cardiovascular Disease Deaths Per 100,000 Population (Ages 35 And Over)",AHRQ:CDCA_HEART_DTH_RATE_ABOVE35,2022-01-01,1,,,,,,,,,
CDCA_HEART_HOSP_RATE_ABOVE65,0,OMOP SDOH,Observation,AHRQ Item,"Total Cardiovascular Disease Hospitalizations Per 1,000 Medicare Beneficiaries (Ages 65 And Over)",AHRQ:CDCA_HEART_HOSP_RATE_ABOVE65,2022-01-01,1,,,,,,,,,
CCBP_ANNUAL_TOT_POP,0,OMOP SDOH,Observation,AHRQ Item,Total Census County Population,AHRQ:CCBP_ANNUAL_TOT_POP,2022-01-01,1,,,,,,,,,
ACS_TOT_CIVIL_EMPLOY_POP,0,OMOP SDOH,Observation,AHRQ Item,Total Civilian Employed Population (Ages 16 And Over),AHRQ:ACS_TOT_CIVIL_EMPLOY_POP,2022-01-01,1,,,,,,,,,
ACS_TOT_CIVIL_NONINST_POP,0,OMOP SDOH,Observation,AHRQ Item,Total Civilian Noninstitutionalized Population,AHRQ:ACS_TOT_CIVIL_NONINST_POP,2022-01-01,1,,,,,,,,,
ACS_TOT_CIVIL_NONINST_POP_POV,0,OMOP SDOH,Observation,AHRQ Item,Total Civilian Noninstitutionalized Population For Whom Poverty Status Is Determined,AHRQ:ACS_TOT_CIVIL_NONINST_POP_POV,2022-01-01,1,,,,,,,,,
ACS_TOT_CIVIL_POP_ABOVE18,0,OMOP SDOH,Observation,AHRQ Item,Total Civilian Population (Ages 18 And Over),AHRQ:ACS_TOT_CIVIL_POP_ABOVE18,2022-01-01,1,,,,,,,,,
ACS_TOT_CIVIL_POP_POV,0,OMOP SDOH,Observation,AHRQ Item,Total Civilian Population For Whom Poverty Status Is Determined (Ages 18 And Over),AHRQ:ACS_TOT_CIVIL_POP_POV,2022-01-01,1,,,,,,,,,
ACS_TOT_CIVIL_VET_POP_ABOVE25,0,OMOP SDOH,Observation,AHRQ Item,Total Civilian Population Who Are Veterans (Ages 25 And Over),AHRQ:ACS_TOT_CIVIL_VET_POP_ABOVE25,2022-01-01,1,,,,,,,,,
CHR_TOT_POPULATION,0,OMOP SDOH,Observation,AHRQ Item,Total County Population (Denominator For Provider Rate),AHRQ:CHR_TOT_POPULATION,2022-01-01,1,,,,,,,,,
CCD_TOT_STUDENTS,0,OMOP SDOH,Observation,AHRQ Item,Total Enrollment,AHRQ:CCD_TOT_STUDENTS,2022-01-01,1,,,,,,,,,
CCD_TOT_EXPENDITURE,0,OMOP SDOH,Observation,AHRQ Item,Total Expenditure (Dollars) Per Student,AHRQ:CCD_TOT_EXPENDITURE,2022-01-01,1,,,,,,,,,
AHRF_TOT_N_ST_G_EXP_1000,0,OMOP SDOH,Observation,AHRQ Item,"Total Expenses From Short-Term General Hospitals Reporting Expenses (Dollars In $1,000s)",AHRQ:AHRF_TOT_N_ST_G_EXP_1000,2022-01-01,1,,,,,,,,,
CCD_TOT_FED_REVENUE,0,OMOP SDOH,Observation,AHRQ Item,Total Federal Revenue (Dollars) Per Student,AHRQ:CCD_TOT_FED_REVENUE,2022-01-01,1,,,,,,,,,
17.1.1,0,OMOP SDOH,Observation,SDG Indicator,"Total government revenue as a proportion of GDP, by source",,2017-03-01,1,,,,,,,,,
ACS_TOT_GRANDCHILDREN_GP,0,OMOP SDOH,Observation,AHRQ Item,Total Grandchildren Under 18 Living With Grandparent Householder,AHRQ:ACS_TOT_GRANDCHILDREN_GP,2022-01-01,1,,,,,,,,,
13.2.2,0,OMOP SDOH,Observation,SDG Indicator,Total greenhouse gas emissions per year,,2017-03-01,1,,,,,,,,,
CDCA_BLOOD_HOSP_RATE_ABOVE65,0,OMOP SDOH,Observation,AHRQ Item,"Total High Blood Pressure Hospitalizations Per 1,000 Medicare Beneficiaries (Ages 65 And Over)",AHRQ:CDCA_BLOOD_HOSP_RATE_ABOVE65,2022-01-01,1,,,,,,,,,
ACS_TOT_HU,0,OMOP SDOH,Observation,AHRQ Item,Total Housing Units,AHRQ:ACS_TOT_HU,2022-01-01,1,,,,,,,,,
CCD_TOT_LOCAL_REVENUE,0,OMOP SDOH,Observation,AHRQ Item,Total Local Revenue (Dollars) Per Student,AHRQ:CCD_TOT_LOCAL_REVENUE,2022-01-01,1,,,,,,,,,
AHRF_TOT_MDCD_IP_DAY_ST_G,0,OMOP SDOH,Observation,AHRQ Item,"Total Medicaid Inpatient Days, Short-Term General Hospitals",AHRQ:AHRF_TOT_MDCD_IP_DAY_ST_G,2022-01-01,1,,,,,,,,,
AHRF_TOT_MCR_IP_DAY_ST_G,0,OMOP SDOH,Observation,AHRQ Item,"Total Medicare Inpatient Days, Short-Term General Hospitals",AHRQ:AHRF_TOT_MCR_IP_DAY_ST_G,2022-01-01,1,,,,,,,,,
3.b.2,0,OMOP SDOH,Observation,SDG Indicator,Total net official development assistance to medical research and basic health sectors,,2017-03-01,1,,,,,,,,,
GIS1002693,0,OMOP SDOH,Observation,GIS Measure,Total Number,,2024-09-15,1,,,,,,,,,
AHRF_TOT_NHSC_ACTIVE,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Active National Health Service Corps Sites,AHRQ:AHRF_TOT_NHSC_ACTIVE,2022-01-01,1,,,,,,,,,
AHRF_NHSC_ACTIVE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Active National Health Service Corps Sites Per 1,000 Population",AHRQ:AHRF_NHSC_ACTIVE_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_NURSE_MIDWIVES,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Advanced Practice Nurse Midwives With Npi,AHRQ:AHRF_TOT_NURSE_MIDWIVES,2022-01-01,1,,,,,,,,,
AHRF_NURSE_MIDWIVES_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Advanced Practice Nurse Midwives With Npi Per 1,000 Population",AHRQ:AHRF_NURSE_MIDWIVES_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ADV_NURSES,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Advanced Practice Registered Nurses With Npi,AHRQ:AHRF_TOT_ADV_NURSES,2022-01-01,1,,,,,,,,,
AHRF_ADV_NURSES_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Advanced Practice Registered Nurses With Npi Per 1,000 Population",AHRQ:AHRF_ADV_NURSES_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ARBRNE_ST_G_ISO_ROOMS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Airborne Infection Isolation Rooms In Short-Term General Hospitals,AHRQ:AHRF_TOT_ARBRNE_ST_G_ISO_ROOMS,2022-01-01,1,,,,,,,,,
AHRF_ARBRNE_ST_G_ISO_ROOMS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Airborne Infection Isolation Rooms In Short-Term General Hospitals Per 1,000 Population",AHRQ:AHRF_ARBRNE_ST_G_ISO_ROOMS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ARBRNE_STNGLT_ISO_ROOM,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Airborne Infection Isolation Rooms In Short-Term, Non-General, And Long-Term Hospitals",AHRQ:AHRF_TOT_ARBRNE_STNGLT_ISO_ROOM,2022-01-01,1,,,,,,,,,
AHRF_ARBRNE_STNGLT_ISO_ROOM_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Airborne Infection Isolation Rooms In Short-Term, Non-General, And Long-Term Hospitals Per 1,000 Population",AHRQ:AHRF_ARBRNE_STNGLT_ISO_ROOM_RATE,2022-01-01,1,,,,,,,,,
CHR_INFANT_DEATH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of All Infant Deaths Per 1,000 Live Births (Age 1 Year And Below)",AHRQ:CHR_INFANT_DEATH_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_ALT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Alternative Schools In The County,AHRQ:CRDC_TOT_ALT,2022-01-01,1,,,,,,,,,
POS_TOT_ASC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Ambulatory Surgical Centers,AHRQ:POS_TOT_ASC,2022-01-01,1,,,,,,,,,
POS_ASC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Ambulatory Surgical Centers Per 1,000 Population",AHRQ:POS_ASC_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_AIAN_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of American Indian And Alaska Native Female Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_AIAN_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_AIAN_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of American Indian And Alaska Native Female Students In The County,AHRQ:CRDC_TOT_STUD_AIAN_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_AIAN_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of American Indian And Alaska Native Male Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_AIAN_M,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_AIAN_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of American Indian And Alaska Native Male Students In The County,AHRQ:CRDC_TOT_STUD_AIAN_M,2022-01-01,1,,,,,,,,,
FARA_TOT_AIAN_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of American Indian Or Alaska Native Population (Denominator For Low Access American Indian Or Alaska Native Population Rates),AHRQ:FARA_TOT_AIAN_DENOM,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_ASN_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Asian Female Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_ASN_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_ASN_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Asian Female Students In The County,AHRQ:CRDC_TOT_STUD_ASN_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_ASN_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Asian Male Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_ASN_M,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_ASN_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Asian Male Students In The County,AHRQ:CRDC_TOT_STUD_ASN_M,2022-01-01,1,,,,,,,,,
FARA_TOT_ASIAN_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Asian Population (Denominator For Low Access Asian Population Rates),AHRQ:FARA_TOT_ASIAN_DENOM,2022-01-01,1,,,,,,,,,
AHRF_TOT_HOSP_BEDS_LT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Beds In Long-Term Hospital,AHRQ:AHRF_TOT_HOSP_BEDS_LT,2022-01-01,1,,,,,,,,,
AHRF_HOSP_BEDS_LT_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Beds In Long-Term Hospital Per 1,000 Population",AHRQ:AHRF_HOSP_BEDS_LT_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_BWLSTORES,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Beer, Wine And Liquor Stores",AHRQ:CCBP_TOT_BWLSTORES,2022-01-01,1,,,,,,,,,
CCBP_BWLSTORES_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Beer, Wine And Liquor Stores Per 1,000 People",AHRQ:CCBP_BWLSTORES_RATE,2022-01-01,1,,,,,,,,,
CHR_TEEN_BIRTH_RATE_15_19,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Births Per 1,000 Females (Ages 15-19)",AHRQ:CHR_TEEN_BIRTH_RATE_15_19,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_BLK_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Black Female Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_BLK_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_BLK_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Black Female Students In The County,AHRQ:CRDC_TOT_STUD_BLK_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_BLK_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Black Male Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_BLK_M,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_BLK_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Black Male Students In The County,AHRQ:CRDC_TOT_STUD_BLK_M,2022-01-01,1,,,,,,,,,
FARA_TOT_BLACK_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Black Or African American Population (Denominator For Low Access Black Or African American Population Rates),AHRQ:FARA_TOT_BLACK_DENOM,2022-01-01,1,,,,,,,,,
AHRF_TOT_CARDIOVAS_SPEC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Cardiovascular Disease Specialists,AHRQ:AHRF_TOT_CARDIOVAS_SPEC,2022-01-01,1,,,,,,,,,
AHRF_CARDIOVAS_SPEC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Cardiovascular Disease Specialists Per 1,000 Population",AHRQ:AHRF_CARDIOVAS_SPEC_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_NURSE_ANESTH,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Certified Registered Nurse Anesthetists With Npi,AHRQ:AHRF_TOT_NURSE_ANESTH,2022-01-01,1,,,,,,,,,
AHRF_NURSE_ANESTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Certified Registered Nurse Anesthetists With Npi Per 1,000 Population",AHRQ:AHRF_NURSE_ANESTH_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_CHARTER,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Charter Schools In The County,AHRQ:CRDC_TOT_CHARTER,2022-01-01,1,,,,,,,,,
CCBP_TOT_CHILD,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Child Day Care Services,AHRQ:CCBP_TOT_CHILD,2022-01-01,1,,,,,,,,,
CCBP_CHILD_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Child Day Care Services Per 1,000 People",AHRQ:CCBP_CHILD_RATE,2022-01-01,1,,,,,,,,,
ACS_TOT_CIVIL_VET_POP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Civilian Veterans (Ages 18 And Over),AHRQ:ACS_TOT_CIVIL_VET_POP,2022-01-01,1,,,,,,,,,
AHRF_TOT_CLIN_NURSE_SPEC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Clinical Nurse Specialists With Npi,AHRQ:AHRF_TOT_CLIN_NURSE_SPEC,2022-01-01,1,,,,,,,,,
AHRF_CLIN_NURSE_SPEC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Clinical Nurse Specialists With Npi Per 1,000 Population",AHRQ:AHRF_CLIN_NURSE_SPEC_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_COLON_SRG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Colorectal Surgeons,AHRQ:AHRF_TOT_COLON_SRG,2022-01-01,1,,,,,,,,,
AHRF_COLON_SRG_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Colorectal Surgeons Per 1,000 Population",AHRQ:AHRF_COLON_SRG_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_CFS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Community Food Services,AHRQ:CCBP_TOT_CFS,2022-01-01,1,,,,,,,,,
CCBP_CFS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Community Food Services Per 1,000 People",AHRQ:CCBP_CFS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_COM_HEALTH_GRANT,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Community Health Centers, Grantees Only",AHRQ:AHRF_TOT_COM_HEALTH_GRANT,2022-01-01,1,,,,,,,,,
AHRF_COM_HEALTH_GRANT_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Community Health Centers, Grantees Only, Per 1,000 Population",AHRQ:AHRF_COM_HEALTH_GRANT_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_CHS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Community Housing Services,AHRQ:CCBP_TOT_CHS,2022-01-01,1,,,,,,,,,
CCBP_CHS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Community Housing Services Per 1,000 People",AHRQ:CCBP_CHS_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_CMHC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Community Mental Health Centers,AHRQ:POS_TOT_CMHC,2022-01-01,1,,,,,,,,,
POS_CMHC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Community Mental Health Centers Per 1,000 Population",AHRQ:POS_CMHC_RATE,2022-01-01,1,,,,,,,,,
CDCAP_CHLAMYDIA_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Confirmed Chlamydia Diagnoses Per 100,000 Population",AHRQ:CDCAP_CHLAMYDIA_RATE,2022-01-01,1,,,,,,,,,
CDCAP_GONORRHEA_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Confirmed Gonorrhea Diagnoses Per 100,000 Population",AHRQ:CDCAP_GONORRHEA_RATE,2022-01-01,1,,,,,,,,,
CDCAP_SYPHILIS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Confirmed Primary And Secondary Syphilis Diagnoses Per 100,000 Population",AHRQ:CDCAP_SYPHILIS_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_RET,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Continuing Care Retirement Communities And Assisted Living Facilities For The Elderly,AHRQ:CCBP_TOT_RET,2022-01-01,1,,,,,,,,,
CCBP_RET_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Continuing Care Retirement Communities And Assisted Living Facilities For The Elderly Per 1,000 People",AHRQ:CCBP_RET_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_CS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Convenience Stores,AHRQ:CCBP_TOT_CS,2022-01-01,1,,,,,,,,,
CCBP_CS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Convenience Stores Per 1,000 People",AHRQ:CCBP_CS_RATE,2022-01-01,1,,,,,,,,,
AHRF_DAYS_AIR_QLT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Days Air Quality Is Measured,AHRQ:AHRF_DAYS_AIR_QLT,2022-01-01,1,,,,,,,,,
NEPHTN_HEATIND_100,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Days With Daily Maximum Heat Index, Absolute Threshold: 100?F",AHRQ:NEPHTN_HEATIND_100,2022-01-01,1,,,,,,,,,
NEPHTN_HEATIND_105,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Days With Daily Maximum Heat Index, Absolute Threshold: 105?F",AHRQ:NEPHTN_HEATIND_105,2022-01-01,1,,,,,,,,,
NEPHTN_HEATIND_90,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Days With Daily Maximum Heat Index, Absolute Threshold: 90?F",AHRQ:NEPHTN_HEATIND_90,2022-01-01,1,,,,,,,,,
NEPHTN_HEATIND_95,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Days With Daily Maximum Heat Index, Absolute Threshold: 95?F",AHRQ:NEPHTN_HEATIND_95,2022-01-01,1,,,,,,,,,
NEPHTN_TEMPERATURE_100,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Days With Daily Maximum Temperature, Absolute Threshold: 100?F",AHRQ:NEPHTN_TEMPERATURE_100,2022-01-01,1,,,,,,,,,
NEPHTN_TEMPERATURE_105,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Days With Daily Maximum Temperature, Absolute Threshold: 105?F",AHRQ:NEPHTN_TEMPERATURE_105,2022-01-01,1,,,,,,,,,
NEPHTN_TEMPERATURE_90,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Days With Daily Maximum Temperature, Absolute Threshold: 90?F",AHRQ:NEPHTN_TEMPERATURE_90,2022-01-01,1,,,,,,,,,
NEPHTN_TEMPERATURE_95,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Days With Daily Maximum Temperature, Absolute Threshold: 95?F",AHRQ:NEPHTN_TEMPERATURE_95,2022-01-01,1,,,,,,,,,
CHR_CHILD_DEATH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Deaths Among Children Per 100,000 Population (Ages 17 And Below)",AHRQ:CHR_CHILD_DEATH_RATE,2022-01-01,1,,,,,,,,,
NOAAS_TOT_DEATHS_DIRECT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Deaths Directly Caused By Storm Events During The Year,AHRQ:NOAAS_TOT_DEATHS_DIRECT,2022-01-01,1,,,,,,,,,
CHR_FIREARM_DEATH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Deaths Due To Firearms Per 100,000 Population",AHRQ:CHR_FIREARM_DEATH_RATE,2022-01-01,1,,,,,,,,,
CDCW_ASSAULT_DTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Deaths From Assault Per 100,000 Population",AHRQ:CDCW_ASSAULT_DTH_RATE,2022-01-01,1,,,,,,,,,
CDCW_INJURY_DTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Deaths From Injury Per 100,000 Population",AHRQ:CDCW_INJURY_DTH_RATE,2022-01-01,1,,,,,,,,,
CDCW_SELFHARM_DTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Deaths From Intentional Self Harm Per 100,000 Population",AHRQ:CDCW_SELFHARM_DTH_RATE,2022-01-01,1,,,,,,,,,
CDCW_TRANSPORT_DTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Deaths From Transport Accidents Per 100,000 Population",AHRQ:CDCW_TRANSPORT_DTH_RATE,2022-01-01,1,,,,,,,,,
NOAAS_TOT_DEATHS_INDIRECT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Deaths Indirectly Caused By Storm Events During The Year,AHRQ:NOAAS_TOT_DEATHS_INDIRECT,2022-01-01,1,,,,,,,,,
AHRF_TOT_DENTISTS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Dentists With Npi,AHRQ:AHRF_TOT_DENTISTS,2022-01-01,1,,,,,,,,,
AHRF_DENTISTS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Dentists With Npi Per 1,000 Population",AHRQ:AHRF_DENTISTS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_DERMATOLOGY,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Dermatology Specialists,AHRQ:AHRF_TOT_DERMATOLOGY,2022-01-01,1,,,,,,,,,
AHRF_DERMATOLOGY_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Dermatology Specialists Per 1,000 Population",AHRQ:AHRF_DERMATOLOGY_RATE,2022-01-01,1,,,,,,,,,
AHRF_TXC_SITE_NO_CNTRL,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Designated Toxic Sites Not Under Control,AHRQ:AHRF_TXC_SITE_NO_CNTRL,2022-01-01,1,,,,,,,,,
AHRF_TXC_SITE_CNTRL,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Designated Toxic Sites Under Control,AHRQ:AHRF_TXC_SITE_CNTRL,2022-01-01,1,,,,,,,,,
AHRF_TXC_SITE_NO_DATA,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Designated Toxic Sites With Insufficient Data,AHRQ:AHRF_TXC_SITE_NO_DATA,2022-01-01,1,,,,,,,,,
NOAAS_TOT_DROUGHT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Drought,AHRQ:NOAAS_TOT_DROUGHT,2022-01-01,1,,,,,,,,,
CDCW_OPIOID_DTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Drug Overdose Deaths Involving Any Opioid Per 100,000 Population",AHRQ:CDCW_OPIOID_DTH_RATE,2022-01-01,1,,,,,,,,,
CDCW_DRUG_DTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Drug Poisoning Deaths Per 100,000 Population",AHRQ:CDCW_DRUG_DTH_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_EORS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Emergency And Other Relief Services,AHRQ:CCBP_TOT_EORS,2022-01-01,1,,,,,,,,,
CCBP_EORS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Emergency And Other Relief Services Per 1,000 People",AHRQ:CCBP_EORS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ER_VST_ST_G_HOSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Emergency Department Visits In Short-Term General Hospitals,AHRQ:AHRF_TOT_ER_VST_ST_G_HOSP,2022-01-01,1,,,,,,,,,
AMFAR_TOT_MHFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Facilities That Provide Mental Health Services,AHRQ:AMFAR_TOT_MHFAC,2022-01-01,1,,,,,,,,,
AMFAR_TOT_MEDMHFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Facilities That Provide Mental Health Services And Accept Medicaid,AHRQ:AMFAR_TOT_MEDMHFAC,2022-01-01,1,,,,,,,,,
AMFAR_MEDMHFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Facilities That Provide Mental Health Services And Accept Medicaid Per 1,000 Population",AHRQ:AMFAR_MEDMHFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_MHFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Facilities That Provide Mental Health Services Per 1,000 Population",AHRQ:AMFAR_MHFAC_RATE,2022-01-01,1,,,,,,,,,
FEA_TOT_FARMERS_MARKET,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Farmers' Markets,AHRQ:FEA_TOT_FARMERS_MARKET,2022-01-01,1,,,,,,,,,
POS_TOT_FQHC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Federally Qualified Health Centers (Fqhcs),AHRQ:POS_TOT_FQHC,2022-01-01,1,,,,,,,,,
POS_FQHC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Federally Qualified Health Centers (Fqhcs) Per 1,000 Population",AHRQ:POS_FQHC_RATE,2022-01-01,1,,,,,,,,,
AHRF_MEDICAID_FEMALE_ELIG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Female Medicaid Eligible Beneficiaries,AHRQ:AHRF_MEDICAID_FEMALE_ELIG,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_F_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Females Living With Diagnosed Hiv At The End Of The Year Per 100,000 (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_F_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CCBP_TOT_FCRSC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Fitness Centers And Recreational Sports Centers,AHRQ:CCBP_TOT_FCRSC,2022-01-01,1,,,,,,,,,
CCBP_FCRSC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Fitness Centers And Recreational Sports Centers Per 1,000 People",AHRQ:CCBP_FCRSC_RATE,2022-01-01,1,,,,,,,,,
NOAAS_TOT_FLOOD,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Floods,AHRQ:NOAAS_TOT_FLOOD,2022-01-01,1,,,,,,,,,
FEA_TOT_FOODBANK,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Food Banks (From Feeding America'S Nationwide Network Of Food Banks),AHRQ:FEA_TOT_FOODBANK,2022-01-01,1,,,,,,,,,
CCBP_TOT_FSR,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Full Service Restaurants,AHRQ:CCBP_TOT_FSR,2022-01-01,1,,,,,,,,,
CCBP_FSR_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Full Service Restaurants Per 1,000 People",AHRQ:CCBP_FSR_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_FTENURSE,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Full Time Equivalent Nurses In The County,AHRQ:CRDC_TOT_FTENURSE,2022-01-01,1,,,,,,,,,
CRDC_TOT_FTEPSY,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Full Time Equivalent Psychologists In The County,AHRQ:CRDC_TOT_FTEPSY,2022-01-01,1,,,,,,,,,
CRDC_TOT_FTECOUNSELORS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Full Time Equivalent School Counselors In The County,AHRQ:CRDC_TOT_FTECOUNSELORS,2022-01-01,1,,,,,,,,,
CRDC_TOT_FTESOC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Full Time Equivalent Social Workers In The County,AHRQ:CRDC_TOT_FTESOC,2022-01-01,1,,,,,,,,,
CRDC_TOT_FTETEACH_CERT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Full Time Equivalent Teachers Who Are Certified In The County,AHRQ:CRDC_TOT_FTETEACH_CERT,2022-01-01,1,,,,,,,,,
CRDC_TOT_FTETEACH_NOTCERT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Full Time Equivalent Teachers Who Are Not Certified In The County,AHRQ:CRDC_TOT_FTETEACH_NOTCERT,2022-01-01,1,,,,,,,,,
CRDC_TOT_FTETEACH_ABSENT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Full Time Equivalent Teachers Who Were Absent More Than 10 School Days During The Year,AHRQ:CRDC_TOT_FTETEACH_ABSENT,2022-01-01,1,,,,,,,,,
CCBP_TOT_GAMBLING,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Gambling Establishments,AHRQ:CCBP_TOT_GAMBLING,2022-01-01,1,,,,,,,,,
CCBP_GAMBLING_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Gambling Establishments Per 1,000 People",AHRQ:CCBP_GAMBLING_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_GASTROENTEROLOGY,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Gastroenterology Specialists,AHRQ:AHRF_TOT_GASTROENTEROLOGY,2022-01-01,1,,,,,,,,,
AHRF_GASTROENTEROLOGY_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Gastroenterology Specialists Per 1,000 Population",AHRQ:AHRF_GASTROENTEROLOGY_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_GENRL_SURG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of General Surgeons,AHRQ:AHRF_TOT_GENRL_SURG,2022-01-01,1,,,,,,,,,
AHRF_GENRL_SURG_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of General Surgeons Per 1,000 Population",AHRQ:AHRF_GENRL_SURG_RATE,2022-01-01,1,,,,,,,,,
NOAAS_TOT_HAIL,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hail Events,AHRQ:NOAAS_TOT_HAIL,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Health Insurance Marketplace Enrollees,AHRQ:AHRF_MARKET_ENROL,2022-01-01,1,,,,,,,,,
NOAAS_TOT_HEAT_EVENTS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Heat Events,AHRQ:NOAAS_TOT_HEAT_EVENTS,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_HIS_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hispanic Female Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_HIS_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_HIS_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hispanic Female Students In The County,AHRQ:CRDC_TOT_STUD_HIS_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_HIS_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hispanic Male Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_HIS_M,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_HIS_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hispanic Male Students In The County,AHRQ:CRDC_TOT_STUD_HIS_M,2022-01-01,1,,,,,,,,,
FARA_TOT_HISP_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hispanic Or Latino Population (Denominator For Low Access Hispanic Or Latino Population Rates),AHRQ:FARA_TOT_HISP_DENOM,2022-01-01,1,,,,,,,,,
POS_TOT_HHA,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Home Health Agencies,AHRQ:POS_TOT_HHA,2022-01-01,1,,,,,,,,,
POS_HHA_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Home Health Agencies Per 1,000 Population",AHRQ:POS_HHA_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_HOME,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Home Health Care Services,AHRQ:CCBP_TOT_HOME,2022-01-01,1,,,,,,,,,
CCBP_HOME_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Home Health Care Services Per 1,000 People",AHRQ:CCBP_HOME_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSPICE,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospices,AHRQ:POS_TOT_HOSPICE,2022-01-01,1,,,,,,,,,
POS_HOSPICE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospices Per 1,000 Population",AHRQ:POS_HOSPICE_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_HOSP_ADMISSIONS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospital Admissions,AHRQ:AHRF_TOT_HOSP_ADMISSIONS,2022-01-01,1,,,,,,,,,
AHRF_TOT_HOSP_BED,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospital Beds,AHRQ:AHRF_TOT_HOSP_BED,2022-01-01,1,,,,,,,,,
AHRF_HOSP_BED_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospital Beds Per 1,000 Population",AHRQ:AHRF_HOSP_BED_RATE,2022-01-01,1,,,,,,,,,
AHRF_IP_DAY_NH_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospital Inpatient Days Including Nursing Homes Per 1,000 Population",AHRQ:AHRF_IP_DAY_NH_HOSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_HOSPS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals,AHRQ:AHRF_TOT_HOSPS,2022-01-01,1,,,,,,,,,
AHRF_HOSPS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals Per 1,000 Population",AHRQ:AHRF_HOSPS_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_ALC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Alcohol And/Or Drug Abuse Inpatient Care,AHRQ:POS_TOT_HOSP_ALC,2022-01-01,1,,,,,,,,,
POS_HOSP_ALC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Alcohol And/Or Drug Abuse Inpatient Care Per 1,000 Population",AHRQ:POS_HOSP_ALC_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_AMBULANCE,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Ambulance Services,AHRQ:POS_TOT_HOSP_AMBULANCE,2022-01-01,1,,,,,,,,,
POS_HOSP_AMBULANCE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Ambulance Services Per 1,000 Population",AHRQ:POS_HOSP_AMBULANCE_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_BURN,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Burn Care,AHRQ:POS_TOT_HOSP_BURN,2022-01-01,1,,,,,,,,,
POS_HOSP_BURN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Burn Care Per 1,000 Population",AHRQ:POS_HOSP_BURN_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_CHEMO,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Chemotherapy,AHRQ:POS_TOT_HOSP_CHEMO,2022-01-01,1,,,,,,,,,
POS_HOSP_CHEMO_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Chemotherapy Per 1,000 Population",AHRQ:POS_HOSP_CHEMO_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_ED,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Emergency Department,AHRQ:POS_TOT_HOSP_ED,2022-01-01,1,,,,,,,,,
POS_HOSP_ED_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Emergency Department Per 1,000 Population",AHRQ:POS_HOSP_ED_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_MEDSURG_ICU,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Medical-Surgical ICU,AHRQ:POS_TOT_HOSP_MEDSURG_ICU,2022-01-01,1,,,,,,,,,
POS_HOSP_MEDSURG_ICU_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Medical-Surgical ICU Per 1,000 Population",AHRQ:POS_HOSP_MEDSURG_ICU_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_HOSP_MOBILE,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Mobile Health Services,AHRQ:AHRF_TOT_HOSP_MOBILE,2022-01-01,1,,,,,,,,,
AHRF_HOSP_MOBILE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Mobile Health Services Per 1,000 Population",AHRQ:AHRF_HOSP_MOBILE_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_OBSTETRIC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Obstetric Care,AHRQ:POS_TOT_HOSP_OBSTETRIC,2022-01-01,1,,,,,,,,,
POS_HOSP_OBSTETRIC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Obstetric Care Per 1,000 Population",AHRQ:POS_HOSP_OBSTETRIC_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_PED_ICU,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Pediatric ICU,AHRQ:POS_TOT_HOSP_PED_ICU,2022-01-01,1,,,,,,,,,
POS_HOSP_PED_ICU_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Pediatric ICU Per 1,000 Population",AHRQ:POS_HOSP_PED_ICU_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_PSYCH,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Psychiatric Care,AHRQ:POS_TOT_HOSP_PSYCH,2022-01-01,1,,,,,,,,,
POS_HOSP_PSYCH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Psychiatric Care Per 1,000 Population",AHRQ:POS_HOSP_PSYCH_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_HOSP_REHAB,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Rehabilitative Care,AHRQ:POS_TOT_HOSP_REHAB,2022-01-01,1,,,,,,,,,
POS_HOSP_REHAB_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Rehabilitative Care Per 1,000 Population",AHRQ:POS_HOSP_REHAB_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_HOSP_TELE_ICU,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Telehealth Eicu,AHRQ:AHRF_TOT_HOSP_TELE_ICU,2022-01-01,1,,,,,,,,,
AHRF_HOSP_TELE_ICU_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Telehealth Eicu Per 1,000 Population",AHRQ:AHRF_HOSP_TELE_ICU_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_HOSP_TELE_STROKE,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hospitals With Telehealth Stroke Care,AHRQ:AHRF_TOT_HOSP_TELE_STROKE,2022-01-01,1,,,,,,,,,
AHRF_HOSP_TELE_STROKE_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Hospitals With Telehealth Stroke Care Per 1,000 Population",AHRQ:AHRF_HOSP_TELE_STROKE_RATE,2022-01-01,1,,,,,,,,,
ACS_TOT_HH,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Households,AHRQ:ACS_TOT_HH,2022-01-01,1,,,,,,,,,
NOAAS_TOT_HURRICANE_STORM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Hurricanes And Tropical Storms,AHRQ:NOAAS_TOT_HURRICANE_STORM,2022-01-01,1,,,,,,,,,
CRDC_TOT_FIREARM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Incidents Of Possession Of A Firearm Or Explosive Device,AHRQ:CRDC_TOT_FIREARM,2022-01-01,1,,,,,,,,,
CRDC_TOT_RAPE_ASSAULT,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Incidents Of Rape, Attempted Rape, Or Sexual Assault",AHRQ:CRDC_TOT_RAPE_ASSAULT,2022-01-01,1,,,,,,,,,
IHS_HEALTH_FACILITY,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Indian Health Service Health Care Facilities,AHRQ:IHS_HEALTH_FACILITY,2022-01-01,1,,,,,,,,,
IHS_HEALTH_FACILITY_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Indian Health Service Health Care Facilities Per 1,000 Population",AHRQ:IHS_HEALTH_FACILITY_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_IDEA,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Individuals With Disabilities Education Act (Idea) Students In The County,AHRQ:CRDC_TOT_STUD_IDEA,2022-01-01,1,,,,,,,,,
NOAAS_TOT_INJURIES_DIRECT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Injuries Directly Caused By Storm Events During The Year,AHRQ:NOAAS_TOT_INJURIES_DIRECT,2022-01-01,1,,,,,,,,,
NOAAS_TOT_INJURIES_INDIRECT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Injuries Indirectly Caused By Storm Events During The Year,AHRQ:NOAAS_TOT_INJURIES_INDIRECT,2022-01-01,1,,,,,,,,,
AHRF_IP_DAY_ST_G_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Inpatient Days In Short-Term General Hospitals Per 1,000 Population",AHRQ:AHRF_IP_DAY_ST_G_HOSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_IP_DAY_STNG_LT_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Inpatient Days In Short-Term, Non-General, And Long-Term Hospitals Per 1,000 Population",AHRQ:AHRF_IP_DAY_STNG_LT_RATE,2022-01-01,1,,,,,,,,,
AHRF_SURG_OPRN_IP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Inpatient Surgical Operations In Short-Term General Hospitals Per 1,000 Population",AHRQ:AHRF_SURG_OPRN_IP_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_FF,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Limited Service Restaurants (Fast Food Establishments),AHRQ:CCBP_TOT_FF,2022-01-01,1,,,,,,,,,
CCBP_FF_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Limited Service Restaurants (Fast Food Establishments) Per 1,000 People",AHRQ:CCBP_FF_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_LEA,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Local Education Authorities In A County,AHRQ:CRDC_TOT_LEA,2022-01-01,1,,,,,,,,,
AHRF_TOT_LT_HOSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Long-Term Hospitals,AHRQ:AHRF_TOT_LT_HOSP,2022-01-01,1,,,,,,,,,
AHRF_LT_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Long-Term Hospitals Per 1,000 Population",AHRQ:AHRF_LT_HOSP_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_MAGNET,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Magnet Schools Or Schools Operating A Magnet Program In The County,AHRQ:CRDC_TOT_MAGNET,2022-01-01,1,,,,,,,,,
AHRF_MEDICAID_MALE_ELIG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Male Medicaid Eligible Beneficiaries,AHRQ:AHRF_MEDICAID_MALE_ELIG,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_M_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Males Living With Diagnosed Hiv At The End Of The Year Per 100,000 (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_M_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_ACTIVE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, Active Reenrollees",AHRQ:AHRF_MARKET_ENROL_ACTIVE,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_AUTO,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, Automatic Reenrollees",AHRQ:AHRF_MARKET_ENROL_AUTO,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_150,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, Household Income 100% To 150% Of Fpl",AHRQ:AHRF_MARKET_ENROL_150,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_200,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, Household Income >150% To 200% Of Fpl",AHRQ:AHRF_MARKET_ENROL_200,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_250,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, Household Income >200% To 250% Of Fpl",AHRQ:AHRF_MARKET_ENROL_250,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_300,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, Household Income >250% To 300% Of Fpl",AHRQ:AHRF_MARKET_ENROL_300,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_400,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, Household Income >300% To 400% Of Fpl",AHRQ:AHRF_MARKET_ENROL_400,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_NEW,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, New Consumers",AHRQ:AHRF_MARKET_ENROL_NEW,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_NO_ASST,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, No Financial Assistance Requested",AHRQ:AHRF_MARKET_ENROL_NO_ASST,2022-01-01,1,,,,,,,,,
AHRF_MARKET_ENROL_OTHER,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Marketplace Enrollees, Other Federal Poverty Level",AHRQ:AHRF_MARKET_ENROL_OTHER,2022-01-01,1,,,,,,,,,
CDCW_MATERNAL_DTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Maternal Deaths Per 100,000 Population",AHRQ:CDCW_MATERNAL_DTH_RATE,2022-01-01,1,,,,,,,,,
AHRF_MEDICAID_ELIG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medicaid Eligible Beneficiaries,AHRQ:AHRF_MEDICAID_ELIG,2022-01-01,1,,,,,,,,,
CCBP_TOT_LAB,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medical And Diagnostic Laboratories,AHRQ:CCBP_TOT_LAB,2022-01-01,1,,,,,,,,,
CCBP_LAB_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Medical And Diagnostic Laboratories Per 1,000 People",AHRQ:CCBP_LAB_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_MED_SPEC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medical Specialists,AHRQ:AHRF_TOT_MED_SPEC,2022-01-01,1,,,,,,,,,
AHRF_MED_SPEC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Medical Specialists Per 1,000 Population",AHRQ:AHRF_MED_SPEC_RATE,2022-01-01,1,,,,,,,,,
MP_MEDICARE_ADVTG_ENROLLED,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medicare Advantage Enrollees In The County,AHRQ:MP_MEDICARE_ADVTG_ENROLLED,2022-01-01,1,,,,,,,,,
MGV_TOT_BEN_PART_A_B,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medicare Beneficiaries With Part A And Part B,AHRQ:MGV_TOT_BEN_PART_A_B,2022-01-01,1,,,,,,,,,
AHRF_TOT_MCR_BN_READM,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Medicare Beneficiary Acute Hospital Readmissions, Fee For Service",AHRQ:AHRF_TOT_MCR_BN_READM,2022-01-01,1,,,,,,,,,
AHRF_MCR_BN_READM_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Medicare Beneficiary Hospital Readmission Rate, Fee For Service",AHRQ:AHRF_MCR_BN_READM_RATE,2022-01-01,1,,,,,,,,,
MP_MEDICARE_ELIGIBLES,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medicare Eligibles In The County,AHRQ:MP_MEDICARE_ELIGIBLES,2022-01-01,1,,,,,,,,,
MGV_TOT_BEN_FFS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medicare Ffs Beneficiaries,AHRQ:MGV_TOT_BEN_FFS,2022-01-01,1,,,,,,,,,
AHRF_PRESC_ENROLLMENT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medicare Prescription Drug Plan Enrollees,AHRQ:AHRF_PRESC_ENROLLMENT,2022-01-01,1,,,,,,,,,
AHRF_DUAL_ELIG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Medicare/Medicaid Dual Eligible Beneficiaries,AHRQ:AHRF_DUAL_ELIG,2022-01-01,1,,,,,,,,,
CHR_TOT_MENTAL_PROV,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Mental Health Care Providers,AHRQ:CHR_TOT_MENTAL_PROV,2022-01-01,1,,,,,,,,,
CHR_MENTAL_PROV_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Mental Health Care Providers Per 100,000 Population",AHRQ:CHR_MENTAL_PROV_RATE,2022-01-01,1,,,,,,,,,
FARA_TOT_MR_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Multiracial Population (Denominator For Low Access Multiracial Population Rates),AHRQ:FARA_TOT_MR_DENOM,2022-01-01,1,,,,,,,,,
AHRF_TOT_NHSC_FTE_PROV,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of National Health Service Corps Full Time Equivalent Providers,AHRQ:AHRF_TOT_NHSC_FTE_PROV,2022-01-01,1,,,,,,,,,
AHRF_NHSC_FTE_PROV_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of National Health Service Corps Full Time Equivalent Providers Per 1,000 Population",AHRQ:AHRF_NHSC_FTE_PROV_RATE,2022-01-01,1,,,,,,,,,
FARA_TOT_NHPI_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Native Hawaiian And Other Pacific Islander Population (Denominator For Low Access Native Hawaiian And Other Pacific Islander Population Rates),AHRQ:FARA_TOT_NHPI_DENOM,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_NHPI_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Native Hawaiian And Pacific Islander Female Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_NHPI_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_NHPI_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Native Hawaiian And Pacific Islander Female Students In The County,AHRQ:CRDC_TOT_STUD_NHPI_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_NHPI_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Native Hawaiian And Pacific Islander Male Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_NHPI_M,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_NHPI_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Native Hawaiian And Pacific Islander Male Students In The County,AHRQ:CRDC_TOT_STUD_NHPI_M,2022-01-01,1,,,,,,,,,
AHRF_TOT_NEUROLOGICAL_SURG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Neurological Surgeons,AHRQ:AHRF_TOT_NEUROLOGICAL_SURG,2022-01-01,1,,,,,,,,,
AHRF_NEUROLOGICAL_SURG_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Neurological Surgeons Per 1,000 Population",AHRQ:AHRF_NEUROLOGICAL_SURG_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ALLERGY_IMM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Allergy And Immunology Specialists,AHRQ:AHRF_TOT_ALLERGY_IMM,2022-01-01,1,,,,,,,,,
AHRF_ALLERGY_IMM_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Allergy And Immunology Specialists Per 1,000 Population",AHRQ:AHRF_ALLERGY_IMM_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ANESTH,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Anesthesiologists,AHRQ:AHRF_TOT_ANESTH,2022-01-01,1,,,,,,,,,
AHRF_ANESTH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Anesthesiologists Per 1,000 Population",AHRQ:AHRF_ANESTH_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_CHLD_PSYCH,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Child Psychiatrists,AHRQ:AHRF_TOT_CHLD_PSYCH,2022-01-01,1,,,,,,,,,
AHRF_CHLD_PSYCH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Child Psychiatrists Per 1,000 Population",AHRQ:AHRF_CHLD_PSYCH_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ER_MED,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Emergency Medicine Physicians,AHRQ:AHRF_TOT_ER_MED,2022-01-01,1,,,,,,,,,
AHRF_ER_MED_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Emergency Medicine Physicians Per 1,000 Population",AHRQ:AHRF_ER_MED_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_GEN_INTERNAL_MED,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal General Internal Medicine Physicians,AHRQ:AHRF_TOT_GEN_INTERNAL_MED,2022-01-01,1,,,,,,,,,
AHRF_GEN_INTERNAL_MED_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal General Internal Medicine Physicians Per 1,000 Population",AHRQ:AHRF_GEN_INTERNAL_MED_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_GEN_PREV,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal General Preventive Medicine Specialists,AHRQ:AHRF_TOT_GEN_PREV,2022-01-01,1,,,,,,,,,
AHRF_GEN_PREV_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal General Preventive Medicine Specialists Per 1,000 Population",AHRQ:AHRF_GEN_PREV_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_MDS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal MDS,AHRQ:AHRF_TOT_MDS,2022-01-01,1,,,,,,,,,
AHRF_MDS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal MDS Per 1,000 Population",AHRQ:AHRF_MDS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_OB_GYN,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Obstetric Gynecologists,AHRQ:AHRF_TOT_OB_GYN,2022-01-01,1,,,,,,,,,
AHRF_OB_GYN_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Obstetric Gynecologists Per 1,000 Population",AHRQ:AHRF_OB_GYN_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ORTH_SURG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Orthopedic Surgeons,AHRQ:AHRF_TOT_ORTH_SURG,2022-01-01,1,,,,,,,,,
AHRF_ORTH_SURG_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Orthopedic Surgeons Per 1,000 Population",AHRQ:AHRF_ORTH_SURG_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_PEDIATRICS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Pediatric And General Physicians,AHRQ:AHRF_TOT_PEDIATRICS,2022-01-01,1,,,,,,,,,
AHRF_PEDIATRICS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Pediatric And General Physicians Per 1,000 Population",AHRQ:AHRF_PEDIATRICS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_PHYS_PRIMARY,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Primary Care Physicians,AHRQ:AHRF_TOT_PHYS_PRIMARY,2022-01-01,1,,,,,,,,,
AHRF_PHYS_PRIMARY_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Primary Care Physicians Per 1,000 Population",AHRQ:AHRF_PHYS_PRIMARY_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_PSYCH,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Psychiatrists,AHRQ:AHRF_TOT_PSYCH,2022-01-01,1,,,,,,,,,
AHRF_PSYCH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Psychiatrists Per 1,000 Population",AHRQ:AHRF_PSYCH_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_RADI,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Radiologists,AHRQ:AHRF_TOT_RADI,2022-01-01,1,,,,,,,,,
AHRF_RADI_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Radiologists Per 1,000 Population",AHRQ:AHRF_RADI_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_UROL,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Non-Federal Urologists,AHRQ:AHRF_TOT_UROL,2022-01-01,1,,,,,,,,,
AHRF_UROL_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Non-Federal Urologists Per 1,000 Population",AHRQ:AHRF_UROL_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_NURSE_PRACT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Nurse Practitioners With Npi,AHRQ:AHRF_TOT_NURSE_PRACT,2022-01-01,1,,,,,,,,,
AHRF_NURSE_PRACT_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Nurse Practitioners With Npi Per 1,000 Population",AHRQ:AHRF_NURSE_PRACT_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_NF,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Nursing Facilities,AHRQ:POS_TOT_NF,2022-01-01,1,,,,,,,,,
POS_NF_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Nursing Facilities Per 1,000 Population",AHRQ:POS_NF_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_NF_BEDS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Nursing Facility Certified Beds,AHRQ:POS_TOT_NF_BEDS,2022-01-01,1,,,,,,,,,
POS_NF_BEDS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Nursing Facility Certified Beds Per 1,000 Population",AHRQ:POS_NF_BEDS_RATE,2022-01-01,1,,,,,,,,,
LTC_TOT_BEDS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Nursing Home Beds In The County,AHRQ:LTC_TOT_BEDS,2022-01-01,1,,,,,,,,,
LTC_TOT_BEDS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Nursing Home Beds In The County Per 1,000 Population",AHRQ:LTC_TOT_BEDS_RATE,2022-01-01,1,,,,,,,,,
NHC_TOT_FACS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Nursing Home Facilities,AHRQ:NHC_TOT_FACS,2022-01-01,1,,,,,,,,,
NHC_FACS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Nursing Home Facilities Per 100,000 People",AHRQ:NHC_FACS_RATE,2022-01-01,1,,,,,,,,,
LTC_TOT_RESIDENTS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Nursing Home Residents In The County,AHRQ:LTC_TOT_RESIDENTS,2022-01-01,1,,,,,,,,,
LTC_TOT_RESIDENTS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Nursing Home Residents In The County Per 1,000 Population",AHRQ:LTC_TOT_RESIDENTS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_OPRT_ROOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Operating Rooms In Short-Term General Hospitals,AHRQ:AHRF_TOT_OPRT_ROOM,2022-01-01,1,,,,,,,,,
AHRF_OPRT_ROOM_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Operating Rooms In Short-Term General Hospitals Per 1,000 Population",AHRQ:AHRF_OPRT_ROOM_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_OPHTHALMOLOGY,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Ophthalmology Specialists,AHRQ:AHRF_TOT_OPHTHALMOLOGY,2022-01-01,1,,,,,,,,,
AHRF_OPHTHALMOLOGY_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Ophthalmology Specialists Per 1,000 Population",AHRQ:AHRF_OPHTHALMOLOGY_RATE,2022-01-01,1,,,,,,,,,
AMFAR_OPIOIDRX_RATE,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Opioid Prescriptions Per 100 Population,AHRQ:AMFAR_OPIOIDRX_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_OTHER_SPEC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Other Specialists,AHRQ:AHRF_TOT_OTHER_SPEC,2022-01-01,1,,,,,,,,,
AHRF_OTHER_SPEC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Other Specialists Per 1,000 Population",AHRQ:AHRF_OTHER_SPEC_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_OTOLARYNGOLOGY,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Otolaryngology Specialists,AHRQ:AHRF_TOT_OTOLARYNGOLOGY,2022-01-01,1,,,,,,,,,
AHRF_OTOLARYNGOLOGY_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Otolaryngology Specialists Per 1,000 Population",AHRQ:AHRF_OTOLARYNGOLOGY_RATE,2022-01-01,1,,,,,,,,,
AHRF_SURG_OPRN_OP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Outpatient Surgical Operations In Short-Term General Hospitals Per 1,000 Population",AHRQ:AHRF_SURG_OPRN_OP_RATE,2022-01-01,1,,,,,,,,,
AHRF_OP_VST_LT_ER_OP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Outpatient Visits In Long-Term Hospital Emergency Departments Per 1,000 Population",AHRQ:AHRF_OP_VST_LT_ER_OP_RATE,2022-01-01,1,,,,,,,,,
AHRF_OP_VST_ST_G_OTHR_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Outpatient Visits In Other Short-Term General Hospitals Per 1,000 Population",AHRQ:AHRF_OP_VST_ST_G_OTHR_RATE,2022-01-01,1,,,,,,,,,
AHRF_OP_VST_ST_G_ER_OP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Outpatient Visits In Short-Term General Hospital Emergency Department And Other Outpatient Visits Per 1,000 Population",AHRQ:AHRF_OP_VST_ST_G_ER_OP_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_OUTPAT_VST_STNGH,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Outpatient Visits In Short-Term Non-General Hospital Emergency Department And Other Outpatient Visits,AHRQ:AHRF_TOT_OUTPAT_VST_STNGH,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of People Living With Diagnosed Hiv At The End Of The Year Per 100,000 Population (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_AIAN_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of People Living With Diagnosed Hiv At The End Of The Year Per 100,000, American Indian And Alaska Native (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_AIAN_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_ASN_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of People Living With Diagnosed Hiv At The End Of The Year Per 100,000, Asian (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_ASN_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_BLK_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of People Living With Diagnosed Hiv At The End Of The Year Per 100,000, Black Non-Hispanic (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_BLK_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_HIS_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of People Living With Diagnosed Hiv At The End Of The Year Per 100,000, Hispanic (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_HIS_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_MTR_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of People Living With Diagnosed Hiv At The End Of The Year Per 100,000, Multiple Races (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_MTR_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_NHPI_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of People Living With Diagnosed Hiv At The End Of The Year Per 100,000, Native Hawaiian And Other Pacific Islander (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_NHPI_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CDCAP_HIVDIAG_WHT_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of People Living With Diagnosed Hiv At The End Of The Year Per 100,000, White Non-Hispanic (Ages 13 And Over)",AHRQ:CDCAP_HIVDIAG_WHT_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
CDCAP_HIV_RATE_ABOVE13,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Persons With Hiv Diagnosed During The Year Per 100,000 Population (Ages 13 And Over)",AHRQ:CDCAP_HIV_RATE_ABOVE13,2022-01-01,1,,,,,,,,,
AHRF_TOT_PHYSICIAN_ASSIST,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Physician Assistants With Npi,AHRQ:AHRF_TOT_PHYSICIAN_ASSIST,2022-01-01,1,,,,,,,,,
AHRF_PHYSICIAN_ASSIST_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Physician Assistants With Npi Per 1,000 Population",AHRQ:AHRF_PHYSICIAN_ASSIST_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_PHYS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Physician Offices,AHRQ:CCBP_TOT_PHYS,2022-01-01,1,,,,,,,,,
CCBP_PHYS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Physician Offices Per 1,000 People",AHRQ:CCBP_PHYS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_PLASTIC_SURG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Plastic Surgeons,AHRQ:AHRF_TOT_PLASTIC_SURG,2022-01-01,1,,,,,,,,,
AHRF_PLASTIC_SURG_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Plastic Surgeons Per 1,000 Population",AHRQ:AHRF_PLASTIC_SURG_RATE,2022-01-01,1,,,,,,,,,
FARA_TOT_POP_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Population In The Tract From 2010 Census (Denominator For Low Access Population Rates),AHRQ:FARA_TOT_POP_DENOM,2022-01-01,1,,,,,,,,,
CHR_PREMAT_DEATH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Premature Deaths: Age-Adjusted Per 100,000 Population (Ages 74 And Below)",AHRQ:CHR_PREMAT_DEATH_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Preschool-Aged Children Served (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL,2022-01-01,1,,,,,,,,,
CRDC_TOT_SCHOOLS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Public Schools In The County,AHRQ:CRDC_TOT_SCHOOLS,2022-01-01,1,,,,,,,,,
AHRF_TOT_PULMONARY_SPEC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Pulmonary Disease Specialists,AHRQ:AHRF_TOT_PULMONARY_SPEC,2022-01-01,1,,,,,,,,,
AHRF_PULMONARY_SPEC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Pulmonary Disease Specialists Per 1,000 Population",AHRQ:AHRF_PULMONARY_SPEC_RATE,2022-01-01,1,,,,,,,,,
CHR_VIOLENT_CRIME_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Reported Violent Crime Offenses Per 100,000 Population",AHRQ:CHR_VIOLENT_CRIME_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_RHC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Rural Health Clinics (Rhcs),AHRQ:POS_TOT_RHC,2022-01-01,1,,,,,,,,,
POS_RHC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Rural Health Clinics (Rhcs) Per 1,000 Population",AHRQ:POS_RHC_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_RURL_REFRRL_CNT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Rural Referral Centers,AHRQ:AHRF_TOT_RURL_REFRRL_CNT,2022-01-01,1,,,,,,,,,
AHRF_RURL_REFRRL_CNT_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Rural Referral Centers Per 1,000 Population",AHRQ:AHRF_RURL_REFRRL_CNT_RATE,2022-01-01,1,,,,,,,,,
AMFAR_TOT_RWFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Ryan White Hiv Medical Providers,AHRQ:AMFAR_TOT_RWFAC,2022-01-01,1,,,,,,,,,
AMFAR_RWFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Ryan White Hiv Medical Providers Per 1,000 Population",AHRQ:AMFAR_RWFAC_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_SCH_FIREARM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Schools In The County With At Least One Incident That Involved A Shooting,AHRQ:CRDC_TOT_SCH_FIREARM,2022-01-01,1,,,,,,,,,
AHRF_TOT_ST_COMM_HOSP_ADMS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term Community Hospital Admissions,AHRQ:AHRF_TOT_ST_COMM_HOSP_ADMS,2022-01-01,1,,,,,,,,,
AHRF_TOT_ST_COMM_HOSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term Community Hospitals,AHRQ:AHRF_TOT_ST_COMM_HOSP,2022-01-01,1,,,,,,,,,
AHRF_ST_COMM_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term Community Hospitals Per 1,000 Population",AHRQ:AHRF_ST_COMM_HOSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ST_G_HOSP_ADMS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospital Admissions,AHRQ:AHRF_TOT_ST_G_HOSP_ADMS,2022-01-01,1,,,,,,,,,
AHRF_TOT_ST_G_HOSP_BED,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospital Beds,AHRQ:AHRF_TOT_ST_G_HOSP_BED,2022-01-01,1,,,,,,,,,
AHRF_ST_G_HOSP_BED_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospital Beds Per 1,000 Population",AHRQ:AHRF_ST_G_HOSP_BED_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_CARDIAC_IC_BEDS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospital Cardiac Intensive Care Beds,AHRQ:AHRF_TOT_CARDIAC_IC_BEDS,2022-01-01,1,,,,,,,,,
AHRF_CARDIAC_IC_BEDS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospital Cardiac Intensive Care Beds Per 1,000 Population",AHRQ:AHRF_CARDIAC_IC_BEDS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_MEDSURGIC_BEDS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospital Intensive Care Beds,AHRQ:AHRF_TOT_MEDSURGIC_BEDS,2022-01-01,1,,,,,,,,,
AHRF_MEDSURGIC_BEDS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospital Intensive Care Beds Per 1,000 Population",AHRQ:AHRF_MEDSURGIC_BEDS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_NEONATALIC_BEDS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospital Neonatal Intensive Care Beds,AHRQ:AHRF_TOT_NEONATALIC_BEDS,2022-01-01,1,,,,,,,,,
AHRF_NEONATALIC_BEDS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospital Neonatal Intensive Care Beds Per 1,000 Population",AHRQ:AHRF_NEONATALIC_BEDS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ST_G_HOSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospitals,AHRQ:AHRF_TOT_ST_G_HOSP,2022-01-01,1,,,,,,,,,
AHRF_ST_G_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospitals Per 1,000 Population",AHRQ:AHRF_ST_G_HOSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_N_ST_G_EXP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospitals Reporting Expenses,AHRQ:AHRF_TOT_N_ST_G_EXP,2022-01-01,1,,,,,,,,,
AHRF_TOT_N_ST_G_PAYRLL,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospitals Reporting Payroll Expenses,AHRQ:AHRF_TOT_N_ST_G_PAYRLL,2022-01-01,1,,,,,,,,,
AHRF_TOT_ARBRNE_ST_G_ISO_HOSPS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospitals With Airborne Infection Isolation Rooms,AHRQ:AHRF_TOT_ARBRNE_ST_G_ISO_HOSPS,2022-01-01,1,,,,,,,,,
AHRF_ARBRNE_ST_G_ISO_HOSPS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospitals With Airborne Infection Isolation Rooms Per 1,000 Population",AHRQ:AHRF_ARBRNE_ST_G_ISO_HOSPS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_CARDIAC_IC_HOSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospitals With Cardiac Intensive Care,AHRQ:AHRF_TOT_CARDIAC_IC_HOSP,2022-01-01,1,,,,,,,,,
AHRF_CARDIAC_IC_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospitals With Cardiac Intensive Care Per 1,000 Population",AHRQ:AHRF_CARDIAC_IC_HOSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_MEDSURGIC_HOSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospitals With Medical Surgical Intensive Care,AHRQ:AHRF_TOT_MEDSURGIC_HOSP,2022-01-01,1,,,,,,,,,
AHRF_MEDSURGIC_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospitals With Medical Surgical Intensive Care Per 1,000 Population",AHRQ:AHRF_MEDSURGIC_HOSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_NEONATALIC_HOSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term General Hospitals With Neonatal Intensive Care,AHRQ:AHRF_TOT_NEONATALIC_HOSP,2022-01-01,1,,,,,,,,,
AHRF_NEONATALIC_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term General Hospitals With Neonatal Intensive Care Per 1,000 Population",AHRQ:AHRF_NEONATALIC_HOSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_NH_BED_STNGH,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term Non-General Hospital Nursing Home Beds,AHRQ:AHRF_TOT_NH_BED_STNGH,2022-01-01,1,,,,,,,,,
AHRF_NH_BED_STNGH_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term Non-General Hospital Nursing Home Beds Per 1,000 Population",AHRQ:AHRF_NH_BED_STNGH_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_ST_N_G_HOSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Short-Term Non-General Hospitals,AHRQ:AHRF_TOT_ST_N_G_HOSP,2022-01-01,1,,,,,,,,,
AHRF_ST_N_G_HOSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term Non-General Hospitals Per 1,000 Population",AHRQ:AHRF_ST_N_G_HOSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_STNG_LT_HOSP_ADMS,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Short-Term, Non-General, And Long-Term Hospital Admissions",AHRQ:AHRF_TOT_STNG_LT_HOSP_ADMS,2022-01-01,1,,,,,,,,,
POS_TOT_SNF,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Skilled Nursing Facilities,AHRQ:POS_TOT_SNF,2022-01-01,1,,,,,,,,,
POS_SNF_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Skilled Nursing Facilities Per 1,000 Population",AHRQ:POS_SNF_RATE,2022-01-01,1,,,,,,,,,
POS_TOT_SNF_BEDS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Skilled Nursing Facility Certified Beds,AHRQ:POS_TOT_SNF_BEDS,2022-01-01,1,,,,,,,,,
POS_SNF_BEDS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Skilled Nursing Facility Certified Beds Per 1,000 Population",AHRQ:POS_SNF_BEDS_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_SA,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Social Associations,AHRQ:CCBP_TOT_SA,2022-01-01,1,,,,,,,,,
CCBP_SA_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Social Associations Per 1,000 People",AHRQ:CCBP_SA_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_SPEDS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Special Education Schools In The County,AHRQ:CRDC_TOT_SPEDS,2022-01-01,1,,,,,,,,,
CCBP_TOT_SFS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Specialized Food Stores,AHRQ:CCBP_TOT_SFS,2022-01-01,1,,,,,,,,,
CCBP_SFS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Specialized Food Stores Per 1,000 People",AHRQ:CCBP_SFS_RATE,2022-01-01,1,,,,,,,,,
FEA_TOT_WIC_STORES,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Stores Authorized To Accept Wic Program Benefits,AHRQ:FEA_TOT_WIC_STORES,2022-01-01,1,,,,,,,,,
FEA_WIC_STORES_PER_1000,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Stores Authorized To Accept Wic Program Benefits Per 1,000 Population",AHRQ:FEA_WIC_STORES_PER_1000,2022-01-01,1,,,,,,,,,
NOAAS_TOT_STORMEVENT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Storm Events,AHRQ:NOAAS_TOT_STORMEVENT,2022-01-01,1,,,,,,,,,
CRDC_TOT_DIST_ENROLL,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students Enrolled In Distance Educational Courses,AHRQ:CRDC_TOT_DIST_ENROLL,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUDENTS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students In The County,AHRQ:CRDC_TOT_STUDENTS,2022-01-01,1,,,,,,,,,
CRDC_TOT_TRANSFER_IDEA,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students With Disabilities Transferred To An Alternative School For Disciplinary Reasons,AHRQ:CRDC_TOT_TRANSFER_IDEA,2022-01-01,1,,,,,,,,,
CRDC_TOT_SUSP_IDEA,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students With Disabilities Who Received One Or More In-School Suspensions,AHRQ:CRDC_TOT_SUSP_IDEA,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_LEP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students With Limited English Proficiency In The County,AHRQ:CRDC_TOT_STUD_LEP,2022-01-01,1,,,,,,,,,
CRDC_TOT_SUSP_IDEA_LEP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students With Limited English Proficiency With Disabilities Who Received One Or More In-School Suspensions,AHRQ:CRDC_TOT_SUSP_IDEA_LEP,2022-01-01,1,,,,,,,,,
CRDC_TOT_SUSP_LEP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students With Limited English Proficiency Without Disabilities Who Received One Or More In-School Suspensions,AHRQ:CRDC_TOT_SUSP_LEP,2022-01-01,1,,,,,,,,,
CRDC_TOT_TRANSFER,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students Without Disabilities Transferred To An Alternative School For Disciplinary Reasons,AHRQ:CRDC_TOT_TRANSFER,2022-01-01,1,,,,,,,,,
CRDC_TOT_SUSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Students Without Disabilities Who Received One Or More In-School Suspensions,AHRQ:CRDC_TOT_SUSP,2022-01-01,1,,,,,,,,,
AMFAR_TOT_HIVHCVTFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Facilities Offering Both Hiv Test And Hepatitis C Screening,AHRQ:AMFAR_TOT_HIVHCVTFAC,2022-01-01,1,,,,,,,,,
AMFAR_TOT_MEDHIVHCVTFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Facilities Offering Both Hiv Test And Hepatitis C Screening And Accept Medicaid,AHRQ:AMFAR_TOT_MEDHIVHCVTFAC,2022-01-01,1,,,,,,,,,
AMFAR_MEDHIVHCVTFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Facilities Offering Both Hiv Test And Hepatitis C Screening And Accept Medicaid Per 1,000 Population",AHRQ:AMFAR_MEDHIVHCVTFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_HIVHCVTFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Facilities Offering Both Hiv Test And Hepatitis C Screening Per 1,000 Population",AHRQ:AMFAR_HIVHCVTFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_TOT_HCVTFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Facilities Offering Hepatitis C Screening,AHRQ:AMFAR_TOT_HCVTFAC,2022-01-01,1,,,,,,,,,
AMFAR_TOT_MEDHCVTFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Facilities Offering Hepatitis C Screening And Accept Medicaid,AHRQ:AMFAR_TOT_MEDHCVTFAC,2022-01-01,1,,,,,,,,,
AMFAR_MEDHCVTFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Facilities Offering Hepatitis C Screening And Accept Medicaid Per 1,000 Population",AHRQ:AMFAR_MEDHCVTFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_HCVTFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Facilities Offering Hepatitis C Screening Per 1,000 Population",AHRQ:AMFAR_HCVTFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_TOT_HIVTFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Facilities Offering Hiv Testing,AHRQ:AMFAR_TOT_HIVTFAC,2022-01-01,1,,,,,,,,,
AMFAR_TOT_MEDHIVTFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Facilities Offering Hiv Testing And Accept Medicaid,AHRQ:AMFAR_TOT_MEDHIVTFAC,2022-01-01,1,,,,,,,,,
AMFAR_MEDHIVTFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Facilities Offering Hiv Testing And Accept Medicaid Per 1,000 Population",AHRQ:AMFAR_MEDHIVTFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_HIVTFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Facilities Offering Hiv Testing Per 1,000 Population",AHRQ:AMFAR_HIVTFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_TOT_MEDSAFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Services Facilities Accepting Medicaid,AHRQ:AMFAR_TOT_MEDSAFAC,2022-01-01,1,,,,,,,,,
AMFAR_MEDSAFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Services Facilities Accepting Medicaid Per 1,000 Population",AHRQ:AMFAR_MEDSAFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_TOT_MEDAMATFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Treatment Facilities Offering All Three Medication Assisted Treatment Services That Accept Medicaid,AHRQ:AMFAR_TOT_MEDAMATFAC,2022-01-01,1,,,,,,,,,
AMFAR_MEDAMATFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Treatment Facilities Offering All Three Medication Assisted Treatment Services That Accept Medicaid Per 1,000 Population",AHRQ:AMFAR_MEDAMATFAC_RATE,2022-01-01,1,,,,,,,,,
AMFAR_TOT_AMATFAC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Substance Abuse Treatment Facilities With All Three Medication Assisted Treatment Services,AHRQ:AMFAR_TOT_AMATFAC,2022-01-01,1,,,,,,,,,
AMFAR_AMATFAC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Substance Abuse Treatment Facilities With All Three Medication Assisted Treatment Services Per 1,000 Population",AHRQ:AMFAR_AMATFAC_RATE,2022-01-01,1,,,,,,,,,
CCBP_TOT_SOGS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Supermarkets And Other Grocery (Except Convenience) Stores,AHRQ:CCBP_TOT_SOGS,2022-01-01,1,,,,,,,,,
CCBP_SOGS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Supermarkets And Other Grocery (Except Convenience) Stores Per 1,000 People",AHRQ:CCBP_SOGS_RATE,2022-01-01,1,,,,,,,,,
AHRF_TOT_SURG_SPECS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Surgical Specialists,AHRQ:AHRF_TOT_SURG_SPECS,2022-01-01,1,,,,,,,,,
AHRF_SURG_SPECS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Surgical Specialists Per 1,000 Population",AHRQ:AHRF_SURG_SPECS_RATE,2022-01-01,1,,,,,,,,,
AMFAR_SSP,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Syringe Exchange Programs,AHRQ:AMFAR_SSP,2022-01-01,1,,,,,,,,,
AMFAR_SSP_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Syringe Exchange Programs Per 1,000 Population",AHRQ:AMFAR_SSP_RATE,2022-01-01,1,,,,,,,,,
AHRF_HOSP_TEACHING,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Teaching Hospitals,AHRQ:AHRF_HOSP_TEACHING,2022-01-01,1,,,,,,,,,
CCBP_TOT_SHELTERS,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Temporary Shelters,AHRQ:CCBP_TOT_SHELTERS,2022-01-01,1,,,,,,,,,
CCBP_SHELTERS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Temporary Shelters Per 1,000 People",AHRQ:CCBP_SHELTERS_RATE,2022-01-01,1,,,,,,,,,
F_HVM,0,OMOP SDOH,Observation,EJI HVM Item,Total Number Of Tertile Flags (>0.6666),EJI:F_HVM,2022-01-01,1,,,,,,,,,
FEA_TOT_FDPIR,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of The Food Distribution Program On Indian Reservations (Fdpir) Sites,AHRQ:FEA_TOT_FDPIR,2022-01-01,1,,,,,,,,,
AHRF_TOT_THORACIC_SURG,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Thoracic Surgeons,AHRQ:AHRF_TOT_THORACIC_SURG,2022-01-01,1,,,,,,,,,
AHRF_THORACIC_SURG_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Thoracic Surgeons Per 1,000 Population",AHRQ:AHRF_THORACIC_SURG_RATE,2022-01-01,1,,,,,,,,,
NOAAS_TOT_TORNADO,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Tornadoes,AHRQ:NOAAS_TOT_TORNADO,2022-01-01,1,,,,,,,,,
CDCAP_TUBERCULOSIS_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Tuberculosis Diagnoses Per 100,000 Population",AHRQ:CDCAP_TUBERCULOSIS_RATE,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_MTR_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Two Or More Races Female Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_MTR_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_MTR_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Two Or More Races Female Students In The County,AHRQ:CRDC_TOT_STUD_MTR_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_MTR_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Two Or More Races Male Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_MTR_M,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_MTR_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Two Or More Races Male Students In The County,AHRQ:CRDC_TOT_STUD_MTR_M,2022-01-01,1,,,,,,,,,
HIFLD_UC,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Urgent Care Organizations,AHRQ:HIFLD_UC,2022-01-01,1,,,,,,,,,
HIFLD_UC_RATE,0,OMOP SDOH,Observation,AHRQ Item,"Total Number Of Urgent Care Organizations Per 1,000 Population",AHRQ:HIFLD_UC_RATE,2022-01-01,1,,,,,,,,,
NEPHTN_NUMDROUGHT,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Weeks Of Cumulative Moderate Drought Or Worse Per Year,AHRQ:NEPHTN_NUMDROUGHT,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_WHT_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of White Female Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_WHT_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_WHT_F,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of White Female Students In The County,AHRQ:CRDC_TOT_STUD_WHT_F,2022-01-01,1,,,,,,,,,
CRDC_TOT_PRESCHOOL_WHT_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of White Male Preschool-Aged Children (Ages 2-5),AHRQ:CRDC_TOT_PRESCHOOL_WHT_M,2022-01-01,1,,,,,,,,,
CRDC_TOT_STUD_WHT_M,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of White Male Students In The County,AHRQ:CRDC_TOT_STUD_WHT_M,2022-01-01,1,,,,,,,,,
FARA_TOT_WHITE_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of White Population (Denominator For Low Access White Population Rates),AHRQ:FARA_TOT_WHITE_DENOM,2022-01-01,1,,,,,,,,,
NOAAS_TOT_WILDFIRE,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Wildfires,AHRQ:NOAAS_TOT_WILDFIRE,2022-01-01,1,,,,,,,,,
NOAAS_TOT_WIND,0,OMOP SDOH,Observation,AHRQ Item,Total Number Of Wind Events,AHRQ:NOAAS_TOT_WIND,2022-01-01,1,,,,,,,,,
LTC_OCCUPANCY_RATE,0,OMOP SDOH,Observation,AHRQ Item,Total Nursing Home Occupancy Rate In The County,AHRQ:LTC_OCCUPANCY_RATE,2022-01-01,1,,,,,,,,,
1.a.1,0,OMOP SDOH,Observation,SDG Indicator,Total official development assistance grants from all donors that focus on poverty reduction as a share of the recipient country?s gross national income,,2017-03-01,1,,,,,,,,,
2.a.2,0,OMOP SDOH,Observation,SDG Indicator,Total official flows (official development assistance plus other official flows) to the agriculture sector,,2017-03-01,1,,,,,,,,,
9.a.1,0,OMOP SDOH,Observation,SDG Indicator,Total official international support (official development assistance plus other official flows) to infrastructure,,2017-03-01,1,,,,,,,,,
ACS_TOT_OWN_CHILD_BELOW17,0,OMOP SDOH,Observation,AHRQ Item,Total Own Children (Ages 17 And Below),AHRQ:ACS_TOT_OWN_CHILD_BELOW17,2022-01-01,1,,,,,,,,,
AHRF_TOT_N_ST_G_PAYRLL_1000,0,OMOP SDOH,Observation,AHRQ Item,"Total Payroll Expenses From Short-Term General Hospitals Reporting Payroll Expenses (Dollars In $1,000s)",AHRQ:AHRF_TOT_N_ST_G_PAYRLL_1000,2022-01-01,1,,,,,,,,,
11.4.1,0,OMOP SDOH,Observation,SDG Indicator,"Total per capita expenditure on the preservation, protection and conservation of all cultural and natural heritage, by source of funding (public, private), type of heritage (cultural, natural) and level of government (national, regional, and local/muni...","Total per capita expenditure on the preservation, protection and conservation of all cultural and natural heritage, by source of funding (public, private), type of heritage (cultural, natural) and level of government (national, regional, and local/municipal)",2017-03-01,1,,,,,,,,,
GIS1010348,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Total population,,2024-09-15,1,,,,,,,,,
ACS_TOT_POP_ABOVE15,0,OMOP SDOH,Observation,AHRQ Item,Total Population (Ages 15 And Over),AHRQ:ACS_TOT_POP_ABOVE15,2022-01-01,1,,,,,,,,,
ACS_TOT_POP_ABOVE16,0,OMOP SDOH,Observation,AHRQ Item,Total Population (Ages 16 And Over),AHRQ:ACS_TOT_POP_ABOVE16,2022-01-01,1,,,,,,,,,
ACS_TOT_POP_ABOVE25,0,OMOP SDOH,Observation,AHRQ Item,Total Population (Ages 25 And Over),AHRQ:ACS_TOT_POP_ABOVE25,2022-01-01,1,,,,,,,,,
ACS_TOT_POP_ABOVE5,0,OMOP SDOH,Observation,AHRQ Item,Total Population (Ages 5 And Over),AHRQ:ACS_TOT_POP_ABOVE5,2022-01-01,1,,,,,,,,,
ACS_TOT_POP_16_19,0,OMOP SDOH,Observation,AHRQ Item,Total Population (Between Ages 16 And 19),AHRQ:ACS_TOT_POP_16_19,2022-01-01,1,,,,,,,,,
CDCW_TOT_POPULATION,0,OMOP SDOH,Observation,AHRQ Item,Total Population (CDC Wonder),AHRQ:CDCW_TOT_POPULATION,2022-01-01,1,,,,,,,,,
CRE_TOT_POP_DENOM,0,OMOP SDOH,Observation,AHRQ Item,Total Population Estimated From The Census Bureau'S Population Estimates Program (Pep) (Denominator For Rates Of Individuals With Risk Factors),AHRQ:CRE_TOT_POP_DENOM,2022-01-01,1,,,,,,,,,
ACS_TOT_POP_POV,0,OMOP SDOH,Observation,AHRQ Item,Total Population For Whom Poverty Status Is Determined,AHRQ:ACS_TOT_POP_POV,2022-01-01,1,,,,,,,,,
ACS_TOT_CIVILIAN_LABOR,0,OMOP SDOH,Observation,AHRQ Item,Total Population In The Civilian Labor Force (Ages 16 And Over),AHRQ:ACS_TOT_CIVILIAN_LABOR,2022-01-01,1,,,,,,,,,
ACS_TOT_POP_US_ABOVE1,0,OMOP SDOH,Observation,AHRQ Item,Total Population In The U.S. (Ages 1 And Over),AHRQ:ACS_TOT_POP_US_ABOVE1,2022-01-01,1,,,,,,,,,
10.b.1,0,OMOP SDOH,Observation,SDG Indicator,"Total resource flows for development, by recipient and donor countries and type of flow (e.g. official development assistance, foreign direct investment and other flows)",,2017-03-01,1,,,,,,,,,
CCD_TOT_REVENUE,0,OMOP SDOH,Observation,AHRQ Item,Total Revenue (Dollars) Per Student,AHRQ:CCD_TOT_REVENUE,2022-01-01,1,,,,,,,,,
AHRF_TOT_MDCR_FFS_STD_COST,0,OMOP SDOH,Observation,AHRQ Item,"Total Standardized Medicare Costs, Fee For Service (Dollars)",AHRQ:AHRF_TOT_MDCR_FFS_STD_COST,2022-01-01,1,,,,,,,,,
CCD_TOT_STATE_REVENUE,0,OMOP SDOH,Observation,AHRQ Item,Total State Revenue (Dollars) Per Student,AHRQ:CCD_TOT_STATE_REVENUE,2022-01-01,1,,,,,,,,,
CDCA_STROKE_DTH_RATE_ABOVE35,0,OMOP SDOH,Observation,AHRQ Item,"Total Stroke Deaths Per 100,000 Population (Ages 35 And Over)",AHRQ:CDCA_STROKE_DTH_RATE_ABOVE35,2022-01-01,1,,,,,,,,,
CDCA_STROKE_HOSP_RATE_ABOVE65,0,OMOP SDOH,Observation,AHRQ Item,"Total Stroke Hospitalizations Per 1,000 Medicare Beneficiaries (Ages 65 And Over)",AHRQ:CDCA_STROKE_HOSP_RATE_ABOVE65,2022-01-01,1,,,,,,,,,
16.4.1,0,OMOP SDOH,Observation,SDG Indicator,Total value of inward and outward illicit financial flows (in current United States dollars),,2017-03-01,1,,,,,,,,,
ACS_TOT_POP_WT,0,OMOP SDOH,Observation,AHRQ Item,Total Weighted Population,AHRQ:ACS_TOT_POP_WT,2022-01-01,1,,,,,,,,,
ACS_TOT_WORKER_HH,0,OMOP SDOH,Observation,AHRQ Item,Total Workers In Households (Ages 16 And Over),AHRQ:ACS_TOT_WORKER_HH,2022-01-01,1,,,,,,,,,
ACS_TOT_WORKER_NWFH,0,OMOP SDOH,Observation,AHRQ Item,Total Workers Who Do Not Work From Home (Ages 16 And Over),AHRQ:ACS_TOT_WORKER_NWFH,2022-01-01,1,,,,,,,,,
GIS1002694,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Tourism,,2024-09-15,1,,,,,,,,,
8.9.1,0,OMOP SDOH,Observation,SDG Indicator,Tourism direct GDP as a proportion of total GDP and in growth rate,,2017-03-01,1,,,,,,,,,
AREA_SQMI,0,OMOP SDOH,Geographic Feature,SVI Item,Tract Area In Square Miles,SVI:AREA_SQMI,2018-01-01,1,,,,,,,,,
FIPS,0,OMOP SDOH,Geographic Feature,SVI Item,Tract-Level FIPS Code,SVI:FIPS,2018-01-01,1,,,,,,,,,
GIS1002695,0,OMOP SDOH,Observation,SDG Goal,Trade,,2017-03-01,1,,,,,,,,,
GIS1002698,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Trade Tariffs,,2024-09-15,1,,,,,,,,,
147,0,OMOP SDOH,Observation,SDOHO Item,Traditional Retail Food Environment Index,SDOHO:147; Traditional_Retail_Food_Environment_Index,2022-01-01,1,,,,,,,,,
153,0,OMOP SDOH,Behavioral Feature,SDOHO Value,Transgender,SDOHO:153; Transgender,2022-01-01,1,,,,,,,,,
GIS1002699,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Transport Infrastructure,,2024-09-15,1,,,,,,,,,
747,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Transportation,SDOHO:747; Transportation,2022-01-01,1,,,,,,,,,
674,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Transportation And Material Moving Occupation,SDOHO:674; Transportation_and_Material_Moving_Occupation,2022-01-01,1,,,,,,,,,
747_POP,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Transportation In Population,,2024-09-15,1,,,,,,,,,
967,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Transsexualism,SDOHO:967; Transsexualism,2022-01-01,1,,,,,,,,,
699,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Travel Expense,SDOHO:699; Travel_Expense,2022-01-01,1,,,,,,,,,
87,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Treatment Adherence And Compliance,SDOHO:87; Treatment_Adherence_and_Compliance,2022-01-01,1,,,,,,,,,
GIS1010356,0,OMOP SDOH,Observation,GIS Measure,Trimmed Mean,,2024-09-15,1,,,,,,,,,
3.3.2,0,OMOP SDOH,Observation,SDG Indicator,"Tuberculosis incidence per 100,000 population",,2017-03-01,1,,,,,,,,,
E_TWOMORE,0,OMOP SDOH,Observation,SVI Item,"Two Or More Races, Not Hispanic Or Latino Persons Estimate",SVI:E_TWOMORE,2018-01-01,1,,,,,,,,,
M_TWOMORE,0,OMOP SDOH,Observation,SVI Item,"Two Or More Races, Not Hispanic Or Latino Persons Estimate MOE",SVI:M_TWOMORE,2018-01-01,1,,,,,,,,,
615,0,OMOP SDOH,Observation,SDOHO Item,Type Of Insurance,SDOHO:615; Type_of_Insurance,2022-01-01,1,,,,,,,,,
3.2.1,0,OMOP SDOH,Observation,SDG Indicator,Under-5 mortality rate,,2017-03-01,1,,,,,,,,,
5.a,0,OMOP SDOH,Observation,SDG Goal,"Undertake reforms to give women equal rights to economic resources, as well as access to ownership and control over land and other forms of property, financial services, inheritance and natural resources, in accordance with national laws",,2017-03-01,1,,,,,,,,,
212,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Unemployed,SDOHO:212; Unemployed,2022-01-01,1,,,,,,,,,
GIS1002700,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Unemployment Rate,,2024-09-15,1,,,,,,,,,
EP_UNEMP,0,OMOP SDOH,Observation,SVI Item,Unemployment Rate Estimate,SVI:EP_UNEMP,2018-01-01,1,,,,,,,,,
MP_UNEMP,0,OMOP SDOH,Observation,SVI Item,Unemployment Rate Estimate MOE,SVI:MP_UNEMP,2018-01-01,1,,,,,,,,,
AHRF_UNEMPLOYED_RATE,0,OMOP SDOH,Observation,AHRQ Item,Unemployment Rate Per 100 Population (Ages 16 And Over),AHRQ:AHRF_UNEMPLOYED_RATE,2022-01-01,1,,,,,,,,,
8.5.2,0,OMOP SDOH,Observation,SDG Indicator,"Unemployment rate, by sex, age and persons with disabilities",,2017-03-01,1,,,,,,,,,
E_UNINSUR,0,OMOP SDOH,Observation,SVI Item,Uninsured In The Total Civilian Noninstitutionalized Population Estimate,SVI:E_UNINSUR,2018-01-01,1,,,,,,,,,
M_UNINSUR,0,OMOP SDOH,Observation,SVI Item,Uninsured In The Total Civilian Noninstitutionalized Population Estimate MOE,SVI:M_UNINSUR,2018-01-01,1,,,,,,,,,
16.3.2,0,OMOP SDOH,Observation,SDG Indicator,Unsentenced detainees as a proportion of overall prison population,,2017-03-01,1,,,,,,,,,
GIS1002701,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Urban Living Conditions,,2024-09-15,1,,,,,,,,,
GIS1002702,0,OMOP SDOH,Geographic Feature,SDOH Construct,Urban Open Space,,2024-09-15,1,,,,,,,,,
GIS1002703,0,OMOP SDOH,Geographic Feature,SDOH Construct,Urban Policies,,2024-09-15,1,,,,,,,,,
GIS1002704,0,OMOP SDOH,Geographic Feature,AHRQ Item,Urban/Rural Codes,,2022-01-01,1,,,,,,,,,
SEDH:5.1,0,OMOP SDOH,Observation,SEDH Item,"USA National Transportation Noise Database 2018 Noise Combined Data For Road, Aviation, And Passenger Rail",SEDH:5.1,2021-01-01,1,,,,,,,,,
AHRF_USDA_RUCC_2013,0,OMOP SDOH,Geographic Feature,AHRQ Item,Usda Rural-Urban Continuum Code 2013,AHRQ:AHRF_USDA_RUCC_2013,2022-01-01,1,,,,,,,,,
683,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Utility Cost,SDOHO:683; Utility_Cost,2022-01-01,1,,,,,,,,,
GIS1002712,0,OMOP SDOH,Socioeconomic Feature,AHRQ Determinant,Utilization And Costs,,2022-01-01,1,,,,,,,,,
GIS1002714,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Utilization And Costs In Population,,2024-09-15,1,,,,,,,,,
GIS1002776,0,OMOP SDOH,Phenotypic Feature,SDOH Determinant,Vaccination Status,,2024-09-15,1,,,,,,,,,
943,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Vaping,SDOHO:943; Vaping,2022-01-01,1,,,,,,,,,
GIS1010357,0,OMOP SDOH,Observation,GIS Measure,Variance,,2024-09-15,1,,,,,,,,,
GIS1002777,0,OMOP SDOH,Observation,GIS Measure,Variance Or Standard Deviation,,2024-09-15,1,,,,,,,,,
SEDH:1.26,0,OMOP SDOH,Observation,SEDH Item,Veteran Population Status For The Civilian Population,SEDH:1.26,2021-01-01,1,,,,,,,,,
SEDH:1.14,0,OMOP SDOH,Observation,SEDH Item,Veteran Segment Service-Connected Disability Profiles,SEDH:1.14,2021-01-01,1,,,,,,,,,
SEDH:1.13,0,OMOP SDOH,Observation,SEDH Item,Veteran Segment Service-Connected Disability Profiles By Vulnerability Level,SEDH:1.13,2021-01-01,1,,,,,,,,,
SEDH:1.12,0,OMOP SDOH,Observation,SEDH Item,Veteran Segment Vulnerability Profiles,SEDH:1.12,2021-01-01,1,,,,,,,,,
SEDH:1.11,0,OMOP SDOH,Observation,SEDH Item,Veteran Segment Vulnerability Profiles By Vulnerability Level,SEDH:1.11,2021-01-01,1,,,,,,,,,
SEDH:1.9,0,OMOP SDOH,Observation,SEDH Item,Veteran Segments By Census Block Group,SEDH:1.9,2021-01-01,1,,,,,,,,,
SEDH:1.16,0,OMOP SDOH,Observation,SEDH Item,Veteran Segments By Census Tract,SEDH:1.16,2021-01-01,1,,,,,,,,,
SEDH:1.8,0,OMOP SDOH,Observation,SEDH Item,Veteran Segments By Vulnerability Level By Census Block Group,SEDH:1.8,2021-01-01,1,,,,,,,,,
SEDH:1.15,0,OMOP SDOH,Observation,SEDH Item,Veteran Segments By Vulnerability Level By Census Tract,SEDH:1.15,2021-01-01,1,,,,,,,,,
692,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Veteran Status,SDOHO:692; Veteran,2022-01-01,1,,,,,,,,,
692_POP,0,OMOP SDOH,Socioeconomic Feature,SDOH Determinant,Veteran Status In Population,,2024-09-15,1,,,,,,,,,
811,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Violence,SDOHO:811; Violence,2022-01-01,1,,,,,,,,,
GIS1002778,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Violence Against Youth,,2024-09-15,1,,,,,,,,,
GIS1002779,0,OMOP SDOH,Type Concept,Exposure Type Concept,Vision Claim,,2024-09-15,1,,,,,,,,,
250,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Vocational History,SDOHO:250; Vocational_History,2022-01-01,1,,,,,,,,,
235,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Vocational Training,SDOHO:235; Vocational_Training,2022-01-01,1,,,,,,,,,
4.b.1,0,OMOP SDOH,Observation,SDG Indicator,Volume of official development assistance flows for scholarships by sector and type of study,,2017-03-01,1,,,,,,,,,
2.3.1,0,OMOP SDOH,Observation,SDG Indicator,Volume of production per labour unit by classes of farming/pastoral/forestry enterprise size,,2017-03-01,1,,,,,,,,,
17.3.2,0,OMOP SDOH,Observation,SDG Indicator,Volume of remittances (in United States dollars) as a proportion of total GDP,,2017-03-01,1,,,,,,,,,
935,0,OMOP SDOH,Socioeconomic Feature,SDOHO Determinant,Walkability,SDOHO:935; Walkability,2022-01-01,1,,,,,,,,,
GIS1002780,0,OMOP SDOH,Geographic Feature,SDOH Determinant,Waste Management,,2024-09-15,1,,,,,,,,,
GIS1002781,0,OMOP SDOH,Behavioral Feature,SDOH Construct,Water Intake,,2024-09-15,1,,,,,,,,,
GIS1002786,0,OMOP SDOH,Environmental Feature,SDOH Construct,Water Pollution,,2024-09-15,1,,,,,,,,,
865,0,OMOP SDOH,Environmental Feature,SDOHO Construct,Water Quality,SDOHO:865; Water_Quality,2022-01-01,1,,,,,,,,,
GIS1002788,0,OMOP SDOH,Type Concept,Exposure Type Concept,Water Quality Database,,2024-09-15,1,,,,,,,,,
950,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Weak Support,SDOHO:950; Weak_Support,2022-01-01,1,,,,,,,,,
272,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Wealth,SDOHO:272; Wealth,2022-01-01,1,,,,,,,,,
869,0,OMOP SDOH,Environmental Feature,SDOHO Construct,Weather,SDOHO:869; Weather,2022-01-01,1,,,,,,,,,
EPAA_MEAN_WTD_PM10,0,OMOP SDOH,Observation,AHRQ Item,Weighted Annual Mean (Mean Weighted By Calendar Quarter) For The Year Of PM10 (Ug/M3),AHRQ:EPAA_MEAN_WTD_PM10,2022-01-01,1,,,,,,,,,
EPAA_MEAN_WTD_PM25,0,OMOP SDOH,Observation,AHRQ Item,Weighted Annual Mean (Mean Weighted By Calendar Quarter) For The Year Of PM2.5 (Ug/M3),AHRQ:EPAA_MEAN_WTD_PM25,2022-01-01,1,,,,,,,,,
17.12.1,0,OMOP SDOH,Observation,SDG Indicator,"Weighted average tariffs faced by developing countries, least developed countries and small island developing States",,2017-03-01,1,,,,,,,,,
GIS1002789,0,OMOP SDOH,Socioeconomic Feature,SDOH Construct,Well-Being,,2024-09-15,1,,,,,,,,,
5.1.1,0,OMOP SDOH,Observation,SDG Indicator,"Whether or not legal frameworks are in place to promote, enforce and monitor equality and non-discrimination on the basis of sex",,2017-03-01,1,,,,,,,,,
166,0,OMOP SDOH,Demographic Feature,SDOHO Value,White,SDOHO:166; White,2022-01-01,1,,,,,,,,,
FEA_WIC_REDEMP_PER_CAPITA,0,OMOP SDOH,Observation,AHRQ Item,Wic Redemptions Per Capita (Dollar),AHRQ:FEA_WIC_REDEMP_PER_CAPITA,2022-01-01,1,,,,,,,,,
FEA_WIC_REDEMP_PER_STORE,0,OMOP SDOH,Observation,AHRQ Item,Wic Redemptions Per Wic-Authorized Stores (Dollar),AHRQ:FEA_WIC_REDEMP_PER_STORE,2022-01-01,1,,,,,,,,,
784,0,OMOP SDOH,Socioeconomic Feature,SDOHO Value,Widowed,SDOHO:784; Widowed,2022-01-01,1,,,,,,,,,
809,0,OMOP SDOH,Behavioral Feature,SDOHO Construct,Work Stress,SDOHO:809; Work_Stress,2022-01-01,1,,,,,,,,,
259,0,OMOP SDOH,Socioeconomic Feature,SDOHO Construct,Work-Related Challenge,SDOHO:259; Work-Related_Challenge,2022-01-01,1,,,,,,,,,
17.10.1,0,OMOP SDOH,Observation,SDG Indicator,Worldwide weighted tariff-average,,2017-03-01,1,,,,,,,,,
year,0,OMOP SDOH,Observation,COI Item,Year Of Observation (2010 Or 2015); 2008-12 5-Year ACS Data Is Labeled 2010. 2013-17 Data Is Labeled 2015,COI:year,2020-01-01,1,,,,,,,,,
368,0,OMOP SDOH,Observation,SDOHO Item,Years Of Education,SDOHO:368; Years_of_Education,2022-01-01,1,,,,,,,,,
GIS1002806,0,OMOP SDOH,Geographic Feature,SDOH Determinant,ZIP Code,,2024-09-15,1,,,,,,,,,
170,0,OMOP SDOH,Geographic Feature,SDOHO Item,ZIP Code And Geography,SDOHO:170; Zip_Code_and_Geography,2022-01-01,1,,,,,,,,,
ZCTA,0,OMOP SDOH,Geographic Feature,SVI Item,"ZIP Code Tabulation Area, 5-Digits",SVI:ZCTA,2018-01-01,1,,,,,,,,,
ZIPCODE,0,OMOP SDOH,Geographic Feature,SVI Item,"ZIP Code, 5-Digits",SVI:ZIPCODE,2018-01-01,1,,,,,,,,,
zSE_HOME,0,OMOP SDOH,Observation,COI Item,Zse_Home,COI:zSE_HOME,2020-01-01,1,,,,,,,,,
zSE_MHE,0,OMOP SDOH,Observation,COI Item,Zse_Mhe,COI:zSE_MHE,2020-01-01,1,,,,,,,,,
zSE_OCC,0,OMOP SDOH,Observation,COI Item,Zse_Occ,COI:zSE_OCC,2020-01-01,1,,,,,,,,,
zSE_POVRATE,0,OMOP SDOH,Observation,COI Item,Zse_Povrate,COI:zSE_POVRATE,2020-01-01,1,,,,,,,,,
zSE_PUBLIC,0,OMOP SDOH,Observation,COI Item,Zse_Public,COI:zSE_PUBLIC,2020-01-01,1,,,,,,,,,
GIS1002808,0,OMOP GIS,Observation,Geometry Type,0D (Zero-Dimensional) Geometry,,2024-09-15,1,,,,,,,,,
GIS1002809,0,OMOP GIS,Observation,Geometry Type,1D (One-Dimensional) Geometry,,2024-09-15,1,,,,,,,,,
GIS1002810,0,OMOP GIS,Observation,Geometry Type,2D (Two-Dimensional) Geometry,,2024-09-15,1,,,,,,,,,
GIS1002811,0,OMOP GIS,Observation,Geometry Relationship,Adjacent to,,2024-09-15,1,,,,,,,,,
GIS1002812,0,OMOP GIS,Observation,Location,Administrative Boundary,,2024-09-15,1,,,,,,,,,
GIS1002822,0,OMOP GIS,Observation,Location,Air Quality Monitoring Station,,2024-09-15,1,,,,,,,,,
GIS1002824,0,OMOP GIS,Observation,Location,Air Quality Station,,2024-09-15,1,,,,,,,,,
GIS1002826,0,OMOP GIS,Observation,Location,Anti-Malaria Mosquito Net Distribution,,2024-09-15,1,,,,,,,,,
GIS1002828,0,OMOP GIS,Observation,Location,Arable Land Zone,,2024-09-15,1,,,,,,,,,
GIS1002830,0,OMOP GIS,Observation,Location,Atmospheric Monitoring Station,,2024-09-15,1,,,,,,,,,
GIS1002832,0,OMOP GIS,Observation,Geometry Relationship,Beyond [specific distance],,2024-09-15,1,,,,,,,,,
GIS1002833,0,OMOP GIS,Observation,Location,Biodiversity Hotspot,,2024-09-15,1,,,,,,,,,
GIS1002835,0,OMOP GIS,Observation,Location,Borough,,2024-09-15,1,,,,,,,,,
GIS1002839,0,OMOP GIS,Observation,Location,Buffer zone,,2024-09-15,1,,,,,,,,,
GIS1002840,0,OMOP GIS,Observation,Location,Canton,,2024-09-15,1,,,,,,,,,
GIS1002843,0,OMOP GIS,Observation,Location,Census Block,,2024-09-15,1,,,,,,,,,
GIS1002844,0,OMOP GIS,Observation,Location,Census Block Group,,2024-09-15,1,,,,,,,,,
GIS1002845,0,OMOP GIS,Observation,Location,Census Division,,2024-09-15,1,,,,,,,,,
GIS1002847,0,OMOP GIS,Observation,Location,Census Tract,,2024-09-15,1,,,,,,,,,
GIS1002848,0,OMOP GIS,Observation,Location,Chemical Disaster Recovery Zone,,2024-09-15,1,,,,,,,,,
GIS1002850,0,OMOP GIS,Observation,Location,Chemical Factory Zone,,2024-09-15,1,,,,,,,,,
GIS1002852,0,OMOP GIS,Observation,Location,Chemical Spill Zone,,2024-09-15,1,,,,,,,,,
GIS1002854,0,OMOP GIS,Observation,Location,City,,2024-09-15,1,,,,,,,,,
GIS1002856,0,OMOP GIS,Observation,Location,Commercial area,,2024-09-15,1,,,,,,,,,
GIS1002857,0,OMOP GIS,Observation,Location,Commune,,2024-09-15,1,,,,,,,,,
GIS1002859,0,OMOP GIS,Observation,Geometry Type,Complex Geometry,,2024-09-15,1,,,,,,,,,
GIS1002860,0,OMOP GIS,Observation,Location,Conflict Zone,,2024-09-15,1,,,,,,,,,
GIS1002862,0,OMOP GIS,Observation,Location,Conservation area or National Park,,2024-09-15,1,,,,,,,,,
GIS1002863,0,OMOP GIS,Observation,Location,Contaminated Ocean Zone,,2024-09-15,1,,,,,,,,,
GIS1002865,0,OMOP GIS,Observation,Location,Contaminated Sea Zone,,2024-09-15,1,,,,,,,,,
GIS1002867,0,OMOP GIS,Observation,Location,Contaminated Soil Zone,,2024-09-15,1,,,,,,,,,
GIS1002869,0,OMOP GIS,Observation,Location,Continent,,2024-09-15,1,,,,,,,,,
GIS1002870,0,OMOP GIS,Observation,Location,Coral Reef,,2024-09-15,1,,,,,,,,,
GIS1002872,0,OMOP GIS,Observation,Location,Countries / Nation-States,,2024-09-15,1,,,,,,,,,
GIS1002875,0,OMOP GIS,Observation,Location,Country,,2024-09-15,1,,,,,,,,,
GIS1002876,0,OMOP GIS,Observation,Location,County,,2024-09-15,1,,,,,,,,,
GIS1002880,0,OMOP GIS,Observation,Location,County Boundary,,2024-09-15,1,,,,,,,,,
GIS1002882,0,OMOP GIS,Observation,Location,Critical Transportation Hub,,2024-09-15,1,,,,,,,,,
GIS1002884,0,OMOP GIS,Geographic Feature,Geometry Type,CurvePolygon,,2024-09-15,1,,,,,,,,,
GIS1002885,0,OMOP GIS,Observation,Location,Desert,,2024-09-15,1,,,,,,,,,
GIS1002887,0,OMOP GIS,Observation,Location,Desertification Risk Zone,,2024-09-15,1,,,,,,,,,
GIS1002889,0,OMOP GIS,Observation,Location,Disease Outbreak Area,,2024-09-15,1,,,,,,,,,
GIS1002891,0,OMOP GIS,Observation,Location,District,,2024-09-15,1,,,,,,,,,
GIS1002895,0,OMOP GIS,Observation,Location,Earthquake Fault Line,,2024-09-15,1,,,,,,,,,
GIS1002897,0,OMOP GIS,Observation,Location,Economic or political union,,2024-09-15,1,,,,,,,,,
GIS1002899,0,OMOP GIS,Observation,Location,Economic zone,,2024-09-15,1,,,,,,,,,
GIS1002900,0,OMOP GIS,Observation,Location,Educational Institution,,2024-09-15,1,,,,,,,,,
GIS1002902,0,OMOP GIS,Observation,Geometry Type,Element Relevant To Geometry,,2024-09-15,1,,,,,,,,,
GIS1002903,0,OMOP GIS,Observation,Location,Environmental Zones & Features,,2024-09-15,1,,,,,,,,,
GIS1002930,0,OMOP GIS,Observation,Location,Flood Risk Zone,,2024-09-15,1,,,,,,,,,
GIS1002928,0,OMOP GIS,Observation,Location,Floodplain,,2024-09-15,1,,,,,,,,,
GIS1002932,0,OMOP GIS,Observation,Location,Freshwater Reservoir,,2024-09-15,1,,,,,,,,,
GIS1002934,0,OMOP GIS,Observation,Location,Freshwater Source,,2024-09-15,1,,,,,,,,,
GIS1010318,0,OMOP GIS,Observation,Location,Geographical and Administrative Boundaries,,2024-09-15,1,,,,,,,,,
GIS1002938,0,OMOP GIS,Observation,Location,Geographical Boundaries,,2024-09-15,1,,,,,,,,,
GIS1002945,0,OMOP GIS,Observation,Location,Geographical region,,2024-09-15,1,,,,,,,,,
GIS1002947,0,OMOP GIS,Observation,Geometry Type,GeometryCollection,,2024-09-15,1,,,,,,,,,
GIS1002949,0,OMOP GIS,Observation,Location,Glacier,,2024-09-15,1,,,,,,,,,
GIS1010319,0,OMOP GIS,Observation,Location,Global Boundaries,,2024-09-15,1,,,,,,,,,
GIS1002951,0,OMOP GIS,Observation,Location,Global Health Organization,,2024-09-15,1,,,,,,,,,
GIS1002953,0,OMOP GIS,Observation,Location,Global Internet Cable,,2024-09-15,1,,,,,,,,,
GIS1002955,0,OMOP GIS,Observation,Location,Global Seed Vault,,2024-09-15,1,,,,,,,,,
GIS1002957,0,OMOP GIS,Observation,Location,Governorate / Province,,2024-09-15,1,,,,,,,,,
GIS1002958,0,OMOP GIS,Observation,Location,Groundwater Recharge Zone,,2024-09-15,1,,,,,,,,,
GIS1002960,0,OMOP GIS,Observation,Location,Hamlet,,2024-09-15,1,,,,,,,,,
GIS1002965,0,OMOP GIS,Observation,Location,Health-Related Zones & Facilities,,2024-09-15,1,,,,,,,,,
GIS1002963,0,OMOP GIS,Observation,Location,Healthcare Accessibility Zone,,2024-09-15,1,,,,,,,,,
GIS1002987,0,OMOP GIS,Observation,Location,Hemisphere,,2024-09-15,1,,,,,,,,,
GIS1002988,0,OMOP GIS,Observation,Location,Historical and Cultural Heritage Site,,2024-09-15,1,,,,,,,,,
GIS1002991,0,OMOP GIS,Observation,Location,HIV Prevalence Region,,2024-09-15,1,,,,,,,,,
GIS1002993,0,OMOP GIS,Observation,Location,HIV Testing Center,,2024-09-15,1,,,,,,,,,
GIS1002995,0,OMOP GIS,Observation,Location,Hospital Location,,2024-09-15,1,,,,,,,,,
GIS1002997,0,OMOP GIS,Observation,Location,Industrial zone,,2024-09-15,1,,,,,,,,,
GIS1002998,0,OMOP GIS,Observation,Location,International Border,,2024-09-15,1,,,,,,,,,
GIS1003000,0,OMOP GIS,Observation,Geometry Relationship,Intersects,,2024-09-15,1,,,,,,,,,
GIS1003001,0,OMOP GIS,Observation,Geometry Type,LineString,,2024-09-15,1,,,,,,,,,
GIS1003010,0,OMOP GIS,Observation,Location,Local Boundaries,,2024-09-15,1,,,,,,,,,
GIS1003011,0,OMOP GIS,Observation,Location,Makeshift Field Hospital,,2024-09-15,1,,,,,,,,,
GIS1003013,0,OMOP GIS,Observation,Location,Malaria Endemic Zone,,2024-09-15,1,,,,,,,,,
GIS1003015,0,OMOP GIS,Observation,Location,Malaria Prevalence Zones,,2024-09-15,1,,,,,,,,,
GIS1003017,0,OMOP GIS,Observation,Location,Man-made Infrastructure & Zones,,2024-09-15,1,,,,,,,,,
GIS1003030,0,OMOP GIS,Observation,Location,Metropolitan Area,,2024-09-15,1,,,,,,,,,
GIS1003033,0,OMOP GIS,Observation,Location,Metropolitan Areas / Counties / Districts,,2024-09-15,1,,,,,,,,,
GIS1003039,0,OMOP GIS,Observation,Location,Migration Pathway (Animals),,2024-09-15,1,,,,,,,,,
GIS1003041,0,OMOP GIS,Geographic Feature,Geometry Type,MultiLineString,,2024-09-15,1,,,,,,,,,
GIS1003042,0,OMOP GIS,Geographic Feature,Geometry Type,MultiPoint,,2024-09-15,1,,,,,,,,,
GIS1003043,0,OMOP GIS,Geographic Feature,Geometry Type,MultiPolygon,,2024-09-15,1,,,,,,,,,
GIS1003044,0,OMOP GIS,Observation,Location,Municipalities / Cities / Towns / Villages,,2024-09-15,1,,,,,,,,,
GIS1003050,0,OMOP GIS,Observation,Location,Municipality,,2024-09-15,1,,,,,,,,,
GIS1003053,0,OMOP GIS,Observation,Location,Municipality / City,,2024-09-15,1,,,,,,,,,
GIS1003057,0,OMOP GIS,Observation,Location,Nation-State,,2024-09-15,1,,,,,,,,,
GIS1003056,0,OMOP GIS,Observation,Location,National Boundaries,,2024-09-15,1,,,,,,,,,
GIS1003058,0,OMOP GIS,Observation,Location,Natural & Cultural Sites,,2024-09-15,1,,,,,,,,,
GIS1003066,0,OMOP GIS,Observation,Location,Natural Geographic Divisions,,2024-09-15,1,,,,,,,,,
GIS1003069,0,OMOP GIS,Observation,Geometry Relationship,Near/Proximity to,,2024-09-15,1,,,,,,,,,
GIS1003070,0,OMOP GIS,Observation,Location,Neighborhood,,2024-09-15,1,,,,,,,,,
GIS1003071,0,OMOP GIS,Observation,Location,Non-Administrative Divisions,,2024-09-15,1,,,,,,,,,
GIS1003076,0,OMOP GIS,Observation,Location,Non-US-centric Boundaries,,2024-09-15,1,,,,,,,,,
GIS1003077,0,OMOP GIS,Observation,Location,Nuclear Reactor,,2024-09-15,1,,,,,,,,,
GIS1003079,0,OMOP GIS,Observation,Location,Organizations & Institutions,,2024-09-15,1,,,,,,,,,
GIS1003082,0,OMOP GIS,Observation,Geometry Relationship,Overlaps,,2024-09-15,1,,,,,,,,,
GIS1003083,0,OMOP GIS,Observation,Location,Parish,,2024-09-15,1,,,,,,,,,
GIS1003087,0,OMOP GIS,Observation,Location,Park or Green Space,,2024-09-15,1,,,,,,,,,
GIS1003089,0,OMOP GIS,Observation,Location,Patient Residence,,2024-09-15,1,,,,,,,,,
GIS1003091,0,OMOP GIS,Observation,Geometry Type,Point,,2024-09-15,1,,,,,,,,,
GIS1003114,0,OMOP GIS,Observation,Location,Pollution Hotspot,,2024-09-15,1,,,,,,,,,
GIS1003116,0,OMOP GIS,Observation,Geometry Type,Polygon,,2024-09-15,1,,,,,,,,,
GIS1003155,0,OMOP GIS,Observation,Location,Prefecture,,2024-09-15,1,,,,,,,,,
GIS1003158,0,OMOP GIS,Observation,Location,Province,,2024-09-15,1,,,,,,,,,
GIS1003160,0,OMOP GIS,Observation,Location,Public Transportation Route,,2024-09-15,1,,,,,,,,,
GIS1003162,0,OMOP GIS,Observation,Location,Radiation Hotspot,,2024-09-15,1,,,,,,,,,
GIS1003164,0,OMOP GIS,Observation,Location,Radiation Zone,,2024-09-15,1,,,,,,,,,
GIS1003166,0,OMOP GIS,Observation,Location,Rainforest,,2024-09-15,1,,,,,,,,,
GIS1003168,0,OMOP GIS,Observation,Geometry Type,Raster,,2024-09-15,1,,,,,,,,,
GIS1003170,0,OMOP GIS,Observation,Location,Refugee Movement Path,,2024-09-15,1,,,,,,,,,
GIS1003172,0,OMOP GIS,Observation,Location,Region,,2024-09-15,1,,,,,,,,,
GIS1003175,0,OMOP GIS,Observation,Location,Regional Boundaries,,2024-09-15,1,,,,,,,,,
GIS1003176,0,OMOP GIS,Observation,Location,Regions / Provinces / States,,2024-09-15,1,,,,,,,,,
GIS1003180,0,OMOP GIS,Observation,Location,Renewable Energy Installation,,2024-09-15,1,,,,,,,,,
GIS1003182,0,OMOP GIS,Observation,Location,Residential zone,,2024-09-15,1,,,,,,,,,
GIS1003183,0,OMOP GIS,Observation,Location,River basin,,2024-09-15,1,,,,,,,,,
GIS1003184,0,OMOP GIS,Observation,Location,Rural Area,,2024-09-15,1,,,,,,,,,
GIS1003186,0,OMOP GIS,Type Concept,Exposure Type Concept,Satellite Imagery,,2024-09-15,1,,,,,,,,,
GIS1003187,0,OMOP GIS,Observation,Location,School district,,2024-09-15,1,,,,,,,,,
GIS1003188,0,OMOP GIS,Observation,Geometry Relationship,Separated by [specific distance],,2024-09-15,1,,,,,,,,,
GIS1003189,0,OMOP GIS,Geographic Feature,Geometry Type,Solid,,2024-09-15,1,,,,,,,,,
GIS1003190,0,OMOP GIS,Observation,Location,Space Observatories and Telescopes,,2024-09-15,1,,,,,,,,,
GIS1003192,0,OMOP GIS,Observation,Location,Special Boundaries,,2024-09-15,1,,,,,,,,,
GIS1003193,0,OMOP GIS,Observation,Location,Special economic zone,,2024-09-15,1,,,,,,,,,
GIS1003194,0,OMOP GIS,Observation,Location,Special Purpose Zones,,2024-09-15,1,,,,,,,,,
GIS1003198,0,OMOP GIS,Observation,Location,State,,2024-09-15,1,,,,,,,,,
GIS1003200,0,OMOP GIS,Observation,Location,State Boundary,,2024-09-15,1,,,,,,,,,
GIS1003202,0,OMOP GIS,Observation,Location,Sub-Municipal Region,,2024-09-15,1,,,,,,,,,
GIS1003203,0,OMOP GIS,Observation,Location,Sub-Municipal Regions / Neighborhoods / Boroughs,,2024-09-15,1,,,,,,,,,
GIS1003207,0,OMOP GIS,Observation,Location,Sub-National Boundaries,,2024-09-15,1,,,,,,,,,
GIS1003208,0,OMOP GIS,Observation,Location,Suburb,,2024-09-15,1,,,,,,,,,
GIS1003211,0,OMOP GIS,Observation,Location,Supranational / Continental Regions,,2024-09-15,1,,,,,,,,,
GIS1003216,0,OMOP GIS,Observation,Location,Territory,,2024-09-15,1,,,,,,,,,
GIS1003217,0,OMOP GIS,Observation,Location,Town,,2024-09-15,1,,,,,,,,,
GIS1003220,0,OMOP GIS,Observation,Location,Transportation and Border Geometries,,2024-09-15,1,,,,,,,,,
GIS1003222,0,OMOP GIS,Geographic Feature,Geometry Type,Triangulated Irregular Network(TIN),,2024-09-15,1,,,,,,,,,
GIS1003223,0,OMOP GIS,Observation,Location,Tribal land or Indigenous territory,,2024-09-15,1,,,,,,,,,
GIS1003224,0,OMOP GIS,Observation,Location,Tsunami Evacuation Route,,2024-09-15,1,,,,,,,,,
GIS1003226,0,OMOP GIS,Observation,Location,Tsunami Hazard Zone,,2024-09-15,1,,,,,,,,,
GIS1003228,0,OMOP GIS,Observation,Location,Urban Area,,2024-09-15,1,,,,,,,,,
GIS1003230,0,OMOP GIS,Observation,Location,US-centric Boundaries,,2024-09-15,1,,,,,,,,,
GIS1003231,0,OMOP GIS,Observation,Location,Village,,2024-09-15,1,,,,,,,,,
GIS1003235,0,OMOP GIS,Observation,Location,Volcano,,2024-09-15,1,,,,,,,,,
GIS1003238,0,OMOP GIS,Observation,Location,Voting precinct,,2024-09-15,1,,,,,,,,,
GIS1003239,0,OMOP GIS,Observation,Location,Walkability Index Area,,2024-09-15,1,,,,,,,,,
GIS1003241,0,OMOP GIS,Observation,Location,War Casualty Site,,2024-09-15,1,,,,,,,,,
GIS1003246,0,OMOP GIS,Observation,Location,War Zone,,2024-09-15,1,,,,,,,,,
GIS1003243,0,OMOP GIS,Observation,Location,Ward,,2024-09-15,1,,,,,,,,,
GIS1003251,0,OMOP GIS,Observation,Location,Waste Disposal Area,,2024-09-15,1,,,,,,,,,
GIS1003253,0,OMOP GIS,Observation,Location,Waste Recycling Center,,2024-09-15,1,,,,,,,,,
GIS1003255,0,OMOP GIS,Observation,Location,Watershed,,2024-09-15,1,,,,,,,,,
GIS1003256,0,OMOP GIS,Observation,Geometry Relationship,Within,,2024-09-15,1,,,,,,,,,
GIS1003257,0,OMOP GIS,Observation,Geometry Relationship,Within a Radius of [specific distance],,2024-09-15,1,,,,,,,,,
GIS1003258,0,OMOP GIS,Observation,Location,World Heritage Forest,,2024-09-15,1,,,,,,,,,
595-05-1,0,OMOP Exposome,Observation,Substance,(+)-Calycanthine,Calycanthine; CHEBI:3333,2014-12-24,1,,,,,,,,,
7785-26-4,0,OMOP Exposome,Observation,Substance,(-)-alpha-Pinene,"1S-(-)-a-Pinene; L-a-Pinene; 1S-a-Pinene; (-)-\u03b1-Pinene; 1S,5S-(-)-alpha-Pinene; (-)-a-Pinene; (1S)-(-)-a-Pinene; (1S)-2,6,6-trimethylbicyclo3.1.1hept-2-ene; (1S,5S)-2,6,6-Trimethylbicyclo3.1.1hept-2-ene; (-)-a-pinene; CHEBI:28660",2014-12-24,1,,,,,,,,,
90141-22-3,0,OMOP Exposome,Observation,Substance,(-)-Gossypol,"Pogosin; Tash 1; Sodium salt, gossypol; Racemic-gossypol; Gossypol, (-)-isomer; Gossypol, (+-)-isomer; Gossypol, (+)-isomer; Gossypol sodium salt; Gossypol from cotton seeds; Gossypol dipotassium salt; Gossypol; Dipotassium salt, gossypol; (R)-gossypol; (R)-(-)-gossypol; (+/-)-gossypol; (+-)-gossypol; (+)-gossypol; CHEBI:25520",2014-12-24,1,,,,,,,,,
94662-64-3,0,OMOP Exposome,Observation,Substance,(2E)-1-Methyl-2-(nitromethylidene)pyrrolidine,,2014-12-24,1,,,,,,,,,
58842-20-9,0,OMOP Exposome,Observation,Substance,"(2E)-2-(Nitromethylidene)-1,3-thiazinane",,2014-12-24,1,,,,,,,,,
40990-27-0,0,OMOP Exposome,Observation,Substance,(2E)-2-(Nitromethylidene)-1-prop-2-enylpyrrolidine,,2014-12-24,1,,,,,,,,,
94776-91-7,0,OMOP Exposome,Observation,Substance,"(2E)-3-Benzyl-2-(nitromethylidene)-1,3-thiazolidine",,2014-12-24,1,,,,,,,,,
110-44-1,0,OMOP Exposome,Observation,Substance,"(2E,4E)-2,4-Hexadienoic acid","Panosorb; trans-trans-2,4-Hexadienoic acid; Trans,trans-sorbic acid; trans,trans-2,4-Hexadienoic acid; Sorbistat; Sorbic acid, potassium salt; Sorbic acid (NF); Sorbic acid; Preservastat; Hexadienoic acid1,3-pentadiene-1-carboxylic acid; Hexadienoic acid, (e,e); Hexadienoic acid; Hexadienic acid; Hexa-2,4-dienoic acid; FEMA 3921; Crotylidene-Acetic acid; Crotylidene acetic acid; alpha-trans-Laquo gammaRaquo -trans-sorbic acid; alpha-trans-gamma-trans-Sorbic acid; Acidum sorbicum; 2E,4E-Hexadienoic acid; 2-Propenylacrylic acid; 2,4-Hexadienoic acid; 2, 4-Hexadienoic acid potassium salt; 1,3-Pentadiene-1-carboxylic acid; (e,e)-Sorbic acid; (E,E)-2,4-Hexadienoic acid; (E,E)-1,3-Pentadiene-1-carboxylic acid; (2E,4E)-hexa-2,4-dienoic acid; (2e,4e)-2,4-Hexadienoic acid; (2e,4e)-2,4-Hexadienoate; (2-Butenylidene)acetic acid; (2-butenylidene)-Acetic acid; CHEBI:38358",2014-12-24,1,,,,,,,,,
300-54-9,0,OMOP Exposome,Observation,Substance,"(2S,4R,5S)-Muscarine","Muscarine (the alkaloid); Muscarine; Muscarin; L-(+)-Muscarine; (+)-muscarine; (+)-(2S,4R,5S)-Muscarine; Trimethyl(tetrahydro-4-hydroxy-5-methylfurfuryl)-Ammonium; Muskarin; Muscarine II; Muscarine chloride; Muscarine (alkaloid); CHEBI:522933",2014-12-24,1,,,,,,,,,
57734-58-4,0,OMOP Exposome,Observation,Substance,(2Z)-1-Benzyl-2-(nitromethylidene)pyrrolidine,,2014-12-24,1,,,,,,,,,
26171-04-0,0,OMOP Exposome,Observation,Substance,(2Z)-1-Ethyl-2-(nitromethylidene)pyrrolidine,,2014-12-24,1,,,,,,,,,
26171-05-1,0,OMOP Exposome,Observation,Substance,(2Z)-1-Methyl-2-(nitromethylidene)pyrrolidine,,2014-12-24,1,,,,,,,,,
56593-86-3,0,OMOP Exposome,Observation,Substance,"(3Z)-2-Ethyl-3-(nitromethylidene)-3a,4,5,6,7,7a-hexahydro-1H-isoindole",,2014-12-24,1,,,,,,,,,
58350-08-6,0,OMOP Exposome,Observation,Substance,"(4E)-4-(Nitromethylidene)-1,2,3,5-tetrahydro-3-benzazepine",,2014-12-24,1,,,,,,,,,
900-95-8,0,OMOP Exposome,Observation,Substance,(Acetyloxy)triphenylstannane,,2014-12-24,1,,,,,,,,,
12082-08-5,0,OMOP Exposome,Observation,Substance,(Benzene)chromium tricarbonyl,,2014-12-24,1,,,,,,,,,
6923-22-4,0,OMOP Exposome,Observation,Substance,(E)-Monocrotophos,"Susvin; 3-Hydroxy-N-methyl-cis-crotonamide dimethyl phosphate; 3-Dimethoxyphosphinoyloxy-N-methylisocrotonamide; 3-(Dimethoxyphosphinyloxy)N-methyl-cis-crotonamide; (e)-Monocrotophos; Glore phos 36; Monodrin; Hazodrin; Monocil; Monocil 40; Monocron; Monocrotophos; Monocrotophos 40 EC; Monostar; N-Desmethyl bidrin; Nuvacron; Nuvacron 20; Bilobran; Biloborn; Azodrin-71; Nuvacron-20; O,O-Dimethyl cis-1-methyl-2-methylcarbamoylvinylphosphate; Des-N-methyl dicrotophos; Azodrin insecticide; Azodrin 202R; Azodrin; Azadrin; Apadrin; Dimethyl (E)-1-methyl-2-(methylcarbamoyl)vinyl phosphate; Dimethyl (E)-3-hydroxy-N-methylcrotonamide; Dimethyl 1-methyl-2-(methylcarbamoyl)vinyl phosphate, cis; E-Monocrotophos; Dimethyl phosphate of 3-hydroxy-N-methyl-cis-crotonamide; Aimocron; 3-Hydroxy-N-methyl-dimethylphosphatecis-Crotonamide; 3-Hydroxy-N-methyl-dimethylphosphate(E)-Crotonamide; 3-Hydroxy-N-methyl-cis-crotonamide dimethyl phosphate ester; O,O-Dimethyl-O-(2-N-methylcarbamoyl-1-methyl-vinyl)-fosfaat; Monokrotofosz; cis-1-Methyl-2-methyl carbamoyl vinyl phosphate; Corophos; O,O-Dimetil-O-(2-N-metilcarbamoil-1-metil-vinil)-fosfato; Pandar; Parryfos; Pillardrin; Crisodin; Plantdrin; Shell sd 9129; Crisodrin; Croton 36; Crotos; Ulvair; CHEBI:38728",2014-12-24,1,,,,,,,,,
102787-23-5,0,OMOP Exposome,Observation,Substance,(E)-N-[2-[[5-(Dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-(4-methylpiperazin-1-yl)-2-nitroethenamine,,2014-12-24,1,,,,,,,,,
62-46-4,0,OMOP Exposome,Observation,Substance,(R)-lipoic acid,"Thioctansaeure; 6,8-thioctic acid; Acetate-replacing factor; 5-(1,2-dithiolan-3-yl)valeric acid; 5-3-(1,2-dithiolanyl)pentanoic acid; 5-(dithiolan-3-yl)valeric acid; Thioctic acid d-form; Thioctsaeure; Thioktsaeure; \u03b1-lipoic acid; 6-thioctic acid; 6,8-thiotic acid; 6-thiotic acid; RLA; R-LA; liponic acid; alpha-Lipoic acid; Lipoic acid; (+)-alpha-Lipoic acid; Biletan; (R)-(+)-lipoic acid; (R)-1,2-Dithiolane-3-pentanoic acid; (R)-1,2-dithiolane-3-valeric acid; (R)-6,8-thioctic acid; (R)-Lipoate; (R)-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; 1,2-dithiolane-3-valeric acid; Thioctic acid; alpha-Liponsaeure; CHEBI:16494",2014-12-24,1,,,,,,,,,
458-88-8,0,OMOP Exposome,Observation,Substance,(S)-2-Propylpiperidine,(2S)-2-propylpiperidine; (+)-Coniine; Conine; ConIIne; ConIIn; Cicutin; Cicutine; alpha-Conine; 2-Propylpiperidine; (S)-beta-propylpiperidine; D-Conicine; (S)-(+)-conIIne; CHEBI:127791,2014-12-24,1,,,,,,,,,
475-67-2,0,OMOP Exposome,Observation,Substance,(S)-Isocorydine,"L-(+)-Isocorydine; (+)-Isocorydine; (+)-(S)-Isocorydine; 1,2,10-Trimethoxy-6a-alpha-Aporphin-11-ol; S-Luteanine; S-Artabotrine; (S)-(+)-Isocorydine; CHEBI:561752",2014-12-24,1,,,,,,,,,
17924-92-4,0,OMOP Exposome,Observation,Substance,"(S,E)-Zearalenone",,2014-12-24,1,,,,,,,,,
88-85-7,0,OMOP Exposome,Observation,Substance,"(?)-2-(1-Methylpropyl)-4,6-dinitrophenol",,2014-12-24,1,,,,,,,,,
57837-19-1,0,OMOP Exposome,Observation,Substance,(?)-Metalaxyl,"Apron; Apron 2E; Apron FL; Apron SD 35; Caswell No. 375AA; D,L-N-(2,6-Dimethylphenyl)-N-(2'-methoxyacetyl)alaninate de methyle; Mefenoxam; N-(2,6-Dimethylphenyl)-N-(methoxyacetyl)-alanine methyl ester; Methyl N-(2-methoxyacetyl)-N-(2,6-xylyl)-DL-alaninate; Metalasyl; Subdue 5SP; Subdue 2E; Methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate; Metaxanin; Ridomil vino; Methyl 2-(methoxyacetyl)-2,6-dimethylanilinopropanoate; Metasyl; Metanaxin; Metalaxyl; Metalaxil; Ridomil 72WP; Ridomil 2E; rac-Metalaxyl; (+-)-Metalaxyl; (r)-Metalaxyl; (\u00b1)-metalaxyl; Allegiance; CHEBI:6790",2014-12-24,1,,,,,,,,,
115182-35-9,0,OMOP Exposome,Observation,Substance,(?)-Methamidophos,"Amidor; Chevron ortho 9006; Filitox; Chevron 9006; Tamaron; Tamanox; Tahmabon; Sniper; Pillaron; Phosphoramidothioic acid, O,S-dimethyl ester; Patrole; Ortho monitor; O,S-Dimethylphosphoroamidothioate; O,S-Dimethyl phosphoroamidothioate; O,S-Dimethyl phosphoramidothiolate; O,S-Dimethyl phosphoramidothioate; O,S-Dimethyl amidothiophosphate; MTD; Monitor (insecticide); Monitor; Methyl phosphoramidothioate ((MeO)(MeS)P(O)(NH2)); Methyl phosphoramidothioate; Methamidophos; Metamidophos; Metamidofos estrella; Hamidop; (\u00b1)-methamidophos; Acephate-met; CHEBI:38721",2014-12-24,1,,,,,,,,,
300-76-5,0,OMOP Exposome,Observation,Substance,(?)-Naled,"Fosbrom; dimethyl-1,2-dibromo-2,2-dichloroethyl phosphate; Dimethyl 1,2-dibromo-2,2-dichloroethyl phosphate; Dibromfos; Bromex 50; Bromex; BRP; Phosphoric acid, 1,2-dibromo-2,2-dichloroethyl dimethyl ester; Orthodibromo; Ortho-dibrom; Ortho Dibrom 8E; o-Dibrom 8E; O-(1,2-Dibromo-2,2-dichloroethyl)-O,O-dimethyl phosphate; O,O-Dimethyl-O-(1,2-dibromo-2,2-dichloroethyl)phosphate; O,O-dimethyl O-2,2-dichloro-1,2-dibromoethyl phosphate; Nikabrom; Naled; Hibrom; Flibol ex; Bromchlophos; Arthodibrom; Alvora; Dibrom; (\u00b1)-naled; 1,2-Dibromo-2,2-Dichloroethyl dimethyl phosphate; 1,2-Dibromo-2,2-dichloroethyl dimethyl phosphatic acid; CHEBI:38729",2014-12-24,1,,,,,,,,,
2094-98-6,0,OMOP Exposome,Observation,Substance,"1,1'-Azobis(cyclohexanecarbonitrile)",,2014-12-24,1,,,,,,,,,
71-55-6,0,OMOP Exposome,Observation,Substance,"1,1,1-Trichloroethane","Trichloro-1,1,1-ethane; Tafclean; Solvethane; Methyltrichloromethane; Methylchloroform; Ethana NU; Genklene LB; Chlorten; 1,1,1 Trichloroethane; alpha-T; Aerothene TT; 2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1,1-trichloroethane; 1,1,1-Tricloroetano; 1,1,1-Trichloro-Ethane; 1,1,1-TCE; 1,1,1-Trichloraethan; 1,1,1-Trichlorathan; 1,1,1-Trichloro-2-(O-chlorophenyl)-2-(p-chlorophenyl)ethane; 1,1,1-Trichlorethane; ICI-CF 2; Inhibisol; Methyl-Chloroform; Chlorothene; Chlorotene; CH3CCl3; alpha-Trichloroethane; Tri-ethane; Chlorothane NU; Cleanite; Distillex DS1; Ethana; Trichloromethylmethane; Trichloroethane; CHEBI:36015",2014-12-24,1,,,,,,,,,
79-27-6,0,OMOP Exposome,Observation,Substance,"1,1,2,2-Tetrabromoethane",,2014-12-24,1,,,,,,,,,
79-34-5,0,OMOP Exposome,Observation,Substance,"1,1,2,2-Tetrachloroethane","SYM-tetrachloroethane; Westron; Westrol; Tetrachloroethane; Tetrachlorethane; Symmetrical tetrachloroethane; S-tetrachloroethane; Ethane,1,1,2,2-Tetrachloro; Dichloro 2,2 dichloroethane; Cellon, bonoform; Cellon; Bonoform; Acetylene tetrachloride; 1,1-Dichloro-2,2-dichloroethane; 1,1-Dichloro-2, 2-dichloroethane; 1,1,2,2-Tetrachlorethane; 1,1,2,2-Tetrachloraethan; CHEBI:36026",2014-12-24,1,,,,,,,,,
79-00-5,0,OMOP Exposome,Observation,Substance,"1,1,2-Trichloroethane","Ethane trichloride; 1,1, 2-Trichloroethane; 1,1,2-Trichloraethan; 1,1,2-Trichlorethane; 1,2,2-Trichloroethane; beta-T; Beta-trichloroethane; Beta.-trichloroethane; Trichloroethane; Vinyl trichloride; Vinyltrichloride; CHEBI:36018",2014-12-24,1,,,,,,,,,
557-91-5,0,OMOP Exposome,Observation,Substance,"1,1-Dibromoethane",,2014-12-24,1,,,,,,,,,
75-34-3,0,OMOP Exposome,Observation,Substance,"1,1-Dichloroethane",,2014-12-24,1,,,,,,,,,
75-35-4,0,OMOP Exposome,Observation,Substance,"1,1-Dichloroethene","Vinylidene dichloride; Vinylidine chloride; Sconatex; Vinylidene chloride; Vinylidene chloride, monomer; Vinylidene chloride (II); Vinylidene chloride, inhibited; Vinylidene chloride(II); 1,1-DCE; 1,1-Dichloroethene monomer; 1,1-Dichloroethylene; Monovinylidene chloride; CHEBI:34031",2014-12-24,1,,,,,,,,,
563-58-6,0,OMOP Exposome,Observation,Substance,"1,1-Dichloropropene",,2014-12-24,1,,,,,,,,,
657-24-9,0,OMOP Exposome,Observation,Substance,"1,1-Dimethylbiguanide","PMS-Metformin; Nu-Metformin; Novo-Metformin; N1,N1-Dimethylbiguanide; Diabex; Diabefagos; Apo-Metformin; 1,1-Dimethyl biguanide; N,N-Dimethylimidodicarbonimidic diamide; N,N-Dimethylbiguanide; Mylan-Metformin; Metiguanide; Metforminum; Glucophage; Glucophage XR; Glumetza; Haurymellin; Meguan; Metformin; Metformina; Metformine; Metformine pamoate; Dimethylbiguanide; Dimethylbiguanid; DMBG; Fortamet; Gen-Metformin; Dianben; Diaformin; Teva-Metformin; Sandoz Metformin; Riomet; Ratio-Metformin; Ran-Metformin; Obimet; CHEBI:6801",2014-12-24,1,,,,,,,,,
66-71-7,0,OMOP Exposome,Observation,Substance,"1,10-Phenanthroline",,2014-12-24,1,,,,,,,,,
31107-44-5,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7,8,9,10,10,11,11-Dodecachloro-1,4,4a,5a,6,9,9a,9b-octahydro-1,4:6,9- dimethanodibenzofuran",,2014-12-24,1,,,,,,,,,
"39001-02-0
",0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7,8,9-Octachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
107555-95-3,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7,8-Heptabromodibenzofuran",,2014-12-24,1,,,,,,,,,
35822-46-9,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
38998-75-3,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7,8-Heptachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58200-70-7,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7,9-Heptachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-25-8,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7,9-Heptachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
107207-36-3,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7-Hexabromo-8,9-dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
124388-78-9,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7-Hexabromodibenzofuran",,2014-12-24,1,,,,,,,,,
58200-66-1,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
79060-60-9,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,7-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
69698-58-4,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,8,9-Heptachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58200-67-2,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,8-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
69698-60-8,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,8-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58200-68-3,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,9-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
91538-83-9,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
67028-19-7,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-47-6,0,OMOP Exposome,Observation,Substance,"1,2,3,4,6-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
161880-51-9,0,OMOP Exposome,Observation,Substance,"1,2,3,4,7,8,9-Heptabromodibenzofuran",,2014-12-24,1,,,,,,,,,
55673-89-7,0,OMOP Exposome,Observation,Substance,"1,2,3,4,7,8,9-Heptachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
129880-08-6,0,OMOP Exposome,Observation,Substance,"1,2,3,4,7,8-Hexabromodibenzofuran",,2014-12-24,1,,,,,,,,,
39227-28-6,0,OMOP Exposome,Observation,Substance,"1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-26-9,0,OMOP Exposome,Observation,Substance,"1,2,3,4,7,8-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
91538-84-0,0,OMOP Exposome,Observation,Substance,"1,2,3,4,7,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
39227-61-7,0,OMOP Exposome,Observation,Substance,"1,2,3,4,7-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-48-7,0,OMOP Exposome,Observation,Substance,"1,2,3,4,7-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
92341-07-6,0,OMOP Exposome,Observation,Substance,"1,2,3,4,8,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
67517-48-0,0,OMOP Exposome,Observation,Substance,"1,2,3,4,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-49-8,0,OMOP Exposome,Observation,Substance,"1,2,3,4,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
30746-58-8,0,OMOP Exposome,Observation,Substance,"1,2,3,4-Tetrachlorodibenzo-p-dioxin","1,2,3,4-tetrachlorodibenzob,e1,4dioxin; 1,2,3,4-tetrachlorodibenzodioxine; 1,2,3,4-Tetrachlorodibenzodioxin; 1,2,3,4-Tetrachlorodibenzo-para-dioxin; 1,2,3,4-Tetrachlorodibenzo-P-dioxin; 1,2,3,4-TCDD; 1,2,3,4-Tetrachlorooxanthrene; CHEBI:27785",2014-12-24,1,,,,,,,,,
24478-72-6,0,OMOP Exposome,Observation,Substance,"1,2,3,4-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
107555-94-2,0,OMOP Exposome,Observation,Substance,"1,2,3,6,7,8-Hexabromodibenzofuran",,2014-12-24,1,,,,,,,,,
57653-85-7,0,OMOP Exposome,Observation,Substance,"1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
64461-98-9,0,OMOP Exposome,Observation,Substance,"1,2,3,6,7,9-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
92341-06-5,0,OMOP Exposome,Observation,Substance,"1,2,3,6,7,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71925-15-0,0,OMOP Exposome,Observation,Substance,"1,2,3,6,7-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
57117-42-7,0,OMOP Exposome,Observation,Substance,"1,2,3,6,7-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58200-69-4,0,OMOP Exposome,Observation,Substance,"1,2,3,6,8,9-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
75198-38-8,0,OMOP Exposome,Observation,Substance,"1,2,3,6,8,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71925-16-1,0,OMOP Exposome,Observation,Substance,"1,2,3,6,8-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-51-2,0,OMOP Exposome,Observation,Substance,"1,2,3,6,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-34-7,0,OMOP Exposome,Observation,Substance,"1,2,3,6,9-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-52-3,0,OMOP Exposome,Observation,Substance,"1,2,3,6,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71669-25-5,0,OMOP Exposome,Observation,Substance,"1,2,3,6-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-21-6,0,OMOP Exposome,Observation,Substance,"1,2,3,6-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
161880-49-5,0,OMOP Exposome,Observation,Substance,"1,2,3,7,8,9-Hexabromodibenzofuran",,2014-12-24,1,,,,,,,,,
19408-74-3,0,OMOP Exposome,Observation,Substance,"1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
72918-21-9,0,OMOP Exposome,Observation,Substance,"1,2,3,7,8,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
107555-93-1,0,OMOP Exposome,Observation,Substance,"1,2,3,7,8-Pentabromodibenzofuran",,2014-12-24,1,,,,,,,,,
40321-76-4,0,OMOP Exposome,Observation,Substance,"1,2,3,7,8-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
57117-41-6,0,OMOP Exposome,Observation,Substance,"1,2,3,7,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71925-17-2,0,OMOP Exposome,Observation,Substance,"1,2,3,7,9-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-53-4,0,OMOP Exposome,Observation,Substance,"1,2,3,7,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
67028-18-6,0,OMOP Exposome,Observation,Substance,"1,2,3,7-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-22-7,0,OMOP Exposome,Observation,Substance,"1,2,3,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71925-18-3,0,OMOP Exposome,Observation,Substance,"1,2,3,8,9-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-54-5,0,OMOP Exposome,Observation,Substance,"1,2,3,8,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
53555-02-5,0,OMOP Exposome,Observation,Substance,"1,2,3,8-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
62615-08-1,0,OMOP Exposome,Observation,Substance,"1,2,3,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71669-26-6,0,OMOP Exposome,Observation,Substance,"1,2,3,9-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-23-8,0,OMOP Exposome,Observation,Substance,"1,2,3,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
87-61-6,0,OMOP Exposome,Observation,Substance,"1,2,3-Trichlorobenzene","1,2,3-Trichlorbenzol; Trichlorbenzene; Vic-trichlorobenzene; 1,2,6-Trichlorobenzene; 1,2, 3-Trichlorobenzene; CHEBI:35289",2014-12-24,1,,,,,,,,,
54536-17-3,0,OMOP Exposome,Observation,Substance,"1,2,3-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83636-47-9,0,OMOP Exposome,Observation,Substance,"1,2,3-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
67562-40-7,0,OMOP Exposome,Observation,Substance,"1,2,4,6,7,8-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
39227-62-8,0,OMOP Exposome,Observation,Substance,"1,2,4,6,7,9-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
75627-02-0,0,OMOP Exposome,Observation,Substance,"1,2,4,6,7,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-35-8,0,OMOP Exposome,Observation,Substance,"1,2,4,6,7-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-50-1,0,OMOP Exposome,Observation,Substance,"1,2,4,6,7-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58802-09-8,0,OMOP Exposome,Observation,Substance,"1,2,4,6,8,9-Hexachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
69698-59-5,0,OMOP Exposome,Observation,Substance,"1,2,4,6,8,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71998-76-0,0,OMOP Exposome,Observation,Substance,"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
69698-57-3,0,OMOP Exposome,Observation,Substance,"1,2,4,6,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-36-9,0,OMOP Exposome,Observation,Substance,"1,2,4,6,9-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-24-7,0,OMOP Exposome,Observation,Substance,"1,2,4,6,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71669-27-7,0,OMOP Exposome,Observation,Substance,"1,2,4,6-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
71998-73-7,0,OMOP Exposome,Observation,Substance,"1,2,4,6-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58802-08-7,0,OMOP Exposome,Observation,Substance,"1,2,4,7,8-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
58802-15-6,0,OMOP Exposome,Observation,Substance,"1,2,4,7,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-37-0,0,OMOP Exposome,Observation,Substance,"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
71998-74-8,0,OMOP Exposome,Observation,Substance,"1,2,4,7,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71669-28-8,0,OMOP Exposome,Observation,Substance,"1,2,4,7-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83719-40-8,0,OMOP Exposome,Observation,Substance,"1,2,4,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-38-1,0,OMOP Exposome,Observation,Substance,"1,2,4,8,9-Pentachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-23-6,0,OMOP Exposome,Observation,Substance,"1,2,4,8,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71669-29-9,0,OMOP Exposome,Observation,Substance,"1,2,4,8-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
64126-87-0,0,OMOP Exposome,Observation,Substance,"1,2,4,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71665-99-1,0,OMOP Exposome,Observation,Substance,"1,2,4,9-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-24-9,0,OMOP Exposome,Observation,Substance,"1,2,4,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
120-82-1,0,OMOP Exposome,Observation,Substance,"1,2,4-Trichlorobenzene","As-trichlorobenzene; 1,2,5-Trichlorobenzene; 1,2,4-Trichlorobenzol; 1,2,4-Trichlorbenzol; 1,2, 4-Trichlorobenzene; Trichlorobenzene A; Trichlorobenzol; Unsym-trichlorobenzene; 1,3,4-Trichlorobenzene; CHEBI:28222",2014-12-24,1,,,,,,,,,
39227-58-2,0,OMOP Exposome,Observation,Substance,"1,2,4-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
95-63-6,0,OMOP Exposome,Observation,Substance,"1,2,4-Trimethylbenzene","Uns-trimethylbenzene; .psi.-Cumene; 1,2, 4-Trimethylbenzene; 1,2,4-Trimethyl-Benzene; 1,2,4-Trimethylbenzene (pseudocumene); 1,2,5-Trimethyl-Benzene; 1,2,5-Trimethylbenzene; 1,3,4-Trimethylbenzene; As-Trimethylbenzene; Asymmetrical trimethylbenzene; laquo Psiraquo -Cumene; Pseudocumene; Pseudocumol; Psi-cumene; CHEBI:34039",2014-12-24,1,,,,,,,,,
40581-90-6,0,OMOP Exposome,Observation,Substance,"1,2,6,7-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-25-0,0,OMOP Exposome,Observation,Substance,"1,2,6,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
67323-56-2,0,OMOP Exposome,Observation,Substance,"1,2,6,8-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83710-07-0,0,OMOP Exposome,Observation,Substance,"1,2,6,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
40581-91-7,0,OMOP Exposome,Observation,Substance,"1,2,6,9-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-18-9,0,OMOP Exposome,Observation,Substance,"1,2,6,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
69760-96-9,0,OMOP Exposome,Observation,Substance,"1,2,6-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
64560-15-2,0,OMOP Exposome,Observation,Substance,"1,2,6-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
84761-80-8,0,OMOP Exposome,Observation,Substance,"1,2,7,8-Tetrabromodibenzofuran",,2014-12-24,1,,,,,,,,,
58802-20-3,0,OMOP Exposome,Observation,Substance,"1,2,7,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-26-1,0,OMOP Exposome,Observation,Substance,"1,2,7,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-30-3,0,OMOP Exposome,Observation,Substance,"1,2,7-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-37-4,0,OMOP Exposome,Observation,Substance,"1,2,7-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
62470-54-6,0,OMOP Exposome,Observation,Substance,"1,2,8,9-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-22-5,0,OMOP Exposome,Observation,Substance,"1,2,8,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-31-4,0,OMOP Exposome,Observation,Substance,"1,2,8-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-34-1,0,OMOP Exposome,Observation,Substance,"1,2,8-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-32-5,0,OMOP Exposome,Observation,Substance,"1,2,9-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-38-5,0,OMOP Exposome,Observation,Substance,"1,2,9-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
2634-33-5,0,OMOP Exposome,Observation,Substance,"1,2-Benzisothiazol-3(2H)-one","Benzisothiazolone; 2-Thiobenzimide; C7H5NOS; 1,2-Benzisothiazoline-3-one; 1,2-Benzisothiazolin-3-one; IPX; BenzoDisothiazol-3-one; Proxan; Proxel; 1,2-Benzisothiazolinone; Proxel PL; CHEBI:167099",2014-12-24,1,,,,,,,,,
13246-32-7,0,OMOP Exposome,Observation,Substance,"1,2-Bis(dimethylarsino)benzene","1,2-phenylenebis(dimethylarsane); 1,2-phenylenebis(dimethylarsine); 2-Phenylene-bis-dimethylarsine; O-phenylenebis(dimethylarsine); Diars; Benzene-1,2-diylbis(dimethylarsane); CHEBI:30628",2014-12-24,1,,,,,,,,,
96-12-8,0,OMOP Exposome,Observation,Substance,"1,2-Dibromo-3-chloropropane",,2014-12-24,1,,,,,,,,,
106-93-4,0,OMOP Exposome,Observation,Substance,"1,2-Dibromoethane","Bromofume; Dibromoethylene; Dibromoethane; DBE; Edabrom; EDB; Ethylene Bromide; Ethylene Dibromide; Garden dowfume; Glycol bromide; Glycol dibromide; Iscobrome D; Kopfume; Nefis; Nephis; Sanhyuum; Soilbrom; Soilfume; SYM dibromoethane; SYM-dibromoethane; Unifume; 1,2,Dibromoethane; 1,2-Dibromoethane(Ethylene bromide); 1,2-Dibromomethane; 1,2-Ethylene dibromide; Dowfume; Alpha,beta-dibromoethane; Alpha,omega-dibromoethane; Celmide; CHEBI:28534",2014-12-24,1,,,,,,,,,
78-75-1,0,OMOP Exposome,Observation,Substance,"1,2-Dibromopropane",,2014-12-24,1,,,,,,,,,
95-50-1,0,OMOP Exposome,Observation,Substance,"1,2-Dichlorobenzene","Dichloricide; Chloroden; Chloroben; 1,2-Dichlorbenzene; ODCB; ortho-Dichlorobenzene; Orthodichlorobenzene; Orthodichlorobenzol; ODB; o-dichlorobenzol; o-Dichlorobenzene; o-dichlorbenzol; o-dichlorbenzene; o-dichlor benzol; Dowtherm e; Dizene; Dilantin DB; Dichlorobenzol; Dichlorobenzene; Cloroben; CHEBI:35290",2014-12-24,1,,,,,,,,,
54536-18-4,0,OMOP Exposome,Observation,Substance,"1,2-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
64126-85-8,0,OMOP Exposome,Observation,Substance,"1,2-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
107-06-2,0,OMOP Exposome,Observation,Substance,"1,2-Dichloroethane","DCE; Ethylene chloride; Ethane dichloride; EDC; 1,2-DCE; a,b-Dichloroethane; alpha,beta-Dichloroethane; Glycol dichloride; Ethylene dichloride; CHEBI:27789",2014-12-24,1,,,,,,,,,
563-54-2,0,OMOP Exposome,Observation,Substance,"1,2-Dichloropropene",,2014-12-24,1,,,,,,,,,
Q9BV57,0,OMOP Exposome,Observation,Substance,"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase",,2024-09-14,1,,,,,,,,,
122-66-7,0,OMOP Exposome,Observation,Substance,"1,2-Diphenylhydrazine",,2014-12-24,1,,,,,,,,,
524-42-5,0,OMOP Exposome,Observation,Substance,"1,2-Naphthoquinone",,2014-12-24,1,,,,,,,,,
Q07973,0,OMOP Exposome,Observation,Substance,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",,2024-09-14,1,,,,,,,,,
71998-75-9,0,OMOP Exposome,Observation,Substance,"1,3,4,6,7,8-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
92341-05-4,0,OMOP Exposome,Observation,Substance,"1,3,4,6,7,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-36-3,0,OMOP Exposome,Observation,Substance,"1,3,4,6,7-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-55-6,0,OMOP Exposome,Observation,Substance,"1,3,4,6,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
70648-15-6,0,OMOP Exposome,Observation,Substance,"1,3,4,6,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-27-2,0,OMOP Exposome,Observation,Substance,"1,3,4,6-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58802-16-7,0,OMOP Exposome,Observation,Substance,"1,3,4,7,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
70648-20-3,0,OMOP Exposome,Observation,Substance,"1,3,4,7,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
70648-16-7,0,OMOP Exposome,Observation,Substance,"1,3,4,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
70872-82-1,0,OMOP Exposome,Observation,Substance,"1,3,4,8,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
92341-04-3,0,OMOP Exposome,Observation,Substance,"1,3,4,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-28-3,0,OMOP Exposome,Observation,Substance,"1,3,4,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82911-61-3,0,OMOP Exposome,Observation,Substance,"1,3,4-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
108-70-3,0,OMOP Exposome,Observation,Substance,"1,3,5-Trichlorobenzene","SYM-trichlorobenzene; S-trichlorobenzene; TCZ; 1,3,5-Trichloro-benzene; 1,3, 5-Trichlorobenzene; 1,3,5-Trichlorbenzol; CHEBI:49916",2014-12-24,1,,,,,,,,,
99-35-4,0,OMOP Exposome,Observation,Substance,"1,3,5-Trinitrobenzene","Trinitrobenzene; 1,3,5-Trinitrobenzol; 1,3, 5-Trinitrobenzene; 2,4,6-trinitrobenzene; Benzite; S-trinitrobenzene; SYM-trinitrobenzene; Symmetric trinitrobenzene; SYN-trinitrobenzene; TNB; CHEBI:48113",2014-12-24,1,,,,,,,,,
57117-36-9,0,OMOP Exposome,Observation,Substance,"1,3,6,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
33423-92-6,0,OMOP Exposome,Observation,Substance,"1,3,6,8-Tetrachlorodibenzo-p-dioxin","1,3,6,8-Tetrachlorodibenzo1,4dioxin; 1,3,6,8-tetrachlorodibenzob,e1,4dioxin; 1,3,6,8-Tetrachlorooxanthrene; 1,3,6,8-TCDD; 1,3,6,8-Tetrachlorobenzo-p-dioxin; 1,3,6,8-Tetrachlorodibenzo-P-dioxin; 1,3,6,8-Tetrachlorodibenzo-para-dioxin; 1,3,6,8-Tetrachlorodibenzodioxin; 1,3,6,8-tetrachlorodibenzodioxine; CHEBI:27936",2014-12-24,1,,,,,,,,,
71998-72-6,0,OMOP Exposome,Observation,Substance,"1,3,6,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
71669-24-4,0,OMOP Exposome,Observation,Substance,"1,3,6,9-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83690-98-6,0,OMOP Exposome,Observation,Substance,"1,3,6,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-33-6,0,OMOP Exposome,Observation,Substance,"1,3,6-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-39-6,0,OMOP Exposome,Observation,Substance,"1,3,6-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
50585-46-1,0,OMOP Exposome,Observation,Substance,"1,3,7,8-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
57117-35-8,0,OMOP Exposome,Observation,Substance,"1,3,7,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
62470-53-5,0,OMOP Exposome,Observation,Substance,"1,3,7,9-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
64560-17-4,0,OMOP Exposome,Observation,Substance,"1,3,7,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
67028-17-5,0,OMOP Exposome,Observation,Substance,"1,3,7-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
64560-16-3,0,OMOP Exposome,Observation,Substance,"1,3,7-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82306-61-4,0,OMOP Exposome,Observation,Substance,"1,3,8-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
76621-12-0,0,OMOP Exposome,Observation,Substance,"1,3,8-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82306-62-5,0,OMOP Exposome,Observation,Substance,"1,3,9-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-40-9,0,OMOP Exposome,Observation,Substance,"1,3,9-Trichlorodibenzofuran",,2024-09-14,1,,,,,,,,,
108-46-3,0,OMOP Exposome,Observation,Substance,"1,3-Benzenediol","Resorcin; m-Hydroxy-Phenol; m-Hydroxyphenol; Resorcinol, 8CI; Resorzin; 1,3-Dihydroxybenzene; 3-Hydroxyphenol; FEMA 3589; m-Hydroquinone; m-Benzenediol; m-Dihydroxybenzene; m-Dioxybenzene; 1,3-Dihydroxy-Benzene; Rezorsine; CHEBI:27810",2014-12-24,1,,,,,,,,,
A2QLK4,0,OMOP Exposome,Observation,Substance,"1,3-beta-glucan synthase component FKS1",,2024-09-14,1,,,,,,,,,
106-99-0,0,OMOP Exposome,Observation,Substance,"1,3-Butadiene","alpha,gamma-Butadiene; 1,3-Butadien; Vinylethylene; Pyrrolylene; Divinyl; CH2=CHCH=CH2; CH22CH1CH2CH2; Butadiene; Butadien; Erythrene; Butadieen; Buta-1,3-diene; Buta-1,3-dien; Buta-1,3-dieen; Bivinyl; Biethylene; alpha,\u00abgamma\u00bb-Butadiene; CHEBI:39478",2014-12-24,1,,,,,,,,,
107-88-0,0,OMOP Exposome,Observation,Substance,"1,3-Butanediol","b-Butylene glycol; (+/-)-1,3-Butanediol; (.+/-.)-1,3-Butanediol; (R)-(-)-Butane-1,3-diol; (R)-1,3-Butanediol; (RS)-1,3-Butandiol; (S)-(+)-1,3-Butanediol; (S)-(+)-Butane-1,3-diol; (S)-1,3-Butanediol; 1,3 Butylene glycol; 1,3-Butandiol; 1,3-Butanodiol; 1,3-Butylene glycol; 1,3-Butylenglykol; 1,3-Dihydroxybutane; 1-Methyl-1,3-propanediol; BD; beta-Butylene glycol; Butane-1,3-diol; Butylene glycol; DL-1,3-butanediol; Methyltrimethylene glycol; CHEBI:52683",2014-12-24,1,,,,,,,,,
77-48-5,0,OMOP Exposome,Observation,Substance,"1,3-Dibromo-5,5-dimethylhydantoin",,2014-12-24,1,,,,,,,,,
109-64-8,0,OMOP Exposome,Observation,Substance,"1,3-Dibromopropane",,2014-12-24,1,,,,,,,,,
50585-39-2,0,OMOP Exposome,Observation,Substance,"1,3-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
94538-00-8,0,OMOP Exposome,Observation,Substance,"1,3-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
6440-58-0,0,OMOP Exposome,Observation,Substance,"1,3-Dimethylol-5,5-dimethylhydantoin",,2014-12-24,1,,,,,,,,,
99-65-0,0,OMOP Exposome,Observation,Substance,"1,3-Dinitrobenzene",,2014-12-24,1,,,,,,,,,
66794-59-0,0,OMOP Exposome,Observation,Substance,"1,4,6,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82911-58-8,0,OMOP Exposome,Observation,Substance,"1,4,6,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
40581-93-9,0,OMOP Exposome,Observation,Substance,"1,4,6,9-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-19-0,0,OMOP Exposome,Observation,Substance,"1,4,6,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82911-60-2,0,OMOP Exposome,Observation,Substance,"1,4,6-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
40581-94-0,0,OMOP Exposome,Observation,Substance,"1,4,7,8-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
83704-29-4,0,OMOP Exposome,Observation,Substance,"1,4,7,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-41-0,0,OMOP Exposome,Observation,Substance,"1,4,7-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82306-64-7,0,OMOP Exposome,Observation,Substance,"1,4,8-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
64560-14-1,0,OMOP Exposome,Observation,Substance,"1,4,8-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82306-63-6,0,OMOP Exposome,Observation,Substance,"1,4,9-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-13-4,0,OMOP Exposome,Observation,Substance,"1,4,9-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
106-46-7,0,OMOP Exposome,Observation,Substance,"1,4-Dichlorobenzene","Dichlorobenzene; 1, 4-Dichlorobenzene; 1,4-Chlorobenzene; 1,4-Dichloorbenzeen; 1,4-Dichlor-benzol; 1,4-Dichloro-Benzene; Di-chloricide; Dichlorocide; Evola; Globol; Kaydox; p-Chlorophenyl chloride; p-Dichlorbenzol; p-Dichloro-Benzene; p-Dichlorobenzene; p-Dichlorobenzol; p-Diclorobenzene; PARA; Para crystals; para-Dichlorobenzene; Paracide; Paradi; Paradichlorbenzol; Paradichlorobenzene; Paradichlorobenzol; Paradow; Paramoth; Paranuggets; Parazene; PDB; PDCB; Persia-Perazol; Santochlor; CHEBI:28618",2014-12-24,1,,,,,,,,,
54536-19-5,0,OMOP Exposome,Observation,Substance,"1,4-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
94538-01-9,0,OMOP Exposome,Observation,Substance,"1,4-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
123-91-1,0,OMOP Exposome,Observation,Substance,"1,4-Dioxane","Tetrahydro-para-dioxin; Diethylene dioxide; Diethylene ether; Diethylene oxide; Dioxan; Dioxan-1,4; Dioxane; 1,4-Diethyleneoxide; Tetrahydro-p-dioxin; Dioxyethylene ether; Glycol ethylene ether; P-dioxane; Para-dioxane; Tetrahydro-1,4-dioxin; Dioxane-1,4; 1,4-Diethylenedioxide; 1,4-Dioxacyclohexane; 1,4-Dioxan; Di(ethylene oxide); 1, 4-Diethylene dioxide; 1,4 Dioxane; 1,4-DIethylene dioxide; CHEBI:47032",2014-12-24,1,,,,,,,,,
130-15-4,0,OMOP Exposome,Observation,Substance,"1,4-Naphthoquinone","alpha-Naphthoquinone; 1,4-dihydro-1,4-Diketonaphthalene; 1,4-Naphthalenedione; Naphthoquinone; P-Naphthoquinone; CHEBI:27418",2014-12-24,1,,,,,,,,,
38178-38-0,0,OMOP Exposome,Observation,Substance,"1,6-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
74992-97-5,0,OMOP Exposome,Observation,Substance,"1,6-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82306-65-8,0,OMOP Exposome,Observation,Substance,"1,7,8-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
82291-26-7,0,OMOP Exposome,Observation,Substance,"1,7-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
94538-02-0,0,OMOP Exposome,Observation,Substance,"1,7-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82291-27-8,0,OMOP Exposome,Observation,Substance,"1,8-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
81638-37-1,0,OMOP Exposome,Observation,Substance,"1,8-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
64560-13-0,0,OMOP Exposome,Observation,Substance,"1,9-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
70648-14-5,0,OMOP Exposome,Observation,Substance,"1,9-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
24483-78-1,0,OMOP Exposome,Observation,Substance,"1-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-2,3,4,5-tetrahydro-1-benzazepine",,2014-12-24,1,,,,,,,,,
60737-54-4,0,OMOP Exposome,Observation,Substance,1-(Cyclopropylmethyl)-2-(nitromethylidene)pyrrolidine,,2014-12-24,1,,,,,,,,,
72126-78-4,0,OMOP Exposome,Observation,Substance,"1-[(6-Chloropyridin-3-yl)methyl]-2-(nitromethylidene)-1,3-diazinane",,2014-12-24,1,,,,,,,,,
16079-88-2,0,OMOP Exposome,Observation,Substance,"1-Bromo-3-chloro-5,5-dimethylhydantoin",,2014-12-24,1,,,,,,,,,
109-65-9,0,OMOP Exposome,Observation,Substance,1-Bromobutane,,2014-12-24,1,,,,,,,,,
111-25-1,0,OMOP Exposome,Observation,Substance,1-Bromohexane,,2014-12-24,1,,,,,,,,,
106-94-5,0,OMOP Exposome,Observation,Substance,1-Bromopropane,1-BROMO-PROPANE; Bromo propane; Bromopropane; n-C3H7Br; N-propyl bromide; Propyl bromide; CHEBI:47105,2014-12-24,1,,,,,,,,,
39227-53-7,0,OMOP Exposome,Observation,Substance,1-Chlorodibenzo-p-dioxin,,2014-12-24,1,,,,,,,,,
42934-53-2,0,OMOP Exposome,Observation,Substance,1-Chlorodibenzofuran,,2014-12-24,1,,,,,,,,,
36653-82-4,0,OMOP Exposome,Observation,Substance,1-Hexadecanol,Cetaffine; Elfacos C; 1-Cetanol; 1-Hexadecyl alc; 1-Hexadecyl alcohol; 1-Hexanedecanol; 1-Hydroxyhexadecane; 16-Hexadecanol; Adol; Adol 52; Adol 52 NF; Adol 52NF; Adol 54; Alcohol C-16; Aldol 54; Alfol 16; Atalco C; C16 alcohol; Cachalot C-50; Cachalot C-50 NF; Cachalot C-51; Cachalot C-52; Ceraphyl ICA; Cetal; Cetalol CA; Cetanol; Cetostearyl alcohol; Cetyl alcohol; Cetyl alcohol NF; Cetylic alcohol; Cetylol; Crodacol C; Crodacol C70; Crodacol C95NF; Crodacol-CAS; Crodacol-CAT; Cyclal cetyl alcohol; Dehydag wax 16; Epal 16NF; Ethal; Ethol; Eutanol G16; Exxal 16; Fancol CA; Fatty alcohol; Hexadecan-1-ol; Hexadecanol; Hexadecanol NF; Hexadecyl alcohol; Dytol F-11; Hyfatol; Hyfatol 16; Isocetyl alcohol; Isohexadecanol; Isohexadecyl alcohol; Lanette 16; Lanol C; Lipocol C; SSD RP; SSD; Siponol wax-A; Siponol CC; Rita CA; Product 308; Philcohol 1600; Palmityl alcohol; Normal primary hexadecyl alcohol; N-Hexadecyl alcohol; N-Hexadecanol; N-Hexadecan-1-ol; N-Cetyl alcohol; N-1-Hexadecanol; Myristyl alcohol; Michel XO-150-16; Loxiol VPG 1743; Loxanwachs SK; Loxanol K extra; Loxanol K; LorolL 24; Lorol C16; Lorol 24; CHEBI:16125,2014-12-24,1,,,,,,,,,
111-27-3,0,OMOP Exposome,Observation,Substance,1-Hexanol,"Amylcarbinol; Alcohol(C6); Alcohol C-6; 1-Hydroxyhexane; 1-Hexyl alcohol; Hexalin; Hexan-1-ol; Hexanol; Hexyl alcohol (natural); Hexyl alcohol, active; Pentylcarbinol; Cyclohexanol; Epal 6; Exxal 6; Fatty alcohol(C6); HEX; Cyclohexan-1-ol; Caproyl alcohol; N-Hexyl alcohol; N-Hexenol; N-Hexanol; N-Hexan-1-ol; Hexahydrophenol; Hexanol-(1); Hexyl alcohol; Hexanol-CMPD; Caproic alcohol; C6 alcohol; BHL; CHEBI:113441",2014-12-24,1,,,,,,,,,
5315-79-7,0,OMOP Exposome,Observation,Substance,1-Hydroxypyrene,,2014-12-24,1,,,,,,,,,
872-50-4,0,OMOP Exposome,Observation,Substance,1-Methyl-2-pyrrolidone,,2014-12-24,1,,,,,,,,,
28289-54-5,0,OMOP Exposome,Observation,Substance,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","1,2,3,6-Tetrahydro-1-methyl-4-phenylpyridine; N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPTP; CHEBI:17963",2014-12-24,1,,,,,,,,,
105650-23-5,0,OMOP Exposome,Observation,Substance,"1-Methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine","2-Amino-1-methyl-6-phenyl-1H-imidazo4,5-bpyridine; 1-Methyl-6-phenyl-1H-imidazo(4,5-b)pyridin-2-amine; 1-Methyl-6-phenyl-1H-imidazo4,5-bpyridin-2-amine, 9CI; 1H-Imidazo(4,5-b)pyridin-2-amine, 1-methyl-6-phenyl- (9CI); 1H-Imidazo(4,5-b)pyridine; 2-Amino-1-methyl-6-phenyl-imidazo 4,5-b pyridine; 2-Amino-1-methyl-6-phenyl-Imidazo(4,5-b)pyridine; 2-Amino-1-methyl-6-phenylimidazo 4,5-bpyridine (PhIP); 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine; 2-Amino-1-methyl-6-phenylimidazo4,5-bpyridine; PhIP; PIQ; CHEBI:76290",2014-12-24,1,,,,,,,,,
90-12-0,0,OMOP Exposome,Observation,Substance,1-Methylnaphthalene,Methyl-Naphthalene; Methyl-1-naphthalene; a-Methyl-Naphthalene; a-Methylnaphthalene; alpha-Methylnaphthalene; 1-Methyl naphthalene; 1-Methyl-Naphthalene; alpha-Methyl-Naphthalene; Methyl naphthalene; CHEBI:50717,2014-12-24,1,,,,,,,,,
90-15-3,0,OMOP Exposome,Observation,Substance,1-Naphthol,Zoba ERN; 1-Hydroxynaphthalene; 1-Naphthyl alcohol; alpha-Hydroxynaphthalene; Ursol ERN; Furro ER; Nako TRB; Naphthol-1; Naphthyl-1-ol; Tertral ERN; alpha-Naphthol; alpha-Naphthyl alcohol; BASF Ursol ERN; Durafur Developer D; Fouramine ERN; Fourrine 99; Fourrine ERN; CHEBI:10319,2014-12-24,1,,,,,,,,,
86-57-7,0,OMOP Exposome,Observation,Substance,1-Nitronaphthalene,,2014-12-24,1,,,,,,,,,
3391-86-4,0,OMOP Exposome,Observation,Substance,1-Octen-3-Ol,,2014-12-24,1,,,,,,,,,
109-67-1,0,OMOP Exposome,Observation,Substance,1-Pentene,,2014-12-24,1,,,,,,,,,
2906-39-0,0,OMOP Exposome,Observation,Substance,1-Pyrroline-5-carboxylic acid,"delta-1-Pyrroline-5-carboxylic acid; (S)-1-pyrroline-5-carboxylate; 1-Pyrroline-5-carboxylate; 3,4-Dihydro-2h-pyrrole-2-carboxylate; 3,4-Dihydro-2h-pyrrole-2-carboxylic acid; D1-Pyrroline-5-carboxylate; D1-Pyrroline-5-carboxylic acid; delta(1)Pyrroline-5-carboxylate; delta-1-Pyrroline-5-carboxylate; DL-1-Pyrroline-5-carboxylate; DL-1-Pyrroline-5-carboxylic acid; L-1-Pyrroline-5-carboxylate; L-delta 1-Pyrroline-5-carboxylate; Pyrroline 5-carboxylate; Pyrroline-5-carboxylate; CHEBI:1372",2018-03-21,1,,,,,,,,,
Q92781,0,OMOP Exposome,Observation,Substance,11-cis retinol dehydrogenase,,2024-09-14,1,,,,,,,,,
GIS1003260,0,OMOP Exposome,Observation,Substance,14-alpha Demethylase Inhibitor,,2024-09-14,1,,,,,,,,,
88337-96-6,0,OMOP Exposome,Observation,Substance,15-Acetyl-4-deoxynivalenol,,2014-12-24,1,,,,,,,,,
38818-66-5,0,OMOP Exposome,Observation,Substance,15-Deacetylcalonectrin,,2014-12-24,1,,,,,,,,,
GIS1003261,0,OMOP Exposome,Observation,Substance,17-alpha-hydroxylase deficiency (CYP17),,2024-09-14,1,,,,,,,,,
GIS1003262,0,OMOP Exposome,Observation,Substance,17-Beta Hydroxysteroid Dehydrogenase III Deficiency,,2024-09-14,1,,,,,,,,,
O14756,0,OMOP Exposome,Observation,Substance,17-beta-hydroxysteroid dehydrogenase type 6,,2024-09-14,1,,,,,,,,,
68-96-2,0,OMOP Exposome,Observation,Substance,17-Hydroxyprogesterone,"17a-Hydroxyprogesterone; 17a-Hydroxypregn-4-ene-3,20-dione; 17-OHP; 17-OH Progesterone; 17-Hydroxypregn-4-ene-3,20-dione; 17-alpha-Hydroxyprogesterone; Prodox; Prodix; Pregn-4-en-17a-ol-3,20-dione; Hydroxyprogesterone; Gestageno Gador; Gestageno; D4-Pregnen-17a-ol-3,20-dione; 17alpha-hydroxyprogesterone; CHEBI:17252",2014-12-24,1,,,,,,,,,
630-56-8,0,OMOP Exposome,Observation,Substance,17-Hydroxyprogesterone caproate,,2014-12-24,1,,,,,,,,,
57-91-0,0,OMOP Exposome,Observation,Substance,17a-Estradiol,"Epiestradiol; alpha-Estradiol; Alfatradiol; a-Estradiol; 3,17a-Dihydroxyoestra-1,3,5(10)-triene; 3,17a-Dihydroxyestra-1,3,5(10)-triene; 3,17-Dihydroxyestratriene; 17a-Oestradiol; 17-Epiestradiol; 13b-Methyl-1,3,5(10)-gonatriene-3,17a-diol; 1,3,5-Estratriene-3,17a-diol; Oestra-1,3,5(10)-triene-3,17a-diol; Estra-1,3,5(10)-triene-3,17a-diol; Epiestrol; CHEBI:17160",2014-12-24,1,,,,,,,,,
561-65-9,0,OMOP Exposome,Observation,Substance,18-Hydroxycorticosterone,"11b,18,21-Trihydroxy-pregn-4-ene-3,20-dione; CHEBI:16485",2018-03-21,1,,,,,,,,,
74114-77-5,0,OMOP Exposome,Observation,Substance,"2',3,4,4',5-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
149-30-4,0,OMOP Exposome,Observation,Substance,2(3H)-Benzothiazolethione,,2014-12-24,1,,,,,,,,,
69278-61-1,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5',6-Octabromobiphenyl",,2014-12-24,1,,,,,,,,,
13654-09-6,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,5',6,6'-Decabromobiphenyl",,2014-12-24,1,,,,,,,,,
1163-19-5,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,5',6,6'-Decabromobiphenyl Ether",,2014-12-24,1,,,,,,,,,
69278-62-2,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,5',6-Nonabromobiphenyl",,2014-12-24,1,,,,,,,,,
40186-72-9,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl",,2014-12-24,1,,,,,,,,,
67889-00-3,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,5'-Octabromobiphenyl",,2014-12-24,1,,,,,,,,,
35694-08-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,5'-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
42740-50-1,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,6'-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
60586-57-4,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,6,6'-Nonabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-79-3,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-78-2,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5,6-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
69278-60-0,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
35065-30-6,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',5-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-59-4,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',6,6'-Octabromobiphenyl",,2014-12-24,1,,,,,,,,,
33091-17-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',6,6'-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-71-5,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
82865-89-2,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,4'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-70-4,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5',6'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
69887-11-2,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5',6,6'-Octabromobiphenyl",,2014-12-24,1,,,,,,,,,
40186-71-8,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5',6,6'-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
40186-70-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
82865-90-5,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-66-8,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-75-9,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,5',6'-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-63-0,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,5',6,6'-Nonabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-77-1,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-17-2,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,5',6-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
82865-92-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,5'-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-74-8,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,5'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
88700-04-3,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,6'-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
38411-25-5,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,6'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-60-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,6,6'-Octabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-73-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,6,6'-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-16-1,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5,6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
55215-18-4,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,5-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-50-5,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,6'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
38380-05-1,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-65-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,6,6'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
61798-70-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4,6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
GIS1003263,0,OMOP Exposome,Observation,Substance,"2,2',3,3',4-Pentabromobiphenyl",,2024-09-14,1,,,,,,,,,
59080-41-0,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,5',6,6'-Octabromobiphenyl",,2014-12-24,1,,,,,,,,,
2136-99-4,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,5',6,6'-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-54-9,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,5',6-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-67-9,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,5',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
55066-76-7,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
35694-04-3,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,5'-Hexachlorobiphenyl","2,2',3,3',5,5'-Hexachloro-1,1'-biphenyl; 2,3,5,2',3',5'-Hexachlorobiphenyl; PCB 133; 2,2',3,3',5,5'-PCB; CHEBI:34197",2014-12-24,1,,,,,,,,,
119264-51-6,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,6'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
52744-13-5,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-64-6,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,6,6'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52704-70-8,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5,6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
60145-20-2,0,OMOP Exposome,Observation,Substance,"2,2',3,3',5-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
38411-22-2,0,OMOP Exposome,Observation,Substance,"2,2',3,3',6,6'-Hexachlorobiphenyl","2,2',3,3',6,6'-Hexachloro-1,1'-biphenyl; 2,3,6,2',3',6'-Hexachloro-1,1'-biphenyl; 2,2',3,3',6,6'-PCB; PCB 136; 2,2', 3,3',6,6'-Hexachlorobiphenyl; 2,3,6,2',3',6'-Hexachlorobiphenyl; CHEBI:34199",2014-12-24,1,,,,,,,,,
52663-60-2,0,OMOP Exposome,Observation,Substance,"2,2',3,3',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
GIS1003271,0,OMOP Exposome,Observation,Substance,"2,2',3,3'-Tetrabromobiphenyl",,2024-09-14,1,,,,,,,,,
38444-93-8,0,OMOP Exposome,Observation,Substance,"2,2',3,3'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
69278-59-7,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5',6-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
38380-04-0,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
41464-51-1,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
84303-49-1,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5,5',6-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-68-0,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5,5',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
51908-16-8,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5,5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
93261-83-7,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5,6'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
74472-41-6,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5,6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-58-3,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5,6,6'-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
74487-85-7,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5,6,6'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-13-8,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5,6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-07-0,0,OMOP Exposome,Observation,Substance,"2,2',3,4',5-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
60233-25-2,0,OMOP Exposome,Observation,Substance,"2,2',3,4',6'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-08-1,0,OMOP Exposome,Observation,Substance,"2,2',3,4',6,6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-05-8,0,OMOP Exposome,Observation,Substance,"2,2',3,4',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
36559-22-5,0,OMOP Exposome,Observation,Substance,"2,2',3,4'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-69-1,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
67888-98-6,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
35065-28-2,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-76-0,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5,5',6-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
67733-52-2,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5,5'-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
35065-29-3,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5,5'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-55-0,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5,6'-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
60145-23-5,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5,6'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-61-8,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5,6,6'-Octabromobiphenyl",,2014-12-24,1,,,,,,,,,
74472-52-9,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5,6,6'-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-47-2,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5,6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
81381-52-4,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
35694-06-5,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',5-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
59291-64-4,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-56-1,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',6,6'-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
74472-48-3,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
56030-56-9,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
65510-45-4,0,OMOP Exposome,Observation,Substance,"2,2',3,4,4'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-52-7,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5',6-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
68194-14-9,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
38380-02-8,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52712-05-7,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5,5',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
120991-47-1,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5,5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
52712-04-6,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5,5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-15-0,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5,6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-57-2,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5,6,6'-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
74472-49-4,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5,6,6'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
GIS1003279,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5,6-Hexabromobiphenyl",,2024-09-14,1,,,,,,,,,
41411-61-4,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5,6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
55312-69-1,0,OMOP Exposome,Observation,Substance,"2,2',3,4,5-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
73575-57-2,0,OMOP Exposome,Observation,Substance,"2,2',3,4,6'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-40-5,0,OMOP Exposome,Observation,Substance,"2,2',3,4,6,6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
77910-04-4,0,OMOP Exposome,Observation,Substance,"2,2',3,4,6-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
55215-17-3,0,OMOP Exposome,Observation,Substance,"2,2',3,4,6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-59-9,0,OMOP Exposome,Observation,Substance,"2,2',3,4-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
88700-05-4,0,OMOP Exposome,Observation,Substance,"2,2',3,5',6-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
38379-99-6,0,OMOP Exposome,Observation,Substance,"2,2',3,5',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
41464-39-5,0,OMOP Exposome,Observation,Substance,"2,2',3,5'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
119264-53-8,0,OMOP Exposome,Observation,Substance,"2,2',3,5,5',6-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-63-5,0,OMOP Exposome,Observation,Substance,"2,2',3,5,5',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-61-3,0,OMOP Exposome,Observation,Substance,"2,2',3,5,5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
73575-55-0,0,OMOP Exposome,Observation,Substance,"2,2',3,5,6'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-09-2,0,OMOP Exposome,Observation,Substance,"2,2',3,5,6,6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
73575-56-1,0,OMOP Exposome,Observation,Substance,"2,2',3,5,6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70362-46-8,0,OMOP Exposome,Observation,Substance,"2,2',3,5-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
41464-47-5,0,OMOP Exposome,Observation,Substance,"2,2',3,6'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
73575-54-9,0,OMOP Exposome,Observation,Substance,"2,2',3,6,6'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
GIS1003287,0,OMOP Exposome,Observation,Substance,"2,2',3,6-Tetrabromobiphenyl",,2024-09-14,1,,,,,,,,,
70362-45-7,0,OMOP Exposome,Observation,Substance,"2,2',3,6-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
38444-78-9,0,OMOP Exposome,Observation,Substance,"2,2',3-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
59080-40-9,0,OMOP Exposome,Observation,Substance,"2,2',4,4',5,5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
35065-27-1,0,OMOP Exposome,Observation,Substance,"2,2',4,4',5,5'-Hexachlorobiphenyl","2,2',4,4',5,5'-Hexachloro-1,1'biphenyl; 2,2',4,4',5,5'-Hexachloro-1,1'-biphenyl; 2,2',4,4',5,5'-PCB; 2,2',4,4'5,5'-Hexachlorobiphenyl; 2,4,5,2',4',5'-Hexachloro-1,1'-biphenyl; 2,4,5,2',4',5'-Hexachlorobiphenyl; Hexachlorobiphenyl; PCB 153; CHEBI:34202",2014-12-24,1,,,,,,,,,
36402-15-0,0,OMOP Exposome,Observation,Substance,"2,2',4,4',5,6'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
60145-22-4,0,OMOP Exposome,Observation,Substance,"2,2',4,4',5,6'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
81397-99-1,0,OMOP Exposome,Observation,Substance,"2,2',4,4',5-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
38380-01-7,0,OMOP Exposome,Observation,Substance,"2,2',4,4',5-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
59261-08-4,0,OMOP Exposome,Observation,Substance,"2,2',4,4',6,6'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
33979-03-2,0,OMOP Exposome,Observation,Substance,"2,2',4,4',6,6'-Hexachlorobiphenyl","2,2',4,4',6,6'-PCB; 2,2',4,4',6,6'-Hexachlorodiphenyl; 2,4,6,2',4',6'-Hexachloro-1,1'-biphenyl; 2,4,6,2',4',6'-Hexachlorobiphenyl; 2,2',4,4',6,6'-Hcb; PCB 155; 2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl; CHEBI:34203",2014-12-24,1,,,,,,,,,
97038-97-6,0,OMOP Exposome,Observation,Substance,"2,2',4,4',6-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
39485-83-1,0,OMOP Exposome,Observation,Substance,"2,2',4,4',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
66115-57-9,0,OMOP Exposome,Observation,Substance,"2,2',4,4'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
59080-39-6,0,OMOP Exposome,Observation,Substance,"2,2',4,5',6-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
60145-21-3,0,OMOP Exposome,Observation,Substance,"2,2',4,5',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
60044-24-8,0,OMOP Exposome,Observation,Substance,"2,2',4,5'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
41464-40-8,0,OMOP Exposome,Observation,Substance,"2,2',4,5'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
67888-96-4,0,OMOP Exposome,Observation,Substance,"2,2',4,5,5'-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
37680-73-2,0,OMOP Exposome,Observation,Substance,"2,2',4,5,5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
80274-92-6,0,OMOP Exposome,Observation,Substance,"2,2',4,5,6'-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
68194-06-9,0,OMOP Exposome,Observation,Substance,"2,2',4,5,6'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70362-47-9,0,OMOP Exposome,Observation,Substance,"2,2',4,5-Tetrachlorobiphenyl","2,2'4,5-Tetrachlorobiphenyl; 2,2',4,5-Tetrachloro-1,1'-biphenyl; 2,2',4,5-PCB; PCB 48; CHEBI:34205",2014-12-24,1,,,,,,,,,
97038-95-4,0,OMOP Exposome,Observation,Substance,"2,2',4,6'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
68194-04-7,0,OMOP Exposome,Observation,Substance,"2,2',4,6'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
97063-75-7,0,OMOP Exposome,Observation,Substance,"2,2',4,6,6'-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
56558-16-8,0,OMOP Exposome,Observation,Substance,"2,2',4,6,6'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
62796-65-0,0,OMOP Exposome,Observation,Substance,"2,2',4,6-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
37680-66-3,0,OMOP Exposome,Observation,Substance,"2,2',4-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
59080-37-4,0,OMOP Exposome,Observation,Substance,"2,2',5,5'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
35693-99-3,0,OMOP Exposome,Observation,Substance,"2,2',5,5'-Tetrachlorobiphenyl","2,2',5,5'-Tetrachloro-1,1'-biphenyl; 2,2',5,5'-TCB; 2,2',5,5'-PCB; PCB 52; 2,5,2',5'-Tetrachlorobiphenyl; 2,3',5,6'-Tetrachlorobiphenyl; 2,2 ,5,5 -Tetrachlorobiphenyl; CHEBI:34206",2014-12-24,1,,,,,,,,,
60044-25-9,0,OMOP Exposome,Observation,Substance,"2,2',5,6'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
41464-41-9,0,OMOP Exposome,Observation,Substance,"2,2',5,6'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
59080-34-1,0,OMOP Exposome,Observation,Substance,"2,2',5-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
37680-65-2,0,OMOP Exposome,Observation,Substance,"2,2',5-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
97038-96-5,0,OMOP Exposome,Observation,Substance,"2,2',6,6'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
15968-05-5,0,OMOP Exposome,Observation,Substance,"2,2',6,6'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
38444-73-4,0,OMOP Exposome,Observation,Substance,"2,2',6-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
13029-09-9,0,OMOP Exposome,Observation,Substance,"2,2'-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
13029-08-8,0,OMOP Exposome,Observation,Substance,"2,2'-Dichlorobiphenyl",,2014-12-24,1,,,,,,,,,
594-82-1,0,OMOP Exposome,Observation,Substance,"2,2,3,3-Tetramethylbutane",,2014-12-24,1,,,,,,,,,
464-06-2,0,OMOP Exposome,Observation,Substance,"2,2,3-Trimethylbutane",,2014-12-24,1,,,,,,,,,
564-02-3,0,OMOP Exposome,Observation,Substance,"2,2,3-Trimethylpentane",,2014-12-24,1,,,,,,,,,
6846-50-0,0,OMOP Exposome,Observation,Substance,"2,2,4-Trimethyl-1,3-pentadienol diisobutyrate",,2014-12-24,1,,,,,,,,,
540-84-1,0,OMOP Exposome,Observation,Substance,"2,2,4-Trimethylpentane",Isooctane; Isobutyltrimethylmethane; Isobutyltrimethylethane; Iso-octane; (CH3)2CHCH2C(CH3)3; Trimethylpentane; CHEBI:62805,2014-12-24,1,,,,,,,,,
75-83-2,0,OMOP Exposome,Observation,Substance,"2,2-Dimethylbutane",,2014-12-24,1,,,,,,,,,
590-73-8,0,OMOP Exposome,Observation,Substance,"2,2-Dimethylhexane",,2014-12-24,1,,,,,,,,,
590-35-2,0,OMOP Exposome,Observation,Substance,"2,2-Dimethylpentane",,2014-12-24,1,,,,,,,,,
74472-39-2,0,OMOP Exposome,Observation,Substance,"2,3',4',5',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70362-48-0,0,OMOP Exposome,Observation,Substance,"2,3',4',5'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70424-70-3,0,OMOP Exposome,Observation,Substance,"2,3',4',5,5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
59080-38-5,0,OMOP Exposome,Observation,Substance,"2,3',4',5-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
32598-11-1,0,OMOP Exposome,Observation,Substance,"2,3',4',5-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
41464-46-4,0,OMOP Exposome,Observation,Substance,"2,3',4',6-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
38444-86-9,0,OMOP Exposome,Observation,Substance,"2,3',4'-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
84303-48-0,0,OMOP Exposome,Observation,Substance,"2,3',4,4',5',6-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
59291-65-5,0,OMOP Exposome,Observation,Substance,"2,3',4,4',5',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
65510-44-3,0,OMOP Exposome,Observation,Substance,"2,3',4,4',5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
67888-99-7,0,OMOP Exposome,Observation,Substance,"2,3',4,4',5,5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
52663-72-6,0,OMOP Exposome,Observation,Substance,"2,3',4,4',5,5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
67888-97-5,0,OMOP Exposome,Observation,Substance,"2,3',4,4',5-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
31508-00-6,0,OMOP Exposome,Observation,Substance,"2,3',4,4',5-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
86029-64-3,0,OMOP Exposome,Observation,Substance,"2,3',4,4',6-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
56558-17-9,0,OMOP Exposome,Observation,Substance,"2,3',4,4',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
84303-45-7,0,OMOP Exposome,Observation,Substance,"2,3',4,4'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
32598-10-0,0,OMOP Exposome,Observation,Substance,"2,3',4,4'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
56558-18-0,0,OMOP Exposome,Observation,Substance,"2,3',4,5',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
73575-52-7,0,OMOP Exposome,Observation,Substance,"2,3',4,5'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
80407-70-1,0,OMOP Exposome,Observation,Substance,"2,3',4,5,5'-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
68194-12-7,0,OMOP Exposome,Observation,Substance,"2,3',4,5,5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
73575-53-8,0,OMOP Exposome,Observation,Substance,"2,3',4,5-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
60233-24-1,0,OMOP Exposome,Observation,Substance,"2,3',4,6-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
55712-37-3,0,OMOP Exposome,Observation,Substance,"2,3',4-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
74338-23-1,0,OMOP Exposome,Observation,Substance,"2,3',5',6-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
37680-68-5,0,OMOP Exposome,Observation,Substance,"2,3',5'-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
41464-42-0,0,OMOP Exposome,Observation,Substance,"2,3',5,5'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
59080-35-2,0,OMOP Exposome,Observation,Substance,"2,3',5-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
38444-81-4,0,OMOP Exposome,Observation,Substance,"2,3',5-Trichlorobiphenyl","2,5,3'-Trichlorobiphenyl; PCB 26; 3,2',5'-Trichlorobiphenyl; 2,3,5-Trichlorobiphenyl; 2,3',5-Trichloro-1,1'-biphenyl; 2,3',5-PCB; CHEBI:34215",2014-12-24,1,,,,,,,,,
38444-76-7,0,OMOP Exposome,Observation,Substance,"2,3',6-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
49602-90-6,0,OMOP Exposome,Observation,Substance,"2,3'-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
25569-80-6,0,OMOP Exposome,Observation,Substance,"2,3'-Dichlorobiphenyl",,2014-12-24,1,,,,,,,,,
82865-91-5,0,OMOP Exposome,Observation,Substance,"2,3,3',4',5',6-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
74472-45-0,0,OMOP Exposome,Observation,Substance,"2,3,3',4',5',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
76842-07-4,0,OMOP Exposome,Observation,Substance,"2,3,3',4',5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
69782-91-8,0,OMOP Exposome,Observation,Substance,"2,3,3',4',5,5',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
39635-34-2,0,OMOP Exposome,Observation,Substance,"2,3,3',4',5,5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-44-9,0,OMOP Exposome,Observation,Substance,"2,3,3',4',5,6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70424-68-9,0,OMOP Exposome,Observation,Substance,"2,3,3',4',5-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
38380-03-9,0,OMOP Exposome,Observation,Substance,"2,3,3',4',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
41464-43-1,0,OMOP Exposome,Observation,Substance,"2,3,3',4'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-50-7,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
84303-47-9,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
69782-90-7,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
32536-52-0,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5,5',6'-Octabromobiphenyl Ether",,2014-12-24,1,,,,,,,,,
74472-53-0,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5,5',6-Octachlorobiphenyl",,2014-12-24,1,,,,,,,,,
88700-06-5,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5,5'-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
39635-31-9,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5,5'-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
79682-25-0,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5,6-Heptabromobiphenyl",,2014-12-24,1,,,,,,,,,
41411-64-7,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5,6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
77607-09-1,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
38380-08-4,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',5-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-42-7,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
32598-14-4,0,OMOP Exposome,Observation,Substance,"2,3,3',4,4'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-43-8,0,OMOP Exposome,Observation,Substance,"2,3,3',4,5',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70362-41-3,0,OMOP Exposome,Observation,Substance,"2,3,3',4,5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-51-8,0,OMOP Exposome,Observation,Substance,"2,3,3',4,5,5',6-Heptachlorobiphenyl",,2014-12-24,1,,,,,,,,,
120991-48-2,0,OMOP Exposome,Observation,Substance,"2,3,3',4,5,5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
39635-35-3,0,OMOP Exposome,Observation,Substance,"2,3,3',4,5,5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
41411-62-5,0,OMOP Exposome,Observation,Substance,"2,3,3',4,5,6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70424-69-0,0,OMOP Exposome,Observation,Substance,"2,3,3',4,5-Pentachlorobiphenyl","2,3,3',4,5-PCB; 2,3,4,5,3'-Pentachloro-1,1'-biphenyl; PCB 106; 2,3,4,5,3'-Pentachlorobiphenyl; 2,3,3',4,5-Pentachloro-1,1'-biphenyl; CHEBI:34216",2014-12-24,1,,,,,,,,,
74472-35-8,0,OMOP Exposome,Observation,Substance,"2,3,3',4,6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
97038-99-8,0,OMOP Exposome,Observation,Substance,"2,3,3',4-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
74338-24-2,0,OMOP Exposome,Observation,Substance,"2,3,3',4-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
68194-10-5,0,OMOP Exposome,Observation,Substance,"2,3,3',5',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
41464-49-7,0,OMOP Exposome,Observation,Substance,"2,3,3',5'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-46-1,0,OMOP Exposome,Observation,Substance,"2,3,3',5,5',6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
39635-32-0,0,OMOP Exposome,Observation,Substance,"2,3,3',5,5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-36-9,0,OMOP Exposome,Observation,Substance,"2,3,3',5,6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70424-67-8,0,OMOP Exposome,Observation,Substance,"2,3,3',5-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-33-6,0,OMOP Exposome,Observation,Substance,"2,3,3',6-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
38444-84-7,0,OMOP Exposome,Observation,Substance,"2,3,3'-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
560-21-4,0,OMOP Exposome,Observation,Substance,"2,3,3-Trimethylpentane",,2014-12-24,1,,,,,,,,,
68194-11-6,0,OMOP Exposome,Observation,Substance,"2,3,4',5,6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-34-7,0,OMOP Exposome,Observation,Substance,"2,3,4',5-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
52663-58-8,0,OMOP Exposome,Observation,Substance,"2,3,4',6-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
38444-85-8,0,OMOP Exposome,Observation,Substance,"2,3,4'-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
41411-63-6,0,OMOP Exposome,Observation,Substance,"2,3,4,4',5,6-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
96551-70-1,0,OMOP Exposome,Observation,Substance,"2,3,4,4',5-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
74472-37-0,0,OMOP Exposome,Observation,Substance,"2,3,4,4',5-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
74472-38-1,0,OMOP Exposome,Observation,Substance,"2,3,4,4',6-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
33025-41-1,0,OMOP Exposome,Observation,Substance,"2,3,4,4'-Tetrachlorobiphenyl","PCB 60; 2,3,4,4'-Tetrachloro-1,1'-biphenyl; 2,3,4,4'-PCB; CHEBI:34218",2014-12-24,1,,,,,,,,,
38421-62-4,0,OMOP Exposome,Observation,Substance,"2,3,4,5,6-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
18259-05-7,0,OMOP Exposome,Observation,Substance,"2,3,4,5,6-Pentachlorobiphenyl","Pentachlorobiphenyl; 2,3,4,5,6-Pentachloro-1,1'-biphenyl; Diphenyl pentachloride; PCB 116; Pentachlorodiphenyl; 2,3,4,5,6-PCB; Pentachloro-1,1'-biphenyl; CHEBI:34219",2014-12-24,1,,,,,,,,,
115245-09-5,0,OMOP Exposome,Observation,Substance,"2,3,4,5-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
33284-53-6,0,OMOP Exposome,Observation,Substance,"2,3,4,5-Tetrachlorobiphenyl","2,3,4,5-Tetrachloro-1,1'-biphenyl; 2,3,4,5-PCB; PCB 61; CHEBI:34221",2014-12-24,1,,,,,,,,,
25167-83-3,0,OMOP Exposome,Observation,Substance,"2,3,4,5-Tetrachlorophenol",,2014-12-24,1,,,,,,,,,
GIS1003295,0,OMOP Exposome,Observation,Substance,"2,3,4,6,7,8,11-Heptachlorotridecane",,2024-09-14,1,,,,,,,,,
161880-50-8,0,OMOP Exposome,Observation,Substance,"2,3,4,6,7,8-Hexabromodibenzofuran",,2014-12-24,1,,,,,,,,,
GIS1003304,0,OMOP Exposome,Observation,Substance,"2,3,4,6,7,8-Hexachlorodecane",,2024-09-14,1,,,,,,,,,
60851-34-5,0,OMOP Exposome,Observation,Substance,"2,3,4,6,7,8-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
124388-77-8,0,OMOP Exposome,Observation,Substance,"2,3,4,6,7-Pentabromodibenzofuran",,2014-12-24,1,,,,,,,,,
57117-43-8,0,OMOP Exposome,Observation,Substance,"2,3,4,6,7-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
67481-22-5,0,OMOP Exposome,Observation,Substance,"2,3,4,6,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
115245-10-8,0,OMOP Exposome,Observation,Substance,"2,3,4,6-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
54230-22-7,0,OMOP Exposome,Observation,Substance,"2,3,4,6-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
83704-30-7,0,OMOP Exposome,Observation,Substance,"2,3,4,6-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
57117-44-9,0,OMOP Exposome,Observation,Substance,"2,3,4,7,8,9-Hexachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
131166-92-2,0,OMOP Exposome,Observation,Substance,"2,3,4,7,8-Pentabromodibenzofuran",,2014-12-24,1,,,,,,,,,
57117-31-4,0,OMOP Exposome,Observation,Substance,"2,3,4,7,8-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
70648-21-4,0,OMOP Exposome,Observation,Substance,"2,3,4,7,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-31-8,0,OMOP Exposome,Observation,Substance,"2,3,4,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
69433-00-7,0,OMOP Exposome,Observation,Substance,"2,3,4,8,9-Pentachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-32-9,0,OMOP Exposome,Observation,Substance,"2,3,4,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-33-0,0,OMOP Exposome,Observation,Substance,"2,3,4,9-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
55702-46-0,0,OMOP Exposome,Observation,Substance,"2,3,4-Trichlorobiphenyl","Trichloro-1,1'-biphenyl; 2,3,4-PCB; Apirolio 1431 C; 2,3,4-Trichloro-1,1'-biphenyl; PCB 21; Pyranol 1499; CHEBI:34222",2014-12-24,1,,,,,,,,,
57117-34-7,0,OMOP Exposome,Observation,Substance,"2,3,4-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
565-75-3,0,OMOP Exposome,Observation,Substance,"2,3,4-Trimethylpentane",,2014-12-24,1,,,,,,,,,
33284-54-7,0,OMOP Exposome,Observation,Substance,"2,3,5,6-Tetrachlorobiphenyl","2,3,5,6-PCB; 2,3,5,6-Tetrachloro-1,1'-biphenyl; PCB 65; CHEBI:34224",2014-12-24,1,,,,,,,,,
935-95-5,0,OMOP Exposome,Observation,Substance,"2,3,5,6-Tetrachlorophenol","2,3,5, 6-Tetrachlorophenol; 2,3,5,6-Tetrachloro phenol; 2,3,5,6-Tetrachlorophenol solution; WLN: QR bg CG eg FG; 2,3,5,6-Tetrachlorophenate; CHEBI:52048",2014-12-24,1,,,,,,,,,
55720-44-0,0,OMOP Exposome,Observation,Substance,"2,3,5-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
2655-15-4,0,OMOP Exposome,Observation,Substance,"2,3,5-Trimethylphenyl methylcarbamate","Carbamic acid, methyl-, 2,3,5-trimethylphenyl ester; 2,3,5-Trimethylphenol methylcarbamate; 2,3,5-Trimethacarb; 2,3,5-Landrin; 2,3,5(or 3,4,5)-Trimethylphenol methylcarbamate; Trimethylphenyl methylcarbamate; Trimethacarb; Shell SD 8786; 2,3,5-Trimethylphenyl methylcarbamic acid; Phenol, 2,3,5-trimethyl-, methylcarbamate (9CI); Phenol, 2,3,5(or 3,4,5)-trimethyl-, methylcarbamate (9CI); Phenol, 2,3,5(or 3,4,5)-trimethyl-, methylcarbamate; Methylcarbamic acid 2,3,5-trimethylphenyl ester; Landrin b; Landrin; Broot; 2,3,5-trimethylphenyl N-methylcarbamate; CHEBI:38893",2014-12-24,1,,,,,,,,,
34816-53-0,0,OMOP Exposome,Observation,Substance,"2,3,6,7-Tetrachlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
57117-39-2,0,OMOP Exposome,Observation,Substance,"2,3,6,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
57117-37-0,0,OMOP Exposome,Observation,Substance,"2,3,6,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
GIS1003313,0,OMOP Exposome,Observation,Substance,"2,3,6,9-Tetrachlorodecane",,2024-09-14,1,,,,,,,,,
57117-33-6,0,OMOP Exposome,Observation,Substance,"2,3,6-Trichlordibenzofuran",,2014-12-24,1,,,,,,,,,
55702-45-9,0,OMOP Exposome,Observation,Substance,"2,3,6-Trichlorobiphenyl","2,3,6-PCB; PCB 24; 2,3,6-Trichloro-1,1'-biphenyl; CHEBI:34225",2014-12-24,1,,,,,,,,,
67733-57-7,0,OMOP Exposome,Observation,Substance,"2,3,7,8-Tetrabromodibenzofuran",,2014-12-24,1,,,,,,,,,
1746-01-6,0,OMOP Exposome,Observation,Substance,"2,3,7,8-Tetrachlorodibenzo-p-dioxin","2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzo(b,e)(1,4)dioxin; 2,3,7,8-Tetrachlorodibenzob,e1,4dioxin; 2,3,7,8-Tetrachlorooxanthrene; Dibenzo-dioxin, 2,3,7,8-tetrachlorinated; 2,3,7,8-Tetrachlorodibenzo(b,e)(1,4)dioxan; 2,3,7,8-Tetrachloro(b,f)dibenzodioxin; 2,3,7,8-Tetrachloro(b,e)dibenzodioxin; 2,3,7,8-Tetra polychlorinated dibenzo-p-dioxin; Tetrachlorodibenzo-1,4-dioxin; Tetrachlorodibenzo-p-dioxin; Tetrachlorodibenzodioxin; Tetradioxin; 2,3,7,8-:tetrachlorodibenzo-p-dioxin; 2,3,7,8-tetrachlorodibenzodioxin; 2,3,7,8-Tetrachlorodibenzo-P-dioxin; 2,3,7,8-Tetrachlorodibenzo-1,4-Dioxin; 2,3,6,7-Tetrachlorodibenzo-p-dioxin; CHEBI:28119",2014-12-24,1,,,,,,,,,
51207-31-9,0,OMOP Exposome,Observation,Substance,"2,3,7,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
33857-28-2,0,OMOP Exposome,Observation,Substance,"2,3,7-Trichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
58802-17-8,0,OMOP Exposome,Observation,Substance,"2,3,7-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
57117-32-5,0,OMOP Exposome,Observation,Substance,"2,3,8-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58802-18-9,0,OMOP Exposome,Observation,Substance,"2,3,9-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
115245-06-2,0,OMOP Exposome,Observation,Substance,"2,3-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
62046-37-1,0,OMOP Exposome,Observation,Substance,"2,3-Dichlorobenzyl methylcarbamate",,2014-12-24,1,,,,,,,,,
16605-91-7,0,OMOP Exposome,Observation,Substance,"2,3-Dichlorobiphenyl",,2014-12-24,1,,,,,,,,,
29446-15-9,0,OMOP Exposome,Observation,Substance,"2,3-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
64126-86-9,0,OMOP Exposome,Observation,Substance,"2,3-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
78-88-6,0,OMOP Exposome,Observation,Substance,"2,3-Dichloropropene",,2014-12-24,1,,,,,,,,,
79-29-8,0,OMOP Exposome,Observation,Substance,"2,3-Dimethylbutane",,2014-12-24,1,,,,,,,,,
565-59-3,0,OMOP Exposome,Observation,Substance,"2,3-Dimethylpentane",,2014-12-24,1,,,,,,,,,
59080-36-3,0,OMOP Exposome,Observation,Substance,"2,4',5-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
16606-02-3,0,OMOP Exposome,Observation,Substance,"2,4',5-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
64258-03-3,0,OMOP Exposome,Observation,Substance,"2,4',6-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
38444-77-8,0,OMOP Exposome,Observation,Substance,"2,4',6-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
49602-91-7,0,OMOP Exposome,Observation,Substance,"2,4'-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
34883-43-7,0,OMOP Exposome,Observation,Substance,"2,4'-Dichlorobiphenyl","2,4'-Dichloro-1,1'-diphenyl; PCB 8; 2,4'-DiCB; 2,4'-Dichloro-1,1'-biphenyl; 2,4'-PCB; CHEBI:34232",2014-12-24,1,,,,,,,,,
32690-93-0,0,OMOP Exposome,Observation,Substance,"2,4,4',5-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
64258-02-2,0,OMOP Exposome,Observation,Substance,"2,4,4',6-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
32598-12-2,0,OMOP Exposome,Observation,Substance,"2,4,4',6-Tetrachlorobiphenyl","2,4,4',6-PCB; 2,4,6,4'-tetrachlorobiphenyl; PCB 75; 2,4,4'6-Tetrachlorobiphenyl; 2,4,4',6-Tetrachloro-1,1'-biphenyl; CHEBI:34233",2014-12-24,1,,,,,,,,,
6430-90-6,0,OMOP Exposome,Observation,Substance,"2,4,4'-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
7012-37-5,0,OMOP Exposome,Observation,Substance,"2,4,4'-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
107-39-1,0,OMOP Exposome,Observation,Substance,"2,4,4,-Trimethyl-1-pentene",,2014-12-24,1,,,,,,,,,
115245-07-3,0,OMOP Exposome,Observation,Substance,"2,4,5-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
15862-07-4,0,OMOP Exposome,Observation,Substance,"2,4,5-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
95-95-4,0,OMOP Exposome,Observation,Substance,"2,4,5-Trichlorophenol","TCP; 2,4, 5-Trichlorophenol; 2,4,5-TCP; Collunosol; Dowcide 2; Dowicide 2; Dowicide b; Nurelle; Preventol I; CHEBI:28520",2014-12-24,1,,,,,,,,,
93-76-5,0,OMOP Exposome,Observation,Substance,"2,4,5-Trichlorophenoxyacetic acid","RCRA waste no. U232; (2,4,5-Trichlor-phenoxy)-essigsaeure; Brush-off 445 low volatile brush killer; Brushtox; Caswell No. 881; Crossbow; Debroussaillant concentre; Debroussaillant super concentre; Decamine 4T; Ded-weed; Ded-weed brush killer; Ded-weed lv-6 brush kil and t-5 brush kil; Dinoxol; (2,4,5-Trichlorophenoxy)acetic acid; (2,4,5-Trichlorphenoxy)essigsaeure; 2,4,5-(Trichlorophenoxy)acetic acid; 2,4,5-T; 2,4,5-T acid; 2,4,5-Trichlorophenoxyacetate; 2,4,5-Trichlorphenoxyessigsaeure; Envert-t; 4,5-Trichlorophenoxyacetic acid; 93-76-5 (FREE ACID); Acide 2,4,5-trichloro phenoxyacetique; Acido (2,4,5-tricloro-fenossi)-acetico; Arbokan; BCF-bushkiller; Brush killer; Brush rhap; Brush tox; Estercide t-2 and t-245; Esteron; Esteron 245; Esteron 245 be; Esteron brush killer; Farmco fence rider; Fence rider; Forron; Forst U 46; Fortex; Fruitone a; Inverton 245; Line rider; Lo-vol; Phortox; Reddon; Reddox; Spontox; Super d weedone; T-nox; Tippon; Tippontormona; Tormona; Transamine; Tributon; Trinoxol; Trioxon; Trioxone; VEON; Verton 2-T; Verton 2T; Visko rhap; Visko rhap low volatile ester; Weedar; Weedone; Weedone 2,4,5-T; (2,4, 5-Trichlorophenoxy)acetic acid; CHEBI:27903",2014-12-24,1,,,,,,,,,
57117-38-1,0,OMOP Exposome,Observation,Substance,"2,4,6,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58802-19-0,0,OMOP Exposome,Observation,Substance,"2,4,6,8-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
59080-33-0,0,OMOP Exposome,Observation,Substance,"2,4,6-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
118-79-6,0,OMOP Exposome,Observation,Substance,"2,4,6-Tribromophenol","2,4,6-Tribromo-3-methylphenol; Xeroform; Great lakes PH-73; Tribromophenol; TBP; Micatex; 2,4,6-Tribromo-Phenol; 2,4,6-Tribromophenol, bismuth (3+) salt; 5175-83-7 (Bismuth(3+) salt); Bismuth tribromophenate; Bromol; C6H3Br3O; Bromkal Pur 3; Flammex 3BP; 2,4,6-Tribromo-m-cresol; CHEBI:47696",2014-12-24,1,,,,,,,,,
35693-92-6,0,OMOP Exposome,Observation,Substance,"2,4,6-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
58802-14-5,0,OMOP Exposome,Observation,Substance,"2,4,6-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
88-06-2,0,OMOP Exposome,Observation,Substance,"2,4,6-Trichlorophenol","Dowcide 2S; Phenachlor; Phenaclor; 1,3,5-Trichloro-2-hydroxybenzene; Dowicide 2S; Trichloro-2-hydroxybenzene; Trichloro-2-hydroxybenzene, 2,4,6-Trichlorophenol; 1,3,5-Trichlorophenol; 2,4,6-TCP; 2,4,6-Trichloro-2-hydroxybenzene; CHEBI:28755",2014-12-24,1,,,,,,,,,
118-96-7,0,OMOP Exposome,Observation,Substance,"2,4,6-Trinitrotoluene","sym-Trinitrotoluol; 1-Methyl-2,4,6-trinitrobenzene; 2,4,6-TNT; 2,4,6-Trinitrotoluol; s-Trinitrotoluol; Trotyl; TNT; Trinitrotoluene; Trinitrotoluol; Tritol; CHEBI:46053",2014-12-24,1,,,,,,,,,
83704-42-1,0,OMOP Exposome,Observation,Substance,"2,4,7-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
54589-71-8,0,OMOP Exposome,Observation,Substance,"2,4,8-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
82911-59-9,0,OMOP Exposome,Observation,Substance,"2,4,9-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
96-76-4,0,OMOP Exposome,Observation,Substance,"2,4-Di-tert-butylphenol",,2014-12-24,1,,,,,,,,,
53592-10-2,0,OMOP Exposome,Observation,Substance,"2,4-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
33284-50-3,0,OMOP Exposome,Observation,Substance,"2,4-Dichlorobiphenyl",,2014-12-24,1,,,,,,,,,
24478-74-8,0,OMOP Exposome,Observation,Substance,"2,4-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
120-83-2,0,OMOP Exposome,Observation,Substance,"2,4-Dichlorophenol","4,6-Dichlorophenol; 1,3-Dichloro-4-hydroxybenzene; 2,4-Dichloro-Phenol; 2,4-Dichlorophenate; 2,4-Dichlorophenic acid; CHEBI:16738",2014-12-24,1,,,,,,,,,
94-75-7,0,OMOP Exposome,Observation,Substance,"2,4-Dichlorophenoxyacetic acid","Dacamine; Weedtrol; Weedone LV4; Weedone; Weedez wonder bar; Weedatul; Weedar-64; Weedar; Weed-Rhap; Weed-B-gon; Weed-ag-bar; Weed tox; Visko-rhap; Vidon 638; Vertron 2D; Verton D; Verton 2D; Verton 2-D; Verton; Vergemaster; Uniso; Trinoxol; Tributon; Transamine; Tiller S; Superormone concentre; Super D weedone; Spritz-hormit/2,4-D; Spritz-hormin/2,4-D; Spontox; Salvo; Rhodia; Plantgard; Planotox; Pielik; Phenox; Pennamine D; Pennamine; Netagrone 600; Netagrone; Moxone; Mota Maskros; Monosan; Miracle; Macrondray; Lawn-keep; Krotiline; Ipaner; Huragan; Herbidal; Hedonal; Formula 40; Foredex 75; Ferxone; Fernoxone; Fernimine; Fernesta; Farmco; Estone; Esterone four; Esterone; Esteron brush killer; Esteron 99 concentrate; Esteron 99; Esteron 76 BE; Esteron 44 weed killer; Esteron; Envert dt; Envert 171; Emulsamine E-3; Emulsamine bk; Dormone; DMA-4; Dinoxol; Dicotox; Dicopur; Diclordon; Dezormon; Desormone; Ded-Weed LV-69; Ded-Weed; Decamine; Debroussaillant 600; Crotilin; Crop rider; Chloroxone; Chipco turf herbicide quot DQuot; Chipco turf herbicide D; Brush-rhap; Barrage HF; B-Selektonon; Atlas D; Aqua-Kleen; Amoxone; Aminopielik 50SL; Amidox; Agrotect; 2,4-Dichlorophenoxyethanoic acid; 2,4-Dichlorophenoxyacetate; 2,4-D Mecoprop; 2,4-D; (Dichlorophenoxy)acetic acid; (2,4-Dichlorphenoxy)acetic acid; (2,4-Dichlorophenyloxy)acetic acid; (2,4-Dichlorophenoxy)acetic acid; (2,4-dichlorophenoxy)-Acetic acid; (2, 4-Dichlorophenoxy)acetic acid; CHEBI:28854",2014-12-24,1,,,,,,,,,
94-82-6,0,OMOP Exposome,Observation,Substance,"2,4-Dichlorophenoxybutyric acid","(2,4-Dichlorophenoxy)butyric acid; 2,4-(Dichlorophenoxy)butyric acid; 2,4-D Butyric; 2,4-D Butyric acid; 2,4-DB; 2,4-Dichlorophenoxybutyrate; 4-(2, 4-Dichlorophenoxy)butyric acid; 4-(2,4-DB); 4-(2,4-Dichlorophenoxy)butanoic acid; 4-(2,4-Dichlorophenoxy)butyric acid; Butirex; Butormone; Butoxon; Butoxone; Butoxone amine; Butoxone ester; Butyrac; Butyrac 118; Butyrac 200; Butyrac ester; Campbell's DB straight; Caswell No. 316; Dichlorophenoxy)butyric acid; Embutone; Embutox; Embutox e; Embutox klean-up; gamma-(2,4-Dichlorophenoxy)-butanoic acid; gamma-(2,4-Dichlorophenoxy)-butyric acid; gamma-(2,4-Dichlorophenoxy)butanoic acid; gamma-(2,4-Dichlorophenoxy)butyric acid; Legumex; Legumex d; Sys 67 Buratal; Venceweed; CHEBI:73173",2014-12-24,1,,,,,,,,,
26419-73-8,0,OMOP Exposome,Observation,Substance,"2,4-Dimethyl-1,3-dithiolane-2-carboxaldehyde O-(methylcarbamoyl)oxime",,2014-12-24,1,,,,,,,,,
589-43-5,0,OMOP Exposome,Observation,Substance,"2,4-Dimethylhexane",,2014-12-24,1,,,,,,,,,
108-08-7,0,OMOP Exposome,Observation,Substance,"2,4-Dimethylpentane",,2014-12-24,1,,,,,,,,,
51-28-5,0,OMOP Exposome,Observation,Substance,"2,4-Dinitrophenol","1-Hydroxy-2,4-dinitrobenzene; Solfo black; Tertrosulfur black PB; Tertrosulfur PBR; Tertrosulphur black PB; Tertrosulphur PBR; Osmotox-plus; Osmoplastic-R; Nitro kleenup; NIN; Maroxol-50; Fenoxyl carbon N; Fenoxyl; DNP; DNF; Dinofan; Dinitrophenol; Dinitra; Alpha.-dinitrophenol; Alpha-dinitrophenol; Aldifen; 2,4-DNP; 2,4 Dinitrophenol; 1'alpha-2,4-Dinitrophenol; CHEBI:918",2014-12-24,1,,,,,,,,,
121-14-2,0,OMOP Exposome,Observation,Substance,"2,4-Dinitrotoluene","2,4-Dinitromethylbenzene; 1-Methyl-2,4-dinitrobenzene; 2,4-Dinitro-1-methylbenzene; 2,4-Dinitrotoluol; 2,4-DNT; 4-Methyl-1,3-dinitrobenzene; DNT; CHEBI:920",2014-12-24,1,,,,,,,,,
584-84-9,0,OMOP Exposome,Observation,Substance,"2,4-Toluene diisocyanate","2,4-Diisocyanate, Toluene; 2,4-/2,6-Toluene diisocyanate mixture; 2,4 Toluenediisocyanate; Mondur TD; Mondur td-80; Mondur TDS; Nacconate 100; Scuranate; TDI; Tolueen-dIIsocyanaat; Toluen-disocianato; Nacconate ioo; Niax tdi; Niax tdi-p; Poly(tolylene 2,4-diisocyanate) solution; Toluene 2,4-Diisocyanate; Toluene dIIsocyanate; TOLUENE, 2,4-DIISOCYANATE; Toluene-2,4-diisocyanate; Toluene-2,4-diyl diisocyanate; Toluilenodwuizocyjanian; Toluylene-2,4-diisocyanate; 4-Methyl-phenylene diisocyanate; 4-Methyl-phenylene isocyanate; Benzene, 2,4-diisocyanato-1-methyl-, homopolymer; Cresorcinol dIIsocyanate; Desmodur T80; Di-iso-cyanatoluene; Di-isocyanate de toluylene; DIIsocyanat-toluol; DIIsocyanate, tolylene; DIIsocyanate, toluene; DIIsocyanatomethylbenzene; DIIsocyanatotoluene; Hylene t; Hylene tcpa; Hylene TLC; Hylene TM; Hylene tm-65; Hylene TRF; Isocyanic acid, 4-methyl-m-phenylene ester; Isocyanic acid, 4-methyl-m-phenylene ester (8ci); 4-METHYL-m-PHENYLENEDIISOTHIOCYANATE; 4-Methyl-m-phenylene isocyanate; 4-Methyl-m-phenylene diisocyanate; 4-Methyl-1,3-phenylene diisocyanate; 2,4-Tolylene diisocyanate; 2,4-Toluenediisocyanate; Tolyene 2,4-diisocyanate; Tolylene 2,4-diisocyanate; Tolylene dIIsocyanate; Tolylene-2,4-diisocyanate; 2,4-Toluene diisocyanic acid; 2,4-Toluene diisocyanate, homopolymer; 2,4-TDI; TuluylendIIsocyanat; Voranate t-80, type I, type II; RCRA waste no. U223; Rubinate tdi 80/20; Rcra waste number U223; 2,4-Diisocyanatotoluene; 2,4-Diisocyanato-1-methylbenzene (9CI); Isocyanic acid, methylphenylene ester; Meta-tolylene dIIsocyanate; 2,4-Diisocyanato-1-methylbenzene; CHEBI:53556",2014-12-24,1,,,,,,,,,
95-80-7,0,OMOP Exposome,Observation,Substance,"2,4-Toluenediamine","Fourrine 94; Fourrine M; m-Toluenediamine; m-Toluylendiamin; m-Toluylenediamine; m-Tolylenediamine; Nako TMT; Pelagol Grey J; Pelagol J; Pontamine Developer TN; Rcra waste number U221; Renal MD; C.I. Oxidation Base 35; Tertral G; Toluene-2,4-diamine; Tolylene-2,4-diamine; Zoba GKE; Zogen developer H; 5-Amino-O-toluidine; 4-Methyl-m-phenylenediamine; 4-Methyl-1,3-phenylenediamine; 4-Methyl-1,3-benzenediamine; 4-m-Tolylenediamine; 3-Amino-p-toluidine; 2,4-Tolylenediamine; 2,4-Diamino-1-methylbenzene; 2,4-Diamino-1-toluene; 2,4-Diaminotoluen; 2,4-Diaminotoluene; 1,3-Diamino-4-methylbenzene; TDA; Developer 14; Developer B; Developer DB; Developer DBJ; Developer MC; Developer MT; Benzofur MT; Brown for Fur T; C.I. Oxidation base 200; Developer MT-CF; 2,4-Diaminotoluol; 2,4-Tolamine; Developer MTD; Developer T; Eucanine GB; Fouramine J; CHEBI:34237",2014-12-24,1,,,,,,,,,
57422-77-2,0,OMOP Exposome,Observation,Substance,"2,5-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
34883-39-1,0,OMOP Exposome,Observation,Substance,"2,5-Dichlorobiphenyl","3,6-Dichlorobiphenyl; 2,5-PCB; PCB 9; 2,5-Dichloro-1,1'-biphenyl; 2,5-DiCB; CHEBI:34246",2014-12-24,1,,,,,,,,,
625-86-5,0,OMOP Exposome,Observation,Substance,"2,5-Dimethylfuran",,2014-12-24,1,,,,,,,,,
592-13-2,0,OMOP Exposome,Observation,Substance,"2,5-Dimethylhexane",,2014-12-24,1,,,,,,,,,
136-45-8,0,OMOP Exposome,Observation,Substance,"2,5-Pyridinedicarboxylic acid, dipropyl ester",,2014-12-24,1,,,,,,,,,
4130-42-1,0,OMOP Exposome,Observation,Substance,"2,6-Di-tert-butyl-4-ethylphenol",,2014-12-24,1,,,,,,,,,
128-37-0,0,OMOP Exposome,Observation,Substance,"2,6-Di-tert-butyl-4-methylphenol","Ionol; Popol; 2,6-Bis(1,1-dimethylethyl)-4-methylphenol, 9CI; FEMA 2184; E321; Butylhydroxytoluene; Butylated hydroxytoluene; Butyl hydroxy toluene; BHT; 2,6-Di-tert-butyl-p-cresol, 8CI; 2,6-Di-t-butyl-4-methylphenol; CHEBI:34247",2014-12-24,1,,,,,,,,,
59080-32-9,0,OMOP Exposome,Observation,Substance,"2,6-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
1194-65-6,0,OMOP Exposome,Observation,Substance,"2,6-Dichlorobenzonitrile","Du-sprex; 2,6-DBN; 2,6-Dichlorbenzonitril; 2,6-Dichlorobenzoic acid nitrile; 2,6-Dichlorophenyl cyanide; 2.6-Dichlorobenzonitrile; BH prefix d; Carsoron; Casaron; Casoron; Casoron 133; Casoron g; Casoron G-10; Casoron G-4; Casoron G20 SR; Casoron G4; Casoron GSR; Casoron W-50; Code H 133; Cyclomec; DBN; DBN (pesticide); DBN (the herbicide); DCB; Decabane; Dichlobanil; Dichlobenil; (14-C)2,6-Dichlorobenzonitrile; Dyclomec; Fydulan; Fydumas; Fydusit; Niagara 5,996; Niagara 5006; Norosac; Surfassol; CHEBI:943",2014-12-24,1,,,,,,,,,
33146-45-1,0,OMOP Exposome,Observation,Substance,"2,6-Dichlorobiphenyl","2,6-PCB; PCB 10; 2,6-DiCB; 2,6-Dichloro-1,1'-biphenyl; CHEBI:34249",2014-12-24,1,,,,,,,,,
60390-27-4,0,OMOP Exposome,Observation,Substance,"2,6-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
579-66-8,0,OMOP Exposome,Observation,Substance,"2,6-Diethylaniline",,2014-12-24,1,,,,,,,,,
108-83-8,0,OMOP Exposome,Observation,Substance,"2,6-Dimethyl-4-heptanone",,2014-12-24,1,,,,,,,,,
87-62-7,0,OMOP Exposome,Observation,Substance,"2,6-Dimethylaniline","2,6-Dimethylphenylamine; 2,6-DMA; 2,6-Xylidine; 2,6-Xylylamine; 2-amino-1,3-Xylene; O-Xylidine; Vic-m-xylidine; 2-amino-1,3-Dimethylbenzene; 2-amino-m-Xylene; 1-amino-2,6-Dimethylbenzene; 2,6-Dimethylbenzenamine; CHEBI:28738",2014-12-24,1,,,,,,,,,
576-26-1,0,OMOP Exposome,Observation,Substance,"2,6-Dimethylphenol",,2014-12-24,1,,,,,,,,,
606-20-2,0,OMOP Exposome,Observation,Substance,"2,6-Dinitrotoluene","1,3-Dinitro 2-methyl benzene; 2-methyl-1,3-dinitrobenzene; 2-Methyl-1,3-dinitro-benzene; 1-Methyl-2,6-dinitrobenzene; 2,4-/2,6-Dinitrotoluene mixture; 2,6-dinitromethylbenzene; 2,6-DNT; DNT; CHEBI:957",2014-12-24,1,,,,,,,,,
91-08-7,0,OMOP Exposome,Observation,Substance,"2,6-Toluene diisocyanate","desmodur t100; Hylene-t; Hylene tm-65; Hylene TM; Hylene tic; Hylene tcpa; DIIsocyanatotoluene; DIIsocyanatomethylbenzene; Desmodur T 80; Benzene, 1,3-diisocyanatomethyl-, homopolymer; 2-Methyl-meta-phenylene isocyanate; 2-Methyl-meta-phenylene diisocyanate; 2-Methyl-m-phenylene isocyanate; 2-Methyl-m-phenylene diisocyanate; 2,6-Tolylene diisocyanate; M-tolylene dIIsocyanate; M-tolylidene dIIsocyanate; Meta-tolylene dIIsocyanate; 2,6-Toluenediiosocyanate; 2,6-toluene-diisocyanate; 2,6-Toluene diisocyanic acid; 2,6-TDI; 2,6-Diisocyanatotoluene, conjugate diacid; 2,6-diisocyanatotoluene monoformate; 2,6-Diisocyanatotoluene; 2,6-Diisocyanato-1-methylbenzene; 2,4/2,6-Toluene diisocyanate isomeric mixture; 2,4-Toluene diisocyanate; 2,4-diisocyanato-1-methylbenzene; 2,4-and2,6-Toluene Diisocyanate; 2,4-and2,6- Toluene Diisocyanate; 2,4-/2,6-Toluene diisocyanate mixture; 2,4- and 2,6-Toluene diisocyanate; Methyl-m-phenylene isocyanate; 2,4 and 2,6-TOLUENE DIISOCYANATE; 2,4 + 2,6-Toluenediisocyanate; 1,3-Diisocyanatomethylbenzene; 1,3-Diisocyanato-2-methylbenzene; Methyl-meta-phenylene dIIsocyanate; Methylphenylene isocyanate; Mondur TD-80; Mondur-TD; mondur-td-80; nacconate-100; Rubinate tdi; rubinate tdi 80/20; TDI; Toluene 2,6-Diisocyanate; Toluene dIIsocy anates; Toluene dIIsocyanate; Toluene diisocyanate; Toluene dIIsocyanate (unspecified isomer); Toluene dIIsocyanate polymer; TOLUENE DIISOCYANATE, COMMERCIAL GRADE; TOLUENE DIISOCYANATE, MONOMER; Toluene-2,6-diisocyanate; Tolylene 2,6-diisocyanate; Tolylene dIIsocyanate; Tolylene dIIsocyanate, homopolymer; Tolylene isocyanate; Tolylene-2,6-diisocyanate; Isocyanic acid, methyl-m-phenylene ester; Isocyanic acid, 2-methyl-m-phenylene ester; Isocyanic acid, 2-methyl-meta-phenylene ester; Hylene TRF; CHEBI:53557",2014-12-24,1,,,,,,,,,
65489-80-7,0,OMOP Exposome,Observation,Substance,"2,7-Dibromodibenzofuran",,2014-12-24,1,,,,,,,,,
33857-26-0,0,OMOP Exposome,Observation,Substance,"2,7-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
74992-98-6,0,OMOP Exposome,Observation,Substance,"2,7-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
10016-52-1,0,OMOP Exposome,Observation,Substance,"2,8-Dibromodibenzofuran","2,8-Dibromodibenzob,dfuran; CHEBI:33083",2014-12-24,1,,,,,,,,,
38964-22-6,0,OMOP Exposome,Observation,Substance,"2,8-Dichlorodibenzo-p-dioxin",,2014-12-24,1,,,,,,,,,
5409-83-6,0,OMOP Exposome,Observation,Substance,"2,8-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
13067-90-8,0,OMOP Exposome,Observation,Substance,2-(Chloroacetyl)dibenzofuran,,2014-12-24,1,,,,,,,,,
13623-98-8,0,OMOP Exposome,Observation,Substance,2-(Nitromethylene)imidazolidine,,2014-12-24,1,,,,,,,,,
94662-60-9,0,OMOP Exposome,Observation,Substance,"2-(Nitromethylidene)-1,3-thiazolidine",,2014-12-24,1,,,,,,,,,
302544-16-7,0,OMOP Exposome,Observation,Substance,2-[(2E)-2-(Nitromethylene)hydrazino]naphthalene,,2014-12-24,1,,,,,,,,,
1164504-23-7,0,OMOP Exposome,Observation,Substance,2-[(2E)-2-(Nitromethylidene)pyrrolidin-1-yl]acetonitrile,,2014-12-24,1,,,,,,,,,
O75600,0,OMOP Exposome,Observation,Substance,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1003322,0,OMOP Exposome,Observation,Substance,2-aminoadipic 2-oxoadipic aciduria,,2024-09-14,1,,,,,,,,,
118-92-3,0,OMOP Exposome,Observation,Substance,2-Aminobenzoic acid,H-2-Abz-OH; O-Carboxyaniline; O-Aminobenzoic acid; Carboxyaniline; Anthranilic acid; Vitamin L1; Vitamin L; Anthranilate; Anthranic acid; Kyselina anthranilova; Ortho-amidobenzoate; Ortho-amidobenzoic acid; Ortho-aminobenzoate; Ortho-aminobenzoic acid; Kyselina O-aminobenzoova; Anthranate; 2-Carboxyaniline; 2-Aminophenylacetic acid; 2-Aminophenylacetate; 2-Aminobenzoate; O-Anthranilate; O-Amino-Benzoate; O-Amino-Benzoic acid; 2-Amino-Benzoic acid; 2-Amino-Benzoate; 1-Amino-2-carboxybenzene; O-Aminobenzoate; Anthranilic acid gr; O-Anthranilic acid; CHEBI:30754,2014-12-24,1,,,,,,,,,
91-59-8,0,OMOP Exposome,Observation,Substance,2-Aminonaphthalene,USAF CB-22; 2-Amino-naphthalene; 2-Aminonaftalen; 2-Naftilamina; 2-Naftylamin; 2-Naftylamine; 2-Naphthalamine; 2-Naphthalenamine; 2-Naphthylamin; 2-Naphthylamine; 6-Naphthylamine; beta-Naftalamin; beta-Naftilamina; beta-Naftylamin; beta-Naftyloamina; beta-Naphthylamin; beta-Naphthylamine; BNA; Fast Scarlet Base B; Naphthalen-2-amine; RCRA waste number U168; CHEBI:27878,2014-12-24,1,,,,,,,,,
95-55-6,0,OMOP Exposome,Observation,Substance,2-Aminophenol,2-Hydroxyaniline; 1-Amino-2-hydroxybenzene; 1-Hydroxy-2-aminobenzene; 2-Amino-1-hydroxybenzene; 2-Amino-phenole; 2-Aminobenzenol; 2-AMINOPHENOL; 2-Hydroxyanaline; Benzofur GG; Fouramine op; Nako Yellow 3GA; Nako yellow ga; O-aminophenol; O-hydroxyaniline; O-hydroxyphenylamine; Orsin; Ortho-aminophenol; Paradone olive green b; Pelagol 3GA; Pelagol grey GG; Questiomycin b; CHEBI:18112,2014-12-24,1,,,,,,,,,
90-43-7,0,OMOP Exposome,Observation,Substance,2-Biphenylol,"Biphenylol; O-Hydroxydiphenyl; O-Phenylphenate; O-Phenylphenol; O-Xenol; O-Hydroxybiphenyl; (1,1'-Biphenyl)-2-ol; (1,1-Biphenyl)-2-ol; 1,1'-Biphenyl-2-ol; 1-Hydroxy-2-phenylbenzene; Orthoxenol; 2-Fenylfenol; 2-Hydroxy biphenyl; Stellisept; Rotoline; 2-Hydroxy-1,1'-biphenyl; 2-Hydroxybiphenyl; O-Diphenylol; O-Biphenylol; Nipacide OPP; Nectryl; Manusept; Hydroxybiphenyl; Hydroxy-2-phenylbenzene; Hydroxdiphenyl; HBP; FEMA 3959; E231; Dowicide 1; Orthohydroxydiphenyl; Orthophenylphenol; O-Xonal; 2-Hydroxydiphenyl; 2-Phenylphenol, BSI, ISO; OPP?; Phenylphenol; Torsite; Ortho-phenylphenate; Ortho-phenylphenol; Orthohydroxydipbenyl; O-Phenyl phenol; CHEBI:17043",2014-12-24,1,,,,,,,,,
78-76-2,0,OMOP Exposome,Observation,Substance,2-Bromobutane,,2014-12-24,1,,,,,,,,,
86-76-0,0,OMOP Exposome,Observation,Substance,2-Bromodibenzofuran,,2014-12-24,1,,,,,,,,,
3377-86-4,0,OMOP Exposome,Observation,Substance,2-Bromohexane,,2014-12-24,1,,,,,,,,,
75-26-3,0,OMOP Exposome,Observation,Substance,2-Bromopropane,,2014-12-24,1,,,,,,,,,
14357-82-5,0,OMOP Exposome,Observation,Substance,"2-Chloro-4,5-xylyl N-hydroxy-N-methylcarbamate",,2014-12-24,1,,,,,,,,,
2698-41-1,0,OMOP Exposome,Observation,Substance,2-Chlorobenzylidene malononitrile,,2014-12-24,1,,,,,,,,,
2051-60-7,0,OMOP Exposome,Observation,Substance,2-Chlorobiphenyl,"2-Chloro-1, 1'-biphenyl; 2-PCB; Arochlor-1254; 1-Chloro-2-phenylbenzene; 2-Chloro-1,1'-biphenyl; Chloro-1,1'-biphenyl; Chlorodiphenyl; Diphenylchloride; 2-Monochlorobiphenyl; PCB 1; 2-Chlorodiphenyl; 2-Chlorbiphenyl; o-Chlorodiphenyl; o-Chlorobiphenyl; Monochlorobiphenyl; Chlorobiphenyl; CHEBI:34269",2014-12-24,1,,,,,,,,,
39227-54-8,0,OMOP Exposome,Observation,Substance,2-Chlorodibenzo-p-dioxin,,2014-12-24,1,,,,,,,,,
51230-49-0,0,OMOP Exposome,Observation,Substance,2-Chlorodibenzofuran,,2014-12-24,1,,,,,,,,,
95-57-8,0,OMOP Exposome,Observation,Substance,2-Chlorophenol,2-Chloro-1-hydroxybenzene; Septi-kleen; Pine-o disinfectant; Ortho-monochlorophenol; Ortho-chlorophenol; o-monochlorophenol; o-chlorphenol; o-chlorophenol; O-Chlorophenic acid; 1-Chloro-2-hydroxybenzene; Chlorophenols; Chlorophenol; 2-Hydroxychlorobenzene; CHEBI:47083,2014-12-24,1,,,,,,,,,
3282-00-6,0,OMOP Exposome,Observation,Substance,2-Cyclopentylphenyl methylcarbamate,,2014-12-24,1,,,,,,,,,
110-80-5,0,OMOP Exposome,Observation,Substance,2-Ethoxyethanol,Solvulose; Ethyl 2-hydroxyethyl ether; Ethyl cellosolve; Ethyl ethylene glycol; Ethyl glycol; Ethyl icinol; Ethyl-2-hydroxyethyl ether; Ethylene glycol ethyl ether; Ethylene glycol monoethyl ether; Ethylene glycol monoethyl ether (egmee); Ethylethylene glycol; Etoksyetylowy alkohol; ETX; Glycol ether ee; Glycol ethyl ether; Glycol monoethyl ether; HOCH2CH2OC2H5; HSDB 54; Hydroxy ether; Jeffersol ee; Oxitol; Plastiazan 60; Poly-solv ee; Solvid; Ethoxyethanol; 2-Ethoxy-Ethanol; 2-Ethoxyethanol (cellosolve); 2-Ethoxyethyl alcohol; Athylenglykol-monoathylather; beta-Ethoxyethanol; Bikanol E 1; Bikanol E1; Cellosolve; Cellosolve solvent; Cellosolve(R); Celosolv; Dowanol 8; Dowanol ee; Ee solvent; EGEE; Emkanol; Eter monoetilico del etilenglicol; Ether monoethylique de L'ethylene-glycol; CHEBI:46788,2014-12-24,1,,,,,,,,,
126-92-1,0,OMOP Exposome,Observation,Substance,2-Ethyl-1-hexanol sulfate,,2014-12-24,1,,,,,,,,,
149-57-5,0,OMOP Exposome,Observation,Substance,2-Ethylhexanoic acid,2-Ethylhexoic acid; Butylethylacetic acid; alpha-Ethylhexanoic acid; alpha-Ethylcaproic acid; 2-Ethyl-1-hexanoic acid; 2-Ethyl-hexoic acid; 2-Ethyl-Hexonic acid; 2-Ethylcaproic acid; (+/-)-2-ETHYLHEXANOIC ACID; 2-Butylbutanoic acid; 2-Ethyl hexanoic acid; 2-Ethylcapronic acid; 2-Ethylhexanoate; 3-Heptanecarboxylic acid; CHEBI:744024,2014-12-24,1,,,,,,,,,
2463-63-0,0,OMOP Exposome,Observation,Substance,2-Heptenal,,2014-12-24,1,,,,,,,,,
505-57-7,0,OMOP Exposome,Observation,Substance,2-Hexenal,,2014-12-24,1,,,,,,,,,
18294-85-4,0,OMOP Exposome,Observation,Substance,2-Hydroxyadipic acid,"2-Hydroxy-hexanedioic acid; 2,3,4-Trideoxyhexaric acid; a-Hydroxyadipic acid; alpha-Hydroxyadipic acid; 2-Hydroxyhexanedioate; 2,3,4-Trideoxyhexarate; 2-Hydroxyadipate; a-Hydroxyadipate; 2-Hydroxy-adipate; 2-Hydroxyhexanedioic acid; DL-2-Hydroxyadipic acid; 2-Hydroxy-adipic acid; DL-2-Hydroxyadipate; 2-Hydroxy-hexanedioate; alpha-Hydroxyadipate; CHEBI:17023",2018-03-21,1,,,,,,,,,
90-02-8,0,OMOP Exposome,Observation,Substance,2-Hydroxybenzaldehyde,"Salicylic aldehyde; Salicylaldehyde, 8CI; FEMA 3004; O-Hydroxybenzaldehyde; O-Formylphenol; 2-Formylphenol; CHEBI:16008",2014-12-24,1,,,,,,,,,
52806-53-8,0,OMOP Exposome,Observation,Substance,2-hydroxyflutamide,,2014-12-24,1,,,,,,,,,
GIS1003323,0,OMOP Exposome,Observation,Substance,2-Hydroxyglutric Aciduria (D And L Form),,2024-09-14,1,,,,,,,,,
10309-97-4,0,OMOP Exposome,Observation,Substance,2-Hydroxyphenyl methylcarbamate,,2014-12-24,1,,,,,,,,,
88-69-7,0,OMOP Exposome,Observation,Substance,2-Isopropylphenol,"O-Hydroxycumene; Isopropylphenol, ortho; Isopropyl-Phenol; FEMA 3461; 2-(1-Methylethyl)phenol; 2-(1-Methylethyl)-Phenol; 2-(Propan-2-yl)phenol; O-Cumenol; 2-(1-Methylethyl)phenol, 9CI; Ortho-isopropylphenol; 1-Hydroxy-3-isopropylbenzene; 1-Hydroxy-2-isopropylbenzene; Prodox 131; O-Isopropylphenol; O-Isopropyl-Phenol; CHEBI:38506",2014-12-24,1,,,,,,,,,
2631-40-5,0,OMOP Exposome,Observation,Substance,2-Isopropylphenyl methylcarbamate,"N-Methyl-2-isopropylphenylcarbam; Mipcin; O-Isopropylphenyl methylcarbamate; Etrolan; Hytox; O-Isopropylphenyl N-methylcarbamate; Isoprocarb, BSI, ISO; Isopropyl phenylmethyl carbamate; O-Isopropylphenol methylcarbamate; O-Cumenyl N-methylcarbamate; O-Cumenyl methylcarbamate; Isopropylphenol methylcarbamate; Mipsin; MIPC, JMAF; Methylcarbamic acid, O-cumenyl ester; Phenol, 2-(1-methylethyl)-, methylcarbamate; 2-(1-Methylethyl)phenyl methylcarbamate, 9CI; 2-(1-Methylethyl)phenol methylcarbamate; 2-(Propan-2-yl)phenyl methylcarbamate; 2-Isopropylphenyl methylcarbamic acid; 2-Isopropylphenyl N-methylcarbamate; Carbamic acid, methyl-, 2-(1-methylethyl)phenyl ester; Carbamic acid, methyl-, O-cumenyl ester; Carbamic acid, methyl-, O-isopropylphenyl ester; Cumenyl N-methylcarbamate; Etrofolan; Phenol, 2-(1-methylethyl)-, 1-(N-methylcarbamate); CHEBI:38505",2014-12-24,1,,,,,,,,,
GIS1003324,0,OMOP Exposome,Observation,Substance,2-ketoglutarate dehydrogenase complex deficiency,,2024-09-14,1,,,,,,,,,
2785-87-7,0,OMOP Exposome,Observation,Substance,2-Methoxy-4-propylphenol,,2014-12-24,1,,,,,,,,,
563-46-2,0,OMOP Exposome,Observation,Substance,2-Methyl-1-butene,2-Methylbutene; Gamma-isoamylene; 1-Isoamylene; 2-Methylbut-1-ene; C2H5C(CH3)=CH2; 2-Methylbutene-1; Isopentenes; Isopentene; CHEBI:77915,2014-12-24,1,,,,,,,,,
513-35-9,0,OMOP Exposome,Observation,Substance,2-Methyl-2-butene,".beta.-isoamylene; 1,1, 2-Trimethylethylene; 1,1,2-Trimethylethylene; 2-Methyl-2-butene solution; 2-Methylbut-2-ene; 2-methylbutene-2; 3-Methyl-2-butene; Amylene; B-isoamylene; Beta-isoamylene; Isopentene; Methyl butene; (CH3)2C=CHCH3; Methyl butene (dot); N-amylene; Trimethylethylene; CHEBI:77916",2014-12-24,1,,,,,,,,,
GIS1003325,0,OMOP Exposome,Observation,Substance,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,,2024-09-14,1,,,,,,,,,
94-74-6,0,OMOP Exposome,Observation,Substance,2-Methyl-4-chlorophenoxyacetic acid,"FLUID 4; Hedapur M 52; Hedarex m; Chafer MCPA 675; Hedonal; Hedonal m; Herbicide m; Hormotuho; Hornotuho; Cekherbex; Caswell No. 557C; Campbell's MCPA 25, 50; Brominal m and plus; Bordermaster; BH MCPA 75; Trasan; U 46 M-FLUID; Kilsem; Kilsem4k-2m; Krezone; Legumex DB; Leuna m; Leyspray; Linormone; MCP; MCP ester; MCPA; Mcpa; Mcpa ester; Mcpa solution; Mecpa; Mephanac; Metaxon; Methoxone; Methyl chlorophenoxy acetic acid; Methylchlorophenoxyacetic acid; MSS MCPA 50; Netazol; Okultin m; Star mcpa; Ustinex; Vacate; Verdone; Phenoxylene 50; Phenoxylene plus; Phenoxylene super; Power mcpa; Raphone; Razol dock killer; Vesakontuho mcpa; Weed-rhap; Weedar; Weedar mcpa; BH mcpa; Banvel m; Rhomenc; Soviet technical herbicide 2M-4C; Shamrox; Rhomene; Selektonon m; Seppic MMD; Rhonox; Agritox; B-selektonon m; Atlas mcpa; Anicon m; 4-chloro-O-Tolyloxyacetic acid; Anicon kombi; Albar-m; Agroxone 50; Agroxone; Agroxon; Acetic acid, {(4-chloro-O-tolyl)oxy-}; Acme mcpa amine 4; Weedar mcpa concentrate; Agritox 50; ((4-chloro-O-Tolyl)oxy)acetic acid; (2-Methyl-4-chlorophenoxy)acetic acid; (4-chloro-2-Methylphenoxy)acetic acid; (4-chloro-O-Cresoxy)acetic acid; (4-chloro-O-Toloxy)acetic acid; 2,4-MCPA; Agrichem MCPA-25, 50; {(4-chloro-O-tolyl)oxyacetic} acid; 2-(4-chloro-2-Methylphenoxy)acetic acid; 2-Methyl-4-chlorophenoxyacetate; 2-Methyl-4-chlorophenoxymethylacetic acid; 2-Methyl-4-chlorphenoxyessigsaeure; 4-chloro-2-Methylphenoxyacetic acid; (4-Chloro-O-tolyl)oxyacetic acid; Zelan; WLN: QV1OR DG B1; Agricorn 500; Weedone mcpa ester; 4-chloro-O-Cresoxyacetic acid; 4-chloro-O-Toloxyacetic acid; Weedone; Chwastox 30; Chwastox; chloro-(O-Tolyloxy)acetic acid; chloro-(O-Cresoxy)acetic acid; Chiptox; Chwastox extra; Chwastox f; CMP acetate; Cornox-m; Ded-weed; Dicotex; Dicopur-m; Dikotes; Dikotex; Dow MCP amine weed killer; Emcepan; Empal; Farmon MCPA 50; FBC mcpa; CHEBI:50099",2014-12-24,1,,,,,,,,,
592-27-8,0,OMOP Exposome,Observation,Substance,2-Methylheptane,,2014-12-24,1,,,,,,,,,
591-76-4,0,OMOP Exposome,Observation,Substance,2-Methylhexane,,2014-12-24,1,,,,,,,,,
91-57-6,0,OMOP Exposome,Observation,Substance,2-Methylnaphthalene,Methyl-2-naphthalene; Beta.-methylnaphthalene; Beta-methylnaphthalene; Beta-methyl naphthalenes; B-methylnaphthalene; 2-Methylnaphthalene (beta); 2-Naphthylmethyl radical; CHEBI:50720,2014-12-24,1,,,,,,,,,
107-83-5,0,OMOP Exposome,Observation,Substance,2-Methylpentane,,2014-12-24,1,,,,,,,,,
252-07-7,0,OMOP Exposome,Observation,Substance,2-Monobromobiphenyl,,2014-12-24,1,,,,,,,,,
135-19-3,0,OMOP Exposome,Observation,Substance,2-Naphthol,2-Hydroxynaphthalene; 2-Naftolo; Hydronaphthol; Isonaphthol; 2-Naphthalenol; 2-Naphtol; Developer BN; Betanaphthol; beta.-Hydroxynaphthalene; beta-Napthol; beta-Naphtol; beta-Naphthyl hydroxide; beta-Naphthyl alcohol; beta-Naphthol; beta-Naftolo; beta-Naftol; beta-Monoxynaphthalene; beta-Hydroxynaphthalene; Azogen developer a; Antioxygene BN; Naphthol b; Trimetin; 2-Naftol; CHEBI:10432,2014-12-24,1,,,,,,,,,
61018-99-3,0,OMOP Exposome,Observation,Substance,2-Nitromethylene-azepane,,2014-12-24,1,,,,,,,,,
50902-03-9,0,OMOP Exposome,Observation,Substance,2-Nitromethylene-piperidine,,2014-12-24,1,,,,,,,,,
88-75-5,0,OMOP Exposome,Observation,Substance,2-Nitrophenol,2-nitrophenol  ammonium salt; 2-Hydroxynitrobenzene; 2-(hydroxy(oxido)amino)phenol; O-hydroxynitrobenzene; O-nitrofenol; O-nitrophenol; O-Nitrophenol; O-nitrophenol (molten); Ortho-nitrophenol; CHEBI:16260,2014-12-24,1,,,,,,,,,
2463-53-8,0,OMOP Exposome,Observation,Substance,2-Nonenal,,2014-12-24,1,,,,,,,,,
2363-89-5,0,OMOP Exposome,Observation,Substance,2-Octenal,,2014-12-24,1,,,,,,,,,
Q02218,0,OMOP Exposome,Observation,Substance,"2-oxoglutarate dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
591-78-6,0,OMOP Exposome,Observation,Substance,2-Oxohexane,N-Butyl methyl ketone; Propylacetone; 2-Hexanone; Butyl methyl ketone; Hexan-2-one; Methyl butyl ketone; 2-Hexanone Methyl N-butyl ketone; MNBK; Methyl N-butyl ketone; CHEBI:421633,2014-12-24,1,,,,,,,,,
109-68-2,0,OMOP Exposome,Observation,Substance,2-Pentene,Methylethylethylene; Trans-beta-n-amylene; trans-Pent-2-ene; .beta.-n-amylene; (E)-2-Pentene; (2E)-2-Pentene; S-methylethylethylene; Trans-beta-amylene; trans-2-Pentene; Pent-2-ene; b-n-amylene; Beta-n-amylene; Methylbut-1-ene; SYM-methylethylethylene; CHEBI:41275,2014-12-24,1,,,,,,,,,
122-40-7,0,OMOP Exposome,Observation,Substance,2-Pentyl-3-phenyl-2-propenal,,2014-12-24,1,,,,,,,,,
122-99-6,0,OMOP Exposome,Observation,Substance,2-Phenoxyethanol,"Newpol EFP; Dalpad A; Ethylene glycol monophenyl ether; Ethylene glycol phenyl ether; 1-Hydroxy-2-phenoxyethane; 2-Hydroxyethyl phenyl ether; 2-Phenoxyethanol, 9CI; Phenylcellosolve; Phenoxetol; CHEBI:64275",2014-12-24,1,,,,,,,,,
2835-39-4,0,OMOP Exposome,Observation,Substance,2-Propenyl 3-methylbutanoate,,2014-12-24,1,,,,,,,,,
1948-33-0,0,OMOP Exposome,Observation,Substance,"2-tert-Butyl-1,4-benzenediol","2-Tert-Butyl(1,4)hydroquinone; 2-t-Butylhydroquinone; t-Butyl-Hydroquinone; 2-t-Butyl-1,4-benzenediol; T-Butyl hydroquinone; Sustane; 2-(1,1-Dimethylethyl)-1,4-Benzenediol; 2-(1,1-Dimethylethyl)benzene-1,4-diol; 2-(1,1-Dimethylethyl)-1,4-benzenediol, 9CI; Tert-Butylhydroquinone; T-BHQ; Tenox TBHO; Tenox TBHQ; Tert-butylhydrochinone; MTBHQ; Monotertiary butyl hydroquinone; Mono-tertiarybutylhydroquinone; Tenox 20; Tert-butyl-Hydroquinone; TBHQ; Tert-Butyl-1,4-benzenediol; T-Butylhydroquinone; Mono-tert-butylhydroquinone; EYK; Eastman MTBHQ; Banox 20BA; 2-Tertiary-butylhydroquinone; 2-Tert-Butylhydroquinone; Sustane TBHQ; Tenox TBHQTBHQ; Tertiary-butylhydroquinone; 2-Tert-butylbenzene-1,4-diol; 2-Tert-butyl-1,4-benzenediol; CHEBI:78886",2014-12-24,1,,,,,,,,,
88-18-6,0,OMOP Exposome,Observation,Substance,2-Tert-butylphenol,,2014-12-24,1,,,,,,,,,
71827-03-7,0,OMOP Exposome,Observation,Substance,"22,23-dihydroavermectin b1a",,2014-12-24,1,,,,,,,,,
70209-81-3,0,OMOP Exposome,Observation,Substance,"22,23-dihydroavermectin b1b",,2014-12-24,1,,,,,,,,,
O15528,0,OMOP Exposome,Observation,Substance,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",,2024-09-14,1,,,,,,,,,
P82675,0,OMOP Exposome,Observation,Substance,"28S ribosomal protein S5, mitochondrial",,2024-09-14,1,,,,,,,,,
P14060,0,OMOP Exposome,Observation,Substance,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,,2024-09-14,1,,,,,,,,,
60044-26-0,0,OMOP Exposome,Observation,Substance,"3,3',4,4',5,5'-Hexabromobiphenyl",,2014-12-24,1,,,,,,,,,
32774-16-6,0,OMOP Exposome,Observation,Substance,"3,3',4,4',5,5'-Hexachlorobiphenyl",,2014-12-24,1,,,,,,,,,
84303-46-8,0,OMOP Exposome,Observation,Substance,"3,3',4,4',5-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
57465-28-8,0,OMOP Exposome,Observation,Substance,"3,3',4,4',5-Pentachlorobiphenyl","PCB 126; 3,4,3',4',5'-Pentachlorobiphenyl; 3,4,3',4',5-Pentachloro-1,1'-biphenyl; 3,4,5,3',4'-Penta coplanar polychlorinated biphenyl; 3,4,5,3',4'-Pentachloro-1,1'-biphenyl; 3,4,5,3',4'-Pentachlorobiphenyl; 3,3',4,4',5-PCB; 3,3',4,4',5-pentachloro-1,1'-biphenyl; CHEBI:34317",2014-12-24,1,,,,,,,,,
77102-82-0,0,OMOP Exposome,Observation,Substance,"3,3',4,4'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
32598-13-3,0,OMOP Exposome,Observation,Substance,"3,3',4,4'-Tetrachlorobiphenyl","3,3',4,4'-PCB; 3,3',4,4'-Tetrachloro-1,1'-biphenyl; 3,3',4,4'-tetrachlorobinphenyl; 3,4,3',4'-Tetra coplanar polychlorinated biphenyl; 3,4,3',4'-Tetrachloro-biphenyl; 3,4,3',4'-Tetrachlorobiphenyl; PCB 77; CHEBI:1367",2014-12-24,1,,,,,,,,,
97038-98-7,0,OMOP Exposome,Observation,Substance,"3,3',4,5'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
41464-48-6,0,OMOP Exposome,Observation,Substance,"3,3',4,5'-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
81902-33-2,0,OMOP Exposome,Observation,Substance,"3,3',4,5,5'-Pentabromobiphenyl",,2014-12-24,1,,,,,,,,,
39635-33-1,0,OMOP Exposome,Observation,Substance,"3,3',4,5,5'-Pentachlorobiphenyl",,2014-12-24,1,,,,,,,,,
70362-49-1,0,OMOP Exposome,Observation,Substance,"3,3',4,5-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
37680-69-6,0,OMOP Exposome,Observation,Substance,"3,3',4-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
16400-50-3,0,OMOP Exposome,Observation,Substance,"3,3',5,5'-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
16400-51-4,0,OMOP Exposome,Observation,Substance,"3,3'-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
91-94-1,0,OMOP Exposome,Observation,Substance,"3,3'-Dichlorobenzidine","3,3 Dichlorobenzidine; Ortho,ortho'-dichlorobenzidine; o,o'-dichlorobenzidine; Dichlorobenzidine; 4,4'Ddiamino-3,3'-dichlorobiphenyl; 4,4'-Diamino-3,3'-dichlorodiphenyl; 4'-Amino-3,3'-dichloro1,1'-biphenyl-4-ylamine; 4'-Amino-3,3'-dichloro(1,1'-biphenyl)-4-ylamine; 3,3-Dichlorobenzidine; 3,3-Dichloro-1,1-biphenyl-4,4-diamine; 3,3'-dichloro1,1'-biphenyl-4,4'-diamine; 3,3'-dichlorobiphenyl-4,4'-ylenediamine; 3,3'-Dichlorobiphenyl-4,4'-diamine; 3,3'-Dichloro-p,p'-bianiline; 3,3'-dichloro-Benzidine; 3,3'-Dichloro-4,4'-diaminobiphenyl; 3,3'-Dichloro-4,4'-diamino(1,1-biphenyl); 3,3'-Dichloro-4,4'-biphenyldiamine; 3,3'-Dichloro-4, 4'-diaminodiphenyl; 3,3'-dichloro-(1,1'-Biphenyl)-4,4'-diamine; 3,3' Dichlorobenzidine; 3, 3'-Dichlorobenzidine; CHEBI:25520",2014-12-24,1,,,,,,,,,
2050-67-1,0,OMOP Exposome,Observation,Substance,"3,3'-Dichlorobiphenyl",,2014-12-24,1,,,,,,,,,
91-93-0,0,OMOP Exposome,Observation,Substance,"3,3'-Dimethoxybenzidine-4,4'-diisocyanate",,2014-12-24,1,,,,,,,,,
563-57-5,0,OMOP Exposome,Observation,Substance,"3,3-Dichloropropene",,2014-12-24,1,,,,,,,,,
563-16-6,0,OMOP Exposome,Observation,Substance,"3,3-Dimethylhexane",,2014-12-24,1,,,,,,,,,
562-49-2,0,OMOP Exposome,Observation,Substance,"3,3-Dimethylpentane",,2014-12-24,1,,,,,,,,,
72416-87-6,0,OMOP Exposome,Observation,Substance,"3,4',5-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
38444-88-1,0,OMOP Exposome,Observation,Substance,"3,4',5-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
57186-90-0,0,OMOP Exposome,Observation,Substance,"3,4'-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
2974-90-5,0,OMOP Exposome,Observation,Substance,"3,4'-Dichlorobiphenyl",,2014-12-24,1,,,,,,,,,
59589-92-3,0,OMOP Exposome,Observation,Substance,"3,4,4',5-Tetrabromobiphenyl",,2014-12-24,1,,,,,,,,,
70362-50-4,0,OMOP Exposome,Observation,Substance,"3,4,4',5-Tetrachlorobiphenyl",,2014-12-24,1,,,,,,,,,
6683-35-8,0,OMOP Exposome,Observation,Substance,"3,4,4'-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
38444-90-5,0,OMOP Exposome,Observation,Substance,"3,4,4'-Trichlorobiphenyl",,2014-12-24,1,,,,,,,,,
115245-08-4,0,OMOP Exposome,Observation,Substance,"3,4,5-Tribromobiphenyl",,2014-12-24,1,,,,,,,,,
53555-66-1,0,OMOP Exposome,Observation,Substance,"3,4,5-Tricholobiphenyl",,2014-12-24,1,,,,,,,,,
57117-40-5,0,OMOP Exposome,Observation,Substance,"3,4,6,7-Tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-43-2,0,OMOP Exposome,Observation,Substance,"3,4,6-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-44-3,0,OMOP Exposome,Observation,Substance,"3,4,7-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-45-4,0,OMOP Exposome,Observation,Substance,"3,4,8-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
83704-46-5,0,OMOP Exposome,Observation,Substance,"3,4,9-Trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
60108-72-7,0,OMOP Exposome,Observation,Substance,"3,4-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
2328-31-6,0,OMOP Exposome,Observation,Substance,"3,4-Dichlorobenzyl methylcarbamate",,2014-12-24,1,,,,,,,,,
2974-92-7,0,OMOP Exposome,Observation,Substance,"3,4-Dichlorobiphenyl",,2014-12-24,1,,,,,,,,,
94570-83-9,0,OMOP Exposome,Observation,Substance,"3,4-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
95-77-2,0,OMOP Exposome,Observation,Substance,"3,4-Dichlorophenol",,2014-12-24,1,,,,,,,,,
102-36-3,0,OMOP Exposome,Observation,Substance,"3,4-Dichlorophenyl isocyanate",,2014-12-24,1,,,,,,,,,
583-48-2,0,OMOP Exposome,Observation,Substance,"3,4-Dimethylhexane",,2014-12-24,1,,,,,,,,,
95-65-8,0,OMOP Exposome,Observation,Substance,"3,4-Dimethylphenol","3,4-Xylenol, 8CI; 4,5-Dimethylphenol; 4-Hydroxy-1,2-dimethylbenzene; 4-Hydroxy-O-xylene; Asym-O-Xylenol; FEMA 3596; 1,2,4-Xylenol; 1,2-Dimethyl-4-hydroxybenzene; 1,3,4-Xylenol; 1-Hydroxy-3, 4-dimethylbenzene; 1-Hydroxy-3,4-dimethylbenzene; 3, 4-Xylenol; 3,4-Dimethyl phenol; 3,4-Dimethyl-Phenol; 3,4-Xylenol; CHEBI:39839",2014-12-24,1,,,,,,,,,
16372-96-6,0,OMOP Exposome,Observation,Substance,"3,5-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
34883-41-5,0,OMOP Exposome,Observation,Substance,"3,5-Dichlorobiphenyl","3,5-Dichloro-1,1'-biphenyl; 3,5-PCB; 3,5-DiCB; PCB 14; CHEBI:34326",2014-12-24,1,,,,,,,,,
330-64-3,0,OMOP Exposome,Observation,Substance,"3,5-Diisopropylphenyl methylcarbamate","Carbamic acid, methyl-, 3,5-diisopropylphenyl ester; Decylic acid; 3,5-Diisopropylphenyl methylcarbamic acid; 3,5-Bis(1-methylethyl)phenyl methylcarbamate; 3,5-Bis(1-methylethyl)phenol, methylcarbamate; Phenol, 3,5-diisopropyl-, methylcarbamate; Phenol, 3,5-bis(1-methylethyl)-, methylcarbamate; N-Capric acid; Hooker hrs-1422; 3,5-Diisopropylphenyl N-methylcarbamate; Carbamic acid, methyl-, 3,5-bis(1-methylethyl)phenyl ester; Caswell No. 356A; CHEBI:27689",2014-12-24,1,,,,,,,,,
2655-14-3,0,OMOP Exposome,Observation,Substance,"3,5-Dimethylphenyl methylcarbamate","Macbal; 3,5-Xylylester kyseliny methylkarbaminove; 3,5-Xylyl N-methylcarbamate; 3,5-Xylyl methylcarbamate (8CI); 3,5-Xylyl methylcarbamate; 3,5-Xylenyl N-methylcarbamate; Maqbal; Maqbarl; Methylcarbamic acid 3,5-xylyl ester; 3,5-Xylenol, methylcarbamate; 3,5-Dimethylphenyl N-methylcarbamate; 3,5-Dimethylphenyl methylcarbamic acid; 3,5-Dimethylphenyl methylcarbamate (9CI); 3,5-Dimethylphenol methylcarbamate; XMC; N-Methyl-3,5-xylyl carbamate; Phenol, 3,5-dimethyl-, methylcarbamate; XMC (pesticide); XMC, JMAF; Phenol, 3,5-dimethyl-, methylcarbamate (9CI); Profam; Cosban; Carbaron; Carbamic acid, methyl-, 3,5-xylyl ester; CHEBI:38571",2014-12-24,1,,,,,,,,,
74918-40-4,0,OMOP Exposome,Observation,Substance,"3,6-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
58802-21-4,0,OMOP Exposome,Observation,Substance,"3,7-Dichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
78-69-3,0,OMOP Exposome,Observation,Substance,"3,7-Dimethyl-3-octanol",,2014-12-24,1,,,,,,,,,
672-04-8,0,OMOP Exposome,Observation,Substance,3-(1-Ethylpropyl)phenyl methylcarbamate,,2014-12-24,1,,,,,,,,,
2282-34-0,0,OMOP Exposome,Observation,Substance,3-(1-Methylbutyl)phenyl N-methylcarbamate,,2014-12-24,1,,,,,,,,,
3247-75-4,0,OMOP Exposome,Observation,Substance,3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid,,2018-03-21,1,,,,,,,,,
91978-88-0,0,OMOP Exposome,Observation,Substance,3-[(2E)-2-(Nitromethylidene)hydrazinyl]benzoic acid,,2014-12-24,1,,,,,,,,,
70402-13-0,0,OMOP Exposome,Observation,Substance,"3-Acetoxyscirpene-4,15-diol",,2014-12-24,1,,,,,,,,,
771-03-9,0,OMOP Exposome,Observation,Substance,3-Acetyl-4-hydroxy-6-methyl-2H-pyran-2-one,,2014-12-24,1,,,,,,,,,
2243-47-2,0,OMOP Exposome,Observation,Substance,3-Aminobiphenyl,,2014-12-24,1,,,,,,,,,
591-27-5,0,OMOP Exposome,Observation,Substance,3-Aminophenol,Rodinal; Tertral eg; Ursol eg; Futramine eg; M-aminofenol; M-aminophenol; M-hydroxyaminobenzene; M-hydroxyaniline; M-hydroxyphenylamine; 3-Hydroxyanilinel AC; 3-Hydroxyaniline; 3-Amino-1-hydroxybenzene; 1-Amino-3-hydroxybenzene; -hydroxybenzenamine; 3-Hydroxybenzenamine; Basf ursol eg; Fouramine eg; Fourrine 65; Fourrine eg; Furro eg; Nako teg; Renal eg; Pelagol eg; CHEBI:28924,2014-12-24,1,,,,,,,,,
Q15125,0,OMOP Exposome,Observation,Substance,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",,2024-09-14,1,,,,,,,,,
86879-39-2,0,OMOP Exposome,Observation,Substance,3-Carboxy-4-methyl-5-propyl-2-furan-propanoic acid,"U(3,3); 3-Carboxy-4-methyl-5-propyl-2-furan-propanoate; CHEBI:41254",2014-12-24,1,,,,,,,,,
2051-61-8,0,OMOP Exposome,Observation,Substance,3-Chlorobiphenyl,"3-monochloro-1,1'-biphenyl; 3-Chloro-1,1'-biphenyl; 3-Chloro-1,1'-diphenyl; 3-Chlorodiphenyl; 3-Monochlorobiphenyl; 3-PCB; m-chloro diphenyl; m-chlorobiphenyl; PCB2; CHEBI:36716",2014-12-24,1,,,,,,,,,
25074-67-3,0,OMOP Exposome,Observation,Substance,3-Chlorodibenzofuran,,2014-12-24,1,,,,,,,,,
609-26-7,0,OMOP Exposome,Observation,Substance,3-Ethyl-2-methylpentane,,2014-12-24,1,,,,,,,,,
1067-08-9,0,OMOP Exposome,Observation,Substance,3-Ethyl-3-methylpentane,,2014-12-24,1,,,,,,,,,
619-99-8,0,OMOP Exposome,Observation,Substance,3-Ethylhexane,,2014-12-24,1,,,,,,,,,
617-78-7,0,OMOP Exposome,Observation,Substance,3-Ethylpentane,,2014-12-24,1,,,,,,,,,
620-17-7,0,OMOP Exposome,Observation,Substance,3-Ethylphenol,,2014-12-24,1,,,,,,,,,
GIS1003326,0,OMOP Exposome,Observation,Substance,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,,2024-09-14,1,,,,,,,,,
P04035,0,OMOP Exposome,Observation,Substance,3-hydroxy-3-methylglutaryl-coenzyme A reductase,,2024-09-14,1,,,,,,,,,
16655-82-6,0,OMOP Exposome,Observation,Substance,3-Hydroxy-carbofuran,,2014-12-24,1,,,,,,,,,
6344-67-8,0,OMOP Exposome,Observation,Substance,3-Hydroxyfluorene,,2014-12-24,1,,,,,,,,,
638-18-6,0,OMOP Exposome,Observation,Substance,3-Hydroxyglutaric acid,,2018-03-21,1,,,,,,,,,
GIS1003327,0,OMOP Exposome,Observation,Substance,3-hydroxyisobutyric acid dehydrogenase deficiency,,2024-09-14,1,,,,,,,,,
GIS1003328,0,OMOP Exposome,Observation,Substance,3-hydroxyisobutyric aciduria,,2024-09-14,1,,,,,,,,,
Q6NVY1,0,OMOP Exposome,Observation,Substance,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial",,2024-09-14,1,,,,,,,,,
625-08-1,0,OMOP Exposome,Observation,Substance,3-Hydroxyisovaleric acid,beta-Hydroxyisovalerate; beta-Hydroxyisovaleric acid; beta-Hydroxy-beta-methylbutyrate; B-Hydroxyisovaleric acid; B-Hydroxyisovalerate; B-Hydroxy-b-methylbutyric acid; B-Hydroxy-b-methylbutyrate; 3-OH-isovaleric acid; 3-Hydroxyisovalerate; 3-Hydroxy-isovaleric acid; 3-Hydroxy-3-methylbutyric acid; 3-Hydroxy-3-methylbutyrate; 3-Hydroxy-3-methylbutanoic acid; 3-Hydroxy-3-methylbutanoate; 3-Hydroxy-3-methyl-Butanoate; beta-Hydroxy-beta-methylbutyric acid; 3-Hydroxy-3-methyl-Butyric acid; 3-Hydroxy-3-methyl-Butanoic acid; CHEBI:37084,2018-03-21,1,,,,,,,,,
503-49-1,0,OMOP Exposome,Observation,Substance,3-Hydroxymethylglutaric acid,3-Hydroxy-3-methyl-Glutaric acid; Dicrotalic acid; 3-Hydroxy-3-methylglutarate; 3-Hydroxy-3-methylglutaric acid; 3-Hydroxymethylglutarate; 3-Methyl-3-hydroxyglutarate; 3-Methyl-3-hydroxyglutaric acid; b-Hydroxy-b-methylglutarate; b-Hydroxy-b-methylglutaric acid; beta-Hydroxy-beta-methylglutarate; beta-Hydroxy-beta-methylglutaric acid; CB 337; Dicrotalate; CHEBI:16831,2018-03-21,1,,,,,,,,,
55406-53-6,0,OMOP Exposome,Observation,Substance,3-Iodo-2-propynyl butyl carbamate,,2014-12-24,1,,,,,,,,,
563-45-1,0,OMOP Exposome,Observation,Substance,3-Methyl-1-butene,Isopentene; Vinylisopropyl; Isopropylethylene; Alpha-isoamylene; a-isoamylene; 3-methylbutene-1; 3-Methylbut-1-ene; 2-Methyl-3-butene; (CH3)2CHCH=CH2; CHEBI:77914,2014-12-24,1,,,,,,,,,
1460-34-0,0,OMOP Exposome,Observation,Substance,3-Methyl-2-oxovaleric acid,3-Methyl-2-oxopentanoic acid; alpha-Keto-beta-methylvalerate; alpha-Keto-beta-Methyl-N-valeric acid; alpha-Keto-beta-Methyl-N-valerate; 2-Oxo-3-methylpentanoic acid; (3R)-3-Methyl-2-oxopentanoic acid; 3-Methyl-2-oxo-Valerate; (R)-3-methyl-2-oxopentanoate; (R)-3-methyl-2-oxopentanoic acid; 3-Methyl-2-oxo-pentanoic acid; 3-Methyl-2-oxo-pentanoate; 2-Oxo-3-methylvaleric acid; (S)-3-methyl-2-oxopentanoate; (S)-3-methyl-2-oxopentanoic acid; 2-Keto-3-methylvalerate; 3-Methyl-2-oxovalerate; 2-Keto-3-methylvaleric acid; 3-Methyl-2-oxopentanoate; a-Oxo-b-methylvaleric acid; a-Keto-b-Methyl-N-valerate; 2-Oxo-3-methylpentanoate; 2-Oxo-3-methyl-N-valeric acid; (3R)-3-Methyl-2-oxopentanoate; 2-Oxokolavenate; a-Keto-b-Methyl-N-valeric acid; alpha-Keto-beta-methylvaleric acid; 2-Oxo-3-methylvalerate; 3-Methyl-2-oxo-Valeric acid; 2-Oxoisoleucine; a-Keto-b-methylvalerate; a-Oxo-b-methylvalerate; 3-Methyl-2-oxovaleric; a-Oxo-b-methyl-N-valeric acid; a-Oxo-b-methyl-N-valerate; a-Keto-b-methylvaleric acid; alpha-Oxo-beta-methylvaleric acid; 2-Oxo-3-methyl-N-valerate; alpha-Oxo-beta-methylvalerate; alpha-Oxo-beta-methyl-N-valeric acid; 2-Oxokolavenic acid; alpha-Oxo-beta-methyl-N-valerate; CHEBI:35932,2018-03-21,1,,,,,,,,,
922-62-3,0,OMOP Exposome,Observation,Substance,3-Methyl-2-pentene,,2014-12-24,1,,,,,,,,,
127-51-5,0,OMOP Exposome,Observation,Substance,"3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one",,2014-12-24,1,,,,,,,,,
GIS1003329,0,OMOP Exposome,Observation,Substance,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,,2024-09-14,1,,,,,,,,,
5746-90-7,0,OMOP Exposome,Observation,Substance,3-Methylglutaconic acid,b-Methylglutaconate; 3-Methylglutaconate; beta-Methylglutaconate; b-Methylglutaconic acid; beta-Methylglutaconic acid; CHEBI:37245,2018-03-21,1,,,,,,,,,
GIS1003330,0,OMOP Exposome,Observation,Substance,3-Methylglutaconic Aciduria Type I,,2024-09-14,1,,,,,,,,,
GIS1003331,0,OMOP Exposome,Observation,Substance,3-Methylglutaconic Aciduria Type III,,2024-09-14,1,,,,,,,,,
GIS1003332,0,OMOP Exposome,Observation,Substance,3-Methylglutaconic Aciduria Type IV,,2024-09-14,1,,,,,,,,,
589-81-1,0,OMOP Exposome,Observation,Substance,3-Methylheptane,3-Methyl-(S)-Heptane; 2-Ethylhexane; 3-Methyl-Heptane; CHEBI:35547,2014-12-24,1,,,,,,,,,
589-34-4,0,OMOP Exposome,Observation,Substance,3-Methylhexane,,2014-12-24,1,,,,,,,,,
96-14-0,0,OMOP Exposome,Observation,Substance,3-Methylpentane,,2014-12-24,1,,,,,,,,,
2113-57-7,0,OMOP Exposome,Observation,Substance,3-Monobromobiphenyl,,2014-12-24,1,,,,,,,,,
P18405,0,OMOP Exposome,Observation,Substance,3-oxo-5-alpha-steroid 4-dehydrogenase 1,,2024-09-14,1,,,,,,,,,
P31213,0,OMOP Exposome,Observation,Substance,3-oxo-5-alpha-steroid 4-dehydrogenase 2,,2024-09-14,1,,,,,,,,,
P51857,0,OMOP Exposome,Observation,Substance,3-oxo-5-beta-steroid 4-dehydrogenase,,2024-09-14,1,,,,,,,,,
16709-30-1,0,OMOP Exposome,Observation,Substance,3-Oxo-carbofuran,,2014-12-24,1,,,,,,,,,
O15530,0,OMOP Exposome,Observation,Substance,3-phosphoinositide-dependent protein kinase 1,,2024-09-14,1,,,,,,,,,
97508-29-7,0,OMOP Exposome,Observation,Substance,3-tert-Butylphenyl sec-butylcarbamate,,2014-12-24,1,,,,,,,,,
92-86-4,0,OMOP Exposome,Observation,Substance,"4,4'-Dibromobiphenyl",,2014-12-24,1,,,,,,,,,
2050-47-7,0,OMOP Exposome,Observation,Substance,"4,4'-Dibromobiphenyl Ether",,2014-12-24,1,,,,,,,,,
2050-68-2,0,OMOP Exposome,Observation,Substance,"4,4'-Dichlorobiphenyl","PCB 15; 4, 4'-Dichloro-1,1'-biphenyl; 4-DCB cpd; Polychlorobiphenyl; 4,4'-PCB; p,p-DCBP; 4,4'-DiCB; p,p'-dichlorobiphenyl; 4,4'-Dichloro-1,1'-biphenyl; CHEBI:34364",2014-12-24,1,,,,,,,,,
101-14-4,0,OMOP Exposome,Observation,Substance,"4,4'-Methylenebis(2-chloroaniline)","Bisamine; p,p'-methylenebiso-chloroaniline; p,p'-methylenebis.alpha.-chloroaniline; p,p'-methylenebis(ortho-chloroaniline); p,p'-methylenebis(o-chloroaniline); p,p'-methylenebis(alpha-chloroaniline); p,p'-methylenebis(a-chloroaniline); MOCA; Millionate m; Methylenebis3-Chloro-4-aminobenzene; Methylenebis(chloroaniline); Methylenebis(3-chloro-4-aminobenzene); Methylenebis(2-chloroaniline); Methylene-bis-orthochloroaniline; Methylene-4,4'-bis(o-chloroaniline); Methylene bis(chloroaniline); Methylene 4,4'-bis(o-chloroaniline); Diamet KH; Di(4-amino-3-chlorophenyl)methane; Di(-4-amino-3-chlorophenyl)methane; Cyanaset; Curalin m; Cuamine MT; Cuamine m; CL-mda; Bisamine s; Bis-amine a; Bis(4-amino-3-chlorophenyl)methane; Bis(3-chloro-4-aminophenyl)methane; 4-(4-Amino-3-chlorobenzyl)-2-chlorophenylamine; 4,4-Methylene bis(2-chloroaniline); 4,4'-Methylenebiso-chloroaniline; 4,4'-Methylenebis2-chlorobenzenamine; 4,4'-Methylenebis2-chloroaniline; 4,4'-Methylenebis2-chloroaniline; 4,4'-Methylenebiso-chloroaniline; 4,4'-Methylenebis-2-chlorobenzenamine; 4,4'-Methylenebis-(2-Chlorobenzenamine); 4,4'-Methylenebis-(2-Chlorobenzenamine ); 4,4'-Methylenebis(o-chloroaniline); 4,4'-Methylenebis(2-chlorobenzenamine); 4,4'-Methylene-bis-2-chloroaniline; 4,4'-Methylene-bis-(2-chloroaniline); 4,4'-Methylene-bis(2-chloroaniline); 4,4'-Methylene(bis)-chloroaniline; 4,4'-Methylene bis(2-chloroaniline); 4,4'-Diamino-3,3'-dichlorodiphenylmethane; 4,4'-Diamino-3,3'-dichlorodiphenyl methane; 4,4'-Diamino-3,3'-(dichlorodiphenyl)methane; 4,4'-Diamino-3, 3'-(dichlorodiphenyl)methane; 4, {4'-Methylenebiso-chloroaniline}; 4'-Methylenebiso-chloroaniline; 3,3'-Dichloro-4,4'-Diaminodiphenylmethane; 3,3'-Dichloro-4,4'-diaminodiphenyl methane; 3,3'-Dichloro-4, 4'-diaminodiphenylmethane; 2,2'Dichloro-4,4'-methylene dianiline; 2,2'-dichloro-4,4'-methylendianiline; CHEBI:25520",2014-12-24,1,,,,,,,,,
101-77-9,0,OMOP Exposome,Observation,Substance,"4,4'-Methylenedianiline","4, 4'-Methylenebis(aniline); p, p'-Methylenedianiline; DDM; Di(4-aminophenyl)methane; 4,4'-Methylene(bisaniline); 4, 4'-Diphenylmethanediamine; Bis(p-aminophenyl)methane; Diaminodiphenylmethane; Bis(aminophenyl)methane; Di-(4-aminophenyl)methane; 4,4'-Diphenylmethanediamine; 4,4'-Diaminodiphenylmethane; 4,4'-Diaminodiphenylmethan; Ancamine TL; Sumicure M; p,p'-Methylenedianiline; p,p'-Diaminodiphenylmethane; alpha-(p-Aminophenyl)-p-Toluidine; p,p'-Diaminodifenylmethan; Bis-p-aminofenylmethan; Curithane; DADPM; DAPM; Tonox; 4-(4-Aminobenzyl)phenylamine; 4-(4-Aminobenzyl)aniline; 4,4-Methylenedianiline; 4,4'-Methylenedibenzenamine; 4,4'-Methylenedi-Aniline; 4,4'-Methylenebisaniline; 4,4'-Methylenebis-Benzenamine; 4,4'-Methylenebis(benzeneamine); 4,4'-Methylene-Dianiline; Dianilinemethane; Dianilinomethane; Bis(4-aminophenyl)methane; Epicure DDM; Epikure DDM; Jeffamine AP-20; MDA; Methylenebis(aniline); Methylenedianiline; Methylenebisaniline; Araldite hardener 972; CHEBI:32506",2014-12-24,1,,,,,,,,,
139-93-5,0,OMOP Exposome,Observation,Substance,"4,4-Arsenobis(2-aminophenol) dihydrochloride","Arsabenzosol; 6,6'-Dihydroxy-3,3'-diarsene-1,2-diyldianilinium dichloride; Eparsenol; Kharsivan; Novarsol; Phenarsenamine; Phenol, {4,4'-arsenobis2-amino-,} dihydrochloride; Salavarsan; Salvarsan; Sanluol; Ehrlich 606; Sodium arsenobenzol; Tanvarsan; Diarsenol; Arsphenamine; Arsenphenolamine hydrochloride; Arsenobenzol dihydrochloride; Arsenobenzol; Arsaminol; 4,4'-Arsenobis(2-aminophenol) dihydrochloride; 4,4'-(Diarsene-1,2-diyl)bis(2-aminophenol) dihydrochloride; 4,4'-(1,2-Diarsenediyl)bis(2-aminophenol) dihydrochloride; 3,3'-Diamino-4,4'-dihydroxyarsenobenzene dihydrochloride; 3,3'-Diamino-4, 4'-dihydroxyarsenobenzene dihydrochloride; CHEBI:9016",2014-12-24,1,,,,,,,,,
1192-52-5,0,OMOP Exposome,Observation,Substance,"4,5-Dichloro-3H-1,3-dithiol-2-one",,2014-12-24,1,,,,,,,,,
534-52-1,0,OMOP Exposome,Observation,Substance,"4,6-Dinitro-o-cresol","2, 4-Dinitro-o-cresol; Dekryll; Degrassan; Capsine; Arborol; Antinonnin; Antinonin; 6-Methyl-2,4-dinitrophenol; 4,6-DNOC; 4,6-Dinitro-O-cresol; 4,6-Dinitro-2-methylphenol; 3,5-Dinitro-2-hydroxytoluene; 3, 5-Dinitro-2-hydroxytoluene; 2-Methyl-4,6-dinitrophenol; 2,4-Dinitro-o-cresol; 2,4-Dinitro-6-methylphenol; 2,4-bis(hydroxy(oxido)amino)-6-methylphenol; Winterwash; Trifrina; Trifocide; Sinox; Selinon; Sandolin; Raphatox; Rafex 35; Rafex; Prokarbol; Nitrofan; Nitrador; Neudorff DN 50; Lipan; Krezotol 50; Kresonite-e; Kresamone; Kreozan; Krenite; Hedolite; Hedolit; Flavin-samdoz; Extrar; Elipol; Elgetox; Elgetol 30; Elgetol; Effusan; DNOC; Ditrosol; Dinurania; Dinok; Dinoc; Dinitrosol; Dinitromethyl cyclohexyltrienol; Dinitrol; Dinitrodendtroxal; Dinitrocresol; Dinitro-o-cresol; Dinitro; Dillex; Detol; Detal; Dekrysil; CHEBI:39349",2014-12-24,1,,,,,,,,,
94-81-5,0,OMOP Exposome,Observation,Substance,4-(4-Chloro-2-methylphenoxy)butanoic acid,,2014-12-24,1,,,,,,,,,
10389-50-1,0,OMOP Exposome,Observation,Substance,"4-(Methylamino)-3,5-xylyl methylcarbamate",,2014-12-24,1,,,,,,,,,
76014-81-8,0,OMOP Exposome,Observation,Substance,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol,,2014-12-24,1,,,,,,,,,
3566-00-5,0,OMOP Exposome,Observation,Substance,4-(Methylthio)-m-tolyl methylcarbamate,,2014-12-24,1,,,,,,,,,
13171-00-1,0,OMOP Exposome,Observation,Substance,"4-Acetyl-6-tert-butyl-1,1-dimethylindane",,2014-12-24,1,,,,,,,,,
831-76-5,0,OMOP Exposome,Observation,Substance,"4-Amino-3,5-xylyl methylcarbamate",,2014-12-24,1,,,,,,,,,
92-67-1,0,OMOP Exposome,Observation,Substance,4-Aminobiphenyl,"4-Biphenylamine hydrochloride; 4-Amino-1,1'-biphenyl; p-Biphenylamine; (4-phenyl-phenyl)-amine; (1,1'-Biphenyl)-4-amine; 4-Aminodiphenyl; Biphenyl-4-amine; Aminobiphenyl; 4-Phenylaniline; p-Aminodiphenyl; 4-Biphenylylamine; 4-Biphenylamine; {1,1'-Biphenyl-4-amine}; 1,1'-biphenyl-4-ylamine; Biphenyl-4-ylamine; 1,1'-Biphenyl-4-amine; Xenylamine; Paraaminodiphenyl; p-Xenylamine; p-Phenylaniline; p-Aminobiphenyl; Biphenylamine; CHEBI:1784",2014-12-24,1,,,,,,,,,
P80404,0,OMOP Exposome,Observation,Substance,"4-aminobutyrate aminotransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
123-30-8,0,OMOP Exposome,Observation,Substance,4-Aminophenol,Fouramine P; Activol; Aminophenol; Energol; 1-Amino-4-hydroxybenzene; Paramidophenol; p-Hydroxyphenylamine; p-Hydroxyaniline; Paranol; p-Aminophenol; 4-Aminobenzenol; 4-Hydroxyaniline; 4-Amino-1-hydroxybenzene; CHEBI:17602,2014-12-24,1,,,,,,,,,
504-24-5,0,OMOP Exposome,Observation,Substance,4-Aminopyridine,4-Aminopyridine; P-Aminopyridine; N07XX07; gamma-Aminopyridine; Fampyra; Fampridinum; Fampridine-SR; Fampridine; Fampridina; EL-970; Dalfampridine; 4-Pyridinamine; Avitrol; 4-AP; Ampyra; 4-Pyridylamine; CHEBI:34385,2014-12-24,1,,,,,,,,,
115656-08-1,0,OMOP Exposome,Observation,Substance,"4-Bromo-2,3,7,8-tetrachlorodibenzofuran",,2014-12-24,1,,,,,,,,,
101-55-3,0,OMOP Exposome,Observation,Substance,4-Bromobiphenyl Ether,"RCRA waste no. U030; 1-Bromo-4-phenoxybenzene; 4-Bromobiphenyl ether; 4-Bromodiphenyl ether; 4-BROMODIPHENYLOXIDE; 4-Bromophenoxybenzene; 4-Bromophenyl phenyl ether; 4-Phenoxy-1-bromobenzene; Ether, 4-bromophenyl phenyl; Ether, p-bromophenyl phenyl; Ether, p-bromophenyl phenyl (8CI); NSC 5619; P-(phenoxy)bromobenzene; P-bromodiphenyl ether; P-bromophenoxybenzene; P-bromophenyl phenyl ether; P-bromphenyl phenyl ether; P-phenoxybromobenzene; P-phenoxyphenyl bromide; Phenyl (4-bromophenyl) ether; CHEBI:77421",2014-12-24,1,,,,,,,,,
2051-62-9,0,OMOP Exposome,Observation,Substance,4-Chlorobiphenyl,"4-Chloro-1, 1'-biphenyl; 4-Chlorbiphenyl; 1-Chloro-4-phenylbenzene; p-Chlorobiphenyl; p-Chlorodiphenyl; 1-chloro-4-phenyl benzene; 4-PCB; 4-Monochlorobiphenyl; 4-Monochloro-biphenyl; 4-Chlorodiphenyl; 4-Chloro-1,1'-biphenyl; CHEBI:27757",2014-12-24,1,,,,,,,,,
74992-96-4,0,OMOP Exposome,Observation,Substance,4-Chlorodibenzofuran,,2014-12-24,1,,,,,,,,,
106-48-9,0,OMOP Exposome,Observation,Substance,4-Chlorophenol,,2014-12-24,1,,,,,,,,,
2620-53-3,0,OMOP Exposome,Observation,Substance,4-Chlorophenyl-N-methylcarbamate,,2014-12-24,1,,,,,,,,,
30390-50-2,0,OMOP Exposome,Observation,Substance,4-Decenal,,2014-12-24,1,,,,,,,,,
123-07-9,0,OMOP Exposome,Observation,Substance,4-Ethylphenol,1-Hydroxy-4-ethylbenzene; 1-Ethyl-4-hydroxybenzene; 4-Hydroxyphenylethane; p-Ethylphenol; CHEBI:49584,2014-12-24,1,,,,,,,,,
18809-57-9,0,OMOP Exposome,Observation,Substance,4-Ethylthiophenyl methylcarbamate,,2014-12-24,1,,,,,,,,,
591-81-1,0,OMOP Exposome,Observation,Substance,4-Hydroxybutyric acid,4-Hydroxybutyric acid monosodium salt; gamma-Hydroxybutyrate sodium; gamma-Hydroxybutyrate; gamma-Hydroxy sodium butyrate; Xyrem; gamma-Hydroxybutyric acid; \u03b3-Hydroxybutyric acid; GHB; Hydroxybutyric acid; Monosodium salt; Sodium oxybate; Sodium gamma-oxybutyrate; Sodium gamma-hydroxybutyrate; 3-carboxypropoxy acid; 4-Hydroxy-Butanoate; 4-Hydroxy-Butanoic acid; 4-Hydroxy-butyric acid; 4-Hydroxybutanoate; Oxybate sodium; oxy-n-butyric acid; 4-Hydroxybutanoic acid; 4-Hydroxybutyrate; 4-Hydroxybutyrate sodium; gamma-Hydroxy butyrate; CHEBI:16724,2018-03-21,1,,,,,,,,,
GIS1003333,0,OMOP Exposome,Observation,Substance,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,,2024-09-14,1,,,,,,,,,
73529-64-3,0,OMOP Exposome,Observation,Substance,4-Hydroxydecenal,,2014-12-24,1,,,,,,,,,
109710-36-3,0,OMOP Exposome,Observation,Substance,4-Hydroxyhexanal,,2014-12-24,1,,,,,,,,,
75899-68-2,0,OMOP Exposome,Observation,Substance,4-Hydroxynonenal,"4-Hydroxynon-2-enal; 4-Hydroxy-2-Nonenal; 4-Hydroxy-2,3-nonenal; trans-4-Hydroxy-2-nonenal; CHEBI:58968",2014-12-24,1,,,,,,,,,
17449-15-9,0,OMOP Exposome,Observation,Substance,4-Hydroxyoctenal,,2014-12-24,1,,,,,,,,,
51-35-4,0,OMOP Exposome,Observation,Substance,4-Hydroxyproline,"Hydroxy-proline; Hydroxyproline; delta-Hydroxyproline; L-4-Hydroxyproline; (4R)-4-hydroxy-L-proline; (2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid; L-Threo-4-hydroxyproline; 4-Hydroxy-L-proline; 4-L-Hydroxyproline; Hydroxy-L-proline; 4-Hydroxy-2-pyrrolidinecarboxylic acid; L-Hydroxyproline; LS-hydroxyproline; Oxaceprol; trans-4-Hydroxy-L-proline; trans-4-Hydroxyproline; Trans-hydroxyproline; Trans-L-hydroxyproline; Hydroxiproline; (2S,4R)-4-hydroxy-2-pyrrolidinecarboxylic acid; CHEBI:18095",2014-12-24,1,,,,,,,,,
68047-06-3,0,OMOP Exposome,Observation,Substance,4-Hydroxytamoxifen,4-(1-{4-(2-Dimethylamino-ethoxy)-phenyl-phenyl-methylene}-propyl)-phenol; 4-(1Z)-1-{4-2-(Dimethylamino)ethoxyphenyl}-1-phenyl-1-buten-2-ylphenol; 4-(1Z)-1-{4-2-(dimethylamino)ethoxyphenyl}-1-phenylbut-1-en-2-ylphenol; 4-{(1Z)-1-{4-2-(Dimethylamino)ethoxyphenyl}(phenyl)methylenepropyl}phenol; CHEBI:44616,2014-12-24,1,,,,,,,,,
141-79-7,0,OMOP Exposome,Observation,Substance,"4-Methyl-3-penten-2-one, 9CI",,2014-12-24,1,,,,,,,,,
10233-94-0,0,OMOP Exposome,Observation,Substance,"4-Methylformamido-3,5-xylyl methylcarbamate",,2014-12-24,1,,,,,,,,,
589-53-7,0,OMOP Exposome,Observation,Substance,4-Methylheptane,4-Methyl-heptane; CHEBI:67193,2014-12-24,1,,,,,,,,,
92-66-0,0,OMOP Exposome,Observation,Substance,4-Monobromobiphenyl,,2014-12-24,1,,,,,,,,,
100-02-7,0,OMOP Exposome,Observation,Substance,4-Nitrophenol,p-Hydroxynitrobenzene; Mononitrophenol; 1-Hydroxy-4-nitrobenzene; 4-Hydroxynitrobenzene; Niphen; p-Nitrophenol; Paranitrophenol; para-Nitrophenol; para-Hydroxynitrobenzene; CHEBI:16836,2014-12-24,1,,,,,,,,,
104-40-5,0,OMOP Exposome,Observation,Substance,4-Nonylphenol,"P -N -Nonylphenol; Phenol, nonyl derivs.; Para-nonylphenol; Para nonyl phenol; P-Nonylphenol (endocrine disrupter); P-Nonylphenol; p-Nonyl-Phenol; P-N-Nonylphenol; Nonylphenol (mixed); Nonylphenol; Nonyl-Phenol; 4-Tert-nonylphenol; 4-Nonyl-Phenol; 4-N-Nonylphenol; 4-N-Nonyl phenol; PPT; CHEBI:34440",2014-12-24,1,,,,,,,,,
92-69-3,0,OMOP Exposome,Observation,Substance,4-Phenylphenol,Para-hydroxydiphenyl; P-Hydroxybiphenyl; 4-Hydroxybiphenyl; P-Phenylphenol; 4-Hydroxydiphenyl; Para-phenylphenol; P-Biphenylol; P-Hydroxydiphenyl; 4-Biphenylol; 4-Diphenylol; CHEBI:34422,2014-12-24,1,,,,,,,,,
98-54-4,0,OMOP Exposome,Observation,Substance,4-tert-Butylphenol,"Lowinox PTBT; 1-Hydroxy-4-tert-butylbenzene; Lowinox 070; P-Terc.butylfenol; p-Tert-butyl-Phenol; P-Tert-butylphenol; PTBP; Para-tertiary-butylphenol; T-Butylphenol; Ucar butylphenol 4-T flake; Ucar butylphenol 4-T; Lowinox TBMX; p-(Tert-butyl)-Phenol; P-Sec-butylphenol; P-t-Butyl phenol; P-t-Butylphenol; 4-t-Butylphenol; 4-(1,1-Dimethylethyl)phenol, 9CI; 4-(1,1-Dimethylethyl)phenol; 4-(1,1-Dimethylethyl)-Phenol; 4-Tert-butyl-Phenol; 4-Tert-butylphenol; 4-Tertiary-butylphenol; Butylphen; FEMA 3918; 4-(1, 1-Dimethylethyl)phenol; 2-(4-Hydroxyphenyl)-2-methylpropane; CHEBI:34444",2014-12-24,1,,,,,,,,,
87-18-3,0,OMOP Exposome,Observation,Substance,4-tert-Butylphenyl salicylate,,2014-12-24,1,,,,,,,,,
140-66-9,0,OMOP Exposome,Observation,Substance,4-Tert-octylphenol,,2014-12-24,1,,,,,,,,,
P49189,0,OMOP Exposome,Observation,Substance,4-trimethylaminobutyraldehyde dehydrogenase,,2024-09-14,1,,,,,,,,,
BE0004907,0,OMOP Exposome,Observation,Substance,5'-AMP-activated protein kinase,,2024-09-14,1,,,,,,,,,
Q13131,0,OMOP Exposome,Observation,Substance,5'-AMP-activated protein kinase catalytic subunit alpha-1,,2024-09-14,1,,,,,,,,,
P54646,0,OMOP Exposome,Observation,Substance,5'-AMP-activated protein kinase catalytic subunit alpha-2,,2024-09-14,1,,,,,,,,,
Q9Y478,0,OMOP Exposome,Observation,Substance,5'-AMP-activated protein kinase subunit beta-1,,2024-09-14,1,,,,,,,,,
O43741,0,OMOP Exposome,Observation,Substance,5'-AMP-activated protein kinase subunit beta-2,,2024-09-14,1,,,,,,,,,
P54619,0,OMOP Exposome,Observation,Substance,5'-AMP-activated protein kinase subunit gamma-1,,2024-09-14,1,,,,,,,,,
Q9UGJ0,0,OMOP Exposome,Observation,Substance,5'-AMP-activated protein kinase subunit gamma-2,,2024-09-14,1,,,,,,,,,
Q9UGI9,0,OMOP Exposome,Observation,Substance,5'-AMP-activated protein kinase subunit gamma-3,,2024-09-14,1,,,,,,,,,
1136-84-1,0,OMOP Exposome,Observation,Substance,"5,6,7,8-Tetrahydro-1-naphthyl methylcarbamate",,2014-12-24,1,,,,,,,,,
480-40-0,0,OMOP Exposome,Observation,Substance,"5,7-Dihydroxyflavone",,2014-12-24,1,,,,,,,,,
GIS1003334,0,OMOP Exposome,Observation,Substance,5-alpha Reductase Inhibitor,,2024-09-14,1,,,,,,,,,
Q5JAM2,0,OMOP Exposome,Observation,Substance,5-aminolevulinate synthase,,2024-09-14,1,,,,,,,,,
P22557,0,OMOP Exposome,Observation,Substance,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",,2024-09-14,1,,,,,,,,,
P13196,0,OMOP Exposome,Observation,Substance,"5-aminolevulinate synthase, nonspecific, mitochondrial",,2024-09-14,1,,,,,,,,,
106-60-5,0,OMOP Exposome,Observation,Substance,5-Aminolevulinic acid,Kerastick; 5-Aminolaevulinate; 5-Aminolaevulinic acid; Gliolan; Aladerm; Aminolevulinate; delta-Aminolevulinic acid; delta-Aminolevulinate; delta-ALA; DALA; Aminolevulinic acid; 5-ALA; 5-Amino-4-oxovaleric acid; 5-Amino-4-oxovalerate; 5-Amino-4-oxopentanoic acid; Amino-levulinic acid; 5-Aminolevulinate; ALA; 5-Amino-4-oxopentanoate; 5-Amino-4-oxo-Pentanoic acid; 5-Amino-4-oxo-Pentanoate; ALA-PDT; Levulan Kerastick; 5-Amino-Levulinate; Levulan; 5-Amino-Levulinic acid; CHEBI:17549,2014-12-24,1,,,,,,,,,
51-20-7,0,OMOP Exposome,Observation,Substance,5-Bromouracil,"1,2,3,4-tetrahydro-5-bromo-2,4-pyrimidinedione; 2,4-Pyrimidinedione, 1,2,3,4-tetrahydro-5-bromo; Bromouracil; 5-Bromo-2,4-pyrimidinediol; 5-Bromo-2,4-dihydroxypyrimidine; URB; 5-Bromo-2,4(1H,3H)-pyrimidinedione; Uracil, 5-bromo-; C4H3BrN2O2; Bromuracil; 5-bromopyrimidine-2,4(1H,3H)-dione; CHEBI:20552",2014-12-24,1,,,,,,,,,
4350-09-8,0,OMOP Exposome,Observation,Substance,5-Hydroxy-L-tryptophan,5-Hydroxyl-L-tryptophan; 5-Hydroxytryptophan; 5-Hydroxytryptophan L form; 5-Hydroxytryptophan L-form; Cincofarm; Hydroxy-5 L-tryptophane; Hydroxytryptophan; L-5-Hydroxytryptophan; Levothym; Levotinine; Triptene; Quietim; Pretonine; Oxytryptophan; Oxyfan; Oxitriptan; Telesol; Serotonyl; Tript-OH; (+-)-5-Hydroxytryptophan; (S)-5-Hydroxytryptophan; 5-Hydroxy-tryptophan; CHEBI:17780,2018-03-21,1,,,,,,,,,
Q9P2Q4,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine (Serotonin) receptor 1F,,2024-09-14,1,,,,,,,,,
BE0004881,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine 2 receptor,,2024-09-14,1,,,,,,,,,
BE0004958,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 1,,2024-09-14,1,,,,,,,,,
P08908,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 1A,,2024-09-14,1,,,,,,,,,
P28222,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 1B,,2024-09-14,1,,,,,,,,,
P28221,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 1D,,2024-09-14,1,,,,,,,,,
P28566,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 1E,,2024-09-14,1,,,,,,,,,
P30939,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 1F,,2024-09-14,1,,,,,,,,,
BE0004957,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 2,,2024-09-14,1,,,,,,,,,
P28223,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 2A,,2024-09-14,1,,,,,,,,,
P41595,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 2B,,2024-09-14,1,,,,,,,,,
P28335,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 2C,,2024-09-14,1,,,,,,,,,
P46098,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 3A,,2024-09-14,1,,,,,,,,,
O95264,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 3B,,2024-09-14,1,,,,,,,,,
Q8WXA8,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 3C,,2024-09-14,1,,,,,,,,,
Q70Z44,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 3D,,2024-09-14,1,,,,,,,,,
A5X5Y0,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 3E,,2024-09-14,1,,,,,,,,,
Q13639,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 4,,2024-09-14,1,,,,,,,,,
P47898,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 5A,,2024-09-14,1,,,,,,,,,
P50406,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 6,,2024-09-14,1,,,,,,,,,
P34969,0,OMOP Exposome,Observation,Substance,5-hydroxytryptamine receptor 7,,2024-09-14,1,,,,,,,,,
110-12-3,0,OMOP Exposome,Observation,Substance,5-Methyl-2-hexanone,,2014-12-24,1,,,,,,,,,
O14841,0,OMOP Exposome,Observation,Substance,5-oxoprolinase,,2024-09-14,1,,,,,,,,,
GIS1003335,0,OMOP Exposome,Observation,Substance,5-oxoprolinase deficiency,,2024-09-14,1,,,,,,,,,
GIS1003336,0,OMOP Exposome,Observation,Substance,5-Oxoprolinuria,,2024-09-14,1,,,,,,,,,
Q8IUZ5,0,OMOP Exposome,Observation,Substance,5-phosphohydroxy-L-lysine phospho-lyase,,2024-09-14,1,,,,,,,,,
139341-09-6,0,OMOP Exposome,Observation,Substance,54-Deoxyciguatoxin,,2014-12-24,1,,,,,,,,,
145414-76-2,0,OMOP Exposome,Observation,Substance,"6,7-Dihydroxybergamottin",,2014-12-24,1,,,,,,,,,
8063-85-2,0,OMOP Exposome,Observation,Substance,"6-Chloro-3,4-xylyl methylcarbamate",,2014-12-24,1,,,,,,,,,
125652-15-5,0,OMOP Exposome,Observation,Substance,"6-Cyclohexyl-1,3,8-trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
1007-28-9,0,OMOP Exposome,Observation,Substance,6-Deisopropylatrazine,Deisopropylatrazine; 2-chloro-4-amino-6-Ethylamino-S-triazine; 2-amino-4-chloro-6-Ethylamino-S-triazine; 2-amino-4-chloro-6-(Ethylamino)-S-triazine; amino-2-chloro-6-Ethylamino-S-triazine; CHEBI:27399,2014-12-24,1,,,,,,,,,
118174-38-2,0,OMOP Exposome,Observation,Substance,"6-Methyl-1,3,8-trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
2532-49-2,0,OMOP Exposome,Observation,Substance,6-Methyl-2-propyl-4-pyrimidinyl dimethylcarbamate,,2014-12-24,1,,,,,,,,,
132194-83-3,0,OMOP Exposome,Observation,Substance,"6-Methyl-8-iodo-1,3-dichlordibenzofuran",,2014-12-24,1,,,,,,,,,
125652-17-7,0,OMOP Exposome,Observation,Substance,"6-Nitro-1,3,8-trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
BE0005180,0,OMOP Exposome,Observation,Substance,6-phosphofructokinase type C,,2024-09-14,1,,,,,,,,,
BE0005179,0,OMOP Exposome,Observation,Substance,"6-phosphofructokinase, liver type",,2024-09-14,1,,,,,,,,,
BE0005178,0,OMOP Exposome,Observation,Substance,"6-phosphofructokinase, muscle type",,2024-09-14,1,,,,,,,,,
P52209,0,OMOP Exposome,Observation,Substance,"6-phosphogluconate dehydrogenase, decarboxylating",,2024-09-14,1,,,,,,,,,
125652-12-2,0,OMOP Exposome,Observation,Substance,"6-tert-Butyl-1,3,8-trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
74423-77-1,0,OMOP Exposome,Observation,Substance,"7,8-Dichloro-2-dibenzofuranol",,2014-12-24,1,,,,,,,,,
Q9UBM7,0,OMOP Exposome,Observation,Substance,7-dehydrocholesterol reductase,,2024-09-14,1,,,,,,,,,
123-35-3,0,OMOP Exposome,Observation,Substance,"7-Methyl-3-methylene-1,6-octadiene","7-Methyl-3-methylene-1,6-octadiene (myrcene); Myrcene; FEMA 2762; beta-Myrcene; beta -myrcene; beta -mircene; b-Myrcene; B-Geraniolene; 7-Methyl-3-methylideneocta-1,6-diene; 7-Methyl-3-methyleneoctadiene-(1,6); 7-Methyl-3-methyleneocta-1,6-diene; 7-Methyl-3-methylene-octa-1,6-diene; 7-Methyl-3-methylene-1,6-octadiene (beta -myrcene); 3-Methylene-7-methyl-1,6-octadiene; 3-Methylene-7-methyl-1, 6-octadiene; 2-Methyl-6-methylene-2,7-octadiene; CHEBI:17221",2014-12-24,1,,,,,,,,,
P08253,0,OMOP Exposome,Observation,Substance,72 kDa type IV collagenase,,2024-09-14,1,,,,,,,,,
P11021,0,OMOP Exposome,Observation,Substance,78 kDa glucose-regulated protein,,2024-09-14,1,,,,,,,,,
194-59-2,0,OMOP Exposome,Observation,Substance,"7H-Dibenzo[c,g]carbazole",,2014-12-24,1,,,,,,,,,
103124-72-7,0,OMOP Exposome,Observation,Substance,"8-Bromo-2,3,4-trichlorodibenzofuran",,2014-12-24,1,,,,,,,,,
51596-39-5,0,OMOP Exposome,Observation,Substance,8-Chloro-3-dibenzofuranol,,2014-12-24,1,,,,,,,,,
88847-89-6,0,OMOP Exposome,Observation,Substance,8-Hydroxy-deoxyguanosine,"8-Oxo-7,8-dihydrodeoxyguanosine; 8-Hydroxy-2'deoxyguanosine; 8-Hydroxy-2-deoxyguanosine; 8-OHdG; 8-Hydroxydeoxyguanosine; 8-Oxo-dG; 8-Oxodg; Oh8dG; 7,8-Dihydro-8-oxo-2'-deoxyguanosine; 7,8-Dihydro-8-oxodeoxyguanosine; 8-Hydroxy-2'-deoxyguanosine; 8-Oxo-7,8-dihydro-2'-deoxyguanosine; 8-Hydroxydeoxy-guanosine; 8-Hydroxydeoxyguanine; CHEBI:40304",2014-12-24,1,,,,,,,,,
14899-08-2,0,OMOP Exposome,Observation,Substance,"9-(2-Carboxyphenyl)-3,6-bis(diethylamino)xanthylium(1+)",,2014-12-24,1,,,,,,,,,
302-79-4,0,OMOP Exposome,Observation,Substance,9-cis-Retinoic acid,"All-trans- Vitamin A1 acid; Stieva-a; Sotret; Solage; Ro 1-5488; Retisol-a; Retionic acid; Retinoic acid; Retin-a micro; Retinoate; Retinova; 15-Apo-beta-caroten-15-oic acid; 15-Apo-beta-caroten-15-oate; 9-Retinoic acid; Aberel; Aberela; AGN 100335; K\u00e9trel; Isotretinoin retinoic acid; Isotretinoin retinoate; Tretinoina; (all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; Tretinoin/all-trans retinoic acid; Tretinoin/all-trans retinoate; Tretinoin; TRETIN.X; Tretin-X; 9-Retinoate; 9-cis-Tretinoin; 9-cis-Retinoate; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl); Panretin gel; Panretyn; Panrexin; Vitinoin; Panretin; B-Retinoic acid; B-Retinoate; Avitoin; Avita; Atralin; Atragen; ATRA; Amnesteem; alpha-Vitaminsyre; all-trans-Vitamin a1 acid; Aknoten; Alitretinoin; all trans Retinoic acid; all trans-Retinoic acid; all-(e)-Retinoic acid; All-trans-b-retinoate; All-trans-b-retinoic acid; All-trans-beta-retinoate; Refissa; Renova; All-trans-beta-retinoic acid; Retacnyl; Retin a; Retin-a; All-trans-vitamin a acid; Vitamin A acid; Vesnaroid; Vesanoid; Tretinon; all-trans-Retinoic acid; Tretinoinum; Tr\u00e9tino\u00efne; Tretin m; trans-Vitamin a acid; Trans-retinoic acid; Trans-retinoate; all-trans-Tretinoin; Eudyna; Epi-aberel; Effederm; Dermairol; Claravis; beta-Retinoic acid; Airol; beta-Retinoate; CHEBI:15367",2014-12-24,1,,,,,,,,,
1603-47-0,0,OMOP Exposome,Observation,Substance,9-Hydroxy-4-methoxypsoralen,,2014-12-24,1,,,,,,,,,
1689-64-1,0,OMOP Exposome,Observation,Substance,9-Hydroxyfluorene,Diphenylene carbinol; 9-Fluorenol; fluoren-9-ol; 9H-fluoren-9-ol; CHEBI:16904,2014-12-24,1,,,,,,,,,
484-17-3,0,OMOP Exposome,Observation,Substance,9-Hydroxyphenanthrene,9-phenanthrol; 9-phenanthrenol; phenanthren-9-ol; CHEBI:28820,2014-12-24,1,,,,,,,,,
91417-82-2,0,OMOP Exposome,Observation,Substance,[2-(Nitromethylene)-1-pyrrolidinyl]acetonitrile,,2014-12-24,1,,,,,,,,,
121-59-5,0,OMOP Exposome,Observation,Substance,[4-(Aminocarbonyl-amino)phenyl] arsonic acid,,2014-12-24,1,,,,,,,,,
Q15118,0,OMOP Exposome,Observation,Substance,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",,2024-09-14,1,,,,,,,,,
Q15119,0,OMOP Exposome,Observation,Substance,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",,2024-09-14,1,,,,,,,,,
Q15120,0,OMOP Exposome,Observation,Substance,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",,2024-09-14,1,,,,,,,,,
Q16654,0,OMOP Exposome,Observation,Substance,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",,2024-09-14,1,,,,,,,,,
BE0003862,0,OMOP Exposome,Observation,Substance,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",,2024-09-14,1,,,,,,,,,
BE0004348,0,OMOP Exposome,Observation,Substance,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",,2024-09-14,1,,,,,,,,,
BE0004330,0,OMOP Exposome,Observation,Substance,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",,2024-09-14,1,,,,,,,,,
BE0004284,0,OMOP Exposome,Observation,Substance,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial",,2024-09-14,1,,,,,,,,,
532-27-4,0,OMOP Exposome,Observation,Substance,a-Chloroacetophenone,,2014-12-24,1,,,,,,,,,
GIS1003347,0,OMOP Exposome,Observation,Substance,Abc transporters,,2024-09-14,1,,,,,,,,,
GIS1003338,0,OMOP Exposome,Observation,Substance,"ABCB1 (MDR1, P-gp)",,2024-09-14,1,,,,,,,,,
GIS1003337,0,OMOP Exposome,Observation,Substance,ABCB11 (BSEP),,2024-09-14,1,,,,,,,,,
GIS1003339,0,OMOP Exposome,Observation,Substance,ABCB4 (MDR3),,2024-09-14,1,,,,,,,,,
GIS1003340,0,OMOP Exposome,Observation,Substance,ABCC1 (MRP1),,2024-09-14,1,,,,,,,,,
GIS1003341,0,OMOP Exposome,Observation,Substance,"ABCC2 (MRP2, cMOAT)",,2024-09-14,1,,,,,,,,,
GIS1003342,0,OMOP Exposome,Observation,Substance,ABCC3 (MRP3),,2024-09-14,1,,,,,,,,,
GIS1003343,0,OMOP Exposome,Observation,Substance,ABCC4 (MRP4),,2024-09-14,1,,,,,,,,,
GIS1003344,0,OMOP Exposome,Observation,Substance,ABCC5 (MRP5),,2024-09-14,1,,,,,,,,,
GIS1003345,0,OMOP Exposome,Observation,Substance,ABCC6 (MRP6),,2024-09-14,1,,,,,,,,,
GIS1003346,0,OMOP Exposome,Observation,Substance,"ABCG2 (BCRP, MXR)",,2024-09-14,1,,,,,,,,,
P42684,0,OMOP Exposome,Observation,Substance,Abelson tyrosine-protein kinase 2,,2024-09-14,1,,,,,,,,,
GIS1003348,0,OMOP Exposome,Observation,Substance,Abortifacient Agent,,2024-09-14,1,,,,,,,,,
53597-23-2,0,OMOP Exposome,Observation,Substance,Abrin-a,,2014-12-24,1,,,,,,,,,
GIS1003349,0,OMOP Exposome,Observation,Substance,Abrin-b,,2024-09-14,1,,,,,,,,,
53597-24-3,0,OMOP Exposome,Observation,Substance,Abrin-c,,2014-12-24,1,,,,,,,,,
1393-62-0,0,OMOP Exposome,Observation,Substance,Abrin-d,,2014-12-24,1,,,,,,,,,
77337-76-9,0,OMOP Exposome,Observation,Substance,Acamprosate,Regtect; 3-(Acetylamino)propanesulphonic acid; 3-Acetamido-1-propanesulfonic acid; Acamprosato; Acamprosatum; Acamprosic acid; Campral; N-acetyl homotaurine; N-Acetylhomotaurine; CHEBI:51041,2014-12-24,1,,,,,,,,,
126601-49-8,0,OMOP Exposome,Observation,Substance,Acanthophin,,2014-12-24,1,,,,,,,,,
GIS1003355,0,OMOP Exposome,Observation,Substance,Acaricide,,2024-09-14,1,,,,,,,,,
83-32-9,0,OMOP Exposome,Observation,Substance,Acenaphthene,"1,2-Dihydroacenaphthylene; 1,8-Ethylenenaphthalene; Ethylenenaphthalene; 1,8-Dihydroacenaphthalene; Acenaphthene solution; Peri-ethylenenaphthalene; Acenaphtene; Naphthyleneethylene; Acenaphthylene; 1, 2-Dihydroacenaphthylene; CHEBI:22154",2014-12-24,1,,,,,,,,,
208-96-8,0,OMOP Exposome,Observation,Substance,Acenaphthylene,Acenaphthalene; Acenaphthylene solution; Cyclopenta(de)naphthalene; Cyclopentadenaphthalene; CHEBI:33081,2014-12-24,1,,,,,,,,,
152-72-7,0,OMOP Exposome,Observation,Substance,Acenocoumarol,3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin; Nitrovarfarian; Nitrophenylacetylethyl-4-hydroxycoumarine; Nicumalon; Nicoumalone; Mini-sintrom; Ascumar; Acenokumarin; Acenocumarolo; Acenocumarol; Acenocoumarolum; Acenocoumarin; 4-Hydroxy-3-1-(4-nitrophenyl)-3-oxobutyl-2H-chromen-2-one; 4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one; 3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin; 3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin; 3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; 3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin; Sintrom; Sinkumar; Nitrowarfarin; CHEBI:53766,2014-12-24,1,,,,,,,,,
30560-19-1,0,OMOP Exposome,Observation,Substance,Acephate,"N-(Methoxy(methylthio)phosphinoyl)acetamide; O,S-Dimethylacetylphosphoroamidothioate; Acephic acid; Acetamidophos; Acetylphosphoramidothioic acid O,S-dimethyl ester; O,S-Dimethyl acetylamidothiophosphate; CHEBI:34520",2014-12-24,1,,,,,,,,,
75-07-0,0,OMOP Exposome,Observation,Substance,Acetaldehyde,Ethyl aldehyde; Acetic aldehyde; Aldehyde; Ethanal; CHEBI:15343,2014-12-24,1,,,,,,,,,
60-35-5,0,OMOP Exposome,Observation,Substance,Acetamide,CH3CONH2; Acetic acid amide; Acetimidic acid; Methanecarboxamide; Ethanamide; Amid kyseliny octove; ACM; CHEBI:27856,2014-12-24,1,,,,,,,,,
103-90-2,0,OMOP Exposome,Observation,Substance,Acetaminophen,4-Acetaminophenol; Alpiny; alpha-Per; Allay; Algotropyl; Algomol; Algina; Algesidal; Actimol Chewable Tablets; Actimol Children'S Suspension; Actimol Infants' Suspension; Actimol Junior Strength Caplets; Actron; Afebrin; Afebryl; Aferadol; Acetalgin; Acetaminophene; Acetaminophen Uniserts; Acetamol; Acenol; Accu-Tap; Acamol; Abrolet; Abrol; Abensanil; Abenol; A.F. Anacin; A-Per; 4-Hydroxyanilid kyseliny octove; 4-Hydroxyacetanilide; 4-Acetamidophenol; 4-(Acetylamino)phenol; 4'-Hydroxyacetanilide; Acetofen; Acetagesic; Actamin; Actamin Extra; Actamin Super; Actifed Plus; Aceta Tablets; Aceta Elixir; Acertol; Acetaminofen; Acephen; Actimol; Hy-Phen; Hycomine Compound; Hydrocet; Ildamol; Inalgex; Infadrops; Infants' Feverall; Influbene N; Injectapap; Intensin; Janupap; Junior Disprol; Kataprin; Kinder Finimal; Korum; Kratofin simplex; Labamol; Lekadol; Lemgrip; Lemsip; Lestemp; Liquagesic; Liquigesic Co; Liquiprin; Liquiprin Children'S Elixir; Liquiprin Infants Drops; Lonarid; Lonarid Mono; Lorcet-Hd; Lortab; Lupocet; Lyteca; Lyteca Syrup; Magnidol; Malex N; Malgis; Malidens; Maxadol; Medigesic Plus; Medinol Paediatric; Medocodene; Melabon Infantil; Mexalen; Midol Maximum Strength; Midol PM Night Time Formula; Midol Regular Strength; Midol Teen Formula; Migraleve Yellow; Minafen; Minoset; Miralgin; Momentum; Mono Praecimed; Multin; N-(4-Hydroxyphenyl)acetamide; N-Acetyl-4-aminophenol; N-Acetyl-p-aminophenol; Naldegesic; NAPA; Napafen; Napap; Naprinol; Nealgyl; Nebs; Neo-Fepramol; NeoCitran; Neodol; Neodolito; Neopap; Neotrend; Neuridon; New Cortal for Children; NilnOcen; Nina; No-Febril; Nobedon; Nodolex; Noral; Norcet; Norco; O-Acetaminophenol; Ofirmev; Oltyl; Oralgan; Oraphen-PD; Ortensan; Oxycet; Oxycocet; Oxycodone 2.5/Apap 500; Oxycodone 5/Apap 500; p-(Acetylamino)phenol; p-Acetamidophenol; p-Acetaminophenol; p-Acetylaminophenol; p-Hydroxyacetanilide; p-Hydroxyphenolacetamide; Paceco; Pacemo; Pacemol; Pacet; Pacimol; Paedialgon; Paedol; Painex; Paldesic; Pamol; Panacete; Panadeine; Panadeine Co; Panadiene; Panado-Co; Panado-Co Caplets; Panadol; Panadol Extra Strength; Panadol Junior Strength Caplets; Panadol Maximum Strength Caplets; Panadol Maximum Strength Tablets; Panaleve; Panamax; Panasorb; Panasorbe; Panets; Panex; Panodil; Panofen; Pantalgin; Papa-Deine #3; Papa-Deine #4; Para-Suppo; Para-Tabs; Paracemol; Paracenol; Paracet; Paracetamol; Paracetamol AL; Paracetamol Antipanin P; Paracetamol Basics; Paracetamol BC; Paracetamol DC; Paracetamol Dr. Schmidgall; Paracetamol Fecofar; Paracetamol Genericon; Paracetamol Hanseler; Paracetamol Harkley; Paracetamol Heumann; Paracetamol Hexal; Paracetamol Italfarmaco; Paracetamol Nycomed; Paracetamol PB; Paracetamol Raffo; Paracetamol Ratiopharm; Paracetamol Rosch; Paracetamol Saar; Paracetamol SmithKline Beecham; Paracetamol Stada; Paracetamol von ct; Paracetamol Winthrop; Paracetamole; Paracetamolo; Paracetamolum; Paracetanol; Paracetol; Paracin; Paracod; Paracodol; Parador; Paradrops; Parakapton; Parake; Paralen; Paralief; Paralink; Paralyoc; Paramol; Paramolan; Paranox; Parapan; Parasedol; Parasin; Paraspen; Parcetol; Parelan; Parmol; Parogal; Paroma; Pasolind; Pasolind N; PCM Paracetamol Lichtenstein; Pe-Tam; Pediapirin; Pediatrix; Pedric; Percocet; Percocet-5; Percocet-Demi; Percogesic with Codeine; Perdolan Mono; Phenaphen; Phenaphen Caplets; Phenaphen W/Codeine; Phendon; Phenipirin; Phogoglandin; Phrenilin; Phrenilin Forte; Pinex; Piramin; Pirinasol; Plicet; Polmofen; Predimol; Predualito; Prestwick_13; Prodol; Prompt; Prontina; Propacet; Propacet 100; Proval #3; Puernol; Pulmofen; Pyregesic-C; Pyrigesic; Pyrinazine; Pyromed; Quiet World; Redutemp; Reliv; Remedol; Rhinex D-Lay Tablets; Robigesic; Robitussin Night Relief; Rockamol Plus; Rounox; Roxicet; Roxicet 5/500; Roxilox; RubieMol; Rubophen; Rupemol; Salzone; Sanicet; Sanicopyrine; Scanol; Scentalgyl; Scherzatabletten Rezeptur 534; Schmerzex; Sedalito; Sedapap; Semolacin; Servigesic; Seskamol; Setakop; Setamol; Setol; Sifenol; Sinaspril; Sine-Off Sinus Medicine Caplets; Sinedol; Sinmol; Sinubid; SK-Apap; Snaplets-FR; Spalt fur die nacht; Spalt N; St Joseph Aspirin-Free; St Joseph Aspirin-Free for Children; St. Joseph Cold Tablets for Children; St. Joseph Fever Reducer; Stanback; Stopain; Sudafed Severe Cold Formula; Sudafed Sinus; Sunetheton; Supac; Supadol mono; Supofen; Suppap; Suppap-120; Suppap-325; Suppap-650; Supramol-M; Synalgos-Dc-A; Tabalgin; Tachiprina; Talacen; Tapanol; Tapanol Extra Strength Caplets; Tapanol Extra Strength Tablets; Tapar; Tavist Allergy/Sinus/Headache; Tazamol; Temlo; Tempanal; Tempra; Tempra Caplets; Tempra Chewable Tablets; Tempra D.S; Tempra Drops; Tempra Syrup; Tencon; Termacet; Termalgin; Termalgine; Termofren; TheraFlu; Tibinide; Tibizide; Tiffy; Tisin; Tisiodrazida; Titralgan; Tizide; Tocris-1706; Toximer P; Tralgon; Treupel mon; Treupel N; Treuphadol; Triad; Triaminic Sore Throat Formula; Triaprin; Tricoton; Tussapap; Tycolet; TYL; Tylenol; Tylenol Allergy Sinus; Tylenol Arthritis Extended Relief; Tylenol Caplets; Tylenol Children'S Chewable Tablets; Tylenol Children'S Elixir; Tylenol Children'S Suspension Liquid; Tylenol Drops; Tylenol Elixir; Tylenol Extra Strength Adult Liquid Pain Reliever; Tylenol Extra Strength Caplets; Tylenol Extra Strength Gelcaps; Tylenol Extra Strength Tablets; Tylenol Gelcaps; Tylenol Infants Drops; Tylenol Infants Suspension Drops; Tylenol Junior Strength Caplets; Tylenol Junior Strength Chewable Tablets; Tylenol Regular Strength Caplets; Tylenol Regular Strength Tablets; Tylenol Tablets; Tylex; Tylex CD; Tylol; Tylox; Tylox-325; Tymol; Ultracet; Upsanol; Utragin; Valadol; Valgesic; Valorin; Valorin Extra; Vanquish; Veralgina; Vermidon; Verpol; Viclor Richet; Vicodin; Vicodin Es; Vicodin Hp; Vips; Viruflu; Vivimed; Volpan; Wygesic; Zatinol; Zolben; Alpinyl; Rivalgyl; Alvedon; Amadil; Aminofen; Aminofen Max; Anacin-3; Anacin-3 Extra Strength; Anadin dla dzieci; Anaflon; Analter; Anapap; Andox; Anelix; Anexsia; Anexsia 10/660; Anexsia 5/325; Anexsia 7.5/325; Anexsia 7.5/650; Anhiba; Anoquan; Anti-Algos; Antidol; Apacet; Apacet Capsules; Apacet Elixir; Apacet Extra Strength Caplets; Apacet Extra Strength Tablets; Apacet Regular Strength Tablets; Apadon; Apamid; Apamide; APAP; Apitrelal; Apo-Acetaminophen; Arfen; Asetam; Asomal; Aspac; Aspirin Free Anacin Maximum Strength Caplets; Aspirin Free Anacin Maximum Strength Gel Caplets; Aspirin Free Anacin Maximum Strength Tablets; Aspirin-Free Anacin; Aspirin-Free Excedrin Caplets; Asplin; Atasol Caplets; Atasol Drops; Atasol Forte Caplets; Atasol Forte Tablets; Atasol Oral Solution; Atasol Tablets; Atralidon; Babikan; Bacetamol; Bancap; Bancap Hc; Banesin; Bayer Select Allergy-Sinus; Bayer Select Head Cold; Bayer Select Headache Pain; Bayer Select Maximum Strength Headache Pain Relief Formula; Bayer Select Menstrual Multi-Symptom; Bayer Select Sinus Pain Relief; Ben-u-ron; Benmyo; Bickie-mol; Biocetamol; Bucet; Butalbital; Butapap; Cadafen; Calapol; Calmanticold; Calpol; Capital with Codeine; Captin; Causalon; Cefalex; Cetadol; Children'S Acetaminophen Elixir Drops; Children'S Acetaminophen Oral Solution; Children'S Tylenol Chewable; Claradol Codeine; Clixodyne; Co-Gesic; Cod-Acamol Forte; Codabrol; Codalgin; Codapane; Codicet; Codisal; Codisal Forte; Codoliprane; Codral Pain Relief; Cofamol; Conacetol; Contac Cough & Sore Throat Formula; Contra-Schmerz P; Coricidin; Coricidin D; Coricidin Sinus; Cosutone; Croix Blanche; Cuponol; Curadon; Curpol; Custodial; Dafalgan; Dapa X-S; Darocet; Darvocet; Darvocet-N 50; Datril; Datril Extra-Strength; Daygrip; Demilets; Deminofen; Democyl; Demogripal; Desfebre; Dhamol; Dhc Plus; Dial-a-gesic; Dial-alpha-gesic; Dimindol; Dirox; Disprol; Dol-Stop; Dolcor; Dolefin; Dolegrippin; Dolene Ap-65; Dolgesic; Doliprane; Dolko; Dolofugin; Doloreduct; Dolorfug; Dolorol Forte; Dolorstop; Dolotec; Dolprone; Dorocoff; Dresan; Dristan Cold No Drowsiness; Dristancito; Duracetamol; Duradyne Dhc; Durapan; Dymadon; Dymadon Co; Dymadon Forte; Dypap; Ecosetol; Elixodyne; Empracet; Endecon; Enelfa; Eneril; Esgic; Esgic-Plus; Eu-Med; Excedrin; Excedrin Caplets; Excedrin Extra Strength Caplets; Excipain; Exdol; Exdol Strong; Fanalgic; Farmadol; Febranine; Febrectal; Febrectol; Febrex; Febricet; Febridol; Febrilix; Febrin; Febrinol; Febro-Gesic; Febrolin; Femcet; Fendon; Fensum; Fepanil; Feverall; Feverall Junior Strength; Feverall Sprinkle Caps Junior Strength; Fevor; Finimal; Finiweh; Fioricet; Fluparmol; Fortalidon P; Freka-cetamol; Gattaphen T; Gelocatil; Geluprane; Genapap; Genapap Children'S Elixir; Genapap Children'S Tablets; Genapap Extra Strength Caplets; Genapap Extra Strength Tablets; Genapap Regular Strength Tablets; Genebs; Genebs Extra Strength Caplets; Genebs Regular Strength Tablets; Genebs X-Tra; Geralgine-P; Gripin Bebe; Grippostad; Gynospasmine; Hedex; Helon N; Homoolan; CHEBI:2386,2014-12-24,1,,,,,,,,,
135410-20-7,0,OMOP Exposome,Observation,Substance,Acetamiprid,(e)-N-((6-chloro-3-Pyridinyl)methyl)-n'-cyano-N-methylethanimidamide; (e)-N-(6-chloro-3-Pyridyl)methyl-n'-cyano-N-methylacetamidine; CHEBI:CHEBI:39164,2014-12-24,1,,,,,,,,,
97-44-9,0,OMOP Exposome,Observation,Substance,Acetarsol,,2014-12-24,1,,,,,,,,,
64-19-7,0,OMOP Exposome,Observation,Substance,Acetic acid,"Ethanoat; VoSoL; Volsol; Vinegar acid; Vinegar; Methanecarboxylic acid; Methanecarboxylate; MeCO2 anion; Kyselina octova; Glacial acetic acid; Glacial acetate; Ethylic acid; Ethylate; Ethanoic acid; Ethanoate; CH3-COO(-); Borofair; Azetat; Acetic acid, ion(1-); ACETATE ion; Acetate; Acetasol; CHEBI:30089",2014-12-24,1,,,,,,,,,
34256-82-1,0,OMOP Exposome,Observation,Substance,Acetochlor,Azetochlor; Caswell No. 003B; Nevirex; Harness; Erunit; 2-Chloro-2'-methyl-6-ethyl-N-ethoxymethylacetanilide; 2-Chloro-N-(ethoxymethyl)-6'-ethyl-o-acetotoluidide; 2-Chloro-N-(ethoxymethyl)-6'-ethylacet-o-toluidide; Acenit; Acetochlore; CHEBI:2394,2014-12-24,1,,,,,,,,,
67-64-1,0,OMOP Exposome,Observation,Substance,Acetone,Dimethylformaldehyde; b-Ketopropane; 2-Propanone; 2-Ketopropane; beta-Ketopropane; Pyroacetic ether; Pyroacetic spirit; Propanone; Dimethyl formaldehyde; Dimethyl ketone; Methyl ketone; CHEBI:15347,2014-12-24,1,,,,,,,,,
75-86-5,0,OMOP Exposome,Observation,Substance,Acetone cyanohydrin,"Acetoncyanhydrin; 2-Cyano-2-hydroxypropane; .alpha.-hydroxyisobutyronitrile; Acetone cyanohydrin, stabilized; Acetone cyanhydrin; Acetoncyaanhydrine; Acetoncianidrina; Acetoncianhidrinei; a-hydroxyisobutyronitrile; 2-Propanone, cyanohydrin; 2-Methyllactonitrile; Acetone-cyanohydrin; Alpha-hydroxyisobutyronitrile; 2-Hydroxyisobutyronitrile; 2-Hydroxy-2-methylpropionitrile; 2-Hydroxy-2-methylpropanenitrile; Acetonkyanhydrin; Acetonecyanhydrine; 2-Cyanopropan-2-ol; USAF rh-8; Rcra waste number P069; RCRA waste no. P069; Cyanhydrine d'acetone; CNH; 2-Cyano-2-propanol; CHEBI:15348",2014-12-24,1,,,,,,,,,
75-05-8,0,OMOP Exposome,Observation,Substance,Acetonitrile,"acetonitrile, 1-(14)C-labeled; NCMe; Methylkyanid; Methyl cyanide; Methanecarbonitrile; MeCN; Ethanonitrile; Ethanenitrile; Ethane nitrile; Cyanure de methyl; Cyanomethane; CH3CN; CH3-C#N; AN; ACN; acetonitrile, 3H-labeled; Acetonitrile solution; ACETONITRILE; Acetonitril; CHEBI:38472",2014-12-24,1,,,,,,,,,
77-90-7,0,OMOP Exposome,Observation,Substance,Acetyl tributyl citrate,,2014-12-24,1,,,,,,,,,
P24752,0,OMOP Exposome,Observation,Substance,"Acetyl-CoA acetyltransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q13085,0,OMOP Exposome,Observation,Substance,Acetyl-CoA carboxylase 1,,2024-09-14,1,,,,,,,,,
O00763,0,OMOP Exposome,Observation,Substance,Acetyl-CoA carboxylase 2,,2024-09-14,1,,,,,,,,,
Q9NUB1,0,OMOP Exposome,Observation,Substance,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9NR19,0,OMOP Exposome,Observation,Substance,"Acetyl-coenzyme A synthetase, cytoplasmic",,2024-09-14,1,,,,,,,,,
P02708,0,OMOP Exposome,Observation,Substance,Acetylcholine receptor subunit alpha,,2024-09-14,1,,,,,,,,,
P11230,0,OMOP Exposome,Observation,Substance,Acetylcholine receptor subunit beta,,2024-09-14,1,,,,,,,,,
Q07001,0,OMOP Exposome,Observation,Substance,Acetylcholine receptor subunit delta,,2024-09-14,1,,,,,,,,,
Q04844,0,OMOP Exposome,Observation,Substance,Acetylcholine receptor subunit epsilon,,2024-09-14,1,,,,,,,,,
P07510,0,OMOP Exposome,Observation,Substance,Acetylcholine receptor subunit gamma,,2024-09-14,1,,,,,,,,,
P58154,0,OMOP Exposome,Observation,Substance,Acetylcholine-binding protein,,2024-09-14,1,,,,,,,,,
P22303,0,OMOP Exposome,Observation,Substance,Acetylcholinesterase,,2024-09-14,1,,,,,,,,,
50722-38-8,0,OMOP Exposome,Observation,Substance,Acetyldeoxynivalenol,,2014-12-24,1,,,,,,,,,
GIS1003356,0,OMOP Exposome,Observation,Substance,Acetylsalicylic Acid Pathway,,2024-09-14,1,,,,,,,,,
P46597,0,OMOP Exposome,Observation,Substance,Acetylserotonin O-methyltransferase,,2024-09-14,1,,,,,,,,,
135158-54-2,0,OMOP Exposome,Observation,Substance,Acibenzolar-S-Methyl,"BTH; 7-(Methylthiocarbonyl)-benzo-1,2,3-thiadiazole; S-Methyl benzo1,2,3thiadiazole-7-carbothioate; Benzo-(1,2,3)-thiadiazole-7-carbothioic acid S-methyl ester; Actigard; Acibenzolar-S-methyl; 1,2,3-Benzothiadiazole-7-carboxlic acid thiomethyl ester; CHEBI:73178",2014-12-24,1,,,,,,,,,
1934-21-0,0,OMOP Exposome,Observation,Substance,Acid yellow 23,Tartrazine lake; 1310 Yellow; 1409 Yellow; C.I. acid yellow 23; C.I. Food Yellow 4; Dye yellow lake; FD and C Yellow No. 5; Food Yellow No. 4; Hexacol tartrazine; Hidazid tartrazine; Hydrazine yellow; Lake yellow; Tartar yellow FS; Tartraphenine; Tartrazine; Tartrazine Yellow 5; Tartrazol yellow; Yellow No. 5; Yellow Lake 69; CHEBI:9405,2014-12-24,1,,,,,,,,,
P78348,0,OMOP Exposome,Observation,Substance,Acid-sensing ion channel 1,,2024-09-14,1,,,,,,,,,
Q6ZQY3,0,OMOP Exposome,Observation,Substance,Acidic amino acid decarboxylase GADL1,,2024-09-14,1,,,,,,,,,
P60045,0,OMOP Exposome,Observation,Substance,Acidic phospholipase A2 3,,2024-09-14,1,,,,,,,,,
50594-66-6,0,OMOP Exposome,Observation,Substance,Acifluorfen,"Scifluorfen; Acifluorfene; Tackle; Carbofluorfen; (sodium salt) scifluorfen; 2-Nitro-5-(2-chloro-4-(trifluoromethyl)phenoxy)benzoic acid; 5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoate; Tackle 25; 5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid; 5-(2-Chloro-4-trifluoromethylphenoxy)-2-nitrobenzoic acid; 5-2-Chloro-4-(trifluoromethyl)phenoxy-2-nitrobenzoic acid; C14H7ClF3NO5; Blazer; ACJ; 5-2-Chloro-4-(trifluoromethyl)phenoxy-2-nitrobenzoic acid, 9CI; CHEBI:73172",2014-12-24,1,,,,,,,,,
Q99798,0,OMOP Exposome,Observation,Substance,"Aconitate hydratase, mitochondrial",,2024-09-14,1,,,,,,,,,
302-27-2,0,OMOP Exposome,Observation,Substance,Aconitine,"(1\u2018\u00b1,3\u2018\u00b1,6\u2018\u00b1,14\u2018\u00b1,16beta)-8-(acetyloxy)-20-ethyl-3,13,15-trihydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl benzoate; Aconitane; Aconitin cristallisat; CHEBI:2430",2014-12-24,1,,,,,,,,,
260-94-6,0,OMOP Exposome,Observation,Substance,Acridine,"Acrydine; 10-Azaanthracene; 2,3,5,6-dibenzopyridine; 2,3-Benzoquinoline; 9-Azaanthracene; Aceridine; Benzo(b)quinoline; Benzobquinoline; Dibenzo(b,e)pyridine; Dibenzob,epyridine; CHEBI:36420",2014-12-24,1,,,,,,,,,
101007-06-1,0,OMOP Exposome,Observation,Substance,Acrinathrin,"Rufast; (S)-a-Cyano-3-phenoxybenzyl (Z)-(1R,3S)-2,2-dimethyl-3-2-(2,2,2-trifluoro-1-trifluoromethylethoxycarbonyl)vinylcyclopropanecarboxylate; (S)-Cyano(3-phenoxyphenyl)methyl (1R,3S)-3-{(1Z)-3-(1,1,1,3,3,3-hexafluoropropan-2-yl)oxy-3-oxoprop-1-en-1-yl}-2,2-dimethylcyclopropanecarboxylate; CHEBI:39091",2014-12-24,1,,,,,,,,,
107-02-8,0,OMOP Exposome,Observation,Substance,Acrolein,"Aqualin; Aqualine; Biocide; CH2=CHCHO; 2-Propenaldehyde; trans-Acrolein Formylethylene; Slimicide; Propylene aldehyde; Propenal; Magnacide; Ethylene aldehyde; Prop-2-enal; Prop-2-En-1-al; Papite; Magnacide H; 2-Propenal; 2-Propen-1-one; Propenaldehyde; Allyl aldehyde; Acrylic Aldehyde; Aldehyde, acrylic; Acrylaldehyde; Acraldehyde; Crolean; Acquinite; CHEBI:15368",2014-12-24,1,,,,,,,,,
GIS1003357,0,OMOP Exposome,Observation,Substance,Acrosome,,2024-09-14,1,,,,,,,,,
1979-06-01,0,OMOP Exposome,Observation,Substance,Acrylamide,Stokopol D 2624; Stipix ad; Vinyl amide; Versicol W 11; Sursolan P 5; Solvitose 433; Sanpoly A 520; Reten 420; Propenoic acid amide; Propenoic acid; Propenoate; Propeneamide; Propenamide; Prop-2-enamide; Praestol 2800; Porisutoron; Polystoron; Polystolon; Polyhall 402; Polyhall 27; Superfloc 900; Superfloc 84; Polyacrylamide; Acrylagel; Polyacrylamide resin; Polyacrylamide solution; Sumitex A 1; Sumirez A 27; Sumirez A 17; Amid kyseliny akrylove; American Cyanamid P-250; American cyanamid kpam; Cytame 5; Akrylamid; Aerofloc 3453; Dow ET 597; Ethylene carboxamide; Acrylic acid amide; Flokonit e; Amide propenoate; Amide propenoic acid; Aminogen pa; Amresco Acryl-40; Acrylic amide; Ethylenecarboxamide; Magnafloc R 292; Bio-Gel P 2; BioGel P-100; Cyanamer P 250; Cyanamer P 35; Optimum; Nacolyte 673; K-Pam; Himoloc SS 200; Gelamide 250; Flygtol GB; 2-Propenamide; 2-Propeneamide; CHEBI:28619,2014-12-24,1,,,,,,,,,
107-13-1,0,OMOP Exposome,Observation,Substance,Acrylonitrile,"Acrylonitrile, inhibited; Vinyl cyanide; Ventox; VCN; Propenitrile; Propenenitrile; Propenenenitrile; Polyacrylonitrile; Nitrile acrylique; Nitrile acrilico; Miller's fumigrain; Fumigrain; Cyanure de vinyle; Cyanoethylene; Cyanoethene; Cyanide, vinyl; Cianuro di vinile; CH2CHCN; Carbacryl; AN; Akrylonitryl; Akrylonitril; Acrylsaeurenitril; Acrylonitrile vinyl cyanide; Acrylonitrile monomer; Acrylon; Acrylofume; Acrylnitril; Acritet; ACN; 2-Propenenitrile; Vinylkyanid; CHEBI:28217",2014-12-24,1,,,,,,,,,
GIS1003358,0,OMOP Exposome,Observation,Substance,Actin Cytoskeleton,,2024-09-14,1,,,,,,,,,
GIS1003359,0,OMOP Exposome,Observation,Substance,Actin Filament,,2024-09-14,1,,,,,,,,,
P68032,0,OMOP Exposome,Observation,Substance,"Actin, alpha cardiac muscle 1",,2024-09-14,1,,,,,,,,,
P68133,0,OMOP Exposome,Observation,Substance,"Actin, alpha skeletal muscle",,2024-09-14,1,,,,,,,,,
P62736,0,OMOP Exposome,Observation,Substance,"Actin, aortic smooth muscle",,2024-09-14,1,,,,,,,,,
P60709,0,OMOP Exposome,Observation,Substance,"Actin, cytoplasmic 1",,2024-09-14,1,,,,,,,,,
P63261,0,OMOP Exposome,Observation,Substance,"Actin, cytoplasmic 2",,2024-09-14,1,,,,,,,,,
P63267,0,OMOP Exposome,Observation,Substance,"Actin, gamma-enteric smooth muscle",,2024-09-14,1,,,,,,,,,
14952-40-0,0,OMOP Exposome,Observation,Substance,Actinium-227,,2014-12-24,1,,,,,,,,,
77536-66-4,0,OMOP Exposome,Observation,Substance,Actinolite Asbestos,,2014-12-24,1,,,,,,,,,
Q07912,0,OMOP Exposome,Observation,Substance,Activated CDC42 kinase 1,,2024-09-14,1,,,,,,,,,
GIS1003360,0,OMOP Exposome,Observation,Substance,Activated T-Lymphocytes,,2024-09-14,1,,,,,,,,,
BE0004924,0,OMOP Exposome,Observation,Substance,activator protein 1,,2024-09-14,1,,,,,,,,,
Q04771,0,OMOP Exposome,Observation,Substance,Activin receptor type-1,,2024-09-14,1,,,,,,,,,
P36896,0,OMOP Exposome,Observation,Substance,Activin receptor type-1B,,2024-09-14,1,,,,,,,,,
GIS1003361,0,OMOP Exposome,Observation,Substance,Acute Intermittent Porphyria,,2024-09-14,1,,,,,,,,,
P07108,0,OMOP Exposome,Observation,Substance,Acyl-CoA-binding protein,,2024-09-14,1,,,,,,,,,
578-94-9,0,OMOP Exposome,Observation,Substance,Adamsite,,2014-12-24,1,,,,,,,,,
106685-40-9,0,OMOP Exposome,Observation,Substance,Adapalene,Adapalenum; Adapaleno; Adaferin; 6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid; Differin; Differine; CHEBI:31174,2014-12-24,1,,,,,,,,,
73-24-5,0,OMOP Exposome,Observation,Substance,Adenine,"6-Amino-3H-purine; 6-Amino-1H-purine; 3,6-Dihydro-6-iminopurine; 1H-Purine-6-amine; 1H-Purin-6-amine; 1,6-Dihydro-6-iminopurine; 6-Amino-Purine; 6-Aminopurine; 9H-Purin-6-amine; 9H-Purin-6-yl-amin; 9H-Purin-6-ylamine; 9H-Purine-6-amine; A; Ade; Adenin; Adeninimine; Leuco-4; Vitamin B4; 6-Amino-9H-purine; 6-Amino-7H-purine; CHEBI:16708",2014-12-24,1,,,,,,,,,
P07741,0,OMOP Exposome,Observation,Substance,Adenine phosphoribosyltransferase,,2024-09-14,1,,,,,,,,,
58-61-7,0,OMOP Exposome,Observation,Substance,Adenosine,"9beta-D-ribofuranosyl-9H-Purin-6-amine; (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose; 1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; 6-Amino-9beta-D-ribofuranosyl-9H-purine; 6-Amino-9beta-delta-ribofuranosyl-9H-purine; 9-beta-D-Arabinofuranosyladenine; 9-beta-D-Ribofuranosidoadenine; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; 9-beta-D-Ribofuranosyladenine; 9-beta-delta-Arabinofuranosyladenine; 9-beta-delta-Ribofuranosidoadenine; 9-beta-delta-Ribofuranosyl-9H-purin-6-amine; 9-beta-delta-Ribofuranosyladenine; 9beta-D-Ribofuranosyladenine; 9beta-delta-ribofuranosyl-9H-Purin-6-amine; 9beta-delta-Ribofuranosyladenine; Ade-rib; Adenin riboside; Adenine deoxyribonucleoside; Adenine nucleoside; Adenine riboside; Adenine-9beta-D-Ribofuranoside; Adenine-9beta-delta-Ribofuranoside; Adenocard; Adenocor; Adenoject; Adenoscan; Adenosin; Adenosina; Ad\u00e9nosine; Adenosinum; Adenoz; Adenozer; Adenyldeoxyriboside; Adesin; Ado; Adrekar; At\u00e9pad\u00e8ne; b-D-Adenosine; beta-Adenosine; beta-D-Adenosine; beta-delta-Adenosine; Boniton; Cardimax; Cardiovert; Desoxyadenosine; Krenosin; Myocol; Nucleocardyl; Osiden; Pisdeno; Sandesin; Tricor; CHEBI:16335",2018-03-21,1,,,,,,,,,
P00813,0,OMOP Exposome,Observation,Substance,Adenosine deaminase,,2024-09-14,1,,,,,,,,,
GIS1003362,0,OMOP Exposome,Observation,Substance,Adenosine Deaminase Deficiency,,2024-09-14,1,,,,,,,,,
GIS1003363,0,OMOP Exposome,Observation,Substance,Adenosine Deaminase Inhibitor,,2024-09-14,1,,,,,,,,,
P55263,0,OMOP Exposome,Observation,Substance,Adenosine kinase,,2024-09-14,1,,,,,,,,,
P30542,0,OMOP Exposome,Observation,Substance,Adenosine receptor A1,,2024-09-14,1,,,,,,,,,
P29274,0,OMOP Exposome,Observation,Substance,Adenosine receptor A2a,,2024-09-14,1,,,,,,,,,
P29275,0,OMOP Exposome,Observation,Substance,Adenosine receptor A2b,,2024-09-14,1,,,,,,,,,
P0DMS8,0,OMOP Exposome,Observation,Substance,Adenosine receptor A3,,2024-09-14,1,,,,,,,,,
56-65-5,0,OMOP Exposome,Observation,Substance,Adenosine triphosphate,Adenylpyrophosphoric acid; Adephos; Adetol; Adynol; Atipi; ATP; Atriphos; Cardenosine; Fosfobion; Triphosphoric acid adenosine ester; Triphosphaden; Triadenyl; Striadyne; Phosphobion; Myotriphos; Glucobasin; 5'-(Tetrahydrogen triphosphate) Adenosine; 5'-ATP; Adenosine 5'-triphosphate; Adenosine 5'-triphosphorate; Adenosine 5'-triphosphoric acid; Adenosine triphosphic acid; Adenosine-5'-triphosphate; Adenylpyrophosphorate; CHEBI:15422,2014-12-24,1,,,,,,,,,
13870-90-1,0,OMOP Exposome,Observation,Substance,Adenosylcobalamin,(5'-Deoxy-5'-adenosyl)cobamide coenzyme; Cobamamide 5'-phosphate; Calomide; Deoxyadenosylcobalamin; Cobalamin coenzyme; Cobamamide; Cobamide coenzyme; Dibencozide; 5'-Deoxy-5'-adenosylcobalamin; Funacomide; Coenzyme B12; Vitamin B12 coenzymes; 5'-Deoxy-5'-adenosyl vitamin B12; Adenosylcobalamin 5'-phosphate; Vitamin B12 coenzyme; CHEBI:18408,2014-12-24,1,,,,,,,,,
P23526,0,OMOP Exposome,Observation,Substance,Adenosylhomocysteinase,,2024-09-14,1,,,,,,,,,
Q08828,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 1,,2024-09-14,1,,,,,,,,,
Q96PN6,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 10,,2024-09-14,1,,,,,,,,,
Q08462,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 2,,2024-09-14,1,,,,,,,,,
O60266,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 3,,2024-09-14,1,,,,,,,,,
Q8NFM4,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 4,,2024-09-14,1,,,,,,,,,
O95622,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 5,,2024-09-14,1,,,,,,,,,
O43306,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 6,,2024-09-14,1,,,,,,,,,
P51828,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 7,,2024-09-14,1,,,,,,,,,
P40145,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 8,,2024-09-14,1,,,,,,,,,
O60503,0,OMOP Exposome,Observation,Substance,Adenylate cyclase type 9,,2024-09-14,1,,,,,,,,,
P54819,0,OMOP Exposome,Observation,Substance,"Adenylate kinase 2, mitochondrial",,2024-09-14,1,,,,,,,,,
P27144,0,OMOP Exposome,Observation,Substance,"Adenylate kinase 4, mitochondrial",,2024-09-14,1,,,,,,,,,
Q96M32,0,OMOP Exposome,Observation,Substance,Adenylate kinase 7,,2024-09-14,1,,,,,,,,,
P00568,0,OMOP Exposome,Observation,Substance,Adenylate kinase isoenzyme 1,,2024-09-14,1,,,,,,,,,
Q9Y6K8,0,OMOP Exposome,Observation,Substance,Adenylate kinase isoenzyme 5,,2024-09-14,1,,,,,,,,,
Q9Y3D8,0,OMOP Exposome,Observation,Substance,Adenylate kinase isoenzyme 6,,2024-09-14,1,,,,,,,,,
GIS1003364,0,OMOP Exposome,Observation,Substance,Adenylosuccinate Lyase Deficiency,,2024-09-14,1,,,,,,,,,
O94910,0,OMOP Exposome,Observation,Substance,Adhesion G protein-coupled receptor L1,,2024-09-14,1,,,,,,,,,
O95490,0,OMOP Exposome,Observation,Substance,Adhesion G protein-coupled receptor L2,,2024-09-14,1,,,,,,,,,
Q9HAR2,0,OMOP Exposome,Observation,Substance,Adhesion G protein-coupled receptor L3,,2024-09-14,1,,,,,,,,,
GIS1003365,0,OMOP Exposome,Observation,Substance,Adhesive,,2024-09-14,1,,,,,,,,,
111-69-3,0,OMOP Exposome,Observation,Substance,Adiponitrile,,2014-12-24,1,,,,,,,,,
GIS1003366,0,OMOP Exposome,Observation,Substance,Adipose Tissue,,2024-09-14,1,,,,,,,,,
GIS1003367,0,OMOP Exposome,Observation,Substance,Adjuvant,,2024-09-14,1,,,,,,,,,
Q9BW91,0,OMOP Exposome,Observation,Substance,"ADP-ribose pyrophosphatase, mitochondrial",,2024-09-14,1,,,,,,,,,
BE0005459,0,OMOP Exposome,Observation,Substance,ADP-ribosyl cyclase 1,,2024-09-14,1,,,,,,,,,
BE0001241,0,OMOP Exposome,Observation,Substance,ADP-ribosyl cyclase 2,,2024-09-14,1,,,,,,,,,
P28907,0,OMOP Exposome,Observation,Substance,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,,2024-09-14,1,,,,,,,,,
Q10588,0,OMOP Exposome,Observation,Substance,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,,2024-09-14,1,,,,,,,,,
P84077,0,OMOP Exposome,Observation,Substance,ADP-ribosylation factor 1,,2024-09-14,1,,,,,,,,,
P12235,0,OMOP Exposome,Observation,Substance,ADP/ATP translocase 1,,2024-09-14,1,,,,,,,,,
P05141,0,OMOP Exposome,Observation,Substance,ADP/ATP translocase 2,,2024-09-14,1,,,,,,,,,
P12236,0,OMOP Exposome,Observation,Substance,ADP/ATP translocase 3,,2024-09-14,1,,,,,,,,,
GIS1003368,0,OMOP Exposome,Observation,Substance,Adrenal Cortex,,2024-09-14,1,,,,,,,,,
GIS1003369,0,OMOP Exposome,Observation,Substance,Adrenal Gland,,2024-09-14,1,,,,,,,,,
GIS1003370,0,OMOP Exposome,Observation,Substance,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,,2024-09-14,1,,,,,,,,,
GIS1003371,0,OMOP Exposome,Observation,Substance,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,,2024-09-14,1,,,,,,,,,
GIS1003372,0,OMOP Exposome,Observation,Substance,Adrenal Medulla,,2024-09-14,1,,,,,,,,,
GIS1003373,0,OMOP Exposome,Observation,Substance,Adrenergic Agent,,2024-09-14,1,,,,,,,,,
GIS1003374,0,OMOP Exposome,Observation,Substance,Adrenergic alpha-1 Receptor Antagonist,,2024-09-14,1,,,,,,,,,
GIS1003375,0,OMOP Exposome,Observation,Substance,Adrenergic alpha-2 Receptor Agonist,,2024-09-14,1,,,,,,,,,
GIS1003376,0,OMOP Exposome,Observation,Substance,Adrenergic alpha-Agonist,,2024-09-14,1,,,,,,,,,
GIS1003377,0,OMOP Exposome,Observation,Substance,Adrenergic alpha-Antagonist,,2024-09-14,1,,,,,,,,,
GIS1003378,0,OMOP Exposome,Observation,Substance,Adrenergic Antagonist,,2024-09-14,1,,,,,,,,,
GIS1003379,0,OMOP Exposome,Observation,Substance,Adrenergic beta-1 Receptor Antagonist,,2024-09-14,1,,,,,,,,,
GIS1003380,0,OMOP Exposome,Observation,Substance,Adrenergic beta-2 Receptor Agonist,,2024-09-14,1,,,,,,,,,
GIS1003381,0,OMOP Exposome,Observation,Substance,Adrenergic beta-Agonist,,2024-09-14,1,,,,,,,,,
GIS1003382,0,OMOP Exposome,Observation,Substance,Adrenergic beta-Antagonist,,2024-09-14,1,,,,,,,,,
GIS1003383,0,OMOP Exposome,Observation,Substance,Adrenergic Uptake Inhibitor,,2024-09-14,1,,,,,,,,,
P10109,0,OMOP Exposome,Observation,Substance,"Adrenodoxin, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1003384,0,OMOP Exposome,Observation,Substance,Adrenoleukodystrophy,,2024-09-14,1,,,,,,,,,
GIS1003385,0,OMOP Exposome,Observation,Substance,Aerosol Spray Component,,2024-09-14,1,,,,,,,,,
GIS1003386,0,OMOP Exposome,Observation,Substance,Affinity Label,,2024-09-14,1,,,,,,,,,
Q9Y4W6,0,OMOP Exposome,Observation,Substance,AFG3-like protein 2,,2024-09-14,1,,,,,,,,,
29611-03-8,0,OMOP Exposome,Observation,Substance,Aflatoxicol,,2014-12-24,1,,,,,,,,,
1162-65-8,0,OMOP Exposome,Observation,Substance,Aflatoxin B1,AFB1; Aflatoxin b1; AFBI; CHEBI:2504,2014-12-24,1,,,,,,,,,
7220-81-7,0,OMOP Exposome,Observation,Substance,Aflatoxin B2,,2014-12-24,1,,,,,,,,,
GIS1003387,0,OMOP Exposome,Observation,Substance,Aflatoxin Biosynthesis,,2024-09-14,1,,,,,,,,,
1165-39-5,0,OMOP Exposome,Observation,Substance,Aflatoxin G,,2014-12-24,1,,,,,,,,,
7241-98-7,0,OMOP Exposome,Observation,Substance,Aflatoxin G2,,2014-12-24,1,,,,,,,,,
6795-23-9,0,OMOP Exposome,Observation,Substance,Aflatoxin M1,,2014-12-24,1,,,,,,,,,
6885-57-0,0,OMOP Exposome,Observation,Substance,Aflatoxin M2,,2014-12-24,1,,,,,,,,,
70553-75-2,0,OMOP Exposome,Observation,Substance,Aflatrem,,2014-12-24,1,,,,,,,,,
155646-21-2,0,OMOP Exposome,Observation,Substance,Agitoxin,,2014-12-24,1,,,,,,,,,
548-42-5,0,OMOP Exposome,Observation,Substance,Agroclavine,,2014-12-24,1,,,,,,,,,
15972-60-8,0,OMOP Exposome,Observation,Substance,Alachlor,"Alanex; Satochlor; Ralchlor; 2-Chloro-2',6'-diethyl-N-(methoxymethyl)-acetanilde; 2-Chloro-2',6'-diethyl-N-(methoxymethyl)-Acetanilide; 2-Chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide; 2-Chloro-N-(2,6-diethyl)phenyl-N-methoxymethylacetamide; 2-Chloro-N-(2,6-diethylphenyl)-N-(methoxymethyl)acetamide; 2-Chloro-N-(2,6-diethylphenyl)-N-(methoxymethyl)acetamide, 9CI; Alachlor (pesticides mixture); Alachlor technical; Alachlor technical (90% or more); Alachlor-atrazine; Alachlore; Alagan; Alanox; Alapaz; Alatox; Pillarzo; Nitala; N-(Methoxymethyl)-2,6-diethylchloroacetanilide; Lasso; Methachlor; Metachlor; Alatox 480; Alazine; Alochlor; alpha-Chloro-2',6'-diethyl-N-methoxymethylacetanilide; Bullet; LAZO; Lasso micro-tech; Lasagrin; Chimiclor; CHEBI:2533",2014-12-24,1,,,,,,,,,
P24298,0,OMOP Exposome,Observation,Substance,Alanine aminotransferase 1,,2024-09-14,1,,,,,,,,,
Q8TD30,0,OMOP Exposome,Observation,Substance,Alanine aminotransferase 2,,2024-09-14,1,,,,,,,,,
GIS1003388,0,OMOP Exposome,Observation,Substance,Alanine Metabolism,,2024-09-14,1,,,,,,,,,
Q9BYV1,0,OMOP Exposome,Observation,Substance,"Alanine--glyoxylate aminotransferase 2, mitochondrial",,2024-09-14,1,,,,,,,,,
P49588,0,OMOP Exposome,Observation,Substance,"Alanine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
Q5JTZ9,0,OMOP Exposome,Observation,Substance,"Alanine--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9UJX1,0,OMOP Exposome,Observation,Substance,Alanine-glyoxylate aminotransferase homolog,,2024-09-14,1,,,,,,,,,
83130-01-2,0,OMOP Exposome,Observation,Substance,Alanycarb,"Ethyl (3Z)-9-benzyl-3,7-dimethyl-6-oxo-5-oxa-2,8-dithia-4,7,9-triazadodec-3-en-12-oate; CHEBI:38463",2014-12-24,1,,,,,,,,,
54965-21-8,0,OMOP Exposome,Observation,Substance,Albendazole,Albenza; Valbazen; Rycobendazole; O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate; Proftril; Ricobendazole; Eskazole; Despar; Dalben; Clearworm; Cidazole; Ciclopar; Champs; Cental; Buxol; Bruzol; Biwom; Bevindazol; Benzole; Zentel; Zolben; Benzol; Bentil; Benrod; Ben-A; Bazole; Bandy; Band; Albendazolum; Albendazol; AL; Adazol; Acure; ABZ; Abentel; 5-(Propylthio)-2-carbomethoxyaminobenzimidazole; (5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester; CHEBI:16664,2014-12-24,1,,,,,,,,,
GIS1003389,0,OMOP Exposome,Observation,Substance,Alcohol Antagonist,,2024-09-14,1,,,,,,,,,
P07327,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase 1A,,2024-09-14,1,,,,,,,,,
P00325,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase 1B,,2024-09-14,1,,,,,,,,,
P00326,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase 1C,,2024-09-14,1,,,,,,,,,
P08319,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase 4,,2024-09-14,1,,,,,,,,,
P28332,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase 6,,2024-09-14,1,,,,,,,,,
P14550,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase [NADP(+)],,2024-09-14,1,,,,,,,,,
P40394,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase class 4 mu/sigma chain,,2024-09-14,1,,,,,,,,,
P11766,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase class-3,,2024-09-14,1,,,,,,,,,
P00327,0,OMOP Exposome,Observation,Substance,Alcohol dehydrogenase E chain,,2024-09-14,1,,,,,,,,,
GIS1003390,0,OMOP Exposome,Observation,Substance,Alcohol Deterrent,,2024-09-14,1,,,,,,,,,
23214-96-2,0,OMOP Exposome,Observation,Substance,Alcuronium,"Alcuronium kation; 4,4'-Didemethyl-4,4'-di-2-propenyl-toxiferine I; 4,4'-Didemethyl-4,4'-di-2-propenyl-toxiferine I (9CI); Alcuronium dichloride; Alcuronum; Allnortoxiferine; Alloferin; Alloferine; Dialferine; Diallylbis(nortoxiferine); Diallylnortoxiferine; Diallyltoxiferine; N,n'-diallylnortoxiferinium; N,n'-diallylnortoxiferinium dichloride; CHEBI:25520",2014-12-24,1,,,,,,,,,
GIS1003391,0,OMOP Exposome,Observation,Substance,Aldehyde,,2024-09-14,1,,,,,,,,,
P47895,0,OMOP Exposome,Observation,Substance,Aldehyde dehydrogenase family 1 member A3,,2024-09-14,1,,,,,,,,,
Q8IZ83,0,OMOP Exposome,Observation,Substance,Aldehyde dehydrogenase family 16 member A1,,2024-09-14,1,,,,,,,,,
P43353,0,OMOP Exposome,Observation,Substance,Aldehyde dehydrogenase family 3 member B1,,2024-09-14,1,,,,,,,,,
P48448,0,OMOP Exposome,Observation,Substance,Aldehyde dehydrogenase family 3 member B2,,2024-09-14,1,,,,,,,,,
Q9H2A2,0,OMOP Exposome,Observation,Substance,Aldehyde dehydrogenase family 8 member A1,,2024-09-14,1,,,,,,,,,
P30837,0,OMOP Exposome,Observation,Substance,"Aldehyde dehydrogenase X, mitochondrial",,2024-09-14,1,,,,,,,,,
P30838,0,OMOP Exposome,Observation,Substance,"Aldehyde dehydrogenase, dimeric NADP-preferring",,2024-09-14,1,,,,,,,,,
P05091,0,OMOP Exposome,Observation,Substance,"Aldehyde dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q06278,0,OMOP Exposome,Observation,Substance,Aldehyde oxidase,,2024-09-14,1,,,,,,,,,
116-06-3,0,OMOP Exposome,Observation,Substance,Aldicarb,"Temik; Sulfone aldoxycarb; RCRA waste no. P070; N-methylcarbamoyloxime,2-methylthio-2-methylpropionaldehyde; Caswell No. 011A; Carbamyl; Ambush; Temik g; Temic; CHEBI:2555",2014-12-24,1,,,,,,,,,
1646-87-3,0,OMOP Exposome,Observation,Substance,Aldicarb sulfoxide,,2014-12-24,1,,,,,,,,,
Q04828,0,OMOP Exposome,Observation,Substance,Aldo-keto reductase family 1 member C1,,2024-09-14,1,,,,,,,,,
P52895,0,OMOP Exposome,Observation,Substance,Aldo-keto reductase family 1 member C2,,2024-09-14,1,,,,,,,,,
P42330,0,OMOP Exposome,Observation,Exposome Target,Aldo-keto reductase family 1 member C3,,2024-09-14,1,,,,,,,,,
P17516,0,OMOP Exposome,Observation,Substance,Aldo-keto reductase family 1 member C4,,2024-09-14,1,,,,,,,,,
P15121,0,OMOP Exposome,Observation,Substance,Aldose reductase,,2024-09-14,1,,,,,,,,,
1646-88-4,0,OMOP Exposome,Observation,Substance,Aldoxycarb,,2014-12-24,1,,,,,,,,,
309-00-2,0,OMOP Exposome,Observation,Substance,Aldrin,"Tipula; Tatuzinho; Soilgrin; Seedrin; Octalene; Murald; Kortofin; HHPN; HHDN; Hexachlorohexahydro-endo-exo-dimethanonaphthalene; Hexachlorohexahydro-endo,exo-dimethanonaphthalene; Hexachlorohexahydro-endo, exo-dimethanonaphthalene; Drinox; Altox; Algran; Aldrosol; Aldron; Aldrite; Aldrin-r; Aldrin dust; Aldrex 40; Aldrex 30; Aldrex; Aldocit; CHEBI:2564",2014-12-24,1,,,,,,,,,
66376-36-1,0,OMOP Exposome,Observation,Substance,Alendronic acid,Dronat; Durost; Fixopan; Forosa; Fosagen; Fosalen; Fosamax; Fosmin; Fostolin; Fosval; Oseolen; (4-Amino-1-hydroxybutylidene)bisphosphonic acid; Acide Alendronique; Acido Alendronico; Acidum Alendronicum; Alendronate; Alendronate Sodium; Alendronate sodium hydrate; Alenotop; Alned; Arendal; Beenos; Berlex; Binosto; Denfos; Densidron; Huesobone; Lendrate; Ostemax; CHEBI:2567,2014-12-24,1,,,,,,,,,
71195-58-9,0,OMOP Exposome,Observation,Substance,Alfentanil,Alfentanilum; Alfentanyl; N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide; Rapifen; Alfenta; CHEBI:2569,2014-12-24,1,,,,,,,,,
Q9UM73,0,OMOP Exposome,Observation,Substance,ALK tyrosine kinase receptor,,2024-09-14,1,,,,,,,,,
P05187,0,OMOP Exposome,Observation,Substance,"Alkaline phosphatase, placental type",,2024-09-14,1,,,,,,,,,
P10696,0,OMOP Exposome,Observation,Substance,"Alkaline phosphatase, placental-like",,2024-09-14,1,,,,,,,,,
P05186,0,OMOP Exposome,Observation,Substance,"Alkaline phosphatase, tissue-nonspecific isozyme",,2024-09-14,1,,,,,,,,,
GIS1003392,0,OMOP Exposome,Observation,Substance,Alkaptonuria,,2024-09-14,1,,,,,,,,,
GIS1003393,0,OMOP Exposome,Observation,Substance,Alkylating Agent,,2024-09-14,1,,,,,,,,,
GIS1003420,0,OMOP Exposome,Observation,Substance,All Tissues,,2024-09-14,1,,,,,,,,,
Q6NUM9,0,OMOP Exposome,Observation,Substance,"All-trans-retinol 13,14-reductase",,2024-09-14,1,,,,,,,,,
97-59-6,0,OMOP Exposome,Observation,Substance,Allantoin,"Allantol; (S)-allantoin; 2,5-Dioxo-4-imidazolidinyl-urea; 4-Ureido-2,5-Imidazolidinedione; 5-Ureido-Hydantoin; 5-Ureidohydantoin; 5-Ureidohydrantoin; Alantan; Alloxantin; AVC/Dienestrolcream; Septalan; Cordianine; D00121; Fancol TOIN; Glyoxyldiureid; Glyoxyldiureide; Glyoxylic diureide; N-(2,5-Dioxo-4-imidazolidinyl)urea; Psoralon; Sebical; CHEBI:15676",2014-12-24,1,,,,,,,,,
584-79-2,0,OMOP Exposome,Observation,Substance,Allethrin,"(+)-Trans-bioallethrin; 3-Allyl-2-methyl-4-oxocyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate; Bioaletrina (portuguese); Bioaletrina; Binamin forte; Alpha-DL-trans-allethrin; Allylrethronyl DL-cis-trans-chrysanthemate; Allyl homolog of cinerin I; Allyl cinerin I; Alleviate; Allethrolone ester OF chrysanthemummonocarboxylic acid; Allethrine; ALLETHRIN-2; ALLETHRIN-1; Allethrin I; Allethrin coil; 3-Allyl-4-keto-2-methylcyclopentenyl chrysanthemum monocarboxylate; (+ )-Trans-bioallethrin; D-allethrin; Cis-allethrin; Cinerin I allyl homolog; Wasp stopper CF; Wasp killer II; Trans-allethrin; Trans-(+)-allethrin; S-bioallethrin; Pyrocide; Pyrexcel; Pyrethrin; Pyresyn; Pyresin; Pynamin-forte; Pynamin; Pallethrine; Necarboxylic acid; MGK allethrin concentrate; Matox; Exthrin; Esdepallethrine; Esbiothrin; Caswell No. 025; Bioallethrin; (+)-Allelrethonyl (+)-cis,trans-chrysanthemate; (+)-Allethronyl (+)-trans-chrysanthemumate; Esbiol TM Intermediate 3336; Esbiol concentrate; Esbiol; Esbioallethrin; Duocide; Depallethrin; D-trans allethrin; D-t-allethrin; D-cis,trans-allethrin; D-allethrolone d-trans-chrysanthemumate; D-allethrolone chrysanthemumate; 3-Allyl-2-methyl-4-oxo-2-cyclopenten-1-yl chrysanthemate; (+)-trans-Chrysanthemumic acid ester OF (+-)-allethrolone; (+)-trans-Chrysanthemumic acid ester OF (.+-.)-allethrolone; (+-)-Allerethonyl (+-)-cis,trans-chrysanthemate; (.+-.)-Allelrethonyl (.+-.)-cis,trans-chrysanthemate; (.+/-.)-allelrethonyl (.+/-.)-cis,trans-chrysanthemate; 2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid 2-methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl ester; CHEBI:34572",2014-12-24,1,,,,,,,,,
GIS1003419,0,OMOP Exposome,Observation,Substance,Allograft Rejection,,2024-09-14,1,,,,,,,,,
73376-38-2,0,OMOP Exposome,Observation,Substance,Allopumiliotoxin,,2014-12-24,1,,,,,,,,,
315-30-0,0,OMOP Exposome,Observation,Substance,Allopurinol,"Zyrik; 4-Hydroxypyrazolo(3,4-D)pyrimidine; 4-Hydroxypyrazolopyrimidine; 4-Hydroxypyrazolyl(3,4-D)pyrimidine; 4H-Pyrazolo(3,4-D)pyrimidin-4-one; Adenock; AL-100; Allohexal; Allopurinolum; Alloril; Aloprim; Alopurinol; Aluron; Milurit; Progout; Zyloprim; Zyloric; 4-Hydroxy-3,4-pyrazolopyrimidine; 1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one; 1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one; 1H-Pyrazolo(3,4-D)pyrimidin-4-ol; 4'-Hydroxypyrazolol(3,4-D)pyrimidine; 4-HPP; 4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine; CHEBI:40279",2014-12-24,1,,,,,,,,,
25956-17-6,0,OMOP Exposome,Observation,Substance,Allura red AC,,2014-12-24,1,,,,,,,,,
106-95-6,0,OMOP Exposome,Observation,Substance,Allyl bromide,,2014-12-24,1,,,,,,,,,
57-06-7,0,OMOP Exposome,Observation,Substance,Allyl isothiocyanate,Allyl isosulfocyanate; Allyl isosulphocyanate; Allyl isothiocyanic acid; Allyl mustard oil; Allyl sevenolum; Allylsenevol; Allylsenfoel; Allylsevenolum; Allyspol; Artificial mustard oil; Carbospol; Isothiocyansaeureallylester; Mustard oil; Oil of mustard; Oleum sinapis; Redskin; Senfoel; Synthetic mustard oil; Volatile oil of mustard; Volatile mustard oil; 2-Propenyl isothiocyanate; 3-Iso-Thiocyanatoprop-1-ene; 3-Isothiocyanato-1-propene; 3-Isothiocyanatoprop-1-ene; AITC; CHEBI:494804,2014-12-24,1,,,,,,,,,
12012-95-2,0,OMOP Exposome,Observation,Substance,Allylpalladium chloride dimer,,2014-12-24,1,,,,,,,,,
6392-46-7,0,OMOP Exposome,Observation,Substance,Allyxycarb,,2014-12-24,1,,,,,,,,,
181183-52-8,0,OMOP Exposome,Observation,Substance,Almotriptan,1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine; Axert; Almogran; CHEBI:520985,2014-12-24,1,,,,,,,,,
BE0004888,0,OMOP Exposome,Observation,Substance,Alpha adrenergic receptor,,2024-09-14,1,,,,,,,,,
GIS1003444,0,OMOP Exposome,Observation,Substance,Alpha Linolenic Acid and Linoleic Acid Metabolism,,2024-09-14,1,,,,,,,,,
BE0004863,0,OMOP Exposome,Observation,Substance,Alpha-1 adrenergic receptors,,2024-09-14,1,,,,,,,,,
P26572,0,OMOP Exposome,Observation,Substance,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",,2024-09-14,1,,,,,,,,,
Q59GM9,0,OMOP Exposome,Observation,Substance,"Alpha-1,4 glucan phosphorylase",,2024-09-14,1,,,,,,,,,
P02763,0,OMOP Exposome,Observation,Substance,Alpha-1-acid glycoprotein 1,,2024-09-14,1,,,,,,,,,
P19652,0,OMOP Exposome,Observation,Substance,Alpha-1-acid glycoprotein 2,,2024-09-14,1,,,,,,,,,
P35348,0,OMOP Exposome,Observation,Substance,Alpha-1A adrenergic receptor,,2024-09-14,1,,,,,,,,,
P35368,0,OMOP Exposome,Observation,Substance,Alpha-1B adrenergic receptor,,2024-09-14,1,,,,,,,,,
P25100,0,OMOP Exposome,Observation,Substance,Alpha-1D adrenergic receptor,,2024-09-14,1,,,,,,,,,
BE0004864,0,OMOP Exposome,Observation,Substance,Alpha-2 adrenergic receptors,,2024-09-14,1,,,,,,,,,
P08913,0,OMOP Exposome,Observation,Substance,Alpha-2A adrenergic receptor,,2024-09-14,1,,,,,,,,,
P18089,0,OMOP Exposome,Observation,Substance,Alpha-2B adrenergic receptor,,2024-09-14,1,,,,,,,,,
P18825,0,OMOP Exposome,Observation,Substance,Alpha-2C adrenergic receptor,,2024-09-14,1,,,,,,,,,
Q693P7,0,OMOP Exposome,Observation,Substance,Alpha-7 nicotinic cholinergic receptor subunit,,2024-09-14,1,,,,,,,,,
128549-96-2,0,OMOP Exposome,Observation,Substance,alpha-Agatoxin,,2014-12-24,1,,,,,,,,,
23109-05-9,0,OMOP Exposome,Observation,Substance,alpha-Amanitin,"Alpha-amanitin, amanita SP.; Alpha-amanitin; a-Amanitin; .alpha.-amanitin; Amanitin; \u03b1-Amanitin; Alpha-amatoxin; Alpha-amanitine; CHEBI:37415",2014-12-24,1,,,,,,,,,
P49419,0,OMOP Exposome,Observation,Substance,Alpha-aminoadipic semialdehyde dehydrogenase,,2024-09-14,1,,,,,,,,,
Q9UDR5,0,OMOP Exposome,Observation,Substance,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",,2024-09-14,1,,,,,,,,,
P04745,0,OMOP Exposome,Observation,Substance,Alpha-amylase 1,,2024-09-14,1,,,,,,,,,
P19961,0,OMOP Exposome,Observation,Substance,Alpha-amylase 2B,,2024-09-14,1,,,,,,,,,
11032-79-4,0,OMOP Exposome,Observation,Substance,alpha-Bungarotoxin,,2014-12-24,1,,,,,,,,,
20562-03-2,0,OMOP Exposome,Observation,Substance,alpha-Chaconine,,2014-12-24,1,,,,,,,,,
769933-79-1,0,OMOP Exposome,Observation,Substance,alpha-Cobratoxin,,2014-12-24,1,,,,,,,,,
GIS1003421,0,OMOP Exposome,Observation,Substance,alpha-Conotoxin (Conus geographus),,2024-09-14,1,,,,,,,,,
10016-20-3,0,OMOP Exposome,Observation,Substance,Alpha-Cyclodextrin (Cyclohexa-Amylose),,2014-12-24,1,,,,,,,,,
P06733,0,OMOP Exposome,Observation,Substance,Alpha-enolase,,2024-09-14,1,,,,,,,,,
94716-94-6,0,OMOP Exposome,Observation,Substance,Alpha-hemolysin,,2014-12-24,1,,,,,,,,,
319-84-6,0,OMOP Exposome,Observation,Substance,alpha-Hexachlorocyclohexane,"PMS-lindane; Gamtox; PMS lindane; Pflanzol; Pedraczak; Kokotine; Geobilan; Gexane; Kwell; Kwell-r; Lasochron; Owadziak; Ovadziak; Omnitox; Novigan; Novigam; Lendine; Lentox; Lidenal; Hexachlorocyclohexane; Hexachlorocyclohexane, gamma isomer; Lindafor; Epsilon-benzenehexachloride; Hexachlorocyclohexane, gamma-isomer; Epsilon HCH; Hexachlorocyclohexane-alpha; Hexachlorocyclohexane-beta; Jacutin; Isotox; Isot ox; Entomoxan; Devoran; Detmol extract; Delta-lindane; Delta-hexachlorocyclohexane; Gamma hexachlor; Gyben; Heclotox; Hecoltox; Hexablanc; Hexachlor; Hexachloran; Gamma benzene hexachloride; Gallogama; Gamacarbatox; Gamaphex; Lindagam; Lindagrain; Lindagranox; Lindalo; Lindam ul; Lindamul; Lindaterra; Lindatox; Lindex; Lindosep; Lintox; Linvur; Lorexane; Mglawik l; Mszycol; Neo-scabicidol; Nexen FB; Nexen-FB; Nexi t-stark; Nexit; Nexit-stark; Nexol-e; Nicochloran; Gamene; Gamiso; Delta-benzenehexachloride; Delta-benzene hexachloride; delta-1,2,3,4,5,6-Hexachlorocyclohexane; Delitex; Hexachlorocyclohexanes; Aplidal; Arbitex; Arcotal S; Benhexachlor; Hexachlorzyklohexan; Hexamul; Hexapoudre; Hexatox; Hexaverm; Benhexol; Isatox; Insecticide, BHC; Inexit; Hortex; Hilbeech; Forst-nexen; Forlin; Exagama; Benzanex; Benzene hexachloride; Benzene hexachloride, all isomers; Cyclohexane, 1,2,3,4,5,6-hexachloro-, a-isomer; Codechine; Chloresene; alpha-HCH; Benzene hexachloride-a-isomer; Benzene hexachloride-alpha-isomer; Celanex; Benzene hexachloride-gamma isomer; Bexol; Beta-lindane; Hilbeec h; Benzene hexachloride-gamma-isomer; Hexyclan; Hexicide; Beta-isomer; Beta-hexachlorocyclohexanes; Beta-hexachlorocyclohexane; Benzene-1,2,3,4,5,6-hexachloride ((Ambiguous); Hexachloride, gamma-benzene; Hexachloride, benzene; Hexachlorane; Gammahexane; Gammahexa; Gamma-lindane; Gamma-linda ne; Gamma-hexachlorocyclohexane; Gamma-hexachlorobenzene; Gamma-hexachlorane; Gamma-benzohexachloride; Hexcidum; Gamma-benzenehexachloride; Gamma-benzene hexachloride; gamma-1,2,3,4,5,6-Hexachlorocyclohexane; Beta-hexachlorobenzene; Beta-hexachloran; Beta-hexac hlorocyclohexane; Beta-benzene hexachloride; Alpha-benzenehexachloride; Alpha-benzene hexachloride; alpha-1,2,3,4,5,6-Hexachlorocyclohexane; a-hexachlorocyclohexane; a-Hexachlorocyclohexane; a-hexachlorcyclohexane; Viton; Tetocid; Silvanol; a-hexachlorane; a-hexachloran; a-benzene hexachloride; Alpha-lindane; Alpha-hexachlorocyclohexanes; Am eisenatod; Ameisenatod; Ameisentod; beta-1,2,3,4,5,6-Hexachlorocyclohexane; Benzex; Benzenehexachloride-alpha-isomer; Benzenehexachloride, mixed isomers; Benzene-trans-hexachloride; Benzene-cis-hexachloride; Gammalin; Gammaterr; Aparasin; Aphtitria; Aphtiria; Alpha-hexachlorocyclohexane; a-1,2,3,4,5,6-Hexachlorocyclohexane; Alpha-hexachlorane; Alpha-hexachloran; \u03b1-Hexachlorocyclohexane; Gammex; Gammexane; Gammopaz; Gamma hexachlorocyclohexane; a-1,2,3,4,5,6-Hexachlorcyclohexane; 1alpha,2alpha,3beta,4alpha,5beta,6beta-Hexachlorocyclohexane; (1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; Esoderm; Eso derm; Epsilon-hexachlorocyclohexane; Scabisan; Scabene; Scabecid; Epsilon-HCH; CHEBI:32888",2014-12-24,1,,,,,,,,,
127-41-3,0,OMOP Exposome,Observation,Substance,alpha-Ionone,"alpha-(E)-ionone; alpha-cyclocitrylideneacetone; trans-alpha-Ionone; alpha-Ionon; \u03b1-Ionone; (3E)-4-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-3-buten-2-on; (E)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; (E)-alpha-Ionone; a-Ionone; CHEBI:32319",2014-12-24,1,,,,,,,,,
3715-10-4,0,OMOP Exposome,Observation,Substance,Alpha-keto-delta-guanidinovaleric acid,,2014-12-24,1,,,,,,,,,
BE0002205,0,OMOP Exposome,Observation,Substance,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2,,2024-09-14,1,,,,,,,,,
Q96Q83,0,OMOP Exposome,Observation,Substance,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,,2024-09-14,1,,,,,,,,,
Q9C0B1,0,OMOP Exposome,Observation,Substance,Alpha-ketoglutarate-dependent dioxygenase FTO,,2024-09-14,1,,,,,,,,,
759-05-7,0,OMOP Exposome,Observation,Substance,Alpha-ketoisovaleric acid,2-Ketovaline; \u03b1-Ketoisovaleric acid; \u03b1-Ketoisovalerate; Ketovaline; Isopropylglyoxylic acid; Isopropylglyoxylate; Dimethylpyruvic acid; Dimethylpyruvate; alpha-Oxoisovaleric acid; alpha-Oxoisovalerate; alpha-Oxo-beta-methylbutyric acid; alpha-Oxo-beta-methylbutyrate; alpha-Ketovaline; alpha-Ketoisovaleric acid; Alpha-Ketoisovaleric acid; alpha-Ketoisovalerate; alpha-Keto-Isovaleric acid; alpha-Keto-Isovalerate; alpha-Keto-beta-Methylbutyric acid; alpha-Keto-beta-Methylbutyrate; a-Oxoisovaleric acid; a-Oxoisovalerate; a-Oxo-b-methylbutyric acid; a-Oxo-b-methylbutyrate; a-Ketoisovaleric acid; a-Ketoisovalerate; a-Keto-Isovaleric acid; a-Keto-Isovalerate; a-Keto-b-Methylbutyric acid; a-Keto-b-Methylbutyrate; 3-Methyl-2-oxobutyric acid; 3-Methyl-2-oxobutyrate; 3-Methyl-2-oxobutinoic acid; 3-Methyl-2-oxobutinoate; 3-Methyl-2-oxobutanoic acid; 3-Methyl-2-oxobutanoate; 3-Methyl-2-oxo-Butyric acid; 3-Methyl-2-oxo-Butyrate; 3-Methyl-2-oxo-Butanoic acid; 3-Methyl-2-oxo-Butanoate; 2-Oxoisovaleric acid; 2-Oxoisovalerate; 2-Oxoisopentanoate; 2-Oxo-3-methylbutyric acid; 2-Oxo-3-methylbutyrate; 2-Oxo-3-methylbutanoic acid; 2-Oxo-3-methylbutanoate; 2-Oxo-3-methyl-butyrate; 2-Ketoisvaleric acid; 2-Ketoisovaleric acid; 2-Ketoisovalerate; 2-Keto-3-Methylbutyric acid; 2-Keto-3-Methylbutyrate; CHEBI:16530,2018-03-21,1,,,,,,,,,
P00709,0,OMOP Exposome,Observation,Substance,Alpha-lactalbumin,,2024-09-14,1,,,,,,,,,
65988-34-3,0,OMOP Exposome,Observation,Substance,alpha-Latrotoxin,,2014-12-24,1,,,,,,,,,
463-40-1,0,OMOP Exposome,Observation,Substance,Alpha-Linolenic Acid,"(9Z,12Z,15Z)-Octadecatrienoic acid; \u03b1-linolenic acid; \u03b1-Linolenic acid; \u03b1-Linolenate; Linolenic acid; Linolenate; Industrene 120; cis-delta(9,12,15)-Octadecatrienoic acid; cis-9,12,15-Octadecatrienoic acid; cis-9,12,15-Octadecatrienoate; cis,cis,cis-9,12,15-Octadecatrienoic acid; cis,cis,cis-9,12,15-Octadecatrienoate; alpha-Linolenic acid; alpha-Linolenate; All-cis-9,12,15-Octadecatrienoic acid; All-cis-9,12,15-Octadecatrienoate; ALA; a-Linolenic acid; a-Linolenate; 9-cis,12-cis,15-cis-Octadecatrienoic acid; 9-cis,12-cis,15-cis-Octadecatrienoate; 9,12,15-Octadecatrienoic acid; 9,12,15-Octadecatrienoate; (Z,Z,Z)-9,12,15-Octadecatrienoic acid; (Z,Z,Z)-9,12,15-Octadecatrienoate; (9Z,12Z,15Z)-Octadecatrienoate; (9,12,15)-linolenic acid; (9,12,15)-linolenate; CHEBI:27432",2014-12-24,1,,,,,,,,,
Q16706,0,OMOP Exposome,Observation,Substance,Alpha-mannosidase 2,,2024-09-14,1,,,,,,,,,
Q9NTJ4,0,OMOP Exposome,Observation,Substance,Alpha-mannosidase 2C1,,2024-09-14,1,,,,,,,,,
P49641,0,OMOP Exposome,Observation,Substance,Alpha-mannosidase 2x,,2024-09-14,1,,,,,,,,,
P17050,0,OMOP Exposome,Observation,Substance,Alpha-N-acetylgalactosaminidase,,2024-09-14,1,,,,,,,,,
202075-91-0,0,OMOP Exposome,Observation,Substance,alpha-Pompilidotoxin,,2014-12-24,1,,,,,,,,,
P47710,0,OMOP Exposome,Observation,Substance,Alpha-S1-casein,,2024-09-14,1,,,,,,,,,
86243-64-3,0,OMOP Exposome,Observation,Substance,alpha-Sarcin (Aspergillus giganteus),,2014-12-24,1,,,,,,,,,
20562-02-1,0,OMOP Exposome,Observation,Substance,alpha-Solanine,,2014-12-24,1,,,,,,,,,
P37840,0,OMOP Exposome,Observation,Substance,Alpha-synuclein,,2024-09-14,1,,,,,,,,,
59-02-9,0,OMOP Exposome,Observation,Substance,Alpha-Tocopherol,"(R,R,R)-\u03b1-tocopherol; (R,R,R)-alpha-Tocopherol; (R,R,R)-a-Tocopherol; (2R,4'R,8'R)-alpha-Tocopherol; (2R,4'R,8'R)-a-Tocopherol; (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4R,8R)-4,8,12-trimethyltridecyl-2H-1-benzopyran-6-ol; (+)-\u03b1-tocopherol; (+)-alpha-Tocopherol; (+)-a-Tocopherol; RRR-alpha-tocopherol; RRR-alpha-tocopheryl; Vitamin Ea; \u03b1-Tocopherol; Vitamin E; Eprolin; Phytogermin; Denamone; delta-alpha-Tocopherol; d-\u03b1-tocopherol; D-alpha-Tocopherol; Aquasol E; Amino-Opti-E; alpha-Tocopherol; alpha-delta-Tocopherol; a-Tocopherol; a-D-Tocopherol; Phytogermine; 5,7,8-Trimethyltocol; CHEBI:18145",2014-12-24,1,,,,,,,,,
P49638,0,OMOP Exposome,Observation,Substance,Alpha-tocopherol transfer protein,,2024-09-14,1,,,,,,,,,
GIS1003445,0,OMOP Exposome,Observation,Substance,Alpha-toxin (Clostridium perfringens),,2024-09-14,1,,,,,,,,,
36455-72-8,0,OMOP Exposome,Observation,Substance,alpha-Zearalenol,,2014-12-24,1,,,,,,,,,
BE0004879,0,OMOP Exposome,Observation,Substance,alpha1-acid glycoprotein,,2024-09-14,1,,,,,,,,,
28981-97-7,0,OMOP Exposome,Observation,Substance,Alprazolam,"Alprazolan; Alplax; 8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine; Niravam; Tranquinal; Xanax XR; Xanax; TUS-1; Esparon; Ralozam; Restyl; Cassadan; Solanax; Tafil; Trankimazin; Xanor; Alviz; Alpronax; Alprox; CHEBI:2611",2014-12-24,1,,,,,,,,,
105857-23-6,0,OMOP Exposome,Observation,Substance,Alteplase,,2014-12-24,1,,,,,,,,,
641-38-3,0,OMOP Exposome,Observation,Substance,Alternariol,"3,7,9-Trihydroxy-1-methyl-6H-dibenzob,Dpyran-6-one, 9CI; 3,7,9-Trihydroxy-1-methyl-6H-dibenzo(b,D)pyran-6-one; 3,7,9-Trihydroxy-1-methyl-6H-benzocchromen-6-one; AOH; Alternariol from alternaria SP.; 3,4',5-Trihydroxy-6'-methyldibenzo-a-pyrone; 1-Methyl-3,7,9-trihydroxy-6H-Dibenzo(b,D)pyran-6-one; 3,7,9-Trihydroxy-1-methyl-6H-Dibenzob,Dpyran-6-one; Alternariol 3,4',5-Trihydroxy-6'-methyl-dibenzoapyrone; CHEBI:64983",2014-12-24,1,,,,,,,,,
23452-05-3,0,OMOP Exposome,Observation,Substance,Alternariol methyl ether,,2014-12-24,1,,,,,,,,,
56258-32-3,0,OMOP Exposome,Observation,Substance,Altertoxin-1,,2014-12-24,1,,,,,,,,,
19022-77-6,0,OMOP Exposome,Observation,Substance,Aluminium acetoacetate,,2014-12-24,1,,,,,,,,,
25152-52-7,0,OMOP Exposome,Observation,Substance,Aluminium antimonide,,2014-12-24,1,,,,,,,,,
22831-42-1,0,OMOP Exposome,Observation,Substance,Aluminium arsenide,,2014-12-24,1,,,,,,,,,
52869-91-7,0,OMOP Exposome,Observation,Substance,Aluminium barium titanium oxide,,2014-12-24,1,,,,,,,,,
7727-15-3,0,OMOP Exposome,Observation,Substance,Aluminium bromide,,2014-12-24,1,,,,,,,,,
1299-86-1,0,OMOP Exposome,Observation,Substance,Aluminium carbide,,2014-12-24,1,,,,,,,,,
7446-70-0,0,OMOP Exposome,Observation,Substance,Aluminium chloride,AlCl3; Aluminium(III) chloride; Aluminum chloride anhydrous; Aluminum trichloride; Anhydrol forte; AlCl3; Trichloroaluminum; Trichloroalumane; Trichloridoaluminium; Caswell No. 029; Aluminium trichloride; CHEBI:30114,2014-12-24,1,,,,,,,,,
1327-41-9,0,OMOP Exposome,Observation,Substance,Aluminium chlorohydrate,,2014-12-24,1,,,,,,,,,
142-03-0,0,OMOP Exposome,Observation,Substance,Aluminium diacetate hydroxide,,2014-12-24,1,,,,,,,,,
12041-50-8,0,OMOP Exposome,Observation,Substance,Aluminium diboride,,2014-12-24,1,,,,,,,,,
12041-54-2,0,OMOP Exposome,Observation,Substance,Aluminium dodecaboride,,2014-12-24,1,,,,,,,,,
7784-21-6,0,OMOP Exposome,Observation,Substance,Aluminium hydride,Aluminum hydride (AlH3); AlH3; Aluminium trihydride; a-aluminum trihydride; AlH3; Alane; Aluminum hydride; Aluminum trihydride; CHEBI:30136,2014-12-24,1,,,,,,,,,
21645-51-2,0,OMOP Exposome,Observation,Substance,Aluminium hydroxide,"Kudrox; Liquigel; Maalox; Maalox HRF; Maalox plus; Mylanta; Tricreamalate; Trihydrated alumina; Trihydroxidoaluminium; Trihydroxyaluminum; Trisogel; Wingel; Alusal; Alterna gel; Alternagel; Alugelibye; Alumigel; Alumina trihydrate; aluminium(3+) hydroxide; Aluminium(III) hydroxide; Aluminiumhydroxid; Aluminum hydroxide; Aluminum hydroxide gel; Aluminum hydroxide, dried; Aluminum oxide hydrated; Aluminum oxide trihydrate; Aluminum trihydroxide; Aluminum(III) hydroxide; Amberol ST 140F; Amorphous alumina; Amphogel; Amphojel; Antipollon HT; Apyral; Boehmite; British aluminum AF 260; Calcitrel; Calmogastrin; Camalox; Di-gel liquid; Di-mu-hydroxytetrahydroxydialuminum; Dialume; Gelusil; Higilite; Hydroxyde d' aluminium; CHEBI:33130",2014-12-24,1,,,,,,,,,
7784-23-8,0,OMOP Exposome,Observation,Substance,Aluminium iodide,,2014-12-24,1,,,,,,,,,
555-31-7,0,OMOP Exposome,Observation,Substance,Aluminium isopropoxide,,2014-12-24,1,,,,,,,,,
7784-18-1,0,OMOP Exposome,Observation,Substance,Aluminium lactate,Aluminum tris(alpha-hydroxypropionate); Tris(2-hydroxypropanoato)aluminum; Aluminium trilactate; Aluminium lactic acid; Tris2-(hydroxy-kappao)propanoato-kappaoaluminium; Aluminum fluoride; Aluminum lactate; CHEBI:49464,2014-12-24,1,,,,,,,,,
15123-80-5,0,OMOP Exposome,Observation,Substance,Aluminium molybdate,,2014-12-24,1,,,,,,,,,
13595-81-8,0,OMOP Exposome,Observation,Substance,Aluminium monochloride,Aluminum chloride; ALCL; alcl; Chloridoaluminium; Aluminum monochloride; CHEBI:30131,2014-12-24,1,,,,,,,,,
13595-82-9,0,OMOP Exposome,Observation,Substance,Aluminium monofluoride,,2014-12-24,1,,,,,,,,,
7047-84-9,0,OMOP Exposome,Observation,Substance,Aluminium monostearate,"Aluminum monostearate (JP15/NF); Aluminum monostearate; Aluminium monostearic acid; Stearates; Dihydroxyaluminum stearate; Dihydroxyaluminium stearate, pure; Dihydroxy(stearato)aluminum; Dihydroxy(stearato)aluminium; Dihydroxido(octadecanoato)aluminium; Dibasic aluminum stearate; Aluminum, monostearate; Aluminum, dihydroxide stearate; Stearic acid aluminum dihydroxide salt; CHEBI:31197",2014-12-24,1,,,,,,,,,
13473-90-0,0,OMOP Exposome,Observation,Substance,Aluminium nitrate,,2014-12-24,1,,,,,,,,,
24304-00-5,0,OMOP Exposome,Observation,Substance,Aluminium nitride,Aluminum nitride; CHEBI:50884,2014-12-24,1,,,,,,,,,
637-12-7,0,OMOP Exposome,Observation,Substance,Aluminium octadecanoate,"Aluminum (III) stearate; Aluminium tristearate; Aluminium octadecanoic acid; Aluminium stearate; Aluminium trioctadecanoate; Stearic acid, aluminum salt; Octadecanoic acid, aluminum salt; Monoaluminum stearate; Aluminum(III) stearate; Aluminum tristearate; Aluminum trioctadecanoate; Aluminum stearate; Aluminum octadecanoate; CHEBI:37867",2014-12-24,1,,,,,,,,,
12633-97-5,0,OMOP Exposome,Observation,Substance,Aluminium oxynitride,,2014-12-24,1,,,,,,,,,
7784-30-7,0,OMOP Exposome,Observation,Substance,Aluminium phosphate,,2014-12-24,1,,,,,,,,,
20859-73-8,0,OMOP Exposome,Observation,Substance,Aluminium phosphide,Fumitoxin; Celphos; Aluminum phosphide; Aluminum phosphide (alp); Caswell No. 031; Celphide; Celphine; Talunex; RCRA waste number P006; Phostoxin-a; Phostoxin; Gastion; CHEBI:38495,2014-12-24,1,,,,,,,,,
1302-82-5,0,OMOP Exposome,Observation,Substance,Aluminium selenide,,2014-12-24,1,,,,,,,,,
1335-30-4,0,OMOP Exposome,Observation,Substance,Aluminium silicate,,2014-12-24,1,,,,,,,,,
10043-01-3,0,OMOP Exposome,Observation,Substance,Aluminium sulfate,"Dialuminum sulphate; Dialuminum sulfate; Aluminium sulfic acid; Aluminium sulphate; Aluminium sulphic acid; Aluminum sulfate; Aluminum sulfate (3:2); Aluminum sulphate; Aluminum sulphate (3:2); Aluminum trisulfate; Sulfuric acid, aluminum(3+) salt (3:2); Sulfuric acid, aluminum salt (3:2); Sulfuric acid, aluminum potassium salt (2:1:1); Aluminum trisulphate; Alunogenite; Sulfuric acid aluminum(3+) salt (3:2); E520; Dialuminum trisulphate; Dialuminum trisulfate; CHEBI:74768",2014-12-24,1,,,,,,,,,
1302-81-4,0,OMOP Exposome,Observation,Substance,Aluminium sulfide,,2014-12-24,1,,,,,,,,,
12004-36-3,0,OMOP Exposome,Observation,Substance,Aluminium(I) oxide,,2014-12-24,1,,,,,,,,,
457-64-8,0,OMOP Exposome,Observation,Substance,Aluminium(II) oxide,,2014-12-24,1,,,,,,,,,
1344-28-1,0,OMOP Exposome,Observation,Substance,Aluminium(III) oxide,"Aluminum sesquioxide; Purdox; Faserton; Fasertonerde; Fiber FP; Flame guard; Florite; a-alumina trihydrate; a-ruvite; Aluminum oxide, dispersion; Aluminum oxide, mesoporous; Boileezers; Aluminum trioxide; Alumite (oxide); Bauxite; Bikorit; Hydrated aluminum oxide; Dialuminum trioxide; Versal 150; Theta alumina; Tealox; Tabular alumina; Corundite; Saffil; Jubenon r; Ketjen b; KHP 2; Saffie; Korund; Lucalox; Ludox CL; MAFE; Maftec; Martipol; Dural F 30; Dural; Dycron; Electrocorundum; Emery; Eta-alumina; Corubin; Corowalt; Corotox; Martisorb; RUBY; REX; Rewagit; Realox; RC 172DBM; Q-Loid A 30; Martoxin; Marttisorb; Corolox; Microgrit wca; MP 1 (Refractory); Neobead c; Porocel; Oxide, aluminum; Poraminar; Conopal; Compalox; Ceramic, alumina; Porocel SRC; Portalum A 25; Catapal SB alumina; Catapal s; Carbo-corundum; Carbo alumina; Calcined alumina; Calcinated alumina; Cab-o-grip; Brockmann, aluminum oxide; Brasivol; Boxite; Borolon; PS 1 (Alumina); Borite; Boiling stones; Dotment 358; Dotment 324; Dispal m; Selexsorb cos; Sapphire; Saphire; Dispal alumina; Dirubin; Diadur; Delta alumina; Hypalox II; Inhibitor removers; Italcor; Crystalline aluminum oxide; Corundum; CHEBI:30187",2014-12-24,1,,,,,,,,,
7429-90-5,0,OMOP Exposome,Observation,Substance,Aluminum,Aluminum(3+) ion; Aluminium(3+) ion; Aluminium(III) cation; Metallic Aluminum; Aluminum(III) cation; Aluminum(3+); 13Al; Al; Aluminium; Aluminium(3+); CHEBI:28984,2014-12-24,1,,,,,,,,,
7784-25-0,0,OMOP Exposome,Observation,Substance,Aluminum ammonium sulfate,,2014-12-24,1,,,,,,,,,
2269-22-9,0,OMOP Exposome,Observation,Substance,Aluminum butylate,,2014-12-24,1,,,,,,,,,
44-01-0,0,OMOP Exposome,Observation,Substance,Aluminum calcium sodium silicate,,2014-12-24,1,,,,,,,,,
GIS1003453,0,OMOP Exposome,Observation,Substance,Aluminum Compound,,2024-09-14,1,,,,,,,,,
300-92-5,0,OMOP Exposome,Observation,Substance,Aluminum distearate,,2014-12-24,1,,,,,,,,,
555-75-9,0,OMOP Exposome,Observation,Substance,Aluminum ethylate,,2014-12-24,1,,,,,,,,,
688-37-9,0,OMOP Exposome,Observation,Substance,Aluminum oleate,,2014-12-24,1,,,,,,,,,
555-35-1,0,OMOP Exposome,Observation,Substance,Aluminum palmitate,,2014-12-24,1,,,,,,,,,
10102-71-3,0,OMOP Exposome,Observation,Substance,Aluminum sodium sulfate,,2014-12-24,1,,,,,,,,,
139-12-8,0,OMOP Exposome,Observation,Substance,Aluminum triacetate,,2014-12-24,1,,,,,,,,,
21150-21-0,0,OMOP Exposome,Observation,Substance,Amanin,,2014-12-24,1,,,,,,,,,
58311-65-2,0,OMOP Exposome,Observation,Substance,Amaninamide,,2014-12-24,1,,,,,,,,,
768-94-5,0,OMOP Exposome,Observation,Substance,Amantadine,"1-adamantanamine; 1-adamantylamine; Amantadine Hydrochloride; Amantadine HCL; Amantadine Base; Amantadina; Adamantylamine; Virosol; Viregyt; Tricyclo3.3.1.1(3,7)decane-1-amine; Adamantanamine; Adamantamine; 1-Aminoadamantane; Tricyclo3.3.1.1(3,7)decan-1-ylamine; Tricyclo3.3.1.1(3,7)decan-1-amine; Amantadinum; Amantidine; Aminoadamantane; Endantadine; PK-Merz; Symadine; Symmetrel; CHEBI:2618",2014-12-24,1,,,,,,,,,
21803-57-6,0,OMOP Exposome,Observation,Substance,Amanullin,,2014-12-24,1,,,,,,,,,
54532-45-5,0,OMOP Exposome,Observation,Substance,Amanullinic acid,,2014-12-24,1,,,,,,,,,
7648-98-8,0,OMOP Exposome,Observation,Substance,Ambenonium,Ambenonium base; Mytelase; Ambenonum; Mysuran; CHEBI:2627,2014-12-24,1,,,,,,,,,
GIS1003454,0,OMOP Exposome,Observation,Substance,Amebicide,,2024-09-14,1,,,,,,,,,
7440-35-9,0,OMOP Exposome,Observation,Substance,Americium,Amerizium; Am; Americio; Americium 243; Americium(III); Americium-243; (243)Am; 243Am; 95Am; CHEBI:33389,2014-12-24,1,,,,,,,,,
GIS1003455,0,OMOP Exposome,Observation,Substance,Americium Compound,,2024-09-14,1,,,,,,,,,
86954-36-1,0,OMOP Exposome,Observation,Substance,Americium-241,,2014-12-24,1,,,,,,,,,
834-12-8,0,OMOP Exposome,Observation,Substance,Ametryn,"N-Ethyl-n'-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine; Evik; Gesapax; 2-(methylthio)-4-(Ethylamino)-6-(isopropylamino)-S-triazine; 2-Ethylamino-4-isopropylamino-6-methylmercapto-S-triazine; Ametryne; Ametrex; 2-methylthio-4-Ethylamino-6-isopropylamino-S-triazine; N-Ethyl-n'-(1-methylethyl)-6-(methylthio)-1,3,5-triazine-2,4-diamine; N-Ethyl-n'-(1-methylethyl)-6-(methylthio)-2,4-diaminetriazine; CHEBI:22472",2014-12-24,1,,,,,,,,,
GIS1003456,0,OMOP Exposome,Observation,Substance,Amide,,2024-09-14,1,,,,,,,,,
40164-67-8,0,OMOP Exposome,Observation,Substance,Amidochlor,,2014-12-24,1,,,,,,,,,
Q06203,0,OMOP Exposome,Observation,Substance,Amidophosphoribosyltransferase,,2024-09-14,1,,,,,,,,,
GIS1003457,0,OMOP Exposome,Observation,Substance,Amine,,2024-09-14,1,,,,,,,,,
P21397,0,OMOP Exposome,Observation,Substance,Amine oxidase [flavin-containing] A,,2024-09-14,1,,,,,,,,,
P27338,0,OMOP Exposome,Observation,Substance,Amine oxidase [flavin-containing] B,,2024-09-14,1,,,,,,,,,
GIS1003458,0,OMOP Exposome,Observation,Substance,Amino Acid,,2024-09-14,1,,,,,,,,,
GIS1003461,0,OMOP Exposome,Observation,Substance,Amino Sugar Metabolism,,2024-09-14,1,,,,,,,,,
542-32-5,0,OMOP Exposome,Observation,Substance,Aminoadipic acid,(+/-)-2-Aminoadipate; L-alpha-Aminoadipate; L-alpha-Aminoadipic acid; a-Aminoadipic acid; L-2-Aminohexanedioic acid; L-2-Aminohexanedioate; DL-2-Aminohexanedioate; L-2-Aminoadipic acid; 2-Aminoadipic acid; a-Aminoadipate; 2-Aminoadipate; (+/-)-2-Aminoadipic acid; DL-2-Aminohexanedioic acid; DL-a-Aminoadipate; DL-a-Aminoadipic acid; DL-alpha-Aminoadipate; L-2-Aminoadipate; DL-alpha-Aminoadipic acid; DL-2-Aminoadipic acid; DL-2-Aminoadipate; Aminoadipate; alpha-Aminoadipic acid; alpha-Aminoadipate; alpha-Amino-adipic acid; CHEBI:37024,2018-03-21,1,,,,,,,,,
2032-59-9,0,OMOP Exposome,Observation,Substance,Aminocarb,"(4-Dimethylamino-3-methylphenyl) N-methylcarbamate; 4-Dimethylamino-3-methylphenyl methylcarbamate; Matacil; 4-(Dimethylamino)-3-methylphenol methyl carbamate; m-Cresol, 4-(dimethylamino)-, methylcarbamate (ester); 4-(Dimethylamino)-3-cresyl methylcarbamate; 3-Methyl-4-dimethylaminophenyl methylcarbamate; 3-Methyl-4-(Dimethylamino)phenyl methylcarbamate; (4-Dimethylamino-3-methyl-phenyl)N-methyl-carbamate; Phenol, 4-(dimethylamino)-3-methyl-, methylcarbamate; N-Methylcarbamate de 4-dimethylamino 3-methyl phenyle; Mitacil; m-Cresol, 4-(dimethylamino)-, methylcarbamate; Caswell No. 360; Carbamic acid, methyl-, 4-dimethylamino-m-tolyl ester; Carbamic acid, methyl-, 4-(dimethylamino)-m-tolyl ester; Aminocarbe; Methylcarbamic acid 4-(dimethylamino)-m-tolyl ester; 4-Dimethylamino-3-cresyl methylcarbamate; 4-Dimethylamino- m-cresyl methylcarbamate; 4-Dimethylamine m-cresyl methylcarbamate; 4-(Dimethylamino)-m-tolyl methylcarbamate; 4-(Dimethylamino)-3-tolyl methylcarbamate; 4-(dimethylamino)-3-methylphenyl N-methylcarbamate; 4-(Dimethylamino)-3-methylphenyl methylcarbamate; 4-(Dimethylamino)-3-methylphenol methylcarbamate (ester); 4-(Dimethylamino)-3-methylphenol methyl carbamate (ester); Matacil 180D; CHEBI:2653",2014-12-24,1,,,,,,,,,
125-84-8,0,OMOP Exposome,Observation,Substance,Aminoglutethimide,"3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine; 2-(p-Aminophenyl)-2-ethylglutarimide; Aminoglutetimide; Cytadren; Aminoglutetimida; Aminoglutethimidum; Dl-Aminoglutethimide; Aminoglut\u00e9thimide; P-Aminoglutethimide; Orimeten; Mamomit; Elipten; Rogluten; Aminoglutethimid; alpha-(P-Aminophenyl)-alpha-ethylglutarimide; CHEBI:2654",2014-12-24,1,,,,,,,,,
GIS1003459,0,OMOP Exposome,Observation,Substance,Aminoglycoside,,2024-09-14,1,,,,,,,,,
GIS1003460,0,OMOP Exposome,Observation,Substance,Aminoglycosides,,2024-09-14,1,,,,,,,,,
54-62-6,0,OMOP Exposome,Observation,Substance,Aminopterin,"4'-Amino-folsaeure; 4-Aminofolic acid; N-(4-{(2,4-Diamino-6-pteridinyl)methylamino}benzoyl)glutamic acid; Minopterin; L-N-p-(2,4-Diamino-6-pteridinyl)methylaminobenzoyl-Glutamic acid; APGA; Aminopterine; Aminopteridine; A-ninopterin; 4-Aminopteroylglutamic acid; 4-Aminopteroylglutamate; Pteramina; 4-Aminofolate; 4-Amino-PGA; 4-Amino-4-deoxypteroylglutamate; CHEBI:376180",2014-12-24,1,,,,,,,,,
1951-25-3,0,OMOP Exposome,Observation,Substance,Amiodarone,"Tachyra; 2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran; Arycor; Atlansil; Cordarone; Nexterone; Pacerone; Amio-Aqueous IV; Amiodarona; Amiodaronum; Aratac; 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran; 2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone; CHEBI:2663",2014-12-24,1,,,,,,,,,
33089-61-1,0,OMOP Exposome,Observation,Substance,Amitraz,,2014-12-24,1,,,,,,,,,
50-48-6,0,OMOP Exposome,Observation,Substance,Amitriptyline,"Syneudon; Tryptanol; Tryptizol; Uxen Retard; 3-(10,11-dihydro-5H-Dibenzoa,Dcyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene; Amitriprolidine; Amitriptilina; Amitriptylin; Amitriptylinum; Amitryp; 10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine; 10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene; Adepril; 5-(gamma-Dimethylaminopropylidene)-5H-dibenzoa,D1,4cycloheptadiene; Amitryptiline; Amitryptyline; 3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine; Amytriptiline; Conmitrip; Elavil; Endep; Fiorda; Kamitrin; Laroxyl; Latilin; Maxitrip; Redomex; Saroten; Sarotex; Sarotex Retard; CHEBI:2666",2014-12-24,1,,,,,,,,,
7664-41-7,0,OMOP Exposome,Observation,Substance,Ammonia,Anhydrous ammonia; Ammonia water; Spirit of hartshorn; NH3; Ammonia anhydrous; NH(3); Liquid ammonia; Azane; CHEBI:16134,2018-03-21,1,,,,,,,,,
GIS1003462,0,OMOP Exposome,Observation,Substance,Ammonia Recycling,,2024-09-14,1,,,,,,,,,
7784-44-3,0,OMOP Exposome,Observation,Substance,Ammonium arsenate,,2014-12-24,1,,,,,,,,,
12124-97-9,0,OMOP Exposome,Observation,Substance,Ammonium bromide,,2014-12-24,1,,,,,,,,,
7788-98-9,0,OMOP Exposome,Observation,Substance,Ammonium chromate,,2014-12-24,1,,,,,,,,,
7789-09-5,0,OMOP Exposome,Observation,Substance,Ammonium dichromate,,2014-12-24,1,,,,,,,,,
7783-22-4,0,OMOP Exposome,Observation,Substance,Ammonium diuranate,,2014-12-24,1,,,,,,,,,
7440-05-3,0,OMOP Exposome,Observation,Substance,Ammonium hexachloro-palladate(IV),,2014-12-24,1,,,,,,,,,
32612-48-9,0,OMOP Exposome,Observation,Substance,Ammonium laureth sulfate,"Polyoxyethylene (9) lauryl ether sulfate ammonium salt; Sodium lauryl ether sulfate; Polyoxyethylene (7) lauryl ether sulfate ammonium salt; Polyoxyethylene (5) lauryl ether sulfate ammonium salt; Polyoxyethylene (12) lauryl ether sulfate ammonium salt; Polyoxyethylene (1-4) lauryl ether sulfate ammonium salt; Polyethylene glycol lauryl ether sulfate ammonium salt; Polyethylene glycol 600 lauryl ether sulfate ammonium salt; Polyethylene glycol 450 lauryl ether sulfate ammonium salt; Polyethylene Glycol (7) Lauryl Ether Sulfate Ammonium Salt; Polyethylene glycol (5) lauryl ether sulfate ammonium salt; PEG-9 Lauryl ether sulfate ammonium salt; PEG-7 Lauryl ether sulfate ammonium salt; PEG-5 Lauryl ether sulfate ammonium salt; PEG-12 Lauryl ether sulfate ammonium salt; PEG-(1-4) Lauryl ether sulfate, ammonium salt; Ammonium polyoxyethylene (7) lauryl ether sulfate; Ammonium polyoxyethylene (5) lauryl ether sulfate; Ammonium polyoxyethylene (12) lauryl ether sulfate; Ammonium polyethylene glycol (450) lauryl ether sulfate; Ammonium lauryl ether sulfate; Ammonium laureth-9 sulfate; Ammonium laureth-7 sulfate; Ammonium laureth-5 sulfate; Ammonium laureth-12 sulfate; Ammonium laureth sulphic acid; Ammonium laureth sulphate; Ammonium laureth sulfic acid; CHEBI:53474",2014-12-24,1,,,,,,,,,
2235-54-3,0,OMOP Exposome,Observation,Substance,Ammonium lauryl sulfate,Dodecyl sulfate ammonium salt; Ammonium lauryl sulphic acid; Ammonium lauryl sulfic acid; Ammonium dodecyl sulfate; Ammonium lauryl sulfate solution; Ammonium lauryl sulphate; CHEBI:53474,2014-12-24,1,,,,,,,,,
7803-55-6,0,OMOP Exposome,Observation,Substance,Ammonium metavanadate,,2014-12-24,1,,,,,,,,,
6484-52-2,0,OMOP Exposome,Observation,Substance,Ammonium nitrate,"Ammonium nitricum; Ammonium hydrogendinitrate; Ammonium saltpeter; Nitrate d'ammonium; Ammonium(I) nitrate (1:1); Nitrate of ammonia; Nitrato amonico; Nitric acid ammonium salt; Nitric acid ammonium salt (1:1); Nitric acid, ammonium salt; Herco prills; Norway saltpeter; Varioform I; Ammonium nitrate (pesticide/fertilizer mixture); Merco prills; Nitram; Ammonium nitrate solution; Ammonium nitrate urea solution (containing ammonia); Ammonium nitrate urea solution (not containing ammonia); Ammonium nitric acid; CHEBI:63038",2014-12-24,1,,,,,,,,,
13446-48-5,0,OMOP Exposome,Observation,Substance,Ammonium nitrite,,2014-12-24,1,,,,,,,,,
7790-98-9,0,OMOP Exposome,Observation,Substance,Ammonium perchlorate,,2014-12-24,1,,,,,,,,,
13446-10-1,0,OMOP Exposome,Observation,Substance,Ammonium permanganate,,2014-12-24,1,,,,,,,,,
19168-23-1,0,OMOP Exposome,Observation,Substance,Ammonium tetrachloro-palladate(II),,2014-12-24,1,,,,,,,,,
13573-16-5,0,OMOP Exposome,Observation,Substance,Ammonium tetrathiocyanato-diamminechromate(III),,2014-12-24,1,,,,,,,,,
1762-95-4,0,OMOP Exposome,Observation,Substance,Ammonium thiocyanate,,2014-12-24,1,,,,,,,,,
57-43-2,0,OMOP Exposome,Observation,Substance,Amobarbital,"Barbamyl; Barbamil; Amytal; Amylobarbitone; 5-Ethyl-5-isopentylbarbituric acid; 5-Ethyl-5-isoamylbarbituric acid; 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-Ethyl-5-(3-methylbutyl)barbituric acid; Isomytal; CHEBI:2673",2014-12-24,1,,,,,,,,,
12172-73-5,0,OMOP Exposome,Observation,Substance,Amosite asbestos,Trans-dihydronarciclasine; Amosite; Brown asbestos; Cis-dihydronarciclasine; CHEBI:46678,2014-12-24,1,,,,,,,,,
14028-44-5,0,OMOP Exposome,Observation,Substance,Amoxapine,"Oxamine; Oxcap; Desmethylloxapin; Asendis; Asendin; Amoxepine; 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine; Adisen; Demolox; D\u00e9fanyl; Amoxapinum; Amoxapina; Amoxapin; Amoxan; Amolife; CHEBI:2675",2014-12-24,1,,,,,,,,,
300-62-9,0,OMOP Exposome,Observation,Substance,Amphetamine,1-(3-Methoxyphenyl)-2-propylamine; \u03b1-methylbenzeneethaneamine; (+/-)-Benzedrine; (+/-)-beta-Phenylisopropylamine; (+/-)-Desoxynorephedrine; 1-Methyl-2-phenylethylamine; 1-Phenyl-2-aminopropane; 1-Phenylpropan-2-amin; 3-Methoxyamphetamine; alpha-Methylbenzeneethaneamine; alpha-Methylphenylethylamine; Amfetamine; Amfetaminum; Amphetamin; Amphetamine Sulfate; beta-Aminopropylbenzene; beta-Phenyl-isopropylamine; beta-Phenylisopropylamin; beta-Phenylisopropylamine; Desoxynorephedrine; Dl-1-Phenyl-2-aminopropane; \u03b2-phenylisopropylamine; \u03b2-aminopropylbenzene; \u03b1-methylphenethylamine; DL-alpha-Methylphenethylamine; Dl-Benzedrine; Dl-Amphetamine; Fenylo-izopropylaminyl; m-Methoxyamphetamine; Methamphetamine HCL; CHEBI:2679,2014-12-24,1,,,,,,,,,
161814-49-9,0,OMOP Exposome,Observation,Substance,Amprenavir,"Amprenavirum; Prozei; Agenerase; VX-478; Agemerase; (3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate; AMP; AMV; CHEBI:2684",2014-12-24,1,,,,,,,,,
51264-14-3,0,OMOP Exposome,Observation,Substance,Amsacrine,4'-(9-Acridinylamino)methanesulfon-m-anisidide; 4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide; 4'-(9-Acridinylamino)methanesulfon-meta-anisidide; 4'-(9-Acridinylamino)methanesulphon-m-anisidide; Acridinyl Anisidide; Amekrin; AMSA P-D; Amsidine; Amsidyl; M-AMSA; MAMSA; CHEBI:2687,2014-12-24,1,,,,,,,,,
29883-15-6,0,OMOP Exposome,Observation,Substance,Amygdalin,D-Amygdalin; D(-)-Mandelonitrile-\u03b2-D-gentiobioside; D(-)-Mandelonitrile-beta-D-gentiobioside; Amygdaloside; (-)-D-mandelonitrile beta-D-gentiobioside; (R)-laenitrile; (R)-amygdaloside; Mandelonitrile gentiobioside; NSC 15780; Mandelonitrile-\u03b2-gentiobioside; Glucoprunasin; D-Mandelonitrile-beta-D-glucosido-6-beta-D-glucoside; (R)-amygdalin; CHEBI:27613,2014-12-24,1,,,,,,,,,
P05067,0,OMOP Exposome,Observation,Substance,Amyloid beta A4 protein,,2024-09-14,1,,,,,,,,,
13078-04-1,0,OMOP Exposome,Observation,Substance,Anabasine,S-(-)-Anabasine; Neonikotin; Anabazin; Anabasin; 3-(2-Piperidinyl)pyridine; 2-(3'-Pyridyl) piperidine; (S)-3-(2-Piperidinyl)pyridine; (-)-Anabasine; (-)-2-(3'-Pyridyl)piperidine; Neonicotine; (+/-)-Anabasine; (+-)-Anabasine; L-3-(2'-Piperidyl)pyridine; DL-Anabasine; 2-(3-Pyridinyl)piperidine; CHEBI:28986,2014-12-24,1,,,,,,,,,
GIS1003463,0,OMOP Exposome,Observation,Substance,Anabolic Agent,,2024-09-14,1,,,,,,,,,
GIS1003464,0,OMOP Exposome,Observation,Substance,Analgesic,,2024-09-14,1,,,,,,,,,
120511-73-1,0,OMOP Exposome,Observation,Substance,Anastrozole,"alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; Arimidex; Anastrozol; Anastrole; CHEBI:2704",2014-12-24,1,,,,,,,,,
64285-06-9,0,OMOP Exposome,Observation,Substance,Anatoxin a,,2014-12-24,1,,,,,,,,,
103170-78-1,0,OMOP Exposome,Observation,Substance,Anatoxin-a(s),,2014-12-24,1,,,,,,,,,
GIS1003548,0,OMOP Exposome,Observation,Substance,Androgen,,2024-09-14,1,,,,,,,,,
GIS1003553,0,OMOP Exposome,Observation,Substance,Androgen and Estrogen Metabolism,,2024-09-14,1,,,,,,,,,
GIS1003554,0,OMOP Exposome,Observation,Substance,Androgen Antagonist,,2024-09-14,1,,,,,,,,,
P10275,0,OMOP Exposome,Observation,Substance,Androgen receptor,,2024-09-14,1,,,,,,,,,
63-05-8,0,OMOP Exposome,Observation,Substance,Androstenedione,"Androst-4-ene-3,17-dione; Fecundin; Delta4-androstenedione; D4-Androstene-3,17-dione; 4-Androstenedione; Androstendione; 4-14Candrost-4-ene-3,17-dione; (4)-Androsten-3,17-dione; 17-Ketotestosterone; 3,17-Dioxoandrost-4-ene; 4-Androsten-3,17-dione; 4-Androstene-3,17-dione; 4-14C-androstenedione; CHEBI:16422",2014-12-24,1,,,,,,,,,
GIS1003555,0,OMOP Exposome,Observation,Substance,Anesthetic,,2024-09-14,1,,,,,,,,,
523-50-2,0,OMOP Exposome,Observation,Substance,Angelicin,"2H-Furo2,3-H-1-benzopyran-2-one; Isopsoralin; Isopsoralen; Furo5',4':7,8coumarin; Furo2,3-hcoumarin; Bakuchicin; 4-Hydroxy-5-benzofuranacrylic acid gamma-lactone; 2H-Furo2,3-Hchromen-2-one; 3-(4-Hydroxy-5-benzofuranyl)-2-propenoic acid gamma-lactone; Angelecin; Angecin; CHEBI:28928",2014-12-24,1,,,,,,,,,
GIS1003601,0,OMOP Exposome,Observation,Substance,Angiogenesis Inhibitor,,2024-09-14,1,,,,,,,,,
P03950,0,OMOP Exposome,Observation,Substance,Angiogenin,,2024-09-14,1,,,,,,,,,
Q02763,0,OMOP Exposome,Observation,Substance,Angiopoietin-1 receptor,,2024-09-14,1,,,,,,,,,
P12821,0,OMOP Exposome,Observation,Substance,Angiotensin-converting enzyme,,2024-09-14,1,,,,,,,,,
GIS1003602,0,OMOP Exposome,Observation,Substance,Angiotensin-Converting Enzyme Inhibitor,,2024-09-14,1,,,,,,,,,
166663-25-8,0,OMOP Exposome,Observation,Substance,Anidulafungin,"(4R,5R)-4,5-Dihydroxy-N\u00b2-4''-(pentyloxy)-p-terphenyl-4-ylcarbonyl-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6->1)-peptide; V-Echinocandin; Eraxis; Ecalta; Anidulafunginum; Anidulafungine; Anidulafungina; CHEBI:55346",2014-12-24,1,,,,,,,,,
101-05-3,0,OMOP Exposome,Observation,Substance,Anilazine,Dyrene; CHEBI:82076,2014-12-24,1,,,,,,,,,
144-14-9,0,OMOP Exposome,Observation,Substance,Anileridine,Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate; Sulfathalidine; 1-2-(4-Aminophenyl)ethyl-4-phenyl-4-piperidinecarboxlic acid ethyl ester; Anileridina; Anileridinum; Apodol; Phthalylsulfathiazole; ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate; Ethyl 1-(P-aminophenethyl)-4-phenylisonipecotate; Leritine; N-\u03b2-(p-aminophenyl)ethylnormeperidine; N-beta-(P-Aminophenyl)ethylnormeperidine; N-(beta-(P-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine; CHEBI:61203,2014-12-24,1,,,,,,,,,
62-53-3,0,OMOP Exposome,Observation,Substance,Aniline,"Aniline oil; Anilina; Anilin; Aminophen; Aminobenzene; Anyvim; Arylamine; Benzamine; Benzenamine; Benzene, amino; Benzene,amino (aniline); Benzeneamine; Benzidam; BIDD:ER0581; Blue oil; C.I. Oxidation base 1; CI Oxidation Base 1; Cyanol; D'Aniline; HSDB 43; Huile d'aniline; Krystallin; Kyanol; nchembio.257-comp9; Phenylamine; Phenyleneamine; Anilinum; Aniline, acs; Aniline(S#299)-Liq; Aniline reagent; Aniline oil, phenylamine; Aniline hydrobromide; CHEBI:17296",2014-12-24,1,,,,,,,,,
GIS1003620,0,OMOP Exposome,Observation,Substance,Animal Toxin,,2024-09-14,1,,,,,,,,,
5230-87-5,0,OMOP Exposome,Observation,Substance,Anisatin,,2014-12-24,1,,,,,,,,,
P04083,0,OMOP Exposome,Observation,Substance,Annexin A1,,2024-09-14,1,,,,,,,,,
P12429,0,OMOP Exposome,Observation,Substance,Annexin A3,,2024-09-14,1,,,,,,,,,
P08758,0,OMOP Exposome,Observation,Substance,Annexin A5,,2024-09-14,1,,,,,,,,,
GIS1003621,0,OMOP Exposome,Observation,Substance,Anorexigenic Agent,,2024-09-14,1,,,,,,,,,
191-26-4,0,OMOP Exposome,Observation,Substance,Anthanthrene,,2014-12-24,1,,,,,,,,,
GIS1003622,0,OMOP Exposome,Observation,Substance,Anthelmintic,,2024-09-14,1,,,,,,,,,
77536-67-5,0,OMOP Exposome,Observation,Substance,Anthophyllite Asbestos,,2014-12-24,1,,,,,,,,,
600880-63-9,0,OMOP Exposome,Observation,Substance,Anthopleurin (Anthopleura xanthogrammica),,2014-12-24,1,,,,,,,,,
120-12-7,0,OMOP Exposome,Observation,Substance,Anthracene,Paranaphthalene; p-naphthalene; Green oil; Coal tar pitch volatiles:anthracene; Bis-alkylamino anthracene; Anthraxcene; Anthracene oil; Sterilite hop defoliant; Polyacenes; CHEBI:35298,2014-12-24,1,,,,,,,,,
GIS1003644,0,OMOP Exposome,Observation,Substance,Anti-Acne Preparation,,2024-09-14,1,,,,,,,,,
GIS1003645,0,OMOP Exposome,Observation,Substance,Anti-Allergic Agent,,2024-09-14,1,,,,,,,,,
GIS1003646,0,OMOP Exposome,Observation,Substance,Anti-Anemic Agent,,2024-09-14,1,,,,,,,,,
GIS1003647,0,OMOP Exposome,Observation,Substance,Anti-Anxiety Agent,,2024-09-14,1,,,,,,,,,
GIS1003648,0,OMOP Exposome,Observation,Substance,Anti-Arrhythmia Agent,,2024-09-14,1,,,,,,,,,
GIS1003650,0,OMOP Exposome,Observation,Substance,Anti-Bacterial Agent,,2024-09-14,1,,,,,,,,,
GIS1003923,0,OMOP Exposome,Observation,Substance,Anti-Craving Agent,,2024-09-14,1,,,,,,,,,
GIS1004106,0,OMOP Exposome,Observation,Substance,Anti-Dyskinesia Agent,,2024-09-14,1,,,,,,,,,
GIS1004128,0,OMOP Exposome,Observation,Substance,Anti-HIV Agent,,2024-09-14,1,,,,,,,,,
GIS1004177,0,OMOP Exposome,Observation,Substance,Anti-Infective Agent,,2024-09-14,1,,,,,,,,,
GIS1004413,0,OMOP Exposome,Observation,Substance,Anti-Inflammatory Agent,,2024-09-14,1,,,,,,,,,
GIS1004465,0,OMOP Exposome,Observation,Substance,Anti-Menopausal Agent,,2024-09-14,1,,,,,,,,,
GIS1004487,0,OMOP Exposome,Observation,Substance,Anti-Migraine Agent,,2024-09-14,1,,,,,,,,,
Q16671,0,OMOP Exposome,Observation,Substance,Anti-Muellerian hormone type-2 receptor,,2024-09-14,1,,,,,,,,,
GIS1006512,0,OMOP Exposome,Observation,Substance,Anti-Obesity Agent,,2024-09-14,1,,,,,,,,,
GIS1007082,0,OMOP Exposome,Observation,Substance,Anti-Ulcer Agent,,2024-09-14,1,,,,,,,,,
GIS1007163,0,OMOP Exposome,Observation,Substance,Anti-Wrinkle Agent,,2024-09-14,1,,,,,,,,,
GIS1003649,0,OMOP Exposome,Observation,Substance,Antiarrhythmic Drugs,,2024-09-14,1,,,,,,,,,
GIS1003651,0,OMOP Exposome,Observation,Substance,Antibiotic,,2024-09-14,1,,,,,,,,,
GIS1003873,0,OMOP Exposome,Observation,Substance,Anticancer Agent,,2024-09-14,1,,,,,,,,,
GIS1003874,0,OMOP Exposome,Observation,Substance,Anticestodal Agent,,2024-09-14,1,,,,,,,,,
GIS1003875,0,OMOP Exposome,Observation,Substance,Anticholesteremic Agent,,2024-09-14,1,,,,,,,,,
GIS1003876,0,OMOP Exposome,Observation,Substance,Anticoagulant,,2024-09-14,1,,,,,,,,,
GIS1003877,0,OMOP Exposome,Observation,Substance,Anticonvulsant,,2024-09-14,1,,,,,,,,,
GIS1003922,0,OMOP Exposome,Observation,Substance,Anticonvulsants,,2024-09-14,1,,,,,,,,,
GIS1003924,0,OMOP Exposome,Observation,Substance,Antidepressant,,2024-09-14,1,,,,,,,,,
GIS1003984,0,OMOP Exposome,Observation,Substance,Antidepressive Agent,,2024-09-14,1,,,,,,,,,
GIS1003985,0,OMOP Exposome,Observation,Substance,Antidiabetic Agent,,2024-09-14,1,,,,,,,,,
GIS1004065,0,OMOP Exposome,Observation,Substance,Antidiabetics,,2024-09-14,1,,,,,,,,,
GIS1004066,0,OMOP Exposome,Observation,Substance,Antidiarrheal,,2024-09-14,1,,,,,,,,,
GIS1004067,0,OMOP Exposome,Observation,Substance,Antidote,,2024-09-14,1,,,,,,,,,
GIS1004107,0,OMOP Exposome,Observation,Substance,Antidyskinetic,,2024-09-14,1,,,,,,,,,
GIS1004108,0,OMOP Exposome,Observation,Substance,Antidystonic Agent,,2024-09-14,1,,,,,,,,,
GIS1004109,0,OMOP Exposome,Observation,Substance,Antiemetic,,2024-09-14,1,,,,,,,,,
GIS1004118,0,OMOP Exposome,Observation,Substance,Antiendometriotic Agent,,2024-09-14,1,,,,,,,,,
GIS1004119,0,OMOP Exposome,Observation,Substance,Antiepileptic Agent,,2024-09-14,1,,,,,,,,,
GIS1004120,0,OMOP Exposome,Observation,Substance,Antifibrinolytic Agent,,2024-09-14,1,,,,,,,,,
GIS1004121,0,OMOP Exposome,Observation,Substance,Antifungal Agent,,2024-09-14,1,,,,,,,,,
GIS1004125,0,OMOP Exposome,Observation,Substance,Antifungal Agents,,2024-09-14,1,,,,,,,,,
GIS1004126,0,OMOP Exposome,Observation,Substance,Antigen Processing And Presentation,,2024-09-14,1,,,,,,,,,
GIS1004127,0,OMOP Exposome,Observation,Substance,Antihistamine Derivative,,2024-09-14,1,,,,,,,,,
GIS1004129,0,OMOP Exposome,Observation,Substance,Antihypertensive Agent,,2024-09-14,1,,,,,,,,,
GIS1004175,0,OMOP Exposome,Observation,Substance,Antihypocalcemic Agent,,2024-09-14,1,,,,,,,,,
GIS1004176,0,OMOP Exposome,Observation,Substance,Antihypoparathyroid Agent,,2024-09-14,1,,,,,,,,,
GIS1004440,0,OMOP Exposome,Observation,Substance,Antilipemic Agent,,2024-09-14,1,,,,,,,,,
GIS1004449,0,OMOP Exposome,Observation,Substance,Antimalarial,,2024-09-14,1,,,,,,,,,
GIS1004464,0,OMOP Exposome,Observation,Substance,Antimanic Agent,,2024-09-14,1,,,,,,,,,
GIS1004466,0,OMOP Exposome,Observation,Substance,Antimetabolite,,2024-09-14,1,,,,,,,,,
GIS1004488,0,OMOP Exposome,Observation,Substance,Antimitotic Agent,,2024-09-14,1,,,,,,,,,
7440-36-0,0,OMOP Exposome,Observation,Substance,Antimony,Sb(5+); Sb(3+); Sb; Antimony(V); Antimony (3+) ion; Antimony (5+) ion; Antimony black; Antimony cation; Antimony element; Antimony ion; Antimony(II); Sb(V); Sb(III); Stibium; CHEBI:49867,2014-12-24,1,,,,,,,,,
3643-76-3,0,OMOP Exposome,Observation,Substance,Antimony acetate,,2014-12-24,1,,,,,,,,,
GIS1004489,0,OMOP Exposome,Observation,Substance,Antimony Compound,,2024-09-14,1,,,,,,,,,
12067-17-3,0,OMOP Exposome,Observation,Substance,Antimony monosulfide,,2014-12-24,1,,,,,,,,,
7647-18-9,0,OMOP Exposome,Observation,Substance,Antimony pentachloride,,2014-12-24,1,,,,,,,,,
1315-04-4,0,OMOP Exposome,Observation,Substance,Antimony pentasulfide,,2014-12-24,1,,,,,,,,,
1314-60-9,0,OMOP Exposome,Observation,Substance,Antimony pentoxide,,2014-12-24,1,,,,,,,,,
28300-74-5,0,OMOP Exposome,Observation,Substance,Antimony potassium tartrate,Dipotassium bis{mu-2-(hydroxy-1kappao)-3-(hydroxy-2kappao)succinato(4-)-1kappao(4):2kappao(4)}diantimonate(2-) trihydrate; Antimony potassium tartric acid; CHEBI:2761,2014-12-24,1,,,,,,,,,
12597-17-0,0,OMOP Exposome,Observation,Substance,Antimony tetramer,,2014-12-24,1,,,,,,,,,
7789-61-9,0,OMOP Exposome,Observation,Substance,Antimony tribromide,,2014-12-24,1,,,,,,,,,
10025-91-9,0,OMOP Exposome,Observation,Substance,Antimony trichloride,,2014-12-24,1,,,,,,,,,
1309-64-4,0,OMOP Exposome,Observation,Substance,Antimony trioxide,,2014-12-24,1,,,,,,,,,
1315-05-5,0,OMOP Exposome,Observation,Substance,Antimony triselenide,,2014-12-24,1,,,,,,,,,
1345-04-6,0,OMOP Exposome,Observation,Substance,Antimony trisulfide,,2014-12-24,1,,,,,,,,,
10433-06-4,0,OMOP Exposome,Observation,Substance,Antimony(III) ethoxide,,2014-12-24,1,,,,,,,,,
18770-47-3,0,OMOP Exposome,Observation,Substance,Antimony(III) isopropoxide,,2014-12-24,1,,,,,,,,,
GIS1004490,0,OMOP Exposome,Observation,Substance,Antimuscarinic,,2024-09-14,1,,,,,,,,,
GIS1004491,0,OMOP Exposome,Observation,Substance,Antimyasthenic Agent,,2024-09-14,1,,,,,,,,,
GIS1004492,0,OMOP Exposome,Observation,Substance,Antimycobacterial,,2024-09-14,1,,,,,,,,,
GIS1004516,0,OMOP Exposome,Observation,Substance,Antineoplastic,,2024-09-14,1,,,,,,,,,
GIS1004517,0,OMOP Exposome,Observation,Substance,Antineoplastic Agent,,2024-09-14,1,,,,,,,,,
GIS1006513,0,OMOP Exposome,Observation,Substance,Antioxidant,,2024-09-14,1,,,,,,,,,
GIS1006514,0,OMOP Exposome,Observation,Substance,Antiparasitic Agent,,2024-09-14,1,,,,,,,,,
GIS1006515,0,OMOP Exposome,Observation,Substance,Antiparkinson Agent,,2024-09-14,1,,,,,,,,,
GIS1006549,0,OMOP Exposome,Observation,Substance,Antiperistaltic Agent,,2024-09-14,1,,,,,,,,,
GIS1006550,0,OMOP Exposome,Observation,Substance,Antiprotozoal Agent,,2024-09-14,1,,,,,,,,,
GIS1006596,0,OMOP Exposome,Observation,Substance,Antipruritic,,2024-09-14,1,,,,,,,,,
GIS1006597,0,OMOP Exposome,Observation,Substance,Antipsoriatic Agent,,2024-09-14,1,,,,,,,,,
GIS1006598,0,OMOP Exposome,Observation,Substance,Antipsychotic Agent,,2024-09-14,1,,,,,,,,,
GIS1006668,0,OMOP Exposome,Observation,Substance,Antipsychotics,,2024-09-14,1,,,,,,,,,
GIS1006669,0,OMOP Exposome,Observation,Substance,Antipyretic,,2024-09-14,1,,,,,,,,,
GIS1006987,0,OMOP Exposome,Observation,Substance,Antiresorptive,,2024-09-14,1,,,,,,,,,
GIS1006988,0,OMOP Exposome,Observation,Substance,Antirheumatic Agent,,2024-09-14,1,,,,,,,,,
GIS1006996,0,OMOP Exposome,Observation,Substance,Antiscabies Agent,,2024-09-14,1,,,,,,,,,
GIS1006997,0,OMOP Exposome,Observation,Substance,Antiseptic Agent,,2024-09-14,1,,,,,,,,,
GIS1007016,0,OMOP Exposome,Observation,Substance,Antisickling Agent,,2024-09-14,1,,,,,,,,,
GIS1007017,0,OMOP Exposome,Observation,Substance,Antispasmodic,,2024-09-14,1,,,,,,,,,
GIS1007018,0,OMOP Exposome,Observation,Substance,Antispasmodic Agent,,2024-09-14,1,,,,,,,,,
P01008,0,OMOP Exposome,Observation,Substance,Antithrombin-III,,2024-09-14,1,,,,,,,,,
GIS1007019,0,OMOP Exposome,Observation,Substance,Antithyroid Agent,,2024-09-14,1,,,,,,,,,
GIS1007027,0,OMOP Exposome,Observation,Substance,Antitubercular Agent,,2024-09-14,1,,,,,,,,,
GIS1007054,0,OMOP Exposome,Observation,Substance,Antituberculosis Agent,,2024-09-14,1,,,,,,,,,
GIS1007081,0,OMOP Exposome,Observation,Substance,Antitussive Agent,,2024-09-14,1,,,,,,,,,
GIS1007083,0,OMOP Exposome,Observation,Substance,Antiulcer Drugs,,2024-09-14,1,,,,,,,,,
GIS1007084,0,OMOP Exposome,Observation,Substance,Antiviral Agent,,2024-09-14,1,,,,,,,,,
GIS1007162,0,OMOP Exposome,Observation,Substance,Antiviral Agents,,2024-09-14,1,,,,,,,,,
Q96A70,0,OMOP Exposome,Observation,Substance,Antizyme inhibitor 2,,2024-09-14,1,,,,,,,,,
GIS1007164,0,OMOP Exposome,Observation,Substance,Anxiolytic,,2024-09-14,1,,,,,,,,,
GIS1007194,0,OMOP Exposome,Observation,Substance,Anxiolytics,,2024-09-14,1,,,,,,,,,
24345-16-2,0,OMOP Exposome,Observation,Substance,Apamin (Apis mellifera),,2014-12-24,1,,,,,,,,,
P35414,0,OMOP Exposome,Observation,Substance,Apelin receptor,,2024-09-14,1,,,,,,,,,
GIS1007195,0,OMOP Exposome,Observation,Substance,Apical Membrane,,2024-09-14,1,,,,,,,,,
520-36-5,0,OMOP Exposome,Observation,Substance,Apigenin,"5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone; 4',5,7-Trihydroxy-Flavone; 4,5, 7-Trihydroxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; Apigenol; Chamomile; Spigenin; Versulin; CHEBI:18388",2014-12-24,1,,,,,,,,,
52659-57-1,0,OMOP Exposome,Observation,Substance,Aplysiatoxin,,2014-12-24,1,,,,,,,,,
P02647,0,OMOP Exposome,Observation,Substance,Apolipoprotein A-I,,2024-09-14,1,,,,,,,,,
P04114,0,OMOP Exposome,Observation,Substance,Apolipoprotein B-100,,2024-09-14,1,,,,,,,,,
BE0005853,0,OMOP Exposome,Observation,Substance,Apolipoprotein C,,2024-09-14,1,,,,,,,,,
P02654,0,OMOP Exposome,Observation,Substance,Apolipoprotein C-I,,2024-09-14,1,,,,,,,,,
P02655,0,OMOP Exposome,Observation,Substance,Apolipoprotein C-II,,2024-09-14,1,,,,,,,,,
P02656,0,OMOP Exposome,Observation,Substance,Apolipoprotein C-III,,2024-09-14,1,,,,,,,,,
P55056,0,OMOP Exposome,Observation,Substance,Apolipoprotein C-IV,,2024-09-14,1,,,,,,,,,
P05090,0,OMOP Exposome,Observation,Substance,Apolipoprotein D,,2024-09-14,1,,,,,,,,,
P02649,0,OMOP Exposome,Observation,Substance,Apolipoprotein E,,2024-09-14,1,,,,,,,,,
41372-20-7,0,OMOP Exposome,Observation,Substance,Apomorphine,"Uprima; VR-040; R-(-)-Apomorphine; L-Apomorphine; VR-400; VR004; Apomorphine Hydrochloride Hemihydrate; Apomorphin; Apomorfin; (-)-10,11-Dihydroxyaporphine; (6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzode,gquinoline-10,11-diol; (R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzode,gquinoline-10,11-diol; (\u2212)-10,11-dihydroxyaporphine; Apomorphinium Chloride Hemihydrate; Ixense; Apormorphine; Apokyn; Spontane; R-(\u2212)-apomorphine; CHEBI:48538",2014-12-24,1,,,,,,,,,
GIS1007196,0,OMOP Exposome,Observation,Substance,Apoptosis,,2024-09-14,1,,,,,,,,,
P10415,0,OMOP Exposome,Observation,Substance,Apoptosis regulator Bcl-2,,2024-09-14,1,,,,,,,,,
O15304,0,OMOP Exposome,Observation,Substance,Apoptosis regulatory protein Siva,,2024-09-14,1,,,,,,,,,
O14727,0,OMOP Exposome,Observation,Substance,Apoptotic protease-activating factor 1,,2024-09-14,1,,,,,,,,,
GIS1007197,0,OMOP Exposome,Observation,Substance,Appetite Depressant,,2024-09-14,1,,,,,,,,,
P29972,0,OMOP Exposome,Observation,Substance,Aquaporin-1,,2024-09-14,1,,,,,,,,,
Q96PS8,0,OMOP Exposome,Observation,Substance,Aquaporin-10,,2024-09-14,1,,,,,,,,,
Q8NBQ7,0,OMOP Exposome,Observation,Substance,Aquaporin-11,,2024-09-14,1,,,,,,,,,
Q8IXF9,0,OMOP Exposome,Observation,Substance,Aquaporin-12A,,2024-09-14,1,,,,,,,,,
A6NM10,0,OMOP Exposome,Observation,Substance,Aquaporin-12B,,2024-09-14,1,,,,,,,,,
P41181,0,OMOP Exposome,Observation,Substance,Aquaporin-2,,2024-09-14,1,,,,,,,,,
Q92482,0,OMOP Exposome,Observation,Substance,Aquaporin-3,,2024-09-14,1,,,,,,,,,
P55087,0,OMOP Exposome,Observation,Substance,Aquaporin-4,,2024-09-14,1,,,,,,,,,
P55064,0,OMOP Exposome,Observation,Substance,Aquaporin-5,,2024-09-14,1,,,,,,,,,
Q13520,0,OMOP Exposome,Observation,Substance,Aquaporin-6,,2024-09-14,1,,,,,,,,,
O14520,0,OMOP Exposome,Observation,Substance,Aquaporin-7,,2024-09-14,1,,,,,,,,,
O94778,0,OMOP Exposome,Observation,Substance,Aquaporin-8,,2024-09-14,1,,,,,,,,,
O43315,0,OMOP Exposome,Observation,Substance,Aquaporin-9,,2024-09-14,1,,,,,,,,,
P18054,0,OMOP Exposome,Observation,Substance,"Arachidonate 12-lipoxygenase, 12S-type",,2024-09-14,1,,,,,,,,,
P16050,0,OMOP Exposome,Observation,Substance,Arachidonate 15-lipoxygenase,,2024-09-14,1,,,,,,,,,
P09917,0,OMOP Exposome,Observation,Substance,Arachidonate 5-lipoxygenase,,2024-09-14,1,,,,,,,,,
P20292,0,OMOP Exposome,Observation,Substance,Arachidonate 5-lipoxygenase-activating protein,,2024-09-14,1,,,,,,,,,
GIS1007198,0,OMOP Exposome,Observation,Substance,Arachidonic Acid Metabolism,,2024-09-14,1,,,,,,,,,
63-75-2,0,OMOP Exposome,Observation,Substance,Arecoline,"Arecaidine methyl ester; 1,2,5,6-Tetrahydro-1-methylnicotinic acid, methyl ester; N-Methyltetrahydronicotinic acid, methyl ester; Methyl N-methyl-1,2,5, 6-tetrahydronicotinate; Methyl 1-methyl-5,6-dihydro-2H-pyridine-3-carboxylate; Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate; Methyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate; Methyl 1,2,5,6-tetrahydro-1-methylnicotinate; Methyl 1,2,5, 6-tetrahydro-1-methylnicotinate; Arekolin; Arecoline hydrobromide; Arecoline base; Arecolin; Arecholine; Arecholin; Arecaline; Nicotinic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester; Methyl N-methyl-1,2,5,6-tetrahydronicotinate; N-Methyl-beta -carboxylic acid methyl ester; Methylarecaidin; Methylarecaiden; Methyl N-methyltetrahydronicotinate; CHEBI:101022",2014-12-24,1,,,,,,,,,
464-74-4,0,OMOP Exposome,Observation,Substance,Arenobufagin,,2014-12-24,1,,,,,,,,,
P05089,0,OMOP Exposome,Observation,Substance,Arginase-1,,2024-09-14,1,,,,,,,,,
P78540,0,OMOP Exposome,Observation,Substance,"Arginase-2, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1007199,0,OMOP Exposome,Observation,Substance,Arginine and Proline Metabolism,,2024-09-14,1,,,,,,,,,
BE0000448,0,OMOP Exposome,Observation,Substance,Arginine decarboxylase,,2024-09-14,1,,,,,,,,,
GIS1007200,0,OMOP Exposome,Observation,Substance,Argininemia,,2024-09-14,1,,,,,,,,,
157-07-3,0,OMOP Exposome,Observation,Substance,Argininic acid,,2014-12-24,1,,,,,,,,,
P04424,0,OMOP Exposome,Observation,Substance,Argininosuccinate lyase,,2024-09-14,1,,,,,,,,,
P00966,0,OMOP Exposome,Observation,Substance,Argininosuccinate synthase,,2024-09-14,1,,,,,,,,,
Q5T6L4,0,OMOP Exposome,Observation,Substance,"Argininosuccinate synthetase, isoform CRA_a",,2024-09-14,1,,,,,,,,,
2387-71-5,0,OMOP Exposome,Observation,Substance,Argininosuccinic acid,2-(N(Omega)-L-arginine)succinate; 2-(N(Omega)-L-arginine)succinic acid; 2-(N(Omega)-L-arginino)succinate; N-(4-Amino-4-carboxybutyl)aminoiminomethyl-L-Aspartic acid; N-(4-Amino-4-carboxybutyl)aminoiminomethyl-L-Aspartate; N-(4-Amino-4-carboxybutyl)amidino-L-Aspartic acid; N-(4-Amino-4-carboxybutyl)amidino-L-Aspartate; N-(L-Arginino)succinic acid; N-(L-Arginino)succinate; N-(L-Arginino) succinic acid; N-(L-Arginino) succinate; N-(((4-Amino-4-carboxybutyl)amino)iminomethyl)-L-Aspartic acid; N-(((4-Amino-4-carboxybutyl)amino)iminomethyl)-L-Aspartate; N(Omega)-(L-arginino)succinic acid; N(Omega)-(L-arginino)succinate; L-Arginosuccinic acid; L-Arginosuccinate; L-Argininosuccinic acid; L-Argininosuccinate; ASA; Arginosuccinic acid; Arginosuccinate; Argininosuccinate; 2-(Nw-L-arginino)butanedioic acid; 2-(Nw-L-arginino)butanedioate; 2-(N(Omega)-L-arginino)succinic acid; CHEBI:15682,2014-12-24,1,,,,,,,,,
GIS1007201,0,OMOP Exposome,Observation,Substance,Argininosuccinic Aciduria,,2024-09-14,1,,,,,,,,,
129722-12-9,0,OMOP Exposome,Observation,Substance,Aripiprazole,Aripiprazol; Abilitat; OPC 31; Abilify; Aripiprazolum; CHEBI:31236,2014-12-24,1,,,,,,,,,
313-67-7,0,OMOP Exposome,Observation,Substance,Aristolochic acid,"Aristolochate; Aristolochic acid a; 3,4-Methylenedioxy-8-methoxy-10-nitro-1-phenanthrenecarboxylic acid; Aristolochin; 8-Methoxy-6-nitrophenanthol (3,4-D) 1,3-dioxole-5-carboxylic acid; Aristolochic acid-i; CHEBI:CHEBI:2825",2014-12-24,1,,,,,,,,,
167114-89-8,0,OMOP Exposome,Observation,Substance,Arisugacin A,,2014-12-24,1,,,,,,,,,
12674-11-2,0,OMOP Exposome,Observation,Substance,Aroclor 1016,,2014-12-24,1,,,,,,,,,
11104-28-2,0,OMOP Exposome,Observation,Substance,Aroclor 1221,,2014-12-24,1,,,,,,,,,
12672-29-6,0,OMOP Exposome,Observation,Substance,Aroclor 1248,"3,3',5,5'-Tetrachloro-Biphenyl; 3,3',5, 5'-Tetrachlorodiphenyl; 3,3',5,5'-Tetrachloro-1,1'-Biphenyl; 3,3',5,5'-Tetrachlorodiphenyl; 3,5,3',5'-Tetrachlorobiphenyl; Kanechlor 400; Kaneclor 400; CHEBI:35445",2014-12-24,1,,,,,,,,,
11097-69-1,0,OMOP Exposome,Observation,Substance,Aroclor 1254,,2014-12-24,1,,,,,,,,,
11096-82-5,0,OMOP Exposome,Observation,Substance,Aroclor 1260,,2014-12-24,1,,,,,,,,,
P11511,0,OMOP Exposome,Observation,Substance,Aromatase,,2024-09-14,1,,,,,,,,,
GIS1007202,0,OMOP Exposome,Observation,Substance,Aromatase deficiency,,2024-09-14,1,,,,,,,,,
GIS1007203,0,OMOP Exposome,Observation,Substance,Aromatase Inhibitor,,2024-09-14,1,,,,,,,,,
GIS1007209,0,OMOP Exposome,Observation,Substance,Aromatic Hydrocarbon,,2024-09-14,1,,,,,,,,,
GIS1007210,0,OMOP Exposome,Observation,Substance,Aromatic L-Aminoacid Decarboxylase Deficiency,,2024-09-14,1,,,,,,,,,
P20711,0,OMOP Exposome,Observation,Substance,Aromatic-L-amino-acid decarboxylase,,2024-09-14,1,,,,,,,,,
289-31-6,0,OMOP Exposome,Observation,Substance,Arsabenzene,,2014-12-24,1,,,,,,,,,
98-50-0,0,OMOP Exposome,Observation,Substance,Arsanilic acid,(4-Aminophenyl)arsonic acid; (p-Aminophenyl)arsonic acid; 4-Aminobenzenearsonic acid; 4-aminophenylarsonic acid; 4-Arsanilic acid; Aminophenylarsine acid; Antoxylic acid; Arsanilate; Atoxylic acid; o-Aminobenzenearsonic acid; o-Arsanilic acid; p-Aminobenzenearsonic acid; p-Aminophenylarsine acid; p-Aminophenylarsonic acid; p-Anilinearsonic acid; p-Arsanilic acid; Pro-gen; Pro-Gen 227 Premix; Progen 90; R-sonic; CHEBI:49477,2014-12-24,1,,,,,,,,,
531-72-6,0,OMOP Exposome,Observation,Substance,Arsenamide,4-Carbamylphenyl biscarboxymethylthioarsenite; Thioarsenite; Thiacetarsamidum; Thiacetarsamide; P-(bis(carboxymethylmercapto)arsino)benzamide; Dithioglycolyl p-arsenobenzamide; Caparsolate; Capariside; Bis(carboxymethylmercapto)(p-carbamylphenyl)-arsine; 4-Carbamylphenyl bis(carboxymethylthio)arsenite; CHEBI:25520,2014-12-24,1,,,,,,,,,
15584-04-00,0,OMOP Exposome,Observation,Substance,Arsenate,Arsenate(3-); Tetraoxoarsenate(3-); Arsorate; Arsenic acid; ART; Tetraoxidoarsenate(3-); Arsenate ion; Tetraoxoarsenate(V); CHEBI:18231,2014-12-24,1,,,,,,,,,
7440-38-2,0,OMOP Exposome,Observation,Substance,Arsenic,As; Arsenic(III); Arsenic(3+) ion; Arsenic(3+); Arsenic ion; As3+; As(3+); Arsenic(III) cation; CHEBI:35828,2014-12-24,1,,,,,,,,,
GIS1007211,0,OMOP Exposome,Observation,Substance,Arsenic Compound,,2024-09-14,1,,,,,,,,,
1303-32-8,0,OMOP Exposome,Observation,Substance,Arsenic disulfide,,2014-12-24,1,,,,,,,,,
22441-45-8,0,OMOP Exposome,Observation,Substance,Arsenic pentachloride,,2014-12-24,1,,,,,,,,,
7784-36-3,0,OMOP Exposome,Observation,Substance,Arsenic pentafluoride,AsF5; Pentafluoridoarsenic; AsF5; pentafluoro-lambda(5)-arsane; Arsenic pentfluoride; Pentafluoroarsorane; CHEBI:30530,2014-12-24,1,,,,,,,,,
1303-34-0,0,OMOP Exposome,Observation,Substance,Arsenic pentasulfide,,2014-12-24,1,,,,,,,,,
1303-28-2,0,OMOP Exposome,Observation,Substance,Arsenic pentoxide,,2014-12-24,1,,,,,,,,,
7784-33-0,0,OMOP Exposome,Observation,Substance,Arsenic tribromide,,2014-12-24,1,,,,,,,,,
7784-34-1,0,OMOP Exposome,Observation,Substance,Arsenic trichloride,Arsenous trichloride; Arsenous chloride; Arsenious chloride; Arsenic(III) trichloride; Arsenic(III) chloride; Fuming liquid arsenic; Trichloroarsine; Arsenic(3+) chloride; Butter of arsenic; Arsenic chloride; Arsenic butter; AsCl3; Arsenous-trichloride; Caustic arsenic chloride; Caustic oil of arsenic; CHEBI:63952,2014-12-24,1,,,,,,,,,
7784-35-2,0,OMOP Exposome,Observation,Substance,Arsenic trifluoride,,2014-12-24,1,,,,,,,,,
7784-45-4,0,OMOP Exposome,Observation,Substance,Arsenic triiodide,,2014-12-24,1,,,,,,,,,
1327-53-3,0,OMOP Exposome,Observation,Substance,Arsenic trioxide,Arsenious Trioxide; Arsentrioxide; Diarsenic trioxide; White arsenic; Arsenic sesquioxide; Arseneous anhydride; Arsenious acid; Areseneous oxide; Arsenic(III) oxide; CHEBI:30621,2014-12-24,1,,,,,,,,,
1303-36-2,0,OMOP Exposome,Observation,Substance,Arsenic triselenide,,2014-12-24,1,,,,,,,,,
1303-33-9,0,OMOP Exposome,Observation,Substance,Arsenic trisulfide,,2014-12-24,1,,,,,,,,,
64436-13-1,0,OMOP Exposome,Observation,Substance,Arsenobetaine,,2014-12-24,1,,,,,,,,,
39895-81-3,0,OMOP Exposome,Observation,Substance,Arsenocholine,,2014-12-24,1,,,,,,,,,
13464-58-9,0,OMOP Exposome,Observation,Substance,Arsenous acid,Arsenious acid; Arsenic trioxide; Arsenic oxide; Chem pels c; Chem-Sen 56; Penite; Prodalumnol; Prodalumnol double; Rat death liquid; Sodanit; Trihydroxyarsenite(III); As(OH)3; CHEBI:49900,2014-12-24,1,,,,,,,,,
7784-42-1,0,OMOP Exposome,Observation,Substance,Arsine,Hydrogen arsenide; Arsane; Trihydridoarsenic; AsH3; Arsenous hydride; Arseniuretted hydrogen; Arsenic trihydrie; CHEBI:47217,2014-12-24,1,,,,,,,,,
287-77-4,0,OMOP Exposome,Observation,Substance,Arsole,Arsacyclopentadiene; 1H-Arsole; Arsenole; 1H-Arsol; CHEBI:33131,2014-12-24,1,,,,,,,,,
GIS1007212,0,OMOP Exposome,Observation,Substance,Artery,,2024-09-14,1,,,,,,,,,
P35869,0,OMOP Exposome,Observation,Substance,Aryl hydrocarbon receptor,,2024-09-14,1,,,,,,,,,
P11245,0,OMOP Exposome,Observation,Substance,Arylamine N-acetyltransferase 2,,2024-09-14,1,,,,,,,,,
GIS1007213,0,OMOP Exposome,Observation,Substance,Ascorbate and aldarate metabolism,,2024-09-14,1,,,,,,,,,
137-66-6,0,OMOP Exposome,Observation,Substance,Ascorbyl palmitate,,2014-12-24,1,,,,,,,,,
P08243,0,OMOP Exposome,Observation,Substance,Asparagine synthetase [glutamine-hydrolyzing],,2024-09-14,1,,,,,,,,,
O43776,0,OMOP Exposome,Observation,Substance,"Asparagine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
Q2TU84,0,OMOP Exposome,Observation,Substance,Aspartate aminotransferase,,2024-09-14,1,,,,,,,,,
P17174,0,OMOP Exposome,Observation,Substance,"Aspartate aminotransferase, cytoplasmic",,2024-09-14,1,,,,,,,,,
P00505,0,OMOP Exposome,Observation,Substance,"Aspartate aminotransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1007214,0,OMOP Exposome,Observation,Substance,Aspartate Metabolism,,2024-09-14,1,,,,,,,,,
P45381,0,OMOP Exposome,Observation,Substance,Aspartoacylase,,2024-09-14,1,,,,,,,,,
Q9ULA0,0,OMOP Exposome,Observation,Substance,Aspartyl aminopeptidase,,2024-09-14,1,,,,,,,,,
Q12797,0,OMOP Exposome,Observation,Substance,Aspartyl/asparaginyl beta-hydroxylase,,2024-09-14,1,,,,,,,,,
50-78-2,0,OMOP Exposome,Observation,Substance,Aspirin,O-Acetoxybenzoate; \u00e1cido acetilsalic\u00edlico; O-(Acetyloxy)benzoate; Nu-seals; Entrophen; Endydol; Endosprin; O-(Acetyloxy)benzoic acid; O-Acetoxybenzoic acid; O-Acetylsalicylic acid; O-Carboxyphenyl acetate; Persistin; Pharmacin; Polopiryna; Premaspin; Rheumintabletten; Rhodine; Rhonal; Salcetogen; Saletin; Salicylic acid acetate; Salospir; Solprin; Solprin acid; Solpyron; St. Joseph Aspirin for Adults; Tasprin; Temperal; Toldex; Triaminicin; Empirin; Ecotrin; Ecolen; Easprin; Cardioaspirina; Caprin; Bufferin; Bialpirinia; Benaspir; Bayer Aspirin; Azetylsalizyls\u00e4ure; Azetylsalizylsaeure; Aspro; Aspirdrops; Aspergum; Asatard; ASA; Adiro; Acylpyrin; 2-(Acetyloxy)benzoate; 2-(Acetyloxy)benzoic acid; 2-Acetoxybenzenecarboxylic acid; 2-Acetoxybenzoate; 2-Acetoxybenzoic acid; 2-Carboxyphenyl acetate; Acenterine; Acetard; Aceticyl; Acetol; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acetylsalicylic acid; Acetylsalicylsaeure; Acetyonyl; Acetysal; Acetysalicylic acid; Acide 2-(acetyloxy)benzoique; Acide ac\u00e9tylsalicylique; Acidum acetylsalicylicum; CHEBI:15365,2014-12-24,1,,,,,,,,,
79663-49-3,0,OMOP Exposome,Observation,Substance,Asteltoxin,,2014-12-24,1,,,,,,,,,
68844-77-9,0,OMOP Exposome,Observation,Substance,Astemizole,Astemizolum; Ast\u00e9mizole; Astemizol; Hismanal; Astesen; Astemison; 1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole; Alerkin; 1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole; Acemiz; Stemiz; Lergibrumizol; Histalong; CHEBI:2896,2014-12-24,1,,,,,,,,,
3337-71-1,0,OMOP Exposome,Observation,Substance,Asulam,,2014-12-24,1,,,,,,,,,
2302-17-2,0,OMOP Exposome,Observation,Substance,"Asulam, sodium salt",,2014-12-24,1,,,,,,,,,
30315-93-6,0,OMOP Exposome,Observation,Substance,Asymmetric dimethylarginine,"N(5)-((Dimethylamino)iminomethyl)-L-ornithine; N(g),N(g)-dimethylarginine; Nomega,Nomega'-Dimethyl-L-arginine; NG-dimethylarginine; N(g),N(g)-dimethyl-l-arginine; N(5)-(dimethylamino)(imino)methyl-L-ornithine; Dimethyl-L-arginine; ADMA; 2-Amino-5-(amino-dimethylamino-methylidene)amino-pentanoic acid; 2-Amino-5-(amino-dimethylamino-methylidene)amino-pentanoate; NG,NG-Dimethyl-L-arginine; N(Omega),N(omega)-dimethyl-L-arginine; Guanidino-n,n-dimethylarginine; N(G1),N(G1)-Dimethylarginine; NG,NG-dimethylarginine; N(g)-dimethylarginine; CHEBI:17929",2014-12-24,1,,,,,,,,,
29122-68-7,0,OMOP Exposome,Observation,Substance,Atenolol,Ibinolo; Hypoten; Hipres; Felo-Bits; Farnormin; Evitocor; Duratenol; Duraatenolol; Cuxanorm; Corotenol; Cardiopress; Cardaxen; Blokium; Blocotenol; Betatop Ge; Atenblock; Ormidol; Vascoten; Vericordin; Uniloc; Unibloc; Tredol; Tensimin; Tenormine; Tenormin; Tenoretic; Tenoprin; Tenolol; Tenoblock; Tenobloc; Tenidon; Stermin; Servitenol; Serten; Selobloc; Seles beta; Scheinpharm Atenol; Prinorm; Prenormine; Prenolol; Premorine; Plenacor; Panapres; Oraday; Noten; Normiten; Normalol; Myocord; Lotenal; Loten; Lo-ten; Juvental; Jenatenol; Internolol; Atehexal; Atecard; Atcardil; Apo-Atenolol; Antipressan; Anselol; Altol; Wesipin; Alinor; Xaten; Aircrit; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; Betasyn; Betacard; Betablok; Aterol; Atereal; Atenomel; Atenololum; Atenolin; Atenol-Wolff; Atenol-ratiopharm; Atenol-Mepha; Atenol von ct; Atenol Trom; Atenol Tika; Atenol Stada; Atenol Quesada; Atenol PB; Atenol Nordic; Atenol NM Pharma; Atenol MSD; Atenol Heumann; Atenol GNR; Atenol Genericon; Atenol Gador; Atenol Fecofar; Atenol ct; Atenol Cophar; Atenol Atid; Atenol AL; Atenol acis; Atenol 1A pharma; Atenil; Ateni; Atenet; Atendol; CHEBI:2904,2014-12-24,1,,,,,,,,,
82248-59-7,0,OMOP Exposome,Observation,Substance,Atomoxetine,Attentin; Tomoxetinum; Strattera; Tomoxetin; Tomoxetine; Tomoxetina; (-)-Tomoxetine; CHEBI:127342,2014-12-24,1,,,,,,,,,
134523-00-5,0,OMOP Exposome,Observation,Substance,Atorvastatin,Atorvastatin calcium; Atorvastatin acid; Atogal; Lipovastatinklonal; Tulip; Xanator; Xarator; Zurinel; Totalip; Torvast; Torvacard; Sortis; Sincol; Normalip; Lowden; Liprimar; Vastina; Lipotropic; Lipitor; Hipolixan; Faboxim; Cardyl; CHEBI:2910,2014-12-24,1,,,,,,,,,
P25705,0,OMOP Exposome,Observation,Substance,"ATP synthase subunit alpha, mitochondrial",,2024-09-14,1,,,,,,,,,
P06576,0,OMOP Exposome,Observation,Substance,"ATP synthase subunit beta, mitochondrial",,2024-09-14,1,,,,,,,,,
P30049,0,OMOP Exposome,Observation,Substance,"ATP synthase subunit delta, mitochondrial",,2024-09-14,1,,,,,,,,,
P36542,0,OMOP Exposome,Observation,Substance,"ATP synthase subunit gamma, mitochondrial",,2024-09-14,1,,,,,,,,,
O95477,0,OMOP Exposome,Observation,Substance,ATP-binding cassette sub-family A member 1,,2024-09-14,1,,,,,,,,,
Q09428,0,OMOP Exposome,Observation,Substance,ATP-binding cassette sub-family C member 8,,2024-09-14,1,,,,,,,,,
O60706,0,OMOP Exposome,Observation,Substance,ATP-binding cassette sub-family C member 9,,2024-09-14,1,,,,,,,,,
P61221,0,OMOP Exposome,Observation,Substance,ATP-binding cassette sub-family E member 1,,2024-09-14,1,,,,,,,,,
P45844,0,OMOP Exposome,Observation,Substance,ATP-binding cassette sub-family G member 1,,2024-09-14,1,,,,,,,,,
Q9UNQ0,0,OMOP Exposome,Observation,Substance,ATP-binding cassette sub-family G member 2,,2024-09-14,1,,,,,,,,,
P53396,0,OMOP Exposome,Observation,Substance,ATP-citrate synthase,,2024-09-14,1,,,,,,,,,
P17858,0,OMOP Exposome,Observation,Substance,"ATP-dependent 6-phosphofructokinase, liver type",,2024-09-14,1,,,,,,,,,
P08237,0,OMOP Exposome,Observation,Substance,"ATP-dependent 6-phosphofructokinase, muscle type",,2024-09-14,1,,,,,,,,,
Q01813,0,OMOP Exposome,Observation,Substance,"ATP-dependent 6-phosphofructokinase, platelet type",,2024-09-14,1,,,,,,,,,
P48048,0,OMOP Exposome,Observation,Substance,ATP-sensitive inward rectifier potassium channel 1,,2024-09-14,1,,,,,,,,,
P78508,0,OMOP Exposome,Observation,Substance,ATP-sensitive inward rectifier potassium channel 10,,2024-09-14,1,,,,,,,,,
Q14654,0,OMOP Exposome,Observation,Substance,ATP-sensitive inward rectifier potassium channel 11,,2024-09-14,1,,,,,,,,,
Q14500,0,OMOP Exposome,Observation,Substance,ATP-sensitive inward rectifier potassium channel 12,,2024-09-14,1,,,,,,,,,
Q9UNX9,0,OMOP Exposome,Observation,Substance,ATP-sensitive inward rectifier potassium channel 14,,2024-09-14,1,,,,,,,,,
Q99712,0,OMOP Exposome,Observation,Substance,ATP-sensitive inward rectifier potassium channel 15,,2024-09-14,1,,,,,,,,,
Q15842,0,OMOP Exposome,Observation,Substance,ATP-sensitive inward rectifier potassium channel 8,,2024-09-14,1,,,,,,,,,
BE0004905,0,OMOP Exposome,Observation,Substance,ATP-sensitive potassium channel,,2024-09-14,1,,,,,,,,,
O43681,0,OMOP Exposome,Observation,Substance,ATPase ASNA1,,2024-09-14,1,,,,,,,,,
Q96QE3,0,OMOP Exposome,Observation,Substance,ATPase family AAA domain-containing protein 5,,2024-09-14,1,,,,,,,,,
193981-10-1,0,OMOP Exposome,Observation,Substance,"Atracotoxin, omega- (Hadronyche versuta)",,2014-12-24,1,,,,,,,,,
1912-24-9,0,OMOP Exposome,Observation,Substance,Atrazine,"Crisatrina; Atraflow plus; Atranex; Atrasine; Atrataf; Atratol; Atratol A; Atrazin; Aatrex 80W; Aatrex nine-O; Actinite PK; Atrazine 4L; Akticon; Atrazine 80W; Atred; Atrex; Attrex; ATZ; Aktikon; Azinotox 500; Candex; Cekuzina-T; Chromozin; Crisamina; Crisazine; Cyazin; Farmco atrazine; Farmozine; Fenamin; Fenamine; Fenatrol; Fogard; Gesaprim; Gesaprim 50; Gesoprim; Griffex; Griffex 4L; Herbatoxol; Hungazin; Hungazin PK; Inakor; Laddock; Maizina; Mebazine; Oleogesaprim; Pitezin; Primatol; Primatol A; Primaze; Primoleo; Radazin; Radazin T; Radizin; Radizine; Strazine; Triazine A 1294; Vectal; Vectal SC; Weedex A; Wonuk; Zeaphos; Zeapos; Zeazin; Zeazine; Zeopos; Atraflow; Atazinax; Argezin; Aktinit PK; Aktinit A; 1-Chloro-3-(ethylamino)-5-(isopropylamino)-2,4,6-triazine; 1-Chloro-3-(ethylamino)-5-(isopropylamino)-S-triazine; 2-Aethylamino-4-chlor-6-isopropylamino-1,3,5-triazin; 2-Chloro-4-(2-propylamino)-6-(ethylamino)-S-triazine; 2-Chloro-4-(ethylamino)-6-(isopropylamino)-1,3,5-triazine; 2-Chloro-4-(ethylamino)-6-(isopropylamino)-S-Triazine; 2-Chloro-4-ethylamineisopropylamine-S-triazine; 2-Chloro-4-ethylamino-6-isopropylamino-1,3,5-triazine; 2-Chloro-4-ethylamino-6-isopropylamino-S-Triazine; 2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE; 2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO-1,3,5-TRIAZINE; 2-Ethylamino-4-isopropylamino-6-chloro-S-triazine; 6-Chloro-4-(ethylamino)-2-(isopropylamino)-S-triazine; 6-Chloro-N-ethyl-N'-(1-methylethyl)-1,3,5-triazine-2,4-diamine; 6-Chloro-N-ethyl-N'-(propan-2-yl)-1,3,5-triazine-2,4-diamine; 6-Chloro-N-ethyl-N'-isopropyl-1,3,5-triazine-2,4-diamine; Aatram; Aatrex; Aatrex 4L; Aatrex 4LC; Aktikon PK; CHEBI:15930",2014-12-24,1,,,,,,,,,
GIS1007215,0,OMOP Exposome,Observation,Substance,Atrazine Degradation,,2024-09-14,1,,,,,,,,,
O14965,0,OMOP Exposome,Observation,Substance,Aurora kinase A,,2024-09-14,1,,,,,,,,,
55350-03-3,0,OMOP Exposome,Observation,Substance,Aurovertin B,,2014-12-24,1,,,,,,,,,
65256-31-7,0,OMOP Exposome,Observation,Substance,Aurovertin D,,2014-12-24,1,,,,,,,,,
GIS1007216,0,OMOP Exposome,Observation,Substance,Autonomic Agent,,2024-09-14,1,,,,,,,,,
GIS1007217,0,OMOP Exposome,Observation,Substance,Avermectin,,2024-09-14,1,,,,,,,,,
65195-55-3,0,OMOP Exposome,Observation,Substance,Avermectin B1a,5-O-Demethylavermectin A1a; Abamectin; Abamectin komponente B1a; Antibiotic C 076B1a; Avermectin B(1)a; Avermectin B1; Avermectin b1a; Caswell No. 063AB; CHEBI:29534,2014-12-24,1,,,,,,,,,
65195-56-4,0,OMOP Exposome,Observation,Substance,Avermectin B1b,,2014-12-24,1,,,,,,,,,
GIS1007219,0,OMOP Exposome,Observation,Substance,Axon guidance,,2024-09-14,1,,,,,,,,,
GIS1007218,0,OMOP Exposome,Observation,Substance,Axoneme,,2024-09-14,1,,,,,,,,,
320-67-2,0,OMOP Exposome,Observation,Substance,Azacitidine,5-Azacytidine; 5 AZC; 4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one; Vidaza; Mylosar; Ladakamycin; Azacytidine; Azacitidinum; Azacitidina; CHEBI:2038,2014-12-24,1,,,,,,,,,
35575-96-3,0,OMOP Exposome,Observation,Substance,Azamethiphos,"S-((6-chloro-2-Oxooxazolo(4,5-b)pyridin-3(2H)-yl)methyl) O,O-dimethylphosphorothioate; S-((6-Chloro-2,3-dihydro-2-oxo-1,3-oxazolo-(4,5-b)pyridin-3-yl)methyl) O,O-dimethyl phosphorothioate; 6-chloro-3-Dimethoxyphosphinoylthiomethyl-1,3-oxazolo(4,5-b)pyridin-2(3H)-one; S-(6-chloro-2-oxo1,3Oxazolo4,5-bpyridin-3(2H)-yl)methyl O,O-dimethyl thiophosphate; S-6-chloro-2,3-dihydro-2-oxo-1,3-Oxazolo(4,5-b)pyridin-3-ylmethyl O,O-dimethyl phosphorothioate; CHEBI:38578",2014-12-24,1,,,,,,,,,
214899-21-5,0,OMOP Exposome,Observation,Substance,Azaspiracid,,2014-12-24,1,,,,,,,,,
446-86-6,0,OMOP Exposome,Observation,Substance,Azathioprine,Azamun; Azanin; Azasan; Azathioprin; Imuran; Imurek; Imurel; Azatioprin; Azothioprine; 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine; CHEBI:2948,2014-12-24,1,,,,,,,,,
123-99-9,0,OMOP Exposome,Observation,Substance,Azelaic Acid,"Nonandis\u00e4ure; Ami; Aknoren; Acnesafe; Acnederm; Acnean; Acne-Derm; Acidum azelaicum; Acidum acelaicum; \u00c1cido azelaico; Acide az\u00e9la\u00efque; 1,9-Nonanedioic acid; 1,9-Nonanedioate; 1,7-Heptanedicarboxylic acid; Anchoate; Anchoic acid; 1,7-Heptanedicarboxylate; 1,7-Dicarboxyheptane; Arbonid; Azalaic acid; Azelaate; Azelaic acid; Azelaicacidtech; Azelainic acid; Azelainsaeure; Azelains\u00e4ure; Azelate; Azelex; Emerox 1110; Emerox 1144; Emery'S L-110; Zumilin; Finacea; Skinoren; Skinorem; Finevin; Heptanedicarboxylic acid; Lepargylate; Lepargylic acid; N-Nonanedioate; N-Nonanedioic acid; Nonandisaeure; Nonanedioate; Nonanedioic acid; Nonanedioic acid azelaic acid; Nonanedioic acid homopolymer; Poly(azelaic anhydride); Polyazelaic anhydride; CHEBI:48131",2014-12-24,1,,,,,,,,,
58581-89-8,0,OMOP Exposome,Observation,Substance,Azelastine,Azelastinum; Optivar; Astelin; 4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone; Astepro; Azelastina; CHEBI:2950,2014-12-24,1,,,,,,,,,
41083-11-8,0,OMOP Exposome,Observation,Substance,Azocyclotin,"1-(Tricyclohexylstannyl)-1H-1,2,4-triazole; (1H-1,2,4-triazol-1-yl)tricyclohexylstannane; (1H-1,2,4-Triazolyl)tricyclohexylstannane; Clermait; Peropal; Tri(cyclohexyl)-1H-1,2,4-triazol-1-yltin; Tricyclotin; CHEBI:2959",2014-12-24,1,,,,,,,,,
131860-33-8,0,OMOP Exposome,Observation,Substance,Azoxystrobin,Methyl (e)-2-2-6-(2-cyanophenoxy)pyrimidin-4-yloxyphenyl-3-methoxyacrylate; (AlphaE)-2-6-(2-cyanophenoxy)-4-pyrimidinyloxy-alpha-(methoxymethylene) benzeneacetic acid methyl ester; CHEBI:40909,2014-12-24,1,,,,,,,,,
275-51-4,0,OMOP Exposome,Observation,Substance,Azulene,"Azunamic; Bicyclo(0.3.5)deca-1,3,5,7,9-pentaene; Bicyclo(5.3.0)-1,3,5,7,9-decapentaene; Azulekeep; Azulen; Cyclopentacycloheptene; Bicyclo(5.3.0)-deca-2,4,6,8,10-pentaene; Bicyclo(5.3.0)decapentaene; Bicyclo5.3.0decapentaene; CHEBI:31249",2014-12-24,1,,,,,,,,,
P11836,0,OMOP Exposome,Observation,Substance,B-lymphocyte antigen CD20,,2024-09-14,1,,,,,,,,,
P46663,0,OMOP Exposome,Observation,Substance,B1 bradykinin receptor,,2024-09-14,1,,,,,,,,,
1134-47-0,0,OMOP Exposome,Observation,Substance,Baclofen,Gablofen; gamma-Amino-beta-(P-chlorophenyl)butyric acid; Kemstro; Lioresal; Lioresal Intrathecal; Nu-Baclofen; DL-4-Amino-3-P-chlorophenylbutanoic acid; beta-(P-Chlorophenyl)-gamma-aminobutyric acid; beta-(Aminomethyl)-P-chlorohydrocinnamic acid; DL-Baclofen; beta-(Aminomethyl)-4-chlorobenzenepropanoic acid; beta-(4-Chlorophenyl)gaba; Baclon; Baclofenum; Baclofeno; Baclofene; 4-Amino-3-(4-chlorophenyl)butyric acid; (+-)-Baclofen; Pms-Baclofen; CHEBI:2972,2014-12-24,1,,,,,,,,,
GIS1007220,0,OMOP Exposome,Observation,Substance,Bacterial Chemotaxis,,2024-09-14,1,,,,,,,,,
GIS1007221,0,OMOP Exposome,Observation,Substance,Bacterial Toxin,,2024-09-14,1,,,,,,,,,
80573-04-2,0,OMOP Exposome,Observation,Substance,Balsalazide,"(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid; (e)-5-({p-(2-carboxyethyl)carbamoylphenyl}azo)-2-salicylic acid; 3-(2-{4-(2-carboxyethyl)carbamoylphenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid; 5-4-(2-Carboxy-ethylcarbamoyl)-phenylazo-2-hydroxy-benzoic acid; Balsalazida; Balsalazide disodium; Balsalazido; Balsalazidum; Colazal; Colazide; GIAZO; CHEBI:267413",2014-12-24,1,,,,,,,,,
101-27-9,0,OMOP Exposome,Observation,Substance,Barban,"Fisons B25; Karbin; Barbane; Barbanate; Barbamate; Neoban; RCRA waste no. U280; Caryne; 2-Butyn-1-ol, 4-chloro-, m-chlorocarbanilate; Carbyne; 4-Chloro-2-butynyl N-(3-chlorophenyl)carbamate; 2-Butynyl-4-chloro-m-chlorocarbanilate; 4-Chlorobut-2-ynyl-m-chlorocarbanilate; 4-Chlorobut-2-ynyl 3-chlorophenylcarbamate; 4-chlorobut-2-yn-1-yl (3-chlorophenyl)carbamate; 4-Chloro-2-butynylm-chlorocarbanilate; 4-Chloro-2-butynyl-m-chlorocarbanilate; Chlorinat; Carbanilic acid, m-chloro-, 4-chloro-2-butynyl ester; Caswell No. 068; Chloro-2-butynyl m-chlorocarbamate; (3-Chlorophenyl)carbamic acid 4-chloro-2-butynyl ester; 4-Chloro-2-butynyl 3-chlorocarbanilate; 4-Chloro-2-butynyl meta-chlorocarbanilate; 4-Chloro-2-butynyl m-chlorophenylcarbamate; 4-Chloro-2-butynyl 3-chlorophenylcarbamate; 4-Chloro-2-Butynyl m-chlorocarbanilate; Carbin; Carbamic acid, (3-chlorophenyl)-, 4-chloro-2-butynyl ester; Carbine; m-Chlorocarbanilic acid, 4-chloro-2-butynyl ester; CHEBI:33421",2014-12-24,1,,,,,,,,,
GIS1007222,0,OMOP Exposome,Observation,Substance,Barbiturate,,2024-09-14,1,,,,,,,,,
7440-39-3,0,OMOP Exposome,Observation,Substance,Barium,Barium(2+); Barium(2+) ion; Barium(II); Barium(II) ion; Barium(II) cation; Ba(2+); Ba2+; Barium ion; CHEBI:37136,2014-12-24,1,,,,,,,,,
543-80-6,0,OMOP Exposome,Observation,Substance,Barium acetate,,2014-12-24,1,,,,,,,,,
18810-58-7,0,OMOP Exposome,Observation,Substance,Barium azide,,2014-12-24,1,,,,,,,,,
13967-90-3,0,OMOP Exposome,Observation,Substance,Barium bromate,,2014-12-24,1,,,,,,,,,
10553-31-8,0,OMOP Exposome,Observation,Substance,Barium bromide,,2014-12-24,1,,,,,,,,,
1191-79-3,0,OMOP Exposome,Observation,Substance,Barium cadmium stearate,,2014-12-24,1,,,,,,,,,
52869-93-9,0,OMOP Exposome,Observation,Substance,Barium calcium titanium oxide,,2014-12-24,1,,,,,,,,,
513-77-9,0,OMOP Exposome,Observation,Substance,Barium carbonate,,2014-12-24,1,,,,,,,,,
13477-00-4,0,OMOP Exposome,Observation,Substance,Barium chlorate,,2014-12-24,1,,,,,,,,,
10361-37-2,0,OMOP Exposome,Observation,Substance,Barium chloride,BaCl2; Dichlorobarium; CHEBI:63317,2014-12-24,1,,,,,,,,,
10294-40-3,0,OMOP Exposome,Observation,Substance,Barium chromate,,2014-12-24,1,,,,,,,,,
GIS1007239,0,OMOP Exposome,Observation,Substance,Barium Compound,,2024-09-14,1,,,,,,,,,
542-62-1,0,OMOP Exposome,Observation,Substance,Barium cyanide,,2014-12-24,1,,,,,,,,,
13773-23-4,0,OMOP Exposome,Observation,Substance,Barium ferrate,,2014-12-24,1,,,,,,,,,
11138-11-7,0,OMOP Exposome,Observation,Substance,Barium ferrite,,2014-12-24,1,,,,,,,,,
7787-32-8,0,OMOP Exposome,Observation,Substance,Barium fluoride,,2014-12-24,1,,,,,,,,,
17194-00-2,0,OMOP Exposome,Observation,Substance,Barium hydroxide,"Barium(II) hydroxide; Barium hydroxide, a; Caustic baryta; Barium hydroxide lime; Barium hydroxide (Ba(OH)2); Ba(OH)2; Aetzbaryt; Bariumhydroxid; barium(2+) hydroxide; CHEBI:32592",2014-12-24,1,,,,,,,,,
13477-10-6,0,OMOP Exposome,Observation,Substance,Barium hypochlorite,,2014-12-24,1,,,,,,,,,
13718-50-8,0,OMOP Exposome,Observation,Substance,Barium iodide,,2014-12-24,1,,,,,,,,,
12047-11-9,0,OMOP Exposome,Observation,Substance,Barium iron oxide,,2014-12-24,1,,,,,,,,,
10022-31-8,0,OMOP Exposome,Observation,Substance,Barium nitrate,,2014-12-24,1,,,,,,,,,
516-02-9,0,OMOP Exposome,Observation,Substance,Barium oxalate,,2014-12-24,1,,,,,,,,,
1304-28-5,0,OMOP Exposome,Observation,Substance,Barium oxide,,2014-12-24,1,,,,,,,,,
13465-95-7,0,OMOP Exposome,Observation,Substance,Barium perchlorate,,2014-12-24,1,,,,,,,,,
7787-36-2,0,OMOP Exposome,Observation,Substance,Barium permanganate,,2014-12-24,1,,,,,,,,,
1304-29-6,0,OMOP Exposome,Observation,Substance,Barium peroxide,,2014-12-24,1,,,,,,,,,
17125-80-3,0,OMOP Exposome,Observation,Substance,Barium silicofluoride,,2014-12-24,1,,,,,,,,,
7727-43-7,0,OMOP Exposome,Observation,Substance,Barium sulfate,,2014-12-24,1,,,,,,,,,
21109-95-5,0,OMOP Exposome,Observation,Substance,Barium sulfide,Barium sulfide (ba(SX)); Barium sulfide (bas); Barium sulphide; Bariumsulfid; BAS; bas; Polybarit; Neopol; Barium polysulfide; CHEBI:32590,2014-12-24,1,,,,,,,,,
12047-27-7,0,OMOP Exposome,Observation,Substance,Barium titanate,,2014-12-24,1,,,,,,,,,
12009-21-1,0,OMOP Exposome,Observation,Substance,Barium zirconium oxide,,2014-12-24,1,,,,,,,,,
GIS1007240,0,OMOP Exposome,Observation,Substance,Basal Ganglia,,2024-09-14,1,,,,,,,,,
GIS1007241,0,OMOP Exposome,Observation,Substance,Base excision repair,,2024-09-14,1,,,,,,,,,
19049-40-2,0,OMOP Exposome,Observation,Substance,Basic beryllium acetate,,2014-12-24,1,,,,,,,,,
66104-24-3,0,OMOP Exposome,Observation,Substance,Basic beryllium carbonate,,2014-12-24,1,,,,,,,,,
51404-69-4,0,OMOP Exposome,Observation,Substance,Basic lead acetate,,2014-12-24,1,,,,,,,,,
1319-46-6,0,OMOP Exposome,Observation,Substance,Basic lead carbonate,,2014-12-24,1,,,,,,,,,
P59071,0,OMOP Exposome,Observation,Substance,Basic phospholipase A2 VRV-PL-VIIIa,,2024-09-14,1,,,,,,,,,
GIS1007242,0,OMOP Exposome,Observation,Substance,Basolateral Membrane,,2024-09-14,1,,,,,,,,,
23509-16-2,0,OMOP Exposome,Observation,Substance,Batrachotoxin,,2014-12-24,1,,,,,,,,,
Q07817,0,OMOP Exposome,Observation,Substance,Bcl-2-like protein 1,,2024-09-14,1,,,,,,,,,
Q92843,0,OMOP Exposome,Observation,Substance,Bcl-2-like protein 2,,2024-09-14,1,,,,,,,,,
BE0003421,0,OMOP Exposome,Observation,Substance,Bcl2 antagonist of cell death,,2024-09-14,1,,,,,,,,,
Q92934,0,OMOP Exposome,Observation,Substance,Bcl2-associated agonist of cell death,,2024-09-14,1,,,,,,,,,
Q16620,0,OMOP Exposome,Observation,Substance,BDNF/NT-3 growth factors receptor,,2024-09-14,1,,,,,,,,,
26048-05-5,0,OMOP Exposome,Observation,Substance,Beauvericin,"cyclo(D-alpha-Hydroxyisovaleryl-L-N-methyl-Phe)3; Cyclo(D-.alpha.-hydroxyisovaleryl-N-methyl-L-phenylalanyl-D-.alpha.-hydroxyisovaleryl-N-methyl-L-phenylalanyl-D-.alpha.-hydroxyisovaleryl-N-methyl-L-phenylalanyl); 1,7,13-Trioxa-4,10,16-triazacyclooctadecane, cyclic peptide deriv.; CHEBI:3000",2014-12-24,1,,,,,,,,,
22781-23-3,0,OMOP Exposome,Observation,Substance,Bendiocarb,"1,3-Benzodioxol-4-ol, 2,2-dimethyl-, methylcarbamate; Turcam; Tattoo; Tatoo; Seedoxin; Seedox SC; Seedox 80W; Seedox; Sedox; Rotate; RCRA waste no. U278; Niomil; Multimet; Multamat; Methylcarbamic acid 2,3-(isopropylidenedioxy)phenyl ester; Garvox; FUAM; Fisons NC 6897; Ficam z; Ficam w; Ficam ulv' ul; Ficam ulv; Ficam plus; Ficam d; Ficam b; FICAM 80W; Ficam 80 W; Ficam; Dycarb; Bendiocarbe; Bendiocarbamate; Bencarbate; 2,3-Isopropylidenedioxyphenyl methylcarbamate; 2,3-Isopropylidene-dioxyphenyl methylcarbamate; 2,2-Dimethylbenzo-1,3-dioxol-4-yl methylcarbamate; 2,2-dimethyl-4-(methylcarbamoyloxy)-1,3-benzodioxole; 2,2-dimethyl-1,3-benzodioxole-N-methylcarbamate; 2,2-Dimethyl-1,3-benzodioxol-4-yl methylcarbamate; 2,2-Dimethyl-1,3-benzodioxol-4-ol methylcarbamate; 2,2-Dimethyl-1,3-benzdioxol-4-yl N-methylcarbamate; CHEBI:34556",2014-12-24,1,,,,,,,,,
1861-40-1,0,OMOP Exposome,Observation,Substance,Benfluralin,,2014-12-24,1,,,,,,,,,
82560-54-1,0,OMOP Exposome,Observation,Substance,Benfuracarb,"Caswell No. 349C; Oncol 5G; Oncol 10G; Aminofuracarb; Oncol; N-(((((2,3-dihydro-2,2-Dimethyl-7-benzofuranyl)oxy)carbonyl)methylamino)thio)-N-(1-methylethyl)-beta-alanine, ethyl ester; Furacon; CHEBI:3014",2014-12-24,1,,,,,,,,,
17804-35-2,0,OMOP Exposome,Observation,Substance,Benomyl,"Chinoin-fundazol; 1-(Butylcarbamoyl)-2-benzimidazol-methylcarbamat; 1-(N-Butylcarbamoyl)-2-(methoxy-carboxamido)-benzimidazol; Agrocit; Arbortrine; Arilate; BBC; Benex; Benlat; Benlate; Benlate 50; Benlate 50 W; Benlate 50W; Benomil; Benomyl 50W; Benomyl-imex; Benosan; BNM; Du Pont 1991; Dupont 1991; Fibenzol; Fundasol; Fundazol; Fundazol 50WP; Fungicide 1991; Fungicide D-1991; Fungochrom; Kribenomy; Kribenomyl; MBCL; Methyl 1-(butylamino)carbonyl-1H-benzimidazol-2-ylcarbamate; Methyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate; Methyl 1-(butylcarbamoyl)-2-benzimidazolylcarbamate; Methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate; Methyl 1-(butylamino)carbonyl-1H-benzimidazol-2-ylcarbamate, 9CI; Methyl N-(1-butylcarbamoyl-2-benzimidazole)carbamate; Methyl 1-(butylcarbamoyl)-1H-benzimidazol-2-ylcarbamate; NS 02 (fungicide); Tersan 1991; Uzgen; CHEBI:3015",2014-12-24,1,,,,,,,,,
83055-99-6,0,OMOP Exposome,Observation,Substance,Bensulfuron-methyl,,2014-12-24,1,,,,,,,,,
741-58-2,0,OMOP Exposome,Observation,Substance,Bensulide,,2014-12-24,1,,,,,,,,,
25057-89-0,0,OMOP Exposome,Observation,Substance,Bentazon,,2014-12-24,1,,,,,,,,,
413615-35-7,0,OMOP Exposome,Observation,Substance,Benthiavalicarb,,2014-12-24,1,,,,,,,,,
177406-68-7,0,OMOP Exposome,Observation,Substance,Benthiavalicarb-isopropyl,,2014-12-24,1,,,,,,,,,
86-13-5,0,OMOP Exposome,Observation,Substance,Benzatropine,"Benzatropine mesilate; Benzatropina; Apo-Benztropine; 3\u03b1-benzhydryloxy-8-methyl-8-azabicyclo3.2.1octane; 3\u03b1-(diphenylmethoxy)tropane; 3\u03b1-(diphenylmethoxy)-1\u03b1H,5\u03b1H-tropane; 3endo-benzhydryloxytropane; 3alpha-Benzhydryloxy-8-methyl-8-azabicyclo3.2.1octane; 3alpha-(Diphenylmethoxy)tropane; 3-alpha-(diphenylmethoxy)tropane; 3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane; Tropine Benzohydryl Ether; PMS Benztropine; Cogentinol; Cogentin; Benztropine; Benztropinum; Benzhydryl 8-methyl-8-azabicyclo3.2.1oct-3-yl ether; Benzatropinum; CHEBI:3048",2014-12-24,1,,,,,,,,,
71-43-2,0,OMOP Exposome,Observation,Substance,Benzene,Polystream; Pyrobenzole; RNG; Benzol; Benzinum; Benzine; Benzin; Benzen; Benzeen; Aromatic alkane; Annulene; Coal naphtha; Carbon oil; BNZ; Bicarburet of hydrogen; Benzolum; Benzolo; Benzolene; Benzole; Cyclohexatriene; Fenzen; Mineral naphtha; Benzol 90; Motor benzol; Phene; Phenyl hydride; Pyrobenzol; CHEBI:16716,2014-12-24,1,,,,,,,,,
140-29-4,0,OMOP Exposome,Observation,Substance,Benzeneacetonitrile,"alpha -tolunitrile; alpha-Cyanotoluene; alpha-Tolunitrile; Benzeneacetonitrile, 9CI; Benzyl cyanide; Benzyl nitrile; Benzylkyanid; Benzylnitrile; Cyanophenylmethane; Enzylcyanide; laquo Omegaraquo -cyanotoluene; Omega-cyanotoluene; Phenacetonitrile; Phenyl acetyl nitrile; Phenyl-Acetonitrile; Phenylacetonitrile; Phenylacetonitrile, liquid; (Cyanomethyl)benzene; .omega.-cyanotoluene; 2-Phenylacetonitrile; Acetic acid, phenyl-nitrile; alpha -cyanotoluene; alpha-Cyano-Toluene; CHEBI:25979",2014-12-24,1,,,,,,,,,
98-05-5,0,OMOP Exposome,Observation,Substance,Benzenearsonic acid,Phenylarsonic acid; Benzenearsonate; PhAsO(OH)2; Monophenylarsonic acid; CHEBI:29851,2014-12-24,1,,,,,,,,,
645-96-5,0,OMOP Exposome,Observation,Substance,Benzeneselenol,,2014-12-24,1,,,,,,,,,
92-87-5,0,OMOP Exposome,Observation,Substance,Benzidine,,2014-12-24,1,,,,,,,,,
56-55-3,0,OMOP Exposome,Observation,Substance,Benzo[a]anthracene,"1,2-Benzanthracene; 1, 2-Benzoanthracene; 1, 2-Benzanthracene; Tetraphene; Naphthanthracene; Benzaanthracene; Benzobphenanthrene; Benzoaphenanthrene; Benzoanthracene; Benzo(b)phenanthrene; Benzo(a)anthracene; Benzanthrene; Benzanthracene; Benz(a)anthracene; 2,3-Benzphenanthrene; 2,3-Benzophenanthrene; 1,2-Benzoanthracene; 1,2-Benzanthrene; 1,2-Benzanthrazen; 1,2-Benz(a)anthracene; CHEBI:51348",2014-12-24,1,,,,,,,,,
50-32-8,0,OMOP Exposome,Observation,Substance,Benzo[a]pyrene,"Benzpyrene; 3,4-Benzypyrene; Benzo(d,e,f)chrysene; 3,4-BP; 4,5-Benzpyrene; 6,7-Benzopyrene; Benzoapyrene solution; Benzopyrene; Benzo(def)chrysene; Benzo(a)pyrene; Benz(a)pyrene; Benzodefchrysene; BenzoPQRtetraphene; BP; Benzod,e,fchrysene; 1,2-Benzpyrene; 3,4 Benzopyrene; 3,4 Benzpyrene; 3,4-Benz(a)pyrene; 3,4-Benzo(a)pyrene; 3,4-Benzopyrene; 3,4-Benzpyrene; 3,4-benzylpyrene; CHEBI:29865",2014-12-24,1,,,,,,,,,
205-99-2,0,OMOP Exposome,Observation,Substance,Benzo[b]fluoranthene,"3,4-Benz(e)acephenanthrylene; 3,4-Benzofluoranthene; BF; Benzbfluoranthene; Benzoefluoranthene; Benzoeacephenanthrylene; 3,4-Benzofluoranthrene; b(b)F; Benzobfluoranthene solution; 2,3-Benzofluoranthene; 2,3-Benzfluoranthene; 2, 3-Benzofluoranthene; Benzo(e)fluoranthene; Benzo(b)fluoranthene; Benz(e)acephenanthrylene; 4,5-Benzofluoranthene; 2,3-Benzofluoranthrene; 3,4-Benzfluoranthene; 3,{4-Benzeacephenanthrylene}; CHEBI:34565",2014-12-24,1,,,,,,,,,
192-97-2,0,OMOP Exposome,Observation,Substance,Benzo[e]pyrene,"4,5-Benzpyrene; 9,10-Benzpyrene; B(e)P; Benz(e)pyrene; 1,2-Benzpyrene; Benzo(e)pyrene; 1,2-Benzopyrene; Benzo(l)pyrene; Benzopyrene; 4,5-Benzopyrene; 1,2-benzo(e)pyrene; CHEBI:34567",2014-12-24,1,,,,,,,,,
191-24-2,0,OMOP Exposome,Observation,Substance,Benzo[ghi]perylene,,2014-12-24,1,,,,,,,,,
205-82-3,0,OMOP Exposome,Observation,Substance,Benzo[j]fluoranthene,,2014-12-24,1,,,,,,,,,
207-08-9,0,OMOP Exposome,Observation,Substance,Benzo[k]fluoranthene,,2014-12-24,1,,,,,,,,,
GIS1007243,0,OMOP Exposome,Observation,Substance,Benzoate Degradation,,2024-09-14,1,,,,,,,,,
94-09-7,0,OMOP Exposome,Observation,Substance,Benzocaine,4-(Ethoxycarbonyl)phenylamine; (p-(Ethoxycarbonyl)phenylamine; 4-(Ethoxycarbonyl)aniline; Topcaine; 4-Aminobenzoate; 4-Aminobenzoic acid; 4-Aminobenzoic acid ethyl ester; 4-Carbethoxyaniline; Aethoform; Amben ethyl ester; Americaine; Solu H; Solarcaine; Anacaine; Anaesthan-syngala; Anaesthesin; Anaesthin; Anbesol Baby; Anestezin; Anesthesin; Slim Mint Gum; Parathesine; Parathesin; p-Ethoxycarboxylic aniline; p-Carbethoxyaniline; p-Aminobenzoic acid ethyl ester; p-Aminobenzoic acid; p-Aminobenzoate; p-(Ethoxycarbonyl)aniline; Orthesin; Orabase-B; Ora-jel; Norcaine; Norcain; Keloform; Identhesin; Hurricaine; Ethylester kyseliny p-aminobenzoove; Ethyl p-aminophenylcarboxylate; Ethyl p-aminobenzoic acid; Ethyl p-aminobenzoate; Ethyl p-aminobenzenecarboxylate; Ethyl aminobenzoic acid; Ethyl aminobenzoate; Ethyl 4-aminobenzoic acid; Ethyl 4-aminobenzoate; Ethoform; Diet Ayds; Dermoplast; Benzocainum; Benzocaina; Benzoak; Baby Anbesol; Anesthone; Anesthesine; CHEBI:116735,2014-12-24,1,,,,,,,,,
GIS1007244,0,OMOP Exposome,Observation,Substance,Benzodiazepine,,2024-09-14,1,,,,,,,,,
56832-73-6,0,OMOP Exposome,Observation,Substance,Benzofluoranthene,,2014-12-24,1,,,,,,,,,
65-85-0,0,OMOP Exposome,Observation,Substance,Benzoic acid,Phenylcarboxylic acid; Phenylcarboxylate; Phenylformate; Benzoate; Oracylic acid; Dracylic acid; Benzenecarboxylate; Benzenecarboxylic acid; Benzenemethonic acid; Benzenemethanoic acid; Sodium benzoic acid; Benzenemethanoate; Benzeneformic acid; Benzeneformate; Sodium benzoate; Phenylformic acid; Benzoic acid sodium salt; Carboxybenzene; Diacylate; Diacylic acid; Dracylate; CHEBI:30746,2014-12-24,1,,,,,,,,,
119-53-9,0,OMOP Exposome,Observation,Substance,Benzoin,"Phenylbenzoyl carbinol; Benzoylphenylcarbinol; DL-Benzoin; 2-Hydroxy-1,2-diphenylethanone, 9CI; 2-Hydroxy-2-phenyl-Acetophenone; (RS)-Benzoin; FEMA 2132; Phenyl-alpha -hydroxybenzyl ketone; Phenyl-alpha-hydroxybenzyl ketone; a-Hydroxybenzyl phenyl ketone; alpha -Hydroxy-alpha -phenylacetophenone; alpha -Hydroxybenzyl phenyl ketone; 2-Hydroxy-2-phenylacetophenone; (+-)-Benzoin; alpha-Hydroxy-a-phenylacetophenone; alpha-Hydroxy-alpha-phenylacetophenone; alpha-Hydroxybenzyl phenyl ketone; CHEBI:17682",2014-12-24,1,,,,,,,,,
100-47-0,0,OMOP Exposome,Observation,Substance,Benzonitrile,Fenylkyanid; Cyanobenzene; Phenyl cyanide; Phenylcyanide; C6H5-CN; Benzoic acid nitrile; Benzenenitrile; Benzenecarbonitrile; CHEBI:27991,2014-12-24,1,,,,,,,,,
119-61-9,0,OMOP Exposome,Observation,Substance,Benzophenone,"Ketone, diphenyl; Di(phenyl)methanone; Diphenyl ketone; Diphenyl-methanon; Diphenyl-Methanone; Diphenylketone; Diphenylmethanone; Diphenylmethanone, 9CI; FEMA 2134; Kayacure BP; BZQ; METHANONE, DIPHENYL- (9CI); Phenyl ketone; A-Oxoditane; Adjutan 6016; ADK STAB 1413; A-Oxodiphenylmethane; alpha -oxodiphenylmethane; 1dzp; alpha -oxoditane; alpha-Oxodiphenylmethane; alpha-Oxoditane; Benzopheneone; BENZOPHENONE (8CI); Benzophenone (diphenyl-ketone); Benzoyl-Benzene; Benzoylbenzene; CHEBI:3034",2014-12-24,1,,,,,,,,,
10275-07-7,0,OMOP Exposome,Observation,Substance,Benzoquinoneacetic acid,,2018-03-21,1,,,,,,,,,
156-08-1,0,OMOP Exposome,Observation,Substance,Benzphetamine,"(+)-N-Benzyl-N,alpha-dimethylphenethylamine; Didrex; d-N-methyl-N-benzyl-\u03b2-phenylisopropylamine; N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine; Regimex; (S)-(+)-benzphetamine; Benzfetaminum; (AlphaS)-N,alpha-dimethylphenethylamine; (+)-N,\u03b1-dimethyl-N-(phenylmethyl)-benzeneethanamine; Benzfetamine; (+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine; (S)-benzphetamine; Benzaphetamine; (+)-N-benzyl-N,\u03b1-dimethylphenethylamine; Recede; (+)-benzphetamine; (S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine; (S)-(+)-N-benzyl-N,\u03b1-dimethylphenethylamine; Benzylamphetamine; D-N-Methyl-N-benzyl-beta-phenylisopropylamine; Benzfetamina; CHEBI:3044",2014-12-24,1,,,,,,,,,
91-33-8,0,OMOP Exposome,Observation,Substance,Benzthiazide,"Aquatag; Benzothiazide; Benztiazide; Benzotiazida; Benzthiazid; Benzthiazidum; Foven; 3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide; Dihydrex; Diucen; Edemax; Exna; 3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzoe1,2,4thiadiazine-7-sulfonamide; 6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; CHEBI:3047",2014-12-24,1,,,,,,,,,
140-11-4,0,OMOP Exposome,Observation,Substance,Benzyl acetate,"Phenylmethyl acetate; (acetoxymethyl)benzene; Acetic acid phenylmethyl ester; Phenylmethyl ethanoate; Plastolin I; Acetic acid benzyl ester; Benzyl ethanoate; Acetic acid, benzyl ester; Acetic acid, phenylmethyl ester; alpha-Acetoxytoluene; Benzyl acetate + glycine combination; Benzyl acetic acid; Benzyl ester of acetic acid; Acetato de bencilo; Benzylester kyseliny octove; FEMA 2135; Nchem.167-comp5; CHEBI:52051",2014-12-24,1,,,,,,,,,
100-39-0,0,OMOP Exposome,Observation,Substance,Benzyl bromide,"1-Bromotoluene; Phenylmethyl bromide; Cyclite; Bromotoluene, a; Bromotoluene; Bromophenylmethane; Bromomethyl-benzene; \u00c2\u00abomega\u00c2\u00bb-bromotoluene; Ambap7; Alpha-bromotoluene; a-bromotoluene; Toluene,alpha-bromo; .omega.-bromotoluene; .alpha.-bromotoluene; (Bromomethyl)benzene; (bromomethyl)benzene; CHEBI:59858",2014-12-24,1,,,,,,,,,
85-68-7,0,OMOP Exposome,Observation,Substance,Benzyl butyl phthalate,,2014-12-24,1,,,,,,,,,
103-41-3,0,OMOP Exposome,Observation,Substance,Benzyl cinnamate,,2014-12-24,1,,,,,,,,,
122-57-6,0,OMOP Exposome,Observation,Substance,Benzylideneacetone,"2-Phenylvinyl methyl ketone; 1-Buten-3-one-1-phenyl; (E)-4-Phenyl-3-buten-2-one; Acetocinnamone; 4-Phenylbutenone; 4-Phenylbut-3-en-2-one; 4-Phenyl-3-butene-2-one; 4-Phenyl-3-Buten-2-one; 4-Phenyl-(E)-3-Buten-2-one; 3-BUTEN,2-ONE,4-PHENYL (TRANS) BENZALACETONE; Methyl 2-phenylvinyl ketone; Ketone, methyl STYRYL; Ghl.PD_Mitscher_leg0.147; FEMA 2881; Benzylideneacetone, (z)-isomer; Benzylideneacetone, (e)-isomer; Trans-benzalacetone; Benzylidene acetone; Benzilideneacetone; Benzilidene acetone; Trans-benzylidenacetone; Trans-benzylideneacetone; Benzalacetone; Benzalaceton; (3E)-4-phenylbut-3-en-2-one; (3E)-4-Phenyl-3-buten-2-one; trans-4-Phenyl-3-butene-2-one; trans-4-Phenyl-3-buten-2-one; TPBO; T-Pbo; STYRYL methyl ketone; Methyl trans-STYRYL ketone; Methyl styryl ketone; Methyl STYRYL acetone; Methyl beta-STYRYL ketone; trans-4-Phenylbut-3-en-2-one; Methyl beta -STYRYL ketone; CHEBI:217301",2014-12-24,1,,,,,,,,,
125602-71-3,0,OMOP Exposome,Observation,Substance,Bepotastine,Talion; TAU-284DS; Bepreve; CHEBI:71204,2014-12-24,1,,,,,,,,,
7380-40-7,0,OMOP Exposome,Observation,Substance,Bergamottin,,2014-12-24,1,,,,,,,,,
7440-41-7,0,OMOP Exposome,Observation,Substance,Beryllium,Beryllium(II) ion; Be(2+); Beryllium(II); Beryllium(2+) ion; Beryllium(2+); Beryllium ion; Berylliium(II) cation; Be2+; CHEBI:30502,2014-12-24,1,,,,,,,,,
543-81-7,0,OMOP Exposome,Observation,Substance,Beryllium acetate,,2014-12-24,1,,,,,,,,,
7787-46-4,0,OMOP Exposome,Observation,Substance,Beryllium bromide,,2014-12-24,1,,,,,,,,,
13106-47-3,0,OMOP Exposome,Observation,Substance,Beryllium carbonate,,2014-12-24,1,,,,,,,,,
7787-47-5,0,OMOP Exposome,Observation,Substance,Beryllium chloride,"Beryllium chloride, anhydrous; BeCl2; Beryllium dichloride; Beryllium chloride, b; CHEBI:62843",2014-12-24,1,,,,,,,,,
GIS1007284,0,OMOP Exposome,Observation,Substance,Beryllium Compound,,2024-09-14,1,,,,,,,,,
11133-98-5,0,OMOP Exposome,Observation,Substance,Beryllium copper,,2014-12-24,1,,,,,,,,,
7787-49-7,0,OMOP Exposome,Observation,Substance,Beryllium fluoride,Beryllium fluoride (BeF2); Fluoroberyllate; Beryllofluoride; Beryllium fluoride(Be2F4); Beryllium difluoride; BeF2; Be2F4; CHEBI:49499,2014-12-24,1,,,,,,,,,
7787-52-2,0,OMOP Exposome,Observation,Substance,Beryllium hydride,BeH2; Beryllium dihydride; BeH2; CHEBI:33787,2014-12-24,1,,,,,,,,,
13327-32-7,0,OMOP Exposome,Observation,Substance,Beryllium hydroxide,Beryllium dihydroxide; Beryllium hydrate; beryllium(2+) hydroxide; Beryllium(II) hydroxide; Hydrated beryllia; CHEBI:35102,2014-12-24,1,,,,,,,,,
7787-53-3,0,OMOP Exposome,Observation,Substance,Beryllium iodide,,2014-12-24,1,,,,,,,,,
13597-99-4,0,OMOP Exposome,Observation,Substance,Beryllium nitrate,,2014-12-24,1,,,,,,,,,
1304-56-9,0,OMOP Exposome,Observation,Substance,Beryllium oxide,"Berylla; Beryllia; Bromellete; Beryllium monoxide; Glucina; Natural bromellite; BeO; Beryllium oxide, a; CHEBI:62842",2014-12-24,1,,,,,,,,,
13598-15-7,0,OMOP Exposome,Observation,Substance,Beryllium phosphate,,2014-12-24,1,,,,,,,,,
13598-00-0,0,OMOP Exposome,Observation,Substance,Beryllium silicate,,2014-12-24,1,,,,,,,,,
13510-49-1,0,OMOP Exposome,Observation,Substance,Beryllium sulfate,"Beryllium sulphate; Beryllium sulfic acid; Beryllium sulfate, a; BeSO4; Beryllium sulfate tetrahydrate; Beryllium sulphic acid; CHEBI:53473",2014-12-24,1,,,,,,,,,
12232-27-8,0,OMOP Exposome,Observation,Substance,Beryllium telluride,,2014-12-24,1,,,,,,,,,
BE0004872,0,OMOP Exposome,Observation,Substance,Beta adrenergic receptor,,2024-09-14,1,,,,,,,,,
GIS1007286,0,OMOP Exposome,Observation,Substance,Beta Cell,,2024-09-14,1,,,,,,,,,
33213-65-9,0,OMOP Exposome,Observation,Substance,beta Endosulfan,,2014-12-24,1,,,,,,,,,
GIS1007289,0,OMOP Exposome,Observation,Substance,Beta Oxidation of Very Long Chain Fatty Acids,,2024-09-14,1,,,,,,,,,
P08588,0,OMOP Exposome,Observation,Substance,Beta-1 adrenergic receptor,,2024-09-14,1,,,,,,,,,
BE0005316,0,OMOP Exposome,Observation,Substance,"Beta-1,3-glucan synthase",,2024-09-14,1,,,,,,,,,
P07550,0,OMOP Exposome,Observation,Substance,Beta-2 adrenergic receptor,,2024-09-14,1,,,,,,,,,
P61769,0,OMOP Exposome,Observation,Substance,Beta-2-microglobulin,,2024-09-14,1,,,,,,,,,
P13945,0,OMOP Exposome,Observation,Substance,Beta-3 adrenergic receptor,,2024-09-14,1,,,,,,,,,
P25098,0,OMOP Exposome,Observation,Substance,Beta-adrenergic receptor kinase 1,,2024-09-14,1,,,,,,,,,
P35626,0,OMOP Exposome,Observation,Substance,Beta-adrenergic receptor kinase 2,,2024-09-14,1,,,,,,,,,
107-95-9,0,OMOP Exposome,Observation,Substance,Beta-Alanine,Omega-Aminopropionic acid; b-Aminopropanoate; b-Alanine; B-Alanine; beta-Aminopropionic acid; Omega-Aminopropionate; b-Aminopropanoic acid; \u03b2-Alanine; Abufene; 3-Aminopropionic acid; 3-Amino-Propanoate; 3-Amino-Propanoic acid; 3-Aminopropanoate; 3-Aminopropanoic acid; 3-Aminopropionate; 2-Carboxyethylamine; beta-Aminopropionate; beta-Aminopropanoic acid; beta-Aminopropanoate; beta-Alanine; beta Alanine; b-Aminopropionic acid; b-Aminopropionate; CHEBI:16958,2018-03-21,1,,,,,,,,,
GIS1007285,0,OMOP Exposome,Observation,Substance,Beta-Alanine Metabolism,,2024-09-14,1,,,,,,,,,
21150-22-1,0,OMOP Exposome,Observation,Substance,beta-Amanitin,,2014-12-24,1,,,,,,,,,
151-18-8,0,OMOP Exposome,Observation,Substance,Beta-Aminopropionitrile,beta-Cyanoethylamine; 2-Cyanoethylamine; 3-Aminopropanenitrile; 3-Aminopropionitrile; 3-Aminopropiononitrile; Aminopropionitrile; b-Alaminenitrile; b-Alaninenitrile; b-Aminoethyl cyanide; b-Aminopropionitrile; b-Cyanoethylamine; BAPN; beta-Alaminenitrile; beta-Alaninenitrile; beta-Aminoethyl cyanide; beta-Aminopropionitrile; \u03b2-Aminopropionitrile; CHEBI:27413,2014-12-24,1,,,,,,,,,
12778-32-4,0,OMOP Exposome,Observation,Substance,beta-Bungarotoxin,,2014-12-24,1,,,,,,,,,
P16278,0,OMOP Exposome,Observation,Substance,Beta-galactosidase,,2024-09-14,1,,,,,,,,,
106-24-1,0,OMOP Exposome,Observation,Substance,beta-Geraniol,"2-trans-3,7-Dimethyl-2,6-octadiene-1-ol; 2E-Geraniol; 3,7-Dimethyl-(2E)-2,6-Octadien-1-ol; trans-3,7-Dimethy- octa-2,6-dien-1-ol; trans-2,6-Dimethyl-2,6-octadien-8-ol; Lemonol; Geranyl alcohol; Geraniol; FEMA 2507; b-Geraniol; 3,7-Dimethyl-trans-2,6-Octadien-1-ol; 3,7-Dimethyl-(E)-2,6-Octadien-1-ol; \u03b2-Geraniol; trans-Geraniol; trans-3,7-Dimethyl-2,6-octadien-1-ol; (2E)-3,7-Dimethyl-2,6-octadien-1-ol; (2E)-3,7-Dimethylocta-2,6-dien-1-ol; (E)-3,7-Dimethyl-2,6-octadien-1-ol; (E)-Geraniol; (E)-Nerol; 2-trans-3,7-Dimethyl-2,6-octadien-1-ol; CHEBI:17447",2014-12-24,1,,,,,,,,,
143257-99-2,0,OMOP Exposome,Observation,Substance,Beta-hemolysin,,2014-12-24,1,,,,,,,,,
319-85-7,0,OMOP Exposome,Observation,Substance,beta-Hexachlorocyclohexane,"Hexachlorocyclohexane gamma-isomer; (1r,2c,3c,4t,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2c,3t,4t,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2r,3r,4r,5r,6r)-1,2,3,4,5,6-hexachlorocyclohexane; (1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2R,3S,4R,5R,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2R,3S,4s,5R,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1R,2R,3S,4S,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1s,2R,3R,4s,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; 1,2,3,4,5,6-hexachloro-Cyclohexane; 1,2,3,4,5,6-Hexachloro-Cyclohexane alpha-isomer; 1,2,3,4,5,6-Hexachloro-Cyclohexane b-isomer; 1,2,3,4,5,6-Hexachloro-Cyclohexane beta-isomer; 1,2,3,4,5,6-Hexachloro-Cyclohexane delta-isomer; 1,2,3,4,5,6-Hexachloro-Cyclohexane gamma-isomer; 1,2,3,4,5,6-Hexachlorocyclohexane; 1a,2a,3b,4a,5b,6b-hexachlorocyclohexane; 1a,2b,3a,4b,5a,6b-hexachlorocyclohexane; Aalindan; Aficide; Agrocide; Agrocide III; Agrocide WP; Agronexit; alpha-1,2,3,4,5,6-Hexachloro-Cyclohexane; alpha-1,2,3,4,5,6-Hexachlorocyclohexane; Alpha-benzene hexachloride; Alpha-benzenehexachloride; Alpha-BHC; Alpha-HCH; Alpha-hexachloran; Alpha-hexachlorane; Alpha-hexachlorocyclohexane; Alpha-lindane; Am eisenatod; Ameisenatod; Ameisenmittel merck; Ameisentod; Aparasin; Aphtiria; Aphtitria; Aplidal; Arbitex; Arcotal s; b,1,2,3,4,5,6-Hexachlorocyclohexane; b-1,2,3,4,5,6-Hexachloro-Cyclohexane; b-benzene hexachloride; b-BHC; b-HCH; b-Hexachlorocyclohexane; b-hexachlorocyclohexane; b-lindane; BBH; BCH; Ben-hex; Benhexachlor; Benhexol; Benzanex; Benzene hexachloride; Benzene hexachloride-alpha-isomer; Benzene hexachloride-gamma isomer; Benzene hexachloride-gamma-isomer; Benzene-1,2,3,4,5,6-hexachloride (Ambiguous); Benzene-cis-hexachloride; Benzene-trans-hexachloride; Benzenehexachloride mixed isomers; Benzenehexachloride-alpha-isomer; Benzex; beta-1,2,3,4,5,6-Hexachlorocyclohexane; Beta-benzene hexachloride; Beta-BHC; Beta-HCH; Beta-hexac hlorocyclohexane; Beta-hexachloran; Beta-hexachlorobenzene; Beta-hexachlorocyclohexane; Beta-hexachlorocyclohexanes; Beta-lindane; Bexol; BHC; BHC-b isomer; Borer spray; Celanex; Chinoin brand of lindane; Chloresene; Codechine; DBH; Delitex; delta-(Aeeeee)-1,2,3,4,5,6-hexachlorocyclohexane; delta-1,2,3,4,5,6-Hexachloro-Cyclohexane; delta-1,2,3,4,5,6-Hexachlorocyclohexane; Delta-benzene hexachloride; Delta-benzenehexachloride; Delta-BHC; Delta-HCH; Delta-hexachlorocyclohexane; Delta-lindane; Detmol extract; Detmol-extrakt; Devoran; Dol granule; Dolmix; Entomoxan; Epsilon HCH; Epsilon-benzenehexachloride; Epsilon-HCH; Epsilon-hexachlorocyclohexane; Eso derm; Esoderm; Exagama; Fenoform forte; Forlin; Forst-nexen; Gallogama; Gamacarbatox; Gamacid; Gamacide; Gamacide 20; Gamaphex; Gamene; Gamiso; Gamma benzene hexachloride; \u03b2-Hexachlorocyclohexane; Viton; Verindal ultra; Trives-t; TRI-6; Trans-alpha-benzenehexachloride; Trans-a-benzenehexachloride; trans-1,2,3,4,5,6-Hexachloro-Cyclohexane; Tetocid; TBH; T-HCH; Submar; Streunex; Stiefel brand of lindane; Spruehpflanzol; Spritzlindane; Spritz-rapidin; Silvanol; Scabisan; Scabene; Scabecid; Sang gamma; Quellada; Pmslindane; PMS-lindane; PMS lindane; Pharmascience brand of lindane; Pflanzol; Pedraczak; Owadziak; Ovadziak; Omnitox; Novigan; Novigam; Nicochloran; Nexol-e; Nexit-stark; Nexen-FB; Neo-scabicidol; Mszycol; Linvur; Lintox; Lindosep; Lindex; Lindatox; Lindaterra; Lindapoudre; Lindane (gamma-HCH); Lindane; Lindamul; Lindam ul; Lindalo; Lindagranox; Lindagrain; Lindagam; Lindafor; Lidenal; Lentox; Lendine; Lasochron; Laccohilin; Kwell-r; Kwell; Kokotine; Jacutin; Isotox; Isot ox; Isatox; Insecticide, BHC; Infectopharm brand of lindane; Inexit; Hortex; Hilbeech; Hilbeec h; HGI; Hexyclan; Hexit lotion; Hexicide; Hexcidum; Hexaverm; Hexatox; Gamma BHC; Gamma hexachlor; Gamma hexachlorocyclohexane; Hexapoudre; gamma-1,2,3,4,5,6-Hexachloro-Cyclohexane; gamma-1,2,3,4,5,6-Hexachlorocyclohexane; Gamma-666; Gamma-:hexachlorocyclohexane; Gamma-benzene hexachloride; Gamma-benzenehexachloride; Gamma-benzohexachloride; Gamma-BHC; Gamma-BHC benhexachlor; Gamma-col; Gamma-HCH; Gamma-hexachlorane; Gamma-hexachlorcyclohexanum; Gamma-hexachlorobenzene; Gamma-hexachlorocyclohexane; Gamma-lindane; Gammahexa; Gammahexane; Gammalin; Gammaterr; Gammex; Gammexane; Gammopaz; Gamtox; Geobilan; Gexane; Gyben; Hexamul; HCH (alpha); HCH (beta); HCH-b; Heclotox; Hecoltox; Hexachlorzyklohexan; HEXA; Hexablanc; Hexachlor; Hexachlorocyclohexanes; Hexachlorocyclohexane-beta; Hexachloran; Hexachlorane; Hexachloride, benzene; Hexachloride, gamma-benzene; Hexachlorocyclohexane; Hexachlorocyclohexane gamma isomer; Hexachlorocyclohexane-alpha; CHEBI:28428",2014-12-24,1,,,,,,,,,
GIS1007288,0,OMOP Exposome,Observation,Substance,Beta-Ketothiolase Deficiency,,2024-09-14,1,,,,,,,,,
15920-93-1,0,OMOP Exposome,Observation,Substance,beta-Methylamino-L-alanine,,2014-12-24,1,,,,,,,,,
216064-36-7,0,OMOP Exposome,Observation,Substance,beta-Pompilidotoxin,,2014-12-24,1,,,,,,,,,
P56817,0,OMOP Exposome,Observation,Substance,Beta-secretase 1,,2024-09-14,1,,,,,,,,,
71030-11-0,0,OMOP Exposome,Observation,Substance,beta-Zearalenol,,2014-12-24,1,,,,,,,,,
GIS1007287,0,OMOP Exposome,Observation,Substance,Betaine Metabolism,,2024-09-14,1,,,,,,,,,
Q93088,0,OMOP Exposome,Observation,Substance,Betaine--homocysteine S-methyltransferase 1,,2024-09-14,1,,,,,,,,,
674-38-4,0,OMOP Exposome,Observation,Substance,Bethanechol,"Bethaine Choline Chloride; Bethanechol Chloride; BTC; (2-Hydroxypropyl)trimethylammonium carbamate; Urecholine; Myotonachol; 2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium; 2-Carbamoyloxypropyl-trimethylazanium; Amidopropyldimethylbetaine; Besacholine; beta-Methyl Carbachol Chloride; Urabeth; Uro-Carb; Myotonine; Duvoid; Carbamylmethylcholine Chloride; carbamyl-\u03b2-methylcholine; Carbamyl-beta-methylcholine; carbamoyl-\u03b2-methylcholine; Carbamoyl-beta-methylcholine; CHEBI:3084",2014-12-24,1,,,,,,,,,
90357-06-5,0,OMOP Exposome,Observation,Substance,Bicalutamide,Casodex; CHEBI:100717,2014-12-24,1,,,,,,,,,
485-49-4,0,OMOP Exposome,Observation,Substance,Bicuculline,Bicculine; Bicucullin; D-Bicuculline; CHEBI:CHEBI:3092,2014-12-24,1,,,,,,,,,
149877-41-8,0,OMOP Exposome,Observation,Substance,Bifenazate,"2-(4-Methoxy(1,1'-biphenyl)-3-yl)hydrazinecarboxylic acid 1-methylethyl ester; Bifenazic acid; Isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate; CHEBI:38660",2014-12-24,1,,,,,,,,,
82657-04-3,0,OMOP Exposome,Observation,Substance,Bifenthrin,,2014-12-24,1,,,,,,,,,
O43252,0,OMOP Exposome,Observation,Substance,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,,2024-09-14,1,,,,,,,,,
P34913,0,OMOP Exposome,Observation,Substance,Bifunctional epoxide hydrolase 2,,2024-09-14,1,,,,,,,,,
P07814,0,OMOP Exposome,Observation,Substance,Bifunctional glutamate/proline--tRNA ligase,,2024-09-14,1,,,,,,,,,
566070-83-5,0,OMOP Exposome,Observation,Substance,Bifunctional hemolysin/adenylate cyclase (Bordetella pertussis),,2014-12-24,1,,,,,,,,,
BE0005827,0,OMOP Exposome,Observation,Substance,Bifunctional protein NCOAT,,2024-09-14,1,,,,,,,,,
P31939,0,OMOP Exposome,Observation,Substance,Bifunctional purine biosynthesis protein PURH,,2024-09-14,1,,,,,,,,,
GIS1007290,0,OMOP Exposome,Observation,Substance,Bile Acid Biosynthesis,,2024-09-14,1,,,,,,,,,
Q96RI1,0,OMOP Exposome,Observation,Substance,Bile acid receptor,,2024-09-14,1,,,,,,,,,
Q14032,0,OMOP Exposome,Observation,Substance,Bile acid-CoA:amino acid N-acyltransferase,,2024-09-14,1,,,,,,,,,
GIS1007291,0,OMOP Exposome,Observation,Substance,Bile Duct,,2024-09-14,1,,,,,,,,,
O95342,0,OMOP Exposome,Observation,Substance,Bile salt export pump,,2024-09-14,1,,,,,,,,,
Q06520,0,OMOP Exposome,Observation,Substance,Bile salt sulfotransferase,,2024-09-14,1,,,,,,,,,
GIS1007292,0,OMOP Exposome,Observation,Substance,Bile secretion,,2024-09-14,1,,,,,,,,,
635-65-4,0,OMOP Exposome,Observation,Substance,Bilirubin,"3-(2-((3-(2-Carboxyethyl)-4-methyl-5-(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl-1H-pyrrol-2-yl)methyl)-4-methyl-5-(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene; 3-2-3-(2-Carboxyethyl)-5-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl-4-methyl-1H-pyrrol-2-ylmethyl-5-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl-4-methyl-1H-pyrrol-3-ylpropanoate; 3-2-3-(2-Carboxyethyl)-5-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl-4-methyl-1H-pyrrol-2-ylmethyl-5-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl-4-methyl-1H-pyrrol-3-ylpropanoic acid; 3-2-3-(2-Carboxyethyl)-5-(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl-4-methyl-1H-pyrrol-2-ylmethyl-5-(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl-4-methyl-1H-pyrrol-3-ylpropanoate; 3-2-3-(2-Carboxyethyl)-5-(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl-4-methyl-1H-pyrrol-2-ylmethyl-5-(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl-4-methyl-1H-pyrrol-3-ylpropanoic acid; Bilirubin IX-alpha; Cholerythrin; (4Z,15Z)-Bilirubin IXa; (Z,Z)-Bilirubin IXa; 1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate; 1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid; 2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate; 2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid; 3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate; 3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid; Hematoidin; CHEBI:16990",2014-12-24,1,,,,,,,,,
P53004,0,OMOP Exposome,Observation,Substance,Biliverdin reductase A,,2024-09-14,1,,,,,,,,,
491-80-5,0,OMOP Exposome,Observation,Substance,Biochanin A,"5,7-Dihydroxy-4'-methoxy-Isoflavone; 4'-Methylgenistein; Biochanin; Biochanin a; Biochanine a; Genistein 4-methyl ether; Olmelin; 5,7-Dihydroxy-4'-methoxy-Isoflavone (8CI); 5,7-Dihydroxy-3-p-methoxyphenyl-4H-chromen-4-one; CHEBI:17574",2014-12-24,1,,,,,,,,,
28434-01-7,0,OMOP Exposome,Observation,Substance,Bioresmethrin,Biobenzyfuroline; 1R-trans-Resemethrin; Resmethrin; 5-Benzyl-3-furylmethyl (+)-trans-chrysanthemate; (+)-trans-resmethrin; 5-Benzyl-3-furylmethyl (1R)-trans-chrysanthemate; CHEBI:39280,2014-12-24,1,,,,,,,,,
GIS1007293,0,OMOP Exposome,Observation,Substance,Biosynthesis Of Amino Acids,,2024-09-14,1,,,,,,,,,
58-85-5,0,OMOP Exposome,Observation,Substance,Biotin,"Biotine; -(+)-biotin; 1swk; 1swn; 1swr; 5-(2-Oxohexahydro-1H-thieno3,4-Dimidazol-4-yl)pentanoate; 5-(2-Oxohexahydro-1H-thieno3,4-Dimidazol-4-yl)pentanoic acid; Appearex; Biodermatin; Bioepiderm; Bios h; Bios II; Biotin Forte; Biotina; Biotinum; cis-(+)-Tetrahydro-2-oxothieno3,4imidazoline-4-valerate; cis-(+)-Tetrahydro-2-oxothieno3,4imidazoline-4-valeric acid; cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid; cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid; Coenzyme R; D(+)-Biotin; D-(+)-Biotin; D-Biotin; D-Biotin factor S; delta-(+)-Biotin; delta-Biotin; delta-Biotin factor S; Factor S; Factor S (vitamin); Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoate; Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoic acid; Hexahydro-2-oxo-3aS-(3aa,4b,6aa)-1H-Thieno3,4-Dimidazole-4-pentanoate; Hexahydro-2-oxo-3aS-(3aa,4b,6aa)-1H-Thieno3,4-Dimidazole-4-pentanoic acid; Hexahydro-2-oxo-3as-(3alpha,4beta,6alpha)-1H-Thieno3,4-Dimidazole-4-pentanoate; Hexahydro-2-oxo-3as-(3alpha,4beta,6alpha)-1H-Thieno3,4-Dimidazole-4-pentanoic acid; Lutavit H2; Meribin; Nail-ex; Rovimix H 2; Vitamin B7; Vitamin H; Vitamin-h; (+)-Biotin; (+)-cis-Hexahydro-2-oxo-1H-thieno3,4imidazole-4-valerate; (+)-cis-Hexahydro-2-oxo-1H-thieno3,4imidazole-4-valeric acid; (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno3,4-Dimidazole-4-valerate; (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno3,4-Dimidazole-4-valeric acid; CHEBI:15956",2014-12-24,1,,,,,,,,,
GIS1007295,0,OMOP Exposome,Observation,Substance,Biotin Metabolism,,2024-09-14,1,,,,,,,,,
P50747,0,OMOP Exposome,Observation,Substance,Biotin--protein ligase,,2024-09-14,1,,,,,,,,,
GIS1007294,0,OMOP Exposome,Observation,Substance,Biotinidase Deficiency,,2024-09-14,1,,,,,,,,,
514-65-8,0,OMOP Exposome,Observation,Substance,Biperiden,Biperideno; alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol; Ipsatol; 1-Bicyclo2.2.1hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol; Akineton; Beperiden; Biperidenum; Biperidine; alpha-Bicyclo2.2.1hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol; Bilino; Biperidene; CHEBI:3112,2014-12-24,1,,,,,,,,,
92-52-4,0,OMOP Exposome,Observation,Substance,Biphenyl,"Phenylbenzene; Lemonene; FEMA 3129; Diphenyl; Bibenzene; 1,1'-Biphenyl; 1, 1'-Diphenyl; Xenene; Tetrosin LY; PHPH; Phenador-X; CHEBI:17097",2014-12-24,1,,,,,,,,,
32005-36-0,0,OMOP Exposome,Observation,Substance,"Bis(1,5-diphenyl-1,4-pentadien-3-one) palladium(0)",,2014-12-24,1,,,,,,,,,
14024-61-4,0,OMOP Exposome,Observation,Substance,"Bis(2,4-pentanedionato) palladium(II)",,2014-12-24,1,,,,,,,,,
111-44-4,0,OMOP Exposome,Observation,Substance,Bis(2-chloroethyl) ether,,2014-12-24,1,,,,,,,,,
34006-76-3,0,OMOP Exposome,Observation,Substance,Bis(2-methoxyethyl) phthalate,,2014-12-24,1,,,,,,,,,
62207-76-5,0,OMOP Exposome,Observation,Substance,Bis(3-fluorosalicylaldehyde)-ethylenediimine-cobalt,,2014-12-24,1,,,,,,,,,
P49789,0,OMOP Exposome,Observation,Substance,Bis(5'-adenosyl)-triphosphatase,,2024-09-14,1,,,,,,,,,
1271-54-1,0,OMOP Exposome,Observation,Substance,Bis(benzene)chromium,,2014-12-24,1,,,,,,,,,
1295-35-8,0,OMOP Exposome,Observation,Substance,Bis(cyclooctadiene)nickel(0),,2014-12-24,1,,,,,,,,,
1779-25-5,0,OMOP Exposome,Observation,Substance,Bis(isobutyl)aluminum chloride,,2014-12-24,1,,,,,,,,,
56-35-9,0,OMOP Exposome,Observation,Substance,Bis(tributyltin) oxide,,2014-12-24,1,,,,,,,,,
39995-74-9,0,OMOP Exposome,Observation,Substance,"Biscarbofuran N,N'-disulfide",,2014-12-24,1,,,,,,,,,
1980-05-07,0,OMOP Exposome,Observation,Substance,Bisphenol A,"Bisphenol a, sodium salt; Hydrogenated bisphenol a; Isopropylidenebis(4-hydroxybenzene); Millad hbpa; Diphenylolpropane; Dimethylmethylene-p,p'-diphenol; Noname; p, p'-Dihydroxydiphenyldimethylmethane; p, p'-Dihydroxydiphenylpropane; p, p'-Isopropylidenediphenol; p,p'-Bisphenol a; p,p'-Dihydroxydiphenyldimethylmethane; p,p'-Dihydroxydiphenylpropane; beta, beta'-Bis(p-hydroxyphenyl)propane; 4-1-(4-Hydroxyphenyl)-1-methylethylphenol; 4,4-Isopropylidenediphenol; 4,4-Isopropylidenediphenol; 4,4'-Propane-2,2-diyldiphenol; 4,4'-Isopropylidenediphenol B; 4,4'-Isopropylidenediphenol; 4,4'-Isopropylidenedi-Phenol; 4,4'-Isopropylidenebisphenol; 4,4'-Isopropylidenebisphenol; 4,4'-Isopropylidene diphenol; 4,4'-Dimethylmethylenediphenol; 4,4'-Dimethylmethylenedi-Phenol; 4,4'-Dihydroxydiphenylpropane; 4,4'-Dihydroxydiphenyldimethylmethane; 4,4'-Dihydroxydiphenyl-2,2-propane; 4,4'-Dihydroxy-2,2-diphenylpropane; 4,4'-Dihydroxdiphenylpropane; 4,4'-Bisphenol A; 4,4'-(Propane-2,2-diyl)diphenol; 4,4'-(1-Methylethylidene)bisphenol, 9CI; 4,4'-(1-Methylethylidene)bisphenol; 4,4'-(1-Methylethylidene)bis-Phenol; 4,4'-(1-Methylethane-1,1-diyl)diphenol; 4,4' Isopropylidinediphenol; 4, 4'-Dihydroxydiphenylpropane; 4, 4'-Dihydroxydiphenyldimethylmethane; 4, 4'-Dihydroxydiphenyl-2,2-propane; 2,2-(4,4'-Dihydroxydiphenyl)propane; 2,2-(4,4-Dihydroxydiphenyl)propane; 2,2-Bis (4-hydroxyphenol) propane; 4, 4'-Bisphenol A; 2,2-Di-(4'-Hydroxyphenyl)-propane; 2,2-Di(4-phenylol)propane; 2,2-Di(4-hydroxyphenyl)propane; 2,2-Bis4-Hydroxyphenylpropane; 2,2-Bis-4'-hydroxyfenylpropan; 2,2-Bis(p-hydroxyphenyl)propane; 2,2-Bis(p-hydroxyphenyl)-Propane; 2,2-Bis(hydroxyphenyl)propane; 2,2-Bis(4-hydroxyphenyl)propane; 2,2-Bis(4,4'-hydroxyphenyl)propane; 2,2-Bis(4'-hydroxyphenyl)propane; p,p'-Isopropylidenebisphenol; p,p'-Isopropylidenediphenol; Parabis; Parabis a; Rikabanol; Ucar bisphenol a; (1-methylethylidene)bis-Phenol; 1,1'-(1-Methylethylidene)bisphenylol, 9CI; 2, 2-Bis(4-hydroxyphenyl)propane; 2, 2-Bis(hydroxyphenyl)propane; Dimethylbis(p-hydroxyphenyl)methane; Dimethyl bis(p-hydroxyphenyl)methane; Diano; Dian; Di-2,2-(4-Hydroxyphenyl)propane; BPA; Bisphenol a.; Ipognox 88; Bisphenol a, disodium salt; Bisphenol a (bpa); Bisphenol a; 2, 2-Di(4-phenylol)propane; 2,2'-Bis(4-hydroxyphenyl)propane; Bisphenol; Bisferol a; Bis(p-hydroxyphenyl)propane; Ucar bisphenol HP; Bis(4-hydroxyphenyl)propane; Bis(4-hydroxyphenyl)dimethylmethane; Bis(4-hydroxyphenyl) propane; Bis(4-hydroxyphenyl) dimethylmethane; Bis(4-hyd roxyphenyl) dimethylmethane; Biphenol a; beta-Di-p-hydroxyphenylpropane; beta-Di-(p-hydroxyphenyl)propane; beta,beta-Di-(p-hydroxyphenyl)propane; beta,beta'-Bis(p-hydroxyphenyl)propane; CHEBI:33216",2014-12-24,1,,,,,,,,,
GIS1007296,0,OMOP Exposome,Observation,Substance,Bisphosphonate,,2024-09-14,1,,,,,,,,,
GIS1007307,0,OMOP Exposome,Observation,Substance,Bladder,,2024-09-14,1,,,,,,,,,
11056-06-7,0,OMOP Exposome,Observation,Substance,Bleomycin,Bleomycin sulphate; Bleomycine; Bleomycinum; BLM; Bleomycin sulfate; Bleo; Blenoxane; Bleocin; Bleomicin; Bleomicina; Bleomycin A2; CHEBI:22907,2014-12-24,1,,,,,,,,,
GIS1007308,0,OMOP Exposome,Observation,Substance,Blood,,2024-09-14,1,,,,,,,,,
GIS1007309,0,OMOP Exposome,Observation,Substance,Bone Density Conservation Agent,,2024-09-14,1,,,,,,,,,
GIS1007310,0,OMOP Exposome,Observation,Substance,Bone Marrow,,2024-09-14,1,,,,,,,,,
Q13873,0,OMOP Exposome,Observation,Substance,Bone morphogenetic protein receptor type-2,,2024-09-14,1,,,,,,,,,
10043-35-3,0,OMOP Exposome,Observation,Substance,Boric acid (H3BO3),"Orthoboric acid (H3BO3); Super flea eliminator; Tetraborate; Three elephant; Trihydroxidoboron; Trihydroxyborane; Trihydroxyborone; B(OH)3; (10B)Orthoboric acid; 1332-77-0 (Di-potassium salt); Acidum boricum; Ant flip; B(OH)3; Basilit b; Bluboro; Boracic acid; Borate; Borate (B4O7(2-)); Borate (H3bo3); Boric acid; Boric acid (BH3O3); Boric acid (H310BO3); Boric acid (H3bo3); Boric acid (JP15/NF); Boric acid, acs; Borofax; Boron hydroxide; Boron trihydroxide; Collyrium eye wash; Dr.'S 1 Flea Terminator DF; Dr.'S 1 Flea Terminator DFPBO; Dr.'S 1 Flea Terminator DT; Dr.'S 1 Flea Terminator DTPBO; Flea prufe; Heptaoxotetra-Borate(2-); Homberg'S salt; Hydrogen orthoborate; Kill-off; Kjel-sorb; Orthboric acid; Orthoboric acid; Orthoboric acid (B(OH)3); CHEBI:33118",2014-12-24,1,,,,,,,,,
12005-69-5,0,OMOP Exposome,Observation,Substance,Boron arsenide,,2014-12-24,1,,,,,,,,,
20205-91-8,0,OMOP Exposome,Observation,Substance,Boron phosphide,,2014-12-24,1,,,,,,,,,
10294-33-4,0,OMOP Exposome,Observation,Substance,Boron tribromide,,2014-12-24,1,,,,,,,,,
188425-85-6,0,OMOP Exposome,Observation,Substance,Boscalid,,2014-12-24,1,,,,,,,,,
GIS1007311,0,OMOP Exposome,Observation,Substance,Botulinal Neurotoxin,,2024-09-14,1,,,,,,,,,
GIS1007312,0,OMOP Exposome,Observation,Substance,Botulinum neurotoxin type A,,2024-09-14,1,,,,,,,,,
GIS1007319,0,OMOP Exposome,Observation,Substance,Botulinum neurotoxin type B,,2024-09-14,1,,,,,,,,,
GIS1007326,0,OMOP Exposome,Observation,Substance,Botulinum neurotoxin type C1,,2024-09-14,1,,,,,,,,,
GIS1007333,0,OMOP Exposome,Observation,Substance,Botulinum neurotoxin type D,,2024-09-14,1,,,,,,,,,
GIS1007340,0,OMOP Exposome,Observation,Substance,Botulinum neurotoxin type E,,2024-09-14,1,,,,,,,,,
GIS1007347,0,OMOP Exposome,Observation,Substance,Botulinum neurotoxin type F,,2024-09-14,1,,,,,,,,,
GIS1007354,0,OMOP Exposome,Observation,Substance,Botulinum neurotoxin type G,,2024-09-14,1,,,,,,,,,
93384-43-1,0,OMOP Exposome,Observation,Substance,Botulinum toxin,,2014-12-24,1,,,,,,,,,
504-88-1,0,OMOP Exposome,Observation,Substance,Bovinocidin,"3-NPA; 3-NP acid; 3-Nitropropionic acid, 8CI; 3-Nitropropionic acid; 3-Nitropropionate; 3-Nitropropanoate; 3-Nitro-Propionic acid; 3-Nitro-Propanoic acid; Propanoic acid, 3-nitro- (9CI); NSC 64266; Nitropropionic acid, beta; 3-Nitro-1-propionate; Hiptagenic acid; BNP; beta-Nitropropionic acid; beta-Nitropropanoic acid; beta-Nitropropanoate; beta -nitropropionic acid; 504-88-1 (FREE ACID); CHEBI:16348",2014-12-24,1,,,,,,,,,
GIS1007361,0,OMOP Exposome,Observation,Substance,Box jellyfish toxin (Chironex fleckeri),,2024-09-14,1,,,,,,,,,
GIS1007368,0,OMOP Exposome,Observation,Substance,Brain,,2024-09-14,1,,,,,,,,,
GIS1007369,0,OMOP Exposome,Observation,Substance,Brain Plaques,,2024-09-14,1,,,,,,,,,
P54687,0,OMOP Exposome,Observation,Substance,"Branched-chain-amino-acid aminotransferase, cytosolic",,2024-09-14,1,,,,,,,,,
O15382,0,OMOP Exposome,Observation,Substance,"Branched-chain-amino-acid aminotransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1007370,0,OMOP Exposome,Observation,Substance,Brassinosteroid Biosynthesis,,2024-09-14,1,,,,,,,,,
98112-41-5,0,OMOP Exposome,Observation,Substance,Brevetoxin,,2014-12-24,1,,,,,,,,,
79580-28-2,0,OMOP Exposome,Observation,Substance,Brevetoxin B,,2014-12-24,1,,,,,,,,,
59803-98-4,0,OMOP Exposome,Observation,Substance,Brimonidine,Brimonidine tartrate; Bromoxidine; Alphagan; Mirvaso; Brimonidinum; Brimonidina; 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline; CHEBI:3175,2014-12-24,1,,,,,,,,,
56073-10-0,0,OMOP Exposome,Observation,Substance,Brodifacoum,,2014-12-24,1,,,,,,,,,
314-40-9,0,OMOP Exposome,Observation,Substance,Bromacil,,2014-12-24,1,,,,,,,,,
28772-56-7,0,OMOP Exposome,Observation,Substance,Bromadiolone,,2014-12-24,1,,,,,,,,,
GIS1007371,0,OMOP Exposome,Observation,Substance,Bromate Compound,,2024-09-14,1,,,,,,,,,
1812-30-2,0,OMOP Exposome,Observation,Substance,Bromazepam,"Ultramidol; Bromazepamum; Lekotam; Durazanil; Creosedin; Calmepam; Lectopam; Lexotan; 7-Bromo-5-(2-pyridyl)-3H-1,4-benzodiazepin-2(1H)-one; Lexomil; Lexilium; Normoc; 7-Bromo-5-(2-pyridyl)-3H-1,4-benzodiaxepin-2(1H)-one; Lexaurin; CHEBI:116960",2014-12-24,1,,,,,,,,,
7789-31-3,0,OMOP Exposome,Observation,Substance,Bromic acid,Bromsaeure; HBrO3; Hydroxidodioxidobromine; BrO2(OH); Bromate; CHEBI:49382,2014-12-24,1,,,,,,,,,
GIS1007372,0,OMOP Exposome,Observation,Substance,Bromide Compound,,2024-09-14,1,,,,,,,,,
24959-67-9,0,OMOP Exposome,Observation,Substance,Bromide ion,Bromide (1-); Br(-); Bromide; Bromine anion; CHEBI:15858,2014-12-24,1,,,,,,,,,
GIS1007373,0,OMOP Exposome,Observation,Substance,Brominated Dibenzofuran,,2024-09-14,1,,,,,,,,,
7726-95-6,0,OMOP Exposome,Observation,Substance,Bromine,Brom; Br2; Bromine gas; Bromine liquid; Dibromine; CHEBI:29224,2014-12-24,1,,,,,,,,,
21255-83-4,0,OMOP Exposome,Observation,Substance,Bromine dioxide,(obro)(.); BrO2(.); Dioxidobromine(.); OBrO; CHEBI:29874,2014-12-24,1,,,,,,,,,
7789-30-2,0,OMOP Exposome,Observation,Substance,Bromine pentafluoride,,2014-12-24,1,,,,,,,,,
7787-71-5,0,OMOP Exposome,Observation,Substance,Bromine trifluoride,,2014-12-24,1,,,,,,,,,
13863-41-7,0,OMOP Exposome,Observation,Substance,Bromine(I) chloride,,2014-12-24,1,,,,,,,,,
79-08-3,0,OMOP Exposome,Observation,Substance,Bromoacetic acid,,2014-12-24,1,,,,,,,,,
598-31-2,0,OMOP Exposome,Observation,Substance,Bromoacetone,"1-Bromo-2-propanone; Martonite; CH3COCH2Br; Bromomethyl methyl ketone; Monobromoacetone; Bromo-2-propanone; Ba (tear gas); BA; B-stoff; Alpha-bromoacetone; Acetylmethyl bromide; Acetyl methyl bromide; Acetonyl bromide; a-bromoacetone; 2-Propanone, 1-bromo- (9CI); 1-bromopropan-2-one; 1-Bromoacetone; .alpha.-bromoacetone; CHEBI:51845",2014-12-24,1,,,,,,,,,
108-86-1,0,OMOP Exposome,Observation,Substance,Bromobenzene,"bromobenzene, 14C-labeled; C6H5Br; Monobromobenzene; PhBr; Phenyl bromide; 1-Bromobenzene; 4-Bromopolystyrene; Bromo-benzene; CHEBI:3179",2014-12-24,1,,,,,,,,,
5798-79-8,0,OMOP Exposome,Observation,Substance,Bromobenzyl cyanide,,2014-12-24,1,,,,,,,,,
71418-44-5,0,OMOP Exposome,Observation,Substance,Bromobimane,"Monobromobimane; MBBR; Bimane monobromide; Thiolyte\u00c2\u00ae MB reagent; 9,10-Dioxa-syn-(bromomethyl,methyl)(methyl,methyl)bimane; MBB; Thiolyte MB; CHEBI:62825",2014-12-24,1,,,,,,,,,
25614-03-3,0,OMOP Exposome,Observation,Substance,Bromocriptine,"Bromocriptina; (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman; (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman; 2-Bromo-alpha-ergocryptine; 2-Bromo-alpha-ergokryptin; 2-Bromo-alpha-ergokryptine; 2-bromo-\u03b1-ergocryptine; 2-bromo-\u03b1-ergokryptin; 2-bromo-\u03b1-ergokryptine; Apo-Bromocriptine; Bagren; Bromergocryptine; Bromocriptin; Bromocriptine Methanesulfonate; Bromocriptinum; Bromocryptine; Bromoergocriptine; Bromoergocryptine; CYCLOSET; Ergoset; Parlodel; Parlodel Snaptabs; Pravidel; CHEBI:3181",2014-12-24,1,,,,,,,,,
59-14-3,0,OMOP Exposome,Observation,Substance,Bromodeoxyuridine,"5-Budr; Uridine, 5-bromo-2'-deoxy- ( ); Radibud; BUDR; Brudr; Broxuridine; Bromouracil deoxyriboside; Bromoouridine; BRDU; BDU; 5-Bromouracil-2-deoxyriboside; 5-Bromouracil deoxyriboside; 5-Bromodesoxyuridine; 5-Bromodeoxyuridine; 5-Bromo-dURD; 5-Bromo-2-deoxyuridine; 5-Bromo-2'-deoxyuridine (BRDU); 5-BROMO-2'-DEOXYURIDINE; 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil; 5-BrdU; 5-Bdu; CHEBI:472552",2014-12-24,1,,,,,,,,,
107227-60-1,0,OMOP Exposome,Observation,Substance,Bromodichlorodibenzofuran,,2014-12-24,1,,,,,,,,,
3832-48-2,0,OMOP Exposome,Observation,Substance,Bromodifluoroacetyl chloride,,2014-12-24,1,,,,,,,,,
118-23-0,0,OMOP Exposome,Observation,Substance,Bromodiphenhydramine,"Amodryl; 2-(P-Bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine; beta-(P-Bromobenzhydryloxy)ethyldimethylamine; beta-Dimethylaminoethyl P-bromobenzhydryl ether; Bromazin; Bromazina; Bromazine; Bromazinum; Bromdiphenhydramine; CHEBI:59177",2014-12-24,1,,,,,,,,,
O60885,0,OMOP Exposome,Observation,Substance,Bromodomain-containing protein 4,,2024-09-14,1,,,,,,,,,
74-96-4,0,OMOP Exposome,Observation,Substance,Bromoethane,,2014-12-24,1,,,,,,,,,
75-25-2,0,OMOP Exposome,Observation,Substance,Bromoform,MBR; Methyl tribromide; Tribrommethaan; Tribrommethan; Tribromometan; Tribromomethane; Tribromomethane; methyl tribromide; Tribromomethyl radical; Bromoforme; Bromoformio; CHBr3; Methenyl tribromide; CHEBI:38682,2014-12-24,1,,,,,,,,,
74-83-9,0,OMOP Exposome,Observation,Substance,Bromomethane,"Bromur di metile; Bromometano; Bromo-Methane; Brommethan; Brom-O-sol; Brom-O-gaz; EDCO; Drexel plant bed gas; Dowfume mc-33; Dowfume MC-2R; Dowfume mc-2 soil fumigant; Brom-O-gas methyl bromide soil fumigant; Brom-O-gas; Brom-methan; BMM; Bercema; Zytox; Tri-brom; Terr-O-gas 67; Terr-O-gas 100; Terr-O-gas; Dow Fume MC2; Terr-O-cide II; Terabol; Halon 1001; Methyl bromide rodent fumigant (with chloropicrin); Curafume; Fumigant-1 (Obs.); Fumigant-1; Embafume; Dawson 100; Detia gas ex-m; CH3Br; Celfume; Broommethaan; Bromuro di metile; Bromure de methyle; Methyl bromide, 14C-labeled; Methyl bromide, BSI, ISO, JMAF; Methyl fume; Methylbromid; Methylbromide; Metylu bromek; Monobrommethan; Monobromomethane; Pestmaster; Pestmaster (obs.); Pestmaster Soil Fumigant-1; Profume; Dowfume MC-2 Fumigant; Dowfume mc-2; Dowfume; Haltox; Iscobrome; Kayafume; M-b-c Fumigant; MB; MBC soil fumigant; Superior Methyl Bromide-2; Rotox; Rfdfif@; R 40B1; Profume (obs.); Mbc-33 Soil Fumigant; MBX; Meb R; MEBR; Merth-O-gas; Metafume; Meth-O-gas; Methogas; Methyl bromide; Methyl bromide as a structural fumigant; Chlorodibromomethane; CHEBI:39275",2014-12-24,1,,,,,,,,,
816-40-0,0,OMOP Exposome,Observation,Substance,Bromomethyl ethyl ketone,,2014-12-24,1,,,,,,,,,
14220-21-4,0,OMOP Exposome,Observation,Substance,Bromopentacarbonylrhenium(I),,2014-12-24,1,,,,,,,,,
1689-84-5,0,OMOP Exposome,Observation,Substance,Bromoxynil,"Hydroxy-3,5-dibromobenzonitrile; Labuctril; Labuctril 25; Litarol; Litarol m; ME4 BROMINAL; Merit; Novacorn; Nu-lawn weeder; Oxytril m; PACK; Pardner; Sabre; Terset; Toplan; Torch; Bromoxynil, sodium salt; Bromoxynil, potassium salt; Bromoxynil + atrazine; Buctril-atrazine; Bromoxynil (acn); Bromotril; Brominil; Brominex; Brominal triple; Brominal plus; Brominal ME4; Brominal industrial; Brominal; Brittox; Broxynil; 4-Cyano-2,6-dibromophenol; 3,5-Dibromo-4-hydroxyphenylcyanide; 3,5-dibromo-4-hydroxyphenyl cyanide; 3,5-Dibromo-4-hydroxybenzonitrile; 3,5-Dibromo-4-hydroxybenzonitril (ACN); 2,6-Dibromo-4-cyanophenol; Certrol b; Butilchlorofos; Chipco buctril; Chipco crab-kleen; Buctril industrial; Butil chlorofos; Buctril 4EC; Buctril; Bucril; 4-Hydroxy-3,5-dibromobenzonitrile; Butilchorofos; Dibromo-4-cyanophenol; Bronate; Bromoxynil-methyl ether; Dibromo-4-hydroxybenzonitrile; Dibromo-4-hydroxyphenyl cyanide; Harness; CHEBI:17192",2014-12-24,1,,,,,,,,,
86-22-6,0,OMOP Exposome,Observation,Substance,Brompheniramine,"3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; Bromfeniramina; Dimetane; Bromfenex; Lodrane; 3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl-dimethyl-amine; Brompheniramin; Bromph\u00e9niramine; BPN; Brompheniraminum; 3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine; 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine; 1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; Bromfed; CHEBI:3183",2014-12-24,1,,,,,,,,,
GIS1007374,0,OMOP Exposome,Observation,Substance,Bronchodilator Agent,,2024-09-14,1,,,,,,,,,
30007-47-7,0,OMOP Exposome,Observation,Substance,Bronidox,,2014-12-24,1,,,,,,,,,
52-51-7,0,OMOP Exposome,Observation,Substance,Bronopol,,2014-12-24,1,,,,,,,,,
57801-81-7,0,OMOP Exposome,Observation,Substance,Brotizolam,,2014-12-24,1,,,,,,,,,
521-74-4,0,OMOP Exposome,Observation,Substance,Broxyquinoline,,2014-12-24,1,,,,,,,,,
357-57-3,0,OMOP Exposome,Observation,Substance,Brucine,,2014-12-24,1,,,,,,,,,
487-93-4,0,OMOP Exposome,Observation,Substance,Bufotenin,"Indol-5-ol, {3-2-(dimethylamino)ethyl-}; 5-Hydroxy-N,N-dimethyltryptamine; DM5-HT; Mapine; Mappin; Mappine; 5-Hydroxy-N, N-dimethyltryptamine; 3-beta-(Dimethylamino)ethyl-5-hydroxyindole; 3-2-(Dimethylamino)ethylindol-5-ol; 3-2-(Dimethylamino)ethyl-Indol-5-ol; 3-2-(Dimethylamino)ethyl-5-indolol; 3-2-(Dimethylamino)ethyl-1H-Indol-5-ol; 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-Dimethylaminoethyl)indol-5-ol; 3-(2-Dimethylaminoethyl)-5-indolol; 3-(2-(dimethylamino)Ethyl)-1H-indol-5-ol; 1H-Indol-5-ol, {3-2-(dimethylamino)ethyl-}; N, N-Dimethylserotonin; N,N-Dimethyl-5-hydroxytryptamine; N,N-Dimethylserotonin; {3-(2-Dimethylamino)ethyl-5-indolol}; {3-(beta-Dimethylamino)ethyl-5-hydroxyindole}; Dimethylserotonin; Cohoba; Cinobufotenine; Bufotenine; CHEBI:3210",2014-12-24,1,,,,,,,,,
2180-92-9,0,OMOP Exposome,Observation,Substance,Bupivacaine,"Sensorcaine-MPF; Sensorcaine; Racemic bupivacaine; dl-1-Butyl-2',6'-pipecoloxylidide; DL-Bupivacaine; DUR-843; EXPAREL; LAC-43; Bupivacaine HCL KIT; Bupivacaina; Bupivacaine HCL; Bloqueina; Marcaina; Marcain; Marcaine; Bupivacainum; Bupivan; Carbostesin; CBupivacaine; 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide; 1-Butyl-2',6'-pipecoloxylidide; (RS)-bupivacaine; (+-)-Bupivacaine; Vivacaine; CHEBI:3215",2014-12-24,1,,,,,,,,,
GIS1007375,0,OMOP Exposome,Observation,Substance,Bupivacaine Pathway,,2024-09-14,1,,,,,,,,,
52485-79-7,0,OMOP Exposome,Observation,Substance,Buprenorphine,"Buprenex; Tidigesic; Temgesic; Subutex; Probuphine; Norspan; (-)-Buprenorphine; (\u2212)-buprenorphine; 17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol; 2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol; 2-3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo13.2.2.12,8.01,6.06,14.07,12icosa-7,9,11-trien-16-yl-3,3-dimethyl-2-butanol; 21-Cyclopropyl-7alpha-(S)-1-hydroxy-1,2,2-trimethylpropyl-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine; Addnok; Buprel; Buprenophine; Buprenorfina; Buprenorphinum; Buprigesic; Butrans; Morgesic; Norphin; CHEBI:3216",2014-12-24,1,,,,,,,,,
69327-76-0,0,OMOP Exposome,Observation,Substance,Buprofezin,"(2Z)-2-(Tert-butylimino)-3-isopropyl-5-phenyl-1,3,5-thiadiazinan-4-one; CHEBI:39381",2014-12-24,1,,,,,,,,,
34841-39-9,0,OMOP Exposome,Observation,Substance,Bupropion,Wellbatrin; Wellbutrin; Wellbutrin SR; Forfivo; Voxra; Wellbutrin XL; Amfebutamone; Prexaton; (+-)-Bupropion; Amfebutamona; Zyban; Elontril; BUPROBAN; Aplenzin; Budeprion; Amfebutamonum; CHEBI:3219,2014-12-24,1,,,,,,,,,
36505-84-7,0,OMOP Exposome,Observation,Substance,Buspirone,"Epsilat; Dalpas; Buspon; Buspironum; Buspirona; Buspiron; Buspar; Pasrin; Spamilan; Buscalm; 8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione; Ansial; Busp; Anxiron; Anxut; Bespar; CHEBI:3223",2014-12-24,1,,,,,,,,,
55-98-1,0,OMOP Exposome,Observation,Substance,Busulfan,"Buzulfan; Tetramethylenester Kyseliny Methansulfonove; Tetramethylene Dimethane Sulfonate; Tetramethylene bis(methanesulfonate); Sulphabutin; Sulfabutin; Myleran; Myeloleukon; Mitostan; Misulban; Mielucin; Mablin; Leucosulfan; Butanedioldimethanesulfonate; Busulphane; Busulphan; Busulfex; Busulfanum; Busulfano; Busilvex; Bisulfex; 1,4-Dimethanesulfonoxybutane; 1,4-Dimesyloxybutane; 1,4-Butanediol dimethanesulfonate; 1,4-Bis(methanesulfonoxy)butane; CHEBI:28901",2014-12-24,1,,,,,,,,,
125-40-6,0,OMOP Exposome,Observation,Substance,Butabarbital,"Butisol; Butrate; Sarisol No. 2; Secbubarbital; 5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; Secbutabarbital; Secbutobarbital; Secbutobarbitone; Sodium Butabarbital; 5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione; Butabarbitone; 5-Sec-butyl-5-ethylbarbituric acid; 5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-Ethyl-5-(1-methylpropyl)barbituric acid; Butalan; CHEBI:3228",2014-12-24,1,,,,,,,,,
2655-19-8,0,OMOP Exposome,Observation,Substance,Butacarb,,2014-12-24,1,,,,,,,,,
23184-66-9,0,OMOP Exposome,Observation,Substance,Butachlor,,2014-12-24,1,,,,,,,,,
134605-64-4,0,OMOP Exposome,Observation,Substance,Butafenacil,,2014-12-24,1,,,,,,,,,
GIS1007376,0,OMOP Exposome,Observation,Substance,Butanoate metabolism,,2024-09-14,1,,,,,,,,,
78-93-3,0,OMOP Exposome,Observation,Substance,Butanone,Butan-2-one; 2-Butanone; Methyl ethyl ketone; MEK; Ethyl methyl ketone; CHEBI:28398,2014-12-24,1,,,,,,,,,
16275-44-8,0,OMOP Exposome,Observation,Substance,Butenolide,,2014-12-24,1,,,,,,,,,
77-28-1,0,OMOP Exposome,Observation,Substance,Butethal,"5-Butyl-5-ethylbarbituric acid; 5-Butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; Butyl,5-ethylbarbituric acid; Butobarbital; Butobarbitural; Butobarbitone; Butobarbitalum; Butabarbitol; 5-Ethyl-5-N-butylbarbituric acid; Neonal; Soneryl; 5-Ethyl-5-butylbarbituric acid; CHEBI:519412",2014-12-24,1,,,,,,,,,
34681-10-2,0,OMOP Exposome,Observation,Substance,Butocarboxim,"Butocarboxime; Drawin 755; N-(methylcarbamoyloxy)-3-(methylsulfanyl)butan-2-imine; 2-Butanone, 3-(methylthio)-, O-(N-methylcarbamoyl)oxime; 2-Methylthio-O-(N-methylcarbamoyl)-butanonoxim-3; 3-(Methylthio)-2-butanone O-((methylamino)carbonyl)oxime; 3-(Methylthio)-2-butanone O-(methylcarbamoyl)oxime; 3-(Methylthio)-O-((methylamino)carbonyl)oxime-2-butanone; 3-(Methylthio)butanone O-methylcarbamoyloxime; Afiline; CHEBI:38465",2014-12-24,1,,,,,,,,,
42408-82-2,0,OMOP Exposome,Observation,Substance,Butorphanol,"Butorfanol; Butaro; (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol; (-)-Butorphanol; (-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan; Stadol NS; Stadol; Butrum; Butorphanolum; Butorphanol Tartrate; CHEBI:3242",2014-12-24,1,,,,,,,,,
34681-23-7,0,OMOP Exposome,Observation,Substance,Butoxycarboxim,"Butoxycarboxime; 3-(Methylsulfonyl)-2-butanone O-(methylcarbamoyl)oxime; 3-(Sulfonyl)-O-((methylamino)carbonyl)oxime-2-butanone; Plant pin; 3-Methylsulfonylbutanone O-methylcarbamoyloxime; 3-Methylsulphonylbutanone O-methylcarbamoyloxime; 2-Butanone, 3-methylsulfonyl-, O-(N-methylcarbamoyl)oxime; N-(methylcarbamoyloxy)-3-(methanesulfonyl)butan-2-imine; Caswell No. 120A; 3-Mesylbutanone O-methylcarbamoyloxime; CHEBI:38470",2014-12-24,1,,,,,,,,,
33629-47-9,0,OMOP Exposome,Observation,Substance,Butralin,,2014-12-24,1,,,,,,,,,
6606-65-1,0,OMOP Exposome,Observation,Substance,Butyl cyanoacrylate,"n-Butyl-2-cyanoacrylate; Enbucrilate; Histoacryl; Butyl 2-cyanoacrylate polymers; Butyl 2-cyanoacrylate; Polybutylcyanoacrylate nanoparticles; Butyl 2-cyano-2-propenoate; 2-Propenoic acid, 2-cyano-, butyl ester; Acrylic acid, 2-cyano-, butyl ester, polymers; Butyl cyanoacrylic acid; Polybutylcyanoacrylate; CHEBI:25520",2014-12-24,1,,,,,,,,,
84-64-0,0,OMOP Exposome,Observation,Substance,Butyl cyclohexyl phthalate,"Butyl cyclohexyl phthalic acid; 1,2-Benzenedicarboxylic acid 1-butyl 2-cyclohexyl ester; 1,2-Benzenedicarboxylic acid butyl cyclohexyl ester; Phthalic acid, butyl cyclohexyl ester (8CI); Elastex 50B; Cyclohexyl butyl phthalate; 1-Butyl 2-cyclohexyl phthalate; CHEBI:36605",2014-12-24,1,,,,,,,,,
89-19-0,0,OMOP Exposome,Observation,Substance,Butyl decyl phthalate,"Butyl decyl phthalic acid; Phthalic acid, butyl decyl ester; Decyl butyl phthalate; Plasticizer BDP; 1,2-Benzenedicarboxylic acid, butyl decyl ester; 1-Butyl 2-decyl phthalate; Bis(2-ethylhexyl)phthalate; Dioctyl phthalate; CHEBI:17747",2014-12-24,1,,,,,,,,,
138-22-7,0,OMOP Exposome,Observation,Substance,Butyl lactate,,2014-12-24,1,,,,,,,,,
2008-41-5,0,OMOP Exposome,Observation,Substance,Butylate,,2014-12-24,1,,,,,,,,,
104-51-8,0,OMOP Exposome,Observation,Substance,Butylbenzene,n-butylbenzene; 1-phenylbutane; 1-butylbenzene; CHEBI:44194,2014-12-24,1,,,,,,,,,
94-26-8,0,OMOP Exposome,Observation,Substance,Butylparaben,,2014-12-24,1,,,,,,,,,
107-92-6,0,OMOP Exposome,Observation,Substance,Butyric acid,N-Butanoic acid; Kyselina maselna; Honey robber; Ethylacetic acid; Ethylacetate; Butyrate; Buttersaeure; Butanoic acid; Butanoate; Butanic acid; Butanate; 1-Propanecarboxylic acid; 1-Propanecarboxylate; 1-Butyric acid; 1-Butyrate; 1-Butanoic acid; 1-Butanoate; Propylformic acid; Propylformate; Propanecarboxylic acid; Propanecarboxylate; N-Butyric acid; N-Butyrate; N-Butanoate; CHEBI:30772,2014-12-24,1,,,,,,,,,
109-74-0,0,OMOP Exposome,Observation,Substance,Butyronitrile,"n-C3H7CN; 1-Cyanopropane, butyronitrile; Butane nitrile; Butyric acid nitrile; Butyrylonitrile; N-butanenitrile; N-butanitrile; N-butyronitrile; N-propyl cyanide; 1-Cyanopropane; Propyl cyanide; Propylkyanid; CHEBI:51937",2014-12-24,1,,,,,,,,,
GIS1007377,0,OMOP Exposome,Observation,Substance,Butyrophenone,,2024-09-14,1,,,,,,,,,
GIS1007388,0,OMOP Exposome,Observation,Substance,Butyrophenones,,2024-09-14,1,,,,,,,,,
P41597,0,OMOP Exposome,Observation,Substance,C-C chemokine receptor type 2,,2024-09-14,1,,,,,,,,,
P51679,0,OMOP Exposome,Observation,Substance,C-C chemokine receptor type 4,,2024-09-14,1,,,,,,,,,
P13500,0,OMOP Exposome,Observation,Substance,C-C motif chemokine 2,,2024-09-14,1,,,,,,,,,
Q9Y258,0,OMOP Exposome,Observation,Substance,C-C motif chemokine 26,,2024-09-14,1,,,,,,,,,
P80075,0,OMOP Exposome,Observation,Substance,C-C motif chemokine 8,,2024-09-14,1,,,,,,,,,
7168-64-1,0,OMOP Exposome,Observation,Substance,C-Curarine,,2014-12-24,1,,,,,,,,,
Q9UQF2,0,OMOP Exposome,Observation,Substance,C-Jun-amino-terminal kinase-interacting protein 1,,2024-09-14,1,,,,,,,,,
Q13387,0,OMOP Exposome,Observation,Substance,C-Jun-amino-terminal kinase-interacting protein 2,,2024-09-14,1,,,,,,,,,
Q9UPT6,0,OMOP Exposome,Observation,Substance,C-Jun-amino-terminal kinase-interacting protein 3,,2024-09-14,1,,,,,,,,,
O60271,0,OMOP Exposome,Observation,Substance,C-Jun-amino-terminal kinase-interacting protein 4,,2024-09-14,1,,,,,,,,,
P25024,0,OMOP Exposome,Observation,Substance,C-X-C chemokine receptor type 1,,2024-09-14,1,,,,,,,,,
P02778,0,OMOP Exposome,Observation,Substance,C-X-C motif chemokine 10,,2024-09-14,1,,,,,,,,,
Q07325,0,OMOP Exposome,Observation,Substance,C-X-C motif chemokine 9,,2024-09-14,1,,,,,,,,,
4548-53-2,0,OMOP Exposome,Observation,Substance,C.I. Food Red 1,,2014-12-24,1,,,,,,,,,
81409-90-7,0,OMOP Exposome,Observation,Substance,Cabergoline,(8R)-6-Allyl-N-3-(dimethylamino)propyl-N-(ethylcarbamoyl)ergoline-8-carboxamide; 1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea; 1-(6-Allylergoline-8beta-yl)carbonyl-1-3-(dimethylamino)propyl-3-ethylurea; Cabaser; Cabergolina; Cabergolinum; Dostinex; (8beta)-N-3-(dimethylamino)Propyl-N-(ethylamino)carbonyl-6-(2-propenyl)-ergoline-8-carboxamide; 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; CHEBI:3286,2014-12-24,1,,,,,,,,,
471-35-2,0,OMOP Exposome,Observation,Substance,Cacodyl,,2014-12-24,1,,,,,,,,,
503-80-0,0,OMOP Exposome,Observation,Substance,Cacodyl oxide,,2014-12-24,1,,,,,,,,,
7440-43-9,0,OMOP Exposome,Observation,Substance,Cadmium,Cadmium(II); Cadmium(2+) ion; Cd(2+); Cd2+; Metallic cadmium; Cadmium(II) ion; Cadmium(II) cation; Cadmium ion; Cadmium(2+); CHEBI:48775,2014-12-24,1,,,,,,,,,
2420-98-6,0,OMOP Exposome,Observation,Substance,Cadmium 3-ethylhexanoate,,2014-12-24,1,,,,,,,,,
543-90-8,0,OMOP Exposome,Observation,Substance,Cadmium acetate,Cadmium(II) acetate; ACT; ACY; Bis(acetoxy)cadmium; Cadmium ethanoate; Cadmium diacetate; Cadmium acetic acid; Cadmium di(acetate); Cadmium(2+) acetate; CHEBI:15366,2014-12-24,1,,,,,,,,,
12006-15-4,0,OMOP Exposome,Observation,Substance,Cadmium arsenide,,2014-12-24,1,,,,,,,,,
14518-94-6,0,OMOP Exposome,Observation,Substance,Cadmium bromate,,2014-12-24,1,,,,,,,,,
7789-42-6,0,OMOP Exposome,Observation,Substance,Cadmium bromide,,2014-12-24,1,,,,,,,,,
513-78-0,0,OMOP Exposome,Observation,Substance,Cadmium carbonate,,2014-12-24,1,,,,,,,,,
10108-64-2,0,OMOP Exposome,Observation,Substance,Cadmium chloride,"cadmium(2+) chloride; Vi-cad; Chloride, cadmium; Cadmium(II) chloride; Dichlorocadmium; Dichloride, cadmium; Cadmium turf fungicide; CdCl2; CHEBI:35456",2014-12-24,1,,,,,,,,,
GIS1007389,0,OMOP Exposome,Observation,Substance,Cadmium Compound,,2024-09-14,1,,,,,,,,,
542-83-6,0,OMOP Exposome,Observation,Substance,Cadmium cyanide,,2014-12-24,1,,,,,,,,,
55700-14-6,0,OMOP Exposome,Observation,Substance,Cadmium cyclohexane-butyrate,,2014-12-24,1,,,,,,,,,
14486-19-2,0,OMOP Exposome,Observation,Substance,Cadmium fluoborate,,2014-12-24,1,,,,,,,,,
7790-79-6,0,OMOP Exposome,Observation,Substance,Cadmium fluoride,,2014-12-24,1,,,,,,,,,
17010-21-8,0,OMOP Exposome,Observation,Substance,Cadmium fluosilicate,,2014-12-24,1,,,,,,,,,
21041-95-2,0,OMOP Exposome,Observation,Substance,Cadmium hydroxide,,2014-12-24,1,,,,,,,,,
7790-80-9,0,OMOP Exposome,Observation,Substance,Cadmium iodide,,2014-12-24,1,,,,,,,,,
16039-55-7,0,OMOP Exposome,Observation,Substance,Cadmium lactate,,2014-12-24,1,,,,,,,,,
1345-09-1,0,OMOP Exposome,Observation,Substance,Cadmium mercury sulfide,,2014-12-24,1,,,,,,,,,
10325-94-7,0,OMOP Exposome,Observation,Substance,Cadmium nitrate,"Cadmium nitric acid; Cadmium(2+I) nitrate; Cadmium(II) dinitrate; Cadmium(II) nitrate; Cd(NO3)2; Nitric acid, cadmium salt; Nitric acid, cadmium salt (2:1); Cadmium dinitrate; Cadmium(2+I) dinitrate; CHEBI:77732",2014-12-24,1,,,,,,,,,
1306-19-0,0,OMOP Exposome,Observation,Substance,Cadmium oxide fume,,2014-12-24,1,,,,,,,,,
13477-17-3,0,OMOP Exposome,Observation,Substance,Cadmium phosphate,,2014-12-24,1,,,,,,,,,
1306-24-7,0,OMOP Exposome,Observation,Substance,Cadmium selenide,CdSe; Selanylidenecadmium; Cadmium(2+) selenide; Cadmium(II) selenide; Cadmoselite; CHEBI:50834,2014-12-24,1,,,,,,,,,
141-00-4,0,OMOP Exposome,Observation,Substance,Cadmium succinate,,2014-12-24,1,,,,,,,,,
10124-36-4,0,OMOP Exposome,Observation,Substance,Cadmium sulfate,"Cadmium(II) sulfate; Cadmium(II) sulphate; CdSO4; Sulfuric acid, cadmium salt; Sulphuric acid, cadmium salt, tetrahydrate; Cadmium(2+) sulphate; Cadmium sulfic acid; Cadmium sulphate; Cadmium sulphic acid; Cadmium(2+) sulfate; Cadmium mesosulfate; Cadmium mesosulphate; Cadmium monosulfate; Cadmium monosulphate; Cadmium sulfate monohydrate; Cadmium sulfate tetrahydrate; Cadmium sulfate, hydrate; Cadmium sulfate, tetrahydrate; CHEBI:50292",2014-12-24,1,,,,,,,,,
1306-23-6,0,OMOP Exposome,Observation,Substance,Cadmium sulphide,CdS; Ferro orange yellow; Ferro yellow; Greenockite; Orange cadmium; Jaune brilliant; Hawleyite; GSK; Ferro lemon yellow; Aurora yellow; C.I. Pigment Yellow 37; C.P. Golden Yellow 55; Cadmium golden 366; Cadmium lemon Yellow 527; Cadmium monosulfide; Cadmium orange; Cadmium primrose 819; Cadmium sulfide; Cadmium sulfide yellow; Cadmium yellow; Capsebon; Cadmopur yellow; Cadmium Yellow 000; Cadmium Yellow 10G Conc; Cadmium Yellow 892; Cadmium yellow oz dark; Cadmium Yellow Primrose 47-4100; Cadmium(2+) sulfide; Cadmopur golden yellow n; Cadmium(II) sulfide; Primrose 1466; CHEBI:50833,2014-12-24,1,,,,,,,,,
1306-25-8,0,OMOP Exposome,Observation,Substance,Cadmium telluride,,2014-12-24,1,,,,,,,,,
7790-85-4,0,OMOP Exposome,Observation,Substance,Cadmium tungstate,,2014-12-24,1,,,,,,,,,
79110-87-5,0,OMOP Exposome,Observation,Substance,Cadmium(I) tetrachloroaluminate,,2014-12-24,1,,,,,,,,,
331-39-5,0,OMOP Exposome,Observation,Substance,Caffeic acid,"3,4-Dihydroxybenzeneacrylate; Caffeic acid pure; Caffeicacid; cis-Caffeate; cis-Caffeic acid; 3,4-Dihydroxybenzeneacrylic acid; 3,4-Dihydroxycinnamate; 3,4-Dihydroxycinnamic acid; Caffeate; CHEBI:17395",2014-12-24,1,,,,,,,,,
58-08-2,0,OMOP Exposome,Observation,Substance,Caffeine,"Vivarin; 1,3,7-Trimethyl-2,6-dioxopurine; 1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione; 1,3,7-trimethylpurine-2,6-dione; 1,3,7-Trimethylxanthine; 1-Methyl-Theobromine; 1-methyltheobromine; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion; 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; 7-Methyl Theophylline; 7-methyltheophylline; Anhydrous caffeine; Anhydrous caffeine (JP15); Cafcit; Cafe\u00edna; Caf\u00e9ine; Caffedrine; Coffein; Dexitac; Durvitan; Enerjets; Guaranine; Hycomine; Koffein; Lanorinal; Mate\u00edna; Methyltheobromide; Methyltheobromine; Methylxanthine theophylline; Monohydrate Caffeine; No-Doz; Pep-Back; Quick Pep; Teina; Thein; Theine; Wake-Up; CHEBI:27732",2014-12-24,1,,,,,,,,,
GIS1007390,0,OMOP Exposome,Observation,Substance,Caffeine Metabolism,,2024-09-14,1,,,,,,,,,
178037-96-2,0,OMOP Exposome,Observation,Substance,Calcicludine,,2014-12-24,1,,,,,,,,,
19356-17-3,0,OMOP Exposome,Observation,Substance,Calcidiol,"25(OH)D3; Calcifediol anhydrous; Calcifediolum; Calderol; Caldiol; De Kai; Dedrogyl; (3\u03b2,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol; Calcifediol; 25-Hydroxy-cholecalciferol; Didrogyl; Hidroferol; 25-Hydroxycholecalciferol; 9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol; 5,6-cis-25-Hydroxyvitamin D3; (5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol; 3-{2-1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene-ethylidene}-4-methylene-cyclohexanol; (3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol; (3S,5Z,7e)-9,10-Secocholesta-5,7,10-triene-3,25-diol; 25-Hydroxyvitamin D3; CHEBI:17933",2014-12-24,1,,,,,,,,,
P63098,0,OMOP Exposome,Observation,Substance,Calcineurin subunit B type 1,,2024-09-14,1,,,,,,,,,
Q96LZ3,0,OMOP Exposome,Observation,Substance,Calcineurin subunit B type 2,,2024-09-14,1,,,,,,,,,
112965-21-6,0,OMOP Exposome,Observation,Substance,Calcipotriol,Calcitrene; Dovonex; Daivonex; Calcipotriene; SORILUX; CHEBI:50749,2014-12-24,1,,,,,,,,,
134710-25-1,0,OMOP Exposome,Observation,Substance,Calciseptine,,2014-12-24,1,,,,,,,,,
32222-06-3,0,OMOP Exposome,Observation,Substance,Calcitriol,"1a,25-(OH)2D3; Toptriol; (3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol; (1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol; (1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol; 1-alpha-25-Dihydroxyvitamin D3; Soltriol; Topitriol; 1-alpha,25-Dihydroxyvitamin D3; Dihydroxyvitamin D3; 1alpha,25-Dihydroxyvitamin D3; 1,25-Dihydroxyvitamin D3; 1,25-Dihydroxyvitamin D; 1alpha,25-Dihydroxycholecalciferol; Decostriol; Calcitriolum; Calcitriol Oral Solution; Calcijex; 5-{2-1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene-ethylidene}-4-methylene-cyclohexane-1,3-diol; 25-Dihydroxycholecalciferol; 1\u03b1,25-dihydroxyvitamin D3; (5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol; 1alpha,25(OH)2D3; 1a,25-Dihydroxyvitamin D3; 1a,25-Dihydroxycholecalciferol; Ro 21-5535; Rocaltrol; Silkis; 1\u03b1,25(OH)2D3; Vectical; 1\u03b1,25-dihydroxycholecalciferol; 1,25 Dihydroxycholecalciferol; 1,25-DHCC; 1,25-Dihydroxycholecalciferol; CHEBI:17823",2014-12-24,1,,,,,,,,,
7440-70-2,0,OMOP Exposome,Observation,Substance,Calcium,Calcium element; Ca; CHEBI:22984,2014-12-24,1,,,,,,,,,
7778-44-1,0,OMOP Exposome,Observation,Substance,Calcium arsenate,,2014-12-24,1,,,,,,,,,
52740-16-6,0,OMOP Exposome,Observation,Substance,Calcium arsenite,,2014-12-24,1,,,,,,,,,
7789-41-5,0,OMOP Exposome,Observation,Substance,Calcium bromide,Kalziumbromid; CaBr2; Calcium bromide (CaBr2); Hydrobromic acid calcium salt; CHEBI:31338,2014-12-24,1,,,,,,,,,
GIS1007391,0,OMOP Exposome,Observation,Substance,Calcium Channel Agonist,,2024-09-14,1,,,,,,,,,
GIS1007392,0,OMOP Exposome,Observation,Substance,Calcium Channel Blocker,,2024-09-14,1,,,,,,,,,
Q5SQC4,0,OMOP Exposome,Observation,Substance,"Calcium channel, voltage-dependent, L type, alpha 1B subunit",,2024-09-14,1,,,,,,,,,
10060-08-9,0,OMOP Exposome,Observation,Substance,Calcium chromate dihydrate,,2014-12-24,1,,,,,,,,,
592-01-8,0,OMOP Exposome,Observation,Substance,Calcium cyanide,,2014-12-24,1,,,,,,,,,
10124-37-5,0,OMOP Exposome,Observation,Substance,Calcium nitrate,"Nitric acid, calcium salt; Nitrocalcite; Norge saltpeter; Norway saltpeter; Norwegian saltpeter; Saltpeter; Synfat 1006; Anhydrous calcium nitrate; Calcium dinitrate; Calcium nitrate solution; Calcium nitric acid; Calcium saltpeter; Calcium standard for aas; Calcium(II) nitrate (1:2); Lime nitrate; Lime saltpeter; CHEBI:64205",2014-12-24,1,,,,,,,,,
10118-76-0,0,OMOP Exposome,Observation,Substance,Calcium permanganate,,2014-12-24,1,,,,,,,,,
1305-99-3,0,OMOP Exposome,Observation,Substance,Calcium phosphide,,2014-12-24,1,,,,,,,,,
Q96D31,0,OMOP Exposome,Observation,Substance,Calcium release-activated calcium channel protein 1,,2024-09-14,1,,,,,,,,,
P49069,0,OMOP Exposome,Observation,Substance,Calcium signal-modulating cyclophilin ligand,,2024-09-14,1,,,,,,,,,
GIS1007418,0,OMOP Exposome,Observation,Substance,Calcium signaling pathway,,2024-09-14,1,,,,,,,,,
A8K7I4,0,OMOP Exposome,Observation,Substance,Calcium-activated chloride channel regulator 1,,2024-09-14,1,,,,,,,,,
Q9UQC9,0,OMOP Exposome,Observation,Substance,Calcium-activated chloride channel regulator 2,,2024-09-14,1,,,,,,,,,
Q14CN2,0,OMOP Exposome,Observation,Substance,Calcium-activated chloride channel regulator 4,,2024-09-14,1,,,,,,,,,
Q9Y6N3,0,OMOP Exposome,Observation,Substance,Calcium-activated chloride channel regulator family member 3,,2024-09-14,1,,,,,,,,,
BE0004906,0,OMOP Exposome,Observation,Substance,Calcium-activated potassium channel,,2024-09-14,1,,,,,,,,,
Q12791,0,OMOP Exposome,Observation,Substance,Calcium-activated potassium channel subunit alpha-1,,2024-09-14,1,,,,,,,,,
Q16558,0,OMOP Exposome,Observation,Substance,Calcium-activated potassium channel subunit beta-1,,2024-09-14,1,,,,,,,,,
Q9Y691,0,OMOP Exposome,Observation,Substance,Calcium-activated potassium channel subunit beta-2,,2024-09-14,1,,,,,,,,,
Q9NPA1,0,OMOP Exposome,Observation,Substance,Calcium-activated potassium channel subunit beta-3,,2024-09-14,1,,,,,,,,,
Q86W47,0,OMOP Exposome,Observation,Substance,Calcium-activated potassium channel subunit beta-4,,2024-09-14,1,,,,,,,,,
P98194,0,OMOP Exposome,Observation,Substance,Calcium-transporting ATPase type 2C member 1,,2024-09-14,1,,,,,,,,,
O75185,0,OMOP Exposome,Observation,Substance,Calcium-transporting ATPase type 2C member 2,,2024-09-14,1,,,,,,,,,
P54750,0,OMOP Exposome,Observation,Substance,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",,2024-09-14,1,,,,,,,,,
Q01064,0,OMOP Exposome,Observation,Substance,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",,2024-09-14,1,,,,,,,,,
Q14123,0,OMOP Exposome,Observation,Substance,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",,2024-09-14,1,,,,,,,,,
118354-83-9,0,OMOP Exposome,Observation,Substance,Calitoxin,,2014-12-24,1,,,,,,,,,
P0DP23,0,OMOP Exposome,Observation,Substance,Calmodulin,,2024-09-14,1,,,,,,,,,
P20810,0,OMOP Exposome,Observation,Substance,Calpastatin,,2024-09-14,1,,,,,,,,,
P27797,0,OMOP Exposome,Observation,Substance,Calreticulin,,2024-09-14,1,,,,,,,,,
36104-80-0,0,OMOP Exposome,Observation,Substance,Camazepam,,2014-12-24,1,,,,,,,,,
Q9Y233,0,OMOP Exposome,Observation,Substance,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",,2024-09-14,1,,,,,,,,,
P17612,0,OMOP Exposome,Observation,Substance,cAMP-dependent protein kinase catalytic subunit alpha,,2024-09-14,1,,,,,,,,,
P27815,0,OMOP Exposome,Observation,Substance,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",,2024-09-14,1,,,,,,,,,
Q07343,0,OMOP Exposome,Observation,Substance,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",,2024-09-14,1,,,,,,,,,
Q08493,0,OMOP Exposome,Observation,Substance,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",,2024-09-14,1,,,,,,,,,
Q08499,0,OMOP Exposome,Observation,Substance,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",,2024-09-14,1,,,,,,,,,
Q9NP56,0,OMOP Exposome,Observation,Substance,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",,2024-09-14,1,,,,,,,,,
Q92887,0,OMOP Exposome,Observation,Substance,Canalicular multispecific organic anion transporter 1,,2024-09-14,1,,,,,,,,,
GIS1007419,0,OMOP Exposome,Observation,Substance,Canavan Disease,,2024-09-14,1,,,,,,,,,
52025-76-0,0,OMOP Exposome,Observation,Substance,Cannabielsoin,,2014-12-24,1,,,,,,,,,
P21554,0,OMOP Exposome,Observation,Substance,Cannabinoid receptor 1,,2024-09-14,1,,,,,,,,,
P34972,0,OMOP Exposome,Observation,Substance,Cannabinoid receptor 2,,2024-09-14,1,,,,,,,,,
GIS1007420,0,OMOP Exposome,Observation,Substance,Cannabinoid Receptor Agonist,,2024-09-14,1,,,,,,,,,
154361-50-9,0,OMOP Exposome,Observation,Substance,Capecitabine,"Xeloda; Capecitabin; Capecitabinum; Capecitabina; Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-ylcarbamate; (1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester; Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate; R340; CHEBI:31348",2014-12-24,1,,,,,,,,,
GIS1007421,0,OMOP Exposome,Observation,Substance,Capecitabine Pathway,,2024-09-14,1,,,,,,,,,
334-48-5,0,OMOP Exposome,Observation,Substance,Capric acid,Prifac 296; 1-Nonanecarboxylic acid; 1-Nonanecarboxylate; Lunac 10-98; Decoic acid; Decoate; Caprynic acid; Caprynate; Caprinic acid; Caprinate; Caprate; N-Caprate; N-Capric acid; N-Decanoate; Lunac 10-95; Emery 659; Decylic acid; Decylate; N-Decanoic acid; N-Decoate; N-Decoic acid; N-Decylate; N-Decylic acid; Prifac 2906; CHEBI:30813,2014-12-24,1,,,,,,,,,
142-62-1,0,OMOP Exposome,Observation,Substance,Caproic acid,Capronic acid; Hexanoate; Caproate; Hexanoic acid; Hexylate; Hexoic acid; Hexoate; 1-Pentanecarboxylate; 1-Hexanoate; N-Caproic acid; N-Caproate; Butylacetic acid; 1-Pentanecarboxylic acid; N-Hexanoate; N-Hexanoic acid; Butylacetate; Pentylformate; N-Hexylic acid; N-Hexylate; N-Hexoic acid; Pentylformic acid; 1-Hexanoic acid; Capronate; N-Hexoate; Hexylic acid; CHEBI:30776,2014-12-24,1,,,,,,,,,
124-07-2,0,OMOP Exposome,Observation,Substance,Caprylic acid,Neo-Fat 8; N-Octanoic acid; N-Octoate; N-Octoic acid; N-Octylate; N-Octylic acid; N-Caprylic acid; N-Caprylate; Lunac 8-98; Lunac 8-95; Neo-Fat 8S; octanoate; Kortacid 0899; Kaprylsaeure; Enantic acid; Emery 657; Caprylsaeure; capryloate; Caprylate; N-Octanoate; 1-Heptanecarboxylic acid; 1-Heptanecarboxylate; octanoic acid; Octic acid; octoic acid; Octylate; Octylic acid; Prifac 2901; CHEBI:28837,2014-12-24,1,,,,,,,,,
404-86-4,0,OMOP Exposome,Observation,Substance,Capsaicin,epsilon-Capsaicin; (E)-8-Methyl-N-vanillyl-6-nonenamide(8cl); (E)8-methyl-N-vanillyl-6-Nonenamide; Axsain; E-Capsaicin; Isodecenoate; Isodecenoic acid; Isodecenoic acid vanillylamide; N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide; Styptysat; trans-8-Methyl-N-vanillyl-6-nonenamide; Transacin; Zostrix; CHEBI:3374,2014-12-24,1,,,,,,,,,
2425-06-1,0,OMOP Exposome,Observation,Substance,Captafol,,2014-12-24,1,,,,,,,,,
133-06-2,0,OMOP Exposome,Observation,Substance,Captan,Merpan; Orthocide; CHEBI:34608,2014-12-24,1,,,,,,,,,
GIS1007422,0,OMOP Exposome,Observation,Substance,Carbamate,,2024-09-14,1,,,,,,,,,
298-46-4,0,OMOP Exposome,Observation,Substance,Carbamazepine,"5-Carbamoyl-5H-dibenzb,Fazepine; 5-Carbamoyl-5H-dibenz(b,f)azepine; TEGretol Chewtabs; TEGretol-CR; Anleptic; Actebral; Versizur; Versitol; Timonil; Teril; TEGretol-XR; 5H-Dibenz(b,F)azepine-5-carboxamide; 5-Carbamyl-5H-dibenzo(b,F)azepine; Carbamazepen; Carbamat; Biston; Equetro; Neurotop; TEGretol; 5-Carbamoyl-5H-dibenzo(b,F)azepine; Carbamezepine; Carbatrol; CBZ; Epitol; Carbamazepinum; Carbamaz\u00e9pine; Carbamazepina; Carbamazepin; CHEBI:3387",2014-12-24,1,,,,,,,,,
463-77-4,0,OMOP Exposome,Observation,Substance,Carbamic acid,Maolate; Chlorphenesin carbamate; Carbamate ion; Carbamate; Aminoformic acid; Aminoformate; CHEBI:28616,2014-12-24,1,,,,,,,,,
GIS1007423,0,OMOP Exposome,Observation,Substance,Carbamoyl Phosphate Synthetase Deficiency,,2024-09-14,1,,,,,,,,,
671-04-5,0,OMOP Exposome,Observation,Substance,Carbanolate,,2014-12-24,1,,,,,,,,,
63-25-2,0,OMOP Exposome,Observation,Substance,Carbaril,"N-Methyl-1-naphthyl carbamate; N-methyl-a-naphthylcarbamate; N-methyl-a-naphthylurethan; N-methyl-alpha-naphthylcarbamate; N-methyl-alpha-naphthylurethan; NAC; naphthalen-1-yl methylcarbamate; Naphthalenol, methylcarbamate; Naphthyl n-methylcarbamate; Noflo 5 vet; Novartis brand of carbaril; O-(1-Naphthyl)-N-methylcarbamat; Occoxil; Olititox; Oltitox; Ornis brand of carbaril; Panam; Pomex; Poudre insecticide moureau; Poudre insecticide vetoquinol; Poutic; Prosevor 85; Ravyon; Rylam; Sanofi brand of carbaril; Savit; Seffein; Septene; Sevimol; Sevin; Sevin (carbaryl); Sevin 4; Sevin brand SL; Sewin; Skatta tick flea louse powder; Sogeval brand of carbaril; SOK; Suleo; Tercyl; Thinsec; Tigal; Tolyspaz; Tomado; Tornado; Toxan; Tricarnam; Union Carbide 7,744; Vetoquinol, poudre insecticide; Vetox; Vioxan; Virbac brand of carbaril; VO 18, Concentrat; Wasp destroyer; Antigale; 18, Concentrat VO; Arilat; Arilate; Arylam; Atoxan; Avicopharma brand of carbaril; Bercema NMC50; Bug master; Caprolin; Carbamic acid, methyl-, naphthalenyl ester; Carbamic acid, N-methyl,1-naphthyl ester; Carbamic-14C acid, methyl-, 1-naphthyl ester; Carbamine; Carbaril avicopharma brand; Carbaril biov brand; Carbaril novartis brand; Carbaril ornis brand; Carbaril sanofi brand; Carbaril sogeval brand; Carbaril coophavet brand; Carbaril virbac brand; Carbaril vtoquinol brand; Carbarilo; Carbaril intraveno brand; Carbaril mavlab brand; 1-Naphthyl N-methylcarbamateacid O,O-diethyl ester; 1-Naphthyl N-methylcarbamate; 1-Naphthyl methylcarbamate; 1-Naphthol N-methylcarbamate; 1-Naphthalenyl methylcarbamate; 1-Naphthalenol, methylcarbamate; a-naftyl-n-methylkarbamat; a-naphthalenyl methylcarbamate; a-naphthyl methylcarbamate; 1-Naphthalenol methylcarbamate; a-naphthyl n-methylcarbamate; Alpha-naphthalenyl methylcarbamate; Alpha-naphthyl methylcarbamate; Alpha-naphthyl n-methylcarbamate; alpha.Naftyl-n-methylkarbamat; alpha.Naphthalenyl methylcarbamate; alpha.Naphthyl methylcarbamate; alpha.Naphthyl n-methylcarbamate; Carbarilum; Carbaryl; N-methyl naphthylcarbamate; N-methyl-.alpha.-naphthylurethan; Monsur; Moureau, poudre insecticide; Mugan; Murvin; Murvin 85; N-methyl-.alpha.-naphthylcarbamate; Carbaryl (sevin); Carbaryl solution; Carbaryl, Manganese (2+) Salt; Carbaryl, Nickel (2+) Salt; Carbatox; Carbatox 75; Carbatox-60; Carbatox-75; Carbavur; Carbomate; Carbyl; Carpolin; Carylderm; Caswell No. 160; Cekubaryl; Clinicide; Compound 7744; Concentrat VO 18; Coophavet brand of carbaril; Crag sevin; Crunch; David veterinary laboratories brand of carbaril; Denapon; Derbac; Devicarb; Dicarbam; Dicarbament 23,969; Dog net insecticide poudre; Dog-net insecticide poudre; Dognet insecticide poudre; Dyna-carbyl; Experimental Insecticide 7744; Fido's free itch; Fido's free-itch; Fido's freeitch; Flea and tick powder; G wizz; Gamonil; Gwizz; Hexavin; Insecticide moureau, poudre; Insecticide vetoquinol, poudre; Intraveno brand of carbaril; Joseph LYDDY; Karbaryl; Karbaspray; Karbatox; Karbatox 75; Karbatox zawiesinowy; Karbosep; Kid pest project (carbaryl) (see also carbaryl); Mavlab brand of carbaril; Menaphtam; Methylcarbamat of e 1-naphthol; Methylcarbamate 1-naphthalenol; Methylcarbamate 1-naphthol; Methylcarbamate, 1-naphthalenol; Methylcarbamic acid, 1-naphthyl ester; Microcarb; CHEBI:3390",2014-12-24,1,,,,,,,,,
1773-37-1,0,OMOP Exposome,Observation,Substance,Carbasulam,,2014-12-24,1,,,,,,,,,
10605-21-7,0,OMOP Exposome,Observation,Substance,Carbendazim,"Kolfugo extra; Zhiweiling; Triticol; Thicoper; Supercarb; Subeej; Stempor; Stein; Spin (pesticide); SPIN; Sarfun; Protek; Preventol BCM; Preparation G 665; Pillarstin; Olgin (fungicide); Olgin; MYCO; Methylbenzimidazole-2-ylcarbamate; Methyl-N-(2-benzimidazolyl)carbamate; Methyl-2-benzimidazole carbamate; Methyl N-2-benzimidazolecarbamate; Methyl benzimidazolylcarbamate; Methyl benzimidazolecarbamate; Methyl benzimidazol-2-ylcarbamate; Methyl 2-benzimidazolylcarbamate; Methyl 2-benzimidazolecarbamate; Methyl 2-benzimidazil carbamate; Methyl 1H-benzimidazolylcarbamate; Methyl 1H-benzimidazole-2-carbamate; Methyl 1H-benzimidazol-2-ylcarbamate, 9CI; Methyl 1H-benzimidazol-2-ylcarbamate (9CI); Methyl 1H-benzimidazol-2-ylcarbamate; Methoxybenzimidazole-2-carbamic acid; Mekarzole; Medamine; Mecarzole; MBC; Kolfugo 25FW; Kolfugo 25 FW; Kolfugo; Kid pest project (carbendazim) (see also carbendazim); Kemdazin; Karben stefes flo; Karben flo stefes; Karben; Jkstein; Jkatein; Ipo y; Garbenda; Fungoxan; Fungisol; Funaben 50; Funaben 3; Funaben; Falicarben; Equitdazin; Derosal 60PM; Derosal; Delsene 10; Delsene; Custos; Carbendazyme; Carbendazym; Carbendazole; Carbendazol, JMAF; Carbendazol; Carbendazin; Carbendazime; Carben VL; Carbamic acid, N-1H-benzimidazol-2-yl-, methyl ester; Carbamic acid, 1H-benzimidazolyl-, methyl ester; Carbamic acid, 1H-benzimidazol-2-yl-, methyl ester; BMK (fungicide); BMK; BMC?; BMC; Bitosen; Bercema-bitosen; Benzimidazolecarbamic; Benzimidazolecarbamate methyl ester; Benzimidazole-2-carbamic acid, methyl ester; Benzimidazole carbamate de methyle; Bengard; BCM (fungicide); BCM; Bavistine; Bavistin FL; Bavistin 50SD; Bavistin 3460; Bavistin 25SD; Bavistin; Bavistan; Battal; Antibac MF; Agrizim; A 118 (Pesticide); 2-(Methoxycarbonyl)aminobenzimidazole; 2-Methyl benzimidazolecarbamate; 2-MBC; 2-Bezimidazolecarbamic acid methyl ester; 2-Benzimidazolecarbamic acid, methyl ester; 2-(Methoxycarboxamido)benzimidazole; 2-(Methoxycarbonylamino)benzimidazole; 2-(Methoxycarbonylamino)-benzimidazole; 2-(Methoxycarbamoyl)benzimidazole; 2-(Methoxy-carbonylamino)-benzimidazol; 2-(Carbomethoxyamino)benzimidazole; 1H-Benzimidazole-2-carbamic acid, methyl ester; 1H-Benzimidazol-2-ylcarbamic acid, methyl ester; 1H-Benzimidazol-2-ylcarbamic acid methyl ester; 1H-Benzimidazol-2-yl-carbamic acid, methyl ester; Carbendazine; CHEBI:3392",2014-12-24,1,,,,,,,,,
16118-49-3,0,OMOP Exposome,Observation,Substance,Carbetamide,,2014-12-24,1,,,,,,,,,
486-16-8,0,OMOP Exposome,Observation,Substance,Carbinoxamine,Karbinal; Histin; (+-)-Carbinoxamine; Rotoxamine; {2-(4-chloro-phenyl)-pyridin-2-yl-methoxy-ethyl}-dimethyl-amine; Arbinoxa; Carbinoxamin; Carbinoxamina; 2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine; Satinmin; Carbinoxamine base; Carbinoxaminum; Clistin; Paracarbinoxamine; Allergefon; Palgic; CHEBI:3398,2014-12-24,1,,,,,,,,,
1563-66-2,0,OMOP Exposome,Observation,Substance,Carbofuran,"Carbofurane; Chinufur; Crisfuran; Curaterr; FMC 10242; Furacarb; Furadan; Furadan 3G; Furadan 4f; Furadan 75 WP; Tripart nex; 2,2-Dimethyl-2,3-dihydro-7-benzofuranyl N-methylcarbamate; Furadan g; Furadane; Furodan; NEX; Karbofuranu; 2,3-Dihydro-2,2-dimethyl-7-benzofuranol methylcarbamate; 2,3-Dihydro-2,2-dimethyl-7-benzofuranol N-methylcarbamate; 2,3-DIHYDRO-2,2-DIMETHYL-7-BENZOFURANOL, METHYLCARBAMATE; 2,3-Dihydro-2,2-dimethyl-7-benzofuranyl methylcarbamate; 2,2-Dimethyl-2,3-dihydro-1-benzofuran-7-yl methylcarbamate; 2,2-Dimethyl-2,2-dihydrobenzofuranyl-7 N-methylcarbamate; 2,3-Dihydro-2,2-dimethyl-7-benzofuranyl methylcarbamate, 9CI; 2,3-Dihydro-2,2-dimethylbenzofuran-7-yl methylcarbamate; 2, 3-Dihydro-2,2-dimethylbenzofuranyl-7-N-methylcarbamate; 2,3-Dihydro-2,2-dimethylbenzofuranyl-7-N-methylcarbamate; 7-Benzofurano, 2,3-dihydro-2,2-dimethyl, methylcarbamate; 7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-, methylcarbamate; 2, 3-Dihydro-2,2-dimethyl-7-benzofuranyl methylcarbamate; Kenofuran; Bay 70143; Brifur; Carbodan; Carbofuran (pesticide/fertilizer mixture); Carbofuran mixture; Niagaral 242; Pillarfuran; Rampart; Sipcam UK carbosip 5G; 2,2-Dimethyl-2,3-dihydrobenzoduranyl-7-N-methylcarbamate; Yaltox; 2,2-Dimethyl-7-coumaranyl N-methylcarbamate; CHEBI:34611",2014-12-24,1,,,,,,,,,
124-38-9,0,OMOP Exposome,Observation,Substance,Carbon dioxide,Carbon oxide; Carbonic anhydride; Carbon-12 dioxide; Carbonic acid gas; Carbonic acid anhydride; CHEBI:16526,2014-12-24,1,,,,,,,,,
506-80-9,0,OMOP Exposome,Observation,Substance,Carbon diselenide,,2014-12-24,1,,,,,,,,,
75-15-0,0,OMOP Exposome,Observation,Substance,Carbon disulfide,"Dithiocarbonic anhydride; Carbon bisulfide; Carbon bisulphide; Carbon disulphide; Carbon disulphide, BSI; Carbon sulfide (CS2); CHEBI:23012",2014-12-24,1,,,,,,,,,
GIS1007430,0,OMOP Exposome,Observation,Substance,Carbon Metabolism,,2024-09-14,1,,,,,,,,,
630-08-0,0,OMOP Exposome,Observation,Substance,Carbon monoxide,Carbon(II) oxide; Carbonous oxide; CO; CHEBI:17245,2014-12-24,1,,,,,,,,,
56-23-5,0,OMOP Exposome,Observation,Substance,Carbon tetrachloride,Carbontetrachloride; Necatorine; Methane tetrachloride; Carbon tet; Tetrachloro-Methane; Carbon chloride; Tetrasol; Tetrachloromethane; Perchloromethane; CHEBI:27385,2014-12-24,1,,,,,,,,,
14762-75-5,0,OMOP Exposome,Observation,Substance,Carbon-14,,2014-12-24,1,,,,,,,,,
P00915,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 1,,2024-09-14,1,,,,,,,,,
O43570,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 12,,2024-09-14,1,,,,,,,,,
Q8N1Q1,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 13,,2024-09-14,1,,,,,,,,,
Q9ULX7,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 14,,2024-09-14,1,,,,,,,,,
P00918,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 2,,2024-09-14,1,,,,,,,,,
P07451,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 3,,2024-09-14,1,,,,,,,,,
P22748,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 4,,2024-09-14,1,,,,,,,,,
P35218,0,OMOP Exposome,Observation,Substance,"Carbonic anhydrase 5A, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9Y2D0,0,OMOP Exposome,Observation,Substance,"Carbonic anhydrase 5B, mitochondrial",,2024-09-14,1,,,,,,,,,
P23280,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 6,,2024-09-14,1,,,,,,,,,
P43166,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 7,,2024-09-14,1,,,,,,,,,
Q16790,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase 9,,2024-09-14,1,,,,,,,,,
GIS1007424,0,OMOP Exposome,Observation,Substance,Carbonic Anhydrase Inhibitor,,2024-09-14,1,,,,,,,,,
P35219,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase-related protein,,2024-09-14,1,,,,,,,,,
Q9NS85,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase-related protein 10,,2024-09-14,1,,,,,,,,,
O75493,0,OMOP Exposome,Observation,Substance,Carbonic anhydrase-related protein 11,,2024-09-14,1,,,,,,,,,
555-60-2,0,OMOP Exposome,Observation,Substance,Carbonyl cyanide m-chlorophenyl hydrazone,"CCCP; CCP; M-chlorophenyl carbonylcyanide hydrazone; M-CL-CCP; Mesoxalonitrile 3-chlorophenylhydrazone; Mesoxalonitrile, (m-chlorophenyl)hydrazone; Carbonyl cyanide meta chlorophenyl hydrazone; Mesoxalonitrile, (m-chlorophenyl)hydrazone (8CI); N'-(3-chlorophenyl)carbonohydrazonoyl dicyanide; Propanedinitrile, {(3-chlorophenyl)hydrazono-}; (3-chlorophenyl)hydrazonomalononitrile; (3-chlorophenyl)hydrazonopropanedinitrile; 2-(3-chlorophenyl)hydrazinylidenepropanedinitrile; Carbonyl cyanide, 3-chlorophenylhydrazone; Carbonyl cyanide-m-chlorophenylhydrazone; Carbonylcyanide m-chlorophenylhydrazone; Carbonylcyanide-3-chlorophenylhydrazone; ((3-Chlorophenyl)hydrazono)malononitrile; ((3-Chlorophenyl)hydrazono)propanedinitrile; (3-Chlorophenyl)hydrazonomalononitrile; 2-((3-Chlorophenyl)hydrazono)malononitrile; 2-(3-Chlorophenyl)hydrazinylidenepropanedinitrile; Carbonyl cyanide (m-chlorophenyl)hydrazone; Carbonyl cyanide 3-chlorophenylhydrazone; Carbonyl cyanide chlorophenylhydrazone; Carbonyl cyanide m chlorophenyl hydrazone; Carbonyl cyanide m-chlorophenylhydrazone; Carbonyl cyanide meta-chlorophenyl hydrazone; Carbonyl cyanide, (3-chlorophenyl)hydrazone; CARBONYL CYANIDE, 3-CHLORO-PHENYLHYDRAZONE; Carbonylcyanide-m-chlorophenylhydrazone; CHEBI:3259",2014-12-24,1,,,,,,,,,
370-86-5,0,OMOP Exposome,Observation,Substance,Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone,"CARBONYL CYANIDE, 4-TRIFLUOROMETHOXY-PHENYLHYDRAZONE; Para-trifluoromethoxyphenylhydrazone, carbonyl cyanide; P-trifluoromethoxyphenylhydrazone, carbonyl cyanide; Mesoxalonitrile, (p-(trifluoromethoxy)phenyl)hydrazone; Mesoxalonitrile 4-trifluoromethoxyphenylhydrazone; FCCP; Cyanide para-trifluoromethoxyphenylhydrazone, carbonyl; Cyanide p-trifluoromethoxyphenylhydrazone, carbonyl; Carbonyl cyanide-P-trifluoromethoxyphenylhydrazone; Carbonyl cyanide, 4-trifluoromethoxyphenylhydrazone; Carbonyl cyanide para-trifluoromethoxyphenylhydrazone; Carbonyl cyanide para trifluoromethoxyphenylhydrazone; Carbonyl cyanide p-trifluoromethoxyphenylhydrazone; Carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone; Carbonyl cyanide p trifluoromethoxyphenylhydrazone; Carbonyl cyanide 4-trifluoromethoxyphenylhydrazone; Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; (4-(Trifluoromethoxy)phenyl)hydrazonopropanedinitrile; ((4-(Trifluoromethoxy)phenyl)hydrazono)malononitrile; CHEBI:25520",2014-12-24,1,,,,,,,,,
P16152,0,OMOP Exposome,Observation,Substance,Carbonyl reductase [NADPH] 1,,2024-09-14,1,,,,,,,,,
55285-14-8,0,OMOP Exposome,Observation,Substance,Carbosulfan,Sheriff; RCRA waste no. P189; Marshal/suscon; Posse; Caswell No. 463C; Dibutylaminosulfenylcarbofuran; Marshal; Marshal 10G; Marshall 10G; Marshall; Advantage; CHEBI:38476,2014-12-24,1,,,,,,,,,
55808-13-4,0,OMOP Exposome,Observation,Substance,Carboxazole,,2014-12-24,1,,,,,,,,,
5234-68-4,0,OMOP Exposome,Observation,Substance,Carboxin,,2014-12-24,1,,,,,,,,,
Q9GZU7,0,OMOP Exposome,Observation,Substance,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,,2024-09-14,1,,,,,,,,,
P15086,0,OMOP Exposome,Observation,Substance,Carboxypeptidase B,,2024-09-14,1,,,,,,,,,
P16870,0,OMOP Exposome,Observation,Substance,Carboxypeptidase E,,2024-09-14,1,,,,,,,,,
Q9Y646,0,OMOP Exposome,Observation,Substance,Carboxypeptidase Q,,2024-09-14,1,,,,,,,,,
GIS1007431,0,OMOP Exposome,Observation,Substance,Carcinogen,,2024-09-14,1,,,,,,,,,
GIS1007432,0,OMOP Exposome,Observation,Substance,Cardiac muscle contraction,,2024-09-14,1,,,,,,,,,
GIS1007433,0,OMOP Exposome,Observation,Substance,Cardiotonic Agent,,2024-09-14,1,,,,,,,,,
155808-00-7,0,OMOP Exposome,Observation,Substance,Cardiotoxin (Naja atra),,2014-12-24,1,,,,,,,,,
GIS1007434,0,OMOP Exposome,Observation,Substance,Cardiovascular Agent,,2024-09-14,1,,,,,,,,,
128639-02-1,0,OMOP Exposome,Observation,Substance,Carfentrazone-ethyl,,2014-12-24,1,,,,,,,,,
78-44-4,0,OMOP Exposome,Observation,Substance,Carisoprodol,"Tensaprin; Carbamic acid 2-isopropylcarbamoyloxymethyl-2-methyl-pentyl ester; 2-Methyl-2-propyltrimethylene carbamate isopropylcarbamate; (+-)-2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate; Carisoprodatum; (1-Methylethyl)carbamic acid 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester; Carisoprodate; Carisoma; Gencari; Genesafe; Hiranin; Isobamate; Isomeprobamate; Isopropyl meprobamate; Isopropylmeprobamate; Isoprotane; Isoprothane; Listaflex; N-Isopropy-2-methyl-2-propyl-1,3-propanediol dicarbamate; Sanoma; Soma; Someprobamate; (RS)-2-{(aminocarbonyl)oxymethyl}-2-methylpentyl isopropylcarbamate; 2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate; Carisoprodolum; CHEBI:3419",2014-12-24,1,,,,,,,,,
1260-17-9,0,OMOP Exposome,Observation,Substance,Carmine red,,2014-12-24,1,,,,,,,,,
154-93-8,0,OMOP Exposome,Observation,Substance,Carmustine,"Carmustin; Carmustinum; Carustine; Gliadel; Gliadel Wafer; N,N'-Bis(2-chloroethyl)-N-nitrosourea; Nitrumon; BCNU; Becenun; Bicnu; BiCNU; bis-chloroethylnitrosourea; Bischlorethylnitrosourea; Bischlorethylnitrosurea; Bischloroethyl nitrosourea; Carmubris; Carmustina; CHEBI:3423",2014-12-24,1,,,,,,,,,
P43155,0,OMOP Exposome,Observation,Substance,Carnitine O-acetyltransferase,,2024-09-14,1,,,,,,,,,
P50416,0,OMOP Exposome,Observation,Substance,"Carnitine O-palmitoyltransferase 1, liver isoform",,2024-09-14,1,,,,,,,,,
Q92523,0,OMOP Exposome,Observation,Substance,"Carnitine O-palmitoyltransferase 1, muscle isoform",,2024-09-14,1,,,,,,,,,
P23786,0,OMOP Exposome,Observation,Substance,"Carnitine O-palmitoyltransferase 2, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1007903,0,OMOP Exposome,Observation,Substance,Carnitine palmitoyl transferase deficiency (I),,2024-09-14,1,,,,,,,,,
GIS1007904,0,OMOP Exposome,Observation,Substance,Carnitine Synthesis,,2024-09-14,1,,,,,,,,,
GIS1007902,0,OMOP Exposome,Observation,Substance,Carnitine-acylcarnitine translocase deficiency,,2024-09-14,1,,,,,,,,,
2622-30-2,0,OMOP Exposome,Observation,Substance,Carphenazine,Proketazin; Proketazine; Procethazine; Carphenazin; Carfenazine; CHEBI:51235,2014-12-24,1,,,,,,,,,
GIS1007905,0,OMOP Exposome,Observation,Substance,Cartilage,,2024-09-14,1,,,,,,,,,
P49747,0,OMOP Exposome,Observation,Substance,Cartilage oligomeric matrix protein,,2024-09-14,1,,,,,,,,,
P48729,0,OMOP Exposome,Observation,Substance,Casein kinase I isoform alpha,,2024-09-14,1,,,,,,,,,
P48730,0,OMOP Exposome,Observation,Substance,Casein kinase I isoform delta,,2024-09-14,1,,,,,,,,,
P68400,0,OMOP Exposome,Observation,Substance,Casein kinase II subunit alpha,,2024-09-14,1,,,,,,,,,
P67870,0,OMOP Exposome,Observation,Substance,Casein kinase II subunit beta,,2024-09-14,1,,,,,,,,,
P29466,0,OMOP Exposome,Observation,Substance,Caspase-1,,2024-09-14,1,,,,,,,,,
P42574,0,OMOP Exposome,Observation,Substance,Caspase-3,,2024-09-14,1,,,,,,,,,
P51878,0,OMOP Exposome,Observation,Substance,Caspase-5,,2024-09-14,1,,,,,,,,,
Q14790,0,OMOP Exposome,Observation,Substance,Caspase-8,,2024-09-14,1,,,,,,,,,
P04040,0,OMOP Exposome,Observation,Substance,Catalase,,2024-09-14,1,,,,,,,,,
P21964,0,OMOP Exposome,Observation,Substance,Catechol O-methyltransferase,,2024-09-14,1,,,,,,,,,
Q86VU5,0,OMOP Exposome,Observation,Substance,Catechol O-methyltransferase domain-containing protein 1,,2024-09-14,1,,,,,,,,,
GIS1007906,0,OMOP Exposome,Observation,Substance,Catecholamine Biosynthesis,,2024-09-14,1,,,,,,,,,
P35222,0,OMOP Exposome,Observation,Substance,Catenin beta-1,,2024-09-14,1,,,,,,,,,
P07858,0,OMOP Exposome,Observation,Substance,Cathepsin B,,2024-09-14,1,,,,,,,,,
P07339,0,OMOP Exposome,Observation,Substance,Cathepsin D,,2024-09-14,1,,,,,,,,,
P52569,0,OMOP Exposome,Observation,Substance,Cationic amino acid transporter 2,,2024-09-14,1,,,,,,,,,
Q8WY07,0,OMOP Exposome,Observation,Substance,Cationic amino acid transporter 3,,2024-09-14,1,,,,,,,,,
O43246,0,OMOP Exposome,Observation,Substance,Cationic amino acid transporter 4,,2024-09-14,1,,,,,,,,,
P00760,0,OMOP Exposome,Observation,Substance,Cationic trypsin,,2024-09-14,1,,,,,,,,,
GIS1007907,0,OMOP Exposome,Observation,Substance,Caveolae,,2024-09-14,1,,,,,,,,,
P17676,0,OMOP Exposome,Observation,Substance,CCAAT/enhancer-binding protein beta,,2024-09-14,1,,,,,,,,,
1183-04-6,0,OMOP Exposome,Observation,Substance,CE(10:0),,2014-12-24,1,,,,,,,,,
73384-59-5,0,OMOP Exposome,Observation,Substance,Ceftriaxone,"Rocephin; Ceftriaxonum; Ceftriaxona; Rocephine; (6R,7R)-7-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetylamino}-3-{(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanylmethyl}-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid; Acantex; Biotrakson; Cefatriaxone; Ceftriazone; CHEBI:29007",2014-12-24,1,,,,,,,,,
169590-42-5,0,OMOP Exposome,Observation,Substance,Celecoxib,Artix; Artilog; Celocoxib; Celecoxibum; Celebrex; Articox; Articoxib; Artiflex; Celebra; Artrixib; Onsenal; P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide; Blockten; Valdyne; Caditar; Cefinix; Celact; CHEBI:3520,2014-12-24,1,,,,,,,,,
GIS1007908,0,OMOP Exposome,Observation,Substance,Cell cycle,,2024-09-14,1,,,,,,,,,
P60953,0,OMOP Exposome,Observation,Substance,Cell division control protein 42 homolog,,2024-09-14,1,,,,,,,,,
Q12834,0,OMOP Exposome,Observation,Substance,Cell division cycle protein 20 homolog,,2024-09-14,1,,,,,,,,,
GIS1007909,0,OMOP Exposome,Observation,Substance,Cell junction,,2024-09-14,1,,,,,,,,,
GIS1007910,0,OMOP Exposome,Observation,Substance,Cell membrane,,2024-09-14,1,,,,,,,,,
GIS1007911,0,OMOP Exposome,Observation,Substance,Cell projection,,2024-09-14,1,,,,,,,,,
GIS1007912,0,OMOP Exposome,Observation,Substance,Cell Stimulant and Proliferant,,2024-09-14,1,,,,,,,,,
GIS1007913,0,OMOP Exposome,Observation,Substance,Cell surface,,2024-09-14,1,,,,,,,,,
P29373,0,OMOP Exposome,Observation,Substance,Cellular retinoic acid-binding protein 2,,2024-09-14,1,,,,,,,,,
P04637,0,OMOP Exposome,Observation,Substance,Cellular tumor antigen p53,,2024-09-14,1,,,,,,,,,
9004-70-0,0,OMOP Exposome,Observation,Substance,Cellulose nitrate,,2014-12-24,1,,,,,,,,,
GIS1007914,0,OMOP Exposome,Observation,Substance,Central alpha-Agonist,,2024-09-14,1,,,,,,,,,
GIS1007915,0,OMOP Exposome,Observation,Substance,Central Nervous System,,2024-09-14,1,,,,,,,,,
GIS1007916,0,OMOP Exposome,Observation,Substance,Central Nervous System Agent,,2024-09-14,1,,,,,,,,,
GIS1008411,0,OMOP Exposome,Observation,Substance,Central Nervous System Depressant,,2024-09-14,1,,,,,,,,,
GIS1008412,0,OMOP Exposome,Observation,Substance,Central Nervous System Stimulant,,2024-09-14,1,,,,,,,,,
GIS1008413,0,OMOP Exposome,Observation,Substance,Centriole,,2024-09-14,1,,,,,,,,,
GIS1008414,0,OMOP Exposome,Observation,Substance,Centrosome,,2024-09-14,1,,,,,,,,,
97519-39-6,0,OMOP Exposome,Observation,Substance,Cephalosporin,"cis-Ceftibuten; Ceftibutenum; (+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; Ceftibuteno; Ceftibutene; Cedax; CHEBI:3510",2014-12-24,1,,,,,,,,,
Q16739,0,OMOP Exposome,Observation,Substance,Ceramide glucosyltransferase,,2024-09-14,1,,,,,,,,,
131436-22-1,0,OMOP Exposome,Observation,Substance,Cercosporamide,,2014-12-24,1,,,,,,,,,
GIS1008415,0,OMOP Exposome,Observation,Substance,Cerebrotendinous Xanthomatosis (CTX),,2024-09-14,1,,,,,,,,,
16774-21-3,0,OMOP Exposome,Observation,Substance,Ceric ammonium nitrate,,2014-12-24,1,,,,,,,,,
14457-87-5,0,OMOP Exposome,Observation,Substance,Cerium(III) bromide,,2014-12-24,1,,,,,,,,,
17397-89-6,0,OMOP Exposome,Observation,Substance,Cerulenin,"(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide; (2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide; Helicocerin; CHEBI:171741",2014-12-24,1,,,,,,,,,
P00450,0,OMOP Exposome,Observation,Substance,Ceruloplasmin,,2024-09-14,1,,,,,,,,,
GIS1008416,0,OMOP Exposome,Observation,Substance,Cervical,,2024-09-14,1,,,,,,,,,
7440-46-2,0,OMOP Exposome,Observation,Substance,Cesium,Casium; Zasium; Cs; Caesium; CHEBI:30514,2014-12-24,1,,,,,,,,,
7787-69-1,0,OMOP Exposome,Observation,Substance,Cesium bromide,,2014-12-24,1,,,,,,,,,
56320-90-2,0,OMOP Exposome,Observation,Substance,Cesium chromate,,2014-12-24,1,,,,,,,,,
7789-18-6,0,OMOP Exposome,Observation,Substance,Cesium nitrate,,2014-12-24,1,,,,,,,,,
10045-97-3,0,OMOP Exposome,Observation,Substance,Cesium-137,,2014-12-24,1,,,,,,,,,
83881-51-0,0,OMOP Exposome,Observation,Substance,Cetirizine,Virlix; Zyrtec; Zyrlex; Zirtek; Alerlisin; Benaday; Cetirizin; Cetirizina; Cetirizine hydrochloride; Cetirizinum; Cetryn; Formistin; Hitrizin; Humex; Reactine; CHEBI:3561,2014-12-24,1,,,,,,,,,
57-09-0,0,OMOP Exposome,Observation,Substance,Cetyl-Trimethyl-Ammonium,,2014-12-24,1,,,,,,,,,
O00408,0,OMOP Exposome,Observation,Substance,"cGMP-dependent 3',5'-cyclic phosphodiesterase",,2024-09-14,1,,,,,,,,,
P29973,0,OMOP Exposome,Observation,Substance,cGMP-gated cation channel alpha-1,,2024-09-14,1,,,,,,,,,
Q14432,0,OMOP Exposome,Observation,Substance,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",,2024-09-14,1,,,,,,,,,
Q13370,0,OMOP Exposome,Observation,Substance,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",,2024-09-14,1,,,,,,,,,
O76074,0,OMOP Exposome,Observation,Substance,"cGMP-specific 3',5'-cyclic phosphodiesterase",,2024-09-14,1,,,,,,,,,
95751-30-7,0,OMOP Exposome,Observation,Substance,Charybdotoxin,,2014-12-24,1,,,,,,,,,
GIS1008417,0,OMOP Exposome,Observation,Substance,Chelating Agent,,2024-09-14,1,,,,,,,,,
34316-15-9,0,OMOP Exposome,Observation,Substance,Chelerythrine,"1,2-Dimethoxy-12-methyl(1,3)benzodioxolo(5,6-c)phenanthridinium; CHEBI:CHEBI:78373",2014-12-24,1,,,,,,,,,
476-32-4,0,OMOP Exposome,Observation,Substance,Chelidonine,Khelidonin; (+)-Chelidonine; Chelidonin; Helidonine; Stylophorin; CHEBI:CHEBI:31389,2014-12-24,1,,,,,,,,,
GIS1008418,0,OMOP Exposome,Observation,Substance,Chemical Warfare Agent,,2024-09-14,1,,,,,,,,,
1398-61-4,0,OMOP Exposome,Observation,Substance,Chitin,"Poly 2-Acetamido-2-deoxy-D-glucose; Poly 2-Acetamido-2-deoxy-delta-glucose; 1,4-(N-Acetyl-beta-D-glucosaminyl)N; 1,4-(N-Acetyl-beta-D-glucosaminyl)N+1; beta-1,4-Poly-N-acetyl-delta-glucosamine; beta-1,4-Poly-N-acetyl-D-glucosamine; 1,4-(N-Acetyl-beta-delta-glucosaminyl)N; 1,4-(N-Acetyl-beta-delta-glucosaminyl)N+1; CHEBI:17029",2018-03-21,1,,,,,,,,,
Q13231,0,OMOP Exposome,Observation,Substance,Chitotriosidase-1,,2024-09-14,1,,,,,,,,,
791-35-5,0,OMOP Exposome,Observation,Substance,Chlophedianol,Clofedanolum; Ulone; 1-(2-Chlorophenyl)-3-(dimethylamino)-1-phenyl-1-propanol; 1-Phenyl-1-(O-chlorophenyl)-3-dimethylaminopropanol; 2-Chloro-alpha-(2-(dimethylamino)ethyl)benzhydrol; alpha-(Dimethylaminoethyl)-O-chlorobenzhydrol; Antitussin; Chlofedanol; Clofedano; Clofedanol; Clophedianol base; Clofedianolo; CHEBI:775264,2014-12-24,1,,,,,,,,,
78-95-5,0,OMOP Exposome,Observation,Substance,Chloracetone,Monochloroacetone; 3-Chloro-2-propanone; 1-Chloro-2-propanone; Chloromethyl methyl ketone; Acetonyl chloride; Chloropropanone; alpha-Chloroacetone; CHLOROACETONE; 1-Chloro-2-ketopropane; CHEBI:47220,2014-12-24,1,,,,,,,,,
305-03-3,0,OMOP Exposome,Observation,Substance,Chlorambucil,"Celkeran; Chlorobutine; gamma-P-Di(2-chloroethyl)aminophenylbutyric acid; Phenylbutyric acid nitrogen mustard; N,N-di-2-chloroethyl-\u03b3-p-aminophenylbutyric acid; N,N-Di-2-chloroethyl-gamma-P-aminophenylbutyric acid; Leukeran; \u03b3-p-di(2-chloroethyl)aminophenylbutyric acid; Chlorobutin; Chloroambucil; Chlorbutine; Chlorbutin; Chloraminophene; CHLORAMBUCIL; Chlocambucil; Ambochlorin; 4-p-bis(2-chloroethyl)aminophenylbutyric acid; 4-(p-bis(\u03b2-chloroethyl)aminophenyl)butyric acid; 4-(P-Bis(beta-chloroethyl)aminophenyl)butyric acid; Chloraminophen; CHEBI:28830",2014-12-24,1,,,,,,,,,
56-75-7,0,OMOP Exposome,Observation,Substance,Chloramphenicol,"Chlorsig; Cloramfenicol; D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide; D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol; Fenicol; Globenicol; Halomycetin; Levomicetina; Levomycetin; Oleomycetin; Sificetina; Laevomycetinum; Chlorocid; Chlornitromycin; Chloramphenicolum; Chloramex; Brochlor; Chlorocol; Chloromycetin; CHEBI:17698",2014-12-24,1,,,,,,,,,
510-15-6,0,OMOP Exposome,Observation,Substance,Chlorbenzylate,,2014-12-24,1,,,,,,,,,
1967-16-4,0,OMOP Exposome,Observation,Substance,Chlorbufam,,2014-12-24,1,,,,,,,,,
57-74-9,0,OMOP Exposome,Observation,Substance,Chlordane,"Octachlordane; Unexan-koeder; Trans-chlordane; Trans-chlordan; Toxichlor; Topiclor 20; Topiclor; Topichlor 20; Termi-ded; Termex; Technical Chlordane; Tat Chlor 4; T-chlordane; Synklor; Syndane; Sydane; Steraskin; Starchlor; Shell sd-5532; Photochlordane; Ortho-klor; Oktaterr; Oindane; Octachlorohexahydromethanoindene; Octachlorodihydrodicyclopentadiene; Octachloro-4,7-methanotetrahydroindane; Octachloro-4,7-methanohydroindane; Octachloro-4, 7-methanohydroindane; Velsicol 1068; Octachlor; Octach lorohexahydromethanoindene; Octa-klor; Liquid Chlordane; Kypchlor; Kilex lindane; Intox 8; Intox; Gold crest; Dowchlor; Dow-klor; Dichlorochlordene; Cortilan-neu; Corodane; Compound k; Clordano; Clordan; Cis-photochlordane; Cis-chlordane; Chlortox; Chlorotox; Chlorodane; Chlorindan; Chlordane-technical; Chlordan; Chlor kill; C-chlordane; C orodane; Aspon-chlordane; Alpha-chlordane; Alpha-chlordan; 1,3,4,7,8,9,10,10-octachlorotricyclo5.2.1.0(2,6)dec-8-ene; CHEBI:34623",2014-12-24,1,,,,,,,,,
143-50-0,0,OMOP Exposome,Observation,Substance,Chlordecone,"Chlordecone (kepone); Perchloropentacyclo5.3.0.02,6.03,9.04,8decan-5-one; Decachlorotetrahydro-4,7-methanoindeneone; Hlordecane; Chlordecane; Clordecone; Decachloro-1,3,4-metheno-2H-cyclobuta(cd)pentalen-2-one; Decachloroketone; Decachlorooctahydrokepone-2-one; Decachlorotetracyclodecanone; Chlorodecone; Perchloropentacyclo(5.3.0.0(2,6).0(3,9).0(4,8))decan-5-one; Kepone; Decachloropentacyclo(5.3.0.02,6.04,10.05,9)decan-3-one; Decachloropentacyclo5.2.1.0(2,6).0(3,9).0(5,8)decan-4-one; CHEBI:16548",2014-12-24,1,,,,,,,,,
58-25-3,0,OMOP Exposome,Observation,Substance,Chlordiazepoxide,"Tropium; Sonimen; Silibrin; Risolid; 7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide; Clopoxide; Elenium; Helogaphen; Klopoxid; Libritabs; Librium; Methaminodiazepoxide; Multum; Napoton; Angirex; CDP; Chloradiazepoxide; Chlordiazepoxide base; Radepur; Chlordiazepoxidum; CHEBI:3611",2014-12-24,1,,,,,,,,,
54593-83-8,0,OMOP Exposome,Observation,Substance,Chlorethoxyfos,"Chlorethoxyphos; O,O-Diethyl O-(1,2,2,2-tetrachloroethyl) thiophosphate; Chloroethoxyfos; CHEBI:CHEBI:38590",2014-12-24,1,,,,,,,,,
122453-73-0,0,OMOP Exposome,Observation,Substance,Chlorfenapyr,Kotetsu; Pylon; Pirate 3F; CL 303630; AC 303630; Pirate; CHEBI:39347,2014-12-24,1,,,,,,,,,
1698-60-8,0,OMOP Exposome,Observation,Substance,Chloridazon,,2014-12-24,1,,,,,,,,,
P40879,0,OMOP Exposome,Observation,Substance,Chloride anion exchanger,,2024-09-14,1,,,,,,,,,
Q96S66,0,OMOP Exposome,Observation,Substance,Chloride channel CLIC-like protein 1,,2024-09-14,1,,,,,,,,,
P35523,0,OMOP Exposome,Observation,Substance,Chloride channel protein 1,,2024-09-14,1,,,,,,,,,
P51788,0,OMOP Exposome,Observation,Substance,Chloride channel protein 2,,2024-09-14,1,,,,,,,,,
P51800,0,OMOP Exposome,Observation,Substance,Chloride channel protein ClC-Ka,,2024-09-14,1,,,,,,,,,
P51801,0,OMOP Exposome,Observation,Substance,Chloride channel protein ClC-Kb,,2024-09-14,1,,,,,,,,,
O00299,0,OMOP Exposome,Observation,Substance,Chloride intracellular channel protein 1,,2024-09-14,1,,,,,,,,,
O15247,0,OMOP Exposome,Observation,Substance,Chloride intracellular channel protein 2,,2024-09-14,1,,,,,,,,,
O95833,0,OMOP Exposome,Observation,Substance,Chloride intracellular channel protein 3,,2024-09-14,1,,,,,,,,,
Q9Y696,0,OMOP Exposome,Observation,Substance,Chloride intracellular channel protein 4,,2024-09-14,1,,,,,,,,,
Q9NZA1,0,OMOP Exposome,Observation,Substance,Chloride intracellular channel protein 5,,2024-09-14,1,,,,,,,,,
Q96NY7,0,OMOP Exposome,Observation,Substance,Chloride intracellular channel protein 6,,2024-09-14,1,,,,,,,,,
22537-115-1,0,OMOP Exposome,Observation,Substance,Chloride ion,Chloride (1-); Chloride; Cl(1-); Cl(-); Chlorine anion; CHEBI:29310,2014-12-24,1,,,,,,,,,
P51797,0,OMOP Exposome,Observation,Substance,Chloride transport protein 6,,2024-09-14,1,,,,,,,,,
GIS1008420,0,OMOP Exposome,Observation,Substance,Chlorinated Dibenzo-p-dioxin,,2024-09-14,1,,,,,,,,,
GIS1008419,0,OMOP Exposome,Observation,Substance,Chlorinated Dibenzofuran,,2024-09-14,1,,,,,,,,,
7782-50-5,0,OMOP Exposome,Observation,Substance,Chlorine gas,Chlorine; Molecular chlorine; Cl; Cl2; Diatomic chlorine; Dichlorine; CHEBI:29310,2014-12-24,1,,,,,,,,,
14545-72-3,0,OMOP Exposome,Observation,Substance,Chlorine nitrate,,2014-12-24,1,,,,,,,,,
80-77-3,0,OMOP Exposome,Observation,Substance,Chlormezanone,"Chlormethazone; Trancopal; Fenaprim; Dl-Chlormezanone; Dichloromezanone; Dichloromethazanone; Clormezanone; Clormezanona; Clormetazon; Clormetazanone; Chlormezanonum; Chlormezanona; Chlormezanon; Chlormethazanone; 2-(P-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide; 2-(P-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide; (\u00b1)-chlormezanone; (+-)-Chlormezanone; CHEBI:3619",2014-12-24,1,,,,,,,,,
107-20-0,0,OMOP Exposome,Observation,Substance,Chloroacetaldehyde,2-Chloro-Acetaldehyde; Monochloroacetaldehyde; Rcra waste number P023; Chloroaldehyde; Chloroacetaldehyde monomer; Chloroacetalaldehyde; CH2ClCHO; 2-Chloroethanal; 2-Chloroacetaldehyde; 2-Chloro-1-ethanal; Chloroethanal; CHEBI:27871,2014-12-24,1,,,,,,,,,
GIS1008421,0,OMOP Exposome,Observation,Substance,Chloroacetanilide,,2024-09-14,1,,,,,,,,,
108-90-7,0,OMOP Exposome,Observation,Substance,Chlorobenzene,"6-Chlorohydroxyquinol; Tetrosin SP; Phenyl Chloride; PhCl; Monoclorobenzene; Monochlorobenzene; Monochlorbenzol; Monochlorbenzene; Mono-Chlorobenzene; MCB; Clorobenzene; Chlorobenzol; Chlorobenzen; Chloro-Benzene; Chlorbenzol; Chlorbenzene; Benzene chloride; Abluton T30; 6-Chlorobenzene-1,2,4-triol; CHEBI:28097",2014-12-24,1,,,,,,,,,
96-10-6,0,OMOP Exposome,Observation,Substance,Chlorodiethyaluminum,,2014-12-24,1,,,,,,,,,
75-00-3,0,OMOP Exposome,Observation,Substance,Chloroethane,Monochloroethane; Muriatic ether; 1-Chloroethane; Anodynon; Chelen; Chlorene; Chlorethyl; Chloryl; Chloryl anesthetic; EtCl; Ether hydrochloric; Ether muriatic; Ethyl chloride; Hydrochloric ether; Kelene; Mono-chloroethane; Monochlorethane; Narcotile; CHEBI:47554,2014-12-24,1,,,,,,,,,
13077-54-8,0,OMOP Exposome,Observation,Substance,Chlorofluorotrimethylantimony,,2014-12-24,1,,,,,,,,,
67-66-3,0,OMOP Exposome,Observation,Substance,Chloroform,"Trichloro-Methane; Methyl trichloride; Formyl trichloride; 1,1,1-Trichloromethane; CHCl3; Methylidyne trichloride; CF; Trichloromethane; Methenyl trichloride; Methenyl chloride; Methane trichloride; Trichloroform; TCM; CHEBI:35255",2014-12-24,1,,,,,,,,,
36368-97-5,0,OMOP Exposome,Observation,Substance,Chlorohydroxytriphenylantimony,,2014-12-24,1,,,,,,,,,
107-30-2,0,OMOP Exposome,Observation,Substance,Chloromethyl methyl ether,,2014-12-24,1,,,,,,,,,
2675-77-6,0,OMOP Exposome,Observation,Substance,Chloroneb,,2014-12-24,1,,,,,,,,,
11006-34-1,0,OMOP Exposome,Observation,Substance,Chlorophyllin,,2014-12-24,1,,,,,,,,,
76-06-2,0,OMOP Exposome,Observation,Substance,Chloropicrin,"1,1,1-Trichloronitromethane; Chlorpikrin; Trichlornitromethan; Trichloronitromethane; CHEBI:39285",2014-12-24,1,,,,,,,,,
133-16-4,0,OMOP Exposome,Observation,Substance,Chloroprocaine,Nesacaine-CE; Piocaine; Chloroprocainum; Chlorprocaine; Chloroprocain; 4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester; 2-Chloroprocaine; Cloroprocaina; Nesacaine; CHEBI:3636,2014-12-24,1,,,,,,,,,
GIS1008422,0,OMOP Exposome,Observation,Substance,Chloroprocaine Pathway,,2024-09-14,1,,,,,,,,,
GIS1008423,0,OMOP Exposome,Observation,Substance,Chloropropene,,2024-09-14,1,,,,,,,,,
54-05-7,0,OMOP Exposome,Observation,Substance,Chloroquine,"Aralen; Artrichin; Bemaphate; Capquin; Chloraquine; Chlorochin; N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine; Malarex; Cloroquina; Clorochina; Chlorochine; Chloroquina; Chlorquin; Chloroquinum; Nivaquine b; Resochin; Resoquine; Chloroquinium; Reumachlor; Sanoquin; CHEBI:3638",2014-12-24,1,,,,,,,,,
1189-71-5,0,OMOP Exposome,Observation,Substance,Chlorosulfonyl isocyanate,,2014-12-24,1,,,,,,,,,
1897-45-6,0,OMOP Exposome,Observation,Substance,Chlorothalonil,"Farber; TPN (pesticide); Tripart faber; Tripart ultrafaber; Tuffcide; Vanox; Termil; Ferti-lome; Forturf; Groutcide 75; Hydroxychlorothalonil; Jupital; TCIN; Taloberg; Sweep; Pro-care multi-purpose fungicide; PS1020 SUPELCO; Repulse; Security fungi-g ard; Security fungi-gard; Siclor; Sipcam UK rover 500; Dexol fungicide containing daconil; Ortho multi-purpose fungicide daconil 2787; Ortho Multi-Purpose Fungicide Dacon il 2787; OLE; Nuocide; 1,3-Dicyano-2,4,5,6-tetrachlorobenzene; 1,3-Dicyanotetrachlorobenzene; 2,4,5,6-Tetrachloro-1,3-benzenedicarbonitrile; 2,4,5,6-Tetrachloro-1,3-benzenedicarbonitrile (8CI); 2,4,5,6-Tetrachloro-1,3-benzenedicarbonitrile (8CI)(9CI); 2,4,5,6-Tetrachloro-1,3-dicyanobenzene; 2,4,5,6-Tetrachloro-3-cyanobenzonitrile; 2,4,5,6-tetrachlorobenzene-1,3-dicarbonitrile; 2,4,5,6-Tetrachloroisophthalonitrile; 2,4:5,6-Tetrachloroisophthalonitrile; BB chlorothalonil; Bombardier; Bonide; Bravo; Bravo 500; Bravo 6f; Bravo-W-75; Chiltern ole; Chloroalonil; Chlorothalonil solution; Chlorothanonil; Chlorthalonil; Clortocaf ramato; Clortocaffaro; Clortosip; Contact 75; Dacobre; Daconil; Daconil 2787; Daconil 2787 flowable fungicide; Power chlorothalonil 50; Nopcocide N40D and N96; Nopcocide N-96-S; Pillarich; Nopcocide N-96; Nopcocide N-40-D; Nopcocide N 96; Nopcocide; Meta-tetrachlorophthalodinitrile; Meta-TCPN; M-tetrachlorophthalonitrile; M-tetrachlorophthalodinitrile; M-TCPN; Terraclactyl; Daconil 2787 W-75 Fungicide; Daconil 2787 W75; Daconil flowable; Daconil m; Daconil turf; DaconilDAC-2787; Dacosoil; Pennington's pride multi-purpose fungicide; Dragon daconil 2787; Echo 75; Evade; Exotherm; Exotherm termil; Faber; Tetrachlorisoftalonitril; Tetrachloro-1,3-dicyanobenzene; Tetrachloro-m-phthalodinitrile; Tetrachloroisophthalodinitrile; Tetrachloroisophthalonitrile; Tetrachloroisophthalonitrilem-tetrachlorophthalodinitrile; TPN; CHEBI:3639",2014-12-24,1,,,,,,,,,
163515-35-3,0,OMOP Exposome,Observation,Substance,Chlorotoxin,,2014-12-24,1,,,,,,,,,
132-22-9,0,OMOP Exposome,Observation,Substance,Chlorpheniramine,"Aller-Chlor; Chlorophenylpyridamine; Chlorphenamin; Chlorphenamine; Chlorphenaminum; Chlorpheniaramine maleate; 1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; Haynon; Chlorphenamine hydrogen maleate; Teldrin; Piriton; Clorfenamina; Chlorpheniraminum; Chlo-Amine; 1-(P-Chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine; 2-P-chloro-alpha-2-(dimethylamino)Ethylbenzylpyridine; 3-(P-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; \u03b3-(4-chlorophenyl)-\u03b3-(2-pyridyl)propyldimethylamine; Chlorpheniramine Maleate; Clofeniramina; Chlorphenamine Maleate; gamma-(4-Chlorophenyl)-gamma-(2-pyridyl)propyldimethylamine; Clorfeniramina; Chloropheniramine maleate; Chlor-Tripolon; Chlor-trimeton; gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine; CHEBI:52010",2014-12-24,1,,,,,,,,,
23121-99-5,0,OMOP Exposome,Observation,Substance,Chlorprocarb,,2014-12-24,1,,,,,,,,,
50-53-3,0,OMOP Exposome,Observation,Substance,Chlorpromazine,"3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine; Thorazine; N-(3-Dimethylaminopropyl)-3-chlorophenothiazine; Largactil; CPZ; Contomin; Clorpromazina; Chlorpromazinum; Chlorpromados; Chloropromazine; Chlorderazin; Aminazine; 3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine; CHEBI:3647",2014-12-24,1,,,,,,,,,
101-21-3,0,OMOP Exposome,Observation,Substance,Chlorpropham,"Isopropyl n-(m-chlorophenyl)carbamate; Isopropyl N-3-chlorophenyl; Isopropyl n-chlorophenylcarbamate; Isopropyl-m-chlorocarbanilate; Isopropyl-N-(3-chlorophenyl)carbamate; Isopropyl-N-(3-chlorphenyl)-carbamat; Isopropyl-N-3-chlorophenyl carbamate; Carbamate pesticide cipc; (3-Chlorophenyl)carbamic acid, 1-methylethyl ester; Furlow Chloro IPC 20G; 1-Methylethyl (3-chlorophenyl)carbamate; 1-Methylethyl(3-chlorophenyl)carbamate; 3-Chlorocarbanilic acid, isopropyl ester; Atlas CIPC 40; Beet-kleen; Bud nip; Carbamate; Bud-nip; Furloe Chloro IPC 4EC; Furloe 4EC; Furloe 3EC; Isopropyl 3-chlorophenylcarbamate; Furloe; Elbanil; Croptex chrome; CL-ifk; CIPC; Ci-ipc; Bygran; Isopropyl-n-m-chlorophenyl-carbamate; Jack wilson chloro 51 oil; Jack Wilson chloro 51(oil); Keim-stop; Liro cipc; Ci-ifk; m-Chlorocarbanilic acid isopropyl ester; m-Chlorocarbanilic acid, isopropyl ester; Metoxon; Mirvale; MSS cipc; Furloe 3 EC; Isopropyl chlorocarbanilate; Isopropyl m-chlorocarb anilate; Isopropyl m-chlorocarbanilate; Isopropyl meta-chlorocarbanilate; Isopropyl N-(3-Chlorophenol)carbamate; Isopropyl N-(3-Chlorophenyl) Carbamate; Isopropyl N-(3-chlorophenyl)carbamate; Chlor ocarbanilic acid isopropyl ester; Chlor ipc; Chlor ifk; Chlor ifc; Caswell No. 510A; Carbanilic acid, m-chloro-, isopropyl ester; Carbamic acid, (3-chlorophenyl)-, 1-methylethyl ester; N-(3-Chloor-fenyl)-isopropyl carbamaat; N-(3-Chlor-phenyl)-isopropyl-carbamat; N-(3-Chloro phenyl)carbamate d'isopropyle; N-(3-Chlorophenyl)carbamic acid, isopropyl ester; N-(3-Chlorophenyl)isopropyl carbamate; N-(3-Cloro-fenil)-isopropil-carbammato; N-3-Chlorophenylisopropylcarbamate; Nexoval; o-Isopropyl N-(3-chlorophenyl)carbamate; Prevenol; Prevenol 56; Preventol; Preventol 56; Preweed; Residuren; Sopropyl N-3-chlorophenyl; Sprout nip; Sprout-nip ec; Spud-nic; Spud-nie; Spud-nip; Stopgerme-s; Taterpex; Warefog; Isopropyl 3-chlorocarbanilate; Isopropyl (3-chlorophenyl)carbamate; Gro stop; Chlorprophame; Chlorpropham cipc; Chlorpropam; Chloropropham; Chlorocarbanilic acid isopropyl ester; Chloro-ipc; Chloro-ifk; Chloro-icp; Chloro ipc; Chloripc; Chlor-ifc; CHEBI:34630",2014-12-24,1,,,,,,,,,
113-59-7,0,OMOP Exposome,Observation,Substance,Chlorprothixene,Chlorprothixine; Chlorprothixen; Chloroprothixene; Chlorprotixen; Chlorprotixene; Chlorprotixine; Chlothixen; Cis-Chlorprothixene; Clothixen; Cloxan; Taractan; alpha-Chlorprothixene; CHEBI:3651,2014-12-24,1,,,,,,,,,
2921-88-2,0,OMOP Exposome,Observation,Substance,Chlorpyrifos,"Lentrek; Lorsban; m-Chlorpyrifos; O,O-Diaethyl-O-3,5,6-trichlor-2-pyridylmonothiophosphat; O,O-Diethyl O-(3,5,6-trichloro-2-pyridinyl)phosphorothioate; O,O-Diethyl O-(3,5,6-Trichloro-2-pyridyl) phosphorothioate; O,O-Diethyl O-(3,5,6-trichloropyridin-2-yl) phosphorothioate; O,O-Diethyl O-(3,5,6-trichloropyridin-2-yl) thiophosphate; O,O-Diethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothioate; Pageant; Phosphorothioic acid, O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl) ester; Piridane; Pyrinex; Silrifos; Spannit; Stipend; SuSCon; Suscon blue; Suscon green; Tafaban; Terial; Trichlorpyrphos; Zidil; Chlorpyrifos-ethyl; Chloropyriphos; Chloropyrifos; Bonidel; Coroban; Killmaster; Chlorpyrophos; Chlorpyrofos; Geodinfos; Dursban 2E; Chlorpyriphos; Dursban 10CR; Dursban; Durmet; Dowco 179; Detmol U.A.; Danusban; Dursban F; Dursban 4E; Brodan; Chlorpyriphos-ethyl; Ethyl chlorpyriphos; Dursban R; CHEBI:34631",2014-12-24,1,,,,,,,,,
5598-15-2,0,OMOP Exposome,Observation,Substance,Chlorpyrifos oxon,,2014-12-24,1,,,,,,,,,
5598-13-0,0,OMOP Exposome,Observation,Substance,Chlorpyrifos-methyl,"Chlorpyrifos O,O-dimethyl analog; Methyl chlorpyriphos; O,O-Dimethyl O-(3,5,6-trichloro-2-pyridyl) phosphorothioate; O,O-Dimethyl O-(3,5,6-trichloropyridin-2-yl) thiophosphate; O,O-Dimethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothioate; Phosphorothioic acid, O,O-dimethyl O-(3,5,6-trichloro-2-pyridinyl) ester; Phosphorothioic acid, O,O-dimethyl O-(3,5,6-trichloro-2-pyridyl) ester; Trichlormethylfos; Chloropyriphos-methyl; Methyl chlorpyrifos; CHEBI:34632",2014-12-24,1,,,,,,,,,
64902-72-3,0,OMOP Exposome,Observation,Substance,Chlorsulfuron,,2014-12-24,1,,,,,,,,,
67-97-0,0,OMOP Exposome,Observation,Substance,Cholecalciferol,"delta-D; Colecalciferol; CC; Vitamin D3; Activated 7-dehydrocholesterol; Vigantol; Optimal-D; (+)-vitamin D3; Calciol; Oleovitamin D3; Micro-D; (1S,3Z)-3-(2e)-2-(1R,3AR,7as)-7a-methyl-1-(2R)-6-methylheptan-2-yl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylideneethylidene-4-methylidene-cyclohexan-1-ol; (3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol; (5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol; CHEBI:28940",2014-12-24,1,,,,,,,,,
P32238,0,OMOP Exposome,Observation,Substance,Cholecystokinin receptor type A,,2024-09-14,1,,,,,,,,,
9012-63-9,0,OMOP Exposome,Observation,Substance,Cholera toxin,,2014-12-24,1,,,,,,,,,
57-88-5,0,OMOP Exposome,Observation,Substance,Cholesterol,Dythol; Dusoran; Cholestrin; Cholesteryl alcohol; (3b)-cholest-5-en-3-ol; (-)-Cholesterol; (+)-ent-Cholesterol; Dusoline; Dastar; 5:6-Cholesten-3beta-ol; Tegolan; Super hartolan; Cholest-5-en-3-ol; Nimco cholesterol base No. 712; Nimco cholesterol base H; Cholesterol base H; Cholesterin; Cordulan; 20-Epi-cholesterol; 20-Iso-cholesterol; 20bFH-cholest-5-en-3b-ol; (3beta)-Cholest-5-en-3-ol; Cholesterine; (20bFH)-cholest-5-en-3b-ol; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3B-ol; Cholest-5-en-3beta-ol; 5-Cholesten-3beta-ol; Cholest-5-en-3b-ol; 5:6-Cholesten-3-ol; Cholestrol; Liquid crystal CN/9; Lanol; Kathro; Hydrocerin; Fancol CH; Epicholesterol; Epicholesterin; CHEBI:1307929,2018-03-21,1,,,,,,,,,
P05108,0,OMOP Exposome,Observation,Substance,"Cholesterol side-chain cleavage enzyme, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1008424,0,OMOP Exposome,Observation,Substance,Cholesteryl ester storage disease,,2024-09-14,1,,,,,,,,,
81-25-4,0,OMOP Exposome,Observation,Substance,Cholic acid,"Cholalic acid; Cholalate; 5b-Cholic acid; 5b-Cholate; 5b-Cholanic acid-3a,7a,12a-triol; 3a,7a,12a-Trihydroxycholanic acid; 3a,7a,12a-Trihydroxycholanate; 3a,7a,12a-Trihydroxy-beta-cholanic acid; 3a,7a,12a-Trihydroxy-beta-cholanate; Colalin; 17b-1-Methyl-3-carboxypropyletiocholane-3a,7a,12a-triol; 3a,7a,12a-Trihydroxy-b-cholanic acid; 3a,7a,12a-Trihydroxy-b-cholanate; 3a,7a,12a-Trihydroxy-5b-cholan-24-oate; 3a,7a,12a-Trihydroxy-5b-cholan-24-oic acid; 3a,7a,12a-Trihydroxy-5b-cholanate; 3a,7a,12a-Trihydroxy-5b-cholanic acid; 3a,7a,12a-Trihydroxy-5b-cholanoate; Cholate; 3a,7a,12a-Trihydroxy-5b-cholanoic acid; Cholalin; CHEBI:16359",2018-03-21,1,,,,,,,,,
P28329,0,OMOP Exposome,Observation,Substance,Choline O-acetyltransferase,,2024-09-14,1,,,,,,,,,
Q9Y6K0,0,OMOP Exposome,Observation,Substance,Choline/ethanolaminephosphotransferase 1,,2024-09-14,1,,,,,,,,,
GIS1008425,0,OMOP Exposome,Observation,Substance,Cholinergic Agent,,2024-09-14,1,,,,,,,,,
GIS1008426,0,OMOP Exposome,Observation,Substance,Cholinergic Antagonist,,2024-09-14,1,,,,,,,,,
GIS1008427,0,OMOP Exposome,Observation,Substance,Cholinergic synapse,,2024-09-14,1,,,,,,,,,
P06276,0,OMOP Exposome,Observation,Substance,Cholinesterase,,2024-09-14,1,,,,,,,,,
GIS1008428,0,OMOP Exposome,Observation,Substance,Cholinesterase Inhibitor,,2024-09-14,1,,,,,,,,,
BE0005825,0,OMOP Exposome,Observation,Substance,Choriogonadotropin subunit beta,,2024-09-14,1,,,,,,,,,
P0DN86,0,OMOP Exposome,Observation,Substance,Choriogonadotropin subunit beta 3,,2024-09-14,1,,,,,,,,,
P0DN87,0,OMOP Exposome,Observation,Substance,Choriogonadotropin subunit beta 7,,2024-09-14,1,,,,,,,,,
Q494W8,0,OMOP Exposome,Observation,Substance,CHRNA7-FAM7A fusion protein,,2024-09-14,1,,,,,,,,,
P54219,0,OMOP Exposome,Observation,Substance,Chromaffin granule amine transporter,,2024-09-14,1,,,,,,,,,
37337-13-6,0,OMOP Exposome,Observation,Substance,Chromated copper arsenate,,2014-12-24,1,,,,,,,,,
7738-94-5,0,OMOP Exposome,Observation,Substance,Chromic acid,Chromium hydroxide oxide; Chromic Acid; Chromate; CrO2(OH)2; Tetraoxochromic acid; H2CrO4; Dihydroxidodioxidochromium; Dihydrogen(tetraaoxidochromate); CHEBI:33143,2014-12-24,1,,,,,,,,,
7440-47-3,0,OMOP Exposome,Observation,Substance,Chromium,Chromium ion; Chromium ion (Cr6+); Chromium(6+); Chromium(VI); Chromium(6+) ion; Chromium (VI) cation; Cr6+; Cr(6+); Cr; CHEBI:28073,2014-12-24,1,,,,,,,,,
12012-35-0,0,OMOP Exposome,Observation,Substance,Chromium carbide,,2014-12-24,1,,,,,,,,,
13007-92-6,0,OMOP Exposome,Observation,Substance,Chromium carbonyl,Cr(CO)6; Chromium(0) hexacarbonyl; Chromcarbonyl; Cr(CO)6; Hexacarbonylchromium; Chromium hexacarbonyl; CHEBI:33031,2014-12-24,1,,,,,,,,,
41261-95-4,0,OMOP Exposome,Observation,Substance,Chromium chromate,,2014-12-24,1,,,,,,,,,
GIS1008429,0,OMOP Exposome,Observation,Substance,Chromium Compound,,2024-09-14,1,,,,,,,,,
24094-93-7,0,OMOP Exposome,Observation,Substance,Chromium nitride,,2014-12-24,1,,,,,,,,,
1308-14-1,0,OMOP Exposome,Observation,Substance,Chromium trihydroxide,,2014-12-24,1,,,,,,,,,
14976-80-8,0,OMOP Exposome,Observation,Substance,Chromium(II) acetate,,2014-12-24,1,,,,,,,,,
10049-05-5,0,OMOP Exposome,Observation,Substance,Chromium(II) chloride,Chromium chloride; Chromous chloride; CHEBI:33038,2014-12-24,1,,,,,,,,,
814-90-4,0,OMOP Exposome,Observation,Substance,Chromium(II) oxalate,,2014-12-24,1,,,,,,,,,
12018-00-7,0,OMOP Exposome,Observation,Substance,Chromium(II) oxide,,2014-12-24,1,,,,,,,,,
1066-30-4,0,OMOP Exposome,Observation,Substance,Chromium(III) acetate,,2014-12-24,1,,,,,,,,,
21679-31-2,0,OMOP Exposome,Observation,Substance,Chromium(III) acetylacetonate,"Chromium tris(2,4-pentanedionate); Chromium tris(acetylacetonate); Chromium(3+) acetylacetonate; Chromium(III) 2,4-pentanedionate; Chromium(III) acetylacetonic acid; Tris(acetylacetonato)chromium; Tris(2,4-pentanedionato)chromium; Tris(acetylacetonato)chromium(III); Chromic acetylacetonate; Chromium acetylacetonate; Chromium triacetylacetonate; CHEBI:33035",2014-12-24,1,,,,,,,,,
10025-73-7,0,OMOP Exposome,Observation,Substance,Chromium(III) chloride,Trichlorochromium; Chromic chloride; Chromic chloride hexahydrate; Chromium chloride; Chromium trichloride; CrCl3; Puratronic chromium chloride; CHEBI:53351,2014-12-24,1,,,,,,,,,
7788-97-8,0,OMOP Exposome,Observation,Substance,Chromium(III) fluoride,,2014-12-24,1,,,,,,,,,
13548-38-4,0,OMOP Exposome,Observation,Substance,Chromium(III) nitrate,,2014-12-24,1,,,,,,,,,
1308-38-9,0,OMOP Exposome,Observation,Substance,Chromium(III) oxide,Green chromium oxide; chromium(3+) oxide; Chromium trioxide; Chromium sesquioxide; Chromium oxide greens; Chromium oxide green; Chromic acid green; Levanox green ga; Leaf green; Green rouge; Green oxide of chromium; Green cinnabar; Green chromic oxide; Green chrome oxide; Dichromium trioxide; Chromium(III) sesquioxide; Chromium(3+) trioxide; CHEBI:48242,2014-12-24,1,,,,,,,,,
14639-25-9,0,OMOP Exposome,Observation,Substance,Chromium(III) picolinate,"Chromium tripicolinate; Chromium(III) picolinic acid; Chromium(III) trispicolinat; Picolinic acid, chromium salt; Tris(2-pyridinecarboxylato-N(1),O(2))chromium; Chromium picolinate; 2-Pyridinecarboxylic acid, chromium salt; Chromium 2-pyridinecarboxylate; CHEBI:50369",2014-12-24,1,,,,,,,,,
10141-00-1,0,OMOP Exposome,Observation,Substance,Chromium(III) potassium sulfate,,2014-12-24,1,,,,,,,,,
10101-53-8,0,OMOP Exposome,Observation,Substance,Chromium(III) sulfate,,2014-12-24,1,,,,,,,,,
12018-22-3,0,OMOP Exposome,Observation,Substance,Chromium(III) sulfide,,2014-12-24,1,,,,,,,,,
12018-01-8,0,OMOP Exposome,Observation,Substance,Chromium(IV) oxide,"Chromium(3+) hydroxide; Dichromium trioxide hydrate; CrO2; Chromium(III) hydroxide; Chromium oxide; Chromium hydroxide; Chromic oxide, hydrous; Chromic oxide gel; Chromic hydroxide; Chromic (III) hydroxide; Chromdioxid; CHEBI:48263",2014-12-24,1,,,,,,,,,
1333-82-0,0,OMOP Exposome,Observation,Substance,Chromium(VI) oxide,Monochromium trioxide; Anadonis green; CrO3; Trioxochromium; Sintered chromium trioxide; Red oxide of chromium; Pure Chromium Oxide Green 59; Puratronic chromium trioxide; Pigment green 17; Oxide of chromium; Monochromium oxide; Levanox green GA; Green rouge; Green oxide of chromium; Green cinnabar; Green chromium oxide; Green chromic oxide; Green chrome oxide; CrO3; Chromtrioxid; Chromous trioxide; Chromosulfuric acid; Chromium trioxide sintered; Chromium sesquioxide; Chromium oxide green; Chromium oxide; Chromic trioxide; Chromic oxide; Chromic anhydride; Chromia; Chrome oxide green GP; Chrome oxide green GN-m; Chrome oxide green BX; Chrome oxide; Chrome ochre; Chrome ocher; Chrome Green F3; Chrome green; Chrome bronze; Casalis green; CHEBI:48240,2014-12-24,1,,,,,,,,,
1271-24-5,0,OMOP Exposome,Observation,Substance,Chromocene,"Bis(cyclopentadienyl)chromium; Bis(cyclopentadienyl)chromium(II); Bis(eta5-cyclopenta-2,4-dien-1-yl)chromium; Chromium, bis(eta(5)-2,4-cyclopentadien-1-yl); Di((eta-5)-cyclopentadienyl)chromium; Bis(.eta.5-cyclopentadienyl) chromium; Dicyclopentadienylchromium; Bis(cyclopentadiene)chromium; Bis(cyclopentadiene)chromium(II); CHEBI:30677",2014-12-24,1,,,,,,,,,
O14646,0,OMOP Exposome,Observation,Substance,Chromodomain-helicase-DNA-binding protein 1,,2024-09-14,1,,,,,,,,,
O95239,0,OMOP Exposome,Observation,Substance,Chromosome-associated kinesin KIF4A,,2024-09-14,1,,,,,,,,,
Q2VIQ3,0,OMOP Exposome,Observation,Substance,Chromosome-associated kinesin KIF4B,,2024-09-14,1,,,,,,,,,
14977-61-8,0,OMOP Exposome,Observation,Substance,Chromyl chloride,"Chromium dioxide dichloride; Oxychlorure chromique; CrCl2O2; (T-4)-dichlorodioxochromium; Chromic oxychloride; Chromium chloride oxide; Chromium dichloride dioxide; Cromile, cloruro di; Dioxodichlorochromium; Dichlorodioxochromium; Chromoxychlorid; Cromo, ossicloruro di; Chromylchlorid; Chroomoxychloride; CHEBI:33038",2014-12-24,1,,,,,,,,,
218-01-9,0,OMOP Exposome,Observation,Substance,Chrysene,"Benzo(a)phenanthrene; Benz(a)phenanthrene; Ambap84; 1,2-Benzphenanthrene; 1,2-Benzophenanthrene; Chrysen; Benzaphenanthrene; 1,2,5,6-Dibenzonaphthalene; 1,2, 5,6-Dibenzonaphthalene; Benzoaphenanthrene; Crysene; Benzophenanthrene; CHEBI:51687",2014-12-24,1,,,,,,,,,
12001-29-5,0,OMOP Exposome,Observation,Substance,Chrysotile asbestos,"Asbestos, serpentine; Asbestos, Chrysotile(SR); Asbestos, chrysotile; Asbestos (chrysotile); Antigorite; Chrysotile uicc; Serpentine; Serpentine asbestos; Serpentine chrysotile; Sylodex; White asbestos; Asbestos, Serpentine, Chrysotile (Mg3(OH)4(Si2O5)); Avibest c; Chrysotile a asbestos; CHEBI:46664",2014-12-24,1,,,,,,,,,
Q9UNI1,0,OMOP Exposome,Observation,Substance,Chymotrypsin-like elastase family member 1,,2024-09-14,1,,,,,,,,,
29342-05-0,0,OMOP Exposome,Observation,Substance,Ciclopirox,Batrafen; Stieprox; Penlac; Mycoster; Loprox; HOE-296b; HOE 296b; CNL8; Ciclopiroxum; Ciclopiroxolamine; Ciclopirox-Olamin; Ciclopirox Olamin; Ciclodan; 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone; CHEBI:453011,2014-12-24,1,,,,,,,,,
505-75-9,0,OMOP Exposome,Observation,Substance,Cicutoxin,,2014-12-24,1,,,,,,,,,
GIS1008430,0,OMOP Exposome,Observation,Substance,Cigarette Toxin,,2024-09-14,1,,,,,,,,,
11050-21-8,0,OMOP Exposome,Observation,Substance,Ciguatoxin 1,CTX 1; CTX; Ciguatoxin; Ciguatoxin CTX 1; Pacific ciguatoxin-1; Pacific ciguatoxin 1; P-CTX-1; P-CTX 1; CHEBI:36467,2014-12-24,1,,,,,,,,,
142185-85-1,0,OMOP Exposome,Observation,Substance,Ciguatoxin 2,,2014-12-24,1,,,,,,,,,
123676-76-6,0,OMOP Exposome,Observation,Substance,Ciguatoxin 4B,Scaritoxin; GTX 4b; Gambiertoxin-4b; Gambiertoxin 4b; Ciguatoxin 4b; 52-epi-CTX 4A; 52-epi-Ciguatoxin 4A; CHEBI:68281,2014-12-24,1,,,,,,,,,
51481-61-9,0,OMOP Exposome,Observation,Substance,Cimetidine,Tagamet HB; Ulcerfen; Ulcedine; Tagamet HB200; Tagamet hb 200; Cimetidina; Cimetidin; N-Cyano-n'-methyl-n''-(2-((5-methyl-1H-imidazol-4-yl)methylsulfanyl)ethyl)guanidine; Tagamet; 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; Cimetidine Hcl; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; Cimetag; Ulcimet; Cim\u00e9tidine; Cimetidinum; N''-cyano-N-methyl-n'-(2-{(5-methyl-1H-imidazol-4-yl)methylthio}ethyl)guanidine; CHEBI:3699,2014-12-24,1,,,,,,,,,
GIS1008431,0,OMOP Exposome,Observation,Substance,Cimetidine Pathway,,2024-09-14,1,,,,,,,,,
25402-06-6,0,OMOP Exposome,Observation,Substance,Cinerin I,,2014-12-24,1,,,,,,,,,
121-20-0,0,OMOP Exposome,Observation,Substance,Cinerin II,"3-(3-Methoxy-2-methyl-3-oxo-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid 3-(2-butenyl)-2-methyl-4-oxo-2-cyclopenten-1-yl ester; 3-(But-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate; CHEBI:3707",2014-12-24,1,,,,,,,,,
87818-31-3,0,OMOP Exposome,Observation,Substance,Cinmethylin,,2014-12-24,1,,,,,,,,,
104-55-2,0,OMOP Exposome,Observation,Substance,Cinnamaldehyde,trans-3-Phenyl-2-propenal; Cinnemaldehyde; Cinnamylaldehyde; 3-Fenylpropenal; (E)-Cinnamaldehyde; (E)-3-Phenyl-2-propenal; (E)-3-Phenylpropenal; (2E)-3-phenylacrylaldehyde; (2E)-3-Phenyl-2-propenal; Cinnamyl aldehyde; Cinnamic aldehyde; Cinnamal; beta-Phenylcrolein; Benzylideneacetaldehyde; 3-Phenylpropenal; 3-Phenylprop-2-enal; 3-Phenylacrylaldehyde; 3-Phenylacrolein; 3-Phenyl-2-propenaldehyde; 3-Phenyl-2-propen-1-al; trans-Cinnamylaldehyde; trans-Cinnamic aldehyde; trans-Cinnamaldehyde; CHEBI:16731,2014-12-24,1,,,,,,,,,
470-37-1,0,OMOP Exposome,Observation,Substance,Cinobufagin,,2014-12-24,1,,,,,,,,,
75696-02-5,0,OMOP Exposome,Observation,Substance,Cinolazepam,"1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; Gerodorm; Cinolazepamum; 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile; 7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile; CHEBI:59514",2014-12-24,1,,,,,,,,,
85721-33-1,0,OMOP Exposome,Observation,Substance,Ciprofloxacin,"Cifloxin; Ciprinol; Cipro; Ciprobay; Ciprocinol; Ciprodar; Ciprofloxacin monohydrochloride; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciproxan; Ciproxin; Flociprin; Proquin; Proquin XR; 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid; 1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid; Bacquinor; Baycip; Ciflox; Ciloxan; CHEBI:100241",2014-12-24,1,,,,,,,,,
GIS1008432,0,OMOP Exposome,Observation,Substance,Circadian rhythm,,2024-09-14,1,,,,,,,,,
10061-01-5,0,OMOP Exposome,Observation,Substance,"cis-1,3-Dichloropropene","1,3-Dichloropropene (cis+trans); 1,3-Dichloropropene; 1,3-Dichloro-2-propene; 1,3-Dichloro-1-propene (Z); 1,3-Dichloro-1-propene; .gamma.-chloroallyl chloride; .alpha.-chloroallyl chloride; (1Z)-1,3-Dichloro-1-propene; 1,3-DICHLOROPROPENE, HIGH BOILING, PRACT; (Z)-1,3-Dichloro-1-propene; (Z)-1,3-Dichloropropene; .alpha.,.gamma.-dichloropropylene; Vidden d; Telone II; Telone c; Telone; Nemex; Dichloropropene; D-d mixture; Cis-DCP; cis-1,3-Dichloropropylene; cis-1,3-Dichloro-1-Propene; 3-Chloropropenyl chloride; 1-Propene, 1,3-dichloro-, (Z)- (9CI); 1,3-Dichloropropylene; 1,3-DICHLOROPROPENE-1,LOW BOILING; 1,3-Dichloropropene-1; (1Z)-1,3-dichloroprop-1-ene; CHEBI:18809",2014-12-24,1,,,,,,,,,
5103-71-9,0,OMOP Exposome,Observation,Substance,cis-Chlordane,Alpha-chlordane; a-chlordan; cis-Chlordan; Chlordane cis; a-chlordane; CHEBI:39068,2014-12-24,1,,,,,,,,,
5392-40-5,0,OMOP Exposome,Observation,Substance,cis-Citral,citral B; Lemonal; FEMA 2303; Neral; CHEBI:29020,2014-12-24,1,,,,,,,,,
14323-43-4,0,OMOP Exposome,Observation,Substance,cis-Diamminedichloro-palladium(II),,2014-12-24,1,,,,,,,,,
14040-32-5,0,OMOP Exposome,Observation,Substance,cis-Dichlorobis(ethylenediamine)cobalt(III) chloride,,2014-12-24,1,,,,,,,,,
81098-60-4,0,OMOP Exposome,Observation,Substance,Cisapride,cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide; 4-Amino-5-chloro-N-{1-3-(4-fluoro-phenoxy)-propyl-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide; 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide; Propulsid Quicksolv; Kinestase; Enteropride; Cisapridum; Cisaprida; (+-)-Cisapride; Cisaprid; cis-4-amino-5-chloro-N-{1-3-(P-fluorophenoxy)propyl-3-methoxy-4-piperidinyl}-O-anisamide; cis-4-amino-5-chloro-N-{1-3-(4-fluorophenoxy)propyl-3-methoxy-4-piperidinyl}-2-methoxybenzamide; Pridesia; Prepulsid; Propulsid; CHEBI:3720,2014-12-24,1,,,,,,,,,
35764-59-1,0,OMOP Exposome,Observation,Substance,Cismethrin,,2014-12-24,1,,,,,,,,,
15663-27-1,0,OMOP Exposome,Observation,Substance,Cisplatin,Cis-DDP; Platidiam; Trans-DDP; Cisplatyl; CDDP; CHEBI:27899,2014-12-24,1,,,,,,,,,
59729-33-8,0,OMOP Exposome,Observation,Substance,Citalopram,Dalsan; Citrol; Citox; Citopam; Citol; Citalopram hydrobromide; Citalec; Citadur; Citabax; Ciprapine; Cipramil; Cipram; Cilift; Ciazil; Celexa; Celapram; Bonitrile; Akarin; Oropram; Zetalo; Zentius; Vodelax; Temperax; Talohexal; Talam; Seropram; Recital; Pramcit; Nitalapram; Humorup; Elopram; CHEBI:3723,2014-12-24,1,,,,,,,,,
O75390,0,OMOP Exposome,Observation,Substance,"Citrate synthase, mitochondrial",,2024-09-14,1,,,,,,,,,
25425-12-1,0,OMOP Exposome,Observation,Substance,Citreoviridin A,,2014-12-24,1,,,,,,,,,
GIS1008433,0,OMOP Exposome,Observation,Substance,Citric Acid Cycle,,2024-09-14,1,,,,,,,,,
518-75-2,0,OMOP Exposome,Observation,Substance,Citrinin,"Antimycin; (3R,4S)-8-hydroxy-3,4,5-trimethyl-6-oxo-4,6-dihydro-3H-isochromene-7-carboxylic acid; Citriain; (3R-trans)-4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran-7-carboxylic acid; (3R,4S)-4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran-7-carboxylic acid; CHEBI:48707",2014-12-24,1,,,,,,,,,
372-75-8,0,OMOP Exposome,Observation,Substance,Citrulline,2-Amino-5-uredovaleric acid; (S)-2-Amino-5-ureidopentanoic acid; \u03b4-ureidonorvaline; \u03b1-amino-\u03b4-ureidovaleric acid; Ureidovaleric acid; Ureidovalerate; Sitrulline; Ureidonorvaline; (S)-2-Amino-5-ureidopentanoate; L-2-Amino-5-ureidovalerate; Cytrulline; L-2-Amino-5-ureidovaleric acid; L(+)-2-Amino-5-ureidovalerate; L-Citrulline; Ndelta-carbamylornithine; Ngamma-carbamylornithine; CIT; CIR; Amino-ureidovaleric acid; Amino-ureidovalerate; alpha-Amino-gamma-ureidovaleric acid; alpha-Amino-gamma-ureidovalerate; alpha-Amino-delta-ureidovaleric acid; alpha-Amino-delta-ureidovalerate; A-Amino-D-ureidovaleric acid; A-Amino-D-ureidovalerate; 2-Amino-5-ureidovaleric acid; 2-Amino-5-ureidovalerate; 2-Amino-5-uredovalerate; (S)-2-amino-5-(aminocarbonyl)aminopentanoic acid; (2S)-2-amino-5-(carbamoylamino)pentanoate; (2S)-2-amino-5-(carbamoylamino)pentanoic acid; (S)-2-amino-5-(aminocarbonyl)aminopentanoate; L-Cytrulline; L-N5-carbamoyl-Ornithine; N()-Carbamylornithine; N(5)-(Aminocarbonyl)-DL-Ornithine; N(5)-(Aminocarbonyl)-L-ornithine; N(delta)-Carbamylornithine; N-Carbamylornithine; N5-(Aminocarbonyl)-L-ornithine; N5-(aminocarbonyl)-Ornithine; N5-(Aminocarbonyl)ornithine; N5-Carbamoyl-L-ornithine; N5-carbamoylornithine; N5-carbamylornithine; N<SUP>5</SUP>-(aminocarbonyl)ornithine; ND-carbamylornithine; Ndelta-carbamy-ornithine; D-Ureidonorvaline; H-Cit-oh; Gammaureidonorvaline; DL-citrulline; delta-Ureidonorvaline; L(+)-2-Amino-5-ureidovaleric acid; L(+)-Citrulline; L-2-Amino-5-ureido-valerate; L-2-Amino-5-ureido-valeric acid; CHEBI:16349,2014-12-24,1,,,,,,,,,
GIS1008434,0,OMOP Exposome,Observation,Substance,Citrullinemia Type I,,2024-09-14,1,,,,,,,,,
4291-63-8,0,OMOP Exposome,Observation,Substance,Cladribine,"CldAdo; Cladribinum; Chlorodeoxyadenosine; Movectro; Mylinax; Litak; Leustatin; 2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine; 2-Chloro-2'-deoxyadenosine; 2-Chlorodeoxyadenosine; 2-chloro-Deoxyadenosine; 2-Chloro-2'-deoxy-beta-adenosine; 2-CdA; (2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2ClAdo; Cladribina; CHEBI:567361",2014-12-24,1,,,,,,,,,
GIS1008435,0,OMOP Exposome,Observation,Substance,Clathrin Coated Vesicle,,2024-09-14,1,,,,,,,,,
18323-44-9,0,OMOP Exposome,Observation,Substance,Clindamycin,"Clindamycine; Dalacin T Topical Solution; Dalacin C; Clinimycin; Clindesse; Clindamax; Clindagel; Clinda-Derm; Cleocin; 7-CDL; 7(S)-Chloro-7-deoxylincomycin; Clindamycinum; Clindamicina; Clindets; Clindamycin Phosphate; Zindaclin; Evoclin; Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside; CHEBI:3745",2014-12-24,1,,,,,,,,,
GIS1008436,0,OMOP Exposome,Observation,Substance,Clindamycin Pathway,,2024-09-14,1,,,,,,,,,
22316-47-8,0,OMOP Exposome,Observation,Substance,Clobazam,"Urbanyl; Sederlona; 1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine; Clobamax; Noiafren; Onfi; Castilium; Clobam; Clobazamum; Frisium; Grifoclobam; Urbanil; Mystan; Venium; Urbanol; 7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzob1,4diazepine-2,4-dione; Aedon; CHEBI:31413",2014-12-24,1,,,,,,,,,
105512-06-9,0,OMOP Exposome,Observation,Substance,Clodinafop-propargyl,,2014-12-24,1,,,,,,,,,
10596-23-3,0,OMOP Exposome,Observation,Substance,Clodronate,"Clasteon; Clodronic acid; Clodronsaeure; Clodrons\u00e4ure; (Dichloromethylene)bisphosphonic acid; (Dichloro-phosphono-methyl)-phosphonic acid; (Dichloromethylene)diphosphonic acid; Acide Clodronique; Acido Clodronico; Acidum Clodronicum; Sindronat; Ostac; Lytos; Loron; Lodronat; Dichloromethylidene diphosphonate; Dichloromethylene-1,1-diphosphonic acid; Dichloromethylene-1,1-bisphosphonic acid; Dichloromethanediphosphonic acid; Bonefos; CHEBI:110423",2014-12-24,1,,,,,,,,,
51487-69-5,0,OMOP Exposome,Observation,Substance,Cloethocarb,,2014-12-24,1,,,,,,,,,
50-29-3,0,OMOP Exposome,Observation,Substance,Clofenotane,"1,1'-(2,2,2-Trichloroethylidene)bis(4-chloro)-Benzene; 1,1,1-Trichloro-2,2-bis(4,4'-dichlorodiphenyl)ethane; 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)-Ethane; 1,1,1-Trichloro-2,2-bis(p-chlorophenyl)-Ethane; 1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane; 1,1,1-Trichloro-2,2-bis-(4'-chlorophenyl)ethane; 1,1,1-Trichloro-2,2-di(4-chlorophenyl)-ethane; 1,1,1-Trichloro-2-2-bis(4-chlorophenyl)ethane; 1,1,1-Trichlorobis(chlorophenyl)ethane; 1,1-Bis(4-chlorophenyl)-2,2,2-trichloroethane; 1,1-Bis(p-Chlorophenyl)-2,2,2-trichIoroethane; 1,1-Bis-(p-chlorophenyl)-2,2,2-trichloroethane; 2,2,2-Trichlorobis(4-chlorophenyl)ethane; 2,2-Bis(p-chlorophenyl)-1,1,1-trichloroethane; Chlorophenothane; Chlofenotan; Zithiol; Zerdane; Zeidane; 1,1'-(2,2,2-Trichloroethane-1,1-diyl)bis(4-chlorobenzene); p,p'-DDT, BSI; Diphenyltrichloroethane; Bis(p-chlorophenyl)-2,2,2-trichloroethane; Dicophane, BAN; DDT; Chlorphenotane; 1,1'-(2,2,2-Trichloroethylidene)bis(4-chlorobenzene)I; 1-Chloro-4-2,2,2-trichloro-1-(4-chlorophenyl)ethylbenzene; 2,2,2-Trichloro-1,1-bis(4-chlorophenyl)ethane; 2,2,2-Trichloro-1,1-bis(p-chlorophenyl)-Ethane; CHEBI:16130",2014-12-24,1,,,,,,,,,
74115-24-5,0,OMOP Exposome,Observation,Substance,Clofentezine,"Bisclofentazin; Apollo; 3,6-Bis(O-chlorophenyl)-1,2,4,5-tetrazine; Bisclofentazine; CHEBI:39315",2014-12-24,1,,,,,,,,,
637-07-0,0,OMOP Exposome,Observation,Substance,Clofibrate,"Lipofacton; Liprin; Myanlin; Chlorphenisate; alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester; CPIB; Koliva; Clofibric acid; Clofibratum; Clofibrato; Clofibate; Clobrate; 2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester; 2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester; Hisunsero; Ethyl para-chlorophenoxyisobutyrate; Chlorfenisate; Binograc; Atromid-S; Alufibrate; alpha-p-Chlorophenoxyisobutyryl ethyl ester; Ethyl p-chlorophenoxyisobutyrate; Ethyl clofibrate; Ethyl chlorophenoxyisobutyrate; Ethyl 2-(P-chlorophenoxy)isobutyrate; EPIB; ELPI; CHEBI:3750",2014-12-24,1,,,,,,,,,
81777-89-1,0,OMOP Exposome,Observation,Substance,Clomazone,,2014-12-24,1,,,,,,,,,
911-45-5,0,OMOP Exposome,Observation,Substance,Clomifene,"Androxal; Omifin; Clostilbegyt; Clomiphene citrate (Z,E); Serophene; Racemic clomiphene citrate; Zuclomiphene citrate; Clomiphene Citrate; Clomiphene; Clomifert; Clomifenum; Clomifeno; Clomifene citrate; Clomid; Cisclomiphene; Chloramiphene; Chloramifene; Chlomaphene; CHEBI:3752",2014-12-24,1,,,,,,,,,
303-49-1,0,OMOP Exposome,Observation,Substance,Clomipramine,"Chlorimipramine; Clomipramina; Clomipraminum; g 34586; 3-(3-chloro-10,11-dihydro-5H-Dibenzob,Fazepin-5-yl)-N,N-dimethyl-1-propanamine; 3-(3-CHLORO-5H-dibenzob,Fazepin-5-yl)-N,N-dimethylpropan-1-amine; Monochlorimipramine; Hydiphen; 3-Chloroimipramine; Anafranil; CHEBI:47780",2014-12-24,1,,,,,,,,,
1622-61-3,0,OMOP Exposome,Observation,Substance,Clonazepam,"Antelepsin; 5-(2-Chlorophenyl)-7-nitro-1H-benzoe1,4diazepin-2(3H)-one; Clonazepamum; Chlonazepam; 5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzoe1,4diazepin-2-one; 1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one; Klonopin; Rivotril; Iktorivil; CLONAZEPAM; CHEBI:3756",2014-12-24,1,,,,,,,,,
4205-90-7,0,OMOP Exposome,Observation,Substance,Clonidine,"Winpress; Velaril; Chlofazoline; Chlornidinum; Clonidin; Clonidina; 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2-(2,6-Dichlorophenyl)iminoimidazoline; Catapres; Clonidinhydrochlorid; Clonidinum; Catapres-TTS; Dixarit; Duraclon; Catapressan; Catapresan; Isoglaucon; Kapvay; Nexiclon; Run Rui; ST 155BS; CHEBI:46631",2014-12-24,1,,,,,,,,,
101-10-0,0,OMOP Exposome,Observation,Substance,Cloprop,,2014-12-24,1,,,,,,,,,
1702-17-6,0,OMOP Exposome,Observation,Substance,Clopyralid,"Acide dichloro-3,6 picolinique; 3,6-Dichloro-2-Pyridinecarboxylicacid; Acide 3,6-dichloropicolinique; 3,6-Dichloropyridine-2-carboxylic acid; 3,6-Dichloro-2-pyridinecarboxylic acid, 3,6-Dichloropicolinic acid; CHEBI:CHEBI:62961",2014-12-24,1,,,,,,,,,
57754-85-5,0,OMOP Exposome,Observation,Substance,Clopyralid-olamine,,2014-12-24,1,,,,,,,,,
23887-31-2,0,OMOP Exposome,Observation,Substance,Clorazepate,"Cloranxen; Calner; Anksen; Clorazepic acid; Tranxene T-Tab; 7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid; Tranx\u00e8ne; Tranxen; Transene; Trancap; Tencilan; Polizep; Mendon; Medipax; Manotran; Justum; Gen-xene; Flulium; Dipot; Clozene; Clorazepatum; Zetran-5; Tranxilium; Tranxilene; CHEBI:3761",2014-12-24,1,,,,,,,,,
120-32-1,0,OMOP Exposome,Observation,Substance,Clorophene,,2014-12-24,1,,,,,,,,,
210880-92-5,0,OMOP Exposome,Observation,Substance,Clothianidin,(e)-N-(2-chloro-5-Thiazolyl)methyl-n'-methyl-n''-nitroguanidine; CHEBI:39177,2014-12-24,1,,,,,,,,,
33671-46-4,0,OMOP Exposome,Observation,Substance,Clotiazepam,Rizen; Clotiazepamum; Tienor; Rize; Distensan; Clozan; CHEBI:1178501,2014-12-24,1,,,,,,,,,
23593-75-1,0,OMOP Exposome,Observation,Substance,Clotrimazole,"Fem Care; Desamix F; Tibatin; Trimysten; Trivagizole 3; Veltrim; 1-(\u03b1-(2-Chlorophenyl)benzhydryl)imidazole; Empecid; Canesten; Gyne lotrimin; Gyne-lotrimin; Gyne-Lotrimin 3; Gyne-Lotrimin 3 Combination Pack; Gyne-Lotrimin Combination Pack; Gyne-Lotrimin3; Gyne-Lotrimin3 Combination Pack; Gynix; Lopac-C-6019; Lotrimax; Myclo-Derm; Myclo Spray Solution; Myclo Solution; Myclo Cream; Mycelex: MycosporinRimazole; Mycelex-G; Mycelex-7 Combination Pack; Mycelex-7; Mycelex Twin Pack; Mycelex Troches; Lotrimin; Lotrimin AF; Lotrimin AF Cream; Lotrimin AF Jock-Itch Cream; Lotrimin AF Lotion; Lotrimin AF Solution; Lotrimin Cream; Lotrimin Lotion; 1-(O-Chlorotrityl)imidazole; Lotrimin Solution; Lotrisone; Mono-baycuten; Monobaycuten; Mycelax; Mycelex; Mycelex 7; Mycelex Cream; Mycelex G; (Chlorotrityl)imidazole; 1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole; 1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole; 1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole; 1-(o-Chloro-\u03b1,\u03b1-diphenylbenzyl)imidazole; Mycelex OTC; Mycelex Solution; Clotrimazolum; Clotrimazol; Clotrimaderm Cream; Clotrimaderm; Chlotrimazole; Canifug; Rimazole; Canestine; Canesten Solution; Prestwick_120; Pedisafe; Canesten Cream; Canesten Combi-Pak 3-Day Therapy; Canesten Combi-Pak 1-Day Therapy; Otomax; Neo-Zol Cream; Mykosporin; Mycosporin; Myclo-Gyne; Canesten 6-Day Therapy; FemCare; Fungicip; Canesten 3-Day Therapy; Canesten 1-Day Therapy; Canesten 1-Day Cream Combi-Pak; CHEBI:3764",2014-12-24,1,,,,,,,,,
24166-13-0,0,OMOP Exposome,Observation,Substance,Cloxazolam,,2014-12-24,1,,,,,,,,,
5786-21-0,0,OMOP Exposome,Observation,Substance,Clozapine,Azaleptine; Sensipin; Refraxol; Refract; Mezapin; Luften; Lozapin; Lodux; Leponex; Lapenax; Lanolept; Cloment; Clonex; Sizopin; Sizopril; Syclop; Syzopin; Tanyl; Uspen; VERSACLOZ; Zapen; Zapenia; FazaClo; Clopin; Clopine; Clopsine; Clozapin; Clozapina; Clorazem; Zapine; Clozaril; Ziproc; Zopin; Clozapinum; Sequax; CHEBI:3766,2014-12-24,1,,,,,,,,,
P00740,0,OMOP Exposome,Observation,Substance,Coagulation factor IX,,2024-09-14,1,,,,,,,,,
P08709,0,OMOP Exposome,Observation,Substance,Coagulation factor VII,,2024-09-14,1,,,,,,,,,
P00742,0,OMOP Exposome,Observation,Substance,Coagulation factor X,,2024-09-14,1,,,,,,,,,
P00488,0,OMOP Exposome,Observation,Substance,Coagulation factor XIII A chain,,2024-09-14,1,,,,,,,,,
Q96EY8,0,OMOP Exposome,Observation,Substance,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
7440-48-4,0,OMOP Exposome,Observation,Substance,Cobalt,Cobalt ion; Co(2+); Cobalt(II) ion; Cobalt(II) cation; Cobalt(II); Co2+; Cobalt(2+) ion; Cobalt(2+); CHEBI:48828,2014-12-24,1,,,,,,,,,
136-52-7,0,OMOP Exposome,Observation,Substance,Cobalt bis(2-ethylhexanoate),,2014-12-24,1,,,,,,,,,
GIS1008437,0,OMOP Exposome,Observation,Substance,Cobalt Compound,,2024-09-14,1,,,,,,,,,
10124-43-3,0,OMOP Exposome,Observation,Substance,Cobalt sulfate,"Cobalt(II) sulphate; Cobaltous sulfate; Cobaltous sulfate salt (1:1); Cobaltous sulphate; Cobaltous sulphate salt (1:1); CoSO4; Sulfuric acid, cobalt(2+) salt (1:1); Cobalt (2+) sulfate; Cobalt (2+) sulphate; Cobalt brown; Cobalt monosulfate; Cobalt monosulphate; Cobalt sulfate (1:1); Cobalt sulfate (CoSO4); Cobalt sulfate, heptahydrate; Cobalt sulfic acid; Cobalt sulphate; Cobalt sulphate (1:1); Cobalt sulphate (CoSO4); Cobalt sulphate, heptahydrate; Cobalt sulphic acid; Cobalt(2+) sulfate; Cobalt(2+) sulphate; Cobalt(II) sulfate; CHEBI:53470",2014-12-24,1,,,,,,,,,
1317-42-6,0,OMOP Exposome,Observation,Substance,Cobalt sulfide,,2014-12-24,1,,,,,,,,,
71-48-7,0,OMOP Exposome,Observation,Substance,Cobalt(II) acetate,,2014-12-24,1,,,,,,,,,
7789-43-7,0,OMOP Exposome,Observation,Substance,Cobalt(II) bromide,,2014-12-24,1,,,,,,,,,
513-79-10,0,OMOP Exposome,Observation,Substance,Cobalt(II) carbonate,,2014-12-24,1,,,,,,,,,
12069-68-0,0,OMOP Exposome,Observation,Substance,Cobalt(II) carbonate hydroxide (1:1),,2014-12-24,1,,,,,,,,,
12602-23-2,0,OMOP Exposome,Observation,Substance,Cobalt(II) carbonate hydroxide (2:3),,2014-12-24,1,,,,,,,,,
866-81-9,0,OMOP Exposome,Observation,Substance,Cobalt(II) citrate,,2014-12-24,1,,,,,,,,,
542-84-7,0,OMOP Exposome,Observation,Substance,Cobalt(II) cyanide,,2014-12-24,1,,,,,,,,,
10026-17-2,0,OMOP Exposome,Observation,Substance,Cobalt(II) fluoride,,2014-12-24,1,,,,,,,,,
544-18-3,0,OMOP Exposome,Observation,Substance,Cobalt(II) formate,,2014-12-24,1,,,,,,,,,
21041-93-0,0,OMOP Exposome,Observation,Substance,Cobalt(II) hydroxide,,2014-12-24,1,,,,,,,,,
15238-00-3,0,OMOP Exposome,Observation,Substance,Cobalt(II) iodide,,2014-12-24,1,,,,,,,,,
21158-51-0,0,OMOP Exposome,Observation,Substance,Cobalt(II) mesoporphyrin,,2014-12-24,1,,,,,,,,,
13762-14-6,0,OMOP Exposome,Observation,Substance,Cobalt(II) molybdenum(VI) oxide,,2014-12-24,1,,,,,,,,,
61789-51-3,0,OMOP Exposome,Observation,Substance,Cobalt(II) naphthenate,,2014-12-24,1,,,,,,,,,
10141-05-6,0,OMOP Exposome,Observation,Substance,Cobalt(II) nitrate,,2014-12-24,1,,,,,,,,,
1307-96-6,0,OMOP Exposome,Observation,Substance,Cobalt(II) oxide,,2014-12-24,1,,,,,,,,,
3267-76-3,0,OMOP Exposome,Observation,Substance,Cobalt(II) succinate,,2014-12-24,1,,,,,,,,,
14017-41-5,0,OMOP Exposome,Observation,Substance,Cobalt(II) sulfamate,,2014-12-24,1,,,,,,,,,
1308-06-1,0,OMOP Exposome,Observation,Substance,"Cobalt(II, III) oxide",,2014-12-24,1,,,,,,,,,
917-69-1,0,OMOP Exposome,Observation,Substance,Cobalt(III) acetate,,2014-12-24,1,,,,,,,,,
10026-18-3,0,OMOP Exposome,Observation,Substance,Cobalt(III) fluoride,,2014-12-24,1,,,,,,,,,
1307-86-4,0,OMOP Exposome,Observation,Substance,Cobalt(III) hydroxide,,2014-12-24,1,,,,,,,,,
1308-04-9,0,OMOP Exposome,Observation,Substance,Cobalt(III) oxide,,2014-12-24,1,,,,,,,,,
10198-40-0,0,OMOP Exposome,Observation,Substance,Cobalt-60,,2014-12-24,1,,,,,,,,,
1277-43-6,0,OMOP Exposome,Observation,Substance,Cobaltocene,"di-pi-cyclopentadienyl-Cobalt; bis(eta-cyclopentadienyl)-Cobalt; bis(eta-2,4-cyclopentadien-1-yl)-Cobalt; Bis(cyclopentadienyl)cobalt; bis(eta5-2,4-cyclopentadien-1-yl)-Cobalt; CO(eta(5)-C5H5)2; bis-(eta-Cyclopentadienyl) cobalt; Dicyclopentadienylcobalt; CHEBI:30678",2014-12-24,1,,,,,,,,,
7646-79-9,0,OMOP Exposome,Observation,Substance,Cobaltous chloride,"CoCl2; Dichlorocobalt; Cobalt chloride?; Cobalt muriate; Cobalt dichloride; Cobalt(2+) chloride; Cobalt chloride; Cobalt chloride (CoCl2); Cobalt chloride (ous); Cobaltous chloride, anhydrous; Cobaltous chloride anhydrous; Cobalt(II)chloride; Cobalt(II) chloride; Cobalt(2+) dichloride; Cobaltous dichloride; CoCl(2); CHEBI:35696",2014-12-24,1,,,,,,,,,
211688-17-4,0,OMOP Exposome,Observation,Substance,Cobatoxin,,2014-12-24,1,,,,,,,,,
50-36-2,0,OMOP Exposome,Observation,Substance,Cocaine,"Benzoylmethylecgonine; L-Cocain; Cocain; 2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester); (\u2212)-cocaine; (-)-Cocaine; Methyl 1R-(exo,exo)-3-(benzoyloxy)-8-methyl-8-azabicyclo3.2.1octane-2-carboxylate; Methyl benzoylecgonine; 1R-(Exo,exo)-3-(benzoyloxy)-8-methyl-8-azabicyclo3.2.1octane-2-carboxylic acid, methyl ester; Neurocaine; beta-Cocain; Cocaina; Cocainum; Kokain; L-Cocaine; CHEBI:27958",2014-12-24,1,,,,,,,,,
O00748,0,OMOP Exposome,Observation,Substance,Cocaine esterase,,2024-09-14,1,,,,,,,,,
Q16568,0,OMOP Exposome,Observation,Substance,Cocaine- and amphetamine-regulated transcript protein,,2024-09-14,1,,,,,,,,,
783292-49-9,0,OMOP Exposome,Observation,Substance,Cocoyl sarcosine,,2014-12-24,1,,,,,,,,,
76-57-3,0,OMOP Exposome,Observation,Substance,Codeine,"Galcodine; Farmacod; Dinco; Coutan; (-)-Codeine; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol; (5\u03b1,6\u03b1)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol; 3-Methylmorphin; 3-methylmorphine; 7,8-Didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol; Actacode; Bisoltus; Bromophar; Bronchicum; Pectoral; Tussoret; Bronchodine; Codant; Codedrill; Codein; Cougel; O(3)-Methylmorphine; morphine-3-methyl ether; Morphine monomethyl ether; Morphine 3-methyl ether; Methylmorphine; L-Codeine; Code\u00edna; Codicalm; Coderpina; Codeisan; Codeinum; Codeine anhydrous; Norcodeine, N-Methyl; Norcodine, N-Methyl; O3-Methylmorphine; Coducept; Codinex; Codicept; CHEBI:16714",2014-12-24,1,,,,,,,,,
GIS1008438,0,OMOP Exposome,Observation,Substance,Codeine Pathway,,2024-09-14,1,,,,,,,,,
64-86-8,0,OMOP Exposome,Observation,Substance,Colchicine,Colchicina; Colcrys; Colchicinum; Colchicin; CHEBI:23359,2014-12-24,1,,,,,,,,,
P02461,0,OMOP Exposome,Observation,Substance,Collagen alpha-1(III) chain,,2024-09-14,1,,,,,,,,,
P45452,0,OMOP Exposome,Observation,Substance,Collagenase 3,,2024-09-14,1,,,,,,,,,
GIS1008439,0,OMOP Exposome,Observation,Substance,Colon,,2024-09-14,1,,,,,,,,,
P02745,0,OMOP Exposome,Observation,Substance,Complement C1q subcomponent subunit A,,2024-09-14,1,,,,,,,,,
P02746,0,OMOP Exposome,Observation,Substance,Complement C1q subcomponent subunit B,,2024-09-14,1,,,,,,,,,
P02747,0,OMOP Exposome,Observation,Substance,Complement C1q subcomponent subunit C,,2024-09-14,1,,,,,,,,,
P00736,0,OMOP Exposome,Observation,Substance,Complement C1r subcomponent,,2024-09-14,1,,,,,,,,,
P09871,0,OMOP Exposome,Observation,Substance,Complement C1s subcomponent,,2024-09-14,1,,,,,,,,,
P01024,0,OMOP Exposome,Observation,Substance,Complement C3,,2024-09-14,1,,,,,,,,,
P07360,0,OMOP Exposome,Observation,Substance,Complement component C8 gamma chain,,2024-09-14,1,,,,,,,,,
P08174,0,OMOP Exposome,Observation,Substance,Complement decay-accelerating factor,,2024-09-14,1,,,,,,,,,
GIS1008440,0,OMOP Exposome,Observation,Substance,Conditionally Essential Amino Acid,,2024-09-14,1,,,,,,,,,
P51160,0,OMOP Exposome,Observation,Substance,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",,2024-09-14,1,,,,,,,,,
GIS1008441,0,OMOP Exposome,Observation,Substance,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,,2024-09-14,1,,,,,,,,,
GIS1008442,0,OMOP Exposome,Observation,Substance,Congenital lactic acidosis,,2024-09-14,1,,,,,,,,,
GIS1008443,0,OMOP Exposome,Observation,Substance,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,,2024-09-14,1,,,,,,,,,
GIS1008444,0,OMOP Exposome,Observation,Substance,Connective Tissue,,2024-09-14,1,,,,,,,,,
GIS1008445,0,OMOP Exposome,Observation,Substance,Contraceptive,,2024-09-14,1,,,,,,,,,
GIS1008446,0,OMOP Exposome,Observation,Substance,Contraceptive Agent,,2024-09-14,1,,,,,,,,,
GIS1008465,0,OMOP Exposome,Observation,Substance,Contrast Media,,2024-09-14,1,,,,,,,,,
GIS1008511,0,OMOP Exposome,Observation,Substance,Contryphan (Conus ventricosus),,2024-09-14,1,,,,,,,,,
508-75-8,0,OMOP Exposome,Observation,Substance,Convallatoxin,"Strophanthidin, 3-(6-deoxy-alpha-L-mannopyranoside); Convallatoxoside; Convallaton; 3beta-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-5beta-card-20(22)-enolide; (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-Dihydroxy-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)hexadecahydro-1H-cyclopentaaphenanthrene-10-carbaldehyde; 5beta,14beta-Dihydroxy-19-oxo-3beta(alpha-L-rhamnopyranosyl)oxycard-20,22-enolide; Strophanthidin 3-O-alpha-L-rhamnoside; Korglykon; Corglycone; Corglycon; Convallotoxin; (3beta,5beta)-3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-card-20(22)-enolide; CHEBI:CHEBI:27663",2014-12-24,1,,,,,,,,,
37206-04-5,0,OMOP Exposome,Observation,Substance,Convulxin,,2014-12-24,1,,,,,,,,,
GIS1008550,0,OMOP Exposome,Observation,Substance,Coolant,,2024-09-14,1,,,,,,,,,
7440-50-8,0,OMOP Exposome,Observation,Substance,Copper,Copper(2+) ion; Cu2+; Cu(2+); Copper(II) ion; Copper(II) cation; Copper ion; Copper(2+); Copper(II); CHEBI:30052,2014-12-24,1,,,,,,,,,
13395-16-9,0,OMOP Exposome,Observation,Substance,Copper acetylacetonate,,2014-12-24,1,,,,,,,,,
10103-61-4,0,OMOP Exposome,Observation,Substance,Copper arsenate,,2014-12-24,1,,,,,,,,,
16102-92-4,0,OMOP Exposome,Observation,Substance,Copper arsenate hydroxide,,2014-12-24,1,,,,,,,,,
23642-01-5,0,OMOP Exposome,Observation,Substance,Copper aspirinate,,2014-12-24,1,,,,,,,,,
533-01-7,0,OMOP Exposome,Observation,Substance,Copper benzoate,,2014-12-24,1,,,,,,,,,
O14618,0,OMOP Exposome,Observation,Substance,Copper chaperone for superoxide dismutase,,2024-09-14,1,,,,,,,,,
1332-65-6,0,OMOP Exposome,Observation,Substance,Copper chloride hydroxide,,2014-12-24,1,,,,,,,,,
12053-18-8,0,OMOP Exposome,Observation,Substance,Copper chromite,,2014-12-24,1,,,,,,,,,
GIS1008551,0,OMOP Exposome,Observation,Substance,Copper Compound,,2024-09-14,1,,,,,,,,,
544-19-4,0,OMOP Exposome,Observation,Substance,Copper formate,,2014-12-24,1,,,,,,,,,
527-09-3,0,OMOP Exposome,Observation,Substance,Copper gluconate,,2014-12-24,1,,,,,,,,,
814-81-3,0,OMOP Exposome,Observation,Substance,Copper lactate,,2014-12-24,1,,,,,,,,,
1338-02-9,0,OMOP Exposome,Observation,Substance,Copper naphthenate,,2014-12-24,1,,,,,,,,,
10103-48-7,0,OMOP Exposome,Observation,Substance,Copper orthophosphate,,2014-12-24,1,,,,,,,,,
12159-07-8,0,OMOP Exposome,Observation,Substance,Copper silicide,,2014-12-24,1,,,,,,,,,
27004-40-6,0,OMOP Exposome,Observation,Substance,Copper tartrate,,2014-12-24,1,,,,,,,,,
O00244,0,OMOP Exposome,Observation,Substance,Copper transport protein ATOX1,,2024-09-14,1,,,,,,,,,
1117-94-8,0,OMOP Exposome,Observation,Substance,Copper(I) acetylide,,2014-12-24,1,,,,,,,,,
7787-70-4,0,OMOP Exposome,Observation,Substance,Copper(I) bromide,,2014-12-24,1,,,,,,,,,
7758-89-6,0,OMOP Exposome,Observation,Substance,Copper(I) chloride,Copper(1+) chloride; Copper chloride; Copper chloride (cucl); Copper monochloride; Copper(1) chloride; Cu-lyt; CuCl; Cuproid; Cuprous chloride; Dicopper dichloride; CHEBI:53472,2014-12-24,1,,,,,,,,,
544-92-3,0,OMOP Exposome,Observation,Substance,Copper(I) cyanide,,2014-12-24,1,,,,,,,,,
13478-41-6,0,OMOP Exposome,Observation,Substance,Copper(I) fluoride,,2014-12-24,1,,,,,,,,,
7681-65-4,0,OMOP Exposome,Observation,Substance,Copper(I) iodide,,2014-12-24,1,,,,,,,,,
1317-39-1,0,OMOP Exposome,Observation,Substance,Copper(I) oxide,,2014-12-24,1,,,,,,,,,
12019-57-7,0,OMOP Exposome,Observation,Substance,Copper(I) phosphide,,2014-12-24,1,,,,,,,,,
22205-45-4,0,OMOP Exposome,Observation,Substance,Copper(I) sulfide,Copper(+1) Cation Sulfide; Cuprasulfide; Kupfer(I)-sulfid; Dicopper sulphide; Dicopper sulfide; Cuprous sulfide; Dicopper monosulfide; Copper(I) sulphide; CHEBI:51114,2014-12-24,1,,,,,,,,,
142-71-2,0,OMOP Exposome,Observation,Substance,Copper(II) acetate,,2014-12-24,1,,,,,,,,,
12002-03-8,0,OMOP Exposome,Observation,Substance,Copper(II) acetoarsenite,,2014-12-24,1,,,,,,,,,
10290-12-7,0,OMOP Exposome,Observation,Substance,Copper(II) arsenite,,2014-12-24,1,,,,,,,,,
14215-30-6,0,OMOP Exposome,Observation,Substance,Copper(II) azide,,2014-12-24,1,,,,,,,,,
7789-45-9,0,OMOP Exposome,Observation,Substance,Copper(II) bromide,,2014-12-24,1,,,,,,,,,
1184-64-1,0,OMOP Exposome,Observation,Substance,Copper(II) carbonate,,2014-12-24,1,,,,,,,,,
7447-39-4,0,OMOP Exposome,Observation,Substance,Copper(II) chloride,Cupric chloride dihydrate; Copper dichloride; Copper chloride (cucl2); Copper bichloride; Coclor; Copper(II)chloride; Copper(2+) chloride; Coppertrace; CuCl2; Copper(2+)chloride; Cupric chloride anhydrous; Copper(II) chloride dihydrate; Dichlorocopper; Cupric chloride; Cupric dichloride; CHEBI:49553,2014-12-24,1,,,,,,,,,
7789-19-7,0,OMOP Exposome,Observation,Substance,Copper(II) fluoride,,2014-12-24,1,,,,,,,,,
20427-59-2,0,OMOP Exposome,Observation,Substance,Copper(II) hydroxide,,2014-12-24,1,,,,,,,,,
1332-03-2,0,OMOP Exposome,Observation,Substance,Copper(II) hydroxide sulfate,,2014-12-24,1,,,,,,,,,
3251-23-8,0,OMOP Exposome,Observation,Substance,Copper(II) nitrate,"Copper(2+) nitrate; Copper nitrate trihydrate; Copper nitrate; Copper dinitrate trihydrate; Copper dinitrate; Copper(2+) nitrate trihydrate; Copper(II) nitrate trihydrate; Copper(II) nitric acid; Cu(NO3)2; Cupric dinitrate; Cupric nitrate; Cupric nitrate trihydrate; Gerhardite; Nitric acid, copper salt; Nitric acid, copper(2+) salt; Nitric acid, copper(2+) salt, trihydrate; CHEBI:78036",2014-12-24,1,,,,,,,,,
1317-38-0,0,OMOP Exposome,Observation,Substance,Copper(II) oxide,,2014-12-24,1,,,,,,,,,
7798-23-4,0,OMOP Exposome,Observation,Substance,Copper(II) phosphate,,2014-12-24,1,,,,,,,,,
10102-90-6,0,OMOP Exposome,Observation,Substance,Copper(II) pyrophosphate,,2014-12-24,1,,,,,,,,,
7758-98-7,0,OMOP Exposome,Observation,Substance,Copper(II) sulfate,"Sulfuric acid, copper salt; Copper(2+) sulphate; Copper sulphate; Sulfuric acid, copper(2+) salt; Tobacco states brand copper sulfate; Blue copperas; Blue copper; Basic copper sulfate; Trinagle; Vitriol, blue; CuSO4; Copper sulfate, anhydrous; Copper sulfate pentahydrate; Copper sulfate; Copper monosulfate; Bonide root destroyer; Cupric sulfate anhydrous; Cupric sulfate; Monocopper sulfate; Sulfate, copper; Sulfate, cupric; Copper(II) sulphic acid; Copper(II) sulphate; Copper(II) sulfic acid; CHEBI:23414",2014-12-24,1,,,,,,,,,
1317-40-4,0,OMOP Exposome,Observation,Substance,Copper(II) sulfide,Copper monosulfide; Natural covellite; Monocopper monosulfide; Horace vernet's blue; Cupric sulfide; Covellite; Covelline; Copper(II) sulphide; Copper(2+) sulfide; Copper sulphide; Copper sulfide; CHEBI:51110,2014-12-24,1,,,,,,,,,
34946-82-2,0,OMOP Exposome,Observation,Substance,Copper(II) triflate,,2014-12-24,1,,,,,,,,,
Q04656,0,OMOP Exposome,Observation,Substance,Copper-transporting ATPase 1,,2024-09-14,1,,,,,,,,,
P35670,0,OMOP Exposome,Observation,Substance,Copper-transporting ATPase 2,,2024-09-14,1,,,,,,,,,
14643-66-4,0,OMOP Exposome,Observation,Substance,Coproporphyrin III,"3,8,13,17-Tetramethylporphyrin-2,7,12,18-tetrapropanoic acid; CHEBI:27609",2014-12-24,1,,,,,,,,,
2624-63-7,0,OMOP Exposome,Observation,Substance,Coproporphyrinogen III,"Coproporphyrinogen; Coproporphyrinogen-III; 3,8,13,17-Tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoate; 5,10,15,20,22,24-Hexahydro-3,8,13,17-tetramethyl-21H,23H-Porphine-2,7,12,18-tetrapropanoic acid; 5,10,15,20,22,24-Hexahydro-3,8,13,17-tetramethyl-21H,23H-Porphine-2,7,12,18-tetrapropanoate; 5,10,15,20,22,24-Hexahydro-3,8,13,17-tetramethyl-2,7,12,18-Porphinetetrapropionic acid; 3,8,13,17-Tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoic acid; 5,10,15,20,22,24-Hexahydro-3,8,13,17-tetramethyl-2,7,12,18-Porphinetetrapropionate; CHEBI:15439",2018-03-21,1,,,,,,,,,
2571-86-0,0,OMOP Exposome,Observation,Substance,Coriamyrtin,,2014-12-24,1,,,,,,,,,
191-07-1,0,OMOP Exposome,Observation,Substance,Coronene,"Superbenzene; Hexabenzobenzene; Dibenzo(ghi,pqr)perylene; Coronene solution; CHEBI:29863",2014-12-24,1,,,,,,,,,
P28845,0,OMOP Exposome,Observation,Substance,Corticosteroid 11-beta-dehydrogenase isozyme 1,,2024-09-14,1,,,,,,,,,
GIS1008552,0,OMOP Exposome,Observation,Substance,Corticosterone methyl oxidase I deficiency (CMO I),,2024-09-14,1,,,,,,,,,
GIS1008553,0,OMOP Exposome,Observation,Substance,Corticosterone methyl oxidase II deficiency - CMO II,,2024-09-14,1,,,,,,,,,
GIS1008554,0,OMOP Exposome,Observation,Substance,Cosmetic Toxin,,2024-09-14,1,,,,,,,,,
436-41-9,0,OMOP Exposome,Observation,Substance,Costaclavine,,2014-12-24,1,,,,,,,,,
486-56-6,0,OMOP Exposome,Observation,Substance,Cotinine,Cotinina; S-(-)-Cotinine; Cotininum; (S)-Cotinine; (S)-(-)-Cotinine; (-)-Cotinine; CHEBI:127762,2014-12-24,1,,,,,,,,,
56-72-4,0,OMOP Exposome,Observation,Substance,Coumaphos,"3-Chloro-4-methyl-7-coumarinyl diethyl phosphorothioate, 3-Chloro-4-methyl-7-hydroxycoumarin diethyl thiophosphoric acid ester; Phosphorothioic acid, O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl) O,O-diethyl ester; O-(3-chloro-4-Methyl-2-oxo-2H-chromen-7-yl) O,O-diethyl thiophosphate; O,O-Diethyl O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl)phosphorothioate; O,O-Diethyl 3-chloro-4-methyl-7-umbelliferone thiophosphate; Coumafos, Meldane, Asunthol, Azunthol, Muscatox, Agridip, Asuntol, Meldone, Resitox, Baymix; 3-Chloro-7-hydroxy-4-methyl-coumarin O,O-diethyl phosphorothioate; 3-Chloro-7-diethoxyphosphinothioyloxy-4-methylcoumarin; CHEBI:CHEBI:3903",2014-12-24,1,,,,,,,,,
91-64-5,0,OMOP Exposome,Observation,Substance,Coumarin,"Benzo-a-pyrone; Coumarine; 2-Oxo-1,2-benzopyran; 2-Oxo-2H-1-Benzopyran; 2H-1-Benzopyran-2-one; 2H-Benzobpyran-2-one; 2H-Chromen-2-one; 5,6-Benzo-2-pyrone; Benzo-alpha-pyrone; cis-O-Coumarinic acid lactone; 1, 2-Benzopyrone; Coumarinic anhydride; Cumarin; Kumarin; O-Hydroxycinnamic acid lactone; O-Hydroxycinnamic lactone; O-Hydroxyzimtsaure-lacton; Rattex; Tonka bean camphor; {2H-Benzobpyran-2-one}; CHEBI:28794",2014-12-24,1,,,,,,,,,
GIS1008555,0,OMOP Exposome,Observation,Substance,Coumarin and Indandione Rodenticide,,2024-09-14,1,,,,,,,,,
145742-28-5,0,OMOP Exposome,Observation,Substance,CP-122721,,2014-12-24,1,,,,,,,,,
57-00-1,0,OMOP Exposome,Observation,Substance,Creatine,Phosphagen; ((amino(imino)methyl)(methyl)amino)acetate; ((amino(imino)methyl)(methyl)amino)acetic acid; (alpha-Methylguanido)acetate; (alpha-Methylguanido)acetic acid; (N-methylcarbamimidamido)acetic acid; (\u03b1-methylguanido)acetic acid; alpha-Methylguanidino acetic acid; Cosmocair C 100; Creatin; Creatine hydrate; Kreatin; Krebiozon; Methylglycocyamine; Methylguanidoacetate; Methylguanidoacetic acid; N-(Aminoiminomethyl)-N-Methyl-Glycine; N-(aminoiminomethyl)-N-methylglycine; N-Amidinosarcosine; N-Carbamimidoyl-N-methylglycine; N-Methyl-N-guanylglycine; N-(e)-AMINO(imino)methyl-N-methylglycine; Amino(imino)methyl(methyl)aminoacetate; Amino(imino)methyl(methyl)aminoacetic acid; CHEBI:16919,2014-12-24,1,,,,,,,,,
GIS1008556,0,OMOP Exposome,Observation,Substance,Creatine deficiency,,2024-09-14,1,,,,,,,,,
P12277,0,OMOP Exposome,Observation,Substance,Creatine kinase B-type,,2024-09-14,1,,,,,,,,,
P06732,0,OMOP Exposome,Observation,Substance,Creatine kinase M-type,,2024-09-14,1,,,,,,,,,
P17540,0,OMOP Exposome,Observation,Substance,"Creatine kinase S-type, mitochondrial",,2024-09-14,1,,,,,,,,,
P12532,0,OMOP Exposome,Observation,Substance,"Creatine kinase U-type, mitochondrial",,2024-09-14,1,,,,,,,,,
12001-28-4,0,OMOP Exposome,Observation,Substance,Crocidolite Asbestos,Blue Asbestos; Abriachanite; Crocidolite; Cape Blue; Blue Ironstone; CHEBI:46666,2014-12-24,1,,,,,,,,,
GIS1008557,0,OMOP Exposome,Observation,Substance,Cross-Linking Reagent,,2024-09-14,1,,,,,,,,,
58740-15-1,0,OMOP Exposome,Observation,Substance,Crotamine,,2014-12-24,1,,,,,,,,,
21284-11-7,0,OMOP Exposome,Observation,Substance,Crotocin,,2014-12-24,1,,,,,,,,,
9007-40-3,0,OMOP Exposome,Observation,Substance,Crotoxin,,2014-12-24,1,,,,,,,,,
GIS1008558,0,OMOP Exposome,Observation,Substance,Cryoprotective Agent,,2024-09-14,1,,,,,,,,,
P17812,0,OMOP Exposome,Observation,Substance,CTP synthase 1,,2024-09-14,1,,,,,,,,,
O60494,0,OMOP Exposome,Observation,Substance,Cubilin,,2024-09-14,1,,,,,,,,,
13426-91-0,0,OMOP Exposome,Observation,Substance,Cupriethylenediamine,,2014-12-24,1,,,,,,,,,
420-04-2,0,OMOP Exposome,Observation,Substance,Cyanamide,Cyanoamine; H2N-C#N; NH2CN; Amidocyanogen; Carbamonitrile; Carbodiimide; CHEBI:16698,2014-12-24,1,,,,,,,,,
21725-46-2,0,OMOP Exposome,Observation,Substance,Cyanazine,"2-Chloro-4-(1-cyano-1-methylethylamino)-6-ethylamine-1,3,5-triazine; 2-chloro-4-(1-Cyano-1-methylethylamino)-6-ethylamino-1,3,5-triazine; Fortrol; Bladex; 2-4-chloro-6-(Ethylamino)-S-triazin-2-ylamino-2-methylpropionitrile; 2-(4-chloro-6-(Ethylamino)-1,3,5-triazin-2-ylamino)-2-methylpropanenitrile; CHEBI:38069",2014-12-24,1,,,,,,,,,
1957-12-05,0,OMOP Exposome,Observation,Substance,Cyanide,Carbon nitride ion; Nitrile ion; Isocyanide; Cyanure; Nitrodicarbonate; Prussiate; Cyano; Cyanide(1-) ion; Cyanide ion; CN(1-); CHEBI:17514,2014-12-24,1,,,,,,,,,
GIS1008559,0,OMOP Exposome,Observation,Substance,Cyanide Compound,,2024-09-14,1,,,,,,,,,
107-91-5,0,OMOP Exposome,Observation,Substance,Cyanoacetamide,,2014-12-24,1,,,,,,,,,
372-09-8,0,OMOP Exposome,Observation,Substance,Cyanoacetic acid,Malonic mononitrile; Malonic acid mononitrile; Kyselina kyanoctova; Acide cyanacetique; Cyanocetic acid; 2-Cyanoacetic acid; Cyanessigsaeure; Cyanoacetate; CAA; Cyanoethanoic acid; Cyanoacetic acid (acd/name 4.0); NCCH2COOH; Monocyanoacetic acid; CHEBI:51889,2014-12-24,1,,,,,,,,,
68-19-9,0,OMOP Exposome,Observation,Substance,Cyanocobalamin,Virubra; Vibisone; Vibalt; Sytobex; Rubrocitol; Rubripca; Rubramin PC; Rubramin; Docemine; Docibin; Docivit; Anacobin; Bedodeka; Bedoz; Berubigen; Betalin; Betalin 12 Crystalline; Betaline-12; Betolvex; Bevidox; Bevidox concentrate; Biocobalamine; Byladoce; Cabadon M; Cobadoce forte; Rebramin; Primabalt; Poyamin; Dicopac; Cobalin; Cobavite; Cobione; Cobolin-M; Copharvit 5000; Covit; Crystamin; Crystamine; Crystimin; Depinar; Cytobion; Dodecabee; Dodecavite; Dodex; Duodecibin; Embiol; Crystwel; Cyano-B12; Cyanobalamin concentrate; Cyanocob(III)alamin; Cyanocobalamine; Cyanocobalmin; Cyanoject; Cycobemin; Cycolamin; Cykobemin; Cykobeminet; Cyomin; Cyredin; Cytacon; Cytakon; Cytamen; Emociclina; Eritrone; Erycytol; Erythrotin; Euhaemon; Extrinsic factor; Dimethylbenzimidazoylcobamide; Distivit; Factor II; Fermin; Fresmin; Hemomin; Hepagon; Hepavis; Hepcovite; Hylugel plus; Macrabin; Megabion; Megalovel; Milbedoce; Millevit; Nagravon; Nascobal; Neuroforte-R; Normocytin; Novidroxin; Pernaemon; Pernaevit; Pernipuron; Redamina; Plecyamin; Redisol; Rhodacryst; Rubesol; Vitral; Vitarubin; Vitamin B12 Preparation; Vitamin B12 complex; Vitamin B12; Vitabee 12; Vita-rubra; CHEBI:17439,2014-12-24,1,,,,,,,,,
460-19-5,0,OMOP Exposome,Observation,Substance,Cyanogen,Oxalonitrile; Oxalyl cyanide; Oxalic nitrile; Oxalic acid dinitrile; Nitriloacetonitrile; Carbon nitride; Carbon mononitride; C2N2; Bis(nitridocarbon)(C--C); Ethanedinitrile; Monocyanogen; Dicyanogen; Dicyan; Cyanogen radical; Cyanogen gas; Carbon nitride (C2N2); NCCN; (CN)2; Prussite; CHEBI:29308,2014-12-24,1,,,,,,,,,
506-68-3,0,OMOP Exposome,Observation,Substance,Cyanogen bromide,,2014-12-24,1,,,,,,,,,
506-77-4,0,OMOP Exposome,Observation,Substance,Cyanogen chloride,,2014-12-24,1,,,,,,,,,
506-78-5,0,OMOP Exposome,Observation,Substance,Cyanogen iodide,,2014-12-24,1,,,,,,,,,
GIS1008560,0,OMOP Exposome,Observation,Substance,Cyanogenic Glycoside,,2024-09-14,1,,,,,,,,,
96180-79-9,0,OMOP Exposome,Observation,Substance,Cyanoginosin-LA,"Toxin BE 4; (10S,13S,18S,19S,22R)-8-Isobutyl-18-((1E,3E)-(5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-hepta-1,3-dienyl)-1,5,12,15-tetramethyl-19-(R)-methyl-2-methylene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21heptaaza-cyclopentacosane-11,22-dicarboxylic acid; (5R,8S,11R,12S,15S,18S,19S,22R)-8-Isobutyl-18-((1E,3E)-(5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-hepta-1,3-dienyl)-1,5,12,15,19-pentamethyl-2-methylene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21heptaaza-cyclopentacosane-11,22-dicarboxylic acid; Cyanoginosin LA; Cyanoginosin-la; CHEBI:261694",2014-12-24,1,,,,,,,,,
120116-88-3,0,OMOP Exposome,Observation,Substance,Cyazofamid,,2014-12-24,1,,,,,,,,,
113136-77-9,0,OMOP Exposome,Observation,Substance,Cyclanilide,,2014-12-24,1,,,,,,,,,
P18846,0,OMOP Exposome,Observation,Substance,Cyclic AMP-dependent transcription factor ATF-1,,2024-09-14,1,,,,,,,,,
P15336,0,OMOP Exposome,Observation,Substance,Cyclic AMP-dependent transcription factor ATF-2,,2024-09-14,1,,,,,,,,,
P18847,0,OMOP Exposome,Observation,Substance,Cyclic AMP-dependent transcription factor ATF-3,,2024-09-14,1,,,,,,,,,
P18848,0,OMOP Exposome,Observation,Substance,Cyclic AMP-dependent transcription factor ATF-4,,2024-09-14,1,,,,,,,,,
Q9Y2D1,0,OMOP Exposome,Observation,Substance,Cyclic AMP-dependent transcription factor ATF-5,,2024-09-14,1,,,,,,,,,
P18850,0,OMOP Exposome,Observation,Substance,Cyclic AMP-dependent transcription factor ATF-6 alpha,,2024-09-14,1,,,,,,,,,
P17544,0,OMOP Exposome,Observation,Substance,Cyclic AMP-dependent transcription factor ATF-7,,2024-09-14,1,,,,,,,,,
P16220,0,OMOP Exposome,Observation,Substance,Cyclic AMP-responsive element-binding protein 1,,2024-09-14,1,,,,,,,,,
O43889,0,OMOP Exposome,Observation,Substance,Cyclic AMP-responsive element-binding protein 3,,2024-09-14,1,,,,,,,,,
Q02930,0,OMOP Exposome,Observation,Substance,Cyclic AMP-responsive element-binding protein 5,,2024-09-14,1,,,,,,,,,
BE0004922,0,OMOP Exposome,Observation,Substance,Cyclic nucleotide phosphodiesterase,,2024-09-14,1,,,,,,,,,
Q16280,0,OMOP Exposome,Observation,Substance,Cyclic nucleotide-gated olfactory channel,,2024-09-14,1,,,,,,,,,
P06493,0,OMOP Exposome,Observation,Substance,Cyclin-dependent kinase 1,,2024-09-14,1,,,,,,,,,
Q96Q40,0,OMOP Exposome,Observation,Substance,Cyclin-dependent kinase 15,,2024-09-14,1,,,,,,,,,
P24941,0,OMOP Exposome,Observation,Substance,Cyclin-dependent kinase 2,,2024-09-14,1,,,,,,,,,
Q00534,0,OMOP Exposome,Observation,Substance,Cyclin-dependent kinase 6,,2024-09-14,1,,,,,,,,,
P61024,0,OMOP Exposome,Observation,Substance,Cyclin-dependent kinases regulatory subunit 1,,2024-09-14,1,,,,,,,,,
1134-23-2,0,OMOP Exposome,Observation,Substance,Cycloate,,2014-12-24,1,,,,,,,,,
12663-46-6,0,OMOP Exposome,Observation,Substance,Cyclochlorotine,,2014-12-24,1,,,,,,,,,
110-82-7,0,OMOP Exposome,Observation,Substance,Cyclohexane,Hexanaphthene; Hexahydro-Benzene; Hexahydrobenzene; Hexamethylene; CHEBI:29005,2014-12-24,1,,,,,,,,,
108-93-0,0,OMOP Exposome,Observation,Substance,Cyclohexanol,,2014-12-24,1,,,,,,,,,
GIS1008561,0,OMOP Exposome,Observation,Substance,Cyclooxygenase Inhibitor,,2024-09-14,1,,,,,,,,,
GIS1008562,0,OMOP Exposome,Observation,Substance,Cyclooxygenase Inhibitors,,2024-09-14,1,,,,,,,,,
4449-51-8,0,OMOP Exposome,Observation,Substance,Cyclopamine,,2014-12-24,1,,,,,,,,,
12078-25-0,0,OMOP Exposome,Observation,Substance,Cyclopentadienylcobalt dicarbonyl,,2014-12-24,1,,,,,,,,,
287-92-3,0,OMOP Exposome,Observation,Substance,Cyclopentane,Ciclopentano; Cyclopentadienes; Cyclopentan; Cyclopentanes; Zyklopentan; Cyclopentene; Pentamethylene; CHEBI:23492,2014-12-24,1,,,,,,,,,
50-18-0,0,OMOP Exposome,Observation,Substance,Cyclophosphamide,"2-Bis(2-chloroethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide; (RS)-Cyclophosphamide; (+-)-Cyclophosphamide; Sendoxan; Revimmune; Procytox; Neosar; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide; Ledoxina; Cytophosphane; Endoxan; Cytoxan; Cyclophosphamidum; Cyclophosphamide anhydrous; Cyclophosphamid; Ciclofosfamide; Ciclofosfamida; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; CHEBI:4027",2014-12-24,1,,,,,,,,,
18172-33-3,0,OMOP Exposome,Observation,Substance,Cyclopiazonic acid,,2014-12-24,1,,,,,,,,,
63935-38-6,0,OMOP Exposome,Observation,Substance,Cycloprothrin,"(RS)-alpha-cyano-3-phenoxybenzyl (rs)-2,2-dichloro-1-(4-ethoxyphenyl)cyclopropanecarboxylate; CHEBI:39283",2014-12-24,1,,,,,,,,,
59865-13-3,0,OMOP Exposome,Observation,Substance,Cyclosporin,Sangcya; Sandimmune; Restasis; Neoral; CsA; Gengraf; Cyclosporin A; Ciclosporin; CyA; CHEBI:4031,2014-12-24,1,,,,,,,,,
121-82-4,0,OMOP Exposome,Observation,Substance,Cyclotrimethylenetrinitramine,"Hexahydro-1,3,5-trinitro-1,3,5-triazine; 1,3,5-Trinitrohexahydro-1,3,5-triazine; 1,3,5-trinitrohexahydro-p-triazine; 1,3,5-Trinitrohexahydro-s-triazine; 1,3,5-Trinitroperhydro-1,3, 5-triazine; 1,3,5-Trinitroperhydro-1,3,5-triazine; Cyclonit; Cyclonite; 1,3,5-Trinitro-1,3,5-triazinane; 1,3,5-Trinitro-1,3,5-triazacyclohexane; 1,3,5-Trinitro-1,3, 5-triazacyclohexane; 1,3,5-Triaza-1,3,5-trinitrocyclohexane; Cyclonite (cyclotrimethylene trinitramine); Cyclotrimethylenenitramine; Geksogen; Hexahydro-1,3 ,5-trinitro-1,3 5-triazine; Hexahydro-1,3, 5-trinitro-1,3,5-triazine; Hexahydro-1,3,5-trinitro-s-triazine; Hexogen; Hexolite; Perhydro-1,3,5-trinitro-1,3,5-triazine; RDX; SYM-trimethylene trinitramine; SYM-trimethylenetrinitramine; Trinitrocyclotrimethylene triamine; Trinitrohexahydrotriazine; Trinitrotrimethylenetriamine; 1,3, 5-Trinitrohexahydro-1,3,5-triazine; CHEBI:24556",2014-12-24,1,,,,,,,,,
68359-37-5,0,OMOP Exposome,Observation,Substance,Cyfluthrin,"Baythroid h; Baythroid 2; Caswell No. 266E; b-Cyfluthrin; Solfac; Responsar; Eulan SP; Cylence; Bulldock; Beta-cyfluthrin; (RS)-.alpha.-Cyano-4-fluoro-3-phenoxybenzyl (1RS,3RS; (R,S)-alpha-Cyano-4-fluoro-3-phenoxybenzyl-(1R,S)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; Syfrutrin; Cyfoxylate; BAY-FCR 1272; (RS)-a-Cyano-4-fluoro-3-phenoxybenzyl (1RS,3RS; Cyfluthrine; Baythroid; Cyfluthin; Baytroid; Baythroid(r); CHEBI:4034",2014-12-24,1,,,,,,,,,
122008-85-9,0,OMOP Exposome,Observation,Substance,Cyhalofop-butyl,,2014-12-24,1,,,,,,,,,
68085-85-8,0,OMOP Exposome,Observation,Substance,Cyhalothrin,"Lambdacyhalothrin; Lambda-cyhalothrin; Coopertix; Lambclacyhalothrin; 3-(2-Chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid cyano(3-phenoxyphenyl)methyl ester; Sentinel; Matador; ICON; Karate insecticide; Commodore; CHEBI:4035",2014-12-24,1,,,,,,,,,
143545-90-8,0,OMOP Exposome,Observation,Substance,Cylindrospermopsin,,2014-12-24,1,,,,,,,,,
57966-95-7,0,OMOP Exposome,Observation,Substance,Cymoxanil,,2014-12-24,1,,,,,,,,,
Q14097,0,OMOP Exposome,Observation,Substance,CYP2B protein,,2024-09-14,1,,,,,,,,,
28559-00-4,0,OMOP Exposome,Observation,Substance,Cypendazole,,2014-12-24,1,,,,,,,,,
52315-07-8,0,OMOP Exposome,Observation,Substance,Cypermethrin,"Ripcord; Polytrin; Nurelle; Nurele; Cyperkill; Barricade (insecticide); Rycopel; Kalif super; Kordon; Mustang; Kreokhin; Cyperil; Cypercopal; Cyperco; Cypercare; Cypemethrim; Cymperator; Cympa-ti; Antiborer 3767; Excis; Ectopor; Cymbush; Creokhin; Ectomin; Ecofleece sheep dip (non-op); Dysect; Drago; COLT; Cis-cypermethrin; Chinmix; Caswell No. 268AA; Demon TC; Ammo (pesticide); AMMO; Ambush CY; Beta-cypermethrin; Basathrin; Ambush c; alpha-Cyano(3-phenoxyphenyl)methyl (+-)cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; Barricade 10EC; .alpha.-cypermethrin; Demon; Cyrux; Cypor; Cypersect; Cypermethrine; Agrothrin; Cypermethrin-25EC; Toppel; Topclip parasol; Theta-cypermethrin; Supercypermethrin forte; Supercypermethrin; Siperin; Ustaad; Vucht 424; Fenom; Fenom (pesticide); Zeta-cypermethrin; Zetagard; Flectron; Barricade; Asymmethrin; FURY; Fury insecticide; Neramethrin EC 50; Neramethrin; Arrivo; Ardap; Sherpa; Hilcyperin; CHEBI:4042",2014-12-24,1,,,,,,,,,
39515-40-7,0,OMOP Exposome,Observation,Substance,Cyphenothrin,Gokilaht; S 2703 forte; D.d-t-cyphenothrin; CHEBI:31450,2014-12-24,1,,,,,,,,,
94361-06-5,0,OMOP Exposome,Observation,Substance,Cyproconazole,,2014-12-24,1,,,,,,,,,
121552-61-2,0,OMOP Exposome,Observation,Substance,Cyprodinil,,2014-12-24,1,,,,,,,,,
129-03-3,0,OMOP Exposome,Observation,Substance,Cyproheptadine,"Ciproheptadina; Ciprovit; Ciptadine; Periactin; Cyllermin; 1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine; Periactine; Periatin; Reactin; Apitup; Axoprol; Biohept; Ciplactin; Glutodina; Dihexazin; Cyproheptadinum; Cyproheptadin; Cyheptine; 4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine; 4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine; 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine; 4-Dibenzoa,Dcyclohepten-5-ylidene-1-methyl-piperidine; 5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene; Apeplus; Cipractine; CHEBI:4046",2014-12-24,1,,,,,,,,,
427-51-0,0,OMOP Exposome,Observation,Substance,Cyproterone acetate,Cyproterone acetic acid; Androcur; Cyprostat; Cyproterone 17-O-acetate; CHEBI:50743,2014-12-24,1,,,,,,,,,
66215-27-8,0,OMOP Exposome,Observation,Substance,Cyromazine,"Cyromazin; Cyclopropylmelamine; Cyclopropyl-1,3,5-triazine-2,4,6-triamine; Citation; Ciromazina; CGA 72662; Azimethiphos; Armor; 2,4-Diamino-6-(cyclopropylamino)-S-triazine; 2,4-Diamino-6-(cyclopropylamino)-S-triazine (8CI); 2-Cyclopropylamino-4,6-diamino-S-triazine; Vetrazine; Vetrazin (pesticide); Vetrazin; Trigard; Neporex; Neoprex; N2-cyclopropyl-1,3,5-triazine-2,4,6-triamine; N-Cyclopropyltriazine-2,4,6-triamine; N-Cyclopropylmelamine; N-Cyclopropyl-2,4,6-triamino-1,3,5-triazine; N-Cyclopropyl-1,3,5-triazine-2,4,6-triamine, 9CI; N-Cyclopropyl-1,3,5-Triazine-2,4,6-triamine; N-Cyclopropyl-1,3,5-triazin-2,4,6-triamine; N(2)-Cyclopropyl-1,3,5-triazine-2,4,6-triamine; Larvadex premix; Larvadex; Diamino-6-(cyclopropylamino)-S-triazine; Cyromazinum; Cypromazine; CHEBI:30260",2014-12-24,1,,,,,,,,,
P35520,0,OMOP Exposome,Observation,Substance,Cystathionine beta-synthase,,2024-09-14,1,,,,,,,,,
GIS1008563,0,OMOP Exposome,Observation,Substance,Cystathionine Beta-Synthase Deficiency,,2024-09-14,1,,,,,,,,,
P32929,0,OMOP Exposome,Observation,Substance,Cystathionine gamma-lyase,,2024-09-14,1,,,,,,,,,
Q9Y697,0,OMOP Exposome,Observation,Substance,"Cysteine desulfurase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q16857,0,OMOP Exposome,Observation,Substance,Cysteine dioxygenase,,2024-09-14,1,,,,,,,,,
Q16878,0,OMOP Exposome,Observation,Substance,Cysteine dioxygenase type 1,,2024-09-14,1,,,,,,,,,
GIS1008564,0,OMOP Exposome,Observation,Substance,Cysteine Metabolism,,2024-09-14,1,,,,,,,,,
Q9Y600,0,OMOP Exposome,Observation,Substance,Cysteine sulfinic acid decarboxylase,,2024-09-14,1,,,,,,,,,
P49589,0,OMOP Exposome,Observation,Substance,"Cysteine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
P13569,0,OMOP Exposome,Observation,Substance,Cystic fibrosis transmembrane conductance regulator,,2024-09-14,1,,,,,,,,,
Q9UPY5,0,OMOP Exposome,Observation,Substance,Cystine/glutamate transporter,,2024-09-14,1,,,,,,,,,
147-94-4,0,OMOP Exposome,Observation,Substance,Cytarabine,"Citarabina; Udicil; Tarabine; Spongocytidine; Iretin; Erpalfa; Depocyte; Depocyt; Cytosinearabinoside; cytosine-\u03b2-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosine-beta -D-arabinofuranoside; Cytosine-beta -arabinoside; Cytosine-1-beta-D-arabinofuranoside hydrochloride; Cytosine-1-beta-D-arabinofuranoside; Cytosine, beta-D-arabinoside; Cytosine, beta -D-arabinoside; Cytosine beta-D-arabinoside; Cytosine beta-D-arabinofuranoside; (beta-D-arabinofuranosyl)cytosine; 1-Arabinofuranosylcytosine; 1-beta -D-Arabinofaranosylcytosine; 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta -D-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosyl-Cytosine; Cytosine arabinoside; Cytosine arabinose; Cytosine arabinofuranoside; Cytosine 1-beta-D-arabinofuranoside; Cytosar-U; Cytosar; 1-beta-D-Arabinofuranosylcytosine; Cytonal; Cytarabinum; Cytarabinoside; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; Alexan; Ara-C; Cytarabine liposome injection; Cytarabina; Arabinocytidine; Arabinofuranosyl Cytidine; Arabinofuranosylcytosine; Arabinosylcytosine; Arabitin; AraC; Aracytidine; Aracytin; Aracytine; Arafcyt; beta -arabinosylcytosine; beta -cytosine arabinoside; beta -D-arabinosylcytosine; beta-Ara c; beta-Arabinosylcytosine; beta-Cytosine arabinoside; beta-D-Arabinosylcytosine; Cytarabin; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosyl-Cytosine; 1-beta-D-Arabinosylcytosine; 1beta -Arabinofuranasylcytosine; 1beta -D-Arabinofuranosylcytosine; 1beta -D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; CHEBI:28680",2014-12-24,1,,,,,,,,,
14110-64-6,0,OMOP Exposome,Observation,Substance,Cytochalasin A,,2014-12-24,1,,,,,,,,,
14930-96-2,0,OMOP Exposome,Observation,Substance,Cytochalasin B,,2014-12-24,1,,,,,,,,,
22144-76-9,0,OMOP Exposome,Observation,Substance,Cytochalasin C,,2014-12-24,1,,,,,,,,,
22144-77-0,0,OMOP Exposome,Observation,Substance,Cytochalasin D,,2014-12-24,1,,,,,,,,,
36011-19-5,0,OMOP Exposome,Observation,Substance,Cytochalasin E,,2014-12-24,1,,,,,,,,,
53760-19-3,0,OMOP Exposome,Observation,Substance,Cytochalasin H,,2014-12-24,1,,,,,,,,,
56144-22-0,0,OMOP Exposome,Observation,Substance,Cytochalasin J,,2014-12-24,1,,,,,,,,,
P00156,0,OMOP Exposome,Observation,Substance,Cytochrome b,,2024-09-14,1,,,,,,,,,
P04839,0,OMOP Exposome,Observation,Substance,Cytochrome b-245 heavy chain,,2024-09-14,1,,,,,,,,,
P13498,0,OMOP Exposome,Observation,Substance,Cytochrome b-245 light chain,,2024-09-14,1,,,,,,,,,
P31930,0,OMOP Exposome,Observation,Substance,"Cytochrome b-c1 complex subunit 1, mitochondrial",,2024-09-14,1,,,,,,,,,
O14957,0,OMOP Exposome,Observation,Substance,Cytochrome b-c1 complex subunit 10,,2024-09-14,1,,,,,,,,,
P22695,0,OMOP Exposome,Observation,Substance,"Cytochrome b-c1 complex subunit 2, mitochondrial",,2024-09-14,1,,,,,,,,,
P07919,0,OMOP Exposome,Observation,Substance,"Cytochrome b-c1 complex subunit 6, mitochondrial",,2024-09-14,1,,,,,,,,,
P14927,0,OMOP Exposome,Observation,Substance,Cytochrome b-c1 complex subunit 7,,2024-09-14,1,,,,,,,,,
O14949,0,OMOP Exposome,Observation,Substance,Cytochrome b-c1 complex subunit 8,,2024-09-14,1,,,,,,,,,
Q9UDW1,0,OMOP Exposome,Observation,Substance,Cytochrome b-c1 complex subunit 9,,2024-09-14,1,,,,,,,,,
P47985,0,OMOP Exposome,Observation,Substance,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",,2024-09-14,1,,,,,,,,,
P00167,0,OMOP Exposome,Observation,Substance,Cytochrome b5,,2024-09-14,1,,,,,,,,,
P99999,0,OMOP Exposome,Observation,Substance,Cytochrome c,,2024-09-14,1,,,,,,,,,
P00395,0,OMOP Exposome,Observation,Substance,Cytochrome c oxidase subunit 1,,2024-09-14,1,,,,,,,,,
P00403,0,OMOP Exposome,Observation,Substance,Cytochrome c oxidase subunit 2,,2024-09-14,1,,,,,,,,,
P00414,0,OMOP Exposome,Observation,Substance,Cytochrome c oxidase subunit 3,,2024-09-14,1,,,,,,,,,
P13073,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",,2024-09-14,1,,,,,,,,,
Q96KJ9,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 4 isoform 2, mitochondrial",,2024-09-14,1,,,,,,,,,
P20674,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 5A, mitochondrial",,2024-09-14,1,,,,,,,,,
P10606,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 5B, mitochondrial",,2024-09-14,1,,,,,,,,,
P12074,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 6A1, mitochondrial",,2024-09-14,1,,,,,,,,,
Q02221,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 6A2, mitochondrial",,2024-09-14,1,,,,,,,,,
P14854,0,OMOP Exposome,Observation,Substance,Cytochrome c oxidase subunit 6B1,,2024-09-14,1,,,,,,,,,
Q6YFQ2,0,OMOP Exposome,Observation,Substance,Cytochrome c oxidase subunit 6B2,,2024-09-14,1,,,,,,,,,
P09669,0,OMOP Exposome,Observation,Substance,Cytochrome c oxidase subunit 6C,,2024-09-14,1,,,,,,,,,
P24310,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 7A1, mitochondrial",,2024-09-14,1,,,,,,,,,
P14406,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 7A2, mitochondrial",,2024-09-14,1,,,,,,,,,
P24311,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 7B, mitochondrial",,2024-09-14,1,,,,,,,,,
Q8TF08,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 7B2, mitochondrial",,2024-09-14,1,,,,,,,,,
P15954,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 7C, mitochondrial",,2024-09-14,1,,,,,,,,,
P10176,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 8A, mitochondrial",,2024-09-14,1,,,,,,,,,
Q7Z4L0,0,OMOP Exposome,Observation,Substance,"Cytochrome c oxidase subunit 8C, mitochondrial",,2024-09-14,1,,,,,,,,,
P08574,0,OMOP Exposome,Observation,Substance,"Cytochrome c1, heme protein, mitochondrial",,2024-09-14,1,,,,,,,,,
P15538,0,OMOP Exposome,Observation,Substance,"Cytochrome P450 11B1, mitochondrial",,2024-09-14,1,,,,,,,,,
P19099,0,OMOP Exposome,Observation,Substance,"Cytochrome P450 11B2, mitochondrial",,2024-09-14,1,,,,,,,,,
BE0002090,0,OMOP Exposome,Observation,Substance,Cytochrome P450 19A1,,2024-09-14,1,,,,,,,,,
P04798,0,OMOP Exposome,Observation,Substance,Cytochrome P450 1A1,,2024-09-14,1,,,,,,,,,
P05177,0,OMOP Exposome,Observation,Substance,Cytochrome P450 1A2,,2024-09-14,1,,,,,,,,,
Q16678,0,OMOP Exposome,Observation,Substance,Cytochrome P450 1B1,,2024-09-14,1,,,,,,,,,
P11509,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2A6,,2024-09-14,1,,,,,,,,,
P20813,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2B6,,2024-09-14,1,,,,,,,,,
P33260,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2C18,,2024-09-14,1,,,,,,,,,
P33261,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2C19,,2024-09-14,1,,,,,,,,,
P10632,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2C8,,2024-09-14,1,,,,,,,,,
P11712,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2C9,,2024-09-14,1,,,,,,,,,
P10635,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2D6,,2024-09-14,1,,,,,,,,,
P05181,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2E1,,2024-09-14,1,,,,,,,,,
P51589,0,OMOP Exposome,Observation,Substance,Cytochrome P450 2J2,,2024-09-14,1,,,,,,,,,
BE0005319,0,OMOP Exposome,Observation,Substance,Cytochrome P450 3A3,,2024-09-14,1,,,,,,,,,
P08684,0,OMOP Exposome,Observation,Substance,Cytochrome P450 3A4,,2024-09-14,1,,,,,,,,,
Q9HB55,0,OMOP Exposome,Observation,Substance,Cytochrome P450 3A43,,2024-09-14,1,,,,,,,,,
P20815,0,OMOP Exposome,Observation,Substance,Cytochrome P450 3A5,,2024-09-14,1,,,,,,,,,
P24462,0,OMOP Exposome,Observation,Substance,Cytochrome P450 3A7,,2024-09-14,1,,,,,,,,,
Q02928,0,OMOP Exposome,Observation,Substance,Cytochrome P450 4A11,,2024-09-14,1,,,,,,,,,
P13584,0,OMOP Exposome,Observation,Substance,Cytochrome P450 4B1,,2024-09-14,1,,,,,,,,,
Q9HCS2,0,OMOP Exposome,Observation,Substance,Cytochrome P450 4F12,,2024-09-14,1,,,,,,,,,
GIS1008565,0,OMOP Exposome,Observation,Substance,Cytoplasm,,2024-09-14,1,,,,,,,,,
P21399,0,OMOP Exposome,Observation,Substance,Cytoplasmic aconitate hydratase,,2024-09-14,1,,,,,,,,,
GIS1008566,0,OMOP Exposome,Observation,Substance,Cytoplasmic vesicle,,2024-09-14,1,,,,,,,,,
GIS1008567,0,OMOP Exposome,Observation,Substance,Cytoskeleton,,2024-09-14,1,,,,,,,,,
GIS1008568,0,OMOP Exposome,Observation,Substance,Cytosol,,2024-09-14,1,,,,,,,,,
O75891,0,OMOP Exposome,Observation,Substance,Cytosolic 10-formyltetrahydrofolate dehydrogenase,,2024-09-14,1,,,,,,,,,
P49902,0,OMOP Exposome,Observation,Substance,Cytosolic purine 5'-nucleotidase,,2024-09-14,1,,,,,,,,,
BE0004889,0,OMOP Exposome,Observation,Substance,D(1) dopamine receptor,,2024-09-14,1,,,,,,,,,
P21728,0,OMOP Exposome,Observation,Substance,D(1A) dopamine receptor,,2024-09-14,1,,,,,,,,,
P21918,0,OMOP Exposome,Observation,Substance,D(1B) dopamine receptor,,2024-09-14,1,,,,,,,,,
P14416,0,OMOP Exposome,Observation,Substance,D(2) dopamine receptor,,2024-09-14,1,,,,,,,,,
P35462,0,OMOP Exposome,Observation,Substance,D(3) dopamine receptor,,2024-09-14,1,,,,,,,,,
P21917,0,OMOP Exposome,Observation,Substance,D(4) dopamine receptor,,2024-09-14,1,,,,,,,,,
2889-31-8,0,OMOP Exposome,Observation,Substance,D-2-Hydroxyglutaric acid,D-2-Hydroxyglutarate; (R)-2-Hydroxyglutarate; (R)-2-Hydroxyglutaric acid; (R)-a-Hydroxyglutarate; (R)-a-Hydroxyglutaric acid; (R)-2-hydroxy-Pentanedioic acid; (R)-2-hydroxy-Pentanedioate; (R)-alpha-Hydroxyglutarate; (R)-alpha-Hydroxyglutaric acid; 2-Hydroxy-D-Glutarate; 2-Hydroxy-D-Glutaric acid; 2-Hydroxy-delta-Glutarate; delta-alpha-Hydroxyglutaric acid; delta-alpha-Hydroxyglutarate; delta-2-Hydroxyglutaric acid; delta-2-Hydroxyglutarate; D-a-Hydroxyglutaric acid; D-a-Hydroxyglutarate; 2-Hydroxy-delta-Glutaric acid; CHEBI:32796,2018-03-21,1,,,,,,,,,
P14920,0,OMOP Exposome,Observation,Substance,D-amino-acid oxidase,,2024-09-14,1,,,,,,,,,
GIS1008569,0,OMOP Exposome,Observation,Substance,D-Arginine and D-Ornithine Metabolism,,2024-09-14,1,,,,,,,,,
53188-23-1,0,OMOP Exposome,Observation,Substance,D-Fructose,Levulose; delta-Fructose; lnulon; Fructon; beta-D-Fructose; FRU; Levugen; Fructose; Fructosteril; beta-delta-Arabino-hexulose; beta-delta-Fructofuranose; beta-delta-Fructose; beta-Fruit sugar; beta-Levulose; D-(-)-Fructose; delta-(-)-Fructose; beta-D-Arabino-hexulose; beta-D-Fructofuranose; CHEBI:28645,2014-12-24,1,,,,,,,,,
6485-39-8,0,OMOP Exposome,Observation,Substance,D-Gluconic acid Mn(II) salt,D-Gluconic acid mn(II) salt; D-Gluconate mn(II) salt; Gluconic acid (manganese2:1 salt); CHEBI:33198,2014-12-24,1,,,,,,,,,
50-99-7,0,OMOP Exposome,Observation,Substance,D-Glucose,Glucolin; (+)-Glucose; Anhydrous dextrose; Dextrosol; Cerelose; Cerelose 2001; Clintose L; Clearsweet 95; Corn sugar; Vadex; Tabfine 097(HS); Staleydex 95M; Staleydex 111; Roferose st; Meritose; CPC hydrate; D(+)-Glucose; Glucodin; Grape sugar; Dextrose; Dextropur; Glucose; Goldsugar; CHEBI:4167,2015-06-05,1,,,,,,,,,
GIS1008608,0,OMOP Exposome,Observation,Substance,D-glyceric acidura,,2024-09-14,1,,,,,,,,,
13269-35-7,0,OMOP Exposome,Observation,Substance,D-Hyoscyamine,"Levsin; Levbid; L-Tropine Tropate; L-Hyoscyamine; Hyoscyaminum; Hyoscyamine; Hyoscyamin; Egazil; Duboisine; Donnamar; Daturine; Daturin; Cytospaz; Cystospaz; Buwecon; Boots Travel Calm; Atropen; Anaspaz; Anapaz; Acupaz; (\u2212)-hyoscyamine; (\u2212)-atropine; (S)-atropine; (S)-(\u2212)-hyoscyamine; (S)-(-)-Hyoscyamine; (-)-Hyoscyamine; (-)-Atropine; Tropine-L-tropate; 3(S)-Endo-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo3.2.1oct-3-yl ester; Levsinex; NuLev; Symax; Tropine, (-)-tropate; CHEBI:48882",2014-12-24,1,,,,,,,,,
10326-41-7,0,OMOP Exposome,Observation,Substance,D-Lactic acid,delta-2-Hydroxypropanoic acid; (-)-Lactic acid; delta-2-Hydroxypropionic acid; delta-Lactate; delta-Lactic acid; DLA; L-(+)-Lactate; L-Lactic acid; Propel; Tisulac; delta-2-Hydroxypropionate; (R)-(-)-Lactate; (R)-(-)-Lactic acid; (R)-2-Hydroxypropanoate; (R)-2-Hydroxypropanoic acid; (R)-2-Hydroxypropionate; (R)-2-Hydroxypropionic acid; (R)-a-Hydroxypropionate; (R)-a-Hydroxypropionic acid; (R)-alpha-Hydroxypropionate; (R)-alpha-Hydroxypropionic acid; (R)-Lactate; (R)-Lactic acid; D-(-)-Lactate; D-(-)-Lactic acid; D-2-Hydroxypropanoate; (-)-Lactate; D-2-Hydroxypropanoic acid; D-2-Hydroxypropionate; D-2-Hydroxypropionic acid; D-Lactate; delta-(-)-Lactate; delta-(-)-Lactic acid; delta-2-Hydroxypropanoate; CHEBI:341,2014-12-24,1,,,,,,,,,
58-86-6,0,OMOP Exposome,Observation,Substance,D-Xylose,Xylo-pfan; Wood sugar; D-Xylo-pentose; Xylomed; D-(+)-Xylose; Xyloside; Xylose; CHEBI:53455,2014-12-24,1,,,,,,,,,
4342-03-4,0,OMOP Exposome,Observation,Substance,Dacarbazine,"NSC 45388; Biocarbazine; Biocarbazine R; Dacarbazin; Dacarbazina; Dacarbazinum; Dacatic; D\u00e9tic\u00e8ne; Detimedac; DIC; DTCI; DTIC; Dtic-Dome; Dtic-dome; DTIE; HSDB 3219; 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide; 4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide; 4-(Dimethyltriazeno)imidazole-5-carboxamide; 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide; 5-(Dimethyltriazeno)imidazole-4-carboxamide; ICDMT; ICDT; Imidazole Carboxamide; NCI-C04717; NSC-45388; CHEBI:4305",2014-12-24,1,,,,,,,,,
486-66-8,0,OMOP Exposome,Observation,Substance,Daidzein,"7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7,4'-Dihydroxyisoflavone; 4',7-Dihydroxyisoflavone; 4',7-Dihydroxy-Isoflavone; Daidzeol; Isoaurostatin; CHEBI:28197",2014-12-24,1,,,,,,,,,
1596-84-5,0,OMOP Exposome,Observation,Substance,Daminozide,,2014-12-24,1,,,,,,,,,
80-08-0,0,OMOP Exposome,Observation,Substance,Dapsone,"P,P'-diaminodiphenyl sulfone; 4,4'-sulfonyldianiline; 1,1'-Sulfonylbis(4-aminobenzene); 1,1'-Sulfonylbis4-aminobenzene; 4,4'-Dapsone; 4,4'-Diaminodiphenyl sulfone; 4,4'-Diaminodiphenylsulfone; P-Aminophenyl sulfone; P,P-Sulphonylbisbenzenamine; P,P-Sulphonylbisbenzamine; 4,4'-Sulfonylbisaniline; 4,4'-Diaminodiphenyl sulphone; 4,4'-Sulfonylbisbenzenamine; DADPS; Bis(P-aminophenyl) sulfone; Bis(4-aminophenyl)sulfone; Aczone; 4-Aminophenyl sulfone; 4-(4-Aminophenylsulfonyl)benzenamine; 4-(4-Aminophenylsulfonyl)aniline; 4-(4-amino-Benzenesulfonyl)-phenylamine; 4,4'-Sulfonylbisbenzeneamine; Dapsona; DAPSONE; 4,4'-Sulfonyldianilin; Dapsonum; DDS; DDS, pharmaceutical; DIAPHENYLSULFONE; CHEBI:4325",2014-12-24,1,,,,,,,,,
133099-04-4,0,OMOP Exposome,Observation,Substance,Darifenacin,"(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide; Darifenacina; Enablex; Emselex; Xelena; Darif\u00e9nacine; Darifenacinum; CHEBI:391960",2014-12-24,1,,,,,,,,,
20830-81-3,0,OMOP Exposome,Observation,Substance,Daunorubicin,"Daunorubicina; Daunomycin; Daunorrubicina; Acetyladriamycin; Cerubidin; Cerubidine; Daunoblastin; Leukaemomycin C; Daunoblastina; Rubidomycin; Maxidauno; DaunoXome; Daunorubicinum; Daunorubicine; (+)-Daunomycin; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; CHEBI:4330",2014-12-24,1,,,,,,,,,
533-74-4,0,OMOP Exposome,Observation,Substance,Dazomet,"DMTT; Dimethylformocarbothialdine; Dazoberg; Crag 974; Basamid; 3,5-Dimethyltetrahydro-2H-1,3,5-thiadiazine-2-thione; 3,5-Dimethyltetrahydro-1,3,5-thiadiazine-2-thione; 3,5-Dimethyltetrahydro-1,3,5-2H-thiadiazine-2-thione; 3,5-Dimethyl-2-thionotetrahydro-1,3,5-thiadiazine; 3,5-Dimethyl-1,3,5-(2H)-tetrahydrothiadiazine-2-thione; 2-Thio-3,5-dimethyltetrahydro-1,3,5-thiadiazine; UCC 974; Tiazon; NSC 4737; Tetrahydro-2H-3,5-dimethyl-1,3,5-thiadiazine-2-thione; Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione; Mylone; CHEBI:75212",2014-12-24,1,,,,,,,,,
Q6IBS8,0,OMOP Exposome,Observation,Substance,DDC protein,,2024-09-14,1,,,,,,,,,
GIS1008570,0,OMOP Exposome,Observation,Substance,Ddt Degradation,,2024-09-14,1,,,,,,,,,
62732-91-6,0,OMOP Exposome,Observation,Substance,Debacarb,,2014-12-24,1,,,,,,,,,
52423-28-6,0,OMOP Exposome,Observation,Substance,Debromoaplysiatoxin,,2014-12-24,1,,,,,,,,,
2051-24-3,0,OMOP Exposome,Observation,Substance,Decachlorobiphenyl,"Decachloro-1,1'-biphenyl; 2,2',3,3',4,4',5,5',6,6'-Decachloro-1,1'-biphenyl; 2,2',3,3',4,4', 5,5',6,6'-PCB; 2,2',3,3',4,4', 5,5',6,6'-Decachlorobiphenyl; Perchlorobiphenyl; PCB 209; 2,2',3,3',4,4',5,5',6,6'-Decachlorobiphenyl; CHEBI:34666",2014-12-24,1,,,,,,,,,
112-31-2,0,OMOP Exposome,Observation,Substance,Decanal,N-Decanal; Capraldehyde; 1-Decanal; Decylic aldehyde; Decyl aldehyde; Decanaldehyde; Decaldehyde; N-Decyl aldehyde; N-Decanal (capric aldehyde); N-Decaldehyde; Caprinic aldehyde; Caprinaldehyde; Capric aldehyde; Aldehyde c10; C-10 Aldehyde; 1-Decanal(mixed isomers); 1-Decyl aldehyde; CHEBI:31457,2014-12-24,1,,,,,,,,,
1563-67-3,0,OMOP Exposome,Observation,Substance,Decarbofuran,,2014-12-24,1,,,,,,,,,
GIS1008571,0,OMOP Exposome,Observation,Substance,Degradation Of Aromatic Compounds,,2024-09-14,1,,,,,,,,,
651-48-9,0,OMOP Exposome,Observation,Substance,Dehydroepiandrosterone sulfate,17-Oxoandrost-5-en-3beta-yl hydrogen sulphate; 3beta-hydroxy-Androst-5-en-17-one hydrogen sulfate; 3beta-hydroxy-Androst-5-en-17-one hydrogen sulphate; 3beta-hydroxyandrost-5-en-17-one 3-sulfate; DHEA sulfate; 3beta-hydroxyandrost-5-en-17-one 3-sulphate; Dehydroisoandrosterone sulphate; Dehydroisoandrosterone sulfate; Dehydroepiandrosterone-3-sulphate; Dehydroepiandrosterone-3-sulfate; DHEA sulphate; DHEAS; Formylisoglutamic acid; Inflarest; Prasterone sulfate; Prasterone sulphate; Prasterone-3-sulfate; Prasterone-3-sulphate; Dehydroepiandrosterone sulphic acid; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone sulfic acid; 3b-Hydroxyandrost-5-en-17-one 3-sulphate; 3-b-Hydroxyandrost-5-en-17-one 3-sulphate; 3-beta-Hydroxyandrost-5-en-17-one 3-sulfate; 3-beta-Hydroxyandrost-5-en-17-one 3-sulphate; 17-Oxoandrost-5-en-3beta-yl hydrogen sulfate; 17-Oxoandrost-5-en-3b-yl hydrogen sulphate; 17-Oxoandrost-5-en-3b-yl hydrogen sulfate; 17-Oxoandrost-5-en-3-yl hydrogen sulphate; 17-Oxoandrost-5-en-3-yl hydrogen sulfate; (3beta)-3-(sulfooxy)-Androst-5-en-17-one; 3b-Hydroxy-Androst-5-en-17-one hydrogen sulfate; 3b-Hydroxy-Androst-5-en-17-one hydrogen sulphate; 3b-Hydroxyandrost-5-en-17-one 3-sulfate; 3-b-Hydroxyandrost-5-en-17-one 3-sulfate; CHEBI:16814,2014-12-24,1,,,,,,,,,
Q9BTZ2,0,OMOP Exposome,Observation,Substance,Dehydrogenase/reductase SDR family member 4,,2024-09-14,1,,,,,,,,,
Q9BPW9,0,OMOP Exposome,Observation,Substance,Dehydrogenase/reductase SDR family member 9,,2024-09-14,1,,,,,,,,,
2894-67-9,0,OMOP Exposome,Observation,Substance,Delorazepam,,2014-12-24,1,,,,,,,,,
561-07-9,0,OMOP Exposome,Observation,Substance,Delphinine,,2014-12-24,1,,,,,,,,,
P54886,0,OMOP Exposome,Observation,Substance,Delta-1-pyrroline-5-carboxylate synthase,,2024-09-14,1,,,,,,,,,
P13716,0,OMOP Exposome,Observation,Substance,Delta-aminolevulinic acid dehydratase,,2024-09-14,1,,,,,,,,,
GIS1008572,0,OMOP Exposome,Observation,Substance,delta-Conotoxin (Conus striatus),,2024-09-14,1,,,,,,,,,
74838-20-3,0,OMOP Exposome,Observation,Substance,Delta-hemolysin,,2014-12-24,1,,,,,,,,,
319-86-8,0,OMOP Exposome,Observation,Substance,delta-Hexachlorocyclohexane,"Gamacide; Gamacide 20; Gammopaz; bentox 10; Benzanex; Benzene hexachloride; Gammexane; Gammex; Gammaterr; Gammalin; Gammahexane; Gammahexa; Gamma-linda ne; Gamma-hexachlorocyclohexane; Gamma-hexachlorobenzene; Gamma-benzene hexachloride; Gamma-benzohexachloride; Gamma-BHC (lindane); Gamma-BHC benhexachlor; Alpha-hexachlorane; Hexachlorocyclohexane-beta; Hexachlorzyklohexan; Hexamul; Hexapoudre; Hexatox; Hexaverm; Hexcidum; Hexicide; Hexyclan; Hortex; Inexit; Infectopharm brand of lindane; Isatox; Isotox; Jacutin; Kokotine; Lacco hi lin; Lasochron; Lendine; Lentox; Hexachloride, gamma-benzene; Lidenal; Lindafor; Lindagam; Hexachlorocyclohexane; Hexachlorocyclohexane-alpha; Lindagrain; Lindagranox; Lindalo; Lindane (benzene hexachloroide-gamma isomer); Lindane (gamma-HCH); Benhexachlor; Hexachloride, benzene; Hexachlorane; Hexachloran; Hexachlor; Hexablanc; Lindapoudre; Lindaterra; Lindatox; Lindex; Lindosep; Lintox; Linvur; Lorexane; Mszycol; Neo-scabicidol; Nicochloran; Novigam; Novigan; Omnitox; Ovadziak; Owadziak; Benzene hexachloride (ambiguous); Benzene hexachloride, all isomers; Benzene hexachloride-alpha-isomer; Benzene hexachloride-gamma isomer; Benzene hexachloride-gamma-isomer; Benzene-1,2,3,4,5,6-hexachloride ((Ambiguous); Benzene-cis-hexachloride; Benzene-trans-hexachloride; Benhexol; Benzenehexachloride mixed isomers; Benzenehexachloride-alpha-isomer; Benzex; Pedraczak; Pflanzol; Pharmascience brand of lindane; PLK; PMS lindane; PMS-lindane; Pmslindane; Quellada; Sang gamma; Scabecid; Scabene; Scabisan; Silvanol; Spritz-rapidin; Spritzlindane; Spruehpflanzol; beta-1,2,3,4,5,6-Hexachloro-Cyclohexane; beta-1,2,3,4,5,6-Hexachlorocyclohexane; Beta-benzene hexachloride; Beta-BHC; Beta-HCH; Beta-HCH solution; Beta-hexac hlorocyclohexane; Beta-hexachloran; Stiefel brand of lindane; Streunex; Submar; Technical HCH; Technical hexachlorocyclohexane; Tetocid; Trans-alpha-benzenehexachloride; Tri-6; Trives-t; Verindal ultra; Viton; \u03b4-Hexachlorocyclohexane; Arcotal s; Arbitex; Aplidal; Aphtitria; Aphtiria; Aparasin; Ameisentod; Ameisenmittel merck; Beta-hexachlorobenzene; Beta-hexachlorocyclohexane; Beta-hexachlorocyclohexanes; Beta-isomer; Beta-lindane; Bexol; Borer spray; Celanex; Chinoin brand of lindane; Chloresene; Codechine; DBH; Delitex; delta,1,2,3,4,5,6-hexachloro-Cyclohexane; delta,1,2,3,4,5,6-Hexachlorocyclohexane; delta-1,2,3,4,5,6-hexachloro-Cyclohexane; delta-1,2,3,4,5,6-Hexachlorocyclohexane; Delta-benzene hexachloride; Delta-benzenehexachloride; Delta-BHC; Delta-HCH; Delta-hexachlorocyclohexane; Delta-lindane; Detmol extract; Detmol-extrakt; detox 25; Devoran; Dol granule; Dolmix; Drill tox-spezial aglukon; Drilltox-spezial aglukon; Entomoxan; Epsilon HCH; Epsilon-benzenehexachloride; Epsilon-HCH; Epsilon-hexachlorocyclohexane; Eso derm; Esoderm; Exagama; Fenoform forte; Hecoltox; Heclotox; Gyben; Gexane; Geobilan; Gamtox; Forlin; Forst-nexen; Gallogama; Gamacarbatox; (1r,2r,3r,4r,5r,6r)-1,2,3,4,5,6-hexachlorocyclohexane; (1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2R,3S,4r,5R,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2R,3S,4s,5R,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1R,2R,3S,4S,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1s,2R,3R,4s,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; 1,2,3,4,5,6-hexachloro-Cyclohexane; Ameisenatod; Am eisenatod; Gamma benzene hexachloride; Gamma BHC; Gamma hexachlor; Gamma hexachlorocyclohexane; 1,2,3,4,5,6-Hexachlorocyclohexane; 1,2,3,4,5,6-hexachlorocyclohexane alpha isomer; 1,2,3,4,5,6-Hexachlorocyclohexane gamma isomer; 1a,2a,3b,4a,5b,6b-hexachlorocyclohexane; 1a,2b,3a,4b,5a,6b-hexachlorocyclohexane; Aalindan; Agronexit; alpha-1,2,3,4,5,6-Hexachlorocyclohexane; Alpha-benzene hexachloride; Alpha-benzenehexachloride; Alpha-BHC; Alpha-HCH; Alpha-hexachloran; Alpha-lindane; Alpha-hexachlorocyclohexanes; Alpha-hexachlorocyclohexane; gamma-1,2,3,4,5,6-Hexachlorocyclohexane; Gamma-benzenehexachloride; Gamma-hexachlorcyclohexanum; Gamma-hexachlorane; Gamma-HCH; Gamma-col; Gamaphex; Gamene; Gamiso; (1alpha,2alpha,3alpha,4beta,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane; (1r,2c,3c,4t,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2c,3t,4t,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane; CHEBI:39095",2014-12-24,1,,,,,,,,,
P41143,0,OMOP Exposome,Observation,Substance,Delta-type opioid receptor,,2024-09-14,1,,,,,,,,,
1972-08-3,0,OMOP Exposome,Observation,Substance,delta9-Tetrahydrocannabinol,,2014-12-24,1,,,,,,,,,
52918-63-5,0,OMOP Exposome,Observation,Substance,Deltamethrin,"Decamethrine; Butox; Zorcis; Suspend; Phagase 1; New Musigie; K-Othrine; K-Othrin; K-Obiol; Glossinex 200; Esbecythrin; Deltamethrine; Deltagran; DeltaGard; Dekametrin; Decis 2.5ULV; Decis 1.5ULV; (S)-cyano(3-phenoxyphenyl)methyl (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropanecarboxylate; Cislin; Crackdown; Decamethrin; Decis; Decis 0.5ULV; CHEBI:4388",2014-12-24,1,,,,,,,,,
127-33-3,0,OMOP Exposome,Observation,Substance,Demeclocycline,"4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Declostatin; Demeclociclina; 6-Demethylchlorotetracycline; 7-Chloro-6-demethyltetracycline; Demethylchlortetracyclinum; DMCT; DMCTC; Ledermycin; Methylchlorotetracycline; Tri-demethylchlortetracycline; Declomycin; Demeclocyclinum; Demethylchlorotetracycline; Demethylchlortetracyclin; Demethylchlortetracycline; 6-Demethyl-7-chlorotetracycline; CHEBI:4392",2014-12-24,1,,,,,,,,,
GIS1008593,0,OMOP Exposome,Observation,Substance,Demeclocycline Action Pathway,,2024-09-14,1,,,,,,,,,
GIS1008594,0,OMOP Exposome,Observation,Substance,Dendritic Process,,2024-09-14,1,,,,,,,,,
74504-53-3,0,OMOP Exposome,Observation,Substance,Dendrotoxin (Dendroaspis angusticeps),,2014-12-24,1,,,,,,,,,
119128-61-9,0,OMOP Exposome,Observation,Substance,Dendrotoxin (Dendroaspis polylepis polylepis),,2014-12-24,1,,,,,,,,,
958-09-8,0,OMOP Exposome,Observation,Substance,Deoxyadenosine,"9-(2-Deoxy-b-D-erythro-pentofuranosyl)-9H-Purin-6-amine; 2'-Deoxyadenosine; 1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-beta-delta-Ribofuranose; 1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-beta-D-Ribofuranose; 1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-b-D-Ribofuranose; 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-9H-Purin-6-amine; 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)adenine; 9-(2-Deoxy-beta-delta-ribofuranosyl)-9H-Purin-6-amine; Adenine deoxyribonucleoside; Adenine deoxyribose; Adenine-9 2-deoxy-b-D-erythro-Pentofuranoside; Adenine-9 2-deoxy-beta-D-erythro-Pentofuranoside; Adenine-9 2-deoxy-beta-delta-erythro-Pentofuranoside; Adenyldeoxyriboside; DA; Desoxyadenosine; 9-(2-Deoxy-beta-D-ribofuranosyl)-9H-Purin-6-amine; 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)adenine; 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)-9H-Purin-6-amine; 9-(2-Deoxy-b-D-ribofuranosyl)-9H-Purin-6-amine; 9-(2-Deoxy-b-D-erythro-pentofuranosyl)adenine; 2-Deoxyadenosine; CHEBI:17256",2018-03-21,1,,,,,,,,,
1927-31-7,0,OMOP Exposome,Observation,Substance,Deoxyadenosine triphosphate,2'-Deoxyadenosine 5'-triphosphate; Deoxy-ATP; dATP; 2'-Deoxyadenosine triphosphate; 2'-Deoxy-ATP; 2'-Deoxy-5'-ATP; Deoxyadenosine-triphosphate; Deoxyadenosine triphosphic acid; Deoxyadenosine 5'-triphosphate; CHEBI:16284,2018-03-21,1,,,,,,,,,
83-44-3,0,OMOP Exposome,Observation,Substance,Deoxycholic acid,"5b-Deoxycholate; Deoxycholatic acid; Deoxycholate; Deoxycholatate; Deoxy-Cholic acid; Deoxy-Cholate; Degalol; Cholorebic; Cholerebic; 7-Deoxycholic acid; 7-Deoxycholate; 5b-Deoxycholic acid; 5b-Cholanic acid-3a,12a-diol; CHEBI:28834",2018-03-21,1,,,,,,,,,
64-85-7,0,OMOP Exposome,Observation,Substance,Deoxycorticosterone,"21-Hydroxy-D4-pregnene-3,20-dione; 21-Hydroxy-Pregn-4-ene-3,20-dione; 21-Hydroxy-Progesterone; 21-Hydroxypregn-4-ene-3,20-dione; 21-Hydroxy-D4-pregnane-3,20-dione; 21-Hydroxy-3,20-dioxopregn-4-ene; 11-Desoxycorticosterone; 11-Deoxycorticosterone; 11-Deoxy-Corticosterone; 11-Dehydroxycorticosterone; DOC; Doca; Kendall'S desoxy compound B; Reichstein'S substance Q; D4-Pregnene-21-ol-3,20-dione; 21-Hydroxyprogesterone; Desoxycortone; Desoxycorticosterone; 4-Pregnen-21-ol-3,20-dione; Deoxycortone; Cortexone; CHEBI:16973",2018-03-21,1,,,,,,,,,
P27707,0,OMOP Exposome,Observation,Substance,Deoxycytidine kinase,,2024-09-14,1,,,,,,,,,
51481-10-8,0,OMOP Exposome,Observation,Substance,Deoxynivalenol,,2014-12-24,1,,,,,,,,,
1173-82-6,0,OMOP Exposome,Observation,Substance,Deoxyuridine triphosphate,Deoxy-UTP; 2'-Deoxyuridine 5'-triphosphate; 2'-Deoxyuridine-5'-triphosphorate; 2'-Deoxyuridine-5'-triphosphoric acid = dUTP; dUTP; Deoxyuridine-5'-Triphosphate; 2'-Deoxyuridine-5'-triphosphoric acid; Deoxyuridine triphosphic acid; CHEBI:17625,2018-03-21,1,,,,,,,,,
GIS1008595,0,OMOP Exposome,Observation,Substance,Depressant,,2024-09-14,1,,,,,,,,,
GIS1008596,0,OMOP Exposome,Observation,Substance,Dermatologic Agent,,2024-09-14,1,,,,,,,,,
GIS1008597,0,OMOP Exposome,Observation,Substance,Dermonecrotic toxin (Pasteurella multocida),,2024-09-14,1,,,,,,,,,
57041-67-5,0,OMOP Exposome,Observation,Substance,Desflurane,"(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether; Difluoromethyl 1,2,2,2-tetrafluoroethyl ether; Suprane; Desfluranum; Desflurano; 1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane; CHEBI:4445",2014-12-24,1,,,,,,,,,
50-47-5,0,OMOP Exposome,Observation,Substance,Desipramine,"Norpramine; Pertofrane; Pertofran; Norpramin; Norimipramine; N-(3-methylaminopropyl)iminobibenzyl; Monodemethylimipramine; Methylaminopropyliminodibenzyl; DMI; Dimethylimipramine; Dezipramine; Desmethylimipramine; Desipraminum; Desipramina; Desipramin; Desimpramine; Desimipramine; Demethylimipramine; 5-(\u03b3-methylaminopropyl)iminodibenzyl; 5-(gamma-Methylaminopropyl)iminodibenzyl; 3-(10,11-DIHYDRO-5H-dibenzob,Fazepin-5-yl)-N-methylpropan-1-amine; CHEBI:47781",2014-12-24,1,,,,,,,,,
100643-71-8,0,OMOP Exposome,Observation,Substance,Desloratadine,"NeoClarityn; Descarboethoxyloratadine; 8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine; Aerius; Claramax; Clarinex; DESLORATADINE; 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo5,6cyclohepta1,2-bpyridine; CHEBI:291342",2014-12-24,1,,,,,,,,,
13684-56-5,0,OMOP Exposome,Observation,Substance,Desmedipham,,2014-12-24,1,,,,,,,,,
50-02-2,0,OMOP Exposome,Observation,Substance,Dexamethasone,"Dexason; Decasone; Decaspray; Dectancyl; Dekacort; delta1-9-alpha-Fluoro-16-alpha-methylcortisol; Delta1-9alpha-Fluoro-16alpha-methylcortisol; Deltafluorene; Dergramin; Desadrene; Desametasone; Desamethasone; Desameton; Deseronil; DEX; Dex-ide; DEXA; Dexa mamallet; Dexa-cortidelt; Dexa-cortisyl; Dexa-scheroson; Dexa-sine; Dexacidin; Dexacort; Dexacortal; DEXONE 4; Dexacortin; Dexadeltone; Dexafarma; Dexalona; Dexametasona; Dexametasone; Dexameth; Dexamethansone; Dexamethasone Acetate; Dexamethasone alcohol; DEXONE 1.5; Dexamethasone base; DEXONE 0.75; DEXONE 0.5; Dexamethasone intensol; Dexamethasone Sodium Phosphate; Dexamethasone-omega; Dexamethasonum; Dexamethazone; Dexapolcort; Dexapos; Dexone; Dexinoral; Dexinolon; Dexasporin; Dexasone 4mg; Dexasone 0.75mg; Dexasone 0.5mg; Dexasone; Dexaprol; Visumetazone; Turbinaire; Tresaderm (veterinary); Tobramycin and dexamethasone; Tobradex; Superprednol; Sunia sol D; Spoloven; SK-dexamethasone; Sandoz dexamethasone; Prodex; Prednisolone f; Prednisolon f; Policort; PMS-dexamethasone; Pms Dexamethasone Elixir 0.5mg/5ml; PHL-dexamethasone; Pet derm III; OZURDEX; Oradexon; Ocu-trol; NSC 34521; Neomycin and polymyxin b sulphates and dexamethasone; Neomycin and polymyxin b sulfates and dexamethasone; Naquasone (veterinary); Mymethasone; Mexidex; Methylfluorprednisolone; Mediamethasone; Maxitrol; Maxidex Sus 0.1%; Maxidex Ont 0.1%; Maxidex; Luxazone; Loverine; Lokalison f; Isopto-dex; HL-dex; Hexadrol elixir; Hexadrol; Hexadecadrol; Gammacorten; Fortecortin; Fluormethylprednisolone; DXMS; DXM; Dinormon; Dezone; Dextelan; 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone; 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone; 1-Dehydro-16\u03b1-methyl-9\u03b1-fluorohydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol; 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoroprednisolone; 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol; 16alpha -Methyl-9alpha -fluoroprednisolone; 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol; 16alpha-Methyl-9alpha-fluoro-delta1-hydrocortisone; 16alpha-Methyl-9alpha-fluoroprednisolone; 16\u03b1-Methyl-9\u03b1-fluoro-1-dehydrocortisol; 9-alpha-Fluoro-16-alpha-methylprednisolone; 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione; 9-Fluoro-16-methylprednisolone; 9A-FLUORO-16BETA-METHYLPREDNISOLONE; 9alpha -Fluoro-16alpha -methylprednisolone; 9alpha-fluoro-16alpha-methyl-Prednisolone; 9alpha-Fluoro-16alpha-methylprednisolone; 9\u03b1-Fluoro-16\u03b1-methylprednisolone; Aeroseb-D; Aeroseb-dex; Ak Dex Oph Otic Soln 0.1%; alpha -Fluoro-16-alpha -methylcortisol; Anaflogistico; Aphtasolon; Apo-dexamethasone; Auxiron; Azimycin (veterinary); Azium; Azium (veterinary); Baycadron; Bisu DS; Calonat; Corson; Corsone; Cortisumman; Decacortin; Decaderm; Decadron; Decagel; Decalix; CHEBI:41879",2014-12-24,1,,,,,,,,,
3239-44-9,0,OMOP Exposome,Observation,Substance,Dexfenfluramine,(+)-fenfluramine; Dexfenfluramina; D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine; (S)-N-Ethyl-1-3-(trifluoromethyl)phenylpropan-2-amine; Adifax; Redux; Dextrofenfluramine; Dexfenfluraminum; (S)-fenfluramine; CHEBI:439329,2014-12-24,1,,,,,,,,,
40431-64-9,0,OMOP Exposome,Observation,Substance,Dexmethylphenidate,,2014-12-24,1,,,,,,,,,
24584-09-6,0,OMOP Exposome,Observation,Substance,Dexrazoxane,"Zinecard; Cardioxane; (+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane; 4-(2S)-2-(3,5-dioxopiperazin-1-yl)propylpiperazine-2,6-dione; Totect; Ao Nuo Xian; Desrazoxane; Dexrazoxan; Dexrazoxano; Dexrazoxanum; (+)-(S)-4,4'-Propylenedi-2,6-piperazinedione; Dextrorazoxane; Icrf-187; Savene; CHEBI:50223",2014-12-24,1,,,,,,,,,
51-64-9,0,OMOP Exposome,Observation,Substance,Dextroamphetamine,(AlphaS)-alpha-methylbenzeneethanamine; (S)-amphetamine; (S)-alpha-Methylbenzeneethanamine; (S)-1-Phenyl-2-propylamine; (S)-1-Phenyl-2-aminopropane; (S)-(+)-beta-Phenylisopropylamine; Dexamphetamine; Dexedrine; Attentin; D-Amphetamine; ProCentra; Zenzedi; (+)-Amphetamine; (+)-(S)-amphetamine; (+)-alpha-Methylphenethylamine; (+)-alpha-Methylphenylethylamine; (S)-(+)-Amphetamine; CHEBI:4469,2014-12-24,1,,,,,,,,,
125-71-3,0,OMOP Exposome,Observation,Substance,Dextromethorphan,Robitussin Cold & Cough; Balminil DM; Bayer Select Flu Relief; Bayer Select Head & Chest Cold; Bayer Select Night Time Cold; Benylin DM; Benylin dm; Cerose-DM; Chloraseptic DM; Contac Day & Night Cold/Flu Day Caplets; Contac Jr. Non-drowsy Formula; Contac Nighttime Cold Medicine; Contac Severe Cold Formula Maximum Strength; Contac Severe Cold Formula Non-Drowsy; Coricidin Syrup; Cough-X; D-Methorphan; D-Methorphan Hydrobromide; Delsym; delta-Methorphan; Demorphan; Demorphan Hydrobromide; Demorphine; Destrometerfano; Dextromethorfan; Dextromethorphan Bromhydrate; Dextromethorphan Bromide; Dextromethorphan hydrobromide; Dextromethorphan hydrobromide monohydrate; Dextromethorphan hydrobromide OROS Tablets; Dextrom\u00e9thorphane; Dextromethorphanum; Dextrometorfano; Dextrometorphan; Dextromorphan; Dexyromethorphan; Dimacol; Dimetapp DM; DM; DMHM; Drixoral Cough; Drixoral Cough & Congestion; Drixoral Cough & Sore Throat; DXM; Endotussin-NN; Endotussin-NN Pediatric; Hold; Koffex DM; L-Methorphan; Levomethorphan; Methorate; Naldecon-DX; Ornex Severe Cold Formula; Orthoxicol; PediaCare 1; PediaCare Cough-Cold Formula; Prestwick_686; Robitussin CF; Robitussin Cough Calmers; Robitussin DM; Robitussin Maximum Strength Cough; Robitussin pediatric cough; Robitussin Pediatric Cough & Cold; Robitussin Pediatric Night Relief; Romilar; Rondec dm; Ru-Tuss Expectorant; St. Joseph Cough Syrup; Sudafed Cough Syrup; Triaminic; Trind-DM; Tussar DM; Tussi-Organidin; Tussi-Organidin DM NR; Tussi-Organidin DM-S NR; Tylenol Cold and Flu Multi-Symptom; Tylenol Cold and Flu No Drowsiness; Tylenol Cold No Drowsiness; Tylenol Cough + Decongestant Liquid; Tylenol Cough Liquid; Tylenol Flu No Drowsiness Gelcaps; Vicks Formula 44; Viro-Med; CHEBI:4470,2014-12-24,1,,,,,,,,,
117-81-7,0,OMOP Exposome,Observation,Substance,Di(2-ethylhexyl)phthalate,"N-dioctyl phthalate; Nuoplaz dop; O-Benzenedicarboxylic acid, dioctyl ester; Phthalic acid, bis(2-ethylhexyl) ester; Phthalic acid dioctyl ester; Phthalic acid di(2-ethylhexyl) ester; Phthalic acid bis(2-ethylhexyl) ester; Phthalic acid bis(2-ethylhexyl ester)-ring-ul-14C; Phthalic acid bis(2-ethylhexyl ester); Octyl phthalate; Octyl PH thalate; Octoil; Di-iso-octyl phthalate; Di-2-ethylhexylphthalate; Di-2-ethylhexyl phthalate; Di-2-ethyl hexyl azelate; 1,2-Benzenedicarboxylic acid, bis(ethylhexyl) ester; 1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester; Di-2 ethyl hexyl adipate; 1,2-Benzenedicarboxylic acid bis-(1-ethylhexyl) ester; 1,2-Benzenedicarboxylic acid bis(2-ethylhexyl) ester; 1,2-Benzenedicarboxylic acid; 1, 2-Benzenedicarboxylic acid, bis(ethylhexyl) ester; 1, 2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester; Di-sec-octyl phthalate; Diacizer dop; Dicapryl phthalate; Di-(2-ethylhexyl) phthalate; Di(ethylhexyl) phthalate; Di(2-ethylhexyl)phthalic acid; Diethylhexyl phthalate; Dioctyl o-benzenedicarboxylate; Dioctyl phthalate; Dioctyl-o-benzenedicarboxylate; Dioctylphthalate; Ergoplas t fdo; Ergoplast fdo; Ergoplast fdo-s; Etalon; Etalon (plasticizer); Witcizer 312; Vinicizer 80; Vestinol ah; Union carbide flexol 380; Union carbide flexo l 380; Truflex dop; Ethyl hexyl phthalate; Ethylhexyl phthalate; Fleximel; Flexol dop; Flexol plasticizer dop; Staflex dop; Sicol 150; Sconamoll dop; Sansocizer R 8000; Sansocizer dop; Reomol dop; Reomol DCP; Reomol D 79P; RC plasticizer dop; Di(2-ethylhexyl)orthophthalate; Di(2-ethylhexyl) phthalate; Polycizer dop; Di(2-ethylhexyl) orthophthalate; Di(2-ethylhexyl) o-phthalate; Di(2-Ethylhexyl phthalate); Good-rite gp 264; Hatcol dop; Bis(2-ethylhexyl)ester phthalic acid; Bis(ethylhexyl) phthalate; Bis-(2-ethylhexyl) 1,2-benzenedicar boxylate; Bis-(2-ethylhexyl) 1,2-benzenedicarboxylate; Bis(2-ethylhexyl) phthalate-ring-UL-14C; Bis(2-ethylhexyl) phthalate; Bis(2-ethylhexyl) o-phthalate; Bis(2-ethylhexyl) 1,2-benzenedicarboxylate; Bis(2-ethylhexyl) 1, 2-benzenedicarboxylate; Bis(2-ethylhexy) phthalate; Polycizer 162; Plasticizer 28P; Plasthall dop; Pittsburgh PX-138; Bis (2-Ethylhexyl) Phthalate (Dioctyl phthalate); Bis (2-Etheylexyl) Phthalate; Bi(2-ethylhexyl)trimellitate ester; Benzenedicarboxylic acid, bis(2-ethylhexyl) ester; Bis-(2-ethylhexyl)-phthalate (DEHP); 2-Ethylhexyl phthalate; 1,2-Benzenedicarboxylic acid, bis-(1-ethylhexyl) ester; Hercoflex 260; Jayflex dop; Kodaflex dehp; Phthalic acid, dioctyl ester; DEHP; Kodaflex dop; Bis-2-ethyl-hexyl-phthalate; Kodaflex DP; Merrol dop; Mollan o; Monocizer dop; Morflex 310; Morflex 410; CHEBI:17747",2014-12-24,1,,,,,,,,,
117-84-0,0,OMOP Exposome,Observation,Substance,Di(n-octyl) phthalate,"Dicapryl phthalate; Phthalic acid dioctyl ester; Phthalic acid di-n-octyl ester; Octyl phthalate; O-benzenedicarboxylic acid dioctyl ester; N-octyl phthalate; Dioctyl phthalate; Dioctyl o-phthalate; Dioctyl o-benzenedicarboxylate; Dioctyl 1,2-benzenedicarboxylate; Dioctyl 1, 2-benzenedicarboxylate; Dinopol nop; Di(N-octyl) phthalic acid; Di(N-octyl) phthalate; Bis(n-octyl) phthalate; Benzenedicarboxylic acid di-n-octyl ester; 1,2-Benzenedicarboxylic acid dioctyl ester; 1,2-Benzenedicarboxylic acid 1,2-dioctyl ester; 1,2-Benzenedicarbonic acid, dioctyl ester; CHEBI:17747",2014-12-24,1,,,,,,,,,
2303-16-4,0,OMOP Exposome,Observation,Substance,Di-allate,,2014-12-24,1,,,,,,,,,
84-75-3,0,OMOP Exposome,Observation,Substance,Di-n-hexyl phthalate,"Di-n-hexylphthalate; Phthalic acid dihexyl ester; Di-N-hexyl phthalate; Dihexyl phthalate; Dihexyl 1,2-benzenedicarboxylate; Di-N-hexyl phthalic acid; 1,2-Benzenedicarboxylic acid 1,2-dihexyl ester; 1,2-Benzenedioic acid dihexyl ester; 1,2-Hexyl phthalate; Bis(n-hexyl) phthalate; N-dihexyl phthalate; Di(n-hexyl)phthalate; CHEBI:33308",2014-12-24,1,,,,,,,,,
3542-36-7,0,OMOP Exposome,Observation,Substance,Di-n-octyltin dichloride,,2014-12-24,1,,,,,,,,,
131-18-0,0,OMOP Exposome,Observation,Substance,Di-n-pentyl phthalate,"1, 2-Benzenedicarboxylic acid dipentyl ester; 1,2-Benzenedicarboxylic acid 1,2-dipentyl ester; DPNP; dipentyl phthalate; Dipentyl phthalate; Dipentyl 1,2-benzenedicarboxylate; Diamyl phthalate; Di-n-pentylphthalate; Di-N-pentyl phthalic acid; Di-N-pentyl phthalate; Di-n-amyl phthalate; Amyl phthalate; 1,2-Benzenedicarboxylic acid dipentyl ester; Phthalic acid dipentyl ester; Phthalic acid diamyl ester; DPP; CHEBI:33308",2014-12-24,1,,,,,,,,,
131-16-8,0,OMOP Exposome,Observation,Substance,Di-n-propyl phthalate,"1,2-Benzenedicarboxylic acid 1,2-dipropyl ester; N-dipropyl phthalate; 1,2-Benzenedicarboxylic acid dipropyl ester; Phthalic acid di-n-propyl ester; Phthalic acid, dipropyl ester; Dipropyl phthalate; Di-n-propylphthalate; Di-N-propyl phthalic acid; Di-N-propyl phthalate; CHEBI:33308",2014-12-24,1,,,,,,,,,
2270-40-8,0,OMOP Exposome,Observation,Substance,Diacetoxyscirpenol,,2014-12-24,1,,,,,,,,,
431-03-8,0,OMOP Exposome,Observation,Substance,Diacetyl,"Dimethylglyoxal; Butanedione; Butane-2,3-dione; Butan-2,3-dione; Butadione; Biacetyl; Acetoacetaldehyde; 2,3-Dioxobutane; 2,3-Diketobutane; 2,3-Butanedione; 2,3-Butandione; 2,3-Butadione; Dimethyl diketone; Dimethyl glyoxal; CHEBI:16583",2014-12-24,1,,,,,,,,,
14287-82-2,0,OMOP Exposome,Observation,Substance,Diacetylnivalenol,,2014-12-24,1,,,,,,,,,
2198-94-9,0,OMOP Exposome,Observation,Substance,Diacetylverrucarol,,2014-12-24,1,,,,,,,,,
P23743,0,OMOP Exposome,Observation,Substance,Diacylglycerol kinase alpha,,2024-09-14,1,,,,,,,,,
131-17-9,0,OMOP Exposome,Observation,Substance,Diallyl phthalate,"Diallylester phthalic acid; O-phthalic acid, diallyl ester; Phthalic acid diallyl ester; Diallylphthalate; Nonflammable decobest da; Diallyl phthalic acid; Diallyl ester of phthalic acid; Diallyl ester o-phthalic acid; Di-2-propenyl 1,2-benzenedicarboxylate; 1,2-Benzenedicarboxylic acid 1,2-di-2-propen-1-yl ester; O-phthalic acid diallyl ester; CHEBI:33308",2014-12-24,1,,,,,,,,,
193095-46-4,0,OMOP Exposome,Observation,Substance,Diantimony diselenide,,2014-12-24,1,,,,,,,,,
12359-48-7,0,OMOP Exposome,Observation,Substance,Diantimony tetrasulfide,,2014-12-24,1,,,,,,,,,
14457-84-2,0,OMOP Exposome,Observation,Substance,Diaspore,Kayserite; alpha-Aluminum oxide hydroxide; Hydroxidooxidoaluminum; Aluminium oxyhydroxide; Tanatarite; Metaaluminic acid; Empholite; CHEBI:30190,2014-12-24,1,,,,,,,,,
123-77-3,0,OMOP Exposome,Observation,Substance,Diazenedicarboxamide,"Paramid K1; Azodicarbamide; Azodicarboamide; Azodicarbonamide; Azodicarboxamide; Azodicarboxylic acid diamide; Azodiformamide; Azoform A; Azoformamide; Azoplastone; Celogen AZ; Evipor; Genitron EPC; Vinyfor; Azocel; Azobisformamide; Azobiscarboxamide; Azobiscarbonamide; Azobis CA 51C; Azobis CA 110B; AZM 2S; 1,1'-Azodiformamide; 1,1'-Azobisformamide; 1,1'-Azobiscarbamide; CHEBI:140828",2014-12-24,1,,,,,,,,,
439-14-5,0,OMOP Exposome,Observation,Substance,Diazepam,"Methyl diazepinone; Diazemuls; Diastat; Diapam; Nervium; Methyldiazepinone; Valium; Relanium; 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one; CHEBI:49575",2014-12-24,1,,,,,,,,,
333-41-5,0,OMOP Exposome,Observation,Substance,Diazinon,"Fezudin; Exodin; Ektoband; Dyzol; Drawizon; Dizinon; Kayazinon; Kayazol; Knox-out; Meodinon; Nedcidol; Neocidol; Dizinil; Diziktol; Dizictol; Neodinon; Disonex; Dipofene; Dimpylate; Diethyl dimpylatum; Diethyl 2-isopropyl-4-methyl-6-pyrimidyl thionophosphate; Dicid; Diazol; Diazitol; Diazinone; Diazide; Dianon; Diagran; Delzinon; Dazzel; Dassitox; Neotsidol; Nipsan; Dacutox; Nucidol; O,O-Diethyl 2-isopropyl-4-methylpyrimidyl-6-thiophosphate; Oleodiazinon; Optimizer; Root guard; Sarolex; Spectracide; Spertacide; Srolex; Compass; Ciazinon; Bazudine; Bazudin; Bazuden; Basudin; Bassadinon; Antlak; Antigal; Alfa-tox; Agridin 60; Terminator; Gardentox; Isopropylmethylpyrimidyl diethyl thiophosphate; Galesan; Flytrol; CHEBI:34682",2014-12-24,1,,,,,,,,,
78491-02-8,0,OMOP Exposome,Observation,Substance,Diazolidinyl urea,,2014-12-24,1,,,,,,,,,
962-58-3,0,OMOP Exposome,Observation,Substance,Diazoxon,,2014-12-24,1,,,,,,,,,
257-07-8,0,OMOP Exposome,Observation,Substance,"Dibenz(b,F)-1,4-oxazepine",,2014-12-24,1,,,,,,,,,
53-70-3,0,OMOP Exposome,Observation,Substance,"Dibenzo[a,h]anthracene","1,2:5,6-Benzanthracene; 1,2:5,6-Dibenz(a)anthracene; 1,2:5,6-Dibenzanthracene; 1,2:5,6-Dibenzoanthracene; Benzoktetraphene; Benza,hanthracene; DBA; Dibenz(a,h)anthracene; Dibenz(a,h)antracene; Dibenzathracene; Dibenzaa,h-anthracene; 1,2,5,6-Dibenzanthracene; Dibenza,Hanthracene; Dibenzoa,Hanthracene; Dibenzo(a,h)anthracene; 1,2:5, 6-Dibenzanthracene; CHEBI:35299",2014-12-24,1,,,,,,,,,
GIS1008609,0,OMOP Exposome,Observation,Substance,Dibenzofuran,,2024-09-14,1,,,,,,,,,
538-58-9,0,OMOP Exposome,Observation,Substance,Dibenzylideneacetone,,2014-12-24,1,,,,,,,,,
124-48-1,0,OMOP Exposome,Observation,Substance,Dibromochloromethane,,2014-12-24,1,,,,,,,,,
74-95-3,0,OMOP Exposome,Observation,Substance,Dibromomethane,"methylene bromide, 82Br-labeled; methylene bromide, 80Br2-labeled; methylene bromide, 80Br-labeled; methylene bromide ion (1+); Methylene bromide; Dibromoethane; methylene bromide, 79Br2-labeled; Methylene dibromide; Dibrommethan; Dibromomethylene; methylene bromide, 82Br2-labeled; CH2Br2; Qmacd\\qih; Methylenbromid; CHEBI:47077",2014-12-24,1,,,,,,,,,
16629-56-4,0,OMOP Exposome,Observation,Substance,Dibromotributylantimony,,2014-12-24,1,,,,,,,,,
496-00-4,0,OMOP Exposome,Observation,Substance,Dibrompropamidine,,2014-12-24,1,,,,,,,,,
109-43-3,0,OMOP Exposome,Observation,Substance,Dibutyl decanedioate,,2014-12-24,1,,,,,,,,,
84-74-2,0,OMOP Exposome,Observation,Substance,Dibutyl phthalate,"Morflex 240; Benzene-O-dicarboxylic acid di-N-butyl ester; Benzene-O-dicarboxylic acid, di-N-butyl ester; Benzenedicarboxylic acid, dibutyl ester; BUFA; Butyl phthalate; Butylphthalate; Celluflex DPB; DBP (ester); Di N butyl phthalate; Di-N-butyl phthalate; Di-N-butyl phthalate (dbup); Di-N-butylester kyseliny ftalove; Dibutyl phthalic acid; Dibutyl-1,2-benzenedicarboxylate; Dibutyl-O-phthalate; Di-N-butylorthophthalate; di-N-butyphthalatel; Dibutyl 1, 2-benzenedicarboxylate; Dibutyl 1,2-benzenedicarboxylate; Dibutyl ester of 1,2-benzenedicarboxylic acid; Dibutyl O-phthalate; Dibutyl phthalated; Araldite 502; 1,2-Benzenedicarboxylic acid, dibutyl ester; 1,2-Benzenedicarboxylic acid, 1,2-dibutyl ester; Dibutyl-Phthalate; Dibutyll phthalate; Dibutylphthalate; Dibutylphthatlate; Elaol; Ergoplast FDB; Ersoplast fda; Genoplast B; Hatcol DBP; Hexaplas m/b; Kodaflex DBP; N-Butyl phthalate; N-Butylphthalate; O-Benzenedicarboxylic acid, dibutyl ester; Ortho-dibutyl phthalate; Phthalic acid di-N-butyl ester; Phthalic acid dibutyl ester; Phthalic acid, dibutyl ester; Polycizer DBP; Rapidcelltrade markP; RC plasticizer DBP; Staflex DBP; Uniflex DBP; Unimoll DB; Uniplex 150; Witcizer 300; CHEBI:535597",2014-12-24,1,,,,,,,,,
1067-33-0,0,OMOP Exposome,Observation,Substance,Dibutyltin diacetate,,2014-12-24,1,,,,,,,,,
683-18-1,0,OMOP Exposome,Observation,Substance,Dibutyltin dichloride,,2014-12-24,1,,,,,,,,,
77-58-7,0,OMOP Exposome,Observation,Substance,Dibutyltin dilaurate,,2014-12-24,1,,,,,,,,,
1002-53-5,0,OMOP Exposome,Observation,Substance,Dibutyltin hydride,sn(Bu)2H2; Dibutyltin; Dibutylstannane; Di-n-butyltin; DBT; SnBu2H2; CHEBI:23686,2014-12-24,1,,,,,,,,,
818-08-6,0,OMOP Exposome,Observation,Substance,Dibutyltin oxide,,2014-12-24,1,,,,,,,,,
1918-00-9,0,OMOP Exposome,Observation,Substance,Dicamba,,2014-12-24,1,,,,,,,,,
517-66-8,0,OMOP Exposome,Observation,Substance,Dicentrine,,2014-12-24,1,,,,,,,,,
99-30-9,0,OMOP Exposome,Observation,Substance,Dichloran,,2014-12-24,1,,,,,,,,,
1966-58-1,0,OMOP Exposome,Observation,Substance,Dichlormate,,2014-12-24,1,,,,,,,,,
12107-56-1,0,OMOP Exposome,Observation,Substance,"Dichloro(1,5-cyclooctadiene) palladium(II)",,2014-12-24,1,,,,,,,,,
79-43-6,0,OMOP Exposome,Observation,Substance,Dichloroacetic Acid,Dichloroacetic acid; DCA; Dichloroacetate; dichloroacetate; CHEBI:36386,2014-12-24,1,,,,,,,,,
22980-82-1,0,OMOP Exposome,Observation,Substance,Dichlorobis(ethylenediamine)nickel(II),,2014-12-24,1,,,,,,,,,
563-43-9,0,OMOP Exposome,Observation,Substance,Dichloroethylaluminum,,2014-12-24,1,,,,,,,,,
1975-09-02,0,OMOP Exposome,Observation,Substance,Dichloromethane,Solmethine; Solaesthin; Salesthin; CH2Cl2; DCM; Methane dichloride; M-Clean D; Dichloro-Methane; Distillex DS3; Freon 30; Driverit; Nevolin; Narkotil; Methylene dichloride; Methylene chloride; Methylene bichloride; Methoklone; Aerothene MM; Aerothene; CHEBI:15767,2014-12-24,1,,,,,,,,,
107819-07-8,0,OMOP Exposome,Observation,Substance,Dichloromethoxydibenzofuran,,2014-12-24,1,,,,,,,,,
19493-17-5,0,OMOP Exposome,Observation,Substance,Dichlorotribenzylantimony,,2014-12-24,1,,,,,,,,,
120-36-5,0,OMOP Exposome,Observation,Substance,Dichlorprop,"2,4-Dichlorophenoxy-.alpha.-propionic acid; Weedone DP; Weedone CB 1.3; Weedone 2,4-DP; Weedone 170; Ustilan NK25; U46 DP-FLUID; Tri-cornox sprcial; Textrone m; Seritox 50; R-(+)-2-(2,4-Dichlorophenoxy)propionic acid; Polytox; Polymone; Polyclene; Oxytril p; MSS 2,4-DP; Mayclene; (+ Or -)-2-(2,4-dichlorophenoxy)propanoic acid; Kildip; (+ Or -)-2-(2,4-dichlorophenoxy)propionic acid; (+-)-2-(2,4-Dichlorophenoxy)propanoic acid; (+-)-2-(2,4-Dichlorophenoxy)propionic acid; (+-)-Dichlorprop; (2R)-2-(2,4-Dichlorophenoxy)propanoic acid; (2R)-2-(2,4-Dichlorophenyl)oxypropanoic acid; 2, 4-Dichlorophenoxy-a-propionic acid; 2,4-D + dichlorprop (ester); 2-(2,4-Dichloor-fenoxy)-propionzuur; 2,4-Dichlorophenoxy-a-propionic acid; Hormatox; Herbizid DP; Herbatox; Hedonal DP; Hedonal; Graminon-plus; Envert 171; Dichloroprop solution; Dichloroprop; Desormone; Cornoxynil; Cornox RK extra concentrate; Cornox RK 64; Cornox RK; Cornox RD; Celatox-DP; Celatox DP; Caswell No. 320; Canapur DP; Campbell's redipon; BH 2,4-DP; Basagran DP; Alpha.-(2,4-dichlorophenoxy)propionic acid; 2,4-Dichlorophenoxy-alpha-propionic acid; alpha-(2,4-Dichlorophenoxy) propionic acid; Acide 2-(2,4-dichloro-phenoxy)propionique; a-(2,4-Dichlorophenoxy)propionic acid; 2-(2,4-Dichlorophenoxy)propionic acid; 2-(2,4-Dichlorophenoxy)propanoic acid; 2-(2,4-Dichlorophenoxy) propionic acid; 2-(2,4-Dichlor-phenoxy)-propionsaeure; 2-(2, 4-Dichlorophenoxy)propionic acid; 2-(2,4-(Dichlorophenoxy))propionic acid; CHEBI:75370",2014-12-24,1,,,,,,,,,
62-73-7,0,OMOP Exposome,Observation,Substance,Dichlorvos,"Nuvan; O,O-Dimethyl 2,2-dichlorovinyl phosphate; O,O-Dimethyl dichlorovinyl phosphate; O-(2,2-Dichloroethenyl) O,O-dimethyl phosphate; O-(2,2-Dichlorvinyl)-O,O-dimethylphosphate; Panaplate; Phosphoric acid 2,2-dichloroethenyl dimethyl ester; Algard; Dichlorophos; Diclorvos; Dichloroethenyl dimethyl phosphate; DDVP; Dimethyl 2,2-dichloroethenyl phosphate; Dimethyl 2,2-dichlorovinyl phosphate; Dimethyl dichlorovinyl phosphate; Dimethyl O,O-dichlorovinyl-2,2-phosphate; Dimethyl-2,2-dichlorovinyl phosphate; Dimethyldichlorovinyl phosphate; Divipan; Duravos; Equigand; Equigard; Cypona; Cyanophos; Chlorvinphos; Cekusan; Canogard; Brevinyl; Bibesol; Equigel; Equiguard; Ethenol, 2,2-dichloro-, dimethyl phosphate; 2,2-Dichlorovinyl alcohol dimethyl phosphate; 2,2-Dichlorovinyl dimethyl phosphate; Atgard; 2,2-Dichlorovinyl dimethyl phosphoric acid ester; 2,2-Dichlorovinyl-O,O-dimethyl phosphate; 2,2-Dimethyldichlorovinyl phosphate; Apavap; Aquaguard; Astrobot; Benfos; Fecama; Herkal; Herkol; Insectigas D; Krecalvin; Lindan; Lindanmafu; Nerkol; Nogos; Novotox; Phosphoric acid 2,2-dichlorovinyl dimethyl ester; Phosvit; Tetravos; Topanol; Unifos; Unitox; Vapona; Verdican; Verdipor; 2,2-Dichloroethenyl phosphoric acid dimethyl ester; 2,2-Dichloroethenyl dimethyl phosphate; 2,2-Dichloroethenol dimethyl phosphate; Verdisol; CHEBI:34690",2014-12-24,1,,,,,,,,,
15307-86-5,0,OMOP Exposome,Observation,Substance,Diclofenac,"ISV-205; Flector; 2-(2,6-Dichloroanilino)phenylacetic acid; Nu-Diclo; Pennsaid; Primofenac; Prophenatin; Rhumalgan; Solaraze; Voltaren; Voltaren Emulgel; Voltarol; Zipsor; Zorvolex; 2-((2,6-Dichlorophenyl)amino)benzeneacetic acid; Aclonac; Allvoran; CAMBIA; Cataflam; Diclofenac acid; Diclofenaco; Diclofenacum; Dyloject; Ecofenac; Effekton; CHEBI:4507",2014-12-24,1,,,,,,,,,
51338-27-3,0,OMOP Exposome,Observation,Substance,Diclofop-methyl,,2014-12-24,1,,,,,,,,,
145701-21-9,0,OMOP Exposome,Observation,Substance,Diclosulam,,2014-12-24,1,,,,,,,,,
36499-65-7,0,OMOP Exposome,Observation,Substance,Dicobalt edetate,,2014-12-24,1,,,,,,,,,
10210-68-1,0,OMOP Exposome,Observation,Substance,Dicobalt octacarbonyl,,2014-12-24,1,,,,,,,,,
115-32-2,0,OMOP Exposome,Observation,Substance,Dicofol,"1,1-bis-(chlorophenyl)-2,2,2-trichloroethanol; 1,1-Bis-(p-chlorophenyl)-2,2,2-trichloroethanol; Bis(chlorophenyl)-2,2,2-trichl oroethanol; Acarin; 4-chloro-alpha-(4-Chlorophenyl)-alpha-(trichloromethyl)benzenemethanol; 4,4'-Dichloro-alpha-(trichloromethyl)benzhydrol; 4,4'-Dichloro-a-(trichloromethyl)benzhydrol; 4,4'-Dichloro-.alpha.-(trichloromethyl)benzhydrol; 2,2,2-Trichloro-1,1-di-(4-chlorophenyl)ethanol; 2,2,2-Trichloro-1,1-bis(4-chlorophenyl)ethanol; 2,2,2-Trichloro-1,1-bis(p-chlorophenyl)ethanol; 2,2,2-Trichloro-1,1-di(4-chlorophenyl)ethanol; Kelthane a; Kelthane dust base; Kelthanethanol; Kelthone; Mifol; Milbol; Mitigan; p,p'-di cofol; p,p'-dicofol; p,p'-kelthane; p,p-dicofol; Para,para'-kelthane; Tricofol; Carbax; Bis(chlorophenyl)-2,2,2-trichloroethanol; Carbox; Cekudifol; Decofol; Di-(p-chlorophenyl)trichloromethylcarbinol; Dichlorokelthane; Dicomite; DTMC; Fumite dicofol; Hilfol; Hifol; Keltane; Kelthane; 1,1-Bis(4-chlorophenyl)-2,2,2-trichloroethanol; 1,1-Bis(chlorophenyl)-2,2,2-trichloroethanol; 1,1-Bis(p-Chlorophenyl)-2,2,2-trichloroethanol; CHEBI:34692",2014-12-24,1,,,,,,,,,
141-66-2,0,OMOP Exposome,Observation,Substance,Dicrotophos,"(e)-Phosphoric acid, 3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl ester; 3-Dimethoxyphosphinoyloxy-N,N-dimethylisocrotonamide; Dimethyl (e)-2-dimethyl-carbamoyl-1-methylvinyl phosphate; Bidrin; 3-(Dimethoxyphosphinyloxy)-N,N-dimethyl-cis-crotonamide; (e)-2-Dimethylcarbamoyl-1-methylvinyl dimethyl phosphate; CHEBI:38658",2014-12-24,1,,,,,,,,,
484-29-7,0,OMOP Exposome,Observation,Substance,Dictamnine,,2014-12-24,1,,,,,,,,,
66-76-2,0,OMOP Exposome,Observation,Substance,Dicumarol,"Dicoumarol; Dicoumarin; di-(4-hydroxy-3-coumarinyl)methane; Bishydroxycoumarin; Bis-Hydroxycoumarin; bis-3,3'-(4-hydroxycoumarinyl)methane; Bis(4-hydroxycoumarin-3-yl)methane; 3,3'-Methylenebis(4-hydroxycoumarin); 3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone); 3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one); 3,3'-Methylen-bis(4-hydroxy-cumarin); Dicoumarolum; 3,3'-Methylene-bis(4-hydroxycoumarine); CHEBI:4513",2014-12-24,1,,,,,,,,,
GIS1008610,0,OMOP Exposome,Observation,Substance,Dicumarol Pathway,,2024-09-14,1,,,,,,,,,
84-61-7,0,OMOP Exposome,Observation,Substance,Dicyclohexyl phthalate,"Phthalic acid, dicyclohexyl ester; Ergoplast FDC; Dicyclohexyl benzene-1,2-dicarboxylate; Dicyclohexyl phthalic acid; 1, 2-Benzenedicarboxylic acid, dicyclohexyl ester; 1,2-Benzenedicarboxylic acid, 1,2-dicyclohexyl ester; Diclohexyl 1,2-benzenedicarboxylate; Ergoplast.FDC; CHEBI:33308",2014-12-24,1,,,,,,,,,
69655-05-6,0,OMOP Exposome,Observation,Substance,Didanosine,"9-(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl-1,9-dihydro-6H-purin-6-one; 9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol; Didanosina; DdIno; Videx; Videx EC; 2,3-Dideoxyinosine; 9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one; 9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one; Dideoxyinosine; Didanosinum; DDI; CHEBI:490877",2014-12-24,1,,,,,,,,,
60-57-1,0,OMOP Exposome,Observation,Substance,Dieldrin,"Exo-dieldrin; Hexachloroepoxyoctahydro-endo,exo-dimethanonaphthalene; HEOD; (1Aalpha,2beta,2aalpha,3beta,6beta,6aalpha,7beta,7aalpha)-3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-2,7:3,6-dimethanonaphtho2,3-boxirene; (1R,4S,4AS,5R,6R,7S,8S,8ar)-1,2,3,4,10,10-hexachloro-1,4,4a,5,6,7,8,8a-octahydro-6,7-epoxy-1,4:5,8-dimethanonaphthalene; Shelltox; Alvit; Termitox; Termitoxrm; Quintox; Panoram D-31; Oxralox; Octalox; Murdiel; Kombi-albertan; Insectlack; Illoxol; Alvit 55; Deildrin; Dieldren; Dieldrex; Dieldrine; Dieldrite; Dieldrix; Dielmoth; Dildrin; Dorytox; 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4-endo-exo-5,8-dimethanonaphthalene; Aldrin epoxide; CHEBI:34696",2014-12-24,1,,,,,,,,,
GIS1010316,0,OMOP Exposome,Observation,Substance,Diesel,,2024-09-14,1,,,,,,,,,
GIS1008611,0,OMOP Exposome,Observation,Substance,Dietary Supplement,,2024-09-14,1,,,,,,,,,
111-42-2,0,OMOP Exposome,Observation,Substance,Diethanolamine,"Iminodiethanol; Niax DEOA-LF; 2-(2-Hydroxyethyl)aminoethanol; Aliphatic amine; Bis(2-hydroxyethyl)amine; Bis(2-hydroxyethyl)tallow amine oxide; Bis(hydroxyethyl)amine; Bis-2-hydroxyethylamine; DEA; Di(2-hydroxyethyl)amine; Di(beta-hydroxyethyl)amine; Diaethanolamin; Diethanolamin; Diethylolamine; Dihydroxyethyl tallowamine oxide; Diolamine; H2dea; 2,2'-Iminodiethanol; 2,2'-Iminodi-1-ethanol; 2,2'-Iminobisethanol; 2,2'-Iminobis; 2-(2-Hydroxyethylamino)ethanol; N,N'-Iminodiethanol; 2,2'Iminobisethanol; N,N-Di(hydroxyethyl)amine; N,N-Diethanolamine; 2,2'-Dihydroxydiethylamine; N,N-Bis(2-hydroxyethyl)amine; CHEBI:28123",2014-12-24,1,,,,,,,,,
87130-20-9,0,OMOP Exposome,Observation,Substance,Diethofencarb,"Isopropyl 3,4-diethoxycarbanilate; Isopropyl 3,4-diethoxyphenylcarbamate; Isopropyl N-(3,4-diethoxyphenyl)carbamate; Isopropyl-3,4-diethoxycarbanilat; Powmyl WP; isopropyl-3,4-diethoxycarbanilate; 1-Methylethyl (3,4-diethoxyphenyl)carbamate; 3,4-Dietoxicarbanilato de isopropilo; Carbamic acid, (3,4-diethoxyphenyl)-, 1-methylethyl ester; CHEBI:4520",2014-12-24,1,,,,,,,,,
627-44-1,0,OMOP Exposome,Observation,Substance,Diethyl mercury,,2014-12-24,1,,,,,,,,,
84-66-2,0,OMOP Exposome,Observation,Substance,Diethyl phthalate,"Solvanol; Unimoll da; Ethyl phthalate; Diethylphthalate; Diethyl-o-phthalate; Phthalsaeurediaethylester; Diethyl phthalic acid; Diethyl phthalate (NF); Diethyl o-phthalate; Diethyl o-phenylenediacetate; Diethyl ester of 1,2-Benzenedicarboxylic acid; Diethyl ester; Diethyl benzene-1,2-dicarboxylate; Diethyl 1,2-benzenedicarboxylate; Di-n-ethyl phthalate; Iethylphthalate; Kodaflex dep; Neantine; Benzenedicarboxylic acid diethyl ester; O-benzenedicarboxylic acid diethyl ester; Anozol; 1,2-Diethyl phthalate; 1,2-benzenedicarboxylic acid diethyl ester; O-bis(ethoxycarbonyl)benzene; 1,2-Benzenedicarboxylic acid diethyl ester; 1,2-Benzenedicarboxylic acid di-C4-13-alkyl esters; 1,2-Benzenedicarboxylic acid 1,2-diethyl ester; -benzenedicarboxylic acid diethyl ester; Phthalic acid diethyl ester; Phthalol; Diethyl-1,2-benzenedicarboxylate; Placidol e; CHEBI:34698",2014-12-24,1,,,,,,,,,
71247-25-1,0,OMOP Exposome,Observation,Substance,Diethylamine,"Caerulein diethylamine; 5-Oxo-L-prolyl-L-glutaminyl-L-alpha-aspartyl-O-sulfo-L-tyrosyl-L-threonylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamideN-ethylethanamine (1/1); NDEA; Diaethylamin; DEA; Ceruletide diethylamine; Diethamine; Diethylnitrosamine; Dietilamina; Dwuetyloamina; N,N-Diethylamine; N-Ethylethanamine; CHEBI:59223",2014-12-24,1,,,,,,,,,
1762-27-2,0,OMOP Exposome,Observation,Substance,Diethyldimethyl lead,,2014-12-24,1,,,,,,,,,
111-40-0,0,OMOP Exposome,Observation,Substance,Diethylenetriamine,"beta ,beta '-diaminodiethylamine; 2, 2'-Diaminodiethylamine; 2,2'-Diamino-Diethylamine; 2,2'-Iminodiethylamine; 2,2-Iminodiethylamine; 2-(2-Aminoethylamino)ethylamine; 3-Aza-1,5-diaminopentane; 3-Aza-1,5-pentanediamine; 3-Azapentane-1,5-diamine; Aminoethylethandiamine; Ancamine deta; Barsamide 115; 1,5-Diamino-3-azapentane; Bis(2-amino-ethyl)-amine; Bis(2-aminoethyl)amine; Bis(beta-aminoethyl)amine; Bisbeta -aminoethylamine; ChS-P 1; 2,2'-Diaminodiethylamine; DETA; Di(2-aminoethyl)amine; DIEN; Diethylene triamine; Diethylenetriamine adduct; Epicure t; Imino-bis-ethylamine; N,N-Bis(2-aminoethyl)amine; N-(2-Aminoethyl)-1,2-Ethanediamine; N-(2-Aminoethyl)-1,2-ethanediamine, 9CI; N-(2-Aminoethyl)-Ethylenediamine; N-(2-Aminoethyl)ethane-1,2-diamine; N-(2-Aminoethyl)ethylenediamine; N1-(2-aminoethyl)-1,2-Ethanediamine; Texacure EA-20; 2,2'-Iminobis(ethanamine); 2,2'-Iminobis-Ethylamine; 2,2'-Iminobisethylamine; 2,2'-Iminodi(ethylamine); (aminoethyl)ethanediamine; 1,4,7-Triazaheptane; CHEBI:30629",2014-12-24,1,,,,,,,,,
598-02-7,0,OMOP Exposome,Observation,Substance,Diethylphosphate,"O,O-Diethyl hydrogen phosphate; Diethyl hydrogen phosphate; Diethyl phosphoric acid; Diethyl phosphate; Diethyl acid phosphate; Di-Ethyl phosphate; O,O-Diethylphosphoric acid; Phosphoric acid diethyl ester; DPF; O,O-Diethyl phosphate; DEP; Ethyl phosphate; Diethylphosphoric acid; Diethylphosphic acid; CHEBI:38598",2014-12-24,1,,,,,,,,,
90-84-6,0,OMOP Exposome,Observation,Substance,Diethylpropion,Frekentine; Tylinal; (+-)-Diethylpropion; (\u00b1)-diethylpropion; 1-phenyl-2-diethylamino-1-propanone; 2-(Diethylamino)-1-phenyl-1-propanone; 2-(Diethylamino)propiophenone; alpha-Benzoyltriethylamine; Tepanil; Tenuate; Regenon; Prefamone; Nobesine; Neobes; Moderatan; alpha-Diethylaminopropiophenone; Amfepramone; Linea; Amfepramonum; Anfepramona; Anorex; DEA No. 1610; Diethylcathinone; Diethylpropione; Dobesin; CHEBI:4530,2014-12-24,1,,,,,,,,,
56-53-1,0,OMOP Exposome,Observation,Substance,Diethylstilbestrol,"Rcra waste number U089; Stilbetin; alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol; DES; Diethylstilbesterol; Diethylstilbestrol BP; Diethylstilbestrolum; Diethylstilboesterol; 4,4'-dihydroxy-\u03b1,\u03b2-diethylstilbene; 4,4'-Dihydroxy-alpha,beta-diethylstilbene; \u03b1,\u03b1'-diethyl-(E)-4,4'-stilbenediol; trans-Diethylstilboesterol; (e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol; (E)-3,4-bis(4-hydroxyphenyl)-3-hexene; Dietilestilbestrol; Distilbene; trans-Diethylstilbestrol; trans-Diethylstilbesterol; trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol; Stilboestrol; Percutatrine oestrogenique iscovesco; Stilbestrol; CHEBI:4531",2014-12-24,1,,,,,,,,,
5871-17-0,0,OMOP Exposome,Observation,Substance,Diethylthiophosphate,"Diethylthiophosphoric acid; Diethylthiophosphorate; Diethylthiophosphic acid; O,O-Diethyl phosphorothionate; DETP; CHEBI:28006",2014-12-24,1,,,,,,,,,
134-62-3,0,OMOP Exposome,Observation,Substance,Diethyltoluamide,"Dietiltoluamida; Flypel; Metadelphene; Muscol; Off; Repel; 3-Methyl-N,N-diethylbenzamide; Autan; Deet; Detamide; Diethyl toluamide; Diethyltoluamidum; CHEBI:7071",2014-12-24,1,,,,,,,,,
557-20-0,0,OMOP Exposome,Observation,Substance,Diethylzinc,Diethyl zinc; Zinc diethyl; (C2H5)2Zn; Zinc ethide; DEZ; ZnEt2; Zincdiethyl; Zinc ethyl; Diethylzinc solution; Diethylzink; CHEBI:51496,2014-12-24,1,,,,,,,,,
56073-07-5,0,OMOP Exposome,Observation,Substance,Difenacoum,,2014-12-24,1,,,,,,,,,
119446-68-3,0,OMOP Exposome,Observation,Substance,Difenoconazole,,2014-12-24,1,,,,,,,,,
43222-48-6,0,OMOP Exposome,Observation,Substance,Difenzoquat metilsulfate,,2014-12-24,1,,,,,,,,,
35367-38-5,0,OMOP Exposome,Observation,Substance,Diflubenzuron,"N-(4-Chlorophenylcarbamoyl)-2,6-difluorobenzamide; N-(4-Chlorophenyl)aminocarbonyl-2,6-difluorobenzamide, 9CI; N-(4-Chlorophenyl)amnocarbonyl-2,6-difluorobenzamide; Philips-duphar PH 60-40; Larvakil; Duphacid; Dioflubenzuron; Dimilin WP-25; Dimilin ODC-45; Thompson-Hayward 6040; Thompson-hayward TH6040; Dimilin G4; Dimilin G1; Dimilin; 1-(p-Chlorophenyl)-3-(2,6-difluorobenzoyl)urea; 1-(4-Chlorophenyl)-3-(2,6-difluorobenzoyl)urea; Micromite; N-(((4-Chlorophenyl)amino)carbonyl)-2,6-difluorobenzamide; N-(4-Chlorophenyl)-N'-(2,6-difluorobenzoyl)urea; N-(4-Chlorophenyl)carbamoyl-2,6-difluorobenzamide; 1-(p-Chlorophenyl)-3-(2,6-difluorobenzoyl)-Urea; Astonex; Difluron; Thompson Hayward 6040; CHEBI:34703",2014-12-24,1,,,,,,,,,
22494-42-4,0,OMOP Exposome,Observation,Substance,Diflunisal,"Anton; 5-(2,4-Difluorophenyl)salicylic acid; 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid; 2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid; Dolobid; Diflunisalum; CHEBI:39669",2014-12-24,1,,,,,,,,,
GIS1008612,0,OMOP Exposome,Observation,Substance,Diflunisal Pathway,,2024-09-14,1,,,,,,,,,
71-63-6,0,OMOP Exposome,Observation,Substance,Digitoxin,Digitoxinum; Crystodigin; Digitoksin; Tardigal; Digitoxoside; CHEBI:28544,2014-12-24,1,,,,,,,,,
20830-75-5,0,OMOP Exposome,Observation,Substance,Digoxin,Lanacrist; Dilanacin; Dynamos; Eudigox; Homolle'S digitalin; Lanacordin; Lanadicor; Lanicor; Lanoxicaps; Digazolan; Digitalis glycoside; Digitek; Digacin; Davoxin; Cogoxin; Vanoxin; SK-Digoxin; Rougoxin; Neo-Lanicor; Centoxin; Celoxin; Cardoxin; Lenoxin; Lanoxin; Cardioxin; Cardiogoxin; Cardiacin; Agoxin; 12beta-Hydroxydigitoxin; 12\u03b2-hydroxydigitoxin; Digocard-G; Digossina; DIGOX; Digoxin Pediatric; Digoxina; Digoxine; Digoxinum; CHEBI:4551,2014-12-24,1,,,,,,,,,
57129-71-2,0,OMOP Exposome,Observation,Substance,Dihydro-5-propyl-2(3H)-furanone,,2014-12-24,1,,,,,,,,,
39156-67-7,0,OMOP Exposome,Observation,Substance,Dihydrocytochalasin B,,2014-12-24,1,,,,,,,,,
14110-71-5,0,OMOP Exposome,Observation,Substance,Dihydrocytochalasin B gamma-lactone,,2014-12-24,1,,,,,,,,,
6190-39-2,0,OMOP Exposome,Observation,Substance,Dihydroergotamine,"(2R,4R,7R)-N-(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo7.3.0.02,6dodecan-4-yl-6-methyl-6,11-diazatetracyclo7.6.1.02,7.012,16hexadeca-1(16),9,12,14-tetraene-4-carboxamide; Verladyn; Orstanorm; Migranal; Ikaran; Ergotonin; Ergont; Diidroergotamina; Dihydroergotaminum; Dihydroergotamine monomethanesulfonate; Dihydroergotamine methanesulfonate; Dihydroergotamine mesylate; Dihydroergotamin; Dihydergot; Dihidroergotamina; D.H.E. 45; 9,10-dihydroergotamine; 9,10-Dihydro-ergotamine; 9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione; 5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman; CHEBI:4562",2014-12-24,1,,,,,,,,,
P00374,0,OMOP Exposome,Observation,Substance,Dihydrofolate reductase (human),,2024-09-14,1,,,,,,,,,
P16184,0,OMOP Exposome,Observation,Substance,Dihydrofolate reductase (pneumocystis carinii),,2024-09-14,1,,,,,,,,,
P10515,0,OMOP Exposome,Observation,Substance,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",,2024-09-14,1,,,,,,,,,
P36957,0,OMOP Exposome,Observation,Substance,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial",,2024-09-14,1,,,,,,,,,
Q02127,0,OMOP Exposome,Observation,Exposome Target,"Dihydroorotate dehydrogenase (quinone), mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1008613,0,OMOP Exposome,Observation,Substance,Dihydropyrimidinase Deficiency,,2024-09-14,1,,,,,,,,,
Q16555,0,OMOP Exposome,Observation,Substance,Dihydropyrimidinase-related protein 2,,2024-09-14,1,,,,,,,,,
Q12882,0,OMOP Exposome,Observation,Substance,Dihydropyrimidine dehydrogenase [NADP(+)],,2024-09-14,1,,,,,,,,,
67-96-9,0,OMOP Exposome,Observation,Substance,Dihydrotachysterol,Dihydrotachysterolum; Dygratyl; Hytakerol; Tachystin; Vitamin D4; Anti-tetany substance 10; AT 10; Atiten; Dihidrotaquisterol; Dihydral; CHEBI:4591,2014-12-24,1,,,,,,,,,
521-18-6,0,OMOP Exposome,Observation,Substance,Dihydrotestosterone,"Stanorone; 17-Hydroxyandrostan-3-one; 5-alpha-Androstanolone; 5-a-Androstanolone; 4-Dihydrotestosterone; 4,5a-Dihydrotestosterone; 17beta-Hydroxyandrostan-3-one; 17beta-Hydroxy-5alpha-androstane-3-one; 17beta-hydroxy-5alpha-androstan-3-one; 17b-Hydroxy-3-androstanone; 5alpha dihydrotestosterone; Anaprotin; Andractim; Androlone; 5alpha-Dihydrotestosterone; 5A-Androstan-3-on-17B-ol; 5a-Dihydrotestosterone; 5alpha-androstan-17beta-ol-3-one; Proteina; Cristerona MB; Androstanolone; Androstan-17beta-ol-3-one; Neodrol; 5a-Androstan-17b-ol-3-one; 5.alpha.-Dihydrotestosterone; Drolban; DHT; Androstan-17b-ol-3-one; (5a,17b)-17-Hydroxyandrostan-3-one; Androstalone; Stanolone; Stanaprol; Protona; 5B-Androstan-3-on-17B-ol; Anaboleen; Anabolex; (5alpha,17beta)-17-hydroxyandrostan-3-one; 17-Hydroxy-androstan-3-one; CHEBI:16330",2014-12-24,1,,,,,,,,,
696-04-8,0,OMOP Exposome,Observation,Substance,Dihydrothymine,"5-Methyl-5,6-dihydrouracil; Dihydro-5-methyl-2,4(1H,3H)-Pyrimidinedione; 5,6-Dihydro-5-methyluracil; 5,6-Dihydrothymine; 5-Methyl-Hydrouracil; 5-Methyldihydropyrimidine-2,4(1H,3H)-dione; CHEBI:27468",2018-03-21,1,,,,,,,,,
504-07-4,0,OMOP Exposome,Observation,Substance,Dihydrouracil,"Dihydrouracile; Dihydro-pyrimidine-2,4-dione; Dihydro-2,4(1H,3H)-pyrimidinedione; 5,6-Dihydrouracil; 5,6-Dihydro-2,4-dihydroxypyrimidine; 5,6-Dihydro-2,4(1H,3H)-pyrimidinedione; Hydrouracil; CHEBI:15901",2018-03-21,1,,,,,,,,,
13682-92-3,0,OMOP Exposome,Observation,Substance,Dihydroxyaluminium,,2014-12-24,1,,,,,,,,,
63-84-3,0,OMOP Exposome,Observation,Substance,Dihydroxyphenylalanine,,2014-12-24,1,,,,,,,,,
84-69-5,0,OMOP Exposome,Observation,Substance,Diisobutyl phthalate,"Kodaflex DIBP; 1,2-Benzenedicarboxylic acid, 1,2-bis(2-methylpropyl) ester; 1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester; 1,2-Benzenedicarboxylic acid, di(2-methylpropyl) ester; Bis(2-methylpropyl) phthalate; Di-2-methylpropyl phthalate; DIBP; Diisobutyl phthalic acid; Diisobutylester kyseliny ftalove; Hexaplas M/1B; Isobutyl phthalate; Isobutyl-O-phthalate; Phthalic acid, diisobutyl ester; CHEBI:894546",2014-12-24,1,,,,,,,,,
1191-15-7,0,OMOP Exposome,Observation,Substance,Diisobutylaluminium hydride,,2014-12-24,1,,,,,,,,,
26761-40-0,0,OMOP Exposome,Observation,Substance,Diisodecyl phthalate,"Didp (plasticizer); DIIsodecyl phthalate; Diisodecyl phthalic acid; 1,2-Benzenedicarboxylic acid 1,2-diisodecyl ester; Bis(8-methylnonyl) phthalate; Bis(isodecyl) phthalate; Di(C9-C11) branched alkyl phthalate; Di(I-decyl) phthalate; Di-isodecyl phthalate; Isodecyl phthalate; Plasticized DDP; Phthalic acid bis(8-methylnonyl) ester; Phthalic acid dIIsodecyl ester; CHEBI:33308",2014-12-24,1,,,,,,,,,
41451-28-9,0,OMOP Exposome,Observation,Substance,Diisoheptyl phthalate,,2014-12-24,1,,,,,,,,,
146-50-9,0,OMOP Exposome,Observation,Substance,Diisohexyl phthalate,"Phthalic acid dIIsohexyl ester; Diisohexyl phthalic acid; Bis(4-methylpentyl) 1,2-benzenedicarboxylate; bis(4-methyl-2-pentyl) phthalate; Carboxylic ester; Bis(4-methylpentyl) phthalate; DIIsohexyl phthalate; 1,2-Benzenedicarboxylic acid diisohexyl ester; Phthalic acid di(4-methylpentyl) ester; CHEBI:33308",2014-12-24,1,,,,,,,,,
28553-12-0,0,OMOP Exposome,Observation,Substance,Diisononyl phthalate,"Phthalisocizer dinp; Di-isononylphthalate; Bis-(3,5,5-trimethylhexyl) phthalate; Bis(3,5,5-trimethylhexyl) phthalate; Alpha-dinonyl phthalate; 1,2-Benzenedicarboxylic acid diisononyl ester; 1,2-Benzenedicarboxylic acid 1,2-diisononyl ester; Diisononyl phthalic acid; Diisononylphthalate; Jay-dinp; Jayflex dinp; Phthalic acid dIIsononyl ester; Sansocizer dinp; CHEBI:35459",2014-12-24,1,,,,,,,,,
27554-26-3,0,OMOP Exposome,Observation,Substance,Diisooctyl phthalate,"Phthalic acid, dIIsooctyl ester; Di-iso-octyl phthalate; 1,2-Benzenedicarboxylic acid, 1,2-diisooctyl ester; Phthalic acid, bis(6-methylheptyl)ester; Bis(6-methylheptyl) phthalate; Phthalic acid, bis(6-methylheptyl) ester; Diisocapryl phthalate; Diisooctyl phthalic acid; Diisooctyl 1,2-benzenedicarboxylate; Isooctyl phthalate; CHEBI:33308",2014-12-24,1,,,,,,,,,
625-81-0,0,OMOP Exposome,Observation,Substance,Diisopropylzinc,,2014-12-24,1,,,,,,,,,
68515-47-9,0,OMOP Exposome,Observation,Substance,Diisotridecyl phthalate,,2014-12-24,1,,,,,,,,,
85507-79-5,0,OMOP Exposome,Observation,Substance,Diisoundecyl phthalate,,2014-12-24,1,,,,,,,,,
42399-41-7,0,OMOP Exposome,Observation,Substance,Diltiazem,"Diltiazemum; Calcicard; Cardizem; Cartia; Cartia XT; D-cis-Diltiazem; Dilacor; Dilacor-XR; Dilcontin; Dilrene; DILT-CD; Diltia XT; Anoheal; Dilticard; DILTZAC; Dilzem; Herbesser; Incoril AP; Masdil; Surazem; TAZTIA; Tiazac; Viazem; (+)-cis-5-2-(dimethylamino)Ethyl-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester; (2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzob1,4thiazepin-3-yl acetate; (2S-cis)-3-(Acetyloxy)-5-2-(dimethylamino)ethyl-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one; Acalix; Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzob1,4thiazepin-3-yl ester; Adizem; Altiazem; CHEBI:101278",2014-12-24,1,,,,,,,,,
10170-69-1,0,OMOP Exposome,Observation,Substance,Dimanganese decacarbonyl,,2014-12-24,1,,,,,,,,,
122-15-6,0,OMOP Exposome,Observation,Substance,Dimetan,,2014-12-24,1,,,,,,,,,
87674-68-8,0,OMOP Exposome,Observation,Substance,Dimethenamid,,2014-12-24,1,,,,,,,,,
60-51-5,0,OMOP Exposome,Observation,Substance,Dimethoate,"Rogor 20L; Rogor; Rogodan; Fosfatox R; Fosfamid; Fortion NM; Ferkethion; Dimevur; Fostion MM; Lurgo; Turbair; Trimetion; Systoate; Dimeton; Dimethyl S-(N-(methylcarbamoyl)methyl) phosphorodithioate; Dimethyl S-((methylcarbamoyl)methyl) phosphorodithioate; Dimethoic acid; Dimethogen; Dimethoate solution; Rogor l; Rogor p; Roxion; Roxion ua; S-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate; Sevigor; Dimethoate 30 EC; Dimetate; Dimate 267; Devigon; Demos-L40; De-fend; Daphene; Cygon insecticide; Cygon 4E; Cygon 400; Cygon 2-E; Cygon; Fosfotox R 35; 2-Dimethoxyphosphinothioylthio-N-methylacetamide; Rebelate; Racusan; Phosphorodithioic acid, O,O-dimethyl S-(2-(methylamino)-2-oxoethyl) ester; Maxima phlanzenschutz; Phosphamide; Phosphamid; Fosfotox R; Fosfotox; Perfekthion; Perfecthion; Sinoratox; Sistemin; O,O-dimethyl methylcarbamoylmethyl phosphorodithioate; O,O-dimethyl S-((methylcarbamoyl)methyl)phosphorodithioate; O,O-dimethyl S-(N-methylcarbamoylmethyl) dithiophosphate; O,O-dimethyl S-(N-methylcarbamoylmethyl) phosphorodithioate; O,O-dimethyl S-(N-methylcarbamylmethyl) thiothionophosphate; O,O-dimethyl S-methylcarbamoylmethyl phosphorodithioate; O,O-Dimethyl S-2-(methylamino)-2-oxoethyl dithiophosphate; Systemin; Systemic insecticide; Solut; O,O-Dimethyl-S-(2-oxo-3-aza-butyl)-dithiophosphate; Rogor 40; CHEBI:34714",2014-12-24,1,,,,,,,,,
110488-70-5,0,OMOP Exposome,Observation,Substance,Dimethomorph,,2014-12-24,1,,,,,,,,,
627-93-0,0,OMOP Exposome,Observation,Substance,Dimethyl adipate,,2014-12-24,1,,,,,,,,,
8001-54-5,0,OMOP Exposome,Observation,Substance,Dimethyl dialkyl ammonium chloride,,2014-12-24,1,,,,,,,,,
593-74-8,0,OMOP Exposome,Observation,Substance,Dimethyl mercury,Dimethylmercury; HgMe2; Methylmercury; HgMe2; CHEBI:30786,2014-12-24,1,,,,,,,,,
131-11-3,0,OMOP Exposome,Observation,Substance,Dimethyl phthalate,"Mipax; NTM; Phtalate de dimethyle; Phthalic acid dimethyl ester; Dimethyl benzene-o-dicarboxylate; Dimethyl benzeneorthodicarboxylate; Dimethyl 1,2-benzenedicarboxylate; Dimethyl 1,2-benzenedicarboxylate acid; Dimethyl 1,2-benzendicarboxylate; 1,2-dimethyl phthalate; 1,2-Benzenedicarboxylic acid dimethyl ester; 1,2-Benzenedicarboxylic acid 1,2-dimethyl ester; 1, 2-Benzenedicarboxylic acid dimethyl ester; Dimethyl o-phthalate; Dimethyl orthophthalate; Dimethyl phthalic acid; Dimethylphthalate; Fermine; Solvarone; Solvanom; Repeftal; Kemester DMP; Kodaflex DMP; Phthalsaeuredimethylester; Phthalic acid methyl ester; Methyl phthalate; CHEBI:17747",2014-12-24,1,,,,,,,,,
67-68-5,0,OMOP Exposome,Observation,Substance,Dimethyl sulfoxide,Rimso-50; Dimethylsulfoxyde; Dimetil sulfoxido; DMSO; Methylsulfinylmethane; Dimethylsulfoxid; Dimethyli sulfoxidum; Dimethyl sulpoxide; Dimethyl sulphoxide; Dimethyl sulfur oxide; Dimethyl sulfoxixde; (methylsulfinyl)methane; (CH3)2SO; S(O)Me2; Sulfinylbis(methane); CHEBI:28262,2014-12-24,1,,,,,,,,,
124-40-3,0,OMOP Exposome,Observation,Substance,Dimethylamine,"Dimethylamine anhydrous (dot); Dimethylamine solution; N-Methylmethanamine; N-Methyl-Methanamine; N,N-Dimethylamine; Dimethylamine aqueous solution; Dimethylamine hydrobromide; Dimethylamine anhydrous; CHEBI:17170",2014-12-24,1,,,,,,,,,
15132-04-4,0,OMOP Exposome,Observation,Substance,Dimethylarsinate,Cacodylic acid; Erase; Hydroxydimethylarsine oxide; Moncide; Phytar; Phytar 560; Silvisar; DMAA; Dimethylarsinic acid; Chexmate; Ansar; Arsan; Bolate; Bolls; Cacodylate; CHEBI:16223,2014-12-24,1,,,,,,,,,
593-57-7,0,OMOP Exposome,Observation,Substance,Dimethylarsine,,2014-12-24,1,,,,,,,,,
108-01-0,0,OMOP Exposome,Observation,Substance,Dimethylethanolamine,"2-(Dimethylamino) ethanol; Varesal; Toyocat -dma; Tonibral; Texacat dme; Tegoamin dmea; Propamine a; Phosphatidyl-N-dimethylethanolamine; Norcholine; N-Dimethylaminoethanol; N-CBZ-L-tyrosine; N-Benzyloxycarbonyl-L-tyrosine; N-(Dimethylamino)ethanol; N-(2-Hydroxyethyl)dimethylamine; N,N-Dimethylethanolamine; N,N-Dimethylaminoethanol (dmae); N,N-Dimethylaminoethanol; N,N-Dimethyl-N-ethanolamine; N,N-Dimethyl-N-(beta-hydroxyethyl)amine; N,N-Dimethyl-N-(beta -hydroxyethyl)amine; N,N-Dimethyl-N-(2-hydroxyethyl)amine; N,N-Dimethyl-beta -hydroxyethylamine; N,N-Dimethyl-2-hydroxyethylamine; N,N-Dimethyl-2-aminoethanol; N,N-Dimethyl(2-hydroxyethyl)amine; N,N'-Dimethylethanolamine; N, N-Dimethyl-N-(beta -hydroxyethyl)amine; N, N-Dimethyl-N-(2-hydroxyethyl)amine; N, N-Dimethyl(2-hydroxyethyl)amine; Liparon; Kalpur p; DMEA; DMAE; Dimethylmonoethanolamine; Dimethylethanoiamine; Dimethylaminoethanol; Dimethylaminoaethanol; Dimethylaethanolamin; Dimethyl(hydroxyethyl)amine; Dimethyl(2-hydroxyethyl)amine; Demanyl; Demanol; Deanol; Dabco dmea; Bimanol; beta-Hydroxyethyldimethylamine; beta-Dimethylaminoethyl alcohol; beta -hydroxyethyldimethylamine; beta -dimethylaminoethyl alcohol; beta -(dimethylamino)ethyl alcohol; beta -(dimethylamino)ethanol; Amietol M 21; 2-Dwumetyloaminoetanolu; 2-Dimethylaminoethanol; 2-DIMETHYLAMINOETHANOL; 2-Dimethylamino-Ethanol; 2-Dimethylamino; 2-(N,N-Dimethylamino)ethanol; 2-(Dimethylamino)ethanol; 2-(Dimethylamino)-Ethanol; 2-(Dimethylamino)-1-ethanol; (dimethylamino)ethanol; (CH3)2NCH2CH2OH; (2-Hydroxyethyl)dimethylamine; CHEBI:271436",2014-12-24,1,,,,,,,,,
26636-01-1,0,OMOP Exposome,Observation,Substance,Dimethyltin bis(isooctyl mercaptoacetate),,2014-12-24,1,,,,,,,,,
753-73-1,0,OMOP Exposome,Observation,Substance,Dimethyltin dichloride,,2014-12-24,1,,,,,,,,,
544-97-8,0,OMOP Exposome,Observation,Substance,Dimethylzinc,(CH3)2Zn; Methylzinc; ZnMe2; Qmbaxch; Dimethyl zinc; Zinc methyl; CHEBI:51497,2014-12-24,1,,,,,,,,,
644-64-4,0,OMOP Exposome,Observation,Substance,Dimetilan,,2014-12-24,1,,,,,,,,,
83657-24-3,0,OMOP Exposome,Observation,Substance,Diniconazole,,2014-12-24,1,,,,,,,,,
10544-72-6,0,OMOP Exposome,Observation,Substance,Dinitrogen tetroxide,N(NO2)O2; Dinitrogen tetraoxide; Distickstofftetroxid; Nitrogen tetraoxide; Nitrogen tetroxide; O2NNO2; CHEBI:29803,2014-12-24,1,,,,,,,,,
81720-10-7,0,OMOP Exposome,Observation,Substance,Dinophysistoxin 1,,2014-12-24,1,,,,,,,,,
6988-21-2,0,OMOP Exposome,Observation,Substance,Dioxacarb,,2014-12-24,1,,,,,,,,,
12361-66-9,0,OMOP Exposome,Observation,Substance,Dioxygenyl hexafluoroantimonate,,2014-12-24,1,,,,,,,,,
P27487,0,OMOP Exposome,Observation,Substance,Dipeptidyl peptidase 4,,2024-09-14,1,,,,,,,,,
58-73-1,0,OMOP Exposome,Observation,Substance,Diphenhydramine,"Dermodrin; Allergina; Alledryl; Aleryl; 2-diphenylmethoxy-N,N-demthylethanamine; 2-(Benzhydryloxy)-N,N-dimethylethylamine; Allerdryl; Allergan; \u03b2-dimethylaminoethyl benzhydryl ether; Dimedrolum; Dimedrol; Difenhydramine; Difenhidramina; Dibondrin; Desentol; alpha-(2-Dimethylaminoethoxy)diphenylmethane; beta-Dimethylaminoethyl benzhydryl ether; beta-Dimethylaminoethanol diphenylmethyl ether; Benzantin; Benylan; Bendylate; Benadryl; Belix; Beldin; Baramine; Banophen; Silphen Cough; Siladryl; Restamin; O-benzhydryldimethylaminoethanol; Nytol Quickgels; Nytol Quickcaps; N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine; Hyrexin; Histaxin; Genahist; Dormarex 2; Dobacen; Diphenhydraminum; Diphenhist; Diphen; Diphantine; Diphamine; Dimethylamine benzhydryl ester; CHEBI:4636",2014-12-24,1,,,,,,,,,
915-30-0,0,OMOP Exposome,Observation,Substance,Diphenoxylate,"Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate; Diphenoxylic acid; Diphenoxylatum; Diphenoxalate; Difenoxilato; 2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile; Difenossilato; Lomotil; Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate; Dea No. 9170; 4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile; 1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester; CHEBI:4639",2014-12-24,1,,,,,,,,,
1666-13-3,0,OMOP Exposome,Observation,Substance,Diphenyl diselenide,,2014-12-24,1,,,,,,,,,
122-39-4,0,OMOP Exposome,Observation,Substance,Diphenylamine,"Diphenylamine indicator; Diphenyl-amine; Diphenpyramide; No-scald; Difenylamin; DFA; Deccoscald 282; C6H5-NH-C6H5; Big dipper; Benzenamine, N-phenyl-, styrenated; Anilinobenzene; Naugalube 428L; 2-Biphenylyl-N-pyridylacetamide; 2-Biphenylyl-N-pyridyl-Acetamide; (phenylamino)benzene; (phenylamino)-Benzene; No-Scald DPA 283; Phenylaniline; Poly(diphenylamine); N-Phenylbenzenamine; N-Phenylbenzenamine, 9CI; N-Phenylbenzenamine, styrenated; N-Phenylbenzeneamine; Diphenylamine, reaction product with 2,2,4-trimethylpentene; Anilino-Benzene; N-Phenyl-Aniline; Pyridyl-biphenylyl-acetamide; N-Phenyl-Benzenamine; Scaldip; N-Phenylaniline; N,N-Diphenylamine; Shield dpa; Styrenated diphenylamine; Styrene, reaction product with diphenylamine; N-Fenylanilin; No scald; No scald dpa 283; Diphenylamine, acs; CHEBI:4640",2014-12-24,1,,,,,,,,,
712-48-1,0,OMOP Exposome,Observation,Substance,Diphenylchlorarsine,,2014-12-24,1,,,,,,,,,
23525-22-6,0,OMOP Exposome,Observation,Substance,Diphenylcyanoarsine,,2014-12-24,1,,,,,,,,,
GIS1008614,0,OMOP Exposome,Observation,Substance,Diphtheria toxin (Corynephage omega),,2024-09-14,1,,,,,,,,,
Q9H2P9,0,OMOP Exposome,Observation,Substance,Diphthine methyl ester synthase,,2024-09-14,1,,,,,,,,,
BE0004441,0,OMOP Exposome,Observation,Substance,Diphthine synthase,,2024-09-14,1,,,,,,,,,
759-94-4,0,OMOP Exposome,Observation,Substance,Dipropylcarbamothioic acid S-ethyl ester,,2014-12-24,1,,,,,,,,,
85-00-7,0,OMOP Exposome,Observation,Substance,Diquat dibromide,,2014-12-24,1,,,,,,,,,
GIS1008622,0,OMOP Exposome,Observation,Substance,Disinfectant,,2024-09-14,1,,,,,,,,,
Q9UKQ2,0,OMOP Exposome,Observation,Substance,Disintegrin and metalloproteinase domain-containing protein 28,,2024-09-14,1,,,,,,,,,
GIS1008623,0,OMOP Exposome,Observation,Substance,Disintegrin echistatin (Echis carinatus),,2024-09-14,1,,,,,,,,,
P78352,0,OMOP Exposome,Observation,Substance,Disks large homolog 4,,2024-09-14,1,,,,,,,,,
2783-94-0,0,OMOP Exposome,Observation,Substance,Disodium 6-hydroxy-5-[(4-sulfophenyl)azo]-2-naphthalenesulfonate,,2014-12-24,1,,,,,,,,,
97-77-8,0,OMOP Exposome,Observation,Substance,Disulfiram,"Antietanol; Antabuse; Antabus; 1,1'-dithiobis(N,N-diethylthioformamide); Bis(diethylthiocarbamoyl) disulfide; Chronol; Disulfuram; Disulphuram; Dupon 4472; Tetraethylthiuram Disulfide; Usaf B-33; TTD; Tetraethylthiuran Disulfide; Tetraethylthiuram Sulfide; Anticol; Antalcol; Tetraethylthiuram Disulphide; Tetraethylthiram Disulfide; TETD; Dupont Fungicide 4472; Esperal; Tetraethylthioperoxydicarbonic Diamide; N,N,N',N'-tetraethylthiuram disulfide; Tetraethylthiram Disulphide; Tetraethylthiuram; TATD; Antaethyl; CHEBI:4659",2014-12-24,1,,,,,,,,,
GIS1008632,0,OMOP Exposome,Observation,Substance,Disulfiram Pathway,,2024-09-14,1,,,,,,,,,
298-04-4,0,OMOP Exposome,Observation,Substance,Disulfoton,"O,O-Ethyl S-2(ethylthio)ethyl phosphorodithioate; Di-syston; Disipton; Disulfoton mixture; Disyston FE-10; Disystox; Dithiodemeton; Dithiosystox; Dution; Ekatin TD; Ekatine; Ethyl thiometon; Ethylthiodemeton; Ethylthiometon; Ethylthiometon b; Glebofos; Insyst-d; O,O-Diaethyl-S-(2-aethylthio-aethyl)-dithiophosphat; O,O-diethyl 2-(ethylthio)ethyl dithiophosphate; O,O-Diethyl 2-ethylthioethyl phosphorodithioate; O,O-Diethyl S-(2-(ethylthio)ethyl) dithiophosphate; O,O-Diethyl S-(2-(ethylthio)ethyl)phosphorodithioate; O,O-Diethyl S-(2-eththioethyl) phosphorodithioate; O,O-Diethyl S-(2-eththioethyl) thiothionophosphate; O,O-Diethyl S-(2-ethylmercaptoethyl) dithiophosphate; O,O-Diethyl S-2-(ethylthio)ethyl phosphorodithioate; O,O-Diethyl S-2-(ethylsulfanyl)ethyl dithiophosphate; O,O-Diethyl S-2-(Ethylthio)ethyl dithiophosphate; O,O-Diethyl S-2-(ethylthio)ethyl phosphorodithioate; O,o-diethyl-s-ethylmercapto-ethyl dithiophosphate; S-2-(ethylsulfanyl)ethyl O,O-dimethyl dithiophosphate; Solvigran; Solvirex; Thiodemeton; Thiodemetron; CHEBI:38661",2014-12-24,1,,,,,,,,,
97886-45-8,0,OMOP Exposome,Observation,Substance,Dithiopyr,,2014-12-24,1,,,,,,,,,
119-06-2,0,OMOP Exposome,Observation,Substance,Ditridecyl phthalate,"Undecyl dodecyl phthalate; Ditridecyl phthalic acid; Ditridecyl 1,2-benzenedicarboxylate; Di(tridecyl) phthalate; Nuoplaz; Bis(tridecyl) phthalate; Nuoplaz DTDP; Jayflex DTDP; Truflex DTDP; Staflex DTDP; CHEBI:36605",2014-12-24,1,,,,,,,,,
3648-20-2,0,OMOP Exposome,Observation,Substance,Diundecyl phthalate,"Diundecyl phthalic acid; Carboxylic ester; Di-711-phthalate; Di-n-undecyl phthalate; Diundecyl linear phthalate; 1,2-Benzenedicarboxylic acid, 1,2-diundecyl ester; CHEBI:33308",2014-12-24,1,,,,,,,,,
GIS1008633,0,OMOP Exposome,Observation,Substance,Diuretic,,2024-09-14,1,,,,,,,,,
330-54-1,0,OMOP Exposome,Observation,Substance,Diuron,"N,N,-Dimethyl-n'-(3,4-dichlorophenyl)urea; 3-(3,4-Dichloro-phenyl)-1,1-dimethyl-urea; 3-(3,4-Dichlorophenyl)-1,1-dimethylurea; N'-(3,4-dichlorophenyl)-N,N-dimethylurea; DCMU; DCMU (3-(3,4-dichlorophenyl)-1,1-dimethylurea); 1,1-Dimethyl-3-(3,4-dichlorophenyl)urea, 1-(3,4-Dichlorophenyl)-3,3-dimethylurea; 1-(3,4-Dichlorophenyl)-3,3-dimethyluree; 3-(3,4-Dichlor-phenyl)-1,1-dimethyl-harnstoff; N-(3,4-Dichlorophenyl)-n',n'-dimethylurea; CHEBI:CHEBI:116509",2014-12-24,1,,,,,,,,,
498-59-9,0,OMOP Exposome,Observation,Substance,Djenkolic acid,,2014-12-24,1,,,,,,,,,
P26358,0,OMOP Exposome,Observation,Substance,DNA (cytosine-5)-methyltransferase 1,,2024-09-14,1,,,,,,,,,
Q9UBC3,0,OMOP Exposome,Observation,Substance,DNA (cytosine-5)-methyltransferase 3B,,2024-09-14,1,,,,,,,,,
Q9HC16,0,OMOP Exposome,Observation,Substance,DNA dC->dU-editing enzyme APOBEC-3G,,2024-09-14,1,,,,,,,,,
P18858,0,OMOP Exposome,Observation,Substance,DNA ligase 1,,2024-09-14,1,,,,,,,,,
P49916,0,OMOP Exposome,Observation,Substance,DNA ligase 3,,2024-09-14,1,,,,,,,,,
Q6NS38,0,OMOP Exposome,Observation,Substance,DNA oxidative demethylase ALKBH2,,2024-09-14,1,,,,,,,,,
P09884,0,OMOP Exposome,Observation,Substance,DNA polymerase alpha catalytic subunit,,2024-09-14,1,,,,,,,,,
Q14181,0,OMOP Exposome,Observation,Substance,DNA polymerase alpha subunit B,,2024-09-14,1,,,,,,,,,
P06746,0,OMOP Exposome,Observation,Substance,DNA polymerase beta,,2024-09-14,1,,,,,,,,,
Q07864,0,OMOP Exposome,Observation,Substance,DNA polymerase epsilon catalytic subunit A,,2024-09-14,1,,,,,,,,,
P56282,0,OMOP Exposome,Observation,Substance,DNA polymerase epsilon subunit 2,,2024-09-14,1,,,,,,,,,
Q9NRF9,0,OMOP Exposome,Observation,Substance,DNA polymerase epsilon subunit 3,,2024-09-14,1,,,,,,,,,
Q9NR33,0,OMOP Exposome,Observation,Substance,DNA polymerase epsilon subunit 4,,2024-09-14,1,,,,,,,,,
P54098,0,OMOP Exposome,Observation,Substance,DNA polymerase subunit gamma-1,,2024-09-14,1,,,,,,,,,
Q9UHN1,0,OMOP Exposome,Observation,Substance,"DNA polymerase subunit gamma-2, mitochondrial",,2024-09-14,1,,,,,,,,,
P23025,0,OMOP Exposome,Observation,Substance,DNA repair protein complementing XP-A cells,,2024-09-14,1,,,,,,,,,
GIS1008676,0,OMOP Exposome,Observation,Substance,Dna replication,,2024-09-14,1,,,,,,,,,
GIS1008677,0,OMOP Exposome,Observation,Substance,DNA Replication Fork,,2024-09-14,1,,,,,,,,,
P11387,0,OMOP Exposome,Observation,Substance,DNA topoisomerase 1,,2024-09-14,1,,,,,,,,,
P11388,0,OMOP Exposome,Observation,Substance,DNA topoisomerase 2-alpha,,2024-09-14,1,,,,,,,,,
Q02880,0,OMOP Exposome,Observation,Substance,DNA topoisomerase 2-beta,,2024-09-14,1,,,,,,,,,
P78527,0,OMOP Exposome,Observation,Substance,DNA-dependent protein kinase catalytic subunit,,2024-09-14,1,,,,,,,,,
O95602,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase I subunit RPA1,,2024-09-14,1,,,,,,,,,
Q9H9Y6,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase I subunit RPA2,,2024-09-14,1,,,,,,,,,
O15446,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase I subunit RPA34,,2024-09-14,1,,,,,,,,,
Q3B726,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase I subunit RPA43,,2024-09-14,1,,,,,,,,,
Q9GZS1,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase I subunit RPA49,,2024-09-14,1,,,,,,,,,
P24928,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB1,,2024-09-14,1,,,,,,,,,
P52435,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB11-a,,2024-09-14,1,,,,,,,,,
Q9GZM3,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB11-b1,,2024-09-14,1,,,,,,,,,
Q9H1A7,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB11-b2,,2024-09-14,1,,,,,,,,,
P30876,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB2,,2024-09-14,1,,,,,,,,,
P19387,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB3,,2024-09-14,1,,,,,,,,,
O15514,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB4,,2024-09-14,1,,,,,,,,,
P62487,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB7,,2024-09-14,1,,,,,,,,,
P36954,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase II subunit RPB9,,2024-09-14,1,,,,,,,,,
P0A7Z4,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase subunit alpha,,2024-09-14,1,,,,,,,,,
P0A8V2,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase subunit beta,,2024-09-14,1,,,,,,,,,
P9WGY7,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerase subunit beta',,2024-09-14,1,,,,,,,,,
O15160,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerases I and III subunit RPAC1,,2024-09-14,1,,,,,,,,,
Q9Y2S0,0,OMOP Exposome,Observation,Substance,DNA-directed RNA polymerases I and III subunit RPAC2,,2024-09-14,1,,,,,,,,,
P19388,0,OMOP Exposome,Observation,Substance,"DNA-directed RNA polymerases I, II, and III subunit RPABC1",,2024-09-14,1,,,,,,,,,
P61218,0,OMOP Exposome,Observation,Substance,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",,2024-09-14,1,,,,,,,,,
P52434,0,OMOP Exposome,Observation,Substance,"DNA-directed RNA polymerases I, II, and III subunit RPABC3",,2024-09-14,1,,,,,,,,,
P53803,0,OMOP Exposome,Observation,Substance,"DNA-directed RNA polymerases I, II, and III subunit RPABC4",,2024-09-14,1,,,,,,,,,
P62875,0,OMOP Exposome,Observation,Substance,"DNA-directed RNA polymerases I, II, and III subunit RPABC5",,2024-09-14,1,,,,,,,,,
114977-28-5,0,OMOP Exposome,Observation,Substance,Docetaxel,"N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; Docetaxel, Trihydrate; Docetaxel anhydrous; Taxotere; TXL; Docefrez; CHEBI:4672",2014-12-24,1,,,,,,,,,
GIS1008678,0,OMOP Exposome,Observation,Substance,Docetaxel Pathway,,2024-09-14,1,,,,,,,,,
143-07-7,0,OMOP Exposome,Observation,Substance,Dodecanoic acid,"1-Undecanecarboxylate; Wecoline 1295; Vulvic acid; Vulvate; Univol U-314; Univol U 314; Undecane-1-carboxylic acid; Prifrac 2920; Prifac 2920; Philacid 1200; Nissan NAA 122; Ninol AA62 extra; Neo-Fat 12-43; Neo-Fat 12; N-Dodecanoic acid; N-Dodecanoate; Lunac L 98; Lunac L 70; Laurostearic acid; Laurostearate; Laurinsaeure; Lauric acid, pure; Lauric acid (natural); Lauric acid; Laurate; LAU; LAP; Kortacid 1299; Hystrene 9512; Hydrofol acid 1295; Hydrofol acid 1255; Emery 651; Emery 650; Edenor C 1298-100; Duodecylic acid; Duodecyclic acid; Dodecylic acid; Dodecylcarboxylate; Dodecylate; Dodecoic acid; Dodecanoic acid (lauric acid); Dodecanoic (lauric) acid; Dodecanoate; DAO; Coconut oil fatty acids; C12 fatty acid; Aliphat No. 4; ABL; 1-Undecanecarboxylic acid; CHEBI:30805",2014-12-24,1,,,,,,,,,
1166-52-5,0,OMOP Exposome,Observation,Substance,Dodecyl gallate,,2014-12-24,1,,,,,,,,,
14277-97-5,0,OMOP Exposome,Observation,Substance,Domoic acid,,2014-12-24,1,,,,,,,,,
120014-06-4,0,OMOP Exposome,Observation,Substance,Donepezil,Donepezil hydrochloride; Alzepil; Aricept; Aricept ODT; Davia; Depzil; Domepezil; Donecept; Donecil; Donep; Donepex; Donepezilo; Donepezilum; Donesyn; Dopezil; Eranz; Memac; Nomi-Nox; Pezale; Redumas; Zolpezil; CHEBI:53289,2014-12-24,1,,,,,,,,,
51-61-6,0,OMOP Exposome,Observation,Substance,Dopamine,"3-Hydroxytyramine; Revimine; Oxytyramine; Intropin; Hydroxytyramine; Hydroxytyramin; Dynatra; Dophamine; Dopastat; Dopaminum; Dopamina; Dopamin; Deoxyepinephrine; alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; a-(3,4-Dihydroxyphenyl)-b-aminoethane; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)-Pyrocatechol; 4-(2-Aminoethyl)-1,2-benzenediol; 3,4-Dihydroxyphenylethylamine; 3,4-Dihydroxyphenethylamine; 2-(3,4-Dihydroxyphenyl)ethylamine; Revivan; CHEBI:18243",2018-03-21,1,,,,,,,,,
GIS1008679,0,OMOP Exposome,Observation,Substance,Dopamine Agent,,2024-09-14,1,,,,,,,,,
GIS1008689,0,OMOP Exposome,Observation,Substance,Dopamine Agonist,,2024-09-14,1,,,,,,,,,
GIS1008690,0,OMOP Exposome,Observation,Substance,Dopamine Antagonist,,2024-09-14,1,,,,,,,,,
P09172,0,OMOP Exposome,Observation,Substance,Dopamine beta-hydroxylase,,2024-09-14,1,,,,,,,,,
GIS1008691,0,OMOP Exposome,Observation,Substance,Dopamine beta-hydroxylase deficiency,,2024-09-14,1,,,,,,,,,
GIS1008693,0,OMOP Exposome,Observation,Substance,Dopamine Uptake Inhibitor,,2024-09-14,1,,,,,,,,,
GIS1008692,0,OMOP Exposome,Observation,Substance,Dopaminergic,,2024-09-14,1,,,,,,,,,
40762-15-0,0,OMOP Exposome,Observation,Substance,Doxefazepam,,2014-12-24,1,,,,,,,,,
1668-19-5,0,OMOP Exposome,Observation,Substance,Doxepin,Aponal; Doxepine; Prudoxin; Quitaxon; Silenor; Curatin; Cidoxepin; Adapin; Sinequan; Zonalon; CHEBI:4710,2014-12-24,1,,,,,,,,,
23214-92-8,0,OMOP Exposome,Observation,Substance,Doxorubicin,"Rubex; (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; Doxorubicinum; Hydroxydaunorubicin; 14-hydroxydaunomycin; 14-hydroxydaunorubicine; Adriablastina; Adriamycin; Adriblastin; Caelyx; Doxil; Myocet; Doxorubicine; CHEBI:28748",2014-12-24,1,,,,,,,,,
564-25-0,0,OMOP Exposome,Observation,Substance,Doxycycline,"Oracea; Periostat; Supracyclin; Vibramycin; Vibra-Tabs; 5-Hydroxy-alpha-6-deoxytetracycline; 6-alpha-deoxy-5-oxytetracycline; (4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; 6alpha-Deoxy-5-oxytetracycline; 6\u03b1-deoxy-5-oxytetracycline; Adoxa; Alodox; Atridox; Doryx; Doxcycline anhydrous; Doxiciclina; Doxy; Doxycin; Doxycyclin; Doxycycline (anhydrous); Doxycycline Hyclate; Doxycycline Monohydrate; Doxycyclinum; Doxylin; Doxytetracycline; Jenacyclin; Microdox; Monodox; Morgidox; NicAzelDoxyKit; Nu-Doxycycline; Ocudox; CHEBI:50845",2014-12-24,1,,,,,,,,,
GIS1008694,0,OMOP Exposome,Observation,Substance,Doxycycline Action Pathway,,2024-09-14,1,,,,,,,,,
469-21-6,0,OMOP Exposome,Observation,Substance,Doxylamine,"2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine; Doxylaminum; Doxilminio; N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine; Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether; Doxilamina; Dossilamina; 2-Dimethylaminoethoxyphenylmethyl-2-picoline; CHEBI:51380",2014-12-24,1,,,,,,,,,
58-19-5,0,OMOP Exposome,Observation,Substance,Drostanolone,2alpha-Methyldihydrotestosterone; Dromostanolone; Drostanolona; Drostanolonum; Masteril; Masteron; Medrosteron; Medrotestron; Metholone; Drolban; 17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one; Dihydro-2alpha-methyltestosterone; CHEBI:34838,2014-12-24,1,,,,,,,,,
GIS1008695,0,OMOP Exposome,Observation,Substance,Drug,,2024-09-14,1,,,,,,,,,
Q9HCR9,0,OMOP Exposome,Observation,Substance,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",,2024-09-14,1,,,,,,,,,
Q02750,0,OMOP Exposome,Observation,Substance,Dual specificity mitogen-activated protein kinase kinase 1,,2024-09-14,1,,,,,,,,,
P36507,0,OMOP Exposome,Observation,Substance,Dual specificity mitogen-activated protein kinase kinase 2,,2024-09-14,1,,,,,,,,,
P46734,0,OMOP Exposome,Observation,Substance,Dual specificity mitogen-activated protein kinase kinase 3,,2024-09-14,1,,,,,,,,,
P45985,0,OMOP Exposome,Observation,Substance,Dual specificity mitogen-activated protein kinase kinase 4,,2024-09-14,1,,,,,,,,,
Q13163,0,OMOP Exposome,Observation,Substance,Dual specificity mitogen-activated protein kinase kinase 5,,2024-09-14,1,,,,,,,,,
P52564,0,OMOP Exposome,Observation,Substance,Dual specificity mitogen-activated protein kinase kinase 6,,2024-09-14,1,,,,,,,,,
O14733,0,OMOP Exposome,Observation,Substance,Dual specificity mitogen-activated protein kinase kinase 7,,2024-09-14,1,,,,,,,,,
P28562,0,OMOP Exposome,Observation,Substance,Dual specificity protein phosphatase 1,,2024-09-14,1,,,,,,,,,
P51452,0,OMOP Exposome,Observation,Substance,Dual specificity protein phosphatase 3,,2024-09-14,1,,,,,,,,,
Q9Y463,0,OMOP Exposome,Observation,Substance,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,,2024-09-14,1,,,,,,,,,
136434-34-9,0,OMOP Exposome,Observation,Substance,Duloxetine,LY 248686; Cymbalta; (3S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine; Ariclaim; Xeristar; Yentreve; Duzela; Dulane; CHEBI:36795,2014-12-24,1,,,,,,,,,
GIS1008696,0,OMOP Exposome,Observation,Substance,Dye,,2024-09-14,1,,,,,,,,,
Q05193,0,OMOP Exposome,Observation,Substance,Dynamin-1,,2024-09-14,1,,,,,,,,,
P16581,0,OMOP Exposome,Observation,Substance,E-selectin,,2024-09-14,1,,,,,,,,,
O15344,0,OMOP Exposome,Observation,Substance,E3 ubiquitin-protein ligase Midline-1,,2024-09-14,1,,,,,,,,,
Q07108,0,OMOP Exposome,Observation,Substance,Early activation antigen CD69,,2024-09-14,1,,,,,,,,,
GIS1008697,0,OMOP Exposome,Observation,Substance,Early endosome,,2024-09-14,1,,,,,,,,,
P18146,0,OMOP Exposome,Observation,Substance,Early growth response protein 1,,2024-09-14,1,,,,,,,,,
27220-47-9,0,OMOP Exposome,Observation,Substance,Econazole,"ECOZA; Ecostatin; (+-)-Econazole; 1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole; Pevaryl; Palavale; Ifenec; Gyno-Pevaryl; Spectazole; Econazole Nitrate; CHEBI:4754",2014-12-24,1,,,,,,,,,
921236-86-4,0,OMOP Exposome,Observation,Substance,Edema factor,,2014-12-24,1,,,,,,,,,
62-33-9,0,OMOP Exposome,Observation,Substance,Edetic Acid,,2014-12-24,1,,,,,,,,,
GIS1008698,0,OMOP Exposome,Observation,Substance,EENT Preparation,,2024-09-14,1,,,,,,,,,
Q9GZT9,0,OMOP Exposome,Observation,Substance,Egl nine homolog 1,,2024-09-14,1,,,,,,,,,
Q96KS0,0,OMOP Exposome,Observation,Substance,Egl nine homolog 2,,2024-09-14,1,,,,,,,,,
Q9H6Z9,0,OMOP Exposome,Observation,Substance,Egl nine homolog 3,,2024-09-14,1,,,,,,,,,
GIS1008699,0,OMOP Exposome,Observation,Substance,Eicosanoids,,2024-09-14,1,,,,,,,,,
69-25-0,0,OMOP Exposome,Observation,Substance,Eledoisin (Eledone cirrhosa),,2014-12-24,1,,,,,,,,,
P13639,0,OMOP Exposome,Observation,Substance,Elongation factor 2,,2024-09-14,1,,,,,,,,,
Q9GZR5,0,OMOP Exposome,Observation,Substance,Elongation of very long chain fatty acids protein 4,,2024-09-14,1,,,,,,,,,
548-43-6,0,OMOP Exposome,Observation,Substance,Elymoclavine,,2014-12-24,1,,,,,,,,,
121124-29-6,0,OMOP Exposome,Observation,Substance,Emamectin B1a,Emamectin b1a; emamectin B1a; CHEBI:39231,2014-12-24,1,,,,,,,,,
121424-52-0,0,OMOP Exposome,Observation,Substance,Emamectin B1b,emamectin B1b; Emamectin b1b; CHEBI:39232,2014-12-24,1,,,,,,,,,
155569-91-8,0,OMOP Exposome,Observation,Substance,Emamectin benzoate,,2014-12-24,1,,,,,,,,,
97816-62-1,0,OMOP Exposome,Observation,Substance,Emestrin,,2014-12-24,1,,,,,,,,,
518-82-1,0,OMOP Exposome,Observation,Substance,Emodin,"6-Methyl-1,3,8-trihydroxy-9,10-anthracenedione; Schuttgelb; 4,5,7-Trihydroxy-2-methylanthraquinone; Archin; Rheum-emodin; 6-Methyl-1,3,8-trihydroxyanthraquinone; 9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl- (9CI); 1,3, 8-Trihydroxy-6-methyl-9,10-anthraquinone; 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione, 9CI; 1,3,8-Trihydroxy-6-methylanthra-9,10-quinone; Frangulinic acid; Frangulic acid; Frangula emodin; Emodol; 3-Methyl-1,6,8-trihydroxyanthraquinone; CHEBI:42223",2014-12-24,1,,,,,,,,,
Q9BY08,0,OMOP Exposome,Observation,Substance,Emopamil-binding protein-like,,2024-09-14,1,,,,,,,,,
66778-36-7,0,OMOP Exposome,Observation,Substance,Encainide,Encainida; 4-Methoxy-2'-2-(1-methyl-2-piperidyl)ethylbenzanilide; 4-Methoxy-N-{2-2-(1-methyl-piperidin-2-yl)-ethyl-phenyl}-benzamide; Enkaid; (+-)-2'-2-(1-Methyl-2-piperidyl)ethyl-P-anisanilide; Encainidum; (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide; CHEBI:4788,2014-12-24,1,,,,,,,,,
GIS1008700,0,OMOP Exposome,Observation,Substance,Endocytic Vesicle,,2024-09-14,1,,,,,,,,,
GIS1008701,0,OMOP Exposome,Observation,Substance,Endocytosis,,2024-09-14,1,,,,,,,,,
Q96FI4,0,OMOP Exposome,Observation,Substance,Endonuclease 8-like 1,,2024-09-14,1,,,,,,,,,
Q969S2,0,OMOP Exposome,Observation,Substance,Endonuclease 8-like 2,,2024-09-14,1,,,,,,,,,
GIS1008702,0,OMOP Exposome,Observation,Substance,Endoplasmic reticulum,,2024-09-14,1,,,,,,,,,
GIS1008703,0,OMOP Exposome,Observation,Substance,Endoplasmic reticulum lumen,,2024-09-14,1,,,,,,,,,
Q9UKM7,0,OMOP Exposome,Observation,Substance,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",,2024-09-14,1,,,,,,,,,
GIS1008704,0,OMOP Exposome,Observation,Substance,Endoplasmic reticulum membrane,,2024-09-14,1,,,,,,,,,
P14625,0,OMOP Exposome,Observation,Substance,Endoplasmin,,2024-09-14,1,,,,,,,,,
GIS1008705,0,OMOP Exposome,Observation,Substance,Endosome,,2024-09-14,1,,,,,,,,,
1031-07-8,0,OMOP Exposome,Observation,Substance,Endosulfan sulfate,,2014-12-24,1,,,,,,,,,
P25101,0,OMOP Exposome,Observation,Substance,Endothelin-1 receptor,,2024-09-14,1,,,,,,,,,
72-20-8,0,OMOP Exposome,Observation,Substance,Endrin,,2014-12-24,1,,,,,,,,,
7421-93-4,0,OMOP Exposome,Observation,Substance,Endrin aldehyde,,2014-12-24,1,,,,,,,,,
53494-70-5,0,OMOP Exposome,Observation,Substance,Endrin ketone,,2014-12-24,1,,,,,,,,,
13838-16-9,0,OMOP Exposome,Observation,Substance,Enflurane,"Anesthetic 347; Alyrane; 2-chloro-1,1,2-trifluoroethyl difluoromethyl ether; Anesthetic Compound No. 347; Compound 347; Efrane; Methylflurether; Ethrane; Enfluranum; Endurane; Enfluran; Enflurano; Ohio 347; CHEBI:4792",2014-12-24,1,,,,,,,,,
35554-44-0,0,OMOP Exposome,Observation,Substance,Enilconazole,,2014-12-24,1,,,,,,,,,
2503-13-1,0,OMOP Exposome,Observation,Substance,Enniatin A,,2014-12-24,1,,,,,,,,,
4530-21-6,0,OMOP Exposome,Observation,Substance,Enniatin A1,,2014-12-24,1,,,,,,,,,
917-13-5,0,OMOP Exposome,Observation,Substance,Enniatin B,,2014-12-24,1,,,,,,,,,
19914-20-6,0,OMOP Exposome,Observation,Substance,Enniatin B1,,2014-12-24,1,,,,,,,,,
P30084,0,OMOP Exposome,Observation,Substance,"Enoyl-CoA hydratase, mitochondrial",,2024-09-14,1,,,,,,,,,
130929-57-6,0,OMOP Exposome,Observation,Substance,Entacapone,"Anxopone; 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; (e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; Comtess; Comtan; Comtade; N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide; Entacaponum; Entacapona; CHEBI:4798",2014-12-24,1,,,,,,,,,
76543-15-2,0,OMOP Exposome,Observation,Substance,Enterolactone,"2,3-Bis(3'-hydroxybenzyl)butyrolactone; 3,4-Bis((3-hydroxyphenyl)methyl)dihydro-2-(3H)-furanone; Dihydro-3,4-bis((3-hydroxyphenyl)methyl)-2(3H)-Furanone; CHEBI:562788",2014-12-24,1,,,,,,,,,
GIS1008706,0,OMOP Exposome,Observation,Substance,Enterotoxin type A,,2024-09-14,1,,,,,,,,,
GIS1008713,0,OMOP Exposome,Observation,Substance,Enterotoxin type B,,2024-09-14,1,,,,,,,,,
GIS1008719,0,OMOP Exposome,Observation,Substance,Enzyme Inhibitor,,2024-09-14,1,,,,,,,,,
P12724,0,OMOP Exposome,Observation,Substance,Eosinophil cationic protein,,2024-09-14,1,,,,,,,,,
P11678,0,OMOP Exposome,Observation,Substance,Eosinophil peroxidase,,2024-09-14,1,,,,,,,,,
299-42-3,0,OMOP Exposome,Observation,Substance,Ephedrine,"(-)-Ephedrine; (1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane; L-Ephedrine; L-erythro-2-(Methylamino)-1-phenylpropan-1-ol; L(-)-Ephedrine; CHEBI:15407",2014-12-24,1,,,,,,,,,
P29317,0,OMOP Exposome,Observation,Substance,Ephrin type-A receptor 2,,2024-09-14,1,,,,,,,,,
140111-52-0,0,OMOP Exposome,Observation,Substance,Epibatidine,,2014-12-24,1,,,,,,,,,
P00533,0,OMOP Exposome,Observation,Substance,Epidermal growth factor receptor,,2024-09-14,1,,,,,,,,,
GIS1008720,0,OMOP Exposome,Observation,Substance,Epidermis,,2024-09-14,1,,,,,,,,,
O75715,0,OMOP Exposome,Observation,Substance,Epididymal secretory glutathione peroxidase,,2024-09-14,1,,,,,,,,,
Q9Y2E5,0,OMOP Exposome,Observation,Substance,Epididymis-specific alpha-mannosidase,,2024-09-14,1,,,,,,,,,
56420-45-2,0,OMOP Exposome,Observation,Substance,Epirubicin,Epirubicinum; Epirubicine; Epirubicina; 4'-Epiadriamycin; Pidorubicinum; Epirubicin Ebewe; Epiadriamycin; Ellence; Pidorubicine; Pharmorubicin; Pidorubicina; CHEBI:47898,2014-12-24,1,,,,,,,,,
21705-02-2,0,OMOP Exposome,Observation,Substance,epsilon-Amanitin,,2014-12-24,1,,,,,,,,,
Q9Y6I3,0,OMOP Exposome,Observation,Substance,Epsin-1,,2024-09-14,1,,,,,,,,,
Q99808,0,OMOP Exposome,Observation,Substance,Equilibrative nucleoside transporter 1,,2024-09-14,1,,,,,,,,,
Q14542,0,OMOP Exposome,Observation,Substance,Equilibrative nucleoside transporter 2,,2024-09-14,1,,,,,,,,,
474-86-2,0,OMOP Exposome,Observation,Substance,Equilin,"7-Dehydroestrone; Dihydroequilenin; 1,3,5,7-Estratetraen-3-ol-17-one; CHEBI:42309",2014-12-24,1,,,,,,,,,
531-95-3,0,OMOP Exposome,Observation,Substance,Equol,"(-)-(S)-Equol; (S)-Equol; 4',7-Dihydroxyisoflavan; 4',7-Isoflavandiol; (-)-Equol; (S)-(-)-4',7-Isoflavandiol; (S)-3,4-dihydro-3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol; CHEBI:428126",2014-12-24,1,,,,,,,,,
59536-69-5,0,OMOP Exposome,Observation,Substance,Erabutoxin,,2014-12-24,1,,,,,,,,,
478-94-4,0,OMOP Exposome,Observation,Substance,Ergine,,2014-12-24,1,,,,,,,,,
50-14-6,0,OMOP Exposome,Observation,Substance,Ergocalciferol,"Ergocalciferol oil; Ergocalciferolum; Ergorone; Ergosterol activated; Ergosterol irradiated; Ertron; Fortodyl; Geltabs; Hi-Deratol; Infron; Irradiated ergosta-5,7,22-trien-3beta-ol; Metadee; Mina D2; Mulsiferol; Mykostin; Novovitamin-D; Oleovitamin D; Oleovitamin D2; Osteil; Ostelin; Radiostol; Radstein; Radsterin; Rodine C; Shock-ferol; Shock-ferol sterogyl; Sterogyl; Synthetic Vitamin D; Uvesterol D; Vio D; Vio-D; Viostdrol; Viosterol; Viosterol in Oil; Vitamin D2; Vitamina D2; Vitavel-D; Uvesterol-D; (+)-Vitamin D2; (3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol; (5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol; (5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol; (5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol; 22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol; 4-Methylene-3-2-tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylideneethylidene-Cyclohexanol; 9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol; Activated ergosterol; beta-Ol; Buco-D; Calcidol; Calciferol; Calciferon 2; Condacaps; Condocaps; Condol; Crtron; Crystallina; D-Arthin; D-Tracetten; Daral; Davitamon D; Davitin; De-rat concentrate; Decaps; Dee-Osterol; Dee-Ron; Dee-Ronal; Dee-Roual; delta-Arthin; delta-Tracetten; Deltalin; Deratol; Detalup; Diactol; Divit urto; Doral; Drisdol; Ercalciol; CHEBI:28934",2014-12-24,1,,,,,,,,,
564-36-3,0,OMOP Exposome,Observation,Substance,Ergocornine,,2014-12-24,1,,,,,,,,,
511-08-0,0,OMOP Exposome,Observation,Substance,Ergocristine,,2014-12-24,1,,,,,,,,,
511-09-1,0,OMOP Exposome,Observation,Substance,Ergocryptine,,2014-12-24,1,,,,,,,,,
60-79-7,0,OMOP Exposome,Observation,Substance,Ergonovine,"D-Lysergic acid 1-hydroxymethylethylamide; 9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8beta(S)-carboxamide; N-(alpha-(Hydroxymethyl)ethyl)-D-lysergamide; N-(2-Hydroxy-1-methylethyl)-D(+)-lysergamide; Ergotrate maleate; Ergotrate; Ergometrinum; Ergometrine; Ergometrina; Ergobasine; 8beta(S)-9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide; 9,10-Didehydro-N-(alpha-(hydroxymethyl)ethyl)-6-methylergoline-8-beta-carboxamide; D-Lysergic acid-L-propanolamide; (6AR,9R)-7-methyl-4,6,6a,7,8,9-hexahydro-indolo4,3-fgquinoline-9-carboxylic acid ((S)-2-hydroxy-1-methyl-ethyl)-amide; CHEBI:4822",2014-12-24,1,,,,,,,,,
P40030,0,OMOP Exposome,Observation,Substance,Ergosterol biosynthetic protein 28,,2024-09-14,1,,,,,,,,,
113-15-5,0,OMOP Exposome,Observation,Substance,Ergotamine,"Cafergot; Anervan; Wigrettes; Gynergen; Gynaemine; Ergotaminum; Ergotamina; Ergotamin; Ergomar; Antimigraine; Ergo-Kranit; Ergam; Enxak; 12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione; (5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione; CHEBI:64318",2014-12-24,1,,,,,,,,,
2873-38-3,0,OMOP Exposome,Observation,Substance,Ergovaline,,2014-12-24,1,,,,,,,,,
3844-45-9,0,OMOP Exposome,Observation,Substance,Erioglaucine A disodium salt,,2014-12-24,1,,,,,,,,,
GIS1008721,0,OMOP Exposome,Observation,Substance,Erythrocyte,,2024-09-14,1,,,,,,,,,
114-07-8,0,OMOP Exposome,Observation,Substance,Erythromycin,Eritromicina; Ery; Ery-Ped; ERY-TAB; Eryc; Erygel; Erythra-Derm; Erythrocin Stearate; Erythromycin A; Erythromycin C; Erythromycin ethylsuccinate; Erythromycin glucoheptonate; Erythromycin lactobionate; Erythromycin oxime; Erythromycin Stearate; Erythromycine; Erythromycinum; Ilosone; ILOTYCIN; Staticin; T-stat; 3''-O-demethylerythromycin; Abomacetin; Akne-Mycin; E.E.S; E.E.S.; EM; CHEBI:48923,2014-12-24,1,,,,,,,,,
128196-01-0,0,OMOP Exposome,Observation,Substance,Escitalopram,(S)-Citalopram; S(+)-Citalopram; (+)-Citalopram; Escitalopramum; Lexapro; Escitalopram Oxalate; S-(+)-Citalopram; Cipralex; Esertia; CHEBI:36791,2014-12-24,1,,,,,,,,,
66230-04-4,0,OMOP Exposome,Observation,Substance,Esfenvalerate,"Asana; Asana XL; Esfenvaleric acid; Fenvalerate (s,s)-isomer; Fenvalerate a; Fenvalerate a a; Halmark; S 5602 A a; Sumi-a; Sumi-alfa; Sumicidin a a; CHEBI:39346",2014-12-24,1,,,,,,,,,
161796-78-7,0,OMOP Exposome,Observation,Substance,Esomeprazole,(R)-(+)-Omeprazole; Perprazole; Nexium i.v.; Nexium; Nexiam; Lucen; Esorest; Esopral; Esomeprazolum; \u00c9som\u00e9prazole; Esomeprazol Genfar; Esomeprazol; Esomep; Esomenta; Esomarfan; Esolok; Esogastrosedol; Esofag; Eso; Esmep; ES-OD; Emozul; Emep; Emanera; Cronopep; Cor; Axagon; Awa-Block; Alenia; (S)-Omeprazole; (-)-Omeprazole; (+)-Omeprazole; CHEBI:50275,2014-12-24,1,,,,,,,,,
GIS1008722,0,OMOP Exposome,Observation,Substance,Essential Vitamin,,2024-09-14,1,,,,,,,,,
29975-16-4,0,OMOP Exposome,Observation,Substance,Estazolam,"8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine; Esilgan; Nuctalon; ProSom; Eurodin; Estazolamum; CHEBI:4858",2014-12-24,1,,,,,,,,,
GIS1008723,0,OMOP Exposome,Observation,Substance,Ester,,2024-09-14,1,,,,,,,,,
50-28-2,0,OMOP Exposome,Observation,Substance,Estradiol,"Innofem; (17beta)-Estra-1,3,5(10)-triene-3,17-diol; 17beta Oestradiol; 17beta-Estra-1,3,5(10)-triene-3,17-diol; 17beta-Oestradiol; Alora; Benzhormovarine; beta-Estradiol; cis-Estradiol; Climara; Depo-Estradiol; Dihydrofollicular hormone; Dihydrofolliculin; Dihydrotheelin; Dihydroxyestrin; Divigel; Elestrin; Estrace; Estraderm MX; Estraderm TTS; Estradiol-17beta; Estradiolum; Estrasorb; Estring; Estrofem; Estrogel; EvaMist; Femestral; Femring; Femtrace; Lio-Oid; Menostar; Minivelle; Vagifem; Vivelle; Vivelle-Dot; CHEBI:16469",2014-12-24,1,,,,,,,,,
P14061,0,OMOP Exposome,Observation,Substance,Estradiol 17-beta-dehydrogenase 1,,2024-09-14,1,,,,,,,,,
P37059,0,OMOP Exposome,Observation,Substance,Estradiol 17-beta-dehydrogenase 2,,2024-09-14,1,,,,,,,,,
50-27-1,0,OMOP Exposome,Observation,Substance,Estriol,"3,16alpha,17beta-Trihydroxy-1,3,5(10)-estratriene; 3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene; 3,16alpha,17beta-Trihydroxyestra-1,3,5(10)-triene; Aacifemine; Colpoestriol; Colpogyn; Colpovister; Destriol; Deuslon A; Deuslon-A; Estra-1,3,5(10)-triene-3,16a,17b-triol; Estratriol; Estriel; Follicular hormone hydrate; Gynasan; Hemostyptanon; Holin V; Hormomed; Incurin; Klimax E; Klimoral; 3,16a,17b-Trihydroxyestra-1,3,5(10)-triene; 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol; 13b-Methyl-1,3,5(10)-gonatriene-3,16a,17b-triol; 16-alpha,17-beta-Estriol; 16-alpha,17-beta-Oestriol; Triovex; Oekolp; Oestratriol; Oestriol; Oestriolum; Orestin; Orgastyptin; Ortho-Gynest; Ovesterin; Ovestin; Ovestinon; Ovestrion; Trihydroxyestrin; Tridestrin; Theelol; Synapause E; 16-alpha-Hydroxyestradiol; 16a,17b-Estriol; 16a-Estriol; 16a-Hydroxyestradiol; 16alpha,17beta-Estriol; 16alpha,17beta-Oestriol; 16alpha-Hydroxy-17beta-estradiol; 16alpha-Hydroxyestradiol; 16alpha-Hydroxyoestradiol; 16\u03b1-hydroxyestradiol; 3,16a,17b-Estriol; Ovo-Vinces; (16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol; (16\u03b1,17\u03b2)-estra-1,3,5(10)-triene-3,16,17-triol; CHEBI:27974",2014-12-24,1,,,,,,,,,
GIS1008724,0,OMOP Exposome,Observation,Substance,Estrogen,,2024-09-14,1,,,,,,,,,
GIS1008725,0,OMOP Exposome,Observation,Substance,Estrogen Antagonist,,2024-09-14,1,,,,,,,,,
P03372,0,OMOP Exposome,Observation,Substance,Estrogen receptor,,2024-09-14,1,,,,,,,,,
BE0000123,0,OMOP Exposome,Observation,Substance,Estrogen receptor alpha,,2024-09-14,1,,,,,,,,,
Q92731,0,OMOP Exposome,Observation,Substance,Estrogen receptor beta,,2024-09-14,1,,,,,,,,,
P49888,0,OMOP Exposome,Observation,Substance,Estrogen sulfotransferase,,2024-09-14,1,,,,,,,,,
P62508,0,OMOP Exposome,Observation,Substance,Estrogen-related receptor gamma,,2024-09-14,1,,,,,,,,,
53-16-7,0,OMOP Exposome,Observation,Substance,Estrone,"3-Hydroxy-17-keto-estra-1,3,5-triene; Folliculin; 3-Hydroxy-1,3,5(10)-estratrien-17-one; 1,3,5(10)-Estratrien-3-ol-17-one; Oestrone; follicular hormone; Estronum; Estrona; D1,3,5(10)-Estratrien-3-ol-17-one; 3-Hydroxyoestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-triene-17-one; (+)-Estrone; 3-Hydroxyestra-1,3,5(10)-trien-17-one; CHEBI:17263",2014-12-24,1,,,,,,,,,
138729-47-2,0,OMOP Exposome,Observation,Substance,Eszopiclone,"1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo3,4-bpyrazin-5-yl ester; (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate; (+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo3,4-bpyrazin-5-yl-4-methylpiperazine-1-carboxylate; (+)-Zopiclone; (S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo3,4-bpyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate; (S)-Zopiclone; Dorplen; Esleep; Esopiclone; Estorra; Eszop; Fulnite; Inductal; Isoklon; Zopinon; Zopilone; Wen Fei; Valnoc; Sono; Sominex; Lunesta; Nirvan; Noptic; Plessir; Sanilent; Sleepil; CHEBI:53760",2014-12-24,1,,,,,,,,,
55283-68-6,0,OMOP Exposome,Observation,Substance,Ethalfluralin,,2014-12-24,1,,,,,,,,,
97780-06-8,0,OMOP Exposome,Observation,Substance,Ethametsulfuron methyl,,2014-12-24,1,,,,,,,,,
64-17-5,0,OMOP Exposome,Observation,Substance,Ethanol,Ethyl hydroxide; EtOH; Hinetoless; Fermentation alcohol; Grain alcohol; Alcare Hand Degermer; Alcohol; Potato alcohol; Molasses alcohol; Algrain; Alkohol; Alkoholu etylowego; Methylcarbinol; Lux; Jaysol S; Jaysol; Infinity Pure; Hydroxyethane; Anhydrol; Anhydrous alcohol; C2H5OH; Cologne spirit; Cologne spirits; Dehydrated alcohol; Dehydrated ethanol; Denatured alcohol; Denatured ethanol; Diluted Alcohol; Distilled spirits; Etanol; Ethanol 200 proof; Ethanol solution; Thanol; Undenatured Ethanol; CH2Me(OH); OEtH; Ethicap; Ethyl alc; Tecsol C; Tecsol; Ethyl alcohol; Ethyl alcohol anhydrous; Ethyl hydrate; Synasol; Spirt; Spiritus vini; Absolute ethanol; Spirits of wine; Absolute alcohol; Spirit; 1-Hydroxyethane; Silent spirit; Pyro; Punctilious ethyl alcohol; Absolute ethyl alcohol; Aethanol; Aethylalkohol; CHEBI:16236,2014-12-24,1,,,,,,,,,
GIS1008730,0,OMOP Exposome,Observation,Substance,Ethanol Degradation,,2024-09-14,1,,,,,,,,,
141-43-5,0,OMOP Exposome,Observation,Substance,Ethanolamine,MEA; Monoaethanolamin; Monoethanolamine; Olamine; Envision Conditioner PDD 9020; 2-Ethanolamine; 2-Aminoethyl alcohol; 2-Aminoethanol; 2-Amino-1-ethanol; 2-Hydroxyethanamine; 2-Hydroxyethylamine; Aethanolamin; Aminoethanol; b-Aminoethanol; b-Aminoethyl alcohol; b-Ethanolamine; b-Hydroxyethylamine; beta-Aminoethanol; beta-Aminoethyl alcohol; beta-Ethanolamine; beta-Hydroxyethylamine; Colamine; eta; Ethylolamine; 1-Amino-2-hydroxyethane; Glycinol; H-Glycinol; CHEBI:16000,2014-12-24,1,,,,,,,,,
GIS1008729,0,OMOP Exposome,Observation,Substance,Ethanolamine Derivative,,2024-09-14,1,,,,,,,,,
113-18-8,0,OMOP Exposome,Observation,Substance,Ethchlorvynol,Placidyl; \u03b2-chlorovinyl ethyl ethynyl carbinol; Serenesil; 3-(\u03b2-chlorovinyl)-1-pentyn-3-ol; ethyl \u03b2-chlorovinyl ethynyl carbinol; Ethclorvynol; Ethchlorvinyl; Ethchlorvinol; Ethchlorovynol; Etchlorvinolo; Arvynol; Ethochlorvynol; Ethychlorvynol; Aethyl-chlorvynol; Roeridorm; Nostel; 1-chloro-3-ethyl-1-penten-4-yn-3-ol; 1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol; 3-(beta-chlorovinyl)-1-pentyn-3-ol; CHEBI:4882,2014-12-24,1,,,,,,,,,
108-05-4,0,OMOP Exposome,Observation,Substance,Ethenyl acetate,"Ethenyl acetate, 9CI; CH3CO2CH=CH2; Vinyle; Vinnapas A 50; Vinile; VAC; Vinyl ester of acetic acid; Vinyl acetate; Unocal 76 Res S-55; Unocal 76 Res 6206; Everflex 81L; Ethenyl acetic acid; CHEBI:46916",2014-12-24,1,,,,,,,,,
16672-87-0,0,OMOP Exposome,Observation,Substance,Ethephon,2-Chloroethanephosphonic acid; 2-Cepa; Chloroethylphosphonic acid; Acide chloro-2-ethyl-phosphonique; 2-Chloraethyl-phosphonsaeure; CHEBI:52741,2014-12-24,1,,,,,,,,,
GIS1008731,0,OMOP Exposome,Observation,Substance,Ether,,2024-09-14,1,,,,,,,,,
GIS1008732,0,OMOP Exposome,Observation,Substance,Ether lipid metabolism,,2024-09-14,1,,,,,,,,,
126-52-3,0,OMOP Exposome,Observation,Substance,Ethinamate,Valamin; Valmid; USAF EL-42; Etinamato; Etinamate; Ethinimate; Ethinamic acid; Ethinamatum; Ethinamat; Aethinyl-cyclohexyl-carbamat; 1-Ethynylcyclohexanol carbamate; CHEBI:4884,2014-12-24,1,,,,,,,,,
57-63-6,0,OMOP Exposome,Observation,Substance,Ethinyl Estradiol,"Estigyn; Esteed; Esclim; Ertonyl; Dyloform; Diogyn-E; Diogyn E; Diognat-E; Chee-O-Genf; Chee-O-Gen; Anovlar; Amenoron; Alora; 17\u03b1-ethynylestradiol; 17alpha-Ethinyl estradiol; 17a-Ethynyloestradiol-17b; 17a-Ethynyloestradiol; 17a-Ethynylestradiol-l7b; 17a-Ethynyl-17b-oestradiol; 17a-Ethinylestradiol; 17a-Ethinyl-17b-estradiol; 17-Ethynyloestradiol; 17-Ethynylestradiol ram; 17-Ethynylestradiol; 17-Ethinylestradiol; 17-Ethinyl-3,17-oestradiol; 17-Ethinyl-3,17-estradiol; 17 alpha-Ethynyloestradiol; 17 alpha-Ethynylestradiol; 17 alpha-Ethinylestradiol; Neo-Estrone; Primogyn M; Progynon C; Progynon M; Spanestrin; Thiuram E; Thiuranide; Nogest-S; Novestrol; Oradiol; Orestralyn; Orestrayln; Vagifem; Ylestrol; Ovex; Palonyl; Perovex; Primogyn; Primogyn C; Menostar; Menolyn; Lynoral; Linoral; Kolpolyn; Innofem; Inestra; Gynolett; Gynodiol; Ginestrene; Follicoral; Fempatch; Feminone; Etivex; Etistradiol; Etinoestryl; Etinilestradiol; Etinestryl; Etinestrol; Eticylol; Eticyclol; Eticyclin; Ethynyloestradiol; Ethynylestradiol; Ethynyl estradiol; Ethinyloestradiol; Ethinylestriol; Ethinylestradiolum; Ethinylestradiol; Ethinyl estradiol; Ethinyl-Oestranol; Ethinoral; Ethidol; Estrogen; Estring; Estorals; Estoral {Orion}; Estoral; Eston-E; Estinyl; CHEBI:4903",2014-12-24,1,,,,,,,,,
29973-13-5,0,OMOP Exposome,Observation,Substance,Ethiofencarb,"Croneton 500; (2-Ethylthiomethyl-phenyl)-N-methylcarbamate; 2-((Ethylthio)methyl)phenol methylcarbamate; 2-((Ethylthio)methyl)phenyl methylcarbamate; 2-(Ethylthiomethyl)phenyl methylcarbamate, 9CI; 2-Ethyl-mercaptomethyl-phenyl-N-methylcarbamate; 2-Ethylthiomethylphenyl N-methylcarbamate; 2-(Ethylsulfanyl)methylphenyl methylcarbamate; alpha-(Ethylthio)-O-tolyl methylcarbamate; alpha-Ethylthio-O-tolyl methylcarbamate; Arylmate; BAY-HOX-1901; Carbamic acid, methyl-, 2-(ethylthiomethyl)phenyl ester; Phenol, 2-(ethylthio)methyl-, methylcarbamate; Phenol, 2-((ethylthio)methyl)-, methylcarbamate (9CI); Phenol, 2-((ethylthio)methyl)-, methylcarbamate; N-Methyl-O-(2-ethylthiomethyl) phenylcarbamate; Kronetone; Ethiophencarbe; Carbamic acid, methyl-, alpha-(ethylthio)-O-tolyl ester; Croneton; CHEBI:38483",2014-12-24,1,,,,,,,,,
563-12-2,0,OMOP Exposome,Observation,Substance,Ethion,"RP-thion; Trecator-SC; Tetraethyl S,S'-methylene bis(phosphorothiolothionate); Soprathion; Vegfru fosmite; Vegfru-fosmite; Bis(s-(diethoxyphosphinothioyl)mercapto)methane; Diethion; Embathion; Ethanox; Ethiol; Ethodan; Ethopaz; Ethyl methylene phosphorodithioate; Fosfatox e; Fosfono 50; Hylemax; Hylemox; Itopaz; O,O,O',O'-tetraethyl S,S'-methanediyl bis(dithiophosphate); O,O,O',O'-tetraethyl S,S'-methylene bis(dithiophosphate); O,O,O',O'-tetraethyl S,S'-methylene bisphosphorodithioate; O,O,O',O'-tetraethyl S,S'-methylene di(phosphorodithioate); O,O,O',O'-tetraethyl S,S'-methylenebis(phosphorodithioate); S,S'-methylene O,O,O',O'-tetraethyl phosphorodithioate; S,S'-methylene O,O,O',O'-tetraethyl di(phosphorodithioate); S,S'-methylene bis(o,o-diethyl phosphorodithioate); Rodocide; Rodocid; Rhodocide; Rhodiacide; Phosphotox e; O,O,O,O-tetraethyl S,S'-methylenebis(dithiophosphate); O,O,O',O'-tetraethyl-S,S'-methylenebisphosphorodithioate; O,O,O',O'-tetraethyl-S,S'-methylene di(phosphorodithioate); O,O,O',O'-tetraethyl S,S'-methylenebisphosphordithioate; CHEBI:38663",2014-12-24,1,,,,,,,,,
26225-79-6,0,OMOP Exposome,Observation,Substance,Ethofumesate,,2014-12-24,1,,,,,,,,,
13194-48-4,0,OMOP Exposome,Observation,Substance,Ethoprop,"Phosphorodithioic acid O-ethyl S,S-dipropyl ester; O-ethyl-S,S-dipropyl phosphorodiothioate; O-ethyl-S,S-dipropyl phosphorodithionate; S,S-dipropyl O-ethyl phosphorodithioate; Rovokil; Prophos; Phosethoprop; Mocap; O-ethyl S,S-dipropyl dithiophosphate; O-Ethyl S,S-dipropyl phosphorodithioate; O-ethyl S,S-dipropylphosphorodithioate; Phophos; Phosphorodithioic acid, O-ethyl S,S-dipropyl ester; CHEBI:38665",2014-12-24,1,,,,,,,,,
77-67-8,0,OMOP Exposome,Observation,Substance,Ethosuximide,"3-Ethyl-3-methylsuccinimide; Etosuximida; Ethymal; Ethosuximidum; 3-Methyl-3-ethylpyrrolidine-2,5-dione; 3-Methyl-3-ethylsuccinimide; Aethosuximide; alpha-Ethyl-alpha-methylsuccinimide; alpha-Methyl-alpha-ethylsuccinimide; Atysmal; Emeside; Ethosuccimide; Ethosuccinimide; Ethosuxide; Ethosuximid; \u03b3-ethyl-\u03b3-methyl-succinimide; Zarontin; Zarondan; Thilopemal; (+-)-2-Ethyl-2-methylsuccinimide; (\u00b1)-2-ethyl-2-methylsuccinimide; 2-ethyl-2-methylsuccinimide; 2-Methyl-2-ethylsuccinimide; Suxinutin; Suxilep; Petnidan; Petinimid; Petimid; gamma-Methyl-gamma-ethyl-succinimide; gamma-Ethyl-gamma-methyl-succinimide; 3-ethyl-3-methyl-2,5-pyrrolidinedione; Etoxin; CHEBI:4887",2014-12-24,1,,,,,,,,,
86-35-1,0,OMOP Exposome,Observation,Substance,Ethotoin,"3-Ethyl-5-phenyl-imidazolidine-2,4-dione; Pegoanone; Peganone; Etotoina; Ethotoinum; Ethoto\u00efne; Accenon; 3-Ethyl-5-phenylimidazolidin-2,4-dione; 3-Ethyl-5-phenylhydantoin; 3-Ethyl-5-phenyl-2,4-imidazolidinedione; 1-Ethyl-2,5-dioxo-4-phenylimidazolidine; (+-)-3-Ethyl-5-phenylhydantoin; CHEBI:4888",2014-12-24,1,,,,,,,,,
26983-51-7,0,OMOP Exposome,Observation,Substance,Ethoxyethyl hydroxy mercury,,2014-12-24,1,,,,,,,,,
91-53-2,0,OMOP Exposome,Observation,Substance,Ethoxyquin,"(-)-lobeline; Santoflex a; Santoflex aw; Santoquin; Santoquine; Santoquineq; Stop-scald; 2,2,4-Trimethyl-6-ethoxy-1,2-dihydroquinoline; 2,2, 4-Trimethyl-6-ethoxy-1,2-dihydroquinoline; 1,2-Dihydro-6-ethoxy-2,2,4-trimethylquinoline; 1,2-Dihydro-2,2,4-trimethyl-6-ethoxyquinoline; Nix-scald; Nocrack aw; Nocrac aw; Niflex D; Niflex; Lobeline; Ethyl 2,2,4-trimethyl-1,2-dihydro-6-quinolinyl ether; Permanax 103; Ethoxyquine; Polyflex; Santoflex; Quinol ed; Ethoxychin; EQ; EMQ; Dawe'S nutrigard; Aries antox; Antox; Antioxidant ec; Antage aw; Alterungsschutzmittel ec; 6-ETMDQ; 6-Ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline; 6-Ethoxy-2,2,4-trimethyl-1, 2-dihydroquinoline; 6-Ethoxy-1,2-dihydro-2,2,4-trimethylquinoline, 9CI, 8CI; 6-Ethoxy-1,2-dihydro-2,2,4-trimethyl-Quinoline; 6-Ethoxy-1, 2-dihydro-2,2,4-trimethylquinoline; 6-(Ethyloxy)-2,2,4-trimethyl-1,2-dihydroquinoline; CHEBI:48723",2014-12-24,1,,,,,,,,,
3025-30-7,0,OMOP Exposome,Observation,Substance,"Ethyl 2Z,4E-decadienoic acid",,2014-12-24,1,,,,,,,,,
140-88-5,0,OMOP Exposome,Observation,Substance,Ethyl acrylate,,2014-12-24,1,,,,,,,,,
93-89-0,0,OMOP Exposome,Observation,Substance,Ethyl benzoate,"Orsellinate; O-Orsellinic acid; FEMA 2422; Ethylester kyseliny benzoove; Ethyl benzoic acid; Ethyl benzenecarboxylate; Benzoic acid, C14-15-alkyl esters; Benzoyl ethyl ether; 4,6-Dihydroxy-O-toluic acid; Benzoic ether; Benzoic acid, C12-13-alkyl esters; Benzoic acid,ethyl ester; Benzoic acid, C9-11-alkyl esters; 2,4-Dihydroxy-6-methylbenzoate; 2,4-Dihydroxy-6-methylbenzoic acid; 2-Methoxy-1-phenyl-ethanone; Benzoic acid, ethyl ester; CHEBI:32807",2014-12-24,1,,,,,,,,,
105-36-2,0,OMOP Exposome,Observation,Substance,Ethyl bromoacetate,,2014-12-24,1,,,,,,,,,
51-79-6,0,OMOP Exposome,Observation,Substance,Ethyl carbamate,"U-Compound; Ethyl ester of carbamic acid; Ethyl urethan; Ethyl urethane; Ethylcarbamate; Ethylester kyseliny karbaminove; NH2COOC2H5; NSC 746; O-Ethyl carbamate; Pracarbamin; Pracarbamine; Urethanum; Urethane, INN; Urethane + ethanol (combination); Urethane; Urethan; Uretano; Uretan etylowy; Uretan; Leucothane; Aethylcarbamat; Aethylurethan; O-Ethyl urethane; O-Ethylurethane; Carbamate, ethyl; Leucethane; Ethylurethane; Ethylurethan; Carbamic acid ethyl ester; Carbamic acid, ethyl ester; Carbamidsaeure-aethylester; Estane 5703; Ethyl aminoformate; Ethyl carbamic acid; CHEBI:17967",2014-12-24,1,,,,,,,,,
105-56-6,0,OMOP Exposome,Observation,Substance,Ethyl cyanoacetate,,2014-12-24,1,,,,,,,,,
7085-85-0,0,OMOP Exposome,Observation,Substance,Ethyl cyanoacrylate,,2014-12-24,1,,,,,,,,,
60-29-7,0,OMOP Exposome,Observation,Substance,Ethyl ether,"Sulfuric ether, anesthetic ether; Sulfuric ether; Solvent ether; Ethoxyethane; Ethyl oxide; Pronarcol; Anaesthetic ether; Ether; Diethylaether; Diethyl ether; Anesthesia ether; Aether; 3-Oxapentane; 1-Ethoxyethane; 1,1'-oxydiethane; 1,1'-Oxybisethane; CHEBI:35702",2014-12-24,1,,,,,,,,,
623-48-3,0,OMOP Exposome,Observation,Substance,Ethyl iodoacetate,,2014-12-24,1,,,,,,,,,
29177-84-2,0,OMOP Exposome,Observation,Substance,Ethyl loflazepate,,2014-12-24,1,,,,,,,,,
542-90-5,0,OMOP Exposome,Observation,Substance,Ethyl thiocyanate,,2014-12-24,1,,,,,,,,,
12075-68-2,0,OMOP Exposome,Observation,Substance,Ethylaluminum sesquichloride,,2014-12-24,1,,,,,,,,,
75-04-7,0,OMOP Exposome,Observation,Substance,Ethylamine,Aminoethane; Aethylamine; Ethyl amine; Ethylamine solution; Etilamina; 1-Aminoethane; Etyloamina; Monoethylamine; ETHYLAMINE; Ethanamine; CHEBI:15862,2014-12-24,1,,,,,,,,,
100-41-4,0,OMOP Exposome,Observation,Substance,Ethylbenzene,Ethylbenzol; alpha-methyltoluene; Aethylbenzol; Phenylethane; CHEBI:16101,2014-12-24,1,,,,,,,,,
598-14-1,0,OMOP Exposome,Observation,Substance,Ethyldichloroarsine,,2014-12-24,1,,,,,,,,,
109-78-4,0,OMOP Exposome,Observation,Substance,Ethylene cyanohydrin,,2014-12-24,1,,,,,,,,,
107-21-1,0,OMOP Exposome,Observation,Substance,Ethylene glycol,"2-Hydroxyethanol; Ethanediol; Ethane-1,2-diol; Dowtherm SR 1; Dihydroxyethane; Aliphatic diol; 1,2-Ethanediol; 1,2-Dihydroxyethane; 1,2-Ethandiol; Norkool; Monoethylene glycol; Macrogol 400 BPC; HO-CH2-CH2-OH; Glygen; Glycol, polyethylene; Glycol alcohol; Glycol; Fridex; Ethylene gycol; Ethylene glycol; Ethylene dihydrate; Ethylene alcohol; CHEBI:30742",2014-12-24,1,,,,,,,,,
75-21-8,0,OMOP Exposome,Observation,Substance,Ethylene Oxide,"Oxidoethane; Oxiraan; Oxiran; Oxirane; Oxyfume; Oxyfume 12; Qazi-ketcham; Sterilizing gas ethylene oxide 100%; T-Gas; D.E.R. 736 Epoxy resin; Dihydro-Oxirene; Dihydrooxirene; Dimethylene oxide; E.O.; Epoxyethane; Ethene oxide; Ethox; Ethyleenoxide; Ethylene oxide; Ethylene oxide, 8CI; ETO; Etylenu tlenek; D.E.R. 732 Epoxy resin; Anproline; Anprolene; Amprolene; alpha,beta-Oxidoethane; FEMA 2433; Aethylenoxid; 1,2-Epoxyethane; Merpol; Oxacyclopropane; 1,2-Epoxyaethan; Polypropylene glycol, (chloromethyl)oxirane polymer; Oxide, ethylene; CHEBI:27561",2014-12-24,1,,,,,,,,,
96-45-7,0,OMOP Exposome,Observation,Substance,Ethylenethiourea,,2014-12-24,1,,,,,,,,,
601-75-2,0,OMOP Exposome,Observation,Substance,Ethylmalonic acid,"alpha-Carboxybutyrate; alpha-Carboxybutyric acid; Ethyl-Malonic acid; 1,1-Propanedicarboxylic acid; a-Carboxybutyrate; a-Carboxybutyric acid; Ethylmalonate; 1,1-Propanedicarboxylate; CHEBI:741548",2018-03-21,1,,,,,,,,,
2235-25-8,0,OMOP Exposome,Observation,Substance,Ethylmercuric phosphate,,2014-12-24,1,,,,,,,,,
107-27-7,0,OMOP Exposome,Observation,Substance,Ethylmercury chloride,,2014-12-24,1,,,,,,,,,
120-47-8,0,OMOP Exposome,Observation,Substance,Ethylparaben,,2014-12-24,1,,,,,,,,,
78-40-0,0,OMOP Exposome,Observation,Substance,Ethylphosphate,O-Phosphoric acid triethyl ester; Ethylphosphic acid; Mono-Ethyl phosphate; O-Ethyl dihydrogen phosphate; Ethyl phosphate; Phosphoric acid monoethyl ester; CHEBI:45927,2014-12-24,1,,,,,,,,,
1762-26-1,0,OMOP Exposome,Observation,Substance,Ethyltrimethyl lead,,2014-12-24,1,,,,,,,,,
7414-83-7,0,OMOP Exposome,Observation,Substance,Etidronic acid,"Acidum etidronicum; Oxyethylidenediphosphonic acid; Hydroxyethanediphosphonic acid; HEDP; Etidrons\u00e4ure; Etidronsaeure; Etidronate Disodium; Etidronate; Etidron; Ethane-1-hydroxy-1,1-diphosphonic acid; Ethane-1-hydroxy-1,1-diphosphonate; Ethane-1-hydroxy-1,1-bisphosphonic acid; EHDP; Didronel; Acido etidronico; Acide etidronique; Acetodiphosphonic acid; 1-Hydroxyethylidene-1,1-diphosphonic acid; 1-Hydroxyethylidene-1,1-bisphosphonate; 1-Hydroxyethanediphosphonic acid; 1-Hydroxyethane-1,1-diphosphonic acid; 1-Hydroxyethane-1,1-diphosphonate; 1-Hydroxyethane-1,1-bisphosphonic acid; 1-hydroxyethane 1,1-diphosphonic acid; 1-Hydroxy-1,1-diphosphonoethane; 1,1,1-Ethanetriol diphosphonate; (Hydroxyethylidene)diphosphonic acid; (1-Hydroxyethylidene)diphosphonic acid; (1-Hydroxyethylidene)bisphosphonic acid; (1-Hydroxyethylidene)bis(phosphonic acid); (1-Hydroxyethylene)diphosphonic acid; CHEBI:4907",2014-12-24,1,,,,,,,,,
40054-69-1,0,OMOP Exposome,Observation,Substance,Etizolam,,2014-12-24,1,,,,,,,,,
33419-42-0,0,OMOP Exposome,Observation,Substance,Etoposide,"Etoposido; VP-16; EPEG; Epipodophyllotoxin; EPE; 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); (-)-Etoposide; Vepesid K; Vepesid; trans-Etoposide; Eposin; Etopofos; Etopophos; V\u00e9p\u00e9side; Etoposid; Toposar; Nexvep; Lastet; Etoposidum; CHEBI:4911",2014-12-24,1,,,,,,,,,
153233-91-1,0,OMOP Exposome,Observation,Substance,Etoxazole,"2-(2,6-Difluorophenyl)-4-(4-(1,1-dimethylethyl)-2-ethoxyphenyl)-4,5-dihydrooxazole; (RS)-5-tert-butyl-2-2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-ylphenetole; CHEBI:39329",2014-12-24,1,,,,,,,,,
2593-15-9,0,OMOP Exposome,Observation,Substance,Etridiazole,,2014-12-24,1,,,,,,,,,
97-53-0,0,OMOP Exposome,Observation,Substance,Eugenol,P-Eugenol; Caryophyllic acid; Engenol; Eugenic acid; Eugenol (natural); P-Allylguaiacol; 1-Hydroxy-2-methoxy-4-propenylbenzene; Synthetic eugenol; Allylguaiacol; 5-Allylguaiacol; 4-Hydroxy-3-methoxyallylbenzene; 4-Hydroxy-3-methoxy-1-allylbenzene; 4-Allylguaiacol; 4-Allylcatechol-2-methyl ether; 4-Allylcatechol 2-methyl ether; 4-Allyl-2-methoxyphenol; 4-Allyl-2-methoxy-Phenol; 4-Allyl-1-hydroxy-2-methoxybenzene; 2-Methoxy-4-prop-2-enylphenol; 2-Methoxy-4-allylphenol; 2-Methoxy-4-(prop-2-en-1-yl)phenol; 2-Methoxy-4-(3-propenyl)phenol; 2-Methoxy-4-(2-propenyl)phenol; 2-Methoxy-1-hydroxy-4-allylbenzene; 1-Hydroxy-2-methoxy-4-allylbenzene; 2-Hydroxy-5-allylanisole; 1-Hydroxy-2-methoxy-4-prop-2-enylbenzene; CHEBI:4917,2014-12-24,1,,,,,,,,,
Q04637,0,OMOP Exposome,Observation,Substance,Eukaryotic translation initiation factor 4 gamma 1,,2024-09-14,1,,,,,,,,,
P06730,0,OMOP Exposome,Observation,Substance,Eukaryotic translation initiation factor 4E,,2024-09-14,1,,,,,,,,,
GIS1008733,0,OMOP Exposome,Observation,Substance,Excitatory Amino Acid Antagonist,,2024-09-14,1,,,,,,,,,
P43003,0,OMOP Exposome,Observation,Substance,Excitatory amino acid transporter 1,,2024-09-14,1,,,,,,,,,
P43004,0,OMOP Exposome,Observation,Substance,Excitatory amino acid transporter 2,,2024-09-14,1,,,,,,,,,
P43005,0,OMOP Exposome,Observation,Substance,Excitatory amino acid transporter 3,,2024-09-14,1,,,,,,,,,
P48664,0,OMOP Exposome,Observation,Substance,Excitatory amino acid transporter 4,,2024-09-14,1,,,,,,,,,
O00341,0,OMOP Exposome,Observation,Substance,Excitatory amino acid transporter 5,,2024-09-14,1,,,,,,,,,
GIS1008734,0,OMOP Exposome,Observation,Substance,Exotoxin A (Pseudomonas aeruginosa),,2024-09-14,1,,,,,,,,,
GIS1008742,0,OMOP Exposome,Observation,Substance,Expectorant,,2024-09-14,1,,,,,,,,,
GIS1008743,0,OMOP Exposome,Observation,Substance,Explosive Agent,,2024-09-14,1,,,,,,,,,
GIS1008744,0,OMOP Exposome,Observation,Substance,Extracellular,,2024-09-14,1,,,,,,,,,
P41180,0,OMOP Exposome,Observation,Substance,Extracellular calcium-sensing receptor,,2024-09-14,1,,,,,,,,,
GIS1008745,0,OMOP Exposome,Observation,Substance,Extracellular matrix,,2024-09-14,1,,,,,,,,,
P08294,0,OMOP Exposome,Observation,Substance,Extracellular superoxide dismutase [Cu-Zn],,2024-09-14,1,,,,,,,,,
GIS1008746,0,OMOP Exposome,Observation,Substance,Eye Lens,,2024-09-14,1,,,,,,,,,
GIS1008747,0,OMOP Exposome,Observation,Substance,Eyes,,2024-09-14,1,,,,,,,,,
GIS1008748,0,OMOP Exposome,Observation,Substance,Familial Hypercholanemia (FHCA),,2024-09-14,1,,,,,,,,,
131807-57-3,0,OMOP Exposome,Observation,Substance,Famoxadone,"(RS)-3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione, 3-Anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione; CHEBI:CHEBI:59340",2014-12-24,1,,,,,,,,,
GIS1008749,0,OMOP Exposome,Observation,Substance,Fanconi anemia pathway,,2024-09-14,1,,,,,,,,,
GIS1008750,0,OMOP Exposome,Observation,Substance,Fanconi-bickel syndrome,,2024-09-14,1,,,,,,,,,
4602-84-0,0,OMOP Exposome,Observation,Substance,Farnesol,"2-cis,6-trans-Farnesol; 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; Farnesyl alcohol; FCI 119a; Nikkosome; 2-trans,6-trans-Farnesol; CHEBI:28600",2014-12-24,1,,,,,,,,,
P14324,0,OMOP Exposome,Observation,Substance,Farnesyl pyrophosphate synthase,,2024-09-14,1,,,,,,,,,
Q8TES7,0,OMOP Exposome,Observation,Substance,Fas-binding factor 1,,2024-09-14,1,,,,,,,,,
2353-45-9,0,OMOP Exposome,Observation,Substance,Fast green FCF,,2014-12-24,1,,,,,,,,,
GIS1008751,0,OMOP Exposome,Observation,Substance,Fatty Acid Biosynthesis,,2024-09-14,1,,,,,,,,,
GIS1008752,0,OMOP Exposome,Observation,Substance,Fatty Acid Degradation,,2024-09-14,1,,,,,,,,,
O60427,0,OMOP Exposome,Observation,Substance,Fatty acid desaturase 1,,2024-09-14,1,,,,,,,,,
O95864,0,OMOP Exposome,Observation,Substance,Fatty acid desaturase 2,,2024-09-14,1,,,,,,,,,
GIS1008753,0,OMOP Exposome,Observation,Substance,Fatty acid elongation,,2024-09-14,1,,,,,,,,,
GIS1008754,0,OMOP Exposome,Observation,Substance,Fatty Acid Elongation In Mitochondria,,2024-09-14,1,,,,,,,,,
GIS1008755,0,OMOP Exposome,Observation,Substance,Fatty acid Metabolism,,2024-09-14,1,,,,,,,,,
P49327,0,OMOP Exposome,Observation,Substance,Fatty acid synthase,,2024-09-14,1,,,,,,,,,
GIS1008756,0,OMOP Exposome,Observation,Substance,Fatty Acid Synthesis Inhibitor,,2024-09-14,1,,,,,,,,,
P15090,0,OMOP Exposome,Observation,Substance,"Fatty acid-binding protein, adipocyte",,2024-09-14,1,,,,,,,,,
O15540,0,OMOP Exposome,Observation,Substance,"Fatty acid-binding protein, brain",,2024-09-14,1,,,,,,,,,
Q01469,0,OMOP Exposome,Observation,Substance,"Fatty acid-binding protein, epidermal",,2024-09-14,1,,,,,,,,,
P05413,0,OMOP Exposome,Observation,Substance,"Fatty acid-binding protein, heart",,2024-09-14,1,,,,,,,,,
P12104,0,OMOP Exposome,Observation,Substance,"Fatty acid-binding protein, intestinal",,2024-09-14,1,,,,,,,,,
P51648,0,OMOP Exposome,Observation,Substance,Fatty aldehyde dehydrogenase,,2024-09-14,1,,,,,,,,,
O00519,0,OMOP Exposome,Observation,Substance,Fatty-acid amide hydrolase 1,,2024-09-14,1,,,,,,,,,
Q6GMR7,0,OMOP Exposome,Observation,Substance,Fatty-acid amide hydrolase 2,,2024-09-14,1,,,,,,,,,
16423-68-0,0,OMOP Exposome,Observation,Substance,Fd&c red no. 3,,2014-12-24,1,,,,,,,,,
25451-15-4,0,OMOP Exposome,Observation,Substance,Felbamate,"Carbamic acid 2-phenyltrimethylene ester; 2-Phenyl-1,3-propanediol dicarbamate; Taloxa; Felbatol; Felbamyl; Felbamic acid; Felbamatum; Felbamato; Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester; CHEBI:4995",2014-12-24,1,,,,,,,,,
161326-34-7,0,OMOP Exposome,Observation,Substance,Fenamidone,,2014-12-24,1,,,,,,,,,
22224-92-6,0,OMOP Exposome,Observation,Substance,Fenamiphos,"Ethyl 4-methylthio-m-tolyl isopropylphosphoramidate, 8CI; BAY SRA 3886; Ethyl 3-methyl-4-(methylthio)phenyl 1-methylethylphosphoramidate, 9CI; Ethyl 3-methyl-4-(methylthio)phenyl isopropylamidophosphate; Ethyl 4-(methylthio)-m-tolyl isopropylphosphoramidate; Ethyl 4-(methylthio)m-tolyl isopropylphosphoroamidate; Ethyl-4-(methylthio)-m-tolyl isopropylphosphoramidate; m-Cresol, 4-(methylthio)-, ethyl isopropylphosphoramidate; Methaphenamiphos; Nemacur; Nemacur p; Phenamifos sulfoxide; Phenamiphos; CHEBI:38680",2014-12-24,1,,,,,,,,,
60168-88-9,0,OMOP Exposome,Observation,Substance,Fenarimol,,2014-12-24,1,,,,,,,,,
78357-48-9,0,OMOP Exposome,Observation,Substance,Fenasulam,,2014-12-24,1,,,,,,,,,
114369-43-6,0,OMOP Exposome,Observation,Substance,Fenbuconazole,,2014-12-24,1,,,,,,,,,
1209-98-9,0,OMOP Exposome,Observation,Substance,Fencamfamine,Fencanfamina; Glucoenergan; Fencamfamin; Fencamfamina; Reactivan; 2-Aethylamino-3-phenyl-nor-camphan; Fencamfaminum; CHEBI:101009,2014-12-24,1,,,,,,,,,
30087-47-9,0,OMOP Exposome,Observation,Substance,Fenethacarb,,2014-12-24,1,,,,,,,,,
126833-17-8,0,OMOP Exposome,Observation,Substance,Fenhexamid,,2014-12-24,1,,,,,,,,,
122-14-5,0,OMOP Exposome,Observation,Substance,Fenitrothion,"Macbar; Verthion; Tionfos 50 LE; Sumitomo S-1102A; Sumithion; Sumithian; Sumigran; Sumifene; Phenitrothion; Pennwalt C-4852; Owadophos; Owadofos; Ovadofos; Oleosumifene; Oleometathion; O,O-Dimetil-O-(3-metil-4-nitrofenil) fosforotioato; O,O-Dimetil-O-(3-metil-4-nitro-fenil)-monotiofosfato; O,O-Dimethyl-O-(4-nitro-5-methylphenyl)-thionophosphate; O,O-Dimethyl-O-(3-methyl-4-nitrofenyl)-monothiofosfaat; O,O-Dimethyl-O-(3-methyl-4-nitro-phenyl)-monothiophosphate; O,O-Dimethyl O-4-nitro-m-tolyl thiophosphate; O,O-Dimethyl O-4-nitro-m-tolyl phosphorothioate; O,O-Dimethyl O-(4-nitro-3-methylphenyl)thiophosphate; O,O-Dimethyl O-(3-methyl-4-nitrophenyl)phosphorothioate; O,O-Dimethyl O-(3-methyl-4-nitrophenyl) thiophosphate; O,O-Dimethyl O-(3-methyl-4-nitrophenyl) phosphorothioate; O,O-DiMe O-(3-methyl-4-nitrophenyl) thiophosphate; Nuvanol; Novathion; Nitrophos; Mglawik F; Methylnitrophos; Metation E-50; Metation; Metathionine E-50; Metathionine; Metathione; Metathion E-50; Metathion; Metathio E-50; MEP (Phosphorus insecticide); MEP (Pesticide); MEP; Kotion; Folithion ec 50; Folithion; Fenitrotion; Fenitox; Falithion; Dimethyl 4-nitro-m-tolyl phosphorothionate; Dimethyl 3-methyl-4-nitrophenyl phosphorothionate; Dicofen; Cyten; Cytel; Cyfen; Cekutrothion; Bis-Fenitrothion; Bayer S 5660; Arbogal; American cyanamid cl-47,300; Akotion; Agrothion; Agriya 1050; Aceothion; Accothion; CHEBI:34757",2014-12-24,1,,,,,,,,,
3766-81-2,0,OMOP Exposome,Observation,Substance,Fenobucarb,"Methylcarbamic acid O-sec-butylphenyl ester; 2-(1-Methylpropyl)phenyl methylcarbamate; 2-(Butan-2-yl)phenyl methylcarbamate; 2-Butylphenyl methylcarbamate; 2-Sec-butylphenyl methylcarbamate; 2-sec-Butylphenyl N-methylcarbamate; Barizon; Bassa; Baycarb; BPMC; Carbamic acid, methyl-, O-sec-butylphenyl ester; Carvil; Fenobcarb; Geocarb 50EC; O-sec-butylphenyl methylcarbamate; CHEBI:34304",2014-12-24,1,,,,,,,,,
49562-28-9,0,OMOP Exposome,Observation,Substance,Fenofibrate,TriCor; FIBRICOR; FNF; Finofibrate; Trilipix; Triglide; Tricor; Procetofen; Lofibra; Lipofen; Lipidil; Lipantil; Lipanthyl; Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate; 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester; Antara; Fenofibrato; Fenofibratum; Fenofibric acid; Fenogal; Fenoglide; Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate; CHEBI:5001,2014-12-24,1,,,,,,,,,
66441-23-4,0,OMOP Exposome,Observation,Substance,Fenoxaprop-ethyl,,2014-12-24,1,,,,,,,,,
72490-01-8,0,OMOP Exposome,Observation,Substance,Fenoxycarb,"Insegar; Logic; N-(2-(P-Phenoxyphenoxy)ethyl)carbamic acid; O-Ethyl N-2-(4-phenoxyphenoxy)ethylcarbamate; (2-(4-Phenoxyphenoxy)ethyl)carbamic acid ethyl ester; 2-(4-(Phenoxy-phenoxy)ethyl)carbamic acid ethyl ester; Carbamic acid, (2-(4-phenoxyphenyl)ethyl)-, ethyl ester; Caswell No. 652C; Ethyl (2-(4-phenoxyphenoxy)ethyl)carbamate; Ethyl (2-(p-phenoxy)ethyl)carbamate; ethyl (2-(p-phenoxyphenoxy)ethyl)carbamate; Ethyl 2-(4-phenoxyphenoxy)ethylcarbamate; ethyl 2-(4-phenoxyphenoxy)ethylcarbamate; Pictyl; Pyctyl; Torus; Varikill; ethyl(2-(4-phenoxyphenoxy)ethyl)carbamate; Ethyl(2-(p-phenoxyphenoxy)ethyl)carbamate; Carbamic acid, (2-(4-phenoxyphenoxy)ethyl)-, ethyl ester; Fenasulam; CHEBI:5009",2014-12-24,1,,,,,,,,,
39515-41-8,0,OMOP Exposome,Observation,Substance,Fenpropathrin,"Fenpropanate; TAME; Smash; RODY; Ortho danitol; Miothrin; Kilumal; Fenpropathrine; Fenpropathrin, (s)-isomer; Fenpropathrin, (r)-isomer; Fenpropathrin, (+-)-isomer; Danitrol; Danitol fiori; Danitol; Danimen; 2,2,3,3-Tetramethylcyclopropanecarboxylic acid cyano(3-phenoxyphenyl)methyl ester; (+-)-fenpropathrin; Herald; Meothrin; Meiothrin; CHEBI:39353",2014-12-24,1,,,,,,,,,
67306-03-0 and 67564-91-4,0,OMOP Exposome,Observation,Substance,Fenpropimorph,"Mistral t; 4-3-(4-Tert-Butylphenyl)-2-methylpropyl-2,6-dimethylmorpholine; 4-3-4-(1,1-Dimethylethyl)phenyl-2-methylpropyl-2,6-dimethylmorpholine, 9CI; Corbel; Fenpropemorph; Fenpropimorphe; Funbas; Mildofix; Mistral; Power task; CHEBI:50148",2014-12-24,1,,,,,,,,,
437-38-7,0,OMOP Exposome,Observation,Substance,Fentanyl,Subsys; 1-Phenethyl-4-(N-phenylpropionamido)piperidine; 1-Phenethyl-4-N-propionylanilinopiperidine; Abstral; Actiq; Duragesic; Durogesic; Fentanest; Fentanil; Fentanila; Fentanilo; Fentanyl citrate; Fentanylum; Lazanda; N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide; N-(1-Phenethyl-4-piperidyl)propionanilide; N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide; N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide; N-Phenethyl-4-(N-propionylanilino)piperidine; N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide; Nasalfent; Phentanyl; Rapinyl; CHEBI:119915,2014-12-24,1,,,,,,,,,
"55-38-9",0,OMOP Exposome,Observation,Substance,Fenthion,"4-Methylmercapto-3-methylphenyl dimethyl thiophosphate; Phosphorothioic acid, O,O-dimethyl O-(3-methyl-4-(methylthio)phenyl) ester; Mercaptophos; O,O-Dimethyl-O-4-(methylmercapto)-3-methylphenyl thiophosphate; O,O-Dimethyl O-3-methyl-4-(methylsulfanyl)phenyl thiophosphate; O,O-Dimethyl O-4-(methylmercapto)-3-methylphenyl phosphorothioate; O,O-Dimethyl O-4-methylthio-m-tolyl phosphorothioate; MPP; CHEBI:34761",2014-12-24,1,,,,,,,,,
51630-58-1,0,OMOP Exposome,Observation,Substance,Fenvalerate,"Phenoxin; Sumicidin; a-Cyano-3-phenoxybenzyl 2-(4-chlorophenyl)-3-methylbutyrate; Agrofen; alpha-Cyano-3-phenoxybenzyl 2-(4-chlorophenyl)isovalerate; Aqmatrine; Asana; Belmark; Cyano(3-phenoxyphenyl)methyl 4-chloro-a-(1-methylethyl)benzeneacetate, 9CI; Ectrin; Esfenvalerate; Evercide 2362; Fenaxin; Fenkem; Fenkill; Fenoxin; Pydrin; Phenvalerate; Fenval; Fenvaleric acid; CHEBI:5014",2014-12-24,1,,,,,,,,,
10102-49-5,0,OMOP Exposome,Observation,Substance,Ferric arsenate,,2014-12-24,1,,,,,,,,,
14038-43-8,0,OMOP Exposome,Observation,Substance,Ferric hexacyanoferrate,"Pigment Blue 27; Preussischblau; Prussian blue; Iron(III) ferrocyanide; iron(3+) hexacyanidoferrate(4-); iron(3+) ferrocyanide; Iron(3+ ) ferrocyanide; Iron hexacyanoferrate; Ferric hexacyanoferrate (II); Ferric hexacyanoferric acid; Ferrihexacyanoferrate; Hexacyanoiron; Iron blue; Iron ferrocyanide; Iron cyanide; Milori blue HCB; N 650 (pigment); Paris blue; Manox iron blue; Iron(III) hexacyanoferrate(II); Iron(III) hexacyanidoferrate(II); iron(3+) hexacyanoferrate(4-); Ammonium prussian blue; Berlin blue; Berlin blue (b); Berliner blau; Berliner blue; Blue HO 208; C.I. Pigment Blue 27; Chinese blue; Fe4Fe(CN)63; Ferrate(4-), hexacyano-, iron(3+ ) (3:4); Ferrate(4-), hexakis(cyano-C)-, iron(3+) (3:4); Ferric blue; Ferric ferrocyanide; Prussian Blue {Fe4Fe(CN)63}; Radiogardase; Radiogardase-cs; Tetrairon tris(hexacyanoferrate); Tetrairon(3+) {trishexacyanoferrate(4-)}; Turnbulls blau; Milori Blue 690BB; Milori Blue 690; Milori Blue 671; Milori blue; Maox iron blue; CHEBI:30069",2014-12-24,1,,,,,,,,,
P02792,0,OMOP Exposome,Observation,Substance,Ferritin light chain,,2024-09-14,1,,,,,,,,,
Q7KZA3,0,OMOP Exposome,Observation,Substance,Ferrochelatase,,2024-09-14,1,,,,,,,,,
P22830,0,OMOP Exposome,Observation,Substance,"Ferrochelatase, mitochondrial",,2024-09-14,1,,,,,,,,,
10102-50-8,0,OMOP Exposome,Observation,Substance,Ferrous arsenate,,2014-12-24,1,,,,,,,,,
GIS1008757,0,OMOP Exposome,Observation,Substance,Fertility Agent,,2024-09-14,1,,,,,,,,,
GIS1008758,0,OMOP Exposome,Observation,Substance,Fertilizer,,2024-09-14,1,,,,,,,,,
GIS1008759,0,OMOP Exposome,Observation,Substance,Fetus,,2024-09-14,1,,,,,,,,,
83799-24-0,0,OMOP Exposome,Observation,Substance,Fexofenadine,"Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Vifas; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra; Carboxyterfenadine; Fastofen; Fexidine; Fexofenadine hydrochloride; Telfast; CHEBI:5050",2014-12-24,1,,,,,,,,,
P02671,0,OMOP Exposome,Observation,Substance,Fibrinogen alpha chain,,2024-09-14,1,,,,,,,,,
GIS1008760,0,OMOP Exposome,Observation,Substance,Fibrinolytic Agent,,2024-09-14,1,,,,,,,,,
P05230,0,OMOP Exposome,Observation,Substance,Fibroblast growth factor 1,,2024-09-14,1,,,,,,,,,
O95750,0,OMOP Exposome,Observation,Substance,Fibroblast growth factor 19,,2024-09-14,1,,,,,,,,,
P09038,0,OMOP Exposome,Observation,Substance,Fibroblast growth factor 2,,2024-09-14,1,,,,,,,,,
P08620,0,OMOP Exposome,Observation,Substance,Fibroblast growth factor 4,,2024-09-14,1,,,,,,,,,
P11362,0,OMOP Exposome,Observation,Substance,Fibroblast growth factor receptor 1,,2024-09-14,1,,,,,,,,,
P21802,0,OMOP Exposome,Observation,Substance,Fibroblast growth factor receptor 2,,2024-09-14,1,,,,,,,,,
P22455,0,OMOP Exposome,Observation,Substance,Fibroblast growth factor receptor 4,,2024-09-14,1,,,,,,,,,
GIS1008761,0,OMOP Exposome,Observation,Substance,Fibroblasts,,2024-09-14,1,,,,,,,,,
98319-26-7,0,OMOP Exposome,Observation,Substance,Finasteride,"Prostide; Propecia; Proscar; Finastid; (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; Chibro-proscar; Finasteridum; Finpecia; Finasterida; CHEBI:5062",2014-12-24,1,,,,,,,,,
120068-37-3,0,OMOP Exposome,Observation,Substance,Fipronil,"Fluocyanobenpyrazole; (RS)-5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4- (trifluoromethylsulfinyl)-1H-pyrazole-3-carbonitrile; Termidor; CHEBI:5063",2014-12-24,1,,,,,,,,,
GIS1008762,0,OMOP Exposome,Observation,Substance,Fixative,,2024-09-14,1,,,,,,,,,
GIS1008763,0,OMOP Exposome,Observation,Substance,Flagellar Assembly,,2024-09-14,1,,,,,,,,,
P30043,0,OMOP Exposome,Observation,Substance,Flavin reductase (NADPH),,2024-09-14,1,,,,,,,,,
525-82-6,0,OMOP Exposome,Observation,Substance,Flavone,2-Phenyl-4-chromone; 2-Phenyl-4H-1-benzopyran-4-one; 2-Phenyl-4H-benzopyran-4-one; 2-Phenyl-4H-chromen-4-one; 2-Phenylbenzopyran-4-one; 2-Phenylchromone; CHEBI:42491,2014-12-24,1,,,,,,,,,
GIS1008764,0,OMOP Exposome,Observation,Substance,Flavonoid Biosynthesis,,2024-09-14,1,,,,,,,,,
GIS1008765,0,OMOP Exposome,Observation,Substance,Flavouring Agent,,2024-09-14,1,,,,,,,,,
54143-55-4,0,OMOP Exposome,Observation,Substance,Flecainide,"Almarytm; Tambocor; N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; Flecainidum; Flecainida; Flecaine; CCRIS 313; Apocard; (+-)-Flecainide; CHEBI:127588",2014-12-24,1,,,,,,,,,
GIS1008766,0,OMOP Exposome,Observation,Substance,Flecainide Pathway,,2024-09-14,1,,,,,,,,,
69806-50-4,0,OMOP Exposome,Observation,Substance,Fluazifop-butyl,,2014-12-24,1,,,,,,,,,
79241-46-6,0,OMOP Exposome,Observation,Substance,Fluazifop-P-butyl,,2014-12-24,1,,,,,,,,,
79622-59-6,0,OMOP Exposome,Observation,Substance,Fluazinam,,2014-12-24,1,,,,,,,,,
86386-73-4,0,OMOP Exposome,Observation,Substance,Fluconazole,"Biozole; Diflucan; Elazor; Trican; Flucazol; 2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol; 2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol; Monicure; Flunizol; Flucostat; Fluconazolum; Triflucan; Fluconazol; Pritenzol; CHEBI:46081",2014-12-24,1,,,,,,,,,
70124-77-5,0,OMOP Exposome,Observation,Substance,Flucythrinate,Cyano(3-phenoxyphenyl)methyl 2-4-(difluoromethoxy)phenyl-3-methylbutanoate; (\u00b1)-Cyano-(3-phenoxyphenyl)methyl (+)-4-(difluoromethoxy)-\u03b1-(1-methylethyl)benzeneacetate; CHEBI:34763,2014-12-24,1,,,,,,,,,
2022-85-7,0,OMOP Exposome,Observation,Substance,Flucytosine,Fluocytosine; Fluorcytosine; Flucytosin; Ancotil; Ancobon; 5-Flurocytosine; 5-Fluorocytosine; 5-Fluorocytosin; 5-Fluorocystosine; 5-FC; Flusine; CHEBI:5100,2014-12-24,1,,,,,,,,,
75607-67-9,0,OMOP Exposome,Observation,Substance,Fludarabine,,2014-12-24,1,,,,,,,,,
3900-31-0,0,OMOP Exposome,Observation,Substance,Fludiazepam,"Fludiazepamum; 7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one; Erispan; CHEBI:31618",2014-12-24,1,,,,,,,,,
131341-86-1,0,OMOP Exposome,Observation,Substance,Fludioxonil,,2014-12-24,1,,,,,,,,,
142459-58-3,0,OMOP Exposome,Observation,Substance,Flufenacet,,2014-12-24,1,,,,,,,,,
188489-07-8,0,OMOP Exposome,Observation,Substance,Flufenpyr-ethyl,,2014-12-24,1,,,,,,,,,
69770-45-2,0,OMOP Exposome,Observation,Substance,Flumethrin,Bayticol; CHEBI:39361,2014-12-24,1,,,,,,,,,
62924-70-3,0,OMOP Exposome,Observation,Substance,Flumetralin,,2014-12-24,1,,,,,,,,,
98967-40-9,0,OMOP Exposome,Observation,Substance,Flumetsulam,,2014-12-24,1,,,,,,,,,
87546-18-7,0,OMOP Exposome,Observation,Substance,Flumiclorac-pentyl,,2014-12-24,1,,,,,,,,,
103361-09-7,0,OMOP Exposome,Observation,Substance,Flumioxazin,,2014-12-24,1,,,,,,,,,
1622-62-4,0,OMOP Exposome,Observation,Substance,Flunitrazepam,Hipnosedon; Flunitrazepamum; Hypnodorm; Rohypnol; Narcozep; Roipnol; CHEBI:111715,2014-12-24,1,,,,,,,,,
2164-17-2,0,OMOP Exposome,Observation,Substance,Fluometuron,,2014-12-24,1,,,,,,,,,
206-44-0,0,OMOP Exposome,Observation,Substance,Fluoranthene,"1,2-(1,8-Naphthalenediyl)benzene; 1,2-(1, 8-Naphthylene)benzene; 1,2-(1,8-Naphthalene)benzene; 1,2-(1,8-Naphthylene)benzene; 1,2-Benzacenaphthene; Benzacenaphthylene; Benzo(JK)fluorene; Benzoj,kfluorene; Benzojkfluorene; Fluoranthrene; Fluroanthene; CHEBI:33083",2014-12-24,1,,,,,,,,,
86-73-7,0,OMOP Exposome,Observation,Substance,Fluorene,"2,3-Benzindene; para-Biphenylmethane; p-Biphenylmethane; ortho-Biphenylenemethane; o-Biphenylenemethane; Fluoren; Diphenylenemethane; alpha-diphenylenemethane-9H-fluorene; 9H-Fluorene; 2,3-Benzoindene; 2,2'-Methylenebiphenyl; CHEBI:28266",2014-12-24,1,,,,,,,,,
2321-07-5,0,OMOP Exposome,Observation,Substance,Fluorescein,"Resorcinolphthalein; Solvent Yellow 94; Yellow fluorescein; 2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)-benzoic acid; 3',6'-dihydroxyfluoran; 3,6-fluorandiol; 9-(o-carboxyphenyl)-6-hydroxy-3-isoxanthenone; 9-(o-carboxyphenyl)-6-hydroxy-3H-xanthen-3-one; AK-FLUOR; C.I. Solvent Yellow 94; D and C Yellow No. 7; D&C Yellow No. 7; Fluoresceine; Fluorescite; Fluoreszein; Japan Yellow 201; CHEBI:31624",2014-12-24,1,,,,,,,,,
27072-45-3,0,OMOP Exposome,Observation,Substance,Fluorescein isothiocyanate,"Fitc-celite(r); Fluoreszein-5-isothiocyanat; fluorescein-5-isothiocyanate; Fluorescein-5-isothiocyanat; Fluorescein isothiocyanic acid; Fluorescein isothiocyanate isomer I-celite(r); Fluorescein isothiocyanate isomer I; Fluorescein isothiocyanate isomer 1; Fluorescein 5-isothiocyanate; Fluorescein 5(6)-isothiocyanate; FITC isomer 1; FITC; F5ITC; 5-isothiocyanatofluorescein; 5-FITC; 3',6'-Dihydroxy-5-isothiocyanatospiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one; 2-(6-Hydroxy-3-oxo-(3H)-xanthen-9-yl)-5-isothiocyanatobenzoic acid; CHEBI:37926",2014-12-24,1,,,,,,,,,
GIS1008767,0,OMOP Exposome,Observation,Substance,Fluorescent Dye,,2024-09-14,1,,,,,,,,,
GIS1008768,0,OMOP Exposome,Observation,Substance,Fluoride Compound,,2024-09-14,1,,,,,,,,,
7782-41-4,0,OMOP Exposome,Observation,Substance,Fluorine,Fluorine anion; Fluorine(-1) anion; F(-1); Fluoride; CHEBI:17051,2014-12-24,1,,,,,,,,,
640-19-7,0,OMOP Exposome,Observation,Substance,Fluoroacetamide,Navron; Yanock; 2-Fluoroacetamide; WLN: ZV1F; Sjyhcahiktp; Rodex; Rcra waste number P057; RCRA waste no. P057; Monofluoroacetamide; Megatox; Fussol; Flutritex 1; Fluoroakil 100; Fluoroacetic acid amide; Fluorkill; Fluorakil 100; Fluoracetamide; FAA; Compound 1081; Caswell No. 461; Baran; Amid kyseliny fluoroctove; CHEBI:53124,2014-12-24,1,,,,,,,,,
144-49-0,0,OMOP Exposome,Observation,Substance,Fluoroacetic acid,Acide-monofluoracetique; Monofluorazijnzuur; MFA; HFA; Gifblaar poison; Monofluoressigsaure; Monofluoroacetate; Monofluoroacetic acid; UN 2642; 2-Fluoroacetic acid; Acido monofluoroacetio; Cymonic acid; FAA; Fluoroacetate; Fluoroethanoic acid; CHEBI:30775,2014-12-24,1,,,,,,,,,
51-21-8,0,OMOP Exposome,Observation,Substance,Fluorouracil,"Fluouracil; 5-Fluorouracil; FU; Ftoruracil; 5-Fluoropyrimidine-2,4-dione; Fluorouracilum; Fluorouracilo; Fluoroplex; Fluoro Uracil; Efurix; Efudix; Efudex; Carac; Carzonal; Adrucil; 5-FU; 5-Fluracil; 5-Fluoracil; CHEBI:46345",2014-12-24,1,,,,,,,,,
GIS1008769,0,OMOP Exposome,Observation,Substance,Fluorouracil Pathway,,2024-09-14,1,,,,,,,,,
361377-29-9,0,OMOP Exposome,Observation,Substance,Fluoxastrobin,,2014-12-24,1,,,,,,,,,
54910-89-3,0,OMOP Exposome,Observation,Substance,Fluoxetine,"Animex-On; Sarafem; (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine; (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine; Ladose; Fluoxeren; Prozac; Fluox\u00e9tine; Fluoxetina; Fluoxetin; Fontex; Fluoxetinum; Adofen; CHEBI:5118",2014-12-24,1,,,,,,,,,
76-43-7,0,OMOP Exposome,Observation,Substance,Fluoxymesterone,"Testoral; Fluoximesteronum; Fluoxymesteronum; U-Gono; UItandren; Fluoximesterone; Fluoximesterona; 11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one; Fluoxymestrone; Halotestin; Fluossimesterone; Androxy; 17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone; 17\u03b1-Methyl-9\u03b1-fluoro-11\u03b2-hydroxytesterone; Ora-Testryl; 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one; 9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone; Androfluorene; Androfluorone; CHEBI:5120",2014-12-24,1,,,,,,,,,
2709-56-0,0,OMOP Exposome,Observation,Substance,Flupenthixol,Fluanxol; Flupenthixole; Flupentixol; Flupentixolo; Jexit; Flupentixolum; Depixol; CHEBI:5121,2014-12-24,1,,,,,,,,,
69-23-8,0,OMOP Exposome,Observation,Substance,Fluphenazine,1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine; 10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine; 10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine; 2-(4-(3-2-(Trifluoromethyl)-10H-phenothiazin-10-ylpropyl)-1-piperazinyl)ethanol; 2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine; 4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol; 4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol; 4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol; Anatensol; Dapotum D; Fludecasin; Fludecate; Flufenazina; Flumezin; Fluorfenazine; Fluorophenazine; Fluorphenazine; Fluphenazin; Fluph\u00e9nazine; Fluphenazine Decanoate; Fluphenazinum; Funazine; Lyogen; Lyogen Depot; Lyogen Retard; Metoten; Modecate; Moditen; Moditen Depo; Permitil; Prolixin; Triflumethazine; CHEBI:5123,2014-12-24,1,,,,,,,,,
17617-23-1,0,OMOP Exposome,Observation,Substance,Flurazepam,Dalmadorm medium; Dalmadorm; Flunox; Felison; Dalmane; Insumin; Sompan; Valdorm; Flurazepamum; Flurazepam HCL; CHEBI:195929,2014-12-24,1,,,,,,,,,
5104-49-4,0,OMOP Exposome,Observation,Substance,Flurbiprofen,"TransAct; (+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; 2-(2-Fluorobiphenyl-4-yl)propanoic acid; 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid; 3-Fluoro-4-phenylhydratropic acid; Acustop Cataplasma; Adofeed; Ansaid; Antadys; Cebutid; FLP; Flurbiprofene; Flurbiprofeno; Flurbiprofenum; Flurofen; Froben; Froben Sr; Ocufen; Ocuflur; S-flurbiprofen; Stayban; Strefen; Strepfen; Strepsils; Strepsils Intensive; Urbifen; Zepolas; CHEBI:5130",2014-12-24,1,,,,,,,,,
69377-81-7,0,OMOP Exposome,Observation,Substance,Fluroxypyr,,2014-12-24,1,,,,,,,,,
81406-37-3,0,OMOP Exposome,Observation,Substance,Fluroxypyr-meptyl,,2014-12-24,1,,,,,,,,,
85509-19-9,0,OMOP Exposome,Observation,Substance,Flusilazole,,2014-12-24,1,,,,,,,,,
13311-84-7,0,OMOP Exposome,Observation,Substance,Flutamide,"Dedile; Drogenil; Odyne; 4'-Nitro-3'-trifluoromethylisobutyranilide; alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide; Andraxan; Antipros; Curestat; Cytomid; Flutamidum; Elbat; Etaconil; Euflex; Eulexin; Farostat; Flimutal; Flucinom; Flulem; Flutamid; Prostadirex; FTA; NFBA; Niftolid; Prostanon; Niftolide; Flutamida; Flutamide USP25; CHEBI:5132",2014-12-24,1,,,,,,,,,
117337-19-6,0,OMOP Exposome,Observation,Substance,Fluthiacet-methyl,,2014-12-24,1,,,,,,,,,
66332-96-5,0,OMOP Exposome,Observation,Substance,Flutolanil,,2014-12-24,1,,,,,,,,,
69409-94-5,0,OMOP Exposome,Observation,Substance,Fluvalinate,Fluvalinic acid; Caswell No. 934; Apistan; Kartan; Fluvalinate-tau; Spur 22EW; SPUR; Minadox; Mavrik HR; Mavrik aquaflow; Mavrik 2E; Mavrik 25EC; Mavrik; Klartan; CHEBI:5135,2014-12-24,1,,,,,,,,,
54739-18-3,0,OMOP Exposome,Observation,Substance,Fluvoxamine,Faverin; Dumirox; Fevarin; Floxyfral; Fluvoxamina; Maveral; Fluvoxamine maleate; Fluvoxamine-CR; Fluvoxaminum; Luvox; CHEBI:5138,2014-12-24,1,,,,,,,,,
GIS1008770,0,OMOP Exposome,Observation,Substance,Focal adhesion,,2024-09-14,1,,,,,,,,,
Q05397,0,OMOP Exposome,Observation,Substance,Focal adhesion kinase 1,,2024-09-14,1,,,,,,,,,
GIS1008771,0,OMOP Exposome,Observation,Substance,Folate Metabolism,,2024-09-14,1,,,,,,,,,
P15328,0,OMOP Exposome,Observation,Substance,Folate receptor alpha,,2024-09-14,1,,,,,,,,,
P14207,0,OMOP Exposome,Observation,Substance,Folate receptor beta,,2024-09-14,1,,,,,,,,,
P41439,0,OMOP Exposome,Observation,Substance,Folate receptor gamma,,2024-09-14,1,,,,,,,,,
P41440,0,OMOP Exposome,Observation,Substance,Folate transporter 1,,2024-09-14,1,,,,,,,,,
59-30-3,0,OMOP Exposome,Observation,Substance,Folic acid,"Vitamin B9; Pteroylmonoglutamic acid; Pteroylglutamate; Pteroyl-L-monoglutamic acid; Pteroyl-L-monoglutamate; Pteroyl-L-glutamic acid; Pteroyl-L-glutamate; PteGlu; PGA; N-4-(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methylaminobenzoyl-L-glutamic acid; N-(4-{(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methylamino}phenyl)carbonyl-L-glutamic acid; N-Pteroyl-L-glutamic acid; N-(4-{(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methylamino}benzoyl)-L-glutamic acid; Millafol; Liver Lactobacillus casei factor; Folsaure; Folsav; Incafolic; Acfol; Acifolic; Cytofol; Dosfolat B activ; Folvite; Fefol; Folacid; Folacin; Foliamin; Vitamin Bc; Pteroylglutamic acid; Vitamin M; Folicet; Folipac; Vitamin Be; Folate; Folbal; Folcidin; Foldine; Folettes; Folsan; Folsaeure; CHEBI:27470",2014-12-24,1,,,,,,,,,
GIS1008772,0,OMOP Exposome,Observation,Substance,Folic Acid Antagonist,,2024-09-14,1,,,,,,,,,
133-07-3,0,OMOP Exposome,Observation,Substance,Folpet,"Ortho phaltan 50W; 2-((Trichloromethyl)thio)-1H-Isoindole-1,3(2H)-dione; 2-(Trichloromethylsulfanyl)isoindole-1,3-dione; 2-(Trichloromethyl)sulfanyl-1H-isoindole-1,3(2H)-dione; 2-(Trichloromethyl)thio-1H-Isoindole-1,3(2H)-dione; 2-(Trichloromethyl)thio-1H-isoindole-1,3(2H)-dione, 9CI; Acryptan; Cosan I; Cosan T; Diutrid; Faltan; Faltex; Folnit; Folpan; Folpel; Folpex; Ftalan; Fungitrol; Fungitrol 11; Fungitrol II; Intercide TMP; Murphy'S rose fungicide; N-((Trichloromethyl)thio)-Phthalimide; N-(Trichlor-methylthio)-phthalamid; N-(Trichlormethylthio)phthalimide; N-(Trichloromethanesulphenyl)phthalimide; N-(Trichloromethyl)thiophthalimide; N-(Trichloromethylmercapto)phthalimide; N-(Trichloromethylthio)phthalimide; N-(Trichloromethyl)thio-Phthalimide; N-(Trichloromethyl)thiophthalimide; Orthophaltan; Phaltan; Phaltane; Phalton; Phthalan; Phthalic acid,imide,N-trichloromethyl sulfenyl; Phthaltan; Spolacid; Thiophal; Trichlormethylthioimid kyseliny ftalove; Trichloromethyl(thio)phthalimide; Trichloromethylthiophthalimide; Trifol; Troysan anti-mildew O; Vinicoll; CHEBI:82019",2014-12-24,1,,,,,,,,,
Q05932,0,OMOP Exposome,Observation,Substance,"Folylpolyglutamate synthase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1008773,0,OMOP Exposome,Observation,Substance,Food Additive,,2024-09-14,1,,,,,,,,,
GIS1008774,0,OMOP Exposome,Observation,Substance,Food Preservative,,2024-09-14,1,,,,,,,,,
GIS1008775,0,OMOP Exposome,Observation,Substance,Food Toxin,,2024-09-14,1,,,,,,,,,
68157-60-8,0,OMOP Exposome,Observation,Substance,Forchlorfenuron,,2014-12-24,1,,,,,,,,,
50-00-0,0,OMOP Exposome,Observation,Substance,Formaldehyde,Formic aldehyde; Methaldehyde; Methanal; Methyl aldehyde; Methylene glycol; Methylene oxide; Oxomethane; Oxomethylene; Oxymethylene; Paraform; Paraformaldehyde; Fannoform; Formalin; Formalina; Formaline; Formalith; Formol; CHEBI:16842,2014-12-24,1,,,,,,,,,
22259-30-9,0,OMOP Exposome,Observation,Substance,Formetanate,M-(dimethylamino)methyleneaminophenyl methylcarbamate; M-(((dimethylamino)methylene)amino)phenyl methylcarbamate; Formetanic acid; 3-(Dimethylamino)methyleniminophenyl N-methylcarbamate; 3-Dimethylaminomethyleneaminophenyl methylcarbamate; Formetanat; Dicarzol; Caswell No. 465A; 3-{(dimethylamino)methylideneamino}phenyl methylcarbamate; CHEBI:38491,2014-12-24,1,,,,,,,,,
23422-53-9,0,OMOP Exposome,Observation,Substance,Formetanate hydrochloride,,2014-12-24,1,,,,,,,,,
O95954,0,OMOP Exposome,Observation,Substance,Formimidoyltransferase-cyclodeaminase,,2024-09-14,1,,,,,,,,,
17702-57-7,0,OMOP Exposome,Observation,Substance,Formparanate,,2014-12-24,1,,,,,,,,,
64657-11-0 and 66575-29-9,0,OMOP Exposome,Observation,Substance,Forskolin,,2014-12-24,1,,,,,,,,,
59682-52-9,0,OMOP Exposome,Observation,Substance,Fosamine,,2014-12-24,1,,,,,,,,,
93390-81-9,0,OMOP Exposome,Observation,Substance,Fosphenytoin,Fosphenytoinum; Prodilantin; (3-Phosphoryloxymethyl)phenytoin; Fosphenytoine; Fosfenitoina; Cerebyx; CHEBI:775287,2014-12-24,1,,,,,,,,,
GIS1008776,0,OMOP Exposome,Observation,Substance,Fosphenytoin (Antiarrhythmic) Pathway,,2024-09-14,1,,,,,,,,,
98886-44-3,0,OMOP Exposome,Observation,Substance,Fosthiazate,"(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate; Nemathorin; Fosthiazic acid; S-Sec-butyl O-ethyl (2-oxo-1,3-thiazolidin-3-yl)phosphonothioate; CHEBI:38692",2014-12-24,1,,,,,,,,,
GIS1008777,0,OMOP Exposome,Observation,Substance,Fragrance Toxin,,2024-09-14,1,,,,,,,,,
O15552,0,OMOP Exposome,Observation,Substance,Free fatty acid receptor 2,,2024-09-14,1,,,,,,,,,
GIS1008778,0,OMOP Exposome,Observation,Substance,Free Radical Scavenger,,2024-09-14,1,,,,,,,,,
GIS1008779,0,OMOP Exposome,Observation,Substance,Frog/Toad Toxin,,2024-09-14,1,,,,,,,,,
158747-02-5,0,OMOP Exposome,Observation,Substance,Frovatriptan,Frovatriptan succinate; Frova; Allergo filmtabletten; Miguard; Frovelan; CHEBI:350328,2014-12-24,1,,,,,,,,,
GIS1008781,0,OMOP Exposome,Observation,Substance,Fructose and Mannose Degradation,,2024-09-14,1,,,,,,,,,
GIS1008782,0,OMOP Exposome,Observation,Substance,Fructose intolerance,,2024-09-14,1,,,,,,,,,
GIS1008780,0,OMOP Exposome,Observation,Substance,Fructose-1,,2024-09-14,1,,,,,,,,,
P04075,0,OMOP Exposome,Observation,Substance,Fructose-bisphosphate aldolase A,,2024-09-14,1,,,,,,,,,
P05062,0,OMOP Exposome,Observation,Substance,Fructose-bisphosphate aldolase B,,2024-09-14,1,,,,,,,,,
GIS1008783,0,OMOP Exposome,Observation,Substance,Fructosuria,,2024-09-14,1,,,,,,,,,
GIS1008784,0,OMOP Exposome,Observation,Substance,Fuel,,2024-09-14,1,,,,,,,,,
129453-61-8,0,OMOP Exposome,Observation,Substance,Fulvestrant,"ICI 182,780; Faslodex; CHEBI:31638",2014-12-24,1,,,,,,,,,
23110-15-8,0,OMOP Exposome,Observation,Substance,Fumagillin,,2014-12-24,1,,,,,,,,,
GIS1008785,0,OMOP Exposome,Observation,Substance,Fumarase deficiency,,2024-09-14,1,,,,,,,,,
110-17-8,0,OMOP Exposome,Observation,Substance,Fumaric acid,"trans-1,2-Ethylenedicarboxylic acid; (E)-2-Butenedioate; trans-1,2-Ethylenedicarboxylate; Sodium fumarate; (2E)-But-2-enedioate; (2E)-But-2-enedioic acid; (E)-2-Butenedioic acid; 2-(E)-Butenedioate; 2-(E)-Butenedioic acid; trans-2-Butenedioate; trans-2-Butenedioic acid; trans-Butenedioate; trans-Butenedioic acid; Lichenic acid; Allomaleate; Allomaleic acid; Boletate; Boletic acid; Lichenate; FC 33; Fumarate; CHEBI:18012",2014-12-24,1,,,,,,,,,
117-52-2,0,OMOP Exposome,Observation,Substance,Fumarin,,2014-12-24,1,,,,,,,,,
P16930,0,OMOP Exposome,Observation,Substance,Fumarylacetoacetase,,2024-09-14,1,,,,,,,,,
12626-18-5,0,OMOP Exposome,Observation,Substance,Fumitremorgin A,,2014-12-24,1,,,,,,,,,
12626-17-4,0,OMOP Exposome,Observation,Substance,Fumitremorgin B,,2014-12-24,1,,,,,,,,,
118974-02-0,0,OMOP Exposome,Observation,Substance,Fumitremorgin C,,2014-12-24,1,,,,,,,,,
116355-83-0,0,OMOP Exposome,Observation,Substance,Fumonisin B1,Macrofusine; Macrofusin; Fungal metabolite from fusarium monliforme; Fumonisin b1; CHEBI:38221,2014-12-24,1,,,,,,,,,
116355-84-1,0,OMOP Exposome,Observation,Substance,Fumonisin B2,"Fumonisin B2 from Fusarium moniliforme; Fumonisin B2, Fusarium moniliforme; Fumonisin b2; CHEBI:38225",2014-12-24,1,,,,,,,,,
GIS1008786,0,OMOP Exposome,Observation,Substance,Fungal Toxin,,2024-09-14,1,,,,,,,,,
GIS1008787,0,OMOP Exposome,Observation,Substance,Fungicide,,2024-09-14,1,,,,,,,,,
110-00-9,0,OMOP Exposome,Observation,Substance,Furan,"Furfuran; Furane; Divinylene oxide; 1,4-Epoxy-1,3-butadiene; Oxacyclopentadiene; Oxole; Tetrole; CHEBI:35559",2020-07-08,1,,,,,,,,,
65907-30-4,0,OMOP Exposome,Observation,Substance,Furathiocarb,"2,3-Dihydro-2,2-dimethyl-7-benzofuranyl 2,4-dimethyl-5-oxo-6-oxa-3-thia-2,4-diazadecanoate; Promet 660SCO; Promet; Deltanit; Deltanet; Butyl 2,3-dihydro-2,2-dimethylbenzofuran-7-yl N,N-dimethyl-N,N-thiodicarbamate; CHEBI:38504",2014-12-24,1,,,,,,,,,
P09958,0,OMOP Exposome,Observation,Substance,Furin,,2024-09-14,1,,,,,,,,,
GIS1008788,0,OMOP Exposome,Observation,Substance,Furocoumarin,,2024-09-14,1,,,,,,,,,
23255-69-8,0,OMOP Exposome,Observation,Substance,Fusarenon-X,,2014-12-24,1,,,,,,,,,
536-69-6,0,OMOP Exposome,Observation,Substance,Fusaric Acid,,2014-12-24,1,,,,,,,,,
P48549,0,OMOP Exposome,Observation,Substance,G protein-activated inward rectifier potassium channel 1,,2024-09-14,1,,,,,,,,,
P48051,0,OMOP Exposome,Observation,Substance,G protein-activated inward rectifier potassium channel 2,,2024-09-14,1,,,,,,,,,
Q92806,0,OMOP Exposome,Observation,Substance,G protein-activated inward rectifier potassium channel 3,,2024-09-14,1,,,,,,,,,
P48544,0,OMOP Exposome,Observation,Substance,G protein-activated inward rectifier potassium channel 4,,2024-09-14,1,,,,,,,,,
Q8TDU6,0,OMOP Exposome,Observation,Substance,G-protein coupled bile acid receptor 1,,2024-09-14,1,,,,,,,,,
Q99527,0,OMOP Exposome,Observation,Substance,G-protein coupled estrogen receptor 1,,2024-09-14,1,,,,,,,,,
Q9HC97,0,OMOP Exposome,Observation,Substance,G-protein coupled receptor 35,,2024-09-14,1,,,,,,,,,
Q9Y2T6,0,OMOP Exposome,Observation,Substance,G-protein coupled receptor 55,,2024-09-14,1,,,,,,,,,
P24385,0,OMOP Exposome,Observation,Substance,G1/S-specific cyclin-D1,,2024-09-14,1,,,,,,,,,
P14635,0,OMOP Exposome,Observation,Substance,G2/mitotic-specific cyclin-B1,,2024-09-14,1,,,,,,,,,
GIS1008789,0,OMOP Exposome,Observation,Substance,GABA Agent,,2024-09-14,1,,,,,,,,,
GIS1008790,0,OMOP Exposome,Observation,Substance,GABA Agonist,,2024-09-14,1,,,,,,,,,
GIS1008791,0,OMOP Exposome,Observation,Substance,GABA Antagonist,,2024-09-14,1,,,,,,,,,
GIS1008794,0,OMOP Exposome,Observation,Substance,GABA Modulator,,2024-09-14,1,,,,,,,,,
BE0004797,0,OMOP Exposome,Observation,Substance,GABA-A receptor (anion channel),,2024-09-14,1,,,,,,,,,
GIS1008792,0,OMOP Exposome,Observation,Substance,GABA-A Receptor Agonist,,2024-09-14,1,,,,,,,,,
GIS1008795,0,OMOP Exposome,Observation,Substance,GABA-Transaminase Deficiency,,2024-09-14,1,,,,,,,,,
GIS1008793,0,OMOP Exposome,Observation,Substance,Gabaergic synapse,,2024-09-14,1,,,,,,,,,
60142-96-3,0,OMOP Exposome,Observation,Substance,Gabapentin,Gabapentino; Novo-Gabapentin; Gabapentin GR; Gabapentina; Aclonium; 1-(Aminomethyl)cyclohexaneacetic acid; Gralise; Gabapetin; Gabapentine; Novo-Gabapentine; Gabapentinum; Neurontin; CHEBI:42797,2014-12-24,1,,,,,,,,,
10168-81-7,0,OMOP Exposome,Observation,Substance,Gadolinium nitrate,,2014-12-24,1,,,,,,,,,
608-66-2,0,OMOP Exposome,Observation,Substance,Galactitol,Ambap5938; Melampyrite; Melampyrum; Melampyrit; Meso-galactitol; Melampyrin; Hexitol; Euonymit; Dulcitol; Dulcose; Dulcite; D-Dulcitol; CHEBI:16813,2018-03-21,1,,,,,,,,,
13382-27-9,0,OMOP Exposome,Observation,Substance,Galactonic acid,Galactonate; D-galactonate; D-galactonic acid; CHEBI:16534,2018-03-21,1,,,,,,,,,
GIS1008796,0,OMOP Exposome,Observation,Substance,Galactose Metabolism,,2024-09-14,1,,,,,,,,,
GIS1008797,0,OMOP Exposome,Observation,Substance,Galactosemia,,2024-09-14,1,,,,,,,,,
GIS1008798,0,OMOP Exposome,Observation,Substance,Galactosemia II (GALK),,2024-09-14,1,,,,,,,,,
2238-90-6,0,OMOP Exposome,Observation,Substance,Galactosylsphingosine,"2-Amino-3-hydroxy-4-octadecenyl Galactopyranoside; (E)-DL-erythro-b-D-2-amino-3-hydroxy-4-octadecenyl Galactopyranoside; (E)-DL-erythro-beta-delta-2-amino-3-hydroxy-4-octadecenyl Galactopyranoside; R-R*,S*-(E)-2-amino-3-hydroxy-4-octadecenyl b-D-Galactopyranoside; R-R*,S*-(E)-2-amino-3-hydroxy-4-octadecenyl b-delta-Galactopyranoside; Sphingosine galactoside; Psychosine; Erythro-Psychosine; CHEBI:16874",2018-03-21,1,,,,,,,,,
357-70-0,0,OMOP Exposome,Observation,Substance,Galantamine,Galanthamine hydrobromide; Lycoremine; Nivalin; Galanthamine; Razadyne; Reminyl; (-)-Galanthamine; CHEBI:5264,2014-12-24,1,,,,,,,,,
P05162,0,OMOP Exposome,Observation,Substance,Galectin-2,,2024-09-14,1,,,,,,,,,
P17931,0,OMOP Exposome,Observation,Substance,Galectin-3,,2024-09-14,1,,,,,,,,,
P47929,0,OMOP Exposome,Observation,Substance,Galectin-7,,2024-09-14,1,,,,,,,,,
1303-00-0,0,OMOP Exposome,Observation,Substance,Gallium arsenide,,2014-12-24,1,,,,,,,,,
12063-98-8,0,OMOP Exposome,Observation,Substance,Gallium phosphide,,2014-12-24,1,,,,,,,,,
12024-11-2,0,OMOP Exposome,Observation,Substance,Gallium(II) selenide,,2014-12-24,1,,,,,,,,,
13450-88-9,0,OMOP Exposome,Observation,Substance,Gallium(III) bromide,,2014-12-24,1,,,,,,,,,
12024-24-7,0,OMOP Exposome,Observation,Substance,Gallium(III) selenide,,2014-12-24,1,,,,,,,,,
1318-23-6,0,OMOP Exposome,Observation,Substance,gamma-Aluminum oxide hydroxide,\u03b3-Aluminum oxide hydroxide; Boehmite; Aluminum oxyhydroxide; g-Aluminum oxide hydroxide; Boehmite (al(oh)o); CHEBI:30189,2014-12-24,1,,,,,,,,,
21150-23-2,0,OMOP Exposome,Observation,Substance,gamma-Amanitin,,2014-12-24,1,,,,,,,,,
56-12-2,0,OMOP Exposome,Observation,Substance,Gamma-Aminobutyric acid,Gaballon; GABA; g-Aminobutyric acid; g-Aminobutyrate; Aminalon; 4-Aminobutyric acid; 4-Aminobutyrate; 4-Aminobutanoic acid; 4-Aminobutanoate; 3-Carboxypropylamine; Piperidinate; w-Aminobutyrate; w-Aminobutyric acid; \u03b3-Aminobutyrate; \u03b3-Aminobutyric acid; Mielogen; Gammasol; Gammar; Gammalone; Gammalon; gamma-Aminobutyric acid; gamma-Aminobutyrate; gamma Aminobutyric acid; gamma Aminobutyrate; Gamarex; Mielomade; Omega-Aminobutyrate; Omega-Aminobutyric acid; Piperidate; Piperidic acid; Piperidinic acid; CHEBI:16865,2018-03-21,1,,,,,,,,,
P14867,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit alpha-1,,2024-09-14,1,,,,,,,,,
P47869,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit alpha-2,,2024-09-14,1,,,,,,,,,
P34903,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit alpha-3,,2024-09-14,1,,,,,,,,,
P48169,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit alpha-4,,2024-09-14,1,,,,,,,,,
P31644,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit alpha-5,,2024-09-14,1,,,,,,,,,
Q16445,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit alpha-6,,2024-09-14,1,,,,,,,,,
P18505,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit beta-1,,2024-09-14,1,,,,,,,,,
P47870,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit beta-2,,2024-09-14,1,,,,,,,,,
P28472,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit beta-3,,2024-09-14,1,,,,,,,,,
O14764,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit delta,,2024-09-14,1,,,,,,,,,
P78334,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit epsilon,,2024-09-14,1,,,,,,,,,
Q8N1C3,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit gamma-1,,2024-09-14,1,,,,,,,,,
P18507,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit gamma-2,,2024-09-14,1,,,,,,,,,
Q99928,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit gamma-3,,2024-09-14,1,,,,,,,,,
O00591,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit pi,,2024-09-14,1,,,,,,,,,
P24046,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit rho-1,,2024-09-14,1,,,,,,,,,
P28476,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit rho-2,,2024-09-14,1,,,,,,,,,
A8MPY1,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit rho-3,,2024-09-14,1,,,,,,,,,
Q9UN88,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid receptor subunit theta,,2024-09-14,1,,,,,,,,,
Q9UBS5,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid type B receptor subunit 1,,2024-09-14,1,,,,,,,,,
O75899,0,OMOP Exposome,Observation,Substance,Gamma-aminobutyric acid type B receptor subunit 2,,2024-09-14,1,,,,,,,,,
O75936,0,OMOP Exposome,Observation,Substance,Gamma-butyrobetaine dioxygenase,,2024-09-14,1,,,,,,,,,
96-48-0,0,OMOP Exposome,Observation,Substance,Gamma-Butyrolactone,"1,4-Butanolide; \u03b3-Butyrolactone; Tetrahydro-2-furanone; Paint Clean G; GBL; gamma-Hydroxybutyric acid lactone; gamma-Butyryllactone; gamma-Butyrolactone; gamma-Butalactone; g-Hydroxybutyric acid lactone; g-Butyryllactone; g-Butyrolactone; g-Butalactone; dihydrofuran-2(3h)-one; Dihydro-2(3H)-furanone; Butyrolactone; Butyric acid lactone; 4-Hydroxybutyric acid lactone; 4-Hydroxybutanoic acid lactone; 4-Hydroxybutanoic acid; 4-Hydroxybutanoate; 4-Hydroxy-Butanoic acid g-lactone; 4-Hydroxy-Butanoic acid; 4-Hydroxy-Butanoate; 4-Deoxytetronic acid; 4-Deoxytetronate; 4-Butanolide; 4,5-Dihydro-2(3H)-furanone; 2-Oxotetrahydrofuran; 2-Oxolanone; 2,3,4,5-Tetrahydro-2-furanone; 1-Oxacyclopentan-2-one; 1,4-Lactone; CHEBI:42639",2014-12-24,1,,,,,,,,,
17465-86-0,0,OMOP Exposome,Observation,Substance,gamma-Cyclodextrin,,2014-12-24,1,,,,,,,,,
Q92820,0,OMOP Exposome,Observation,Substance,Gamma-glutamyl hydrolase,,2024-09-14,1,,,,,,,,,
GIS1008800,0,OMOP Exposome,Observation,Substance,Gamma-glutamyl-transpeptidase deficiency,,2024-09-14,1,,,,,,,,,
GIS1008799,0,OMOP Exposome,Observation,Substance,Gamma-Glutamyltransferase Deficiency,,2024-09-14,1,,,,,,,,,
P19440,0,OMOP Exposome,Observation,Substance,Gamma-glutamyltranspeptidase 1,,2024-09-14,1,,,,,,,,,
58-89-9,0,OMOP Exposome,Observation,Substance,gamma-Hexachlorocyclohexane,"\u03b3-lindane; Benzene hexachloride; 1,2,3,4,5,6-Hexachlorocyclohexane; g-Hexachlorocyclohexane; Gamene; gamma-1,2,3,4,5,6-Hexachlorocyclohexane; gamma-Benzene hexachloride; gamma-BHC; gamma-HCH; gamma-Hexachlorocyclohexane; gamma-Hexachlorzyklohexan; gamma-Lindane; Gammallin; \u03b3-Hexachlorzyklohexan; \u03b3-hexachlorocyclohexane; Kwell; Lindan; Gammaxene; Scabene; (1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane; (1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane; \u03b3-Hexachlorocyclohexane; CHEBI:32888",2014-12-24,1,,,,,,,,,
BE0004841,0,OMOP Exposome,Observation,Substance,Gamma-hydroxybutyrate (GHB) receptor,,2024-09-14,1,,,,,,,,,
99-85-4,0,OMOP Exposome,Observation,Substance,Gamma-terpinene,"1-Methyl-4-(1-methylethyl)-1,4-cyclohexadiene; 1,4-p-Menthadiene; 1-Isopropyl-4-methyl-1,4-cyclohexadiene; 1-Isopropyl-4-methylcyclohexa-1,4-diene; \u03b3-Terpinene; Terpinene; p-Mentha-1,4-diene; Moslene; Gamma-Terpinene; gamma-Terpinene; gamma-Terpinen; gamma Terpinene; g-Terpinene; Crithmene; alpha Terpinene; 4-Isopropyl-1-methyl-1,4-cyclohexadiene; 1-Methyl-4-(propan-2-yl)cyclohexa-1,4-diene; CHEBI:10577",2014-12-24,1,,,,,,,,,
GIS1008801,0,OMOP Exposome,Observation,Substance,Ganglionic Stimulant,,2024-09-14,1,,,,,,,,,
P17900,0,OMOP Exposome,Observation,Substance,Ganglioside GM2 activator,,2024-09-14,1,,,,,,,,,
GIS1008802,0,OMOP Exposome,Observation,Substance,Gasoline Additive/Component,,2024-09-14,1,,,,,,,,,
GIS1008803,0,OMOP Exposome,Observation,Substance,Gastric acid secretion,,2024-09-14,1,,,,,,,,,
P32239,0,OMOP Exposome,Observation,Substance,Gastrin/cholecystokinin type B receptor,,2024-09-14,1,,,,,,,,,
GIS1008804,0,OMOP Exposome,Observation,Substance,Gastrointestinal Agent,,2024-09-14,1,,,,,,,,,
GIS1008871,0,OMOP Exposome,Observation,Substance,Gastrointestinal Tract,,2024-09-14,1,,,,,,,,,
P51161,0,OMOP Exposome,Observation,Substance,Gastrotropin,,2024-09-14,1,,,,,,,,,
112811-59-3,0,OMOP Exposome,Observation,Substance,Gatifloxacin,"Gatifloxacinum; AM 1155; Gatifloxacine; Gatifloxacino; Zymar; Tequin; ZYMAXID; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid; CHEBI:5280",2014-12-24,1,,,,,,,,,
509-15-9,0,OMOP Exposome,Observation,Substance,Gelsemine,,2014-12-24,1,,,,,,,,,
25812-30-0,0,OMOP Exposome,Observation,Substance,Gemfibrozil,"Gen-Fibro; Gemfibrozilum; Gemfibrozilo; 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid; 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure; 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure; Lipur; Lopid; Jezil; Genlip; Gemlipid; CHEBI:5296",2014-12-24,1,,,,,,,,,
GIS1008872,0,OMOP Exposome,Observation,Substance,General Anesthetic,,2024-09-14,1,,,,,,,,,
14426-25-6,0,OMOP Exposome,Observation,Substance,Gentian Violet,Pyoctanine; Gentian violet(1+); Methyl Violet 10B; Gentian violet carbocation; Gentian violet; Crystal violet(1+); Crystal violet ion(1); Crystal violet carbocation; Crystal Violet; Gentian violet cation; Pyoctanin; CHEBI:604234,2014-12-24,1,,,,,,,,,
Q9NQX3,0,OMOP Exposome,Observation,Substance,Gephyrin,,2024-09-14,1,,,,,,,,,
105-87-3,0,OMOP Exposome,Observation,Substance,Geranyl acetate,,2014-12-24,1,,,,,,,,,
O95749,0,OMOP Exposome,Observation,Substance,Geranylgeranyl pyrophosphate synthase,,2024-09-14,1,,,,,,,,,
P53609,0,OMOP Exposome,Observation,Substance,Geranylgeranyl transferase type-1 subunit beta,,2024-09-14,1,,,,,,,,,
12065-10-0,0,OMOP Exposome,Observation,Substance,Germanium selenide,,2014-12-24,1,,,,,,,,,
GIS1008899,0,OMOP Exposome,Observation,Substance,Gingiva,,2024-09-14,1,,,,,,,,,
67-99-2,0,OMOP Exposome,Observation,Substance,Gliotoxin,,2014-12-24,1,,,,,,,,,
29094-61-9,0,OMOP Exposome,Observation,Substance,Glipizide,"Glidiab; 1-Cyclohexyl-3-({p-2-(5-methylpyrazinecarboxamido)ethylphenyl}sulfonyl)urea; Aldiab; Glican; Glibetin; Melizide; Mindiab; Glyde; Glupizide; Minidiab; Minidab; Napizide; CP 28,720; CP 28720; CP-28,720; Ozidia; Digrin; Dipazide; K 4024; Minodiab; Sucrazide; Zitrol XR; Glupitel; Glucozide; Glipid; Glipin; Glipizida; GlipizideER; Glipizidum; Glix; Glydiazinamide; Glucotrol XL; Glucotrol; Glucolip; Gluco-rite; N-{4-beta-(5-methylpyrazine-2-carboxamido)ethylbenzenesulphonyl}-n'-cyclohexylurea; Glibenese; CHEBI:239286",2014-12-24,1,,,,,,,,,
P47871,0,OMOP Exposome,Observation,Substance,Glucagon receptor,,2024-09-14,1,,,,,,,,,
GIS1008900,0,OMOP Exposome,Observation,Substance,Glucocorticoid,,2024-09-14,1,,,,,,,,,
P04150,0,OMOP Exposome,Observation,Substance,Glucocorticoid receptor,,2024-09-14,1,,,,,,,,,
P35557,0,OMOP Exposome,Observation,Substance,Glucokinase,,2024-09-14,1,,,,,,,,,
GIS1008917,0,OMOP Exposome,Observation,Substance,Gluconeogenesis,,2024-09-14,1,,,,,,,,,
P46926,0,OMOP Exposome,Observation,Substance,Glucosamine-6-phosphate isomerase 1,,2024-09-14,1,,,,,,,,,
GIS1008919,0,OMOP Exposome,Observation,Substance,Glucose Transporter Defect (SGLT2),,2024-09-14,1,,,,,,,,,
P11413,0,OMOP Exposome,Observation,Substance,Glucose-6-phosphate 1-dehydrogenase,,2024-09-14,1,,,,,,,,,
GIS1008918,0,OMOP Exposome,Observation,Substance,Glucose-Alanine Cycle,,2024-09-14,1,,,,,,,,,
GIS1008920,0,OMOP Exposome,Observation,Substance,Glue Component,,2024-09-14,1,,,,,,,,,
51276-47-2,0,OMOP Exposome,Observation,Substance,Glufosinate,Phosphinothricin hydrochloride; Phosphinothricin; NChemBio.2007.9-comp2; Glufosinic acid; ( -)-phosphinothricin; (+-)-2-amino-4-(Hydroxymethylphosphinyl)butanoic acid; (+-)-2-amino-4-(Hydroxymethylphosphinyl)butanoic acid (9ci); (2S)-2-amino-4-(Hydroxy-methylphosphoryl)butanoic acid; 2-amino-4-(Hydroxy-methyl-phosphoryl)butanoic acid; 2-amino-4-(Hydroxymethylphosphinyl)butanoic acid; 2-amino-4-(Hydroxymethylphosphinyl)butyric acid; 2-amino-4-Methylphosphinobutyric acid; 2-amino-4-Hydroxy(methyl)phosphorylbutanoic acid; 3-amino-3-Carboxypropylmethylphosphinic acid; 4-(Hydroxy(methyl)phosphinoyl)-DL-homoalanine; Ammonium glufosinate; ammonium-DL-homoalanine-4-yl(methyl)-phosphinate; Basta; DL-2-amino-4-(Methylphosphino)butanoic acid; DL-Homoalanin-4-yl (methyl)phosphinic acid; L-phophinothricin; Glufosinate ammonium; DL-phosphinothricin; CHEBI:52136,2014-12-24,1,,,,,,,,,
1724-02-3,0,OMOP Exposome,Observation,Substance,Glutaconic acid,"1-Propene-1,3-dicarboxylate; 1,3-Propenedicarboxylate; (E)-Glutaconic acid; (E)-Glutaconate; (E)-2-Pentenedioic acid; (E)-2-Pentenedioate; Pentenedioate; Pentenedioic acid; trans-Glutaconate; trans-Glutaconic acid; Glutaconate; 1-Propene-1,3-dicarboxylic acid; 1,3-Propenedicarboxylic acid; CHEBI:15670",2018-03-21,1,,,,,,,,,
BE0004852,0,OMOP Exposome,Observation,Substance,Glutamate (NMDA) receptor,,2024-09-14,1,,,,,,,,,
Q04609,0,OMOP Exposome,Observation,Substance,Glutamate carboxypeptidase 2,,2024-09-14,1,,,,,,,,,
Q99259,0,OMOP Exposome,Observation,Substance,Glutamate decarboxylase 1,,2024-09-14,1,,,,,,,,,
Q8IVA8,0,OMOP Exposome,Observation,Substance,"Glutamate decarboxylase 1 (Brain, 67kDa)",,2024-09-14,1,,,,,,,,,
Q05329,0,OMOP Exposome,Observation,Substance,Glutamate decarboxylase 2,,2024-09-14,1,,,,,,,,,
Q5VZ30,0,OMOP Exposome,Observation,Substance,"Glutamate decarboxylase 2 (Pancreatic islets and brain, 65kDa)",,2024-09-14,1,,,,,,,,,
P00367,0,OMOP Exposome,Observation,Substance,"Glutamate dehydrogenase 1, mitochondrial",,2024-09-14,1,,,,,,,,,
P49448,0,OMOP Exposome,Observation,Substance,"Glutamate dehydrogenase 2, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1008921,0,OMOP Exposome,Observation,Substance,Glutamate Metabolism,,2024-09-14,1,,,,,,,,,
P42261,0,OMOP Exposome,Observation,Substance,Glutamate receptor 1,,2024-09-14,1,,,,,,,,,
P42262,0,OMOP Exposome,Observation,Substance,Glutamate receptor 2,,2024-09-14,1,,,,,,,,,
P42263,0,OMOP Exposome,Observation,Substance,Glutamate receptor 3,,2024-09-14,1,,,,,,,,,
P48058,0,OMOP Exposome,Observation,Substance,Glutamate receptor 4,,2024-09-14,1,,,,,,,,,
Q9ULK0,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, delta-1",,2024-09-14,1,,,,,,,,,
O43424,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, delta-2",,2024-09-14,1,,,,,,,,,
P39086,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, kainate 1",,2024-09-14,1,,,,,,,,,
Q13002,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, kainate 2",,2024-09-14,1,,,,,,,,,
Q13003,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, kainate 3",,2024-09-14,1,,,,,,,,,
Q16099,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, kainate 4",,2024-09-14,1,,,,,,,,,
Q16478,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, kainate 5",,2024-09-14,1,,,,,,,,,
Q05586,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, NMDA 1",,2024-09-14,1,,,,,,,,,
Q12879,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, NMDA 2A",,2024-09-14,1,,,,,,,,,
Q13224,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, NMDA 2B",,2024-09-14,1,,,,,,,,,
Q14957,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, NMDA 2C",,2024-09-14,1,,,,,,,,,
O15399,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, NMDA 2D",,2024-09-14,1,,,,,,,,,
Q8TCU5,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, NMDA 3A",,2024-09-14,1,,,,,,,,,
O60391,0,OMOP Exposome,Observation,Substance,"Glutamate receptor ionotropic, NMDA 3B",,2024-09-14,1,,,,,,,,,
P48506,0,OMOP Exposome,Observation,Substance,Glutamate--cysteine ligase catalytic subunit,,2024-09-14,1,,,,,,,,,
P48507,0,OMOP Exposome,Observation,Substance,Glutamate--cysteine ligase regulatory subunit,,2024-09-14,1,,,,,,,,,
GIS1008922,0,OMOP Exposome,Observation,Substance,Glutamatergic synapse,,2024-09-14,1,,,,,,,,,
Q9UGI5,0,OMOP Exposome,Observation,Substance,Glutamic acid decarboxylase,,2024-09-14,1,,,,,,,,,
O94925,0,OMOP Exposome,Observation,Substance,"Glutaminase kidney isoform, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9UI32,0,OMOP Exposome,Observation,Substance,"Glutaminase liver isoform, mitochondrial",,2024-09-14,1,,,,,,,,,
P15104,0,OMOP Exposome,Observation,Substance,Glutamine synthetase,,2024-09-14,1,,,,,,,,,
Q6IA69,0,OMOP Exposome,Observation,Substance,Glutamine-dependent NAD(+) synthetase,,2024-09-14,1,,,,,,,,,
Q16769,0,OMOP Exposome,Observation,Substance,Glutaminyl-peptide cyclotransferase,,2024-09-14,1,,,,,,,,,
Q07075,0,OMOP Exposome,Observation,Substance,Glutamyl aminopeptidase,,2024-09-14,1,,,,,,,,,
O75879,0,OMOP Exposome,Observation,Substance,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial",,2024-09-14,1,,,,,,,,,
111-30-8,0,OMOP Exposome,Observation,Substance,Glutaral,"Gluteraldehyde; 1,3-Diformyl propane; 1,3-Diformylpropane; 1,5-Pentanedial; 1,5-Pentanedione; Aldehyd glutarowy; Aldesan; Aldesen; Alhydex; Aqucar; Bactron K31; Cidex; Cidex 7; Coldcide-25 microbiocide; Dioxopentane; Diswart; Gludesin; Glutaclean; Glutaral(usan); Glutaral, INN, USAN; Glutaraldehyd; Glutaraldehyde; GLUTARALDEHYDE, 25% SOLN; Glutaralum; Glutardialdehyde; Glutarex 28; Glutaric acid dialdehyde; Glutaric aldehyde; Glutaric dialdehyde; Glutarol; Glutarol-1,5-pentanedial; Glutural; Hospex; Novaruca; Pentane-1,5-dial; Pentanedial, homopolymer; Poly(glutaraldehyde); Polyglutaraldehyde; Potentiated acid glutaraldehyde; Protectol GDA, GT 50; PTD; Relugan GT; Relugan GT 50; Relugan GTW; Sonacide; Sporicidin; Sterihyde; Sterihyde L; Ucarcide; Ucarcide 225; Ucarcide 250; Ucarset; Veruca-sep; Verucasep; Virsal; CHEBI:64276",2014-12-24,1,,,,,,,,,
P35754,0,OMOP Exposome,Observation,Substance,Glutaredoxin-1,,2024-09-14,1,,,,,,,,,
Q9NS18,0,OMOP Exposome,Observation,Substance,"Glutaredoxin-2, mitochondrial",,2024-09-14,1,,,,,,,,,
110-94-1,0,OMOP Exposome,Observation,Substance,Glutaric acid,"Pentanedioate; Pentandioate; Glutarate; 1,5-Pentanedioic acid; 1,3-Propanedicarboxylic acid; 1,5-Pentanedioate; 1,3-Propanedicarboxylate; Pentandioic acid; Pentanedioic acid; CHEBI:17859",2018-03-21,1,,,,,,,,,
GIS1008923,0,OMOP Exposome,Observation,Substance,Glutaric Aciduria Type I,,2024-09-14,1,,,,,,,,,
GIS1008924,0,OMOP Exposome,Observation,Substance,Glutaric Aciduria Type III,,2024-09-14,1,,,,,,,,,
544-13-8,0,OMOP Exposome,Observation,Substance,Glutaronitrile,,2014-12-24,1,,,,,,,,,
Q92947,0,OMOP Exposome,Observation,Substance,"Glutaryl-CoA dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
70-18-8,0,OMOP Exposome,Observation,Substance,Glutathione,Tathione; Triptide; L-g-Glutamyl-L-cysteinyl-glycine; Isethion; GSH; Glutinal; Glutide; Glutatione; Glutatiol; Glutathione reduced; Glutathione red; Glutathion; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamyl-L-cysteinyl-glycine; gamma-Glutamylcysteinylglycine; Deltathione; Copren; Bakezyme RX; Agifutol S; 5-L-Glutamyl-L-cysteinylglycine; Glutathione-SH; L-Glutathione reduce; L-Glutathione; L-Glutamyl-L-cysteinylglycine; L-gamma-Glutamyl-L-cysteinylglycine; L-gamma-Glutamyl-L-cysteinyl-glycine; Red. glutathione; Reduced glutathione; Neuthion; N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine; Ledac; Tathion; CHEBI:16856,2014-12-24,1,,,,,,,,,
GIS1008925,0,OMOP Exposome,Observation,Substance,Glutathione biosynthesis,,2024-09-14,1,,,,,,,,,
GIS1008926,0,OMOP Exposome,Observation,Substance,Glutathione Metabolism,,2024-09-14,1,,,,,,,,,
Q6NSD4,0,OMOP Exposome,Observation,Substance,Glutathione peroxidase,,2024-09-14,1,,,,,,,,,
P07203,0,OMOP Exposome,Observation,Substance,Glutathione peroxidase 1,,2024-09-14,1,,,,,,,,,
P18283,0,OMOP Exposome,Observation,Substance,Glutathione peroxidase 2,,2024-09-14,1,,,,,,,,,
P22352,0,OMOP Exposome,Observation,Substance,Glutathione peroxidase 3,,2024-09-14,1,,,,,,,,,
P59796,0,OMOP Exposome,Observation,Substance,Glutathione peroxidase 6,,2024-09-14,1,,,,,,,,,
Q96SL4,0,OMOP Exposome,Observation,Substance,Glutathione peroxidase 7,,2024-09-14,1,,,,,,,,,
P00390,0,OMOP Exposome,Observation,Substance,"Glutathione reductase, mitochondrial",,2024-09-14,1,,,,,,,,,
P08263,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase A1,,2024-09-14,1,,,,,,,,,
P09210,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase A2,,2024-09-14,1,,,,,,,,,
Q16772,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase A3,,2024-09-14,1,,,,,,,,,
O15217,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase A4,,2024-09-14,1,,,,,,,,,
Q7RTV2,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase A5,,2024-09-14,1,,,,,,,,,
Q9Y2Q3,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase kappa 1,,2024-09-14,1,,,,,,,,,
P09488,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase Mu 1,,2024-09-14,1,,,,,,,,,
P28161,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase Mu 2,,2024-09-14,1,,,,,,,,,
P21266,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase Mu 3,,2024-09-14,1,,,,,,,,,
Q03013,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase Mu 4,,2024-09-14,1,,,,,,,,,
P46439,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase Mu 5,,2024-09-14,1,,,,,,,,,
P78417,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase omega-1,,2024-09-14,1,,,,,,,,,
Q9H4Y5,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase omega-2,,2024-09-14,1,,,,,,,,,
P09211,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase P,,2024-09-14,1,,,,,,,,,
BE0005328,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase pi,,2024-09-14,1,,,,,,,,,
P30711,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase theta-1,,2024-09-14,1,,,,,,,,,
P0CG29,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase theta-2,,2024-09-14,1,,,,,,,,,
A8MPT4,0,OMOP Exposome,Observation,Substance,Glutathione S-transferase theta-4,,2024-09-14,1,,,,,,,,,
P48637,0,OMOP Exposome,Observation,Substance,Glutathione synthetase,,2024-09-14,1,,,,,,,,,
GIS1008927,0,OMOP Exposome,Observation,Substance,Glutathione Synthetase Deficiency,,2024-09-14,1,,,,,,,,,
56-82-6,0,OMOP Exposome,Observation,Substance,Glyceraldehyde,"D-(+)-Glyceraldehyde; alpha,beta-Dihydroxypropionaldehyde; 2,3-Dihydroxypropionaldehyde; D-Aldotriose; D-Glyceraldehyde; D-Glycerose; delta-(+)-Glyceraldehyde; 2,3-Dihydroxypropanal; (+/-)-Glyceraldehyde; (+/-)-2,3-dihydroxy-Propanal; delta-2,3-Dihydroxypropanal; Glycerinformal; delta-2,3-Dihydroxypropionaldehyde; Glycerose; delta-Aldotriose; delta-Glyceraldehyde; delta-Glycerose; Dihydroxypropionaldehyde; DL-Glyceraldehyde; Glyceric aldehyde; Glycerinaldehyde; D-2,3-Dihydroxypropionaldehyde; D-2,3-Dihydroxypropanal; CHEBI:5445",2018-03-21,1,,,,,,,,,
P04406,0,OMOP Exposome,Observation,Substance,Glyceraldehyde-3-phosphate dehydrogenase,,2024-09-14,1,,,,,,,,,
O14556,0,OMOP Exposome,Observation,Substance,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",,2024-09-14,1,,,,,,,,,
473-81-4,0,OMOP Exposome,Observation,Substance,Glyceric acid,"a,b-Hydroxypropionic acid; a,b-Hydroxypropionate; Glycerate; D-Glyceric acid; D-Glycerate; (R)-glycerate; CHEBI:32398",2018-03-21,1,,,,,,,,,
56-81-5,0,OMOP Exposome,Observation,Substance,Glycerol,"Bulbold; E 422; Emery 916; Glyceol Opthalgan; Tryhydroxypropane; Trihydroxypropane; RG-S; Propanetriol; Pricerine 9091; Osmoglyn; Mackstat H 66; Incorporation factor; IFP; Glysanin; Glyrol; Glycyl alcohol; Glyceritol; Glycerine; Glycerin; 1,2,3-Trihydroxypropane; Cristal; CHEBI:17522",2018-03-21,1,,,,,,,,,
GIS1008929,0,OMOP Exposome,Observation,Substance,Glycerol Kinase Deficiency,,2024-09-14,1,,,,,,,,,
P21695,0,OMOP Exposome,Observation,Substance,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",,2024-09-14,1,,,,,,,,,
P43304,0,OMOP Exposome,Observation,Substance,"Glycerol-3-phosphate dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1008928,0,OMOP Exposome,Observation,Substance,Glycerolipid Metabolism,,2024-09-14,1,,,,,,,,,
556-52-5,0,OMOP Exposome,Observation,Substance,Glycidol,"(RS)-3-hydroxy-1,2-epoxypropane; 2,3-Epoxy-1-propanol; 3-Hydroxypropylene oxide; 3-Hydroxy-1,2-epoxypropane; Oxiranemethanol; CHEBI:CHEBI:30966",2014-12-24,1,,,,,,,,,
56-40-6,0,OMOP Exposome,Observation,Substance,Glycine,H2N-CH2-COOH; Hgly; Leimzucker; Padil; Glykokoll; G; Glycosthene; Aminoethanoic acid; Aminoethanoate; Glycolixir; Gly; Glycocoll; Glicoamin; 2-Aminoacetate; 2-Aminoacetic acid; Aminoessigsaeure; Aminoacetic acid; Aminoacetate; Amino-Acetic acid; Amino-Acetate; Aciport; Glycin; Gyn-Hydralin; Glyzin; CHEBI:15428,2018-03-21,1,,,,,,,,,
GIS1008930,0,OMOP Exposome,Observation,Substance,Glycine Agent,,2024-09-14,1,,,,,,,,,
P50440,0,OMOP Exposome,Observation,Substance,"Glycine amidinotransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1008931,0,OMOP Exposome,Observation,Substance,Glycine and Serine Metabolism,,2024-09-14,1,,,,,,,,,
P23434,0,OMOP Exposome,Observation,Substance,"Glycine cleavage system H protein, mitochondrial",,2024-09-14,1,,,,,,,,,
P23378,0,OMOP Exposome,Observation,Substance,"Glycine dehydrogenase (decarboxylating), mitochondrial",,2024-09-14,1,,,,,,,,,
BE0000618,0,OMOP Exposome,Observation,Substance,"Glycine dehydrogenase [decarboxylating], mitochondrial",,2024-09-14,1,,,,,,,,,
Q6IB77,0,OMOP Exposome,Observation,Substance,Glycine N-acyltransferase,,2024-09-14,1,,,,,,,,,
Q969I3,0,OMOP Exposome,Observation,Substance,Glycine N-acyltransferase-like protein 1,,2024-09-14,1,,,,,,,,,
Q8WU03,0,OMOP Exposome,Observation,Substance,Glycine N-acyltransferase-like protein 2,,2024-09-14,1,,,,,,,,,
Q14749,0,OMOP Exposome,Observation,Substance,Glycine N-methyltransferase,,2024-09-14,1,,,,,,,,,
GIS1008932,0,OMOP Exposome,Observation,Substance,Glycine N-methyltransferase Deficiency,,2024-09-14,1,,,,,,,,,
BE0004857,0,OMOP Exposome,Observation,Substance,Glycine receptor (alpha-1/beta),,2024-09-14,1,,,,,,,,,
P23415,0,OMOP Exposome,Observation,Substance,Glycine receptor subunit alpha-1,,2024-09-14,1,,,,,,,,,
P23416,0,OMOP Exposome,Observation,Substance,Glycine receptor subunit alpha-2,,2024-09-14,1,,,,,,,,,
O75311,0,OMOP Exposome,Observation,Substance,Glycine receptor subunit alpha-3,,2024-09-14,1,,,,,,,,,
Q5JXX5,0,OMOP Exposome,Observation,Substance,Glycine receptor subunit alpha-4,,2024-09-14,1,,,,,,,,,
P48167,0,OMOP Exposome,Observation,Substance,Glycine receptor subunit beta,,2024-09-14,1,,,,,,,,,
P41250,0,OMOP Exposome,Observation,Substance,Glycine--tRNA ligase,,2024-09-14,1,,,,,,,,,
P09466,0,OMOP Exposome,Observation,Substance,Glycodelin,,2024-09-14,1,,,,,,,,,
P11216,0,OMOP Exposome,Observation,Substance,"Glycogen phosphorylase, brain form",,2024-09-14,1,,,,,,,,,
P06737,0,OMOP Exposome,Observation,Substance,"Glycogen phosphorylase, liver form",,2024-09-14,1,,,,,,,,,
P11217,0,OMOP Exposome,Observation,Substance,"Glycogen phosphorylase, muscle form",,2024-09-14,1,,,,,,,,,
GIS1008934,0,OMOP Exposome,Observation,Substance,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,,2024-09-14,1,,,,,,,,,
P49841,0,OMOP Exposome,Observation,Substance,Glycogen synthase kinase-3 beta,,2024-09-14,1,,,,,,,,,
GIS1008933,0,OMOP Exposome,Observation,Substance,Glycogenosis,,2024-09-14,1,,,,,,,,,
79-14-1,0,OMOP Exposome,Observation,Substance,Glycolic acid,alpha-Hydroxyacetate; 2-Hydroxyacetate; 2-Hydroxyacetic acid; a-Hydroxyacetate; a-Hydroxyacetic acid; alpha-Hydroxyacetic acid; Glycocide; Glycolate; Glycollate; Glycollic acid; GlyPure; GlyPure 70; Hydroxyacetate; Hydroxyacetic acid; Hydroxyethanoate; Hydroxyethanoic acid; Sodium glycolate; CHEBI:29805,2018-03-21,1,,,,,,,,,
Q9NZD2,0,OMOP Exposome,Observation,Substance,Glycolipid transfer protein,,2024-09-14,1,,,,,,,,,
496-46-8,0,OMOP Exposome,Observation,Substance,Glycoluril,,2014-12-24,1,,,,,,,,,
GIS1008935,0,OMOP Exposome,Observation,Substance,Glycolysis,,2024-09-14,1,,,,,,,,,
GIS1008936,0,OMOP Exposome,Observation,Substance,Glycopeptide Antibacterial,,2024-09-14,1,,,,,,,,,
Q5SRI9,0,OMOP Exposome,Observation,Substance,"Glycoprotein endo-alpha-1,2-mannosidase",,2024-09-14,1,,,,,,,,,
Q7Z4J2,0,OMOP Exposome,Observation,Substance,Glycosyltransferase 6 domain-containing protein 1,,2024-09-14,1,,,,,,,,,
298-12-4,0,OMOP Exposome,Observation,Substance,Glyoxylic acid,Oxalaldehydate; Glyoxylate; Glyoxalic acid; Oxoacetate; Glyoxalate; Oxoacetic acid; alpha-Ketoacetate; a-Ketoacetic acid; a-Ketoacetate; Oxalaldehydic acid; Formylformic acid; Oxoethanoate; Oxoethanoic acid; Formylformate; alpha-Ketoacetic acid; CHEBI:16891,2018-03-21,1,,,,,,,,,
P49915,0,OMOP Exposome,Observation,Substance,GMP synthase [glutamine-hydrolyzing],,2024-09-14,1,,,,,,,,,
10294-28-7,0,OMOP Exposome,Observation,Substance,Gold(III) bromide,Hydrogen tetrabromoaurate(III) hydrate; Gold(III) bromide hydrate; gold(3+) bromide; Gold tribromide; Gold Bromide (aubr3); AuBr3; AuBr3; CHEBI:30079,2014-12-24,1,,,,,,,,,
GIS1008937,0,OMOP Exposome,Observation,Substance,Golgi apparatus,,2024-09-14,1,,,,,,,,,
GIS1008938,0,OMOP Exposome,Observation,Substance,Gonadotropin-Releasing Hormone,,2024-09-14,1,,,,,,,,,
GIS1008939,0,OMOP Exposome,Observation,Substance,Gonadotropin-releasing hormone agonist,,2024-09-14,1,,,,,,,,,
P30968,0,OMOP Exposome,Observation,Substance,Gonadotropin-releasing hormone receptor,,2024-09-14,1,,,,,,,,,
GIS1008940,0,OMOP Exposome,Observation,Substance,Gonads,,2024-09-14,1,,,,,,,,,
60748-39-2,0,OMOP Exposome,Observation,Substance,Gonyautoxin I,,2014-12-24,1,,,,,,,,,
60508-89-6,0,OMOP Exposome,Observation,Substance,Gonyautoxin II,,2014-12-24,1,,,,,,,,,
GIS1008941,0,OMOP Exposome,Observation,Substance,Gout Suppressant,,2024-09-14,1,,,,,,,,,
152617-90-8,0,OMOP Exposome,Observation,Substance,Grammotoxin,,2014-12-24,1,,,,,,,,,
4720-09-6,0,OMOP Exposome,Observation,Substance,Grayanotoxin I,,2014-12-24,1,,,,,,,,,
4678-44-8,0,OMOP Exposome,Observation,Substance,Grayanotoxin II,,2014-12-24,1,,,,,,,,,
4678-45-9,0,OMOP Exposome,Observation,Substance,Grayanotoxin III,,2014-12-24,1,,,,,,,,,
126-07-8,0,OMOP Exposome,Observation,Substance,Griseofulvin,Poncyl; Likuden; Lamoryl; Grysio; Grisovin; Fulcin; S-Fulvin; Curling factor; Grifulvin; Fulvicin; Grifulvin V; Gris-PEG; Grisactin; Griseofulvina; Griseofulvine; Griseofulvinum; Grison-250; Spirofulvin; Sporostatin; Crivicin; Amudane; (+)-griseofulvin; CHEBI:27779,2014-12-24,1,,,,,,,,,
GIS1008942,0,OMOP Exposome,Observation,Substance,grivet_ABCB1 (p-glycoprotein),,2024-09-14,1,,,,,,,,,
Q9UNK4,0,OMOP Exposome,Observation,Substance,Group IID secretory phospholipase A2,,2024-09-14,1,,,,,,,,,
Q9NZK7,0,OMOP Exposome,Observation,Substance,Group IIE secretory phospholipase A2,,2024-09-14,1,,,,,,,,,
Q02643,0,OMOP Exposome,Observation,Substance,Growth hormone-releasing hormone receptor,,2024-09-14,1,,,,,,,,,
GIS1008943,0,OMOP Exposome,Observation,Substance,Growth Inhibitor,,2024-09-14,1,,,,,,,,,
P43026,0,OMOP Exposome,Observation,Substance,Growth/differentiation factor 5,,2024-09-14,1,,,,,,,,,
P30793,0,OMOP Exposome,Observation,Substance,GTP cyclohydrolase 1,,2024-09-14,1,,,,,,,,,
Q9UIJ7,0,OMOP Exposome,Observation,Substance,"GTP:AMP phosphotransferase AK3, mitochondrial",,2024-09-14,1,,,,,,,,,
1990-05-01,0,OMOP Exposome,Observation,Substance,Guaiacol,O-Methoxyphenol; Creodon; 2-Methoxy-Phenol; Catechol monomethyl ether; Guaiastil; Methylcatechol; Anastil; O-Hydroxyanisole; Guajakol; Guajol; Guasol; Guiacol; 2-Methoxyphenol; Methoxyphenol; O-Methoxy-Phenol; Guaiacol (liquid) extra pure; O-Methyl catechol; Guaicol; Guaicolina; 2-Hydroxyanisole; 1-Hydroxy-2-methoxybenzene; Pyrocatechol monomethyl ether; Methylcatachol; O-Guaiacol; Pyroguaiac acid; CHEBI:28591,2014-12-24,1,,,,,,,,,
93-14-1,0,OMOP Exposome,Observation,Substance,Guaifenesin,,2014-12-24,1,,,,,,,,,
113-00-8,0,OMOP Exposome,Observation,Substance,Guanidine,Iminourea; Aminoformamidine; (4-Aminobutyl) guanidine; Imidourea; Guanidin; Gu; GUANIDINE; H2N-C(=NH)-NH2; Carbamidine; Carbamamidine; Aminomethanamidine; CHEBI:24435,2014-12-24,1,,,,,,,,,
506-93-4,0,OMOP Exposome,Observation,Substance,Guanidine nitrate,,2014-12-24,1,,,,,,,,,
GIS1008944,0,OMOP Exposome,Observation,Substance,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),,2024-09-14,1,,,,,,,,,
Q14353,0,OMOP Exposome,Observation,Substance,Guanidinoacetate N-methyltransferase,,2024-09-14,1,,,,,,,,,
6133-30-8,0,OMOP Exposome,Observation,Substance,Guanidinosuccinic acid,N-Amidino-L-aspartic acid; Guanidinosuccinate; L-N-Amidinoaspartic acid; N-(Aminoiminomethyl)-L-aspartic acid; N-Amidino-L-aspartate; N-Carbamimidoyl-L-aspartic acid; CHEBI:17072,2014-12-24,1,,,,,,,,,
352-97-6,0,OMOP Exposome,Observation,Substance,Guanidoacetic acid,(aminoiminomethyl)amino-Acetic acid; b-Guanidinoacetic acid; b-Guanidinoacetate; beta-Guanidinoacetate; beta-Guanidinoacetic acid; Betacyamine; Betasyamine; Glycocyamine; Guanidineacetate; Guanidineacetic acid; alpha-Guanidinoacetic acid; alpha-Guanidinoacetate; a-Guanidinoacetic acid; a-Guanidinoacetate; 2-Amino(imino)methylaminoacetic acid; 2-Amino(imino)methylaminoacetate; (carboxymethyl)-Guanidine; Guanidylacetate; Guanidylacetic acid; Guanyl glycine; N-Amidino-Glycine; N-Amidinoglycine; (aminoiminomethyl)amino-Acetate; Guanidinoacetate; Guanidinoacetic acid; Guanidoacetate; CHEBI:16344,2014-12-24,1,,,,,,,,,
Q9Y2T3,0,OMOP Exposome,Observation,Substance,Guanine deaminase,,2024-09-14,1,,,,,,,,,
P63096,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(i) subunit alpha-1,,2024-09-14,1,,,,,,,,,
P04899,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(i) subunit alpha-2,,2024-09-14,1,,,,,,,,,
P59768,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,,2024-09-14,1,,,,,,,,,
P09471,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(o) subunit alpha,,2024-09-14,1,,,,,,,,,
P50148,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(q) subunit alpha,,2024-09-14,1,,,,,,,,,
P63092,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,,2024-09-14,1,,,,,,,,,
Q5JWF2,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas,,2024-09-14,1,,,,,,,,,
P11488,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(t) subunit alpha-1,,2024-09-14,1,,,,,,,,,
P19087,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(t) subunit alpha-2,,2024-09-14,1,,,,,,,,,
A8MTJ3,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein G(t) subunit alpha-3,,2024-09-14,1,,,,,,,,,
Q03113,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein subunit alpha-12,,2024-09-14,1,,,,,,,,,
Q14344,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein subunit alpha-13,,2024-09-14,1,,,,,,,,,
P30679,0,OMOP Exposome,Observation,Substance,Guanine nucleotide-binding protein subunit alpha-15,,2024-09-14,1,,,,,,,,,
GIS1008945,0,OMOP Exposome,Observation,Substance,Gut,,2024-09-14,1,,,,,,,,,
86-50-0,0,OMOP Exposome,Observation,Substance,Guthion,"Dimethyl dithiophosphoric acid N-methylbenzazimidyl ester; 3-(Mercaptomethyl)-1,2,3-benzotriazin-4(3H)-one, O,O-dimethyl phosphorodithioate; Azimil; Azinfos-methyl; Azinophos-methyl; Azinphos; Azinphos methyl; Azinphos methyl mixture; Azinphos-me; Azinphos-metile; Azinphosmethyl; Beetle buster; Benzotriazinedithiophosphoric acid dimethoxy ester; Carfene; Cotneon; Cotnion; Cotnion methyl; Crysthyon; Dimethyldithiophosphoric acid N-methylbenzazimide ester; Go thnion; Gothnion; Gusathion; Gusathion methyl; Gusthion m; Guthion (azinphos-methyl); Guthion mixture; Guthion(r); Guthion, gusation; Gution; Metazintox; Methyl azinphos; Methyl gusathion; Methyl guthion; Methylazinphos; Methylgusathion; Methyltriazotin; Metiltriazotion; N-Methylbenzazimide, dimethyl dithiophosphoric acid ester; N-methylbenzazimide, dimethyldithiophosphoric acid ester; Nitrinal; O,O-Dimethyl S-(3,4-dihydro-4-keto-1,2,3-benzotriazinyl-3-methyl) dithiophosphate; O,O-dimethyl S-(be nzaziminomethyl) dithiophosphate; O,O-dimethyl S-(benzaziminomethyl) dithiophosphate; O,O-Dimethyl S-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)methyl dithiophosphate; O,O-Dimethyl-S-(4-oxobenzotriazin-3-methyl)-dithiophosphat; O,O-dimethyl-s-(benzaziminomethyl) dithiophosphate; Phosphorodithioic acid, O,O-dimethyl S-((4-oxo-1,2,3-benzotriazin-3(4H)-yl)methyl) ester; Zinphos methyl; CHEBI:2953",2014-12-24,1,,,,,,,,,
173792-58-0,0,OMOP Exposome,Observation,Substance,Gymnodimine,,2014-12-24,1,,,,,,,,,
16568-02-8,0,OMOP Exposome,Observation,Substance,Gyromitrin,"Acetaldehyde, N-formyl-N-methylhydrazone; Acetaldehyde N-formyl-N-methylhydrazone; N'--Ethylidene-N-methylformic hydrazide; N'-(1E)-Ethylidene-N-methylformic hydrazide; N'-Ethylidene-N-methylformohydrazide; Ethylidenemethylhydrazinecarboxaldehyde, 9CI; N'-Ethylidene-N-methylformic hydrazide; N'-Ethylidene-N-formyl-N-methylhydrazine; Acetaldehyde N-methyl-N-formylhydrazone; Acetaldehyde N-methylformylhydrazone; Acetaldehyde-N-formyl-N-methylhydrazone; Acetaldehyde-N-methyl-N-formylhydrazone; Acetylaldehyde-N-methyl-N-formylhydrazone; N-Methyl-N-formylhydrazone acetaldehyde; N-Methyl-N-formyl hydrazone of acetaldehyde; Ethylidenemethyl-Hydrazinecarboxaldehyde; Ethylidenemethyl-Hydrazine carboxyaldehyde; Ethylidenemethyl-Hydrazine carboxaldehyde; Acetaldehyde formylmethylhydrazone; Hydrazinecarboxaldehyde, ethylidenemethyl- (9CI); Cetaldehyde methylformylhydrazone; Ethylidene gyromitrin; Formic acid, ethylidenemethylhydrazide; Formic acid, 2-ethylidene-1-methylhydrazide; Formic acid 2-ethylidene-1-methylhydrazide; Acetaldehyde methylformylhydrazone; CHEBI:5583",2014-12-24,1,,,,,,,,,
P51790,0,OMOP Exposome,Observation,Substance,H(+)/Cl(-) exchange transporter 3,,2024-09-14,1,,,,,,,,,
P51793,0,OMOP Exposome,Observation,Substance,H(+)/Cl(-) exchange transporter 4,,2024-09-14,1,,,,,,,,,
P51795,0,OMOP Exposome,Observation,Substance,H(+)/Cl(-) exchange transporter 5,,2024-09-14,1,,,,,,,,,
P51798,0,OMOP Exposome,Observation,Substance,H(+)/Cl(-) exchange transporter 7,,2024-09-14,1,,,,,,,,,
GIS1008946,0,OMOP Exposome,Observation,Substance,Hair,,2024-09-14,1,,,,,,,,,
23092-17-3,0,OMOP Exposome,Observation,Substance,Halazepam,Paxipam; Alapryl; Halazepamum; Pacinone; CHEBI:195970,2014-12-24,1,,,,,,,,,
GIS1008947,0,OMOP Exposome,Observation,Substance,Hallucinogen,,2024-09-14,1,,,,,,,,,
GIS1008948,0,OMOP Exposome,Observation,Substance,Halogen,,2024-09-14,1,,,,,,,,,
52-86-8,0,OMOP Exposome,Observation,Substance,Haloperidol,1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine; Duraperidol; 4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone; Dozic; 4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone; Haldol; Brotopon; Bioperidolo; Haloperidolum; Halosten; Keselan; gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone; Eukystol; Linton; Peluces; Aloperidin; 4-4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl-1-(4-fluorophenyl)-butan-1-one; Serenace; 4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone; Sigaperidol; Einalon S; CHEBI:5613,2014-12-24,1,,,,,,,,,
100784-20-1,0,OMOP Exposome,Observation,Substance,Halosulfuron-methyl,,2014-12-24,1,,,,,,,,,
151-67-7,0,OMOP Exposome,Observation,Substance,Halothane,"Bromchlortrifluoraethanum; Fluothane; Freon 123b1; 2-Bromo-2-Chloro-1,1,1-Trifluoroethane; 2,2,2-Trifluoro-1-chloro-1-bromoethane; 1-Bromo-1-chloro-2,2,2-trifluoroethane; 1,1,1-Trifluoro-2-chloro-2-bromoethane; 1,1,1-Trifluoro-2-bromo-2-chloroethane; Ftorotan; Ftuorotan; Halotan; Halotano; Rhodialothan; Phthorothanum; Bromochlorotrifluoroethane; Narcotane; Halothan; Halothanum; Narcotann ne-spofa; Narcotan; Fluorotane; Alotano; Fluorothane; Cf3chclbr; CHEBI:5615",2014-12-24,1,,,,,,,,,
59128-97-1,0,OMOP Exposome,Observation,Substance,Haloxazolam,,2014-12-24,1,,,,,,,,,
170780-01-5,0,OMOP Exposome,Observation,Substance,Hanatoxin,,2014-12-24,1,,,,,,,,,
P00738,0,OMOP Exposome,Observation,Substance,Haptoglobin,,2024-09-14,1,,,,,,,,,
GIS1008949,0,OMOP Exposome,Observation,Substance,Hartnup Disorder,,2024-09-14,1,,,,,,,,,
63224-90-8,0,OMOP Exposome,Observation,Substance,Hawkinsin,,2018-03-21,1,,,,,,,,,
GIS1008950,0,OMOP Exposome,Observation,Substance,Hawkinsinuria,,2024-09-14,1,,,,,,,,,
Q5T1J1,0,OMOP Exposome,Observation,Substance,"HCG20471, isoform CRA_c",,2024-09-14,1,,,,,,,,,
GIS1008951,0,OMOP Exposome,Observation,Substance,Heart,,2024-09-14,1,,,,,,,,,
P0DMV8,0,OMOP Exposome,Observation,Substance,Heat shock 70 kDa protein 1A,,2024-09-14,1,,,,,,,,,
BE0001022,0,OMOP Exposome,Observation,Substance,Heat shock 70 kDa protein 1A/1B,,2024-09-14,1,,,,,,,,,
P0DMV9,0,OMOP Exposome,Observation,Substance,Heat shock 70 kDa protein 1B,,2024-09-14,1,,,,,,,,,
P11142,0,OMOP Exposome,Observation,Substance,Heat shock cognate 71 kDa protein,,2024-09-14,1,,,,,,,,,
Q00613,0,OMOP Exposome,Observation,Substance,Heat shock factor protein 1,,2024-09-14,1,,,,,,,,,
Q12931,0,OMOP Exposome,Observation,Substance,"Heat shock protein 75 kDa, mitochondrial",,2024-09-14,1,,,,,,,,,
P07900,0,OMOP Exposome,Observation,Substance,Heat shock protein HSP 90-alpha,,2024-09-14,1,,,,,,,,,
P08238,0,OMOP Exposome,Observation,Substance,Heat shock protein HSP 90-beta,,2024-09-14,1,,,,,,,,,
GIS1008952,0,OMOP Exposome,Observation,Substance,Heat-labile enterotoxin (Escherichia coli),,2024-09-14,1,,,,,,,,,
GIS1008962,0,OMOP Exposome,Observation,Substance,Hedgehog Signaling Pathway,,2024-09-14,1,,,,,,,,,
GIS1008963,0,OMOP Exposome,Observation,Substance,Hematinic,,2024-09-14,1,,,,,,,,,
O60760,0,OMOP Exposome,Observation,Substance,Hematopoietic prostaglandin D synthase,,2024-09-14,1,,,,,,,,,
P69905,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit alpha,,2024-09-14,1,,,,,,,,,
P68871,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit beta,,2024-09-14,1,,,,,,,,,
P02042,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit delta,,2024-09-14,1,,,,,,,,,
P02100,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit epsilon,,2024-09-14,1,,,,,,,,,
P69891,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit gamma-1,,2024-09-14,1,,,,,,,,,
P69892,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit gamma-2,,2024-09-14,1,,,,,,,,,
Q6B0K9,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit mu,,2024-09-14,1,,,,,,,,,
P09105,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit theta-1,,2024-09-14,1,,,,,,,,,
P02008,0,OMOP Exposome,Observation,Substance,Hemoglobin subunit zeta,,2024-09-14,1,,,,,,,,,
Q9Y663,0,OMOP Exposome,Observation,Substance,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,,2024-09-14,1,,,,,,,,,
Q9Y251,0,OMOP Exposome,Observation,Substance,Heparanase,,2024-09-14,1,,,,,,,,,
9005-49-6,0,OMOP Exposome,Observation,Substance,Heparin,Fraxiparin; Eparina; Enoxaparin; Dalteparin; Clivarine; Clexane; Certoparin; Calciparine; Calcilean; Bemiparin; Arteven; alpha-Heparin; Novoheparin; Panheprin; Thromboliquine; Heparinate; Heparinic acid; Heparinsodiumsalt; Heparin sulphate; Heparin sulfate; Heparin sodium; Heparin Lock Flush; Liquaemin; Liquemin; Multiparin; Heparin LEO; Hepalean; Hep-lock; CHEBI:28304,2014-12-24,1,,,,,,,,,
Q9BXA1,0,OMOP Exposome,Observation,Substance,Hepatic peroxysomal alanine:glyoxylate aminotransferase,,2024-09-14,1,,,,,,,,,
P08581,0,OMOP Exposome,Observation,Substance,Hepatocyte growth factor receptor,,2024-09-14,1,,,,,,,,,
O14964,0,OMOP Exposome,Observation,Substance,Hepatocyte growth factor-regulated tyrosine kinase substrate,,2024-09-14,1,,,,,,,,,
P41235,0,OMOP Exposome,Observation,Substance,Hepatocyte nuclear factor 4-alpha,,2024-09-14,1,,,,,,,,,
Q14541,0,OMOP Exposome,Observation,Substance,Hepatocyte nuclear factor 4-gamma,,2024-09-14,1,,,,,,,,,
Q6MZM0,0,OMOP Exposome,Observation,Substance,Hephaestin-like protein 1,,2024-09-14,1,,,,,,,,,
35194-78-6,0,OMOP Exposome,Observation,Substance,Heptabromobiphenyl,,2014-12-24,1,,,,,,,,,
68928-80-3,0,OMOP Exposome,Observation,Substance,Heptabromobiphenyl Ether,,2014-12-24,1,,,,,,,,,
76-44-8,0,OMOP Exposome,Observation,Substance,Heptachlor,"Heptachlore; Heptachlorotetrahydro-4,7-methanoindene; Heptagran; Heptagranox; Heptaklor; Heptamak; Heptamul; Heptasol; Heptox; Soleptax; Tetrahydro; Velsicol heptachlor; 3,4,5,6,7,8,8a-Heptachlorodicyclopentadiene; 3,4,5,6,7,8,8-Heptachlorodicyclopentadiene; 3,4,5,6,7,8,8-A-heptachloro-alpha-Dicyclopentadiene; 1,5,7,8,9,10,10-Heptachlorotricyclo5.2.1.0(2,6)deca-3,8-diene; 1,4,5,6,7,8,8-Heptachlorotetrahydro-4,7-methanoindene; 1,4,5,6,7,8,8-Heptachloro-3a,4,7,7a-tetrahydro-4,7-methano-1H-indene; 3-Chlorochlordene; Aahepta; Agroceres; Arbinex 30TN; Basaklor; Drinox; Drinox H-34; Heptachlorane; CHEBI:34785",2014-12-24,1,,,,,,,,,
1024-57-3,0,OMOP Exposome,Observation,Substance,Heptachlor epoxide,Epoxyheptachlor; Heptachlore epoxide; b-heptachlorepoxide; CHEBI:25520,2014-12-24,1,,,,,,,,,
111-71-7,0,OMOP Exposome,Observation,Substance,Heptanal,,2014-12-24,1,,,,,,,,,
111-14-8,0,OMOP Exposome,Observation,Substance,Heptanoic acid,Heptylic acid; N-Heptanoate; N-Heptanoic acid; N-Heptoate; N-Heptoic acid; N-Heptylate; N-Heptylic acid; Oenanthate; Oenanthylic acid; Oenanthylate; Oenanthic acid; 1-Hexanecarboxylate; 1-Hexanecarboxylic acid; Enanthate; Enanthic acid; Enanthylate; Enanthylic acid; Heptanoate; Heptoate; Heptoic acid; Heptylate; CHEBI:45571,2014-12-24,1,,,,,,,,,
1085-12-7,0,OMOP Exposome,Observation,Substance,Heptyl 4-hydroxybenzoate,"Staypro WS 7; P-Hydroxybenzoic acid heptyl ester; Nipaheptyl; Heptylparaben; N-Heptyl 4-hydroxybenzoate; N-Heptyl p-hydroxybenzoate; Heptyl paraben; Heptyl p-hydroxybenzoate; Heptyl p-hydroxy benzoate; Heptyl 4-hydroxybenzoic acid; Benzoic acid, p-hydroxy-, heptyl ester; Benzoic acid, 4-hydroxy-, N-heptyl ester; Benzoic acid, 4-hydroxy-, heptyl ester; CHEBI:17879",2014-12-24,1,,,,,,,,,
61265-06-3,0,OMOP Exposome,Observation,Substance,Heratomin,,2014-12-24,1,,,,,,,,,
GIS1008964,0,OMOP Exposome,Observation,Substance,Herbicide,,2024-09-14,1,,,,,,,,,
GIS1008965,0,OMOP Exposome,Observation,Substance,Hereditary Coproporphyria (HCP),,2024-09-14,1,,,,,,,,,
561-27-3,0,OMOP Exposome,Observation,Substance,Heroin,"diamorphine; diacetylmorphine; 7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate; O,O'-diacetylmorphine; morphine diacetate; 3,6-Diacetylmorphine; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester); CHEBI:27808",2014-12-24,1,,,,,,,,,
189120-72-7,0,OMOP Exposome,Observation,Substance,Heteropodatoxin,,2014-12-24,1,,,,,,,,,
GIS1008966,0,OMOP Exposome,Observation,Substance,Heteroscodratoxin,,2024-09-14,1,,,,,,,,,
36483-60-0,0,OMOP Exposome,Observation,Substance,Hexabromobiphenyl Ether,,2014-12-24,1,,,,,,,,,
25637-99-4,0,OMOP Exposome,Observation,Substance,Hexabromocyclododecane,,2014-12-24,1,,,,,,,,,
118-74-1,0,OMOP Exposome,Observation,Substance,Hexachlorobenzene,"Amatin; 1,2,3,4,5,6-Hexachloro-Benzene; 1,2,3,4,5,6-Hexachlorobenzene; Ceku c.b.; Co-op hexa; Esaclorobenzene; Granox; Granox NM; HCB; Hexa c.b; Hexa c.b.; Hexa CB; Hexachlorbenzol; Hexachloro-Benzene; Julen's carbon chloride; Pentachlorophenyl chloride; Perchlorobenzene; Phenyl perchloryl; S Anocide; Sanocid; Sanocide; Smut-go; Snieciotox; Voronit c; CHEBI:5692",2014-12-24,1,,,,,,,,,
87-68-3,0,OMOP Exposome,Observation,Substance,Hexachlorobutadiene,,2014-12-24,1,,,,,,,,,
608-73-1,0,OMOP Exposome,Observation,Substance,"Hexachlorocyclohexane, technical Grade","(1R,2R,3S,4S,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1s,2R,3R,4s,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; 1,2,3,4,5,6-Hexachlorocyclohexane; 1,2,3,4,5,6-Hexachlorocyclohexane (all stereo isomers); 1,2,3,4,5,6-Hexachlorocyclohexane gamma isomer; 1,2,3,4,5,6-hexachlorocyclohexane, alpha isomer; 1,2,3,4,5,6-Hexachlorocyclohexane, gamma-isomer; 1a,2a,3b,4a,5b,6b-hexachlorocyclohexane; 1a,2b,3a,4b,5a,6b-hexachlorocyclohexane; Aalindan; Aficide; Agrocide; Agrocide III; Agrocide WP; Agronexit; alpha-1,2,3,4,5,6-Hexachlorocyclohexane; Alpha-benzene hexachloride; Alpha-benzenehexachloride; Alpha-hexachloran; Alpha-hexachlorane; Alpha-hexachlorocyclohexane; Alpha-lindane; Am eisenatod; Ameisenatod; Ameisenmittel merck; Ameisentod; Aparasin; Aphtiria; Aphtitria; Aplidal; Arbitex; Arcotal s; Benhexachlor; Benhexol; bentox 10; Benzanex; Benzene hexachloride; Benzene hexachloride (ambiguous); Benzene hexachloride (BHC); Benzene hexachloride, all isomers; Benzene hexachloride-alpha-isomer; Benzene hexachloride-gamma isomer; Benzene hexachloride-gamma-isomer; Benzene-1,2,3,4,5,6-hexachloride ((Ambiguous); Benzene-cis-hexachloride; Benzene-trans-hexachloride; Benzenehexachloride, mixed isomers; Benzenehexachloride-alpha-isomer; Benzex; beta-1,2,3,4,5,6-Hexachlorocyclohexane; Celanex; Chinoin brand of lindane; Chloresene; Codechine; Cyclohexane, 1,2,3,4,5,6-hexachloro-, alpha-isomer; Delitex; delta-1,2,3,4,5,6-Hexachlorocyclohexane; Delta-benzene hexachloride; Delta-benzenehexachloride; Delta-BHC; Delta-HCH; Delta-hexachlorocyclohexane; Delta-lindane; Detmol extract; Detmol-extrakt; Devoran; Dol granule; Dolmix; Drill tox-spezial aglukon; Drilltox-spezial aglukon; Entomoxan; Epsilon HCH; Epsilon-benzenehexachloride; Epsilon-HCH; Epsilon-hexachlorocyclohexane; Eso derm; Esoderm; Exagama; Fenoform forte; Forlin; Forst-nexen; Gallogama; Gamacarbatox; Gamaphex; Gamene; Gamiso; Gamma benzene hexachloride; Gamma hexachlor; Gamma hexachlorocyclohexane; gamma-1,2,3,4,5,6-Hexachlorocyclohexane; Gamma-benzene hexachloride; Gamma-benzenehexachloride; Gamma-benzohexachloride; Gamma-col; Gamma-hexachlorane; Gamma-hexachlorcyclohexanum; Gamma-hexachlorobenzene; Gamma-hexachlorocyclohexane; Gamma-linda ne; Gamma-lindane; Gamma-mean 400; Gamma666; Gammahexa; Gammahexane; Gammalin; Gammaterr; Gammex; Gammexane; Gammopaz; Gamtox; Geobilan; Gexane; Gyben; Heclotox; Hecoltox; Hexablanc; Hexachlor; Hexachloran; Hexachlorane; Hexachloride, benzene; Hexachloride, gamma-benzene; Hexachlorocyclohexane; Hexachlorocyclohexane, gamma isomer; Hexachlorocyclohexane, gamma-isomer; Hexachlorocyclohexane, technical; Hexachlorocyclohexane, technical grade; Hexachlorocyclohexane-alpha; Hexachlorocyclohexane-beta; Hexachlorocyclohexanes; Hexachlorzyklohexan; Hexaklor; Hexamul; Hexapoudre; Hexatox; Hexaverm; Hexcidum; Hexicide; Hexyclan; Hexylan; Hilbeec h; Hilbeech; Hortex; Inexit; Infectopharm brand of lindane; Insecticide, BHC; Isatox; Isot ox; Isotox; Jacutin; Kokotine; Kwell; Kwell-r; Lacco hi lin; Lasochron; Lendine; Lentox; Lidenal; Lindafor; Lindagam; Lindagrain; Lindagranox; Lindalo; Lindam ul; Lindamul; Lindane (benzene hexachloroide-gamma isomer); Lindane (gamma-HCH); Lindapoudre; Lindaterra; Lindatox; Lindex; Lindosep; Lintox; Linvur; Lorexane; Mglawik l; Mixture name; Mszycol; Neo-scabicidol; Nexen FB; Nexen-FB; Nexi t-stark; Nexit; Nexit-stark; Nexol-e; Nicochloran; Novigam; Novigan; Omnitox; Ovadziak; Owadziak; Pedraczak; Pflanzol; Pharmascience brand of lindane; PMS lindane; PMS-lindane; Pmslindane; Quellada; Sang gamma; Scabecid; Scabene; Scabisan; Silvanol; Spritz-rapidin; Spritzlindane; Spruehpflanzol; Stiefel brand of lindane; Streunex; Submar; T-HCH; TBH; Technical HCH; Technical hexachlorocyclohexane; Tetocid; Trans-alpha-benzenehexachloride; Tri-6; Trives-t; Verindal ultra; Viton; (1r,2c,3c,4t,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2c,3t,4t,5c,6t)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2r,3r,4r,5r,6r)-1,2,3,4,5,6-hexachlorocyclohexane; (1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2R,3S,4r,5R,6S)-1,2,3,4,5,6-hexachlorocyclohexane; (1r,2R,3S,4s,5R,6S)-1,2,3,4,5,6-hexachlorocyclohexane; CHEBI:24536",2014-12-24,1,,,,,,,,,
77-47-4,0,OMOP Exposome,Observation,Substance,Hexachlorocyclopentadiene,,2014-12-24,1,,,,,,,,,
79983-71-4,0,OMOP Exposome,Observation,Substance,Hexaconazole,,2014-12-24,1,,,,,,,,,
506-46-7,0,OMOP Exposome,Observation,Substance,Hexacosanoic acid,Cerate; Cerylate; Cerylic acid; Hexacosanoate; Cerotic acid; Cerotate; Cerinic acid; Cerinate; Ceric acid; Ceratinic acid; Hexacosanoate (N-C26:0); N-Hexacosanoate; N-Hexacosanoic acid; Ceratinate; CHEBI:31009,2014-12-24,1,,,,,,,,,
16950-06-4,0,OMOP Exposome,Observation,Substance,Hexafluoroantimonic acid,,2014-12-24,1,,,,,,,,,
13356-08-6,0,OMOP Exposome,Observation,Substance,Hexakis(2-methyl-2-phenylpropyl)distannoxane,"Hexakis(2-methyl-2-phenylpropyl)-Distannoxane; Osdaran; Vendex; Hexakis (2-methyl-2-phenylpropyl)-distannoxane; Hexakis; Bendex; Di(tri-(2,2-dimethyl-2-phenylethyl)tin)oxide; Hexaneophyldistannoxane; Hexakis(beta,beta-dimethylphenethyl)distannoxane; Hexakis(beta,beta-dimethylphenethyl)-Distannoxane; Torque; Fenylbutylstannium oxide; Bistris(2-methyl-2-phenylpropyl)tin oxide; Bis(tris(beta,beta-dimethylphenethyl)tin)oxide; Bistris(2-methyl-2-phenylpropyl)tinoxide; Fenylbutatin oxide; Bis(trineophyltin) oxide; Bis(tris(2-methyl-2-phenylpropyl)tin) oxide; Bis(tris(2-methyl-2-phenylpropyl)tin)oxide; Fenbutatin-oxyde; Fenbutatin-oxide; Fenbutatin oxide, BSI; Fenbutatin oxide; Bistris-(2-methyl-2-phenylpropyl)tin oxide; Neostanox; 1,1,1,3,3,3-Hexakis(2-methyl-2-phenylpropyl)-Distannoxane; 2-(Methyl-2-phenylpropyl)distannoxane; CHEBI:39294",2014-12-24,1,,,,,,,,,
822-06-0,0,OMOP Exposome,Observation,Substance,Hexamethylene diisocyanate,"1,6-Hexamethylene diisocyanate; Hexamethylene-1,6-diisocyanate; Hexane 1,6-diisocyanate; HEXANE,1,6-DIISOCYANATE; HMDI; Isocyanic acid, diester with 1,6-hexanediol; Isocyanic acid, hexamethylene ester; Isocyanic acid, hexamethylene ester (8ci); Metyleno-bis-fenyloizocyjanian; Poly(hexamethylene dIIsocyanate); Szesciometylenodwuizocyjanian; 1,6-Diisocyanatohexane; 1,6-hexane diisocyanate; 1,6-Hexanediol diisocyanate; 1,6-Hexylene diisocyanate; Desmodur h; HDI; Hexamethylene 1,6-diisocyanate; Hexamethylene diisocyanic acid; CHEBI:53578",2014-12-24,1,,,,,,,,,
10534-89-1,0,OMOP Exposome,Observation,Substance,Hexamminecobalt(III) chloride,Hexaminocobaltic chloride; Hexammine cobalt(III) chloride; Hexamminocobalt chloride; Cobalt-hexamine chloride; Cobalt hexammine trichloride; Cobalt hexammine chloride; Hexaaminecobalt chloride; Hexaaminecobalt trichloride; Hexaaminecobalt(3+) trichloride; Hexaamminecobalt chloride; Hexaamminecobalt(3+) trichloride; Hexaamminecobalt(III) chloride; Hexaminecobalt (III) trichloride; Hexaminecobalt(3+) trichloride; CHEBI:63021,2014-12-24,1,,,,,,,,,
66-25-1,0,OMOP Exposome,Observation,Substance,Hexanal,Hexylaldehyde; N-Hexylaldehyde; N-Hexanal; Hexaldehyde; N-Caproaldehyde; Caproic aldehyde; Hexanaldehyde; Capronaldehyde; Caproaldehyde; CHEBI:121338,2014-12-24,1,,,,,,,,,
110-54-3,0,OMOP Exposome,Observation,Substance,Hexane,N-Hexane; CHEBI:29021,2014-12-24,1,,,,,,,,,
18540-29-9,0,OMOP Exposome,Observation,Substance,Hexavalent chromium,Chromium(6+); Chromium(VII) ion; Cr(6+); Chromium(VI); Chromium(VI) cation; Chromium(6+) ion; Chromium ion (6+); Chromium ion; Chromium hexavalent ion; Cr6+; Hexavalent chromium; Metallic chromium; CHEBI:33007,2014-12-24,1,,,,,,,,,
51235-04-2,0,OMOP Exposome,Observation,Substance,Hexazinone,,2014-12-24,1,,,,,,,,,
84-16-2,0,OMOP Exposome,Observation,Substance,Hexestrol,,2014-12-24,1,,,,,,,,,
56-29-1,0,OMOP Exposome,Observation,Substance,Hexobarbital,"5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione; Tobinal; Methylhexabital; Methexenyl; Hexobarbitone; Evipan; 5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-(1-Cyclohexen-1-yl)-1,5-dimethylbarbituric acid; Evipal; CHEBI:5706",2014-12-24,1,,,,,,,,,
P19367,0,OMOP Exposome,Observation,Substance,Hexokinase-1,,2024-09-14,1,,,,,,,,,
136-77-6,0,OMOP Exposome,Observation,Substance,Hexylresorcinol,,2014-12-24,1,,,,,,,,,
78587-05-0,0,OMOP Exposome,Observation,Substance,Hexythiazox,"(4RS,5RS)-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide, (4R,5R)-rel-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidinecarboxamide; CHEBI:CHEBI:39328",2014-12-24,1,,,,,,,,,
Q13946,0,OMOP Exposome,Observation,Substance,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",,2024-09-14,1,,,,,,,,,
O60658,0,OMOP Exposome,Observation,Substance,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",,2024-09-14,1,,,,,,,,,
O95263,0,OMOP Exposome,Observation,Substance,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B",,2024-09-14,1,,,,,,,,,
P30825,0,OMOP Exposome,Observation,Substance,High affinity cationic amino acid transporter 1,,2024-09-14,1,,,,,,,,,
O76083,0,OMOP Exposome,Observation,Substance,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",,2024-09-14,1,,,,,,,,,
P12314,0,OMOP Exposome,Observation,Substance,High affinity immunoglobulin gamma Fc receptor I,,2024-09-14,1,,,,,,,,,
P04629,0,OMOP Exposome,Observation,Substance,High affinity nerve growth factor receptor,,2024-09-14,1,,,,,,,,,
GIS1008979,0,OMOP Exposome,Observation,Substance,Hippo signaling pathway,,2024-09-14,1,,,,,,,,,
GIS1008978,0,OMOP Exposome,Observation,Substance,Hippocampus,,2024-09-14,1,,,,,,,,,
495-69-2,0,OMOP Exposome,Observation,Substance,Hippuric acid,Benzamidoacetic acid; Benzamidoacetate; 2-Benzamidoacetic acid; Benzoylglycine; Hippurate; N-Benzoylglycine; Phenylcarbonylaminoacetate; Phenylcarbonylaminoacetic acid; 2-Benzamidoacetate; (benzoylamino)-Acetic acid; (benzoylamino)-Acetate; CHEBI:18089,2014-12-24,1,,,,,,,,,
GIS1008980,0,OMOP Exposome,Observation,Substance,Histamine Antagonist,,2024-09-14,1,,,,,,,,,
GIS1008981,0,OMOP Exposome,Observation,Substance,Histamine H1 Antagonist,,2024-09-14,1,,,,,,,,,
P35367,0,OMOP Exposome,Observation,Substance,Histamine H1 receptor,,2024-09-14,1,,,,,,,,,
GIS1008982,0,OMOP Exposome,Observation,Substance,Histamine H2 Antagonist,,2024-09-14,1,,,,,,,,,
P25021,0,OMOP Exposome,Observation,Substance,Histamine H2 receptor,,2024-09-14,1,,,,,,,,,
Q9Y5N1,0,OMOP Exposome,Observation,Substance,Histamine H3 receptor,,2024-09-14,1,,,,,,,,,
Q9H3N8,0,OMOP Exposome,Observation,Substance,Histamine H4 receptor,,2024-09-14,1,,,,,,,,,
P50135,0,OMOP Exposome,Observation,Substance,Histamine N-methyltransferase,,2024-09-14,1,,,,,,,,,
P42357,0,OMOP Exposome,Observation,Substance,Histidine ammonia-lyase,,2024-09-14,1,,,,,,,,,
P19113,0,OMOP Exposome,Observation,Substance,Histidine decarboxylase,,2024-09-14,1,,,,,,,,,
GIS1008989,0,OMOP Exposome,Observation,Substance,Histidine Metabolism,,2024-09-14,1,,,,,,,,,
P12081,0,OMOP Exposome,Observation,Substance,"Histidine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
GIS1008990,0,OMOP Exposome,Observation,Substance,Histidinemia,,2024-09-14,1,,,,,,,,,
Q13547,0,OMOP Exposome,Observation,Substance,Histone deacetylase 1,,2024-09-14,1,,,,,,,,,
Q92769,0,OMOP Exposome,Observation,Substance,Histone deacetylase 2,,2024-09-14,1,,,,,,,,,
O15379,0,OMOP Exposome,Observation,Substance,Histone deacetylase 3,,2024-09-14,1,,,,,,,,,
P56524,0,OMOP Exposome,Observation,Substance,Histone deacetylase 4,,2024-09-14,1,,,,,,,,,
Q9UQL6,0,OMOP Exposome,Observation,Substance,Histone deacetylase 5,,2024-09-14,1,,,,,,,,,
Q9UBN7,0,OMOP Exposome,Observation,Substance,Histone deacetylase 6,,2024-09-14,1,,,,,,,,,
Q8WUI4,0,OMOP Exposome,Observation,Substance,Histone deacetylase 7,,2024-09-14,1,,,,,,,,,
Q9BY41,0,OMOP Exposome,Observation,Substance,Histone deacetylase 8,,2024-09-14,1,,,,,,,,,
Q9UKV0,0,OMOP Exposome,Observation,Substance,Histone deacetylase 9,,2024-09-14,1,,,,,,,,,
P07305,0,OMOP Exposome,Observation,Substance,Histone H1.0,,2024-09-14,1,,,,,,,,,
Q02539,0,OMOP Exposome,Observation,Substance,Histone H1.1,,2024-09-14,1,,,,,,,,,
P16403,0,OMOP Exposome,Observation,Substance,Histone H1.2,,2024-09-14,1,,,,,,,,,
P16402,0,OMOP Exposome,Observation,Substance,Histone H1.3,,2024-09-14,1,,,,,,,,,
P10412,0,OMOP Exposome,Observation,Substance,Histone H1.4,,2024-09-14,1,,,,,,,,,
P16401,0,OMOP Exposome,Observation,Substance,Histone H1.5,,2024-09-14,1,,,,,,,,,
Q8IZA3,0,OMOP Exposome,Observation,Substance,Histone H1oo,,2024-09-14,1,,,,,,,,,
P22492,0,OMOP Exposome,Observation,Substance,Histone H1t,,2024-09-14,1,,,,,,,,,
Q92522,0,OMOP Exposome,Observation,Substance,Histone H1x,,2024-09-14,1,,,,,,,,,
P0C0S8,0,OMOP Exposome,Observation,Substance,Histone H2A type 1,,2024-09-14,1,,,,,,,,,
Q96QV6,0,OMOP Exposome,Observation,Substance,Histone H2A type 1-A,,2024-09-14,1,,,,,,,,,
P04908,0,OMOP Exposome,Observation,Substance,Histone H2A type 1-B/E,,2024-09-14,1,,,,,,,,,
Q93077,0,OMOP Exposome,Observation,Substance,Histone H2A type 1-C,,2024-09-14,1,,,,,,,,,
P20671,0,OMOP Exposome,Observation,Substance,Histone H2A type 1-D,,2024-09-14,1,,,,,,,,,
Q96KK5,0,OMOP Exposome,Observation,Substance,Histone H2A type 1-H,,2024-09-14,1,,,,,,,,,
Q99878,0,OMOP Exposome,Observation,Substance,Histone H2A type 1-J,,2024-09-14,1,,,,,,,,,
Q6FI13,0,OMOP Exposome,Observation,Substance,Histone H2A type 2-A,,2024-09-14,1,,,,,,,,,
Q8IUE6,0,OMOP Exposome,Observation,Substance,Histone H2A type 2-B,,2024-09-14,1,,,,,,,,,
Q16777,0,OMOP Exposome,Observation,Substance,Histone H2A type 2-C,,2024-09-14,1,,,,,,,,,
Q7L7L0,0,OMOP Exposome,Observation,Substance,Histone H2A type 3,,2024-09-14,1,,,,,,,,,
P0C5Y9,0,OMOP Exposome,Observation,Substance,Histone H2A-Bbd type 1,,2024-09-14,1,,,,,,,,,
P0C5Z0,0,OMOP Exposome,Observation,Substance,Histone H2A-Bbd type 2/3,,2024-09-14,1,,,,,,,,,
Q9BTM1,0,OMOP Exposome,Observation,Substance,Histone H2A.J,,2024-09-14,1,,,,,,,,,
Q71UI9,0,OMOP Exposome,Observation,Substance,Histone H2A.V,,2024-09-14,1,,,,,,,,,
BE0005146,0,OMOP Exposome,Observation,Substance,Histone H2A.x,,2024-09-14,1,,,,,,,,,
P0C0S5,0,OMOP Exposome,Observation,Substance,Histone H2A.Z,,2024-09-14,1,,,,,,,,,
P16104,0,OMOP Exposome,Observation,Substance,Histone H2AX,,2024-09-14,1,,,,,,,,,
Q96A08,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-A,,2024-09-14,1,,,,,,,,,
P33778,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-B,,2024-09-14,1,,,,,,,,,
P62807,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-C/E/F/G/I,,2024-09-14,1,,,,,,,,,
P58876,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-D,,2024-09-14,1,,,,,,,,,
Q93079,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-H,,2024-09-14,1,,,,,,,,,
P06899,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-J,,2024-09-14,1,,,,,,,,,
O60814,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-K,,2024-09-14,1,,,,,,,,,
Q99880,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-L,,2024-09-14,1,,,,,,,,,
Q99879,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-M,,2024-09-14,1,,,,,,,,,
Q99877,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-N,,2024-09-14,1,,,,,,,,,
P23527,0,OMOP Exposome,Observation,Substance,Histone H2B type 1-O,,2024-09-14,1,,,,,,,,,
Q16778,0,OMOP Exposome,Observation,Substance,Histone H2B type 2-E,,2024-09-14,1,,,,,,,,,
Q5QNW6,0,OMOP Exposome,Observation,Substance,Histone H2B type 2-F,,2024-09-14,1,,,,,,,,,
Q8N257,0,OMOP Exposome,Observation,Substance,Histone H2B type 3-B,,2024-09-14,1,,,,,,,,,
P0C1H6,0,OMOP Exposome,Observation,Substance,Histone H2B type F-M,,2024-09-14,1,,,,,,,,,
P57053,0,OMOP Exposome,Observation,Substance,Histone H2B type F-S,,2024-09-14,1,,,,,,,,,
Q7Z2G1,0,OMOP Exposome,Observation,Substance,Histone H2B type W-T,,2024-09-14,1,,,,,,,,,
P49450,0,OMOP Exposome,Observation,Substance,Histone H3-like centromeric protein A,,2024-09-14,1,,,,,,,,,
P68431,0,OMOP Exposome,Observation,Substance,Histone H3.1,,2024-09-14,1,,,,,,,,,
Q16695,0,OMOP Exposome,Observation,Substance,Histone H3.1t,,2024-09-14,1,,,,,,,,,
Q71DI3,0,OMOP Exposome,Observation,Substance,Histone H3.2,,2024-09-14,1,,,,,,,,,
P84243,0,OMOP Exposome,Observation,Substance,Histone H3.3,,2024-09-14,1,,,,,,,,,
Q6NXT2,0,OMOP Exposome,Observation,Substance,Histone H3.3C,,2024-09-14,1,,,,,,,,,
P62805,0,OMOP Exposome,Observation,Substance,Histone H4,,2024-09-14,1,,,,,,,,,
Q99525,0,OMOP Exposome,Observation,Substance,Histone H4-like protein type G,,2024-09-14,1,,,,,,,,,
Q9UPP1,0,OMOP Exposome,Observation,Substance,Histone lysine demethylase PHF8,,2024-09-14,1,,,,,,,,,
Q86X55,0,OMOP Exposome,Observation,Substance,Histone-arginine methyltransferase CARM1,,2024-09-14,1,,,,,,,,,
Q96KQ7,0,OMOP Exposome,Observation,Substance,Histone-lysine N-methyltransferase EHMT2,,2024-09-14,1,,,,,,,,,
Q8WTS6,0,OMOP Exposome,Observation,Substance,Histone-lysine N-methyltransferase SETD7,,2024-09-14,1,,,,,,,,,
O43463,0,OMOP Exposome,Observation,Substance,Histone-lysine N-methyltransferase SUV39H1,,2024-09-14,1,,,,,,,,,
Q8TEK3,0,OMOP Exposome,Observation,Substance,"Histone-lysine N-methyltransferase, H3 lysine-79 specific",,2024-09-14,1,,,,,,,,,
34272-51-0,0,OMOP Exposome,Observation,Substance,Histrionicotoxin,,2014-12-24,1,,,,,,,,,
GIS1008991,0,OMOP Exposome,Observation,Substance,HIV Protease Inhibitor,,2024-09-14,1,,,,,,,,,
GIS1008992,0,OMOP Exposome,Observation,Substance,Hiv Protease Inhibitors,,2024-09-14,1,,,,,,,,,
P20036,0,OMOP Exposome,Observation,Substance,"HLA class II histocompatibility antigen, DP alpha 1 chain",,2024-09-14,1,,,,,,,,,
P04440,0,OMOP Exposome,Observation,Substance,"HLA class II histocompatibility antigen, DP beta 1 chain",,2024-09-14,1,,,,,,,,,
BE0005071,0,OMOP Exposome,Observation,Substance,"HLA class II histocompatibility antigen, DP(W2) beta chain",,2024-09-14,1,,,,,,,,,
P01903,0,OMOP Exposome,Observation,Substance,"HLA class II histocompatibility antigen, DR alpha chain",,2024-09-14,1,,,,,,,,,
GIS1008994,0,OMOP Exposome,Observation,Substance,Hmg Co A Reductase Inhibitors,,2024-09-14,1,,,,,,,,,
GIS1008993,0,OMOP Exposome,Observation,Substance,Hmg Coa Reductase Inhibitors,,2024-09-14,1,,,,,,,,,
88254-04-0,0,OMOP Exposome,Observation,Substance,Holocyclotoxin,,2014-12-24,1,,,,,,,,,
GIS1008995,0,OMOP Exposome,Observation,Substance,Homeopathic Agent,,2024-09-14,1,,,,,,,,,
GIS1008996,0,OMOP Exposome,Observation,Substance,Homocarnosinosis,,2024-09-14,1,,,,,,,,,
454-29-5,0,OMOP Exposome,Observation,Substance,Homocysteine,"2-Amino-4-mercapto-DL-Butyrate; DL-2-amino-4-mercapto-Butyric acid; (+-)-homocysteine; (S)-2-amino-4-mercapto-Butanoate; (S)-2-amino-4-mercapto-Butanoic acid; 2-Amino-4-mercapto-Butanoate; 2-Amino-4-sulfanylbutanoic acid; 2-Amino-4-sulfanylbutanoate; 2-Amino-4-mercaptobutyric acid; 2-Amino-4-mercapto-DL-Butyric acid; DL-2-Amino-4-mercaptobutyric acid; DL-Homocysteine; DL-homocysteine (free base); HCY; Homo-CYS; L-2-Amino-4-mercapto-Butyric acid; L-Homocysteine; Usaf B-12; 2-Amino-4-mercapto-Butanoic acid; 2-Amino-4-mercapto-Butyric acid; D,L-Homocysteine; CHEBI:17230",2014-12-24,1,,,,,,,,,
GIS1008997,0,OMOP Exposome,Observation,Substance,Homocysteine Degradation,,2024-09-14,1,,,,,,,,,
GIS1008998,0,OMOP Exposome,Observation,Substance,Homocystinuria,,2024-09-14,1,,,,,,,,,
GIS1008999,0,OMOP Exposome,Observation,Substance,Homocystinuria due to defect of N(5,,2024-09-14,1,,,,,,,,,
GIS1009000,0,OMOP Exposome,Observation,Substance,Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism,,2024-09-14,1,,,,,,,,,
451-13-8,0,OMOP Exposome,Observation,Substance,Homogentisic acid,"2,5-Dihydroxy-alpha-toluic acid; 2,5-Dihydroxy-benzeneacetic acid; 2,5-Dihydroxyphenylacetate; 2,5-Dihydroxyphenylacetic acid; Alcapton; Homogentisate; Homogentisate acid; Homogentisinate; Homogentisinic acid; Melanic acid; 2,5-Dihydroxy-a-toluic acid; 2,5-Dihydroxy-alpha-toluate; 2,5-Dihydroxy-benzeneacetate; (2,5-dihydroxyphenyl)-Acetate; (2,5-dihydroxyphenyl)-Acetic acid; 2,5-Dihydroxy-a-toluate; CHEBI:44747",2018-03-21,1,,,,,,,,,
GIS1009001,0,OMOP Exposome,Observation,Substance,Homologous recombination,,2024-09-14,1,,,,,,,,,
203526-59-4,0,OMOP Exposome,Observation,Substance,Hongotoxin,,2014-12-24,1,,,,,,,,,
GIS1009002,0,OMOP Exposome,Observation,Substance,Hormone,,2024-09-14,1,,,,,,,,,
GIS1009003,0,OMOP Exposome,Observation,Substance,Hormone Antagonist,,2024-09-14,1,,,,,,,,,
GIS1009021,0,OMOP Exposome,Observation,Substance,Hormone Replacement Agent,,2024-09-14,1,,,,,,,,,
GIS1009022,0,OMOP Exposome,Observation,Substance,Household Toxin,,2024-09-14,1,,,,,,,,,
2971-36-0,0,OMOP Exposome,Observation,Substance,HPTE,"alpha,alpha-Bis(4-hydroxyphenyl)-beta,beta,beta-trichloroethane; 1,1,1-Trichloro-2,2-bis(4-hydroxyphenyl)ethane; 2,2-Bis(P-hydroxyphenyl)-1,1,1-trichloroethane; 1,1-Bis(4-hydroxyphenyl)-2,2,2-trichloroethane; 1,1,1-Trichloro-2,2-bis(P-hydroxyphenyl)ethane; 1,1-Bis(P-hydroxyphenyl)-2,2,2-trichloroethane; 2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane; 4,4'-(2,2,2-Trichloroethylidene)diphenol; P,P'-hydroxy-ddt; P,P'-HO-ddt; P,P'-(2,2,2-trichloroethylidene)diphenol; hydroxychlor; CHEBI:34025",2014-12-24,1,,,,,,,,,
26934-87-2,0,OMOP Exposome,Observation,Substance,HT-2 Toxin,,2014-12-24,1,,,,,,,,,
526224-73-7,0,OMOP Exposome,Observation,Substance,Huwentoxin,,2014-12-24,1,,,,,,,,,
GIS1009023,0,OMOP Exposome,Observation,Substance,Hydralysin (Chlorohydra viridissima),,2024-09-14,1,,,,,,,,,
302-01-2,0,OMOP Exposome,Observation,Substance,Hydrazine,HDZ; Zerox; Scav-ox II; Oxytreat 35; Nitrogen hydride; Levoxine; Hydrazines; Hydrazine solution; Hydrazine base; Hydrazine (anhydrous); Hydrazin; Diazane; Diamine; Diamide; Catalyzed hydrazine; Amerzine; CHEBI:15571,2014-12-24,1,,,,,,,,,
7647-01-0,0,OMOP Exposome,Observation,Substance,Hydrochloric acid,Hydrochlorate; HCl; HCl; Hydrogen chloride; Hydrochloride; CHEBI:17883,2014-12-24,1,,,,,,,,,
58-93-5,0,OMOP Exposome,Observation,Substance,Hydrochlorothiazide,"Hydrodiuretic; Zide; Ziac; Vetidrex; Vaseretic; Urodiazin; Unipres; Timolide; Thlaretic; Thiuretic; Thiaretic; Servithiazid; Ser-Ap-Es; Ro-hydrazide; Prinzide; Panurin; Oretic; Newtolide; Neoflumen; Neo-codema; Nefrix; Moduretic; Microzide; Megadiuril; Maxzide; Maschitt; Lotensin HCT; Lopressor HCT; Jen-Diril; Ivaugan; Inderide; Idrotiazide; 3,4-Dihydrochlorothiazide; Acuretic; Aldactazide; Aldoril; Apo-hydro; Apresazide; Aquarills; Aquarius; Bremil; Caplaril; Capozide; Chlorosulthiadil; Chlorothiazide; Chlorsulfonamidodihydrobenzothiadiazine dioxide; Chlorzide; Cidrex; Dichlorosal; Dichlotiazid; Dichlotride; Diclotride; Dihydrochlorothiazid; Dihydrochlorothiazide; Dihydrochlorothiazidum; Dihydrochlorurit; Dihydrochlorurite; Dihydroxychlorothiazidum; Direma; Disalunil; Diuril; Drenol; Dyazide; Esidrex; Esidrix; Esimil; Fluvin; HCTZ; HCZ; Hidril; Hidrochlortiazid; Hidroronol; Hidrotiazida; Hydril; Hydro-Aquil; Hydro-D; Hydro-Diuril; Hydrochloro Thiazide; Hydrochlorothiazid; Hydrochlorothiazide Intensol; Hyzaar; Hypothiazide; Hypothiazid; Hydrozide; Hydrothide; Hydrosaluric; Hydropres; Hydrodiuril; Hydrochlorthiazide; CHEBI:102045",2014-12-24,1,,,,,,,,,
125-29-1,0,OMOP Exposome,Observation,Substance,Hydrocodone,"Reprexain; Idrocodone; Hydroconum; Hydrocone; Hydrocodonum; Hydrocodon; Zohydro; (-)-Dihydrocodeinone; 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one; Hidrocodona; Dihydrocodeinone; CHEBI:5779",2014-12-24,1,,,,,,,,,
10035-10-6,0,OMOP Exposome,Observation,Substance,Hydrogen bromide,Hydrogen bromide solution; Broomwaterstof; Bromwasserstoff; Bromure d'hydrogene; Hydrogen bromide in acetic acid; Hydrogen bromide (HBr2); Hydrobromic acid solution; HBR; Hydrogenbromid; Hydrogen dibromide; Acido bromidrico; Bromowodor; Bromidohydrogen; Anhydrous hydrobromic acid; Acide bromhydrique; Hydrobromic acid; HBR; CHEBI:47266,2014-12-24,1,,,,,,,,,
74-90-8,0,OMOP Exposome,Observation,Substance,Hydrogen cyanide,Hydrocyanic acid; Zyklon b; Zyklon; Zootic acid; Zaclondiscoids; Prussic acid; Nitrilomethane; Methanenitrile; Hydrogen(nitridocarbonate); Hydrogen isocyanide; HCN; Hydridonitridocarbon; Carbon hydride nitride; Cyanide; Evercyn; Formic anammonide; Formonitrile; CHEBI:18407,2014-12-24,1,,,,,,,,,
7664-39-3,0,OMOP Exposome,Observation,Substance,Hydrogen fluoride,Fluoric acid; Fluorhydric acid; Fluorane; Fluoridohydrogen; Hydrofluoride; CHEBI:29228,2014-12-24,1,,,,,,,,,
6914-07-4,0,OMOP Exposome,Observation,Substance,Hydrogen isocyanide,CHN; Cyanwasserstoff; Formonitrile; HCN; Hydrocyanic acid; Blausaeure; CHEBI:18407,2014-12-24,1,,,,,,,,,
7783-07-5,0,OMOP Exposome,Observation,Substance,Hydrogen selenide,Dihydrogen monoselenide; Selenium dihydride; Selane; Selenium hydride; Selenium hydride (SeH2); Dihydrogen selenide; CHEBI:16503,2014-12-24,1,,,,,,,,,
7783-06-04,0,OMOP Exposome,Observation,Substance,Hydrogen sulfide,Dihydrogen monosulfide; Sulfur hydroxide; Dihydrogen sulfide; Sulfureted hydrogen; Dihydrogen disulfide; Hepatic acid; Hepatic gas; Hydrogen monosulfide; Hydrogen sulphide; Hydrogen-sulfide; Sulfur hydride; Sour gas; Hydrosulfurate; Hepatate; Hydrosulfuric acid; Sewer gas; Sulfuretted hydrogen; CHEBI:16136,2014-12-24,1,,,,,,,,,
16970-55-1,0,OMOP Exposome,Observation,Substance,Hydrogen tetrachloro-palladate(II),,2014-12-24,1,,,,,,,,,
466-99-9,0,OMOP Exposome,Observation,Substance,Hydromorphone,"(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one; Hidromorfona; Palladone; Idromorfone; Hydromorphonum; Hydromorphon; Hydromorfona; EXALGO; Dimorphone; Dilaudid; Dihydromorphinone; Dihydromorfinon; 7,8-Dihydromorphinone; 6-Deoxy-7,8-dihydro-6-oxomorphine; 4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone; 4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one; CHEBI:5790",2014-12-24,1,,,,,,,,,
123-31-9,0,OMOP Exposome,Observation,Substance,Hydroquinone,"Idrochinone; Melanex; Solaquin forte; Dihydroxybenzene; Dihydroquinone; beta-Quinol; Benzoquinol; Benzohydroquinone; Benzene-1,4-diol; p-Benzenediol; p-Dihydroxybenzene; p-Dioxobenzene; p-Dioxybenzene; p-Hydroquinone; p-Hydroxybenzene; p-Hydroxyphenol; Hydroquinol; Hydroquinole; Hydroquinone for synthesis; b-Quinol; alpha-Hydroquinone; a-Hydroquinone; 4-Hydroxyphenol; 1,4-Diidrobenzene; Hydrochinone; 1,4-Dihydroxybenzen; 1,4-Dihydroxy-benzol; 1,4-Dihydroxy-benzeen; 1,4-Benzenediol; Hydroquinone gr; Phiaquin; Quinol; Hydrochinon; Hydroquinoue; CHEBI:17594",2014-12-24,1,,,,,,,,,
13422-51-0,0,OMOP Exposome,Observation,Substance,Hydroxocobalamin,OH-Cbl; Hydroxycobalamin; Hydroxomin; Alpha-Redisol; Hydrocobamine; Cyanokit; Vitamin B-12b; CHEBI:27786,2014-12-24,1,,,,,,,,,
Q9UJM8,0,OMOP Exposome,Observation,Substance,Hydroxyacid oxidase 1,,2024-09-14,1,,,,,,,,,
Q16836,0,OMOP Exposome,Observation,Substance,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q16775,0,OMOP Exposome,Observation,Substance,"Hydroxyacylglutathione hydrolase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q8TDS4,0,OMOP Exposome,Observation,Substance,Hydroxycarboxylic acid receptor 2,,2024-09-14,1,,,,,,,,,
P49019,0,OMOP Exposome,Observation,Substance,Hydroxycarboxylic acid receptor 3,,2024-09-14,1,,,,,,,,,
118-42-3,0,OMOP Exposome,Observation,Substance,Hydroxychloroquine,Hydroxychloroquinum; Hidroxicloroquina; Plaquenil; Polirreumin; Quensyl; Oxichloroquine; Oxichlorochine; NSC4375; 2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol; HCQ; Dolquine; Axokine; 7-chloro-4-5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentylaminoquinoline; 7-chloro-4-4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylaminoquinoline; 7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline; 7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline; HCQS; (+-)-Hydroxychloroquine; (\u00b1)-hydroxychloroquine; 2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol; CHEBI:529737,2014-12-24,1,,,,,,,,,
13465-08-2,0,OMOP Exposome,Observation,Substance,Hydroxylammonium nitrate,,2014-12-24,1,,,,,,,,,
P35914,0,OMOP Exposome,Observation,Substance,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1009030,0,OMOP Exposome,Observation,Substance,Hydroxymethylglutaryl-CoA Reductase Inhibitor,,2024-09-14,1,,,,,,,,,
P54868,0,OMOP Exposome,Observation,Substance,"Hydroxymethylglutaryl-CoA synthase, mitochondrial",,2024-09-14,1,,,,,,,,,
503-66-2,0,OMOP Exposome,Observation,Substance,Hydroxypropionic acid,3-Hydroxypropionate; Hydroxypropionate; Hydracrylic acid; Ethylenelactic acid; Ethylenelactate; beta-Lactic acid; beta-Lactate; beta-Hydroxypropionic acid; beta-Hydroxypropionate; b-Lactic acid; b-Lactate; b-Hydroxypropionic acid; b-Hydroxypropionate; 3-Hydroxypropionic acid; 3-Hydroxypropanoic acid; 3-Hydroxypropanoate; 2-Deoxyglyceric acid; 2-Deoxyglycerate; CHEBI:33404,2018-03-21,1,,,,,,,,,
76-87-9,0,OMOP Exposome,Observation,Substance,Hydroxytriphenylstannane,"Du-ter fungicide wettable powder; Ashlade flotin; Brestan H 47.5 WP fungicide; Brestan R; Dowco 186; Du-Ter; Du-ter fungicide; Du-Ter PB-47 Fungicide; Du-Ter W-50; Du-Tur Flowable-30; Duter; Duter extra; Erithane; Farmatin; Fenolovo; Fentin; Fentin hydroxide; Fentin hydroxide, BSI; Fentine; Fintin hydroxid; Fintin hydroxyde; Sn(OH)Ph3; Wesley technical triphenyltin hydroxide; Vito spot fungicide; Vancide KS; Triple Tin 4L; Triple tin; Triphenytin hydroxide; Triphenyltin(IV) hydroxide; Triphenyltin oxide; Triphenyltin hydroxide; Triphenylstannium hydroxide; Triphenylstannanol; Triphenylhydroxytin; Triphenyl-zinnhydroxid; Triphenyl-Stannol; Triphenyl tin hydroxide; Trifenylstanniumhydroxid; Trifenyl-tinhydroxyde; Tptoh; TPTH technical; TPTH; Tenhide; Suzu-h; Suzu h; Super Tin 4L Gardian Flowable Fungicide; Super tin 4L; Super tin 4 L; Super tin; Sunitron h; Sn(OH)Ph3; Quadrangle super-tin 4L; Phenostat-h; Phenostat-a h; Kelthone; K 19; Idrossido di stagno trifenile; Ida, Imc Flo-Tin 4L; Hydroxytriphenyltin; Hydroxytriphenyl-Tin; Hydroxytriphenyl-Stannane; Hydroxyde de triphenyl-etain; Haitin WP 60 (fentin hydroxide 60%); Haitin WP 20 (fentin hydroxide 20%); Haitin; Flo-tin 4L; Flo Tin 4L; Fintine hydroxyde; Fintine hydroxide; Fintin idrossido; CHEBI:30473",2014-12-24,1,,,,,,,,,
127-07-1,0,OMOP Exposome,Observation,Substance,Hydroxyurea,Onco-Carbide; Oxyurea; Hydroxycarbamid; Idrossicarbamide; Carbamyl Hydroxamate; Carbamohydroxamic acid; Carbamohydroximic acid; Hydroxycarbamide; Hydroxycarbamidum; Hydroxycarbamine; Hydroxyharnstoff; Hydroxylurea; Hydroxicarbamidum; Carbamohydroxyamic acid; Hydrea; HU; Hidroxicarbamida; Droxia; Carbamoyl Oxime; Litalir; N-Carbamoylhydroxylamine; N-Hydroxyurea; CHEBI:5816,2014-12-24,1,,,,,,,,,
68-88-2,0,OMOP Exposome,Observation,Substance,Hydroxyzine,Hydroksyzyny; Hydroxyzine Pamoate; Hydroxyzine Base; Hydroxyzin; Hydroxycine; Hydroxyzinum; Hydroxyzyne; Hyzine; Idrossizina; Masmoran; Hydroxizinum; Hydroxizine; Hydroxine; Atarax; Hidroxizina; Hychotine; Rezine; Vistaject-50; Vistaril; Vistazine; CHEBI:5818,2014-12-24,1,,,,,,,,,
101-31-5,0,OMOP Exposome,Observation,Substance,Hyoscyamine,"Levbid; L-Tropine Tropate; L-Hyoscyamine; L-Hyopscyamine; L-Hyoscamine; (-)-Atropine; (-)-Hyoscyamine; (leo)-atropine; (leo)-hyoscyamine; (S)-(-)-Hyoscyamine; (S)-(leo)-hyoscyamine; (S)-(\u2212)-hyoscyamine; (S)-atropine; (S)atropine; (\u2212)-atropine; (\u2212)-hyoscyamine; Acupaz; Anapaz; Anaspaz; Atropen; Boots Travel Calm; Buwecon; Cystospaz; Cytospaz; Daturin; Daturine; Donnamar; Duboisine; Egazil; Hyocyamine; Hyoscyamin; Hyoscyaminum; L-Atropine; 3(S)-Endo-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo3.2.1oct-3-yl ester; Tropine-L-tropate; Tropine, (-)-tropate; Symax; NuLev; Levsinex; Levsin; CHEBI:17486",2014-12-24,1,,,,,,,,,
GIS1009031,0,OMOP Exposome,Observation,Substance,Hypercholesterolemia,,2024-09-14,1,,,,,,,,,
GIS1009032,0,OMOP Exposome,Observation,Substance,Hyperglycinemia,,2024-09-14,1,,,,,,,,,
GIS1009033,0,OMOP Exposome,Observation,Substance,Hyperinsulinism-Hyperammonemia Syndrome,,2024-09-14,1,,,,,,,,,
GIS1009034,0,OMOP Exposome,Observation,Substance,Hyperlysinemia I,,2024-09-14,1,,,,,,,,,
GIS1009035,0,OMOP Exposome,Observation,Substance,Hyperlysinemia II or Saccharopinuria,,2024-09-14,1,,,,,,,,,
GIS1009036,0,OMOP Exposome,Observation,Substance,Hypermethioninemia,,2024-09-14,1,,,,,,,,,
GIS1009038,0,OMOP Exposome,Observation,Substance,Hyperornithinemia with gyrate atrophy (HOGA),,2024-09-14,1,,,,,,,,,
GIS1009037,0,OMOP Exposome,Observation,Substance,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],,2024-09-14,1,,,,,,,,,
GIS1009039,0,OMOP Exposome,Observation,Substance,Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,,2024-09-14,1,,,,,,,,,
GIS1009040,0,OMOP Exposome,Observation,Substance,Hyperphenylalaninemia due to dhpr-deficiency,,2024-09-14,1,,,,,,,,,
GIS1009041,0,OMOP Exposome,Observation,Substance,Hyperprolinemia Type I,,2024-09-14,1,,,,,,,,,
GIS1009042,0,OMOP Exposome,Observation,Substance,Hyperprolinemia Type II,,2024-09-14,1,,,,,,,,,
GIS1009043,0,OMOP Exposome,Observation,Substance,Hypnotic and Sedative,,2024-09-14,1,,,,,,,,,
GIS1009044,0,OMOP Exposome,Observation,Substance,Hypoglycemic Agent,,2024-09-14,1,,,,,,,,,
502-37-4,0,OMOP Exposome,Observation,Substance,Hypoglycin B,,2014-12-24,1,,,,,,,,,
GIS1009124,0,OMOP Exposome,Observation,Substance,Hypolipidemic Agent,,2024-09-14,1,,,,,,,,,
GIS1009125,0,OMOP Exposome,Observation,Substance,Hypophosphatasia,,2024-09-14,1,,,,,,,,,
GIS1009126,0,OMOP Exposome,Observation,Substance,Hypothalamus,,2024-09-14,1,,,,,,,,,
68-94-0,0,OMOP Exposome,Observation,Substance,Hypoxanthine,"9H-Purin-6-ol; 9H-Purin-6(1H)-one; 7H-Purin-6-ol; 6-Oxopurine; 6-Hydroxypurine; 1,7-Dihydro-6H-purin-6-one; 1,7-Dihydro-6H-purine-6-one; 1H,7H-Hypoxanthine; 6-Hydroxy-1H-purine; 3H-Purin-6-ol; 4-Hydroxy-1H-purine; 6(1H)-Purinone; Sarkine; Sarkin; Sarcine; Purine-6-ol; Purin-6-ol; Purin-6(3H)-one; Purin-6(1H)-one; Hypoxanthine enol; CHEBI:17368",2014-12-24,1,,,,,,,,,
P00492,0,OMOP Exposome,Observation,Substance,Hypoxanthine-guanine phosphoribosyltransferase,,2024-09-14,1,,,,,,,,,
Q16665,0,OMOP Exposome,Observation,Substance,Hypoxia-inducible factor 1-alpha,,2024-09-14,1,,,,,,,,,
56716-21-3,0,OMOP Exposome,Observation,Substance,Hyquincarb,,2014-12-24,1,,,,,,,,,
114084-78-5,0,OMOP Exposome,Observation,Substance,Ibandronate,,2014-12-24,1,,,,,,,,,
GIS1009127,0,OMOP Exposome,Observation,Substance,Ibandronate Pathway,,2024-09-14,1,,,,,,,,,
129203-60-7,0,OMOP Exposome,Observation,Substance,Iberiotoxin,,2014-12-24,1,,,,,,,,,
2552-55-8,0,OMOP Exposome,Observation,Substance,Ibotenic acid,"alpha-amino-2,3-dihydro-3-oxo-5-Isoxazoleacetic acid; Amanita muscaria; Ibotenate; 4-Isoxazoline-5-acetic acid, alpha-amino-3-oxo- (8ci); (alpha)-Ibotenic acid; alpha-amino-3-Hydroxy-5-isoxazoleacetic acid; CHEBI:25520",2014-12-24,1,,,,,,,,,
15687-27-1,0,OMOP Exposome,Observation,Substance,Ibuprofen,Eve; Urem; Upfen; Unafen; Trendar; Tefin; Tabalon; Suspren; Spidifen; Speedpain NANO; Solpaflex; Seclodin; Salvarina; Rufen; Roidenin; Rimafen; Ratiodolor; Rapidol; Ranfen; Profin; Perifar; Pediaprofen; Para-isobutylhydratropic acid; Panafen; p-Isobutylhydratropic acid; p-Isobutylhydratropate; p-Isobutyl-2-phenylpropionic acid; p-Isobutyl-2-phenylpropionate; Orbifen; Nurofen; Nureflex; Nuprin; Norvectan; Nobgen; Nobfen; NeoProfen; Neobrufen; Naron Ace\t; Narfen; Myprodol; Mypaid; Mynosedin; Motrin; Midol IB; Medipren; Medicol; Lotem; Liptan; Lebrufen; Lamidon; Kratalgin; Junior Strength Motrin; Junior Strength Ibuprofen; Junior Strength Advil; Ipren; Inoven; Inabrin; Ibuxin; Ibux; Ibutid; Ibustar; Ibuprox; Ibuprosyn; Ibuprophen; Ibuprom; Ibuprocin; Ibupain; Ibumidol; Ibumetin; Ibumax; Ibum; Ibuleve; IbuHEXAL; Ibugesic; Ibugel; Ibuflam; Ibu-Vivimed; IBU-Ratiopharm; Ibu-attritin; IBU; Ibalgin; i-profen\t; Herron Blue; Haltran; Galprofen; Finalflex; Fenpaed; Fenbid; Femadon; Espidifen; Epobron; EmuProfen; Ebufac; Duralbuprofen; Dorival; Dolormin; Doloraz; Dolofort; Dolo-dolgit; Dolgit; Dolgirid; Dolgin; Diverin; Dismenol; Dalsy; Children's Motrin; Children's Ibuprofen; Children's Elixsure; Children's Advil; Cap-Profen; Calprofen; Caldolor; Butylenin; Burana; Buprovil; Bugesic; Buburone; Brufort; Brufen; Bonifen; Bluton; Betaprofen; Betagesic; Artofen; Apsifen; Anflagen; Anco; Amibufen; alpha-p-Isobutylphenylpropionic acid; alpha-p-Isobutylphenylpropionate; alpha-(P-Isobutylphenyl)propionic acid; alpha-(4-Isobutylphenyl)propionic acid; alpha-(4-Isobutylphenyl)propionate; Alivium; Algofren; Algoflex; Alges-X; Aktren; Advil Liqui-Gels; Advil; Adran; Adex; Actiprofen; Act-3; 4-Isobutylhydratropic acid; 2-(4-Isobutylphenyl)propanoic acid; (RS)-ibuprofen; (4-Isobutylphenyl)-alpha-methylacetic acid; (+-)-P-Isobutylhydratropic acid; (+-)-Ibuprofen; (+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid; (+-)-2-(P-Isobutylphenyl)propionic acid; CHEBI:5855,2014-12-24,1,,,,,,,,,
119515-38-7,0,OMOP Exposome,Observation,Substance,Icaridin,,2014-12-24,1,,,,,,,,,
3778-73-2,0,OMOP Exposome,Observation,Substance,Ifosfamide,"Celofos; Ifosfamide Sterile; Ifosphamide; Ifosfamida; Ifosfamid; Ifsofamide; Iphosphamid; Iphosphamide; Isofosfamide; Isophosphamide; Ifex; I-Phosphamide; Ifosfamidum; Isosfamide; Mitoxana; Holoxan; Cuantil; Asta Z 4942; 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; CHEBI:5864",2014-12-24,1,,,,,,,,,
P01876,0,OMOP Exposome,Observation,Substance,Ig alpha-1 chain C region,,2024-09-14,1,,,,,,,,,
P01877,0,OMOP Exposome,Observation,Substance,Ig alpha-2 chain C region,,2024-09-14,1,,,,,,,,,
P01854,0,OMOP Exposome,Observation,Substance,Ig epsilon chain C region,,2024-09-14,1,,,,,,,,,
P01857,0,OMOP Exposome,Observation,Substance,Ig gamma-1 chain C region,,2024-09-14,1,,,,,,,,,
P01859,0,OMOP Exposome,Observation,Substance,Ig gamma-2 chain C region,,2024-09-14,1,,,,,,,,,
P01860,0,OMOP Exposome,Observation,Substance,Ig gamma-3 chain C region,,2024-09-14,1,,,,,,,,,
P01861,0,OMOP Exposome,Observation,Substance,Ig gamma-4 chain C region,,2024-09-14,1,,,,,,,,,
P06310,0,OMOP Exposome,Observation,Substance,Ig kappa chain V-II region RPMI 6410,,2024-09-14,1,,,,,,,,,
P06312,0,OMOP Exposome,Observation,Substance,Ig kappa chain V-IV region Len,,2024-09-14,1,,,,,,,,,
P01709,0,OMOP Exposome,Observation,Substance,Ig lambda chain V-II region MGC,,2024-09-14,1,,,,,,,,,
P0CG04,0,OMOP Exposome,Observation,Substance,Ig lambda-1 chain C regions,,2024-09-14,1,,,,,,,,,
473289-62-2,0,OMOP Exposome,Observation,Substance,Ilepatril,,2014-12-24,1,,,,,,,,,
114311-32-9,0,OMOP Exposome,Observation,Substance,Imazamox,,2014-12-24,1,,,,,,,,,
104098-48-8,0,OMOP Exposome,Observation,Substance,Imazapic,,2014-12-24,1,,,,,,,,,
81334-34-1,0,OMOP Exposome,Observation,Substance,Imazapyr,,2014-12-24,1,,,,,,,,,
81335-37-7,0,OMOP Exposome,Observation,Substance,Imazaquin,,2014-12-24,1,,,,,,,,,
105827-78-9,0,OMOP Exposome,Observation,Substance,Imidacloprid,"Confidor; Premise 75; Provado; Merit; Imidacloprid (old RN); Imazethapyr; Gaucho; Confidor SL; Confidor 200 SL; Advantage; Admire; 1-(6-Chloro-3-pyridinyl)methyl-4,5-dihydro-N-nitro-1H-imidazol-2-amine; 1-(2-Chloro-5-pyridylmethyl)-2-(nitroimino)imidazolidine; 1-((6-Chloro-3-pyridyl)methyl)-N-nitro-2-imidazolidinimine; (e)-Imidacloprid; (z)-Imidacloprid; CHEBI:5870",2014-12-24,1,,,,,,,,,
39236-46-9,0,OMOP Exposome,Observation,Substance,Imidazolidinyl urea,,2014-12-24,1,,,,,,,,,
GIS1009128,0,OMOP Exposome,Observation,Substance,Iminoglycinuria,,2024-09-14,1,,,,,,,,,
74431-23-5,0,OMOP Exposome,Observation,Substance,Imipenem,"Tienamycin; Imipenemum; (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo3.2.0hept-2-ene-2-carboxylic acid; Imipenem, n-formimidoyl thienamycin; (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; IMP; Imipemide; N-Formimidoyl thienamycin; Imipenem anhydrous; (5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure; N-formimidoylthienamycin; CHEBI:471744",2014-12-24,1,,,,,,,,,
50-49-7,0,OMOP Exposome,Observation,Substance,Imipramine,"Fronil; Imavate; Imidobenzyle; Antidep; 5-3-(dimethylamino)Propyl-10,11-dihydro-5H-dibenzb,Fazepine; Teperine; Timolet; Tofranil; Tofranil base; Tofranil-Pm; Trimipramine Maleate; Imizine; Irmin; Janimine; Lofepramine; Melipramin; Melipramine; N-(gamma-Dimethylaminopropyl)iminodibenzyl; N-(\u03b3-dimethylaminopropyl)iminodibenzyl; Pramin; Psychoforin; Surmontil; Surplix; Dyna-Zina; DPID; Dimipressin; Depsonil-PM; Depsonil; Declomipramine; Chimoreptin; Berkomine; Antideprin; Dynaprin; Elamin; Eupramin; Feinalmin; Imidol; Imilanyle; Imipramin; Imipramin Dak; Imipraminum; Imiprex; 3-(5H-DIBENZOb,Fazepin-5-yl)-N,N-dimethylpropan-1-amine; 10,11-dihydro-N,N-Dimethyl-5H-dibenzb,Fazepine-5-propanamine; CHEBI:5881",2014-12-24,1,,,,,,,,,
Q6WRI0,0,OMOP Exposome,Observation,Substance,Immunoglobulin superfamily member 10,,2024-09-14,1,,,,,,,,,
GIS1009129,0,OMOP Exposome,Observation,Substance,Immunologic Factor,,2024-09-14,1,,,,,,,,,
GIS1009130,0,OMOP Exposome,Observation,Substance,Immunomodulatory Agent,,2024-09-14,1,,,,,,,,,
GIS1009131,0,OMOP Exposome,Observation,Substance,Immunosuppressive Agent,,2024-09-14,1,,,,,,,,,
GIS1009204,0,OMOP Exposome,Observation,Substance,Immunosuppressive Agents,,2024-09-14,1,,,,,,,,,
482-44-0,0,OMOP Exposome,Observation,Substance,Imperatorin,"9-(3-Methyl-2-butenyloxy)-7-oxofuro3,2-gchromene; 9-(3-Methylbut-2-enyloxy)-7H-furo(3,2-g)chromen-7-one; 9-(3-Methylbut-2-enyloxy)furo3,2-gchromen-7-one; 9-(3-Methyl-2-butenyl)oxy-7H-furo3,2-g1benzopyran-7-one, 9CI; 9-(3-Methylbut-2-en-1-yl)oxy-7H-furo3,2-gchromen-7-one; Ammidin; 5-Hydroxy-8-(1,1-dimethylallyl)psoralen; Marmelide; Marmelosin; Pentasalen, BAN; 8-Isoamylenoxypsoralen; CHEBI:5885",2014-12-24,1,,,,,,,,,
GIS1009205,0,OMOP Exposome,Observation,Substance,Imperatoxin-1,,2024-09-14,1,,,,,,,,,
172451-37-5,0,OMOP Exposome,Observation,Substance,Imperatoxin-A,,2014-12-24,1,,,,,,,,,
95-13-6,0,OMOP Exposome,Observation,Substance,Indene,,2014-12-24,1,,,,,,,,,
193-39-5,0,OMOP Exposome,Observation,Substance,"Indeno(1,2,3-cd)pyrene",,2014-12-24,1,,,,,,,,,
1336-79-4,0,OMOP Exposome,Observation,Substance,Indican,,2014-12-24,1,,,,,,,,,
GIS1009215,0,OMOP Exposome,Observation,Substance,Indicator and Reagent,,2024-09-14,1,,,,,,,,,
1303-11-3,0,OMOP Exposome,Observation,Substance,Indium arsenide,,2014-12-24,1,,,,,,,,,
22398-80-7,0,OMOP Exposome,Observation,Substance,Indium phosphide,,2014-12-24,1,,,,,,,,,
14280-53-6,0,OMOP Exposome,Observation,Substance,Indium(I) bromide,,2014-12-24,1,,,,,,,,,
13465-09-3,0,OMOP Exposome,Observation,Substance,Indium(III) bromide,,2014-12-24,1,,,,,,,,,
12056-07-4,0,OMOP Exposome,Observation,Substance,Indium(III) selenide,,2014-12-24,1,,,,,,,,,
87-51-4,0,OMOP Exposome,Observation,Substance,Indoleacetic acid,alpha-Indol-3-yl-acetic acid; Indol-3-ylacetic acid; Indol-3-ylacetate; beta-Indoleacetic acid; 3-Indolylacetate; 3-Indoleacetic acid; 3-Indoleacetate; 3-Indole-Acetic acid; 3-IAA; 3-(Carboxymethyl)indole; 2-(3-Indolyl)acetic acid; 2-(3-Indolyl)acetate; Skatole carboxylic acid; Skatole carboxylate; Rhizopon A; Rhizopin; 2-(1H-Indol-3-yl)acetic acid; 2-(1H-Indol-3-yl)acetate; 1H-Indole-3-acetic acid; 1H-Indole-3-acetate; 1H-Indol-3-ylacetic acid; 1H-Indol-3-ylacetate; (1H-Indol-3-yl)-acetic acid; (1H-Indol-3-yl)-acetate; Heteroauxin; beta-Indolylacetic acid; beta-Indolylacetate; Kyselina 3-indolyloctova; Indolylacetic acid; Indolylacetate; Indolyl-3-acetic acid; Indolyl-3-acetate; Indoleacetate; Indole-3-acetic acid; beta-Indoleacetate; beta-Indole-3-acetic acid; b-Indolylacetic acid; b-Indolylacetate; b-Indoleacetic acid; b-Indoleacetate; Indole-3-acetate; 3-Indolylacetic acid; CHEBI:16411,2014-12-24,1,,,,,,,,,
O95050,0,OMOP Exposome,Observation,Substance,Indolethylamine N-methyltransferase,,2024-09-14,1,,,,,,,,,
53-86-1,0,OMOP Exposome,Observation,Substance,Indomethacin,Indomethacinum; 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid; Indomethacine; Indometacyna; Mikametan; Nu-Indo; Reumacide; Tivorbex; Aconip; Arthrexin; Elmetacin; IMN; Indaflex; Indocid; Indocin; Indolar SR; Indomed; Indometacin; Indometacina; Indometacine; Indometacinum; Indomethazine; Indomethancin; {1-(4-chlorophenyl)carbonyl-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid; Indomethine; Metindol; Indometicina; Indoxen; CHEBI:5918,2014-12-24,1,,,,,,,,,
173584-44-6,0,OMOP Exposome,Observation,Substance,Indoxacarb,Steward; Avaunt; CHEBI:38630,2014-12-24,1,,,,,,,,,
487-94-5,0,OMOP Exposome,Observation,Substance,Indoxyl sulfate,Indoxyl sulphate; Indoxyl sulfic acid; Indol-3-yl sulphate; Indol-3-yl sulfate; Indol-3-ol; Indoxyl sulphic acid; 3-Indoxylsulfuric acid; 3-Indoxyl sulphate; 1H-Indol-3-yl hydrogen sulfate; 3-Indoxyl sulfate; 1H-Indol-3-yl hydrogen sulphate; Indoxylsulfuric acid; CHEBI:43355,2014-12-24,1,,,,,,,,,
Q07820,0,OMOP Exposome,Observation,Substance,Induced myeloid leukemia cell differentiation protein Mcl-1,,2024-09-14,1,,,,,,,,,
GIS1009216,0,OMOP Exposome,Observation,Substance,Industrial By-product/Pollutant,,2024-09-14,1,,,,,,,,,
GIS1009217,0,OMOP Exposome,Observation,Substance,Industrial Precursor/Intermediate,,2024-09-14,1,,,,,,,,,
GIS1009218,0,OMOP Exposome,Observation,Substance,Industrial/Workplace Toxin,,2024-09-14,1,,,,,,,,,
170277-31-3,0,OMOP Exposome,Observation,Substance,Infliximab,,2014-12-24,1,,,,,,,,,
GIS1009219,0,OMOP Exposome,Observation,Substance,Influenza a,,2024-09-14,1,,,,,,,,,
O15111,0,OMOP Exposome,Observation,Substance,Inhibitor of nuclear factor kappa-B kinase subunit alpha,,2024-09-14,1,,,,,,,,,
O14920,0,OMOP Exposome,Observation,Substance,Inhibitor of nuclear factor kappa-B kinase subunit beta,,2024-09-14,1,,,,,,,,,
Q14164,0,OMOP Exposome,Observation,Substance,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,,2024-09-14,1,,,,,,,,,
35804-66-1,0,OMOP Exposome,Observation,Substance,Inodxyl glucuronide,,2014-12-24,1,,,,,,,,,
GIS1009220,0,OMOP Exposome,Observation,Substance,Inorganic Compound,,2024-09-14,1,,,,,,,,,
Q9BY32,0,OMOP Exposome,Observation,Substance,Inosine triphosphate pyrophosphatase,,2024-09-14,1,,,,,,,,,
P20839,0,OMOP Exposome,Observation,Substance,Inosine-5'-monophosphate dehydrogenase 1,,2024-09-14,1,,,,,,,,,
P12268,0,OMOP Exposome,Observation,Substance,Inosine-5'-monophosphate dehydrogenase 2,,2024-09-14,1,,,,,,,,,
BE0004914,0,OMOP Exposome,Observation,Substance,"Inositol 1,4,5-trisphosphate receptor",,2024-09-14,1,,,,,,,,,
Q14643,0,OMOP Exposome,Observation,Substance,"Inositol 1,4,5-trisphosphate receptor type 1",,2024-09-14,1,,,,,,,,,
Q14571,0,OMOP Exposome,Observation,Substance,"Inositol 1,4,5-trisphosphate receptor type 2",,2024-09-14,1,,,,,,,,,
Q14573,0,OMOP Exposome,Observation,Substance,"Inositol 1,4,5-trisphosphate receptor type 3",,2024-09-14,1,,,,,,,,,
GIS1009221,0,OMOP Exposome,Observation,Substance,Inositol Phosphate Metabolism,,2024-09-14,1,,,,,,,,,
Q9NPH2,0,OMOP Exposome,Observation,Substance,Inositol-3-phosphate synthase 1,,2024-09-14,1,,,,,,,,,
GIS1009223,0,OMOP Exposome,Observation,Substance,Insect Repellent,,2024-09-14,1,,,,,,,,,
GIS1009224,0,OMOP Exposome,Observation,Substance,Insect Toxin,,2024-09-14,1,,,,,,,,,
GIS1009222,0,OMOP Exposome,Observation,Substance,Insecticide,,2024-09-14,1,,,,,,,,,
11061-68-0,0,OMOP Exposome,Observation,Substance,Insulin,Novolin R; Insulin human; Humulin R; CHEBI:5931,2014-12-24,1,,,,,,,,,
P06213,0,OMOP Exposome,Observation,Substance,Insulin receptor,,2024-09-14,1,,,,,,,,,
GIS1009225,0,OMOP Exposome,Observation,Substance,Insulin secretion,,2024-09-14,1,,,,,,,,,
GIS1009226,0,OMOP Exposome,Observation,Substance,Insulin signaling pathway,,2024-09-14,1,,,,,,,,,
P14735,0,OMOP Exposome,Observation,Substance,Insulin-degrading enzyme,,2024-09-14,1,,,,,,,,,
P08069,0,OMOP Exposome,Observation,Substance,Insulin-like growth factor 1 receptor,,2024-09-14,1,,,,,,,,,
P17936,0,OMOP Exposome,Observation,Substance,Insulin-like growth factor-binding protein 3,,2024-09-14,1,,,,,,,,,
P24593,0,OMOP Exposome,Observation,Substance,Insulin-like growth factor-binding protein 5,,2024-09-14,1,,,,,,,,,
Q16270,0,OMOP Exposome,Observation,Substance,Insulin-like growth factor-binding protein 7,,2024-09-14,1,,,,,,,,,
P08514,0,OMOP Exposome,Observation,Substance,Integrin alpha-IIb,,2024-09-14,1,,,,,,,,,
P20701,0,OMOP Exposome,Observation,Substance,Integrin alpha-L,,2024-09-14,1,,,,,,,,,
P06756,0,OMOP Exposome,Observation,Substance,Integrin alpha-V,,2024-09-14,1,,,,,,,,,
P05107,0,OMOP Exposome,Observation,Substance,Integrin beta-2,,2024-09-14,1,,,,,,,,,
P05106,0,OMOP Exposome,Observation,Substance,Integrin beta-3,,2024-09-14,1,,,,,,,,,
GIS1009227,0,OMOP Exposome,Observation,Substance,Intercalating Agent,,2024-09-14,1,,,,,,,,,
P05362,0,OMOP Exposome,Observation,Substance,Intercellular adhesion molecule 1,,2024-09-14,1,,,,,,,,,
P01574,0,OMOP Exposome,Observation,Substance,Interferon beta,,2024-09-14,1,,,,,,,,,
P10914,0,OMOP Exposome,Observation,Substance,Interferon regulatory factor 1,,2024-09-14,1,,,,,,,,,
P01583,0,OMOP Exposome,Observation,Substance,Interleukin-1 alpha,,2024-09-14,1,,,,,,,,,
P01584,0,OMOP Exposome,Observation,Substance,Interleukin-1 beta,,2024-09-14,1,,,,,,,,,
P60568,0,OMOP Exposome,Observation,Substance,Interleukin-2,,2024-09-14,1,,,,,,,,,
P08700,0,OMOP Exposome,Observation,Substance,Interleukin-3,,2024-09-14,1,,,,,,,,,
P05231,0,OMOP Exposome,Observation,Substance,Interleukin-6,,2024-09-14,1,,,,,,,,,
P10145,0,OMOP Exposome,Observation,Substance,Interleukin-8,,2024-09-14,1,,,,,,,,,
O15554,0,OMOP Exposome,Observation,Substance,Intermediate conductance calcium-activated potassium channel protein 4,,2024-09-14,1,,,,,,,,,
GIS1009228,0,OMOP Exposome,Observation,Substance,Intermediate Filament,,2024-09-14,1,,,,,,,,,
P03956,0,OMOP Exposome,Observation,Substance,Interstitial collagenase,,2024-09-14,1,,,,,,,,,
P09923,0,OMOP Exposome,Observation,Substance,Intestinal-type alkaline phosphatase,,2024-09-14,1,,,,,,,,,
GIS1009229,0,OMOP Exposome,Observation,Substance,Intestine,,2024-09-14,1,,,,,,,,,
GIS1009230,0,OMOP Exposome,Observation,Substance,Intracellular Vesicle,,2024-09-14,1,,,,,,,,,
O60928,0,OMOP Exposome,Observation,Substance,Inward rectifier potassium channel 13,,2024-09-14,1,,,,,,,,,
Q9NPI9,0,OMOP Exposome,Observation,Substance,Inward rectifier potassium channel 16,,2024-09-14,1,,,,,,,,,
P63252,0,OMOP Exposome,Observation,Substance,Inward rectifier potassium channel 2,,2024-09-14,1,,,,,,,,,
P48050,0,OMOP Exposome,Observation,Substance,Inward rectifier potassium channel 4,,2024-09-14,1,,,,,,,,,
7553-56-2,0,OMOP Exposome,Observation,Substance,Iodine,Jod; Iode; Iodine-molecule; Iodio; Iodum; I2; Jood; Tincture iodine; CHEBI:17606,2014-12-24,1,,,,,,,,,
15046-84-1,0,OMOP Exposome,Observation,Substance,Iodine-129,"129I; Iodine, isotope of mass 129; (129)53I; (129)I; Iodine 129; CHEBI:52636",2014-12-24,1,,,,,,,,,
10043-66-0,0,OMOP Exposome,Observation,Substance,Iodine-131,,2014-12-24,1,,,,,,,,,
144550-36-7,0,OMOP Exposome,Observation,Substance,Iodosulfuron-methyl-sodium,,2014-12-24,1,,,,,,,,,
GIS1009231,0,OMOP Exposome,Observation,Substance,Ionophore,,2024-09-14,1,,,,,,,,,
96-83-3,0,OMOP Exposome,Observation,Substance,Iopanoic acid,,2014-12-24,1,,,,,,,,,
36734-19-7,0,OMOP Exposome,Observation,Substance,Iprodione,"Roval WP; 'rovral' HN; 1-Isopropyl carbamoyl-3-(3,5-dichlorophenyl)-hydantoin; 1-Isopropylcarbamoyl-3-(3,5-dichlorophenyl)hydantoin; 3-(3,5-Dichlorophenyl)-1-(1-methylethyl)carbamoylhydantion; 3-(3,5-Dichlorophenyl)-1-(1-methylethyl)carbamoylhydantoin; 3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide, 9CI; Kidan; Promidione; Anfor; Cda roval; Glycophen; Glycophen anphor; Roval dust; Roval flo; Roval green; Glycophene; Ipcdph; Iprodial; Rovral; Rovral 50WP; Rovral flo; Rovral PM; Rovrol; Turbair roval; Verisan; Iprodine; CHEBI:28909",2014-12-24,1,,,,,,,,,
7439-89-6,0,OMOP Exposome,Observation,Substance,Iron,Ferrum; Feosol; Feostat; fer; Fer-In-Sol; Feraheme; Feratab; Ferate; Fergon; Ferralet; Ferretts; Ferro sanol; Ferro-Caps; Ferro-Time; Ferrousal; Yieronia; Vitedyn-Slo; Slow Fe; Simron; Siderol; 26Fe; Ed-In-Sol; Eisen; Fe; Fe-40; Hierro; CHEBI:18248,2014-12-24,1,,,,,,,,,
5968-84-3,0,OMOP Exposome,Observation,Substance,Iron cacodylate,,2014-12-24,1,,,,,,,,,
12023-53-9,0,OMOP Exposome,Observation,Substance,Iron phosphide,,2014-12-24,1,,,,,,,,,
7789-46-0,0,OMOP Exposome,Observation,Substance,Iron(II) bromide,,2014-12-24,1,,,,,,,,,
10031-26-2,0,OMOP Exposome,Observation,Substance,Iron(III) bromide,,2014-12-24,1,,,,,,,,,
10294-52-7,0,OMOP Exposome,Observation,Substance,Iron(III) chromate,,2014-12-24,1,,,,,,,,,
10421-48-4,0,OMOP Exposome,Observation,Substance,Iron(III) nitrate,,2014-12-24,1,,,,,,,,,
P48200,0,OMOP Exposome,Observation,Substance,Iron-responsive element-binding protein 2,,2024-09-14,1,,,,,,,,,
GIS1009232,0,OMOP Exposome,Observation,Substance,Irritant,,2024-09-14,1,,,,,,,,,
42509-80-8,0,OMOP Exposome,Observation,Substance,Isazofos,,2014-12-24,1,,,,,,,,,
106-27-4,0,OMOP Exposome,Observation,Substance,Isoamyl butyrate,,2014-12-24,1,,,,,,,,,
Q7L266,0,OMOP Exposome,Observation,Substance,Isoaspartyl peptidase/L-asparaginase,,2024-09-14,1,,,,,,,,,
482-48-4,0,OMOP Exposome,Observation,Substance,Isobergapten,,2014-12-24,1,,,,,,,,,
2756-56-1,0,OMOP Exposome,Observation,Substance,Isobornyl propionate,,2014-12-24,1,,,,,,,,,
115-31-1,0,OMOP Exposome,Observation,Substance,Isobornyl thiocyanoacetate,,2014-12-24,1,,,,,,,,,
75-28-5,0,OMOP Exposome,Observation,Substance,Isobutane,"1,1-Dimethylethane; (CH3)2CH-CH3; 2-methyl-isobutane-Propane; 2-methyl-Propane; 2-Methylpropane; e943b; I-butane; Isobutane (NF); Methylpropane; R-600a; Tert-butane; Trimethylmethane; CHEBI:30363",2014-12-24,1,,,,,,,,,
GIS1009233,0,OMOP Exposome,Observation,Substance,Isobutyryl-coa dehydrogenase deficiency,,2024-09-14,1,,,,,,,,,
59-63-2,0,OMOP Exposome,Observation,Substance,Isocarboxazid,Isocarbonazid; Isocarboxazida; Isocarboxazide; Isocarboxazidum; Marplan; Isocarboxyzid; Isocarbossazide; Enerzer; CHEBI:775119,2014-12-24,1,,,,,,,,,
P50213,0,OMOP Exposome,Observation,Substance,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",,2024-09-14,1,,,,,,,,,
P51553,0,OMOP Exposome,Observation,Substance,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",,2024-09-14,1,,,,,,,,,
75-13-8,0,OMOP Exposome,Observation,Substance,Isocyanic acid,HNCO; OxidoazanedIIdocarbon; Methenamide; Jhydridonitrato)oxidocarbon; Isozyansaeure; Isocyanate; Carbimide; HN=C=O; Hydrogen isocyanide; Hydrogen isocyanate; ICA; Oxomethanimine; C(NH)O; CHEBI:29202,2014-12-24,1,,,,,,,,,
465-73-6,0,OMOP Exposome,Observation,Substance,Isodrin,,2014-12-24,1,,,,,,,,,
97-54-1,0,OMOP Exposome,Observation,Substance,Isoeugenol,2-Methoxy-4-propenylphenol; trans-4-Propenylgualacol; trans-2-Methoxy-4-propenylphenol; Propenylgualacol; Isoeugenol trans-form; Isoeugenol (I); 4-Hydroxy-3-methoxypropenylbenzene; 4-Hydroxy-3-methoxy-1-propenylbenzene; 4-Hydroxy-3-methoxy-1-propen-1-ylbenzene; 3-Methoxy-4-hydroxypropenylbenzene; 3-Methoxy-4-hydroxy-1-propen-1-ylbenzene; 2-Methoxy-4-(1E)-prop-1-en-1-ylphenol; 2-Methoxy-4-(1E)-1-propenylphenol; 2-Methoxy-4-propenyl-Phenol; Trans-isoeugenol; 2-Methoxy-4-(1-propenyl)phenol; 2-Methoxy-4-(1-propenyl)-Phenol; 1-Hydroxy-2-methoxy-4-propen-1-ylbenzene; 1-(3-Methoxy-4-hydroxyphenyl)-1-propane; (e)-isoeugenol; (E)-2-methoxy-4-propenyl-Phenol; (E)-2-Methoxy-4-(prop-1-enyl)phenol; (E)-2-methoxy-4-(1-propenyl)-Phenol; (E)-2-methoxy-4- (1-propenyl)-Phenol; Trans-p-propenylquaiacol; CHEBI:50545,2014-12-24,1,,,,,,,,,
26675-46-7,0,OMOP Exposome,Observation,Substance,Isoflurane,"1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether; Terrell; Isocane; Forene; Forane; Ethane; Isorane; Isofluranum; Isoflurano; Aerrane; CHEBI:6015",2014-12-24,1,,,,,,,,,
482-45-1,0,OMOP Exposome,Observation,Substance,Isoimperatorin,"4-(3-Methyl-2-butenyl)oxy-7H-furo3,2-gchromen-7-one; Iso-imperatorin; 7,4-(3-Methyl-2-butenyl)oxy-7H-furo3,2-g-1-benzopyran-7-one; CHEBI:66071",2014-12-24,1,,,,,,,,,
119-38-0,0,OMOP Exposome,Observation,Substance,Isolan,,2014-12-24,1,,,,,,,,,
P41252,0,OMOP Exposome,Observation,Substance,"Isoleucine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
Q9NSE4,0,OMOP Exposome,Observation,Substance,"Isoleucine--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
54-85-3,0,OMOP Exposome,Observation,Substance,Isoniazid,Isonicotinylhydrazine; Isonicotinyl hydrazine; Isonicotinyl hydrazide; Rimifon; Servizid; Tibinide; Isohydrazide; INH; Isonicotinhydrazid; Isonicotinic acid hydrazide; Isonicotinic hydrazide; Isonicotinohydrazide; Hydrazide; Hydrazid; HIA; 4-pyridinecarbohydrazide; Nicozid; Nidrazid; Nydrazid; Pyridine-4-carboxylic acid hydrazide; Rimicid; Isonicotinsaeurehydrazid; Isonicotinoylhydrazide; Isonicotinoyl hydrazide; CHEBI:6030,2014-12-24,1,,,,,,,,,
78-78-4,0,OMOP Exposome,Observation,Substance,Isopentane,"Iso-pentane; (CH3)2CH-CH2-CH3; 1,1,2-Trimethylethane; 1,1-dimethylpropane; 2-Methylbutane; Dimethylethylmethane; Ethyldimethylmethane; Exxsol isopentane; Iso-C5H12; Isoamylhydride; Methylbutane; R-601a; CHEBI:30362",2014-12-24,1,,,,,,,,,
123-92-2,0,OMOP Exposome,Observation,Substance,Isopentyl acetate,"Isopentyl ethanoate; 1-Butanol, 3-methyl-, acetate; Isopentyl acetic acid; Isoamyl ethanoate; Isoamyl acetate; FEMA 2055; 3-Methylbutyl ethanoate; 3-Methylbutyl acetate; 3-Methyl-1-butyl acetate; 3-Methyl-1-butanyl acetate; 3-Methyl-1-butanol, acetate; 3-Methyl-1-butanol acetate; 3-Methyl butyl ester acetic acid; 1-Butanol, 3-methyl-, 1-acetate; CHEBI:31725",2014-12-24,1,,,,,,,,,
4098-71-9,0,OMOP Exposome,Observation,Substance,Isophorone diisocyanate,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexylisocyanate; Isophorone diamine dIIsocyanate; 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; Isophorone diisocyanic acid; IPDI; Isocyanic acid, methylene(3,5,5-trimethyl-3,1-cyclohexylene) ester; CHEBI:53214",2014-12-24,1,,,,,,,,,
482-27-9,0,OMOP Exposome,Observation,Substance,Isopimpinellin,"4,9-Dimethoxy-7H-furo(3,2-G) (1)benzopyran-7-one; Isopimpinellin (4,9-Dimethoxypsoralen); Dimethylpsoralen; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4,9-dimethoxy- (8CI); 5,8-Dimethoxypsoralene; 5,8-Dimethoxypsoralen; 5,8-Dimethoxy-6,7-furanocoumarin; 5, 8-Dimethoxypsoralene; 4,9-Dimethoxy-7-oxofuro3,2-gchromene; 4,9-Dimethoxypsoralen; 4,9-Dimethoxy-furo3,2-gchromen-7-one; 4,9-Dimethoxy-7H-furo3,2-g1benzopyran-7-one, 9CI; 4,9-Dimethoxy-7H-Furo3,2-g1benzopyran-7-one; 4,9-Dimethoxy-7H-furo3,2-gchromen-7-one; CHEBI:28853",2014-12-24,1,,,,,,,,,
7683-59-2,0,OMOP Exposome,Observation,Substance,Isoprenaline,"Saventrine; \u03b1-(isopropylaminomethyl)protocatechuyl alcohol; L-Isopropylnoradrenaline; alpha-(Isopropylaminomethyl)protocatechuyl alcohol; Epinephrine Isopropyl Homolog; L-Isoproterenol; Isoprenalinum; (+-)-Isoprenaline; Isopropydrin; Isoprenalina; Isoprenalin; Isopropyl noradrenaline; Isopropyladrenaline; Isopropylarterenol; (+-)-Isoproterenol; (\u00b1)-isoproterenol; N-Isopropylnoradrenaline; Isuprel; Medihaler-Iso; 1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol; 1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol; 3,4-Dihydroxy-alpha-(isopropylamino)methylbenzyl alcohol; Proternol L; N-Isopropylnorepinephrine; (\u00b1)-isoprenaline; Isopropylnoradrenaline; Isopropylnorepinephrine; Isoproterenol; Isoproterenol Chloride; N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine; N-isopropyl-\u03b2-dihydroxyphenyl-\u03b2-hydroxyethylamine; CHEBI:64317",2014-12-24,1,,,,,,,,,
67-63-0,0,OMOP Exposome,Observation,Substance,Isopropyl alcohol,Alcojel; 2-Propyl alcohol; 2-Propanol; Lavaco; Petrohol; Takineocol; Isopropanol; Hartosol; Avantine; Avantin; Alkolave; CHEBI:17824,2014-12-24,1,,,,,,,,,
98-82-8,0,OMOP Exposome,Observation,Substance,Isopropylbenzene,"2-Phenylpropane; Benzene, (1-methylethyl)-, oxidized, polyphenyl residues; (1-methylethyl)benzene (cumene); Cumeen; Cumene; CUMENE (CUMENE HYDROPEROXIDE (80-15-9)); Cumol; I-Propyl-Benzene; I-Propylbenzene; Iso-propylbenzene (cumene); (methylethyl)benzene; (propan-2-yl)benzene; 1-Methylethyl-Benzene; 1-Methylethylbenzene, 9CI; 2-Fenilpropano; Benzene, (1-methylethyl)-, oxidized, sulfurized by-products; Benzene, isopropyl; Benzene,isopropyl cumol; 2-Fenyl-propaan; Isopropilbenzene; Isopropyl-Benzene; Isopropyl-benzol; (1-methylethyl)-Benzene; (1-Methylethyl)benzene; 2-Phenyl-Propane; Sulfurized BY-product of cumene oxidation; Propane, 2-phenyl; Polyphenyl residue; Phenol bottoms; Oxidized cumene polyphenyl residues; Isopropylbenzol; Isopropylbenzen; Isopropylbenzeen; CHEBI:34656",2014-12-24,1,,,,,,,,,
GIS1009234,0,OMOP Exposome,Observation,Substance,Isovaleric acidemia,,2024-09-14,1,,,,,,,,,
GIS1009235,0,OMOP Exposome,Observation,Substance,Isovaleric Aciduria,,2024-09-14,1,,,,,,,,,
82558-50-7,0,OMOP Exposome,Observation,Substance,Isoxaben,"2,6-Dimethoxy-N-(3-(1-ethyl-1-methylpropyl)-5-isoxazolyl)benzamide; N-(3-(1-Ethyl-1-methylpropyl)-5-isoxazolyl)-2,6-dimethoxybenzamide; CHEBI:63956",2014-12-24,1,,,,,,,,,
141112-29-0,0,OMOP Exposome,Observation,Substance,Isoxaflutole,,2014-12-24,1,,,,,,,,,
84625-61-6,0,OMOP Exposome,Observation,Substance,Itraconazole,Itrizole; Sporal; Oriconazole; ITC; ITCZ; Itraconazol; Sporanox; ITZ; Onmel; Itraconazolum; CHEBI:6076,2014-12-24,1,,,,,,,,,
73561-90-7,0,OMOP Exposome,Observation,Substance,Janthitrem B,,2014-12-24,1,,,,,,,,,
73561-91-8,0,OMOP Exposome,Observation,Substance,Janthitrem C,,2014-12-24,1,,,,,,,,,
90986-50-8,0,OMOP Exposome,Observation,Substance,Janthitrem E,,2014-12-24,1,,,,,,,,,
90986-52-0,0,OMOP Exposome,Observation,Substance,Janthitrem F,,2014-12-24,1,,,,,,,,,
90986-51-9,0,OMOP Exposome,Observation,Substance,Janthitrem G,,2014-12-24,1,,,,,,,,,
4466-14-2,0,OMOP Exposome,Observation,Substance,Jasmolin I,JASMOLIN 1; Jasmoline I; Pyrethrin (jasmolin I); CHEBI:39113,2014-12-24,1,,,,,,,,,
1172-63-0,0,OMOP Exposome,Observation,Substance,Jasmolin II,Pyrethrin (jasmolin II); CHEBI:39114,2014-12-24,1,,,,,,,,,
469-59-0,0,OMOP Exposome,Observation,Substance,Jervine,,2014-12-24,1,,,,,,,,,
Q8WYK2,0,OMOP Exposome,Observation,Substance,Jun dimerization protein 2,,2024-09-14,1,,,,,,,,,
520-18-3,0,OMOP Exposome,Observation,Substance,Kaempferol,"Trifolitin; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; Kampferol; Kampherol; Populnetin; Rhamnolutein; 3,4',5,7-Tetrahydroxy-Flavone (7CI,8CI); CHEBI:28499",2014-12-24,1,,,,,,,,,
145199-73-1,0,OMOP Exposome,Observation,Substance,Kaliotoxin,,2014-12-24,1,,,,,,,,,
150769-72-5,0,OMOP Exposome,Observation,Substance,Kaliotoxin-1,,2014-12-24,1,,,,,,,,,
159605-22-8,0,OMOP Exposome,Observation,Substance,Kaliotoxin-2,,2014-12-24,1,,,,,,,,,
223246-26-2,0,OMOP Exposome,Observation,Substance,Kaliotoxin-3,,2014-12-24,1,,,,,,,,,
P06870,0,OMOP Exposome,Observation,Substance,Kallikrein-1,,2024-09-14,1,,,,,,,,,
GIS1009236,0,OMOP Exposome,Observation,Substance,kappa-Atracotoxin (Hadronyche versuta),,2024-09-14,1,,,,,,,,,
GIS1009243,0,OMOP Exposome,Observation,Substance,kappa-Conotoxin (Conus purpurascens),,2024-09-14,1,,,,,,,,,
478621-50-0,0,OMOP Exposome,Observation,Substance,kappa-Hefutoxin,,2014-12-24,1,,,,,,,,,
P41145,0,OMOP Exposome,Observation,Substance,Kappa-type opioid receptor,,2024-09-14,1,,,,,,,,,
4849-32-5,0,OMOP Exposome,Observation,Substance,Karbutilate,,2014-12-24,1,,,,,,,,,
Q14145,0,OMOP Exposome,Observation,Substance,Kelch-like ECH-associated protein 1,,2024-09-14,1,,,,,,,,,
Q99456,0,OMOP Exposome,Observation,Substance,"Keratin, type I cytoskeletal 12",,2024-09-14,1,,,,,,,,,
Q701N4,0,OMOP Exposome,Observation,Substance,Keratin-associated protein 5-2,,2024-09-14,1,,,,,,,,,
Q6L8H2,0,OMOP Exposome,Observation,Substance,Keratin-associated protein 5-3,,2024-09-14,1,,,,,,,,,
GIS1009273,0,OMOP Exposome,Observation,Substance,Keratolytic Agent,,2024-09-14,1,,,,,,,,,
6740-88-1,0,OMOP Exposome,Observation,Substance,Ketamine,CI 581 base; 2-(methylamino)-2-(2-chlorophenyl)cyclohexanone; NMDA; Special k; 2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone; (\u00b1)-ketamine; (S)-Ketamine; (S)-(-)-Ketamine; Ketaject; DL-ketamine; 2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone; Ketamine Base; Ketamine HCL; L-Ketamine; Ketaminum; Ketanest; (-)-Ketamine; KETAMINE; (+-)-Ketamine; Ketalar; Ketamina; CHEBI:6121,2014-12-24,1,,,,,,,,,
27223-35-4,0,OMOP Exposome,Observation,Substance,Ketazolam,,2014-12-24,1,,,,,,,,,
65277-42-1,0,OMOP Exposome,Observation,Substance,Ketoconazole,"Ketoisdin; Nizoral a-D; Fungarest; Extina; Ketoderm; Piperazine; Panfungol; Ketodan; Ketoconazolum; Nizoral Shampoo; cis-1-Acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H- imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-ketoconazol; (+-)-cis-1-acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1- ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine; Fungoral; Nizoral Cream; Xolegel; Nizoral; Ketozole; Ketoconazol; Orifungal M; Orifungal; CHEBI:48339",2014-12-24,1,,,,,,,,,
P50053,0,OMOP Exposome,Observation,Substance,Ketohexokinase,,2024-09-14,1,,,,,,,,,
816-66-0,0,OMOP Exposome,Observation,Substance,Ketoleucine,a-Ketoisocaproic acid; Oxoisocaproic acid; Oxoisocaproate; Methyloxovaleric acid; Methyloxovalerate; Ketoisocaproic acid; Ketoisocaproate; alpha-Oxoisocaproic acid; alpha-Oxoisocaproate; alpha-Ketoisocapronic acid; alpha-Ketoisocapronate; alpha-Ketoisocaproic acid; alpha-Ketoisocaproate; alpha-Keto-isocaproic acid; 2-Keto-4-Methylvalerate; 2-Keto-4-Methylvaleric acid; 2-Ketoisocaproate; 2-Ketoisocaproic acid; 2-Oxo-4-methylpentanoate; 2-Oxo-4-methylpentanoic acid; 2-Oxo-4-methylvalerate; 2-Oxo-4-methylvaleric acid; 2-Oxoisocaproate; 2-Oxoisocaproic acid; 2-Oxoleucine; 4-Methyl-2-oxo-Valerate; 4-Methyl-2-oxo-Valeric acid; 4-Methyl-2-oxopentanoate; 4-Methyl-2-oxopentanoic acid; alpha-Keto-isocaproate; a-Oxoisocaproic acid; a-Oxoisocaproate; a-Ketoisocapronic acid; a-Ketoisocapronate; a-Ketoisocaproate; CHEBI:48430,2018-03-21,1,,,,,,,,,
GIS1009274,0,OMOP Exposome,Observation,Substance,Ketolide,,2024-09-14,1,,,,,,,,,
GIS1009275,0,OMOP Exposome,Observation,Substance,Ketone,,2024-09-14,1,,,,,,,,,
GIS1009276,0,OMOP Exposome,Observation,Substance,Ketone Body Metabolism,,2024-09-14,1,,,,,,,,,
GIS1009277,0,OMOP Exposome,Observation,Substance,Kidney,,2024-09-14,1,,,,,,,,,
Q12840,0,OMOP Exposome,Observation,Substance,Kinesin heavy chain isoform 5A,,2024-09-14,1,,,,,,,,,
O60282,0,OMOP Exposome,Observation,Substance,Kinesin heavy chain isoform 5C,,2024-09-14,1,,,,,,,,,
Q07866,0,OMOP Exposome,Observation,Substance,Kinesin light chain 1,,2024-09-14,1,,,,,,,,,
Q9H0B6,0,OMOP Exposome,Observation,Substance,Kinesin light chain 2,,2024-09-14,1,,,,,,,,,
Q6P597,0,OMOP Exposome,Observation,Substance,Kinesin light chain 3,,2024-09-14,1,,,,,,,,,
Q9NSK0,0,OMOP Exposome,Observation,Substance,Kinesin light chain 4,,2024-09-14,1,,,,,,,,,
P33176,0,OMOP Exposome,Observation,Substance,Kinesin-1 heavy chain,,2024-09-14,1,,,,,,,,,
P52732,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF11,,2024-09-14,1,,,,,,,,,
Q96FN5,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF12,,2024-09-14,1,,,,,,,,,
Q9H1H9,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF13A,,2024-09-14,1,,,,,,,,,
Q9NQT8,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF13B,,2024-09-14,1,,,,,,,,,
Q15058,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF14,,2024-09-14,1,,,,,,,,,
Q9NS87,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF15,,2024-09-14,1,,,,,,,,,
Q96L93,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF16B,,2024-09-14,1,,,,,,,,,
Q9P2E2,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF17,,2024-09-14,1,,,,,,,,,
Q8NI77,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF18A,,2024-09-14,1,,,,,,,,,
Q86Y91,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF18B,,2024-09-14,1,,,,,,,,,
Q2TAC6,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF19,,2024-09-14,1,,,,,,,,,
Q12756,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF1A,,2024-09-14,1,,,,,,,,,
O60333,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF1B,,2024-09-14,1,,,,,,,,,
O43896,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF1C,,2024-09-14,1,,,,,,,,,
O95235,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF20A,,2024-09-14,1,,,,,,,,,
Q96Q89,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF20B,,2024-09-14,1,,,,,,,,,
Q7Z4S6,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF21A,,2024-09-14,1,,,,,,,,,
O75037,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF21B,,2024-09-14,1,,,,,,,,,
Q14807,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF22,,2024-09-14,1,,,,,,,,,
Q02241,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF23,,2024-09-14,1,,,,,,,,,
Q5T7B8,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF24,,2024-09-14,1,,,,,,,,,
Q9UIL4,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF25,,2024-09-14,1,,,,,,,,,
Q9ULI4,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF26A,,2024-09-14,1,,,,,,,,,
Q2KJY2,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF26B,,2024-09-14,1,,,,,,,,,
Q86VH2,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF27,,2024-09-14,1,,,,,,,,,
O00139,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF2A,,2024-09-14,1,,,,,,,,,
Q8N4N8,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF2B,,2024-09-14,1,,,,,,,,,
Q99661,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF2C,,2024-09-14,1,,,,,,,,,
Q9Y496,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF3A,,2024-09-14,1,,,,,,,,,
O15066,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF3B,,2024-09-14,1,,,,,,,,,
O14782,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF3C,,2024-09-14,1,,,,,,,,,
Q6ZMV9,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF6,,2024-09-14,1,,,,,,,,,
Q2M1P5,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF7,,2024-09-14,1,,,,,,,,,
Q9HAQ2,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIF9,,2024-09-14,1,,,,,,,,,
Q9BW19,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIFC1,,2024-09-14,1,,,,,,,,,
Q96AC6,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIFC2,,2024-09-14,1,,,,,,,,,
Q9BVG8,0,OMOP Exposome,Observation,Substance,Kinesin-like protein KIFC3,,2024-09-14,1,,,,,,,,,
GIS1009278,0,OMOP Exposome,Observation,Substance,Kinetochore,,2024-09-14,1,,,,,,,,,
Q9UEF7,0,OMOP Exposome,Observation,Substance,Klotho,,2024-09-14,1,,,,,,,,,
501-30-4,0,OMOP Exposome,Observation,Substance,Kojic acid,"2-(Hydroxymethyl)-5-hydroxy-4H-pyran-4-one; Pyran-4-one, 5-hydroxy-2-(hydroxymethyl); Kojate; KOJ; Acido kojico; 5-Hydroxy-2-hydroxymethyl-4H-4-pyranone; 5-Hydroxy-2-hydroxymethyl-4-pyrone; 5-Hydroxy-2-(hydroxymethyl)pyran-4-one; 5-Hydroxy-2-(hydroxymethyl)-4H-Pyran-4-one; 5-Hydroxy-2-(hydroxymethyl)-4-pyrone; 2-Hydroxymethyl-5-hydroxy-gamma-pyrone; CHEBI:34805",2014-12-24,1,,,,,,,,,
Q13887,0,OMOP Exposome,Observation,Substance,Krueppel-like factor 5,,2024-09-14,1,,,,,,,,,
820959-57-7,0,OMOP Exposome,Observation,Substance,Kurtoxin,,2014-12-24,1,,,,,,,,,
492-27-3,0,OMOP Exposome,Observation,Substance,Kynurenic acid,4-Hydroxy-Quinaldate; Quinurenic acid; Kynurenate; 4-Hydroxyquinoline-2-carboxylic acid; 4-Hydroxyquinoline-2-carboxylate; 4-Hydroxyquinaldinic acid; 4-Hydroxyquinaldinate; 4-Hydroxyquinaldic acid; 4-Hydroxyquinaldate; 4-Hydroxy-Quinaldic acid; 4-Hydroxy-2-Quinolinecarboxylic acid; 2-Carboxy-4-hydroxyquinoline; CHEBI:18344,2014-12-24,1,,,,,,,,,
Q16719,0,OMOP Exposome,Observation,Substance,Kynureninase,,2024-09-14,1,,,,,,,,,
Q63HM1,0,OMOP Exposome,Observation,Substance,Kynurenine formamidase,,2024-09-14,1,,,,,,,,,
Q16773,0,OMOP Exposome,Observation,Substance,Kynurenine--oxoglutarate transaminase 1,,2024-09-14,1,,,,,,,,,
Q6YP21,0,OMOP Exposome,Observation,Substance,Kynurenine--oxoglutarate transaminase 3,,2024-09-14,1,,,,,,,,,
Q8N5Z0,0,OMOP Exposome,Observation,Substance,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
13095-48-2,0,OMOP Exposome,Observation,Substance,L-2-Hydroxyglutaric acid,(S)-2-Hydroxyglutarate; L-alpha-Hydroxyglutarate; L-a-Hydroxyglutaric acid; L-a-Hydroxyglutarate; L-2-Hydroxyglutarate; 2-Hydroxy-L-Glutaric acid; 2-Hydroxy-L-Glutarate; 2-Hydroxy-(S)-Pentanedioic acid; 2-Hydroxy-(S)-Pentanedioate; (S)-2-Hydroxyglutaric acid; (S)-a-Hydroxyglutarate; (S)-a-Hydroxyglutaric acid; (S)-alpha-Hydroxyglutarate; (S)-alpha-Hydroxyglutaric acid; L-alpha-Hydroxyglutaric acid; CHEBI:32797,2018-03-21,1,,,,,,,,,
56-41-7,0,OMOP Exposome,Observation,Substance,L-Alanine,Ala; alpha-Alanine; alpha-Aminopropanoate; alpha-Aminopropanoic acid; alpha-Aminopropionate; L-2-Aminopropanoate; alpha-Aminopropionic acid; L-(+)-Alanine; L-alpha-Alanine; L-a-Aminopropionate; L-alpha-Aminopropionate; L-\u03b1-alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; (2S)-2-Aminopropanoate; (2S)-2-Aminopropanoic acid; (S)-(+)-Alanine; (S)-2-amino-Propanoate; (S)-2-amino-Propanoic acid; (S)-2-Aminopropanoate; (S)-2-Aminopropanoic acid; (S)-Alanine; 2-Aminopropanoate; L-2-Aminopropionate; L-2-Aminopropanoic acid; 2-Aminopropanoic acid; 2-Aminopropionate; 2-Aminopropionic acid; 2-Ammoniopropanoate; 2-Ammoniopropanoic acid; a-Alanine; a-Aminopropionate; a-Aminopropionic acid; Alanine; L-a-Alanine; L-2-Aminopropionic acid; CHEBI:16977,2014-12-24,1,,,,,,,,,
Q96RQ9,0,OMOP Exposome,Observation,Substance,L-amino-acid oxidase,,2024-09-14,1,,,,,,,,,
74-79-3,0,OMOP Exposome,Observation,Substance,L-Arginine,L-alpha-Amino-delta-guanidinovalerate; R-Gene 10; R; N5-(aminoiminomethyl)-L-Ornithine; L-Arginin; L-Arg; L-alpha-Amino-delta-guanidinovaleric acid; L-a-Amino-D-guanidinovaleric acid; L-a-Amino-D-guanidinovalerate; L-(+)-Arginine; Arginine; Arg; 5-(Aminoiminomethyl)amino-L-Norvaline; 2-Amino-5-guanidinovaleric acid; 2-Amino-5-guanidinovalerate; (S)-2-Amino-5-(aminoiminomethyl)aminopentanoic acid; (S)-2-Amino-5-(aminoiminomethyl)aminopentanoate; (S)-2-amino-5-(aminoiminomethyl)amino-Pentanoic acid; (S)-2-amino-5-(aminoiminomethyl)amino-Pentanoate; (S)-2-Amino-5-guanidinovaleric acid; (S)-2-amino-5-guanidinopentanoic acid; (2S)-2-amino-5-Guanidinopentanoic acid; (2S)-2-amino-5-(Carbamimidamido)pentanoic acid; CHEBI:16467,2014-12-24,1,,,,,,,,,
70-47-3,0,OMOP Exposome,Observation,Substance,L-Asparagine,"(2S)-2-amino-3-carbamoylpropanoic acid; Asparagine acid; Asparamide; Aspartamate; Aspartamic acid; Aspartic acid amide; Aspartic acid b-amide; Aspartic acid beta amide; B2,4-(S)-diamino-4-oxo-utanoate; B2,4-(S)-diamino-4-oxo-utanoic acid; Crystal VI; L-2,4-Diamino-4-oxobutanoate; L-2,4-Diamino-4-oxobutanoic acid; L-2-aminosuccinamic acid; L-Asparagin; L-Aspartamine; L-aspartic acid beta-amide; Asparagine; Asn; Altheine; alpha-Aminosuccinamic acid; alpha-Aminosuccinamate; alpha Amminosuccinamic acid; alpha Amminosuccinamate; Agedoite; a-Aminosuccinamic acid; a-Aminosuccinamate; 2-Aminosuccinamic acid; 2-Aminosuccinamate; (S)-Asparagine; (2S)-2,4-diamino-4-oxobutanoic acid; (-)-Asparagine; (S)-2-amino-3-carbamoylpropanoic acid; L-aspartic acid \u03b2-amide; L-b-Asparagine; (S)-2,4-Diamino-4-oxobutanoic acid; L-beta-Asparagine; N; (S)-2,4-Diamino-4-oxobutanoate; \u03b1-aminosuccinamic acid; CHEBI:17196",2014-12-24,1,,,,,,,,,
541-15-1,0,OMOP Exposome,Observation,Substance,L-Carnitine,"Carnipass 20; Carnipass; Carnilean; Carniking 50; Carniking; Carnicor; Carniben; Cardispan; Levocarnitina; Levocarnitine; Cardimax; Bitobionil; Biocarn; Bicarnesine; Aveptol; Albicar; 3-Hydroxy-4-trimethylammoniobutanoic acid; 3-Hydroxy-4-trimethylammoniobutanoate; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; 1-Carnitine; (S)-carnitine; (R)-carnitine; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (-)-L-Carnitine; (-)-L-Carnitin; (-)-carnitine; (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; Levocarnitinum; R-(-)-3-Hydroxy-4-trimethylaminobutyrate; Vitamin BT; Levocarnitin; Lecarna; L-gamma-Trimethyl-beta-hydroxybutyrobetaine; L-(-)-Carnitine; Karnitin; gamma-Trimethyl-hydroxybutyrobetaine; gamma-Trimethyl-beta-hydroxybutyrobetaine; gamma-Trimethyl-ammonium-beta-hydroxybutirate; DL-carnitine; delta-Carnitine; D-Carnitine; Carnitor; Carnitine; Carnitene; CHEBI:16347",2014-12-24,1,,,,,,,,,
58919-61-2,0,OMOP Exposome,Observation,Substance,L-Coprine,,2014-12-24,1,,,,,,,,,
52-90-4,0,OMOP Exposome,Observation,Substance,L-Cysteine,(2R)-2-amino-3-sulfanylpropanoate; Cysteinum; (R)-(+)-cysteine; (2R)-2-amino-3-sulfanylpropanoic acid; Thioserine; Cystein; Cys; Cisteinum; Cysteine; Polycysteine; L-Cystein; L-Cys; L-2-Amino-3-mercaptopropionic acid; Cisteina; Carbocysteine; beta-Mercaptoalanine; B-Mercaptoalanine; alpha-Amino-beta-thiolpropionic acid; Acetylcysteine; 3-Mercapto-L-Alanine; 2-Amino-3-mercaptopropionic acid; 2-Amino-3-mercaptopropionate; (2R)-2-amino-3-mercaptopropanoic acid; (2R)-2-amino-3-mercaptopropanoate; (+)-2-Amino-3-mercaptopropionic acid; 2-Amino-3-mercaptopropanoic acid; 2-Amino-3-mercaptopropanoate; (R)-cysteine; L-2-Amino-3-mercaptopropanoic acid; L-2-Amino-3-mercaptopropanoate; L-(+)-Cysteine; L Cysteine; (R)-2-Amino-3-mercaptopropanoic acid; (R)-2-Amino-3-mercaptopropanoate; (R)-2-amino-3-mercapto-Propanoic acid; (R)-2-amino-3-mercapto-Propanoate; Half-cystine; Free cysteine; CHEBI:17561,2014-12-24,1,,,,,,,,,
59-92-7,0,OMOP Exposome,Observation,Substance,L-Dopa,"L-4-5-Dihydroxyphenylalanine; L-b-(3,4-Dihydroxyphenyl)-a-alanine; L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine; L-beta-(3,4-Dihydroxyphenyl)alanine; L-Dihydroxyphenylalanine; Laradopa; Larodopa; Ledopa; Levedopa; Levodopa; Levodopum; Levopa; Maipedopa; Parda; Pardopa; Prodopa; Syndopa; Veldopa; Weldopa; \u03b2-(3,4-dihydroxyphenyl)alanine; (-)-3-(3,4-dihydroxyphenyl)-L-alanine; (-)-Dopa; (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate; (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; (\u2212)-3-(3,4-dihydroxyphenyl)-L-alanine; (\u2212)-dopa; 3,4-Dihydroxy-L-phenylalanine; 3,4-Dihydroxyphenyl-L-alanine; 3,4-Dihydroxyphenylalanine; 3-(3,4-Dihydroxyphenyl)-L-alanine; 3-Hydroxy-L-tyrosine; b-(3,4-Dihydroxyphenyl)-a-L-alanine; b-(3,4-Dihydroxyphenyl)-L-alanine; b-(3,4-Dihydroxyphenyl)alanine; Bendopa; beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine; beta-(3,4-Dihydroxyphenyl)-L-alanine; beta-(3,4-Dihydroxyphenyl)alanine; Bidopal; Cidandopa; Dihydroxy-L-phenylalanine; Dihydroxyphenylalanine; Dopaflex; Dopaidan; Dopal; Dopalina; Dopar; Doparkine; Doparl; Dopasol; Dopaston; Dopastone; Dopastral; Dopicar; Doprin; Eldopal; Eldopar; Eldopatec; Eurodopa; Helfo-dopa; Insulamina; L-(-)-Dopa; L-3,4-dihydroxyphenylalanine; L-3-(3,4-Dihydroxyphenyl)-Alanine; CHEBI:15765",2014-12-24,1,,,,,,,,,
89762-39-0,0,OMOP Exposome,Observation,Substance,L-Dopachrome,,2018-03-21,1,,,,,,,,,
110810-88-3,0,OMOP Exposome,Observation,Substance,L-Dopaquinone,,2018-03-21,1,,,,,,,,,
56-86-0,0,OMOP Exposome,Observation,Substance,L-Glutamic acid,"alpha-Aminoglutaric acid; Aminoglutarate; Aminoglutaric acid; E; Glt; L-a-Aminoglutarate; L-(+)-Glutamic acid; L-(+)-Glutamate; Glutaton; L-alpha-Aminoglutarate; L-a-Aminoglutaric acid; 2-Aminopentanedioate; 2-Aminopentanedioic acid; a-Aminoglutarate; a-Aminoglutaric acid; a-Glutamate; a-Glutamic acid; Aciglut; alpha-Aminoglutarate; alpha-Glutamate; Glutaminol; Glutaminic acid; Glutamic acid; Glutacid; Glut; Glusate; Glutaminate; Glutamidex; Glutamicol; 1-Amino-propane-1,3-dicarboxylic acid; alpha-Glutamic acid; 1-Amino-propane-1,3-dicarboxylate; (S)-Glutamic acid; (S)-Glutamate; (S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-(+)-Glutamate; (2S)-2-Aminopentanedioic acid; (2S)-2-Aminopentanedioate; L-Glutaminic acid; 1-Aminopropane-1,3-dicarboxylate; (S)-2-Aminopentanedioate; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutarate; Glu; L-Glutaminate; L-Glutamate; L-Glu; L-alpha-Aminoglutaric acid; 2-Aminoglutaric acid; CHEBI:16015",2014-12-24,1,,,,,,,,,
56-85-9,0,OMOP Exposome,Observation,Substance,L-Glutamine,"Levoglutamida; (2S)-2,5-diamino-5-oxopentanoate; (2S)-2,5-diamino-5-oxopentanoic acid; (2S)-2-amino-4-carbamoylbutanoate; (2S)-2-amino-4-carbamoylbutanoic acid; (S)-2,5-Diamino-5-oxopentanoate; (S)-2,5-Diamino-5-oxopentanoic acid; 2-Aminoglutaramic acid; Cebrogen; Earthlink Science Glutamine Chews Chocolate; gamma-Glutamine; Glavamin; Glumin; Glutamic acid 5-amide; Glutamic acid amide; Glutamine; Glutamine Express; Glutamine Fuel Mega; Glutamine fuel powder; L-(+)-Glutamine; L-2-Aminoglutaramic acid; L-2-Aminoglutaramidic acid; L-Glutamic acid 5-amide; L-Glutamic acid gamma-amide; L-glutamic acid \u03b3-amide; L-Glutamid; L-Glutamide; L-Glutamin; L-Glutamine Power; L-Glutaminsaeure-5-amid; L-Glutamins\u00e4ure-5-amid; Levoglutamid; Levoglutamide; Levoglutamidum; Levoglutamina; NutreStore; Polyglutamine; Q; Stimulina; CHEBI:18050",2014-12-24,1,,,,,,,,,
71-00-1,0,OMOP Exposome,Observation,Substance,L-Histidine,L-Histidin; 3-(1H-Imidazol-4-yl)-L-Alanine; (S)1H-Imidazole-4-alanine; Amino-1H-imidazole-4-propanoate; Amino-1H-imidazole-4-propanoic acid; Amino-4-imidazoleproprionate; Amino-4-imidazoleproprionic acid; (S)-1H-Imidazole-4-alanine; (S)-2-Amino-3-(4-imidazolyl)propionsaeure; (S)-4-(2-Amino-2-carboxyethyl)imidazole; His; Histidine; (S)-a-Amino-1H-imidazole-4-propanoate; (S)-a-Amino-1H-imidazole-4-propanoic acid; (S)-alpha-Amino-1H-imidazole-4-propanoate; (S)-alpha-Amino-1H-imidazole-4-propanoic acid; (S)-alpha-Amino-1H-imidazole-4-propionate; L-(\u2212)-histidine; L-(-)-Histidine; H; (S)-alpha-Amino-1H-imidazole-4-propionic acid; (S)-Histidine; (S)-\u03b1-amino-1H-Imidazole-4-propanoic acid; Glyoxaline-5-alanine; CHEBI:15971,2014-12-24,1,,,,,,,,,
156-56-9,0,OMOP Exposome,Observation,Substance,L-Hypoglycin A,,2014-12-24,1,,,,,,,,,
73-32-5,0,OMOP Exposome,Observation,Substance,L-Isoleucine,"alpha-amino-beta-methylvaleric acid; (S,S)-Isoleucine; (2S,3S)-alpha-Amino-beta-methylvaleric acid; S-(R*,R*)-2-Amino-3-methylpentanoic acid; \u03b1-amino-\u03b2-methylvaleric acid; (2S,3S)-alph-Amino-beta-methylvaleric acid; (2S,3S)-alph-Amino-beta-methylvalerate; (2S,3S)-a-Amino-b-methylvaleric acid; (2S,3S)-a-Amino-b-methylvalerate; (2S,3S)-a-Amino-b-methyl-N-valeric acid; (2S,3S)-a-Amino-b-methyl-N-valerate; (2S,3S)-2-Amino-3-methylpentanoic acid; (2S,3S)-2-Amino-3-methylpentanoate; (2S,3S)-alpha-Amino-beta-methylvalerate; (2S,3S)-alpha-Amino-beta-methyl-N-valeric acid; (2S,3S)-alpha-Amino-beta-methyl-N-valerate; (2S,3S)-alpha-Amino-beta-merthylvaleric acid; (2S,3S)-2-amino-3-methyl-Pentanoic acid; (2S,3S)-alpha-Amino-beta-merthylvalerate; (2S,3S)-alpha-Amino-beta-merthyl-N-valeric acid; (2S,3S)-alpha-Amino-beta-merthyl-N-valerate; L-(+)-Isoleucine; Isoleucine; L-Ile; (S)-Isoleucine; 2-Amino-3-methylpentanoic acid; Iso-leucine; Ile; I; Erythro-L-Isoleucine; S-(R*,R*)-2-Amino-3-methylpentanoate; 2-Amino-3-methylpentanoate; 2-Amino-3-methylvalerate; 2S,3S-Isoleucine; 2-Amino-3-methylvaleric acid; (2S,3S)-2-amino-3-methyl-Pentanoate; CHEBI:17191",2014-12-24,1,,,,,,,,,
P00338,0,OMOP Exposome,Observation,Substance,L-lactate dehydrogenase A chain,,2024-09-14,1,,,,,,,,,
79-33-4,0,OMOP Exposome,Observation,Substance,L-Lactic acid,(S)-2-hydroxy-Propanoic acid; (S)-2-Hydroxypropanoate; (S)-2-Hydroxypropanoic acid; (S)-2-Hydroxypropionic acid; (S)-2-Hydroxypropionate; Sarcolactic acid; Milk acid; Lactic acid; Lactate; L-Lactate; L-2-Hydroxypropanoic acid; L-2-Hydroxypropanoate; L-(+)- Lactic acid; alpha-Hydroxypropionic acid; alpha-Hydroxypropionate; alpha-Hydroxypropanoic acid; alpha-Hydroxypropanoate; a-Hydroxypropionic acid; a-Hydroxypropionate; a-Hydroxypropanoic acid; a-Hydroxypropanoate; 2-Hydroxypropionate; 2-Hydroxypropanoic acid; 2-Hydroxypropanoate; 1-Hydroxyethanecarboxylic acid; 1-Hydroxyethanecarboxylate; 1-Hydroxyethane 1-carboxylic acid; 1-Hydroxyethane 1-carboxylate; (S)-Lactic acid; (S)-Lactate; (+)-Lactate; (+)-Lactic acid; (alpha)-Lactate; (alpha)-Lactic acid; (S)-(+)-2-Hydroxypropanoate; (S)-(+)-2-Hydroxypropanoic acid; (S)-2-hydroxy-Propanoate; CHEBI:422,2018-03-21,1,,,,,,,,,
61-90-5,0,OMOP Exposome,Observation,Substance,L-Leucine,(2S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (2S)-2-Amino-4-methylpentanoate; 4-Methyl-L-Norvaline; L; L-(+)-Leucine; L-a-Aminoisocaproate; L-a-Aminoisocaproic acid; L-alpha-Aminoisocaproate; L-alpha-Aminoisocaproic acid; L-Leucin; L-Leuzin; Leu; Leucine; (S)-2-Amino-4-methylvalerate; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylpentanoate; (S)-Leucine; (S)-(+)-Leucine; (2S)-alpha-Leucine; (2S)-alpha-2-Amino-4-methylvaleric acid; 2-Amino-4-methylvaleric acid; CHEBI:15603,2014-12-24,1,,,,,,,,,
63-68-3,0,OMOP Exposome,Observation,Substance,L-Methionine,alpha-Amino-gamma-methylmercaptobutyric acid; (2S)-2-amino-4-(methylsulfanyl)butanoate; (2S)-2-amino-4-(methylsulfanyl)butanoic acid; (L)-methionine; (S)-(+)-methionine; (S)-2-amino-4-(methylthio)-Butanoate; (S)-2-amino-4-(methylthio)-Butanoic acid; (S)-2-Amino-4-(methylthio)butanoate; (S)-2-Amino-4-(methylthio)butanoic acid; (S)-2-amino-4-(methylthio)butyric acid; (S)-methionine; 2-Amino-4-(methylthio)butyrate; 2-Amino-4-(methylthio)butyric acid; 2-Amino-4-methylthiobutanoate; 2-Amino-4-methylthiobutanoic acid; A-Amino-g-methylmercaptobutyrate; A-Amino-g-methylmercaptobutyric acid; Acimethin; alpha-Amino-alpha-aminobutyric acid; alpha-Amino-gamma-methylmercaptobutyrate; Cymethion; G-Methylthio-a-aminobutyrate; G-Methylthio-a-aminobutyric acid; gamma-Methylthio-alpha-aminobutyrate; gamma-Methylthio-alpha-aminobutyric acid; H-Met-h; H-Met-oh; L(-)-Amino-alpha-amino-alpha-aminobutyric acid; L(-)-Amino-gamma-methylthiobutyric acid; L-(-)-Methionine; L-2-Amino-4-(methylthio)butyric acid; L-2-Amino-4-methylthiobutyric acid; L-a-Amino-g-methylthiobutyrate; L-a-Amino-g-methylthiobutyric acid; L-alpha-Amino-gamma-methylmercaptobutyric acid; L-alpha-Amino-gamma-methylthiobutyrate; L-alpha-Amino-gamma-methylthiobutyric acid; L-gamma-Methylthio-alpha-aminobutyric acid; L-Methionin; L-Methioninum; L-\u03b1-amino-\u03b3-methylmercaptobutyric acid; Liquimeth; M; Mepron; MET; Methilanin; Methionine; Methioninum; Metionina; Neo-methidin; Poly-L-methionine; Polymethionine; S-Methionine; S-Methyl-L-homocysteine; Toxin WAR; CHEBI:16643,2018-03-21,1,,,,,,,,,
63-91-2,0,OMOP Exposome,Observation,Substance,L-Phenylalanine,(S)-alpha-Amino-benzenepropanoate; (-)-beta-Phenylalanine; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-amino-3-phenylpropanoate; (S)-2-amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionate; (S)-2-Amino-3-phenylpropionic acid; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionate; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminobenzenepropanoate; (S)-alpha-Aminobenzenepropanoic acid; (S)-alpha-Aminohydrocinnamate; (S)-alpha-Aminohydrocinnamic acid; (S)-Phenylalanine; 3-Phenyl-L-alanine; alpha-Aminohydrocinnamate; alpha-Aminohydrocinnamic acid; beta-Phenyl-alpha-alanine; beta-Phenyl-L-alanine; beta-Phenylalanine; F; L-2-Amino-3-phenylpropionate; L-2-Amino-3-phenylpropionic acid; Phe; Phenyl-Alanine; Phenylalamine; Phenylalanine; \u03b2-phenyl-L-alanine; CHEBI:17295,2018-03-21,1,,,,,,,,,
147-85-3,0,OMOP Exposome,Observation,Substance,L-Proline,(-)-(S)-Proline; (S)-2-Pyrralidinecarboxylate; (S)-2-Pyrralidinecarboxylic acid; (S)-2-Pyrrolidinecarboxylate; (\u2212)-(S)-proline; L-(-)-Proline; L-alpha-pyrrolidinecarboxylic acid; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (2S)-Pyrrolidine-2-carboxylic acid; (\u2212)-2-pyrrolidinecarboxylic acid; (S)-Pyrrolidine-2-carboxylic acid; (-)-Proline; (\u2212)-proline; (S)-(-)-Proline; 2-Pyrrolidinecarboxylate; 2-Pyrrolidinecarboxylic acid; (S)-(-)-Pyrrolidine-2-carboxylate; (S)-(-)-Pyrrolidine-2-carboxylic acid; Prolinum; Proline; Prolina; P; L-\u03b1-pyrrolidinecarboxylic acid; (-)-2-Pyrrolidinecarboxylic acid; L-pyrrolidine-2-carboxylic acid; L-Prolin; (S)-2-Carboxypyrrolidine; (-)-2-Pyrrolidinecarboxylate; CHEBI:17203,2018-03-21,1,,,,,,,,,
56-45-1,0,OMOP Exposome,Observation,Substance,L-Serine,(-)-Serine; (S)-2-Amino-3-hydroxypropanoic acid; (S)-a-Amino-b-hydroxypropionate; (S)-a-Amino-b-hydroxypropionic acid; (S)-alpha-Amino-beta-hydroxypropionate; (S)-alpha-Amino-beta-hydroxypropionic acid; (S)-b-Amino-3-hydroxypropionate; (S)-b-Amino-3-hydroxypropionic acid; (S)-beta-Amino-3-hydroxypropionate; (2S)-2-amino-3-Hydroxypropanoic acid; (S)-(-)-Serine; (S)-(\u2212)-serine; (S)-beta-Amino-3-hydroxypropionic acid; (S)-Serine; 2-Amino-3-hydroxypropanoate; 2-Amino-3-hydroxypropanoic acid; 3-Hydroxy-L-Alanine; (S)-2-amino-3-hydroxy-Propanoate; (S)-2-amino-3-hydroxy-Propanoic acid; (S)-2-Amino-3-hydroxypropanoate; b-Hydroxy-L-alanine; L-3-Hydroxy-2-aminopropionate; L-2-Amino-3-hydroxypropionic acid; L-(\u2212)-serine; L-3-Hydroxy-2-aminopropionic acid; beta-Hydroxyalanine; beta-Hydroxy-L-alanine; Serine; L-3-Hydroxy-alanine; L-Ser; L-Serin; Ser; S; L-(-)-Serine; CHEBI:17115,2014-12-24,1,,,,,,,,,
P20132,0,OMOP Exposome,Observation,Substance,L-serine dehydratase/L-threonine deaminase,,2024-09-14,1,,,,,,,,,
72-19-5,0,OMOP Exposome,Observation,Substance,L-Threonine,"Thr; L-alpha-Amino-beta-hydroxybutyric acid; L-Threonin; L-\u03b1-amino-\u03b2-hydroxybutyric acid; R-(R*,S*)-2-Amino-3-hydroxybutanoate; R-(R*,S*)-2-Amino-3-hydroxybutanoic acid; (S)-Threonine; 2-Amino-3-hydroxybutanoate; 2-Amino-3-hydroxybutanoic acid; 2-Amino-3-hydroxybutyrate; 2-Amino-3-hydroxybutyric acid; L-(-)-Threonine; (R-(R*,S*))-2-Amino-3-hydroxybutanoic acid; (R-(R*,S*))-2-Amino-3-hydroxybutanoate; (2S,3R)-2-Amino-3-hydroxybutyric acid; (2S,3R)-2-Amino-3-hydroxybutyrate; (2S,3R)-(-)-Threonine; (2S)-threonine; L-2-Amino-3-hydroxybutyrate; L-2-Amino-3-hydroxybutyric acid; L-alpha-Amino-beta-hydroxybutyrate; Threonin; Threonine; R-(R*,S*)-2-amino-3-hydroxy-Butanoate; R-(R*,S*)-2-amino-3-hydroxy-Butanoic acid; CHEBI:16857",2014-12-24,1,,,,,,,,,
73-22-3,0,OMOP Exposome,Observation,Substance,L-Tryptophan,Tryptophan; Trp; Trofan; Triptofano; Sedanoct; Pacitron; Tryptophane; Tryptophanum; W; Optimax; Lyphan; Lopac-T-0254; L-\u03b2-3-indolylalanine; L-Tryptophane; L-Tryptofan; L-beta-3-Indolylalanine; L-b-3-Indolylalanine; L-alpha-Aminoindole-3-propionic acid; L-alpha-Amino-3-indolepropionic acid; L-(\u2212)-tryptophan; L-(-)-Tryptophan; Kalma; Indole-3-alanine; H-TRP-oh; Ardeytropin; Alti-Tryptophan; alpha-Aminoindole-3-propionic acid; alpha'-Amino-3-indolepropionic acid; 3-Indol-3-ylalanine; 3-(1H-Indol-3-yl)-L-Alanine; 2-Amino-3-indolylpropanoic acid; 2-Amino-3-indolylpropanoate; 1H-Indole-3-Alanine; 1beta-3-Indolylalanine; 1-beta-3-Indolylalanine; (S)-\u03b1-amino-1H-indole-3-propanoic acid; (S)-tryptophan; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-Aminoindole-3-propionate; (S)-alpha-amino-beta-indolepropionic acid; (S)-alpha-amino-beta-indolepropionate; (S)-alpha-Amino-beta-(3-indolyl)-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-1H-indole-3-propanoate; (S)-a-Aminoindole-3-propionic acid; (S)-a-Aminoindole-3-propionate; (S)-a-amino-b-indolepropionic acid; (S)-a-amino-b-indolepropionate; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-1H-indole-3-propanoate; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-1H-Indole-3-alanine; (L)-tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (2S)-2-amino-3-(1H-indol-3-yl)propanoate; (-)-tryptophan; Tryptan; Tryptacin; CHEBI:16828,2018-03-21,1,,,,,,,,,
60-18-4,0,OMOP Exposome,Observation,Substance,L-Tyrosine,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid; Benzenepropanoate; 4-Hydroxy-L-Phenylalanine; 3-(4-Hydroxyphenyl)-L-alanine; 2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-Propanoic acid; 2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-Propanoate; (\u2212)-\u03b1-amino-p-hydroxyhydrocinnamic acid; (S)-\u03b1-amino-4-hydroxybenzenepropanoic acid; (S)-Tyrosine; (S)-alpha-Amino-4-hydroxybenzenepropanoic acid; (S)-alpha-Amino-4-hydroxybenzenepropanoate; (S)-alpha-amino-4-hydroxy-Benzenepropanoic acid; (S)-alpha-amino-4-hydroxy-Benzenepropanoate; (S)-a-Amino-4-hydroxybenzenepropanoic acid; (S)-a-Amino-4-hydroxybenzenepropanoate; (S)-a-amino-4-hydroxy-Benzenepropanoic acid; (S)-a-amino-4-hydroxy-Benzenepropanoate; (S)-3-(p-Hydroxyphenyl)alanine; (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid; L-p-Tyrosine; L-Tyrosin; p-Tyrosine; Rxosine; Tyr; Tyrosine; Y; (S)-2-Amino-3-(p-hydroxyphenyl)propionate; (S)-(-)-Tyrosine; (-)-alpha-Amino-p-hydroxyhydrocinnamic acid; (-)-alpha-Amino-p-hydroxyhydrocinnamate; (-)-a-Amino-p-hydroxyhydrocinnamic acid; (-)-a-Amino-p-hydroxyhydrocinnamate; Benzenepropanoic acid; CHEBI:17895,2014-12-24,1,,,,,,,,,
72-18-4,0,OMOP Exposome,Observation,Substance,L-Valine,L-a-Amino-b-methylbutyrate; (S)-a-Amino-b-methylbutyric acid; (S)-a-Amino-b-methylbutyrate; (S)-2-Amino-3-methylbutyric acid; (S)-2-Amino-3-methylbutyrate; (S)-2-Amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutanoate; (S)-2-amino-3-methyl-Butanoic acid; (S)-2-amino-3-methyl-Butanoate; (2S)-2-Amino-3-methylbutanoic acid; (2S)-2-Amino-3-methylbutanoate; Valine; Val; L-alpha-Amino-beta-methylbutyric acid; L-alpha-Amino-beta-methylbutyrate; L-a-Amino-b-methylbutyric acid; (S)-alpha-Amino-beta-methylbutyrate; L-(+)-alpha-Aminoisovaleric acid; L-(+)-alpha-Aminoisovalerate; L-(+)-a-Aminoisovaleric acid; L-(+)-a-Aminoisovalerate; 2-Amino-3-methylbutyric acid; 2-Amino-3-methylbutyrate; 2-Amino-3-methylbutanoic acid; 2-Amino-3-methylbutanoate; (S)-Valine; (S)-alpha-Amino-beta-methylbutyric acid; CHEBI:16414,2014-12-24,1,,,,,,,,,
Q7Z4W1,0,OMOP Exposome,Observation,Substance,L-xylulose reductase,,2024-09-14,1,,,,,,,,,
36894-69-6,0,OMOP Exposome,Observation,Substance,Labetalol,Normodyne; Normadate; Latol; Trandate; Labetolol; 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol; 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide; Albetol; Labetalolum; CHEBI:6343,2014-12-24,1,,,,,,,,,
GIS1009279,0,OMOP Exposome,Observation,Substance,Labetalol Pathway,,2024-09-14,1,,,,,,,,,
GIS1009280,0,OMOP Exposome,Observation,Substance,Lachrymator,,2024-09-14,1,,,,,,,,,
Q6UWM7,0,OMOP Exposome,Observation,Substance,Lactase-like protein,,2024-09-14,1,,,,,,,,,
GIS1009281,0,OMOP Exposome,Observation,Substance,Lactic Acidemia,,2024-09-14,1,,,,,,,,,
77501-63-4,0,OMOP Exposome,Observation,Substance,Lactofen,,2014-12-24,1,,,,,,,,,
P22079,0,OMOP Exposome,Observation,Substance,Lactoperoxidase,,2024-09-14,1,,,,,,,,,
GIS1009282,0,OMOP Exposome,Observation,Substance,Lactose Degradation,,2024-09-14,1,,,,,,,,,
GIS1009283,0,OMOP Exposome,Observation,Substance,Lactose Synthesis,,2024-09-14,1,,,,,,,,,
P02788,0,OMOP Exposome,Observation,Substance,Lactotransferrin,,2024-09-14,1,,,,,,,,,
Q04760,0,OMOP Exposome,Observation,Substance,Lactoylglutathione lyase,,2024-09-14,1,,,,,,,,,
84057-84-1,0,OMOP Exposome,Observation,Substance,Lamotrigine,"Labileno; Lamotriginum; Lamotrigina; Lametec; Lamez; Lamect; Lamictin; Epitec; Epiral; Epimil; Epilepax; Lambipol; Elmendos; Lamictal XR; Lamictal CD; Lamictal; Dezepil; Danoptin; Daksol; Dafex; Crisomet; Convulsan; Xebarin; Trogine; Trimolep; Mogine; Medotrigin; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; Larig; Lamotrix; Lameptil; Lameptil S; Epitrigine; GW 273293; CHEBI:6367",2014-12-24,1,,,,,,,,,
Q16850,0,OMOP Exposome,Observation,Substance,Lanosterol 14-alpha demethylase,,2024-09-14,1,,,,,,,,,
13536-79-3,0,OMOP Exposome,Observation,Substance,Lanthanum(III) bromide,,2014-12-24,1,,,,,,,,,
GIS1009284,0,OMOP Exposome,Observation,Substance,Large Intestine,,2024-09-14,1,,,,,,,,,
Q9UHI5,0,OMOP Exposome,Observation,Substance,Large neutral amino acids transporter small subunit 2,,2024-09-14,1,,,,,,,,,
303-34-4,0,OMOP Exposome,Observation,Substance,Lasiocarpine,,2014-12-24,1,,,,,,,,,
GIS1009285,0,OMOP Exposome,Observation,Substance,Late endosome,,2024-09-14,1,,,,,,,,,
BE0005280,0,OMOP Exposome,Observation,Substance,Latrophilin-1,,2024-09-14,1,,,,,,,,,
BE0005281,0,OMOP Exposome,Observation,Substance,Latrophilin-2,,2024-09-14,1,,,,,,,,,
BE0005282,0,OMOP Exposome,Observation,Substance,Latrophilin-3,,2024-09-14,1,,,,,,,,,
97-78-9,0,OMOP Exposome,Observation,Substance,Lauroyl sarcosine,,2014-12-24,1,,,,,,,,,
7439-92-1,0,OMOP Exposome,Observation,Substance,Lead,Lead(II); Lead(2+) ion; Plumbum; Lead (II) cation; Lead ion (Pb2+); Pb(2+); Pb2+; Lead ion; Lead(2+); Pb; CHEBI:49807,2014-12-24,1,,,,,,,,,
301-04-2,0,OMOP Exposome,Observation,Substance,Lead acetate,"Sugar of lead; Plumbous acetate; Normal lead acetate; Lead acetate (Pb(O2C2H3)2); Lead acetate (Pb(OAc)2); Lead acetate (acn); Lead acetate (anhydrous); Lead acetate (Pb(Ac)2); Lead di(acetate); Lead acetic acid; Lead acetate, hydrate; Dibasic lead acetate; Neutral lead acetate; Acetic acid lead(2+) salt; Lead(II) acetate; Lead diacetate; Lead(2+) acetate; Lead(2+) diacetate; Lead dibasic acetate; Salt of saturn; CHEBI:31767",2014-12-24,1,,,,,,,,,
7784-40-9,0,OMOP Exposome,Observation,Substance,Lead arsenate,,2014-12-24,1,,,,,,,,,
10031-13-7,0,OMOP Exposome,Observation,Substance,Lead arsenite,,2014-12-24,1,,,,,,,,,
13424-46-9,0,OMOP Exposome,Observation,Substance,Lead azide,,2014-12-24,1,,,,,,,,,
10031-22-8,0,OMOP Exposome,Observation,Substance,Lead bromide,,2014-12-24,1,,,,,,,,,
598-63-0,0,OMOP Exposome,Observation,Substance,Lead carbonate,,2014-12-24,1,,,,,,,,,
10294-47-0,0,OMOP Exposome,Observation,Substance,Lead chlorate,,2014-12-24,1,,,,,,,,,
7758-95-4,0,OMOP Exposome,Observation,Substance,Lead chloride,,2014-12-24,1,,,,,,,,,
7758-97-6,0,OMOP Exposome,Observation,Substance,Lead chromate,,2014-12-24,1,,,,,,,,,
18454-12-1,0,OMOP Exposome,Observation,Substance,Lead chromate oxide,,2014-12-24,1,,,,,,,,,
GIS1009286,0,OMOP Exposome,Observation,Substance,Lead Compound,,2024-09-14,1,,,,,,,,,
1309-60-0,0,OMOP Exposome,Observation,Substance,Lead dioxide,,2014-12-24,1,,,,,,,,,
7783-46-2,0,OMOP Exposome,Observation,Substance,Lead fluoride,,2014-12-24,1,,,,,,,,,
13814-96-5,0,OMOP Exposome,Observation,Substance,Lead fluoroborate,,2014-12-24,1,,,,,,,,,
19781-14-3,0,OMOP Exposome,Observation,Substance,Lead hydroxide,,2014-12-24,1,,,,,,,,,
10101-63-0,0,OMOP Exposome,Observation,Substance,Lead iodide,,2014-12-24,1,,,,,,,,,
12709-98-7,0,OMOP Exposome,Observation,Substance,Lead molybdenum chromate,,2014-12-24,1,,,,,,,,,
10099-74-8,0,OMOP Exposome,Observation,Substance,Lead nitrate,"Lead(2+) nitrate; lead (2+) nitrate; Lead dinitrate; Pb(NO3)2; Plumbous nitrate; lead nitrate, 210Pb(2+)-labeled; Lead nitrate (Pb(NO3)2); Lead nitric acid; CHEBI:37187",2014-12-24,1,,,,,,,,,
814-93-7,0,OMOP Exposome,Observation,Substance,Lead oxalate,,2014-12-24,1,,,,,,,,,
1317-36-8,0,OMOP Exposome,Observation,Substance,Lead oxide,,2014-12-24,1,,,,,,,,,
13637-76-8,0,OMOP Exposome,Observation,Substance,Lead perchlorate,,2014-12-24,1,,,,,,,,,
7446-27-7,0,OMOP Exposome,Observation,Substance,Lead phosphate,,2014-12-24,1,,,,,,,,,
12069-00-0,0,OMOP Exposome,Observation,Substance,Lead selenide,,2014-12-24,1,,,,,,,,,
1072-35-1,0,OMOP Exposome,Observation,Substance,Lead stearate,,2014-12-24,1,,,,,,,,,
15245-44-0,0,OMOP Exposome,Observation,Substance,Lead styphnate,,2014-12-24,1,,,,,,,,,
1335-32-6,0,OMOP Exposome,Observation,Substance,Lead subacetate,,2014-12-24,1,,,,,,,,,
7446-14-2,0,OMOP Exposome,Observation,Substance,Lead sulfate,,2014-12-24,1,,,,,,,,,
1314-87-0,0,OMOP Exposome,Observation,Substance,Lead sulfide,,2014-12-24,1,,,,,,,,,
1314-91-6,0,OMOP Exposome,Observation,Substance,Lead telluride,,2014-12-24,1,,,,,,,,,
546-67-8,0,OMOP Exposome,Observation,Substance,Lead tetraacetate,,2014-12-24,1,,,,,,,,,
1314-41-6,0,OMOP Exposome,Observation,Substance,Lead tetroxide,,2014-12-24,1,,,,,,,,,
592-87-0,0,OMOP Exposome,Observation,Substance,Lead thiocyanate,,2014-12-24,1,,,,,,,,,
26265-65-6,0,OMOP Exposome,Observation,Substance,Lead thiosulfate,,2014-12-24,1,,,,,,,,,
7759-01-5,0,OMOP Exposome,Observation,Substance,Lead tungstate,,2014-12-24,1,,,,,,,,,
14255-04-0,0,OMOP Exposome,Observation,Substance,Lead-210,,2014-12-24,1,,,,,,,,,
O95237,0,OMOP Exposome,Observation,Substance,Lecithin retinol acyltransferase,,2024-09-14,1,,,,,,,,,
GIS1009287,0,OMOP Exposome,Observation,Substance,Leigh Syndrome,,2024-09-14,1,,,,,,,,,
Q5TDP6,0,OMOP Exposome,Observation,Substance,Lengsin,,2024-09-14,1,,,,,,,,,
GIS1009288,0,OMOP Exposome,Observation,Substance,Lens,,2024-09-14,1,,,,,,,,,
P30301,0,OMOP Exposome,Observation,Substance,Lens fiber major intrinsic protein,,2024-09-14,1,,,,,,,,,
GIS1009289,0,OMOP Exposome,Observation,Substance,Leprostatic Agent,,2024-09-14,1,,,,,,,,,
159233-86-0,0,OMOP Exposome,Observation,Substance,Lethal factor,,2014-12-24,1,,,,,,,,,
Q9Y468,0,OMOP Exposome,Observation,Substance,Lethal(3)malignant brain tumor-like protein 1,,2024-09-14,1,,,,,,,,,
Q96JM7,0,OMOP Exposome,Observation,Substance,Lethal(3)malignant brain tumor-like protein 3,,2024-09-14,1,,,,,,,,,
Q8NA19,0,OMOP Exposome,Observation,Substance,Lethal(3)malignant brain tumor-like protein 4,,2024-09-14,1,,,,,,,,,
112809-51-5,0,OMOP Exposome,Observation,Substance,Letrozole,Letrozol; Femara; CHEBI:6413,2014-12-24,1,,,,,,,,,
Q9UIC8,0,OMOP Exposome,Observation,Substance,Leucine carboxyl methyltransferase 1,,2024-09-14,1,,,,,,,,,
BE0000613,0,OMOP Exposome,Observation,Substance,Leucine carboxyl methyltransferase 2,,2024-09-14,1,,,,,,,,,
Q9P2J5,0,OMOP Exposome,Observation,Substance,"Leucine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
147096-70-6,0,OMOP Exposome,Observation,Substance,Leukocidin F,,2014-12-24,1,,,,,,,,,
GIS1009290,0,OMOP Exposome,Observation,Substance,Leukocidin S,,2024-09-14,1,,,,,,,,,
GIS1009296,0,OMOP Exposome,Observation,Substance,Leukocyte,,2024-09-14,1,,,,,,,,,
Q15722,0,OMOP Exposome,Observation,Substance,Leukotriene B4 receptor 1,,2024-09-14,1,,,,,,,,,
Q16873,0,OMOP Exposome,Observation,Substance,Leukotriene C4 synthase,,2024-09-14,1,,,,,,,,,
102767-28-2,0,OMOP Exposome,Observation,Substance,Levetiracetam,e Keppra; Levitiracetam; Levetiractam; Levetiracetamum; Keppra; CHEBI:352567,2014-12-24,1,,,,,,,,,
27262-47-1,0,OMOP Exposome,Observation,Substance,Levobupivacaine,"L-(-)-Bupivacaine; Chirocaine; Levobupivacaine hydrochloride; L-(-)-1-Butyl-2',6'-pipecoloxylidide; (S)-1-Butyl-2',6'-pipecoloxylidide; (S)-Bupivacaine; (-)-Bupivacaine; CHEBI:6149",2014-12-24,1,,,,,,,,,
GIS1009297,0,OMOP Exposome,Observation,Substance,Levobupivacaine Pathway,,2024-09-14,1,,,,,,,,,
100986-85-4,0,OMOP Exposome,Observation,Substance,Levofloxacin,"Ofloxacin S-(-)-form; Reskuin; Levokacin; Levofloxacine; Levofloxacin hydrate; Tavanic; Ofloxacin; Quixin; Levofloxacinum; Levofloxacino; (-)-Ofloxacin; (3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido1,2,3-de1,4benzoxazine-6-carboxylic acid; (S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido1,2,3-de1,4benzooxazine-6-carboxylic acid; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (S)-Ofloxacin; Cravit; Elequine; Floxel; Floxin; Iquix; L-ofloxacin; Leroxacin; Levaquin; Levox; Levoxacin; Mosardal; Nofaxin; CHEBI:63598",2014-12-24,1,,,,,,,,,
1477-40-3,0,OMOP Exposome,Observation,Substance,Levomethadyl Acetate,"LAAM; (-)-alpha-Acetylmethadol; Levomethadyl acetic acid; Nor-LAAM; Orlaam; (1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate; 1-alpha-Acetylmethadol; Levomethadyl acetate; Levacetilmetadol; Levacetylmethadol; Levacetylmethadolum; Levo-alpha-acetylmethadol; Levo-Alphacetylmethadol; Levo-Methadyl Acetate; Levo-\u03b1-acetylmethadol; Levomethadyl; CHEBI:6441",2014-12-24,1,,,,,,,,,
797-63-7,0,OMOP Exposome,Observation,Substance,Levonorgestrel,"17-Ethynyl-18-methyl-19-nortestosterone; (-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one; (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopentaa phenanthren-3-one; 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one; 13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one; Microlut; Levonorgestrelum; Levonelle; 13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one; Mirena; Microval; Microluton; 17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one; 17-alpha-Ethynyl-13-ethyl-19-nortestosterone; 17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol; 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one; 17alpha-Ethynyl-18-homo-19-nortestosterone; 18-Methyl-17-alpha-ethynyl-19-nortestosterone; 18-Methylnorethisterone; D(-)-Norgestrel; Jadelle; Skyla; Postinor; Plan b; Norplant; NorLevo; Norgeston; Next Choice; Neogest; Levonova; Medonor; CHEBI:6443",2014-12-24,1,,,,,,,,,
77-07-6,0,OMOP Exposome,Observation,Substance,Levorphanol,L\u00e9vorphanol; Racemethorphanum; Methorphinan; Levorphanolum; Levorphanol Dl-Form; Levorphanal; Levorphan; Levorfanolo; Levorfanol; Levo-Dromoran; Lemoran; Dea No. 9733; Dea No. 9220; Cetarin; Aromarone; CHEBI:119572,2014-12-24,1,,,,,,,,,
541-25-3,0,OMOP Exposome,Observation,Substance,Lewisite,,2014-12-24,1,,,,,,,,,
137-58-6,0,OMOP Exposome,Observation,Substance,Lidocaine,"2-(Diethylamino)-2',6'-acetoxylidide; Xylocard; Solarcaine; Esracaine; Xylocaine; L-Caine; Laryng-O-Jet; Lidoderm; Lidoject-1; Xylocaine-MPF; Zingo; \u03b1-diethylamino-2,6-dimethylacetanilide; Zilactin-L; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide; After Burn Double Strength Gel; After Burn Double Strength Spray; After Burn Gel; Lidoject-2; After Burn Spray; Akten; alpha-diethylamino-2,6-dimethylacetanilide; Alphacaine; Anestacon; Anestacon Jelly; Lignocaine; DermaFlex; Norwood Sunburn Spray; Dilocaine; CHEBI:6456",2014-12-24,1,,,,,,,,,
115-95-7,0,OMOP Exposome,Observation,Substance,Linalyl acetate,,2014-12-24,1,,,,,,,,,
554-35-8,0,OMOP Exposome,Observation,Substance,Linamarin,"Manihotoxin; Phaseolunatin; 1-Cyano-1-methylethyl beta-D-glucoside; 2-(b-D-Glucopyranosyloxy)-2-methylpropanenitrile, 9CI; 2-(beta-D-Glucopyranosyloxy)-2-methyl-Propanenitrile; 2-(beta-D-Glucopyranosyloxy)-2-methylpropanenitrile; alpha-Hydroxyisobutyronitrile-beta-D-glucose; CHEBI:16441",2014-12-24,1,,,,,,,,,
GIS1009298,0,OMOP Exposome,Observation,Substance,Lincomycin,,2024-09-14,1,,,,,,,,,
165800-03-3,0,OMOP Exposome,Observation,Substance,Linezolid,Linosept; Linozid; Lizbid; Zyvoxid; Zyvoxam; Zenix; Zyvox; Zolinid; Zodlin; Lizemox; Zizolid; Lizolid; Xolid; Linezolide; N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide; Linezolidum; Antizolid; CHEBI:63607,2014-12-24,1,,,,,,,,,
60-33-3,0,OMOP Exposome,Observation,Substance,Linoleic acid,"Extra Linoleic 90; (9Z,12Z)-9,12-Octadecadienoate; (9Z,12Z)-9,12-Octadecadienoic acid; (Z,Z)-9,12-Octadecadienoate; (Z,Z)-9,12-Octadecadienoic acid; cis-D9,12-Octadecadienoic acid; Linolic acid; Emersol 315; Linolate; Unifac 6550; Polylin 515; Linoleate; 9-cis,12-cis-Linoleate; 9-cis,12-cis-Linoleic acid; 9Z,12Z-Linoleate; 9Z,12Z-Linoleic acid; 9Z,12Z-Octadecadienoate; 9Z,12Z-Octadecadienoic acid; All-cis-9,12-Octadecadienoate; All-cis-9,12-Octadecadienoic acid; cis,cis-Linoleate; cis,cis-Linoleic acid; cis-9,cis-12-Octadecadienoate; cis-9,cis-12-Octadecadienoic acid; cis-D9,12-Octadecadienoate; CHEBI:17351",2014-12-24,1,,,,,,,,,
330-55-2,0,OMOP Exposome,Observation,Substance,Linuron,,2014-12-24,1,,,,,,,,,
6893-02-3,0,OMOP Exposome,Observation,Substance,Liothyronine,"3,5,3'-Triiodothyronine; 3,5,3'-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3',5-Triiodo-L-thyronine; 3,3',5'-Triiodothyronine; 3,3',5'-Triiodo-L-thyronine; Tertroxin; T3; Liothyroninum; Triostat; Triiodothyronine; Triiodo-L-thyronine; Tresitope; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-Tyrosine; Liotironina; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; 3,5,3'TRIIODOTHYRONINE; Cytomel; L-3,3',5-Triiodo-Thyronine; L-3,3',5-Triiodothyronine; L-3,5,3'-Triiodothyronine; L-3-4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl-Alanine; L-Liothyronine; L-T3; L-Triiodothyronine; Liothyronin; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; Cyronine; CHEBI:18258",2014-12-24,1,,,,,,,,,
P31025,0,OMOP Exposome,Observation,Substance,Lipocalin-1,,2024-09-14,1,,,,,,,,,
GIS1009299,0,OMOP Exposome,Observation,Substance,Lipopolysaccharide,,2024-09-14,1,,,,,,,,,
GIS1009347,0,OMOP Exposome,Observation,Substance,Lipopolysaccharide Biosynthesis,,2024-09-14,1,,,,,,,,,
GIS1009348,0,OMOP Exposome,Observation,Substance,Lipoxygenase Inhibitor,,2024-09-14,1,,,,,,,,,
O43766,0,OMOP Exposome,Observation,Substance,"Lipoyl synthase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9Y234,0,OMOP Exposome,Observation,Substance,"Lipoyltransferase 1, mitochondrial",,2024-09-14,1,,,,,,,,,
112627-82-4,0,OMOP Exposome,Observation,Substance,Listeriolysin O,,2014-12-24,1,,,,,,,,,
12003-67-7,0,OMOP Exposome,Observation,Substance,Lithium aluminate,,2014-12-24,1,,,,,,,,,
16853-85-3,0,OMOP Exposome,Observation,Substance,Lithium aluminium hydride,"Lithium aluminohydride; LiAlH4; Lithium tetrahydroaluminate(1-); Lithium tetrahydridoaluminate; Lithium aluminum tetrahydride; Aluminate (1-), tetrahydro-, lithium; Aluminum lithium hydride; LiAlH4; Lithium alanate; Lithium aluminum hydride; CHEBI:30142",2014-12-24,1,,,,,,,,,
7550-35-8,0,OMOP Exposome,Observation,Substance,Lithium bromide,"Lithium monobromide; Lithium bromide, anhydrous; Lithium bromide solution; Lithium bromide (libr); LIBR; Hydrobromic acid lithium salt; CHEBI:63042",2014-12-24,1,,,,,,,,,
14307-35-8,0,OMOP Exposome,Observation,Substance,Lithium chromate,,2014-12-24,1,,,,,,,,,
12190-79-3,0,OMOP Exposome,Observation,Substance,Lithium cobalt oxide,,2014-12-24,1,,,,,,,,,
GIS1009349,0,OMOP Exposome,Observation,Substance,Lithium Compound,,2024-09-14,1,,,,,,,,,
18424-17-4,0,OMOP Exposome,Observation,Substance,Lithium hexafluoroantimonate(V),,2014-12-24,1,,,,,,,,,
7790-69-4,0,OMOP Exposome,Observation,Substance,Lithium nitrate,,2014-12-24,1,,,,,,,,,
7791-03-9,0,OMOP Exposome,Observation,Substance,Lithium perchlorate,,2014-12-24,1,,,,,,,,,
14024-11-4,0,OMOP Exposome,Observation,Substance,Lithium tetrachloroaluminate,,2014-12-24,1,,,,,,,,,
434-13-9,0,OMOP Exposome,Observation,Substance,Lithocholic acid,"3a-Hydroxy-5b-cholan-24-oic acid; Lithocholate; (3a,5b)-3-hydroxy-cholan-24-oate; (3a,5b)-3-hydroxy-cholan-24-oic acid; 3a-Hydroxy-5b-cholan-24-oate; CHEBI:16325",2018-03-21,1,,,,,,,,,
GIS1009353,0,OMOP Exposome,Observation,Substance,Liver,,2024-09-14,1,,,,,,,,,
P23141,0,OMOP Exposome,Observation,Substance,Liver carboxylesterase 1,,2024-09-14,1,,,,,,,,,
81771-19-9,0,OMOP Exposome,Observation,Substance,Lolitrem B,,2014-12-24,1,,,,,,,,,
13010-47-4,0,OMOP Exposome,Observation,Substance,Lomustine,CINU; 1-(2-Chloroethyl)-3-cyclohexylnitrosourea; N-(2-Chloroethyl)-n'-cyclohexyl-N-nitrosourea; Lomustinum; Lomustina; Cyclohexyl chloroethyl nitrosourea; Chloroethylcyclohexylnitrosourea; CeeNU; 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea; Cecenu; CCNU; Belustine; CHEBI:110898,2014-12-24,1,,,,,,,,,
P33121,0,OMOP Exposome,Observation,Substance,Long-chain-fatty-acid--CoA ligase 1,,2024-09-14,1,,,,,,,,,
O60488,0,OMOP Exposome,Observation,Substance,Long-chain-fatty-acid--CoA ligase 4,,2024-09-14,1,,,,,,,,,
GIS1009354,0,OMOP Exposome,Observation,Substance,Long-term depression,,2024-09-14,1,,,,,,,,,
GIS1009355,0,OMOP Exposome,Observation,Substance,Long-term potentiation,,2024-09-14,1,,,,,,,,,
GIS1009356,0,OMOP Exposome,Observation,Substance,Lopap,,2024-09-14,1,,,,,,,,,
61197-73-7,0,OMOP Exposome,Observation,Substance,Loprazolam,,2014-12-24,1,,,,,,,,,
79794-75-5,0,OMOP Exposome,Observation,Substance,Loratadine,Cronopen; Clarityne; Loritine; Loratidine; Nularef; Loratadine antihistamine; Loratadinum; Roletra; Loratadina; Clarityn; Claritine; Civeran; Claritin; Bonalerg; Biloina; Anhissen; Lorastine; Loracert; Lomilan; Sensibit; Amantadine; Alavert; Aerotina; Lisino; Lertamine; Restamine; Loratyne; Loranox; Loradex; Klaritin; Histaloran; Fristamin; Flonidan; CHEBI:210803,2014-12-24,1,,,,,,,,,
846-49-1,0,OMOP Exposome,Observation,Substance,Lorazepam,Idalprem; Lorsilan; Methyllorazepam; N-Methyllorazepam; O-Chlorooxazepam; O-Chloroxazepam; Somagerol; Temesta; Wypax; (\u00b1)-Lorazepam; Almazine; (+/-)-Lorazepam; Lorabenz; Anxiedin; Ativan; CHEBI:52993,2014-12-24,1,,,,,,,,,
848-75-9,0,OMOP Exposome,Observation,Substance,Lormetazepam,"Lormetazepamum; 7-Chloro-5-(O-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one; 7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one; 7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; ()-Lorazepam; O-Chloroxazepam; O-Chlorooxazepam; Noctamide; Noctamid; N-Methyllorazepam; Methyllorazepam; Lorazepam; Loramet; Ergocalm; CHEBI:52993",2014-12-24,1,,,,,,,,,
534-67-8,0,OMOP Exposome,Observation,Substance,Lotaustralin,,2014-12-24,1,,,,,,,,,
75330-75-5,0,OMOP Exposome,Observation,Substance,Lovastatin,"6alpha-Methylcompactin; 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone; MK-803; Mevinolin; Mevacor; Lovastatinum; Lovastatine; 6-alpha-methylcompactin; Lovastatina; 6 alpha-Methylcompactin; LOVASTATIN; (1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate; ML-530b; 6\u03b1-methylcompactin; Altocor; Altoprev; CHEBI:40303",2014-12-24,1,,,,,,,,,
GIS1009363,0,OMOP Exposome,Observation,Substance,Lovastatin Pathway,,2024-09-14,1,,,,,,,,,
P12318,0,OMOP Exposome,Observation,Substance,Low affinity immunoglobulin gamma Fc region receptor II-a,,2024-09-14,1,,,,,,,,,
P31994,0,OMOP Exposome,Observation,Substance,Low affinity immunoglobulin gamma Fc region receptor II-b,,2024-09-14,1,,,,,,,,,
P31995,0,OMOP Exposome,Observation,Substance,Low affinity immunoglobulin gamma Fc region receptor II-c,,2024-09-14,1,,,,,,,,,
P08637,0,OMOP Exposome,Observation,Substance,Low affinity immunoglobulin gamma Fc region receptor III-A,,2024-09-14,1,,,,,,,,,
O75015,0,OMOP Exposome,Observation,Substance,Low affinity immunoglobulin gamma Fc region receptor III-B,,2024-09-14,1,,,,,,,,,
P24666,0,OMOP Exposome,Observation,Substance,Low molecular weight phosphotyrosine protein phosphatase,,2024-09-14,1,,,,,,,,,
P01130,0,OMOP Exposome,Observation,Substance,Low-density lipoprotein receptor,,2024-09-14,1,,,,,,,,,
P98164,0,OMOP Exposome,Observation,Substance,Low-density lipoprotein receptor-related protein 2,,2024-09-14,1,,,,,,,,,
1977-10-2,0,OMOP Exposome,Observation,Substance,Loxapine,"Adasuve; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenzb,f1,4oxazepine; Rosup; oxilapine; Loxitane; Cloxazepine; Loxapinum; Loxapina; Loxapac; Losagen; Lopac; CHEBI:50841",2014-12-24,1,,,,,,,,,
GIS1009364,0,OMOP Exposome,Observation,Substance,Lung,,2024-09-14,1,,,,,,,,,
GIS1009365,0,OMOP Exposome,Observation,Substance,Luteolytic Agent,,2024-09-14,1,,,,,,,,,
21884-44-6,0,OMOP Exposome,Observation,Substance,Luteoskyrin,,2014-12-24,1,,,,,,,,,
476-28-8,0,OMOP Exposome,Observation,Substance,Lycorine,Amarylline; Galanthidine; Licorine; Narcissine; (-)-Lycorine; CHEBI:CHEBI:6601,2014-12-24,1,,,,,,,,,
992-21-2,0,OMOP Exposome,Observation,Substance,Lymecycline,"Chlortetracyclinium chloride; Tetralysal; Tetralisal; Tetracycline-L-methylenelysine; Tetracycline-L-methylene lysine; N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine; N-Lysinomethyltetracycline; N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline; Lymecyclinum; Limeciclina; Eficiclina; CLTC; Chlortetracycline; Chlortetracyclin; Chlorotetracycline; 7-Chlorotetracycline; (+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide; CHEBI:59040",2014-12-24,1,,,,,,,,,
GIS1009366,0,OMOP Exposome,Observation,Substance,Lymecycline Action Pathway,,2024-09-14,1,,,,,,,,,
GIS1009367,0,OMOP Exposome,Observation,Substance,Lymph Node,,2024-09-14,1,,,,,,,,,
GIS1009368,0,OMOP Exposome,Observation,Substance,Lymphoblast,,2024-09-14,1,,,,,,,,,
GIS1009369,0,OMOP Exposome,Observation,Substance,Lymphocyte,,2024-09-14,1,,,,,,,,,
Q9Y6Y9,0,OMOP Exposome,Observation,Substance,Lymphocyte antigen 96,,2024-09-14,1,,,,,,,,,
Q06643,0,OMOP Exposome,Observation,Substance,Lymphotoxin-beta,,2024-09-14,1,,,,,,,,,
70497-14-2,0,OMOP Exposome,Observation,Substance,Lyngbyatoxin A,,2014-12-24,1,,,,,,,,,
50-37-3,0,OMOP Exposome,Observation,Substance,Lysergic Acid Diethylamide,"(+)-lysergic acid diethylamide; N,n-diethyllysergamide; N,n-diethyl-d-lysergamide; N,N-Diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide; n,n-diethyl-(+)-lysergamide; Lysergidum; Lysergide; Lysergic acid diethylamide-25; Lysergic acid diethylamide; Lysergic acid amide; Lysergaure diethylamid; Lysergate diethylamide; Lysergamide; Lysergamid; LSD-25; (+)-LSD; Diethylamid kyseliny lysergove; LSD; Dextrolysergic acid diethylamide; Delysid; D-lysergic acid n,n-diethylamide; D-lysergic acid diethylamide; D-lysergic acid dethylamide; D-LSD-25; D-LSD; 9,10-Didehydro-N,N-diethyl-6-methylergoline-8b-carboxamide; CHEBI:6605",2014-12-24,1,,,,,,,,,
3343-15-5,0,OMOP Exposome,Observation,Substance,Lysergic acid hydroxyethylamide,,2014-12-24,1,,,,,,,,,
602-85-7,0,OMOP Exposome,Observation,Substance,Lysergol,,2014-12-24,1,,,,,,,,,
GIS1009370,0,OMOP Exposome,Observation,Substance,Lysine biosynthesis,,2024-09-14,1,,,,,,,,,
GIS1009371,0,OMOP Exposome,Observation,Substance,Lysine Degradation,,2024-09-14,1,,,,,,,,,
Q15046,0,OMOP Exposome,Observation,Substance,Lysine--tRNA ligase,,2024-09-14,1,,,,,,,,,
Q9Y2K7,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase 2A,,2024-09-14,1,,,,,,,,,
Q9Y4C1,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase 3A,,2024-09-14,1,,,,,,,,,
O75164,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase 4A,,2024-09-14,1,,,,,,,,,
O94953,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase 4B,,2024-09-14,1,,,,,,,,,
Q9H3R0,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase 4C,,2024-09-14,1,,,,,,,,,
Q6B0I6,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase 4D,,2024-09-14,1,,,,,,,,,
B2RXH2,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase 4E,,2024-09-14,1,,,,,,,,,
P41229,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase 5C,,2024-09-14,1,,,,,,,,,
O75151,0,OMOP Exposome,Observation,Substance,Lysine-specific demethylase PHF2,,2024-09-14,1,,,,,,,,,
O60341,0,OMOP Exposome,Observation,Substance,Lysine-specific histone demethylase 1A,,2024-09-14,1,,,,,,,,,
GIS1009372,0,OMOP Exposome,Observation,Substance,Lysinuric Protein Intolerance,,2024-09-14,1,,,,,,,,,
Q8NF37,0,OMOP Exposome,Observation,Substance,Lysophosphatidylcholine acyltransferase 1,,2024-09-14,1,,,,,,,,,
Q7L5N7,0,OMOP Exposome,Observation,Substance,Lysophosphatidylcholine acyltransferase 2,,2024-09-14,1,,,,,,,,,
O00754,0,OMOP Exposome,Observation,Substance,Lysosomal alpha-mannosidase,,2024-09-14,1,,,,,,,,,
GIS1009373,0,OMOP Exposome,Observation,Substance,Lysosome,,2024-09-14,1,,,,,,,,,
P61626,0,OMOP Exposome,Observation,Substance,Lysozyme C,,2024-09-14,1,,,,,,,,,
108-39-4,0,OMOP Exposome,Observation,Substance,m-Cresol,m-Kresol; 1-Hydroxy-3-methylbenzene; Meta-Cresol; m-Toluol; m-Oxytoluene; m-Methylphenol; m-Hydroxytoluene; m-Cresylic acid; 3-Methylphenol; 3-Hydroxytoluene; CHEBI:17231,2014-12-24,1,,,,,,,,,
64-00-6,0,OMOP Exposome,Observation,Substance,m-Cumenyl methylcarbamate,,2014-12-24,1,,,,,,,,,
541-73-1,0,OMOP Exposome,Observation,Substance,m-Dichlorobenzene,"m-phenylene dichloride; 1,3-dichlorobenzene; metadichlorobenzene; meta-dichlorobenzene; CHEBI:36693",2014-12-24,1,,,,,,,,,
P30305,0,OMOP Exposome,Observation,Substance,M-phase inducer phosphatase 2,,2024-09-14,1,,,,,,,,,
P30307,0,OMOP Exposome,Observation,Substance,M-phase inducer phosphatase 3,,2024-09-14,1,,,,,,,,,
108-38-3,0,OMOP Exposome,Observation,Substance,m-Xylene,"1,3-Dimethylbenzol; meta-Xylene; m-Xylol; m-Methyltoluene; m-dimethylbenzene; 3-xylene; 1,3-Xylene; 1,3-Dimethylbenzene; CHEBI:28488",2014-12-24,1,,,,,,,,,
620-13-3,0,OMOP Exposome,Observation,Substance,m-Xylyl bromide,,2014-12-24,1,,,,,,,,,
GIS1009374,0,OMOP Exposome,Observation,Substance,Macrolide,,2024-09-14,1,,,,,,,,,
P09603,0,OMOP Exposome,Observation,Substance,Macrophage colony-stimulating factor 1,,2024-09-14,1,,,,,,,,,
P07333,0,OMOP Exposome,Observation,Substance,Macrophage colony-stimulating factor 1 receptor,,2024-09-14,1,,,,,,,,,
P39900,0,OMOP Exposome,Observation,Substance,Macrophage metalloelastase,,2024-09-14,1,,,,,,,,,
P14174,0,OMOP Exposome,Observation,Substance,Macrophage migration inhibitory factor,,2024-09-14,1,,,,,,,,,
23854-38-8,0,OMOP Exposome,Observation,Substance,Magic acid (fluorosulfuric acid-antimony pentafluoride),,2014-12-24,1,,,,,,,,,
12068-51-8,0,OMOP Exposome,Observation,Substance,Magnesium aluminate,,2014-12-24,1,,,,,,,,,
10103-50-1,0,OMOP Exposome,Observation,Substance,Magnesium arsenate,,2014-12-24,1,,,,,,,,,
7789-48-2,0,OMOP Exposome,Observation,Substance,Magnesium bromide,,2014-12-24,1,,,,,,,,,
10377-60-3,0,OMOP Exposome,Observation,Substance,Magnesium nitrate,,2014-12-24,1,,,,,,,,,
10034-81-8,0,OMOP Exposome,Observation,Substance,Magnesium perchlorate,,2014-12-24,1,,,,,,,,,
7487-88-9,0,OMOP Exposome,Observation,Substance,Magnesium Sulfate,Bitter salt; Magnesium sulfate; Magnesium sulphate heptahydrate; Magnesium Sulphate Hydrate; Magnesium sulfate dried; Magnesium sulfate heptahydrate; Magnesium sulphate; MgSO4; Magnesiumsulfat; Magnesium sulfic acid; Magnesium sulfate (1:1); Magnesium sulfate anhydrous; Magnesium sulphic acid; Magnesium sulphate anhydrous; Magnesium sulphate dried; CHEBI:32599,2014-12-24,1,,,,,,,,,
59392-53-9,0,OMOP Exposome,Observation,Substance,Maitotoxin,,2014-12-24,1,,,,,,,,,
P04156,0,OMOP Exposome,Observation,Substance,Major prion protein,,2024-09-14,1,,,,,,,,,
1634-78-2,0,OMOP Exposome,Observation,Substance,Malaoxon,,2014-12-24,1,,,,,,,,,
P40925,0,OMOP Exposome,Observation,Substance,"Malate dehydrogenase, cytoplasmic",,2024-09-14,1,,,,,,,,,
P40926,0,OMOP Exposome,Observation,Substance,"Malate dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1009375,0,OMOP Exposome,Observation,Substance,Malate-Aspartate Shuttle,,2024-09-14,1,,,,,,,,,
121-75-5,0,OMOP Exposome,Observation,Substance,Malathion,"(Dimethoxyphosphinothioyl)thiobutanedioic acid diethyl ester; Maldison; Malathione; Karbofos; Insecticide no. 4049; Experimental insecticide 4049; Diethyl (dimethoxyphosphinothioylthio)succinate; Derbac-M; Compound 4049; Carbophos; Carbofos; Mercaptosuccinic acid diethyl ester; Mercaptothion; Mercaptotion; MLT; Noury; O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl); O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate; O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate; O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl; O,O-Dimethyldithiophosphate diethylmercaptosuccinate; Oleophosphothion; Ovide; Prioderm; CHEBI:6651",2014-12-24,1,,,,,,,,,
110-16-7,0,OMOP Exposome,Observation,Substance,Maleic acid,"(2Z)-2-Butenedioate; Toxilic acid; Scotchbond multipurpose etchant; Malezid CM; Malenic acid; Maleinic acid; Maleate; MAE; Kyselina maleinova; H2male; Cis-butenedioic acid; Cis-butenedioate; cis-But-2-enedioic acid; cis-But-2-enedioate; cis-2-Butenedioic acid; cis-2-Butenedioate; cis-1,2-Ethylenedicarboxylic acid; 2-Butenedioic acid; 2-Butenedioate; (z)-butenedioic acid; (z)-butenedioate; (Z)-2-Butenedioic acid; (Z)-2-Butenedioate; (2Z)-Butene-2-dioic acid; (2Z)-Butene-2-dioate; (2Z)-but-2-enedioic acid; (2Z)-but-2-enedioate; (2Z)-2-Butenedioic acid; CHEBI:18300",2014-12-24,1,,,,,,,,,
123-33-1,0,OMOP Exposome,Observation,Substance,Maleic hydrazide,,2014-12-24,1,,,,,,,,,
O43708,0,OMOP Exposome,Observation,Substance,Maleylacetoacetate isomerase,,2024-09-14,1,,,,,,,,,
542-78-9,0,OMOP Exposome,Observation,Substance,Malondialdehyde,"Malonodialdehyde; 1,3-Propanedial; 1,3-Propanedialdehyde; 1,3-Propanedione; Malonaldehyde; Malonic aldehyde; Malonic dialdehyde; Malonyldialdehyde; MDD; Propanedial; CHEBI:566274",2014-12-24,1,,,,,,,,,
GIS1009376,0,OMOP Exposome,Observation,Substance,Malonic Aciduria,,2024-09-14,1,,,,,,,,,
109-77-3,0,OMOP Exposome,Observation,Substance,Malononitrile,Propanedinitrile; Cyanoacetonitrile; Dicyanmethane; Dicyanomethane; Dicycanomethane; Dwumetylosulfotlenku; Icycanomethane; Malonic acid dinitrile; Malonic dinitrile; Malonitrile; Malonodinitrile; Malononitrile (nominals); Malonsaeuredinitril; Methylene cyanide; Methylenecyanide; Methylenedinitrile; Nitril kyseliny malonove; CHEBI:33186,2014-12-24,1,,,,,,,,,
GIS1009377,0,OMOP Exposome,Observation,Substance,Malonyl-coa decarboxylase deficiency,,2024-09-14,1,,,,,,,,,
O43451,0,OMOP Exposome,Observation,Substance,"Maltase-glucoamylase, intestinal",,2024-09-14,1,,,,,,,,,
GIS1009378,0,OMOP Exposome,Observation,Substance,Mammal Toxin,,2024-09-14,1,,,,,,,,,
8018-01-07,0,OMOP Exposome,Observation,Substance,Mancozeb,,2014-12-24,1,,,,,,,,,
532-28-5,0,OMOP Exposome,Observation,Substance,Mandelonitrile,"Benzaldehyde cyanohydrin; Amygdalonitrile; Alpha-hydroxyphenylacetonitrile; Alpha-hydroxybenzeneacetonitrile; a-hydroxybenzeneacetonitrile; a-cyanobenzyl alcohol; 2-hydroxy-2-phenylacetonitrile; .alpha.-hydroxybenzeneacetonitrile; (+-)-alpha-hydroxybenzeneacetonitrile; Benzaldehyde, cyanohydrin; Benzaldehydkyanhydrin; Hydroxy(phenyl)acetonitrile; Hydroxybenzyl cyanide; Hydroxyphenylacetonitrile; Mandelic acid nitrile; Nitril kyseliny mandlove; Phenylglycolonitrile; CHEBI:18450",2014-12-24,1,,,,,,,,,
12427-38-2,0,OMOP Exposome,Observation,Substance,Maneb,"2-(dithiocarboxy)aminoethylcarbamodithioato(2-)-kS,kS'manganese; Manganese ethylene-1,2-bisdithiocarbamate, polymer; Manganese ethane-1,2-diyldicarbamodithioate, manganese ethylenebis(dithiocarbamate) (polymeric); CHEBI:CHEBI:52497",2014-12-24,1,,,,,,,,,
140678-14-4,0,OMOP Exposome,Observation,Substance,Mangafodipir,,2014-12-24,1,,,,,,,,,
7439-96-5,0,OMOP Exposome,Observation,Substance,Manganese,Manganese(II) ion; Mn2+; Mn(2+); Metallic manganese; Manganese(II) cation; Manganese(II); Manganese(2+) ion; Manganese ion; Magnanese(2+); CHEBI:29035,2014-12-24,1,,,,,,,,,
61136-68-3,0,OMOP Exposome,Observation,Substance,Manganese arsenate,,2014-12-24,1,,,,,,,,,
13446-03-2,0,OMOP Exposome,Observation,Substance,Manganese bromide,,2014-12-24,1,,,,,,,,,
598-62-9,0,OMOP Exposome,Observation,Substance,Manganese carbonate,,2014-12-24,1,,,,,,,,,
7773-01-5,0,OMOP Exposome,Observation,Substance,Manganese chloride,,2014-12-24,1,,,,,,,,,
5968-88-7,0,OMOP Exposome,Observation,Substance,Manganese citrate,,2014-12-24,1,,,,,,,,,
GIS1009379,0,OMOP Exposome,Observation,Substance,Manganese Compound,,2024-09-14,1,,,,,,,,,
1313-13-9,0,OMOP Exposome,Observation,Substance,Manganese dioxide,,2014-12-24,1,,,,,,,,,
12299-98-8,0,OMOP Exposome,Observation,Substance,Manganese diselenide,,2014-12-24,1,,,,,,,,,
7782-64-1,0,OMOP Exposome,Observation,Substance,Manganese fluoride,,2014-12-24,1,,,,,,,,,
12057-92-0,0,OMOP Exposome,Observation,Substance,Manganese heptaoxide,,2014-12-24,1,,,,,,,,,
14325-24-7,0,OMOP Exposome,Observation,Substance,Manganese phthalocyanine,,2014-12-24,1,,,,,,,,,
7785-87-7,0,OMOP Exposome,Observation,Substance,Manganese sulfate,,2014-12-24,1,,,,,,,,,
18820-29-6,0,OMOP Exposome,Observation,Substance,Manganese sulfide,,2014-12-24,1,,,,,,,,,
19513-05-4,0,OMOP Exposome,Observation,Substance,Manganese triacetate,,2014-12-24,1,,,,,,,,,
7783-53-1,0,OMOP Exposome,Observation,Substance,Manganese trifluoride,,2014-12-24,1,,,,,,,,,
1344-43-0,0,OMOP Exposome,Observation,Substance,Manganese(II) oxide,,2014-12-24,1,,,,,,,,,
1317-35-7,0,OMOP Exposome,Observation,Substance,Manganese(III) oxide (H2Mn3O4),,2014-12-24,1,,,,,,,,,
1317-34-6,0,OMOP Exposome,Observation,Substance,Manganese(III) oxide (Mn2O3),,2014-12-24,1,,,,,,,,,
638-38-0,0,OMOP Exposome,Observation,Substance,Manganous acetate,,2014-12-24,1,,,,,,,,,
P33908,0,OMOP Exposome,Observation,Substance,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA",,2024-09-14,1,,,,,,,,,
O60476,0,OMOP Exposome,Observation,Substance,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",,2024-09-14,1,,,,,,,,,
Q9NR34,0,OMOP Exposome,Observation,Substance,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC",,2024-09-14,1,,,,,,,,,
P49137,0,OMOP Exposome,Observation,Substance,MAP kinase-activated protein kinase 2,,2024-09-14,1,,,,,,,,,
Q8IW41,0,OMOP Exposome,Observation,Substance,MAP kinase-activated protein kinase 5,,2024-09-14,1,,,,,,,,,
GIS1009380,0,OMOP Exposome,Observation,Substance,Mapk signaling pathway,,2024-09-14,1,,,,,,,,,
GIS1009381,0,OMOP Exposome,Observation,Substance,Maple Syrup Urine Disease,,2024-09-14,1,,,,,,,,,
10262-69-8,0,OMOP Exposome,Observation,Substance,Maprotiline,Maprotilina; Ludiomil; Deprilept; Psymion; Maprotylina; Maprotilinum; BA-34276; CHEBI:127713,2014-12-24,1,,,,,,,,,
145808-47-5,0,OMOP Exposome,Observation,Substance,Margatoxin,,2014-12-24,1,,,,,,,,,
GIS1009382,0,OMOP Exposome,Observation,Substance,Marine Toxin,,2024-09-14,1,,,,,,,,,
470-42-8,0,OMOP Exposome,Observation,Substance,Marinobufagenin,,2014-12-24,1,,,,,,,,,
500-38-9,0,OMOP Exposome,Observation,Substance,Masoprocol,,2014-12-24,1,,,,,,,,,
GIS1009383,0,OMOP Exposome,Observation,Substance,Mast Cell,,2024-09-14,1,,,,,,,,,
GIS1009384,0,OMOP Exposome,Observation,Substance,Mast Cell Stabilizer,,2024-09-14,1,,,,,,,,,
P10721,0,OMOP Exposome,Observation,Exposome Target,Mast/stem cell growth factor receptor Kit,,2024-09-14,1,,,,,,,,,
72093-21-1,0,OMOP Exposome,Observation,Substance,Mastoparan (Vespa tropica),,2014-12-24,1,,,,,,,,,
519-02-8,0,OMOP Exposome,Observation,Substance,Matrine,,2014-12-24,1,,,,,,,,,
P08493,0,OMOP Exposome,Observation,Substance,Matrix Gla protein,,2024-09-14,1,,,,,,,,,
P50281,0,OMOP Exposome,Observation,Substance,Matrix metalloproteinase-14,,2024-09-14,1,,,,,,,,,
O43923,0,OMOP Exposome,Observation,Substance,Matrix metalloproteinase-25,,2024-09-14,1,,,,,,,,,
P14780,0,OMOP Exposome,Observation,Substance,Matrix metalloproteinase-9,,2024-09-14,1,,,,,,,,,
269745-22-4,0,OMOP Exposome,Observation,Substance,Maurocalcin,,2014-12-24,1,,,,,,,,,
188240-41-7,0,OMOP Exposome,Observation,Substance,Maurotoxin,,2014-12-24,1,,,,,,,,,
22232-71-9,0,OMOP Exposome,Observation,Substance,Mazindol,Fagolip Plus; Dimagrir; Teronac; Sanorex; Mazindolum; Mazindolo; Mazanor; CHEBI:146385,2014-12-24,1,,,,,,,,,
Q05BQ5,0,OMOP Exposome,Observation,Substance,MBT domain-containing protein 1,,2024-09-14,1,,,,,,,,,
27386-64-7,0,OMOP Exposome,Observation,Substance,Mecarbinzid,RCRA waste no. U271; Caswell No. 075A; CHEBI:82083,2014-12-24,1,,,,,,,,,
51-75-2,0,OMOP Exposome,Observation,Substance,Mechlorethamine,"Bis(beta-chloroethyl)methylamine; Nitrogen mustard; Valchlor; HN2; Methylbis(beta-chloroethyl)amine; Mustargen; Mustine; N-methyl-bis(2-chloroethyl)amine; \u03b2,\u03b2'-dichlorodiethyl-N-methylamine; 2,2'-dichloro-N-methyldiethylamine; beta,Beta'-dichlorodiethyl-N-methylamine; Bis(2-chloroethyl)methylamine; Mecloretamina; Mechloroethamine; MBA; N-Methyl-bis(beta-chloroethyl)amine; Methylbis(2-chloroethyl)amine; Chlorethazine; Chlormethine; CHEBI:28925",2014-12-24,1,,,,,,,,,
569-65-3,0,OMOP Exposome,Observation,Substance,Meclizine,Antivert; Bonamine; Navicalm; Bonine; Chiclida; Dramamine; Meclicot; Sea-Legs; Postafen; Meclozine; Nevidoxine; CHEBI:569632,2014-12-24,1,,,,,,,,,
2898-12-6,0,OMOP Exposome,Observation,Substance,Medazepam,,2014-12-24,1,,,,,,,,,
71-58-9,0,OMOP Exposome,Observation,Substance,Medroxyprogesterone Acetate,"Makena; Provera; MPA; Metigestrona; Methylacetoxyprogesterone; Medroxyprogesterone acetic acid; Medroxyprogesterone acetate; Medroxyprogesterone 17-acetate; Medroxyacetate progesterone; Depo-subq provera 104; Depo-provera; 6\u03b1-Methyl-17\u03b1-hydroxyprogesterone acetate; 6\u03b1-Methyl-17-acetoxy progesterone; 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate; 6alpha-Methyl-17alpha-hydroxyprogesterone acetate; 6alpha-Methyl-17-acetoxy progesterone; 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate; 6-alpha-Methyl-17-alpha-acetoxyprogesterone; 17\u03b1-hydroxy-6\u03b1-methylprogesterone acetate; 17alpha-Hydroxy-6alpha-methylprogesterone acetate; 17-Acetoxy-6\u03b1-methylprogesterone; 17-Acetoxy-6alpha-methylprogesterone; (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione; CHEBI:6715",2014-12-24,1,,,,,,,,,
108-78-1,0,OMOP Exposome,Observation,Substance,Melamine,"1,3,5-Triazine-2,4,6-triamine; 2,4, 6-Triamino-1,3,5-triazine; 2,4,6-Triamino-1,3,5-triazine; 2,4,6-Triamino-S-Triazine; 2,4,6-Triaminotriazine; 2,4,6-Tris(1-aziridinyl)-S-triazine; 4,6-Diamino-1,2-dihydro-2-imino-S-Triazine; ADK Stab ZS 27; Aero; Cyanuramide; Cyanuric triamide; Cyanurotriamide; Cyanurotriamine; Cyanurtriamide; Cymel; DG 002 (amine); Sym-triaminotriazine; Spinflam ML 94M; S-Triazinetriamine; Pluragard C 133; 1,3, 5-Triazine-2,4,6-triamine; Pluragard; Mark ZS 27; Isomelamine; Teoharn; Hicophor PR; Yukamelamine; Virset 656-4; Triaminotriazine; Theoharn; 1,3,5-Triazine-2,4,6(1H,3H,5H)-triimine; CHEBI:27915",2014-12-24,1,,,,,,,,,
Q99705,0,OMOP Exposome,Observation,Substance,Melanin-concentrating hormone receptor 1,,2024-09-14,1,,,,,,,,,
P41968,0,OMOP Exposome,Observation,Substance,Melanocortin receptor 3,,2024-09-14,1,,,,,,,,,
P32245,0,OMOP Exposome,Observation,Substance,Melanocortin receptor 4,,2024-09-14,1,,,,,,,,,
P33032,0,OMOP Exposome,Observation,Substance,Melanocortin receptor 5,,2024-09-14,1,,,,,,,,,
Q01726,0,OMOP Exposome,Observation,Substance,Melanocyte-stimulating hormone receptor,,2024-09-14,1,,,,,,,,,
GIS1009385,0,OMOP Exposome,Observation,Substance,Melanogenesis,,2024-09-14,1,,,,,,,,,
73-31-4,0,OMOP Exposome,Observation,Substance,Melatonin,Melatol; Melatonin (synth.) standard-grade; Melatonin (synth.) ultra-pure; Melatonine; Melovine; MT6; N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide; N-(2-(5-Methoxyindol-3-yl)ethyl)-Acetamide; N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide; N-Acetyl-5-methoxy-tryptamine; N-Acetyl-5-methoxy-tryptamine Melatonine; N-Acetyl-5-methoxytryptamine; N-2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide; N-2-(5-Methoxy-1H-indol-3-yl)ethyl-Acetamide; N-2-(5-Methoxy-1H-indol-3-yl)ethylacetamide; N-2-(5-Methoxyindol-3-yl)ethyl-Acetamide; N-2-(5-Methoxyindol-3-yl)ethylacetamide; Nature'S Harmony; Regulin; Revital Melatonin; Rx Balance; Sleep Right; Vivitas; {N-2-(5-methoxy-1H-indol-3-yl)ethyl-} Acetamide; {N-2-(5-methoxyindol-3-yl)ethyl-} Acetamide; 5-Methoxy-N-acetyltryptamine; Circadin; Mela-T; CHEBI:16796,2014-12-24,1,,,,,,,,,
P48039,0,OMOP Exposome,Observation,Substance,Melatonin receptor type 1A,,2024-09-14,1,,,,,,,,,
P49286,0,OMOP Exposome,Observation,Substance,Melatonin receptor type 1B,,2024-09-14,1,,,,,,,,,
20449-79-0,0,OMOP Exposome,Observation,Substance,Melittin (Apis mellifera),Forapin; Bee venom melittin; Melittin I; Melittin-t; Mellitin; Melittin; Melitten; Honeybee melittin; GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 MELITTIN; GIGAVLKVLTTGLPALISWIKRKRQQ-NH2; Melittin (major) (8CI); Forapine; Melittin (major); Melittin (honeybee); Melittin (apis mellifera); Melittin (apis cerana); CHEBI:25520,2014-12-24,1,,,,,,,,,
71125-38-7,0,OMOP Exposome,Observation,Substance,Meloxicam,UNII-vg2qf83cgl; Achefree; Acticam; Aflamid; Afloxx; Aglan; Ainecox; Aldoron; Alentum; Algiflex; Aliviodol; Anaxicam; Anposel; Antrend; Aponip; Areloger; Aremil; Armex; Arrox; Arsitec; Artex; Arthrobic; Arthrox; Articam; Artipro; Artriclox; Artrifilm; Artriflam; Artrilom; Artrilox; Artrox; Aspicam; Atiflam; Atrozan; Auroxicam; Axius; Meloxicamum; Mobic; CHEBI:120496,2014-12-24,1,,,,,,,,,
GIS1009386,0,OMOP Exposome,Observation,Substance,Meloxicam Pathway,,2024-09-14,1,,,,,,,,,
148-82-3,0,OMOP Exposome,Observation,Substance,Melphalan,"L-PAM; 3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine; L-3-(P-(Bis(2-chloroethyl)amino)phenyl)alanine; Alkeran; 4-(Bis(2-chloroethyl)amino)-L-phenylalanine; Melfalano; 3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine; Melphalanum; p-Bis(beta-chloroethyl)aminophenylalanine; P-Di-(2-chloroethyl)amino-L-phenylalanine; P-L-Sarcolysin; p-N,N-bis(2-chloroethyl)amino-L-phenylalanine; P-N-Bis(2-chloroethyl)amino-L-phenylalanine; Phenylalanine mustard; Phenylalanine nitrogen mustard; L-Sarcolysine; L-Phenylalanine mustard; CHEBI:28876",2014-12-24,1,,,,,,,,,
19982-08-2,0,OMOP Exposome,Observation,Substance,Memantine,"3,5-Dimethyl-1-adamantanamine; Axura; Akatinol; Abixa; 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine; Memox; Namenda; 1,3-Dimethyl-5-adamantanamine; Memantinum; Memantina; Ebixa; 1-Amino-3,5-dimethyladamantane; 3,5-Dimethyl-1-aminoadamantane; CHEBI:64312",2014-12-24,1,,,,,,,,,
GIS1009387,0,OMOP Exposome,Observation,Substance,Membrane,,2024-09-14,1,,,,,,,,,
GIS1009388,0,OMOP Exposome,Observation,Substance,Membrane Fraction,,2024-09-14,1,,,,,,,,,
Q16853,0,OMOP Exposome,Observation,Substance,Membrane primary amine oxidase,,2024-09-14,1,,,,,,,,,
O00264,0,OMOP Exposome,Observation,Substance,Membrane-associated progesterone receptor component 1,,2024-09-14,1,,,,,,,,,
58-27-5,0,OMOP Exposome,Observation,Substance,Menadione,"2-Methyl-1,4-naphthoquinone; Vitamin K3: 1,4-Dihydro-1,4-dioxo-2-methylnaphthalene; Vitamin K3; Vitamin K2; Vitamin K0; Thyloquinone; Synkay; Synkavite; Prokayvit; Panosine; MNQ; Mitenone; Mitenon; Menaquinone O; Menaquinone; Menaphtone; Menaphthone; Menaphthon; Menaphthene; Menadion; Kolklot; Koaxin; Klottone; Kipca-Oil Soluble; Kipca; Kayquinone; Kaynone; Kaykot; Kayklot; Kativ-G; Kareon; Karcon; Kappaxin; Kappaxan; Kanone; Kaergona; K-Vitan; K-Thrombyl; Juva-K; Hemodal; Aquinone; Aquakay; 3-Methyl-1,4-naphthoquinone; 2-Methylnaphthoquinone; 2-Methyl-1,4-naphthodione; 2-Methyl-1,4-naphthochinon; 2-Methyl-1,4-naphthalenedione; 2-Methyl-1,4-naphthalendione; 2-Methyl-1,4-naftochinon; CHEBI:28869",2014-12-24,1,,,,,,,,,
GIS1009389,0,OMOP Exposome,Observation,Substance,Menstruation-Inducing Agent,,2024-09-14,1,,,,,,,,,
2216-51-5,0,OMOP Exposome,Observation,Substance,Menthol,"D-(-)-Menthol; (-)-Menthyl alcohol; (-)-trans-p-Menthan-cis-ol; (1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol; Levomenthol; Levomentholum; Levomentol; Menthacamphor; Menthomenthol; p-Menthan-3-ol; Peppermint camphor; U.S.p. Menthol; Hexahydrothymol; 2-Isopropyl-5-methylcyclohexanol; 5-methyl-2-propan-2-ylcyclohexan-1-ol; 5-Methyl-2-(1-methylethyl)cyclohexanol; (1R,2S,5R)-(-)-menthol; (1R,3R,4S)-(-)-Menthol; (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol; (1R)-(-)-Menthol; L-(-)-Menthol; (-)-menthol; (-)-(1R,3R,4S)-Menthol; L-Menthol; 1-Menthol; (R)-(-)-Menthol; CHEBI:15409",2014-12-24,1,,,,,,,,,
57-42-1,0,OMOP Exposome,Observation,Substance,Meperidine,Petidina; Dolsin; Dolosal; Dolcontral; Dolantin; Demerol; Lydol; Mialgin; Pethidin; P\u00e9thidine; Pethidine dbl; Pethidinum; Petidin; Petydyna; Sauteralgyl; Spasmedal; Spasmodolin; Isonipeca\u00efne; CHEBI:122528,2014-12-24,1,,,,,,,,,
24307-26-4,0,OMOP Exposome,Observation,Substance,Mepiquat chloride,,2014-12-24,1,,,,,,,,,
96-88-8,0,OMOP Exposome,Observation,Substance,Mepivacaine,"Mepivacaine hydrochloride; S-Ropivacaine Mesylate; Polocaine; Scandonest Plain; Scandicaine; N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide; N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide; Mepivicaine; Mepivacainum; (+-)-1-Methyl-2',6'-pipecoloxylidide; Mepivacaine HCL; Mepivacaina; Isocaine; DL-Mepivacaine; Carbocaine; 1-methyl-2',6'-pipecoloxylidide; CHEBI:6759",2014-12-24,1,,,,,,,,,
GIS1009390,0,OMOP Exposome,Observation,Substance,Mepivacaine Pathway,,2024-09-14,1,,,,,,,,,
140-20-5,0,OMOP Exposome,Observation,Substance,Meralluride,,2014-12-24,1,,,,,,,,,
129-16-8,0,OMOP Exposome,Observation,Substance,Merbromin,,2014-12-24,1,,,,,,,,,
20223-84-1,0,OMOP Exposome,Observation,Substance,Mercaptomerin,,2014-12-24,1,,,,,,,,,
10124-48-8,0,OMOP Exposome,Observation,Substance,Mercuric amidochloride,,2014-12-24,1,,,,,,,,,
583-15-3,0,OMOP Exposome,Observation,Substance,Mercuric benzoate,,2014-12-24,1,,,,,,,,,
7487-94-7,0,OMOP Exposome,Observation,Substance,Mercuric chloride,"Calo-clor; Abavit b; Agrosan; Bichloride of mercury; Bichloride, mercury; Calochlor; Dichloromercury; Emisan 6; Fungchex; HgCl2; Mercuric bichloride; Mercuric perchloride; Mercury (II ) chloride; Mercury (II) chloride; Mercury bichloride; Mercury chloride; Mercury chloride (2); Mercury dichloride; Mercury perchloride; Mercury(2+) chloride; Mercury(2+) dichloride; Mercury(II) chloride; Perchloride of mercury; Sublimate; Sublimate, corrosive; CHEBI:31823",2014-12-24,1,,,,,,,,,
1191-80-6,0,OMOP Exposome,Observation,Substance,Mercuric oleate,,2014-12-24,1,,,,,,,,,
591-89-9,0,OMOP Exposome,Observation,Substance,Mercuric potassium cyanide,,2014-12-24,1,,,,,,,,,
7783-33-7,0,OMOP Exposome,Observation,Substance,Mercuric potassium iodide,Potassium iodomercurate; Potassium tetraiodomercurate(II); Potassium tetraiodomercurate - potassium hydroxide solution; Potassium tetraiodomercurate (II); Potassium tetraiodomercurate; Potassium tetraiodidomercurate(II); Potassium tetraiodidomercurate(2-); Potassium tetraiodidomercurate; Potassium mercury iodine; Potassium mercurIIodide; Potassium mercuric iodide; Nessler's reagent; Nessler reagent; Mercury(II) potassium iodide; Mercury(II) chloride - potassium iodide solution; Mercury(2+) potassium iodide; Mercury potassium iodide; Mayer's reagent; K2HgI4; Dipotassium tetraiodomercurate(2-); Dipotassium tetraiodomercurate; Channing's solution; CHEBI:51568,2014-12-24,1,,,,,,,,,
12002-19-6,0,OMOP Exposome,Observation,Substance,Mercurol,,2014-12-24,1,,,,,,,,,
7439-97-6,0,OMOP Exposome,Observation,Substance,Mercury,Mercury(2+); Mercury ion; Mercuric ion; Hg2+; Hg(2+); Mercury(II) ion; Metallic mercury; Mercury(II) cation; Mercury(II); Quicksilver; Mercury(2+) ion; CHEBI:16793,2014-12-24,1,,,,,,,,,
29870-72-2,0,OMOP Exposome,Observation,Substance,Mercury cadmium telluride,,2014-12-24,1,,,,,,,,,
GIS1009391,0,OMOP Exposome,Observation,Substance,Mercury Compound,,2024-09-14,1,,,,,,,,,
1312-03-4,0,OMOP Exposome,Observation,Substance,Mercury oxide sulfate,,2014-12-24,1,,,,,,,,,
20601-83-6,0,OMOP Exposome,Observation,Substance,Mercury selenide,,2014-12-24,1,,,,,,,,,
12068-90-5,0,OMOP Exposome,Observation,Substance,Mercury telluride,,2014-12-24,1,,,,,,,,,
631-60-7,0,OMOP Exposome,Observation,Substance,Mercury(I) acetate,Mercury acetate; Mercury monoacetate; Dimercury di(acetate); HgOAc; Mercurous acetate; Mercury(I) acetic acid; CHEBI:33210,2014-12-24,1,,,,,,,,,
15385-58-7,0,OMOP Exposome,Observation,Substance,Mercury(I) bromide,HgBr; Mercury monobromide; Mercury bromide; Mercurous bromide; CHEBI:49639,2014-12-24,1,,,,,,,,,
10112-91-1,0,OMOP Exposome,Observation,Substance,Mercury(I) chloride,Hydrochloric acid mercury salt; HgCl2; Hg2Cl2; Hg2-Cl2; dimercury(2+) chloride; Dimercury dichloride; Cyclosan; Calotab; Calomel; (dimercury) dichloride; Calogreen; Mild mercury chloride; Mercury subchloride; Mercury protochloride; Mercury monochloride; Mercury chloride (Hg2Cl2); Mercury chloride; Mercurous chloride; Kalomel; CHEBI:33050,2014-12-24,1,,,,,,,,,
13967-25-4,0,OMOP Exposome,Observation,Substance,Mercury(I) fluoride,,2014-12-24,1,,,,,,,,,
15385-57-6,0,OMOP Exposome,Observation,Substance,Mercury(I) iodide,,2014-12-24,1,,,,,,,,,
10415-75-5,0,OMOP Exposome,Observation,Substance,Mercury(I) nitrate,,2014-12-24,1,,,,,,,,,
15829-53-5,0,OMOP Exposome,Observation,Substance,Mercury(I) oxide,,2014-12-24,1,,,,,,,,,
7783-36-0,0,OMOP Exposome,Observation,Substance,Mercury(I) sulfate,,2014-12-24,1,,,,,,,,,
1600-27-7,0,OMOP Exposome,Observation,Substance,Mercury(II) acetate,Bis(acetyloxy)mercury; Mercury(2+) acetate; Mercury(II) acetic acid; Mercury diacetate; Mercury di(acetate); Mercury acetate; Mercuric diacetate; Mercuric acetate; Mercuriacetate; Mercuryl acetate; Diacetoxymercury; CHEBI:33211,2014-12-24,1,,,,,,,,,
7789-47-1,0,OMOP Exposome,Observation,Substance,Mercury(II) bromide,Mercuric dibromide; Dibromomercury; Mercury(2+) bromide; Mercuric bromide; Mercury bromide; HgBr2; Mercury(2)bromide; CHEBI:49639,2014-12-24,1,,,,,,,,,
592-04-1,0,OMOP Exposome,Observation,Substance,Mercury(II) cyanide,Hg(CN)2; Mercury dicyanide; Mercury(2+I) cyanide; Dicyanomercury; Mercury cyanide; Mercuric cyanide; Hg(CN)2; CHEBI:36573,2014-12-24,1,,,,,,,,,
7783-39-3,0,OMOP Exposome,Observation,Substance,Mercury(II) fluoride,,2014-12-24,1,,,,,,,,,
628-86-4,0,OMOP Exposome,Observation,Substance,Mercury(II) fulminate,"Fulminate of mercury; Bis(oxidoazanylidyne)methylmercury; Fulminic acid, mercury(2+) salt; Fulminic acid, mercury(II) salt; Hg(CNO)2; Mercury difulminate; Mercury fulminate; Mercury(II) fulminic acid; CHEBI:39152",2014-12-24,1,,,,,,,,,
7774-29-0,0,OMOP Exposome,Observation,Substance,Mercury(II) iodide,"Mercuric iodide; HgI; Mercuric iodide red; Mercuric iodide, red; Mercury biniodide; Mercury(2+) iodide; Mercury iodide; Mercury (II) iodide; DIIodomercury; Mercuric iodide,red; Alpha-mercury(II) iodide; Mercury(II) iodide red; Red mercuric iodide; HgI2; CHEBI:49659",2014-12-24,1,,,,,,,,,
10045-94-0,0,OMOP Exposome,Observation,Substance,Mercury(II) nitrate,,2014-12-24,1,,,,,,,,,
21908-53-2,0,OMOP Exposome,Observation,Substance,Mercury(II) oxide,,2014-12-24,1,,,,,,,,,
7783-35-9,0,OMOP Exposome,Observation,Substance,Mercury(II) sulfate,,2014-12-24,1,,,,,,,,,
1344-48-5,0,OMOP Exposome,Observation,Substance,Mercury(II) sulfide,,2014-12-24,1,,,,,,,,,
592-85-8,0,OMOP Exposome,Observation,Substance,Mercury(II) thiocyanate,,2014-12-24,1,,,,,,,,,
486-67-9,0,OMOP Exposome,Observation,Substance,Mersalyl acid,Uragan; Salyrgan; Salurin; Mercuramide; Mercusal; Mercurital; Diursal; Sodium mersalyl; Mersalyl acid sodium salt; Mersalyl; Mersalin; Mersalile; Igrosin; CHEBI:25520,2014-12-24,1,,,,,,,,,
2752-64-9,0,OMOP Exposome,Observation,Substance,Mesaconitine,,2014-12-24,1,,,,,,,,,
5588-33-0,0,OMOP Exposome,Observation,Substance,Mesoridazine,Thioridazine Thiomethyl Sulfoxide; thioridazine-2-sulfoxide; TPS-23; TPS23; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine; 10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine; Serentil; Mesoridazinum; 2-Methanesulfinyl-10-2-(1-methyl-piperidin-2-yl)-ethyl-10H-phenothiazine; Lidanar; Lidanil; Mesoridazina; Thioridazien Thiomethyl Sulfoxide; Thioridazine Monosulfoxide Analog; CHEBI:6780,2014-12-24,1,,,,,,,,,
208465-21-8,0,OMOP Exposome,Observation,Substance,Mesosulfuron-methyl,,2014-12-24,1,,,,,,,,,
72-33-3,0,OMOP Exposome,Observation,Substance,Mestranol,"17a-Ethynyl-3-methoxy-1,3,5(10)-estratrien-17b-ol; 3-Methoxy-19-nor-17\u03b1-pregna-1,3,5(10)-trien-20-yn-17-ol; 17-Ethynylestradiol 3-methyl ether; (17\u03b2)-17-Ethynyl-3-methoxyestra-1(10),2,4-trien-17-ol; (8S,9S,13S,14S,17S)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopentaaphenanthren-17-ol; (1S,10R,11S,14R,15S)-14-ethynyl-5-methoxy-15-methyltetracyclo8.7.0.02,7.011,15heptadeca-2(7),3,5-trien-14-ol; (8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopentaaphenanthren-17-ol; 17-Ethynyl-3-methoxy-1,3,5(10)-oestratien-17-\u03b2-ol; (17a)-3-Methoxy-19-norpregna-1,3,5(10)-trien-20-yn-17-ol; (8R,9S,13S,14S,17R)-17-Ethinyl-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopentaaphenanthren-17-ol; 17a-Ethynyl-1,3,5(10)-estratriene-3,17b-diol 3-methyl ether; (17b)-17-ethynyl-3-methoxyestra-1,3,5(10)-trien-17-ol; 17a-Ethynylestradiol 3-Methyl Ether; CHEBI:6784",2014-12-24,1,,,,,,,,,
GIS1009392,0,OMOP Exposome,Observation,Substance,Metabolic Pathways,,2024-09-14,1,,,,,,,,,
GIS1009393,0,OMOP Exposome,Observation,Substance,Metabolite,,2024-09-14,1,,,,,,,,,
Q13255,0,OMOP Exposome,Observation,Substance,Metabotropic glutamate receptor 1,,2024-09-14,1,,,,,,,,,
Q14416,0,OMOP Exposome,Observation,Substance,Metabotropic glutamate receptor 2,,2024-09-14,1,,,,,,,,,
Q14832,0,OMOP Exposome,Observation,Substance,Metabotropic glutamate receptor 3,,2024-09-14,1,,,,,,,,,
Q14833,0,OMOP Exposome,Observation,Substance,Metabotropic glutamate receptor 4,,2024-09-14,1,,,,,,,,,
P41594,0,OMOP Exposome,Observation,Substance,Metabotropic glutamate receptor 5,,2024-09-14,1,,,,,,,,,
O15303,0,OMOP Exposome,Observation,Substance,Metabotropic glutamate receptor 6,,2024-09-14,1,,,,,,,,,
Q14831,0,OMOP Exposome,Observation,Substance,Metabotropic glutamate receptor 7,,2024-09-14,1,,,,,,,,,
O00222,0,OMOP Exposome,Observation,Substance,Metabotropic glutamate receptor 8,,2024-09-14,1,,,,,,,,,
GIS1009394,0,OMOP Exposome,Observation,Substance,Metal,,2024-09-14,1,,,,,,,,,
Q14872,0,OMOP Exposome,Observation,Substance,Metal regulatory transcription factor 1,,2024-09-14,1,,,,,,,,,
Q9Y483,0,OMOP Exposome,Observation,Substance,Metal-response element-binding transcription factor 2,,2024-09-14,1,,,,,,,,,
108-62-3,0,OMOP Exposome,Observation,Substance,Metaldehyde,"Suprasnail; 2,4,6,8-Tetramethyl-1,3,5,7-tetraoxacyclooctane; 2,4,6,8-Tetramethyl-1,3,5,7-tetroxocane; Acetaldehyde tetramer; Agrimort; Ariotox; Cekumeta; Corry's slug death; Halizan; Helarion; Lumacrusk5; Metacetaldehyde; Metaldehyd; Metaldeide; Puzomor; r-2,c-4,c-6,c-8-Tetramethyl-1,3,5,7-tetroxocane; Slug-tox; Snail-kil; CHEBI:15343",2014-12-24,1,,,,,,,,,
GIS1009395,0,OMOP Exposome,Observation,Substance,Metalloid,,2024-09-14,1,,,,,,,,,
BE0001020,0,OMOP Exposome,Observation,Substance,Metalloproteinase,,2024-09-14,1,,,,,,,,,
P01033,0,OMOP Exposome,Observation,Substance,Metalloproteinase inhibitor 1,,2024-09-14,1,,,,,,,,,
P16035,0,OMOP Exposome,Observation,Substance,Metalloproteinase inhibitor 2,,2024-09-14,1,,,,,,,,,
P04731,0,OMOP Exposome,Observation,Substance,Metallothionein-1A,,2024-09-14,1,,,,,,,,,
P02795,0,OMOP Exposome,Observation,Substance,Metallothionein-2,,2024-09-14,1,,,,,,,,,
P25713,0,OMOP Exposome,Observation,Substance,Metallothionein-3,,2024-09-14,1,,,,,,,,,
6734-80-1,0,OMOP Exposome,Observation,Substance,Metam-sodium hydrate,,2014-12-24,1,,,,,,,,,
100-97-0,0,OMOP Exposome,Observation,Substance,Metenamine,"HEX; 1,3,5,7-Tetraazaadamantane; 1,3,5,7-Tetraazatricyclo (3.3.1.1(3,7))decane; 1,3,5,7-Tetraazatricyclo(3.3.1.13,7)decane; 1,3,5,7-Tetraazatricyclo(3.3.1.13,7)decane hydroiodide; 1,3,5,7-Tetraazatricyclo(3.3.1.137)decane; 1,3,5,7-Tetraazatricyclo3.3.1.1(3,7)decane; 1,3,5,7-Tetraazatricyclo3.3.1.13,7 decane; 1,3,5,7-Tetraazatricyclo3.3.1.1~3,7~decane; Aceto HMT; Aminoform; Aminoformaldehyde; Ammoform; Ammonioformaldehyde; Antihydral; Carin; Cystamin; Cystogen; Duirexol; E239; Ekagom h; Esametilentetramina; Formaldehyde-ammonia 6:4; Formamine; Formin; Formin (heterocycle); Formin (the heterocyclic compound); Grasselerator 102; H.m.t.; Herax UTS; Heterin; Hexa; Hexa (vulcanization accelerator); Hexa-flo-pulver; Hexaform; Hexaloids; Hexamethylamine; Hexamethylenamine; Hexamethylene tetramine; Hexamethyleneamine; Hexamethylenetetraamine; Hexamethylenetetramine; Hexamethylenetetramine (aliphatic); Hexamethylenetetramine, 8CI; Hexamethylenetetramine, acs; Hexamethylenetetramine-palladium chloride adduct; Hexamethylenetetraminum; Hexamethylentetramin; Hexamethylentetramine; Hexamethylentetraminum; Hexamine; Hexamine (heterocycle); Hexamine silver; Hexaminum; Hexasan; Hexilmethylenamine; HMT; HMTA; Mandelamine; Metenamina; Methamin; Methenamin; Methenamine; Methenamine silver; Methenaminum; Metramine; Naphthamine; Natasol fast orange GR salt; Nocceler H; Preparation af; Resotropin; S 4 (Heterocycle); Sanceler h; Silver methenamine; Tetraazaadamantane; Uramin; Uratrine; Urisol; Uritone; Uro-phosphate; Urodeine; Urotropin; Urotropine; Vesaloin; Vesalvine; Vulkacit H 30; Vulkacit H30; Xametrin; 16-Adamazane, INN; CHEBI:6824",2014-12-24,1,,,,,,,,,
30674-80-7,0,OMOP Exposome,Observation,Substance,Methacryloyloxyethyl isocyanate,,2014-12-24,1,,,,,,,,,
76-99-3,0,OMOP Exposome,Observation,Substance,Methadone,"(+/-)-Methadone hydrochloride; (+/-)-Methadone; (+-)-Methadone; Mephenon; Ketalgin; Polamidon; Physeptone; Phenadone hydrochloride; METHADOSE; Methadonum; Methadone hydrochloride; DISKETS; Dl-Methadone; DL-Methadone hydrochloride; Dolophine; Heptadon; Heptanon; Methadone HCL; Methadon; Depridol; Adolan; 6-Dimethylamino-4,4-diphenyl-3-heptanone; (\u00b1)-methadone; CHEBI:6807",2014-12-24,1,,,,,,,,,
537-46-2,0,OMOP Exposome,Observation,Substance,Methamphetamine,"Metamphetamine; Methylamphetamine; methyl-\u03b2-phenylisopropylamine; (S)-methamphetamine; (S)-methylamphetamine; (+ )-methylamphetamine; (+)-(S)-deoxyephedrine; (+)-(S)-N-alpha-dimethylphenethylamine; (+)-(S)-N-\u03b1-dimethylphenethylamine; (S)-N,alpha-dimethylbenzeneethanamine; (S)-N,alpha-dimethylbenzeneethanoamine; (S)-N,\u03b1-dimethylbenzeneethanamine; (\u03b1S)-N,\u03b1-dimethylbenzeneethanamine; 1-Phenyl-2-methylaminopropane; 2S-(+)-Methamphetamine; D-(S)-Methamphetamine; D-1-Phenyl-2-methylaminopropane; D-Deoxyephedrine; D-Desoxyephedrine; D-Methamphetamine; D-Methylamphetamine; D-N,alpha-Dimethylphenethylamine; (+)-2-(N-Methylamino)-1-phenylpropane; (+)-methamphetamine; (+)-methylamphetamine; (+)-N,alpha-dimethyl-beta-phenylethylamine; D-N-Methylamphetamine; D-Phenylisopropylmethylamine; Desoxyephedrine hydrochloride; Desoxyn; Dextromethamphetamine; Ice; L-Methamphetamine; M\u00e9tamf\u00e9tamine; Metamfetaminum; N-Methyl-1-phenyl-2-propanamine; (+)-N,alpha-dimethylphenethylamine; (+)-N-methylamphetamine; (2S)-N-methyl-1-phenylpropan-2-amine; (AlphaS)-N,alpha-dimethylbenzeneethanamine; (S)-(+)-deoxyephedrine; (S)-(+)-methamphetamine; (S)-(+)-N,alpha,dimethylphenethylamine; Metanfetamina; Meth; Methamphetaminum; Methyl-beta-phenylisopropylamine; S-(+)-Methamphetamine; N-Methylamphetamine; N-Methyl-beta-phenylisopropylamine; CHEBI:6809",2014-12-24,1,,,,,,,,,
74-82-8,0,OMOP Exposome,Observation,Substance,Methane,Marsh gas; CH4; Tetrahydridocarbon; Biogas; Carbane; Methyl hydride; CHEBI:16183,2014-12-24,1,,,,,,,,,
GIS1009396,0,OMOP Exposome,Observation,Substance,Methane Metabolism,,2024-09-14,1,,,,,,,,,
67-56-1,0,OMOP Exposome,Observation,Substance,Methanol,Colonial spirit; Pyro alcohol; Pyroxylic spirit; Spirit of wood; Wood alcohol; Wood naphtha; Wood spirit; Carbinol; CH3OH; Columbian spirits; Columbian spirit; Methyl alcohol; Hydroxymethane; Methyl hydroxide; Methylol; Monohydroxymethane; CHEBI:17790,2014-12-24,1,,,,,,,,,
50-11-3,0,OMOP Exposome,Observation,Substance,Metharbital,Metarbital; Metharbitalum; Gemonil; CHEBI:102408,2014-12-24,1,,,,,,,,,
1982-37-2,0,OMOP Exposome,Observation,Substance,Methdilazine,Methdilazinum; MD; Tacaryl; Methodilazine; Metodilazina; Methdilazine Monohydrochloride; Dilosyn; CHEBI:774910,2014-12-24,1,,,,,,,,,
950-37-8,0,OMOP Exposome,Observation,Substance,Methidathion,"S-(2,3-dihydro-5-Methoxy-2-oxo-1,3,4-thiadiazol-3-methyl) dimethyl phosphorothiolothionate; Phosphorodithioic acid, S-(5-methoxy-2-oxo-1,3,4-thiadiazol-3(2H)-yl)methyl O,O-dimethyl ester; Supracide; S-(5-Methoxy-2-oxo-1,3,4-thiadiazol-3(2H)-yl)methyl O,O-dimethyl dithiophosphate; CHEBI:34837",2014-12-24,1,,,,,,,,,
2032-65-7,0,OMOP Exposome,Observation,Substance,Methiocarb,"Carbamic acid, methyl-, 4-(methylthio)-3,5-xylyl ester; 3,5-Dimethyl-4-(Methylthio)phenyl methylcarbamate; 3,5-Dimethyl-4-methyl-thiophenyl-N-carbamat; 3,5-Dimethyl-4-methylmercaptophenyl-N-methyl-carbamate; 4-Methylmercapto-3,5-xylyl methylcarbamate; Methyl carbamic acid 4-(methylthio)-3,5-xylyl ester; Methiocarbe; Mesurol phenol; Mesurol; 4-Methylthio-3,5-dimethylphenyl methylcarbamate; 4-Methylthio-3,5-xylyl methylcarbamate; Borderland black; Carbamic acid, N-methyl-, 4-(methylthio)-3,5-xylyl ester; 3,5-Dimethyl-4-(methylthio)phenol methylcarbamate; 3,5-Dimethyl-4-methylthiophenyl N-methylcarbamate; 3,5-Xylenol, 4-(methylthio)-, methylcarbamate; 4-(Methylthio)-3,5-dimethylphenyl methylcarbamate; 4-(Methylthio)-3,5-xylyl methylcarbamate; 4-Methylmercapto-3,5-dimethylphenyl N-methylcarbamate; Phenyl-3,5-dimethyl-4-(methylthio)-, methylcarbamate; Phenol, 3,5-dimethyl-4-(methylthio)-, methylcarbamate (9CI); Phenol, 3,5-dimethyl-4-(methylthio)-, methylcarbamate; Metmercapturon; Metmercapturan; Mercaptodimethur; Certan; CLUB; Draza; Esurol; Grandslam; Lizetan; Caswell No. 578B; 3,5-Dimethyl-4-(methylsulfanyl)phenyl methylcarbamate; CHEBI:38508",2014-12-24,1,,,,,,,,,
2179-25-1,0,OMOP Exposome,Observation,Substance,Methiocarb sulfone,,2014-12-24,1,,,,,,,,,
2635-10-1,0,OMOP Exposome,Observation,Substance,Methiocarb sulfoxide,,2014-12-24,1,,,,,,,,,
19679-38-0,0,OMOP Exposome,Observation,Substance,Methiochlor,,2014-12-24,1,,,,,,,,,
GIS1009397,0,OMOP Exposome,Observation,Substance,Methionine Adenosyltransferase Deficiency,,2024-09-14,1,,,,,,,,,
P53582,0,OMOP Exposome,Observation,Substance,Methionine aminopeptidase 1,,2024-09-14,1,,,,,,,,,
P50579,0,OMOP Exposome,Observation,Substance,Methionine aminopeptidase 2,,2024-09-14,1,,,,,,,,,
GIS1009398,0,OMOP Exposome,Observation,Substance,Methionine Metabolism,,2024-09-14,1,,,,,,,,,
Q99707,0,OMOP Exposome,Observation,Substance,Methionine synthase,,2024-09-14,1,,,,,,,,,
Q9UBK8,0,OMOP Exposome,Observation,Substance,Methionine synthase reductase,,2024-09-14,1,,,,,,,,,
151-83-7,0,OMOP Exposome,Observation,Substance,Methohexital,"Brietal; Methodrexitone; Methohexitalum; Methohexitone; Metohexital; 5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione; 5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid; alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid; Brevital; (+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid; 5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; CHEBI:102216",2014-12-24,1,,,,,,,,,
16752-77-5,0,OMOP Exposome,Observation,Substance,Methomyl,"Methyl N-((methylcarbamoyl)oxy)thioacetimidate; 1-(Methylthio)acetaldehyde O-methylcarbamoyloxime; Thiobutan-2-one, O-(methylcarbamoyl)oxime; Sorex golden FLY bait; S-Methyl N-(methylamino)carbonyloxyethanimidothioate; S-Methyl N-(methylcarbamoyloxy)thioacetimidate; Nudrin; Nu-bait II; N-(Methylamino)carbonyloxy-2-(methylthio)ethanimine; N-(Methylcarbamoyl)oxythioacetimidic acid methyl ester; N-((Methylcarbamoyl)oxy)thioacetimidic acid methyl ester; Metomil; Methyl O-(methylcarbamyl)thiolacetohydroxamate; Methyl O-(methylcarbamoyl)thiolacetohydroxamate; Methyl O-(methylcarbamoyl)thiolacethohydroxamate; 1-(Methylthio)ethylideneamino methylcarbamate; 2-Methylthio-acetaldehyd-O-(methylcarbamoyl)-oxim; 2-Methylthio-acetaldehyd-O-(methylcarbamoyl)-oxime; 2-Methylthio-propionaldehyd-O-(methylcarbamoyl)-oxim; 3-Thiabutan-2-one, O-(methylcarbamoyl)oxime; Acetimidothioic acid, methyl-, N-(methylcarbamoyl) ester; Du Pont 1179; Du Pont Insecticide 1179; Dupont 1179; Flytek; Insecticide 1,179; Insecticide 1179; Kipsin; Lannabait; Lannate; Lannate 20; Lannate L; Lannate LB; Lannate LV; Lannate(R); Lanox; Lanox 216; LANOX 90; Memilene; Mesomile; Methavin; Methomex; Methomyl (lannate); Methomyl 5G; Methomyl lannate; Methyl (1E)-N-((methylamino)carbonyloxy)ethanimidothioate; Methyl N-(methylamino)carbonyloxyethanimidothioate, 9CI; Methyl N-(methylcarbamoyl)oxythioacetimidate; Methyl N-(methylcarbamoyloxy)ethanimidothioate; Methyl N-(((methylamino)carbonyl)oxy)ethanimidothioate; CHEBI:6835",2014-12-24,1,,,,,,,,,
59-05-2,0,OMOP Exposome,Observation,Substance,Methotrexate,"4-amino-10-methylfolic acid; Methylaminopterinum; Metotrexato; Mexate; MTX; N-Bismethylpteroylglutamic acid; N-4-(2,4-Diamino-6-pteridinyl)methylmethylaminobenzoyl-L-glutamic acid; Otrexup; Rheumatrex; Trexall; Trexan; Zexate; Maxtrex; Meisusheng; Methopterin; Methotextrate; Methotrexic acid; Methotrexat; M\u00e9thotrexate; Methotrexatum; Methylaminopterin; Amethopterine; Artrait; Atrexel; Bendatrexat; Carditrex; Dermotrex; Ebetrex; Emtexate; HDMTX; L-Amethopterin; Ledertrexate; 4-amino-N(10)-Methylpteroylglutamic acid; Abitrexate; Alltrex; Amethopterin; CHEBI:6837",2014-12-24,1,,,,,,,,,
60-99-1,0,OMOP Exposome,Observation,Substance,Methotrimeprazine,"Levomepromazinum; Levomepromazine; Nozinan; Nosinan; Neurocil; Levomepromazina; Levoprome; 2-Methoxytrimeprazine; (-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine; (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; CHEBI:6838",2014-12-24,1,,,,,,,,,
298-81-7,0,OMOP Exposome,Observation,Substance,Methoxsalen,"Ammoidin; 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone; 8-Methoxy-2',3',6,7-furocoumarin; 8-Methoxy-4',5':6,7-furocoumarin; 8-Methoxy-furano-3'.2':6.7-coumarin; Xanthotoxine; Xanthoxin; Zanthotoxin; Xanthotoxin; Uvadex; Ultra mop; Oxsoralen-Ultra; Oxsoralen; O-Methylxanthotoxol; M\u00e9thoxsal\u00e8ne; Methoxalen; Meloxine; Meladinine; Deltasoralen; 9-Methoxy-7H-furo3,2-g1benzopyran-7-one; 8-MP; 8-MOP; 8-Methoxypsoralen; 8-Methoxyfuranocoumarin; CHEBI:18358",2014-12-24,1,,,,,,,,,
72-43-5,0,OMOP Exposome,Observation,Substance,Methoxychlor,"2,2,2-Trichloro-1,1-bis(4-methoxyphenyl)ethane; 2,2,2-t richloro-1,1-bis(4-methoxyphenyl)ethane; 2,2-Bis(p-anisyl)-1, 1,1-trichloroethane; 2,2-Bis(p-anisyl)-1,1,1-trichloroethane; 2,2-Bis(p-methoxyphenyl)-1,1, 1-trichloroethane; 2, 2-Di(p-methoxyphenyl)-1,1,1-trichloroethane; 1,1-Bis(p-methoxyphenyl)-2,2,2-trichloroethane; 1,1,1-Trichloro-2,2-di(4-methoxyphenyl)ethane; 1,1,1-Trichloro-2,2-bis-(p-methoxyphenyl)ethane; 1,1,1-Trichloro-2,2-bis(p-methoxyphenyl)ethane; 1,1,1-Trichloro-2,2-bis(p-anisyl)ethane; 1,1,1-Trichloro-2,2-bis(4-methoxyphenyl)ethane; 1,1,1-Trichloro-2, 2-di(4-methoxyphenyl)ethane; 1,1,1-Trichloro-2, 2-bis(p-methoxyphenyl)ethane; 1,1,1-Trichloro-2, 2-bis(p-anisyl)ethane; 1,1'-(2,2,2-Trichloroethylidene)bis(4-methoxybenzene); 1,1'-(2,2,2-trichloroethane-1,1-diyl)bis(4-methoxybenzene); 1,1'-(2,2, 2-Trichloroethylidene)bis(4-methoxybenzene); 1, 1-Bis(p-methoxyphenyl)-2,2,2-trichloroethane; 2,2-Bis(p-methoxyphenyl)-1,1,1-trichloroethane; 2,2-Di(p-anisyl)-1,1,1-trichloroethane; 2,2-Di(p-methoxyphenyl)-1,1,1-trichloroethane; 2,2-Di-(p-methoxyphenyl)-1,1,1-trichloroethane; 2,2-Di-p-anisyl-1,1,1-trichloroethane; 4,4-(2,2,2-Trichloroethylidene)dianisole; Bis(p-anisyl)-1,1,1-trichloroethane; Bis(p-methoxyphenyl)-1,1,1-trichloroethane; Di(p-methoxyphenyl) trichloromethyl methane; Di(p-methoxyphenyl)trichloromethyl methane; Dianisyl trichloroethane; Dianisyltrichlorethane; Dianisyltrichloroethane; Dimethox ydiphenyltrichloroethane; Dimethoxy-DDT; Dimethoxy-DT; Dimethoxydiphenyltrichloroethane; Maralate; Marlate; Maxie; Meocl; Methoxcide; Methoxo; Methoxy DDT; Methoxy-DDT; Metoksychlor; p, p'-methoxychlor; p,p'-(dimethoxydiphenyl)trichloroethane; p,p'-dimethoxydiphenyltrichl oroethane; p,p'-dimethoxydiphenyltrichloroethane; p,p'-DMDT; p,p'-methoxychlor; Pmethoxychlor; Prentox; Trichloroethane dianisyl; 2,2-Bis(4-methoxyphenyl)-1,1,1-trichloroethane; 2,2-Bis (p-methoxyphenol)-1,1,1-trichloroethane; CHEBI:6842",2014-12-24,1,,,,,,,,,
151-38-2,0,OMOP Exposome,Observation,Substance,Methoxyethelmercuric acetate,,2014-12-24,1,,,,,,,,,
161050-58-4,0,OMOP Exposome,Observation,Substance,Methoxyfenozide,"N'-(tert-butyl)-n'-(3,5-dimethylbenzoyl)-3-methoxy-2-methylbenzohydrazide; 3-Methoxy-2-methylbenzoic acid 2-(3,5-dimethylbenzoyl)-2-(1,1-dimethylethyl)hydrazide; N-Tert-butyl-n'-(3-methoxy-O-toluoyl)-3,5-xylohydrazide; CHEBI:38449",2014-12-24,1,,,,,,,,,
76-38-0,0,OMOP Exposome,Observation,Substance,Methoxyflurane,"Methoxyfluran; Methoxyfluoran; Methoxyfluorane; Methoxiflurane; Methoxifluranum; Penthrane; Metoxiflurano; Metoxifluran; Metoxfluran; Metossiflurano; Methoflurane; Methyl 1,1-difluoro-2,2-dichloroethyl ether; Methoxyfluranum; CHEBI:384208",2014-12-24,1,,,,,,,,,
77-41-8,0,OMOP Exposome,Observation,Substance,Methsuximide,"alpha-Methylphensuximide; 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine; 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione; 1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione; 1,3-Dimethyl-3-phenylsuccinimide; Mesuximidum; Mesuximide; Mesuximida; Celontin; Petinutin; N-Methyl-alpha-methyl-alpha-phenylsuccinimide; N,2-Dimethyl-2-phenylsuccinimide; Metsuccimide; Metosuccimmide; Methsuximid; alpha-Methyl-alpha-phenyl N-methyl succinimide; (RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion; CHEBI:131857",2014-12-24,1,,,,,,,,,
78649-93-1,0,OMOP Exposome,Observation,Substance,Methyl (5Z)-3-amino-5-(nitromethylidene)dithiole-4-carboxylate,,2014-12-24,1,,,,,,,,,
119-36-8,0,OMOP Exposome,Observation,Substance,Methyl 2-hydroxybenzoate,"Methyl 2-hydroxybenzoic acid; FEMA 2745; Benzoic acid, 2-hydroxy-, methyl ester; 2-(Methoxycarbonyl)phenol; 2-Carbomethoxyphenol; 2-Hydroxybenzoic acid methyl ester; O-Hydroxybenzoic acid, methyl ester; Methyl salicylate, 8CI; Methyl O-hydroxybenzoate; Methyl ester 2-hydroxy-benzoic acid; CHEBI:31832",2014-12-24,1,,,,,,,,,
12263-85-3,0,OMOP Exposome,Observation,Substance,Methyl aluminum sesquibromide,,2014-12-24,1,,,,,,,,,
93-08-3,0,OMOP Exposome,Observation,Substance,Methyl beta-naphthyl ketone,"2-ACETYL NAPHTHALENE; 1-(2-Naphthalenyl)-Ethanone; 1-(2-Naphthalenyl)ethanone; 1-(2-Naphthyl)ethanone; 1-(Naphthalen-2-yl)ethanone; Oranger crystals; Methyl \u03b2-naphthyl ketone; 1-(Naphthalenyl)-Ethanone; 1-(Naphthyl)ethan-1-one; 1-Naphthalen-2-yl-ethanone; 2'-Acetonaphthone; 2-Acetonaphthone; 2-Acetylnaphthalene; 2-Naphthyl methyl ketone; Acetonaphthone; beta -acetonaphthalene; beta-Acetonaphthone; beta-Acetylnaphthalene; beta-Naphthyl methyl ketone; beta -acetonaphthone; Cetone D; Ketone, methyl 2-naphthyl; Methyl 2-naphthyl ketone; Methyl b-naphthyl ketone; Methyl beta -naphthyl ketone; Oranger cyrstals; beta -acetylnaphthalene; beta -methyl naphthyl ketone; beta -naphthyl methyl ketone; beta-Acetonaphthalene; CHEBI:52364",2014-12-24,1,,,,,,,,,
9004-74-4,0,OMOP Exposome,Observation,Substance,Methyl cellusolve,HOCH2CH2OCH3; 3-Oxa-1-butanol; Methyl cellosolve; Methyl oxitol; Monomethyl ethylene glycol ether; 1-Hydroxy-2-methoxyethane; 2-Hydroxyethyl methyl ether; 2-Methoxy-1-ethanol; 2-METHOXYETHANOL; beta-Methoxyethanol; CHEBI:46790,2014-12-24,1,,,,,,,,,
137-05-3,0,OMOP Exposome,Observation,Substance,Methyl cyanoacrylate,,2014-12-24,1,,,,,,,,,
111-82-0,0,OMOP Exposome,Observation,Substance,Methyl dodecanoate,,2014-12-24,1,,,,,,,,,
1338-23-4,0,OMOP Exposome,Observation,Substance,Methyl ethyl ketone peroxide,,2014-12-24,1,,,,,,,,,
624-83-9,0,OMOP Exposome,Observation,Substance,Methyl isocyanate,"Isocyanatomethane; Methylisocyanaat; Methyl isocyanic acid; Methyl isocyanat; Methyl carbonimide; Methylisocyanate; Methylisokyanat; Isocyanic acid, methyl ester; (Methylimino)(oxo)methane; (methylimino)(oxo)methane; Isocyanate de methyle; Iso-cyanomethane; Iso-cyanatomethane; Metil isocianato; CH3NCO; MIC; C2H3NO; RCRA waste no. P064; Rcra waste number P064; Methylcarbylamine; Methyl isocyanide; CHEBI:59059",2014-12-24,1,,,,,,,,,
593-75-9,0,OMOP Exposome,Observation,Substance,Methyl isocyanide,CH3-NC; MNC; CH3NC; Methyl isonitrile; Methylisonitrile; MENC; CNME; Isocyanomethane; CHEBI:44177,2014-12-24,1,,,,,,,,,
556-61-6,0,OMOP Exposome,Observation,Substance,Methyl isothiocyanate,"Isothiocyanatomethane; Isothiocyanato-Methane; Biomet 33; Vorlex; Vortex; MIC; MIT; MITC; Mencs; Isothiocyanic acid, methyl ester; MTC; Trapex; Trapex-40; Trapexide; Tropex; (methylimino)thioxo-Methane; (methylimino)(thioxo)methane; Methyl thioisocyanate; Methyl mustard oil; Methyl mustard; Methyl isothiocyanic acid; Methane isothiocyanate; Methylimino-sulfanylidenemethane; Morton EP-161E; CHEBI:78337",2014-12-24,1,,,,,,,,,
112-63-0,0,OMOP Exposome,Observation,Substance,Methyl linoleate,,2014-12-24,1,,,,,,,,,
298-00-0,0,OMOP Exposome,Observation,Substance,Methyl parathion,"Pencap m; Parton-m; Paratuf; Paratox; Parathion-methyl solution; Parathion-methyl; Parathion methyl; Parataf; Parapest M-50; P-nitrophenyldimethylthionophosphate; OOo-dim ethyl o-p-nitrophenyl thiophosphate; Oleovofotox; M-parathion; Me-parathion; Partron m; Yphos; Wofotox; Wofatox 80; Wofatox 50 EC; Wofatox; Vofatox; A-gro; Azofos; Azophos; Bladan m; Bladan-m; Cekumethion; DALF; Dalif; Demethylfenitrothion; Thylpar M-50; Thiophenit; Tekwaisa; Sinafid M-48; Quinophos; Phosphorothioic acid, O,O-dimethyl-O-P-nitrophenyl ester; Phosphorothioic acid, O,O-dimethyl O-(P-nitrophenyl) ester; Phosphorothioic acid, O,O-dimethyl O-(4-nitrophenyl) ester; Devithion; Dimethyl 4-nitrophenyl phosphorothionate; Dimethyl o-p-nitrophenyl thioph osphate; Dimethyl o-p-nitrophenyl thiophosphate; Dimethyl p-nitrophenyl monothiophosphate; Dimethyl p-nitrophenyl phosphorothionate; Dimethyl p-nitrophenyl thionophosphate; Dimethyl p-nitrophenyl thiophosphate; Dimethyl parathion; Dimethyl-p-nitrophenyl thionphosphate; Drexel methyl parathion 4E; Folid ol-m; Folidol 600; Folidol m; Folidol M 50; Folidol M-40; folidol-80; Folidol-m; Fosferno M 50; Fulkil; Kilex parathion; Liquid; Phosphorothioic acid O,O-dimethyl O-(4-nitrophenyl) ester; Penncap-m; Penncap MLS; Penncap m; Mepaton; Meptox; Metacid 50; Metacide; Metafos; Metafos (pesticide); Metaphor; Metaphos; Methylparathione; Methylthiophos; Metron; Nitrox; Nitrox 80; O,O-Dimethyl O-(4-nitrophenyl) phosphorothioate; O,O-Dimethyl O-(4-nitrophenyl) thiophosphate; O,O-dimethyl o-(p-nitrophenyl) phosphorothioate; O,O-dimethyl o-(p-nitrophenyl) thionophosphate; O,O-dimethyl O-(p-nitrophenyl) thiophosphate; O,O-Dimethyl O-4-nitrophenyl phosphorothioate; O,O-dimethyl O-p-nitrophenyl phosphorothioate; O,o-dimethyl o-p-nitrophenyl thiophosphate; O,O-Dimethyl-O-(4-nitrophenyl) phosphorothioate; Methylparathion; Methyl-E 605; Methyl-bladan; Methyl niran; Methyl fosferno; Methyl 1605; CHEBI:38746",2014-12-24,1,,,,,,,,,
556-64-9,0,OMOP Exposome,Observation,Substance,Methyl thiocyanate,"Methyl rhodanate; Methylthiokyanat; Methylrhodanid; Methyl thiocyanide; Methyl thiocyanic acid; Methyl sulfocyanate; CH3SCN; MeSCN; Thiocyanic acid,methyl ester; CHEBI:61112",2014-12-24,1,,,,,,,,,
Q9UBB5,0,OMOP Exposome,Observation,Substance,Methyl-CpG-binding domain protein 2,,2024-09-14,1,,,,,,,,,
120144-90-3,0,OMOP Exposome,Observation,Substance,Methylaluminoxane,,2014-12-24,1,,,,,,,,,
74-89-5,0,OMOP Exposome,Observation,Substance,Methylamine,Methyl group; Mercurialin; Imizin; Carbinamine; Anhydrous methylamine; Aminomethane; N-Methylamine; Monomethylamine; MMA; Metyloamina; Metilamine; Methylaminen; Methylamine solutions; Methylamine solution; Methylamine aqueous solution; Methylamine anhydrous; Methyl of gamma-N-methylasparagine; NME; NMA; Methanamine; CHEBI:16830,2014-12-24,1,,,,,,,,,
22113-87-7,0,OMOP Exposome,Observation,Substance,Methylammonium nitrate,,2014-12-24,1,,,,,,,,,
593-52-2,0,OMOP Exposome,Observation,Substance,Methylarsine,,2014-12-24,1,,,,,,,,,
19444-53-2,0,OMOP Exposome,Observation,Substance,"Methylarsonic acid, disodium salt","Methylarsonate; Weed-hoe; Weed-e-rad; Weed broom; Tonarsin; Tonarsan; Stenosine; Somar; Sodium methylarsonate; Ansar 184; Ansar DMSA liquid; Arrhenal; Arsinyl; Arsynal; Cacodyl new; Chipco crab kleen; Clout; Crab-3-rad 100; Crab-e-rad; Cralo-e-rad; Dal-e-rad 100; Di-tac; Diarsen; Dimet; Disodium methanearsenate; Disodium methanearsonate; Disodium methylarsenate; Disodium methylarsonate; Disodium monomethylarsonate; Disomar; Disomear; DSMA; Jon-trol; MAA; MAA sodium salt; MeAsO(OH)2; Methanearsonic acid; Methar; Metharsan; Metharsinat; Methylarsenic acid; Methylarsinic acid; Methylarsonate, disodium salt; Methylarsonic acid; Monomethylarsinic acid; Monomethylarsonate; Monomethylarsonic acid; Namate; Neo-asycodile; Sodar; Sodium methanearsonate; Sodium metharsonate; CHEBI:16005",2014-12-24,1,,,,,,,,,
2163-80-6,0,OMOP Exposome,Observation,Substance,"Methylarsonic acid, monosodium salt",,2014-12-24,1,,,,,,,,,
P16455,0,OMOP Exposome,Observation,Substance,Methylated-DNA--protein-cysteine methyltransferase,,2024-09-14,1,,,,,,,,,
93-65-2,0,OMOP Exposome,Observation,Substance,Methylchlorophenoxypropionic acid,"Mecopex; 2-(2'-Methyl-4'-chlorophenoxy)propionic acid; 2-(2-Methyl-4-chlorophenoxy)propionic acid; 2-(4-Chloor-2-methyl-fenoxy)-propionzuur; 2-(4-Chlor-2-methyl-phenoxy)-propionsaeure; 2-(4-chloro-2-Methylphenoxy)propanoic acid; 2-(4-chloro-2-Methylphenoxy)propionic acid; 2-(4-chloro-2-Tolyloxy)propionic acid; 2-(4-chloro-O-Tolyl)oxylpropionic acid; 2-(4-chloro-O-Tolyloxy)propionic acid; 2-(4-Chlorophenoxy-2-methyl)propionic acid; 2-(P-chloro-O-Tolyloxy)propionic acid; 2-MCPP; 2-Methyl-4-chlorophenoxy-.alpha.-propionic acid; 2-Methyl-4-chlorophenoxy-a-propionic acid; 4-chloro-2-Methylphenoxy-.alpha.-propionic acid; 4-chloro-2-Methylphenoxy-a-propionic acid; 4-chloro-2-Methylphenoxy-alpha-propionic acid; a-(2-Methyl-4-chlorophenoxy)propionic acid; a-(4-chloro-2-Methylphenoxy)propionic acid; alpha-(2-Methyl-4-chlorophenoxy)propionic acid; Alpha.-(2-methyl-4-chlorophenoxy)propionic acid; Anicon b; Anicon p; Astix; BH mecoprop; Caswell No. 559; Celatox CMPP; Chipco turf herbicide MCPP; CMPP; Propionic acid, 2-(4-chloro-2-methylphenoxy); Propionic acid, {2-(4-chloro-O-tolyl)oxy-}; Compitox; Duplosan CMPP; Duplosan new system CMPP; FBC CMPP; Hedonal; Hedonal MCPP; Iso-cornox; Isocarnox; Proponex-plus; Rankotex; Runcatex; Kilprop; Liranox; MCPP; MCPP 2,4-D; MCPP-D-4; MCPP-K-4; Mechlorprop; Mecomec; Mecopar; Mecopeop; (+ )-a-(4-chloro-2-Methylphenoxy) propionic acid; (+)-.alpha.-(4-chloro-2-methylphenoxy) propionic acid; (+)-a-(4-chloro-2-Methylphenoxy) propionic acid; (+)-alpha-(4-chloro-2-Methylphenoxy) propionic acid; (+-)-2-((4-chloro-O-Tolyl)oxy)propionic acid; O-(4-chloro-2-Methylphenyl)lactic acid; N.b. mecoprop; Mwcoprop; Morogal; Methylchlorophenoxypropionate; Methoxone; Mepro; Mecprop; (4-chloro-2-Methylphenoxy)propionic acid; Mecoturf; Mecoprop-p; Mecoprop; Mecoper; CHEBI:75704",2014-12-24,1,,,,,,,,,
13422-55-4,0,OMOP Exposome,Observation,Substance,Methylcobalamin,"Methyl-B12; Methyl vitamin B12; Methyl cobalamine; Methycobal; Mecobalamin; MeCbl; Hitocobamin M; Co-Methylcobalamin; Algobaz; Methylcobaz; Methylcob(III)alamin; Methyl-5,6-dimethylbenzimidazolylcobalamin; CHEBI:28115",2014-12-24,1,,,,,,,,,
Q9HCC0,0,OMOP Exposome,Observation,Substance,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial",,2024-09-14,1,,,,,,,,,
Q96RQ3,0,OMOP Exposome,Observation,Substance,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial",,2024-09-14,1,,,,,,,,,
12108-13-3,0,OMOP Exposome,Observation,Substance,Methylcyclopentadienyl manganese tricarbonyl,,2014-12-24,1,,,,,,,,,
96-37-7,0,OMOP Exposome,Observation,Substance,Methylcyclopentane,,2014-12-24,1,,,,,,,,,
Q8NFU7,0,OMOP Exposome,Observation,Substance,Methylcytosine dioxygenase TET1,,2024-09-14,1,,,,,,,,,
Q6N021,0,OMOP Exposome,Observation,Substance,Methylcytosine dioxygenase TET2,,2024-09-14,1,,,,,,,,,
593-89-5,0,OMOP Exposome,Observation,Substance,Methyldichloroarsine,,2014-12-24,1,,,,,,,,,
555-30-6,0,OMOP Exposome,Observation,Substance,Methyldopa,Alpha medopa; alpha-Methyl dopa; alpha-methyl-L-dopa; Alphamethyldopa; AMD; Dopamet; Hypolag; L-alpha-Methyldopa; L-Methyl Dopa; Medomet; Medopren; Novomedopa; Nu-Medopa; Aldomin; Aldometil; Aldomet; 3-Hydroxy-alpha-methyl-L-tyrosine; (S)-(-)-alpha-Methyldopa; CHEBI:61058,2014-12-24,1,,,,,,,,,
5124-30-1,0,OMOP Exposome,Observation,Substance,Methylene bis(4-cyclohexylisocyanate),"Nacconate H 12; Methylenebis(4-cyclohexylisocyanate); Dicyclohexylmethane-4,4'-di-isocyanate; Dicyclohexylmethane 4,4'-diisocyanate; HMDI; 4,4'-Methylenedicyclohexyl diisocyanate; Bis(4-isocyanatocyclohexyl)methane; Dicyclohexylmethane-4,4'-diisocyanate; Methylene bis-(4-cyclohexylisocyanate); Methylene bis(4-cyclohexylisocyanic acid); Isocyanic acid, methylenedi-4,1-cyclohexylene ester; Hylene w; 1,1'-methylenebis(4-isocyanatocyclohexane); 1,1-Methylenebis(4-isocyanatocyclohexane); 4,4'-Diisocyanato-methylenedicyclohexane; 4,4'-Diisocyanatodicyclohexylmethane; 4,4'-HMDI; 4,4'-Methylene-bis(cyclohexyl isocyanate); Hydrogenated mdi; 4,4'-Methylenedi(cyclohexyl isocyanate); CHEBI:53216",2014-12-24,1,,,,,,,,,
101-68-8,0,OMOP Exposome,Observation,Substance,Methylene diphenyl diisocyanate,"Para,para'-methylenebis(phenyl isocyanate); Desmodur 44; Crude mdi; Caradate 30; Bis(para-isocyanatophenyl)methane; Bis(p-isocyanatophenyl)methane; Bis(4-isocyanatophenyl)methane; Bis(1,4-isocyanatophenyl)methane; Benzene, {1,1'-methylenebis4-isocyanato-}; 4-4'-Diisocyanate de diphenylmethane; 4,4-Diphenylmethane disocyanate; 4,4'-Methylenediphenylene isocyanateThiulin; 4,4'-Methylenediphenylene isocyanate; 4,4'-Methylenediphenylene diisocyanate; 4,4'-Methylenediphenyl isocyanate; 4,4'-methylenediphenyl diisocyanate; 4,4'-Methylenedi-p-phenylene diisocyanate; 4,4'-Methylenedi(phenylene isocyanate); 4,4'-Methylenedi(phenyl isocyanate); 4,4'-Methylenedi(phenyl diisocyanate); 4,4'-Methylenebisphenyl isocyanate; 4,4'-methylenebis(phenylisocyanate); 4,4'-Methylenebis(phenyl isocyanate); 4,4'-Methylene diphenyl diisocyanate; 4,4'-methylene bisphenyl diisocyanate; 4,4'-Diphenylmethanediisocyante; 4,4'-Diphenylmethane Diisocyanate; 4,4'-Diisocyanatodiphenylmethane; 4,4'-Diisocyanate de diphenylmethane; 4,4'-,2,4'-,2,2'-Diisocyanatodiphenylmethane; 4, 4'-Methylenedi-p-phenylene diisocyanate; 4, 4'-Diisocyanatodiphenylmethane; 1-Isocyanato-4-(4-isocyanatobenzyl)benzene; 1,1-Methylenebis4-isocyanatobenzene; 1,1-methylenebis(phenyl)diisocyanate; 1,1'-methylenebis(4-isocyanatobenzene); Di-(4-isocyanatophenyl)methane; Difenil-metan-dIIsocianato; Difenylmethaan-dIIsocyanaat; Difenylmethaan-dissocyanaat; Diphenyl methane dIIsocyanate; Diphenylmethan-4,4'-diisocyanat; Diphenylmethane 4,4'-diisocyanate; Diphenylmethane 4,4-diisocyanate; Diphenylmethane dIIsocyanate; Diphenylmethane p,p'-dIIsocyanate; Diphenylmethane-4', 4-diisocyanate; diphenylmethane-4,4'-diisocyanate; Diphenylmethyl dIIsocyanate; Diphenylmethyl dIIsocyanate methylene bisphenyl isocyanate; Generic mdi; Hylene M50; iphenylmethane-4,4'-diisocyanate; Isocyanic acid, ester with diphenylmethane; Isocyanic acid, methylenedi-P-phenylene ester; Isocyanic acid, methylenediphenylene ester; Isonaphthol; Isonate; Isonate 125 MF; Isonate 125M; Isonate 2125M; MBI; MDI; MDR; Methylbisphenyl isocyanate; Methylene bisphenyl isocyanate; Methylene di(phenylene isocyanate); Methylene di-p-phenylene isocyanate; Methylene diphenyl dIIsocyanate and polymeric methylene diphenyl dIIsocyanate; Methylene diphenyl diisocyanic acid; Methylenebis(4,4'-phenyl isocyanate); Methylenebis(4-isocyanatobenzene); Methylenebis(4-phenyl isocyanate); Methylenebis(4-phenylene isocyanate); Methylenebis(4-phenylisocyanate); Methylenebis(p-phenyl isocyanate); Methylenebis(p-phenylene isocyanate); Methylenebis(p-phenylisocyanate); Methylenebis(para-phenyl isocyanate); Methylenebis(para-phenylene isocyanate); Methylenebis(phenylisocyanate); Methylenebisphenyl diisocyanate; Methylenebis4-isocyanatobenzene; Methylenebis4-phenyl isocyanate; Desmodur VKS-2, VKS-4, VKS-18; Methylenebis4-phenylene isocyanate; Methylenebisp-phenyl isocyanate; Methylenebisp-phenylene isocyanate; Methylenedi(p-phenyl isocyanate); Methylenedi(p-phenylene dIIsocyanate); Methylenedi(p-phenylene isocyanate); Methylenedi-p-phenyl dIIsocyanate; Methylenedi-p-phenylene dIIsocyanate; Methylenedi-para-phenylene dIIsocyanate; Methylenediphenyl dIIsocyanate; Nacconate 300; Nocconate 300; Non-isomeric-specific mdi; P,p'-diphenylmethane dIIsocyanate; P,p'-methylenebis(phenyl isocyanate); P,p'-methylenebisphenyl isocyanate; Para,para'-diphenylmethane dIIsocyanate; PMDI; Rubinate 44; Rubinate LF-168; CHEBI:53218",2014-12-24,1,,,,,,,,,
6317-18-6,0,OMOP Exposome,Observation,Substance,Methylene thiocyanate,,2014-12-24,1,,,,,,,,,
P42898,0,OMOP Exposome,Observation,Substance,Methylenetetrahydrofolate reductase,,2024-09-14,1,,,,,,,,,
GIS1009399,0,OMOP Exposome,Observation,Substance,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),,2024-09-14,1,,,,,,,,,
113-42-8,0,OMOP Exposome,Observation,Substance,Methylergonovine,"Uterjin; Uterowin; Utesel; 9,10-Didehydro-N-1-(hydroxymethyl)-propyl-D-lysergamide; Methylergometrine; Methylergometrin; Methylergometrinum; Methylergobrevin; Methylergobasine; Partan M; Methylergobasin; Methovin; Metherspan; Metherinal; Methergine; M\u00e9thergin; Metermin; Neo-ergo; Metenarin; Mergotrex; Mergot; Mem; Ingagen-M; Glomethyl; Expogin; Ergotyl; Ergomin; Ergomed; Ergogin; Methylergonovin; Methylergonovine maleate; Demergin; D-lysergic acid 1-butanolamide; Metilat; Bledstop; Basofortina; Pospargin; Metiler; Metilergometrina; Metrine; Metrol; Metvell; Myomergin; Myometril; Satergin; Usamema; Utergin; Uterine; CHEBI:775307",2014-12-24,1,,,,,,,,,
93-15-2,0,OMOP Exposome,Observation,Substance,Methyleugenol,"1,2-Dimethoxy-4-(2-propenyl)benzene; 1, 2-Dimethoxy-4-(2-propenyl)benzene; Allyl-1,2-dimethoxybenzene; Benzene, 4-(2-propenyl)-1,2-dimethoxy; Eugenol methyl; FEMA 2475; 4-Allylveratrole; 4-Allyl-1,2-dimethyoxybenzene; 4-Allyl-1,2-dimethoxy-Benzene; 4-Allyl-1, 2-dimethoxybenzene; 1-(3, 4-Dimethoxyphenyl)-2-propene; CHEBI:4918",2014-12-24,1,,,,,,,,,
471-29-4,0,OMOP Exposome,Observation,Substance,Methylguanidine,1-Methylguanidine; Methylguanidin; MGX; Monomethyl guanidin; Monomethylguanidine; N-Methylguanidine; N1-Methylguanidine; CHEBI:16628,2014-12-24,1,,,,,,,,,
GIS1009400,0,OMOP Exposome,Observation,Substance,Methylmalonate Semialdehyde Dehydrogenase Deficiency,,2024-09-14,1,,,,,,,,,
516-05-2,0,OMOP Exposome,Observation,Substance,Methylmalonic acid,"Methyl-Malonic acid; Isosuccinic acid; Isosuccinate; 2-Methylmalonic acid; 2-Methylmalonate; 1,1-Ethanedicarboxylic acid; Methylpropanedioic acid; 1,1-Ethanedicarboxylate; Methylpropanedioate; Methylmalonate; Methyl-Propanedioic acid; Methyl-Propanedioate; Methyl-Malonate; CHEBI:30860",2018-03-21,1,,,,,,,,,
GIS1009401,0,OMOP Exposome,Observation,Substance,Methylmalonic Aciduria,,2024-09-14,1,,,,,,,,,
Q9Y4U1,0,OMOP Exposome,Observation,Substance,Methylmalonic aciduria and homocystinuria type C protein,,2024-09-14,1,,,,,,,,,
GIS1009402,0,OMOP Exposome,Observation,Substance,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,,2024-09-14,1,,,,,,,,,
Q8IVH4,0,OMOP Exposome,Observation,Substance,"Methylmalonic aciduria type A protein, mitochondrial",,2024-09-14,1,,,,,,,,,
P22033,0,OMOP Exposome,Observation,Substance,"Methylmalonyl-CoA mutase, mitochondrial",,2024-09-14,1,,,,,,,,,
125-09-3,0,OMOP Exposome,Observation,Substance,Methylmercuric chloride,,2014-12-24,1,,,,,,,,,
502-39-6,0,OMOP Exposome,Observation,Substance,Methylmercuric dicyanamide,,2014-12-24,1,,,,,,,,,
22967-92-6,0,OMOP Exposome,Observation,Substance,Methylmercury,Methylmercury ion(1+); HgMe(+); HgCH3(+); Monomethylmercury cation; Methylmercury(II) cation; Methylmercury(II); Methylmercury(1+); Methylmercury ion; Methylmercury II; Methyl mercury ion; Methyl mercury; CH3Hg+; CH3Hg(+); CHEBI:49747,2014-12-24,1,,,,,,,,,
99-76-3,0,OMOP Exposome,Observation,Substance,Methylparaben,"Benzoic acid, p-hydroxy-, methyl ester; Methyl 4-hydroxybenzoate; Methyl ester of p-hydroxybenzoic acid; Methyl p-hydroxybenzoate; Methyl p-oxybenzoate; Methyl paraben; P-Hydroxybenzoic methyl ester; Methyl parahydroxybenzoate; Methyl parasept; Methyl-p-hydroxybenzoate; P-Hydroxybenzoic acid, methyl ester; P-Hydroxybenzoic acid methyl ester; P-Carbomethoxyphenol; Nipagin M; Tegosept M; P-Methoxycarbonylphenol; 4-(Methoxycarbonyl)phenol; 4-Hydroxybenzoic acid methyl ester; Benzoic acid, 4-hydroxy-, methyl ester; CHEBI:31835",2014-12-24,1,,,,,,,,,
113-45-1,0,OMOP Exposome,Observation,Substance,Methylphenidate,Methylphenidylacetate hydrochloride; Metilfenidat hydrochloride; Metilfenidato; Ritalin; Rubifen SR; alpha-Phenyl-2-piperidineacetic acid methyl ester; Concerta; D-Methylphenidate HCl; Daytrana; Equasym XL; Medikinet XL; Metadate; Methyl alpha-phenyl-alpha-(2-piperidyl)acetate; Methyl alpha-phenyl-alpha-2-piperidinylacetate; Methyl phenidyl acetate; Methyl phenidylacetate; Methylin; Methylphenidan; Methylphenidate HCl; Methylphenidate hydrochloride; Methylphenidatum; Methylphenidic acid; MPH; Phenidylate; Quillivant; Quillivant XR; Riphenidate; CHEBI:6887,2014-12-24,1,,,,,,,,,
58-18-4,0,OMOP Exposome,Observation,Substance,Methyltestosterone,Virilon; 17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one; 17-beta-Hydroxy-17-methylandrost-4-en-3-one; 17-Methyltestosterone; 17alpha-Methyl-3-oxo-4-androsten-17beta-ol; 17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one; 17alpha-methyl-delta-androsten-17beta-ol-3-one; 17alpha-methyltestosterone; 17beta-Hydroxy-17-methylandrost-4-en-3-one; 17\u03b1-methyl-\u03944-androsten-17\u03b2-ol-3-one; 17\u03b1-methyltestosterone; 4-Androstene-17alpha-methyl-17beta-ol-3-one; Android; Methitest; Methyltestosteronum; Metiltestosterona; NSC-9701; Testred; CHEBI:27436,2014-12-24,1,,,,,,,,,
1762-28-3,0,OMOP Exposome,Observation,Substance,Methyltriethyl lead,,2014-12-24,1,,,,,,,,,
125-64-4,0,OMOP Exposome,Observation,Substance,Methyprylon,Metiprilon; Methyprylonum; Methyprylone; Methyprolon; Methprylon; Dimerin; Dea No. 2575; Noludar; Nodular; Noctan; Metiprilone; Metiprilona; CHEBI:774741,2014-12-24,1,,,,,,,,,
361-37-5,0,OMOP Exposome,Observation,Substance,Methysergide,"Methysergidum; (+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide; (+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide; N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide; Sansert; Methyllysergic acid butanolamide; Metisergida; Desernil; Deseril; 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide; Methysergid; Metisergide; Metisergido; N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide; 1-Methylmethylergonovine; 1-Methyllysergic acid butanolamide; 1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide; 1-Methyl-D-lysergic acid butanolamide; CHEBI:584020",2014-12-24,1,,,,,,,,,
4969-02-2,0,OMOP Exposome,Observation,Substance,Metixene,Methixen; Methixene; Metisene; Metixeno; Metixenum; Tremaril; Tremarit; Cholinfall; Methixart; CHEBI:51024,2014-12-24,1,,,,,,,,,
51218-45-2,0,OMOP Exposome,Observation,Substance,Metolachlor,,2014-12-24,1,,,,,,,,,
1129-41-5,0,OMOP Exposome,Observation,Substance,Metolcarb,"3-Methylphenyl Methylcarbamate; Tumacide; Tsumaunka; Tsumacide; RCRA waste no. P190; MTMC; Methylcarbamic acid m-tolyl ester; Metholcarb; Metacrate; M-tolyl n-methylcarbamate; M-tolyl methylcarbamate; M-methylphenyl methylcarbamate; M-cresyl n-methylcarbamate; M-cresyl methylcarbamate; m-Cresyl ester OF N-methylcarbamic acid; Kumiai; Dicresyl n-methylcarbamate; Dicresyl; Carbamic acid, methyl-, m-tolyl ester; Carbamic acid, methyl-, 3-tolyl ester; Carbamic acid, methyl-, 3-methylphenyl ester; 3-Tolyl N-methylcarbamate; 3-Tolyl methylcarbamate; 3-Methylphenyl N-methylcarbamate; CHEBI:38537",2014-12-24,1,,,,,,,,,
21087-64-9,0,OMOP Exposome,Observation,Substance,Metribuzin,,2014-12-24,1,,,,,,,,,
443-48-1,0,OMOP Exposome,Observation,Substance,Metronidazole,Vagimid; Vagilen; Trikozol; Trikacide; Tricowas B; Trichopol; Trichex; 1-(\u03b2-oxyethyl)-2-methyl-5-nitroimidazole; 2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole; 2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole; 2-methyl-5-nitroimidazole-1-ethanol; Deflamon; Zadstat; Vertisal; 1-(\u03b2-ethylol)-2-methyl-5-nitro-3-azapyrrole; 1-(\u03b2-hydroxyethyl)-2-methyl-5-nitroimidazole; Vandazole; Orvagil; Novonidazol; Noritate; Nidagel; Nalox; Metrotop; Metronidazolum; Metronidazolo; 1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole; 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole; Arilin; 1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole; 1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole; 1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole; Metronidazole in Plastic Container; Clont; Metrogel; Efloran; Elyzol; Entizol; Flagyl; Fossyol; Metronidazole Benzoate; Klion; Klont; Methronidazole; MetroCream; Metronidazol; Metrolyl; MetroLotion; Metrogel-Vaginal; Acromona; Anabact; Trichazole; Takimetol; Rosadan; Protostat; CHEBI:6909,2014-12-24,1,,,,,,,,,
74223-64-6,0,OMOP Exposome,Observation,Substance,Metsulfuron-methyl,Metsulfuron methyl; Metsulfuron methyl ester; CHEBI:39678,2014-12-24,1,,,,,,,,,
7786-34-7,0,OMOP Exposome,Observation,Substance,Mevinphos,,2014-12-24,1,,,,,,,,,
315-18-4,0,OMOP Exposome,Observation,Substance,Mexacarbate,,2014-12-24,1,,,,,,,,,
31868-18-5,0,OMOP Exposome,Observation,Substance,Mexazolam,,2014-12-24,1,,,,,,,,,
113-48-4,0,OMOP Exposome,Observation,Substance,MGK,,2014-12-24,1,,,,,,,,,
22916-47-8,0,OMOP Exposome,Observation,Substance,Miconazole,"Micatin; Monistat; Miconazex; Desenex; Decocort; Daktarin; 1-2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl-1H-imidazole; MCZ; Gyno-Daktarin; 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole; Zimycan; Zeasorb-AF; Femizol-M; Oravig; Monistat-Derm; CHEBI:6923",2014-12-24,1,,,,,,,,,
GIS1009403,0,OMOP Exposome,Observation,Substance,Microcystin,,2024-09-14,1,,,,,,,,,
154037-70-4,0,OMOP Exposome,Observation,Substance,Microcystin-LF,,2014-12-24,1,,,,,,,,,
154037-67-9,0,OMOP Exposome,Observation,Substance,Microcystin-LL,"(8S,11R,12S,15S,18S,19S,22R)-8,15-Diisobutyl-18-(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl-1,5,12,19-tetramethyl-2-methylene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptaa zacyclopentacosane-11,22-dicarboxylate; (8S,11R,12S,15S,18S,19S,22R)-8,15-Diisobutyl-18-(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl-1,5,12,19-tetramethyl-2-methylene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptaa zacyclopentacosane-11,22-dicarboxylic acid; Microcystin LL; CHEBI:562215",2014-12-24,1,,,,,,,,,
101043-37-2,0,OMOP Exposome,Observation,Substance,Microcystin-LR,Microcystis aeruginosa toxin; 5-L-Arginine-microcystin LA; Microcystin-LR microcystis aeruginosa; Microcystin-lr; Microcystin LR; MCYST-LR; Cyanoginosin LR; Toxin LR; Toxin-LR; Acb-arg-add-cab-maa-dal-leu; CHEBI:6925,2014-12-24,1,,,,,,,,,
157622-02-1,0,OMOP Exposome,Observation,Substance,Microcystin-LW,,2014-12-24,1,,,,,,,,,
123304-10-9,0,OMOP Exposome,Observation,Substance,Microcystin-LY,,2014-12-24,1,,,,,,,,,
111755-37-4,0,OMOP Exposome,Observation,Substance,Microcystin-RR,,2014-12-24,1,,,,,,,,,
101064-48-6,0,OMOP Exposome,Observation,Substance,Microcystin-YR,Cyanoginosin LA 3-L-tyrosine-5-L-arginine; 3-tyrosyl-5-arginine-Cyanoginosin LA; cyanoginosin LA 3-L-tyrosyl-5-L-arginine; Microcystin-yr; Microcystin YR; Cyanoginosin-YR; Cyanoginosin YR; CHEBI:421966,2014-12-24,1,,,,,,,,,
GIS1009404,0,OMOP Exposome,Observation,Substance,Micronutrient,,2024-09-14,1,,,,,,,,,
P10620,0,OMOP Exposome,Observation,Substance,Microsomal glutathione S-transferase 1,,2024-09-14,1,,,,,,,,,
Q99735,0,OMOP Exposome,Observation,Substance,Microsomal glutathione S-transferase 2,,2024-09-14,1,,,,,,,,,
O14880,0,OMOP Exposome,Observation,Substance,Microsomal glutathione S-transferase 3,,2024-09-14,1,,,,,,,,,
GIS1009405,0,OMOP Exposome,Observation,Substance,Microsome,,2024-09-14,1,,,,,,,,,
GIS1009406,0,OMOP Exposome,Observation,Substance,Microtubule,,2024-09-14,1,,,,,,,,,
P11137,0,OMOP Exposome,Observation,Substance,Microtubule-associated protein 2,,2024-09-14,1,,,,,,,,,
P27816,0,OMOP Exposome,Observation,Substance,Microtubule-associated protein 4,,2024-09-14,1,,,,,,,,,
P10636,0,OMOP Exposome,Observation,Substance,Microtubule-associated protein tau,,2024-09-14,1,,,,,,,,,
59467-70-8,0,OMOP Exposome,Observation,Substance,Midazolam,Fulsed; Dormid; Dormicum; Doricum; Demizolam; Dea No. 2884; Damizol; Dalam; Buccolam; Benzosed; Hypnofast; Hypnovel; Ipnovel; Midazolam Base; Anquil; Epistatus; Nocturna; Setam; Talentum; Hipnoz; Terap; Versed; Hipnazolam; Gobbizolam; Midazolamum; Drimnorth; Dormonid; Dormixal; Dormitol; Dormire; Dormipron; Fulsed Injection; Flormidal; Garen; CHEBI:127611,2014-12-24,1,,,,,,,,,
84371-65-3,0,OMOP Exposome,Observation,Substance,Mifepristone,"Mif\u00e9pristone; 11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopentaaphenanthren-3-one; Corlux; Korlym; RU486; RU-486; Mefipil; Mifegyne; Mifeprex; Mifepriston; Mifepristona; Mifepristonum; CHEBI:50692",2014-12-24,1,,,,,,,,,
51596-11-3,0,OMOP Exposome,Observation,Substance,Milbemectin (mixture),"Milbemycin A4; (1'R,2R,4'S,5S,6R,8'R,10'E,13'R,14'E,16'E,20'R,21'R,24'S)-6-Ethyl-21',24'-dihydroxy-5,11',13',22'-tetramethyl-3,4,5,6-tetrahydro-2'H-spiropyran-2,6'-3,7,19trioxatetracyclo15.6.1.14,8.020,24pentacosa10,14,16,22tetraen-2'-one; Milbemycin A3; 2,6benzodioxacyclooctadecine-13,2'-pyran-17-one; Milbemectin A4; (2aE,4E,5'S,6R,6'R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-ethyl-20,20b-dihydroxy-5',6,8,19-tetramethyl-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-tetradecahydro-2H,17H-spiro11,15-methanofuro4,3,2-pq; Milbectin A4; (1'R,2R,4'S,5S,6R,8'R,10'E,13'R,14'E,16'E,20'R,21'R,24'S)-6-Ethyl-21',24'-dihydroxy-5,11',13',22'-tetramethyl-3,4,5,6-tetrahydro-2'H-spiropyran-2,6'-3,7,19trioxatetracyclo15.6.1.14,8.020,24pe ntacosa10,14,16,22tetraen-2'-one; CHEBI:39229",2014-12-24,1,,,,,,,,,
GIS1009407,0,OMOP Exposome,Observation,Substance,Mineral,,2024-09-14,1,,,,,,,,,
GIS1009408,0,OMOP Exposome,Observation,Substance,Mineral absorption,,2024-09-14,1,,,,,,,,,
P08235,0,OMOP Exposome,Observation,Substance,Mineralocorticoid receptor,,2024-09-14,1,,,,,,,,,
GIS1009409,0,OMOP Exposome,Observation,Substance,Mineralocorticoid Receptor Antagonist,,2024-09-14,1,,,,,,,,,
GIS1009410,0,OMOP Exposome,Observation,Substance,Miotic,,2024-09-14,1,,,,,,,,,
2385-85-5,0,OMOP Exposome,Observation,Substance,Mirex,"Dechlorane plus; Dechlorane 515; Dechlorane 4070; Dechlorane Plus 515; Hexachloropentadiene dimer; Dechlorane; Paramex; Perchlordecone; Perchlorodihomocubane; Perchloropentacyclo(5.2.1.0(2,6).0(3,9).0(5,8))decane; Perchloropentacyclo(5.2.1.02,6.03,9.05,8)decane; Dodecachloropentacyclodecane; 1,3-Cyclopentadiene, 1,2,3,4,5,5-hexachloro-, dimer; Bichlorendo; Cyclopentadiene, 1,2,3,4,5,5-hexachloro-, dimer; CG-1283; Dechloran plus; Caswell No. 411; Dodecachloropentacyclo(5.2.1.02,6.03,9.05,8)decane; Dodecachloropentacyclo(5.2.1.0(2,6).0(3,9).0(5,8))decane; Cyclopentadiene, hexachloro-, dimer; 1, 3-Cyclopentadiene, 1,2,3,4,5,5-hexachloro-, dimer; Dodecachloropentacyclo(3.2.2.02,6,03,9,05,10)decane; Dodecaclor; Ferriamicide; Fire ant bait; 1,2,3,4,5,5,6,7,8,9,10,10-Dodecachloropentacyclo5.3.0.0(2,6).0(3,9).0(4,8)decane; Perchloropentacyclo(5.3.0.0(2,6).0(3,9).0(4,8))decane; Perchloropentacyclodecane; Dodecachlorooctahydro-1,3,4-metheno-2H-cyclobutacdpentalene; 1,2,3,4,5,5-Hexachloro-1,3-cyclopentadiene dimer; Hexachlorocyclopentadiene dimer; Perchloropentacyclo5.2.1.02,6.03,9.05,8decane; Perchloropentacyclo5.2.1.0(2,6).0(3,9).0(5,8)decane; CHEBI:34852",2014-12-24,1,,,,,,,,,
61337-67-5,0,OMOP Exposome,Observation,Substance,Mirtazapine,"Rexer; Mepirzapine; Mirtazapin; Mirtaz; Mirtabene; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine; Mepirzepine; Avanza; 6-Azamianserin; Zispin; Axit; Remeron SolTab; Remeron; Remergon; Remergil; Promyrtil; Norset; Mirtazon; Mirtazepine; Mirtazapinum; Mirtazapina; CHEBI:6950",2014-12-24,1,,,,,,,,,
GIS1009411,0,OMOP Exposome,Observation,Substance,Mismatch repair,,2024-09-14,1,,,,,,,,,
GIS1009412,0,OMOP Exposome,Observation,Substance,Mitochondria,,2024-09-14,1,,,,,,,,,
Q3SY69,0,OMOP Exposome,Observation,Substance,Mitochondrial 10-formyltetrahydrofolate dehydrogenase,,2024-09-14,1,,,,,,,,,
Q8N8R3,0,OMOP Exposome,Observation,Substance,Mitochondrial basic amino acids transporter,,2024-09-14,1,,,,,,,,,
GIS1009413,0,OMOP Exposome,Observation,Substance,Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,,2024-09-14,1,,,,,,,,,
GIS1009414,0,OMOP Exposome,Observation,Substance,Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,,2024-09-14,1,,,,,,,,,
GIS1009415,0,OMOP Exposome,Observation,Substance,Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,,2024-09-14,1,,,,,,,,,
O43772,0,OMOP Exposome,Observation,Substance,Mitochondrial carnitine/acylcarnitine carrier protein,,2024-09-14,1,,,,,,,,,
BE0000097,0,OMOP Exposome,Observation,Substance,Mitochondrial carnitine/acylcarnitine carrier protein CACL,,2024-09-14,1,,,,,,,,,
GIS1009416,0,OMOP Exposome,Observation,Substance,Mitochondrial complex II deficiency,,2024-09-14,1,,,,,,,,,
Q9UBX3,0,OMOP Exposome,Observation,Substance,Mitochondrial dicarboxylate carrier,,2024-09-14,1,,,,,,,,,
GIS1009417,0,OMOP Exposome,Observation,Substance,Mitochondrial Electron Transport Chain,,2024-09-14,1,,,,,,,,,
Q9H2D1,0,OMOP Exposome,Observation,Substance,Mitochondrial folate transporter/carrier,,2024-09-14,1,,,,,,,,,
Q9H936,0,OMOP Exposome,Observation,Substance,Mitochondrial glutamate carrier 1,,2024-09-14,1,,,,,,,,,
Q9H1K4,0,OMOP Exposome,Observation,Substance,Mitochondrial glutamate carrier 2,,2024-09-14,1,,,,,,,,,
GIS1009418,0,OMOP Exposome,Observation,Substance,Mitochondrial Intermembrane Space,,2024-09-14,1,,,,,,,,,
GIS1009419,0,OMOP Exposome,Observation,Substance,Mitochondrial Matrix,,2024-09-14,1,,,,,,,,,
GIS1009420,0,OMOP Exposome,Observation,Substance,Mitochondrial Membrane,,2024-09-14,1,,,,,,,,,
Q9Y619,0,OMOP Exposome,Observation,Substance,Mitochondrial ornithine transporter 1,,2024-09-14,1,,,,,,,,,
Q9BXI2,0,OMOP Exposome,Observation,Substance,Mitochondrial ornithine transporter 2,,2024-09-14,1,,,,,,,,,
GIS1009421,0,OMOP Exposome,Observation,Substance,Mitochondrion,,2024-09-14,1,,,,,,,,,
P28482,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 1,,2024-09-14,1,,,,,,,,,
P53779,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 10,,2024-09-14,1,,,,,,,,,
Q15759,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 11,,2024-09-14,1,,,,,,,,,
P53778,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 12,,2024-09-14,1,,,,,,,,,
O15264,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 13,,2024-09-14,1,,,,,,,,,
Q16539,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 14,,2024-09-14,1,,,,,,,,,
Q8TD08,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 15,,2024-09-14,1,,,,,,,,,
P27361,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 3,,2024-09-14,1,,,,,,,,,
P31152,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 4,,2024-09-14,1,,,,,,,,,
Q16659,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 6,,2024-09-14,1,,,,,,,,,
Q13164,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 7,,2024-09-14,1,,,,,,,,,
P45983,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 8,,2024-09-14,1,,,,,,,,,
P45984,0,OMOP Exposome,Observation,Substance,Mitogen-activated protein kinase 9,,2024-09-14,1,,,,,,,,,
50-07-7,0,OMOP Exposome,Observation,Substance,Mitomycin,Mitozytrex; Mutamycin; 7-Amino-9alpha-methoxymitosane; Mitamycin; Mitocin-C; MMC; Mitomycin C; 7-Amino-9\u03b1-methoxymitosane; Mitosol; Ametycine; CHEBI:27504,2014-12-24,1,,,,,,,,,
65271-80-9,0,OMOP Exposome,Observation,Substance,Mitoxantrone,"Mitoxantron; Mitoxanthrone; Novantrone; Mitoxantrona; Mitoxantronum; 1,4-DIHYDROXY-5,8-bis({2-(2-hydroxyethyl)aminoethyl}amino)-9,10-anthracenedione; CHEBI:50729",2014-12-24,1,,,,,,,,,
GIS1009422,0,OMOP Exposome,Observation,Substance,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),,2024-09-14,1,,,,,,,,,
1079-33-0,0,OMOP Exposome,Observation,Substance,Mobam,,2014-12-24,1,,,,,,,,,
71320-77-9,0,OMOP Exposome,Observation,Substance,Moclobemide,Moclobemida; Moclamine; Moclamide; Moclaime; Manerix; Aurorix; 4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide; 4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide; 4-Chlor-N-(2-morpholinoethyl)benzamid; Moclobemidum; p-Chloro-N-(2-morpholinoethyl)benzamide; Moclobemid; CHEBI:239099,2014-12-24,1,,,,,,,,,
68693-11-8,0,OMOP Exposome,Observation,Substance,Modafinil,Mentix; Modavigil; Modasomil; Modafinilo; Modiodal; Moderateafinil; Provake; Provigil; Resotyl; Sparlon; Stavigile; Vigicer; Forcilin; Aspendos; Alertex; Alertec; Zalux; Modafinilum; Vigil; CHEBI:417124,2014-12-24,1,,,,,,,,,
2212-67-1,0,OMOP Exposome,Observation,Substance,Molinate,,2014-12-24,1,,,,,,,,,
GIS1009423,0,OMOP Exposome,Observation,Substance,Molybdenium Cofactor Deficiency,,2024-09-14,1,,,,,,,,,
7439-98-7,0,OMOP Exposome,Observation,Substance,Molybdenum,Molybdenum atom; Molybdene; Molybdaen; Mo; Molybdenum elemental; Molybdenum insoluble compounds; Molybdenum metallic; CHEBI:28685,2014-12-24,1,,,,,,,,,
Q96EN8,0,OMOP Exposome,Observation,Substance,Molybdenum cofactor sulfurase,,2024-09-14,1,,,,,,,,,
71376-34-6,0,OMOP Exposome,Observation,Substance,Moniliformin,,2014-12-24,1,,,,,,,,,
2528-16-7,0,OMOP Exposome,Observation,Substance,Mono-benzyl phthalate,,2014-12-24,1,,,,,,,,,
3091-25-6,0,OMOP Exposome,Observation,Substance,Mono-n-octyltin trichloride,,2014-12-24,1,,,,,,,,,
2623-22-5,0,OMOP Exposome,Observation,Substance,Monoacetoxyscirpenol,,2014-12-24,1,,,,,,,,,
BE0004909,0,OMOP Exposome,Observation,Substance,Monoamine oxidase,,2024-09-14,1,,,,,,,,,
GIS1009425,0,OMOP Exposome,Observation,Substance,Monoamine Oxidase Inhibitor,,2024-09-14,1,,,,,,,,,
GIS1009424,0,OMOP Exposome,Observation,Substance,Monoamine oxidase-a deficiency (MAO-A),,2024-09-14,1,,,,,,,,,
131-70-4,0,OMOP Exposome,Observation,Substance,Monobutylphthalate,,2014-12-24,1,,,,,,,,,
78763-54-9,0,OMOP Exposome,Observation,Substance,Monobutyltin,Butyltin; CHEBI:22966,2014-12-24,1,,,,,,,,,
2406-65-7,0,OMOP Exposome,Observation,Substance,Monobutyltin hydride,,2014-12-24,1,,,,,,,,,
1118-46-3,0,OMOP Exposome,Observation,Substance,Monobutyltin trichloride,,2014-12-24,1,,,,,,,,,
P53985,0,OMOP Exposome,Observation,Substance,Monocarboxylate transporter 1,,2024-09-14,1,,,,,,,,,
O60669,0,OMOP Exposome,Observation,Substance,Monocarboxylate transporter 2,,2024-09-14,1,,,,,,,,,
O95907,0,OMOP Exposome,Observation,Substance,Monocarboxylate transporter 3,,2024-09-14,1,,,,,,,,,
O15427,0,OMOP Exposome,Observation,Substance,Monocarboxylate transporter 4,,2024-09-14,1,,,,,,,,,
O15374,0,OMOP Exposome,Observation,Substance,Monocarboxylate transporter 5,,2024-09-14,1,,,,,,,,,
O15375,0,OMOP Exposome,Observation,Substance,Monocarboxylate transporter 6,,2024-09-14,1,,,,,,,,,
O15403,0,OMOP Exposome,Observation,Substance,Monocarboxylate transporter 7,,2024-09-14,1,,,,,,,,,
P36021,0,OMOP Exposome,Observation,Substance,Monocarboxylate transporter 8,,2024-09-14,1,,,,,,,,,
2306-33-4,0,OMOP Exposome,Observation,Substance,Monoethyl phthalate,Monoethyl phthalic acid; 2-(Ethoxycarbonyl)benzoic acid; 2-(Ethoxycarbonyl)benzoate; CHEBI:70973,2014-12-24,1,,,,,,,,,
4376-20-9,0,OMOP Exposome,Observation,Substance,Monoethylhexyl phthalic acid,"MONOOCTYL PHTHALATE; Monoethylhexylphthalate; Monoethylhexyl phthalate (mEHP); Monoethylhexyl phthalate; Mono-ethylhexylphthalate; Mono-ethylhexyl; MONO-2-ETHYLHEXYL PHTHALATE; MEHP; 2-ETHYLHEXYL HYDROGEN PHTHALATE; 1,2-Benzenedicarboxylicacid,mono(2-ethylhexyl)ester; PHTHALICACIDMONOETHYLHEXYL; Phthalicacidmonoethylhexylester; PHTHALICACIDMONO-2-ETHYLEXYLESTER; Phthalicacid,2-ethylhexylester; PHTHALIC ACID MONOOCTYL ESTER; PHTHALIC ACID MONO-2-ETHYLHEXYL ESTER; Phthalic acid hydrogen 1-(2-ethylhexyl) ester; Phthalic acid 1-hydrogen 2-(2-ethylhexyl) ester; CHEBI:17243",2014-12-24,1,,,,,,,,,
Q99685,0,OMOP Exposome,Observation,Substance,Monoglyceride lipase,,2024-09-14,1,,,,,,,,,
30833-53-5,0,OMOP Exposome,Observation,Substance,Monoisobutyl phthalic acid,,2014-12-24,1,,,,,,,,,
4376-18-5,0,OMOP Exposome,Observation,Substance,Monomethyl phthalate,"O-(Methoxycarbonyl)benzoic acid; O-(Methoxycarbonyl)benzoate; Monomethyl phthalic acid; Monomethyl 1,2-benzenedicarboxylate; Methyl phthalate; Methyl hydrogen phthalate; 2-(Methoxycarbonyl)benzoic acid; 2-(Methoxycarbonyl)benzoate; CHEBI:491486",2014-12-24,1,,,,,,,,,
993-16-8,0,OMOP Exposome,Observation,Substance,Monomethyltin trichloride,,2014-12-24,1,,,,,,,,,
54849-38-6,0,OMOP Exposome,Observation,Substance,Monomethyltin tris(isooctyl mercaptoacetate),,2014-12-24,1,,,,,,,,,
57-27-2,0,OMOP Exposome,Observation,Substance,Morphine,"(\u2212)-morphine; Roxanol; Oramorph; MSIR; MS Contin; Morphium; Morphinum; Morphine Sulfate; Morphina; Morphin; Morphia; Morfina; Kapanol; Kadian; Duramorph; D-(-)-Morphine; Avinza; (7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano1benzofuro3,2-eisoquinoline-7,9-diol; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; (5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; (5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol; (-)-Morphine; CHEBI:17303",2014-12-24,1,,,,,,,,,
GIS1009437,0,OMOP Exposome,Observation,Substance,Most Tissues,,2024-09-14,1,,,,,,,,,
Q15797,0,OMOP Exposome,Observation,Substance,Mothers against decapentaplegic homolog 1,,2024-09-14,1,,,,,,,,,
GIS1009438,0,OMOP Exposome,Observation,Substance,"mouse_Abcb1a (Mdr, Pgp, Pgy, Mdr3, P-gp, Abcb4, Mdr1a)",,2024-09-14,1,,,,,,,,,
GIS1009439,0,OMOP Exposome,Observation,Substance,"mouse_Abcb1b (mdr, Mdr1, Pgy1, Abcb1, Mdr1b, Pgy-1)",,2024-09-14,1,,,,,,,,,
GIS1009440,0,OMOP Exposome,Observation,Substance,"mouse_Abcc2 (Mrp2, cMRP, Abc30)",,2024-09-14,1,,,,,,,,,
GIS1009441,0,OMOP Exposome,Observation,Substance,"mouse_Slco1a4 (Oat, Oatp2, Oatp1a4, Slc21a5)",,2024-09-14,1,,,,,,,,,
GIS1009442,0,OMOP Exposome,Observation,Substance,Mouth,,2024-09-14,1,,,,,,,,,
O60942,0,OMOP Exposome,Observation,Substance,mRNA-capping enzyme,,2024-09-14,1,,,,,,,,,
120500-28-9,0,OMOP Exposome,Observation,Substance,mu-Agatoxin,,2014-12-24,1,,,,,,,,,
GIS1009443,0,OMOP Exposome,Observation,Substance,mu-Conotoxin (Conus purpurascens),,2024-09-14,1,,,,,,,,,
P35372,0,OMOP Exposome,Observation,Substance,Mu-type opioid receptor,,2024-09-14,1,,,,,,,,,
Q96FL8,0,OMOP Exposome,Observation,Substance,Multidrug and toxin extrusion protein 1,,2024-09-14,1,,,,,,,,,
Q86VL8,0,OMOP Exposome,Observation,Substance,Multidrug and toxin extrusion protein 2,,2024-09-14,1,,,,,,,,,
P08183,0,OMOP Exposome,Observation,Substance,Multidrug resistance protein 1,,2024-09-14,1,,,,,,,,,
P33527,0,OMOP Exposome,Observation,Substance,Multidrug resistance-associated protein 1,,2024-09-14,1,,,,,,,,,
O95255,0,OMOP Exposome,Observation,Substance,Multidrug resistance-associated protein 6,,2024-09-14,1,,,,,,,,,
GIS1009464,0,OMOP Exposome,Observation,Substance,Multiple carboxylase deficiency,,2024-09-14,1,,,,,,,,,
BE0004890,0,OMOP Exposome,Observation,Substance,Muscarinic acetylcholine receptor,,2024-09-14,1,,,,,,,,,
P11229,0,OMOP Exposome,Observation,Substance,Muscarinic acetylcholine receptor M1,,2024-09-14,1,,,,,,,,,
P08172,0,OMOP Exposome,Observation,Substance,Muscarinic acetylcholine receptor M2,,2024-09-14,1,,,,,,,,,
P20309,0,OMOP Exposome,Observation,Substance,Muscarinic acetylcholine receptor M3,,2024-09-14,1,,,,,,,,,
P08173,0,OMOP Exposome,Observation,Substance,Muscarinic acetylcholine receptor M4,,2024-09-14,1,,,,,,,,,
P08912,0,OMOP Exposome,Observation,Substance,Muscarinic acetylcholine receptor M5,,2024-09-14,1,,,,,,,,,
GIS1009465,0,OMOP Exposome,Observation,Substance,Muscarinic Agonist,,2024-09-14,1,,,,,,,,,
GIS1009466,0,OMOP Exposome,Observation,Substance,Muscarinic Antagonist,,2024-09-14,1,,,,,,,,,
18174-72-6,0,OMOP Exposome,Observation,Substance,Muscimol,"Pantherine; Muscimol hydrobromide; Agarin hydrobromide; Agarin; 5-Aminomethyl-3-isoxyzole hydrobromide; 5-Aminomethyl-3-hydroxyisoxazole hydrobromide; 5-(Aminomethyl)-3-isoxazolol monohydrobromide; 5-(Aminomethyl)-3-isoxazolol hydrobromide; 5-(Aminomethyl)-3(2H)-isoxazolone hydrobromide; 5-(Aminomethyl)-3(2H)-isoxazolone; 3-Isoxazolol, 5-(aminomethyl)-, monohydrobromide (8CI); 3-Isoxazolol, 5-(aminomethyl)-, monohydrobromide; 3(2H)-Isoxazolone, 5-(aminomethyl)-, monohydrobromide; CHEBI:25520",2014-12-24,1,,,,,,,,,
GIS1009467,0,OMOP Exposome,Observation,Substance,Muscle,,2024-09-14,1,,,,,,,,,
GIS1009468,0,OMOP Exposome,Observation,Substance,Muscle Relaxant,,2024-09-14,1,,,,,,,,,
GIS1009469,0,OMOP Exposome,Observation,Substance,Mutagen,,2024-09-14,1,,,,,,,,,
88671-89-0,0,OMOP Exposome,Observation,Substance,Myclobutanil,"(+-)-Myclobutanil; 2-P-Chlorophenyl-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile; alpha-Butyl-alpha-(4-chlorophenyl)-1H-1,2,4-triazole-1-propanenitrile; CHEBI:75281",2014-12-24,1,,,,,,,,,
24280-93-1,0,OMOP Exposome,Observation,Substance,Mycophenolic acid,Melbex; Acide mycophenolique; Myfortic; Mycophenolsaeure; Acido micofenolico; Mycophenolate; Mycophenoic acid; Micofenolico acido; Acidum mycophenolicum; (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid; CHEBI:168396,2014-12-24,1,,,,,,,,,
GIS1009470,0,OMOP Exposome,Observation,Substance,Mycotoxin,,2024-09-14,1,,,,,,,,,
GIS1009471,0,OMOP Exposome,Observation,Substance,Mydriatic,,2024-09-14,1,,,,,,,,,
GIS1009481,0,OMOP Exposome,Observation,Substance,Myelin,,2024-09-14,1,,,,,,,,,
P02686,0,OMOP Exposome,Observation,Substance,Myelin basic protein,,2024-09-14,1,,,,,,,,,
P02689,0,OMOP Exposome,Observation,Substance,Myelin P2 protein,,2024-09-14,1,,,,,,,,,
GIS1009482,0,OMOP Exposome,Observation,Substance,Myeloablative Agonist,,2024-09-14,1,,,,,,,,,
P05164,0,OMOP Exposome,Observation,Substance,Myeloperoxidase,,2024-09-14,1,,,,,,,,,
GIS1009483,0,OMOP Exposome,Observation,Substance,Myocardium,,2024-09-14,1,,,,,,,,,
P02144,0,OMOP Exposome,Observation,Substance,Myoglobin,,2024-09-14,1,,,,,,,,,
132821-30-8,0,OMOP Exposome,Observation,Substance,Myotoxin (Crotalus viridis viridis),,2014-12-24,1,,,,,,,,,
544-63-8,0,OMOP Exposome,Observation,Substance,Myristic acid,N-Tetradecan-1-oate; Tetradecanoic (Myristic) acid; Myristoate; N-Tetradecanoate; Myristoic acid; Tetradecanoic acid; N-Tetradecan-1-oic acid; 1-Tridecanecarboxylate; 1-Tridecanecarboxylic acid; Crodacid; N-Tetradecanoic acid; Tetradecanoate; Myristic acid pure; Myristate; CHEBI:28875,2014-12-24,1,,,,,,,,,
607-91-0,0,OMOP Exposome,Observation,Substance,Myristicin,,2014-12-24,1,,,,,,,,,
16543-55-8,0,OMOP Exposome,Observation,Substance,N'-nitrosonornicotine,,2014-12-24,1,,,,,,,,,
P20933,0,OMOP Exposome,Observation,Substance,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase,,2024-09-14,1,,,,,,,,,
5746-04-3,0,OMOP Exposome,Observation,Substance,N(6)-Carboxymethyllysine,,2014-12-24,1,,,,,,,,,
O94760,0,OMOP Exposome,Observation,Substance,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",,2024-09-14,1,,,,,,,,,
O95865,0,OMOP Exposome,Observation,Substance,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2",,2024-09-14,1,,,,,,,,,
1968-12-02,0,OMOP Exposome,Observation,Substance,"N,N-Dimethylformamide","N,N-Dimethyl-Formamide; N-Formyldimethylamine; Dimethyl formamide; N,N- Dimethylformamide; Dimethyl-Formamide; Dimethylformamide; N,N- Dimethyl formamide; Formyldimethylamine; Dimethylforamide; CHEBI:17741",2014-12-24,1,,,,,,,,,
51078-49-0,0,OMOP Exposome,Observation,Substance,N-(2-Cyanoethyl)valine,,2014-12-24,1,,,,,,,,,
997-55-7,0,OMOP Exposome,Observation,Substance,N-Acetyl-L-aspartic acid,(S)-2-(acetylamino)succinic acid; (2S)-2-acetamidobutanedioate; (2S)-2-acetamidobutanedioic acid; (S)-2-(acetylamino)butanedioate; (S)-2-(acetylamino)butanedioic acid; Acetyl-L-aspartate; Acetyl-L-aspartic acid; Acetylaspartate; Acetylaspartic acid; L-N-Acetylaspartate; L-N-Acetylaspartic acid; N-Acetyl-L-aspartate; N-Acetyl-S-aspartate; N-Acetyl-S-aspartic acid; N-Acetylaspartate; N-Acetylaspartic acid; NAA; CHEBI:21547,2018-03-21,1,,,,,,,,,
Q8N159,0,OMOP Exposome,Observation,Substance,"N-acetylglutamate synthase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q96PD5,0,OMOP Exposome,Observation,Substance,N-acetylmuramoyl-L-alanine amidase,,2024-09-14,1,,,,,,,,,
Q14330,0,OMOP Exposome,Observation,Substance,N-arachidonyl glycine receptor,,2024-09-14,1,,,,,,,,,
128-08-5,0,OMOP Exposome,Observation,Substance,N-Bromosuccinimide,"Succinbromimide; Succinibromimide; Succinimide, N-bromo- (8CI); Bromosuccinimide; N-bromosuccimide; N-bromsuccinimide; N-bromsuccinimid; 1-Bromo-2,5-pyrrolidine-dione; 1-Bromo-2,5-pyrrolidinedione; 1-Bromopyrrolidine-2,5-dione; NBS; Succinbromide; CHEBI:53174",2014-12-24,1,,,,,,,,,
106-97-8,0,OMOP Exposome,Observation,Substance,n-Butane,A 21 (lowing agent); UNK; Sec-butyl group; SBU; R-600; R 600 (alkane); NBU; N-C4H10; N-butane; N-Butane; N-butan; Methylethylmethane; LPG; Liquefied petroleum gas; HC 600 (hydrocarbon); Freon 600; e943a; e-943a; e 943a; Diethyl; Butyl hydride; Butani; Butanes fuel for micro torch; Butanen; Butane pure; Butane (NF); Butane; BUT; Bu-gas; BNG; CHEBI:37808,2014-12-24,1,,,,,,,,,
111-36-4,0,OMOP Exposome,Observation,Substance,n-Butyl isocyanate,"1-Isocyanatobutane; 1-Butyl isocyanate; N-Butyl isocyanate; N-butyl isocyanate; n-C4H9NCO; Isocyanic acid, butyl ester; N-Butyl isocyanic acid; Isocyanic acid N-butyl ester; Butyl isocyanate; BIC; CHEBI:136519",2014-12-24,1,,,,,,,,,
3622-84-2,0,OMOP Exposome,Observation,Substance,N-Butyl-Benzenesulfonamide,,2014-12-24,1,,,,,,,,,
124-18-5,0,OMOP Exposome,Observation,Substance,N-Decane,Decane; CHEBI:32894,2014-12-24,1,,,,,,,,,
GIS1009511,0,OMOP Exposome,Observation,Substance,N-glycan biosynthesis,,2024-09-14,1,,,,,,,,,
142-82-5,0,OMOP Exposome,Observation,Substance,N-Heptane,Heptane; Dipropyl methane; Dipropylmethane; CHEBI:43098,2014-12-24,1,,,,,,,,,
621-64-7,0,OMOP Exposome,Observation,Substance,n-Nitrosodi-n-propylamine,,2014-12-24,1,,,,,,,,,
62-75-9,0,OMOP Exposome,Observation,Substance,N-Nitrosodimethylamine,"N-Methyl-N-nitroso-Methamine; Dimethyl-Nitrosamine; N-Dimethylnitrosoamine; Dimethylnitrosamin; Dimethylnitrosamine; Dimethylnitrosoamine; DMNA; N Nitrosodimethylamine; N, N-Dimethylnitrosamine; Nitrous dimethylamide; Nitrosodimethylamine; N-Nitroaodimethylamine; N-Methyl-N-nitrosomethanamine, 9CI; N-Methyl-N-nitrosomethanamine; N-Methyl-N-nitroso-Methanamine; NDMA; N,N-Dimethylnitrosamine; N-Dimethyl-nitrosamine; N-Nitroso-N,N-dimethylamine; N-Nitroso-Dimethylamine; 1,1-Dimethyl-2-oxohydrazine; NDMA nitrosodimethylamine; CHEBI:35807",2014-12-24,1,,,,,,,,,
119-07-3,0,OMOP Exposome,Observation,Substance,n-Octyl n-decyl phthalate,"Bis(2-ethylhexyl)phthalate; N-octyl-n-decyl phthalate; N-Octyl N-decyl phthalate; Octyl decyl phthalate; N-octyl n-decyl phthalate; N-Octyl N-decyl phthalic acid; Decyl Octyl 1,2-benzenedicarboxylate; Dioctyl phthalate; N-decyl n-octyl phthalate; CHEBI:17747",2014-12-24,1,,,,,,,,,
701-44-0,0,OMOP Exposome,Observation,Substance,N1-Methyl-2-pyridone-5-carboxamide,N'-Methyl-2-pyridone-5-carboxamide; N-Methyl-2-pyridone-5-carboxamide; 1-Methyl-5-carboxylamide-2-pyridone; N'Methyl-2-pyridone-5-carboxamide; N(1)-Methyl-2-pyridone-5-carboxamide; CHEBI:27410,2014-12-24,1,,,,,,,,,
769-49-3,0,OMOP Exposome,Observation,Substance,N1-Methyl-4-pyridone-3-carboxamide,N1-Methyl-4-pyridone-5-carboxamide; 1-Methyl-4-pyridone-3-carboxamide; 1-Methyl-4-pyridone-5-carboxamide; 3-(Aminocarbonyl)-1-methyl-4(1H)-pyridone; N'-Methyl-4-pyridone-5-carboxamide; 5-Aminocarbonyl-1-methyl-4(1H)-pyridone; CHEBI:27838,2014-12-24,1,,,,,,,,,
Q96P20,0,OMOP Exposome,Observation,Substance,"NACHT, LRR and PYD domains-containing protein 3",,2024-09-14,1,,,,,,,,,
P15559,0,OMOP Exposome,Observation,Substance,NAD(P)H dehydrogenase [quinone] 1,,2024-09-14,1,,,,,,,,,
Q96EB6,0,OMOP Exposome,Observation,Substance,NAD-dependent protein deacetylase sirtuin-1,,2024-09-14,1,,,,,,,,,
Q8IXJ6,0,OMOP Exposome,Observation,Substance,NAD-dependent protein deacetylase sirtuin-2,,2024-09-14,1,,,,,,,,,
Q9NTG7,0,OMOP Exposome,Observation,Substance,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9NXA8,0,OMOP Exposome,Observation,Substance,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",,2024-09-14,1,,,,,,,,,
P49821,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial",,2024-09-14,1,,,,,,,,,
P19404,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial",,2024-09-14,1,,,,,,,,,
P56181,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",,2024-09-14,1,,,,,,,,,
O75306,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",,2024-09-14,1,,,,,,,,,
O75489,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",,2024-09-14,1,,,,,,,,,
O43181,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial",,2024-09-14,1,,,,,,,,,
O43920,0,OMOP Exposome,Observation,Substance,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5,,2024-09-14,1,,,,,,,,,
O75380,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",,2024-09-14,1,,,,,,,,,
O75251,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",,2024-09-14,1,,,,,,,,,
O00217,0,OMOP Exposome,Observation,Substance,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial",,2024-09-14,1,,,,,,,,,
P28331,0,OMOP Exposome,Observation,Substance,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial",,2024-09-14,1,,,,,,,,,
P03886,0,OMOP Exposome,Observation,Substance,NADH-ubiquinone oxidoreductase chain 1,,2024-09-14,1,,,,,,,,,
P03891,0,OMOP Exposome,Observation,Substance,NADH-ubiquinone oxidoreductase chain 2,,2024-09-14,1,,,,,,,,,
P03897,0,OMOP Exposome,Observation,Substance,NADH-ubiquinone oxidoreductase chain 3,,2024-09-14,1,,,,,,,,,
P03905,0,OMOP Exposome,Observation,Substance,NADH-ubiquinone oxidoreductase chain 4,,2024-09-14,1,,,,,,,,,
P03901,0,OMOP Exposome,Observation,Substance,NADH-ubiquinone oxidoreductase chain 4L,,2024-09-14,1,,,,,,,,,
P03915,0,OMOP Exposome,Observation,Substance,NADH-ubiquinone oxidoreductase chain 5,,2024-09-14,1,,,,,,,,,
P03923,0,OMOP Exposome,Observation,Substance,NADH-ubiquinone oxidoreductase chain 6,,2024-09-14,1,,,,,,,,,
BE0004904,0,OMOP Exposome,Observation,Substance,NADPH oxidase,,2024-09-14,1,,,,,,,,,
Q9Y5S8,0,OMOP Exposome,Observation,Substance,NADPH oxidase 1,,2024-09-14,1,,,,,,,,,
Q9NPH5,0,OMOP Exposome,Observation,Substance,NADPH oxidase 4,,2024-09-14,1,,,,,,,,,
P16435,0,OMOP Exposome,Observation,Substance,NADPH--cytochrome P450 reductase,,2024-09-14,1,,,,,,,,,
76932-56-4,0,OMOP Exposome,Observation,Substance,Nafarelin,,2014-12-24,1,,,,,,,,,
31329-57-4,0,OMOP Exposome,Observation,Substance,Naftidrofuryl,,2014-12-24,1,,,,,,,,,
20594-83-6,0,OMOP Exposome,Observation,Substance,Nalbuphine,"Nalbufina; Nubain; Nalpain; Mexifen; Nalbuphinum; Nalbuphin; N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol; CHEBI:7454",2014-12-24,1,,,,,,,,,
16590-41-3,0,OMOP Exposome,Observation,Substance,Naltrexone,"Celupan; Naltax; Nalorex; Nalerona; N-Cyclopropylmethylnoroxymorphone; N-Cyclopropylmethyl-14-hydroxydihydromorphinone; MorViva; Dependex; Depade; Arrop; Antaxone; Antaxon; Adepend; Abernil; 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one; 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one; Naltrekson; Naltrexon; Naltrexona; Naltrexonum; Narcoral; Neksi; Nemexin; Opizone; PTI-555; Revez; Revia; Trexan; Vivitrex; Vivitrol; CHEBI:7465",2014-12-24,1,,,,,,,,,
2565-01-7,0,OMOP Exposome,Observation,Substance,Nantenine,,2014-12-24,1,,,,,,,,,
91-20-3,0,OMOP Exposome,Observation,Substance,Naphthalene,Tolboxane; Mothballs; Moth flakes; Moth balls; Camphor tar; Naphthene; Tar camphor; Albocarbon; White tar; Naphthaline; Naphthalin; Naphtalene; Naftalen; CHEBI:16482,2014-12-24,1,,,,,,,,,
GIS1009484,0,OMOP Exposome,Observation,Substance,Naphthalene Degradation,,2024-09-14,1,,,,,,,,,
15299-99-7,0,OMOP Exposome,Observation,Substance,Napropamide,,2014-12-24,1,,,,,,,,,
121679-13-8,0,OMOP Exposome,Observation,Substance,Naratriptan,N-Methyl-2-3-(1-methyl-4-piperidyl)-1H-indol-5-yl-ethanesulfonamide; Naramig; N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide; Naratriptanum; Amerge; CHEBI:7478,2014-12-24,1,,,,,,,,,
GIS1009485,0,OMOP Exposome,Observation,Substance,Narcotic,,2024-09-14,1,,,,,,,,,
GIS1009486,0,OMOP Exposome,Observation,Substance,Narcotic Antagonist,,2024-09-14,1,,,,,,,,,
GIS1009487,0,OMOP Exposome,Observation,Substance,Nasal Passages,,2024-09-14,1,,,,,,,,,
GIS1009488,0,OMOP Exposome,Observation,Substance,Natural Compound,,2024-09-14,1,,,,,,,,,
Q13564,0,OMOP Exposome,Observation,Substance,NEDD8-activating enzyme E1 regulatory subunit,,2024-09-14,1,,,,,,,,,
83366-66-9,0,OMOP Exposome,Observation,Substance,Nefazodone,"Nefazodonum; Dutonin; Serzone; Nefazodona; 1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one; CHEBI:7494",2014-12-24,1,,,,,,,,,
GIS1009489,0,OMOP Exposome,Observation,Substance,Nematicide,,2024-09-14,1,,,,,,,,,
1404-04-2,0,OMOP Exposome,Observation,Substance,Neomycin,Neo-Rx; Caswell No. 595; Myacyne; Mycifradin; Myciguent; Neo-Fradin; Neobiotic; Neomycin B Sulfate; Neomycin Sulfate; Neomycin Sulphate; Nivemycin; USAF CB-19; CHEBI:7507,2014-12-24,1,,,,,,,,,
GIS1009490,0,OMOP Exposome,Observation,Substance,Neomycin Pathway,,2024-09-14,1,,,,,,,,,
GIS1009491,0,OMOP Exposome,Observation,Substance,Neonicotinoid,,2024-09-14,1,,,,,,,,,
463-82-1,0,OMOP Exposome,Observation,Substance,Neopentane,"Tetramethylmethane; 2,2-Dimethylpropane; Dimethylpropane; Tert-pentane; Tetramethylcarbon; (CH3)4C; 1,1,1-Trimethylethane; CHEBI:30358",2014-12-24,1,,,,,,,,,
2009-64-5,0,OMOP Exposome,Observation,Substance,Neopterin,,2014-12-24,1,,,,,,,,,
64296-20-4,0,OMOP Exposome,Observation,Substance,Neosaxitoxin,,2014-12-24,1,,,,,,,,,
36519-25-2,0,OMOP Exposome,Observation,Substance,Neosolaniol,,2014-12-24,1,,,,,,,,,
GIS1009492,0,OMOP Exposome,Observation,Substance,Neoverrucotoxin,,2024-09-14,1,,,,,,,,,
13994-20-2,0,OMOP Exposome,Observation,Substance,Neptunium-237,,2014-12-24,1,,,,,,,,,
7212-44-4,0,OMOP Exposome,Observation,Substance,Nerolidol,"3-Hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene; (+/-)-Nerolidol; 3,7,11-Trimethyl-1,6,10-Dodecatrien-3-ol; Humbertiol?; Melaleucol; Peruviol; Stirrup; CHEBI:7524",2014-12-24,1,,,,,,,,,
GIS1009499,0,OMOP Exposome,Observation,Substance,Nerve Cells,,2024-09-14,1,,,,,,,,,
GIS1009500,0,OMOP Exposome,Observation,Substance,Nerve Fiber,,2024-09-14,1,,,,,,,,,
GIS1009501,0,OMOP Exposome,Observation,Substance,Nerve Synapse,,2024-09-14,1,,,,,,,,,
GIS1009502,0,OMOP Exposome,Observation,Substance,Nervous Tissues,,2024-09-14,1,,,,,,,,,
Q9ULB1,0,OMOP Exposome,Observation,Substance,Neurexin-1,,2024-09-14,1,,,,,,,,,
P58400,0,OMOP Exposome,Observation,Substance,Neurexin-1-beta,,2024-09-14,1,,,,,,,,,
Q9P2S2,0,OMOP Exposome,Observation,Substance,Neurexin-2,,2024-09-14,1,,,,,,,,,
P58401,0,OMOP Exposome,Observation,Substance,Neurexin-2-beta,,2024-09-14,1,,,,,,,,,
Q9Y4C0,0,OMOP Exposome,Observation,Substance,Neurexin-3,,2024-09-14,1,,,,,,,,,
Q9HDB5,0,OMOP Exposome,Observation,Substance,Neurexin-3-beta,,2024-09-14,1,,,,,,,,,
O14594,0,OMOP Exposome,Observation,Substance,Neurocan core protein,,2024-09-14,1,,,,,,,,,
P29120,0,OMOP Exposome,Observation,Substance,Neuroendocrine convertase 1,,2024-09-14,1,,,,,,,,,
P16519,0,OMOP Exposome,Observation,Substance,Neuroendocrine convertase 2,,2024-09-14,1,,,,,,,,,
P12036,0,OMOP Exposome,Observation,Substance,Neurofilament heavy polypeptide,,2024-09-14,1,,,,,,,,,
P07196,0,OMOP Exposome,Observation,Substance,Neurofilament light polypeptide,,2024-09-14,1,,,,,,,,,
P07197,0,OMOP Exposome,Observation,Substance,Neurofilament medium polypeptide,,2024-09-14,1,,,,,,,,,
P29371,0,OMOP Exposome,Observation,Substance,Neuromedin-K receptor,,2024-09-14,1,,,,,,,,,
GIS1009503,0,OMOP Exposome,Observation,Substance,Neuromuscular Agent,,2024-09-14,1,,,,,,,,,
GIS1009504,0,OMOP Exposome,Observation,Substance,Neuromuscular Blocking Agent,,2024-09-14,1,,,,,,,,,
GIS1009505,0,OMOP Exposome,Observation,Substance,Neuromuscular Nondepolarizing Agent,,2024-09-14,1,,,,,,,,,
GIS1009506,0,OMOP Exposome,Observation,Substance,Neuron,,2024-09-14,1,,,,,,,,,
Q9NYX4,0,OMOP Exposome,Observation,Substance,Neuron-specific vesicular protein calcyon,,2024-09-14,1,,,,,,,,,
Q9GZZ6,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit alpha-10,,2024-09-14,1,,,,,,,,,
Q15822,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit alpha-2,,2024-09-14,1,,,,,,,,,
P32297,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit alpha-3,,2024-09-14,1,,,,,,,,,
P43681,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit alpha-4,,2024-09-14,1,,,,,,,,,
P30532,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit alpha-5,,2024-09-14,1,,,,,,,,,
Q15825,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit alpha-6,,2024-09-14,1,,,,,,,,,
P36544,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit alpha-7,,2024-09-14,1,,,,,,,,,
Q9UGM1,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit alpha-9,,2024-09-14,1,,,,,,,,,
P17787,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit beta-2,,2024-09-14,1,,,,,,,,,
Q05901,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit beta-3,,2024-09-14,1,,,,,,,,,
P30926,0,OMOP Exposome,Observation,Substance,Neuronal acetylcholine receptor subunit beta-4,,2024-09-14,1,,,,,,,,,
Q8IY17,0,OMOP Exposome,Observation,Substance,Neuropathy target esterase,,2024-09-14,1,,,,,,,,,
Q6W5P4,0,OMOP Exposome,Observation,Substance,Neuropeptide S receptor,,2024-09-14,1,,,,,,,,,
P25929,0,OMOP Exposome,Observation,Substance,Neuropeptide Y receptor type 1,,2024-09-14,1,,,,,,,,,
P49146,0,OMOP Exposome,Observation,Substance,Neuropeptide Y receptor type 2,,2024-09-14,1,,,,,,,,,
Q15761,0,OMOP Exposome,Observation,Substance,Neuropeptide Y receptor type 5,,2024-09-14,1,,,,,,,,,
GIS1009507,0,OMOP Exposome,Observation,Substance,Neuroprotective Agent,,2024-09-14,1,,,,,,,,,
P30989,0,OMOP Exposome,Observation,Substance,Neurotensin receptor type 1,,2024-09-14,1,,,,,,,,,
GIS1009508,0,OMOP Exposome,Observation,Substance,Neurotransmitter Uptake Inhibitor,,2024-09-14,1,,,,,,,,,
P43007,0,OMOP Exposome,Observation,Substance,Neutral amino acid transporter A,,2024-09-14,1,,,,,,,,,
Q15758,0,OMOP Exposome,Observation,Substance,Neutral amino acid transporter B(0),,2024-09-14,1,,,,,,,,,
GIS1009509,0,OMOP Exposome,Observation,Substance,Neutrophil,,2024-09-14,1,,,,,,,,,
P22894,0,OMOP Exposome,Observation,Substance,Neutrophil collagenase,,2024-09-14,1,,,,,,,,,
P14598,0,OMOP Exposome,Observation,Substance,Neutrophil cytosol factor 1,,2024-09-14,1,,,,,,,,,
P19878,0,OMOP Exposome,Observation,Substance,Neutrophil cytosol factor 2,,2024-09-14,1,,,,,,,,,
Q15080,0,OMOP Exposome,Observation,Substance,Neutrophil cytosol factor 4,,2024-09-14,1,,,,,,,,,
P08246,0,OMOP Exposome,Observation,Substance,Neutrophil elastase,,2024-09-14,1,,,,,,,,,
GIS1009510,0,OMOP Exposome,Observation,Substance,Nf-kappa b signaling pathway,,2024-09-14,1,,,,,,,,,
Q9Y6K9,0,OMOP Exposome,Observation,Substance,NF-kappa-B essential modulator,,2024-09-14,1,,,,,,,,,
P25963,0,OMOP Exposome,Observation,Substance,NF-kappa-B inhibitor alpha,,2024-09-14,1,,,,,,,,,
98-92-0,0,OMOP Exposome,Observation,Substance,Niacinamide,Nandervit-N; Niacevit; Niamide; Niavit PP; Nicamide; Nicamina; Nicamindon; Nicasir; Nicobion; Nicofort; Nicogen; Nicomidol; Nicosan 2; Nicosylamide; Nicota; Nicotamide; Nicotilamide; Nicotililamido; Nicotinamida; Nicotinamide; Nicotine acid amide; Nicovitol; Nicovitina; 3-Carbamoylpyridine; 3-Pyridinecarboxamide; 3-Pyridinecarboxylic acid amide; Acid amide; Amid kyseliny nikotinove; Amide PP; Witamina PP; Vitamin PP; Vitamin B3; Vi-noctyl; Vi-Nicotyl; Savacotyl; Pyridine-3-carboxylic acid amide; Aminicotin; Amixicotyn; Amnicotin; Austrovit PP; b-Pyridinecarboxamide; Benicot; beta-Pyridinecarboxamide; Delonin Amide; Dipegyl; Dipigyl; Endobion; Factor pp; Hansamid; Inovitan PP; m-(Aminocarbonyl)pyridine; Mediatric; NAM; Nicotinamidum; Nicotine amide; Nicotinic acid amide; Nicotinic amide; Nicotinsaureamid; Nicotol; Nicotylamide; Nicotylamidum; Nicovel; Nicovit; Propamine A; PP-Faktor; Pelonin amide; Pelmine; Pelmin; Papulex; Niozymin; Niocinamide; Nikotinsaeureamid; Nikotinamid; Niko-tamin; Nictoamide; Nicozymin; CHEBI:17154,2014-12-24,1,,,,,,,,,
7440-02-0,0,OMOP Exposome,Observation,Substance,Nickel,Nickel(II) cation; Nickel(II); Nickel ion; Ni(2+); Nickel(2+) ion; Ni2+; Nickel(2+); Metallic Nickel; Nickel(II) ion; CHEBI:49786,2014-12-24,1,,,,,,,,,
373-02-4,0,OMOP Exposome,Observation,Substance,Nickel acetate,,2014-12-24,1,,,,,,,,,
12003-78-0,0,OMOP Exposome,Observation,Substance,Nickel aluminide,,2014-12-24,1,,,,,,,,,
15699-18-0,0,OMOP Exposome,Observation,Substance,Nickel ammonium sulfate hexahydrate,,2014-12-24,1,,,,,,,,,
13477-70-8,0,OMOP Exposome,Observation,Substance,Nickel arsenate,,2014-12-24,1,,,,,,,,,
13927-77-0,0,OMOP Exposome,Observation,Substance,Nickel bis(dibutyldithiocarbamate),,2014-12-24,1,,,,,,,,,
13462-88-9,0,OMOP Exposome,Observation,Substance,Nickel bromide,,2014-12-24,1,,,,,,,,,
3333-67-3,0,OMOP Exposome,Observation,Substance,Nickel carbonate,,2014-12-24,1,,,,,,,,,
7718-54-9,0,OMOP Exposome,Observation,Substance,Nickel chloride,Nickel(2+) chloride; Nickel(II) chloride; Nickelous chloride; NiCl2; NiCl2; Dichloronickel; Hexahydrate; Ni(II) chloride; Nichel(II) chloride; Nickel (II) chloride; Nickel dichloride; CHEBI:34887,2014-12-24,1,,,,,,,,,
14721-18-7,0,OMOP Exposome,Observation,Substance,Nickel chromate,,2014-12-24,1,,,,,,,,,
GIS1009512,0,OMOP Exposome,Observation,Substance,Nickel Compound,,2024-09-14,1,,,,,,,,,
557-19-7,0,OMOP Exposome,Observation,Substance,Nickel cyanide,,2014-12-24,1,,,,,,,,,
10028-18-9,0,OMOP Exposome,Observation,Substance,Nickel fluoride,,2014-12-24,1,,,,,,,,,
15843-02-4,0,OMOP Exposome,Observation,Substance,Nickel formate,,2014-12-24,1,,,,,,,,,
12054-48-7,0,OMOP Exposome,Observation,Substance,Nickel hydroxide,,2014-12-24,1,,,,,,,,,
13462-90-3,0,OMOP Exposome,Observation,Substance,Nickel iodide,,2014-12-24,1,,,,,,,,,
13138-45-9,0,OMOP Exposome,Observation,Substance,Nickel nitrate,,2014-12-24,1,,,,,,,,,
1313-99-1,0,OMOP Exposome,Observation,Substance,Nickel oxide,,2014-12-24,1,,,,,,,,,
14396-43-1,0,OMOP Exposome,Observation,Substance,Nickel phosphate,,2014-12-24,1,,,,,,,,,
14220-17-8,0,OMOP Exposome,Observation,Substance,Nickel potassium cyanide,"Potassium tetracyanonickelate; Nickelate, tetracyano-, dipotassium; potassium tetracyanidonickelate(2-); Dipotassium nickel tetracyanide; Potassium tetracyanonickelate(II); Dipotassium tetracyanonickelate; Dipotassium tetracyanoniccolate; Dipotassium tetracyanidonickelate; Potassium tetracyanidonickelate(II); Nickelate(2-), tetracyano-, dipotassium; potassium tetracyanonickelate(2-); CHEBI:30071",2014-12-24,1,,,,,,,,,
12035-72-2,0,OMOP Exposome,Observation,Substance,Nickel subsulfide,,2014-12-24,1,,,,,,,,,
13770-89-3,0,OMOP Exposome,Observation,Substance,Nickel sulfamate,,2014-12-24,1,,,,,,,,,
7786-81-4,0,OMOP Exposome,Observation,Substance,Nickel sulfate,Nickel refinery dust; NiSO4; Nickelous sulfate hexahydrate; Nickelous sulfate; Nickel(II)sulfate hexahydrate; Nickel(II) sulfate hexahydrate (1:1:6); Nickel(II) sulfate hexahydrate; Nickel(II) sulfate hexa-/ heptahydrate; Nickel(II) sulfate (1:1); Nickel(2+)sulfate(1:1); Nickel(2+) sulfate hexahydrate; Nickel(2+) sulfate (1:1); Nickel(2+) sulfate; Nickel sulphic acid; Nickel sulphate hexahydrate; Nickel sulphate; Nickel sulfic acid; Nickel sulfate(1:1); Nickel sulfate hexahydrate; Nickel sulfate (1:1); Nickel monosulfate hexahydrate; Nickel (II) sulfate hexahydrate; Blue salt; CHEBI:53001,2014-12-24,1,,,,,,,,,
11113-75-0,0,OMOP Exposome,Observation,Substance,Nickel sulfide,,2014-12-24,1,,,,,,,,,
13463-39-3,0,OMOP Exposome,Observation,Substance,Nickel tetracarbonyl,Tetracarbonyl nickel; Nickle carbonyl; Nickel carbonyl; Nichel tetracarbonile; Ni(CO)4; (T-4)-Nickel carbonyl; Ni(CO)4; Tetracarbonylnickel; CHEBI:30372,2014-12-24,1,,,,,,,,,
1314-06-3,0,OMOP Exposome,Observation,Substance,Nickel trioxide,,2014-12-24,1,,,,,,,,,
1271-28-9,0,OMOP Exposome,Observation,Substance,Nickelocene,"Nickel, compd with pi-cyclopentadienyl (1:2); Nickel bis(cyclopentadiene); Dicyclopentadienylnickel; Di-pi-cyclopentadienylnickel; Bis(eta5-2,4-cyclopentadien-1-yl)nickel; Bis(eta(5)-2,4-cyclopentadien-1-yl)nickel; Bis(cyclopentadienyl)nickel; Nikelocen; Pi-cyclopentadienyl compd. with nickel; Ni(eta(5)-C5H5)2; Nickel biscyclopentadiene; Nickelocen; CHEBI:30679",2014-12-24,1,,,,,,,,,
50-65-7,0,OMOP Exposome,Observation,Substance,Niclosamide,Niclocide; CHEBI:478218,2014-12-24,1,,,,,,,,,
P40261,0,OMOP Exposome,Observation,Substance,Nicotinamide N-methyltransferase,,2024-09-14,1,,,,,,,,,
GIS1009513,0,OMOP Exposome,Observation,Substance,Nicotinate and Nicotinamide Metabolism,,2024-09-14,1,,,,,,,,,
Q15274,0,OMOP Exposome,Observation,Substance,Nicotinate-nucleotide pyrophosphorylase [carboxylating],,2024-09-14,1,,,,,,,,,
54-11-5,0,OMOP Exposome,Observation,Substance,Nicotine,"Nicotine Alkaloid; Nicotrol; Nikotin; (R,S)-nicotine; (+-)-Nicotine; (+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine; Habitrol; Nicoderm; L-Nicotine; (RS)-nicotine; (\u00b1)-Nicotine; Nicoderm CQ; Nicorette; Nicotin; CHEBI:18723",2014-12-24,1,,,,,,,,,
GIS1009514,0,OMOP Exposome,Observation,Substance,Nicotine addiction,,2024-09-14,1,,,,,,,,,
59-67-6,0,OMOP Exposome,Observation,Substance,Nicotinic acid,Nicangin; \u03b2-pyridinecarboxylic acid; Wampocap; Vitamin B3; Slo-niacin; pyridine-\u03b2-carboxylic acid; Pyridine-beta-carboxylic acid; PP Factor; Pelonin; Pellagrin; Pellagra preventive factor; P.P. factor; Nyclin; Nikotinsaeure; Nicyl; Nicotinipca; Nicotinate; Nicosan 3; Niconacid; Nicolar; Nicodelmine; Nicocap; Nicobid; Nico-Span; 3-Carboxylpyridine; 3-Carboxypyridine; 3-Pyridinecarboxylate; 3-Pyridinecarboxylic acid; 3-Pyridylcarboxylate; 3-Pyridylcarboxylic acid; Acide Nicotinique; Acido nicotinico; Acidum Nicotinicum; Akotin; Anti-pellagra vitamin; Apelagrin; beta-Pyridinecarboxylic acid; Daskil; Efacin; Nicamin; Nicacid; Niaspan; Niacor; Niacine; Niacin; Niac; m-Pyridinecarboxylic acid; Linic; Enduracin; CHEBI:15940,2014-12-24,1,,,,,,,,,
GIS1009515,0,OMOP Exposome,Observation,Substance,Nicotinic Agonist,,2024-09-14,1,,,,,,,,,
GIS1009516,0,OMOP Exposome,Observation,Substance,Nicotinic Antagonist,,2024-09-14,1,,,,,,,,,
9001-84-7,0,OMOP Exposome,Observation,Substance,Nigroxin,,2014-12-24,1,,,,,,,,,
63612-50-0,0,OMOP Exposome,Observation,Substance,Nilutamide,"Anandron; 5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin; Nilutamidum; Nilutamida; Nilandron; CHEBI:7573",2014-12-24,1,,,,,,,,,
2011-67-8,0,OMOP Exposome,Observation,Substance,Nimetazepam,"1,3-dihydro-1-Methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; Nimetazepamum; Methylnitrazepam; Erimin; Dormalon; Ro 5-3453; 1-Methylnitrazepam; 1-Methyl-7-nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 1-Methyl-5-phenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one; CHEBI:31912",2014-12-24,1,,,,,,,,,
12035-04-0,0,OMOP Exposome,Observation,Substance,Niobium tin,,2014-12-24,1,,,,,,,,,
13748-45-0,0,OMOP Exposome,Observation,Substance,Niobium(V) bromide,,2014-12-24,1,,,,,,,,,
Q9Y2I1,0,OMOP Exposome,Observation,Substance,Nischarin,,2024-09-14,1,,,,,,,,,
98-72-6,0,OMOP Exposome,Observation,Substance,Nitarsone,"Histostat-50; Arsonic acid, 4-nitrophenyl; 4-Nitrophenylarsonic acid; 4-Nitrobenzenearsonic acid; Histostat 50; Histostat; (4-Nitrophenyl)-arsonic acid; 4-(Hydroxy(oxido)amino)phenylarsonic acid; (p-nitrophenyl)arsonic acid; Hep-A-Stat; Nitarson; p-Nitrobenzenearsonic acid; C6H6AsNO5; p-Nitro-Benzenearsonic acid; p-Nitrophenylarsonic acid; CHEBI:62629",2014-12-24,1,,,,,,,,,
1929-82-4,0,OMOP Exposome,Observation,Substance,Nitrapyrin,,2014-12-24,1,,,,,,,,,
14797-55-8,0,OMOP Exposome,Observation,Substance,Nitrate,Nitrate(1-); Trioxonitrate(1-); Trioxonitrate; Trioxidonitrate(1-); Trioxidonitrate; Nitric acid; Nitrate ion; CHEBI:17632,2014-12-24,1,,,,,,,,,
146-22-5,0,OMOP Exposome,Observation,Substance,Nitrazepam,"2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-on; 2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one; 7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one; 7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one; Nitrados; 1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; Paxadorm; Neozepam; Pacisyn; Ormodon; Nitrosun; Nitrazepamum; Nitrazadon; Neuchlonic; Alodorm; Apodorm; Arem; Atempol; Benzalin; Calsmin; Eatan; Eunoctin; Gerson; Hipnax; Hipsal; Ibrovek; Imeson; Imesont; Insoma; Mogadon; N-Desmethylnimetazepam; Unisomnia; Trazenin; Surem; Sonnolin; Sonebon; Somnite; Nelbon; Nelmat; Somitran; Ro 5-3059; Ro 4-5360; Remnos; Relact; Radedorm; Persopit; Pelson; Paxisyn; CHEBI:111745",2014-12-24,1,,,,,,,,,
7697-37-2,0,OMOP Exposome,Observation,Substance,Nitric acid,Red fuming nitric acid; Nitrous fumes; Nitricum acidum; Nitric acid standard solution; Hydroxidodioxidonitrogen; Kyselina dusicne; Nital; Nitraline; Hydrogen nitrate; hydrogen trioxonitrate(1-); Nitric acid red fuming; Nitric acid fuming; Nitric acid anhydrous; Nitric acid (red fuming); Nitrate; Acide azotique; Acide nitrique; Acido nitrico; Acidum nitricum; Acidum Nitricum-Injeel Forte Liq (D6-D200); Aqua fortis; Azotic acid; Azotowy kwas; Dynamite acid; Engraver's acid; Engravers acid; Fuming nitric acid; HNO3; HONO2; Salpetersaeure; Salpetersaure; Salpeterzuuroplossingen; Trioxonitric acid; NO2(OH); RFNA; Nitryl hydroxide; CHEBI:48107,2014-12-24,1,,,,,,,,,
P29475,0,OMOP Exposome,Observation,Substance,"Nitric oxide synthase, brain",,2024-09-14,1,,,,,,,,,
P29474,0,OMOP Exposome,Observation,Substance,"Nitric oxide synthase, endothelial",,2024-09-14,1,,,,,,,,,
P35228,0,OMOP Exposome,Observation,Substance,"Nitric oxide synthase, inducible",,2024-09-14,1,,,,,,,,,
29672-19-3,0,OMOP Exposome,Observation,Substance,Nitrilacarb,,2014-12-24,1,,,,,,,,,
GIS1009517,0,OMOP Exposome,Observation,Substance,Nitrile,,2024-09-14,1,,,,,,,,,
139-13-9,0,OMOP Exposome,Observation,Substance,Nitrilotriacetic Acid,,2014-12-24,1,,,,,,,,,
14797-65-0,0,OMOP Exposome,Observation,Substance,Nitrite,Nitrogen peroxide ion; Nitrogen dioxide ion; Nitrite anion; Nitrite ion; Nitrogen dioxide; CHEBI:16301,2014-12-24,1,,,,,,,,,
27861-40-1,0,OMOP Exposome,Observation,Substance,Nitro-methylene-cyclopentane,,2014-12-24,1,,,,,,,,,
98-95-3,0,OMOP Exposome,Observation,Substance,Nitrobenzene,"Oil of Mirbane; Nitrobenzol; Nitrobenzen; Nitrobenzeen; Niphen; p-Nitrophenol; Essence of Mirbane; Oil of Myrbane; Nitrobenzol, liquid(DOT); 4-Hydroxynitrobenzene; Mirbane oil; Nitro-Benzene; Hydroxy(phenyl)azane oxide; Rcra waste number U169; Pnp, p-nitrophenol; Essence of Myrbane; PNP; CHEBI:27798",2014-12-24,1,,,,,,,,,
59-87-0,0,OMOP Exposome,Observation,Substance,Nitrofural,Furacilin; Nitrofurazone; Nitrofurazan; NFZ; Furaderm; Furacin; 5-Nitro-2-furaldehyde semicarbazone; CHEBI:170239,2014-12-24,1,,,,,,,,,
67-20-9,0,OMOP Exposome,Observation,Substance,Nitrofurantoin,5-Nitrofurantoin; Furabid; N-(5-Nitrofurfurylidene)-1-aminohydantoin; Niftran; Siraliden; Macrodantin; Furadantin; Macrobid; Urolong; Urantoin; CHEBI:1039679,2014-12-24,1,,,,,,,,,
GIS1009518,0,OMOP Exposome,Observation,Substance,Nitrogen Metabolism,,2024-09-14,1,,,,,,,,,
15162-90-0,0,OMOP Exposome,Observation,Substance,Nitrogen tribromide,,2014-12-24,1,,,,,,,,,
GIS1009519,0,OMOP Exposome,Observation,Substance,Nitromethylene,,2024-09-14,1,,,,,,,,,
27861-39-8,0,OMOP Exposome,Observation,Substance,Nitromethylidenecyclohexane,,2014-12-24,1,,,,,,,,,
17856-92-7,0,OMOP Exposome,Observation,Substance,Nitronium hexafluoroantimonate(V),,2014-12-24,1,,,,,,,,,
16941-06-3,0,OMOP Exposome,Observation,Substance,Nitrosonium (nitrosyl) hexafluoroantimonate,,2014-12-24,1,,,,,,,,,
7782-77-6,0,OMOP Exposome,Observation,Substance,Nitrous acid,HNO2; Dioxonitric acid; hydrogen dioxonitrate(1-); Hydroxidooxidonitrogen; Hyponitrite; Hyponitrous acid; Kyselina dusite; Nitrosyl hydroxide; Nitrous acid trans; NO(OH); CHEBI:25567,2014-12-24,1,,,,,,,,,
23282-20-4,0,OMOP Exposome,Observation,Substance,Nivalenol,,2014-12-24,1,,,,,,,,,
BE0004956,0,OMOP Exposome,Observation,Substance,NMDA receptor,,2024-09-14,1,,,,,,,,,
GIS1009520,0,OMOP Exposome,Observation,Substance,Nobel Gas,,2024-09-14,1,,,,,,,,,
P41146,0,OMOP Exposome,Observation,Substance,Nociceptin receptor,,2024-09-14,1,,,,,,,,,
118399-22-7,0,OMOP Exposome,Observation,Substance,Nodularin-R,,2014-12-24,1,,,,,,,,,
GIS1009523,0,OMOP Exposome,Observation,Substance,Non Ketotic Hyperglycinemia,,2024-09-14,1,,,,,,,,,
GIS1009521,0,OMOP Exposome,Observation,Substance,Non-Essential Amino Acid,,2024-09-14,1,,,,,,,,,
GIS1009522,0,OMOP Exposome,Observation,Substance,Non-homologous end-joining,,2024-09-14,1,,,,,,,,,
GIS1009524,0,OMOP Exposome,Observation,Substance,Non-Metal,,2024-09-14,1,,,,,,,,,
63936-56-1,0,OMOP Exposome,Observation,Substance,Nonabromobiphenyl Ether,,2014-12-24,1,,,,,,,,,
124-19-6,0,OMOP Exposome,Observation,Substance,Nonanal,,2014-12-24,1,,,,,,,,,
GIS1009525,0,OMOP Exposome,Observation,Substance,Nootropic Agent,,2024-09-14,1,,,,,,,,,
1088-11-5,0,OMOP Exposome,Observation,Substance,Nordiazepam,"Dealkylprazepam; Desmethyldiazepam; 1-Demethyldiazepam; 7-Chloro-1,3-dihydro-5-phenyl-(2H)-1,4-benzodiazepin-2-one; 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one; 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; Chlordesmethyldiazepam; Norprazepam; Nordazepamum; Nordazepam; N-Demethyldiazepam; N-Deoxydemoxepam; N-desmethyldiazepam; N1-Desmethyldiazepam; CHEBI:111762",2014-12-24,1,,,,,,,,,
51-41-2,0,OMOP Exposome,Observation,Substance,Norepinephrine,"L-Arterenol; L-3,4-Dihydroxyphenylethanolamine; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; Arterenol; (R)-Norepinephrine; 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; Aktamin; Adrenor; 4-(1R)-2-Amino-1-hydroxyethyl-1,2-benzenediol; Noradrenaline; Noradrenalin; Nor-Epirenan; Levophed; Levonorepinephrine; Levonoradrenaline; Levonor; Levoarterenol; Levarterenol; (-)-(R)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (-)-Arterenol; (-)-Noradrenaline; (-)-Norepinephrine; (R)-(-)-Norepinephrine; Sympathin E; Norepirenamine; Norepinephrinum; Norepinefrina; Norartrinal; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; L-Norepinephrine; L-Noradrenaline; L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol; CHEBI:18357",2014-12-24,1,,,,,,,,,
GIS1009526,0,OMOP Exposome,Observation,Substance,Norepinephrine Reuptake Inhibitor,,2024-09-14,1,,,,,,,,,
68-22-4,0,OMOP Exposome,Observation,Substance,Norethindrone,"17-alpha-Ethynyl-17-hydroxy-4-estren-3-one; Utovlar; Utovlan; Proluteasi; Primolut-N; Primolut N; Norpregneninolone; Norpregneninlone; Normapause; NORLYROC; Norluton; Norlutin; Norluten; Norlutate; Noriday; Norgestin; Norfor; Noretisterona; Norethynodrone; Norethyndron; Norethisteronum; Norethisterone; Norethisteron; Noresthisterone; Norcolut; Noralutin; Nor-QD; Nor-Q.D.; NET; Minovlar; Mini-pill; Mini-Pe; Micronovum; Micronor; Micronett; Menzol; LYZA; Jolivette; Jencycla; HEATHER; Gestest; Ethynylnortestosterone; Ethinylnortestosterone; Ethinyl-19-nortestosterone; Errin; ENT; Conludag; Conludaf; Camila; Aygestin; Anovule; Anhydrohydroxynorprogesterone; 4-Estren-17alpha-ethynyl-17beta-ol-3-one; 19-Norethisterone; 19-Norethinyltestosterone; 19-Nor-ethindrone; 19-nor-17\u03b1-ethynyltestosterone; 19-Nor-17alpha-ethynyltestosterone; 19-Nor-17alpha-Ethynylandrosten-17beta-ol-3-one; 19-Nor-17alpha-Ethynyl-17beta-hydroxy-4-androsten-3-one; 19-Nor-17-ethinyltestosterone; 19-Nor-17-alpha-ethynyltestosterone; 19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one; 19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one; 17\u03b1-ethinyl-19-nortestosterone; 17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one; 17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one; 17alpha-pregn-4-en-20-yn-3-one; 17alpha-Ethynyl-4-estren-17-ol-3-one; 17alpha-Ethynyl-3-oxo-4-estren-17beta-ol; 17alpha-Ethynyl-19-nortestosterone; 17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one; 17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one; 17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one; 17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one; 17alpha-Ethynyl-17-hydroxyest-4-en-3-one; 17alpha-ethynyl-17-hydroxy-Estr-4-en-3-one; 17alpha-Ethynyl-17-hydroxy-4-estren-3-one; 17alpha-Ethinylestra-4-en-17beta-ol-3-one; 17alpha-Ethinyl-19-Nortestosterone; 17alpha-Ethinyl-17alpha-Ethinyl-19-nortestosterone; 17-Hydroxy-19-Nor-17alpha-pregn-4-en-20-yn-3-one; 17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one; 17-Hydroxy-17-alpha-19-Norpregn-4-en-20-yn-3-one; 17-Hydroxy-(17alpha)-19-Norpregn-4-en-20-yn-3-one; 17-Ethynyl-19-Nortestosterone; 17-Ethynyl-17beta-hydroxyestr-4-en-3-one; 17-Ethynyl-17-hydroxyestr-4-en-3-one; 17-Ethinyl-19-nor-testosterone; 17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one; 17-alpha-Ethynyl-4-estren-17-ol-3-one; 17-alpha-Ethynyl-19-nortestosterone; 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one; 17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one; (17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one; (17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one; CHEBI:7627",2014-12-24,1,,,,,,,,,
27314-13-2,0,OMOP Exposome,Observation,Substance,Norflurazon,"4-chloro-5-(Methylamino)-2-3-(trifluoromethyl)phenyl-3(2H)-pyridazinone; SAN 9789; Solicam; Zorial; 4-chloro-5-(Methylamino)-2-(alpha,alpha,alpha-trifluoro-m-tolyl)-3(2H)-pyridazinone; CHEBI:50842",2014-12-24,1,,,,,,,,,
72-69-5,0,OMOP Exposome,Observation,Substance,Nortriptyline,"Avantyl; Ateben; Allegron; 3-(10,11-dihydro-5H-Dibenzoa,Dcyclohepten-5-ylidene)-N-methyl-1-propanamine; 10,11-dihydro-N-Methyl-5H-dibenzoa,Dcycloheptene-delta(5,gamma)-propylamine; Norpress; Nortrilen; Pamelor; Psychostyl; Sensaval; Sensoval; Noritren; Desmethylamitriptyline; Demethylamitriptyline; Aventyl; CHEBI:7640",2014-12-24,1,,,,,,,,,
GIS1009527,0,OMOP Exposome,Observation,Substance,Notch signaling pathway,,2024-09-14,1,,,,,,,,,
37233-96-4,0,OMOP Exposome,Observation,Substance,Notexin,,2014-12-24,1,,,,,,,,,
116714-46-6,0,OMOP Exposome,Observation,Substance,Novaluron,"Rimon; (RS)-1-3-chloro-4-(1,1,2-trifluoro-2-trifluoromethoxyethoxy)phenyl-3-(2,6-difluorobenzoyl)urea; N-({3-chloro-4-1,1,2-trifluoro-2-(trifluoromethoxy)ethoxyphenyl}amino)carbonyl-2,6-difluorobenzamide, Novaluron; CHEBI:CHEBI:39385",2014-12-24,1,,,,,,,,,
85205-49-8,0,OMOP Exposome,Observation,Substance,Noxiustoxin,,2014-12-24,1,,,,,,,,,
Q16236,0,OMOP Exposome,Observation,Substance,Nuclear factor erythroid 2-related factor 2,,2024-09-14,1,,,,,,,,,
BE0004903,0,OMOP Exposome,Observation,Substance,Nuclear factor NF-kappa-B,,2024-09-14,1,,,,,,,,,
Q00653,0,OMOP Exposome,Observation,Substance,Nuclear factor NF-kappa-B p100 subunit,,2024-09-14,1,,,,,,,,,
P19838,0,OMOP Exposome,Observation,Substance,Nuclear factor NF-kappa-B p105 subunit,,2024-09-14,1,,,,,,,,,
O95644,0,OMOP Exposome,Observation,Substance,"Nuclear factor of activated T-cells, cytoplasmic 1",,2024-09-14,1,,,,,,,,,
GIS1009528,0,OMOP Exposome,Observation,Substance,Nuclear Matrix,,2024-09-14,1,,,,,,,,,
GIS1009529,0,OMOP Exposome,Observation,Substance,Nuclear Membrane,,2024-09-14,1,,,,,,,,,
Q15788,0,OMOP Exposome,Observation,Substance,Nuclear receptor coactivator 1,,2024-09-14,1,,,,,,,,,
Q15596,0,OMOP Exposome,Observation,Substance,Nuclear receptor coactivator 2,,2024-09-14,1,,,,,,,,,
Q9Y6Q9,0,OMOP Exposome,Observation,Substance,Nuclear receptor coactivator 3,,2024-09-14,1,,,,,,,,,
P35398,0,OMOP Exposome,Observation,Substance,Nuclear receptor ROR-alpha,,2024-09-14,1,,,,,,,,,
Q92753,0,OMOP Exposome,Observation,Substance,Nuclear receptor ROR-beta,,2024-09-14,1,,,,,,,,,
P51449,0,OMOP Exposome,Observation,Substance,Nuclear receptor ROR-gamma,,2024-09-14,1,,,,,,,,,
P51843,0,OMOP Exposome,Observation,Substance,Nuclear receptor subfamily 0 group B member 1,,2024-09-14,1,,,,,,,,,
O75469,0,OMOP Exposome,Observation,Substance,Nuclear receptor subfamily 1 group I member 2,,2024-09-14,1,,,,,,,,,
Q14994,0,OMOP Exposome,Observation,Substance,Nuclear receptor subfamily 1 group I member 3,,2024-09-14,1,,,,,,,,,
P43354,0,OMOP Exposome,Observation,Substance,Nuclear receptor subfamily 4 group A member 2,,2024-09-14,1,,,,,,,,,
GIS1009530,0,OMOP Exposome,Observation,Substance,Nucleic Acid Synthesis Inhibitor,,2024-09-14,1,,,,,,,,,
Q14978,0,OMOP Exposome,Observation,Substance,Nucleolar and coiled-body phosphoprotein 1,,2024-09-14,1,,,,,,,,,
GIS1009531,0,OMOP Exposome,Observation,Substance,Nucleolus,,2024-09-14,1,,,,,,,,,
GIS1009532,0,OMOP Exposome,Observation,Substance,Nucleoplasm,,2024-09-14,1,,,,,,,,,
P15531,0,OMOP Exposome,Observation,Substance,Nucleoside diphosphate kinase A,,2024-09-14,1,,,,,,,,,
GIS1009533,0,OMOP Exposome,Observation,Substance,Nucleotide Excision Repair,,2024-09-14,1,,,,,,,,,
GIS1009534,0,OMOP Exposome,Observation,Substance,Nucleus,,2024-09-14,1,,,,,,,,,
GIS1009535,0,OMOP Exposome,Observation,Substance,Nutraceutical,,2024-09-14,1,,,,,,,,,
GIS1009536,0,OMOP Exposome,Observation,Substance,Nutritional Supplement,,2024-09-14,1,,,,,,,,,
GIS1009537,0,OMOP Exposome,Observation,Substance,Nutritional Support,,2024-09-14,1,,,,,,,,,
1400-61-9,0,OMOP Exposome,Observation,Substance,Nystatin,Mycostatin; Diaper NZ; Cazetin; Canstat; Candistin; Candistat; Candidias; Candex; Candermil; Candacide; Biofanal; Afunginal; Adiclair; Fungatin; Fungicidin Leciva; Fungistin; Fungostatin; Funistatin; Gynostatin; Kandistatin; Kenalon; Lederlind; Ledernyst; Lystin; Nilstat; Nistatina; Nyaderm; Nyamyc; NYS; Nystan; Nystatine; Nystatinum; Fukangning; Enystin; Dipni; Nystop; Pedi-Dri; CHEBI:7660,2014-12-24,1,,,,,,,,,
41114-59-4,0,OMOP Exposome,Observation,Substance,Nysted reagent,,2014-12-24,1,,,,,,,,,
53-19-0,0,OMOP Exposome,Observation,Substance,"O,P'-DDD",,2014-12-24,1,,,,,,,,,
789-02-6,0,OMOP Exposome,Observation,Substance,"O,P'-DDT",,2014-12-24,1,,,,,,,,,
3279-46-7,0,OMOP Exposome,Observation,Substance,o-(2-Propynyloxy)phenyl methylcarbamate,,2014-12-24,1,,,,,,,,,
95-48-7,0,OMOP Exposome,Observation,Substance,o-Cresol,o-Hydroxytoluene; o-Methylphenol; o-Methylphenylol; o-Oxytoluene; o-Toluol; ortho-Cresylic acid; ortho-Hydroxytoluene; ortho-Methylphenol; 1-Hydroxy-2-methylbenzene; ortho-Methylphenylol; ortho-Oxytoluene; ortho-Toluol; 2-Cresol; 1-Methyl-2-hydroxybenzene; o-Cresylic acid; O-Cresol; 2-Hydroxytoluene; 2-Methylphenol; CHEBI:28054,2014-12-24,1,,,,,,,,,
21255-69-6,0,OMOP Exposome,Observation,Substance,O-Desmethylangolensin,,2014-12-24,1,,,,,,,,,
Q9HD40,0,OMOP Exposome,Observation,Substance,O-phosphoseryl-tRNA(Sec) selenium transferase,,2024-09-14,1,,,,,,,,,
95-53-4,0,OMOP Exposome,Observation,Substance,O-Toluidine,O-Tolylamine; Ortho-Toluidine; 1-Amino-2-methylbenzene; 1-Methyl-2-aminobenzene; 2-Amino-1-methylbenzene; 2-Aminotoluene; Rcra waste number U328; 2-Methyl-1-aminobenzene; 2-Methyl-Aniline; 2-Methylaniline; 2-Methyl-Benzenamine; 2-Methylbenzenamine; 2-Methylphenylamine; 2-Toluidine; O-Aminotoluene; O-Methylaniline; O-Methylbenzenamine; O-Toluide; O-Toluidin; O-Toluidyna; CHEBI:66892,2014-12-24,1,,,,,,,,,
95-47-6,0,OMOP Exposome,Observation,Substance,o-Xylene,"o-Xylol; ORTHO-XYLENE; 1,2-dimethylbenzene; 1,2-Dimethylbenzol; 1,2-xylene; 2-xylene; 3,4-xylene; o-Dimethylbenzene; o-Methyltoluene; O-Xylene; CHEBI:28063",2014-12-24,1,,,,,,,,,
89-92-9,0,OMOP Exposome,Observation,Substance,o-Xylyl bromide,,2014-12-24,1,,,,,,,,,
BE0005550,0,OMOP Exposome,Observation,Substance,Oat 6 Transporter,,2024-09-14,1,,,,,,,,,
303-47-9,0,OMOP Exposome,Observation,Substance,Ochratoxin A,"OTA; Ochratoxin a; Antibiotic 9663; Phenylalanine - ochratoxin a; N-(5-Chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonylphenylalanine, 9CI; Ochratoxin a-bsa conjugate from aspergillus ochraceus; CHEBI:7719",2014-12-24,1,,,,,,,,,
4825-86-9,0,OMOP Exposome,Observation,Substance,Ochratoxin B,,2014-12-24,1,,,,,,,,,
4865-85-4,0,OMOP Exposome,Observation,Substance,Ochratoxin C,,2014-12-24,1,,,,,,,,,
27858-07-7,0,OMOP Exposome,Observation,Substance,Octabromobiphenyl,,2014-12-24,1,,,,,,,,,
3268-87-9,0,OMOP Exposome,Observation,Substance,Octachlorodibenzo-p-dioxin,,2014-12-24,1,,,,,,,,,
111-65-9,0,OMOP Exposome,Observation,Substance,Octane,N-Octane; CHEBI:17590,2014-12-24,1,,,,,,,,,
6701-17-3,0,OMOP Exposome,Observation,Substance,Octyl cyanoacrylate,,2014-12-24,1,,,,,,,,,
1034-01-1,0,OMOP Exposome,Observation,Substance,Octyl gallate,,2014-12-24,1,,,,,,,,,
Q9NY56,0,OMOP Exposome,Observation,Substance,Odorant-binding protein 2a,,2024-09-14,1,,,,,,,,,
20311-78-8,0,OMOP Exposome,Observation,Substance,Oenanthotoxin,,2014-12-24,1,,,,,,,,,
GIS1009538,0,OMOP Exposome,Observation,Substance,Oesophagus,,2024-09-14,1,,,,,,,,,
GIS1009539,0,OMOP Exposome,Observation,Substance,Ohanin,,2024-09-14,1,,,,,,,,,
78111-17-8,0,OMOP Exposome,Observation,Substance,Okadaic acid,"9,10-Deepithio-9,10-didehydroacanthifolicin; Okadaate; PL toxin II; CHEBI:1137572",2014-12-24,1,,,,,,,,,
132539-06-1,0,OMOP Exposome,Observation,Substance,Olanzapine,"Olanzapinum; Olanzapin; Lazapix; Lapozan; Lapenza; Lanzep; Lanzapin; Lanzac; Lanopin; Kozylex; Jolyon-MD; Frenial; Elynza; Egolanza; Dopin; Dominazol; Deprex; CO Olanzapine; Caprilon; Arkolamyl; Apsico; Apisco; Amulsin; Aedon; 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno2,3-b1,5benzodiazepine; (\u2212)-Omeprazole; (S)-Omeprazole; (S)-(\u2212)-Omeprazole; Zyprexa Zydis; Zyprexa Intramuscular; Zyprexa; Olanzapina; CHEBI:7735",2014-12-24,1,,,,,,,,,
465-16-7,0,OMOP Exposome,Observation,Substance,Oleandrin,,2014-12-24,1,,,,,,,,,
112-80-1,0,OMOP Exposome,Observation,Substance,Oleic acid,"cis-9-Octadecenoate; (9Z)-Octadecenoate; cis-9-Octadecenoic acid; Groco 6; Industrene 104; Industrene 105; Industrene 205; Industrene 206; L'acide oleique; Metaupon; Oelsauere; Oleate; Oleic acid extra pure; Pamolyn 100 FGK; Pamolyn 100 FG; Pamolyn 100; Pamolyn; Oleinic acid; Oleinate; Pamolyn 125; Priolene 6900; Red oil; Tego-oleic 130; Vopcolene 27; Wecoline OO; Z-9-Octadecenoate; Z-9-Octadecenoic acid; cis-Octadec-9-enoate; cis-Octadec-9-enoic acid; cis-Oleate; cis-Oleic acid; Distoline; (Z)-9-Octadecanoate; (9Z)-Octadecenoic acid; Emersol 210; Emersol 211; (9Z)-9-Octadecenoic acid; Emersol 213; Emersol 220 White Oleate; (Z)-9-Octadecanoic acid; (Z)-Octadec-9-enoate; (Z)-Octadec-9-enoic acid; 9,10-Octadecenoate; Emersol 220 White Oleic acid; Emersol 221 Low Titer White Oleate; Emersol 221 Low Titer White Oleic acid; Emersol 233ll; Emersol 6321; Emersol 6333 NF; Emersol 7021; Glycon ro; Glycon wo; 9,10-Octadecenoic acid; 9-(Z)-Octadecenoate; 9-(Z)-Octadecenoic acid; 9-Octadecenoate; Groco 2; 9-Octadecenoic acid; Century cd fatty acid; (9Z)-9-Octadecenoate; Groco 4; Groco 5L; CHEBI:16196",2014-12-24,1,,,,,,,,,
GIS1009546,0,OMOP Exposome,Observation,Substance,Olfactory transduction,,2024-09-14,1,,,,,,,,,
113806-05-6,0,OMOP Exposome,Observation,Substance,Olopatadine,Patanase; Patanol; Olopatadin; Allelock; Opatanol; Alerchek; Alchek; Patanol S; Olopatadinum; Olopatadina; Pataday; CHEBI:763382,2014-12-24,1,,,,,,,,,
145017-83-0,0,OMOP Exposome,Observation,Substance,omega-Agatoxin,,2014-12-24,1,,,,,,,,,
GIS1009547,0,OMOP Exposome,Observation,Substance,omega-Conotoxin (Conus striatus),,2024-09-14,1,,,,,,,,,
73590-58-6,0,OMOP Exposome,Observation,Substance,Omeprazole,"Ompanyt; Ulcesep; Ulcometion; Tedec Ulceral; Secrepina; Sanamidol; Result; Ulcozol; Regulacid; Ramezol; Prysma; Proclor; Ulcsep; Ulsen; Ultop; Procelac; Prilosec OTC; Prilosec; Prestwick_808; Prazolit; Prazidec; Prazentol; Peptilcer; Pepticus; Pepticum; Parizac; Paprazol; Ozoken; Osiren; Ulzol; Victrix; Zefxon; Zegerid; Ortanol; OMZ; OMP; Omizac; Omisec; Omid; Omezolan; Zepral; Zimor; Omezol; Zoltum; Omez; Omesek; Omeprol; Omeprazon; Omeprazolum; Omeprazole Pellets; Omeprazol; Omepral; Omepradex; OMEP; Omegast; Omed; Omebeta 20; Omapren; Olexin; Ocid; Nuclosina; Nopramin; Nilsec; Nexium IV; Nexium; Nexiam; Morecon; Mopral; Miracid; Miol; Mepral; Losec; Lomac; Logastric; Lensor; Inhipump; Inhibitron; Indurgan; Gibancer; Gastroloc; Gastrimut; Gasec; Exter; Esomperazole; Esomeprazole; Erbolin; Epirazole; Emeproton; Elgam; Dudencer; Dizprazol; Desec; Demeprazol; Danlox; Ceprandal; Belmazol; Aulcer; Audazol; Antra MUPS; Antra; 2,3,5-Trimethylpyridine/Omeprazole; (S)-Omeprazole; (S)-(-)-Omeprazole; (-)-Omeprazole; ( -)-Omeprazole; Ulceral; CHEBI:7772",2014-12-24,1,,,,,,,,,
3566-09-4,0,OMOP Exposome,Observation,Substance,Oms 22,,2014-12-24,1,,,,,,,,,
67656-42-2,0,OMOP Exposome,Observation,Substance,Onchidal,,2014-12-24,1,,,,,,,,,
99614-02-5,0,OMOP Exposome,Observation,Substance,Ondansetron,Zofran odt; Zofran; Zuplenz; Zophren; Zudan; CHEBI:103183,2014-12-24,1,,,,,,,,,
GIS1009555,0,OMOP Exposome,Observation,Substance,Opiate Agonist,,2024-09-14,1,,,,,,,,,
GIS1009556,0,OMOP Exposome,Observation,Substance,Opiate Antagonist,,2024-09-14,1,,,,,,,,,
GIS1009562,0,OMOP Exposome,Observation,Substance,Opioid Analgesics,,2024-09-14,1,,,,,,,,,
37338-80-0,0,OMOP Exposome,Observation,Substance,Orellanine,,2016-10-03,1,,,,,,,,,
O43612,0,OMOP Exposome,Observation,Substance,Orexin,,2024-09-14,1,,,,,,,,,
GIS1009563,0,OMOP Exposome,Observation,Substance,Organic Compound,,2024-09-14,1,,,,,,,,,
GIS1009564,0,OMOP Exposome,Observation,Substance,Organobromide,,2024-09-14,1,,,,,,,,,
GIS1009565,0,OMOP Exposome,Observation,Substance,Organochloride,,2024-09-14,1,,,,,,,,,
GIS1009566,0,OMOP Exposome,Observation,Substance,Organofluoride,,2024-09-14,1,,,,,,,,,
GIS1009567,0,OMOP Exposome,Observation,Substance,Organometallic,,2024-09-14,1,,,,,,,,,
GIS1009568,0,OMOP Exposome,Observation,Substance,Organophosphate,,2024-09-14,1,,,,,,,,,
Q59HE2,0,OMOP Exposome,Observation,Substance,Ornithine aminotransferase variant,,2024-09-14,1,,,,,,,,,
P04181,0,OMOP Exposome,Observation,Substance,"Ornithine aminotransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
P00480,0,OMOP Exposome,Observation,Substance,"Ornithine carbamoyltransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
P11926,0,OMOP Exposome,Observation,Substance,Ornithine decarboxylase,,2024-09-14,1,,,,,,,,,
P54368,0,OMOP Exposome,Observation,Substance,Ornithine decarboxylase antizyme 1,,2024-09-14,1,,,,,,,,,
O95190,0,OMOP Exposome,Observation,Substance,Ornithine decarboxylase antizyme 2,,2024-09-14,1,,,,,,,,,
Q9UMX2,0,OMOP Exposome,Observation,Substance,Ornithine decarboxylase antizyme 3,,2024-09-14,1,,,,,,,,,
GIS1009569,0,OMOP Exposome,Observation,Substance,Ornithine Transcarbamylase Deficiency (OTC Deficiency),,2024-09-14,1,,,,,,,,,
65-86-1,0,OMOP Exposome,Observation,Substance,Orotic acid,"2,6-Dihydroxypyrimidine-4-carboxylic acid; Uracil-6-carboxylic acid; Orotyl; Oroturic; Orotsaure; Orotsaeure; Orotonsan; Orotonin; Orotate; Oropur; Vitamin B13; Whey factor; 1,2,3,6-Tetrahydro-2,6-dioxo-4-pyrimidecarboxylic acid; 1,2,3,6-Tetrahydro-2,6-dioxo-4-Pyrimidinecarboxylic acid; 1,2,3,6-Tetrahydro-2,6-dioxopyrimidin-4-carbonsaeure; 2,6-Dihydroxy-4-pyrimidinecarboxylic acid; 2,6-Dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid; 2,6-Dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid; 6-Carboxy-2,4-dihydroxypyrimidine; 6-Carboxyuracil; 6-Uracilcarboxylic acid; Uracil-6-carboxylate; Acide orotique; Acido orotico; Acidum oroticum; Animal galactose factor; Lactinium; Molkensaeure; ORO; Uracil-6-carbosaeure; Orodin; CHEBI:16742",2018-03-21,1,,,,,,,,,
83-98-7,0,OMOP Exposome,Observation,Substance,Orphenadrine,"o-monomethyldiphenhydramine; \u03b2-dimethylaminoethyl 2-methylbenzhydryl ether; Phenyl-O-tolylmethyl dimethyaminoethyl ether; Orphenedrine; Orphenate; 2-(phenyl-o-tolylmethoxy)ethyldimethylamine; 2-methyldiphenhydramine; Antiflex; Banflex; beta-Dimethylaminoethyl 2-methylbenzhydryl ether; Biorphen; Orphenadrinum; Dimethyl-2-(phenyl-O-tolyl-methoxy)-ethyl-amine; Disipal; Flexoject; Orphenadrine Citrate; ORPHENADRINE; Orphenadrin; Orphenadine; Orfro; Orfenadrina; OrfenAce; Mephenamine; Mio-Rel; Myolin; N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine; N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine; N,N-Dimethyl-2-(O-methyl-alpha-phenylbenzyl)oxyethylamine; Norflex; O-Methyldiphenhydramine; CHEBI:7789",2014-12-24,1,,,,,,,,,
19044-88-3,0,OMOP Exposome,Observation,Substance,Oryzalin,,2014-12-24,1,,,,,,,,,
GIS1009570,0,OMOP Exposome,Observation,Substance,OSTalpha (OSTA),,2024-09-14,1,,,,,,,,,
GIS1009571,0,OMOP Exposome,Observation,Substance,OSTbeta (OSTB),,2024-09-14,1,,,,,,,,,
P02818,0,OMOP Exposome,Observation,Substance,Osteocalcin,,2024-09-14,1,,,,,,,,,
GIS1009572,0,OMOP Exposome,Observation,Substance,Osteoclast differentiation,,2024-09-14,1,,,,,,,,,
GIS1009573,0,OMOP Exposome,Observation,Substance,Osteoporosis Prophylactic,,2024-09-14,1,,,,,,,,,
630-60-4,0,OMOP Exposome,Observation,Substance,Ouabain,"Strophanthin-G; Strophanthin G; Strodival; Oubain; Ouabaine; 3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide; Ouabagenin-L-rhamnosid; Ouabagenin L-Rhamnoside; Ouabain, Octahydrate; Ouabain Octahydrate; Ouabain anhydrous; G-Strophanthin; CHEBI:472805",2014-12-24,1,,,,,,,,,
190-26-1,0,OMOP Exposome,Observation,Substance,Ovalene,"1,14:3,4:7,8:10,11-Tetraethenodibenzofg,opnaphthacene; Phenanthro3,4,5,6-qrabccoronene; CHEBI:33091",2014-12-24,1,,,,,,,,,
GIS1009574,0,OMOP Exposome,Observation,Substance,Ovarian Steroidogenesis,,2024-09-14,1,,,,,,,,,
GIS1009575,0,OMOP Exposome,Observation,Substance,Ovary,,2024-09-14,1,,,,,,,,,
19666-30-9,0,OMOP Exposome,Observation,Substance,Oxadiazon,,2014-12-24,1,,,,,,,,,
144-62-7,0,OMOP Exposome,Observation,Substance,Oxalic acid,"Ethanedioic acid; Ethane-1,2-dioic acid; Ethane-1,2-dioate; Ammonium oxalate; Oxalic acid dihydrate; Oxalic acid diammonium salt; Oxalic acid anhydrous; Oxalic acid 2-Hydrate; Oxalate; Oxaalzuur; Kyselina stavelova; Ethanedionic acid; Ethanedionate; Ethanedioic acid dihydrate; Ethanedioate; CHEBI:16995",2014-12-24,1,,,,,,,,,
61825-94-3,0,OMOP Exposome,Observation,Substance,Oxaliplatin,L-OHP; Eloxatin; CHEBI:31941,2014-12-24,1,,,,,,,,,
23135-22-0,0,OMOP Exposome,Observation,Substance,Oxamyl,Blade; Nematicide 1410; Insecticide-nematicide 1410; Du pont 1410; Dioxamyl; Vydate l oxamyl insecticide/nematocide; Vydate l insecticide/nematicide; Vydate; Thioxamyl; Oxamyl (pesticide); CHEBI:38539,2014-12-24,1,,,,,,,,,
144651-06-9,0,OMOP Exposome,Observation,Substance,Oxasulfuron,,2014-12-24,1,,,,,,,,,
604-75-1,0,OMOP Exposome,Observation,Substance,Oxazepam,Murelax; Zaxpam; Vaben; Tazepam; Sobril; Serpax; Seresta; (+-)-Oxazepam; (RS)-Oxazepam; Adumbran; Alepam; Serepax; Serenid; Serenal; Serax; Alopam; Purata; Praxiten; Oxozepam; Oxazipam; Oxascand; Ox-Pam; Anxiolit; Durazepam; Limbial; Medopam; Noripam; Opamox; CHEBI:7823,2014-12-24,1,,,,,,,,,
24143-17-7,0,OMOP Exposome,Observation,Substance,Oxazolam,,2014-12-24,1,,,,,,,,,
28721-07-5,0,OMOP Exposome,Observation,Substance,Oxcarbazepine,"Oxtellar xr; Oxypine; Pharozepine; Prolepsi; Timox; Oxrate; Trexapin; Trileptal; Trileptin; Oxpin; Oxetol; Oxcarbazepinum; Oxcarbazepina; Oxcarbamazepine; Oxalepsy; OCBZ; Lonazet; Deprectal; Carbox; Barzepin; 10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide; Actinium; CHEBI:7824",2014-12-24,1,,,,,,,,,
64211-46-7,0,OMOP Exposome,Observation,Substance,Oxiconazole,,2014-12-24,1,,,,,,,,,
GIS1009576,0,OMOP Exposome,Observation,Substance,Oxidation of Branched Chain Fatty Acids,,2024-09-14,1,,,,,,,,,
GIS1009577,0,OMOP Exposome,Observation,Substance,Oxidative phosphorylation,,2024-09-14,1,,,,,,,,,
3184-35-8,0,OMOP Exposome,Observation,Substance,Oxoadipic acid,alpha-Ketoadipic acid; alpha-Oxoadipate; alpha-Oxoadipic acid; Oxoadipate; 2-Oxohexanedioate; 2-Oxoadipate; a-Oxoadipate; a-Ketoadipic acid; 2-Oxo-hexanedioic acid; 2-Oxo-hexanedioate; alpha-Ketoadipate; 2-Ketoadipic acid; 2-Ketoadipate; 2-Oxoadipic acid; a-Ketoadipate; 2-Oxohexanedionic acid; 2-Keto-adipate; 2-Oxohexanedioic acid; a-Oxoadipic acid; CHEBI:15753,2018-03-21,1,,,,,,,,,
131-57-7,0,OMOP Exposome,Observation,Substance,Oxybenzone,(2-Hydroxy-4-methoxyphenyl)phenylmethanone; 2-Benzoyl-5-methoxyphenol; 2-Hydroxy-4-methoxybenzophenone; 4-Methoxy-2-hydroxybenzophenone; 4-Methoxy-2-hydroxybenzophenone butyric acid; Benzophenone-3; Oxibenzona; Oxybenzonum; CHEBI:34283,2014-12-24,1,,,,,,,,,
76-42-6,0,OMOP Exposome,Observation,Substance,Oxycodone,"Oxycontin; (-)-14-Hydroxydihydrocodeinone; 4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one; 4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one; Dihydro-14-hydroxycodeinone; Dihydrohydroxycodeinone; Dihydrohydroxycondeinone; Dihydrone; Dihydroxycodeinone; Oxanest; Oxecta; Oxicodona; Oxycodonum; OxyIR; PTI-821; Roxicodone; CHEBI:7852",2014-12-24,1,,,,,,,,,
42874-03-3,0,OMOP Exposome,Observation,Substance,Oxyfluorfen,,2014-12-24,1,,,,,,,,,
76-41-5,0,OMOP Exposome,Observation,Substance,Oxymorphone,Dihydrohydroxymorphinone; 14-Hydroxydihydromorphinone; Dihydroxymorphinone; EN3202; Numorphan; Opana; OPANA ER; Oximorphonum; Oxymorphine; CHEBI:194484,2014-12-24,1,,,,,,,,,
Q13133,0,OMOP Exposome,Observation,Substance,Oxysterols receptor LXR-alpha,,2024-09-14,1,,,,,,,,,
P55055,0,OMOP Exposome,Observation,Substance,Oxysterols receptor LXR-beta,,2024-09-14,1,,,,,,,,,
79-57-2,0,OMOP Exposome,Observation,Substance,Oxytetracycline,"Proteroxyna; Oxyterracin; Oxysteclin; Oxypan; Oxypam; Oxymykoin; 2058-46-0 (Mono-hydrochloride); Oxymycin; Oxydon; Oxy-kesso-tetra; Oxitetracyclinum; Oxytetracid; Oxyterracyne; Oxyterracyna; Oxyterracine; Vendarcin; Ursocycline; Ursocyclin; 5-Hydroxy-Tetracycline; 5-Hydroxytetracycline; 6153-64-6 (Di-hydrate); 6153-65-7 (Di-hydrochloride salt, di-hydrate); Unimycin; Tetrasona; Tetran; Terramycin; Terramitsin; Terrafungine; Terrados; Teravit; 7179-50-2 (Calcium (1:1) salt); Oxitetracyclin; Oxitetraciclina; Oxacycline; Oxacin; OTC; Ossitetraciclina; Oksisyklin; NSC9169 (HCL); NSC 9169; Mycoshield TMQTHC 20; Mepatar; Medamycin; Macocyn; Liquamycin LA 200; Liquamycin; Lenocycline; Tarosin; Tarocyn; Stevacin; Stecsolin; Solkaciclina; Ryomycin; Imperacin; Hydroxytetracyclinum; Hydroxytetracycline; Geotilin; Geomycin; Galsenomycin; Fanterrin; Embryostat; Dalimycin; Dabicycline; Corsamycin; Bisolvomycin; Biostat pa; Riomitsin; Pennox 200; Oxytetracyclinum; Oxytetracycline calcium; Oxytetracycline anhydrous; Oxytetracycline amphoteric; Biostat; Oxytetracycline (anhydrous); Oxyt\u00e9tracycline; Berkmycen; Antibiotic TM 25; Anglocycline; Adamycin; Abbocin; 79-57-2 (ANHYDROUS); Oxytetracyclin; CHEBI:27701",2014-12-24,1,,,,,,,,,
GIS1009578,0,OMOP Exposome,Observation,Substance,Oxytetracycline Action Pathway,,2024-09-14,1,,,,,,,,,
GIS1009579,0,OMOP Exposome,Observation,Substance,Oxytocic,,2024-09-14,1,,,,,,,,,
10028-15-6,0,OMOP Exposome,Observation,Substance,Ozone,"OZON; Ozone heavy work; Ozone heavy, moderate, or light workloads (<2 hours); Ozone light work; Ozone moderate work; Ozone, 11CI; Ozono; Triatomic oxygen; Trioxid-2-en-2-ium-1-ide; Trioxygen; Trioxygene; Oxygen, mol (O3); CHEBI:25812",2014-12-24,1,,,,,,,,,
72-54-8,0,OMOP Exposome,Observation,Substance,"P,P'-DDD","1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethane (DDD); 4,4'-DDD solution; DDD; DDD(p,p'); Dichloro-2,2-bis(p-chlorophenyl)ethane; Dichlorodiphenyl dichloroethane; Dichlorodiphenyldichloroethane; 2,2-bis-(4-chlorophenyl)-1,1-dichloroethane; 2,2-Bis(p-chlorophenyl)-1,1-dichloroethane; 2,2-Bis(p-chlorophenyl)-1, 1-dichloroethane; Dilene; p, p'-(dichlorodiphenyl)dichloroethane; p,p'-(dichlorodiphenyl)dichloroethane; P,P'-ddd; p,p'-DDD; 2,2-Bis(4-chlorophenyl)-1,1-dichloroethane; 1-Chloro-4-2,2-dichloro-1-(4-chlorophenyl)ethylbenzene; 1,1-Dicloro-2,2-bis(4-cloro-fenil)-etano; 1,1-Dichloro-2,2-di(4-chlorophenyl)ethane; 1,1-Dichloro-2,2-bis(parachlorophenyl)ethane; 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethane; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethane; 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethane; 1,1-Dichloro-2, 2-di(4-chlorophenyl)ethane; 1,1-Dichloro-2, 2-bis(p-chlorophenyl)ethane; 1,1-Dichloro-2, 2-bis(4-chlorophenyl)ethane; 1,1-Dichlor-2,2-bis(4-chlor-phenyl)-aethan; 1,1-Dichloor-2,2-bis(4-chloor fenyl)-ethaan; 1,1-Bis(p-Chlorophenyl)-2,2-dichloroethane; 1,1-Bis(4-chlorophenyl)-2,2-dichloroethane; P,p'-dichlorodip henyl dichloroethane; p,p'-dichlorodiphenyl dichloroethane; 1,1'-(2,2-dichloroethylidene)bis4-chlorobenzene; 1,1'-(2,2-dichloroethane-1,1-diyl)bis(4-chlorobenzene); 1, 1-Bis(p-chlorophenyl)-2,2-dichloroethane; 1, 1-Bis(4-chlorophenyl)-2,2-dichloroethane; (Dichlorodiphenyl)dichloroethane; p,p'-Dichlorodiphenyl-2,2-dichloroethylene; p,p'-dichlorodiphenyldichloroethane; p,p'-dichlorodiphenyldichloroethane (DDD); p,p'-TDE; p,p-DDD; Rhothane; Rhothane d-3; Rothane; TDE; Tetrachlorodiphenylethane; CHEBI:27841",2014-12-24,1,,,,,,,,,
72-55-9,0,OMOP Exposome,Observation,Substance,"P,P'-DDE","1,1'-(dichloroethenylidene)bis4-chloro-Benzene; 1,1'-(Dichlorovinylidene)bis(chlorobenzene); 1,1'-Bis(chlorophenyl)-2,2-dichloroethylene; 1,1-Bis(p-chlorophenyl)-2,2-dichloroethylene; 1,1-dichloro-2, 2-bis(p-chlorophenyl)-Ethylene; 1,1-Dichloro-2, 2-bis(p-chlorophenyl)ethene; 1,1-Dichloro-2, 2-bis(p-chlorophenyl)ethylene; 1,1-Dichloro-2, 2-di(p-chlorophenyl)ethylene; 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethylene; 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethylene (DDE); 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethene; 1,1'-(dichloroethenylidene)bis4-chloro-Benzene; p,p'-dichlorodiphenyl dichloroethylene; p,p'-dichlorodiphenyldichloroethylene; 2,2-Bis(p-chlorophenyl)-1,1-dichloroethylene; 2,2-bis(p-chlorophenyl)-1,1-dichloroethene; 2,2-Bis(chlorophenyl)-1,1-dichloroethylene; 2,2-bis(chlorophenyl)-1,1-dichloro-Ethylene; 2,2-Bis(4-chlorophenyl)-1,1-dichloroethylene; 2,2-Bis(4-chlorophenyl)-1,1-dichloroethene; 2, 2-Bis(p-chlorophenyl)-1,1-dichloroethylene; 2, 2-Bis(4-chlorophenyl)-1,1-dichloroethylene; 1-Chloro-4-2,2-dichloro-1-(4-chlorophenyl)vinylbenzene; 1-chloro-4-2,2-dichloro-1-(4-chlorophenyl)ethenylbenzene; 1,1-Dichloro-2,2-di(p-chlorophenyl)ethylene; 1,1-Dichloro-2,2-bis4-chlorophenylethylene; 1,1-Dichloro-2,2-bis(para-chlorophenyl) ethylene; 1,1-Dichloro-2,2-Bis(p-chlorophenyl)ethylene; 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethene; 1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethene solution; 4,4'-DDE solution; 4,4'-DDEe; 4,4';-DDE solution; DDE; DDE(p,p'); p,p'-dichlorodiphenyldichloroethylene (dde); DDT dehydrochloride; P,p-dichlorodiphenyldichloroethylene; p,p-dde; 1,1'-(Dichloroethenylidene)bis(chloro)-Benzene; 1,1'-(Dichloroethenylidene)bis(4-chlorobenzene); 1,1'-(dichloroethenylidene)bis(4-chloro)-Benzene; 1,1'-(2,2-dichloroethene-1,1-diyl)bis(4-chlorobenzene); 1, 1-Bis(p-chlorophenyl)-2,2-dichloroethylene; p,p'-dichlorodiphenoldichloroethylene; p,p'-DDE (p,p'-dichlorodiphenyldichloroethylene); p,p'-DDE; P,P'-dde; p,p'-(dichlorodiphenyl)dichloroethylene; p,p'-(Dichlorodiphenyl)-2,2-dichloroethylene; p, p'-(dichlorodiphenyl)dichloroethylene; Dichloroethylene, dichlorodiphenyl; Dichlorodiphenyldichloroethylene; Dichlorodiphenyl dichloroethylene; Dichlorodiphenyl dichloroethene; DDX; Para,para'-DDE; 4,4'-DDE; 1,1'-(Dichloroethenylidene)bis4-chlorobenzene; CHEBI:16598",2014-12-24,1,,,,,,,,,
104-94-9,0,OMOP Exposome,Observation,Substance,p-Anisidine,p-Methoxyphenylamine; 1-Methoxy-4-amino-benzen (p-anisidin); 1-Methoxy-4-amino-benzene / p-anisidine; 4-Aminoanisole; Para-anisidine; 4-Anisidine; 4-Methoxy-1-aminobenzene; 4-METHOXY-ANILINE; 4-Methoxy-Benzenamine; 4-Methoxy-phenylamine; 4-Methoxyaniline; 4-Methoxybenzenamine; 4-Methoxybenzeneamine; beta -anisidine; p-Amino-Anisole; P-Aminoanisole; P-Anisidine; P-Anisylamine; P-Dianisidine; p-Methoxy-Aniline; p-Methoxyaniline; 1-Amino-4-methoxybenzene; CHEBI:163384,2014-12-24,1,,,,,,,,,
7334-23-8,0,OMOP Exposome,Observation,Substance,p-Azobenzenearsonate,"P-Azophenylarsonate; P-azobenzenearsonate; (4,4'-Azodiphenyl)bisarsonic acid; 4-((4-Arsonophenyl)diazenyl)phenylarsonic acid; P-ABA; P-Azobenzenearsonate; Azophenylarsonate; ABA; P-Azobenzenearsonic acid; Para-azobenzenearsonate; Azobenzenearsonate; CHEBI:25520",2014-12-24,1,,,,,,,,,
99-91-2,0,OMOP Exposome,Observation,Substance,P-Chloroacetophenone,,2014-12-24,1,,,,,,,,,
1867-38-5,0,OMOP Exposome,Observation,Substance,P-Chlorobenzylidenemalonitrile,,2014-12-24,1,,,,,,,,,
106-44-5,0,OMOP Exposome,Observation,Substance,p-Cresol,1-Hydroxy-4-methylbenzene; 1-Methyl-4-hydroxybenzene; 4-Cresol; 4-Hydroxytoluene; 4-Methyl phenol; 4-Methyl-phenol; Paramethyl phenol; Paracresol; para-Cresol; p-Tolyl alcohol; p-Toluol; p-Oxytoluene; p-Methylhydroxybenzene; p-Methyl phenol; p-Kresol; p-Hydroxytoluene; p-Cresylic acid; p-Cresylate; P-Cresol; 4-Methylphenol; CHEBI:17847,2014-12-24,1,,,,,,,,,
3233-58-7,0,OMOP Exposome,Observation,Substance,p-Cresol sulfate,"Sulfuric acid mono(p-tolyl) ester (8CI); Para-Cresol sulfate; p-Tolyl sulphate (6CI,7CI); p-Tolyl sulfate (6CI,7CI); p-Cresylsulphate; p-Cresyl-sulfate; P-Cresol sulphate; p-Cresyl sulphate; p-Cresol sulphate; p-Cresylsulfate; Para-Cresol sulphate; P-Cresol sulfate; p-Cresyl sulfate; P-Cresol sulfic acid; P-Cresol sulphic acid; 4-Cresol sulfate; 4-Cresol sulphate; Mono(4-methylphenyl) Sulfate; p-Cresyl-sulphate; CHEBI:82914",2014-12-24,1,,,,,,,,,
99-87-6,0,OMOP Exposome,Observation,Substance,p-Cymene,"Cymene; 4-Isopropyl-1-methylbenzene; 4-Isopropylbenzyl radical; 4-Isopropyltoluene; 4-Methyl-1-(propan-2-yl)benzene; 4-Methyl-1-isopropylbenzene; Camphogen; Cymol; Dolcymene; Isopropyltoluene; P- Isopropylmethylbenzene; P-Cimene; P-Cymene; P-Cymol; P-Isopropyltoluene; p-Mentha-1,3,5-triene; P-Methyl cumene; p-Methyl-Cumene; P-Methylcumene; P-Methylisopropylbenzene; Para-cymene; Paracymene; Paracymol; 1-Methyl-4-(1-methylethyl)benzene; 1-Methyl-4-(1-methylethyl)-benzene; 1-Isopropyl-4-methylbenzene; 1-Isopropyl-4-methyl-Benzene; 2-p-Tolylpropane; 4-Cymene; CHEBI:28768",2014-12-24,1,,,,,,,,,
P16109,0,OMOP Exposome,Observation,Substance,P-selectin,,2024-09-14,1,,,,,,,,,
Q96JQ3,0,OMOP Exposome,Observation,Substance,P-selectin cytoplasmic tail-associated protein (PCAP),,2024-09-14,1,,,,,,,,,
106-42-3,0,OMOP Exposome,Observation,Substance,p-Xylene,"para-xylene; P-Xylene; p-Methyltoluene; p-dimethylbenzene; 4-methyltoluene; 1,4-xylene; 1,4-Dimethylbenzol; 1,4-Dimethylbenzene; p-Xylol; CHEBI:27417",2014-12-24,1,,,,,,,,,
28258-59-5,0,OMOP Exposome,Observation,Substance,p-Xylyl bromide,,2014-12-24,1,,,,,,,,,
P51575,0,OMOP Exposome,Observation,Substance,P2X purinoceptor 1,,2024-09-14,1,,,,,,,,,
P56373,0,OMOP Exposome,Observation,Substance,P2X purinoceptor 3,,2024-09-14,1,,,,,,,,,
Q99571,0,OMOP Exposome,Observation,Substance,P2X purinoceptor 4,,2024-09-14,1,,,,,,,,,
P47900,0,OMOP Exposome,Observation,Substance,P2Y purinoceptor 1,,2024-09-14,1,,,,,,,,,
Q96G91,0,OMOP Exposome,Observation,Substance,P2Y purinoceptor 11,,2024-09-14,1,,,,,,,,,
Q9H244,0,OMOP Exposome,Observation,Substance,P2Y purinoceptor 12,,2024-09-14,1,,,,,,,,,
P51582,0,OMOP Exposome,Observation,Substance,P2Y purinoceptor 4,,2024-09-14,1,,,,,,,,,
33069-62-4,0,OMOP Exposome,Observation,Substance,Paclitaxel,"Paxceed; Paxene; 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine; Taxol; ABI-007; 7-Epi-Paclitaxel; Onxol; Taxol A; Abraxane; 7-Epi-Taxol; 7-Epipaclitaxel; 7-Epitaxol; CHEBI:7887",2014-12-24,1,,,,,,,,,
GIS1009580,0,OMOP Exposome,Observation,Substance,Paclitaxel Pathway,,2024-09-14,1,,,,,,,,,
76738-62-0,0,OMOP Exposome,Observation,Substance,Paclobutrazol,"(2S,3S)-1-(4-Chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)-3-pentanol; Cultar; Bonzi; 1-tert-Butyl-2-(p-chlorobenzyl)-2-(1,2,4-triazol-1-yl)ethanol; Trimmit; (2S,3S)-1-(4-Chlorphenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol; (2S,3S)-1-(4-Chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol; Parlay; Paclobutrazol; Friazole; CHEBI:73162",2014-12-24,1,,,,,,,,,
P26367,0,OMOP Exposome,Observation,Substance,Paired box protein Pax-6,,2024-09-14,1,,,,,,,,,
7440-05-03,0,OMOP Exposome,Observation,Substance,Palladium,Paladio; Pd4+; Pd2+; Pd(II) ion; Pd(4+); Pd(2+); Pd(0); Pd; Palladium(IV) ion; Palladium(IV); Palladium(II) ion); Palladium(II); Palladium ion; CHEBI:33363,2014-12-24,1,,,,,,,,,
24-61-4,0,OMOP Exposome,Observation,Substance,Palladium acetylacetonate,,2014-12-24,1,,,,,,,,,
GIS1009581,0,OMOP Exposome,Observation,Substance,Palladium Compound,,2024-09-14,1,,,,,,,,,
12648-42-9,0,OMOP Exposome,Observation,Substance,Palladium hydride,,2014-12-24,1,,,,,,,,,
3375-31-3,0,OMOP Exposome,Observation,Substance,Palladium(II) acetate,,2014-12-24,1,,,,,,,,,
7647-10-1,0,OMOP Exposome,Observation,Substance,Palladium(II) chloride,,2014-12-24,1,,,,,,,,,
2035-66-7,0,OMOP Exposome,Observation,Substance,Palladium(II) cyanide,,2014-12-24,1,,,,,,,,,
90-38-7,0,OMOP Exposome,Observation,Substance,Palladium(II) iodide,,2014-12-24,1,,,,,,,,,
10102-05-3,0,OMOP Exposome,Observation,Substance,Palladium(II) nitrate,,2014-12-24,1,,,,,,,,,
1314-08-5,0,OMOP Exposome,Observation,Substance,Palladium(II) oxide,,2014-12-24,1,,,,,,,,,
566-03-5,0,OMOP Exposome,Observation,Substance,Palladium(II) sulfate,,2014-12-24,1,,,,,,,,,
57-10-3,0,OMOP Exposome,Observation,Substance,Palmitic acid,PLM; Univol U332; Pristerene 4934; Prifrac 2960; Prifac 2960; 1-Hexyldecanoate; 1-Hexyldecanoic acid; 1-Pentadecanecarboxylic acid; C16 fatty acid; Cetylic acid; Edenor C16; Emersol 140; Emersol 143; FAT; Glycon P-45; Hexadecanoate; Hexadecanoate (n-C16:0); Hexadecanoic acid; Hexadecanoic acid palmitic acid; Hexadecoate; Hexadecoic acid; Hexadecylic acid; Hexaectylic acid; Hydrofol; Hydrofol acid 1690; Hystrene 8016; Hystrene 9016; Industrene 4516; Kortacid 1698; Loxiol EP 278; Lunac P 95; Lunac P 95KC; Lunac P 98; N-Hexadecanoate; N-Hexadecanoic acid; N-Hexadecoate; N-Hexadecoic acid; Palmitate; Palmitinate; Palmitinic acid; Palmitinsaeure; Palmitoate; Palmitoic acid; PAM; Pentadecanecarboxylate; Pentadecanecarboxylic acid; CHEBI:15756,2014-12-24,1,,,,,,,,,
P50897,0,OMOP Exposome,Observation,Substance,Palmitoyl-protein thioesterase 1,,2024-09-14,1,,,,,,,,,
77734-91-9,0,OMOP Exposome,Observation,Substance,Palytoxin,,2014-12-24,1,,,,,,,,,
40391-99-9,0,OMOP Exposome,Observation,Substance,Pamidronate,Pamimed; Acide pamidronique; Acido pamidronico; Ribodroat; Pamidronic acid; Pamidronate Disodium; Aredia; Aminomux; Acidum pamidronicum; CHEBI:160401,2014-12-24,1,,,,,,,,,
GIS1009582,0,OMOP Exposome,Observation,Substance,Pamidronate Pathway,,2024-09-14,1,,,,,,,,,
GIS1009583,0,OMOP Exposome,Observation,Substance,Pancreas,,2024-09-14,1,,,,,,,,,
P04746,0,OMOP Exposome,Observation,Substance,Pancreatic alpha-amylase,,2024-09-14,1,,,,,,,,,
GIS1009584,0,OMOP Exposome,Observation,Substance,Pancreatic secretion,,2024-09-14,1,,,,,,,,,
GIS1009585,0,OMOP Exposome,Observation,Substance,Pantothenate and CoA Biosynthesis,,2024-09-14,1,,,,,,,,,
115-67-3,0,OMOP Exposome,Observation,Substance,Paramethadione,Paradione; Parametadiona; Parametadione; Paramethadionum; CHEBI:250989,2014-12-24,1,,,,,,,,,
311-45-5,0,OMOP Exposome,Observation,Substance,Paraoxon,"O,O-Diethyl-O-p-nitrophenylphosphoric acid; CHEBI:27827",2014-12-24,1,,,,,,,,,
1910-42-5,0,OMOP Exposome,Observation,Substance,Paraquat dichloride,"N,N'-Dimethyl-4, 4'-dipyridylium dichloride; N,N'-Dimethyl-4,4'-dipyridylium dichloride; N,N'-Dimethylviologen; Ortho paraquat CL; Parakwat; Paraquat chloride; Paraquat CL; Paraquat, dichloride; Paraquat-dichloride; Pathclear; Pillarquat; Pillarxone; Toxer total; N,N'-Dimethyl-4,4'-bipyridinium dichloride; N,N'-Dimethyl-4,4'-bipyridylium dichloride; Methylviologen chloride; Methyl-Viologen; Methyl viologen dichloride; Methyl viologen (reduced); Methyl viologen; Herboxone; Herbaxon; Gramuron; Gramoxone w; Gramoxone S; Gramoxone dichloride; Gramoxone D; Gramoxone; Gramixel; Goldquat 276; Galokson; Esgram; Dwuchlorek 1,1'-dwumetylo-4,4'-dwupirydyniowy; Dimethyldipyridyl chloride; Dimethyl viologen chloride; Dexuron; Dextrone-x; Dextrone X; Crisquat; Cekuquat; Bipyridinium, 1,1'-dimethyl-4,4'-, dichloride; 4,4'-Dimethyldipyridyl dichloride; 4,4'-Bipyridinium, 1,1'-dimethyl-, dichloride; 1,1-Dimethyl-4,4-dipyridilium dichloride; 1,1'-Dimethyl-4,4'-bipyridin-1,1'-diium dichloride; 1,1'-Dimethyl-4,4'-dipyridylium dichloride; 1,1'-Dimethyl-4,4'-dipyridinium-dichlorid; 1,1'-Dimethyl-4,4'-bipyridynium dichloride; 1,1'-Dimethyl-4,4'-bipyridinium dichloride hydrate; 1,1'-Dimethyl-4, 4'-dipyridylium chloride; 1,1 -Dimethyl-4,4 -bipyridinium; 1, 1'-Dimethyl-4,4'-bipyridynium dichloride; CHEBI:28786",2014-12-24,1,,,,,,,,,
GIS1009586,0,OMOP Exposome,Observation,Substance,Parasympatholytic,,2024-09-14,1,,,,,,,,,
GIS1009587,0,OMOP Exposome,Observation,Substance,Parasympathomimetic,,2024-09-14,1,,,,,,,,,
56-38-2,0,OMOP Exposome,Observation,Substance,Parathion,"Orthophos; Alkron; Alleron; Aphamite; Aqua 9-Parathion; Aralo; Bladan; Bladen; Corothion; Corthione; Danthion; Deoxynucleoside 5'-triphosphate; Diethyl 4-nitrophenyl phosphorothionate; Diethyl O-p-nitrophenyl phosphorothioate; Diethyl O-p-nitrophenyl phosphorothioic acid; Diethyl p-nitrophenyl thionophosphate; Diethyl p-nitrophenyl thiophosphate; Diethyl para-nitrophenol thiophosphate; Diethyl-p-nitrophenyl monothiophosphate; Diethylparathion; Drexel parathion 8E; Durathion; Ecatox; Ethlon; Ethyl parathion; Ethyl parathion (O,O-diethyl-O-p-nitrophenylthiophosphate); Etilon; Foliclal; Folidol; Folidol e e 605; Folidol e605; Folidol oil; Fosfermo; Fosferno; Fosferno 50; Fosfex; Fosfive; Fosova; Fostern; Fostox; Gearphos; Genithion; Kolphos; Kypthion; Lethalaire g-54; Lirothion; Murfos; Niran; Nitrostygmine; Niuif-100; Nourithion; O,O-Diethyl O-p-nitrophenyl phosphorothioate; O,O-Diethyl O-p-nitrophenyl phosphorothioic acid; O,O-Diethyl-O-(p-nitrophenyl)thionophosphate; Oleofos 20; Oleoparaphene; Oleoparathion; OMS 19; p-Nitrophenol O-ester with O,O-diethylphosphorothioate; p-Nitrophenol O-ester with O,O-diethylphosphorothioic acid; PAC; Pacol; Panthion; Paradust; Paramar; Paramar 50; Paraphos; Parathene; Parathion-E; Parawet; Parthion; Penncap e; Pestox plus; Pethion; Phoskil; Phosphemol; Phosphenol; Phosphorothioate; Phosphorothioic acid; Phosphorothioic acid O,O-diethyl-O-(4-nitrophenyl) ester; Phosphostigmine; Rhodiasol; Rhodiatox; Rhodiatrox; Selephos; Soprathion; Stabilized ethyl parathion; Stathion; Strathion; Sulfos; Super rodiatox; T-47; Thiomex; Thionspray No.84; Thiophos 3422; Tiofos; Vapophos; Viran; Vitrex; CHEBI:27928",2014-12-24,1,,,,,,,,,
61869-08-7,0,OMOP Exposome,Observation,Substance,Paroxetine,"Paxil CR; Sereupin; Pexeva; Paroxetina; Paroxetinum; Paxil; (-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine; Brisdelle; (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine; Aropax; Seroxat CR; Seroxat; PAXILCR; CHEBI:7936",2014-12-24,1,,,,,,,,,
11024-55-8,0,OMOP Exposome,Observation,Substance,Paspalicine,,2014-12-24,1,,,,,,,,,
63722-91-8,0,OMOP Exposome,Observation,Substance,Paspalinine,,2014-12-24,1,,,,,,,,,
63722-90-7,0,OMOP Exposome,Observation,Substance,Paspalitrem A,,2014-12-24,1,,,,,,,,,
63764-58-9,0,OMOP Exposome,Observation,Substance,Paspalitrem B,,2014-12-24,1,,,,,,,,,
GIS1009596,0,OMOP Exposome,Observation,Substance,Pathways In Cancer,,2024-09-14,1,,,,,,,,,
149-29-1,0,OMOP Exposome,Observation,Substance,Patulin,,2014-12-24,1,,,,,,,,,
57186-25-1,0,OMOP Exposome,Observation,Substance,Paxilline,,2014-12-24,1,,,,,,,,,
1114-71-2,0,OMOP Exposome,Observation,Substance,Pebulate,,2014-12-24,1,,,,,,,,,
40487-42-1,0,OMOP Exposome,Observation,Substance,Pendimethalin,,2014-12-24,1,,,,,,,,,
90-65-3,0,OMOP Exposome,Observation,Substance,Penicillic acid,,2014-12-24,1,,,,,,,,,
GIS1009597,0,OMOP Exposome,Observation,Substance,Penicillins,,2024-09-14,1,,,,,,,,,
12627-35-9,0,OMOP Exposome,Observation,Substance,Penitrem A,,2014-12-24,1,,,,,,,,,
11076-67-8,0,OMOP Exposome,Observation,Substance,Penitrem B,,2014-12-24,1,,,,,,,,,
37318-84-6,0,OMOP Exposome,Observation,Substance,Penitrem C,,2014-12-24,1,,,,,,,,,
219714-96-2,0,OMOP Exposome,Observation,Substance,Penoxsulam,,2014-12-24,1,,,,,,,,,
32534-81-9,0,OMOP Exposome,Observation,Substance,Pentabromodiphenyl ethers,,2014-12-24,1,,,,,,,,,
135-48-8,0,OMOP Exposome,Observation,Substance,Pentacene,"Benzobnaphthacene; Lin-dibenzanthracene; Benzo(b)naphthacene; 2,3,6,7-Dibenzanthracene; 2,3:6,7-Dibenzanthracene; Lin-naphthoanthracene; CHEBI:33148",2014-12-24,1,,,,,,,,,
87-86-5,0,OMOP Exposome,Observation,Substance,Pentachlorophenol,"Weedone; 1-Hydroxy-2,3,4,5,6-pentachlorobenzene; 2, 3,4,5,6-Pentachlorophenol; 2,3,4,5,6-Pentachlorophenol; Chem-Tol; Chlorophen; Dowicide 7; Dowicide G; Durotox; Fungifen; Glazd penta; Grundier Arbezol; Lauxtol; Lauxtol A; Liroprem; PCP; Penchlorol; Penta; Penta-Kil; Pentachloro-Phenol; Pentachlorophenate; Pentachlorophenol pure; Pentacon; Pentasol; Penwar; Peratox; Permacide; Permagard; Permasan; Permatox; Permite; Preventol P; Santobrite; Santophen; Santophen 20; Sinituho; Term-i-trol; Thompson'S wood fix; CHEBI:17642",2014-12-24,1,,,,,,,,,
629-62-9,0,OMOP Exposome,Observation,Substance,Pentadecane,CH3-CH213-CH3; Pentadekan; n-Pentadecane; CHEBI:28897,2014-12-24,1,,,,,,,,,
1978-11-05,0,OMOP Exposome,Observation,Substance,Pentaerythritol tetranitrate,"Pentafin; 2,2-Bis((nitrooxy)methyl)-1,3-propanediol dinitrate; 2,2-Bis((nitrooxy)methyl)-1,3-propanediol dinitrate (ester); 2,2-Bis((nitrooxy)methyl)-1,3-propanediol dinitrate ester; 2,2-Bis(Hydroxymethyl)-1,3-propanediol tetranitrate; 2,2-Bisdihydroxymethyl-1,3-propanediol tetranitrate; 2,2-Bis(nitrooxy)methyl-1,3-propanediol dinitrate (ester); 3-(Nitrooxy)-2,2-bis(nitrooxy)methylpropyl nitrate; Angicap; Angitet; Antora; Arcotrate; Baritrate; Cardiacap; CHOT; Corpent; Delt rate-20; Deltrate 20; Deltrate-20; Dilcoran; Dilcoran 80; Dilcoran-80; Dipentrate; Duotrate; El petn; Erinit; Erynitum; Extex; Hasethrol; Kaytrate; Lentrat; Lowetrate; LX 16 (explosive); Martrate 45; Martrate-45; Metranil; Mikardol; Miltrate; Mixture name; Mycardol; Myotrate 10; Neo-corovas; Neopentanetetrayl nitrate; Nexol-e; Nicochloran; Niperyt; Niperyth; Nirason; Nitrin; Nitrinal; Nitrine; Nitrinol; Nitro-riletten; Nitrodex; Nitrolong; Nitropent; Nitropenta; Nitropenta 7W; Nitropentaerythrite; Nitropentaerythritol; Nitropenton; Nitrotalans; Omnitox; Ovadziak; P.E.T.N.; Pen-tetra; Pencard; PENT; Penta; Pentaerithrityl tetranitrate; Pentaerythrite tetranitrate; Pentaerythritol nitrate; Pentaerythritol tetran; Pentaerythritol tetranitrate with D-lactose monohydrate; Pentaerythritol tetranitrate, diluted; Pentaerythritol tetranitric acid; Pentaerythrityl tetranitrate; Pentaerythritylium tetranitricum; Pentafilin; Pentalog; Pentanitrine; Pentanitrol; Pentanitrolum; Pentarit; Pentestan-80; Pentetrate unicelles; Penthrit; Penthrite; Pentitrate; Pentral 80; Pentran; Pentrate; Pentrinat; Pentriol; Pentrite; Pentritol; Pentritol tempules; Pentryate; Pentryate 80; Pergitral; Peridex; Peridex-la; Peritrate; Perityl; PET; PETN; Petn, NF; Prevangor; Quintrate; Rythritol; Subicard; Tanipent; TEN; Tentrate-20; Terpate; Tetranitrate, pentaerythritol; Tetranitropentaerythritol; Tetrasule; Tetrate; Tranite d-lay; Vanguard brand of pentaerythritol tetranitrate; Vasitol; Vaso-80; Vaso-80 unicelies; Vaso-80 Unicelles; Vasodiatol; Vasolat; 1,3-Dinitrato-2,2-bis(nitratomethyl)propane; 1-3 Propanediol,2,2-bis(nitroxy)methyl-dinitrate ester; CHEBI:25520",2014-12-24,1,,,,,,,,,
100-33-4,0,OMOP Exposome,Observation,Substance,Pentamidine,"4,4'-Diamidinodiphenoxypentane; Pentamidina; Pentacarinat; Pentacrinat; Pentam; 4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide; P,P'-(pentamethylenedioxy)dibenzamidine; NebuPent; 1,3-Bis(4-amidinophenoxy)pentane; 1,5-Bis(4-amidinophenoxy)pentane; 4, 4'-Diamidinodiphenoxypentane; 4,4'-(Pentamethylenedioxy)dibenzamidine; Pentam 300; Pentamide; Pentamidin; PNT; Pneumopent; Pentamidinum; Pentamidine Isethionate; Pentamidindiisetionat; CHEBI:45081",2014-12-24,1,,,,,,,,,
109-66-0,0,OMOP Exposome,Observation,Substance,Pentane,N-Pentane; CHEBI:37830,2014-12-24,1,,,,,,,,,
359-83-1,0,OMOP Exposome,Observation,Substance,Pentazocine,Pentazocina; Fortal; Fortral; Fortwin; L-Pentazocine; Pangon; Pentagin; Pentazocaine; Pentazocin; Talwin PX; Talwin; Stopain; Sosegon; Pentazocinum; CHEBI:116117,2014-12-24,1,,,,,,,,,
76-74-4,0,OMOP Exposome,Observation,Substance,Pentobarbital,"5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione; Pentobarbiturate; Pentobarbituric acid; Sodium Pentobarbital; Pentabarbital; Pentabarbitone; Pentobarbitone; Nembutal; 5-ethyl-5-(sec-pentyl)barbituric acid; 5-ethyl-5-(1-methylbutyl)barbituric acid; 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; CHEBI:7983",2014-12-24,1,,,,,,,,,
GIS1009598,0,OMOP Exposome,Observation,Substance,Pentose and glucuronate interconversions,,2024-09-14,1,,,,,,,,,
GIS1009599,0,OMOP Exposome,Observation,Substance,Pentose Phosphate Pathway,,2024-09-14,1,,,,,,,,,
124505-87-9,0,OMOP Exposome,Observation,Substance,Pentosidine,"(2S)-2-amino-6-(2-{(4S)-4-amino-4-carboxybutylamino}-4H-imidazo4,5-bpyridin-4-yl)hexanoic acid; 6-(2-{(4S)-4-Amino-4-carboxybutylamino}-4H-imidazo4,5-bpyridin-4-yl)-L-norleucine; CHEBI:59951",2014-12-24,1,,,,,,,,,
53910-25-1,0,OMOP Exposome,Observation,Substance,Pentostatin,,2014-12-24,1,,,,,,,,,
GIS1009600,0,OMOP Exposome,Observation,Substance,Peptidoglycan Biosynthesis,,2024-09-14,1,,,,,,,,,
P62937,0,OMOP Exposome,Observation,Substance,Peptidyl-prolyl cis-trans isomerase A,,2024-09-14,1,,,,,,,,,
P23284,0,OMOP Exposome,Observation,Substance,Peptidyl-prolyl cis-trans isomerase B,,2024-09-14,1,,,,,,,,,
P45877,0,OMOP Exposome,Observation,Substance,Peptidyl-prolyl cis-trans isomerase C,,2024-09-14,1,,,,,,,,,
P30405,0,OMOP Exposome,Observation,Substance,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",,2024-09-14,1,,,,,,,,,
P62942,0,OMOP Exposome,Observation,Substance,Peptidyl-prolyl cis-trans isomerase FKBP1A,,2024-09-14,1,,,,,,,,,
Q02790,0,OMOP Exposome,Observation,Substance,Peptidyl-prolyl cis-trans isomerase FKBP4,,2024-09-14,1,,,,,,,,,
Q13427,0,OMOP Exposome,Observation,Substance,Peptidyl-prolyl cis-trans isomerase G,,2024-09-14,1,,,,,,,,,
O43447,0,OMOP Exposome,Observation,Substance,Peptidyl-prolyl cis-trans isomerase H,,2024-09-14,1,,,,,,,,,
Q13526,0,OMOP Exposome,Observation,Substance,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,,2024-09-14,1,,,,,,,,,
GIS1009601,0,OMOP Exposome,Observation,Substance,Perchlorate,,2024-09-14,1,,,,,,,,,
335-76-2,0,OMOP Exposome,Observation,Substance,Perfluorodecanoic acid,"PFDA; 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Nonadecafluorodecanoic acid; Ndfda; Nonadecafluoro-N-decanoic acid; Perfluoro-N-decanoic acid; Perfluorodecanoate; CHEBI:CHEBI:35546",2014-12-24,1,,,,,,,,,
375-95-1,0,OMOP Exposome,Observation,Substance,Perfluorononanoic acid,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-Heptadecafluorononanoic acid; Perfluoro-N-nonanoic acid; Perfluorononan-1-oic acid; Perfluorononanoate; Heptadekafluornonansaeure; PFNA; Perfluornonansaeure; Heptadecafluornonansaeure; CHEBI:CHEBI:38397",2014-12-24,1,,,,,,,,,
1763-23-1,0,OMOP Exposome,Observation,Substance,Perfluorooctanesulfonic acid,PFOS; Perfluorooctylsulfonic acid; Perfluorooctanesulfonate; Heptadecafluoro-1-octanesulfonic acid; 1-Perfluorooctanesulfonic acid; CHEBI:39421,2014-12-24,1,,,,,,,,,
335-67-1,0,OMOP Exposome,Observation,Substance,Perfluorooctanoic acid,"Pentadecafluoro-N-octanoic acid; PFOA; Perfluorooctanoate; Perfluoroheptanecarboxylic acid; Perfluorocaprylic acid; Perfluoro-N-octanoic acid; Pentadecafluoro-1-octanoic acid; 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Pentadecafluorooctanoic acid; CHEBI:35549",2014-12-24,1,,,,,,,,,
2058-94-8,0,OMOP Exposome,Observation,Substance,Perfluoroundecanoic acid,,2014-12-24,1,,,,,,,,,
71329-60-7,0,OMOP Exposome,Observation,Substance,Perfringolysin O,,2014-12-24,1,,,,,,,,,
66104-22-1,0,OMOP Exposome,Observation,Substance,Pergolide,Pergolida; Pergolide Mesylate; Pergolide Methanesulfonate; Pergolidum; Permax; CHEBI:63617,2014-12-24,1,,,,,,,,,
6621-47-2,0,OMOP Exposome,Observation,Substance,Perhexiline,"(+)-2-(2,2-Dicyclohexylethyl)piperidine; Perhexilina; Perhexilinum; Perhexilline; 2-(2,2-Dicyclohexylethyl)piperidine; (-)-2-(2,2-Dicyclohexylethyl)piperidine; Perhexilene; CHEBI:35553",2014-12-24,1,,,,,,,,,
O60240,0,OMOP Exposome,Observation,Substance,Perilipin-1,,2024-09-14,1,,,,,,,,,
Q00G26,0,OMOP Exposome,Observation,Substance,Perilipin-5,,2024-09-14,1,,,,,,,,,
GIS1009602,0,OMOP Exposome,Observation,Substance,Perinuclear region,,2024-09-14,1,,,,,,,,,
GIS1009603,0,OMOP Exposome,Observation,Substance,Peripheral Adrenergic Inhibitor,,2024-09-14,1,,,,,,,,,
52645-53-1,0,OMOP Exposome,Observation,Substance,Permethrin,"Nix; (3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate; 3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester; Acticin; Elimite; Lyclear; CHEBI:34911",2014-12-24,1,,,,,,,,,
Q06830,0,OMOP Exposome,Observation,Substance,Peroxiredoxin-1,,2024-09-14,1,,,,,,,,,
P30044,0,OMOP Exposome,Observation,Substance,"Peroxiredoxin-5, mitochondrial",,2024-09-14,1,,,,,,,,,
P30041,0,OMOP Exposome,Observation,Substance,Peroxiredoxin-6,,2024-09-14,1,,,,,,,,,
Q9UKG9,0,OMOP Exposome,Observation,Substance,Peroxisomal carnitine O-octanoyltransferase,,2024-09-14,1,,,,,,,,,
GIS1009604,0,OMOP Exposome,Observation,Substance,Peroxisomal Matrix,,2024-09-14,1,,,,,,,,,
GIS1009605,0,OMOP Exposome,Observation,Substance,Peroxisomal Membrane,,2024-09-14,1,,,,,,,,,
Q9P0Z9,0,OMOP Exposome,Observation,Substance,Peroxisomal sarcosine oxidase,,2024-09-14,1,,,,,,,,,
Q9BY49,0,OMOP Exposome,Observation,Substance,Peroxisomal trans-2-enoyl-CoA reductase,,2024-09-14,1,,,,,,,,,
GIS1009606,0,OMOP Exposome,Observation,Substance,Peroxisome,,2024-09-14,1,,,,,,,,,
Q07869,0,OMOP Exposome,Observation,Substance,Peroxisome proliferator-activated receptor alpha,,2024-09-14,1,,,,,,,,,
Q03181,0,OMOP Exposome,Observation,Substance,Peroxisome proliferator-activated receptor delta,,2024-09-14,1,,,,,,,,,
P37231,0,OMOP Exposome,Observation,Substance,Peroxisome proliferator-activated receptor gamma,,2024-09-14,1,,,,,,,,,
58-39-9,0,OMOP Exposome,Observation,Substance,Perphenazine,Perfenazine; Emesinal; gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine; Fentazin; Ethaperazine; Etaperazine; Etaperazin; 2-(4-3-(2-chloro-10H-Phenothiazin-10-yl)propyl-1-piperazinyl)ethanol; Perphenazin; Perphenan; Trilifan; Trilafon; PZC; Decentan; Chlorpiprazine; Perphenazinum; Chlorperphenazine; Perfenazina; 4-3-(2-Chlorophenothiazin-10-yl)propyl-1-piperazineethanol; 4-3-(2-chloro-10H-Phenothiazin-10-yl)propyl-1-piperazineethanol; 2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine; Perph\u00e9nazine; CHEBI:8028,2014-12-24,1,,,,,,,,,
70323-44-3,0,OMOP Exposome,Observation,Substance,Pertussis toxin,,2014-12-24,1,,,,,,,,,
GIS1009607,0,OMOP Exposome,Observation,Substance,Pesticide,,2024-09-14,1,,,,,,,,,
GIS1009608,0,OMOP Exposome,Observation,Substance,Phagosome,,2024-09-14,1,,,,,,,,,
26645-35-2,0,OMOP Exposome,Observation,Substance,Phallacidin,"28-(2,3-Dihydroxy-2-methylpropyl)-18-hydroxy-31-isopropyl-23-methyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,25,27,30,33,36-octaazapentacyclo12.11.11.03,11.04,9.016,20hexatriaconta-3(11 ),4,6,8-tetraen-34-yl(hydroxy)acetic acid; CHEBI:52732",2014-12-24,1,,,,,,,,,
53568-40-4,0,OMOP Exposome,Observation,Substance,Phallacin,,2014-12-24,1,,,,,,,,,
58286-46-7,0,OMOP Exposome,Observation,Substance,Phallisacin,,2014-12-24,1,,,,,,,,,
19774-69-7,0,OMOP Exposome,Observation,Substance,Phallisin,,2014-12-24,1,,,,,,,,,
17466-45-4,0,OMOP Exposome,Observation,Substance,Phalloidin,Phalloidine; CHEBI:8040,2014-12-24,1,,,,,,,,,
28227-92-1,0,OMOP Exposome,Observation,Substance,Phalloin,,2014-12-24,1,,,,,,,,,
GIS1009609,0,OMOP Exposome,Observation,Substance,Phallotoxin,,2024-09-14,1,,,,,,,,,
GIS1009610,0,OMOP Exposome,Observation,Substance,Pharmaceutic Aid,,2024-09-14,1,,,,,,,,,
2543-94-4,0,OMOP Exposome,Observation,Substance,Phellopterin,,2014-12-24,1,,,,,,,,,
63-98-9,0,OMOP Exposome,Observation,Substance,Phenacemide,Phenylacetylurea; Phenurone; Phenacetylurea; Phenacetylcarbamide; Carbamide phenylacetate; Phenylacetyluree; CHEBI:183000,2014-12-24,1,,,,,,,,,
62-44-2,0,OMOP Exposome,Observation,Substance,Phenacetin,Acetophenetidine; Acetophenetidin; Acetophenetin; Acetphenetidin; Achrocidin; Codempiral; Commotional; Contradol; Contradouleur; CHEBI:8050,2014-12-24,1,,,,,,,,,
70-11-1,0,OMOP Exposome,Observation,Substance,Phenacyl bromide,".omega.-bromoacetophenone; .alpha.-bromoacetophenone; .omega.-bromacetophenone; 2-Bromo-1-phenylethanone; 2-Bromoacetophenone; a-bromoacetophenone; Acetophenone, 2-bromo- (8CI); Alpha-bromoacetophenone; Benzoylmethyl bromide; Bromoacetophenone; Bromomethyl phenyl ketone; Halomethyl Phenyl Ketone deriv. 23; Omega-bromacetophenone; Omega-bromoacetophenone; Stauffer 4644; CHEBI:51846",2014-12-24,1,,,,,,,,,
85-01-8,0,OMOP Exposome,Observation,Substance,Phenanthrene,"9,10-Dehydrophenanthrene; Ravatite; Phenanthracene; Phenanthrin; Phenantrin; CHEBI:28851",2014-12-24,1,,,,,,,,,
58-36-6,0,OMOP Exposome,Observation,Substance,Phenarsazine oxide,,2014-12-24,1,,,,,,,,,
51-71-8,0,OMOP Exposome,Observation,Substance,Phenelzine,\u03b2-Phenylethylhydrazine; Phenelzinum; Nardil; Alazine; Fenelzina; Nardelzine; Monofen; Margyl; Phenelzine Sulfate; Phenelzin; Ph\u00e9nelzine; CHEBI:248018,2014-12-24,1,,,,,,,,,
82-88-2,0,OMOP Exposome,Observation,Substance,Phenindamine,Thephorin; Fenindamina; Phenindaminum; Nolahist; Phenindiamine; CHEBI:130096,2014-12-24,1,,,,,,,,,
83-12-5,0,OMOP Exposome,Observation,Substance,Phenindione,"2-Phenyl-1,3-diketohydrindene; Fenindione; Phenindion; Ph\u00e9nindione; Phenindionum; Fenindiona; PID; Soluthrombine; 2-Phenyl-1,3(2H)-indenedione; 2-Phenyl-1,3-indandione; Fenindion; Dindevan; CHEBI:8066",2014-12-24,1,,,,,,,,,
13684-63-4,0,OMOP Exposome,Observation,Substance,Phenmedipham,,2014-12-24,1,,,,,,,,,
134-49-6,0,OMOP Exposome,Observation,Substance,Phenmetrazine,Phenmetrazinum; USAF Ge-1; Preludin; Phenmetrazin; Oxazimedrine; Fenmetrazina; Fenmetrazin; Dexphenmetrazine; Defenmetrazin; 3-Methyl-2-phenylmorpholine; 2-Phenyl-3-Methylmorpholine; CHEBI:8067,2014-12-24,1,,,,,,,,,
50-06-6,0,OMOP Exposome,Observation,Substance,Phenobarbital,"Phenylethylmalonylurea; 5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione; 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-Ethyl-5-phenylbarbituric acid; 5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione; 5-Phenyl-5-ethylbarbituric acid; Fenobarbital; Luminal; Phenobarbitol; Phenobarbitone; Phenobarbituric acid; Phenylaethylbarbitursaeure; Phenylethylbarbiturate; Phenylethylbarbituric acid; Phenylethylbarbitursaeure; CHEBI:8069",2014-12-24,1,,,,,,,,,
108-95-2,0,OMOP Exposome,Observation,Substance,Phenol,Fenosmolin; Paoscle; Carbolic acid; Hydroxy-benzene; Fenolo; Hydroxybenzene; IPH; IZAL; Karbolsaeure; Liquid phenol; Liquified phenol; Monohydroxy benzene; Monohydroxybenzene; Phenole; Phenosmolin; Phenyl alcohol; Benzophenol; Phenyl hydroxide; Phenylic acid; Phenylic alcohol; Fenol; Cepastat lozenges; Carbolsaure; Carbolsaeure; PHOH; Synthetic phenol; Tea polyphenol; Monophenol; Carbolic oil; Phenic; Campho-phenique liquid; Campho-phenique gel; Benzenol; Anbesol; Campho-phenique cold sore gel; Phenic acid; Phenic alcohol; Phenol alcohol; Phenolated water; Phenol liquid; Oxybenzene; Fenosmoline; Carbolic acid liquid; CHEBI:15882,2014-12-24,1,,,,,,,,,
77-09-8,0,OMOP Exposome,Observation,Substance,Phenolphthalein,,2014-12-24,1,,,,,,,,,
GIS1009611,0,OMOP Exposome,Observation,Substance,Phenothiazine,,2024-09-14,1,,,,,,,,,
GIS1009620,0,OMOP Exposome,Observation,Substance,Phenothiazines,,2024-09-14,1,,,,,,,,,
26002-80-2,0,OMOP Exposome,Observation,Substance,Phenothrin,"(+)-Cis-fenothrin; Wellcide; Sumitrin; Sumithrin; S 2539 (pesticide); Pibutin; Phonothrin; Phenoxythrin; Phenoxybenzyl-d-z/e-chrysanthemate; Phenoxybenzyl chrysanthemate; Phenoxybenzyl (1R)-cis/trans chrysanthemate; Phenothrine; Phenothrin, (trans-(+-))-isomer; Phenothrin, (cis-(+-))-isomer; phenothrin, (1S-trans)-isomer; phenothrin, (1S-cis)-isomer; phenothrin, (1R-trans)-isomer; phenothrin, (1R-cis)-isomer; Multicide Concentrate F-2271; Multicide 2154; Forte; Fenothrin; Delta-(cis-trans)-phenothrin; D-phenthrin (trans); D-phenothrin; Caswell No. 652B; Anvil; Anchimanaito 20S; 3-Phenoxybenzyl D-Z/E chrysanthemate; 3-Phenoxybenzyl chrysanthemate; 3-Phenoxybenzyl (1RS)-cis,trans-chrysanthemate; 3-Phenoxybenzyl (+-)-cis-trans-chrysanthemate; 2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid (3-phenoxyphenyl)methyl ester; (-)-Trans-phenothrin; (+/-)-phenoxybenzyl-cis,trans-chrysanthemate; CHEBI:34916",2014-12-24,1,,,,,,,,,
435-97-2,0,OMOP Exposome,Observation,Substance,Phenprocoumon,3-(1'-Phenyl-propyl)-4-oxycoumarin; Marcoumar; Phenprocumone; 3-(1-Phenylpropyl)-4-hydroxycoumarin; 3-(alpha-Ethylbenzyl)-4-hydroxycoumarin; 3-(alpha-Phenylpropyl)-4-hydroxycoumarin; 4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one; 4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one; Phenprocoumonum; Phenprocoumone; Phenprocoumarole; Phenprocoumarol; Marcumar; Falithrom; Fenprocumon; Fenprocumone; CHEBI:50438,2014-12-24,1,,,,,,,,,
122-09-8,0,OMOP Exposome,Observation,Substance,Phentermine,"Fentermina; Ionamin; Obenix; Obestin-30; Phentercot; Phenterminum; Phentride; Pro-Fast; Suprenza; Teramine; Duromine; Fastin; Zantryl; Adipex-P; alpha,alpha-Dimethylphenethylamine; (alpha,alpha)-Dimethylphenethylamine; CHEBI:8080",2014-12-24,1,,,,,,,,,
103-71-9,0,OMOP Exposome,Observation,Substance,Phenyl isocyanate,"PI; Additive ti; Benzene,isocyanate; Carbanil; Fenylisokyanat; Isocyanatobenzene; Isocyanic acid, phenyl ester; Isocyanic acid, phenyl ester (8ci); Karbanil; Mondur p; Phenyl carbonimide; Phenyl ester OF isocyanic acid; Phenyl isocyanic acid; Phenylcarbimide; PHNCO; CHEBI:53806",2014-12-24,1,,,,,,,,,
103-72-0,0,OMOP Exposome,Observation,Substance,Phenyl isothiocyanate,,2014-12-24,1,,,,,,,,,
118-55-8,0,OMOP Exposome,Observation,Substance,Phenyl salicylate,"Salphenyl; Seesorb 201; Fenylester kyseliny salicylove; Musol; Phenol salicylate; Phenyl salicylic acid; Phenyl 2-hydroxybenzoate; Phenyl-2-hydroxybenzoate; Salicylic acid, phenyl ester; Salol; 2-Hydroxy-benzoic acid phenyl ester; 2-Hydroxybenzoic acid phenyl ester; 2-Hydroxybenzoic acid, phenyl ester; 2-Phenoxycarbonylphenol; Benzoic acid, 2-hydroxy-, phenyl ester; Seesorb K 201; CHEBI:34918",2014-12-24,1,,,,,,,,,
122-78-1,0,OMOP Exposome,Observation,Substance,Phenylacetaldehyde,a-Toluic aldehyde; Phenylethanal; Phenylacetic aldehyde; Phenyl-Acetaldehyde; Phenacetaldehyde; Oxophenylethane; Hyacinthin; FEMA No. 2974; Benzylcarboxaldehyde; Benzeneacetaldehyde; Benzenacetaldehyde; alpha-Toluic aldehyde; alpha-Tolualdehyde; alpha-Phenylacetaldehyde; a-Tolualdehyde; a-Phenylacetaldehyde; 2-Phenylethanal; 2-Phenylacetaldehyde; 1-Oxo-2-phenylethane; .alpha.-toluic aldehyde; CHEBI:16424,2014-12-24,1,,,,,,,,,
GIS1009621,0,OMOP Exposome,Observation,Substance,Phenylacetate Metabolism,,2024-09-14,1,,,,,,,,,
103-82-2,0,OMOP Exposome,Observation,Substance,Phenylacetic acid,Benzylformate; Benzeneacetic acid; Benzeneacetate; alpha-Toluic acid; alpha-Toluate; a-Toluic acid; 2-Phenylethanoic acid; 2-Phenylethanoate; w-Phenylacetate; Phenylethanoic acid; a-Toluate; 2-Phenylacetic acid; 2-Phenylacetate; Phenylethanoate; Phenylacetate; Omega-Phenylacetic acid; Omega-Phenylacetate; Benzylformic acid; w-Phenylacetic acid; CHEBI:30745,2014-12-24,1,,,,,,,,,
GIS1009622,0,OMOP Exposome,Observation,Substance,Phenylalanine and Tyrosine Metabolism,,2024-09-14,1,,,,,,,,,
GIS1009623,0,OMOP Exposome,Observation,Substance,Phenylalanine metabolism,,2024-09-14,1,,,,,,,,,
Q9Y285,0,OMOP Exposome,Observation,Substance,Phenylalanine--tRNA ligase alpha subunit,,2024-09-14,1,,,,,,,,,
Q9NSD9,0,OMOP Exposome,Observation,Substance,Phenylalanine--tRNA ligase beta subunit,,2024-09-14,1,,,,,,,,,
O95363,0,OMOP Exposome,Observation,Substance,"Phenylalanine--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
P00439,0,OMOP Exposome,Observation,Substance,Phenylalanine-4-hydroxylase,,2024-09-14,1,,,,,,,,,
696-28-6,0,OMOP Exposome,Observation,Substance,Phenyldichloroarsine,,2014-12-24,1,,,,,,,,,
4044-65-9,0,OMOP Exposome,Observation,Substance,"Phenylene-1,4-diisothiocyanate",,2014-12-24,1,,,,,,,,,
P11086,0,OMOP Exposome,Observation,Substance,Phenylethanolamine N-methyltransferase,,2024-09-14,1,,,,,,,,,
GIS1009624,0,OMOP Exposome,Observation,Substance,Phenylketonuria,,2024-09-14,1,,,,,,,,,
62-38-4,0,OMOP Exposome,Observation,Substance,Phenylmercuric acetate,"Tag; (acetato)phenylmercury; (acetato-kappao)(phenyl)mercury; (acetato-o)phenylmercury; (aceto)phenylmercury; (acetoxymercuri)benzene; (acetoxymercurio)-benzene; Acetato(phenyl)mercury; Acetoxyphenylmercury; Advacide pma 18; Agrosan; Agrosan d; Agrosan gn 5; Algimycin; Algimycin 200; Anticon; Antimucin WBR; Antimucin WDR; Bufen; Bufen 30; C.I. Pigment Green 2; Cekusil; Celmer; Ceresan; Ceresan universal; Ceresol; Contra creme; Cosan pma; Dyanacide; Femma; FMA; Fungicide r; Fungitox; Fungitox or; Gallotox; Hexasan; Hexasan (fungicide); Hexasan, fungicide; Hong nien; Hostaquick; Hostaquik; Intercide 60; Intercide PMA 18; Kwiksan; Leytosan; Liquiphene; Lorophyn; Meracen; Mercron; Mercuriphenyl acetate; Mercuron; Mercury phenyl acetate; Mergal A25; Mersolite; Mersolite 8; Mersolite d; Metasol 30; Neantina; Nildew AC 30; Norforms; Nuodex PMA 18; Nylmerate; Pamisan; Panomatic; Parasan; Phenmad; Phenomercuric acetate; Phenyl mercuric acetate; Phenylmercuriacetate; Phenylmercuric acetate (NF); Phenylmercuric acetic acid; Phenylmercury acetate; Phenylmercury deriv; Phenylmercury(II) acetate; Phenylmercury(II)acetate; Phenylquecksilberacetate; PHIX; PMA; Pma (fungicide); PMAC; Pmacetate; PMAL; PMAS; Programin; Purasan-sc-10; Puraturf 10; Quicksan; Quicksan 20; Riogen; Ruberon; Samtol; Sanitized SPG; Sanitol; Sanmicron; Scutl; Seedtox; Setrete; Shimmer-ex; Shimmerex; Spor-kil; Spruce seal; TAG; Tag fungicide; Tag HL 331; Tag HL-331; Trigosan; Troysan 30; Troysan PMA 30; Unisan; Verdasan; Volpar; Zaprawa nasienna r; Ziarnik; CHEBI:27684",2014-12-24,1,,,,,,,,,
102-98-7,0,OMOP Exposome,Observation,Substance,Phenylmercuric borate,,2014-12-24,1,,,,,,,,,
100-56-1,0,OMOP Exposome,Observation,Substance,Phenylmercuric chloride,,2014-12-24,1,,,,,,,,,
55-68-5,0,OMOP Exposome,Observation,Substance,Phenylmercuric nitrate,,2014-12-24,1,,,,,,,,,
GIS1009625,0,OMOP Exposome,Observation,Substance,Phenylpropanoid Biosynthesis,,2024-09-14,1,,,,,,,,,
57-41-0,0,OMOP Exposome,Observation,Substance,Phenytoin,"Diphenylan Sodium; Diphenylhydantoin; Diphenylhydatanoin; Epanutin; Eptoin; 5,5-diphenyltetrahydro-1H-2,4-imidazoledione\t; 5,5-Diphenyltetrahydro-1H-2,4-imidazoledione; 5,5-Dwufenylohydantoina; Dihydantoin; Fenitoina; 5,5-diphenylimidazolidine-2,4-dione; 5,5-Diphenylhydantoin; 5,5-Diphenyl-imidazolidine-2,4-dione; PHENTYTOIN; Phenytek; Phenytoin Sodium; Phenytoine; Phenytoinum; DILANTIN; Dilantin-125; CHEBI:8107",2014-12-24,1,,,,,,,,,
77108-00-0,0,OMOP Exposome,Observation,Substance,Philanthotoxin,,2014-12-24,1,,,,,,,,,
GIS1009626,0,OMOP Exposome,Observation,Substance,Phoneutriatoxin,,2024-09-14,1,,,,,,,,,
298-02-2,0,OMOP Exposome,Observation,Substance,Phorate,"O,O-diethyl ethylthiomethyl phosphorodithioate; Forate; Granutox; Volphor; Vergfru foratox; Vegfru foratox; Timet; Thimet; Thimenox; Thimate; Terrathion; Rampart; Phosphorodithioic acid, O,O-diethyl S-((ethylthio)methyl) ester; Phoric acid; O,O-diethyl-S-((ethylthio)methyl)phosphorodithioate; O,O-diethyl S-(ethylthio)methyl phosphorodithioate; O,O-diethyl S-(ethylsulfanyl)methyl phosphorodithioate; O,O-diethyl S-(ethylsulfanyl)methyl dithiophosphate; O,O-diethyl s-ethylthiomethyl thiothionophosphate; O,O-diethyl S-ethylthiomethyl dithiophosphonate; O,O-diethyl S-ethylthiomethyl dithiophosphate; O,O-diethyl S-ethylmercaptomethyl dithiophosphonate; O,O-diethyl s-ethylmercaptomethyl dithiophosphate; O,O-diethyl S-(ethylthiomethyl) phosphorodithioate; O,O-diethyl S-(ethylthio)methyl phosphorodithioate; Aastar; Agrimet; Geomet; CHEBI:38764",2014-12-24,1,,,,,,,,,
17673-25-5,0,OMOP Exposome,Observation,Substance,Phorbol,"4,9,12beta,13,20-Pentahydroxytiglia-1,6-dien-3-one; 4,9,12beta,13,20-Pentahydroxy-1,6-tigliadien-3-on; CHEBI:CHEBI:8116",2014-12-24,1,,,,,,,,,
2310-17-0,0,OMOP Exposome,Observation,Substance,Phosalone,"Fosalon; Fosalone; Azofene; Phasolon; Phosalon; Phosphorodithioic acid, S-((6-chloro-2-oxo-3(2H)-benzoxazolyl)methyl) O,O-diethyl ester; Phozalon; Rubitox; S-(6-Chloro-2-oxo-1,3-benzoxazol-3(2H)-yl)methyl O,O-diethyl dithiophosphate; Zolone; S-(6-Chloro-2-oxo-1,3-benzoxazol-3(2H)-yl)methyl O,O-diethyl phosphorodithioate; Zolone PM; Zoolon; Benzophosphate; 3-O,O-(Diethyldithiophosphoryl)methyl-6-chlorobenzoxazolinone; Agria 1060 A; Fozalon; CHEBI:8121",2014-12-24,1,,,,,,,,,
1794-86-1,0,OMOP Exposome,Observation,Substance,Phosgene oxime,,2014-12-24,1,,,,,,,,,
Q8WUK0,0,OMOP Exposome,Observation,Substance,Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1,,2024-09-14,1,,,,,,,,,
P60484,0,OMOP Exposome,Observation,Substance,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",,2024-09-14,1,,,,,,,,,
P27986,0,OMOP Exposome,Observation,Substance,Phosphatidylinositol 3-kinase regulatory subunit alpha,,2024-09-14,1,,,,,,,,,
O00459,0,OMOP Exposome,Observation,Substance,Phosphatidylinositol 3-kinase regulatory subunit beta,,2024-09-14,1,,,,,,,,,
Q92569,0,OMOP Exposome,Observation,Substance,Phosphatidylinositol 3-kinase regulatory subunit gamma,,2024-09-14,1,,,,,,,,,
P42336,0,OMOP Exposome,Observation,Substance,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",,2024-09-14,1,,,,,,,,,
P42338,0,OMOP Exposome,Observation,Substance,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",,2024-09-14,1,,,,,,,,,
O00329,0,OMOP Exposome,Observation,Substance,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",,2024-09-14,1,,,,,,,,,
P48736,0,OMOP Exposome,Observation,Substance,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",,2024-09-14,1,,,,,,,,,
GIS1009636,0,OMOP Exposome,Observation,Substance,Phosphatidylinositol Phosphate Metabolism,,2024-09-14,1,,,,,,,,,
GIS1009637,0,OMOP Exposome,Observation,Substance,Phosphide,,2024-09-14,1,,,,,,,,,
7803-51-2,0,OMOP Exposome,Observation,Substance,Phosphine,Phosphorus hydride; Phosphene; Trihydrogen phosphide; Phosphorus trihydride; Hydrogen phosphide; Phosphane; PH3; CHEBI:28659,2014-12-24,1,,,,,,,,,
GIS1009638,0,OMOP Exposome,Observation,Substance,Phosphodiesterase Inhibitor,,2024-09-14,1,,,,,,,,,
GIS1009643,0,OMOP Exposome,Observation,Substance,Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),,2024-09-14,1,,,,,,,,,
P35558,0,OMOP Exposome,Observation,Substance,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",,2024-09-14,1,,,,,,,,,
P00558,0,OMOP Exposome,Observation,Substance,Phosphoglycerate kinase 1,,2024-09-14,1,,,,,,,,,
Q9Y263,0,OMOP Exposome,Observation,Substance,Phospholipase A-2-activating protein,,2024-09-14,1,,,,,,,,,
P04054,0,OMOP Exposome,Observation,Substance,Phospholipase A2,,2024-09-14,1,,,,,,,,,
P14555,0,OMOP Exposome,Observation,Substance,"Phospholipase A2, membrane associated",,2024-09-14,1,,,,,,,,,
GIS1009644,0,OMOP Exposome,Observation,Substance,Phospholipid Biosynthesis,,2024-09-14,1,,,,,,,,,
P36969,0,OMOP Exposome,Observation,Substance,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",,2024-09-14,1,,,,,,,,,
O15067,0,OMOP Exposome,Observation,Substance,Phosphoribosylformylglycinamidine synthase,,2024-09-14,1,,,,,,,,,
7664-38-2,0,OMOP Exposome,Observation,Substance,Phosphoric acid,Orthophosphoric acid; White phosphoric acid; Tetrasodium Pyrophosphate Decahydrate; Tetrasodium pyrophosphate 10-hydrate; Tetra-Sodium pyrophosphate; Sonac; Sodium pyrophosphate decahydrate BioChemica; Sodium pyrophosphate decahydrate; Sodium Pyrophosphate; Phosphorsaeure; Phosphorate; Ortho- phosphoric acid; NFB; Marphos; Diphosphate tetrasodium; Acidum phosphoricum; CHEBI:26078,2014-12-24,1,,,,,,,,,
7789-69-7,0,OMOP Exposome,Observation,Substance,Phosphorus pentabromide,,2014-12-24,1,,,,,,,,,
7789-60-8,0,OMOP Exposome,Observation,Substance,Phosphorus tribromide,,2014-12-24,1,,,,,,,,,
BE0002156,0,OMOP Exposome,Observation,Substance,Phosphorylase,,2024-09-14,1,,,,,,,,,
Q9Y617,0,OMOP Exposome,Observation,Substance,Phosphoserine aminotransferase,,2024-09-14,1,,,,,,,,,
P93098,0,OMOP Exposome,Observation,Substance,Photoreceptor,,2024-09-14,1,,,,,,,,,
GIS1009645,0,OMOP Exposome,Observation,Substance,Photosensitizing Agent,,2024-09-14,1,,,,,,,,,
GIS1009646,0,OMOP Exposome,Observation,Substance,Phototransduction,,2024-09-14,1,,,,,,,,,
880886-00-0 or 221872-97-5,0,OMOP Exposome,Observation,Substance,Phrixotoxin,,2014-12-24,1,,,,,,,,,
GIS1009647,0,OMOP Exposome,Observation,Substance,Phthalate,,2024-09-14,1,,,,,,,,,
91-15-6,0,OMOP Exposome,Observation,Substance,Phthalonitrile,,2014-12-24,1,,,,,,,,,
14721-66-5,0,OMOP Exposome,Observation,Substance,Phytanic acid,"Phytanoate; Phytanoic acid; 3,7,11,15-Tetramethyl-hexadecanoate; 3,7,11,15-Tetramethylhexadecanoate; 3,7,11,15-Tetramethylhexadecanoic acid; 3,7,11,15-Tetramethylhexadecoanoate; 3,7,11,15-Tetramethylhexadecoanoic acid; Phytanate; 3,7,11,15-Tetramethyl-hexadecansaeure; 3,7,11,15-Tetramethyl-hexadecanoic acid; CHEBI:16285",2018-03-21,1,,,,,,,,,
GIS1009648,0,OMOP Exposome,Observation,Substance,Phytanic Acid Peroxisomal Oxidation,,2024-09-14,1,,,,,,,,,
84-80-0,0,OMOP Exposome,Observation,Substance,Phytonadione,"Konakion; Mephyton; Phyllochinon; Phyllochinonum; Phylloquinone; Antihemorrhagic vitamin; Phytylmenadione; trans-Phylloquinone; 2', 3'-trans-Vitamin K1; 2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione; 2-Methyl-3-phythyl-1,4-naphthochinon; 2-Methyl-3-phytyl-1,4-naphthochinon; 2-Methyl-3-phytyl-1,4-naphthoquinone; 2-Methyl-3-(2e)-3,7,11,15-tetramethyl-2-hexadecenylnaphthoquinone; 3-Phytylmenadione; alpha-Phylloquinone; Phytonadionum; Aqua-Mephyton; Fitomenadiona; Phythyl-menadion; Phytomenadione; Phytomenadionum; \u03b1-phylloquinone; Vitamin K1; Vitamin K; CHEBI:18067",2014-12-24,1,,,,,,,,,
213-46-7,0,OMOP Exposome,Observation,Substance,Picene,"Beta,beta-binaphthyleneethene; Benzo(a)chrysene; b,b-Binaphthyleneethene; 3,4-Benzchrysene; 1,2:7,8-Dibenzophenanthrene; 1,2,7,8-Dibenzphenanthrene; Pycene; Dibenzo(a,I)phenanthrene; Benzoachrysene; CHEBI:33090",2014-12-24,1,,,,,,,,,
1918-02-1,0,OMOP Exposome,Observation,Substance,Picloram,,2014-12-24,1,,,,,,,,,
GIS1009649,0,OMOP Exposome,Observation,Substance,Pigmenting Agent,,2024-09-14,1,,,,,,,,,
54-71-7,0,OMOP Exposome,Observation,Substance,Pilocarpine,"Pilocarpine hydrochloride; Pilovisc; Pilocarpine HCl; Pilocarpine chloride; Pilocarpin; (3S-cis)-3-Ethyldihydro-4-(1-methyl-1H-imidazol-5-yl)methyl-2(3H)-furanone; (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone; Pilostat; Pilokarpin monohydrochloride; Pilokarpin; Pilocarpine muriate; Pilocarpine monohydrochloride; Salagen; Spersacarpine; Spersacarpine hydrochloride; Timpilo; Miocarpine; Diocarpine; beta-Pilocarpine hydrochloride; Adsorbocarpine; CHEBI:39462",2014-12-24,1,,,,,,,,,
2062-78-4,0,OMOP Exposome,Observation,Substance,Pimozide,Pimozidum; Opiran; Neoperidole; Halomonth; Pimozida; Orap; CHEBI:8212,2014-12-24,1,,,,,,,,,
131-12-4,0,OMOP Exposome,Observation,Substance,Pimpinellin,,2014-12-24,1,,,,,,,,,
52463-83-9,0,OMOP Exposome,Observation,Substance,Pinazepam,,2014-12-24,1,,,,,,,,,
GIS1009650,0,OMOP Exposome,Observation,Substance,Pineal Gland,,2024-09-14,1,,,,,,,,,
111025-46-8,0,OMOP Exposome,Observation,Substance,Pioglitazone,"Pioglitazone Hydrochloride; Actost; Glustin; (+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; Actos; Pioglitazonum; Pioglitazona; Pioglitazone HCl; CHEBI:8228",2014-12-24,1,,,,,,,,,
51-03-6,0,OMOP Exposome,Observation,Substance,Piperonyl butoxide,"(3,4-Methylenedioxy-6-propylbenzyl) (butyl) diethylene glycol ether, (Butylcarbityl)(6-propylpiperonyl)ether; Butyl carbitol 6-propylpiperonyl ether; alpha-2-(2-Butoxyethoxy)ethoxy-4,5-(methylenedioxy)-2-propyltoluene; alpha-(2-(2-N-Butoxyethoxy)-ethoxy)-4,5-methylenedioxy-2-propyltoluene; 6-Propylpiperonyl butyl diethylene glycol ether; 5-Propyl-4-(2,5,8-trioxa-dodecyl)-1,3-benzodioxole; 2-(2-Butoxyethoxy)ethyl 6-propylpiperonyl ether; CHEBI:CHEBI:32687",2014-12-24,1,,,,,,,,,
23103-98-2,0,OMOP Exposome,Observation,Substance,Pirimicarb,"ABOL; Aphox; Pyrimicarbe; Pyrimor; Rapid; TPC-PC001; Caswell No. 359C; ZZ-aphox; DEMO; Pirimor g; Primicarbe; Power demo; Pirimor 50 DP; Pirimor; Pirimor granulate; Phantom; Dimethylcarbamic acid 2-(dimethylamino)-5,6-dimethyl-4-pyrimidinyl ester; Fernos; FBC pirimicarb 50; 2-dimethylamino-5,6-dimethylpyrimidin-4-yldimethylcarbamate; 5,6-Dimethyl-2-dimethylamino-4-pyrimidinyldimethylcarbamate; Aficida; CHEBI:8248",2014-12-24,1,,,,,,,,,
29232-93-7,0,OMOP Exposome,Observation,Substance,Pirimiphos-methyl,"O-2-(Diethylamino)-6-methylpyrimidin-4-yl O,O-dimethyl thiophosphate, Pirimifosmethyl; Pirimiphos methyl; Pirimiphosmethyl; Pyrimiphos methyl; CHEBI:CHEBI:38843",2014-12-24,1,,,,,,,,,
GIS1009651,0,OMOP Exposome,Observation,Substance,Placenta,,2024-09-14,1,,,,,,,,,
GIS1009652,0,OMOP Exposome,Observation,Substance,Plant Growth Regulator,,2024-09-14,1,,,,,,,,,
GIS1009653,0,OMOP Exposome,Observation,Substance,Plant Toxin,,2024-09-14,1,,,,,,,,,
GIS1009655,0,OMOP Exposome,Observation,Substance,Plasma Membrane,,2024-09-14,1,,,,,,,,,
P20020,0,OMOP Exposome,Observation,Substance,Plasma membrane calcium-transporting ATPase 1,,2024-09-14,1,,,,,,,,,
Q01814,0,OMOP Exposome,Observation,Substance,Plasma membrane calcium-transporting ATPase 2,,2024-09-14,1,,,,,,,,,
Q16720,0,OMOP Exposome,Observation,Substance,Plasma membrane calcium-transporting ATPase 3,,2024-09-14,1,,,,,,,,,
P23634,0,OMOP Exposome,Observation,Substance,Plasma membrane calcium-transporting ATPase 4,,2024-09-14,1,,,,,,,,,
GIS1009654,0,OMOP Exposome,Observation,Substance,Plasmalogen Synthesis,,2024-09-14,1,,,,,,,,,
P00747,0,OMOP Exposome,Observation,Substance,Plasminogen,,2024-09-14,1,,,,,,,,,
P05121,0,OMOP Exposome,Observation,Substance,Plasminogen activator inhibitor 1,,2024-09-14,1,,,,,,,,,
GIS1009656,0,OMOP Exposome,Observation,Substance,Plastic,,2024-09-14,1,,,,,,,,,
GIS1009657,0,OMOP Exposome,Observation,Substance,Plasticizer,,2024-09-14,1,,,,,,,,,
GIS1009658,0,OMOP Exposome,Observation,Substance,Platelet,,2024-09-14,1,,,,,,,,,
GIS1009659,0,OMOP Exposome,Observation,Substance,Platelet Aggregation Inhibitor,,2024-09-14,1,,,,,,,,,
P02776,0,OMOP Exposome,Observation,Substance,Platelet factor 4,,2024-09-14,1,,,,,,,,,
P14770,0,OMOP Exposome,Observation,Substance,Platelet glycoprotein IX,,2024-09-14,1,,,,,,,,,
Q9HCN6,0,OMOP Exposome,Observation,Substance,Platelet glycoprotein VI,,2024-09-14,1,,,,,,,,,
P25105,0,OMOP Exposome,Observation,Substance,Platelet-activating factor receptor,,2024-09-14,1,,,,,,,,,
P09619,0,OMOP Exposome,Observation,Substance,Platelet-derived growth factor receptor beta,,2024-09-14,1,,,,,,,,,
13455-12-4,0,OMOP Exposome,Observation,Substance,Platinum(II) bromide,,2014-12-24,1,,,,,,,,,
68936-92-1,0,OMOP Exposome,Observation,Substance,Platinum(IV) bromide,,2014-12-24,1,,,,,,,,,
Q9HB21,0,OMOP Exposome,Observation,Substance,Pleckstrin homology domain-containing family A member 1,,2024-09-14,1,,,,,,,,,
15875-18-0,0,OMOP Exposome,Observation,Substance,Plumbane,Lead tetrahydride; Plumban; Tetrahydridolead; Bleiwasserstoff; PbH4; CHEBI:30181,2014-12-24,1,,,,,,,,,
7440-07-5,0,OMOP Exposome,Observation,Substance,Plutonium,"(9)4Pu; 94Pu; Plutonio; Plutonium, ion; Plutonium, ion(4+); Pu; CHEBI:33388",2014-12-24,1,,,,,,,,,
GIS1009681,0,OMOP Exposome,Observation,Substance,Plutonium Compound,,2024-09-14,1,,,,,,,,,
13981-16-3,0,OMOP Exposome,Observation,Substance,Plutonium-238,,2014-12-24,1,,,,,,,,,
15117-48-3,0,OMOP Exposome,Observation,Substance,Plutonium-239,,2014-12-24,1,,,,,,,,,
14119-33-6,0,OMOP Exposome,Observation,Substance,Plutonium-240,,2014-12-24,1,,,,,,,,,
GIS1009682,0,OMOP Exposome,Observation,Substance,Pneumolysin,,2024-09-14,1,,,,,,,,,
477-47-4,0,OMOP Exposome,Observation,Substance,Podofilox,"9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro3',4':6,7naphtho2,3-D1,3dioxol-6(5ah)-one; (-)-Podophyllotoxin; Podophyllotoxin 7; Podophyllinic acid lactone; Condylox; Podophyllotoxin; PPT; CHEBI:50305",2014-12-24,1,,,,,,,,,
GIS1009688,0,OMOP Exposome,Observation,Substance,Pollutant,,2024-09-14,1,,,,,,,,,
13981-52-7,0,OMOP Exposome,Observation,Substance,Polonium-210,"210Po; Polonium, isotope of mass 210; Polonium 210; 210-Polonium; (210)Po; (210)84Po; CHEBI:37340",2014-12-24,1,,,,,,,,,
P09874,0,OMOP Exposome,Observation,Substance,Poly [ADP-ribose] polymerase 1,,2024-09-14,1,,,,,,,,,
GIS1009689,0,OMOP Exposome,Observation,Substance,Polybrominated Biphenyl,,2024-09-14,1,,,,,,,,,
GIS1009691,0,OMOP Exposome,Observation,Substance,Polychlorinated Biphenyl,,2024-09-14,1,,,,,,,,,
GIS1009692,0,OMOP Exposome,Observation,Substance,Polycyclic Aromatic Hydrocarbon,,2024-09-14,1,,,,,,,,,
25038-59-9,0,OMOP Exposome,Observation,Substance,Polyethylene terephthalate,"Terphan; Tergal; Terfan; Terephtahlic acid-ethylene glycol polyester; Superfloc; Polyethylene terephthalic acid; Poly(oxyethyleneoxyterephthaloyl); Poly(oxy-1,2-ethanediyloxycarbonyl-1,4-phenylenecarbonyl); Pegoterate; Nitron lavsan; Nitron; Meliform; Lawsonite; Lavsan; Estrofol; Cleartuf; Celanar; Iambolen; Hostadur; Alathon; Cleartuf series; Clertuf; Ertalyte; Estar; Traytuf ultra-clear; Traytuf ultra-clea; Terom; CHEBI:53259",2014-12-24,1,,,,,,,,,
1405-20-5,0,OMOP Exposome,Observation,Substance,Polymyxin B Sulfate,Aerosporin; Polymyxinum B; Polyxx; Polymyxin b sulphate; Polymyxin b sulfic acid; Polymyxin B sulfate salt; Polymyxin B sulfate; Polymyxin b sulfate; Polymyxin b; Polymyxin B sulphate; Polymyxin B sulphate salt; Polymixin B sulphate; Polymixin B sulfate; Polyfax; Poly-Rx; Polomyxin B; Polimixina B; Metamyxin; Polymyxin b sulphic acid; Polymyxin-B-Sulfat; Polymyxine b; Polymyxine B (sulfate de); Polymyxini B sulfas; CHEBI:506404,2014-12-24,1,,,,,,,,,
25322-69-4,0,OMOP Exposome,Observation,Substance,"Polypropylene glycol (m w 1,200-3,000)","Niax ppg 1025; Methyloxirane homopolymer; Napter E 8075; Niax polyol ppg 4025; Niax PPG; 2-(2-Hydroxypropoxy)-1-propanol; 2-(2-Hydroxypropoxy)propanol; alpha-Hydro-omega-hydroxypoly(oxy(methyl-1,2-ethanediyl)); alpha-Hydro-omega-hydroxypoly(oxypropylene); Desmophen 360C; Emkapyl; Jeffox PPG 400; Laprol 2002; Laprol 702; Lineartop e; Voranol P 1010; PPG?; Polypropylene glycol (m W 1,200-3,000); Polypropylene glycol; Polyoxypropylene glycol; Polyglycol type P750; Polyglycol type P400; Polyglycol type P3000; Polyglycol type P250; Polyglycol type P2000; Polyglycol type P1200; Polyglycol P-4000; Polyglycol P-2000; Polyglycol P 400; Niax ppg 425; Niax ppg 3025; CHEBI:53262",2014-12-24,1,,,,,,,,,
9003-20-7,0,OMOP Exposome,Observation,Substance,Polyvinyl acetate,,2014-12-24,1,,,,,,,,,
137084-94-7,0,OMOP Exposome,Observation,Substance,Poneratoxin,,2014-12-24,1,,,,,,,,,
487-90-1,0,OMOP Exposome,Observation,Substance,Porphobilinogen,5-(Aminomethyl)-4-(carboxymethyl)-Pyrrole-3-propionic acid; 5-(Aminomethyl)-4-(carboxymethyl)-Pyrrole-3-propionate; 2-aminomethylpyrrol-3-acetic acid 4-propionic acid; 5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid; PBG; CHEBI:17381,2018-03-21,1,,,,,,,,,
GIS1009693,0,OMOP Exposome,Observation,Substance,Porphyria Variegata (PV),,2024-09-14,1,,,,,,,,,
GIS1009694,0,OMOP Exposome,Observation,Substance,Porphyrin Metabolism,,2024-09-14,1,,,,,,,,,
171228-49-2,0,OMOP Exposome,Observation,Substance,Posaconazole,,2014-12-24,1,,,,,,,,,
GIS1009695,0,OMOP Exposome,Observation,Substance,Post Synaptic Density,,2024-09-14,1,,,,,,,,,
7440-09-7,0,OMOP Exposome,Observation,Substance,Potassium,K+; Kalium; Potassium (ion); Potassium (K+); Potassium alloy; Potassium ion(+); Potassium ion (K1+); Potassium ion (K+); UN1420; UN2257; Potassium(I) cation; Potassium(1+) ion; Potassium(1+); Potassium(+); Potassium monocation; Potassium ion(1+); Potassium ion; Potassium cation; K; CHEBI:26216,2014-12-24,1,,,,,,,,,
10043-67-1,0,OMOP Exposome,Observation,Substance,Potassium alum,,2014-12-24,1,,,,,,,,,
14484-69-6,0,OMOP Exposome,Observation,Substance,Potassium aluminium fluoride,,2014-12-24,1,,,,,,,,,
7784-41-0,0,OMOP Exposome,Observation,Substance,Potassium arsenate,,2014-12-24,1,,,,,,,,,
10124-50-2,0,OMOP Exposome,Observation,Substance,Potassium arsenite,,2014-12-24,1,,,,,,,,,
14089-43-1,0,OMOP Exposome,Observation,Substance,Potassium asulam,,2014-12-24,1,,,,,,,,,
7758-01-2,0,OMOP Exposome,Observation,Substance,Potassium bromate,,2014-12-24,1,,,,,,,,,
7758-02-3,0,OMOP Exposome,Observation,Substance,Potassium bromide,,2014-12-24,1,,,,,,,,,
GIS1009696,0,OMOP Exposome,Observation,Substance,Potassium Channel Blocker,,2024-09-14,1,,,,,,,,,
O95069,0,OMOP Exposome,Observation,Substance,Potassium channel subfamily K member 2,,2024-09-14,1,,,,,,,,,
O14649,0,OMOP Exposome,Observation,Substance,Potassium channel subfamily K member 3,,2024-09-14,1,,,,,,,,,
Q9NPC2,0,OMOP Exposome,Observation,Substance,Potassium channel subfamily K member 9,,2024-09-14,1,,,,,,,,,
7447-40-7,0,OMOP Exposome,Observation,Substance,Potassium Chloride,Chloride of potash; K-Dur; K-Tab; Kaliumchlorid; KCl; Sando-K; Kaon Cl; Sylvite; Potassium chloride; Monopotassium chloride; Klor-CON; Muriate of potash; KCl; Klotrix; Micro-K; Slow-K; Kaon-CL 10; Chlorid draselny; CHEBI:32588,2014-12-24,1,,,,,,,,,
7789-00-6,0,OMOP Exposome,Observation,Substance,Potassium chromate,,2014-12-24,1,,,,,,,,,
13782-01-9,0,OMOP Exposome,Observation,Substance,Potassium cobaltinitrite,,2014-12-24,1,,,,,,,,,
590-28-3,0,OMOP Exposome,Observation,Substance,Potassium cyanate,"Potassium isocyanate; Potassium cyanic acid; Miller p.c. weedkiller; KOCN; Isocyanic acid, potassium salt; Green cross crabgrass killer; Dupont PC crabgrass killer; Ded-weed crabgrass killer; D and P double O crabgrass killer; Cyanic acid, potassium salt; Bulpur; Alicyanate; Weedanol cyanol; CHEBI:38904",2014-12-24,1,,,,,,,,,
151-50-8,0,OMOP Exposome,Observation,Substance,Potassium cyanide,"KCN; Cyanide of potassium; Cyanide, potassium; Hydrocyanic acid, potassium salt; Hydrogen cyanide and cyanide salts; Cyanide salts; CHEBI:33191",2014-12-24,1,,,,,,,,,
7778-50-9,0,OMOP Exposome,Observation,Substance,Potassium dichromate,,2014-12-24,1,,,,,,,,,
13746-66-2,0,OMOP Exposome,Observation,Substance,Potassium ferricyanide,K3Fe(CN)6; K3Fe(CN)6; Iron potassium cyanide; Potassium ferricyanate; potassium hexacyanidoferrate(3-); Tripotassium iron hexacyanide; Tripotassium hexacyanoferrate(3-); Tripotassium hexacyanoferrate; Tripotassium hexacyanidoferrate; Potassium hexacyanidoferrate(III); Potassium hexacyanoferrate (III); potassium hexacyanoferrate(3-); Potassium hexacyanoferrate(III); Potassium hexacyanoferrate(III) solution; Red prussiate; Red prussiate of potash; Tripotassium ferric hexacyanide; Tripotassium ferriccyanide; Potassium cyanoferrate; CHEBI:30060,2014-12-24,1,,,,,,,,,
13943-58-3,0,OMOP Exposome,Observation,Substance,Potassium ferrocyanide,Prussiate of potash; Potassium ferrocyanate; K4Fe(CN)6; Ferrate hexacyano tetrapotassium trihydrate; Tetrapotassium hexacyanoferrate; Tetrapotassium hexacyanoferrate(4-); Tetrapotassium hexacyanoferrate(II); Tetrapotassium ferrocyanide; Potassium hexacyanoferrate; Potassium hexacyanoferrate(II); CHEBI:30059,2014-12-24,1,,,,,,,,,
10025-98-6,0,OMOP Exposome,Observation,Substance,Potassium hexachloro-palladate(IV),,2014-12-24,1,,,,,,,,,
16893-92-8,0,OMOP Exposome,Observation,Substance,Potassium hexafluoroantimonate(V),,2014-12-24,1,,,,,,,,,
12208-13-8,0,OMOP Exposome,Observation,Substance,Potassium hexahydroxoantimonate(V),,2014-12-24,1,,,,,,,,,
BE0005326,0,OMOP Exposome,Observation,Substance,"Potassium large conductance calcium-activated channel, subfamily M, alpha member 1",,2024-09-14,1,,,,,,,,,
10294-64-1,0,OMOP Exposome,Observation,Substance,Potassium manganate,,2014-12-24,1,,,,,,,,,
7757-79-1,0,OMOP Exposome,Observation,Substance,Potassium nitrate,"Kalium nitricum; Kaliumnitrat; Salt peter; Potassium nitrate(dot); Vicknite; Collo-bo; Kali nitricum; KalII nitras; Niter; Saltpeter; Nitrate of potash; Nitre; Nitric acid potassium salt; Nitric acid potassium salt (1:1); Nitric acid, potassium salt; Sensodyne; Saltpetre; Potassium nitric acid; Salpetre; CHEBI:63043",2014-12-24,1,,,,,,,,,
7758-09-0,0,OMOP Exposome,Observation,Substance,Potassium nitrite,,2014-12-24,1,,,,,,,,,
7778-74-7,0,OMOP Exposome,Observation,Substance,Potassium perchlorate,,2014-12-24,1,,,,,,,,,
7722-64-7,0,OMOP Exposome,Observation,Substance,Potassium permanganate,,2014-12-24,1,,,,,,,,,
"10090-54-7
",0,OMOP Exposome,Observation,Substance,Potassium pyroantimonate,,2014-12-24,1,,,,,,,,,
506-61-6,0,OMOP Exposome,Observation,Substance,Potassium silver cyanide,,2014-12-24,1,,,,,,,,,
12331-76-9,0,OMOP Exposome,Observation,Substance,Potassium tetraperoxochromate(V),,2014-12-24,1,,,,,,,,,
Q09470,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily A member 1,,2024-09-14,1,,,,,,,,,
Q16322,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily A member 10,,2024-09-14,1,,,,,,,,,
P16389,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily A member 2,,2024-09-14,1,,,,,,,,,
P22001,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily A member 3,,2024-09-14,1,,,,,,,,,
P22459,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily A member 4,,2024-09-14,1,,,,,,,,,
P22460,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily A member 5,,2024-09-14,1,,,,,,,,,
P17658,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily A member 6,,2024-09-14,1,,,,,,,,,
Q96RP8,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily A member 7,,2024-09-14,1,,,,,,,,,
Q14721,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily B member 1,,2024-09-14,1,,,,,,,,,
Q92953,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily B member 2,,2024-09-14,1,,,,,,,,,
P48547,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily C member 1,,2024-09-14,1,,,,,,,,,
Q96PR1,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily C member 2,,2024-09-14,1,,,,,,,,,
Q14003,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily C member 3,,2024-09-14,1,,,,,,,,,
Q03721,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily C member 4,,2024-09-14,1,,,,,,,,,
Q9NSA2,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily D member 1,,2024-09-14,1,,,,,,,,,
Q9NZV8,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily D member 2,,2024-09-14,1,,,,,,,,,
Q9UK17,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily D member 3,,2024-09-14,1,,,,,,,,,
O95259,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily H member 1,,2024-09-14,1,,,,,,,,,
Q12809,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily H member 2,,2024-09-14,1,,,,,,,,,
Q9ULD8,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily H member 3,,2024-09-14,1,,,,,,,,,
Q9H252,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily H member 6,,2024-09-14,1,,,,,,,,,
Q9NS40,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily H member 7,,2024-09-14,1,,,,,,,,,
P51787,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily KQT member 1,,2024-09-14,1,,,,,,,,,
O43526,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily KQT member 2,,2024-09-14,1,,,,,,,,,
O43525,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily KQT member 3,,2024-09-14,1,,,,,,,,,
P56696,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily KQT member 4,,2024-09-14,1,,,,,,,,,
Q9NR82,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily KQT member 5,,2024-09-14,1,,,,,,,,,
Q9BQ31,0,OMOP Exposome,Observation,Substance,Potassium voltage-gated channel subfamily S member 3,,2024-09-14,1,,,,,,,,,
11103-86-9,0,OMOP Exposome,Observation,Substance,Potassium zinc chromate hydroxide,,2014-12-24,1,,,,,,,,,
13966-00-2,0,OMOP Exposome,Observation,Substance,Potassium-40,,2014-12-24,1,,,,,,,,,
P20648,0,OMOP Exposome,Observation,Substance,Potassium-transporting ATPase alpha chain 1,,2024-09-14,1,,,,,,,,,
P54707,0,OMOP Exposome,Observation,Substance,Potassium-transporting ATPase alpha chain 2,,2024-09-14,1,,,,,,,,,
P51164,0,OMOP Exposome,Observation,Substance,Potassium-transporting ATPase subunit beta,,2024-09-14,1,,,,,,,,,
O60741,0,OMOP Exposome,Observation,Substance,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,,2024-09-14,1,,,,,,,,,
Q9UL51,0,OMOP Exposome,Observation,Substance,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,,2024-09-14,1,,,,,,,,,
Q9P1Z3,0,OMOP Exposome,Observation,Substance,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,,2024-09-14,1,,,,,,,,,
Q9Y3Q4,0,OMOP Exposome,Observation,Substance,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,,2024-09-14,1,,,,,,,,,
P14859,0,OMOP Exposome,Observation,Substance,"POU domain, class 2, transcription factor 1",,2024-09-14,1,,,,,,,,,
23031-36-9,0,OMOP Exposome,Observation,Substance,Prallethrin,,2014-12-24,1,,,,,,,,,
104632-26-0,0,OMOP Exposome,Observation,Substance,Pramipexole,"Mirapex; (-)-Pramipexole; (S)-N\u200a\u200a6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; Glepark; Medopexol; Miramel; Miraper; Mirapexin; Pexola; Pramipexol; Pramipexolum; Sifrol; Sifrol ER; CHEBI:8356",2014-12-24,1,,,,,,,,,
2955-38-6,0,OMOP Exposome,Observation,Substance,Prazepam,Centrax; Sedapran; Demetrin; Prazepamum; Trepidan; Lysanxia; CHEBI:195969,2014-12-24,1,,,,,,,,,
53-03-2,0,OMOP Exposome,Observation,Substance,Prednisone,"1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione; Prednisona; Prednisonum; Rayos; Meticorten; Delta-Cortef; Orasone; 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione; Dehydrocortisone; 1,2-Dehydrocortisone; CHEBI:8382",2014-12-24,1,,,,,,,,,
GIS1009697,0,OMOP Exposome,Observation,Substance,Prednisone Pathway,,2024-09-14,1,,,,,,,,,
GIS1009698,0,OMOP Exposome,Observation,Substance,Preservative,,2024-09-14,1,,,,,,,,,
GIS1009699,0,OMOP Exposome,Observation,Substance,Primary bile acid biosynthesis,,2024-09-14,1,,,,,,,,,
GIS1009700,0,OMOP Exposome,Observation,Substance,Primary hyperoxaluria II,,2024-09-14,1,,,,,,,,,
GIS1009701,0,OMOP Exposome,Observation,Substance,Primary Hyperoxaluria Type I,,2024-09-14,1,,,,,,,,,
86209-51-0,0,OMOP Exposome,Observation,Substance,Primisulfuron-methyl,,2014-12-24,1,,,,,,,,,
Q7Z727,0,OMOP Exposome,Observation,Substance,PRKCA protein,,2024-09-14,1,,,,,,,,,
54532-46-6,0,OMOP Exposome,Observation,Substance,Proamanullin,,2014-12-24,1,,,,,,,,,
Q96I59,0,OMOP Exposome,Observation,Substance,"Probable asparagine--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9HA77,0,OMOP Exposome,Observation,Substance,"Probable cysteine--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q86WU2,0,OMOP Exposome,Observation,Substance,"Probable D-lactate dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q5JPH6,0,OMOP Exposome,Observation,Substance,"Probable glutamate--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q8TED1,0,OMOP Exposome,Observation,Substance,Probable glutathione peroxidase 8,,2024-09-14,1,,,,,,,,,
Q15031,0,OMOP Exposome,Observation,Substance,"Probable leucine--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q7L3T8,0,OMOP Exposome,Observation,Substance,"Probable proline--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
59-46-1,0,OMOP Exposome,Observation,Substance,Procaine,\u03b2-(diethylamino)ethyl p-aminobenzoate; Novocaine; beta-(Diethylamino)ethyl P-aminobenzoate; Novocain; p-Aminobenzoic acid 2-diethylaminoethyl ester; 2-Diethylaminoethyl p-aminobenzoate; 4-Aminobenzoic acid 2-diethylaminoethyl ester; beta-(Diethylamino)ethyl 4-aminobenzoate; Procaine HCl; Procainum; Vitamin H3; \u03b2-(diethylamino)ethyl 4-aminobenzoate; Procaina; CHEBI:8430,2014-12-24,1,,,,,,,,,
GIS1009702,0,OMOP Exposome,Observation,Substance,Procaine Pathway,,2024-09-14,1,,,,,,,,,
671-16-9,0,OMOP Exposome,Observation,Substance,Procarbazine,N-Isopropyl-P-(2-methylhydrazinomethyl)-benzamide; Procarbazinum; Procarbazina; MIH; MBH; Matulane; Indicarb; Procarbazin; PCX; P-(2-Methylhydrazinomethyl)-N-isopropylbenzamide; IBZ; Natulan; Ibenzmethyzine; N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide; N-4-Isopropylcarbamoylbenzyl-n'-methylhydrazine; 1-Methyl-2-(P-(isopropylcarbamoyl)benzyl)hydrazine; 2-(P-Isopropylcarbamoylbenzyl)-1-methylhydrazine; 4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide; Ibenzmethyzin; N-Isopropyl-alpha-(2-methylhydrazino)-P-toluamide; N-Isopropyl-4-(2-methylhydrazino)methylbenzamide; CHEBI:366225,2014-12-24,1,,,,,,,,,
67747-09-5,0,OMOP Exposome,Observation,Substance,Prochloraz,,2014-12-24,1,,,,,,,,,
58-38-8,0,OMOP Exposome,Observation,Substance,Prochlorperazine,2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine; 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine; Prochlorpermazine; Prochlorpromazine; Procloperazine; Proclorperazina; 3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine; Buccastem; Capazine; Chlormeprazine; Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine; Chloropernazine; Chlorperazine; Compazine; Compro; Emetiral; N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine; Prochloroperazine; Prochlorpemazine; Prochlorperazin; Prochlorp\u00e9razine; Prochlorperazine edisylate; Prochlorperazine maleate; Prochlorperazinum; Proclorperazine; Stemetil; Stemzine; Volimin; 2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine; CHEBI:8435,2014-12-24,1,,,,,,,,,
Q02809,0,OMOP Exposome,Observation,Substance,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",,2024-09-14,1,,,,,,,,,
O60568,0,OMOP Exposome,Observation,Substance,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",,2024-09-14,1,,,,,,,,,
77-37-2,0,OMOP Exposome,Observation,Substance,Procyclidine,1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride; Osnervan; Kemadrin; 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol; Arpicolin; Extranil; Kdrine; Kemadren; Procyclidinum; Procyclidin; Prociclidina; Tricyclamol; Proimer; Prodine; CHEBI:8448,2014-12-24,1,,,,,,,,,
29091-21-2,0,OMOP Exposome,Observation,Substance,Prodiamine,,2014-12-24,1,,,,,,,,,
GIS1009703,0,OMOP Exposome,Observation,Substance,Prodrug,,2024-09-14,1,,,,,,,,,
41198-08-7,0,OMOP Exposome,Observation,Substance,Profenofos,"O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate; Phosphorothioic acid, O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl ester; Curacron, O-(4-Bromo-2-chlorophenyl) O-ethyl S-propyl thiophosphate; (RS)-(O-4-bromo-2-chlorophenyl O-ethyl S-propyl phosphorothioate); CHEBI:CHEBI:38845",2014-12-24,1,,,,,,,,,
62666-20-0,0,OMOP Exposome,Observation,Substance,Progabide,,2014-12-24,1,,,,,,,,,
P06401,0,OMOP Exposome,Observation,Substance,Progesterone receptor,,2024-09-14,1,,,,,,,,,
O75340,0,OMOP Exposome,Observation,Substance,Programmed cell death protein 6,,2024-09-14,1,,,,,,,,,
127277-53-6,0,OMOP Exposome,Observation,Substance,Prohexadione-calcium,,2014-12-24,1,,,,,,,,,
GIS1009704,0,OMOP Exposome,Observation,Substance,Prokinetic Agent,,2024-09-14,1,,,,,,,,,
P16471,0,OMOP Exposome,Observation,Substance,Prolactin receptor,,2024-09-14,1,,,,,,,,,
O43272,0,OMOP Exposome,Observation,Substance,"Proline dehydrogenase 1, mitochondrial",,2024-09-14,1,,,,,,,,,
O94903,0,OMOP Exposome,Observation,Substance,Proline synthase co-transcribed bacterial homolog protein,,2024-09-14,1,,,,,,,,,
GIS1009705,0,OMOP Exposome,Observation,Substance,Prolinemia Type II,,2024-09-14,1,,,,,,,,,
Q32P28,0,OMOP Exposome,Observation,Substance,Prolyl 3-hydroxylase 1,,2024-09-14,1,,,,,,,,,
Q8IVL5,0,OMOP Exposome,Observation,Substance,Prolyl 3-hydroxylase 2,,2024-09-14,1,,,,,,,,,
Q8IVL6,0,OMOP Exposome,Observation,Substance,Prolyl 3-hydroxylase 3,,2024-09-14,1,,,,,,,,,
P13674,0,OMOP Exposome,Observation,Substance,Prolyl 4-hydroxylase subunit alpha-1,,2024-09-14,1,,,,,,,,,
O15460,0,OMOP Exposome,Observation,Substance,Prolyl 4-hydroxylase subunit alpha-2,,2024-09-14,1,,,,,,,,,
Q7Z4N8,0,OMOP Exposome,Observation,Substance,Prolyl 4-hydroxylase subunit alpha-3,,2024-09-14,1,,,,,,,,,
34264-24-9,0,OMOP Exposome,Observation,Substance,Promacyl,,2014-12-24,1,,,,,,,,,
58-40-2,0,OMOP Exposome,Observation,Substance,Promazine,"N-Dimethylamino-1-methylethyl thiodiphenylamine; N-(3-Dimethylaminopropyl)phenothiazine; N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine; Frenil; Combelen; 10-(3-(Dimethylamino)propyl)phenothiazine; Promazina; Promazin; Prazine; Talofen; Sparine; Promazinum; CHEBI:8459",2014-12-24,1,,,,,,,,,
2631-37-0,0,OMOP Exposome,Observation,Substance,Promecarb,,2014-12-24,1,,,,,,,,,
60-87-7,0,OMOP Exposome,Observation,Substance,Promethazine,"(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine; Sominex; Romergan; Receptozine; Prothiazine; Promethegan; Promethazinum; Prometazina; Proazamine; Phenergan; PHENADOZ; N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine; N,N,\u03b1-trimethyl-10H-phenothiazine-10-ethanamine; N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine; Lergigan; Farganesse; Fargan; Avomine; 10-2-(dimethylamino)Propylphenothiazine; 10-(2-Dimethylaminopropyl)phenothiazine; CHEBI:8461",2014-12-24,1,,,,,,,,,
1610-18-0,0,OMOP Exposome,Observation,Substance,Prometon,"2,4-Bis(isopropylamino)-6-methoxy-S-triazine; 2-Methoxy-4,6-bis(isopropylamino)-1,3,5-triazine; 2-Methoxy-4,6-bis(isopropylamino)-S-triazine; 4,6-Bis(isopropylamino)-2-methoxy-S-triazine; 6-Methoxy-N,n'-bis(1-methylethyl)-1,3,5-triazine-2,4-diamine; Gesafram; Methoxypropazine; N,N'-diisopropyl-6-methoxy-1,3,5-triazine-2,4-diamine; N,N'-diisopropyl-6-methoxy-1,3,5-triazine-2,4-diyldiamine; Pramitol; Prometone; 2,4-Bis(isopropylamino)-6-methoxy-1,3,5-triazine; CHEBI:34934",2014-12-24,1,,,,,,,,,
7287-19-6,0,OMOP Exposome,Observation,Substance,Prometryn,"Prometryne; N,N'-bis(1-methylethyl)-6-methylthio-1,3,5-triazine-2,4-diamine; 2-(methylthio)-4,6-Bis(isopropylamino)-S-triazine; N,N'-diisopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine; CHEBI:26276",2014-12-24,1,,,,,,,,,
1918-16-7,0,OMOP Exposome,Observation,Substance,Propachlor,Tripart sentinel; Albrass; alpha-chloro-N-Isopropylacetanilid; Alpha-chloro-n-isopropylacetanilide; Amber; Atlas orange; Bexton; Bexton 4L; Caswell No. 194; Chloressigsaeure-N-isopropylanilid; Chloro-n-isopropylacetanilide; Croptex; Isopropyl-2-chloroacetanilide; Kartex a; N-Isopropyl-2-chloroacetanilide; N-isopropyl-a-chloroacetanilide; N-isopropyl-alpha-chloroacetanilide; N-Methylethyl-N-chloroacidobenzene; Nitacid; Niticid; Portman propachlor 50FL; Prolex; Prolexpropaclor; Propachlor and atrazine; Propachlore; Ramrod; Ramrod 65; Ramrod flowable; Ramrod-atrazine; Satecid; Sentinel; Tripart granular; 2-Chloro-N-(1-methylethyl)-N-phenylacetamide; 2-Chloro-N-isopropyl-N-phenylacetamide; 2-Chloro-N-isopropylacetanilide; a-Chloro-n-isopropylacetanilide; Acilid; Albras propachlor; CHEBI:19503,2014-12-24,1,,,,,,,,,
24579-73-5,0,OMOP Exposome,Observation,Substance,Propamocarb,,2014-12-24,1,,,,,,,,,
25606-41-1,0,OMOP Exposome,Observation,Substance,Propamocarb hydrochloride,,2014-12-24,1,,,,,,,,,
GIS1009706,0,OMOP Exposome,Observation,Substance,Propanoate Metabolism,,2024-09-14,1,,,,,,,,,
499-67-2,0,OMOP Exposome,Observation,Substance,Proparacaine,Prossimetacaina; Ophthetic; Proximetacainum; Ophthaine; Ocu-Caine; Diocaine; Spectro-Caine; Proxymetacainum; Proxymetacaine; Alcaine; Ak-Taine; Proximetacaina; CHEBI:309007,2014-12-24,1,,,,,,,,,
GIS1009707,0,OMOP Exposome,Observation,Substance,Proparacaine Pathway,,2024-09-14,1,,,,,,,,,
2312-35-8,0,OMOP Exposome,Observation,Substance,Propargite,2-(P-t-Butylphenoxy)cyclohexyl propargyl sulfite; 2-(P-Tert-butylphenoxy)cyclohexyl propargyl sulfite; 2-(4-Tert-butylphenoxy)cyclohexyl prop-2-ynyl sulphite; 2-(P-Tert-butylphenoxy)cyclohexyl 2-propynyl sulfite; 2-(4-Tert-butylphenoxy)cyclohexyl prop-2-ynyl sulfite; BPPS; CHEBI:39300,2014-12-24,1,,,,,,,,,
139-40-2,0,OMOP Exposome,Observation,Substance,Propazine,"6-chloro-N,N'-bis(1-methylethyl)-1,3,5-triazine-2,4-diamine; 6-chloro-N,N'-diisopropyl-1,3,5-triazine-2,4-diyldiamine; 6-chloro-N,N'-diisopropyl-1,3,5-triazine-2,4-diamine; Prozinex; 2,4-Bis(isopropylamino)-6-chloro-S-triazine; 2-Chloro-4,6-bis(isopropylamino)-1,3,5-triazine; 2-chloro-4,6-Bis(isopropylamino)-S-triazine; 6-chloro-N,N'-(1-methylethyl)-1,3,5triazine-2,4-diamine; CHEBI:38067",2014-12-24,1,,,,,,,,,
31218-83-4,0,OMOP Exposome,Observation,Substance,Propetamphos,O-Methyl O-{1-(propan-2-yl)oxycarbonylprop-1-en-2-yl} ethylamidothiophosphate; (e)-1-Methylethyl 3-(((ethylamino)methoxyphosphinothioyl)oxy)-2-butenoate; 1-Methylethyl (e)-3-(((ethylamino)methoxyphosphinothioyl)oxy)-2-butenoate; CHEBI:38864,2014-12-24,1,,,,,,,,,
67739-84-8,0,OMOP Exposome,Observation,Substance,Prophalloin,,2014-12-24,1,,,,,,,,,
122-42-9,0,OMOP Exposome,Observation,Substance,Propham,,2014-12-24,1,,,,,,,,,
60207-90-1,0,OMOP Exposome,Observation,Substance,Propiconazole,"(+-)-1-2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl-methyl-1H-1,2,4-triazole; CHEBI:8489",2014-12-24,1,,,,,,,,,
362-29-8,0,OMOP Exposome,Observation,Substance,Propiomazine,Dorevane; Dorevan; Propiomazina; Propiomazinum; Serentin; Propiomazin; Propavan; Largon; Indorm; 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine; 2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine; 3-Propionyl-10-dimethylaminoisopropylphenothiazine; CHEBI:8491,2014-12-24,1,,,,,,,,,
79-09-4,0,OMOP Exposome,Observation,Substance,Propionic acid,Propanoate; Antischim B; Propanoic acid; Adofeed; Pseudoacetate; MonoProp; Prozoin; Ethanecarboxylic acid; Toxi-Check; Methylacetic acid; Methylacetate; Metacetonic acid; Metacetonate; Luprosil; Ethylformic acid; Ethylformate; Propcorn; Propkorn; Propionate; Propanate; Carboxyethane; Ethanecarboxylate; Pseudoacetic acid; CHEBI:30768,2018-03-21,1,,,,,,,,,
GIS1009708,0,OMOP Exposome,Observation,Substance,Propionic Acidemia,,2024-09-14,1,,,,,,,,,
107-12-0,0,OMOP Exposome,Observation,Substance,Propionitrile,,2014-12-24,1,,,,,,,,,
317-66-8,0,OMOP Exposome,Observation,Substance,Propionyl-CoA,Propanoyl-CoA; Propanoyl-Coenzyme A; Propionyl-coenzyme A; alpha-Methylacetyl-CoA; 2-Methylacetyl-Coenzyme A; alpha-Methylacetyl-Coenzyme A; 2-Methylacetyl-CoA; CHEBI:15539,2014-12-24,1,,,,,,,,,
P05165,0,OMOP Exposome,Observation,Substance,"Propionyl-CoA carboxylase alpha chain, mitochondrial",,2024-09-14,1,,,,,,,,,
P05166,0,OMOP Exposome,Observation,Substance,"Propionyl-CoA carboxylase beta chain, mitochondrial",,2024-09-14,1,,,,,,,,,
2078-54-8,0,OMOP Exposome,Observation,Substance,Propofol,"Propoven; Diisopropylphenol; 2,6-Bis(1-methylethyl)phenol; 2,6-Diisopropylphenol; Anepol; Anespro; Anesvan; Critifol; Diprivan; Disoprivan; Disoprofol; Dormofol; Fresofol; Gobbifol; Hipnolam; Hypro; IV-Pro; Lipuro; Oleo-Lax; Plofed; Profol; Profolen; Propofabb; Propofil; Propofolum; Propogen; Propolipid; Propovan; Provive; Rapinovet; Recofol; Safol; Trivam; Troypofol; Unifol; CHEBI:8495",2014-12-24,1,,,,,,,,,
114-26-1,0,OMOP Exposome,Observation,Substance,Propoxur,"Carbamic acid, methyl-, O-isopropoxyphenyl ester; 2-Isopropoxyphenyl methylcarbamate; 2-Isopropoxyphenyl N-methylcarbamate; 2-Isopropoxyphenyl-N-methylcarbamat; 2-Isopropoxyphenyl-N-methylcarbamate; 2-(1-methylethyl)oxyphenyl methylcarbamate; Aprocarb; Arporcarb; Bayer B 5122; Baygon; Bifex; Blattanex; Carbamic acid, methyl-, 2-(1-methylethoxy)phenyl ester; Brygou; Brifur; Boygon; O-(2-Isopropoxyphenyl) N-methylcarbamate; O isopropoxyphenylmethylcarbamate; 2-(1-Methylethoxy)phenol methylcarbamate; 2-(1-Methylethoxy)phenyl methyl carbamate; 2-(1-methylethoxy)phenyl methylcarbamate; 2-(1-Methylethoxy)phenyl N-methylcarbamate; 2-(propan-2-yloxy)phenyl methylcarbamate; Suncide; Tendex; Tugen; Tugon fliegenkugel; Undeen; Unden (pesticide); Unden 50PM; Undene; Fumite propoxur; Invisi-gard; IPMC; Isocarb; Isopropoxyphenyl methylcarbamate; N-Methyl-2-isopropoxyphenylcarbamate; N-2-(1-Methylethoxy)phenyl methyl-carbamate; Mrowkozol; Chemagro 9010; Caswell No. 508; O-isopropoxyphenylmethylcarbamate; O-isopropoxyphenyl n-methylcarbamate; O-isopropoxyphenyl methylcarbamate; Dalf dust; Blattanex 20; Blattosep; Bolfo; Boruho; Boruho 50; PHC (carbamate); Phenol, o-isopropoxy-, methylcarbamate; Pillargon; Propogon; Propoksuru; Propotox; Propotox m; Propoxure; Propoxylor; Propyon; Rhoden; Sendran; CHEBI:34938",2014-12-24,1,,,,,,,,,
181274-15-7,0,OMOP Exposome,Observation,Substance,Propoxycarbazone-sodium,,2014-12-24,1,,,,,,,,,
469-62-5,0,OMOP Exposome,Observation,Substance,Propoxyphene,Dacoton; Abalgin; Dolene; Doloxene; D-Propoxyphene; Darvon; Darvon-N; Deprancol; Depronal; Destropropossifene; Dextropropoxifeno; Dextropropoxyphen; Dextropropoxyphene; Dextropropoxyphene-M; Dextropropoxyphenum; Dextroproxifeno; CHEBI:51173,2014-12-24,1,,,,,,,,,
Q16549,0,OMOP Exposome,Observation,Substance,Proprotein convertase subtilisin/kexin type 7,,2024-09-14,1,,,,,,,,,
121-79-9,0,OMOP Exposome,Observation,Substance,Propyl gallate,,2014-12-24,1,,,,,,,,,
57-55-6,0,OMOP Exposome,Observation,Substance,Propylene glycol,"Methylethylene glycol; (RS)-1,2-Propanediol; 1,2-(RS)-Propanediol; 1,2-Dihydroxypropane; 1,2-Propanediol; 1,2-Propylene glycol; 1,2-Propylenglykol; 2,3-Propanediol; 2-Hydroxypropanol; a-Propylene glycol; Aliphatic alcohol; alpha-Propylene glycol; Chilisa FE; DL-1,2-Propanediol; Dl-Propylene glycol; Dowfrost; Glycol; Ilexan P; Inhibited 1,2-propylene glycol; Isopropylene glycol; Methyl glycol; Methylethyl glycol; Monopropylene glycol; Prolugen; Propane-1,2-diol; Propanediol; Propylene glycol usp; Propylenglycol; Sentry Propylene Glycol; Sirlene; Solar Winter Ban; Solargard P; Trimethyl glycol; Ucar 35; CHEBI:16997",2014-12-24,1,,,,,,,,,
107-98-2,0,OMOP Exposome,Observation,Substance,Propylene glycol mono- and diesters of fats and fatty acids,,2014-12-24,1,,,,,,,,,
94-13-3,0,OMOP Exposome,Observation,Substance,Propylparaben,"Propagin; P-Hydroxybenzoic propyl ester; P-Hydroxybenzoic acid, propyl ester; P-Hydroxybenzoic acid propyl ester; P-Hydroxybenzoic acid N-propyl ester; N-Propyl 4-hydroxybenzoate; Nipasol; Nipagin p; N-Propylparaben; N-Propyl-p-hydroxybenzoate; N-Propyl p-hydroxybenzoate; Propyl chemsept; Propyl chemosept; Propyl butex; Propyl aseptoform; Propyl 4-hydroxybenzoate; P-Hydroxypropyl benzoate; 4-Hydroxybenzoic acid propyl ester; 4-Hydroxybenzoic acid propylester; Tegosept p; Solbrol P; Protaben p; Propylparasept; Propylparaben, USAN; Propyl-paraben; 4-Hydroxybenzoic acid, propyl ester; Aseptoform p; Benzoic acid, 4-hydroxy-, propyl ester; Benzoic acid, p-hydroxy-, propyl ester; Betacide p; Betacine p; Chemacide PK; Chemocide PK; Propyl-4-hydroxybenzoate; Chemoside PK; Lexgard p; Propyl parasept; Propyl parahydroxybenzoate; Propyl paraben; Propyl p-hydroxybenzoate; CHEBI:32063",2014-12-24,1,,,,,,,,,
51-52-5,0,OMOP Exposome,Observation,Substance,Propylthiouracil,"Propil; 2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone; 2-Mercapto-6-propyl-4-pyrimidone; 2-Mercapto-6-propylpyrimid-4-one; 2-Thio-4-oxo-6-propyl-1,3-pyrimidine; 2-Thio-6-propyl-1,3-pyrimidin-4-one; 4-Propyl-2-thiouracil; 6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione; 6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one; 6-Propylthiouracil; 6-Thio-4-propyluracil; Antiroid; Procasil; Propacil; Propilracil; Propilthiouracil; Propiltiouracilo; Propycil; Propyl-Thiorist; Propyl-Thiorit; Propyl-Thyracil; Propylthiorit; Propylthiouracile; Propylthiouracilum; Propythiouracil; Proracyl; Prothiucil; Prothiurone; Prothuril; Prothycil; Prothyran; Protiural; PTU; Thiuragyl; Thyrosan; Tiotil; Tirostat; Uracil; CHEBI:8502",2014-12-24,1,,,,,,,,,
23950-58-5,0,OMOP Exposome,Observation,Substance,Propyzamide,,2014-12-24,1,,,,,,,,,
Q13258,0,OMOP Exposome,Observation,Substance,Prostaglandin D2 receptor,,2024-09-14,1,,,,,,,,,
Q9Y5Y4,0,OMOP Exposome,Observation,Substance,Prostaglandin D2 receptor 2,,2024-09-14,1,,,,,,,,,
O14684,0,OMOP Exposome,Observation,Substance,Prostaglandin E synthase,,2024-09-14,1,,,,,,,,,
P34995,0,OMOP Exposome,Observation,Substance,Prostaglandin E2 receptor EP1 subtype,,2024-09-14,1,,,,,,,,,
P43116,0,OMOP Exposome,Observation,Substance,Prostaglandin E2 receptor EP2 subtype,,2024-09-14,1,,,,,,,,,
P43115,0,OMOP Exposome,Observation,Substance,Prostaglandin E2 receptor EP3 subtype,,2024-09-14,1,,,,,,,,,
P23219,0,OMOP Exposome,Observation,Substance,Prostaglandin G/H synthase 1,,2024-09-14,1,,,,,,,,,
P35354,0,OMOP Exposome,Observation,Substance,Prostaglandin G/H synthase 2,,2024-09-14,1,,,,,,,,,
Q8N8N7,0,OMOP Exposome,Observation,Substance,Prostaglandin reductase 2,,2024-09-14,1,,,,,,,,,
P41222,0,OMOP Exposome,Observation,Substance,Prostaglandin-H2 D-isomerase,,2024-09-14,1,,,,,,,,,
GIS1009709,0,OMOP Exposome,Observation,Substance,Prostate,,2024-09-14,1,,,,,,,,,
94125-34-5,0,OMOP Exposome,Observation,Substance,Prosulfuron,,2014-12-24,1,,,,,,,,,
P04554,0,OMOP Exposome,Observation,Substance,Protamine-2,,2024-09-14,1,,,,,,,,,
Q9NNZ6,0,OMOP Exposome,Observation,Substance,Protamine-3,,2024-09-14,1,,,,,,,,,
GIS1009710,0,OMOP Exposome,Observation,Substance,Proteasome,,2024-09-14,1,,,,,,,,,
P28074,0,OMOP Exposome,Observation,Substance,Proteasome subunit beta type-5,,2024-09-14,1,,,,,,,,,
643772-15-0,0,OMOP Exposome,Observation,Substance,Protective antigen,,2014-12-24,1,,,,,,,,,
GIS1009711,0,OMOP Exposome,Observation,Substance,Protein,,2024-09-14,1,,,,,,,,,
P02760,0,OMOP Exposome,Observation,Substance,Protein AMBP,,2024-09-14,1,,,,,,,,,
Q9BXJ7,0,OMOP Exposome,Observation,Substance,Protein amnionless,,2024-09-14,1,,,,,,,,,
Q99873,0,OMOP Exposome,Observation,Substance,Protein arginine N-methyltransferase 1,,2024-09-14,1,,,,,,,,,
O60678,0,OMOP Exposome,Observation,Substance,Protein arginine N-methyltransferase 3,,2024-09-14,1,,,,,,,,,
Q9UN42,0,OMOP Exposome,Observation,Substance,Protein ATP1B4,,2024-09-14,1,,,,,,,,,
Q96SW2,0,OMOP Exposome,Observation,Substance,Protein cereblon,,2024-09-14,1,,,,,,,,,
P07237,0,OMOP Exposome,Observation,Substance,Protein disulfide-isomerase,,2024-09-14,1,,,,,,,,,
GIS1009712,0,OMOP Exposome,Observation,Substance,Protein Export,,2024-09-14,1,,,,,,,,,
P49356,0,OMOP Exposome,Observation,Substance,Protein farnesyltransferase subunit beta,,2024-09-14,1,,,,,,,,,
P49354,0,OMOP Exposome,Observation,Substance,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,,2024-09-14,1,,,,,,,,,
BE0004895,0,OMOP Exposome,Observation,Substance,Protein kinase C,,2024-09-14,1,,,,,,,,,
P17252,0,OMOP Exposome,Observation,Substance,Protein kinase C alpha type,,2024-09-14,1,,,,,,,,,
P05771,0,OMOP Exposome,Observation,Substance,Protein kinase C beta type,,2024-09-14,1,,,,,,,,,
Q05655,0,OMOP Exposome,Observation,Substance,Protein kinase C delta type,,2024-09-14,1,,,,,,,,,
Q02156,0,OMOP Exposome,Observation,Substance,Protein kinase C epsilon type,,2024-09-14,1,,,,,,,,,
P24723,0,OMOP Exposome,Observation,Substance,Protein kinase C eta type,,2024-09-14,1,,,,,,,,,
P05129,0,OMOP Exposome,Observation,Substance,Protein kinase C gamma type,,2024-09-14,1,,,,,,,,,
P41743,0,OMOP Exposome,Observation,Substance,Protein kinase C iota type,,2024-09-14,1,,,,,,,,,
Q04759,0,OMOP Exposome,Observation,Substance,Protein kinase C theta type,,2024-09-14,1,,,,,,,,,
Q05513,0,OMOP Exposome,Observation,Substance,Protein kinase C zeta type,,2024-09-14,1,,,,,,,,,
GIS1009713,0,OMOP Exposome,Observation,Substance,Protein Kinase Inhibitor,,2024-09-14,1,,,,,,,,,
P48745,0,OMOP Exposome,Observation,Substance,Protein NOV homolog,,2024-09-14,1,,,,,,,,,
O60502,0,OMOP Exposome,Observation,Substance,Protein O-GlcNAcase,,2024-09-14,1,,,,,,,,,
O60927,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 11,,2024-09-14,1,,,,,,,,,
O14974,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 12A,,2024-09-14,1,,,,,,,,,
O60237,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 12B,,2024-09-14,1,,,,,,,,,
Q9BZL4,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 12C,,2024-09-14,1,,,,,,,,,
Q96A00,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 14A,,2024-09-14,1,,,,,,,,,
Q96C90,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 14B,,2024-09-14,1,,,,,,,,,
Q8TAE6,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 14C,,2024-09-14,1,,,,,,,,,
Q9NXH3,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 14D,,2024-09-14,1,,,,,,,,,
O75807,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 15A,,2024-09-14,1,,,,,,,,,
Q5SWA1,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 15B,,2024-09-14,1,,,,,,,,,
Q96I34,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 16A,,2024-09-14,1,,,,,,,,,
Q13522,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 1A,,2024-09-14,1,,,,,,,,,
Q9UD71,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 1B,,2024-09-14,1,,,,,,,,,
Q8WVI7,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 1C,,2024-09-14,1,,,,,,,,,
Q16821,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 3A,,2024-09-14,1,,,,,,,,,
Q86XI6,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 3B,,2024-09-14,1,,,,,,,,,
Q9UQK1,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 3C,,2024-09-14,1,,,,,,,,,
O95685,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 3D,,2024-09-14,1,,,,,,,,,
Q9H7J1,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 3E,,2024-09-14,1,,,,,,,,,
Q6ZSY5,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 3F,,2024-09-14,1,,,,,,,,,
Q15435,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1 regulatory subunit 7,,2024-09-14,1,,,,,,,,,
P35813,0,OMOP Exposome,Observation,Substance,Protein phosphatase 1A,,2024-09-14,1,,,,,,,,,
P29590,0,OMOP Exposome,Observation,Substance,Protein PML,,2024-09-14,1,,,,,,,,,
P23297,0,OMOP Exposome,Observation,Substance,Protein S100-A1,,2024-09-14,1,,,,,,,,,
P80511,0,OMOP Exposome,Observation,Substance,Protein S100-A12,,2024-09-14,1,,,,,,,,,
Q99584,0,OMOP Exposome,Observation,Substance,Protein S100-A13,,2024-09-14,1,,,,,,,,,
P29034,0,OMOP Exposome,Observation,Substance,Protein S100-A2,,2024-09-14,1,,,,,,,,,
P26447,0,OMOP Exposome,Observation,Substance,Protein S100-A4,,2024-09-14,1,,,,,,,,,
P04271,0,OMOP Exposome,Observation,Substance,Protein S100-B,,2024-09-14,1,,,,,,,,,
O75880,0,OMOP Exposome,Observation,Substance,"Protein SCO1 homolog, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1009779,0,OMOP Exposome,Observation,Substance,Protein Synthesis Inhibitor,,2024-09-14,1,,,,,,,,,
Q93096,0,OMOP Exposome,Observation,Substance,Protein tyrosine phosphatase type IVA 1,,2024-09-14,1,,,,,,,,,
Q12974,0,OMOP Exposome,Observation,Substance,Protein tyrosine phosphatase type IVA 2,,2024-09-14,1,,,,,,,,,
O75365,0,OMOP Exposome,Observation,Substance,Protein tyrosine phosphatase type IVA 3,,2024-09-14,1,,,,,,,,,
Q9ULC6,0,OMOP Exposome,Observation,Substance,Protein-arginine deiminase type-1,,2024-09-14,1,,,,,,,,,
Q9Y2J8,0,OMOP Exposome,Observation,Substance,Protein-arginine deiminase type-2,,2024-09-14,1,,,,,,,,,
Q9ULW8,0,OMOP Exposome,Observation,Substance,Protein-arginine deiminase type-3,,2024-09-14,1,,,,,,,,,
Q9UM07,0,OMOP Exposome,Observation,Substance,Protein-arginine deiminase type-4,,2024-09-14,1,,,,,,,,,
Q6TGC4,0,OMOP Exposome,Observation,Substance,Protein-arginine deiminase type-6,,2024-09-14,1,,,,,,,,,
P21980,0,OMOP Exposome,Observation,Substance,Protein-glutamine gamma-glutamyltransferase 2,,2024-09-14,1,,,,,,,,,
P22061,0,OMOP Exposome,Observation,Substance,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,,2024-09-14,1,,,,,,,,,
Q14289,0,OMOP Exposome,Observation,Substance,Protein-tyrosine kinase 2-beta,,2024-09-14,1,,,,,,,,,
P25116,0,OMOP Exposome,Observation,Substance,Proteinase-activated receptor 1,,2024-09-14,1,,,,,,,,,
P00734,0,OMOP Exposome,Observation,Substance,Prothrombin,,2024-09-14,1,,,,,,,,,
P01100,0,OMOP Exposome,Observation,Substance,Proto-oncogene c-Fos,,2024-09-14,1,,,,,,,,,
P07949,0,OMOP Exposome,Observation,Substance,Proto-oncogene tyrosine-protein kinase receptor Ret,,2024-09-14,1,,,,,,,,,
P12931,0,OMOP Exposome,Observation,Substance,Proto-oncogene tyrosine-protein kinase Src,,2024-09-14,1,,,,,,,,,
Q8TAB3,0,OMOP Exposome,Observation,Substance,Protocadherin-19,,2024-09-14,1,,,,,,,,,
GIS1009780,0,OMOP Exposome,Observation,Substance,Proton Pump Inhibitor,,2024-09-14,1,,,,,,,,,
Q7Z2H8,0,OMOP Exposome,Observation,Substance,Proton-coupled amino acid transporter 1,,2024-09-14,1,,,,,,,,,
Q96NT5,0,OMOP Exposome,Observation,Substance,Proton-coupled folate transporter,,2024-09-14,1,,,,,,,,,
130-86-9,0,OMOP Exposome,Observation,Substance,Protopine,Protopin; Biflorine; Fumarine; Corydinine; Hypercorine; Macleyine; CHEBI:16415,2014-12-24,1,,,,,,,,,
553-12-8,0,OMOP Exposome,Observation,Substance,Protoporphyrin IX,"Porphyrinogen IX; PpIX; Protoporphyrin; Protoporphyrin-IX; Ooporphyrin; Kammerer'S prophyrin; 3,3'-(3,7,12,17-Tetramethyl-8,13-divinylporphine-2,18-diyl)di; 3,3'-(3,7,12,17-Tetramethyl-8,13-divinyl-21H,23H-porphine-2,18-diyl)-bis-propionic acid; 3,3'-(3,7,12,17-Tetramethyl-8,13-divinyl-21H,23H-porphine-2,18-diyl)-bis-propionate; CHEBI:15430",2018-03-21,1,,,,,,,,,
7412-77-3,0,OMOP Exposome,Observation,Substance,Protoporphyrinogen IX,"7,12-Diethenyl-5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoic acid; Protoporphyrinogen; Protoporphyrinogen-IX; 7,12-Diethenyl-3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,18-dipropanoic acid; 7,12-Diethenyl-3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,18-dipropanoate; 7,12-Diethenyl-5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoate; 5,10,15,20,22,24-Hexahydro protoporphyrin IX deriv.; CHEBI:15435",2018-03-21,1,,,,,,,,,
P50336,0,OMOP Exposome,Observation,Substance,Protoporphyrinogen oxidase,,2024-09-14,1,,,,,,,,,
438-60-8,0,OMOP Exposome,Observation,Substance,Protriptyline,"Protriptylin; Vivactil; Triptil; Protryptyline; Protriptylinum; Protriptyline Hydrochloride; Protriptilina; N-Methyl-5H-dibenzoa,Dcycloheptene-5-propylamine; N-Methyl-5H-dibenzoa,Dcycloheptene-5-propanamine; Amimetilina; 7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene; 5-(3-Methylaminopropyl)-5H-dibenzoa,Dcycloheptene; 3-(5H-dibenzoa,d7annulen-5-yl)-N-methylpropan-1-amine; 3-(5H-Dibenzoa,Dcyclohepten-5-yl)-N-methyl-1-propanamine; CHEBI:8597",2014-12-24,1,,,,,,,,,
2828-42-4,0,OMOP Exposome,Observation,Substance,Proximphan,,2014-12-24,1,,,,,,,,,
99-18-3,0,OMOP Exposome,Observation,Substance,Prunasin,(-)-(2R)-Prunasin; D-Prunasin; (2R)-Prunasin; (R)-(beta-D-Glucopyranosyloxy)phenylacetonitrile; (R)-alpha-(beta-D-Glucopyranosyloxy)benzene-acetonitrile; (R)-Mandelonitrile beta-D-glucopyranoside; (-)-Prunasin; (R)-Prunasin; (R)-Mandelonitrile beta-D-glucoside; (2R)-(beta-D-Glucopyranosyloxy)(phenyl)acetonitrile; CHEBI:17396,2014-12-24,1,,,,,,,,,
GIS1009789,0,OMOP Exposome,Observation,Substance,Pseudechetoxin,,2024-09-14,1,,,,,,,,,
90-82-4,0,OMOP Exposome,Observation,Substance,Pseudoephedrine,"Afrinol; Isoephedrine; Decofed; D-Psi-ephedrine; D-Psi-2-methylamino-1-phenyl-1-propanol; D-Pseudoephedrine; Cenafed; D-Isoephedrine; L(+)-Psi-ephedrine; L-(+)-Pseudoephedrine; Maxenal; trans-Ephedrine; Novafed; Sudafed Decongestant; Robidrine; Benylin Decongestant; Psi-ephedrine; Psi-ephedrin; Pseudoephedrinum; Pseudoefedrina; Myfedrine; Genaphed; (+)-(1S,2S)-Pseudoephedrine; Eltor 120; Dimetapp Decongestant; (+)-Pseudoephedrine; (+)-Psi-ephedrine; (+)-threo-Ephedrine; CHEBI:51209",2014-12-24,1,,,,,,,,,
520-53-6,0,OMOP Exposome,Observation,Substance,Psilocin,"Psilocine; 3-(2-(Dimethylamino)ethyl)indol-4-ol; 3-2-(Dimethylamino)ethyl-1H-Indol-4-ol; Psilotsin; N,N-Dimethyl-4-Hydroxytryptamine; 4-Hydroxy-N,N-dimethyltryptamine; 3-2-(Dimethylamino)ethyl-Indol-4-ol; CHEBI:8613",2014-12-24,1,,,,,,,,,
520-52-5,0,OMOP Exposome,Observation,Substance,Psilocybin,"Constituent of \magic mushrooms\; Psilocibin; 3-2'-Dimethylaminoethylindol-4-phosphate; Psilocybine; Psilocybinum; Magic mushrooms; 3-2-(Dimethylamino)ethylindol-4-yl dihydrogen phosphate; Indocybin; 4-Phosphoryloxy-omega-N,N-dimethyltryptamine; 3-(2-Dimethylaminoethyl)indol-4-yl dihydrogen phosphate; 3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol dihydrogen phosphate ester; Psilocin phosphate ester; Teonanacatl; Psylocybin; Psilocibina; O-Phosphoryl-4-hydroxy-N,N-dimethyltryptamine; Psilotsibin; 4-Phosphoryloxy-N,N-dimethyltryptamine; CHEBI:8614",2014-12-24,1,,,,,,,,,
66-97-7,0,OMOP Exposome,Observation,Substance,Psoralen,"Furo(3,2-g)-coumarin; Phytoalexin-CMPD; Furo(4',5',6,7)coumarin; Furocoumarin; Psorline-p; 7H-Furo3,2-gchromen-7-one; Furo2'.3':7.6coumarin; Furo2',3':7,6coumarin; Ficusin; Furo(2',3',7,6)coumarin; 7H-Furo3,2-gbenzopyran-7-one; 7H-Furo(3,2-g)(1)benzopyran-7-one; Phytoalexin; 2H-Furo3,2-gchromen-2-one; 6-Hydroxy-5-benzofuranacrylic acid gamma-lactone; 6-Hydroxy-5-benzofuranacrylic acid delta-lactone; 5-Benzofuranacrylic acid, 6-hydroxy-, delta-lactone; 3-(6-Hydroxy-5-benzofuranyl)-2-propenoic acid delta-lactone; 6-Hydroxy-5-benzofuranacrylic acid beta-lactone; 6,7-Furanocoumarin; 7H-Furo3,2-g1benzopyran-7-one; Psoralene; 7H-Furo3,2-g1benzopyran-7-one, 9CI; Furo4',5':6,7coumarin; Furo3,2-gcoumarin; CHEBI:27616",2014-12-24,1,,,,,,,,,
GIS1009798,0,OMOP Exposome,Observation,Substance,Psychotropic Drug,,2024-09-14,1,,,,,,,,,
GIS1009799,0,OMOP Exposome,Observation,Substance,Pterine Biosynthesis,,2024-09-14,1,,,,,,,,,
1492-18-8,0,OMOP Exposome,Observation,Substance,Pteroyl-D-glutamic acid,"(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid; (6S)-Folinic acid; (6S)-Leucovorin; Mittafol; Mission prenatal; Levoleucovorin; Levofolinic acid; Levofolene; Vitamin B11; Uzel; (S)-Leucovorin; Apo-folic; Pteroylmonoglutamate; Pteroyl-D-glutamate; Novofolacid; Novo-folacid; Nifolin; Leucovorin; L-leucovorin; Antianemia factor; Vitaped; Wellcovorin; N-4-(2-Amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methylaminobenzoyl-D-Glutamic acid; L-Folinic acid; Fusilev; Folinic acid; N-4-({(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-ylmethyl}amino)benzoyl-L-glutamic acid; N-Pteroyl-D-glutamic acid; MVC plus; Citrovorum factor; CHEBI:474191",2014-12-24,1,,,,,,,,,
P35247,0,OMOP Exposome,Observation,Substance,Pulmonary surfactant-associated protein D,,2024-09-14,1,,,,,,,,,
73376-35-9,0,OMOP Exposome,Observation,Substance,Pumiliotoxin,,2014-12-24,1,,,,,,,,,
GIS1009800,0,OMOP Exposome,Observation,Substance,Purine Metabolism,,2024-09-14,1,,,,,,,,,
P00491,0,OMOP Exposome,Observation,Substance,Purine nucleoside phosphorylase,,2024-09-14,1,,,,,,,,,
GIS1009801,0,OMOP Exposome,Observation,Substance,Purine Nucleoside Phosphorylase Deficiency,,2024-09-14,1,,,,,,,,,
GIS1009802,0,OMOP Exposome,Observation,Substance,Purinergic P1 Receptor Antagonist,,2024-09-14,1,,,,,,,,,
O60397,0,OMOP Exposome,Observation,Substance,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",,2024-09-14,1,,,,,,,,,
Q96P88,0,OMOP Exposome,Observation,Substance,Putative gonadotropin-releasing hormone II receptor,,2024-09-14,1,,,,,,,,,
Q6DN03,0,OMOP Exposome,Observation,Substance,Putative histone H2B type 2-C,,2024-09-14,1,,,,,,,,,
Q6DRA6,0,OMOP Exposome,Observation,Substance,Putative histone H2B type 2-D,,2024-09-14,1,,,,,,,,,
BE0005317,0,OMOP Exposome,Observation,Substance,Putative renal organic anion transporter 1,,2024-09-14,1,,,,,,,,,
Q86SH4,0,OMOP Exposome,Observation,Substance,Putative testis-specific prion protein,,2024-09-14,1,,,,,,,,,
A6NKZ8,0,OMOP Exposome,Observation,Substance,Putative tubulin beta chain-like protein ENSP00000290377,,2024-09-14,1,,,,,,,,,
Q99867,0,OMOP Exposome,Observation,Substance,Putative tubulin beta-4q chain,,2024-09-14,1,,,,,,,,,
Q9H853,0,OMOP Exposome,Observation,Substance,Putative tubulin-like protein alpha-4B,,2024-09-14,1,,,,,,,,,
110-60-1,0,OMOP Exposome,Observation,Substance,Putrescine,"1,4-Butanediamine; Putrescin; Tetramethyldiamine; 1,4-Tetramethylenediamine; 1,4-Diaminobutane; Tetramethylenediamine; 1,4-Butylenediamine; Butylenediamine; 1,4-Butanediammonium; CHEBI:17148",2014-12-24,1,,,,,,,,,
123312-89-0,0,OMOP Exposome,Observation,Substance,Pymetrozine,"(e)-4,5-dihydro-6-Methyl-4-((3-pyridinylmethylene)amino)-1,2,4-triazin-3(2H)-one; CHEBI:39311",2014-12-24,1,,,,,,,,,
175013-18-0,0,OMOP Exposome,Observation,Substance,Pyraclostrobin,Pyraclostrobine; CHEBI:78780,2014-12-24,1,,,,,,,,,
129630-19-9,0,OMOP Exposome,Observation,Substance,Pyraflufen-ethyl,,2014-12-24,1,,,,,,,,,
129-00-0,0,OMOP Exposome,Observation,Substance,Pyrene,{Benzodefphenanthrene}; Benzodefphenanthrene; Benzpyrene; beta-Pyrene; CHEBI:39106,2014-12-24,1,,,,,,,,,
GIS1009803,0,OMOP Exposome,Observation,Substance,Pyrethrin,,2024-09-14,1,,,,,,,,,
121-21-1,0,OMOP Exposome,Observation,Substance,Pyrethrin I,"Pyrethrins; Pyrethrolone, chrysanthemum monocarboxylic acid ester; (+)-pyrethronyl (+)-trans-chrysanthemate; Pyrethrin I (pi); Chrysanthemum monocarboxylic acid pyrethrolone ester; Piretrina 1; CHEBI:27815",2014-12-24,1,,,,,,,,,
121-29-9,0,OMOP Exposome,Observation,Substance,Pyrethrin II,Pyrethrins and pyrethroids; (+)-pyrethronyl (+)-pyrethrate; Pyronyl; Dalmatian insect powder; Pyrethrolone ester OF chrsanthemumdicarboxylic acid monomethyl ester; Chrysanthemum cinerareaefolium; Firmotox; Buhach; Cinerin I or II; Pyrethrins; Chrysanthemumdicarboxylic acid monomethyl ester pyrethrolone ester; Pyrethroids; Jasmolin I or II; Pyrethrin I or II; Pyrethrum (insecticide); Persian insect powder; Pyretrin II; Pyrocide; Prentox pyrethrum extract; Pyrethrin; Pyrenone; CHEBI:27474,2014-12-24,1,,,,,,,,,
GIS1009804,0,OMOP Exposome,Observation,Substance,Pyrethroid,,2024-09-14,1,,,,,,,,,
8003-34-7,0,OMOP Exposome,Observation,Substance,Pyrethrum,Chrysanthemum cinerareaefolium; Pyrocide; Pyronyl; Dalmatian insect powder; Firmotox; (+)-pyrethronyl (+)-pyrethrate; Buhach; Jasmolin II; Prentox pyrethrum extract; Pyrenone; Chrysanthemumdicarboxylic acid monomethyl ester pyrethrolone ester; Cinerin II; Pyretrin II; Pyrethrin; Pyrethrin I; Pyrethrin II; Pyrethrins; Pyrethroids; Pyrethrolone ester OF chrsanthemumdicarboxylic acid monomethyl ester; CHEBI:39098,2014-12-24,1,,,,,,,,,
96489-71-3,0,OMOP Exposome,Observation,Substance,Pyridaben,"4-chloro-2-(1,1-Dimethylethyl)-5-(((4-(1,1-dimethylethyl)phenyl)methyl)thio)-3(2H)-pyridazinone; Sanmite; CHEBI:38626",2014-12-24,1,,,,,,,,,
26299-14-9,0,OMOP Exposome,Observation,Substance,Pyridinium chlorochromate,,2014-12-24,1,,,,,,,,,
20039-37-6,0,OMOP Exposome,Observation,Substance,Pyridinium dichromate,,2014-12-24,1,,,,,,,,,
155-97-5,0,OMOP Exposome,Observation,Substance,Pyridostigmine,Astinon; Kalymin; Kalymin forte; Kalymin N; Kalymin retard; Meshanon60; Mestinon; Mestinon retard; Mestinon-SR; Myestin; Pyridine N-Oxide; Pyridostigmin bromid; Pyridostigmine Bromide; Pyridostigmine Bromine; Pyridostigmini Bromidum; Regonol; Pyrimine; Pyridostigminum; Antilon; Amygra; Amiasten; Bromure de Pyridostigmine; Bromuro de piridostigmina; CHEBI:257330,2014-12-24,1,,,,,,,,,
O00764,0,OMOP Exposome,Observation,Substance,Pyridoxal kinase,,2024-09-14,1,,,,,,,,,
Q96GD0,0,OMOP Exposome,Observation,Substance,Pyridoxal phosphate phosphatase,,2024-09-14,1,,,,,,,,,
Q6P996,0,OMOP Exposome,Observation,Substance,Pyridoxal-dependent decarboxylase domain-containing protein 1,,2024-09-14,1,,,,,,,,,
65-23-6,0,OMOP Exposome,Observation,Substance,Pyridoxine,"Piridoxina; Piridossina; Nestrex; Hydoxin; Hexobion; Hexa-Betalin; 2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine; 2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine; 2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine; 2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine; 3-Hydroxy-2-Picoline-4,5-dimethanol; 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine; 3-Hydroxy-4,5-dimethylol-alpha-picoline; 5-Hydroxy-6-methyl-3,4-pyridinedimethanol; Adermine; Becilan; Beesix; Benadon; Bonasanit; Gravidox; Vitamin B6; Pyridoxolum; Pyridoxol; Pyridoxinum; Pyridoxin; CHEBI:16709",2014-12-24,1,,,,,,,,,
Q9NVS9,0,OMOP Exposome,Observation,Substance,Pyridoxine-5'-phosphate oxidase,,2024-09-14,1,,,,,,,,,
58-14-0,0,OMOP Exposome,Observation,Substance,Pyrimethamine,"Chloridine; Pyrimethaminum; Daraprim; Diaminopyritamin; Ethylpyrimidine; Pirimetamin; Pirimetamina; Primethamine; Chloridin; CD; 5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine; Chloridyn; 2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine; 5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine; 5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine; Pyremethamine; Pyrimethamin; CHEBI:8673",2014-12-24,1,,,,,,,,,
53112-28-0,0,OMOP Exposome,Observation,Substance,Pyrimethanil,,2014-12-24,1,,,,,,,,,
GIS1009805,0,OMOP Exposome,Observation,Substance,Pyrimidine Metabolism,,2024-09-14,1,,,,,,,,,
95737-68-1,0,OMOP Exposome,Observation,Substance,Pyriproxyfen,4-Phenoxyphenyl (rs)-2-(2-pyridyloxy)propyl ether; CHEBI:39260,2014-12-24,1,,,,,,,,,
123343-16-8,0,OMOP Exposome,Observation,Substance,Pyrithiobac-sodium,,2014-12-24,1,,,,,,,,,
120-80-9,0,OMOP Exposome,Observation,Substance,Pyrocatechol,"O-Hydroxyphenol; Pyrocatechin; Phthalic alcohol; Fourrine 68; O-Benzenediol; O-Dihydroxybenzene; O-Dioxybenzene; O-Hydroquinone; Pyrocatechine; O-Phenylenediol; Durafur Developer C; Oxyphenate; Oxyphenic acid; Pelagol Grey C; Phthalhydroquinone; Catechol; 2-Hydroxyphenol; 1,2-Dihydroxybenzene; Fouramine PCH; CHEBI:18135",2014-12-24,1,,,,,,,,,
98-79-3,0,OMOP Exposome,Observation,Substance,Pyroglutamic acid,L-5-Oxoproline; L-Glutimate; L-Glutimic acid; L-Glutiminate; L-Glutiminic acid; L-Pyroglutamate; L-Pyroglutamic acid; L-Pyrrolidinonecarboxylate; L-Pyrrolidinonecarboxylic acid; L-Pyrrolidonecarboxylate; L-Pyrrolidonecarboxylic acid; Oxoproline; Oxopyrrolidinecarboxylate; Oxopyrrolidinecarboxylic acid; Pidolate; Pidolic acid; Pidolidone; Pyroglutamate; (S)-(-)-g-Butyrolactam-g-carboxylate; (S)-(-)-2-Pyrrolidone-5-carboxylic acid; Pyrrolidinonecarboxylate; Pyrrolidinonecarboxylic acid; Pyrrolidone-5-carboxylate; Pyrrolidone-5-carboxylic acid; Pyrrolidonecarboxylic acid; (S)-(-)-2-Pyrrolidone-5-carboxylate; (5S)-2-Oxopyrrolidine-5-carboxylic acid; (5S)-2-Oxopyrrolidine-5-carboxylate; (-)-Pyroglutamic acid; (-)-Pyroglutamate; (-)-2-Pyrrolidone-5-carboxylic acid; (-)-2-Pyrrolidone-5-carboxylate; 2-Oxopyrrolidine-5(S)-carboxylic acid; 2-Pyrrolidinone-5-carboxylate; 2-Pyrrolidinone-5-carboxylic acid; 5-Carboxy-2-pyrrolidinone; 5-L-Oxoproline; 2-Oxopyrrolidine-5(S)-carboxylate; 2-L-Pyrrolidone-5-carboxylic acid; 2-L-Pyrrolidone-5-carboxylate; (S)-Pyroglutamic acid; (S)-Pyroglutamate; (S)-5-Oxo-2-pyrrolidinecarboxylic acid; 5-Oxo-L-proline; (S)-5-Oxo-2-pyrrolidinecarboxylate; 5-Oxoproline; 5-Pyrrolidinone-2-carboxylate; 5-Pyrrolidinone-2-carboxylic acid; Ajidew A 100; Glutimate; (S)-2-Pyrrolidone-5-carboxylic acid; (S)-2-Pyrrolidone-5-carboxylate; (S)-(-)-gamma-Butyrolactam-gamma-carboxylic acid; (S)-(-)-gamma-Butyrolactam-gamma-carboxylate; (S)-(-)-g-Butyrolactam-g-carboxylic acid; Glutimic acid; Glutiminate; Glutiminic acid; L-2-Pyrrolidone-5-carboxylate; L-2-Pyrrolidone-5-carboxylic acid; L-5-Carboxy-2-pyrrolidinone; L-5-Oxo-2-pyrrolidinecarboxylate; L-5-Oxo-2-pyrrolidinecarboxylic acid; L-Glutamic acid g-lactam; CHEBI:18183,2018-03-21,1,,,,,,,,,
87-47-8,0,OMOP Exposome,Observation,Substance,Pyrolan,,2014-12-24,1,,,,,,,,,
14000-31-8,0,OMOP Exposome,Observation,Substance,Pyrophosphate,Diphosphate; (P2O74-)Diphosphate; (4-)Diphosphoric acid ion; Pyrophosphic acid; PPi; Pyrometaphosphate; Pyrophosphate tetraanion; Pyrophosphate(4-) ion; Diphosphoric acid; CHEBI:18361,2018-03-21,1,,,,,,,,,
Q4W8W1,0,OMOP Exposome,Observation,Substance,Pyrroline-5-carboxylate reductase,,2024-09-14,1,,,,,,,,,
P32322,0,OMOP Exposome,Observation,Substance,"Pyrroline-5-carboxylate reductase 1, mitochondrial",,2024-09-14,1,,,,,,,,,
Q96C36,0,OMOP Exposome,Observation,Substance,Pyrroline-5-carboxylate reductase 2,,2024-09-14,1,,,,,,,,,
Q53H96,0,OMOP Exposome,Observation,Substance,Pyrroline-5-carboxylate reductase 3,,2024-09-14,1,,,,,,,,,
GIS1009806,0,OMOP Exposome,Observation,Substance,Pyruvaldehyde Degradation,,2024-09-14,1,,,,,,,,,
GIS1009807,0,OMOP Exposome,Observation,Substance,Pyruvate Carboxylase Deficiency,,2024-09-14,1,,,,,,,,,
P11498,0,OMOP Exposome,Observation,Substance,"Pyruvate carboxylase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1009808,0,OMOP Exposome,Observation,Substance,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),,2024-09-14,1,,,,,,,,,
GIS1009809,0,OMOP Exposome,Observation,Substance,Pyruvate Dehydrogenase Complex Deficiency,,2024-09-14,1,,,,,,,,,
GIS1009810,0,OMOP Exposome,Observation,Substance,Pyruvate dehydrogenase deficiency (E2),,2024-09-14,1,,,,,,,,,
GIS1009811,0,OMOP Exposome,Observation,Substance,Pyruvate dehydrogenase deficiency (E3),,2024-09-14,1,,,,,,,,,
P08559,0,OMOP Exposome,Observation,Substance,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",,2024-09-14,1,,,,,,,,,
P29803,0,OMOP Exposome,Observation,Substance,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",,2024-09-14,1,,,,,,,,,
P11177,0,OMOP Exposome,Observation,Substance,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",,2024-09-14,1,,,,,,,,,
O00330,0,OMOP Exposome,Observation,Substance,"Pyruvate dehydrogenase protein X component, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1009812,0,OMOP Exposome,Observation,Substance,Pyruvate kinase deficiency,,2024-09-14,1,,,,,,,,,
P30613,0,OMOP Exposome,Observation,Substance,Pyruvate kinase PKLR,,2024-09-14,1,,,,,,,,,
P14618,0,OMOP Exposome,Observation,Substance,Pyruvate kinase PKM,,2024-09-14,1,,,,,,,,,
GIS1009813,0,OMOP Exposome,Observation,Substance,Pyruvate Metabolism,,2024-09-14,1,,,,,,,,,
127-17-3,0,OMOP Exposome,Observation,Substance,Pyruvic acid,Brenztraubensaeure; \u03b1-ketopropionic acid; Pyruvate; Pyroracemic acid; Pyroracemate; CH3COCOOH; BTS; alpha-Oxopropionsaeure; alpha-Ketopropionic acid; alpha-Ketopropionate; Acide pyruvique; Acetylformic acid; Acetylformate; a-Ketopropionic acid; a-Ketopropionate; 2-Oxopropionsaeure; 2-Oxopropionic acid; 2-Oxopropionate; 2-Oxopropansaeure; 2-Oxopropanoic acid; 2-Oxopropanoate; 2-ketopropionic acid; CHEBI:32816,2014-12-24,1,,,,,,,,,
80702-43-8,0,OMOP Exposome,Observation,Substance,Quaternium-10,,2014-12-24,1,,,,,,,,,
4080-31-3,0,OMOP Exposome,Observation,Substance,Quaternium-15,"Dowco 184; Dowicide q; Dowicil 100; 1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride; 1-(3-Chloroallyl)-3,5,7-triazo-1-azoniaadamantane chloride; Chloroallyl methenamine chloride; Cinartc 200; Dowicil 200; Dowicil 75; Hexamethylenetetramine chloroallyl chloride; Methenamine 3-chloroallylochloride; N-(3-Chloroallyl)hexaminium chloride; Quaternium 15; CHEBI:59607",2014-12-24,1,,,,,,,,,
51812-80-7,0,OMOP Exposome,Observation,Substance,Quaternium-22,,2014-12-24,1,,,,,,,,,
58069-11-7,0,OMOP Exposome,Observation,Substance,Quaternium-52,,2014-12-24,1,,,,,,,,,
36735-22-5,0,OMOP Exposome,Observation,Substance,Quazepam,Dormalin; Quazepamum; Doral; CHEBI:774423,2014-12-24,1,,,,,,,,,
117-39-5,0,OMOP Exposome,Observation,Substance,Quercetin,"3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; Flavin meletin; Quercetol; Quercetin dihydrate; 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; Meletin; 3',4',5,7-Tetrahydroxyflavan-3-ol; Xanthaurine; Sophoretin; Quertin; 3',4',5,7-Tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,4',5,5',7-Pentahydroxy-Flavone; CHEBI:16243",2014-12-24,1,,,,,,,,,
111974-69-7,0,OMOP Exposome,Observation,Substance,Quetiapine,"Seroquel; Quetiapine hemifumarate; Quetiapine fumarate; Quetiapina; 2-2-(4-Dibenzob,F1,4thiazepin-11-yl-1-piperazinyl)ethoxyethanol; Seroquel XR; Quetiapinum; CHEBI:8707",2014-12-24,1,,,,,,,,,
85441-61-8,0,OMOP Exposome,Observation,Substance,Quinapril,Quinazil; Accupril; Accuprin; Accupro; Acequin; Acuitel; Korec; Quinaprilum; CHEBI:8713,2014-12-24,1,,,,,,,,,
84087-01-4,0,OMOP Exposome,Observation,Substance,Quinclorac,,2014-12-24,1,,,,,,,,,
152-43-2,0,OMOP Exposome,Observation,Substance,Quinestrol,Estrovis 4000; Quinestrolo; Quinestrolum; ethinyl estradiol 3-cyclopentyl ether; Plestrovis; Quilea; 17-alpha-Ethinylestradiol 3-cyclopentyl ether; 17alpha-Ethynylestradiol 3-cyclopentyl ether; Eston; Estradiol-17-beta 3-cyclopentyl ether; Estrovis; Estrovister; CHEBI:8716,2014-12-24,1,,,,,,,,,
130-95-0,0,OMOP Exposome,Observation,Substance,Quinine,"6'-Methoxycinchonidine; (R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-(-)-Quinine; (8S,9R)-Quinine; (-)-Quinine; Quinoline Alkaloid; Sulquin; Jasoquin; Quinlup; Qutil; QSM; QUALAQUIN; Quinina; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinineanhydrous; Cinkona; Chininum; Chinine; Chinin; 6'-Methoxycinchonine; CHEBI:15854",2014-12-24,1,,,,,,,,,
55604-87-0,0,OMOP Exposome,Observation,Substance,Quinolacetic acid,,2018-03-21,1,,,,,,,,,
91-22-5,0,OMOP Exposome,Observation,Substance,Quinoline,"Chinoline; Quinolin; Benzo(b)pyridine; 2,3-Benzopyridine; 1-Benzine; 1-Benzazine; 1-Azanaphthalene; Leucol; Benzobpyridine; Chinoleine; Chinolin; Leukol; CHEBI:17362",2014-12-24,1,,,,,,,,,
GIS1009814,0,OMOP Exposome,Observation,Substance,Quinolines,,2024-09-14,1,,,,,,,,,
GIS1009815,0,OMOP Exposome,Observation,Substance,Quinolone,,2024-09-14,1,,,,,,,,,
GIS1009848,0,OMOP Exposome,Observation,Substance,Quinolones,,2024-09-14,1,,,,,,,,,
106-51-4,0,OMOP Exposome,Observation,Substance,Quinone,"p-Chinon; Semiquinone radicals; Semiquinone anion; Quinone1,4-Benzoquinone; Para-Quinone; Para-Benzoquinone; p-Quinone; p-Benzoquinone; Eldoquin; Cyclohexadienedione; Cyclohexadiene-1,4-dione; Chinone; Chinon; Benzoquinone; Benzo-chinon; Benzo-1,4-quinone; 2,5-cyclohexadiene-1-4-dione; 2,5-Cyclohexadiene-1,4-dione; 1,4-Dioxybenzene; 1,4-Dioxy-benzol; 1,4-Diossibenzene; 1,4-Cyclohexadienedione; 1,4-Cyclohexadiene dioxide; 1,4-Benzoquinone; 1,4-Benzoquine; CHEBI:16509",2014-12-24,1,,,,,,,,,
Q08257,0,OMOP Exposome,Observation,Substance,Quinone oxidoreductase,,2024-09-14,1,,,,,,,,,
124495-18-7,0,OMOP Exposome,Observation,Substance,Quinoxyfen,,2014-12-24,1,,,,,,,,,
82-68-8,0,OMOP Exposome,Observation,Substance,Quintozene,"Pentachloronitrobenzene; 2,3,4,5,6-Pentachloronitrobenzene, Nitropentachlorobenzene; PCNB; Pentachlornitrobenzol; PKhNC; CHEBI:CHEBI:34908",2014-12-24,1,,,,,,,,,
76578-14-8,0,OMOP Exposome,Observation,Substance,Quizalofop-ethyl,,2014-12-24,1,,,,,,,,,
P31749,0,OMOP Exposome,Observation,Substance,RAC-alpha serine/threonine-protein kinase,,2024-09-14,1,,,,,,,,,
P31751,0,OMOP Exposome,Observation,Substance,RAC-beta serine/threonine-protein kinase,,2024-09-14,1,,,,,,,,,
Q9Y243,0,OMOP Exposome,Observation,Substance,RAC-gamma serine/threonine-protein kinase,,2024-09-14,1,,,,,,,,,
GIS1009849,0,OMOP Exposome,Observation,Substance,Radiation-Sensitizing Agent,,2024-09-14,1,,,,,,,,,
GIS1009850,0,OMOP Exposome,Observation,Substance,Radioactive,,2024-09-14,1,,,,,,,,,
GIS1009851,0,OMOP Exposome,Observation,Substance,Radioactive Isotope,,2024-09-14,1,,,,,,,,,
10031-23-9,0,OMOP Exposome,Observation,Substance,Radium bromide,,2014-12-24,1,,,,,,,,,
GIS1009852,0,OMOP Exposome,Observation,Substance,Radium Compound,,2024-09-14,1,,,,,,,,,
13982-63-3,0,OMOP Exposome,Observation,Substance,Radium-226,"Radium 226; Radium, isotope of mass 226; 226Ra; 88Ra; Radium; CHEBI:33325",2014-12-24,1,,,,,,,,,
15262-20-1,0,OMOP Exposome,Observation,Substance,Radium-228,,2014-12-24,1,,,,,,,,,
10043-92-2,0,OMOP Exposome,Observation,Substance,Radon,"Radon, isotope of mass 222; Rn; 86Rn; Radon 222; CHEBI:33314",2014-12-24,1,,,,,,,,,
22481-48-7,0,OMOP Exposome,Observation,Substance,Radon-220,"Thoron (Radon-220); Thoron; Radon 220; radon, isotope of mass 220; 220Rn; (220)Rn; (220)86Rn; Tn; CHEBI:33491",2014-12-24,1,,,,,,,,,
14859-67-7,0,OMOP Exposome,Observation,Substance,Radon-222,"222Rn; Radon 222; (222)86Rn; Radon, isotope of mass 222; (222)Rn; CHEBI:33492",2014-12-24,1,,,,,,,,,
P04049,0,OMOP Exposome,Observation,Substance,RAF proto-oncogene serine/threonine-protein kinase,,2024-09-14,1,,,,,,,,,
5459-90-4,0,OMOP Exposome,Observation,Substance,Ranelic acid,,2014-12-24,1,,,,,,,,,
644-69-9,0,OMOP Exposome,Observation,Substance,Ranunculin,,2014-12-24,1,,,,,,,,,
P63000,0,OMOP Exposome,Observation,Substance,Ras-related C3 botulinum toxin substrate 1,,2024-09-14,1,,,,,,,,,
P15153,0,OMOP Exposome,Observation,Substance,Ras-related C3 botulinum toxin substrate 2,,2024-09-14,1,,,,,,,,,
P60763,0,OMOP Exposome,Observation,Substance,Ras-related C3 botulinum toxin substrate 3,,2024-09-14,1,,,,,,,,,
P51151,0,OMOP Exposome,Observation,Substance,Ras-related protein Rab-9A,,2024-09-14,1,,,,,,,,,
GIS1009853,0,OMOP Exposome,Observation,Substance,"rat_Slc22a1 (Oct1, Orct1, Roct1)",,2024-09-14,1,,,,,,,,,
GIS1009854,0,OMOP Exposome,Observation,Substance,"rat_Slc22a2 (OCT2, OCT2r, rOCT2)",,2024-09-14,1,,,,,,,,,
GIS1009855,0,OMOP Exposome,Observation,Substance,rat_Slc22a3 (Oct3),,2024-09-14,1,,,,,,,,,
GIS1009856,0,OMOP Exposome,Observation,Substance,"rat_Slc22a6 (Oat1, Paht, Roat1, Orctl1)",,2024-09-14,1,,,,,,,,,
GIS1009857,0,OMOP Exposome,Observation,Substance,"rat_Slc22a8 (Oat3, Roct)",,2024-09-14,1,,,,,,,,,
GIS1009858,0,OMOP Exposome,Observation,Substance,rat_Slc47a1 (MATE1),,2024-09-14,1,,,,,,,,,
GIS1009859,0,OMOP Exposome,Observation,Substance,rat_Slc7a10 (Asc-1),,2024-09-14,1,,,,,,,,,
GIS1009860,0,OMOP Exposome,Observation,Substance,"rat_Slco1a1 (Oatp1, OATP-1, Slc21a1, Slc21a3)",,2024-09-14,1,,,,,,,,,
98769-81-4,0,OMOP Exposome,Observation,Substance,Reboxetine,Reboxetine mesylate; Edronax; Davedax; (S; Prolift; Norebox; Vestra; Solvex; S)-Reboxetine; Esreboxetine; CHEBI:402799,2014-12-24,1,,,,,,,,,
O43353,0,OMOP Exposome,Observation,Substance,Receptor-interacting serine/threonine-protein kinase 2,,2024-09-14,1,,,,,,,,,
P36888,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein kinase FLT3,,2024-09-14,1,,,,,,,,,
P18433,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase alpha,,2024-09-14,1,,,,,,,,,
P23467,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase beta,,2024-09-14,1,,,,,,,,,
P08575,0,OMOP Exposome,Observation,Exposome Target,Receptor-type tyrosine-protein phosphatase C,,2024-09-14,1,,,,,,,,,
P23468,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase delta,,2024-09-14,1,,,,,,,,,
P23469,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase epsilon,,2024-09-14,1,,,,,,,,,
Q12913,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase eta,,2024-09-14,1,,,,,,,,,
P10586,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase F,,2024-09-14,1,,,,,,,,,
P23470,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase gamma,,2024-09-14,1,,,,,,,,,
Q9HD43,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase H,,2024-09-14,1,,,,,,,,,
Q15262,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase kappa,,2024-09-14,1,,,,,,,,,
P28827,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase mu,,2024-09-14,1,,,,,,,,,
Q92932,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase N2,,2024-09-14,1,,,,,,,,,
Q16827,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase O,,2024-09-14,1,,,,,,,,,
Q15256,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase R,,2024-09-14,1,,,,,,,,,
Q13332,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase S,,2024-09-14,1,,,,,,,,,
O14522,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase T,,2024-09-14,1,,,,,,,,,
Q92729,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase U,,2024-09-14,1,,,,,,,,,
P23471,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase zeta,,2024-09-14,1,,,,,,,,,
Q16849,0,OMOP Exposome,Observation,Substance,Receptor-type tyrosine-protein phosphatase-like N,,2024-09-14,1,,,,,,,,,
GIS1009861,0,OMOP Exposome,Observation,Substance,Red Blood Cell,,2024-09-14,1,,,,,,,,,
GIS1009862,0,OMOP Exposome,Observation,Substance,Reducing Agent,,2024-09-14,1,,,,,,,,,
GIS1009863,0,OMOP Exposome,Observation,Substance,Refrigerant,,2024-09-14,1,,,,,,,,,
GIS1009864,0,OMOP Exposome,Observation,Substance,Refsum Disease,,2024-09-14,1,,,,,,,,,
Q15493,0,OMOP Exposome,Observation,Substance,Regucalcin,,2024-09-14,1,,,,,,,,,
GIS1009865,0,OMOP Exposome,Observation,Substance,Regulation of actin cytoskeleton,,2024-09-14,1,,,,,,,,,
GIS1009866,0,OMOP Exposome,Observation,Substance,Renal Glucosuria,,2024-09-14,1,,,,,,,,,
P00797,0,OMOP Exposome,Observation,Substance,Renin,,2024-09-14,1,,,,,,,,,
GIS1009867,0,OMOP Exposome,Observation,Substance,Renin-angiotensin system,,2024-09-14,1,,,,,,,,,
50-55-5,0,OMOP Exposome,Observation,Substance,Reserpine,"(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-(3,4,5-trimethoxybenzoyl)oxyyohimban-16-carboxylic acid methyl ester; (\u2212)-reserpine; 3,4,5-trimethoxybenzoyl methyl reserpate; Apoplon; Hiserpia; Novoreserpine; Reserfia; Reserpin; Serpalan; Serpanray; Serpasil; (-)-Reserpine; CHEBI:28487",2014-12-24,1,,,,,,,,,
57444-62-9,0,OMOP Exposome,Observation,Substance,Resiniferatoxin,,2014-12-24,1,,,,,,,,,
Q9HD89,0,OMOP Exposome,Observation,Substance,Resistin,,2024-09-14,1,,,,,,,,,
10453-86-8,0,OMOP Exposome,Observation,Substance,Resmethrin,"(+)-trans-resmethrin; (5-Benzyl-3-furyl)methyl chrysanthemate; 1R-trans-Resemethrin; 1S, cis-Resmethrin; 5-Benzyl-3-furylmethyl (+)-trans-chrysanthemate; 5-Benzyl-3-furylmethyl (+-)-cis,trans-chrysanthemate; 5-Benzyl-3-furylmethyl (+-)-cis-trans-chrysanthemate; 5-Benzyl-3-furylmethyl (1R)-trans-chrysanthemate; 5-Benzyl-3-furylmethyl (1R)-trans-chrysanthemate (8CI); 5-Benzyl-3-furylmethyl (1RS)-cis,trans-chrysanthemate; 5-Benzyl-3-furylmethyl (1rs,3rs;1rs,3sr)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; 5-Benzyl-3-furylmethyl(+)-trans-chrysanthemate; 5-Benzyl-3-furylmethyl(+-)-cis,trans-chrysanthemate; Pyretherm; Pyresthrin; Pynosect; 5-Benzyl-3-furylmethyl(.+/-.)-cis,trans-chrysanthemate; Premgard; Penncapthrin; Penick SBP 1382; Penick 1390; Penick 1382; Mixture name; Isatrin; Isathrine; For-SYN; Enforcer; Dimethyl 3-(2-methyl-1-propenyl)cyclopropanecarboxylate; D-trans-resmethrin; D-trans-chrysron; d-trans-(5-Benzyl-3-furyl)methyl chrysanthemate; d-trans-((5-Benzyl-3-furyl)methyl)chrysanthemumate; D-resmethrin; Crossfire; Combat white FLY insecticide; Chrysron; Chryson; Caswell No. 083E; Bioresmetrina; Bioresmethrine; Bioresmethrin (d trans isomer); Bioresmethhrin; Biobenzyfuroline; Benzyfuroline; 5-Benzyl-3-furylmethyl-d-trans-crysanthemate; Benzofuroline; Ari-b; 5-Benzylfurfuryl chrysanthemate; (5-(Phenylmethyl)-3-furanyl)methyl 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate; Whitmire PT-110; Vectrin; Syntox; Synthrin; Sun-Bugger 4; Sun-bugger; Scourge; SB Pennick 1382; S.B. Penick 1382; Resmetrina; Resmethrine; Resbuthrin; Raid flying insect killer; Pyrethroids; Pyrethroid NRDC 107; CHEBI:8811",2014-12-24,1,,,,,,,,,
1406-72-0,0,OMOP Exposome,Observation,Substance,Restrictocin (Aspergillus restrictus),,2014-12-24,1,,,,,,,,,
GIS1009868,0,OMOP Exposome,Observation,Substance,Reticulocyte,,2024-09-14,1,,,,,,,,,
P00352,0,OMOP Exposome,Observation,Substance,Retinal dehydrogenase 1,,2024-09-14,1,,,,,,,,,
O94788,0,OMOP Exposome,Observation,Substance,Retinal dehydrogenase 2,,2024-09-14,1,,,,,,,,,
P12271,0,OMOP Exposome,Observation,Substance,Retinaldehyde-binding protein 1,,2024-09-14,1,,,,,,,,,
P06400,0,OMOP Exposome,Observation,Substance,Retinoblastoma-associated protein,,2024-09-14,1,,,,,,,,,
P10276,0,OMOP Exposome,Observation,Substance,Retinoic acid receptor alpha,,2024-09-14,1,,,,,,,,,
P10826,0,OMOP Exposome,Observation,Substance,Retinoic acid receptor beta,,2024-09-14,1,,,,,,,,,
P13631,0,OMOP Exposome,Observation,Substance,Retinoic acid receptor gamma,,2024-09-14,1,,,,,,,,,
BE0005320,0,OMOP Exposome,Observation,Substance,Retinoic acid receptor gamma-2,,2024-09-14,1,,,,,,,,,
P49788,0,OMOP Exposome,Observation,Substance,Retinoic acid receptor responder protein 1,,2024-09-14,1,,,,,,,,,
P19793,0,OMOP Exposome,Observation,Substance,Retinoic acid receptor RXR-alpha,,2024-09-14,1,,,,,,,,,
P28702,0,OMOP Exposome,Observation,Substance,Retinoic acid receptor RXR-beta,,2024-09-14,1,,,,,,,,,
P48443,0,OMOP Exposome,Observation,Substance,Retinoic acid receptor RXR-gamma,,2024-09-14,1,,,,,,,,,
Q8NFJ5,0,OMOP Exposome,Observation,Substance,Retinoic acid-induced protein 3,,2024-09-14,1,,,,,,,,,
Q96R05,0,OMOP Exposome,Observation,Substance,Retinoid-binding protein 7,,2024-09-14,1,,,,,,,,,
127-47-9,0,OMOP Exposome,Observation,Substance,Retinol acetate,"Davitan A 650; 13-cis-Retinyl acetate; Acetateall-trans-Retinol; Acetic acid, retinyl ester; All-trans-retinol acetate; All-trans-Retinyl acetate; All-trans-retinylacetate; All-trans-vitamin a acetate; Crystalets; Vitamin A1 acetate; Vitamin a, acetate; Vitamin a ester; Vitamin a alcohol acetate; Vitamin a acetate (tritiated); Vitamin a acetate; Vitamin A acetate; Trans-vitamin a acetate; Trans-retinyl acetate; Retinyl acetate; Retinol, acetate, labeled with tritium; Retinol, acetate, all-trans- (8CI); Retinol, acetate; Retinol acetic acid; RETINOL ACETATE (SEE RETINOIDPROJECTS 1 AND 3); Retinol acetate (JP15); O~15~-Acetylretinol; O~15~-Acetyl-retinol; O(15)-Acetylretinol; Myvax; Myvak; CHEBI:32095",2014-12-24,1,,,,,,,,,
Q8TC12,0,OMOP Exposome,Observation,Substance,Retinol dehydrogenase 11,,2024-09-14,1,,,,,,,,,
Q96NR8,0,OMOP Exposome,Observation,Substance,Retinol dehydrogenase 12,,2024-09-14,1,,,,,,,,,
Q8NBN7,0,OMOP Exposome,Observation,Substance,Retinol dehydrogenase 13,,2024-09-14,1,,,,,,,,,
Q9HBH5,0,OMOP Exposome,Observation,Substance,Retinol dehydrogenase 14,,2024-09-14,1,,,,,,,,,
Q9NYR8,0,OMOP Exposome,Observation,Substance,Retinol dehydrogenase 8,,2024-09-14,1,,,,,,,,,
GIS1009869,0,OMOP Exposome,Observation,Substance,Retinol Metabolism,,2024-09-14,1,,,,,,,,,
P09455,0,OMOP Exposome,Observation,Substance,Retinol-binding protein 1,,2024-09-14,1,,,,,,,,,
P50120,0,OMOP Exposome,Observation,Substance,Retinol-binding protein 2,,2024-09-14,1,,,,,,,,,
P10745,0,OMOP Exposome,Observation,Substance,Retinol-binding protein 3,,2024-09-14,1,,,,,,,,,
P02753,0,OMOP Exposome,Observation,Substance,Retinol-binding protein 4,,2024-09-14,1,,,,,,,,,
P82980,0,OMOP Exposome,Observation,Substance,Retinol-binding protein 5,,2024-09-14,1,,,,,,,,,
480-85-3,0,OMOP Exposome,Observation,Substance,Retronecine,,2014-12-24,1,,,,,,,,,
GIS1009870,0,OMOP Exposome,Observation,Substance,Reverse Transcriptase Inhibitor,,2024-09-14,1,,,,,,,,,
O94844,0,OMOP Exposome,Observation,Substance,Rho-related BTB domain-containing protein 1,,2024-09-14,1,,,,,,,,,
Q9BYZ6,0,OMOP Exposome,Observation,Substance,Rho-related BTB domain-containing protein 2,,2024-09-14,1,,,,,,,,,
Q92730,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein Rho6,,2024-09-14,1,,,,,,,,,
P62745,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoB,,2024-09-14,1,,,,,,,,,
P08134,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoC,,2024-09-14,1,,,,,,,,,
O00212,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoD,,2024-09-14,1,,,,,,,,,
P61587,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoE,,2024-09-14,1,,,,,,,,,
Q9HBH0,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoF,,2024-09-14,1,,,,,,,,,
P84095,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoG,,2024-09-14,1,,,,,,,,,
Q15669,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoH,,2024-09-14,1,,,,,,,,,
Q9H4E5,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoJ,,2024-09-14,1,,,,,,,,,
P52198,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoN,,2024-09-14,1,,,,,,,,,
P17081,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoQ,,2024-09-14,1,,,,,,,,,
Q7L0Q8,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoU,,2024-09-14,1,,,,,,,,,
Q96L33,0,OMOP Exposome,Observation,Substance,Rho-related GTP-binding protein RhoV,,2024-09-14,1,,,,,,,,,
989-38-8,0,OMOP Exposome,Observation,Substance,Rhodamine 6g,,2014-12-24,1,,,,,,,,,
P08100,0,OMOP Exposome,Observation,Substance,Rhodopsin,,2024-09-14,1,,,,,,,,,
83-88-5,0,OMOP Exposome,Observation,Substance,Riboflavin,"(-)-Riboflavin; e101; Flavaxin; Flavin BB; Flaxain; Food Yellow 15; Hyre; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavine; Riboflavinum; Ribosyn; Ribotone; Ribovel; Russupteridine yellow III; E 101; San Yellow B; Vitaflavine; Vitamin B2; Vitamin G; Vitasan B2; Bisulase; Benzogpteridine riboflavin deriv.; Beflavine; Beflavin; 7,8-Dimethyl-10-ribitylisoalloxazine; 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine; 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)benzogpteridine-2,4(3H,10H)-dione; 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-Benzogpteridine-2,4(3H,10H)-dione; 6,7-Dimethyl-9-ribitylisoalloxazine; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzogpteridin-10(2H)-yl)pentitol; 1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzogpteridin-10(2H)-yl)-D-ribitol; CHEBI:17015",2014-12-24,1,,,,,,,,,
Q969G6,0,OMOP Exposome,Observation,Substance,Riboflavin kinase,,2024-09-14,1,,,,,,,,,
GIS1009877,0,OMOP Exposome,Observation,Substance,Riboflavin Metabolism,,2024-09-14,1,,,,,,,,,
O60930,0,OMOP Exposome,Observation,Substance,Ribonuclease H1,,2024-09-14,1,,,,,,,,,
O75792,0,OMOP Exposome,Observation,Substance,Ribonuclease H2 subunit A,,2024-09-14,1,,,,,,,,,
Q5TBB1,0,OMOP Exposome,Observation,Substance,Ribonuclease H2 subunit B,,2024-09-14,1,,,,,,,,,
Q8TDP1,0,OMOP Exposome,Observation,Substance,Ribonuclease H2 subunit C,,2024-09-14,1,,,,,,,,,
P07998,0,OMOP Exposome,Observation,Substance,Ribonuclease pancreatic,,2024-09-14,1,,,,,,,,,
P52758,0,OMOP Exposome,Observation,Substance,Ribonuclease UK114,,2024-09-14,1,,,,,,,,,
P23921,0,OMOP Exposome,Observation,Substance,Ribonucleoside-diphosphate reductase large subunit,,2024-09-14,1,,,,,,,,,
P31350,0,OMOP Exposome,Observation,Substance,Ribonucleoside-diphosphate reductase subunit M2,,2024-09-14,1,,,,,,,,,
Q7LG56,0,OMOP Exposome,Observation,Substance,Ribonucleoside-diphosphate reductase subunit M2 B,,2024-09-14,1,,,,,,,,,
P51812,0,OMOP Exposome,Observation,Substance,Ribosomal protein S6 kinase alpha-3,,2024-09-14,1,,,,,,,,,
O75582,0,OMOP Exposome,Observation,Substance,Ribosomal protein S6 kinase alpha-5,,2024-09-14,1,,,,,,,,,
GIS1009878,0,OMOP Exposome,Observation,Substance,Ribosome,,2024-09-14,1,,,,,,,,,
P16083,0,OMOP Exposome,Observation,Substance,Ribosyldihydronicotinamide dehydrogenase [quinone],,2024-09-14,1,,,,,,,,,
9009-86-3,0,OMOP Exposome,Observation,Substance,Ricin,,2014-12-24,1,,,,,,,,,
110140-89-1,0,OMOP Exposome,Observation,Substance,Ridogrel,Ridogrelum; R-68070; CHEBI:127439,2014-12-24,1,,,,,,,,,
72559-06-9,0,OMOP Exposome,Observation,Substance,Rifabutin,"Ansamycin; Rifabutinum; Rifabutine; Rifabutina; Ributin; RBT; Mycobutin; Antibiotic LM 427; Ansatipine; Ansatipin; Ansamicin; 4-N-Isobutylspiropiperidylrifamycin S; 4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S; CHEBI:8857",2014-12-24,1,,,,,,,,,
13292-46-1,0,OMOP Exposome,Observation,Substance,Rifampin,3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv; Rimactane; Rimactan; Rifoldin; Rifampicinum; Rifampicina; Tubocin; Rofact; Rifampicin; Rifadine; RFP; Rifaldin; Rifadin; CHEBI:28077,2014-12-24,1,,,,,,,,,
61379-65-5,0,OMOP Exposome,Observation,Substance,Rifapentine,3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin; Cyclopentyl rifampin; Priftin; Cyclopentylrifampicin; CHEBI:8861,2014-12-24,1,,,,,,,,,
1744-22-5,0,OMOP Exposome,Observation,Substance,Riluzole,Lizorolol; Fanizan; Laidec; Lizolorol; Riluzol; Sclefic; Riluzolum; Xie Yi Li; Rilutek; Zolerilis; Rilustad; CHEBI:138898,2014-12-24,1,,,,,,,,,
122931-48-0,0,OMOP Exposome,Observation,Substance,Rimsulfuron,,2014-12-24,1,,,,,,,,,
105462-24-6,0,OMOP Exposome,Observation,Substance,Risedronate,Ridron; NE-58095; Benet; Atelvia; Actonel; Acidum risedronicum; Acido risedronico; Acide ris\u00e9droniqe; Risedrons\u00e4ure; Risedronic acid; CHEBI:183772,2014-12-24,1,,,,,,,,,
GIS1009879,0,OMOP Exposome,Observation,Substance,Risedronate Pathway,,2024-09-14,1,,,,,,,,,
106266-06-2,0,OMOP Exposome,Observation,Substance,Risperidone,Risperdal M-Tab; Buspirone; Belivon; Risperin; Rispolept; Rispolin; Sequinan; Spiron; Risperidona; Risperidonum; Risperidal M-Tab; risperdone; Risperdal Consta; Risperdal; Rispen; CHEBI:8871,2014-12-24,1,,,,,,,,,
174722-31-7,0,OMOP Exposome,Observation,Substance,Rituximab,,2014-12-24,1,,,,,,,,,
145202-66-0,0,OMOP Exposome,Observation,Substance,Rizatriptan,"MK 462 Free Base; Maxalt-MLT; Maxalt MLT; Rizatriptanum; Rizatriptan benzoate; N,N-Dimethyl-2-5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl-ethanamine; Rizatriptan benzoat; Risatriptan; N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine; Maxalt; CHEBI:48273",2014-12-24,1,,,,,,,,,
GIS1009880,0,OMOP Exposome,Observation,Substance,Rna degradation,,2024-09-14,1,,,,,,,,,
GIS1009881,0,OMOP Exposome,Observation,Substance,Rna polymerase,,2024-09-14,1,,,,,,,,,
GIS1009882,0,OMOP Exposome,Observation,Substance,Rna transport,,2024-09-14,1,,,,,,,,,
91728-12-0,0,OMOP Exposome,Observation,Substance,Robustoxin,,2014-12-24,1,,,,,,,,,
P16499,0,OMOP Exposome,Observation,Substance,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",,2024-09-14,1,,,,,,,,,
P35913,0,OMOP Exposome,Observation,Substance,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta",,2024-09-14,1,,,,,,,,,
GIS1009883,0,OMOP Exposome,Observation,Substance,Rodenticide,,2024-09-14,1,,,,,,,,,
91374-21-9,0,OMOP Exposome,Observation,Substance,Ropinirole,ReQuip; Ropinirolum; Ropinirol; Ronirol; ReQuip XL; ReQuip CR; Adartrel; CHEBI:8888,2014-12-24,1,,,,,,,,,
84057-95-4,0,OMOP Exposome,Observation,Substance,Ropivacaine,"(S)-ropivacaine; (S)-(\u2212)-1-propyl-2',6'-pipecoloxylidide; S-Ropivacaine; Ropivacainum; Ropivacaina; Naropin; L-N-n-propylpipecolic acid-2,6-xylidide; CHEBI:8890",2014-12-24,1,,,,,,,,,
58735-64-1,0,OMOP Exposome,Observation,Substance,Roquefortine,,2014-12-24,1,,,,,,,,,
14729-29-4,0,OMOP Exposome,Observation,Substance,Roridin A,,2014-12-24,1,,,,,,,,,
14682-29-2,0,OMOP Exposome,Observation,Substance,Roridin D,,2014-12-24,1,,,,,,,,,
16891-85-3,0,OMOP Exposome,Observation,Substance,Roridin E,,2014-12-24,1,,,,,,,,,
287714-41-4,0,OMOP Exposome,Observation,Substance,Rosuvastatin,"Vivacor; ZD-4522; Visacor; Sinlip; Simestat; Rovartal; Rosvel; Rosuvastatin calcium; Rosuvast; Rosuvas; Rosustatin; Rosumed; Rosimol; Rosedex; Razel; Provisacor; Crestor; Cresadex; Cirantan; Astende; (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-methyl(methylsulfonyl)aminopyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; CHEBI:38545",2014-12-24,1,,,,,,,,,
83-79-4,0,OMOP Exposome,Observation,Substance,Rotenone,"(-)-cis-Rotenone; Derris, JMAF; Derrin; Nicouline; Tubotoxin; Dri-kil; 1,2,12,12a-Tetrahydro-8,9-dimethoxy-2-(1-methylethenyl)-1benzopyrano3,4-bfuro2,3-h1benzopyran-6(6aH)-one; Dactinol; Noxfish; Paraderil; (-)-Rotenone; CHEBI:28201",2014-12-24,1,,,,,,,,,
GIS1009884,0,OMOP Exposome,Observation,Substance,Rough endoplasmic reticulum,,2024-09-14,1,,,,,,,,,
121-19-7,0,OMOP Exposome,Observation,Substance,Roxarsone,Aklomix-3; 4-Hydroxy-3-nitrophenylarsonic acid; 4-Hydroxy-3-nitrophenyl arsonic acid; 4-Hydroxy-3-nitrobenzenearsonic acid; 3-Nitro-80; 2-Nitrophenol-4-arsonic acid; 2-Nitro-1-hydroxybenzene-4-arsonic acid; Roxarsonum; (4-hydroxy-3-nitrophenyl)-arsonic acid; (4-Hydroxy-3-nitrobenzene)arsonic acid; Ristat; Roxarson; 3-Nitro-50; 3-Nitro-4-hydroxyphenylarsonic acid; 3-Nitro-4-hydroxybenzenearsonic acid; 3-Nitro-20; 3-Nitro-10; 3-Nitro; Ren-O-sal; Ren O-sal; Nitrophenoloarsonic acid; Nitrophenolarsonic acid; C6H6AsNO6; As-(4-hydroxy-3-nitrophenyl)-Arsonic acid; CHEBI:35817,2014-12-24,1,,,,,,,,,
7789-39-1,0,OMOP Exposome,Observation,Substance,Rubidium bromide,,2014-12-24,1,,,,,,,,,
13126-12-0,0,OMOP Exposome,Observation,Substance,Rubidium nitrate,,2014-12-24,1,,,,,,,,,
22467-31-8,0,OMOP Exposome,Observation,Substance,Rubratoxin A,,2014-12-24,1,,,,,,,,,
21794-01-4,0,OMOP Exposome,Observation,Substance,Rubratoxin B,,2014-12-24,1,,,,,,,,,
15662-33-6,0,OMOP Exposome,Observation,Substance,Ryanodine,,2014-12-24,1,,,,,,,,,
P21817,0,OMOP Exposome,Observation,Substance,Ryanodine receptor 1,,2024-09-14,1,,,,,,,,,
Q92736,0,OMOP Exposome,Observation,Substance,Ryanodine receptor 2,,2024-09-14,1,,,,,,,,,
Q15413,0,OMOP Exposome,Observation,Substance,Ryanodine receptor 3,,2024-09-14,1,,,,,,,,,
78-48-8,0,OMOP Exposome,Observation,Substance,"S,S,S-Tributyl phosphorotrithioate","Tributyl S,S,S-phosphorotrithioate; Butifos; Butyl phosphorotrithioate; Fosfall; Butyphos; DEF; Tribuphos; Tribufos; S,S,S-tributyltrithiophosphate; S,S,S-tributylphosphorotrithioate; S,S,S-tributyl trithiophosphate; S,S,S-Tributyl phosphorotrithioic acid; Phosphorotrithioic acid, S,S,S-tributyl ester; Ortho phosphate defoliant; Merphos-oxon; Merphos oxide; Fossfall; Deleaf defoliant; Def defoliant; Butiphos; Tributylphosphorotrithioate; CHEBI:38737",2014-12-24,1,,,,,,,,,
979-92-0,0,OMOP Exposome,Observation,Substance,S-Adenosylhomocysteine,Formycinylhomocysteine; S-Adenosyl-L-homocysteine; S-Adenosyl-homocysteine; S-(5'-Deoxyadenosine-5')-L-homocysteine; S-(5'-Deoxyadenosin-5'-yl)-L-homocysteine; S-(5'-Adenosyl)-L-homocysteine; L-S-Adenosylhomocysteine; L-S-Adenosyl-Homocysteine; (S)-5'-(S)-(3-Amino-3-carboxypropyl)-5'-thioadenosine; 2-S-Adenosyl-L-homocysteine; 5'-Deoxy-S-adenosyl-L-homocysteine; 5'-S-(3-Amino-3-carboxypropyl)-5'-thio-L-Adenosine; Adenosyl-homo-CYS; Adenosyl-L-homocysteine; Adenosylhomo-CYS; Adenosylhomocysteine; Adohcy; L-5'-S-(3-Amino-3-carboxypropyl)-5'-thior-Adenosine; SAH; CHEBI:16680,2018-03-21,1,,,,,,,,,
GIS1009886,0,OMOP Exposome,Observation,Substance,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,,2024-09-14,1,,,,,,,,,
29908-03-0,0,OMOP Exposome,Observation,Substance,S-Adenosylmethionine,"S-(5'-Adenosyl)-L-methionine; S-(5'-Deoxyadenosin-5'-yl)-L-methionine; S-Adenosyl methionine; S-Adenosyl-L-methionine; S-Adenosyl-L-Methionine Disulfate Tosylate; S-Adenosyl-L-Methionine Disulphate Tosylate; S-Adenosyl-methionine; SAM; Sam-Sulfate; SAMe; SAMe Rx-Mood; 1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl(3S)-3-amino-3-carboxypropyl(methyl)sulfonium; (3S)-5'-(3-amino-3-carboxypropyl)methylsulfonio-5'-deoxyadenosine; (3S)-5'-(3-amino-3-Carboxypropyl)methylsulfonio-5'-deoxyadenosine, inner salt; 2-S-Adenosyl-L-methionine; 5'-Deoxyadenosine-5'-L-methionine disulfate ditosylate; 5'-Deoxyadenosine-5'-L-methionine disulphate ditosylate; Active methionine; Acylcarnitine; Ademetionine; Adenosylmethionine; AdoMet; Donamet; L-S-Adenosylmethionine; CHEBI:15414",2014-12-24,1,,,,,,,,,
P17707,0,OMOP Exposome,Observation,Substance,S-adenosylmethionine decarboxylase proenzyme,,2024-09-14,1,,,,,,,,,
Q00266,0,OMOP Exposome,Observation,Substance,S-adenosylmethionine synthase isoform type-1,,2024-09-14,1,,,,,,,,,
P31153,0,OMOP Exposome,Observation,Substance,S-adenosylmethionine synthase isoform type-2,,2024-09-14,1,,,,,,,,,
28434-00-6,0,OMOP Exposome,Observation,Substance,S-Bioallethrin,"(S)-3-Allyl-3-methyl-4-oxocyclopent-2-enyl (+)-trans-chrysanthemate; Bioallethrin S-cyclopentenyl isomer; (1S)-3-Allyl-2-methyl-4-oxocyclopent-2-en-1-yl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate; Bioallethrin S-cyclopentenyl; CHEBI:39115",2014-12-24,1,,,,,,,,,
P10768,0,OMOP Exposome,Observation,Substance,S-formylglutathione hydrolase,,2024-09-14,1,,,,,,,,,
Q13126,0,OMOP Exposome,Observation,Substance,S-methyl-5'-thioadenosine phosphorylase,,2024-09-14,1,,,,,,,,,
Q9H2M3,0,OMOP Exposome,Observation,Substance,S-methylmethionine--homocysteine S-methyltransferase BHMT2,,2024-09-14,1,,,,,,,,,
P63208,0,OMOP Exposome,Observation,Substance,S-phase kinase-associated protein 1,,2024-09-14,1,,,,,,,,,
1637-71-4,0,OMOP Exposome,Observation,Substance,S-Sulfocysteine,Cysteinyl-S-sulfonic acid; Cysteine-S-sulfonic acid; Cysteine-S-sulfonate; L-Cysteine S-sulfate; Cysteinyl-S-sulfonate; Cysteine-S-sulfate; S-Sulphocysteine; S-Sulfo-L-cysteine; CHEBI:27891,2014-12-24,1,,,,,,,,,
997-68-2,0,OMOP Exposome,Observation,Substance,Saccharopine,"(S)-N-(5-amino-5-carboxypentyl)-L-Glutamic acid; N-(5-Amino-5-carboxypentyl)-glutamic acid; L-N-(5-Amino-5-carboxypentyl)-Glutamic acid; L-Saccharopin; L-Saccharopine; N(6)-(L-1,3-Dicarboxypropyl)-L-lysine; Saccharopin; N6-(L-1,3-Dicarboxypropyl)-L-lysine; N-(5S)-5-Amino-5-carboxypentyl-L-Glutamic acid; N-(5-Amino-5-carboxypentyl)-L-glutamic acid; epsilon-N-(L-Glutar-2-yl)-L-lysine; CHEBI:16927",2018-03-21,1,,,,,,,,,
GIS1009885,0,OMOP Exposome,Observation,Substance,Saccharopinuria/Hyperlysinemia II,,2024-09-14,1,,,,,,,,,
94-59-7,0,OMOP Exposome,Observation,Substance,Safrole,"4-Allyl-1, 2-(methylenedioxy)benzene; 3,4-Methylenedioxyallylbenzene; 5-prop-2-enyl-1,3-benzodioxole; 5-Allyl-1,3-benzodioxolerlet DS Base; 5-(2-Propenyl)-1,3-benzodioxole, 9CI; 4-Propenylcatechol methylene ether; Allyldioxybenzene methylene ether; Allylpyrocatechol methylene ether; M-Allylpyrocatechin methylene ether; Shikimol; Shikomol; 3,4-Methylenedioxy-allybenzene; 4-Allyl-1,2-(methylenedioxy)benzene, 8CI; 4-Allylpyrocatechol formaldehyde acetal; Allylcatechol methylene ether; 3-(3,4-Methylenedioxyphenyl)prop-1-ene; 3, 4-(Methylenedioxy)allylbenzene; 1-Allyl,3,4-methylenedioxy benzene; 1,2-Methylenedioxy-4-allyl-Benzene; 1, 2-(Methylenedioxy)-4-allylbenzene; (E)5-1-Propenyl-1,3-benzodioxole; (allyldioxy)benzene methylene ether; CHEBI:8994",2014-12-24,1,,,,,,,,,
3031-95-6,0,OMOP Exposome,Observation,Substance,SAICAR,1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole' 1-(5'-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole; 5-Amino-4-imidazole-N-succinocarboxamide ribonucleotide; L-N-(5-Amino-1-b-D-ribofuranosylimidazol-4-yl)carbonyl-5'-(dihydrogen phosphate); L-N-(5-Amino-1-beta-delta-ribofuranosylimidazol-4-yl)carbonyl-5'-(dihydrogen phosphate); (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinic acid; (S)-2-(5-amino-1-(5-phospho-delta-ribosyl)imidazole-4-carboxamido)succinate; (S)-2-(5-amino-1-(5-phospho-delta-ribosyl)imidazole-4-carboxamido)succinic acid; (S)-2-5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamidosuccinate; N-(5-Amino-1-ribofuranosylimidazol-4-ylcarbonyl)aspartic acid 5'-phosphate; N-5-Amino-1-(5'-phosphoribofuranosyl)-4-imidazolecarbonylaspartate; N-5-Amino-1-(5'-phosphoribofuranosyl)-4-imidazolecarbonylaspartic acid; Phosphoribosylaminoimidazolesuccinocarboxamide; Succinylaminoimidazole carboxamide riboside; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate; SAICAriboside; Succino-AICAR; 1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole; 1-(5'-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole; (S)-2-5-Amino-1-(5-phospho-delta-ribosyl)imidazole-4-carboxamidosuccinate; 5'-Phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole; 5'-Phosphoribosyl-4-(N-succinocarbozamide)-5-aminoimidazole; CHEBI:18319,2018-03-21,1,,,,,,,,,
18559-94-9,0,OMOP Exposome,Observation,Substance,Salbutamol,AccuNeb; Asthavent; Ventoline; Ventolin; Levalbuterol; Ventilan; ProAir; PROAIRHFA; Proventil; Ventorlin; Xopenex; Salamol; Aerolin; VENTOLINHFA; Albuterol; VoSpire; Airomir; Asthalin; Asmol; CHEBI:2549,2014-12-24,1,,,,,,,,,
14167-18-1,0,OMOP Exposome,Observation,Substance,Salcomine,,2014-12-24,1,,,,,,,,,
GIS1009887,0,OMOP Exposome,Observation,Substance,Salicylate,,2024-09-14,1,,,,,,,,,
69-72-7,0,OMOP Exposome,Observation,Substance,Salicylic acid,Freezone; Ionil; Ionil Plus; Ionil Plus shampoo; K 537; K 557; Keralyt; O-Carboxyphenol; O-Hydroxybenzoate; O-Hydroxybenzoic acid; Phenol-2-carboxylate; Phenol-2-carboxylic acid; Psoriacid-S-Stift; Retarder W; Rutranex; Salicylate; Salicylic acid collodion; Salicylic acid Soap; Saligel; Salonil; Stri-Dex; Stridex; Trans-Ver-Sal; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylate; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoate; 2-Hydroxybenzoic acid; Advanced Pain Relief Callus Removers; Advanced Pain Relief Corn Removers; Clear away Wart Remover; Compound W; Dr. Scholl'S Callus Removers; Dr. Scholl'S Corn Removers; Dr. Scholl'S Wart Remover Kit; Duofil Wart Remover; Duoplant; CHEBI:16914,2014-12-24,1,,,,,,,,,
GIS1009889,0,OMOP Exposome,Observation,Substance,Salivary secretion,,2024-09-14,1,,,,,,,,,
89365-50-4,0,OMOP Exposome,Observation,Substance,Salmeterol,,2014-12-24,1,,,,,,,,,
83729-01-5,0,OMOP Exposome,Observation,Substance,Salvinorin A,,2014-12-24,1,,,,,,,,,
99-19-4,0,OMOP Exposome,Observation,Substance,Sambunigrin,(S)-Mandelonitrile beta-D-glucoside; (2S)-Sambunigrin; (2S)-(beta-D-Glucopyranosyloxy)(phenyl)acetonitrile; L-Prunasin; (S)-Prunasin; CHEBI:27761,2014-12-24,1,,,,,,,,,
2447-54-3,0,OMOP Exposome,Observation,Substance,Sanguinarine,"5-Methyl-2,3:7,8-bis(methylenedioxy)benzocphenanthridinium(1+); Benzophenanthridine alkaloid; 13-Methyl1,3benzodioxolo5,6-c-1,3-dioxolo4,5-iphenanthridinium(1+), 9CI; Sanguiritrin; Sangvinarin; Veadent; Viadent; y-Chelerythrine; Dimethylenedioxy benzphenanthridine; Pseudochelerythrine; Sanguinarin; Sanguinarine chloride; Sanguinarium; CHEBI:17183",2014-12-24,1,,,,,,,,,
GIS1009890,0,OMOP Exposome,Observation,Substance,Sarcoplasm,,2024-09-14,1,,,,,,,,,
GIS1009891,0,OMOP Exposome,Observation,Substance,Sarcoplasmic Reticulum,,2024-09-14,1,,,,,,,,,
O14983,0,OMOP Exposome,Observation,Substance,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,,2024-09-14,1,,,,,,,,,
P16615,0,OMOP Exposome,Observation,Substance,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,,2024-09-14,1,,,,,,,,,
Q93084,0,OMOP Exposome,Observation,Substance,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3,,2024-09-14,1,,,,,,,,,
107-97-1,0,OMOP Exposome,Observation,Substance,Sarcosine,(Methylamino)ethanoate; (methylamino)-Acetic acid; Methylglycine; N-Methyl-Glycine; (Methylamino)acetate; (methylamino)-Acetate; N-Methylglycine; N-Methylaminoacetic acid; N-Methylaminoacetate; (Methylamino)acetic acid; Sarcosinic acid; (Methylamino)ethanoic acid; Sarcosinate; Sarcosin; CHEBI:15611,2014-12-24,1,,,,,,,,,
GIS1009892,0,OMOP Exposome,Observation,Substance,Sarcosinemia,,2024-09-14,1,,,,,,,,,
53126-64-0,0,OMOP Exposome,Observation,Substance,Satratoxin H,,2014-12-24,1,,,,,,,,,
35523-89-8,0,OMOP Exposome,Observation,Substance,Saxitoxin,Saxidomus giganteus poison; Mytilus californianus poison; Gonyaulax catenella poison; Saxitoxin (8ci); CHEBI:610951,2014-12-24,1,,,,,,,,,
Q8WTV0,0,OMOP Exposome,Observation,Substance,Scavenger receptor class B member 1,,2024-09-14,1,,,,,,,,,
37133-74-7,0,OMOP Exposome,Observation,Substance,Scirpene,,2014-12-24,1,,,,,,,,,
GIS1009893,0,OMOP Exposome,Observation,Substance,Sclerosing Solution,,2024-09-14,1,,,,,,,,,
51-34-3,0,OMOP Exposome,Observation,Substance,Scopolamine,"(-)-Scopolamine bromide; L-Hyoscine hydrobromide; L-Scopolamine-hydrobromide; Methscopolamine Bromide; Oscine; Pamine; S-(-)-Tropate; Scop; Scopamin; scopine (-)-tropate; scopine (\u2212)-tropate; Scopine tropate; (+)-Hyoscine; (+)-Scopolamine; (-)-Hyoscine; (-)-Hyoscine hydrobromide; (-)-scopolamine; Kwells; (-)-Scopolamine hydrobromide; (1S,3S,5R,6R,7S)-6,7-epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate; 6,7-Epoxytropine Tropate; 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate; alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester; Atrochin; Atroquin; SEE; Scopolammonium bromide; Scopolaminium bromide; Transderm-Scop; Tranaxine; Beldavrin; Buscopan; Epoxytropine tropate; Euscopol; Hydroscine hydrobromide; Scopolamine hydrobromide; Scopolamine bromide; Hyosceine; Scopoderm; Hyoscine; Hyoscine bromide; Hyoscine hydrobromide; Hyoscyine hydrobromide; Hyosol; Hysco; Isopto Hyoscine; Isoscopil; CHEBI:16794",2014-12-24,1,,,,,,,,,
GIS1009894,0,OMOP Exposome,Observation,Substance,Scorpion Toxin,,2024-09-14,1,,,,,,,,,
142948-19-4,0,OMOP Exposome,Observation,Substance,Scyllatoxin,,2014-12-24,1,,,,,,,,,
111-20-6,0,OMOP Exposome,Observation,Substance,Sebacic acid,"4,7-Dioxosebacic acid; Ipomic acid; Dicarboxylic acid C10; Decanedioic acid; Decanedioate; Decanedicarboxylic acid; 1,10-Decanedioate; 1,10-Decanedioic acid; 1,8-Octanedicarboxylate; 1,8-Octanedicarboxylic acid; 4-Oxodecanedioate; 4-Oxodecanedioic acid; Acide sebacique; N-Decanedioate; N-Decanedioic acid; Sebacate; Sebacic acids; Sebacinsaeure; Sebacinsaure; Seracic acid; CHEBI:41865",2014-12-24,1,,,,,,,,,
O76054,0,OMOP Exposome,Observation,Substance,SEC14-like protein 2,,2024-09-14,1,,,,,,,,,
Q9UDX4,0,OMOP Exposome,Observation,Substance,SEC14-like protein 3,,2024-09-14,1,,,,,,,,,
Q9UDX3,0,OMOP Exposome,Observation,Substance,SEC14-like protein 4,,2024-09-14,1,,,,,,,,,
35287-69-5,0,OMOP Exposome,Observation,Substance,Secalonic Acid D,,2014-12-24,1,,,,,,,,,
76-73-3,0,OMOP Exposome,Observation,Substance,Secobarbital,"5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione; Secobarbitale; Secobarbitalum; Secobarbitone; Sodium Secobarbital; Seconal; Sodium quinalbarbitone; (\u00b1)-secobarbital; 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-allyl-5-(1-methylbutyl)barbituric acid; Quinalbarbitone; (+-)-Secobarbital; (+/-)-Secobarbital; CHEBI:9073",2014-12-24,1,,,,,,,,,
GIS1009895,0,OMOP Exposome,Observation,Substance,Secretory Granule,,2024-09-14,1,,,,,,,,,
GIS1009896,0,OMOP Exposome,Observation,Substance,Secretory vesicle,,2024-09-14,1,,,,,,,,,
GIS1009897,0,OMOP Exposome,Observation,Substance,Selective Estrogen Receptor Modulator,,2024-09-14,1,,,,,,,,,
GIS1009898,0,OMOP Exposome,Observation,Substance,Selective Serotonin Agonist,,2024-09-14,1,,,,,,,,,
GIS1009899,0,OMOP Exposome,Observation,Substance,Selective Serotonin Reuptake Inhibitor,,2024-09-14,1,,,,,,,,,
14611-51-9,0,OMOP Exposome,Observation,Substance,Selegiline,Selegilinum; Zelapar; Selegilina; Carbex; Eldepryl; L-Deprenalin; Jumex; (\u2212)-selegiline; EmSam; CHEBI:50217,2014-12-24,1,,,,,,,,,
7783-08-6,0,OMOP Exposome,Observation,Substance,Selenic acid,SeO2(OH)2; H2SeO4; Selenate; CHEBI:18170,2014-12-24,1,,,,,,,,,
7782-49-2,0,OMOP Exposome,Observation,Substance,Selenium,Se(2-); Selanediide; Selenium ion (Se2-); Selenium anion (2-); Selenide(2-); Selenide; CHEBI:60871,2014-12-24,1,,,,,,,,,
GIS1009907,0,OMOP Exposome,Observation,Substance,Selenium Compound,,2024-09-14,1,,,,,,,,,
144-34-3,0,OMOP Exposome,Observation,Substance,Selenium dimethyldithiocarbamate,,2014-12-24,1,,,,,,,,,
7446-08-4,0,OMOP Exposome,Observation,Substance,Selenium dioxide,,2014-12-24,1,,,,,,,,,
7488-56-4,0,OMOP Exposome,Observation,Substance,Selenium disulfide,,2014-12-24,1,,,,,,,,,
7783-79-1,0,OMOP Exposome,Observation,Substance,Selenium hexafluoride,Selenium fluoride; Selenium fluoride (SeF6); Hexafluoridoselenium; selenium(6+) fluoride; SeF6; SeF6; CHEBI:30434,2014-12-24,1,,,,,,,,,
75926-26-0,0,OMOP Exposome,Observation,Substance,Selenium hexasulfide,,2014-12-24,1,,,,,,,,,
7789-51-7,0,OMOP Exposome,Observation,Substance,Selenium oxybromide,,2014-12-24,1,,,,,,,,,
7791-23-3,0,OMOP Exposome,Observation,Substance,Selenium oxydichloride,,2014-12-24,1,,,,,,,,,
7446-34-6,0,OMOP Exposome,Observation,Substance,Selenium Sulfide,,2014-12-24,1,,,,,,,,,
10026-03-6,0,OMOP Exposome,Observation,Substance,Selenium tetrachloride,,2014-12-24,1,,,,,,,,,
13465-66-2,0,OMOP Exposome,Observation,Substance,Selenium tetrafluoride,SeF4; SeF4; selenium(4+) fluoride; Selenium(IV) fluoride; Tetrafluoridoselenium; CHEBI:30435,2014-12-24,1,,,,,,,,,
13768-86-0,0,OMOP Exposome,Observation,Substance,Selenium trioxide,,2014-12-24,1,,,,,,,,,
Q13228,0,OMOP Exposome,Observation,Substance,Selenium-binding protein 1,,2024-09-14,1,,,,,,,,,
GIS1009908,0,OMOP Exposome,Observation,Substance,Selenoamino Acid Metabolism,,2024-09-14,1,,,,,,,,,
Q96I15,0,OMOP Exposome,Observation,Substance,Selenocysteine lyase,,2024-09-14,1,,,,,,,,,
Q59FK2,0,OMOP Exposome,Observation,Substance,Selenocysteine lyase variant,,2024-09-14,1,,,,,,,,,
P49908,0,OMOP Exposome,Observation,Substance,Selenoprotein P,,2024-09-14,1,,,,,,,,,
7783-00-8,0,OMOP Exposome,Observation,Substance,Selenous acid,"SeO(OH)2; Hydrogen selenite; Selenium dioxide, monohydrated; Selenium dioxide; Selenige saeure; Dihydroxidooxidoselenium; Selenious acid; Selenious acid (H2seo3); SELENIOUS ACID, H2SeO3; Monohydrated selenium dioxide; CHEBI:26642",2014-12-24,1,,,,,,,,,
P04279,0,OMOP Exposome,Observation,Substance,Semenogelin-1,,2024-09-14,1,,,,,,,,,
130-01-8,0,OMOP Exposome,Observation,Substance,Senecionine,Aureine; Senecionin; CHEBI:CHEBI:9107,2014-12-24,1,,,,,,,,,
Q96GA7,0,OMOP Exposome,Observation,Substance,Serine dehydratase-like,,2024-09-14,1,,,,,,,,,
Q53ET4,0,OMOP Exposome,Observation,Substance,Serine hydroxymethyltransferase,,2024-09-14,1,,,,,,,,,
P34896,0,OMOP Exposome,Observation,Substance,"Serine hydroxymethyltransferase, cytosolic",,2024-09-14,1,,,,,,,,,
P34897,0,OMOP Exposome,Observation,Substance,"Serine hydroxymethyltransferase, mitochondrial",,2024-09-14,1,,,,,,,,,
O15269,0,OMOP Exposome,Observation,Substance,Serine palmitoyltransferase 1,,2024-09-14,1,,,,,,,,,
O15270,0,OMOP Exposome,Observation,Substance,Serine palmitoyltransferase 2,,2024-09-14,1,,,,,,,,,
Q9NUV7,0,OMOP Exposome,Observation,Substance,Serine palmitoyltransferase 3,,2024-09-14,1,,,,,,,,,
Q9GZT4,0,OMOP Exposome,Observation,Substance,Serine racemase,,2024-09-14,1,,,,,,,,,
P21549,0,OMOP Exposome,Observation,Substance,Serine--pyruvate aminotransferase,,2024-09-14,1,,,,,,,,,
P49591,0,OMOP Exposome,Observation,Substance,"Serine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
Q13315,0,OMOP Exposome,Observation,Substance,Serine-protein kinase ATM,,2024-09-14,1,,,,,,,,,
O94768,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase 17B,,2024-09-14,1,,,,,,,,,
P10398,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase A-Raf,,2024-09-14,1,,,,,,,,,
Q13535,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase ATR,,2024-09-14,1,,,,,,,,,
P15056,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase B-raf,,2024-09-14,1,,,,,,,,,
Q9P0L2,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase MARK1,,2024-09-14,1,,,,,,,,,
P42345,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase mTOR,,2024-09-14,1,,,,,,,,,
P51955,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase Nek2,,2024-09-14,1,,,,,,,,,
O96013,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase PAK 4,,2024-09-14,1,,,,,,,,,
P11309,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase pim-1,,2024-09-14,1,,,,,,,,,
Q9NYY3,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase PLK2,,2024-09-14,1,,,,,,,,,
P37023,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase receptor R3,,2024-09-14,1,,,,,,,,,
O00141,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase Sgk1,,2024-09-14,1,,,,,,,,,
Q9UHD2,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein kinase TBK1,,2024-09-14,1,,,,,,,,,
P30153,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,,2024-09-14,1,,,,,,,,,
P30154,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,,2024-09-14,1,,,,,,,,,
P67775,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,,2024-09-14,1,,,,,,,,,
P62714,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,,2024-09-14,1,,,,,,,,,
Q08209,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,,2024-09-14,1,,,,,,,,,
P16298,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform,,2024-09-14,1,,,,,,,,,
P48454,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,,2024-09-14,1,,,,,,,,,
P53041,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase 5,,2024-09-14,1,,,,,,,,,
P36873,0,OMOP Exposome,Observation,Substance,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,,2024-09-14,1,,,,,,,,,
GIS1009909,0,OMOP Exposome,Observation,Substance,Serotonin 5-HT1 Receptor Agonist,,2024-09-14,1,,,,,,,,,
GIS1009918,0,OMOP Exposome,Observation,Substance,Serotonin Agent,,2024-09-14,1,,,,,,,,,
GIS1009919,0,OMOP Exposome,Observation,Substance,Serotonin Agonist,,2024-09-14,1,,,,,,,,,
GIS1009920,0,OMOP Exposome,Observation,Substance,Serotonin Antagonist,,2024-09-14,1,,,,,,,,,
GIS1009921,0,OMOP Exposome,Observation,Substance,Serotonin Receptor Agonist,,2024-09-14,1,,,,,,,,,
BE0004862,0,OMOP Exposome,Observation,Substance,Serotonin Receptors,,2024-09-14,1,,,,,,,,,
GIS1009930,0,OMOP Exposome,Observation,Substance,Serotonin Reuptake Inhibitor,,2024-09-14,1,,,,,,,,,
GIS1009938,0,OMOP Exposome,Observation,Substance,Serotonin Uptake Inhibitor,,2024-09-14,1,,,,,,,,,
P02787,0,OMOP Exposome,Observation,Substance,Serotransferrin,,2024-09-14,1,,,,,,,,,
99592-32-2,0,OMOP Exposome,Observation,Substance,Sertaconazole,Ertaczo; Demofix; Sertaconazolum; Sertaconazol; CHEBI:775147,2014-12-24,1,,,,,,,,,
79617-96-2,0,OMOP Exposome,Observation,Substance,Sertraline,"(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; Apo-Sertraline; Lustral; Sertralina; Zoloft; Sertralinum; Sertraline hydrochloride; CP 51974; (+)-Sertraline; (1S,4S)-Sertraline; cis-(+)-Sertraline; CHEBI:9123",2014-12-24,1,,,,,,,,,
P02768,0,OMOP Exposome,Observation,Substance,Serum albumin,,2024-09-14,1,,,,,,,,,
P27169,0,OMOP Exposome,Observation,Substance,Serum paraoxonase/arylesterase 1,,2024-09-14,1,,,,,,,,,
Q15166,0,OMOP Exposome,Observation,Substance,Serum paraoxonase/lactonase 3,,2024-09-14,1,,,,,,,,,
74051-80-2,0,OMOP Exposome,Observation,Substance,Sethoxydim,,2014-12-24,1,,,,,,,,,
28523-86-6,0,OMOP Exposome,Observation,Substance,Sevoflurane,"Sevoflurano; Sevofluran; 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane; Ultane; Sevorane; Sojourn; Sevofluranum; CHEBI:9130",2014-12-24,1,,,,,,,,,
P04278,0,OMOP Exposome,Observation,Substance,Sex hormone-binding globulin,,2024-09-14,1,,,,,,,,,
GIS1009946,0,OMOP Exposome,Observation,Substance,Shiga toxin subunit A,,2024-09-14,1,,,,,,,,,
75757-64-1,0,OMOP Exposome,Observation,Substance,Shiga toxin subunit B,,2014-12-24,1,,,,,,,,,
GIS1009952,0,OMOP Exposome,Observation,Substance,Shigella Toxin,,2024-09-14,1,,,,,,,,,
GIS1009953,0,OMOP Exposome,Observation,Substance,Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),,2024-09-14,1,,,,,,,,,
Q9UBN4,0,OMOP Exposome,Observation,Substance,Short transient receptor potential channel 4,,2024-09-14,1,,,,,,,,,
O75911,0,OMOP Exposome,Observation,Substance,Short-chain dehydrogenase/reductase 3,,2024-09-14,1,,,,,,,,,
P45954,0,OMOP Exposome,Observation,Substance,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9Y3R4,0,OMOP Exposome,Observation,Substance,Sialidase-2,,2024-09-14,1,,,,,,,,,
Q9BZZ2,0,OMOP Exposome,Observation,Substance,Sialoadhesin,,2024-09-14,1,,,,,,,,,
106650-56-0,0,OMOP Exposome,Observation,Substance,Sibutramine,Meridia; Medaria; Sibutramina; Reductil; Butramin; Sibutraminum; CHEBI:458192,2014-12-24,1,,,,,,,,,
Q99720,0,OMOP Exposome,Observation,Substance,Sigma non-opioid intracellular receptor 1,,2024-09-14,1,,,,,,,,,
BE0004897,0,OMOP Exposome,Observation,Substance,Sigma receptor,,2024-09-14,1,,,,,,,,,
P42224,0,OMOP Exposome,Observation,Substance,Signal transducer and activator of transcription 1-alpha/beta,,2024-09-14,1,,,,,,,,,
7789-66-4,0,OMOP Exposome,Observation,Substance,Silicon tetrabromide,,2014-12-24,1,,,,,,,,,
7440-22-4,0,OMOP Exposome,Observation,Substance,Silver,Silver metal; Silver(1+); Silver(0); Silver ion (1+); Silver(1+) ion; Silver(I) cation; Silver cation; Argentum; Ag+; Ag(1+); Ag; CHEBI:49468,2014-12-24,1,,,,,,,,,
563-63-3,0,OMOP Exposome,Observation,Substance,Silver acetate,,2014-12-24,1,,,,,,,,,
7659-31-6,0,OMOP Exposome,Observation,Substance,Silver acetylide,,2014-12-24,1,,,,,,,,,
13863-88-2,0,OMOP Exposome,Observation,Substance,Silver azide,,2014-12-24,1,,,,,,,,,
7783-89-3,0,OMOP Exposome,Observation,Substance,Silver bromate,,2014-12-24,1,,,,,,,,,
7785-23-1,0,OMOP Exposome,Observation,Substance,Silver bromide,,2014-12-24,1,,,,,,,,,
534-16-7,0,OMOP Exposome,Observation,Substance,Silver carbonate,,2014-12-24,1,,,,,,,,,
7783-92-8,0,OMOP Exposome,Observation,Substance,Silver chlorate,,2014-12-24,1,,,,,,,,,
7783-90-6,0,OMOP Exposome,Observation,Substance,Silver chloride,Caswell No. 735A; Silver chloride (agcl); Silver monochloride; Silver(I) chloride; AgCl; AgCl; CHEBI:30341,2014-12-24,1,,,,,,,,,
7784-01-2,0,OMOP Exposome,Observation,Substance,Silver chromate,,2014-12-24,1,,,,,,,,,
GIS1009954,0,OMOP Exposome,Observation,Substance,Silver Compound,,2024-09-14,1,,,,,,,,,
506-64-9,0,OMOP Exposome,Observation,Substance,Silver cyanide,,2014-12-24,1,,,,,,,,,
5610-59-3,0,OMOP Exposome,Observation,Substance,Silver fulminate,,2014-12-24,1,,,,,,,,,
26042-63-7,0,OMOP Exposome,Observation,Substance,Silver hexafluorophosphate,,2014-12-24,1,,,,,,,,,
7783-97-3,0,OMOP Exposome,Observation,Substance,Silver iodate,,2014-12-24,1,,,,,,,,,
7783-96-2,0,OMOP Exposome,Observation,Substance,Silver iodide,,2014-12-24,1,,,,,,,,,
13765-74-4,0,OMOP Exposome,Observation,Substance,Silver molybdate,,2014-12-24,1,,,,,,,,,
7761-88-8,0,OMOP Exposome,Observation,Substance,Silver nitrate,"Silver nitrate on silica gel; Silver nitrate(dot); Silver nitrate, alcoholic; Silver Nitrate, Silver (2+) Salt (2:1); Silver nitric acid; Silver saltpeter; Silver(1+) nitrate; Lunar caustic; Nitric acid silver salt; Caswell No. 737; Argerol; Nitric acid silver(1+) salt; Silver mononitrate; Silver nitrate (JP15/USP); Alcoholic silver nitrate; Argenti nitras; AgNO3; Silver(I) nitrate (1:1); CHEBI:32130",2014-12-24,1,,,,,,,,,
533-51-7,0,OMOP Exposome,Observation,Substance,Silver oxalate,,2014-12-24,1,,,,,,,,,
20667-12-3,0,OMOP Exposome,Observation,Substance,Silver oxide,,2014-12-24,1,,,,,,,,,
7783-93-9,0,OMOP Exposome,Observation,Substance,Silver perchlorate,,2014-12-24,1,,,,,,,,,
7784-05-6,0,OMOP Exposome,Observation,Substance,Silver selenite,,2014-12-24,1,,,,,,,,,
1302-01-8,0,OMOP Exposome,Observation,Substance,Silver subfluoride,,2014-12-24,1,,,,,,,,,
22199-08-2,0,OMOP Exposome,Observation,Substance,Silver sulfadiazine,Flamazine; Sulfadiazine silver; Silver sulphadiazine; Silvadene; Sulfadiazine silver salt; Silverol; Silver sulfadiazinate; SSD; Dermazin; Thermazene; CHEBI:9142,2014-12-24,1,,,,,,,,,
10294-26-5,0,OMOP Exposome,Observation,Substance,Silver sulfate,,2014-12-24,1,,,,,,,,,
21548-73-2,0,OMOP Exposome,Observation,Substance,Silver sulfide,,2014-12-24,1,,,,,,,,,
12002-99-2,0,OMOP Exposome,Observation,Substance,Silver telluride,,2014-12-24,1,,,,,,,,,
14104-20-2,0,OMOP Exposome,Observation,Substance,Silver tetrafluoroborate,,2014-12-24,1,,,,,,,,,
1493-13-6,0,OMOP Exposome,Observation,Substance,Silver trifluoromethanesulfonate,,2014-12-24,1,,,,,,,,,
26042-64-8,0,OMOP Exposome,Observation,Substance,Silver(I) hexafluoroantimonate,,2014-12-24,1,,,,,,,,,
1302-09-6,0,OMOP Exposome,Observation,Substance,Silver(I) selenide,,2014-12-24,1,,,,,,,,,
1301-96-8,0,OMOP Exposome,Observation,Substance,"Silver(I,III) oxide",,2014-12-24,1,,,,,,,,,
7775-41-9,0,OMOP Exposome,Observation,Substance,Silver(II) fluoride,Tachyol; Ag-f; AGF; Argentous fluoride; Iachiol; Silver fluoride; Silver fluoride (agf); Silver monofluride; silver(1+) fluoride; Silver(I) fluoride; Tachiol; CHEBI:30340,2014-12-24,1,,,,,,,,,
122-34-9,0,OMOP Exposome,Observation,Substance,Simazine,"2-chloro-4,6-Bis(ethylamino)-1,3,5-triazine; 2-chloro-4,6-Bis(ethylamino)-S-triazine; 6-chloro-N(2),N(4)-Diethyl-1,3,5-triazine-2,4-diamine; Princep; 6-chloro-N,N'-diethyl-1,3,5triazin-2,4-diamine; Simanex; 2,4-Bis(ethylamino)-6-chloro-S-triazine; Gesatop; 2,4-Bis(ethylamino)-6-chloro-1,3,5-triazine; CHEBI:27496",2014-12-24,1,,,,,,,,,
79902-63-9,0,OMOP Exposome,Observation,Substance,Simvastatin,"Starzoko; Liponorm; Modutrol; Colemin; Denan; Eucor; Kolestevan; Sivatin; Sivinar; Sorfox; Sotovastin; Starezin; Lipinorm; Zocord; Cholestat; 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; (+)-Simvastatin; Simovil; Simvastatin lactone; Simvastatina; Simvastatine; Simvastatinum; Simvotin; Nivelipol; Nor-Vastina; Synvinolin; Stativer; Statinal; Statin; Staticor; Statex; Zocor; Rechol; Simcor; Velostatin; Lipex; Pepstatin; Valemia; Sinvacor; Sinvascor; Sivastin; Labistatin; Lipovas; Lodales; Medipo; MK-733; Starstat; Stasiva; CHEBI:9150",2014-12-24,1,,,,,,,,,
53123-88-9,0,OMOP Exposome,Observation,Substance,Sirolimus,Rapamycin; (-)-Rapamycin; Rapamune; CHEBI:9168,2014-12-24,1,,,,,,,,,
GIS1009955,0,OMOP Exposome,Observation,Substance,Skeletal,,2024-09-14,1,,,,,,,,,
GIS1009956,0,OMOP Exposome,Observation,Substance,Skeletal Muscle,,2024-09-14,1,,,,,,,,,
GIS1009957,0,OMOP Exposome,Observation,Substance,Skin,,2024-09-14,1,,,,,,,,,
GIS1009958,0,OMOP Exposome,Observation,Substance,Skin and Mucous Membrane Agent,,2024-09-14,1,,,,,,,,,
20084-93-9,0,OMOP Exposome,Observation,Substance,Slaframine,,2014-12-24,1,,,,,,,,,
GIS1009959,0,OMOP Exposome,Observation,Substance,SLC10A1 (NTCP),,2024-09-14,1,,,,,,,,,
GIS1009960,0,OMOP Exposome,Observation,Substance,"SLC10A2 (ASBT, SBAT2)",,2024-09-14,1,,,,,,,,,
GIS1009961,0,OMOP Exposome,Observation,Substance,SLC15A1 (PEPT1),,2024-09-14,1,,,,,,,,,
GIS1009962,0,OMOP Exposome,Observation,Substance,SLC15A2 (PEPT2),,2024-09-14,1,,,,,,,,,
GIS1009965,0,OMOP Exposome,Observation,Substance,SLC22A1 (OCT1),,2024-09-14,1,,,,,,,,,
GIS1009963,0,OMOP Exposome,Observation,Substance,SLC22A11 (OAT4),,2024-09-14,1,,,,,,,,,
GIS1009964,0,OMOP Exposome,Observation,Substance,SLC22A12 (URAT1),,2024-09-14,1,,,,,,,,,
GIS1009966,0,OMOP Exposome,Observation,Substance,SLC22A2 (OCT2),,2024-09-14,1,,,,,,,,,
GIS1009967,0,OMOP Exposome,Observation,Substance,SLC22A3 (OCT3),,2024-09-14,1,,,,,,,,,
GIS1009968,0,OMOP Exposome,Observation,Substance,SLC22A4 (OCTN1),,2024-09-14,1,,,,,,,,,
GIS1009969,0,OMOP Exposome,Observation,Substance,SLC22A5 (OCTN2),,2024-09-14,1,,,,,,,,,
GIS1009970,0,OMOP Exposome,Observation,Substance,SLC22A6 (OAT1),,2024-09-14,1,,,,,,,,,
GIS1009971,0,OMOP Exposome,Observation,Substance,SLC22A7 (OAT2),,2024-09-14,1,,,,,,,,,
GIS1009972,0,OMOP Exposome,Observation,Substance,SLC22A8 (OAT3),,2024-09-14,1,,,,,,,,,
GIS1009973,0,OMOP Exposome,Observation,Substance,SLC47A1 (MATE1),,2024-09-14,1,,,,,,,,,
GIS1009974,0,OMOP Exposome,Observation,Substance,SLC47A2 (MATE2K),,2024-09-14,1,,,,,,,,,
GIS1009975,0,OMOP Exposome,Observation,Substance,"SLC7A10 (ASC1, HASC-1)",,2024-09-14,1,,,,,,,,,
GIS1009976,0,OMOP Exposome,Observation,Substance,"SLCO1A2 (OATP1A2, OATP-A)",,2024-09-14,1,,,,,,,,,
GIS1009977,0,OMOP Exposome,Observation,Substance,"SLCO1B1 (OATP1B1, OATP-C, OATP2, LST-1)",,2024-09-14,1,,,,,,,,,
GIS1009978,0,OMOP Exposome,Observation,Substance,"SLCO1B3 (OATP1B3, OATP8)",,2024-09-14,1,,,,,,,,,
GIS1009979,0,OMOP Exposome,Observation,Exposome Transporter,"SLCO2B1 (OATP2B1, OATP-B)",,2024-09-14,1,,,,,,,,,
144026-79-9,0,OMOP Exposome,Observation,Substance,Slotoxin,,2014-12-24,1,,,,,,,,,
Q92952,0,OMOP Exposome,Observation,Substance,Small conductance calcium-activated potassium channel protein 1,,2024-09-14,1,,,,,,,,,
Q9H2S1,0,OMOP Exposome,Observation,Substance,Small conductance calcium-activated potassium channel protein 2,,2024-09-14,1,,,,,,,,,
Q9UGI6,0,OMOP Exposome,Observation,Substance,Small conductance calcium-activated potassium channel protein 3,,2024-09-14,1,,,,,,,,,
GIS1009980,0,OMOP Exposome,Observation,Substance,Small Intestine,,2024-09-14,1,,,,,,,,,
Q99835,0,OMOP Exposome,Observation,Substance,Smoothened homolog,,2024-09-14,1,,,,,,,,,
GIS1009981,0,OMOP Exposome,Observation,Substance,Snail Toxin,,2024-09-14,1,,,,,,,,,
GIS1009982,0,OMOP Exposome,Observation,Substance,Snake Venom,,2024-09-14,1,,,,,,,,,
1302-42-7,0,OMOP Exposome,Observation,Substance,Sodium aluminate,,2014-12-24,1,,,,,,,,,
13770-96-2,0,OMOP Exposome,Observation,Substance,Sodium aluminium hydride,Sodium aluminum hydride; Sodium aluminum tetrahydride; Sodium tetrahydroaluminate; sodium tetrahydroaluminate(1-); Aluminum sodium hydride; NaAlH4; Sodium tetrahydridoaluminate; CHEBI:30141,2014-12-24,1,,,,,,,,,
7785-88-8,0,OMOP Exposome,Observation,Substance,Sodium aluminum phosphate,,2014-12-24,1,,,,,,,,,
127-85-5,0,OMOP Exposome,Observation,Substance,Sodium arsanilate,"Sodium aminophenol arsonate; Nuarsol; Piglet pro-gen V; Pro-gen sodium; Protoxyl; Soamin; Sodium aminarsonate; Sodium aniline-arsonate; Sodium anilarsonate; Sodium aminophenylarsonate; Sodium arsanilate tetrahydrate; Trypoxyl; Sonate; Sodium arsanilic acid; Sodium arsenilate; Sodium arsonilate; sodium hydrogen (4-aminophenyl)arsonate; sodium hydrogen 4-aminophenylarsonate; Sodium p-arsanilate; Sodium-analine arsonate; Sodium p-aminophenylarsonate tetrahydrate; (4-Aminophenyl)arsonic acid sodium tetrahydrate; Anhydrous sodium arsanilate; (4-Aminophenyl)arsonic acid sodium salt; Arsamin; Arsanilic acid sodium salt; Arsanilic acid sodium salt tetrahydrate; Arsanilic acid, monosodium salt, tetrahydrate; Arsinosolvin; Sodium p-aminobenzenearsonate; Atoxyl; Sodium p-aminophenylarsonate; monosodium (4-aminophenyl)arsonate; CHEBI:36049",2014-12-24,1,,,,,,,,,
7631-89-2,0,OMOP Exposome,Observation,Substance,Sodium arsenate,,2014-12-24,1,,,,,,,,,
7784-46-5,0,OMOP Exposome,Observation,Substance,Sodium arsenite,Sodanit; Sodium meta-arsenite; Sodium (meta)arsenite; Prodalumnol; Sodium metaarsenite; Penite; Sodium dioxoarsenate; CHEBI:29678,2014-12-24,1,,,,,,,,,
22722-98-1,0,OMOP Exposome,Observation,Substance,Sodium bis(2-methoxyethoxy)aluminumhydride,,2014-12-24,1,,,,,,,,,
7789-38-0,0,OMOP Exposome,Observation,Substance,Sodium bromate,"Sodium bromate (NaBrO3); Sodium bromic acid; Water disinfection model (sodium bromate); Bromate de sodium; Bromic acid (acd/name 4.0); Bromic acid, sodium salt; Dyetone; NaBrO3; Neutralizer K-126; Neutralizer K-140; Neutralizer K-938; Sodium bromate(dot); CHEBI:75229",2014-12-24,1,,,,,,,,,
7647-15-6,0,OMOP Exposome,Observation,Substance,Sodium bromide,"Sodium bromide (nabr); Bromide salt of sodium; Bromide standard for ic; Sodium bromide (JP15); Sedoneural; NABR; Hydrobromic acid sodium salt; Caswell No. 750A; Bromnatrium; Bromosodium; WLN: na e; Trisodium tribromide; sodium bromide, 82Br-labeled; Sodium bromide solution; CHEBI:63004",2014-12-24,1,,,,,,,,,
GIS1009983,0,OMOP Exposome,Observation,Substance,Sodium Channel Blocker,,2024-09-14,1,,,,,,,,,
BE0004901,0,OMOP Exposome,Observation,Substance,Sodium channel protein,,2024-09-14,1,,,,,,,,,
P35498,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 1 subunit alpha,,2024-09-14,1,,,,,,,,,
Q9Y5Y9,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 10 subunit alpha,,2024-09-14,1,,,,,,,,,
Q9UI33,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 11 subunit alpha,,2024-09-14,1,,,,,,,,,
Q99250,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 2 subunit alpha,,2024-09-14,1,,,,,,,,,
Q9NY46,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 3 subunit alpha,,2024-09-14,1,,,,,,,,,
P35499,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 4 subunit alpha,,2024-09-14,1,,,,,,,,,
Q14524,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 5 subunit alpha,,2024-09-14,1,,,,,,,,,
Q01118,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 7 subunit alpha,,2024-09-14,1,,,,,,,,,
Q9UQD0,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 8 subunit alpha,,2024-09-14,1,,,,,,,,,
Q15858,0,OMOP Exposome,Observation,Substance,Sodium channel protein type 9 subunit alpha,,2024-09-14,1,,,,,,,,,
Q07699,0,OMOP Exposome,Observation,Substance,Sodium channel subunit beta-1,,2024-09-14,1,,,,,,,,,
O60939,0,OMOP Exposome,Observation,Substance,Sodium channel subunit beta-2,,2024-09-14,1,,,,,,,,,
Q9NY72,0,OMOP Exposome,Observation,Substance,Sodium channel subunit beta-3,,2024-09-14,1,,,,,,,,,
Q8IWT1,0,OMOP Exposome,Observation,Substance,Sodium channel subunit beta-4,,2024-09-14,1,,,,,,,,,
7647-14-5,0,OMOP Exposome,Observation,Substance,Sodium chloride,,2014-12-24,1,,,,,,,,,
GIS1009984,0,OMOP Exposome,Observation,Substance,Sodium Chloride Symporter Inhibitor,,2024-09-14,1,,,,,,,,,
7775-11-3,0,OMOP Exposome,Observation,Substance,Sodium chromate,,2014-12-24,1,,,,,,,,,
13600-98-1,0,OMOP Exposome,Observation,Substance,Sodium cobaltinitrite,,2014-12-24,1,,,,,,,,,
61791-59-1,0,OMOP Exposome,Observation,Substance,Sodium cocoyl sarcosinate,,2014-12-24,1,,,,,,,,,
143-33-9,0,OMOP Exposome,Observation,Substance,Sodium cyanide,"Hydrogen cyanide and cyanide salts; Sodium cyanide, solid; Sodium cyanide solution; NaCN; Hydrocyanic acid, sodium salt; Cyanogran; Cyanobrik; Cyanide, sodium; Cyanide salts; Cyanide of sodium; CHEBI:33192",2014-12-24,1,,,,,,,,,
4418-26-2,0,OMOP Exposome,Observation,Substance,Sodium dehydroacetate,,2014-12-24,1,,,,,,,,,
10588-01-9,0,OMOP Exposome,Observation,Substance,Sodium dichromate,Celcure; Bichromate of soda; Sodium bichromate; Osmose hollow heart concentrate; Na2Cr2O7; Koppers wolman salts cca; Disodium dichromate; Wolman salts cca-type c; Wolman salts cca-type b; Sodium dichromic acid; Sodium dichromate(VI); Sodium dichromate(2-); Chromic acid disodium salt; Celcure wood presrvative; Sodium dichromate solution; CHEBI:39483,2014-12-24,1,,,,,,,,,
124-65-2,0,OMOP Exposome,Observation,Substance,Sodium dimethylarsinate,,2014-12-24,1,,,,,,,,,
13601-19-9,0,OMOP Exposome,Observation,Substance,Sodium ferrocyanide,Sodium hexacyanidoferrate(II); Sodium hexacyanoferrate(4-); Sodium hexacyanoferrate(II); Sodium prussiate yellow; Tetrasodium ferrocyanide; Tetrasodium hexacyanidoferrate; Tetrasodium hexacyanoferrate; Tetrasodium hexacyanoferrate(4-); Yellow prussiate of soda; Sodium hexacyanidoferrate(4-); Sodium ferrocyanide decahydrate; Na4Fe(CN)6; Sodium hexacyanoferate(II); CHEBI:30061,2014-12-24,1,,,,,,,,,
62-74-8,0,OMOP Exposome,Observation,Substance,Sodium fluoroacetate,Natriumfluoracetat; Sodium fluoroacetic acid; Fluoroacetic acid sodium salt; Sodium monofluoroacetate; CHEBI:38699,2014-12-24,1,,,,,,,,,
13775-53-6,0,OMOP Exposome,Observation,Substance,Sodium hexafluoroaluminate,"Sodium hexafluoroaluminic acid; Trisodium (OC-6-11)-hexafluoroaluminate(3-); Aluminate(3-), hexafluoro-, trisodium; Aluminate(3-), hexafluoro-, trisodium (8CI); Trisodium hexafluoroaluminate(3-); Trisodium hexafluoroaluminate(3); Aluminum sodium fluoride; Aluminum sodium fluoride (Na3AlF6); Aluminum sodium hexafluoride (AlNa3F6); Aluminum trisodium hexafluoride; Dinickel orthosilicate; Na3alf6; Trisodium hexafluoroaluminate; Na3alf6; Trisodium aluminum hexafluoride; Sodium aluminum fluoride; Sodium aluminum hexafluoride; Sodium fluoroaluminate (Na3AlF6); Sodium fluoroaluminate(3-); Sodium hexafluoroaluminate (Na3AlF6); CHEBI:39289",2014-12-24,1,,,,,,,,,
16925-25-0,0,OMOP Exposome,Observation,Substance,Sodium hexafluoroantimonate,,2014-12-24,1,,,,,,,,,
7681-52-9,0,OMOP Exposome,Observation,Substance,Sodium hypochlorite,"NaClO; Sodium oxychloride; NaOCl; Hypochlorous acid, sodium salt; Hypochlorite sodium; CHEBI:32146",2014-12-24,1,,,,,,,,,
9004-82-4,0,OMOP Exposome,Observation,Substance,Sodium laureth sulfate,,2014-12-24,1,,,,,,,,,
137-16-6,0,OMOP Exposome,Observation,Substance,Sodium lauroyl sarcosinate,,2014-12-24,1,,,,,,,,,
151-21-3,0,OMOP Exposome,Observation,Substance,Sodium lauryl sulfate,Anticerumen; NaDS; Natrium laurylsulfuricum; SDS; Sodium lauryl sulphic acid; Sodium lauryl sulphate; Sodium lauryl sulfic acid; Sodium dodecylsulfate; Sodium laurilsulfate; Sodium dodecyl sulphate; Sodium dodecyl sulfate; SLS; Laurylsiran sodny; Irium; Genapol LSS; Empicol; Emal 10; CHEBI:8984,2014-12-24,1,,,,,,,,,
13718-26-8,0,OMOP Exposome,Observation,Substance,Sodium metavanadate,"Sodium metavanadic acid; Sodium metavanadate (NaVO3); NaVO3; Monosodium trioxovanadate(1-); Sodium vanadate; Sodium trioxovanadate(1-); Sodium trioxovanadate; Vanadic acid, monosodium salt; Sodium (meta)vanadate; Vanadic acid (hvo3), sodium salt (8ci); Vanadic acid (hvo3), sodium salt; Vanadate(VO3(1-)), sodium; Vanadate (VO31-), sodium; Sodium vanadium oxide (NaVO3); Sodium vanadium oxide; Sodium vanadite(V), NaVO3; Sodium vanadate(V) (NaVO3) (6CI,7CI); Sodium vanadate (NaVO3); Sodium vanadate (meta); CHEBI:75221",2014-12-24,1,,,,,,,,,
7631-99-4,0,OMOP Exposome,Observation,Substance,Sodium nitrate,"Sodium(I) nitrate (1:1); Cubic niter; Etabisulfite; Natrum nitricum; Natrum Nitricum Liquid; Niter; Nitrate de sodium; Nitrate of soda; Nitratine; Nitric acid monosodium salt; Nitric acid sodium salt; Nitric acid sodium salt (1:1); Nitric acid, sodium salt; Soda niter; Sodium nitrate(dot); Sodium nitric acid; Sodium saltpeter; CHEBI:63005",2014-12-24,1,,,,,,,,,
7632-00-0,0,OMOP Exposome,Observation,Substance,Sodium nitrite,Sodium nitrite(dot); Synfat 1004; Nitrogen peroxide ion; Nitrogen dioxide ion; Azotyn sodowy; Diazoting salts; Diazotizing salts; Dusitan sodny; Erinitrit; Nitrite anion; Filmerine; NaNO2; Nitrite de sodium; Natrium nitrit; Nitrito sodico; Nitrite sodium; Nitrite ion standard solution; Nitrite ion; Sodium nitrite preparation; Nitrous acid sodium salt; Nitrous acid; Sodium nitrite solution; Nitrogen dioxide; Acidified sodium nitrite (asn); Anti-rust; CHEBI:16301,2014-12-24,1,,,,,,,,,
14402-89-2,0,OMOP Exposome,Observation,Substance,Sodium nitroprusside,"Na2Fe(CN)5(NO); C5FeN6O.2H2O.2Na; C5FeN6O.2Na; Disodium nitroprusside dihydrate; Disodium nitrosylpentacyanoferrate; Disodium pentacyanidonitrosylferrate; Disodium pentacyanonitrosylferrate; Disodium pentacyanonitrosylferrate(2-) dihydrate; Nipride; Nitropress; Nitroprusside sodium; Nitroprusside, disodium salt, dihydrate; SNP; Sodium nitroferricyanide; Sodium nitroferricyanide dihydrate; Sodium nitroprussate; Sodium nitroprussiate; Sodium nitroprussiate dihydrate; Sodium nitroprusside (anhydrous); Sodium nitroprusside anhydrous; Sodium nitroprusside dihydrate; Sodium nitrosylpentacyanoferrate; Sodium nitrosylpentacyanoferrate (III); Sodium nitrosylpentacyanoferrate(III) dihydrate; Sodium pentacyanidonitrosylferrate(2-); Sodium pentacyanidonitrosylferrate(III); Sodium pentacyanonitrosylferrate; CHEBI:29321",2014-12-24,1,,,,,,,,,
13721-39-6,0,OMOP Exposome,Observation,Substance,Sodium orthovanadate,"Vanadic acid (H3vo4), trisodium salt (8ci); Vanadic acid, trisodium salt; Vanadic acid (H3vo4), trisodium salt; Vanadic acid (H3vo4), sodium salt; Vanadate, sodium; Vanadate(VO4(3-)), trisodium; Vanadate (vo4(3-)), trisodium; Trisodium vanadate; Trisodium trioxido(oxo)vanadium; Trisodium tetraoxovanadate; Trisodium orthovanadate; Sodium vanadium oxide (Na3VO4); Sodium vanadium oxide; Sodium vanadate(V) (Na3VO4) (6CI); Sodium vanadate(V) (Na3VO4); Sodium vanadate (ortho); Sodium vanadate; sodium tetraoxovanadate(3-); sodium tetraoxidovanadate(3-); Sodium pervanadate; Sodium orthovanadic acid; Sodium o-vanadate; Orthovanadate; Na3VO4; Monovanadate; Metavanadate; Decavanadate; CHEBI:35607",2014-12-24,1,,,,,,,,,
7601-89-0,0,OMOP Exposome,Observation,Substance,Sodium perchlorate,,2014-12-24,1,,,,,,,,,
10101-50-5,0,OMOP Exposome,Observation,Substance,Sodium permanganate,,2014-12-24,1,,,,,,,,,
12058-85-4,0,OMOP Exposome,Observation,Substance,Sodium phosphide,,2014-12-24,1,,,,,,,,,
13410-01-0,0,OMOP Exposome,Observation,Substance,Sodium selenate,"Sodium selenic acid; Selenic acid, disodium salt; Disodium selenate; Selenic acid (H2seo4), disodium salt; Sel-tox SSO2 and SS-20; Sodium selenium oxide; Sodium selenium oxide (Na2SeO4); Caswell No. 791; Natriumseleniat; CHEBI:77775",2014-12-24,1,,,,,,,,,
10102-18-8,0,OMOP Exposome,Observation,Substance,Sodium selenite,"Disodium selenite; H2-O3-Se.1/2Na; Natriumselenit; Selenious acid (H2seo3), disodium salt; Selenious acid, disodium salt; Sodium selenite pentahydrate; Sodium selenite, anhydr; Disodium selenium trioxide; CHEBI:48843",2014-12-24,1,,,,,,,,,
13820-53-6,0,OMOP Exposome,Observation,Substance,Sodium tetrachloro-palladate(II),,2014-12-24,1,,,,,,,,,
1191-50-0,0,OMOP Exposome,Observation,Substance,Sodium Tetradecyl Sulfate,Monotetradecylsulfate sodium salt; Tetradecyl sulphate; Tetradecyl sulfuric acid; Tetradecyl sulfate; Tetradecyl sodium sulphate; Tetradecyl sodium sulfate; Tetradecyl hydrogen sulphate; Tetradecyl hydrogen sulfate; STS; Sodium tetradecyl sulphate; Sodium tetradecyl sulfic acid; Sotradecol; Sodium tetradecyl sulphic acid; Sodium tetradecyl sulfate; Sodium myristyl sulphate; Sodium myristyl sulfate; S.T.D.; Monotetradecylsulphate sodium salt; Fibro-Vein; CHEBI:782257,2014-12-24,1,,,,,,,,,
13776-84-6,0,OMOP Exposome,Observation,Substance,Sodium thioantimonate(V),,2014-12-24,1,,,,,,,,,
13721-34-1,0,OMOP Exposome,Observation,Substance,Sodium uranate,,2014-12-24,1,,,,,,,,,
12179-14-5,0,OMOP Exposome,Observation,Substance,Sodium zincate,,2014-12-24,1,,,,,,,,,
P48065,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent betaine transporter,,2024-09-14,1,,,,,,,,,
P48029,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent creatine transporter 1,,2024-09-14,1,,,,,,,,,
P30531,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent GABA transporter 1,,2024-09-14,1,,,,,,,,,
Q9NSD5,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent GABA transporter 2,,2024-09-14,1,,,,,,,,,
P48066,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent GABA transporter 3,,2024-09-14,1,,,,,,,,,
P48067,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent glycine transporter 1,,2024-09-14,1,,,,,,,,,
Q9Y345,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent glycine transporter 2,,2024-09-14,1,,,,,,,,,
Q9UN76,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),,2024-09-14,1,,,,,,,,,
P31641,0,OMOP Exposome,Observation,Substance,Sodium- and chloride-dependent taurine transporter,,2024-09-14,1,,,,,,,,,
Q9H2H9,0,OMOP Exposome,Observation,Substance,Sodium-coupled neutral amino acid transporter 1,,2024-09-14,1,,,,,,,,,
Q99624,0,OMOP Exposome,Observation,Substance,Sodium-coupled neutral amino acid transporter 3,,2024-09-14,1,,,,,,,,,
Q01959,0,OMOP Exposome,Observation,Substance,Sodium-dependent dopamine transporter,,2024-09-14,1,,,,,,,,,
Q9Y289,0,OMOP Exposome,Observation,Substance,Sodium-dependent multivitamin transporter,,2024-09-14,1,,,,,,,,,
P23975,0,OMOP Exposome,Observation,Substance,Sodium-dependent noradrenaline transporter,,2024-09-14,1,,,,,,,,,
Q99884,0,OMOP Exposome,Observation,Substance,Sodium-dependent proline transporter,,2024-09-14,1,,,,,,,,,
P31645,0,OMOP Exposome,Observation,Substance,Sodium-dependent serotonin transporter,,2024-09-14,1,,,,,,,,,
Q14973,0,OMOP Exposome,Observation,Substance,Sodium/bile acid cotransporter,,2024-09-14,1,,,,,,,,,
P32418,0,OMOP Exposome,Observation,Substance,Sodium/calcium exchanger 1,,2024-09-14,1,,,,,,,,,
Q92911,0,OMOP Exposome,Observation,Substance,Sodium/iodide cotransporter,,2024-09-14,1,,,,,,,,,
P05023,0,OMOP Exposome,Observation,Substance,Sodium/potassium-transporting ATPase subunit alpha-1,,2024-09-14,1,,,,,,,,,
P50993,0,OMOP Exposome,Observation,Substance,Sodium/potassium-transporting ATPase subunit alpha-2,,2024-09-14,1,,,,,,,,,
P13637,0,OMOP Exposome,Observation,Substance,Sodium/potassium-transporting ATPase subunit alpha-3,,2024-09-14,1,,,,,,,,,
Q13733,0,OMOP Exposome,Observation,Substance,Sodium/potassium-transporting ATPase subunit alpha-4,,2024-09-14,1,,,,,,,,,
P05026,0,OMOP Exposome,Observation,Substance,Sodium/potassium-transporting ATPase subunit beta-1,,2024-09-14,1,,,,,,,,,
P14415,0,OMOP Exposome,Observation,Substance,Sodium/potassium-transporting ATPase subunit beta-2,,2024-09-14,1,,,,,,,,,
P54709,0,OMOP Exposome,Observation,Substance,Sodium/potassium-transporting ATPase subunit beta-3,,2024-09-14,1,,,,,,,,,
P54710,0,OMOP Exposome,Observation,Substance,Sodium/potassium-transporting ATPase subunit gamma,,2024-09-14,1,,,,,,,,,
GIS1009985,0,OMOP Exposome,Observation,Substance,Soluble Fraction,,2024-09-14,1,,,,,,,,,
Q13621,0,OMOP Exposome,Observation,Substance,Solute carrier family 12 member 1,,2024-09-14,1,,,,,,,,,
P55011,0,OMOP Exposome,Observation,Substance,Solute carrier family 12 member 2,,2024-09-14,1,,,,,,,,,
P55017,0,OMOP Exposome,Observation,Substance,Solute carrier family 12 member 3,,2024-09-14,1,,,,,,,,,
Q9UP95,0,OMOP Exposome,Observation,Substance,Solute carrier family 12 member 4,,2024-09-14,1,,,,,,,,,
Q9H2X9,0,OMOP Exposome,Observation,Substance,Solute carrier family 12 member 5,,2024-09-14,1,,,,,,,,,
Q9UHW9,0,OMOP Exposome,Observation,Substance,Solute carrier family 12 member 6,,2024-09-14,1,,,,,,,,,
Q9Y666,0,OMOP Exposome,Observation,Substance,Solute carrier family 12 member 7,,2024-09-14,1,,,,,,,,,
Q9BZW2,0,OMOP Exposome,Observation,Substance,Solute carrier family 13 member 1,,2024-09-14,1,,,,,,,,,
Q13183,0,OMOP Exposome,Observation,Substance,Solute carrier family 13 member 2,,2024-09-14,1,,,,,,,,,
Q8WWT9,0,OMOP Exposome,Observation,Substance,Solute carrier family 13 member 3,,2024-09-14,1,,,,,,,,,
P46059,0,OMOP Exposome,Observation,Substance,Solute carrier family 15 member 1,,2024-09-14,1,,,,,,,,,
P11166,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 1",,2024-09-14,1,,,,,,,,,
O95528,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 10",,2024-09-14,1,,,,,,,,,
Q9BYW1,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 11",,2024-09-14,1,,,,,,,,,
Q8TD20,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 12",,2024-09-14,1,,,,,,,,,
P11168,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 2",,2024-09-14,1,,,,,,,,,
P11169,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 3",,2024-09-14,1,,,,,,,,,
P14672,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 4",,2024-09-14,1,,,,,,,,,
P22732,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 5",,2024-09-14,1,,,,,,,,,
Q9UGQ3,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 6",,2024-09-14,1,,,,,,,,,
Q6PXP3,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 7",,2024-09-14,1,,,,,,,,,
Q9NY64,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 8",,2024-09-14,1,,,,,,,,,
Q9NRM0,0,OMOP Exposome,Observation,Substance,"Solute carrier family 2, facilitated glucose transporter member 9",,2024-09-14,1,,,,,,,,,
O15245,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 1,,2024-09-14,1,,,,,,,,,
Q9NSA0,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 11,,2024-09-14,1,,,,,,,,,
Q86VW1,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 16,,2024-09-14,1,,,,,,,,,
O15244,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 2,,2024-09-14,1,,,,,,,,,
A6NK97,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 20,,2024-09-14,1,,,,,,,,,
O75751,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 3,,2024-09-14,1,,,,,,,,,
Q9H015,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 4,,2024-09-14,1,,,,,,,,,
O76082,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 5,,2024-09-14,1,,,,,,,,,
Q4U2R8,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 6,,2024-09-14,1,,,,,,,,,
Q9Y694,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 7,,2024-09-14,1,,,,,,,,,
Q8TCC7,0,OMOP Exposome,Observation,Substance,Solute carrier family 22 member 8,,2024-09-14,1,,,,,,,,,
Q9HAB3,0,OMOP Exposome,Observation,Substance,"Solute carrier family 52, riboflavin transporter, member 2",,2024-09-14,1,,,,,,,,,
P46721,0,OMOP Exposome,Observation,Substance,Solute carrier organic anion transporter family member 1A2,,2024-09-14,1,,,,,,,,,
Q9Y6L6,0,OMOP Exposome,Observation,Substance,Solute carrier organic anion transporter family member 1B1,,2024-09-14,1,,,,,,,,,
Q9NPD5,0,OMOP Exposome,Observation,Substance,Solute carrier organic anion transporter family member 1B3,,2024-09-14,1,,,,,,,,,
Q92959,0,OMOP Exposome,Observation,Substance,Solute carrier organic anion transporter family member 2A1,,2024-09-14,1,,,,,,,,,
O94956,0,OMOP Exposome,Observation,Substance,Solute carrier organic anion transporter family member 2B1,,2024-09-14,1,,,,,,,,,
GIS1009986,0,OMOP Exposome,Observation,Substance,Solvent,,2024-09-14,1,,,,,,,,,
P61278,0,OMOP Exposome,Observation,Substance,Somatostatin,,2024-09-14,1,,,,,,,,,
P30874,0,OMOP Exposome,Observation,Substance,Somatostatin receptor type 2,,2024-09-14,1,,,,,,,,,
P32745,0,OMOP Exposome,Observation,Substance,Somatostatin receptor type 3,,2024-09-14,1,,,,,,,,,
P31391,0,OMOP Exposome,Observation,Substance,Somatostatin receptor type 4,,2024-09-14,1,,,,,,,,,
P35346,0,OMOP Exposome,Observation,Substance,Somatostatin receptor type 5,,2024-09-14,1,,,,,,,,,
Q15465,0,OMOP Exposome,Observation,Substance,Sonic hedgehog protein,,2024-09-14,1,,,,,,,,,
284461-73-0,0,OMOP Exposome,Observation,Substance,Sorafenib,N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; Nexavar; Sorafenib tosylate; Sorafenibum; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; CHEBI:50924,2014-12-24,1,,,,,,,,,
1338-43-8,0,OMOP Exposome,Observation,Substance,Sorbitan oleate,,2014-12-24,1,,,,,,,,,
Q01082,0,OMOP Exposome,Observation,Substance,"Spectrin beta chain, non-erythrocytic 1",,2024-09-14,1,,,,,,,,,
GIS1009987,0,OMOP Exposome,Observation,Substance,Sperm,,2024-09-14,1,,,,,,,,,
P04553,0,OMOP Exposome,Observation,Substance,Sperm protamine P1,,2024-09-14,1,,,,,,,,,
124-20-9,0,OMOP Exposome,Observation,Substance,Spermidine,"N-(3-Aminopropyl)-1,4-diaminobutane; Spermidin; N-(3-Aminopropyl)-1,4-diamino-butane; SPD; N-(4-Aminobutyl)-1,3-diaminopropane; 1,5,10-Triazadecane; N-(gamma-Aminopropyl)tetramethylenediamine; 1,8-Diamino-4-azaoctane; 4-Azaoctamethylenediamine; 4-Azaoctane-1,8-diamine; Aminopropylbutandiamine; N-(3-Aminopropyl)-1,4-butane-diamine; N-(3-Aminopropyl)-1,4-butanediamine; N-(3-Aminopropyl)-4-aminobutylamine; N-(3-aminopropyl)butane-1,4-diamine; CHEBI:16610",2014-12-24,1,,,,,,,,,
GIS1009988,0,OMOP Exposome,Observation,Substance,Spermidine and Spermine Biosynthesis,,2024-09-14,1,,,,,,,,,
71-44-3,0,OMOP Exposome,Observation,Substance,Spermine,"Musculamine; Gerontine; Neuridine; 4,9-Diaza-1,12-dodecanediamine; N,N'-Bis(3-aminopropyl)-1,4-tetramethylenediamine; N,N'-Bis(3-aminopropyl)-1,4-Butanediamine; Diaminopropyltetramethylenediamine; N1,N4-bis(3-aminopropyl)-1,4-butanediamine; N,N'-Bis(3-aminopropyl)butane-1,4-diamine; Diaminopropyl-tetramethylenediamine; Spermin; Spermine dihydrate; 4,9-Diazadodecamethylenediamine; 4,9-Diazadodecane-1,12-diamine; Spermine puriss; SPM; 1,5,10,14-Tetraazatetradecane; CHEBI:15746",2014-12-24,1,,,,,,,,,
Q9NWM0,0,OMOP Exposome,Observation,Substance,Spermine oxidase,,2024-09-14,1,,,,,,,,,
P52788,0,OMOP Exposome,Observation,Substance,Spermine synthase,,2024-09-14,1,,,,,,,,,
GIS1009989,0,OMOP Exposome,Observation,Substance,Sphingolipid Metabolism,,2024-09-14,1,,,,,,,,,
P17405,0,OMOP Exposome,Observation,Substance,Sphingomyelin phosphodiesterase,,2024-09-14,1,,,,,,,,,
9031-54-3,0,OMOP Exposome,Observation,Substance,Sphingomyelinase D (Loxosceles intermedia),,2014-12-24,1,,,,,,,,,
Q99500,0,OMOP Exposome,Observation,Substance,Sphingosine 1-phosphate receptor 3,,2024-09-14,1,,,,,,,,,
O95470,0,OMOP Exposome,Observation,Substance,Sphingosine-1-phosphate lyase 1,,2024-09-14,1,,,,,,,,,
483-66-9,0,OMOP Exposome,Observation,Substance,Sphondin,,2014-12-24,1,,,,,,,,,
GIS1009990,0,OMOP Exposome,Observation,Substance,Spider Toxin,,2024-09-14,1,,,,,,,,,
GIS1009991,0,OMOP Exposome,Observation,Substance,Spinal Cord,,2024-09-14,1,,,,,,,,,
148477-71-8,0,OMOP Exposome,Observation,Substance,Spirodiclofen,,2014-12-24,1,,,,,,,,,
52-01-7,0,OMOP Exposome,Observation,Substance,Spironolactone,Spiresis; Spironolattone; Osyrol; Aldactone; Verospiron; Spiretic; Xenalon; Uractone; Spironolactonum; Espironolactona; Spiroctan; CHEBI:9241,2014-12-24,1,,,,,,,,,
GIS1009992,0,OMOP Exposome,Observation,Substance,Spironolactone Pathway,,2024-09-14,1,,,,,,,,,
118134-30-8,0,OMOP Exposome,Observation,Substance,Spiroxamine,"Prosper; (8-Tert-butyl-1,4-dioxa-spiro4.5dec-2-ylmethyl)-ethyl-propyl-amine; Impulse; KWG4168; 8-(1,1-Dimethylethyl)-N-ethyl-N-propyl-1,4-dioxaspiro(4.5)decane-2-methanamine; CHEBI:9242",2014-12-24,1,,,,,,,,,
GIS1009993,0,OMOP Exposome,Observation,Substance,Spleen,,2024-09-14,1,,,,,,,,,
GIS1009994,0,OMOP Exposome,Observation,Substance,Spliceosome,,2024-09-14,1,,,,,,,,,
Q13838,0,OMOP Exposome,Observation,Substance,Spliceosome RNA helicase DDX39B,,2024-09-14,1,,,,,,,,,
1456-55-9,0,OMOP Exposome,Observation,Substance,Sporidesmin,,2014-12-24,1,,,,,,,,,
P78362,0,OMOP Exposome,Observation,Substance,SRSF protein kinase 2,,2024-09-14,1,,,,,,,,,
2406-52-2,0,OMOP Exposome,Observation,Substance,Stannane,SnH4; SnH4; Tetrahydridotin; Tin tetrahydride; CHEBI:30419,2014-12-24,1,,,,,,,,,
GIS1009995,0,OMOP Exposome,Observation,Substance,Starch and Sucrose Metabolism,,2024-09-14,1,,,,,,,,,
Q9H169,0,OMOP Exposome,Observation,Substance,Stathmin-4,,2024-09-14,1,,,,,,,,,
3056-17-5,0,OMOP Exposome,Observation,Substance,Stavudine,"Stag; 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine; 2',3'-Didehydro-3'-deoxythimidine; 3'-Deoxy-2'-thymidinene; Actastav; Ai Fu Ding; Zerit XR; Zerit; STV; Stavudinum; Stavudin; Stavubergen; Stavir; Stavex; Stamar; Avostav; d4T; Estavudina; Estavudox; Exvihr; Flamistav; Landstav; Lion; Mai Si Ting; S.T.V.; Sanilvudine; Sazi; Stadine; CHEBI:63581",2014-12-24,1,,,,,,,,,
57-11-4,0,OMOP Exposome,Observation,Substance,Stearic acid,Stearophanic acid; Stearex Beads; Stearic acid Cherry; Stearinsaeure; Stearophanate; Lunac; N-Octadecanoate; Bonderlube 235; 1-Heptadecanecarboxylic acid; 1-Heptadecanecarboxylate; N-Octadecanoic acid; Flexichem B; Fatty acids C16-18; N-octadecanoic acidd; Octadecanoate; Octadecanoic acid; C-Lube 10; Emersol 153NF; Octadecansaeure; Isostearic acid; Prodhygine; Dermarone; Cetylacetic acid; Octadecoic acid; OLA; Prifac 2918; Isooctadecanoic acid; Industrene; Stearate; Hystrene; CHEBI:28842,2014-12-24,1,,,,,,,,,
10048-13-2,0,OMOP Exposome,Observation,Substance,Sterigmatocystin,"Sterigmatocystine; 3a,12c-Dihydro-8-hydroxy-6-methoxy-7H-furo3',2':4,5furo2,3-cxanthen-7-one, 9CI; CHEBI:18227",2014-12-24,1,,,,,,,,,
GIS1009996,0,OMOP Exposome,Observation,Substance,Steroid,,2024-09-14,1,,,,,,,,,
P05093,0,OMOP Exposome,Observation,Substance,"Steroid 17-alpha-hydroxylase/17,20 lyase",,2024-09-14,1,,,,,,,,,
P08686,0,OMOP Exposome,Observation,Substance,Steroid 21-hydroxylase,,2024-09-14,1,,,,,,,,,
GIS1009997,0,OMOP Exposome,Observation,Substance,Steroid Biosynthesis,,2024-09-14,1,,,,,,,,,
GIS1009998,0,OMOP Exposome,Observation,Substance,Steroid hormone biosynthesis,,2024-09-14,1,,,,,,,,,
P11474,0,OMOP Exposome,Observation,Substance,Steroid hormone receptor ERR1,,2024-09-14,1,,,,,,,,,
O95718,0,OMOP Exposome,Observation,Substance,Steroid hormone receptor ERR2,,2024-09-14,1,,,,,,,,,
GIS1009999,0,OMOP Exposome,Observation,Substance,Steroidogenesis,,2024-09-14,1,,,,,,,,,
Q13285,0,OMOP Exposome,Observation,Substance,Steroidogenic factor 1,,2024-09-14,1,,,,,,,,,
Q02318,0,OMOP Exposome,Observation,Substance,"Sterol 26-hydroxylase, mitochondrial",,2024-09-14,1,,,,,,,,,
P35610,0,OMOP Exposome,Observation,Substance,Sterol O-acyltransferase 1,,2024-09-14,1,,,,,,,,,
O75908,0,OMOP Exposome,Observation,Substance,Sterol O-acyltransferase 2,,2024-09-14,1,,,,,,,,,
P36956,0,OMOP Exposome,Observation,Substance,Sterol regulatory element-binding protein 1,,2024-09-14,1,,,,,,,,,
Q12772,0,OMOP Exposome,Observation,Substance,Sterol regulatory element-binding protein 2,,2024-09-14,1,,,,,,,,,
7803-52-3,0,OMOP Exposome,Observation,Substance,Stibine,,2014-12-24,1,,,,,,,,,
269658-04-0; 183449-91-4,0,OMOP Exposome,Observation,Substance,Sticholysin,,2014-12-24,1,,,,,,,,,
GIS1010000,0,OMOP Exposome,Observation,Substance,Stimulant,,2024-09-14,1,,,,,,,,,
GIS1010001,0,OMOP Exposome,Observation,Substance,Stonustoxin,,2024-09-14,1,,,,,,,,,
GIS1010008,0,OMOP Exposome,Observation,Substance,Stratum Corneum,,2024-09-14,1,,,,,,,,,
9002-01-1,0,OMOP Exposome,Observation,Substance,Streptokinase,,2014-12-24,1,,,,,,,,,
98072-47-0,0,OMOP Exposome,Observation,Substance,Streptolysin O (Streptococcus pyogenes),,2014-12-24,1,,,,,,,,,
18883-66-4,0,OMOP Exposome,Observation,Substance,Streptozocin,2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose; Estreptozocina; N-D-Glucosyl-(2)-n&#39;-nitrosomethylharnstoff; N-D-Glucosyl-(2)-n'-nitrosomethylurea; Streptozocine; Streptozocinium; Streptozocinum; Streptozotocin; Zanosar; 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose; CHEBI:9288,2014-12-24,1,,,,,,,,,
GIS1010009,0,OMOP Exposome,Observation,Substance,Striatum,,2024-09-14,1,,,,,,,,,
1262235-00-6,0,OMOP Exposome,Observation,Substance,Stromatoxin,,2014-12-24,1,,,,,,,,,
P08254,0,OMOP Exposome,Observation,Substance,Stromelysin-1,,2024-09-14,1,,,,,,,,,
12004-37-4,0,OMOP Exposome,Observation,Substance,Strontium aluminate,,2014-12-24,1,,,,,,,,,
10378-48-0,0,OMOP Exposome,Observation,Substance,Strontium arsenite tetrahydrate,,2014-12-24,1,,,,,,,,,
14519-18-7,0,OMOP Exposome,Observation,Substance,Strontium bromate,,2014-12-24,1,,,,,,,,,
10476-81-0,0,OMOP Exposome,Observation,Substance,Strontium bromide,,2014-12-24,1,,,,,,,,,
7789-06-2,0,OMOP Exposome,Observation,Substance,Strontium chromate,,2014-12-24,1,,,,,,,,,
GIS1010010,0,OMOP Exposome,Observation,Substance,Strontium Compound,,2024-09-14,1,,,,,,,,,
10042-76-9,0,OMOP Exposome,Observation,Substance,Strontium nitrate,,2014-12-24,1,,,,,,,,,
10098-97-2,0,OMOP Exposome,Observation,Substance,Strontium-90,,2014-12-24,1,,,,,,,,,
57-24-9,0,OMOP Exposome,Observation,Substance,Strychnine,(-)-strychnine; (\u00e2\u0088\u0092)-Strychnine; Certox; Dolco mouse cereal; Kwik-kil; Mole death; Mouse-nots; Mouse-rid; Mouse-tox; Pied piper mouse seed; Ro-dex; Sanaseed; STR; Stricnina; Strychnin; Strychnos; Strychnidin-10-one; CHEBI:28973,2014-12-24,1,,,,,,,,,
33636-93-0,0,OMOP Exposome,Observation,Substance,Stryker's reagent,,2014-12-24,1,,,,,,,,,
100-42-5,0,OMOP Exposome,Observation,Substance,Styrene,Cinnamenol; Cinnamene; Cinnamol; Styrol; Vinylbenzene; Vinyl-Benzene; Cinnaminol; Phenethylene; Phenyl-Ethylene; Phenylethene; Vinylbenzol; Phenylethylene; Ethenylbenzene; Vinyl benzene; Styrolene; Ethenyl-Benzene; CHEBI:27452,2014-12-24,1,,,,,,,,,
P21452,0,OMOP Exposome,Observation,Substance,Substance-K receptor,,2024-09-14,1,,,,,,,,,
P25103,0,OMOP Exposome,Observation,Substance,Substance-P receptor,,2024-09-14,1,,,,,,,,,
O14521,0,OMOP Exposome,Observation,Substance,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",,2024-09-14,1,,,,,,,,,
P31040,0,OMOP Exposome,Observation,Substance,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",,2024-09-14,1,,,,,,,,,
P21912,0,OMOP Exposome,Observation,Substance,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",,2024-09-14,1,,,,,,,,,
Q99643,0,OMOP Exposome,Observation,Substance,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",,2024-09-14,1,,,,,,,,,
P07014,0,OMOP Exposome,Observation,Substance,Succinate dehydrogenase iron-sulfur subunit,,2024-09-14,1,,,,,,,,,
Q9BXA5,0,OMOP Exposome,Observation,Substance,Succinate receptor 1,,2024-09-14,1,,,,,,,,,
P51649,0,OMOP Exposome,Observation,Substance,"Succinate-semialdehyde dehydrogenase, mitochondrial",,2024-09-14,1,,,,,,,,,
110-15-6,0,OMOP Exposome,Observation,Substance,Succinic acid,"Acide succinique; Acide butanedioique; Katasuccin; Spirit of amber; Succinate; Wormwood acid; Butanedionic acid; 1,2-Ethanedicarboxylate; HOOC-CH2-CH2-COOH; 1,4-Butanedioic acid; Dihydrofumaric acid; Bernsteinsaeure; Ethylenesuccinic acid; 1,2-Ethanedicarboxylic acid; 1,4-Butanedioate; e363; Dihydrofumarate; Butanedioic acid; Butandisaeure; Bernsteinsaure; Asuccin; Amber acid; Acidum succinicum; CHEBI:15741",2014-12-24,1,,,,,,,,,
692-29-5,0,OMOP Exposome,Observation,Substance,Succinic acid semialdehyde,,2018-03-21,1,,,,,,,,,
GIS1010011,0,OMOP Exposome,Observation,Substance,Succinic semialdehyde dehydrogenase deficiency,,2024-09-14,1,,,,,,,,,
GIS1010012,0,OMOP Exposome,Observation,Substance,Succinimide,,2024-09-14,1,,,,,,,,,
110-61-2,0,OMOP Exposome,Observation,Substance,Succinonitrile,,2014-12-24,1,,,,,,,,,
65115-74-4,0,OMOP Exposome,Observation,Substance,Succinyl acetoacetate,,2018-03-21,1,,,,,,,,,
Q9P2R7,0,OMOP Exposome,Observation,Substance,"Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial",,2024-09-14,1,,,,,,,,,
P53597,0,OMOP Exposome,Observation,Substance,"Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial",,2024-09-14,1,,,,,,,,,
Q96I99,0,OMOP Exposome,Observation,Substance,"Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial",,2024-09-14,1,,,,,,,,,
P55809,0,OMOP Exposome,Observation,Substance,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",,2024-09-14,1,,,,,,,,,
Q9BYC2,0,OMOP Exposome,Observation,Substance,"Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial",,2024-09-14,1,,,,,,,,,
51568-18-4,0,OMOP Exposome,Observation,Substance,Succinylacetone,,2018-03-21,1,,,,,,,,,
GIS1010016,0,OMOP Exposome,Observation,Substance,Sucrase-isomaltase deficiency,,2024-09-14,1,,,,,,,,,
P14410,0,OMOP Exposome,Observation,Substance,"Sucrase-isomaltase, intestinal",,2024-09-14,1,,,,,,,,,
56030-54-7,0,OMOP Exposome,Observation,Substance,Sufentanil,Sufenta Forte; Sufenta; N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide; N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide; Fastfen; Disufen; Chronogesic; Zuftil; Sufentil; Sufentanyl; Sufentanilum; Sufentanilo; Sufentanil Citrate; Sufenta mite; CHEBI:9316,2014-12-24,1,,,,,,,,,
GIS1010017,0,OMOP Exposome,Observation,Substance,Sufentanil Pathway,,2024-09-14,1,,,,,,,,,
95-06-7,0,OMOP Exposome,Observation,Substance,Sulfallate,,2014-12-24,1,,,,,,,,,
599-79-1,0,OMOP Exposome,Observation,Substance,Sulfasalazine,Salicylazosulfapyridine; Pyralin EN; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 2-Hydroxy-5-4-(pyridin-2-ylsulfamoyl)-phenylazo-benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; Salazosulfapyridine; Pleon; Lazafin; Salazosulfapiridina; Lanofen; Salazopyrin EN-Tabs; Salazopyrin EN; Weiliufen; Zopyrin; Bomecon; Colo-Pleon; Disalazin; Eminapyrin; Sulphasalazine; Sulfasalazinum; Sulfasalazina; Sulfasalazin; Salazopyrin; Salazoprin; Salazopirina; Salazine; Salazidin; Salazar; Salasopyrine; Asasurfan; Azopyrin; Azulfdidina; Saaz-DS; Saaz; Iwata; Flogostop; Sulfacol; Sulcolon; Azulfidine; Azulfin; Salazosulfapyridinum; Reumazin; CHEBI:9334,2014-12-24,1,,,,,,,,,
GIS1010018,0,OMOP Exposome,Observation,Substance,Sulfate/Sulfite Metabolism,,2024-09-14,1,,,,,,,,,
122836-35-5,0,OMOP Exposome,Observation,Substance,Sulfentrazone,,2014-12-24,1,,,,,,,,,
14265-45-3,0,OMOP Exposome,Observation,Substance,Sulfite,Sulfur trioxide; Sulfuric anhydride; Sulphite; Trioxosulfate(2-); Trioxosulfate(IV); Trioxosulphate(2-); Sulfonate; Trioxosulphate(IV); Sulfite ions; Sulfite ion; Sulfite dianion; Bisulfite; CHEBI:17359,2018-03-21,1,,,,,,,,,
GIS1010019,0,OMOP Exposome,Observation,Substance,Sulfite oxidase deficiency,,2024-09-14,1,,,,,,,,,
114654-31-8,0,OMOP Exposome,Observation,Substance,Sulfocarbathione,,2014-12-24,1,,,,,,,,,
GIS1010020,0,OMOP Exposome,Observation,Substance,Sulfonamide,,2024-09-14,1,,,,,,,,,
P50225,0,OMOP Exposome,Observation,Substance,Sulfotransferase 1A1,,2024-09-14,1,,,,,,,,,
P50226,0,OMOP Exposome,Observation,Substance,Sulfotransferase 1A2,,2024-09-14,1,,,,,,,,,
P0DMM9,0,OMOP Exposome,Observation,Substance,Sulfotransferase 1A3,,2024-09-14,1,,,,,,,,,
BE0004767,0,OMOP Exposome,Observation,Substance,Sulfotransferase 1A3/1A4,,2024-09-14,1,,,,,,,,,
O00204,0,OMOP Exposome,Observation,Substance,Sulfotransferase family cytosolic 2B member 1,,2024-09-14,1,,,,,,,,,
GIS1010021,0,OMOP Exposome,Observation,Substance,Sulfur metabolism,,2024-09-14,1,,,,,,,,,
GIS1010022,0,OMOP Exposome,Observation,Substance,Sulfur relay system,,2024-09-14,1,,,,,,,,,
15117-53-0,0,OMOP Exposome,Observation,Substance,Sulfur-35,,2014-12-24,1,,,,,,,,,
7664-93-9,0,OMOP Exposome,Observation,Substance,Sulfuric acid,"Sulphurate; SO2(OH)2,H2SO4; S(OH)2O2; Sulphuric acid; Sulfurate; CHEBI:26836",2014-12-24,1,,,,,,,,,
103628-46-2,0,OMOP Exposome,Observation,Substance,Sumatriptan,Migraneitor; Nazdav; NP101; Sapphirex; Sumatran; Sumatriptan Succinate; Sumatriptanum; Imigran; Altaxa; ALSUMA; Adracon; 3-2-(dimethylamino)Ethyl-N-methylindole-5-methanesulfonamide; 3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide; 1-3-(2-Dimethylaminoethyl)-1H-indol-5-yl-N-methyl-methanesulfonamide; (3-2-(dimethylamino)Ethyl-1H-indol-5-yl)-N-methylmethanesulfonamide; Frimig; Cinie; Imitrex Oral; Imitrex; Imigrane; Imigran Recovery; Imigran Radis; Imigran mite; Apigrane; Boots Pharmacy Migraine Relief; Illument; Imigen; ZECUITY; Youshu; triptan; Suminat; Sumax; Migralgin; CHEBI:10650,2014-12-24,1,,,,,,,,,
Q9UBE0,0,OMOP Exposome,Observation,Substance,SUMO-activating enzyme subunit 1,,2024-09-14,1,,,,,,,,,
GIS1010023,0,OMOP Exposome,Observation,Substance,Sunscreening Agent,,2024-09-14,1,,,,,,,,,
P00441,0,OMOP Exposome,Observation,Substance,Superoxide dismutase [Cu-Zn],,2024-09-14,1,,,,,,,,,
P04179,0,OMOP Exposome,Observation,Substance,"Superoxide dismutase [Mn], mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1010024,0,OMOP Exposome,Observation,Substance,Supplement,,2024-09-14,1,,,,,,,,,
Q9Y5Y6,0,OMOP Exposome,Observation,Substance,Suppressor of tumorigenicity 14 protein,,2024-09-14,1,,,,,,,,,
GIS1010025,0,OMOP Exposome,Observation,Substance,Surface-Active Agent,,2024-09-14,1,,,,,,,,,
72741-87-8,0,OMOP Exposome,Observation,Substance,Swainsonine,,2014-12-24,1,,,,,,,,,
1918-18-9,0,OMOP Exposome,Observation,Substance,Swep,,2014-12-24,1,,,,,,,,,
O60264,0,OMOP Exposome,Observation,Substance,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,,2024-09-14,1,,,,,,,,,
30344-00-4,0,OMOP Exposome,Observation,Substance,Symmetric dimethylarginine,"N5-((methylamino)(methylimino)methyl)-L-Ornithine; Guanidino-N(1),N(2)-dimethylarginine; N(G1),N(G2)-Dimethylarginine; N,N'-Dimethylarginine; N5-(N,N'-dimethylamidino)-L-Ornithine; N5-bis(methylamino)methylene-L-Ornithine; NG,N'G-Dimethyl-L-arginine; NG,N'G-dimethylarginine; NG,NG'-dimethylarginine; SDMA; CHEBI:61914",2014-12-24,1,,,,,,,,,
GIS1010026,0,OMOP Exposome,Observation,Substance,Sympatholytic,,2024-09-14,1,,,,,,,,,
GIS1010027,0,OMOP Exposome,Observation,Substance,Sympathomimetic,,2024-09-14,1,,,,,,,,,
GIS1010045,0,OMOP Exposome,Observation,Substance,Synaptic Vesicle,,2024-09-14,1,,,,,,,,,
GIS1010046,0,OMOP Exposome,Observation,Substance,Synaptic vesicle cycle,,2024-09-14,1,,,,,,,,,
Q7L0J3,0,OMOP Exposome,Observation,Substance,Synaptic vesicle glycoprotein 2A,,2024-09-14,1,,,,,,,,,
Q05940,0,OMOP Exposome,Observation,Substance,Synaptic vesicular amine transporter,,2024-09-14,1,,,,,,,,,
P60880,0,OMOP Exposome,Observation,Substance,Synaptosomal-associated protein 25,,2024-09-14,1,,,,,,,,,
Q96C24,0,OMOP Exposome,Observation,Substance,Synaptotagmin-like protein 4,,2024-09-14,1,,,,,,,,,
GIS1010047,0,OMOP Exposome,Observation,Substance,Synthetic Compound,,2024-09-14,1,,,,,,,,,
GIS1010077,0,OMOP Exposome,Observation,Substance,T-Lymphocyte,,2024-09-14,1,,,,,,,,,
21259-20-1,0,OMOP Exposome,Observation,Substance,T2 Toxin,,2014-12-24,1,,,,,,,,,
321-64-2,0,OMOP Exposome,Observation,Substance,Tacrine,"1,2,3,4-tetrahydroacridin-9-amine; THA; Tacrin; Tetrahydroaminocrine; Cognex; Tetrahydroaminocrin; Tetrahydroaminoacridine; Tetrahydroaminacrine; Talem; Tacrinum; CHEBI:9389",2014-12-24,1,,,,,,,,,
104987-11-3,0,OMOP Exposome,Observation,Substance,Tacrolimus,FK 506; Advagraf; 8-DEETHYL-8-but-3-enyl-ascomycin; (-)-FK 506; Tacrolimus anhydrous; Protopic; Prograf; Hecoria; FK506; CHEBI:61049,2014-12-24,1,,,,,,,,,
112154-17-3,0,OMOP Exposome,Observation,Substance,Taicatoxin,,2014-12-24,1,,,,,,,,,
52019-39-3,0,OMOP Exposome,Observation,Substance,Taipoxin,,2014-12-24,1,,,,,,,,,
508220-81-3,0,OMOP Exposome,Observation,Substance,Tamapin,,2014-12-24,1,,,,,,,,,
10540-29-1,0,OMOP Exposome,Observation,Substance,Tamoxifen,"Mammonex; Zemide; Valodex; Trans-Tamoxifen; Tomifen; Tecnotax; Tamtero; Tamoxilon; Tamoxifenum; Tamoxifeno; Tamoxif\u00e8ne; Tamoxifen Citrate; Tamoxen; Tamoxasta; Tamoplex; Tamoneprin; Tamone; Tamofen; Tamizam; Tamifen; Tadex; Soltamox; Retaxim; PMS-Tamoxifen; Oncomox; Novofen; Nourytam; Nolvadex-D; Nolvadex; Noltam; Neophedan; Istubol; Istubal; Gynatam; Genox; Gen-tamoxifen; Fenahex; Ebefen; Doctamoxifene; Diemon; Crisafeno; Citofen; Caditam; Bilem; Apo-tamox; Adopan; Adifen; 1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; (Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; CHEBI:9396",2014-12-24,1,,,,,,,,,
12004-76-1,0,OMOP Exposome,Observation,Substance,Tantalum(III) aluminide,,2014-12-24,1,,,,,,,,,
13451-11-1,0,OMOP Exposome,Observation,Substance,Tantalum(V) bromide,,2014-12-24,1,,,,,,,,,
87-69-4,0,OMOP Exposome,Observation,Substance,Tartaric acid,"(R,R)-(+)-tartaric acid; Weinsaeure; TLA; Threaric acid; Tartrate; Tartarate; TAR; Rechtsweinsaeure; Natural tartaric acid; L-Threaric acid; L-Tartaric acid; L-Tartarate; L-(+)-Tartaric acid; L(+)-Tartaric acid; Dextrotartaric acid; (+)-(2R,3R)-Tartaric acid; (+)-tartarate; (+)-tartaric acid; (1R,2R)-1,2-Dihydroxyethane-1,2-dicarboxylic acid; (2R,3R)-2,3-dihydroxybutanedioate; (2R,3R)-2,3-dihydroxybutanedioic acid; D-Tartaric acid; D-a,b-Dihydroxysuccinic acid; 2,3-Dihydroxysuccinic acid; (2R,3R)-2,3-dihydroxysuccinic acid; (2R,3R)-2,3-tartaric acid; (2R,3R)-Tartarate; (2R,3R)-Tartaric acid; 2,3-Dihydroxybutanedioic acid; 2,3-Dihydroxybutanedioate; 2,3-Dihydroxy-succinic acid; 2,3-Dihydroxy-succinate; 1,2-Dihydroxyethane-1,2-dicarboxylic acid; (R,R)-tartrate; (R,R)-tartaric acid; (R,R)-tartarate; CHEBI:15671",2014-12-24,1,,,,,,,,,
P13686,0,OMOP Exposome,Observation,Substance,Tartrate-resistant acid phosphatase type 5,,2024-09-14,1,,,,,,,,,
GIS1010048,0,OMOP Exposome,Observation,Substance,Taste transduction,,2024-09-14,1,,,,,,,,,
102851-06-9,0,OMOP Exposome,Observation,Substance,Tau-fluvalinate,"Tau-fluvalinic acid; Klartan; N-2-chloro-4-(Trifluoromethyl)phenyl-D-valine cyano(3-phenoxyphenyl)methyl ester; Fluwarol; Fluvarol; (RS)-alpha-cyano-3-phenoxybenzyl N-(2-chloro-alpha,alpha,alpha-trifluoro-P-tolyl)-D-valinate; Fluvalinate; CHEBI:39367",2014-12-24,1,,,,,,,,,
GIS1010049,0,OMOP Exposome,Observation,Substance,Taurine and Hypotaurine Metabolism,,2024-09-14,1,,,,,,,,,
GIS1010050,0,OMOP Exposome,Observation,Substance,Tay-Sachs Disease,,2024-09-14,1,,,,,,,,,
40085-57-2,0,OMOP Exposome,Observation,Substance,Tazimcarb,,2014-12-24,1,,,,,,,,,
79253-92-2,0,OMOP Exposome,Observation,Substance,Taziprinone,,2014-12-24,1,,,,,,,,,
21564-17-0,0,OMOP Exposome,Observation,Substance,TCMTB,,2014-12-24,1,,,,,,,,,
67719-69-1,0,OMOP Exposome,Observation,Substance,Tebbe's reagent,,2014-12-24,1,,,,,,,,,
112410-23-8,0,OMOP Exposome,Observation,Substance,Tebufenozide,"3,5-Dimethylbenzoic acid 1-(1,1-dimethylethyl)-2-(4-ethylbenzoyl)hydrazide; N'-(t-butyl)-n'-(3,5-dimethylbenzoyl)-N-(4-ethylbenzoyl)hydrazine; CHEBI:38452",2014-12-24,1,,,,,,,,,
119168-77-3,0,OMOP Exposome,Observation,Substance,Tebufenpyrad,"N-(4-t-Butylbenzyl)-4-chloro-3-ethyl-1-methylpyrazole-5-carboxamide; Pyranica; 4-chloro-N-((4-(1,1-Dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide; CHEBI:9422",2014-12-24,1,,,,,,,,,
96182-53-5,0,OMOP Exposome,Observation,Substance,Tebupirimfos,"Phosphorothioic acid, O-(2-(1,1-dimethylethyl)-5-pyrimidinyl) O-ethyl O-(1-methylethyl) ester; O-(2-(1,1-Dimethylethyl)-5-pyrimidinyl) O-ethyl O-(1-methylethyl) phosphorothioate; O-(2-Tert-butylpyrimidin-5-yl) O-ethyl O-isopropyl thiophosphate; Tebupirimphos; Phostebupirim; CHEBI:38951",2014-12-24,1,,,,,,,,,
34014-18-1,0,OMOP Exposome,Observation,Substance,Tebuthiuron,,2014-12-24,1,,,,,,,,,
GIS1010051,0,OMOP Exposome,Observation,Substance,Teeth,,2024-09-14,1,,,,,,,,,
79538-32-2,0,OMOP Exposome,Observation,Substance,Tefluthrin,Forza; Tetrafluthrin; Tefluthrine; Force; CHEBI:9430,2014-12-24,1,,,,,,,,,
191114-48-4,0,OMOP Exposome,Observation,Substance,Telithromycin,,2014-12-24,1,,,,,,,,,
GIS1010052,0,OMOP Exposome,Observation,Substance,Telithromycin Pathway,,2024-09-14,1,,,,,,,,,
7789-54-0,0,OMOP Exposome,Observation,Substance,Tellurium dibromide,,2014-12-24,1,,,,,,,,,
10031-27-3,0,OMOP Exposome,Observation,Substance,Tellurium tetrabromide,,2014-12-24,1,,,,,,,,,
297-78-9,0,OMOP Exposome,Observation,Substance,Telodrin,,2014-12-24,1,,,,,,,,,
O14746,0,OMOP Exposome,Observation,Substance,Telomerase reverse transcriptase,,2024-09-14,1,,,,,,,,,
846-50-4,0,OMOP Exposome,Observation,Substance,Temazepam,Norkotral; Normison; Nortem; Oxydiazepam; Remestan; Restoril; Euhypnos; Hydroxydiazepam; Methyloxazepam; N-Methyloxazepam; Temaze; Temtabs; CHEBI:195909,2014-12-24,1,,,,,,,,,
GIS1010053,0,OMOP Exposome,Observation,Substance,Temporal Lobe,,2024-09-14,1,,,,,,,,,
29767-20-2,0,OMOP Exposome,Observation,Substance,Teniposide,"Vumon; 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin-beta-D-thenylidene glucoside; Bang Lai; Teniposido; Teniposidum; VM-26; Epidophyllotoxin; HSDB 6546; NSC 122819; NSC-122819; Teniposid; T\u00e9niposide; CHEBI:75988",2014-12-24,1,,,,,,,,,
GIS1010054,0,OMOP Exposome,Observation,Substance,Teniposide Pathway,,2024-09-14,1,,,,,,,,,
149979-41-9,0,OMOP Exposome,Observation,Substance,Tepraloxydim,,2014-12-24,1,,,,,,,,,
GIS1010055,0,OMOP Exposome,Observation,Substance,Teratogen,,2024-09-14,1,,,,,,,,,
70024-40-7,0,OMOP Exposome,Observation,Substance,Terazosin,"Zayasel; Vicard; Urodie; Terazosinum; Terazosine; Terazosina; Terazosin; Itrin; Hytrinex; Hytrin; Heitrin; Fosfomic; Flumarc; Blavin; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine; CHEBI:9445",2014-12-24,1,,,,,,,,,
5902-51-2,0,OMOP Exposome,Observation,Substance,Terbacil,,2014-12-24,1,,,,,,,,,
14456-47-4,0,OMOP Exposome,Observation,Substance,Terbium(III) bromide,,2014-12-24,1,,,,,,,,,
1918-11-2,0,OMOP Exposome,Observation,Substance,Terbucarb,,2014-12-24,1,,,,,,,,,
50679-08-8,0,OMOP Exposome,Observation,Substance,Terfenadine,Terf\u00e9nadine; Terfenadine FLX; Terfenadinum; Terfin; Ternadin; Trexyl; Triludan; (RS)-1-(4-tert-butylphenyl)-4-{4-hydroxy(diphenyl)methylpiperidin-1-yl}-butan-1-ol; Seldane; Daylert; Servinin; Teldane; Bronal; Terfed; Terfenadin; Terfenadin AL; Terfenadina; CHEBI:119569,2014-12-24,1,,,,,,,,,
586-62-9,0,OMOP Exposome,Observation,Substance,Terpinolene,"1-Methyl-4-(1-methylethylidene)-1-cyclohexene; 1-Methyl-4-(1-methylethylidene)-Cyclohexene; 1-Methyl-4-(1-methylethylidene)cyclohexene, 9CI; Cyclohexene, 3-methyl-6-(1-methylethylidene)- (9CI); 1-Methyl-4-(propan-2-ylidene)cyclohexene; alpha-Terpinolene; alpha -Terpinolene; 4-Isopropylidene-1-methylcyclohexene; 4-Isopropylidene-1-methyl-cyclohexene; 1-Methyl-4-isopropylidene-1-cyclohexene; FEMA 3046; 1,4(8)-p-Menthadiene; 1,4(8)-Terpadiene; CHEBI:9457",2014-12-24,1,,,,,,,,,
70407-19-1,0,OMOP Exposome,Observation,Substance,Territrem A,,2014-12-24,1,,,,,,,,,
70407-20-4,0,OMOP Exposome,Observation,Substance,Territrem B,,2014-12-24,1,,,,,,,,,
89020-33-7,0,OMOP Exposome,Observation,Substance,Territrem C,,2014-12-24,1,,,,,,,,,
7188-38-7,0,OMOP Exposome,Observation,Substance,tert-Butyl isocyanide,,2014-12-24,1,,,,,,,,,
GIS1010056,0,OMOP Exposome,Observation,Substance,Testes,,2024-09-14,1,,,,,,,,,
Q75WM6,0,OMOP Exposome,Observation,Substance,Testis-specific H1 histone,,2024-09-14,1,,,,,,,,,
58-22-0,0,OMOP Exposome,Observation,Substance,Testosterone,"17b-Hydroxy-androst-4-en-3-one; Testim; Testobase; Testoderm; Testoderm TTS; Testogel; Testolent; Testolin; Testopatch; Testopel; Testopel Pellets; Testopropon; Testosteroid; Testosteron; Testosterona; Testost\u00e9rone; Testosteronum; Testoviron Schering; Testoviron T; Testoxyl; Testrin-P.A; Testro AQ; Andryl 200; Andrusol; Androst-4-ene-17b-ol-3-one; Androst-4-en-17b-ol-3-one; Andropository 200; 4-androsten-17\u03b2-ol-3-one; 4-Androsten-17beta-ol-3-one; 17-Hydroxy-D4-androsten-3-one; 17a-Hydroxy-(13a)-androst-4-en-3-one; 17a-Hydroxy-13a-androst-4-en-3-one; 17a-Hydroxy-14b-androst-4-en-3-one; 17a-Hydroxy-androst-4-en-3-one; 17b-Hydroxy-(10a)-androst-4-en-3-one; 17b-Hydroxy-(13a)-androst-4-en-3-one; 17b-Hydroxy-(8a)-androst-4-en-3-one; 17b-Hydroxy-(8a,10a)-androst-4-en-3-one; 17b-Hydroxy-(9b)-androst-4-en-3-one; 17b-Hydroxy-(9b,10a)-androst-4-en-3-one; 17b-Hydroxy-13a-androst-4-en-3-one; 17b-Hydroxy-8a-androst-4-en-3-one; 17beta-hydroxy-4-androsten-3-one; 17b-Testosterone; 17b-Hydroxyandrost-4-ene-3-one; 17b-Hydroxyandrost-4-en-3-one; 17b-Hydroxy-D4-androsten-3-one; Aveed; Axiron; Bio-T-Gel; Cristerona T; 17b-Hydroxy-androst-4-en-3-on; Testrone; (+)-testosterone; D4-Androsten-17b-ol-3-one; Delatestryl; Andropatch; Andronate 200; Andronate 100; Andronaq; Androlin; AndroGel; Androderm; Andriol; 9b-Testosterone; 9b,10a-Testosterone; (+-)-8-iso-testosterone; (+-)-retrotestosterone; (+-)-testosterone; (17b)-17-hydroxy-androst-4-en-3-one; 13-Iso-testosterone; 17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopentaaphenanthren-3-one; 17-Hydroxy-androst-4-en-3-one; 8-Iso-testosterone; 4-Androsten-3-one-17b-ol; Depo-Testadiol; Depo-Testosterone; Epitestosteron; FORTESTA; Geno-cristaux Gremy; Homosteron; Homosterone; Intrinsa; Livensa; Lumitestosteron; Mertestate; Nebido; Neotestis; Oreton; Orquisteron; Perandren; Percutacrine androgenique; Primotest; Primoteston; Rac-17b-hydroxy-(13a)androst-4-en-3-one; Rac-17b-hydroxy-(8a)-androst-4-en-3-one; Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one; Rac-17b-hydroxy-androst-4-en-3-one; Relibra; Retrotestosterone; Striant; Sustanon; Sustanone; Virosterone; Virormone; Viatrel; Tostrex; Tostrelle; Testryl; Sustason 250; Synandrol F; Teslen; Testamone 100; Testandrone; Testaqua IM; Testiculosterone; CHEBI:17347",2014-12-24,1,,,,,,,,,
P37058,0,OMOP Exposome,Observation,Substance,Testosterone 17-beta-dehydrogenase 3,,2024-09-14,1,,,,,,,,,
57-85-2,0,OMOP Exposome,Observation,Substance,Testosterone Propionate,Testex; Testosterone propionate; Testosterone propionic acid; CHEBI:290629,2014-12-24,1,,,,,,,,,
676570-37-9,0,OMOP Exposome,Observation,Substance,Tetanus toxin,,2014-12-24,1,,,,,,,,,
3590-84-9,0,OMOP Exposome,Observation,Substance,Tetra-n-octylstannane,,2014-12-24,1,,,,,,,,,
134620-00-1,0,OMOP Exposome,Observation,Substance,Tetraammine palladium hydrogen carbonate,,2014-12-24,1,,,,,,,,,
13815-17-3,0,OMOP Exposome,Observation,Substance,Tetraammine palladium(II) chloride,,2014-12-24,1,,,,,,,,,
40088-45-7,0,OMOP Exposome,Observation,Substance,Tetrabromobiphenyl,,2014-12-24,1,,,,,,,,,
79-94-7,0,OMOP Exposome,Observation,Substance,Tetrabromobisphenol A,"Tetrabromodian; 2, 2-Bis(3,5-dibromo-4-hydroxyphenyl)propane; 2,2',6,6'-Tetrabromo-4,4'-isopropylidene phenol; 2,2',6,6'-Tetrabromo-4,4'-isopropylidenediphenol; 2,2',6,6'-Tetrabromobisphenol A; 2,2-Bis(3,5-dibromo-4-hydroxyphenyl)propane; 2,2-Bis(4-hydroxy-3, 5-dibromophenyl)propane; 2,2-Bis(4-hydroxy-3,5-dibromophenyl)propane; 3,3',5,5'-Tetrabromo bisphenol A; 3,3',5,5'-TETRABROMO-4,4-DIHYDROXY-2,-2-DIPHENYLPROPANE; 3,3',5,5'-Tetrabromo-4,4-dihydroxy-2,2-diphenylpropane; 3,3',5,5'-Tetrabromobisphenol A; 3,5,3', 5'-Tetrabromobisphenol A; 3,5,3',5'-Tetrabromobisphenol A; 4,4'-(1-Methylethylidene)bis(2,6-dibromophenol); 4,4'-(1-Methylethylidene)bisphenol tetrabromo deriv.; 4,4'-(2,2-propanediyl) bis2,6-dibromophenol; 4,4'-(propane-2,2-diyl)bis(2,6-dibromophenol); 4,4'-isopropylidene-bis(2,6-dibromophenol); 4,4'-Isopropylidenebis(2, 6-dibromophenol); 4,4'-Isopropylidenebis(2,6-dibromophenol); 4,4'-Isopropylylidenebis(2,6-dibromophenol); 4,4'-Osopropylidenebis (2,6-dibromophenol); 4,4'-propane-2,2-diylbis(2,6-dibromophenol); Bromdian; Fire Guard 2000; Firemaster BP 4A; Firemaster BP4A; Great lakes BA-59P; Phenol, 4, {4'-(1-methylethylidene)bis2,6-dibromo-}; Phenol, 4, {4'-isopropylidenebis2,6-dibromo-}; Phenol, 4,4'-(1-methylethylidene)bis-, tetrabromo deriv.; phenol, 4,4'-isopropylidenebis (dibromo-); Phenol, 4,4'-isopropylidenebis(2,6-dibromo- (8CI); Saytex RB 100PC; Saytex RB-100; Saytex RB-100 ABS; Tbbpa CPD; Tetrabromobisphenol a; Tetrabromodiphenylopropane; CHEBI:33217",2014-12-24,1,,,,,,,,,
40088-47-9,0,OMOP Exposome,Observation,Substance,Tetrabromodiphenyl ethers,,2014-12-24,1,,,,,,,,,
558-13-4,0,OMOP Exposome,Observation,Substance,Tetrabromomethane,"Methane, tetrabromide; CBr4; Carbon tetrabromide; Carbon bromide (CBr4); Carbon bromide; Bromid uhlicity; Kohlenstofftetrabromid; Methane tetrabromide; Tetrabromidocarbon; Tetrabromkohlenstoff; Tetrabrommethan; WLN: exeee; CHEBI:47875",2014-12-24,1,,,,,,,,,
45212-19-9,0,OMOP Exposome,Observation,Substance,Tetrabutylantimony(V) bromide,,2014-12-24,1,,,,,,,,,
1461-25-2,0,OMOP Exposome,Observation,Substance,Tetrabutyltin,,2014-12-24,1,,,,,,,,,
92-24-0,0,OMOP Exposome,Observation,Substance,Tetracene,"Naphthacene; Benz(b)anthracene; Methacene; Benzbanthracene; Benzobanthracene; 2,3-Benzanthracene; 2,3-Benzanthrene; Tetracen; Rubene; Chrysogen; CHEBI:32600",2014-12-24,1,,,,,,,,,
79-95-8,0,OMOP Exposome,Observation,Substance,Tetrachlorobisphenol A,,2014-12-24,1,,,,,,,,,
127-18-4,0,OMOP Exposome,Observation,Substance,Tetrachloroethylene,"Tetrachloroethene; PERK; Percosolve; Ethylene tetrachloride; Dow-per; Tetropil; Tetroguer; Tetravec; 1,1,2, 2-Tetrachloroethylene; 1,1,2,2-Tetrachloroethene; 1,1,2,2-Tetrachloroethylene; Ankilostin; Antisal 1; Tetralex; Tetraleno; Tetraguer; Tetracloroetene; Perklone; PerSec; Tetlen; Tetracap; Didakene; Carbon dichloride; Carbon bichloride; Antisol 1; Tetrachlooretheen; Tetrachlorathen; Perclene TG; Tetrachlorethylene; Tetrachloro-Ethene; Tetrachloro-Ethylene; Percloroetilene; Perclene D; Perclene; Perchloroethylene; Perchloroethene; Perchlorethylene, per; Perchlorethylene; Perchlor; PERC; Perawin; PCE; Nema; Fedal-Un; CHEBI:17300",2014-12-24,1,,,,,,,,,
17786-31-1,0,OMOP Exposome,Observation,Substance,Tetracobalt dodecacarbonyl,,2014-12-24,1,,,,,,,,,
112281-77-3,0,OMOP Exposome,Observation,Substance,Tetraconazole,,2014-12-24,1,,,,,,,,,
670-54-2,0,OMOP Exposome,Observation,Substance,Tetracyanoethylene,,2014-12-24,1,,,,,,,,,
1518-16-7,0,OMOP Exposome,Observation,Substance,Tetracyanoquinodimethane,"TCNQ; 7,7,8,8-Tetracyanodimethan; 7,7,8,8-Tetracyanoquinodimethane; Tetracyanoquinodimethan(e); Tetracyanoquinodimethan; Tetracyano-p-quinodimethane; 7,7,8,8-Tetracyano-p-quinodimethane; 2, 5-Cyclohexadiene-a:4,a'-dimalononitrile; 2, 5-Cyclohexadiene-a:4a)dimalononitrile; 2,2'-(2,5-Cyclohexadiene-1,4-diylidene)bismalononitrile; 2,2'-cyclohexa-2,5-diene-1,4-diylidenedipropanedinitrile; 2,5-Cyclohexadiene-1,4-diylidene-alpha,alpha'-dimalononitrile; 2,5-Cyclohexadiene-1,4-Diylidenedimalononitrile; 2,5-Cyclohexadiene-delta1,alpha:4,alpha'-dimalononitrile; 7,7',8, 8'-Tetracyanoquinodimethane; 7,7',8,8'-Tetracyanoquinodimethane; 7,7,8, 8-Tetracyano-p-quinodimethane; 7,7,8,8-Tetracyano-1,4-quinodimethan; CHEBI:52445",2014-12-24,1,,,,,,,,,
60-54-8,0,OMOP Exposome,Observation,Substance,Tetracycline,"Liquamycin; Deschlorobiomycin; (4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; Abramycin; Achromycin; Anhydrotetracycline; Tsiklomitsin; Tetrazyklin; Tetracyclinum; Tetracycline HCl; TETRACYCLINE; Tetracyclin; CHEBI:27902",2014-12-24,1,,,,,,,,,
GIS1010057,0,OMOP Exposome,Observation,Substance,Tetracycline Action Pathway,,2024-09-14,1,,,,,,,,,
GIS1010058,0,OMOP Exposome,Observation,Substance,Tetracyclines,,2024-09-14,1,,,,,,,,,
78-00-2,0,OMOP Exposome,Observation,Substance,Tetraethyl lead,"Tetraethylplumbane; Tel-TML, reacted; Tetraethylplumbium; PbEt4; Lead tetraethyl; TEL; Tetra-ethyl lead; Lead tetraethide; PbEt4; Tetra(methylethyl)lead; CHEBI:30182",2014-12-24,1,,,,,,,,,
112-60-7,0,OMOP Exposome,Observation,Substance,Tetraethylene Glycol,,2014-12-24,1,,,,,,,,,
597-64-8,0,OMOP Exposome,Observation,Substance,Tetraethyltin,,2014-12-24,1,,,,,,,,,
14221-01-3,0,OMOP Exposome,Observation,Substance,Tetrakis(triphenylphosphine)palladium(0),,2014-12-24,1,,,,,,,,,
7696-12-0,0,OMOP Exposome,Observation,Substance,Tetramethrin,"Tetramethrin isomer; PY-kill; Phthalthrin; Neopynamin; Neopinamine; Neopinamin; N-(Chrysanthemoxymethyl)-1-cyclohexene-1,2-dicarboximide; Neo-pynamin; Killgerm PY-kill w; Etramethrin isomer; Cyclohexene-1-dicarboximidomethylchrysanthemate; (1-Cyclohexene-1,2-dicarboximido)methyl chrysanthemumate; (1-Cyclohexene-1,2-dicarboximido)methyl chrysanthemate; CHEBI:39397",2014-12-24,1,,,,,,,,,
75-74-1,0,OMOP Exposome,Observation,Substance,Tetramethyl lead,Tetramethylplumbane; TML; Lead tetramethyl; PbMe4; Tetramethyllead; Tetra-methyl lead; CHEBI:30183,2014-12-24,1,,,,,,,,,
3333-52-6,0,OMOP Exposome,Observation,Substance,Tetramethylsuccinonitrile,,2014-12-24,1,,,,,,,,,
594-27-4,0,OMOP Exposome,Observation,Substance,Tetramethyltin,Tin tetramethyl; Tetramethylstannane; (CH3)4sn; Tetramethyl tin; SnMe4; SnMe4; CHEBI:30420,2014-12-24,1,,,,,,,,,
10380-29-7,0,OMOP Exposome,Observation,Substance,Tetramminecopper(II) sulfate,,2014-12-24,1,,,,,,,,,
16894-69-2,0,OMOP Exposome,Observation,Substance,Tetraphenylantimony bromide,,2014-12-24,1,,,,,,,,,
10379-14-3,0,OMOP Exposome,Observation,Substance,Tetrazepam,,2014-12-24,1,,,,,,,,,
4368-28-9,0,OMOP Exposome,Observation,Substance,Tetrodotoxin,Tetrodin; Tectin; CHEBI:9506,2014-12-24,1,,,,,,,,,
P37173,0,OMOP Exposome,Observation,Substance,TGF-beta receptor type-2,,2024-09-14,1,,,,,,,,,
Q15750,0,OMOP Exposome,Observation,Substance,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,,2024-09-14,1,,,,,,,,,
GIS1010059,0,OMOP Exposome,Observation,Substance,Thalamus,,2024-09-14,1,,,,,,,,,
50-35-1,0,OMOP Exposome,Observation,Substance,Thalidomide,"Thalomid; N-(2,6-dioxo-3-piperidyl)phthalimide; N-Phthalyl-glutaminsaeure-imid; N-Phthalylglutamic acid imide; Pro-ban M; Sedalis; N-Phthaloylglutamimide; N-Phthalimidoglutamic acid imide; \u03b1-phthalimidoglutarimide; \u03b1-N-phthalylglutaramide; \u03b1-(N-phthalimido)glutarimide; Thalidomine USP26; Thalidomidum; Thaled; Talimol; Talidomida; Softenon; (+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide; (+-)-Thalidomide; (\u00b1)-N-(2,6-dioxo-3-piperidyl)phthalimide; (\u00b1)-thalidomide; 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline; 2,6-dioxo-3-phthalimidopiperidine; 3-Phthalimidoglutarimide; alpha-(N-Phthalimido)glutarimide; alpha-N-Phthalylglutaramide; alpha-Phthalimidoglutarimide; Contergan; Distaval; K-17; CHEBI:9513",2014-12-24,1,,,,,,,,,
7440-28-0,0,OMOP Exposome,Observation,Substance,Thallium,81Tl; Talio; Tl; CHEBI:37117,2014-12-24,1,,,,,,,,,
12039-52-0,0,OMOP Exposome,Observation,Substance,Thallium selenide,,2014-12-24,1,,,,,,,,,
7789-40-4,0,OMOP Exposome,Observation,Substance,Thallium(I) bromide,,2014-12-24,1,,,,,,,,,
58-55-9,0,OMOP Exposome,Observation,Substance,Theophylline,"Uniphyl; Unifyl; Uni-Dur; Theovent; Theostat 80; Theophylline-Sr; Theophylline(Anhydrous); Theophylline anhydrous; Theophyllin; Theophyline; Theophyl-Sr; Theophyl-225; Theophyl; Theona P; Theolixir; Theolix; Theolair-Sr; 1,3-dimethyl-7H-purine-2,6-dione; 1,3-Dimethylxanthine; Accurbron; Acet-theocin; Aerolate; Aerolate III; Aerolate SR; Aminophylline; Aquaphyllin; Armophylline; Asbron; Asmax; Austyn; Bronkodyl; Bronkodyl SR; Choledyl SA; Constant-T; Diphyllin; Doraphyllin; Duraphyl; Dyspne-Inhal; Elixex; Elixicon; Elixomin; Elixophyllin; Elixophyllin SR; Elixophylline; Euphylline; Euphylong; Labid; Lanophyllin; Liquophylline; Liquorice; Maphylline; Medaphyllin; Nuelin; Optiphyllin; Parkophyllin; Pseudotheophylline; Quibron T/SR; Quibron-T; Quibron-T/Sr; Respbid; Slo-Bid; Slo-Phyllin; Solosin; Somophyllin-Crt; Somophyllin-DF; Somophyllin-T; Spophyllin retard; Sustaire; Synophylate; Synophylate-L.A. Cenules; T-Phyl; Tefamin; Teofilina; Teofyllamin; Teolair; Theacitin; Theal tabl.; Theal tablets; Theo 24; Theo-24; Theo-Dur; Theo-Dur-Sprinkle; Theobid; Theobid Jr.; Theochron; Theocin; Theoclair-SR; Theoclear 80; Theoclear L.A.-130; Theoclear LA; Theoclear-200; Theoclear-80; Theocontin; Theodel; Theodur G; Theofol; Theograd; Theolair; Xantivent; Xanthium; Uniphyllin; CHEBI:28177",2014-12-24,1,,,,,,,,,
148-79-8,0,OMOP Exposome,Observation,Substance,Thiabendazole,"Thibenzol; 1yvm; 2-(1,3-Thiazol-4-yl)-1H-benzimidazole; 2-(1,3-Thiazol-4-yl)benzimidazole; 2-(4'-Thiazolyl)benzimidazole; 2-(4-Thiazolyl)-1H-Benzimidazole; 2-(4-Thiazolyl)-Benzimidazole; 2-(4-Thiazolyl)benzimidazole; 2-(Thiazol-4-yl)benzimidazole; 2-Thiazol-4-yl-1H-benzoimidazole; 2-Thiazole-4-ylbenzimidazole; 2-4-Thiazolybenzimidazole; 4-(2-benzimidazolyl)thiazole; 5-(4-Thiazolyl)benzimidazole; Apl-luster; Arbotect; Biogard; Bioguard; Bovizole; Captan t; Chemviron TK 100; Cropasal; Drawipas; E-z-Ex; Eprofil; Equivet TZ; Equizole; Equizole a; Helmindrax octelmin; Hokustar HP; Hymush; Lombristop; Mertec; Mertect; Mertect 160; Mertect 340f; Mertect LSP; Metasol tk 10; Metasol TK 100; Metasol TK-100; Mintesol; Mintezol; Mintezole; Minzolum; MK 360; Mycozol; Nemacin; Nemapan; Omnizole; Ormogal; Pitrizet; Polival; RPH; Sanaizol 100; Sistesan; Storite; Syntol M100; TBDZ; TBZ; TBZ 6; TBZ 60W; Tebuzate; Tecto; Tecto 10P; Tecto 40F; Tecto 60; Tecto b; Tecto RPH; Testo; Thiaben; Thiabendazol; Thiabendazole(usan); Thiabendazole, BAN, BSI, ISO, JMAF, USAN; Thiabendazolum; Thiabendole; Thiabenzazole; Thiabenzole; Thibendole; Thibenzole; Thibenzole 200; Thibenzole att; Thiprazole; Tiabenda; Tiabendazol; Tiabendazole; Tiabendazole, INN; Tiabendazolum; Tibimix 20; TMG; Tobaz; Top form wormer; Tresaderm; Triasox; Tubazole; CHEBI:45979",2014-12-24,1,,,,,,,,,
111988-49-9,0,OMOP Exposome,Observation,Substance,Thiacloprid,"(Z)-3-(6-chloro-3-pyridinyl)methyl-2-thiazolidinylidenecyanamide; Thiacloprid, (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; CHEBI:CHEBI:39176",2014-12-24,1,,,,,,,,,
153719-23-4,0,OMOP Exposome,Observation,Substance,Thiamethoxam,,2014-12-24,1,,,,,,,,,
Q9H3S4,0,OMOP Exposome,Observation,Substance,Thiamin pyrophosphokinase 1,,2024-09-14,1,,,,,,,,,
59-43-8,0,OMOP Exposome,Observation,Substance,Thiamine,Vinothiam; Vetalin S; Trophite; Betalin S; Betaxin; Berin; Bethiazine; Beuion; Bevitex; Bevitine; Bewon; Biamine; Bithiamin; Biuno; Bivatin; Bequin; Bivita; Cernevit-12; Clotiamina; Eskapen; Eskaphen; Benerva; Begiolan; Bedome; Beatine; Apate drops; Antiberiberi factor; Hybee; Lixa-beta; Metabolin; Slowten; THD; Aneurin; 3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium; Thiadoxine; Thiamin; Thiaminal; thiamine(1+); thiamine(1+) ion; Thiaminium; Thiamol; Thiavit; Tiamidon; Tiaminal; Vitaneuron; Vitamin B1; VIB; CHEBI:18385,2014-12-24,1,,,,,,,,,
GIS1010060,0,OMOP Exposome,Observation,Substance,Thiamine Metabolism,,2024-09-14,1,,,,,,,,,
O60779,0,OMOP Exposome,Observation,Substance,Thiamine transporter 1,,2024-09-14,1,,,,,,,,,
Q9BZV2,0,OMOP Exposome,Observation,Substance,Thiamine transporter 2,,2024-09-14,1,,,,,,,,,
94662-61-0,0,OMOP Exposome,Observation,Substance,"Thiazolidine, 2-(nitromethylene)",,2014-12-24,1,,,,,,,,,
117718-60-2,0,OMOP Exposome,Observation,Substance,Thiazopyr,,2014-12-24,1,,,,,,,,,
51707-55-2,0,OMOP Exposome,Observation,Substance,Thidiazuron,,2014-12-24,1,,,,,,,,,
28249-77-6,0,OMOP Exposome,Observation,Substance,Thiobencarb,,2014-12-24,1,,,,,,,,,
25171-63-5,0,OMOP Exposome,Observation,Substance,Thiocarboxime,,2014-12-24,1,,,,,,,,,
302-04-5,0,OMOP Exposome,Observation,Substance,Thiocyanate,Thiocyanate ion; Thiocyanic acid; Thiocyanid; Weedazol TL; Ammonium sulfocyanate; Nitrodithiocarbone(1-); Nitrodothiocarbonate; Nitridosulfanidocarbon; Rhodanid; Rhodanide; SCN; CHEBI:18022,2014-12-24,1,,,,,,,,,
59669-26-0,0,OMOP Exposome,Observation,Substance,Thiodicarb,"(3EZ,12EZ)-3,7,9,13-tetramethyl-5,11-dioxa-2,8,14-trithia-4,7,9,12-tetraazapentadeca-3,12-diene-6,10-dione; Dimethyl N,N\u2032-thiobis(methylimino)carbonyloxybisethanimidothioate; CHEBI:38548",2014-12-24,1,,,,,,,,,
39196-18-4,0,OMOP Exposome,Observation,Substance,Thiofanox,"Thiofanocarb; Thiophanox; 3,3-Dimethyl-1-methylthiobutanone O-methylcarbamoyloxime; Benelux; Caswell No. 368BB; Dacamox; RCRA waste no. P045; Rcra waste number P045; CHEBI:38549",2014-12-24,1,,,,,,,,,
GIS1010061,0,OMOP Exposome,Observation,Substance,Thioguanine Pathway,,2024-09-14,1,,,,,,,,,
54-64-8,0,OMOP Exposome,Observation,Substance,Thiomersal,"Sodium salt of 2-(carboxyphenyl)thioethylmercury; ((o-carboxyphenyl)thio) ethylmercury sodium salt; 2-(Ethylmercuriomercapto)benzoic acid sodium salt; Estivin; Ethyl (sodium o-mercaptobenzoato)mercury; ethyl(2-mercaptobenzoato-S)mercury sodium salt; Ethyl(2-mercaptobenzoato-S)mercury, sodium salt; Ethylmercurithiosalicyclic acid, sodium salt; Ethylmercurithiosalicylate sodium; Ethylmercurithiosalicylate sodium salt; Ethylmercurithiosalicylic acid sodium salt; Mercurate(1-), ethyl(2-mercaptobenzoato(2-)-O,S)-, sodium; Mercurate(1-), ethyl(o-mercaptobenzoato(2-))-, sodium; Mercurate(1-), {ethyl2-mercaptobenzoato(2-)-O,S-,} sodium; Mercurate(1-), {ethylo-mercaptobenzoato(2-)-,} sodium; Mercurothiolate; Mercurothiolatum; Merfamin; Merphol; Merseptyl; Merthiolate; Merthiolate salt; Merthiolate sodium; Mertorgan; Merzonin; Merzonin sodium; Merzonin, sodium salt; O-(Ethylmercurithio)benzoic acid sodium salt; Sodium 2-(ethylmercurithio)benzoate; Sodium ethylmercuric thiosalicylate; Sodium ethylmercurithiosalicylate; Sodium merthiolate; Sodium o-(ethylmercurithio)benzoate; Thimerosal; Thimerosalate; Thimerosalum; Thimerosol; Thimersalate; Thiomerosal; Thiomersalat; Thiomersalate; Vitaseptol loesung; (o-carboxyphenyl)thioethylmercury sodium salt; CHEBI:9546",2014-12-24,1,,,,,,,,,
GIS1010062,0,OMOP Exposome,Observation,Substance,Thionin (Pyrularia pubera),,2024-09-14,1,,,,,,,,,
507-16-4,0,OMOP Exposome,Observation,Substance,Thionyl bromide,,2014-12-24,1,,,,,,,,,
76-75-5,0,OMOP Exposome,Observation,Substance,Thiopental,"Pentotex; Penthal; Pentazol; Pental Sodyum; Omexolon; Intraval Sodium; Farmotal; Ekipental; Bitol Sodium; Bitaryl; Bensulf; Anestho; 5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione; 2-Thio-5-ethyl-5-sec-pentylbarbituric acid; (+-)-Thiopental; Thiomebumalum; Thionembutal; Thiopen; Thiopentobarbital; Thiopentobarbitone; Thiopentobarbituric acid; Thiopentone; Thiomebumal; Sodium Pentothal; Ravonal; Pentothiobarbital; Pentothal; Pentotan; Penthotal Sodium; Penthiobarbital; Tiopental; Tiopentale; Trapanal; CHEBI:102166",2014-12-24,1,,,,,,,,,
23564-05-8,0,OMOP Exposome,Observation,Substance,Thiophanate-methyl,"1,2-Di-(3-methoxycarbonyl-2-thioureido)benzene; Thiophanic acid-methyl; CHEBI:35014",2014-12-24,1,,,,,,,,,
P10599,0,OMOP Exposome,Observation,Substance,Thioredoxin,,2024-09-14,1,,,,,,,,,
O95881,0,OMOP Exposome,Observation,Substance,Thioredoxin domain-containing protein 12,,2024-09-14,1,,,,,,,,,
Q16881,0,OMOP Exposome,Observation,Substance,"Thioredoxin reductase 1, cytoplasmic",,2024-09-14,1,,,,,,,,,
Q9NNW7,0,OMOP Exposome,Observation,Substance,"Thioredoxin reductase 2, mitochondrial",,2024-09-14,1,,,,,,,,,
Q86VQ6,0,OMOP Exposome,Observation,Substance,Thioredoxin reductase 3,,2024-09-14,1,,,,,,,,,
Q99757,0,OMOP Exposome,Observation,Substance,"Thioredoxin, mitochondrial",,2024-09-14,1,,,,,,,,,
50-52-2,0,OMOP Exposome,Observation,Substance,Thioridazine,Thioril; Melleretten; Melleril; Novoridazine; Orsanil; Ridazin; Ridazine; Mellerette; Mellerets; Mellaril-S; Sonapax; Thioridazin; Thioridazine Chloride; Thioridazinum; Tioridazina; Mellaril; 10-2-(1-Methyl-2-piperidyl)ethyl-2-methylsulfanyl-phenothiazine; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine; Aldazine; Mallorol; Malloryl; Meleril; CHEBI:9566,2014-12-24,1,,,,,,,,,
52-24-4,0,OMOP Exposome,Observation,Substance,Thiotepa,Thioplex; CHEBI:128310,2014-12-24,1,,,,,,,,,
62-56-6,0,OMOP Exposome,Observation,Substance,Thiourea,"Sulourea; Tsizp 34; TOU; THU; beta-Thiopseudourea; Thiuronium; Urea, thio- (8CI); beta -thiopseudourea; Thiourea, acs; 2-Thiourea; 2-Thiopseudourea; 2-Thio-Urea; 2-Thio-Pseudourea; (NH2)2CS; Thiomocovina; Thiokarbamid; Isothiourea; Thioharnstoff; Thiurea; Thiocarbonic diamide; Thiocarbonic acid diamide; Thiocarbamide; Thiocarbamid; Pseudothiourea; Sulfocarbamide; Sulfourea; Sulfouren; Carbonothioic diamide; H2NC(S)NH2; Thio-Urea; TU; CHEBI:36946",2014-12-24,1,,,,,,,,,
GIS1010069,0,OMOP Exposome,Observation,Substance,Thioxanthene,,2024-09-14,1,,,,,,,,,
137-26-8,0,OMOP Exposome,Observation,Substance,Thiram,"Tetrathiuram disulfide; Thirame; Thiramum; Thiuram; TMTD; Me2NC(S)S2, alpha,Alpha'-dithiobis(dimethylthio)formamide; Arasan; Bis((dimethylamino)carbonothioyl) disulfide; Bis(dimethyl thiocarbamoyl)disulfide; Bis(dimethyl-thiocarbamoyl)-disulfid; Bis(dimethylthiocarbamoyl) disulfide; Disulfure de tetramethylthiourame; N,N'-(dithiodicarbonothioyl)bis(N-methylmethanamine); N,N-Tetramethylthiuram disulfide; Nomersan; Pomarsol; Rezifilm; Tetramethyl-thiram disulfid; Tetramethylenethiuram disulfide; Tetramethylthioperoxydicarbonic diamide; Tetramethylthiuram disulfide; Tetramethylthiurane disulfide; CHEBI:CHEBI:9495",2014-12-24,1,,,,,,,,,
3688-92-4,0,OMOP Exposome,Observation,Substance,Thorin,,2014-12-24,1,,,,,,,,,
7440-29-1,0,OMOP Exposome,Observation,Substance,Thorium,"Thorium 232; Thorium, isotope of mass 232; Thorium-232; 232Th; 90Th; CHEBI:33385",2014-12-24,1,,,,,,,,,
GIS1010070,0,OMOP Exposome,Observation,Substance,Thorium Compound,,2024-09-14,1,,,,,,,,,
15623-47-9,0,OMOP Exposome,Observation,Substance,Thorium-227,,2014-12-24,1,,,,,,,,,
14274-82-9,0,OMOP Exposome,Observation,Substance,Thorium-228,,2014-12-24,1,,,,,,,,,
14269-63-7,0,OMOP Exposome,Observation,Substance,Thorium-230,,2014-12-24,1,,,,,,,,,
GIS1010071,0,OMOP Exposome,Observation,Substance,Threonine and 2-Oxobutanoate Degradation,,2024-09-14,1,,,,,,,,,
Q8IYQ7,0,OMOP Exposome,Observation,Substance,Threonine synthase-like 1,,2024-09-14,1,,,,,,,,,
P26639,0,OMOP Exposome,Observation,Substance,"Threonine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
Q9BW92,0,OMOP Exposome,Observation,Substance,"Threonine--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
GIS1010072,0,OMOP Exposome,Observation,Substance,Thrombolytic Agent,,2024-09-14,1,,,,,,,,,
P07204,0,OMOP Exposome,Observation,Substance,Thrombomodulin,,2024-09-14,1,,,,,,,,,
P21731,0,OMOP Exposome,Observation,Substance,Thromboxane A2 receptor,,2024-09-14,1,,,,,,,,,
BE0005327,0,OMOP Exposome,Observation,Substance,Thromboxane A2 synthase,,2024-09-14,1,,,,,,,,,
P24557,0,OMOP Exposome,Observation,Substance,Thromboxane-A synthase,,2024-09-14,1,,,,,,,,,
O00142,0,OMOP Exposome,Observation,Substance,"Thymidine kinase 2, mitochondrial",,2024-09-14,1,,,,,,,,,
P04183,0,OMOP Exposome,Observation,Substance,"Thymidine kinase, cytosolic",,2024-09-14,1,,,,,,,,,
P19971,0,OMOP Exposome,Observation,Substance,Thymidine phosphorylase,,2024-09-14,1,,,,,,,,,
P04818,0,OMOP Exposome,Observation,Substance,Thymidylate synthase,,2024-09-14,1,,,,,,,,,
P62328,0,OMOP Exposome,Observation,Substance,Thymosin beta-4,,2024-09-14,1,,,,,,,,,
GIS1010073,0,OMOP Exposome,Observation,Substance,Thyroid Gland,,2024-09-14,1,,,,,,,,,
P10827,0,OMOP Exposome,Observation,Substance,Thyroid hormone receptor alpha,,2024-09-14,1,,,,,,,,,
P10828,0,OMOP Exposome,Observation,Substance,Thyroid hormone receptor beta,,2024-09-14,1,,,,,,,,,
GIS1010074,0,OMOP Exposome,Observation,Substance,Thyroid hormone synthesis,,2024-09-14,1,,,,,,,,,
P07202,0,OMOP Exposome,Observation,Substance,Thyroid peroxidase,,2024-09-14,1,,,,,,,,,
P16473,0,OMOP Exposome,Observation,Substance,Thyrotropin receptor,,2024-09-14,1,,,,,,,,,
P05543,0,OMOP Exposome,Observation,Substance,Thyroxine-binding globulin,,2024-09-14,1,,,,,,,,,
115103-54-3,0,OMOP Exposome,Observation,Substance,Tiagabine,Tiagabina; Tiagabinum; Gabitril; CHEBI:222170,2014-12-24,1,,,,,,,,,
51892-60-5,0,OMOP Exposome,Observation,Substance,Tillam sulfoxide,,2014-12-24,1,,,,,,,,,
7440-31-5,0,OMOP Exposome,Observation,Substance,Tin,Sn(II); Sn(4+); Tin flake; Stanum; Sn(IV); Sn; Sn(2+); Tin(IV) ion; Tin(II) ion; Tin(4+) ion; Tin(2+) ion; Tin powder; CHEBI:32990,2014-12-24,1,,,,,,,,,
7646-78-8,0,OMOP Exposome,Observation,Substance,Tin chloride,,2014-12-24,1,,,,,,,,,
GIS1010075,0,OMOP Exposome,Observation,Substance,Tin Compound,,2024-09-14,1,,,,,,,,,
1315-06-0,0,OMOP Exposome,Observation,Substance,Tin selenide,,2014-12-24,1,,,,,,,,,
12040-02-7,0,OMOP Exposome,Observation,Substance,Tin telluride,,2014-12-24,1,,,,,,,,,
10031-24-0,0,OMOP Exposome,Observation,Substance,Tin(II) bromide,,2014-12-24,1,,,,,,,,,
7772-99-8,0,OMOP Exposome,Observation,Substance,Tin(II) chloride (SnCl2),"Dichlorotin; Uniston CR-HT 200; Tin(II)chloride; Tin(II) chloride (sncl2); Tin(II) chloride; Tin salts; Tin salt; Tin protochloride; Tin dichloride; Tin crystals; Tin chloride (SnCl2); Tin (II) chloride, anhydrous; Tin (II) chloride anhydrous; Tin (II) chloride; Stannous dichloride; Stannous chloride, anhydrous; STANNOUS CHLORIDE, 10% W/V; Stannous chloride anhydrous; Stannous chloride; Stannochlor; SnCl2; Single muriate of tin; Fascat 2004; E512; Dichlorostannane; Anhydrous stannous chloride; CHEBI:78067",2014-12-24,1,,,,,,,,,
7783-47-3,0,OMOP Exposome,Observation,Substance,Tin(II) fluoride,,2014-12-24,1,,,,,,,,,
13814-97-6,0,OMOP Exposome,Observation,Substance,Tin(II) fluoroborate,,2014-12-24,1,,,,,,,,,
12026-24-3,0,OMOP Exposome,Observation,Substance,Tin(II) hydroxide,,2014-12-24,1,,,,,,,,,
10294-70-9,0,OMOP Exposome,Observation,Substance,Tin(II) iodide,,2014-12-24,1,,,,,,,,,
21651-19-4,0,OMOP Exposome,Observation,Substance,Tin(II) oxide,,2014-12-24,1,,,,,,,,,
7488-55-3,0,OMOP Exposome,Observation,Substance,Tin(II) sulfate,,2014-12-24,1,,,,,,,,,
1314-95-0,0,OMOP Exposome,Observation,Substance,Tin(II) sulfide,,2014-12-24,1,,,,,,,,,
7789-67-5,0,OMOP Exposome,Observation,Substance,Tin(IV) bromide,,2014-12-24,1,,,,,,,,,
7783-62-2,0,OMOP Exposome,Observation,Substance,Tin(IV) fluoride,,2014-12-24,1,,,,,,,,,
7790-47-8,0,OMOP Exposome,Observation,Substance,Tin(IV) iodide,,2014-12-24,1,,,,,,,,,
18282-10-5,0,OMOP Exposome,Observation,Substance,Tin(IV) oxide,Stannic oxide; Stannic anhydride; Flowers OF tin; Tin peroxide; Cassiterite; Stannic dioxide; Tin dioxide; Tin oxide; Stannoxyl; White tin oxide; CHEBI:52991,2014-12-24,1,,,,,,,,,
1315-01-1,0,OMOP Exposome,Observation,Substance,Tin(IV) sulfide,Tin(IV) sulphide; Stannic sulfide; Tin disulphide; CHEBI:50886,2014-12-24,1,,,,,,,,,
36756-79-3,0,OMOP Exposome,Observation,Substance,Tiocarbazil,,2014-12-24,1,,,,,,,,,
65899-73-2,0,OMOP Exposome,Observation,Substance,Tioconazole,Tioconazol; Vagistat-1; Trosyl; GyneCure; Monistat 1; Trosyd; Tioconazolum; CHEBI:774389,2014-12-24,1,,,,,,,,,
154-42-7,0,OMOP Exposome,Observation,Substance,Tioguanine,"Thioguanine; Tioguanin; Tioguanina; Tioguaninum; 2-Amino-6-purinethiol; 2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-amino-1,9-Dihydropurine-6-thione; 2-amino-1H-purine-6(7H)-thione; ThG; TG; Tabloid; Lanvis; 6-Thioguanine; 2-Aminopurine-6-thiol; 2-Aminopurine-6(1H)-thione; 6-TG; 6-Mercaptoguanine; 6-Mercapto-2-aminopurine; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Aminopurin-6-thiol; CHEBI:9555",2014-12-24,1,,,,,,,,,
51-24-1,0,OMOP Exposome,Observation,Substance,Tiratricol,,2014-12-24,1,,,,,,,,,
P13726,0,OMOP Exposome,Observation,Substance,Tissue factor,,2024-09-14,1,,,,,,,,,
P00750,0,OMOP Exposome,Observation,Exposome Target,Tissue-type plasminogen activator,,2024-09-14,1,,,,,,,,,
12003-96-2,0,OMOP Exposome,Observation,Substance,Titanium aluminide,,2014-12-24,1,,,,,,,,,
GIS1010076,0,OMOP Exposome,Observation,Substance,Titanium Compound,,2024-09-14,1,,,,,,,,,
7789-68-6,0,OMOP Exposome,Observation,Substance,Titanium tetrabromide,,2014-12-24,1,,,,,,,,,
12037-65-9,0,OMOP Exposome,Observation,Substance,Titanium(III) phosphide,,2014-12-24,1,,,,,,,,,
39465-37-7,0,OMOP Exposome,Observation,Substance,Tityustoxin (Tityus serrulatus ),,2014-12-24,1,,,,,,,,,
51322-75-9,0,OMOP Exposome,Observation,Substance,Tizanidine,"Zitanid; Sirdalid; Sirdalud; Sirdalud MR; Sizolan; Spaslax; Telzanine; Ternelin; Tizadin; Tizaflex; Tizalud; Tizan; Tizanidin; Tizanidina; Tizanidinum; Zanaflex; Zanpeak; 5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole; 5-chloro-4-(2-imidazolin-4-on-2-ylamino)-2,1,3-benzothiadiazole; Cimbrar; Musant; Myores; Navizan; Relaxkov; CHEBI:63629",2014-12-24,1,,,,,,,,,
GIS1010078,0,OMOP Exposome,Observation,Substance,Tocolytic Agent,,2024-09-14,1,,,,,,,,,
22345-47-7,0,OMOP Exposome,Observation,Substance,Tofisopam,,2014-12-24,1,,,,,,,,,
1156-19-0,0,OMOP Exposome,Observation,Substance,Tolazamide,"1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea; Diabewas; Desumide; CCRIS 591; BRN 1323565; Tolinase; U 17835; U-17835; Tolazamidum; Tolazamida; Tolazamid; Tolanase; Norglycin; N-{(hexahydro-1H-azepin-1-yl)-aminocarbonyl}-4-methylbenzenesulfonamide; N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea; Esulin; EINECS 214-588-3; 4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide; 1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea; CHEBI:156131",2014-12-24,1,,,,,,,,,
134308-13-7,0,OMOP Exposome,Observation,Substance,Tolcapone,"3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone; (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone; Sen De Ning; Tolcapona; Tolcaponum; Tasmar; 4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone; Tolcapon; 3,4-Dihydroxy-5-nitro-4'-methylbenzophenone; CHEBI:63630",2014-12-24,1,,,,,,,,,
O60603,0,OMOP Exposome,Observation,Substance,Toll-like receptor 2,,2024-09-14,1,,,,,,,,,
O00206,0,OMOP Exposome,Observation,Substance,Toll-like receptor 4,,2024-09-14,1,,,,,,,,,
Q9NYK1,0,OMOP Exposome,Observation,Substance,Toll-like receptor 7,,2024-09-14,1,,,,,,,,,
Q9NR96,0,OMOP Exposome,Observation,Substance,Toll-like receptor 9,,2024-09-14,1,,,,,,,,,
108-88-3,0,OMOP Exposome,Observation,Substance,Toluene,Methylbenzene; Toluol; Phenyl-Methane; Monomethyl benzene; Methylbenzol; Methyl-Benzene; Phenylmethane; CHEBI:17578,2014-12-24,1,,,,,,,,,
GIS1010079,0,OMOP Exposome,Observation,Substance,Toluene Degradation,,2024-09-14,1,,,,,,,,,
86-91-9,0,OMOP Exposome,Observation,Substance,Toluene diisocyanate,"Toluen-disocianato; 2,4 Toluenediisocyanate; 2,4-/2,6-Toluene diisocyanate mixture; 2,4-Diisocyanate, Toluene; 2,4-Diisocyanato-1-methylbenzene; 2,4-diisocyanato-1-methylbenzene; 2,4-Diisocyanato-1-methylbenzene (9CI); TuluylendIIsocyanat; Tolylene-2,4-diisocyanate; 2,4-Diisocyanatotoluene; 2,4-Toluene diisocyanate, homopolymer; 2,4-Toluenediisocyanate; 2,4-Tolylene diisocyanate; 4-Methyl-1,3-phenylene diisocyanate; 4-Methyl-m-phenylene diisocyanate; 4-Methyl-m-phenylene isocyanate; 4-METHYL-m-PHENYLENEDIISOTHIOCYANATE; Benzene, 2,4-diisocyanato-1-methyl-, homopolymer; Cresorcinol dIIsocyanate; Desmodur T80; Tolylene dIIsocyanate; Di-iso-cyanatoluene; Di-isocyanate de toluylene; DIIsocyanat-toluol; DIIsocyanate, toluene; DIIsocyanate, tolylene; DIIsocyanatomethylbenzene; DIIsocyanatotoluene; Hylene t; Tolylene 2,4-diisocyanate; Tolyene 2,4-diisocyanate; Hylene TLC; Isocyanic acid, 4-methyl-m-phenylene ester; Isocyanic acid, 4-methyl-m-phenylene ester (8ci); Isocyanic acid, methylphenylene ester; Mondur TD; Mondur TD-80; Mondur TDS; Nacconate ioo; Poly(tolylene 2,4-diisocyanate) solution; RCRA waste no. U223; Toluylene-2,4-diisocyanate; Toluilenodwuizocyjanian; RCRA waste number U223; TDI; Tolueen-dIIsocyanaat; Toluene-2,4-diisocyanate; TOLUENE, 2,4-DIISOCYANATE; Toluene diisocyanic acid; Toluene 2,4-Diisocyanate; Toluene 2,4 Diisocyanate; CHEBI:25520",2014-12-24,1,,,,,,,,,
36635-61-7,0,OMOP Exposome,Observation,Substance,Toluenesulfonylmethyl isocyanide,,2014-12-24,1,,,,,,,,,
97240-79-4,0,OMOP Exposome,Observation,Substance,Topiramate,"2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; 2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate; Epitomax; McN-4853; RWJ-17021; QUDEXY; Tipiramate; Tipiramato; Topamax; Topamax Sprinkle; Topiramato; Topiramatum; Topiramic acid; Topomax; TPM; Trokendi XR; CHEBI:63631",2014-12-24,1,,,,,,,,,
8001-35-2,0,OMOP Exposome,Observation,Substance,Toxaphene,,2014-12-24,1,,,,,,,,,
6888-23-9,0,OMOP Exposome,Observation,Substance,Toxiferine,,2014-12-24,1,,,,,,,,,
GIS1010080,0,OMOP Exposome,Observation,Substance,Toxin A (Clostridium difficile),,2024-09-14,1,,,,,,,,,
GIS1010106,0,OMOP Exposome,Observation,Substance,Toxin B (Clostridium difficile),,2024-09-14,1,,,,,,,,,
34114-99-3,0,OMOP Exposome,Observation,Substance,Toxin T2 tetrol,,2014-12-24,1,,,,,,,,,
Q96RJ0,0,OMOP Exposome,Observation,Substance,Trace amine-associated receptor 1,,2024-09-14,1,,,,,,,,,
GIS1010132,0,OMOP Exposome,Observation,Substance,Trace Element,,2024-09-14,1,,,,,,,,,
O43617,0,OMOP Exposome,Observation,Substance,Trafficking protein particle complex subunit 3,,2024-09-14,1,,,,,,,,,
87820-88-0,0,OMOP Exposome,Observation,Substance,Tralkoxydim,,2014-12-24,1,,,,,,,,,
66841-25-6,0,OMOP Exposome,Observation,Substance,Tralomethrin,Bengal fire ant killer; Tralomethrine; Scout x-tra; Scout; SAGA; CHEBI:39400,2014-12-24,1,,,,,,,,,
27203-92-5,0,OMOP Exposome,Observation,Substance,Tramadol,Ryzolt; (+)-Tramadol; (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol; ConZip; Durela; Ralivia; Rybix; Tramal; Tridural; Ultram; Zytram xl; CHEBI:238661,2014-12-24,1,,,,,,,,,
156-60-5,0,OMOP Exposome,Observation,Substance,"trans-1,2-Dichloroethene","Trans-dichloroethylene; cis-1,2-Dichloroethylene; Dichloroethylene-trans; cis or trans 1,2-Dichloroethene; Trans-1,2-Dichloroethylene; Trans-1, 2-Dichloroethene; Acetylene dichloride; SYM-dichloroethylene; Ethene,1,2-dichloro; Dioform; Trans-Di-1,2-Chloroethylene; Trans-Di-1, 2-chloroethylene; Trans-acetylene dichloride; 1,trans-2-Dichloroethene; 1,2-trans-Dichloroethylene; 1,2-trans-Dichloroethene; 1,2-Dichloroethylene (trans); 1,2-Dichloroethylene; 1,2-Dichloroethene; 1,2-Dichloro Ethylene; (E)-1,2-Dichloroethylene; (E)-1,2-Dichloroethene; Trans-dichloroethene; CHEBI:29027",2014-12-24,1,,,,,,,,,
10061-02-6,0,OMOP Exposome,Observation,Substance,"trans-1,3-Dichloropropene","Telone II soil fumigant; (1E)-1,3-Dichloro-1-propene; (1E)-1,3-dichloroprop-1-ene; (E)-1,3-Dichloro-1-propene; (E)-1,3-Dichloropropene; 1,3-dichloro-1-propene; 1,3-dichloro-1-propene, (E)-isomer; 1,3-dichloro-1-propene, (Z)-isomer; 1,3-Dichloro-1-propylene; 1,3-Dichloro-2-propene; 1,3-Dichloropropene; 1,3-dichloropropene; 1,3-Dichloropropene (mixed isomers); 1,3-Dichloropropene (mixed); 1,3-Dichloropropene (technical grade); 1,3-DICHLOROPROPENE (TELONE II); 1,3-Dichloropropene-1; 1,3-dichloropropylene; 2,3-DICHLOROPROPENE; 3-Chloroallyl chloride; 3-Chloropropenyl chloride; Alpha,gamma-dichloropropylene; Alpha-chloroallyl chloride; Chloroallyl c hloride; Chloroallyl chloride; Chloropropenyl chloride; Cis-dichloropropene; Di-trapex CP; Dichloropropene; Dichloropropene, 1,3- (Telone II); Dorlone; Dorlone II; E-1,3-Dichloropropene; Gamma-chloroallyl chloride; Nematox; Nemex; Propylene, 1,3-dichloro-, (trans); Sjpdadfhruf`d`; Telone; Telone c; Telone C17; Telone ec; Telone II; Telone II, technical; Telone II, technical grade; Telone II-b; Telone IIr; trans-1,3-Dichloro-1-Propene; trans-1,3-Dichloropropylene; trans-3-Chloroallyl chloride; Trans-telone; Tri-form; Vorlex 201; CHEBI:18624",2014-12-24,1,,,,,,,,,
Q96EM0,0,OMOP Exposome,Observation,Substance,Trans-3-hydroxy-L-proline dehydratase,,2024-09-14,1,,,,,,,,,
5103-74-2,0,OMOP Exposome,Observation,Substance,trans-Chlordane,Chlordane gamma; Beta-chlordane; b-Chlordane; b-Chlordan; Chlordane trans; trans-Chlordan; Trans-gamma-chlordane; Trans-(gamma)-chlordane; CHEBI:39069,2014-12-24,1,,,,,,,,,
140-10-3,0,OMOP Exposome,Observation,Substance,trans-Cinnamic acid,trans-3-Phenylacrylate; trans-3-Phenyl-2-propenoate; (2E)-2-Phenyl-2-propenoate; (2E)-2-Phenyl-2-propenoic acid; (2E)-3-Phenyl-2-propenoate; (2E)-3-phenyl-2-Propenoic acid; (E)-3-Phenylacrylate; (E)-3-Phenylacrylic acid; (E)-3-Phenylprop-2-enoate; (E)-3-Phenylprop-2-enoic acid; (E)-Cinnamate; (E)-Cinnamic acid; trans-b-Carboxystyrene; trans-beta-Carboxystyrene; trans-Cinnamate; trans-3-Phenyl-2-propenoic acid; trans-3-Phenylacrylic acid; CHEBI:35697,2014-12-24,1,,,,,,,,,
13782-33-7,0,OMOP Exposome,Observation,Substance,trans-Diamminedichloro-palladium(II),,2014-12-24,1,,,,,,,,,
28068-05-5,0,OMOP Exposome,Observation,Substance,trans-Diamminedinitro-palladium(II),,2014-12-24,1,,,,,,,,,
14040-33-6,0,OMOP Exposome,Observation,Substance,trans-Dichlorobis(ethylenediamine)cobalt(III) chloride,,2014-12-24,1,,,,,,,,,
965-03-2,0,OMOP Exposome,Observation,Substance,trans-Dichlorobis-(triphenylphosphine) palladium(II),,2014-12-24,1,,,,,,,,,
BE0002337,0,OMOP Exposome,Observation,Substance,Trans-L-3-hydroxyproline dehydratase,,2024-09-14,1,,,,,,,,,
P20061,0,OMOP Exposome,Observation,Substance,Transcobalamin-1,,2024-09-14,1,,,,,,,,,
P20062,0,OMOP Exposome,Observation,Substance,Transcobalamin-2,,2024-09-14,1,,,,,,,,,
P05412,0,OMOP Exposome,Observation,Substance,Transcription factor AP-1,,2024-09-14,1,,,,,,,,,
Q01094,0,OMOP Exposome,Observation,Substance,Transcription factor E2F1,,2024-09-14,1,,,,,,,,,
Q04206,0,OMOP Exposome,Observation,Substance,Transcription factor p65,,2024-09-14,1,,,,,,,,,
P08047,0,OMOP Exposome,Observation,Substance,Transcription factor Sp1,,2024-09-14,1,,,,,,,,,
GIS1010133,0,OMOP Exposome,Observation,Substance,Transcription/Translation,,2024-09-14,1,,,,,,,,,
Q12986,0,OMOP Exposome,Observation,Substance,Transcriptional repressor NF-X1,,2024-09-14,1,,,,,,,,,
GIS1010134,0,OMOP Exposome,Observation,Substance,Transfer of Acetyl Groups into Mitochondria,,2024-09-14,1,,,,,,,,,
Q9Y6A5,0,OMOP Exposome,Observation,Substance,Transforming acidic coiled-coil-containing protein 3,,2024-09-14,1,,,,,,,,,
P01137,0,OMOP Exposome,Observation,Substance,Transforming growth factor beta-1,,2024-09-14,1,,,,,,,,,
P10600,0,OMOP Exposome,Observation,Substance,Transforming growth factor beta-3,,2024-09-14,1,,,,,,,,,
P61586,0,OMOP Exposome,Observation,Substance,Transforming protein RhoA,,2024-09-14,1,,,,,,,,,
O75762,0,OMOP Exposome,Observation,Substance,Transient receptor potential cation channel subfamily A member 1,,2024-09-14,1,,,,,,,,,
Q7Z2W7,0,OMOP Exposome,Observation,Substance,Transient receptor potential cation channel subfamily M member 8,,2024-09-14,1,,,,,,,,,
Q8NER1,0,OMOP Exposome,Observation,Substance,Transient receptor potential cation channel subfamily V member 1,,2024-09-14,1,,,,,,,,,
Q8NET8,0,OMOP Exposome,Observation,Substance,Transient receptor potential cation channel subfamily V member 3,,2024-09-14,1,,,,,,,,,
P29401,0,OMOP Exposome,Observation,Substance,Transketolase,,2024-09-14,1,,,,,,,,,
Q92616,0,OMOP Exposome,Observation,Substance,Translational activator GCN1,,2024-09-14,1,,,,,,,,,
P30536,0,OMOP Exposome,Observation,Substance,Translocator protein,,2024-09-14,1,,,,,,,,,
Q9NXG6,0,OMOP Exposome,Observation,Substance,Transmembrane prolyl 4-hydroxylase,,2024-09-14,1,,,,,,,,,
P02766,0,OMOP Exposome,Observation,Substance,Transthyretin,,2024-09-14,1,,,,,,,,,
155-09-9,0,OMOP Exposome,Observation,Substance,Tranylcypromine,,2014-12-24,1,,,,,,,,,
19794-93-5,0,OMOP Exposome,Observation,Substance,Trazodone,"Desyrel Dividose; Trittico; Trialodine; Trazorel; Trazodonum; Trazodona; Thombran; Oleptro; Molipaxin; Mesyrel; Desyrel; Desirel; Deprax; Beneficat; 2-(3-4-(3-Chlorophenyl)-1-piperazinylpropyl)1,2,4triazolo4,3-apyridin-3(2H)-one; CHEBI:9654",2014-12-24,1,,,,,,,,,
Q03403,0,OMOP Exposome,Observation,Substance,Trefoil factor 2,,2024-09-14,1,,,,,,,,,
GIS1010135,0,OMOP Exposome,Observation,Substance,Trehalose Degradation,,2024-09-14,1,,,,,,,,,
77536-68-6,0,OMOP Exposome,Observation,Substance,Tremolite Asbestos,,2014-12-24,1,,,,,,,,,
16-70-7,0,OMOP Exposome,Observation,Substance,Tri-n-butylaluminum,Adozelesin; Adosar; Tri-N-butylaluminum; Ferrocytochrome c2; CHEBI:16707,2014-12-24,1,,,,,,,,,
1726-66-5,0,OMOP Exposome,Observation,Substance,Tri-n-decylaluminum,,2014-12-24,1,,,,,,,,,
1116-73-0,0,OMOP Exposome,Observation,Substance,Tri-n-hexylaluminum,,2014-12-24,1,,,,,,,,,
2587-76-0,0,OMOP Exposome,Observation,Substance,Tri-n-octyltin chloride,,2014-12-24,1,,,,,,,,,
1070-00-4,0,OMOP Exposome,Observation,Substance,Tri-n-ocylaluminum,,2014-12-24,1,,,,,,,,,
4297-61-4,0,OMOP Exposome,Observation,Substance,Triacetoxyscirpenol,,2014-12-24,1,,,,,,,,,
43121-43-3,0,OMOP Exposome,Observation,Substance,Triadimefon,,2014-12-24,1,,,,,,,,,
55219-65-3,0,OMOP Exposome,Observation,Substance,Triadimenol,,2014-12-24,1,,,,,,,,,
2303-17-5,0,OMOP Exposome,Observation,Substance,Triallate,,2014-12-24,1,,,,,,,,,
124-94-7,0,OMOP Exposome,Observation,Substance,Triamcinolone,"Tristoject; Nasacort; 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione; 11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione; Tiamcinolonum; Tri-Nasal; Fluoxyprednisolone; Fluoxiprednisolone; Delphicort; Azmacort; Aristospan; Aristocort; AllerNaze; 9\u03b1-fluoro-16\u03b1-hydroxyprednisolone; 9alpha-Fluoro-16alpha-hydroxyprednisolone; 9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione; Triacet; Triacort; Oralone; Triaderm; Triamcinalone; Triamcinolona; Triamcinolone acetonide; Oracort; KENALOG-40; Trilone; Flutex; Kenacort; Kenalog; KENALOG-10; TRIESENCE; Triderm; Tricortone; Trianex; Triamcinolonum; Triamcinolone hexacetonide; Triamcinolone diacetate; Omcilon-A; CHEBI:481691",2014-12-24,1,,,,,,,,,
107373-21-7,0,OMOP Exposome,Observation,Substance,Triantimony disulfide,,2014-12-24,1,,,,,,,,,
82097-50-5,0,OMOP Exposome,Observation,Substance,Triasulfuron,,2014-12-24,1,,,,,,,,,
28911-01-5,0,OMOP Exposome,Observation,Substance,Triazolam,Triazolamum; Arring; Apo-Triazo; Asasion; Ascomarna; DEA No. 2887; Halcion; Songar; CHEBI:9674,2014-12-24,1,,,,,,,,,
101200-48-0,0,OMOP Exposome,Observation,Substance,Tribenuron-methyl,"METHYL 2-4-methoxy-6-methyl-1,3,5-trazin-2-yl(methyl)carbamoylsulfamoylbenzoate; Sulfmethmeton-methyl; Tribenuron methyl; Methyl 2-({(4-methoxy-6-methyl-1,3,5-triazin-2-yl)(methyl)aminocarbonyl}amino)sulfonylbenzoate; Tribenuron methyl ester; CHEBI:9678",2014-12-24,1,,,,,,,,,
51202-79-0,0,OMOP Exposome,Observation,Substance,Tribromobiphenyl,,2014-12-24,1,,,,,,,,,
49690-94-0,0,OMOP Exposome,Observation,Substance,Tribromobiphenyl Ether,,2014-12-24,1,,,,,,,,,
103456-41-3,0,OMOP Exposome,Observation,Substance,Tribromodibenzofuran,,2014-12-24,1,,,,,,,,,
17497-85-7,0,OMOP Exposome,Observation,Substance,Tribromoisocyanuric acid,,2014-12-24,1,,,,,,,,,
688-73-3,0,OMOP Exposome,Observation,Substance,Tributyltin,Tributyltin ion; TBT; Tin tributyl hydride; Tri-n-butyl tin maleate; Tri-n-butylstannane hydride; Tri-n-butyltin; Tributyl tin; Tributylstannane; Tributylstannic hydride; Tributyltin hydride; Tributyltin ion (1+); CHEBI:27086,2014-12-24,1,,,,,,,,,
1461-22-9,0,OMOP Exposome,Observation,Substance,Tributyltin chloride,,2014-12-24,1,,,,,,,,,
2155-70-6,0,OMOP Exposome,Observation,Substance,Tributyltin methacrylate,,2014-12-24,1,,,,,,,,,
52-68-6,0,OMOP Exposome,Observation,Substance,Trichlorfon,"(+-)-Trichlorfon; Metrifonatum; Metrifonato; Metrifonate; Methyl chlorophos; Chlorophos; 1-Hydroxy-2,2,2-trichloroethylphosphonic acid dimethyl ester; CHEBI:6908",2014-12-24,1,,,,,,,,,
76-03-9,0,OMOP Exposome,Observation,Substance,Trichloroacetic acid,"Aceto-Caustin; Trichloro-Acetic acid; Trichloroacetate; Trichloroacetic acid solid (DOT); Konesta; Kyselina trichloroctova; TKhUK; Trichloroacetic acid solution (DOT); Trichloroethanoic acid; TCA; TKhU; Trichloressigsaeure; Trichloressigsaure; 2,2,2-Trichloro-Acetic acid; Acetic acid, trichloro- (solid); CCl3COOH; Amchem Grass Killer; Acido tricloroacetico; Acide trichloracetique; Trichloorazijnzuur; Trichloracetic acid; CHEBI:30956",2014-12-24,1,,,,,,,,,
1979-01-06,0,OMOP Exposome,Observation,Substance,Trichloroethylene,"Ethinyl trichloride; Ethylene trichloride; Fleck-flip; Flock flip; Fluate; 1,1,2-Trichloroethene; Gemalgene; Germalgene; Lanadin; Dow-tri; 1,1,1-Trichloroethylene; 1,1,2-Trichloro-Ethene; Trilene; Trichlooretheen; Tric hloroethene; Triasol; Tri-plus m; Tri-plus; Tri-Clene; Trilen; Triklone N; TRI; Trethylene; Threthylene; Threthylen; Tce (chlorohydrocarbon); 1-Chloro-2,2-dichloroethylene; Acetylene trichloride; Algylen; Triklone; Trik lone; Trieline; Trielina; Trielin; Trielene; Tricloroetileno; Tricloroetilene; Tricloretene; Altene DG; Anamenth; Triciene; Trichlorothene; Benzinol; TCE; Philex; Petzinol; Perm-a-clor; Blacosolv; Perm-a-chlor; Nialk; Blancosolv; C2HCl3; Cecolene; Narkosoid; Narkogen; Narcogen; Lethurin; Chlorilen; Chlorylea; Chlorylen; Chorylen; Circosolv; Crawhaspol; 1,1-Dichloro-2-chloroethylene; 1,1,2-Trichloroethylene; Densi nfluat; Densinfluat; Disparit b; Distillex DS2; Dukeron; 1,2,2-Trichloroethylene; Trichloroethylenum; Trichloroethylene (tce); TrichloroetheneI; Trichloroethene; Trichloro-Ethylene; Westrosol; Vitran; Vestrol; Trichloro-Ethene; Trichlorethylenum; Trichlorethylene; Triol; Trichlorethene; Trimar; Triline; Trichloren; Trichlorathane; Trichloran; Trichloraethylen; Trichloraethen; Trichloorethyleen, tri; Trilene TE-141; CHEBI:16602",2014-12-24,1,,,,,,,,,
3711-49-7,0,OMOP Exposome,Observation,Substance,Trichloronitroso-methane,,2014-12-24,1,,,,,,,,,
4682-50-2,0,OMOP Exposome,Observation,Substance,Trichodermin,,2014-12-24,1,,,,,,,,,
2198-93-8,0,OMOP Exposome,Observation,Substance,Trichodermol,,2014-12-24,1,,,,,,,,,
6379-69-7,0,OMOP Exposome,Observation,Substance,Trichothecin,,2014-12-24,1,,,,,,,,,
2199-06-6,0,OMOP Exposome,Observation,Substance,Trichothecolone,,2014-12-24,1,,,,,,,,,
55335-06-3,0,OMOP Exposome,Observation,Substance,Triclopyr,,2014-12-24,1,,,,,,,,,
3380-34-5,0,OMOP Exposome,Observation,Substance,Triclosan,"2,4,4'-Trichloro-2'-hydroxydiphenyl ether; Irgasan DP 30; Stri-Dex cleansing bar; Triclosanum; 5-Chloro-2-(2,4-dichloro-phenoxy)-phenol; DERMAPROT; 5-chloro-2-(2, 4-dichlorophenoxy)phenol; CHEBI:164200",2014-12-24,1,,,,,,,,,
13121-70-5,0,OMOP Exposome,Observation,Substance,Tricyclohexyltin hydroxide,Tricyclohexylzinnhydroxid; Cyhexatin; Tricyclohexylstannanol; Hydroxytricyclohexylstannane; Plyctran; Tricyclohexylhydroxystannane; Tricyclohexylstannium hydroxide; Tricyclohexylhydroxytin; CHEBI:4036,2014-12-24,1,,,,,,,,,
638-53-9,0,OMOP Exposome,Observation,Substance,Tridecanoic acid,(S)-2-Aminotridecanoic acid; 2S-Amino-tridecanoic acid; N-Tridecanoic acid; N-Tridecoate; N-Tridecoic acid; (S)-2-Aminotridecanoate; 2S-Amino-tridecanoate; Tridecylate; Tridecanoate; Tridecylic acid; N-Tridecanoate; CHEBI:45919,2014-12-24,1,,,,,,,,,
81412-43-3,0,OMOP Exposome,Observation,Substance,Tridemorph,,2014-12-24,1,,,,,,,,,
1529-57-3,0,OMOP Exposome,Observation,Substance,Trieicosylaluminum,,2014-12-24,1,,,,,,,,,
102-71-6,0,OMOP Exposome,Observation,Substance,Triethanolamine,"TEOA; Thiofaco T-35; Tri(hydroxyethyl)amine; Triethanolamin; Triethanolamin-NG; Triethanolamine condensate polymer; Triethanolamine homopolymer; Triethylolamine; Trihydroxyethylamine; Trolamine (NF); Tea (amino alcohol); Sting-kill; Sterolamide; Sodium isa; Poly(triethanolamine) ether; Nitrilotris(ethanol); Nitrilotriethanol; Nitrilo-2,2',2quot -triethanol; Nitrilo-2,2',2''-triethanol; N(CH2CH2OH)3; Mobisyl; Mobisy; H3tea; Ethanol, 2,2',2''-nitrilotris-, homopolymer; Trihydroxytriethylamine; Tris(2-Hydroxyethyl) Amine; Tris(2-hydroxyethyl)amine; 2,2', 2''-Nitrilotriethanol; 2,2',2''-Nitrilotri-Ethanol; Triaethanolamin-NG; 2,2',2''-Nitrilotriethanol; Daltogen; 2,2',2''-Nitrilotrisethanol; 2,2',2''-Nitrilotrisethanol; 2,2',2''-Trihydroxy-Triethylamine; 2,2',2''-Trihydroxytriethylamine; 2,2',2'-Nitrilotriethanol; 2,2',2'-Nitrilotris-Ethanol; 2,2',2-Nitrilotriethanol; Cerumenex; BTB; Trolamine; Trola; Tris(hydroxyethyl)amine; 2,2',2-Nitrilotris(ethanol); Alkanolamine 244; Tris(beta-hydroxyethyl)amine; Tris(beta -hydroxyethyl)amine; Alkano; 7376-31-0 (Unspecified sulphate salt); 7376-31-0 (Unspecified sulfate salt); 637-39-8 (Unspecified hydrochloride); 2,2,2-Nitrilotriethanol; 2,2'2''-Nitrilotris-Ethanol; 2,2',2Quot -Nitrilotriethanol; Tris(b-hydroxyethyl)amine; 2,2',2''-Nitrilotris-Ethanol; 2,2',2''-Nitrilotris(ethanol); CHEBI:28621",2014-12-24,1,,,,,,,,,
77-93-0,0,OMOP Exposome,Observation,Substance,Triethyl citrate,,2014-12-24,1,,,,,,,,,
97-93-8,0,OMOP Exposome,Observation,Substance,Triethylaluminium,,2014-12-24,1,,,,,,,,,
3264-67-3,0,OMOP Exposome,Observation,Substance,Triethyloxonium hexachloroantimonate,,2014-12-24,1,,,,,,,,,
2767-54-6,0,OMOP Exposome,Observation,Substance,Triethyltin bromide,,2014-12-24,1,,,,,,,,,
141517-21-7,0,OMOP Exposome,Observation,Substance,Trifloxystrobin,,2014-12-24,1,,,,,,,,,
199119-58-9,0,OMOP Exposome,Observation,Substance,Trifloxysulfuron-sodium,,2014-12-24,1,,,,,,,,,
68694-11-1 and 99387-89-0,0,OMOP Exposome,Observation,Substance,Triflumizole,,2014-12-24,1,,,,,,,,,
117-89-5,0,OMOP Exposome,Observation,Substance,Trifluoperazine,Trifluroperizine; Trifluperazine; Trifluoroperazine; Trifluoromethylperazine; Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine; Trifluoperazinum; Trifluoperazina; Trifluoperazin; Trifluoperaz; Eskazinyl; Eskazine; 10-3-(4-METHYL-piperazin-1-yl)-propyl-2-trifluoromethyl-10H-phenothiazine; 10-3-(4-Methyl-1-piperazinyl)propyl-2-(trifluoromethyl)-10H-phenothiazine; Terfluzine; Stelazine; Modalina; Jatroneural; Triftazin; CHEBI:45951,2014-12-24,1,,,,,,,,,
105879-13-8,0,OMOP Exposome,Observation,Substance,Trifluoromethyl isocyanide,,2014-12-24,1,,,,,,,,,
146-54-3,0,OMOP Exposome,Observation,Substance,Triflupromazine,Triflupromazina; 10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine; 2-(Trifluoromethyl)promazine; 2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine; Fluopromazine; Triflupromazin; Triflupromazinum; Vesprin; CHEBI:9711,2014-12-24,1,,,,,,,,,
1582-09-8,0,OMOP Exposome,Observation,Substance,Trifluralin,,2014-12-24,1,,,,,,,,,
126535-15-7,0,OMOP Exposome,Observation,Substance,Triflusulfuron-methyl,,2014-12-24,1,,,,,,,,,
P22102,0,OMOP Exposome,Observation,Substance,Trifunctional purine biosynthetic protein adenosine-3,,2024-09-14,1,,,,,,,,,
1726-65-4,0,OMOP Exposome,Observation,Substance,Trihexadecylaluminum,,2014-12-24,1,,,,,,,,,
144-11-6,0,OMOP Exposome,Observation,Substance,Trihexyphenidyl,Pacitane; Benzhexol Hydrochloride; Trihexyphenidylum; Pakisonal; Altant; Parales; Parcisol; Benzhexol; Atan; Apo-trihex; Artane; Artine; Triphenidyl; Pargitan; Broflex; Parkin; Parkinane; Parkines; Parkinidyl; Parkisan; Parkitane; Parkizol; Tonaril; Trihexifenidilo; Bexol; Trihexylphenidyl; Trihexylphenidyle; Trihexylphenizyl; Trihexyphenidyle; Benzox; Dyskinil; (RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol; ACA; Acamed; Ea Ten; Hexymer; Cyclodol; Hipokinon; Lahexy; CHEBI:518411,2014-12-24,1,,,,,,,,,
100-99-2,0,OMOP Exposome,Observation,Substance,Triisobutylaluminum,,2014-12-24,1,,,,,,,,,
2686-99-9,0,OMOP Exposome,Observation,Substance,Trimethacarb,"Caswell No. 893A; Carbamic acid, methyl-, 3,4,5-trimethylphenyl ester; Carbamic acid, methyl-, 3,4,5-trimethylphenyl ester (7ci); Landrin-3,4,5; Landrin a; Shell SD-8530; Broot; 3,4,5-Trimethylphenyl N-methylcarbamate; 3,4,5-Trimethylphenyl methylcarbamate; 3,4,5-Trimethylphenol methylcarbamate; 3,4,5-Trimethacarb; 3,4,5-Landrin; Phenol, 3,4,5-trimethyl-, methylcarbamate (9CI); Methylcarbamic acid 3,4,5-trimethylphenyl ester; Landrin 1; CHEBI:38894",2014-12-24,1,,,,,,,,,
127-48-0,0,OMOP Exposome,Observation,Substance,Trimethadione,Minoale; Troxidone; Trimethinum; Trimethdione; Trimethadionum; Trim\u00e9thadione; Trimethadion; Trimetadione; Tridione; CHEBI:131804,2014-12-24,1,,,,,,,,,
75-24-1,0,OMOP Exposome,Observation,Substance,Trimethylaluminium,,2014-12-24,1,,,,,,,,,
75-50-3,0,OMOP Exposome,Observation,Substance,Trimethylamine,"N-Trimethylamine; N,N-Dimethyl-Methanamine; Dimethylmethaneamine; Trimethylamine aqueous solution; Trimethylamine anhydrous; TMA; CHEBI:18139",2014-12-24,1,,,,,,,,,
1184-78-7,0,OMOP Exposome,Observation,Substance,Trimethylamine N-oxide,"TMAO; Trimethylamine oxide; Trimethylamine-N-oxide; Triox; N,N-Dimethylmethanamine N-oxide; TMA-oxide; CHEBI:15724",2014-12-24,1,,,,,,,,,
5835-64-3,0,OMOP Exposome,Observation,Substance,Trimethylantimony bromide,,2014-12-24,1,,,,,,,,,
13059-67-1,0,OMOP Exposome,Observation,Substance,Trimethylantimony dichloride,,2014-12-24,1,,,,,,,,,
13077-53-7,0,OMOP Exposome,Observation,Substance,Trimethylantimony diiodide,,2014-12-24,1,,,,,,,,,
593-88-4,0,OMOP Exposome,Observation,Substance,Trimethylarsine,(CH3)3As; Trimethylarsenic; Trimethylarsane; AsMe3; CHEBI:27130,2014-12-24,1,,,,,,,,,
4964-14-1,0,OMOP Exposome,Observation,Substance,Trimethylarsine oxide,Trimethylarsane oxide; (CH3)3As=O; Trimethylarsorane oxide; CHEBI:27131,2014-12-24,1,,,,,,,,,
Q9NVH6,0,OMOP Exposome,Observation,Substance,"Trimethyllysine dioxygenase, mitochondrial",,2024-09-14,1,,,,,,,,,
54075-76-2,0,OMOP Exposome,Observation,Substance,Trimethyloxonium hexachlorantimonate,,2014-12-24,1,,,,,,,,,
7677-24-9,0,OMOP Exposome,Observation,Substance,Trimethylsilyl cyanide,,2014-12-24,1,,,,,,,,,
1066-45-1,0,OMOP Exposome,Observation,Substance,Trimethyltin chloride,,2014-12-24,1,,,,,,,,,
52128-35-5,0,OMOP Exposome,Observation,Substance,Trimetrexate,CI-898; Neutrexin; TMQ; TMX; Trimetrexato; Trimetrexatum; Trimetrexic acid; CHEBI:119101,2014-12-24,1,,,,,,,,,
739-71-9,0,OMOP Exposome,Observation,Substance,Trimipramine,"Trimeprimina; Tripress; Trimipraminum; Trimipramina; Trimineurin; Trimidura; RP-7162; Sapilent; Stangyl; Trimeproprimine; Trimeprimine; Surmontil; 10,11-dihydro-N,N,beta-Trimethyl-5H-dibenzb,Fazepine-5-propanamine; 5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzob,Fazepine; 5-3-(dimethylamino)-2-Methylpropyl-10,11-dihydro-5H-dibenzb,Fazepine; beta-Methylimipramine; Herphonal; Tydamine; CHEBI:9738",2014-12-24,1,,,,,,,,,
869-59-0,0,OMOP Exposome,Observation,Substance,Trioctyltin stannane,,2014-12-24,1,,,,,,,,,
P60174,0,OMOP Exposome,Observation,Substance,Triosephosphate isomerase,,2024-09-14,1,,,,,,,,,
P04789,0,OMOP Exposome,Observation,Substance,"Triosephosphate isomerase, glycosomal",,2024-09-14,1,,,,,,,,,
603-36-1,0,OMOP Exposome,Observation,Substance,Triphenylantimony,,2014-12-24,1,,,,,,,,,
1538-62-1,0,OMOP Exposome,Observation,Substance,Triphenylantimony diacetate,,2014-12-24,1,,,,,,,,,
57997-56-5,0,OMOP Exposome,Observation,Substance,Triphenylantimony dibenzoate,,2014-12-24,1,,,,,,,,,
594-31-0,0,OMOP Exposome,Observation,Substance,Triphenylantimony dichloride,,2014-12-24,1,,,,,,,,,
603-32-7,0,OMOP Exposome,Observation,Substance,Triphenylarsine,,2014-12-24,1,,,,,,,,,
52704-88-8,0,OMOP Exposome,Observation,Substance,Triphenylcarbenium hexachloroantimonate,,2014-12-24,1,,,,,,,,,
217-59-4,0,OMOP Exposome,Observation,Substance,Triphenylene,"Isochrysene; 9,10-Benzophenanthrene; Benzo(l)phenanthrene; 9,10-Benzphenanthrene; 1,2,3,4-Dibenznaphthalene; CHEBI:33080",2014-12-24,1,,,,,,,,,
28609-58-7,0,OMOP Exposome,Observation,Substance,Triphenylthioantimonate,,2014-12-24,1,,,,,,,,,
668-34-8,0,OMOP Exposome,Observation,Substance,Triphenyltin,SnPh3(+); Triphenylstannylium; SnPh3(+); CHEBI:27139,2014-12-24,1,,,,,,,,,
639-58-7,0,OMOP Exposome,Observation,Substance,Triphenyltin chloride,,2014-12-24,1,,,,,,,,,
892-20-6,0,OMOP Exposome,Observation,Substance,Triphenyltin hydride,SnHPh3; Triphenyl tin; Triphenyl-Stannane; Triphenylstannane; Triphenylstannyl hydride; Triphenylstannylium; Triphenyltin; SnHPh3; CHEBI:30537,2014-12-24,1,,,,,,,,,
27309-70-2,0,OMOP Exposome,Observation,Substance,Tris(1-naphthyl)antimony,,2014-12-24,1,,,,,,,,,
115-96-8,0,OMOP Exposome,Observation,Substance,Tris(2-chloroethyl)phosphate,,2014-12-24,1,,,,,,,,,
386-91-4,0,OMOP Exposome,Observation,Substance,Tris(3-(trifluoromethyl)phenyl)antimony,,2014-12-24,1,,,,,,,,,
24964-91-8,0,OMOP Exposome,Observation,Substance,Tris(4-bromophenyl)aminium hexachloroantimonate,,2014-12-24,1,,,,,,,,,
17946-45-1,0,OMOP Exposome,Observation,Substance,Tris(4-bromophenyl)antimony,,2014-12-24,1,,,,,,,,,
2085-33-8,0,OMOP Exposome,Observation,Substance,Tris(8-hydroxyquinolinato)aluminium,,2014-12-24,1,,,,,,,,,
7289-92-1,0,OMOP Exposome,Observation,Substance,Tris(dimethylamino)antimony,,2014-12-24,1,,,,,,,,,
1529-59-5,0,OMOP Exposome,Observation,Substance,Tris(dodecyl)aluminum,,2014-12-24,1,,,,,,,,,
207802-43-5,0,OMOP Exposome,Observation,Substance,Tris(ethylenediamine)cobalt(III) chloride,,2014-12-24,1,,,,,,,,,
23822-15-3,0,OMOP Exposome,Observation,Substance,Tris(o-tolyl)antimony,,2014-12-24,1,,,,,,,,,
5395-43-7,0,OMOP Exposome,Observation,Substance,Tris(p-tolyl)antimony,,2014-12-24,1,,,,,,,,,
1529-58-4,0,OMOP Exposome,Observation,Substance,Tritetradecylaluminum,,2014-12-24,1,,,,,,,,,
131983-72-7,0,OMOP Exposome,Observation,Substance,Triticonazole,,2014-12-24,1,,,,,,,,,
10028-17-8,0,OMOP Exposome,Observation,Substance,Tritium,T2; (3)H2; CHEBI:29298,2014-12-24,1,,,,,,,,,
1344-59-8,0,OMOP Exposome,Observation,Substance,Triuranium octaoxide,,2014-12-24,1,,,,,,,,,
O14717,0,OMOP Exposome,Observation,Substance,tRNA (cytosine(38)-C(5))-methyltransferase,,2024-09-14,1,,,,,,,,,
O60294,0,OMOP Exposome,Observation,Substance,tRNA wybutosine-synthesizing protein 4,,2024-09-14,1,,,,,,,,,
97322-87-7,0,OMOP Exposome,Observation,Substance,Troglitazone,Romozin; Rezulin; Resulin; Noscal; CHEBI:9753,2014-12-24,1,,,,,,,,,
P02585,0,OMOP Exposome,Observation,Substance,"Troponin C, skeletal muscle",,2024-09-14,1,,,,,,,,,
P63316,0,OMOP Exposome,Observation,Substance,"Troponin C, slow skeletal and cardiac muscles",,2024-09-14,1,,,,,,,,,
GIS1010136,0,OMOP Exposome,Observation,Substance,Trypanocidal Agent,,2024-09-14,1,,,,,,,,,
554-72-3,0,OMOP Exposome,Observation,Substance,Tryparsamide,,2014-12-24,1,,,,,,,,,
P07477,0,OMOP Exposome,Observation,Substance,Trypsin-1,,2024-09-14,1,,,,,,,,,
P07478,0,OMOP Exposome,Observation,Substance,Trypsin-2,,2024-09-14,1,,,,,,,,,
P48775,0,OMOP Exposome,Observation,Substance,"Tryptophan 2,3-dioxygenase",,2024-09-14,1,,,,,,,,,
GIS1010137,0,OMOP Exposome,Observation,Substance,Tryptophan Metabolism,,2024-09-14,1,,,,,,,,,
P23381,0,OMOP Exposome,Observation,Substance,"Tryptophan--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
Q9UGM6,0,OMOP Exposome,Observation,Substance,"Tryptophan--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
6989-98-6,0,OMOP Exposome,Observation,Substance,Tubocurarine,"Isoquinoline Alkaloid; Tubarine; D-Tubocurarine Chloride; D-Tubocurarine; 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium; (+)-tubocurarine; Tubocurarin; Tubocurarine Chloride; Tubocurarinum; CHEBI:9774",2014-12-24,1,,,,,,,,,
GIS1010138,0,OMOP Exposome,Observation,Substance,Tubulin,,2024-09-14,1,,,,,,,,,
P50719,0,OMOP Exposome,Observation,Substance,Tubulin alpha chain,,2024-09-14,1,,,,,,,,,
A6NHL2,0,OMOP Exposome,Observation,Substance,Tubulin alpha chain-like 3,,2024-09-14,1,,,,,,,,,
Q71U36,0,OMOP Exposome,Observation,Substance,Tubulin alpha-1A chain,,2024-09-14,1,,,,,,,,,
P68363,0,OMOP Exposome,Observation,Substance,Tubulin alpha-1B chain,,2024-09-14,1,,,,,,,,,
Q9BQE3,0,OMOP Exposome,Observation,Substance,Tubulin alpha-1C chain,,2024-09-14,1,,,,,,,,,
Q13748,0,OMOP Exposome,Observation,Substance,Tubulin alpha-3C/D chain,,2024-09-14,1,,,,,,,,,
Q6PEY2,0,OMOP Exposome,Observation,Substance,Tubulin alpha-3E chain,,2024-09-14,1,,,,,,,,,
P68366,0,OMOP Exposome,Observation,Substance,Tubulin alpha-4A chain,,2024-09-14,1,,,,,,,,,
Q9NY65,0,OMOP Exposome,Observation,Substance,Tubulin alpha-8 chain,,2024-09-14,1,,,,,,,,,
P07437,0,OMOP Exposome,Observation,Substance,Tubulin beta chain,,2024-09-14,1,,,,,,,,,
Q9H4B7,0,OMOP Exposome,Observation,Substance,Tubulin beta-1 chain,,2024-09-14,1,,,,,,,,,
Q13885,0,OMOP Exposome,Observation,Substance,Tubulin beta-2A chain,,2024-09-14,1,,,,,,,,,
Q9BVA1,0,OMOP Exposome,Observation,Substance,Tubulin beta-2B chain,,2024-09-14,1,,,,,,,,,
Q13509,0,OMOP Exposome,Observation,Substance,Tubulin beta-3 chain,,2024-09-14,1,,,,,,,,,
P04350,0,OMOP Exposome,Observation,Substance,Tubulin beta-4A chain,,2024-09-14,1,,,,,,,,,
P68371,0,OMOP Exposome,Observation,Substance,Tubulin beta-4B chain,,2024-09-14,1,,,,,,,,,
Q9BUF5,0,OMOP Exposome,Observation,Substance,Tubulin beta-6 chain,,2024-09-14,1,,,,,,,,,
Q3ZCM7,0,OMOP Exposome,Observation,Substance,Tubulin beta-8 chain,,2024-09-14,1,,,,,,,,,
A6NNZ2,0,OMOP Exposome,Observation,Substance,Tubulin beta-8 chain-like protein LOC260334,,2024-09-14,1,,,,,,,,,
Q9UJT1,0,OMOP Exposome,Observation,Substance,Tubulin delta chain,,2024-09-14,1,,,,,,,,,
Q9UJT0,0,OMOP Exposome,Observation,Substance,Tubulin epsilon chain,,2024-09-14,1,,,,,,,,,
P23258,0,OMOP Exposome,Observation,Substance,Tubulin gamma-1 chain,,2024-09-14,1,,,,,,,,,
Q9NRH3,0,OMOP Exposome,Observation,Substance,Tubulin gamma-2 chain,,2024-09-14,1,,,,,,,,,
GIS1010139,0,OMOP Exposome,Observation,Substance,Tubulin Modulator,,2024-09-14,1,,,,,,,,,
Q8NG68,0,OMOP Exposome,Observation,Substance,Tubulin--tyrosine ligase,,2024-09-14,1,,,,,,,,,
P01375,0,OMOP Exposome,Observation,Substance,Tumor necrosis factor,,2024-09-14,1,,,,,,,,,
Q9Y275,0,OMOP Exposome,Observation,Substance,Tumor necrosis factor ligand superfamily member 13B,,2024-09-14,1,,,,,,,,,
O14763,0,OMOP Exposome,Observation,Substance,Tumor necrosis factor receptor superfamily member 10B,,2024-09-14,1,,,,,,,,,
P20333,0,OMOP Exposome,Observation,Substance,Tumor necrosis factor receptor superfamily member 1B,,2024-09-14,1,,,,,,,,,
P25942,0,OMOP Exposome,Observation,Substance,Tumor necrosis factor receptor superfamily member 5,,2024-09-14,1,,,,,,,,,
7440-33-7,0,OMOP Exposome,Observation,Substance,Tungsten,Tungsten ion; Wolfram; Wolframium; Tunsten; CHEBI:30517,2014-12-24,1,,,,,,,,,
13470-11-6,0,OMOP Exposome,Observation,Substance,Tungsten(V) bromide,,2014-12-24,1,,,,,,,,,
13520-77-9,0,OMOP Exposome,Observation,Substance,Tungsten(VI) oxytetrabromide,,2014-12-24,1,,,,,,,,,
2571-22-4,0,OMOP Exposome,Observation,Substance,Tutin,,2014-12-24,1,,,,,,,,,
GIS1010140,0,OMOP Exposome,Observation,Substance,Two Component System,,2024-09-14,1,,,,,,,,,
P30556,0,OMOP Exposome,Observation,Substance,Type-1 angiotensin II receptor,,2024-09-14,1,,,,,,,,,
51-67-2,0,OMOP Exposome,Observation,Substance,Tyramine,4-Hydroxy-Benzeneethanamine; Uteramine; Systogene; Tenosin-wirkstoff; Tocosine; 4-(2-Aminoethyl)-Phenol; 4-(2-Aminoethyl)-phenol(thyramin); Tyramin; Tyramine base; Tyrosamine; p-(2-Aminoethyl)phenol; P-beta-Aminoethylphenol; 4- (2-Aminoethyl)-Phenol; 2-(p-Hydroxyphenyl)ethylamine; 2-(4-Hydroxyphenyl)ethylamine; 2-(4'-Hydroxyphenyl)ethylamine; 4-(2-Aminoethyl)phenol; 4-Hydroxy-b-phenylethylamine; alpha-(4-Hydroxyphenyl)-beta-aminoethane; alpha.-(4-Hydroxyphenyl)-beta-aminoethane; b-(4-Hydroxyphenyl)ethylamine; a-(4-Hydroxyphenyl)-b-aminoethane; 4-Hydroxyphenylethylamine; beta-(4-Hydroxyphenyl)ethylamine; P-Hydroxy-b-phenethylamine; p-(2-Aminoethyl)-Phenol; P-Hydroxy-b-phenylethylamine; P-Hydroxy-beta-phenethylamine; 4-Hydroxyphenethylamine; 4-Hydroxy-beta-phenylethylamine; P-Hydroxy-beta-phenylethylamine; P-Hydroxyphenethylamine; P-Hydroxyphenylethylamine; P-Tyramine; CHEBI:15760,2014-12-24,1,,,,,,,,,
P14679,0,OMOP Exposome,Observation,Substance,Tyrosinase,,2024-09-14,1,,,,,,,,,
P07101,0,OMOP Exposome,Observation,Substance,Tyrosine 3-monooxygenase,,2024-09-14,1,,,,,,,,,
P17735,0,OMOP Exposome,Observation,Substance,Tyrosine aminotransferase,,2024-09-14,1,,,,,,,,,
GIS1010141,0,OMOP Exposome,Observation,Substance,Tyrosine Metabolism,,2024-09-14,1,,,,,,,,,
P54577,0,OMOP Exposome,Observation,Substance,"Tyrosine--tRNA ligase, cytoplasmic",,2024-09-14,1,,,,,,,,,
Q9Y2Z4,0,OMOP Exposome,Observation,Substance,"Tyrosine--tRNA ligase, mitochondrial",,2024-09-14,1,,,,,,,,,
P00519,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase ABL1,,2024-09-14,1,,,,,,,,,
Q06187,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase BTK,,2024-09-14,1,,,,,,,,,
P41240,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase CSK,,2024-09-14,1,,,,,,,,,
P06241,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase Fyn,,2024-09-14,1,,,,,,,,,
P08631,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase HCK,,2024-09-14,1,,,,,,,,,
O60674,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase JAK2,,2024-09-14,1,,,,,,,,,
P06239,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase Lck,,2024-09-14,1,,,,,,,,,
P07948,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase Lyn,,2024-09-14,1,,,,,,,,,
P43405,0,OMOP Exposome,Observation,Substance,Tyrosine-protein kinase SYK,,2024-09-14,1,,,,,,,,,
P18031,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 1,,2024-09-14,1,,,,,,,,,
Q06124,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 11,,2024-09-14,1,,,,,,,,,
Q05209,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 12,,2024-09-14,1,,,,,,,,,
Q12923,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 13,,2024-09-14,1,,,,,,,,,
Q15678,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 14,,2024-09-14,1,,,,,,,,,
Q99952,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 18,,2024-09-14,1,,,,,,,,,
P17706,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 2,,2024-09-14,1,,,,,,,,,
Q4JDL3,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 20,,2024-09-14,1,,,,,,,,,
Q16825,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 21,,2024-09-14,1,,,,,,,,,
Q9Y2R2,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 22,,2024-09-14,1,,,,,,,,,
Q9H3S7,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 23,,2024-09-14,1,,,,,,,,,
P26045,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 3,,2024-09-14,1,,,,,,,,,
P29074,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 4,,2024-09-14,1,,,,,,,,,
P54829,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 5,,2024-09-14,1,,,,,,,,,
P29350,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 6,,2024-09-14,1,,,,,,,,,
P35236,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 7,,2024-09-14,1,,,,,,,,,
P43378,0,OMOP Exposome,Observation,Substance,Tyrosine-protein phosphatase non-receptor type 9,,2024-09-14,1,,,,,,,,,
GIS1010142,0,OMOP Exposome,Observation,Substance,Tyrosinemia,,2024-09-14,1,,,,,,,,,
GIS1010143,0,OMOP Exposome,Observation,Substance,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),,2024-09-14,1,,,,,,,,,
GIS1010144,0,OMOP Exposome,Observation,Substance,Tyrosinemia Type 3 (TYRO3),,2024-09-14,1,,,,,,,,,
GIS1010145,0,OMOP Exposome,Observation,Substance,Tyrosinemia Type I,,2024-09-14,1,,,,,,,,,
P62312,0,OMOP Exposome,Observation,Substance,U6 snRNA-associated Sm-like protein LSm6,,2024-09-14,1,,,,,,,,,
P09936,0,OMOP Exposome,Observation,Substance,Ubiquitin carboxyl-terminal hydrolase isozyme L1,,2024-09-14,1,,,,,,,,,
P15374,0,OMOP Exposome,Observation,Substance,Ubiquitin carboxyl-terminal hydrolase isozyme L3,,2024-09-14,1,,,,,,,,,
GIS1010146,0,OMOP Exposome,Observation,Substance,Ubiquitin mediated proteolysis,,2024-09-14,1,,,,,,,,,
P61088,0,OMOP Exposome,Observation,Substance,Ubiquitin-conjugating enzyme E2 N,,2024-09-14,1,,,,,,,,,
O60701,0,OMOP Exposome,Observation,Substance,UDP-glucose 6-dehydrogenase,,2024-09-14,1,,,,,,,,,
P22309,0,OMOP Exposome,Observation,Substance,UDP-glucuronosyltransferase 1-1,,2024-09-14,1,,,,,,,,,
O60656,0,OMOP Exposome,Observation,Substance,UDP-glucuronosyltransferase 1-9,,2024-09-14,1,,,,,,,,,
Q9BY64,0,OMOP Exposome,Observation,Substance,UDP-glucuronosyltransferase 2B28,,2024-09-14,1,,,,,,,,,
P16662,0,OMOP Exposome,Observation,Substance,UDP-glucuronosyltransferase 2B7,,2024-09-14,1,,,,,,,,,
Q6NUS8,0,OMOP Exposome,Observation,Substance,UDP-glucuronosyltransferase 3A1,,2024-09-14,1,,,,,,,,,
GIS1010147,0,OMOP Exposome,Observation,Substance,UMP Synthase Deiciency (Orotic Aciduria),,2024-09-14,1,,,,,,,,,
GIS1010148,0,OMOP Exposome,Observation,Substance,Uncoupling Agent,,2024-09-14,1,,,,,,,,,
112-38-9,0,OMOP Exposome,Observation,Substance,Undecylenic acid,"FEMA 3247; N-UNDECYLENIC ACID (10-1); Omega-Hendecenoic acid; Omega-Undecenoic acid; Renselin; Sevinon; Undec-10-enoic acid; UNDECEN-10-ACID-1; Undecenoic acid; 10-Undecylenic acid; 10-Henedecenoic acid; 10-Hendecenoic acid; 10-Hendecenoic; 9-Undecenoic acid; Undecyl-10-enic acid; Undecylenate; Undecylenenic acid; Undecylenic acid, USAN; Undecylenic acids; Zinc undecylenate (undecylenic acid); 9-Undecylenic acid; Cruex; Declid; Desenex; N-Undecylenic acid; CHEBI:35045",2014-12-24,1,,,,,,,,,
66-75-1,0,OMOP Exposome,Observation,Substance,Uracil mustard,"5-Aminouracil mustard; 5-N,N-Bis(2-chloroethyl)aminouracil; 5-Bis(2-chloroethyl)amino-2,4(1H,3H)-pyrimidinedione; 5-Di(beta-chloroethyl)aminouracil; Uracil nitrogen mustard; 5-(Di-2-chloroethyl)aminouracil; Aminouracil mustard; CHEBI:9884",2014-12-24,1,,,,,,,,,
P13051,0,OMOP Exposome,Observation,Substance,Uracil-DNA glycosylase,,2024-09-14,1,,,,,,,,,
GIS1010149,0,OMOP Exposome,Observation,Substance,Uranium,,2024-09-14,1,,,,,,,,,
12007-36-2,0,OMOP Exposome,Observation,Substance,Uranium boride,,2014-12-24,1,,,,,,,,,
12070-09-6,0,OMOP Exposome,Observation,Substance,Uranium carbide,,2014-12-24,1,,,,,,,,,
10025-93-1,0,OMOP Exposome,Observation,Substance,Uranium chloride,,2014-12-24,1,,,,,,,,,
GIS1010173,0,OMOP Exposome,Observation,Substance,Uranium Compound,,2024-09-14,1,,,,,,,,,
1344-57-6,0,OMOP Exposome,Observation,Substance,Uranium dioxide,,2014-12-24,1,,,,,,,,,
7783-81-5,0,OMOP Exposome,Observation,Substance,Uranium hexafluoride,Uranium fluoride; uranium(6+) fluoride; Hexafluoridouranium; UF6; Hexafluorouranium; CHEBI:30235,2014-12-24,1,,,,,,,,,
12033-83-9,0,OMOP Exposome,Observation,Substance,Uranium nitride,,2014-12-24,1,,,,,,,,,
13470-21-8,0,OMOP Exposome,Observation,Substance,Uranium pentachloride,,2014-12-24,1,,,,,,,,,
10049-14-6,0,OMOP Exposome,Observation,Substance,Uranium pentafluoride,,2014-12-24,1,,,,,,,,,
12036-71-4,0,OMOP Exposome,Observation,Substance,Uranium peroxide,,2014-12-24,1,,,,,,,,,
10026-10-5,0,OMOP Exposome,Observation,Substance,Uranium tetrachloride,,2014-12-24,1,,,,,,,,,
1344-58-6,0,OMOP Exposome,Observation,Substance,Uranium trioxide,,2014-12-24,1,,,,,,,,,
13968-55-3,0,OMOP Exposome,Observation,Substance,Uranium-233,,2014-12-24,1,,,,,,,,,
13966-29-5,0,OMOP Exposome,Observation,Substance,Uranium-234,,2014-12-24,1,,,,,,,,,
15117-96-1,0,OMOP Exposome,Observation,Substance,Uranium-235,,2014-12-24,1,,,,,,,,,
7440-61-1,0,OMOP Exposome,Observation,Substance,Uranium-238,238-U; Uranium I ((238)U); Depleted uranium; DU; Uranium 238; 238U; CHEBI:27214,2014-12-24,1,,,,,,,,,
11079-26-8,0,OMOP Exposome,Observation,Substance,Uranocene,,2014-12-24,1,,,,,,,,,
541-09-3,0,OMOP Exposome,Observation,Substance,Uranyl acetate,,2014-12-24,1,,,,,,,,,
7791-26-6,0,OMOP Exposome,Observation,Substance,Uranyl chloride,,2014-12-24,1,,,,,,,,,
13536-84-0,0,OMOP Exposome,Observation,Substance,Uranyl fluoride,,2014-12-24,1,,,,,,,,,
16984-59-1,0,OMOP Exposome,Observation,Substance,Uranyl formate,,2014-12-24,1,,,,,,,,,
10102-06-4,0,OMOP Exposome,Observation,Substance,Uranyl nitrate,"Bis(nitrato)dioxouranium; Uranium oxynitrate; Uranium nitrate; Bis(nitrato-o,o')dioxouranium; Bis(nitrato-ko)(dioxo)uranium; Uranyl nitric acid; Uranyl dinitrate; Bis(nitrato-o)dioxouranium; Dinitratodioxouranium; CHEBI:25520",2014-12-24,1,,,,,,,,,
1314-64-3,0,OMOP Exposome,Observation,Substance,Uranyl sulfate,,2014-12-24,1,,,,,,,,,
10138-94-0,0,OMOP Exposome,Observation,Substance,Uranyl zinc acetate,,2014-12-24,1,,,,,,,,,
GIS1010174,0,OMOP Exposome,Observation,Substance,Urea Cycle,,2024-09-14,1,,,,,,,,,
GIS1010175,0,OMOP Exposome,Observation,Substance,Uremic Toxin,,2024-09-14,1,,,,,,,,,
Q9BZX2,0,OMOP Exposome,Observation,Substance,Uridine-cytidine kinase 2,,2024-09-14,1,,,,,,,,,
Q9NWZ5,0,OMOP Exposome,Observation,Substance,Uridine-cytidine kinase-like 1,,2024-09-14,1,,,,,,,,,
GIS1010176,0,OMOP Exposome,Observation,Substance,Urinary Antispasmodic,,2024-09-14,1,,,,,,,,,
GIS1010177,0,OMOP Exposome,Observation,Substance,Urinary Bladder,,2024-09-14,1,,,,,,,,,
Q03405,0,OMOP Exposome,Observation,Substance,Urokinase plasminogen activator surface receptor,,2024-09-14,1,,,,,,,,,
P00749,0,OMOP Exposome,Observation,Substance,Urokinase-type plasminogen activator,,2024-09-14,1,,,,,,,,,
607-14-7,0,OMOP Exposome,Observation,Substance,Uroporphyrin I,"3-7,12,17-Tris-(2-carboxy-ethyl)-3,8,13,18-tetrakis-carboxymethyl-22,24-dihydro-porphin-2-yl-propionic acid; 3,3',3'',3'''-(3,8,13,18-Tetrakis-carboxymethyl-porphyrin-2,7,12,17-tetrayl)-tetra-propionate; 2,7,12,17-Porphinetetrapropionate; 2,7,12,17-Porphinetetrapropionic acid; 3,3',3'',3'''-(3,8,13,18-Tetrakis-carboxymethyl-21H,23H-porphine-2,7,12,17-tetrayl)-tetrakis-propionate; 3,3',3'',3'''-(3,8,13,18-Tetrakis-carboxymethyl-21H,23H-porphine-2,7,12,17-tetrayl)-tetrakis-propionic acid; 3-7,12,17-Tris-(2-carboxy-ethyl)-3,8,13,18-tetrakis-carboxymethyl-22,24-dihydro-porphin-2-yl-propionate; 3,8,13,18-Tetrakis(carboxymethyl)porphyrin-2,7,12,17-tetrapropanoic acid; 3,8,13,18-Tetrakis(carboxymethyl)porphyrin-2,7,12,17-tetrapropanoate; 3,3',3'',3'''-(3,8,13,18-Tetrakis-carboxymethyl-porphyrin-2,7,12,17-tetrayl)-tetra-propionic acid; CHEBI:27484",2018-03-21,1,,,,,,,,,
18273-06-8,0,OMOP Exposome,Observation,Substance,Uroporphyrin III,"Coproporphyrin III; 3,8,13,17-Tetrakis(carboxymethyl)porphyrin-2,7,12,18-tetrapropanoate; 3,8,13,17-Tetrakis(carboxymethyl)porphyrin-2,7,12,18-tetrapropanoic acid; 3,8,13,17-Tetramethyl-2,7,12,18-Porphinetetrapropionate; 3,8,13,17-Tetramethyl-2,7,12,18-Porphinetetrapropionic acid; CHEBI:15436",2018-03-21,1,,,,,,,,,
P06132,0,OMOP Exposome,Observation,Substance,Uroporphyrinogen decarboxylase,,2024-09-14,1,,,,,,,,,
GIS1010178,0,OMOP Exposome,Observation,Substance,Urticant,,2024-09-14,1,,,,,,,,,
P11684,0,OMOP Exposome,Observation,Substance,Uteroglobin,,2024-09-14,1,,,,,,,,,
P46939,0,OMOP Exposome,Observation,Substance,Utrophin,,2024-09-14,1,,,,,,,,,
P38606,0,OMOP Exposome,Observation,Substance,V-type proton ATPase catalytic subunit A,,2024-09-14,1,,,,,,,,,
124832-26-4,0,OMOP Exposome,Observation,Substance,Valaciclovir,"L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; Mitanga; Ovalac; Pervioral; Revira; Vacyless; Vadiral; Valaciclovirum; Valacyclover Hydrochloric; Valacyclovir; Valdacir; Valotix; Valtrex; Valvir; Valztrex; Viramixal; Bagovir; Viropel; Cycloval; Vociflon; Zelitrex; Zelivire; CHEBI:35854",2014-12-24,1,,,,,,,,,
GIS1010179,0,OMOP Exposome,Observation,Substance,Valine,,2024-09-14,1,,,,,,,,,
P26640,0,OMOP Exposome,Observation,Substance,Valine--tRNA ligase,,2024-09-14,1,,,,,,,,,
99-66-1,0,OMOP Exposome,Observation,Substance,Valproic acid,2-PROPYL-pentanoic acid; di-n-propylacetic acid; Encorate; Epilim; Epival; Valproate; Deprakine; 2-Propylpentanoic acid; 2-Propylvaleric acid; 4-heptanecarboxylic acid; Convulex; Depakene; Depakine; Depakote; Depakote ER; Depacon; Acidum valproicum; Acido valproico; Acide valproique; 2-n-propyl-n-valeric acid; CHEBI:39867,2014-12-24,1,,,,,,,,,
7440-62-2,0,OMOP Exposome,Observation,Substance,Vanadium,V; Vanadium(II); Vanadium(III); Vanadium(V); Vanadium(IV); Vanadium ion; Vanadate; CHEBI:49948,2014-12-24,1,,,,,,,,,
12070-10-9,0,OMOP Exposome,Observation,Substance,Vanadium carbide,,2014-12-24,1,,,,,,,,,
20644-87-5,0,OMOP Exposome,Observation,Substance,Vanadium carbonyl,Hexacarbonylvanadium; V(CO)6; Vanadium hexacarbonyl; V(CO)6; hexacarbonylvanadate(1-); V(CO)6(-); CHEBI:37856,2014-12-24,1,,,,,,,,,
GIS1010180,0,OMOP Exposome,Observation,Substance,Vanadium Compound,,2024-09-14,1,,,,,,,,,
24646-85-3,0,OMOP Exposome,Observation,Substance,Vanadium nitride,,2014-12-24,1,,,,,,,,,
7727-18-6,0,OMOP Exposome,Observation,Substance,Vanadium oxytrichloride,,2014-12-24,1,,,,,,,,,
7632-51-1,0,OMOP Exposome,Observation,Substance,Vanadium tetrachloride,,2014-12-24,1,,,,,,,,,
10580-52-6,0,OMOP Exposome,Observation,Substance,Vanadium(II) chloride,,2014-12-24,1,,,,,,,,,
12035-98-2,0,OMOP Exposome,Observation,Substance,Vanadium(II) oxide,Vanadium oxide (vo); Vanadium oxide; Vanadium monooxide; VO; CHEBI:30044,2014-12-24,1,,,,,,,,,
13470-26-3,0,OMOP Exposome,Observation,Substance,Vanadium(III) bromide,,2014-12-24,1,,,,,,,,,
7718-98-1,0,OMOP Exposome,Observation,Substance,Vanadium(III) chloride,,2014-12-24,1,,,,,,,,,
10049-12-4,0,OMOP Exposome,Observation,Substance,Vanadium(III) fluoride,,2014-12-24,1,,,,,,,,,
15513-94-7,0,OMOP Exposome,Observation,Substance,Vanadium(III) iodide,,2014-12-24,1,,,,,,,,,
1314-34-7,0,OMOP Exposome,Observation,Substance,Vanadium(III) oxide,,2014-12-24,1,,,,,,,,,
13701-70-7,0,OMOP Exposome,Observation,Substance,Vanadium(III) sulfate,,2014-12-24,1,,,,,,,,,
10049-16-8,0,OMOP Exposome,Observation,Substance,Vanadium(IV) fluoride,,2014-12-24,1,,,,,,,,,
12036-21-4,0,OMOP Exposome,Observation,Substance,Vanadium(IV) oxide,Praseodymium oxide; Vanadium oxide; Vanadium oxide (VO2); VO2; VO2; CHEBI:30047,2014-12-24,1,,,,,,,,,
1314-62-1,0,OMOP Exposome,Observation,Substance,Vanadium(V) oxide,"Vanadium pentoxide; Anhydride vanadique; Divanadium pentaoxide; Divanadium pentoxide; KM vanadium pentoxide; RCRA waste no. P120; Rcra waste number P120; V-o; V2O5; Vanadic acid anhydride; Vanadic anhydride; Vanadio, pentossido di; vanadium (5) oxide; Vanadium dust and fume; Vanadium oxide; Vanadium oxide (5); vanadium oxide (C2O5); Vanadium oxide (V2O5); Vanadium oxide V2O5; Vanadium oxides; Vanadium pentaoxide; Vanadium pentoxide, non-fused form; Vanadium pentoxide, nonfused form; Vanadium, pentoxyde de; Vanadiumpentoxid; Vanadiumpentoxyde; Vandium pentoxide; Wanadu pieciotlenek; CHEBI:30045",2014-12-24,1,,,,,,,,,
13709-31-4,0,OMOP Exposome,Observation,Substance,Vanadium(V) oxytrifluoride,,2014-12-24,1,,,,,,,,,
12083-48-6,0,OMOP Exposome,Observation,Substance,Vanadocene dichloride,,2014-12-24,1,,,,,,,,,
3153-26-2,0,OMOP Exposome,Observation,Substance,Vanadyl acetylacetonate,,2014-12-24,1,,,,,,,,,
27774-13-6,0,OMOP Exposome,Observation,Substance,Vanadyl sulfate,Vanadyl sulphic acid; Oxovanadium(IV) sulfate; oxosulfato(2-)-kappaO-vanadium; Vanadyl sulfate (VSO5); Vanadyl sulfate (VO(SO4)); Vanadium sulfate; Vanadium oxysulfate; Vanadium oxide sulphate; Oxosulfatovanadium(IV); oxidovanadium(2+) sulfate; Vanadium oxide sulfate (VO(SO4)); Vanadyl sulfic acid; Vanadyl sulphate; oxovanadium(2+) sulfate; VOSO4; oxosulfato(2-)-O-vanadium; V(IV)OSO4; Vanadic sulfate; Vanadin(IV) oxide sulfate; CHEBI:33146,2014-12-24,1,,,,,,,,,
1404-90-6,0,OMOP Exposome,Observation,Substance,Vancomycin,Vancomycin HCL; Vancomicina; Vancoled; Vancocin; COVANC; Vancomycine; Vancomycinum; CHEBI:28001,2014-12-24,1,,,,,,,,,
121-33-5,0,OMOP Exposome,Observation,Substance,Vanillin,Vanillin (natural); Vanillic aldehyde; 4-Hydroxy-3-methoxy-Benzaldehyde-5-chlorovanillin; 4-Hydroxy-3-methoxybenzaldehyde; 4-Hydroxy-5-methoxybenzaldehyde; Vanillaldehyde; Vanilla oleoresin; Vanilla; Vaniline; Vanilin; trans-2-Ethoxy-5-(1-propenyl)phenol; 4-Hydroxy-m-anisaldehyde; Protocatechualdehyde 3-methyl ether; Propenylguaethol; P-Vanillin; P-Hydroxy-m-methoxybenzaldehyde; Oleoresin vanilla; Oleo-Resins vanilla-bean; Oleo-Resins vanilla; Methylprotocatechuic aldehyde; Methylprotcatechuic aldehyde; Methyl-Protocatechualdehyde; M-Methoxy-p-hydroxybenzaldehyde; Lioxin; 2-Methoxy-4-formylphenol; 3-Methoxy-4-hydroxybenzaldehyde; 4-Formyl-2-methoxyphenol; 4-hydroxy 3-methoxybenzaldehyde; 4-Hydroxy-3-methoxy-benzaldehyde; Zimco; Vanilline; Vanillin sodium salt; Vanillin (NF); Vanillin (3-methoxy-4-hydroxy- benzaldehyde); CHEBI:18346,2014-12-24,1,,,,,,,,,
GIS1010181,0,OMOP Exposome,Observation,Substance,Vapour,,2024-09-14,1,,,,,,,,,
103222-11-3,0,OMOP Exposome,Observation,Substance,Vapreotide,,2014-12-24,1,,,,,,,,,
249296-44-4,0,OMOP Exposome,Observation,Substance,Varenicline,,2014-12-24,1,,,,,,,,,
P19320,0,OMOP Exposome,Observation,Substance,Vascular cell adhesion protein 1,,2024-09-14,1,,,,,,,,,
P15692,0,OMOP Exposome,Observation,Substance,Vascular endothelial growth factor A,,2024-09-14,1,,,,,,,,,
P17948,0,OMOP Exposome,Observation,Substance,Vascular endothelial growth factor receptor 1,,2024-09-14,1,,,,,,,,,
P35968,0,OMOP Exposome,Observation,Substance,Vascular endothelial growth factor receptor 2,,2024-09-14,1,,,,,,,,,
P35916,0,OMOP Exposome,Observation,Substance,Vascular endothelial growth factor receptor 3,,2024-09-14,1,,,,,,,,,
GIS1010182,0,OMOP Exposome,Observation,Substance,Vascular smooth muscle contraction,,2024-09-14,1,,,,,,,,,
GIS1010183,0,OMOP Exposome,Observation,Substance,Vasoconstrictor Agent,,2024-09-14,1,,,,,,,,,
GIS1010184,0,OMOP Exposome,Observation,Substance,Vasodilator Agent,,2024-09-14,1,,,,,,,,,
P30518,0,OMOP Exposome,Observation,Substance,Vasopressin V2 receptor,,2024-09-14,1,,,,,,,,,
93413-69-5,0,OMOP Exposome,Observation,Substance,Venlafaxine,Venlafaxin; Effexor XR; Elafax; Venlafexine; Venlafaxinum; Venlafaxina; Trevilor; Efectin; Efexor; Effexor; CHEBI:9943,2014-12-24,1,,,,,,,,,
52-53-9,0,OMOP Exposome,Observation,Substance,Verapamil,Verasifar; Zolvera; Vortac; Novapamyl LP; Novo-Veramil; Nu-Verap; Vetrimil; Vertab; Verpamil; Veroptinstada; Verogalid ER; Verogalid; Vermine; Vermin; Verisop; Verelan SR; Verelan PM; Verelan; Verdilac; Akilen; Anpec; Apo-Verap; Arpamyl LP; Berkatens; Bosoptin; Calan; Calan SR; Calaptin; Calaptin 240 SR; Calcan; Cardiabeltin; Cardiagutt; Cardibeltin; Cardioprotect; Caveril; Civicor; Civicor Retard; Coraver; Cordilox; Cordilox SR; Corpamil; Covera-Hs; CP-16533-1; CP-165331; D-365; delta-365; Dignover; Dilacoran; Dilacoran HTA; Durasoptin; Elthon; Falicard; Finoptin; Flamon; Geangin; Harteze; Hexasoptin; Hexasoptin Retard; Hormitol; Ikacor; Ikapress; Inselon; Iproveratril; Isoptin; Isoptin Retard; Isoptin SR; Isoptine; Isoptino; Isotopin; Izoptin; Jenapamil; Lekoptin; Lodixal; Magotiron; Manidon; Manidon Retard; Ormil; Praecicor; Quasar; Rapam; Robatelan; Securon; Tarka; Univer; Univex; Vasolan; Vasomil; Vasopten; Vera-Sanorania; Verabeta; Veracaps SR; Veracor; Verahexal; Veraloc; Veramex; Veramil; Verapamil Acis; Verapamil AL; Verapamil Atid; Verapamil Basics; Verapamil Ebewe; Verapamil HCl; Verapamil Henning; Verapamil Injection; Verapamil MSD; Verapamil NM; Verapamil NM Pharma; Verapamil Nordic; Verapamil PB; Verapamil Riker; Verapamil SR; Verapamil Verla; Verapamil-AbZ; Verapamilo; Verapamilum; Verapin; Verapress 240 SR; Verasal; Veratensin; CHEBI:9948,2014-12-24,1,,,,,,,,,
60-70-8,0,OMOP Exposome,Observation,Substance,Veratramine,"(3beta,23beta)-14,15,16,17-Tetradehydroveratraman-3,23-diol; CHEBI:CHEBI:9951",2014-12-24,1,,,,,,,,,
71-62-5,0,OMOP Exposome,Observation,Substance,Veratridine,,2014-12-24,1,,,,,,,,,
1929-77-7,0,OMOP Exposome,Observation,Substance,Vernolate,,2014-12-24,1,,,,,,,,,
3148-09-2,0,OMOP Exposome,Observation,Substance,Verrucarin A,,2014-12-24,1,,,,,,,,,
2290-11-1,0,OMOP Exposome,Observation,Substance,Verrucarin B,,2014-12-24,1,,,,,,,,,
4643-58-7,0,OMOP Exposome,Observation,Substance,Verrucarin J,,2014-12-24,1,,,,,,,,,
2198-92-7,0,OMOP Exposome,Observation,Substance,Verrucarol,,2014-12-24,1,,,,,,,,,
88389-71-3,0,OMOP Exposome,Observation,Substance,Verrucosidin,,2014-12-24,1,,,,,,,,,
12771-72-1,0,OMOP Exposome,Observation,Substance,Verruculogen,,2014-12-24,1,,,,,,,,,
114264-83-4,0,OMOP Exposome,Observation,Substance,Versutoxin,,2014-12-24,1,,,,,,,,,
P98155,0,OMOP Exposome,Observation,Substance,Very low-density lipoprotein receptor,,2024-09-14,1,,,,,,,,,
P63027,0,OMOP Exposome,Observation,Substance,Vesicle-associated membrane protein 2,,2024-09-14,1,,,,,,,,,
Q9H598,0,OMOP Exposome,Observation,Substance,Vesicular inhibitory amino acid transporter,,2024-09-14,1,,,,,,,,,
60643-86-9,0,OMOP Exposome,Observation,Substance,Vigabatrin,Sabrilex; gamma-Vinyl-gamma-aminobutyric acid; GVG; Vigabatrina; Vigabatrine; Vigabatrinum; gamma-Vinyl GABA; 4-Amino-5-hexenoic acid; Sabrilan; Sabril; CHEBI:63638,2014-12-24,1,,,,,,,,,
865-21-4,0,OMOP Exposome,Observation,Substance,Vinblastine,"Vinko; Vincaleukoblastine; Vinblastinum; Vinblastina; Vinblastin; Vinblasin; Velbe; Velbastin; Velban; Oncostin; Blastivin; Cytoblastin; Lemblastine; Xintoprost; Weibaoding; VLB; (2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine; CHEBI:27375",2014-12-24,1,,,,,,,,,
50471-44-8,0,OMOP Exposome,Observation,Substance,Vinclozolin,,2014-12-24,1,,,,,,,,,
57-22-7,0,OMOP Exposome,Observation,Substance,Vincristine,Vinces; Vincristin; Vincrstine; Vincrystine; Vinlon; Vinracine; Z-D-Val-Lys(Z)-OH; 22-Oxovincaleukoblastin; 22-Oxovincaleukoblastine; Alcavixin; Alcrist; Citomid; Cytocristin; Indole alkaloid; LCR; Leurocristine; Oncocristin; Marqibo; Vincrisin; VIN; VCR; Tevacristin; Sindovin; Vincristina; Vincristinum; Vincrisul; Oncovin; Oncrivin; CHEBI:28445,2014-12-24,1,,,,,,,,,
GIS1010216,0,OMOP Exposome,Observation,Substance,Vincristine Pathway,,2024-09-14,1,,,,,,,,,
53643-48-4,0,OMOP Exposome,Observation,Substance,Vindesine,3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; Vindesine Sulfate; Eldisine; Eldesine; Desacetylvinblastine Amide Sulfate; Desacetylvinblastine amide; 3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; CHEBI:36373,2014-12-24,1,,,,,,,,,
593-60-2,0,OMOP Exposome,Observation,Substance,Vinyl bromide,"Ethylene, bromo-, polymer; Polybromoethylene; Polyvinyl bromide; Polyvinylbromide; PVBR; Saytex VBR; Vinyl bromide polymer; Vinyl bromide solution; Vinyl bromide, inhibited; Vinyl-13C2 Bromide (gas); Vinylbromid; 1-Bromoethylene; Bromoethene; Bromoethene (9CI); Bromoethylene; Bromoethylene polymer; Bromure de vinyle; C2H3Br; Ethene, bromo-, homopolymer; Ethene, bromo-, homopolymer (9CI); Monobromoethylene; CHEBI:51311",2014-12-24,1,,,,,,,,,
75-01-4,0,OMOP Exposome,Observation,Substance,Vinyl chloride,Vinyl chloride monomer; VCM; VC; Refrigerant-1140; Monovinyl chloride; Monochloroethylene; Chloroethene; Monochloroethene; Chloroethylene; CHEBI:28509,2014-12-24,1,,,,,,,,,
GIS1010217,0,OMOP Exposome,Observation,Substance,Viperotoxin,,2024-09-14,1,,,,,,,,,
GIS1010224,0,OMOP Exposome,Observation,Substance,Vipoxin,,2024-09-14,1,,,,,,,,,
GIS1010258,0,OMOP Exposome,Observation,Substance,Vitamin,,2024-09-14,1,,,,,,,,,
68-26-8,0,OMOP Exposome,Observation,Substance,Vitamin A,"(2e,4e,6e,8e)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol; Vitamin A1; (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; All-trans-Retinol; all-trans-retinyl alcohol; trans-Retinol; all-trans-vitamin A alcohol; Alphalin; b-Retinol; beta-Retinol; Chocola a; Vitamin a; Retinol; CHEBI:17336",2014-12-24,1,,,,,,,,,
GIS1010292,0,OMOP Exposome,Observation,Substance,Vitamin B Complex,,2024-09-14,1,,,,,,,,,
GIS1010291,0,OMOP Exposome,Observation,Substance,Vitamin B6 Metabolism,,2024-09-14,1,,,,,,,,,
GIS1010293,0,OMOP Exposome,Observation,Substance,Vitamin D,,2024-09-14,1,,,,,,,,,
Q6VVX0,0,OMOP Exposome,Observation,Substance,Vitamin D 25-hydroxylase,,2024-09-14,1,,,,,,,,,
P02774,0,OMOP Exposome,Observation,Substance,Vitamin D-binding protein,,2024-09-14,1,,,,,,,,,
P11473,0,OMOP Exposome,Observation,Substance,Vitamin D3 receptor,,2024-09-14,1,,,,,,,,,
GIS1010294,0,OMOP Exposome,Observation,Substance,Vitamin D3 Receptor inhibitor,,2024-09-14,1,,,,,,,,,
GIS1010295,0,OMOP Exposome,Observation,Substance,Vitamin K,,2024-09-14,1,,,,,,,,,
GIS1010296,0,OMOP Exposome,Observation,Substance,Vitamin K Antagonist,,2024-09-14,1,,,,,,,,,
Q9BQB6,0,OMOP Exposome,Observation,Substance,Vitamin K epoxide reductase complex subunit 1,,2024-09-14,1,,,,,,,,,
Q8N0U8,0,OMOP Exposome,Observation,Substance,Vitamin K epoxide reductase complex subunit 1-like protein 1,,2024-09-14,1,,,,,,,,,
GIS1010297,0,OMOP Exposome,Observation,Substance,Vitamin K Metabolism,,2024-09-14,1,,,,,,,,,
P38435,0,OMOP Exposome,Observation,Substance,Vitamin K-dependent gamma-carboxylase,,2024-09-14,1,,,,,,,,,
P04070,0,OMOP Exposome,Observation,Substance,Vitamin K-dependent protein C,,2024-09-14,1,,,,,,,,,
P07225,0,OMOP Exposome,Observation,Substance,Vitamin K-dependent protein S,,2024-09-14,1,,,,,,,,,
P22891,0,OMOP Exposome,Observation,Substance,Vitamin K-dependent protein Z,,2024-09-14,1,,,,,,,,,
GIS1010298,0,OMOP Exposome,Observation,Substance,Volatile Isocyanate,,2024-09-14,1,,,,,,,,,
P21796,0,OMOP Exposome,Observation,Substance,Voltage-dependent anion-selective channel protein 1,,2024-09-14,1,,,,,,,,,
P45880,0,OMOP Exposome,Observation,Substance,Voltage-dependent anion-selective channel protein 2,,2024-09-14,1,,,,,,,,,
Q9Y277,0,OMOP Exposome,Observation,Substance,Voltage-dependent anion-selective channel protein 3,,2024-09-14,1,,,,,,,,,
BE0004902,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel,,2024-09-14,1,,,,,,,,,
Q06432,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-1 subunit,,2024-09-14,1,,,,,,,,,
Q9Y698,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-2 subunit,,2024-09-14,1,,,,,,,,,
O60359,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-3 subunit,,2024-09-14,1,,,,,,,,,
Q9UBN1,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-4 subunit,,2024-09-14,1,,,,,,,,,
Q9UF02,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-5 subunit,,2024-09-14,1,,,,,,,,,
Q9BXT2,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-6 subunit,,2024-09-14,1,,,,,,,,,
P62955,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-7 subunit,,2024-09-14,1,,,,,,,,,
Q8WXS5,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-8 subunit,,2024-09-14,1,,,,,,,,,
Q8WXS4,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel gamma-like subunit,,2024-09-14,1,,,,,,,,,
P54289,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel subunit alpha-2/delta-1,,2024-09-14,1,,,,,,,,,
Q9NY47,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel subunit alpha-2/delta-2,,2024-09-14,1,,,,,,,,,
Q8IZS8,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel subunit alpha-2/delta-3,,2024-09-14,1,,,,,,,,,
Q7Z3S7,0,OMOP Exposome,Observation,Substance,Voltage-dependent calcium channel subunit alpha-2/delta-4,,2024-09-14,1,,,,,,,,,
Q13936,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit alpha-1C,,2024-09-14,1,,,,,,,,,
Q01668,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit alpha-1D,,2024-09-14,1,,,,,,,,,
O60840,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit alpha-1F,,2024-09-14,1,,,,,,,,,
Q13698,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit alpha-1S,,2024-09-14,1,,,,,,,,,
Q02641,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit beta-1,,2024-09-14,1,,,,,,,,,
Q6TME4,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit beta-1 splice variant CavB1d,,2024-09-14,1,,,,,,,,,
Q08289,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit beta-2,,2024-09-14,1,,,,,,,,,
P54284,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit beta-3,,2024-09-14,1,,,,,,,,,
O00305,0,OMOP Exposome,Observation,Substance,Voltage-dependent L-type calcium channel subunit beta-4,,2024-09-14,1,,,,,,,,,
Q00975,0,OMOP Exposome,Observation,Substance,Voltage-dependent N-type calcium channel subunit alpha-1B,,2024-09-14,1,,,,,,,,,
O00555,0,OMOP Exposome,Observation,Substance,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,,2024-09-14,1,,,,,,,,,
Q15878,0,OMOP Exposome,Observation,Substance,Voltage-dependent R-type calcium channel subunit alpha-1E,,2024-09-14,1,,,,,,,,,
O43497,0,OMOP Exposome,Observation,Substance,Voltage-dependent T-type calcium channel subunit alpha-1G,,2024-09-14,1,,,,,,,,,
O95180,0,OMOP Exposome,Observation,Substance,Voltage-dependent T-type calcium channel subunit alpha-1H,,2024-09-14,1,,,,,,,,,
Q9P0X4,0,OMOP Exposome,Observation,Substance,Voltage-dependent T-type calcium channel subunit alpha-1I,,2024-09-14,1,,,,,,,,,
GIS1010299,0,OMOP Exposome,Observation,Substance,Voltage-Gated Sodium Channel Blocker,,2024-09-14,1,,,,,,,,,
81-81-2,0,OMOP Exposome,Observation,Substance,Warfarin,Co-rax; Zoocoumarin; Warfarin sodium; Warfant; Waran; Vampirinip III; Vampirinip II; Twin light rat away; Tox-hid; Temus w; Spray-trol brand roden-trol; Sorexa plus; Solfarin; Sewarin; Sakarat; Rough and ready mouse mix; Rough & ready mouse mix; Rosex; Rodex blox; Rodex; Rodafarin c; Rodafarin; Ro-deth; RCR grey squirrel killer concentrate; RAX; Rattunal; Rattentraenke; Rattenstreupulver new schacht; Rattenstreupulver neu schacht; Ratten-koederrohr; Rats-no-more; Ratron g; Ratron; Ratoxin; Ratox; Ratorex; Rat-trol; Rat-ola; Rat-O-cide no. 2; Rat-O-cide #2; Rat-mix; 3-(Acetonylbenzyl)-4-hydroxycoumarin; 3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin; (S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; 1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone; 200 Coumarin; Rat-kill; Rat-a-way; Rat-gard; Rat-beta-gon; Rat-b-gon; Rat and mice bait; Rat & mice bait; Prothromadin; Place-pax; Mouse pak; Maveran; Martin'S mar-frin; Marevan; Mar-frin; Maag rattentod cum; Liqua-tox; Lawarin; Latka 42; Kypfarin; Kumatox; Kumadu; Kumader; Killgerm sewarin p; Jantoven; Frass-ratron; Fasco fascrat powder; Eastern states duocide; DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin; Dicusat e; Dethnel; Dethmor; delta-Con; D-Con; Cov-R-tox; Coumefene; Rat-alpha-way; Coumarins; Coumaphene; Coumaphen; Coumafene; Coumafen; Coumadin; Compound 42; Brumolin; Athrombine-k; Athrombin-k; Arab rat deth; Arab rat death; 4oh-coumarin deriv.; 4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine; 4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine; 4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one; 4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin; 4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine; 4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin; 4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine; 3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin; (phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin; (phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine; 3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin; 3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin; CHEBI:10033,2014-12-24,1,,,,,,,,,
GIS1010300,0,OMOP Exposome,Observation,Substance,Waste Product,,2024-09-14,1,,,,,,,,,
12185-10-3,0,OMOP Exposome,Observation,Substance,White Phosphorus,Phosphorus; White phosphorus; Willie Pete; Willy Pete; WP; Yellow phosphorus; Tetraphosphorus; CHEBI:35895,2014-12-24,1,,,,,,,,,
GIS1010301,0,OMOP Exposome,Observation,Substance,Wnt signaling pathway,,2024-09-14,1,,,,,,,,,
GIS1010302,0,OMOP Exposome,Observation,Substance,Wolman disease,,2024-09-14,1,,,,,,,,,
P17861,0,OMOP Exposome,Observation,Substance,X-box-binding protein 1,,2024-09-14,1,,,,,,,,,
69-89-6,0,OMOP Exposome,Observation,Substance,Xanthine,"2,6(1,3)-Purinedion; 2,6-Dioxopurine; 3,7-Dihydro-1H-purine-2,6-dione; Xanthin; Xanthic oxide; Purine-2,6-diol; Purine-2,6(1H,3H)-dione; Pseudoxanthine; Isoxanthine; Dioxopurine; 9H-Purine-2,6-diol; 9H-Purine-2,6(1H,3H)-dione; 3,7-Dihydropurine-2,6-dione; 1H-Purine-2,6-diol; 2,6-Dihydroxypurine; CHEBI:17712",2014-12-24,1,,,,,,,,,
GIS1010303,0,OMOP Exposome,Observation,Substance,Xanthine Dehydrogenase Deficiency (Xanthinuria),,2024-09-14,1,,,,,,,,,
P47989,0,OMOP Exposome,Observation,Substance,Xanthine dehydrogenase/oxidase,,2024-09-14,1,,,,,,,,,
GIS1010304,0,OMOP Exposome,Observation,Substance,Xanthinuria type I,,2024-09-14,1,,,,,,,,,
GIS1010305,0,OMOP Exposome,Observation,Substance,Xanthinuria type II,,2024-09-14,1,,,,,,,,,
1685-91-2,0,OMOP Exposome,Observation,Substance,Xanthomegnin,,2014-12-24,1,,,,,,,,,
580-74-5,0,OMOP Exposome,Observation,Substance,Xantocillin,,2014-12-24,1,,,,,,,,,
584-94-1,0,OMOP Exposome,Observation,Substance,"xi-2,3-Dimethylhexane",,2014-12-24,1,,,,,,,,,
2425-10-7,0,OMOP Exposome,Observation,Substance,Xylylcarb,"3,4-Dimethylphenol methylcarbamate; Methylcarbamic acid 3,4-xylyl ester; 3,4-Xylyl methylcarbamate; 3,4-Dimethylphenyl N-methylcarbamate; Meobal; Carbamic acid, N-methyl-, (3,4-dimethylphenyl) ester; Carbamic acid, methyl-, 3,4-xylyl ester; 3,4-Dimethylphenyl methylcarbamate; Phenol, 3,4-dimethyl-, methylcarbamate; CHEBI:35048",2014-12-24,1,,,,,,,,,
13759-89-2,0,OMOP Exposome,Observation,Substance,Ytterbium(III) bromide,,2014-12-24,1,,,,,,,,,
107539-20-8,0,OMOP Exposome,Observation,Substance,Yttrium barium copper oxide,,2014-12-24,1,,,,,,,,,
12255-48-0,0,OMOP Exposome,Observation,Substance,Yttrium(III) arsenide,,2014-12-24,1,,,,,,,,,
13469-98-2,0,OMOP Exposome,Observation,Substance,Yttrium(III) bromide,,2014-12-24,1,,,,,,,,,
7481-89-2,0,OMOP Exposome,Observation,Substance,Zalcitabine,"4-amino-1-(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-ylpyrimidin-2(1H)-one; 2',3'-Dideoxycytidine; Dideoxycytidine; HIVID; DDCYD; DDC; CHEBI:10101",2014-12-24,1,,,,,,,,,
151319-34-5,0,OMOP Exposome,Observation,Substance,Zaleplon,"Zalaplon; Sonata; DEA No. 2781; 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide; CHEBI:10102",2014-12-24,1,,,,,,,,,
GIS1010306,0,OMOP Exposome,Observation,Substance,Zellweger Syndrome,,2024-09-14,1,,,,,,,,,
26538-44-3,0,OMOP Exposome,Observation,Substance,Zeranol,,2014-12-24,1,,,,,,,,,
30516-87-1,0,OMOP Exposome,Observation,Substance,Zidovudine,AZT; Zidovudinum; Zidovudin; ZDV; Retrovir; Azidothymidine; CHEBI:10110,2014-12-24,1,,,,,,,,,
7440-66-6,0,OMOP Exposome,Observation,Substance,Zinc,Zinc(2+); Zinc (II) cation; Zinc ion; Zinc ion (Zn2+); Zinc(2+) ion; Zinc(II); Zn; Zn(2+); Zn2+; CHEBI:30185,2014-12-24,1,,,,,,,,,
557-34-6,0,OMOP Exposome,Observation,Substance,Zinc acetate,"Acetic acid, zinc(II) salt; Acetic acid, zinc salt; Zinc diacetate; Zinc acetic acid; Dicarbomethoxyzinc; CHEBI:62984",2014-12-24,1,,,,,,,,,
14639-97-5,0,OMOP Exposome,Observation,Substance,Zinc ammonium chloride,,2014-12-24,1,,,,,,,,,
7783-24-6,0,OMOP Exposome,Observation,Substance,Zinc ammonium sulfate,,2014-12-24,1,,,,,,,,,
12039-35-9,0,OMOP Exposome,Observation,Substance,Zinc antimonide,,2014-12-24,1,,,,,,,,,
13464-44-3,0,OMOP Exposome,Observation,Substance,Zinc arsenate,,2014-12-24,1,,,,,,,,,
12006-40-5,0,OMOP Exposome,Observation,Substance,Zinc arsenide,,2014-12-24,1,,,,,,,,,
10326-24-6,0,OMOP Exposome,Observation,Substance,Zinc arsenite,,2014-12-24,1,,,,,,,,,
39413-47-3,0,OMOP Exposome,Observation,Substance,Zinc beryllium silicate,,2014-12-24,1,,,,,,,,,
1332-07-6,0,OMOP Exposome,Observation,Substance,Zinc borate,,2014-12-24,1,,,,,,,,,
7699-45-8,0,OMOP Exposome,Observation,Substance,Zinc bromide,,2014-12-24,1,,,,,,,,,
68583-45-9,0,OMOP Exposome,Observation,Substance,Zinc cadmium sulfide,,2014-12-24,1,,,,,,,,,
3486-35-9,0,OMOP Exposome,Observation,Substance,Zinc carbonate,,2014-12-24,1,,,,,,,,,
10361-95-2,0,OMOP Exposome,Observation,Substance,Zinc chlorate,,2014-12-24,1,,,,,,,,,
7646-85-7,0,OMOP Exposome,Observation,Substance,Zinc chloride,Butter of zinc; ZnCl2; Zintrace; Zinkchloride; Zine dichloride; Zinctrace; Zinco (cloruro di); Zinco; Zinc(II) chloride; Zinc muriate; Zinc dichloride; Zinc butter; Tinning flux; Hydrochloric acid zinc salt (2:1); Hexite; Dichlorozinc; CHEBI:49976,2014-12-24,1,,,,,,,,,
13530-65-9,0,OMOP Exposome,Observation,Substance,Zinc chromate,,2014-12-24,1,,,,,,,,,
15930-94-6,0,OMOP Exposome,Observation,Substance,Zinc chromate hydroxide,,2014-12-24,1,,,,,,,,,
GIS1010307,0,OMOP Exposome,Observation,Substance,Zinc Compound,,2024-09-14,1,,,,,,,,,
557-21-1,0,OMOP Exposome,Observation,Substance,Zinc cyanide,,2014-12-24,1,,,,,,,,,
14018-95-2,0,OMOP Exposome,Observation,Substance,Zinc dichromate,,2014-12-24,1,,,,,,,,,
14324-55-1,0,OMOP Exposome,Observation,Substance,Zinc diethyldithiocarbamate,,2014-12-24,1,,,,,,,,,
137-30-4,0,OMOP Exposome,Observation,Substance,Zinc dimethyldithiocarbamate,,2014-12-24,1,,,,,,,,,
7779-86-4,0,OMOP Exposome,Observation,Substance,Zinc dithionite,,2014-12-24,1,,,,,,,,,
19210-06-1,0,OMOP Exposome,Observation,Substance,Zinc dithiophosphate,,2014-12-24,1,,,,,,,,,
7783-49-5,0,OMOP Exposome,Observation,Substance,Zinc fluoride,,2014-12-24,1,,,,,,,,,
557-41-5,0,OMOP Exposome,Observation,Substance,Zinc formate,,2014-12-24,1,,,,,,,,,
14018-82-7,0,OMOP Exposome,Observation,Substance,Zinc hydride,,2014-12-24,1,,,,,,,,,
20427-58-1,0,OMOP Exposome,Observation,Substance,Zinc hydroxide,,2014-12-24,1,,,,,,,,,
10139-47-6,0,OMOP Exposome,Observation,Substance,Zinc iodide,,2014-12-24,1,,,,,,,,,
2452-01-9,0,OMOP Exposome,Observation,Substance,Zinc laurate,,2014-12-24,1,,,,,,,,,
13767-32-3,0,OMOP Exposome,Observation,Substance,Zinc molybdate,,2014-12-24,1,,,,,,,,,
7779-88-6,0,OMOP Exposome,Observation,Substance,Zinc nitrate,,2014-12-24,1,,,,,,,,,
557-07-3,0,OMOP Exposome,Observation,Substance,Zinc oleate,,2014-12-24,1,,,,,,,,,
1314-13-2,0,OMOP Exposome,Observation,Substance,Zinc oxide,"Actox 14; Actox 216; Akro-zinc Bar 85; Akro-zinc bar 90; Amalox; Azo-55TT; Azo-66TT; Azo-77TT; Azodox; Azodox-55; Azodox-55TT; Blanc de zinc; C-Weiss 8; C.I. Pigment white 4; Cadox XX 78; Canfelzo; Chinese white; CI Pigment white 4; Colloidal zinc oxide; Decelox; Dense zinc oxide; Denzox; Electox 2500; Electrox; Electrox 2500; Emanay zinc oxide; EMAR; Entrox; Extrox; Felling zinc oxide; Felzodox; Finex-25; Flores de zinci; Flowers of zinc; Fotofax; Garozinc; GIAP 10; Green seal-8; Hubbuck'S white; Hubbucks white; K-Zinc; Kadox 15; Kadox 72; Kadox-25; Ken-zinc; Leaded zinc oxide; Low purity zinc oxide; Methicone; Microx; No-genol; Nogenol; Octocure 553; Outmine; Oxide, zinc; Ozide; OZLO; Paste, lassar's; Permanent white; Philosopher'S wool; Photozinc; Pigment white 4; Powder base 900; Protox 166; Protox 168; Protox 169; Protox type 166; Protox type 167; Protox type 168; Protox type 169; Protox type 267; Protox type 268; Red Seal 9; Rubox; Rvpaque; Snow white; Tertiary zinc oxide; Unichem zo; Vandem vac; Vandem voc; Vandem VPC; Vita zinc; White seal-7; Zinc monoxide; Zinc oxides; Zinc white; Zinca 20; Zinci oxicum; Zinci oxydum; Zincite; Zincoid; Zink white; Zinkoxid; Zinox; Ziradryl; ZnO; Activox; Activox b; Actox 16; CHEBI:36560",2014-12-24,1,,,,,,,,,
23414-72-4,0,OMOP Exposome,Observation,Substance,Zinc permanganate,,2014-12-24,1,,,,,,,,,
1314-22-3,0,OMOP Exposome,Observation,Substance,Zinc peroxide,,2014-12-24,1,,,,,,,,,
127-82-2,0,OMOP Exposome,Observation,Substance,Zinc phenolsulfate,,2014-12-24,1,,,,,,,,,
7779-90-0,0,OMOP Exposome,Observation,Substance,Zinc phosphate,,2014-12-24,1,,,,,,,,,
1314-84-7,0,OMOP Exposome,Observation,Substance,Zinc phosphide,,2014-12-24,1,,,,,,,,,
557-28-8,0,OMOP Exposome,Observation,Substance,Zinc propionate,,2014-12-24,1,,,,,,,,,
13463-41-7,0,OMOP Exposome,Observation,Substance,Zinc pyrithione,"Pyrithione zinc; Zinc pyridinethione; Zincon dandruff shampoo; ZNPT; ZPT; Zinc pyridine-2-thiol-1-oxide; (T-4)-Bis(1-hydroxy-2(1H)-pyridinethionato-O,S)zinc; 2(1H)-Pyridinethione, 1-hydroxy-, zinc complex; 2-Mercaptopyridine 1-oxide zinc salt; 2-Mercaptopyridine-1-oxide, zinc salt; Zinc bis(2-pyridylthio)-N-oxide; 2-Pyridinethiol-1-oxide, zinc salt; Biocut ZP; Bis(1-hydroxy-2(1H)-pyridinethionato)zinc; Bis(1-hydroxy-2-(1H)-pyridinethionato)zinc; Bis(2-pyridinethiol-1-oxide)zinc; Bis(2-pyridylthio)zinc 1,1'-dioxide; Breck one dandruff shampoo; Danex; Evafine P 50; Finecide ZPT; Zinc 2-pyridinethiol-1-oxide; Zinc 1-hydroxypyridine-2-thione; Zinc 1-hydroxy-2-pyridinethione; Head and shoulders; Hokucide ZPT; Niccanon SKT; Zinc - pyrion; Zinc omadine; Zinc PT; Zinc pyrethion; Zinc pyridine-2-thiol 1-oxide; Zinc 2-mercaptopyridine N-oxide; Zinc 2-pyridinethiol 1-oxide; Wella crisan; Vancide ZP; Omadine zinc; Pyrithion-zink; Vancide p; Sebulon shampoo; Tomicide Z 50; Top brass; CHEBI:32076",2014-12-24,1,,,,,,,,,
7446-26-6,0,OMOP Exposome,Observation,Substance,Zinc pyrophosphate,,2014-12-24,1,,,,,,,,,
1315-09-9,0,OMOP Exposome,Observation,Substance,Zinc selenide,,2014-12-24,1,,,,,,,,,
13597-65-4,0,OMOP Exposome,Observation,Substance,Zinc silicate,,2014-12-24,1,,,,,,,,,
16871-71-9,0,OMOP Exposome,Observation,Substance,Zinc silicofluoride,,2014-12-24,1,,,,,,,,,
557-05-1,0,OMOP Exposome,Observation,Substance,Zinc stearate,,2014-12-24,1,,,,,,,,,
7733-02-0,0,OMOP Exposome,Observation,Substance,Zinc sulfate,"Zincosite; Zincomed; Zincate; Zincaps; Zinc(II) sulphate; Zinc(II) sulfate; Zinc(2+) sulphate; Orazinc; Optraex; Zinc sulphate (1:1); Zinc sulphate anhydrous; Solvezink; Optised; Verazinc; Visine-ac; White copperas; Op-thal-zin; Nu-z; Prefrin-z; Solvazinc; Solvezinc; Neozin; White vitriol; Medizinc; Kreatol; Complexonat; Bufopto zinc sulphate; Bufopto zinc sulfate; Bonazen; Zinc sulphate; Z-Span; Zinc sulfate (1:1); ZnSO4; Zinkosite; Zinc sulphate, heptahydrate; Zinc sulphic acid; Sulfate, zinc; Zinc vitriol; Sulfuric acid zinc salt; Sulfuric acid zinc salt (1:1); Zinc sulfic acid; Zinc sulfate, heptahydrate; Sulfuric acid, zinc salt; Zinc sulfate anhydrous; Zinc(2+) sulfate; Zinklet; Zink-gro; Sulfuric acid, zinc salt (1:1); Zincteral; CHEBI:35176",2014-12-24,1,,,,,,,,,
1314-98-3,0,OMOP Exposome,Observation,Substance,Zinc sulfide,,2014-12-24,1,,,,,,,,,
1315-11-3,0,OMOP Exposome,Observation,Substance,Zinc telluride,,2014-12-24,1,,,,,,,,,
54010-75-2,0,OMOP Exposome,Observation,Substance,Zinc trifluoromethanesulfonate,,2014-12-24,1,,,,,,,,,
4468-02-04,0,OMOP Exposome,Observation,Substance,Zinc(II) gluconate,,2014-12-24,1,,,,,,,,,
12122-67-7,0,OMOP Exposome,Observation,Substance,Zineb,"Crystal zineb; Devizeb; Deikusol; Daisen; Cynkotox; Crittox; Clortocaffaro; Zinc ethylene bisdithiocarbamate; Zinc ethylene-1,2-bisdithiocarbamate; Zinc ethylenebis(dithiocarbamate) (polymeric); Zinc ethylenebisdithiocarbamate; Zinc ethylenebisthiocarbamate; Zinc n,n'-ethylenebisdithiocarbamate; Zincethylenebisdithiocarbamate; Zineb 75; Cineb; Chem zineb; Carbadine; Bombardier; Blizene; Blightox; Asporum; Zineb 75 WP; Zineb 80; Zineb-R; Zinosan; Zipar; ethane-1,2-diylbiscarbamodithioato(2-)-kappaSzinc; Aspor; Aphytora; Aaphytora; 1,2-Ethanediylbiscarbamodithioic acid, zinc complex; 1,2-Ethanediylbis(carbamodithioato) (2-)-S,S'-zinc; ((1,2-Ethanediylbis(carbamodithioato))(2-))zinc; Tiazin; Thionic m; Thiodow; Tanazon; Taloberg; Sperlox-z; Polyram z; Pilzol SZ; Phytox; Perozine 75B; Perozine; Perozin; Perosin 75B; Perosin; Parzate zineb; Parzate c; Parzate; Pamosol 2 forte; Novozir N 50; Novozir n; Novozir; Novozin N 50; Novosir n; Micide 55; Micide; Metiram-zinc; Lonacol; Lirotan; Lipotan; Kypzin; Kupratsin; Hexathane; Funjeb; Fungo-pulvit; Fitodith 80; Ethylenebis(dithiocarbamic acid), zinc salt; Ethylenebis(dithiocarbamato)zinc; Ditiamina; Dithane Z-78; Dithane z; Dithane 65; Discon-z; Discon; Dipher; Tiezene; Tritoftorol; Tsineb; Unizeb; Zebenide; Zebtox; Zidan; zinc ethane-1,2-diylbis(dithiocarbamate); Zinc ethane-1,2-diyldicarbamodithioate; CHEBI:52498",2014-12-24,1,,,,,,,,,
1377-25-8,0,OMOP Exposome,Observation,Substance,Zirconium(IV) bromide,,2014-12-24,1,,,,,,,,,
118072-93-8,0,OMOP Exposome,Observation,Substance,Zoledronate,Aclasta; (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; (1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; Reclast; ZOL; Zoledronic acid; Zometa; Zometa Concentrate; CHEBI:46557,2014-12-24,1,,,,,,,,,
GIS1010308,0,OMOP Exposome,Observation,Substance,Zoledronate Pathway,,2024-09-14,1,,,,,,,,,
139264-17-8,0,OMOP Exposome,Observation,Substance,Zolmitriptan,"Zomig; AscoTop; 311C90; (S)-4-({3-2-(dimethylamino)ethyl-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one; Zomitan; Zolmitriptanum; Zolmit; zolmiptriptan; Zomigoro; Zolmiles; Nomi; Zomigon; ZMT; 4-3-(2-Dimethylaminoethyl)-1H-indol-5-ylmethyloxazolidin-2-one; Zomig Rapimelt; CHEBI:10124",2014-12-24,1,,,,,,,,,
82626-48-0,0,OMOP Exposome,Observation,Substance,Zolpidem,"Stilnox CR; Stilnox; Dormizol; Bikalm; Zoltis; Nottem; Stilnoct; Nimadorm; Nasen; N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide; Zolpimist; Ambien CR; Zolsana; Ambien; Myslee; Ivedal; Ivadal; Intermezzo; Hypnogen; Edluar; Zolpidemum; Zolpidem tartrate; Zolpidem Ambien; Adormix; CHEBI:10125",2014-12-24,1,,,,,,,,,
68291-97-4,0,OMOP Exposome,Observation,Substance,Zonisamide,"Exceglan; Excegram; Excegran; Zonegran; Zonisamida; Zonisamidum; 3-(Sulfamoylmethyl)-1,2-benzisoxazole; BenzoDisoxazol-3-yl-methanesulfonamide; 1,2-Benzisoxazole-3-methanesulfonamide; CHEBI:10127",2014-12-24,1,,,,,,,,,
43200-80-2,0,OMOP Exposome,Observation,Substance,Zopiclone,"6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo3,4-bpyrazin-5-yl 4-methyl-1-piperazinecarboxylate; (\u00b1)-zopiclone; (+-)-zopiclone; Zopiclonum; Zopiclona; Zimovane; Rhovane; Imovane; Amoban; CHEBI:32315",2014-12-24,1,,,,,,,,,
156052-68-5,0,OMOP Exposome,Observation,Substance,Zoxamide,,2014-12-24,1,,,,,,,,,
GIS1010309,0,OMOP Exposome,Observation,Substance,Zymogen Granule,,2024-09-14,1,,,,,,,,,